## NCanno Version    : 1.13
## BedAnno Version   : 1.15
## Configure File    : /products/repos/prod/Akso/BNC_v2/BNC/program/NoahCare/config/nc_cd3/anno/config_htpart.pl
## Input File Format : vcf
## Format Options    : offline, single MODE
## DB Version File   : /products/repos/prod/Akso/BNC_v2/BNC/program/NoahCare/config/db_version.list
##
#Chr	Start	Stop	MapLoc	InExcel	SampleID	NbGID	Ref	VarType	Call	Flank	Zygosity	A.Depth	A.Ratio	PhasedGID	A.Index	RepeatTag	Filter	MIM Gene ID	MIM Stat	MIM Pheno IDs	MIM Inheritance	CGD Condition	CGD Inheritance	CGD Allelic Condition	CGD Manifestation Categories	CGD Intervention Categories	CGD References	TestCode	EntrezGeneID	Gene Symbol	FuncRegion	ExIn_ID	pfamName	pfamId	Function	Transcript	Protein	Strand	Primary	cHGVS	pHGVS	CodonChange	PolarChange	MutationName	dbSNP Note	dbSNP Allele Count	dbSNP Allele Freq	dbSNP Mul Tag	1000G EAS AF	1000G AF	ESP6500 AC	ESP6500 AF	ExAC Filter	ExAC EAS HomoAlt Count	ExAC EAS AC	ExAC EAS AF	ExAC HomoAlt Count	ExAC AC	ExAC AF	GAD EAS HomoAlt Count	GAD EAS AC	GAD EAS AF	GAD HomoAlt Count	GAD AC	GAD AF	rsID	Panel ID	Panel AlleleCount	Panel AlleleFreq	PhyloP Primates	PhyloP Vertebrates	PhyloP Placental Mammals	Ens SIFT Score	Ens Polyphen2HumVar Score	Ens Polyphen2HumDiv Score	Ens Condel Score	Ens Condel Pred	Cosmic MutName	Cosmic Site	Cosmic Histology	Cosmic MutStat	Cosmic ID	HGMD ID	HGMD MutName	HGMD Disease	HGMD pmID	HGMD Pred	ClinVar SuspectReason	ClinVar ID	ClinVar RevStat	ClinVar Significant	AutoInterpStatus
1	3334482	3334483	1p36.32	0	normal	.	A	ref	A	CC.CC	het-alt	229	0.85	.	1	.	DUBIOUS	605557	P	615373(MK)	NN	Cardiomyopathy, dilated, ILL; Left ventricular noncompaction 8	AD	.	Cardiovascular	Cardiovascular	23768516|21551322|18506004	.	63976	PRDM16	C11	EX11	.	.	no-change	NM_022114.3	NP_071397.3	+	Y	c.2783A=	.	.	.	NM_022114.3(PRDM16): c.2783A=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4025	0.934900	0.460	3.124	1.853	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	3334482	3334483	1p36.32	1	normal	.	A	snv	C	CC.CC	het-ref	40	0.15	.	2	.	DUBIOUS	605557	P	615373(MK)	NN	Cardiomyopathy, dilated, ILL; Left ventricular noncompaction 8	AD	.	Cardiovascular	Cardiovascular	23768516|21551322|18506004	.	63976	PRDM16	C11	EX11	.	.	missense	NM_022114.3	NP_071397.3	+	Y	c.2783A>C	p.H928P | p.His928Pro	CAC=>CCC	P+=>NP	NM_022114.3(PRDM16): c.2783A>C (p.H928P)	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	1	5.98587e-05	0	3	1.24673e-05	.	.	4025	0.064800	0.460	3.124	1.853	0.3	0.015	0.006	0.029	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
1	3638673	3638674	1p36.32	0	normal	.	C	ref	C	AC.GC	het-alt	243	0.48	.	1	.	PASS	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	C4	EX5	P53 DNA-binding domain	PF00870.13	no-change	NM_005427.3	NP_005418.1	+	Y	c.519C=	.	.	.	NM_005427.3(TP73): c.519C=	;maf-5-some-pop	125058	0.192902	U	0.5268	0.736022	13000	0.150538	PASS	-1099	8606	0.481989	3057	120050	0.189938	.	.	.	.	.	.	rs1801174	.	4024	0.513700	-0.424	-0.240	-0.983	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	3638673	3638674	1p36.32	1	normal	.	C	snv	T	AC.GC	het-ref	261	0.52	.	2	.	PASS	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	C4	EX5	P53 DNA-binding domain	PF00870.13	coding-synon	NM_005427.3	NP_005418.1	+	Y	c.519C>T	p.(T173=) | p.(Thr173=)	ACC=>ACT	.	NM_005427.3(TP73): c.519C>T (p.(T173=))	;maf-5-some-pop	125058	0.807097	U	0.5268	0.736022	13000	0.849462	PASS	1130	8606	0.518011	40280	120050	0.810062	2228	8829	5.13254e-01	81508	197470	8.05067e-01	rs1801174	.	4024	0.486300	-0.424	-0.240	-0.983	.	.	.	.	.	ENST00000378295: c.519C>T (p.T173T)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	3997495	.	.	.	.	.	.	.	.	.	Likely Benign
1	3640084	3640085	1p36.32	0	nullSample	.	C	ref	C	GT.GG	homo-ref	.	.	.	0	.	.	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	IC5	IVS6	.	.	no-change	NM_005427.3	NP_005418.1	+	Y	c.732+52C=	.	.	.	NM_005427.3(TP73): c.732+52C=	MixedObserved,SingleClassQuadAllelic;maf-5-some-pop,rs-cluster-nonoverlapping-alleles|MixedObserved;	72762|52841	0.233721|0.999962	U	0.5407	0.736621	7220	0.161080	PASS	.	4682	0.453439	2000	67754	0.231647	.	.	.	.	.	.	rs6424091|rs751441991	.	1866	0.698300	-3.728	-4.180	-4.252	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	3640084	3640085	1p36.32	0	normal	.	C	snv	G	GT.GG	hom-alt	23	1.00	.	0	.	PASS	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	IC5	IVS6	.	.	intron	NM_005427.3	NP_005418.1	+	Y	c.732+52C>G	.	.	.	NM_005427.3(TP73): c.732+52C>G	MixedObserved,SingleClassQuadAllelic;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	72762	0.765551	U	0.5407	0.736621	7220	0.838920	PASS	645	4682	0.539727	20151	67754	0.767689	1870	7306	5.37048e-01	55452	143659	7.65414e-01	rs6424091	.	1866	0.284000	-3.728	-4.180	-4.252	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	3644348	3644349	1p36.32	0	normal	.	A	ref	A	CC.GG	het-alt	281	0.56	.	1	.	PASS	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	IC7	IVS8	.	.	no-change	NM_005427.3	NP_005418.1	+	Y	c.985+15A=	.	.	.	NM_005427.3(TP73): c.985+15A=	;maf-5-some-pop,maf-5-all-pops	18862	0.295674	U	0.3353	0.64996	12056	0.212177	PASS	-69	568	0.619718	482	13854	0.276021	.	.	.	.	.	.	rs2181486	.	4024	0.697300	-0.480	-0.807	-0.434	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	3644348	3644349	1p36.32	1	normal	.	A	snv	G	CC.GG	het-ref	220	0.44	.	2	.	PASS	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	IC7	IVS8	.	.	intron	NM_005427.3	NP_005418.1	+	Y	c.985+15A>G	.	.	.	NM_005427.3(TP73): c.985+15A>G	;maf-5-some-pop,maf-5-all-pops	18862	0.704326	U	0.3353	0.64996	12056	0.787823	PASS	39	568	0.380282	3585	13854	0.723979	514	3134	3.16310e-01	30974	86373	6.89583e-01	rs2181486	.	4024	0.302700	-0.480	-0.807	-0.434	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	3644373	3644374	1p36.32	0	normal	.	A	ref	A	GG.GA	het-alt	211	0.54	.	1	.	PASS	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	IC7	IVS8	.	.	no-change	NM_005427.3	NP_005418.1	+	Y	c.985+40A=	.	.	.	NM_005427.3(TP73): c.985+40A=	;maf-5-some-pop,maf-5-all-pops	13586	0.301266	U	0.3353	0.64996	11752	0.206093	PASS	-44	392	0.647959	288	8578	0.272791	.	.	.	.	.	.	rs2146657	.	4024	0.698600	-1.479	-1.814	-1.886	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	3644373	3644374	1p36.32	0	normal	.	A	snv	G	GG.GA	het-ref	177	0.46	.	2	.	PASS	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	IC7	IVS8	.	.	intron	NM_005427.3	NP_005418.1	+	Y	c.985+40A>G	.	.	.	NM_005427.3(TP73): c.985+40A>G	;maf-5-some-pop,maf-5-all-pops	13586	0.698734	U	0.3353	0.64996	11752	0.793907	PASS	25	392	0.352041	2237	8578	0.727209	489	2967	3.15504e-01	25222	70604	6.85702e-01	rs2146657	.	4024	0.301400	-1.479	-1.814	-1.886	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	3644668	3644669	1p36.32	0	normal	.	C	ref	C	CC.GC	het-alt	107	0.49	.	1	.	PASS	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	IC7	IVS8	.	.	no-change	NM_005427.3	NP_005418.1	+	Y	c.986-24C=	.	.	.	NM_005427.3(TP73): c.986-24C=	;maf-5-some-pop	119548	0.931492	U	0.0625	0.0722843	13000	0.949462	PASS	.	8490	0.951119	49785	114540	0.931657	.	.	.	.	.	.	rs2236367	.	4024	0.945800	0.478	-0.856	-0.577	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	3644668	3644669	1p36.32	0	normal	.	C	snv	T	CC.GC	het-ref	113	0.51	.	2	.	PASS	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	IC7	IVS8	.	.	intron	NM_005427.3	NP_005418.1	+	Y	c.986-24C>T	.	.	.	NM_005427.3(TP73): c.986-24C>T	;maf-5-some-pop	119548	0.068508	U	0.0625	0.0722843	13000	0.050538	PASS	9	8490	0.048881	343	114540	0.068343	21	824	4.81928e-02	705	15738	6.77224e-02	rs2236367	.	4024	0.054200	0.478	-0.856	-0.577	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	3644714	3644715	1p36.32	0	normal	.	C	ref	C	GC.GT	het-alt	190	0.52	.	1	.	PASS	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	C8	EX9	.	.	no-change	NM_005427.3	NP_005418.1	+	Y	c.1008C=	.	.	.	NM_005427.3(TP73): c.1008C=	;maf-5-some-pop	124244	0.942661	U	0.2163	0.0784744	13006	0.949946	PASS	.	8558	0.771559	53255	119236	0.943549	.	.	.	.	.	.	rs12046074	.	4024	0.789000	-1.114	0.367	0.096	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	3644714	3644715	1p36.32	1	normal	.	C	snv	T	GC.GT	het-ref	174	0.48	.	2	.	PASS	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	C8	EX9	.	.	coding-synon	NM_005427.3	NP_005418.1	+	Y	c.1008C>T	p.(A336=) | p.(Ala336=)	GCC=>GCT	.	NM_005427.3(TP73): c.1008C>T (p.(A336=))	;maf-5-some-pop	124244	0.057339	U	0.2163	0.0784744	13006	0.050054	PASS	224	8558	0.228441	368	119236	0.056451	456	3919	2.28088e-01	685	12812	5.26216e-02	rs12046074	.	4024	0.211000	-1.114	0.367	0.096	.	.	.	.	.	ENST00000378295: c.1008C>T (p.A336A)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5021024	.	.	.	.	.	.	.	.	.	Likely Benign
1	3644753	3644754	1p36.32	0	normal	.	T	ref	T	CA.GG	het-alt	208	0.51	.	1	.	PASS	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	C8	EX9	P53 tetramerisation motif	PF07710.6	no-change	NM_005427.3	NP_005418.1	+	Y	c.1047T=	.	.	.	NM_005427.3(TP73): c.1047T=	;maf-5-some-pop	124704	0.931678	U	0.2163	0.110024	13006	0.913425	PASS	-759	8590	0.772061	52399	119696	0.933423	.	.	.	.	.	.	rs12048341	.	4024	0.788300	-1.070	-0.454	-1.467	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	3644753	3644754	1p36.32	1	normal	.	T	snv	C	CA.GG	het-ref	201	0.49	.	2	.	PASS	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	C8	EX9	P53 tetramerisation motif	PF07710.6	coding-synon	NM_005427.3	NP_005418.1	+	Y	c.1047T>C	p.(H349=) | p.(His349=)	CAT=>CAC	.	NM_005427.3(TP73): c.1047T>C (p.(H349=))	;maf-5-some-pop	124704	0.068322	U	0.2163	0.110024	13006	0.086575	PASS	220	8590	0.227939	520	119696	0.066577	458	3928	2.28478e-01	928	14892	6.10138e-02	rs12048341	.	4024	0.211700	-1.070	-0.454	-1.467	.	.	.	.	.	ENST00000378295: c.1047T>C (p.H349H)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5021026	.	.	.	.	.	.	.	.	.	Likely Benign
1	3644804	3644805	1p36.32	0	nullSample	.	A	ref	A	GC.GC	homo-ref	.	.	.	0	.	.	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	IC8	IVS9	.	.	no-change	NM_005427.3	NP_005418.1	+	Y	c.1074+24A=	.	.	.	NM_005427.3(TP73): c.1074+24A=	;maf-5-some-pop,maf-5-all-pops	123100	0.822136	U	0.2817	0.313099	12998	0.745422	PASS	.	8518	0.724231	41560	118092	0.827871	.	.	.	.	.	.	rs2236366	.	4024	0.733800	-2.797	-0.896	-0.825	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	3644804	3644805	1p36.32	0	normal	.	A	snv	G	GC.GC	hom-alt	205	1.00	.	0	.	PASS	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	IC8	IVS9	.	.	intron	NM_005427.3	NP_005418.1	+	Y	c.1074+24A>G	.	.	.	NM_005427.3(TP73): c.1074+24A>G	;maf-5-some-pop,maf-5-all-pops	123100	0.177864	U	0.2817	0.313099	12998	0.254578	PASS	304	8518	0.275769	2841	118092	0.172129	629	4662	2.74235e-01	4898	37926	1.59555e-01	rs2236366	.	4024	0.266200	-2.797	-0.896	-0.825	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	3645843	3645844	1p36.32	0	normal	.	G	ref	G	CC.TG	het-alt	193	0.54	.	1	.	PASS	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	IC8	IVS9	.	.	no-change	NM_005427.3	NP_005418.1	+	Y	c.1075-47G=	.	.	.	NM_005427.3(TP73): c.1075-47G=	;maf-5-some-pop,maf-5-all-pops	124282	0.335785	U	0.4772	0.539736	13002	0.326796	PASS	.	8578	0.518419	7524	119274	0.330558	.	.	.	.	.	.	rs2096224	.	4024	0.554700	-2.215	-1.119	-1.377	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	3645843	3645844	1p36.32	0	normal	.	G	snv	A	CC.TG	het-ref	163	0.46	.	2	.	PASS	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	IC8	IVS9	.	.	intron	NM_005427.3	NP_005418.1	+	Y	c.1075-47G>A	.	.	.	NM_005427.3(TP73): c.1075-47G>A	;maf-5-some-pop,maf-5-all-pops	124282	0.664215	U	0.4772	0.539736	13002	0.673204	PASS	975	8578	0.481581	27734	119274	0.669442	1901	8167	4.74826e-01	56133	162283	6.67112e-01	rs2096224	.	4024	0.445300	-2.215	-1.119	-1.377	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	3647418	3647419	1p36.32	0	normal	.	G	ref	G	CT.GA	het-alt	144	0.45	.	1	.	PASS	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	IC10	IVS11	.	.	no-change	NM_005427.3	NP_005418.1	+	Y	c.1346-72G=	.	.	.	NM_005427.3(TP73): c.1346-72G=	;maf-5-some-pop	5008	0.891773	U	0.2123	0.108227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs41301973	.	4024	0.794200	-1.080	-0.865	-0.588	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	3647418	3647419	1p36.32	0	normal	.	G	snv	A	CT.GA	het-ref	173	0.55	.	2	.	PASS	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	IC10	IVS11	.	.	intron	NM_005427.3	NP_005418.1	+	Y	c.1346-72G>A	.	.	.	NM_005427.3(TP73): c.1346-72G>A	;maf-5-some-pop	5008	0.108227	U	0.2123	0.108227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs41301973	.	4024	0.205800	-1.080	-0.865	-0.588	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	3649402	3649403	1p36.32	0	normal	.	G	ref	G	GC.CA	het-alt	170	0.49	.	1	.	PASS	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	C13E	EX14E	.	.	no-change	NM_005427.3	NP_005418.1	+	Y	c.1671G=	.	.	.	NM_005427.3(TP73): c.1671G=	;maf-5-some-pop	116954	0.947039	U	0.2143	0.0571086	12974	0.971019	PASS	.	8340	0.770863	50383	111946	0.947225	.	.	.	.	.	.	rs61735051	.	4024	0.794700	0.313	-0.109	-2.906	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	3649402	3649403	1p36.32	1	normal	.	G	snv	A	GC.CA	het-ref	175	0.51	.	2	.	PASS	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	C13E	EX14E	.	.	coding-synon	NM_005427.3	NP_005418.1	+	Y	c.1671G>A	p.(A557=) | p.(Ala557=)	GCG=>GCA	.	NM_005427.3(TP73): c.1671G>A (p.(A557=))	;maf-5-some-pop	116954	0.052961	U	0.2143	0.0571086	12974	0.028981	PASS	211	8340	0.229137	318	111946	0.052775	431	3833	2.24283e-01	624	11547	4.88282e-02	rs61735051	.	4024	0.205300	0.313	-0.109	-2.906	.	.	.	.	.	ENST00000378295: c.1671G>A (p.A557A)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5021043	.	.	.	.	.	.	.	.	.	Likely Benign
1	3649561	3649562	1p36.32	0	normal	.	G	ref	G	GC.GA	het-alt	217	0.52	.	1	.	PASS	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	C13E	EX14E	.	.	no-change	NM_005427.3	NP_005418.1	+	Y	c.1830G=	.	.	.	NM_005427.3(TP73): c.1830G=	;maf-5-some-pop	48542	0.895493	U	0.2123	0.107827	12808	0.924188	PASS	.	3074	0.670462	17460	43534	0.895874	.	.	.	.	.	.	rs9662633	.	4024	0.794200	-0.642	-3.391	-3.522	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	3649561	3649562	1p36.32	1	normal	.	G	snv	A	GC.GA	het-ref	198	0.48	.	2	.	PASS	601990	P	601990(UA)	NN	.	.	.	.	.	.	.	7161	TP73	C13E	EX14E	.	.	coding-synon	NM_005427.3	NP_005418.1	+	Y	c.1830G>A	p.(A610=) | p.(Ala610=)	GCG=>GCA	.	NM_005427.3(TP73): c.1830G>A (p.(A610=))	;maf-5-some-pop	48542	0.104507	U	0.2123	0.107827	12808	0.075812	PASS	104	3074	0.329538	226	43534	0.104126	344	3071	2.30868e-01	643	11561	6.37314e-02	rs9662633	.	4024	0.205800	-0.642	-3.391	-3.522	.	.	.	.	.	ENST00000378295: c.1830G>A (p.A610A)	large_intestine [caecum|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3689642	.	.	.	.	.	.	.	.	.	Likely Benign
1	11187892	11187893	1p36.22	0	nullSample	.	T	ref	T	CA.CA	homo-ref	.	.	.	0	.	.	601231	P	.	NN	.	.	.	.	.	.	.	2475	MTOR	IC42	IVS43	.	.	no-change	NM_004958.3	NP_004949.1	-	Y	c.6034-30A=	.	.	.	NM_004958.3(MTOR): c.6034-30A=	SingleClassTriAllelic,InconsistentAlleles;	124836	0.002099	U	1	0.990016	13006	0.005228	PASS	0	8650	0.000000	2	119828	0.001769	.	.	.	.	.	.	rs1770344	.	4024	0.001000	-0.349	0.186	0.554	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	11187892	11187893	1p36.22	0	normal	.	T	snv	C	CA.CA	hom-alt	542	1.00	.	0	.	PASS	601231	P	.	NN	.	.	.	.	.	.	.	2475	MTOR	IC42	IVS43	.	.	intron	NM_004958.3	NP_004949.1	-	Y	c.6034-30A>G	.	.	.	NM_004958.3(MTOR): c.6034-30A>G	SingleClassTriAllelic,InconsistentAlleles;	124836	0.997901	U	1	0.990016	13006	0.994772	PASS	4325	8650	1.000000	59704	119828	0.998231	8531	17062	1.00000e+00	118060	236493	9.98400e-01	rs1770344	.	4024	0.999000	-0.349	0.186	0.554	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	11205057	11205058	1p36.22	0	nullSample	.	C	ref	C	AT.GC	homo-ref	.	.	.	0	.	.	601231	P	.	NN	.	.	.	.	.	.	.	2475	MTOR	C32	EX33	FAT domain	PF02259.18	no-change	NM_004958.3	NP_004949.1	-	Y	c.4731G=	.	.	.	NM_004958.3(MTOR): c.4731G=	;maf-5-some-pop	126404	0.327244	U	0.8165	0.547524	13006	0.454098	PASS	.	8652	0.179727	7996	121396	0.322078	.	.	.	.	.	.	rs1057079	.	4024	0.208500	-0.886	0.078	-1.369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	11205057	11205058	1p36.22	1	normal	.	C	snv	T	AT.GC	hom-alt	440	1.00	.	0	.	PASS	601231	P	.	NN	.	.	.	.	.	.	.	2475	MTOR	C32	EX33	FAT domain	PF02259.18	coding-synon	NM_004958.3	NP_004949.1	-	Y	c.4731G>A	p.(A1577=) | p.(Ala1577=)	GCG=>GCA	.	NM_004958.3(MTOR): c.4731G>A (p.(A1577=))	;maf-5-some-pop	126404	0.672756	U	0.8165	0.547524	13006	0.545902	PASS	2906	8652	0.820273	29595	121396	0.677922	5712	14029	8.13464e-01	60870	169036	6.86792e-01	rs1057079	.	4024	0.791500	-0.886	0.078	-1.369	.	.	.	.	.	ENST00000361445: c.4731G>A (p.A1577A)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	4142146	.	.	.	.	.	no_record	516654	criteria_provided,_single_submitter	Benign	Likely Benign
1	11288632	11288633	1p36.22	0	nullSample	.	G	ref	G	CA.AG	homo-ref	.	.	.	0	.	.	601231	P	.	NN	.	.	.	.	.	.	.	2475	MTOR	IC18	IVS19	.	.	no-change	NM_004958.3	NP_004949.1	-	Y	c.3030+92C=	.	.	.	NM_004958.3(MTOR): c.3030+92C=	;maf-5-some-pop,maf-5-all-pops	5008	0.361821	U	0.877	0.638179	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4845986	.	4024	0.132200	-0.792	0.013	-0.078	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	11288632	11288633	1p36.22	0	normal	.	G	snv	C	CA.AG	hom-alt	263	1.00	.	0	.	PASS	601231	P	.	NN	.	.	.	.	.	.	.	2475	MTOR	IC18	IVS19	.	.	intron	NM_004958.3	NP_004949.1	-	Y	c.3030+92C>G	.	.	.	NM_004958.3(MTOR): c.3030+92C>G	;maf-5-some-pop,maf-5-all-pops	5008	0.638179	U	0.877	0.638179	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4845986	.	4024	0.867800	-0.792	0.013	-0.078	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	11288757	11288758	1p36.22	0	nullSample	.	G	ref	G	AC.TT	homo-ref	.	.	.	0	.	.	601231	P	.	NN	.	.	.	.	.	.	.	2475	MTOR	C18	EX19	Domain of unknown function (DUF3385)	PF11865.3	no-change	NM_004958.3	NP_004949.1	-	Y	c.2997C=	.	.	.	NM_004958.3(MTOR): c.2997C=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126323	0.258789	U	0.9187	0.700479	13006	0.382439	PASS	.	8654	0.080772	4993	121316	0.257105	.	.	.	.	.	.	rs1064261	.	4024	0.074800	-1.120	-0.406	-0.484	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	11288757	11288758	1p36.22	1	normal	.	G	snv	A	AC.TT	hom-alt	606	1.00	.	0	.	PASS	601231	P	.	NN	.	.	.	.	.	.	.	2475	MTOR	C18	EX19	Domain of unknown function (DUF3385)	PF11865.3	coding-synon	NM_004958.3	NP_004949.1	-	Y	c.2997C>T	p.(N999=) | p.(Asn999=)	AAC=>AAT	.	NM_004958.3(MTOR): c.2997C>T (p.(N999=))	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126323	0.741211	U	0.9187	0.700479	13006	0.617561	PASS	3666	8654	0.919228	34459	121316	0.742886	7281	15837	9.18300e-01	71307	184932	7.51689e-01	rs1064261	.	4024	0.925200	-1.120	-0.406	-0.484	.	.	.	.	.	ENST00000361445: c.2997C>T (p.N999N)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4142152	.	.	.	.	.	.	.	.	.	Likely Benign
1	11301713	11301714	1p36.22	0	nullSample	.	A	ref	A	GC.TC	homo-ref	.	.	.	0	.	.	601231	P	.	NN	.	.	.	.	.	.	.	2475	MTOR	C9	EX10	.	.	no-change	NM_004958.3	NP_004949.1	-	Y	c.1437T=	.	.	.	NM_004958.3(MTOR): c.1437T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126354	0.286093	U	0.878	0.639577	13006	0.414655	PASS	.	8652	0.118932	6052	121346	0.283025	.	.	.	.	.	.	rs1135172	.	4024	0.131500	-1.408	0.008	-0.429	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	11301713	11301714	1p36.22	1	normal	.	A	snv	G	GC.TC	hom-alt	610	1.00	.	0	.	PASS	601231	P	.	NN	.	.	.	.	.	.	.	2475	MTOR	C9	EX10	.	.	coding-synon	NM_004958.3	NP_004949.1	-	Y	c.1437T>C	p.(D479=) | p.(Asp479=)	GAT=>GAC	.	NM_004958.3(MTOR): c.1437T>C (p.(D479=))	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126354	0.713907	U	0.878	0.639577	13006	0.585345	PASS	3363	8652	0.881068	32381	121346	0.716975	6647	15108	8.78168e-01	66792	178432	7.25735e-01	rs1135172	.	4024	0.868500	-1.408	0.008	-0.429	.	.	.	.	.	ENST00000361445: c.1437T>C (p.D479D)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4142157	.	.	.	.	.	no_record	516653	criteria_provided,_single_submitter	Benign	Likely Benign
1	11854456	11854457	1p36.22	0	nullSample	.	G	ref	G	AC.AA	homo-ref	.	.	.	0	.	.	607093	P	181500(SK);188050(SK);236250(MK);601634(SK);607093(SK)	AD;AR	Homocystinuria due to MTHFR deficiency	AR	.	Biochemical; Cardiovascular; Hematologic; Neurologic	Biochemical; Cardiovascular; Hematologic	23124942|22947400|22856671|22807619|22773907|22721898|22665071|22646290|22578003|20850942|20356773|20236116|19697151|18708589|18658082|17409006|16216822|16145688|15979034|15896655|12673793|12142069|11938441|11508552|11274424|11170082|10961793|10923034|10862840|10679944|10536004|10384377|10323741|9878639|9372726|9341863|9244205|9133512|9068801|8994411|8940272|8892013|8826441|8691945|8456826|7920641|7726158|7647779|7564788|3889647|1998339|1866027|1627352	.	4524	MTHFR	C7	EX8	.	.	no-change	NM_005957.4	NP_005948.3	-	Y	c.1305C=	.	.	.	NM_005957.4(MTHFR): c.1305C=	MixedObserved;maf-5-some-pop	126414	0.032987	U	0.996	0.902955	13006	0.109488	PASS	.	8654	0.001040	548	121406	0.030344	.	.	.	.	.	.	rs4846051	.	4024	0.002000	-0.556	0.176	-0.249	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	11854456	11854457	1p36.22	1	normal	.	G	snv	A	AC.AA	hom-alt	486	1.00	.	0	.	PASS	607093	P	181500(SK);188050(SK);236250(MK);601634(SK);607093(SK)	AD;AR	Homocystinuria due to MTHFR deficiency	AR	.	Biochemical; Cardiovascular; Hematologic; Neurologic	Biochemical; Cardiovascular; Hematologic	23124942|22947400|22856671|22807619|22773907|22721898|22665071|22646290|22578003|20850942|20356773|20236116|19697151|18708589|18658082|17409006|16216822|16145688|15979034|15896655|12673793|12142069|11938441|11508552|11274424|11170082|10961793|10923034|10862840|10679944|10536004|10384377|10323741|9878639|9372726|9341863|9244205|9133512|9068801|8994411|8940272|8892013|8826441|8691945|8456826|7920641|7726158|7647779|7564788|3889647|1998339|1866027|1627352	.	4524	MTHFR	C7	EX8	.	.	coding-synon	NM_005957.4	NP_005948.3	-	Y	c.1305C>T	p.(F435=) | p.(Phe435=)	TTC=>TTT	.	NM_005957.4(MTHFR): c.1305C>T (p.(F435=))	MixedObserved;maf-5-some-pop	126414	0.967013	U	0.996	0.902955	13006	0.890512	PASS	4318	8654	0.998960	57567	121406	0.969656	8611	17235	9.99246e-01	117918	240229	9.75525e-01	rs4846051	.	4024	0.998000	-0.556	0.176	-0.249	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	167306	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
1	11856377	11856378	1p36.22	0	normal	.	G	ref	G	CG.CT	het-alt	233	0.53	.	1	.	PASS	607093	P	181500(SK);188050(SK);236250(MK);601634(SK);607093(SK)	AD;AR	Homocystinuria due to MTHFR deficiency	AR	.	Biochemical; Cardiovascular; Hematologic; Neurologic	Biochemical; Cardiovascular; Hematologic	23124942|22947400|22856671|22807619|22773907|22721898|22665071|22646290|22578003|20850942|20356773|20236116|19697151|18708589|18658082|17409006|16216822|16145688|15979034|15896655|12673793|12142069|11938441|11508552|11274424|11170082|10961793|10923034|10862840|10679944|10536004|10384377|10323741|9878639|9372726|9341863|9244205|9133512|9068801|8994411|8940272|8892013|8826441|8691945|8456826|7920641|7726158|7647779|7564788|3889647|1998339|1866027|1627352	.	4524	MTHFR	C4	EX5	Methylenetetrahydrofolate reductase	PF02219.12	no-change	NM_005957.4	NP_005948.3	-	Y	c.665C=	.	.	.	NM_005957.4(MTHFR): c.665C=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,microattr-tpa,submitted-by-lsdb	126404	0.698641	U	0.2956	0.245407	13006	0.729433	PASS	-879	8650	0.694798	30458	121396	0.696333	.	.	.	.	.	.	rs1801133	.	4024	0.585500	0.655	5.223	2.514	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	11856377	11856378	1p36.22	1	normal	.	G	snv	A	CG.CT	het-ref	207	0.47	.	2	.	PASS	607093	P	181500(SK);188050(SK);236250(MK);601634(SK);607093(SK)	AD;AR	Homocystinuria due to MTHFR deficiency	AR	.	Biochemical; Cardiovascular; Hematologic; Neurologic	Biochemical; Cardiovascular; Hematologic	23124942|22947400|22856671|22807619|22773907|22721898|22665071|22646290|22578003|20850942|20356773|20236116|19697151|18708589|18658082|17409006|16216822|16145688|15979034|15896655|12673793|12142069|11938441|11508552|11274424|11170082|10961793|10923034|10862840|10679944|10536004|10384377|10323741|9878639|9372726|9341863|9244205|9133512|9068801|8994411|8940272|8892013|8826441|8691945|8456826|7920641|7726158|7647779|7564788|3889647|1998339|1866027|1627352	.	4524	MTHFR	C4	EX5	Methylenetetrahydrofolate reductase	PF02219.12	missense	NM_005957.4	NP_005948.3	-	Y	c.665C>T	p.A222V | p.Ala222Val	GCC=>GTC	NP=>NP	NM_005957.4(MTHFR): c.665C>T (p.A222V)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,microattr-tpa,submitted-by-lsdb	126404	0.301359	U	0.2956	0.245407	13006	0.270567	PASS	441	8650	0.305202	6624	121396	0.303667	829	5066	2.93715e-01	14288	77385	3.14254e-01	rs1801133	.	4024	0.414500	0.655	5.223	2.514	0.06	0.947	0.997	0.713	deleterious	ENST00000376592: c.665C>T (p.A222V)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	146404	CM950819	NM_005957.4(MTHFR): c.665C>T (p.A222V)	"Cardiovascular disease, association with"	7647779	DFP	no_record	3520	reviewed_by_expert_panel	drug_response	Likely Benign
1	17359675	17359676	1p36.13	0	nullSample	.	C	ref	C	AA.GT	homo-ref	.	.	.	0	.	.	185470	C	115310(MK);171300(MK);606764(MK);606864(MK);612359(MK)	AD	Cowden-like syndrome; Paraganglioma and gastric stromal sarcoma; Gastrointestinal stromal tumor; Pheochromocytoma; Paragangliomas 4	AD	.	Oncologic	Oncologic	22328163|21565294|21366490|21348866|20503330|20301715|19576851|19351833|19251979|18678321|18057081|17848412|17804857|17667967|17652212|17200167|17102084|16522703|16317055|15479192|15328326|14685938|14500403|12364472|12213855|12000816|11404820|490809	FC59;FH44;H41;H54;H62;H68;HD31;HD32;HE15;HG15;HR14;MC58;MH43	6390	SDHB	IC2	IVS2	.	.	no-change	NM_003000.2	NP_002991.2	-	Y	c.201-36G=	.	.	.	NM_003000.2(SDHB): c.201-36G=	;maf-5-some-pop,genotype-conflict	123138	0.028635	U	0.996	0.959065	13006	0.047670	PASS	.	8510	0.001528	69	118130	0.028113	.	.	.	.	.	.	rs1022580	.	4024	0.001700	-0.363	-1.405	-2.303	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	17359675	17359676	1p36.13	0	normal	.	C	snv	A	AA.GT	hom-alt	265	1.00	.	0	.	PASS	185470	C	115310(MK);171300(MK);606764(MK);606864(MK);612359(MK)	AD	Cowden-like syndrome; Paraganglioma and gastric stromal sarcoma; Gastrointestinal stromal tumor; Pheochromocytoma; Paragangliomas 4	AD	.	Oncologic	Oncologic	22328163|21565294|21366490|21348866|20503330|20301715|19576851|19351833|19251979|18678321|18057081|17848412|17804857|17667967|17652212|17200167|17102084|16522703|16317055|15479192|15328326|14685938|14500403|12364472|12213855|12000816|11404820|490809	FC59;FH44;H41;H54;H62;H68;HD31;HD32;HE15;HG15;HR14;MC58;MH43	6390	SDHB	IC2	IVS2	.	.	intron	NM_003000.2	NP_002991.2	-	Y	c.201-36G>T	.	.	.	NM_003000.2(SDHB): c.201-36G>T	;maf-5-some-pop,genotype-conflict	123138	0.971365	U	0.996	0.959065	13006	0.952330	PASS	4242	8510	0.998472	55813	118130	0.971887	8562	17143	9.98893e-01	115252	236715	9.73487e-01	rs1022580	.	4024	0.998300	-0.363	-1.405	-2.303	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	258889	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
1	17371151	17371152	1p36.13	0	normal	.	T	ref	T	CA.CG	het-alt	125	0.50	.	1	.	PASS	185470	C	115310(MK);171300(MK);606764(MK);606864(MK);612359(MK)	AD	Cowden-like syndrome; Paraganglioma and gastric stromal sarcoma; Gastrointestinal stromal tumor; Pheochromocytoma; Paragangliomas 4	AD	.	Oncologic	Oncologic	22328163|21565294|21366490|21348866|20503330|20301715|19576851|19351833|19251979|18678321|18057081|17848412|17804857|17667967|17652212|17200167|17102084|16522703|16317055|15479192|15328326|14685938|14500403|12364472|12213855|12000816|11404820|490809	FC59;FH44;H41;H54;H62;H68;HD31;HD32;HE15;HG15;HR14;MC58;MH43	6390	SDHB	IC2	IVS2	.	.	no-change	NM_003000.2	NP_002991.2	-	Y	c.200+104A=	.	.	.	NM_003000.2(SDHB): c.200+104A=	;maf-5-some-pop,maf-5-all-pops	5008	0.524561	U	0.2887	0.475439	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12073028	.	4020	0.689100	-1.085	-2.319	-2.380	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	17371151	17371152	1p36.13	0	normal	.	T	snv	C	CA.CG	het-ref	123	0.50	.	2	.	PASS	185470	C	115310(MK);171300(MK);606764(MK);606864(MK);612359(MK)	AD	Cowden-like syndrome; Paraganglioma and gastric stromal sarcoma; Gastrointestinal stromal tumor; Pheochromocytoma; Paragangliomas 4	AD	.	Oncologic	Oncologic	22328163|21565294|21366490|21348866|20503330|20301715|19576851|19351833|19251979|18678321|18057081|17848412|17804857|17667967|17652212|17200167|17102084|16522703|16317055|15479192|15328326|14685938|14500403|12364472|12213855|12000816|11404820|490809	FC59;FH44;H41;H54;H62;H68;HD31;HD32;HE15;HG15;HR14;MC58;MH43	6390	SDHB	IC2	IVS2	.	.	intron	NM_003000.2	NP_002991.2	-	Y	c.200+104A>G	.	.	.	NM_003000.2(SDHB): c.200+104A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.475439	U	0.2887	0.475439	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12073028	.	4020	0.310900	-1.085	-2.319	-2.380	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	17380496	17380497	1p36.13	0	nullSample	.	G	ref	G	AG.GC	homo-ref	.	.	.	0	.	.	185470	C	115310(MK);171300(MK);606764(MK);606864(MK);612359(MK)	AD	Cowden-like syndrome; Paraganglioma and gastric stromal sarcoma; Gastrointestinal stromal tumor; Pheochromocytoma; Paragangliomas 4	AD	.	Oncologic	Oncologic	22328163|21565294|21366490|21348866|20503330|20301715|19576851|19351833|19251979|18678321|18057081|17848412|17804857|17667967|17652212|17200167|17102084|16522703|16317055|15479192|15328326|14685938|14500403|12364472|12213855|12000816|11404820|490809	FC59;FH44;H41;H54;H62;H68;HD31;HD32;HE15;HG15;HR14;MC58;MH43	6390	SDHB	C1	EX1	.	.	no-change	NM_003000.2	NP_002991.2	-	Y	c.18C=	.	.	.	NM_003000.2(SDHB): c.18C=	SingleClassTriAllelic;maf-5-some-pop	117776	0.028520	U	0.996	0.957069	13002	0.048531	PASS	-6	8410	0.001427	59	112768	0.027880	.	.	.	.	.	.	rs2746462	.	4024	0.001700	-1.537	0.034	-0.152	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	17380496	17380497	1p36.13	1	normal	.	G	snv	T	AG.GC	hom-alt	378	1.00	.	0	.	PASS	185470	C	115310(MK);171300(MK);606764(MK);606864(MK);612359(MK)	AD	Cowden-like syndrome; Paraganglioma and gastric stromal sarcoma; Gastrointestinal stromal tumor; Pheochromocytoma; Paragangliomas 4	AD	.	Oncologic	Oncologic	22328163|21565294|21366490|21348866|20503330|20301715|19576851|19351833|19251979|18678321|18057081|17848412|17804857|17667967|17652212|17200167|17102084|16522703|16317055|15479192|15328326|14685938|14500403|12364472|12213855|12000816|11404820|490809	FC59;FH44;H41;H54;H62;H68;HD31;HD32;HE15;HG15;HR14;MC58;MH43	6390	SDHB	C1	EX1	.	.	coding-synon	NM_003000.2	NP_002991.2	-	Y	c.18C>A	p.(A6=) | p.(Ala6=)	GCC=>GCA	.	NM_003000.2(SDHB): c.18C>A (p.(A6=))	SingleClassTriAllelic;maf-5-some-pop	117776	0.971463	U	0.996	0.957069	13002	0.951469	PASS	4193	8410	0.998573	53297	112768	0.972102	8514	17045	9.99004e-01	112147	230285	9.73663e-01	rs2746462	.	4024	0.998300	-1.537	0.034	-0.152	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	44641	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
1	22965437	22965438	1p36.12	1	normal	.	A	snv	G	GG.GC	het-ref	323	0.51	.	2	.	PASS	120550	C	613652(MK)	NN	C1q deficiency	AR	.	Allergy/Immunology/Infectious; Dermatologic; Renal	Allergy/Immunology/Infectious	22576477|20560256|10776791|9225968|8840296|7594474|6445507|6319055	.	712	C1QA	C2E	EX3E	Collagen triple helix repeat (20 copies)	PF01391.13	coding-synon	NM_015991.2	NP_057075.1	+	Y	c.276A>G	p.(G92=) | p.(Gly92=)	GGA=>GGG	.	NM_015991.2(C1QA): c.276A>G (p.(G92=))	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	86984	0.543157	U	0.6111	0.616414	12962	0.487965	PASS	1029	5856	0.616974	11213	81976	0.538682	2703	9100	5.90526e-01	27353	105988	4.85498e-01	rs172378	.	4024	0.587200	-0.215	-1.057	-0.601	.	.	.	.	.	ENST00000374642: c.276A>G (p.G92G)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3721050	.	.	.	.	.	.	.	.	.	Likely Benign
1	22965437	22965438	1p36.12	0	normal	.	A	ref	A	GG.GC	het-alt	308	0.49	.	1	.	PASS	120550	C	613652(MK)	NN	C1q deficiency	AR	.	Allergy/Immunology/Infectious; Dermatologic; Renal	Allergy/Immunology/Infectious	22576477|20560256|10776791|9225968|8840296|7594474|6445507|6319055	.	712	C1QA	C2E	EX3E	Collagen triple helix repeat (20 copies)	PF01391.13	no-change	NM_015991.2	NP_057075.1	+	Y	c.276A=	.	.	.	NM_015991.2(C1QA): c.276A=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	86984	0.456843	U	0.6111	0.616414	12962	0.512035	PASS	.	5856	0.383026	8042	81976	0.461318	.	.	.	.	.	.	rs172378	.	4024	0.412800	-0.215	-1.057	-0.601	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	23191745	23191746	1p36.12	0	normal	.	G	ref	G	GC.CT	het-alt	125	0.55	.	1	.	PASS	600997	C	603688(SK)	NN	.	.	.	.	.	.	.	2048	EPHB2	IC5	IVS5	.	.	no-change	NM_004442.6	NP_004433.2	+	Y	c.1303+41G=	.	.	.	NM_004442.6(EPHB2): c.1303+41G=	SingleClassTriAllelic;maf-5-some-pop	125704	0.889590	U	0	0.0547125	13006	0.885437	PASS	-1	8636	0.999768	47744	120696	0.887279	.	.	.	.	.	.	rs45550439	.	4024	0.998800	0.313	0.079	0.142	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	23191745	23191746	1p36.12	0	normal	.	G	ref	G	GC.CT	het-alt	125	0.55	.	1	.	PASS	600997	C	603688(SK)	NN	.	.	.	.	.	.	.	2048	EPHB2	IC5	IVS5	.	.	no-change	NM_017449.3	NP_059145.2	+	N	c.1303+41G=	.	.	.	NM_017449.3(EPHB2): c.1303+41G=	SingleClassTriAllelic;maf-5-some-pop	125704	0.889590	U	0	0.0547125	13006	0.885437	PASS	-1	8636	0.999768	47744	120696	0.887279	.	.	.	.	.	.	rs45550439	.	4024	0.998800	0.313	0.079	0.142	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	23191745	23191746	1p36.12	0	normal	.	G	snv	T	GC.CT	het-ref	103	0.45	.	2	.	PASS	600997	C	603688(SK)	NN	.	.	.	.	.	.	.	2048	EPHB2	IC5	IVS5	.	.	intron	NM_004442.6	NP_004433.2	+	Y	c.1303+41G>T	.	.	.	NM_004442.6(EPHB2): c.1303+41G>T	SingleClassTriAllelic;maf-5-some-pop	125704	0.110402	U	0	0.0547125	13006	0.114563	PASS	0	8636	0.000116	1001	120696	0.112713	0	4	2.32207e-04	1971	27098	1.11726e-01	rs45550439	.	4024	0.001200	0.313	0.079	0.142	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	23191745	23191746	1p36.12	0	normal	.	G	snv	T	GC.CT	het-ref	103	0.45	.	2	.	PASS	600997	C	603688(SK)	NN	.	.	.	.	.	.	.	2048	EPHB2	IC5	IVS5	.	.	intron	NM_017449.3	NP_059145.2	+	N	c.1303+41G>T	.	.	.	NM_017449.3(EPHB2): c.1303+41G>T	SingleClassTriAllelic;maf-5-some-pop	125704	0.110402	U	0	0.0547125	13006	0.114563	PASS	0	8636	0.000116	1001	120696	0.112713	0	4	2.32207e-04	1971	27098	1.11726e-01	rs45550439	.	4024	0.001200	0.313	0.079	0.142	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	23208924	23208925	1p36.12	1	normal	.	G	snv	A	CC.GA	het-ref	152	0.52	.	2	.	PASS	600997	C	603688(SK)	NN	.	.	.	.	.	.	.	2048	EPHB2	C6	EX6	Fibronectin type III domain	PF00041.16	coding-synon	NM_004442.6	NP_004433.2	+	Y	c.1377G>A	p.(P459=) | p.(Pro459=)	CCG=>CCA	.	NM_004442.6(EPHB2): c.1377G>A (p.(P459=))	;maf-5-some-pop,maf-5-all-pops	126376	0.140027	U	0.4901	0.214457	13006	0.118022	PASS	1163	8632	0.518999	1906	121368	0.136955	2380	9072	5.25974e-01	3850	33738	1.37005e-01	rs2229872	.	4024	0.538300	-0.475	-0.845	-2.146	.	.	.	.	.	ENST00000374632: c.1377G>A (p.P459P)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	1178395	.	.	.	.	.	.	.	.	.	Likely Benign
1	23208924	23208925	1p36.12	1	normal	.	G	snv	A	CC.GA	het-ref	152	0.52	.	2	.	PASS	600997	C	603688(SK)	NN	.	.	.	.	.	.	.	2048	EPHB2	C6	EX6	Fibronectin type III domain	PF00041.16	coding-synon	NM_017449.3	NP_059145.2	+	N	c.1377G>A	p.(P459=) | p.(Pro459=)	CCG=>CCA	.	NM_017449.3(EPHB2): c.1377G>A (p.(P459=))	;maf-5-some-pop,maf-5-all-pops	126376	0.140027	U	0.4901	0.214457	13006	0.118022	PASS	1163	8632	0.518999	1906	121368	0.136955	2380	9072	5.25974e-01	3850	33738	1.37005e-01	rs2229872	.	4024	0.538300	-0.475	-0.845	-2.146	.	.	.	.	.	ENST00000374632: c.1377G>A (p.P459P)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	1178395	.	.	.	.	.	.	.	.	.	Likely Benign
1	23208924	23208925	1p36.12	0	normal	.	G	ref	G	CC.GA	het-alt	142	0.48	.	1	.	PASS	600997	C	603688(SK)	NN	.	.	.	.	.	.	.	2048	EPHB2	C6	EX6	Fibronectin type III domain	PF00041.16	no-change	NM_004442.6	NP_004433.2	+	Y	c.1377G=	.	.	.	NM_004442.6(EPHB2): c.1377G=	;maf-5-some-pop,maf-5-all-pops	126376	0.859973	U	0.4901	0.214457	13006	0.881978	PASS	-1077	8632	0.481001	45968	121368	0.863045	.	.	.	.	.	.	rs2229872	.	4024	0.461700	-0.475	-0.845	-2.146	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	23208924	23208925	1p36.12	0	normal	.	G	ref	G	CC.GA	het-alt	142	0.48	.	1	.	PASS	600997	C	603688(SK)	NN	.	.	.	.	.	.	.	2048	EPHB2	C6	EX6	Fibronectin type III domain	PF00041.16	no-change	NM_017449.3	NP_059145.2	+	N	c.1377G=	.	.	.	NM_017449.3(EPHB2): c.1377G=	;maf-5-some-pop,maf-5-all-pops	126376	0.859973	U	0.4901	0.214457	13006	0.881978	PASS	-1077	8632	0.481001	45968	121368	0.863045	.	.	.	.	.	.	rs2229872	.	4024	0.461700	-0.475	-0.845	-2.146	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	23219492	23219493	1p36.12	1	nullSample	.	T	ref	T	GG.TA	homo-ref	.	.	.	0	.	.	600997	C	603688(SK)	NN	.	.	.	.	.	.	.	2048	EPHB2	C7	EX7	Fibronectin type III domain	PF00041.16	coding-synon	NM_004442.6	NP_004433.2	+	Y	c.1545C>T	p.(G515=) | p.(Gly515=)	GGC=>GGT	.	NM_004442.6(EPHB2): c.1545C>T (p.(G515=))	SingleClassTriAllelic;	126384	0.003576	U	1	0.998203	13006	0.005843	PASS	0	8654	0.000000	1	121376	0.003650	.	.	.	.	.	.	rs309472	.	.	.	-0.119	0.441	1.457	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
1	23219492	23219493	1p36.12	1	nullSample	.	T	ref	T	GG.TA	homo-ref	.	.	.	0	.	.	600997	C	603688(SK)	NN	.	.	.	.	.	.	.	2048	EPHB2	C7	EX7	Fibronectin type III domain	PF00041.16	coding-synon	NM_017449.3	NP_059145.2	+	N	c.1545C>T	p.(G515=) | p.(Gly515=)	GGC=>GGT	.	NM_017449.3(EPHB2): c.1545C>T (p.(G515=))	SingleClassTriAllelic;	126384	0.003576	U	1	0.998203	13006	0.005843	PASS	0	8654	0.000000	1	121376	0.003650	.	.	.	.	.	.	rs309472	.	.	.	-0.119	0.441	1.457	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
1	23219492	23219493	1p36.12	0	normal	.	T	snv	C	GG.TA	hom-alt	420	1.00	.	0	.	PASS	600997	C	603688(SK)	NN	.	.	.	.	.	.	.	2048	EPHB2	C7	EX7	Fibronectin type III domain	PF00041.16	no-change	NM_004442.6	NP_004433.2	+	Y	c.1545C=	.	.	.	NM_004442.6(EPHB2): c.1545C=	SingleClassTriAllelic;	126384	0.996416	U	1	0.998203	13006	0.994157	PASS	4327	8654	1.000000	60245	121376	0.996342	8624	17248	1.00000e+00	122263	245379	9.96528e-01	rs309472	.	.	.	-0.119	0.441	1.457	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	23219492	23219493	1p36.12	0	normal	.	T	snv	C	GG.TA	hom-alt	420	1.00	.	0	.	PASS	600997	C	603688(SK)	NN	.	.	.	.	.	.	.	2048	EPHB2	C7	EX7	Fibronectin type III domain	PF00041.16	no-change	NM_017449.3	NP_059145.2	+	N	c.1545C=	.	.	.	NM_017449.3(EPHB2): c.1545C=	SingleClassTriAllelic;	126384	0.996416	U	1	0.998203	13006	0.994157	PASS	4327	8654	1.000000	60245	121376	0.996342	8624	17248	1.00000e+00	122263	245379	9.96528e-01	rs309472	.	.	.	-0.119	0.441	1.457	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	23236825	23236826	1p36.12	0	normal	.	C	ref	C	GA.GC	het-alt	126	0.48	.	1	.	PASS	600997	C	603688(SK)	NN	.	.	.	.	.	.	.	2048	EPHB2	IC13	IVS13	.	.	no-change	NM_004442.6	NP_004433.2	+	Y	c.2506-49C=	.	.	.	NM_004442.6(EPHB2): c.2506-49C=	;maf-5-some-pop,maf-5-all-pops	125018	0.503799	U	0.2659	0.512979	13006	0.417653	PASS	-758	8554	0.770634	15883	120010	0.504500	.	.	.	.	.	.	rs309497	.	4024	0.790300	-0.369	0.097	-0.227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	23236825	23236826	1p36.12	0	normal	.	C	ref	C	GA.GC	het-alt	126	0.48	.	1	.	PASS	600997	C	603688(SK)	NN	.	.	.	.	.	.	.	2048	EPHB2	IC13	IVS13	.	.	no-change	NM_017449.3	NP_059145.2	+	N	c.2503-49C=	.	.	.	NM_017449.3(EPHB2): c.2503-49C=	;maf-5-some-pop,maf-5-all-pops	125018	0.503799	U	0.2659	0.512979	13006	0.417653	PASS	-758	8554	0.770634	15883	120010	0.504500	.	.	.	.	.	.	rs309497	.	4024	0.790300	-0.369	0.097	-0.227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	23236825	23236826	1p36.12	0	normal	.	C	snv	T	GA.GC	het-ref	138	0.52	.	2	.	PASS	600997	C	603688(SK)	NN	.	.	.	.	.	.	.	2048	EPHB2	IC13	IVS13	.	.	intron	NM_004442.6	NP_004433.2	+	Y	c.2506-49C>T	.	.	.	NM_004442.6(EPHB2): c.2506-49C>T	;maf-5-some-pop,maf-5-all-pops	125018	0.496201	U	0.2659	0.512979	13006	0.582347	PASS	223	8554	0.229366	15343	120010	0.495500	441	3903	2.27103e-01	30710	119396	4.91503e-01	rs309497	.	4024	0.209700	-0.369	0.097	-0.227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	23236825	23236826	1p36.12	0	normal	.	C	snv	T	GA.GC	het-ref	138	0.52	.	2	.	PASS	600997	C	603688(SK)	NN	.	.	.	.	.	.	.	2048	EPHB2	IC13	IVS13	.	.	intron	NM_017449.3	NP_059145.2	+	N	c.2503-49C>T	.	.	.	NM_017449.3(EPHB2): c.2503-49C>T	;maf-5-some-pop,maf-5-all-pops	125018	0.496201	U	0.2659	0.512979	13006	0.582347	PASS	223	8554	0.229366	15343	120010	0.495500	441	3903	2.27103e-01	30710	119396	4.91503e-01	rs309497	.	4024	0.209700	-0.369	0.097	-0.227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	27101259	27101260	1p36.11	0	normal	.	G	ref	G	AC.GG	het-alt	386	0.52	.	1	.	PASS	603024	P	614607(MK)	NN	Mental retardation, autosomal dominant 14; Coffin-Siris syndrome	AD	.	Craniofacial; Dermatologic; Musculoskeletal; Neurologic	General	22426309|22426308	.	8289	ARID1A	C18	EX18	.	.	no-change	NM_006015.4	NP_006006.3	+	Y	c.4542G=	.	.	.	NM_006015.4(ARID1A): c.4542G=	;	126252	0.999731	U	0.003	0.000599042	.	.	PASS	.	8648	0.996415	60591	121244	0.999744	.	.	.	.	.	.	rs560211386	.	4024	0.993300	-0.188	-3.051	-2.385	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	27101259	27101260	1p36.11	1	normal	.	G	snv	A	AC.GG	het-ref	360	0.48	.	2	.	PASS	603024	P	614607(MK)	NN	Mental retardation, autosomal dominant 14; Coffin-Siris syndrome	AD	.	Craniofacial; Dermatologic; Musculoskeletal; Neurologic	General	22426309|22426308	.	8289	ARID1A	C18	EX18	.	.	coding-synon	NM_006015.4	NP_006006.3	+	Y	c.4542G>A	p.(T1514=) | p.(Thr1514=)	ACG=>ACA	.	NM_006015.4(ARID1A): c.4542G>A (p.(T1514=))	;	126252	0.000269	U	0.003	0.000599042	.	.	PASS	0	8648	0.003585	0	121244	0.000256	0	56	3.24751e-03	0	57	2.31538e-04	rs560211386	.	4024	0.006700	-0.188	-3.051	-2.385	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
1	29630454	29630455	1p35.3	0	normal	.	C	ref	C	TA.CA	het-alt	176	0.50	.	1	.	PASS	602454	C	.	NN	.	.	.	.	.	.	.	10076	PTPRU	C17	EX17	.	.	no-change	NM_005704.4	NP_005695.3	+	Y	c.2595C=	.	.	.	NM_005704.4(PTPRU): c.2595C=	;maf-5-some-pop,maf-5-all-pops	125598	0.732416	U	0.6419	0.3752	13006	0.798093	PASS	.	8612	0.350790	34127	120590	0.736885	.	.	.	.	.	.	rs2295061	.	4024	0.377000	0.561	0.354	-0.503	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	29630454	29630455	1p35.3	1	normal	.	C	snv	T	TA.CA	het-ref	174	0.50	.	2	.	PASS	602454	C	.	NN	.	.	.	.	.	.	.	10076	PTPRU	C17	EX17	.	.	coding-synon	NM_005704.4	NP_005695.3	+	Y	c.2595C>T	p.(Y865=) | p.(Tyr865=)	TAC=>TAT	.	NM_005704.4(PTPRU): c.2595C>T (p.(Y865=))	;maf-5-some-pop,maf-5-all-pops	125598	0.267584	U	0.6419	0.3752	13006	0.201907	PASS	1808	8612	0.649210	5561	120590	0.263115	3648	11172	6.47953e-01	11620	65633	2.66998e-01	rs2295061	.	4024	0.623000	0.561	0.354	-0.503	.	.	.	.	.	ENST00000345512: c.2595C>T (p.Y865Y)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	1748343	.	.	.	.	.	.	.	.	.	Likely Benign
1	36225947	36225948	1p34.3	0	normal	.	T	ref	T	TG.TG	het-alt	127	0.56	.	1	.	PASS	605434	P	.	NN	.	.	.	.	.	.	.	63967	CLSPN	C8	EX8	.	.	no-change	NM_022111.3	NP_071394.2	-	Y	c.1574A=	.	.	.	NM_022111.3(CLSPN): c.1574A=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	123876	0.720842	U	0.7401	0.453674	13006	0.711287	PASS	-707	8648	0.205597	34243	118868	0.728194	.	.	.	.	.	.	rs7537203	.	4024	0.196100	0.482	3.032	1.907	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	36225947	36225948	1p34.3	1	normal	.	T	snv	C	TG.TG	het-ref	101	0.44	.	2	.	PASS	605434	P	.	NN	.	.	.	.	.	.	.	63967	CLSPN	C8	EX8	.	.	missense	NM_022111.3	NP_071394.2	-	Y	c.1574A>G	p.N525S | p.Asn525Ser	AAC=>AGC	P0=>P0	NM_022111.3(CLSPN): c.1574A>G (p.N525S)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	123876	0.279158	U	0.7401	0.453674	13006	0.288713	PASS	2728	8648	0.794403	7118	118868	0.271806	5489	13732	7.96890e-01	14332	65883	2.69473e-01	rs7537203	.	4024	0.803900	0.482	3.032	1.907	0.01	0.995	0.999	0.863	deleterious	ENST00000318121: c.1574A>G (p.N525S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	5425390	.	.	.	.	.	.	.	.	.	Likely Benign
1	40363053	40363054	1p34.2	0	nullSample	.	G	ref	G	CA.TG	homo-ref	.	.	.	0	.	.	164850	C	.	NN	.	.	.	.	.	.	.	4610	MYCL1	C3E	EX3E	.	.	no-change	NM_001033082.2	NP_001028254.2	-	Y	c.1175C=	.	.	.	NM_001033082.2(MYCL1): c.1175C=	;maf-5-some-pop,genotype-conflict	124716	0.111565	U	1	0.935703	13006	0.096340	PASS	.	8652	0.000578	868	119708	0.113543	.	.	.	.	.	.	rs3134614	.	4024	0.003200	-0.120	1.584	1.316	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	40363053	40363054	1p34.2	1	normal	.	G	snv	C	CA.TG	hom-alt	435	1.00	.	0	.	PASS	164850	C	.	NN	.	.	.	.	.	.	.	4610	MYCL1	C3E	EX3E	.	.	missense	NM_001033082.2	NP_001028254.2	-	Y	c.1175C>G	p.T392S | p.Thr392Ser	ACT=>AGT	P0=>P0	NM_001033082.2(MYCL1): c.1175C>G (p.T392S)	;maf-5-some-pop,genotype-conflict	124716	0.888435	U	1	0.935703	13006	0.903660	PASS	4321	8652	0.999422	47130	119708	0.886457	8550	17114	9.99183e-01	94259	212501	8.84234e-01	rs3134614	.	4024	0.996800	-0.120	1.584	1.316	1	0.001	0	0.000	neutral	ENST00000397332: c.1175C>G (p.T392S)	prostate [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3927628	.	.	.	.	.	.	.	.	.	Likely Benign
1	40364802	40364803	1p34.2	0	nullSample	.	C	ref	C	GA.TT	homo-ref	.	.	.	0	.	.	164850	C	.	NN	.	.	.	.	.	.	.	4610	MYCL1	IC2	IVS2	.	.	no-change	NM_001033082.2	NP_001028254.2	-	Y	c.587-1161G=	.	.	.	NM_001033082.2(MYCL1): c.587-1161G=	;maf-5-some-pop,maf-5-all-pops	5008	0.403754	U	0.5	0.596246	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3134613	.	4024	0.511900	-1.034	0.528	0.509	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	40364802	40364803	1p34.2	0	normal	.	C	snv	A	GA.TT	hom-alt	267	1.00	.	0	.	PASS	164850	C	.	NN	.	.	.	.	.	.	.	4610	MYCL1	IC2	IVS2	.	.	intron	NM_001033082.2	NP_001028254.2	-	Y	c.587-1161G>T	.	.	.	NM_001033082.2(MYCL1): c.587-1161G>T	;maf-5-some-pop,maf-5-all-pops	5008	0.596246	U	0.5	0.596246	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3134613	.	4024	0.488100	-1.034	0.528	0.509	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	40367591	40367592	1p34.2	0	nullSample	.	A	ref	A	AC.Ag	homo-ref	.	.	.	0	.	.	164850	C	.	NN	.	.	.	.	.	.	.	4610	MYCL1	5U1E	EX1	.	.	no-change	NM_001033082.2	NP_001028254.2	-	Y	c.-32T=	.	.	.	NM_001033082.2(MYCL1): c.-32T=	;	5010	0.000000	U	1	1	.	.	PASS	0	0	0	0	2	0.000000	.	.	.	.	.	.	rs804719	.	.	.	-0.220	0.598	0.569	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	40367591	40367592	1p34.2	0	normal	.	A	snv	G	AC.Ag	hom-alt	202	1.00	.	0	.	PASS	164850	C	.	NN	.	.	.	.	.	.	.	4610	MYCL1	5U1E	EX1	.	.	utr-5	NM_001033082.2	NP_001028254.2	-	Y	c.-32T>C	.	.	.	NM_001033082.2(MYCL1): c.-32T>C	;	5010	1.000000	U	1	1	.	.	PASS	0	0	0	1	2	1.000000	0	0	.	91	183	9.73404e-01	rs804719	.	.	.	-0.220	0.598	0.569	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	40367597	40367598	1p34.2	0	nullSample	.	G	ref	G	gc.cc	homo-ref	.	.	.	0	GC_rich|Low_complexity|Low_complexity|+|25	.	164850	C	.	NN	.	.	.	.	.	.	.	4610	MYCL1	5U1E	EX1	.	.	no-change	NM_001033082.2	NP_001028254.2	-	Y	c.-38C=	.	.	.	NM_001033082.2(MYCL1): c.-38C=	.	.	.	.	0.4702	0.185304	.	.	VQSRTrancheINDEL99.00to99.50	0	0	0	0	0	0	.	.	.	.	.	.	.	.	.	.	0.558	1.368	0.896	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	40367598	40367598	1p34.2	0	normal	.	.	ins	C	cg.cc	hom-alt	150	0.95	.	0	GC_rich|Low_complexity|Low_complexity|+|25	PASS	164850	C	.	NN	.	.	.	.	.	.	.	4610	MYCL1	5U1E	EX1	.	.	utr-5	NM_001033082.2	NP_001028254.2	-	Y	c.-46G[8>9] (std: c.-39dupG alt: c.-39_-38insG )	.	.	.	NM_001033082.2(MYCL1): c.-39dupG	;	5008	0.185304	U	0.4702	0.185304	160	0.168750	VQSRTrancheINDEL99.00to99.50	0	0	0	0	0	0	0	0	.	0	0	0.00000e+00	rs145342438	.	4130	0.427600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	45291907	45291908	1p34.1	0	normal	.	G	ref	G	GG.TG	het-alt	298	0.52	.	1	.	PASS	603673	P	109400(MK);155255(MK);605462(MK)	AD	Basal cell nevus syndrome	AD	.	Dermatologic; Musculoskeletal; Oncologic	Oncologic	23479190|22670904|22670903|18285427	.	8643	PTCH2	IC19	IVS19	.	.	no-change	NM_001166292.1	NP_001159764.1	-	Y	c.3114+14C=	.	.	.	NM_001166292.1(PTCH2): c.3114+14C=	;maf-5-some-pop,maf-5-all-pops	116580	0.803551	U	0.2887	0.195687	13006	0.838152	PASS	-830	8180	0.732029	35906	111572	0.803517	.	.	.	.	.	.	rs11211040	.	4024	0.742300	0.655	1.571	2.608	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	45291907	45291908	1p34.1	1	normal	.	G	snv	A	GG.TG	het-ref	272	0.48	.	2	.	PASS	603673	P	109400(MK);155255(MK);605462(MK)	AD	Basal cell nevus syndrome	AD	.	Dermatologic; Musculoskeletal; Oncologic	Oncologic	23479190|22670904|22670903|18285427	.	8643	PTCH2	IC19	IVS19	.	.	intron	NM_001166292.1	NP_001159764.1	-	Y	c.3114+14C>T	.	.	.	NM_001166292.1(PTCH2): c.3114+14C>T	;maf-5-some-pop,maf-5-all-pops	116580	0.196449	U	0.2887	0.195687	13006	0.161848	PASS	266	8180	0.267971	2042	111572	0.196483	599	4547	2.64915e-01	4396	45659	1.86952e-01	rs11211040	.	4024	0.257700	0.655	1.571	2.608	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	45292172	45292173	1p34.1	0	normal	.	G	ref	G	CC.TC	het-alt	359	0.50	.	1	.	PASS	603673	P	109400(MK);155255(MK);605462(MK)	AD	Basal cell nevus syndrome	AD	.	Dermatologic; Musculoskeletal; Oncologic	Oncologic	23479190|22670904|22670903|18285427	.	8643	PTCH2	C18	EX18	Patched family	PF02460.13	no-change	NM_001166292.1	NP_001159764.1	-	Y	c.2963C=	.	.	.	NM_001166292.1(PTCH2): c.2963C=	;maf-5-some-pop,genotype-conflict	124658	0.955205	U	0.1677	0.0628994	13004	0.983928	PASS	-582	8582	0.840830	54781	119650	0.955963	.	.	.	.	.	.	rs11573590	.	4024	0.841900	-0.137	0.884	-0.012	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	45292172	45292173	1p34.1	1	normal	.	G	snv	A	CC.TC	het-ref	364	0.50	.	2	.	PASS	603673	P	109400(MK);155255(MK);605462(MK)	AD	Basal cell nevus syndrome	AD	.	Dermatologic; Musculoskeletal; Oncologic	Oncologic	23479190|22670904|22670903|18285427	.	8643	PTCH2	C18	EX18	Patched family	PF02460.13	missense	NM_001166292.1	NP_001159764.1	-	Y	c.2963C>T	p.T988M | p.Thr988Met	ACG=>ATG	P0=>NP	NM_001166292.1(PTCH2): c.2963C>T (p.T988M)	;maf-5-some-pop,genotype-conflict	124658	0.044795	U	0.1677	0.0628994	13004	0.016072	PASS	101	8582	0.159170	225	119650	0.044037	234	2832	1.64498e-01	505	11413	4.66488e-02	rs11573590	.	4024	0.158100	-0.137	0.884	-0.012	0.09	0.747	0.934	0.571	deleterious	ENST00000372192: c.2963C>T (p.T988M)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	RSS	1162381	.	.	.	.	.	no_record	415448	criteria_provided,_single_submitter	Benign	Likely Benign
1	45292865	45292866	1p34.1	0	normal	.	G	ref	G	GC.TC	het-alt	354	0.52	.	1	.	PASS	603673	P	109400(MK);155255(MK);605462(MK)	AD	Basal cell nevus syndrome	AD	.	Dermatologic; Musculoskeletal; Oncologic	Oncologic	23479190|22670904|22670903|18285427	.	8643	PTCH2	C16	EX16	.	.	no-change	NM_001166292.1	NP_001159764.1	-	Y	c.2487C=	.	.	.	NM_001166292.1(PTCH2): c.2487C=	SingleClassTriAllelic;maf-5-some-pop	126232	0.839716	U	0.1964	0.147764	13006	0.860526	PASS	-751	8622	0.778010	42803	121224	0.839199	.	.	.	.	.	.	rs2295996	.	4024	0.746800	-0.484	0.247	-0.186	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	45292865	45292866	1p34.1	1	normal	.	G	snv	A	GC.TC	het-ref	327	0.48	.	2	.	PASS	603673	P	109400(MK);155255(MK);605462(MK)	AD	Basal cell nevus syndrome	AD	.	Dermatologic; Musculoskeletal; Oncologic	Oncologic	23479190|22670904|22670903|18285427	.	8643	PTCH2	C16	EX16	.	.	coding-synon	NM_001166292.1	NP_001159764.1	-	Y	c.2487C>T	p.(D829=) | p.(Asp829=)	GAC=>GAT	.	NM_001166292.1(PTCH2): c.2487C>T (p.(D829=))	SingleClassTriAllelic;maf-5-some-pop	126232	0.160276	U	0.1964	0.147764	13006	0.139474	PASS	206	8622	0.221990	1683	121224	0.160793	397	3654	2.11900e-01	3413	39935	1.62217e-01	rs2295996	.	4024	0.253200	-0.484	0.247	-0.186	.	.	.	.	.	ENST00000372192: c.2487C>T (p.D829D)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	3751243	.	.	.	.	.	.	.	.	.	Likely Benign
1	45293517	45293518	1p34.1	0	nullSample	.	A	ref	A	TT.GC	homo-ref	.	.	.	0	.	.	603673	P	109400(MK);155255(MK);605462(MK)	AD	Basal cell nevus syndrome	AD	.	Dermatologic; Musculoskeletal; Oncologic	Oncologic	23479190|22670904|22670903|18285427	.	8643	PTCH2	C14	EX14	Patched family	PF02460.13	no-change	NM_001166292.1	NP_001159764.1	-	Y	c.2055T=	.	.	.	NM_001166292.1(PTCH2): c.2055T=	;maf-5-some-pop,maf-5-all-pops	125538	0.613010	U	0.4911	0.445487	13006	0.575581	PASS	.	8582	0.515614	23215	120530	0.615440	.	.	.	.	.	.	rs7525308	.	4024	0.487100	-0.226	1.242	0.371	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	45293517	45293518	1p34.1	1	normal	.	A	snv	G	TT.GC	hom-alt	474	1.00	.	0	.	PASS	603673	P	109400(MK);155255(MK);605462(MK)	AD	Basal cell nevus syndrome	AD	.	Dermatologic; Musculoskeletal; Oncologic	Oncologic	23479190|22670904|22670903|18285427	.	8643	PTCH2	C14	EX14	Patched family	PF02460.13	coding-synon	NM_001166292.1	NP_001159764.1	-	Y	c.2055T>C	p.(A685=) | p.(Ala685=)	GCT=>GCC	.	NM_001166292.1(PTCH2): c.2055T>C (p.(A685=))	;maf-5-some-pop,maf-5-all-pops	125538	0.386990	U	0.4911	0.445487	13006	0.424419	PASS	1014	8582	0.484386	9301	120530	0.384560	2025	8274	4.80655e-01	18446	93493	3.80942e-01	rs7525308	.	4024	0.512900	-0.226	1.242	0.371	.	.	.	.	.	ENST00000372192: c.2055T>C (p.A685A)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3751244	.	.	.	.	.	.	.	.	.	Likely Benign
1	45293751	45293752	1p34.1	0	normal	.	T	ref	T	GC.TC	het-alt	281	0.50	.	1	.	PASS	603673	P	109400(MK);155255(MK);605462(MK)	AD	Basal cell nevus syndrome	AD	.	Dermatologic; Musculoskeletal; Oncologic	Oncologic	23479190|22670904|22670903|18285427	.	8643	PTCH2	C14	EX14	Patched family	PF02460.13	no-change	NM_001166292.1	NP_001159764.1	-	Y	c.1821A=	.	.	.	NM_001166292.1(PTCH2): c.1821A=	;maf-5-some-pop,maf-5-all-pops	126330	0.809396	U	0.2897	0.21266	13006	0.820544	PASS	.	8630	0.740788	39935	121322	0.810306	.	.	.	.	.	.	rs2295997	.	4024	0.742000	0.455	1.636	0.610	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	45293751	45293752	1p34.1	1	normal	.	T	snv	C	GC.TC	het-ref	278	0.50	.	2	.	PASS	603673	P	109400(MK);155255(MK);605462(MK)	AD	Basal cell nevus syndrome	AD	.	Dermatologic; Musculoskeletal; Oncologic	Oncologic	23479190|22670904|22670903|18285427	.	8643	PTCH2	C14	EX14	Patched family	PF02460.13	coding-synon	NM_001166292.1	NP_001159764.1	-	Y	c.1821A>G	p.(E607=) | p.(Glu607=)	GAA=>GAG	.	NM_001166292.1(PTCH2): c.1821A>G (p.(E607=))	;maf-5-some-pop,maf-5-all-pops	126330	0.190604	U	0.2897	0.21266	13006	0.179456	PASS	287	8630	0.259212	2288	121322	0.189694	618	4597	2.66555e-01	4700	46927	1.91426e-01	rs2295997	.	4024	0.258000	0.455	1.636	0.610	.	.	.	.	.	ENST00000372192: c.1821A>G (p.E607E)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019415	.	.	.	.	.	.	.	.	.	Likely Benign
1	45294155	45294156	1p34.1	0	nullSample	.	T	ref	T	GC.GC	homo-ref	.	.	.	0	.	.	603673	P	109400(MK);155255(MK);605462(MK)	AD	Basal cell nevus syndrome	AD	.	Dermatologic; Musculoskeletal; Oncologic	Oncologic	23479190|22670904|22670903|18285427	.	8643	PTCH2	IC12	IVS12	.	.	no-change	NM_001166292.1	NP_001159764.1	-	Y	c.1590+22A=	.	.	.	NM_001166292.1(PTCH2): c.1590+22A=	;maf-5-some-pop,maf-5-all-pops	125180	0.614283	U	0.4921	0.443291	13006	0.578502	PASS	.	8606	0.516500	23228	120172	0.616683	.	.	.	.	.	.	rs2273940	.	4024	0.486800	-1.403	-0.197	-0.034	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	45294155	45294156	1p34.1	0	normal	.	T	snv	C	GC.GC	hom-alt	593	1.00	.	0	.	PASS	603673	P	109400(MK);155255(MK);605462(MK)	AD	Basal cell nevus syndrome	AD	.	Dermatologic; Musculoskeletal; Oncologic	Oncologic	23479190|22670904|22670903|18285427	.	8643	PTCH2	IC12	IVS12	.	.	intron	NM_001166292.1	NP_001159764.1	-	Y	c.1590+22A>G	.	.	.	NM_001166292.1(PTCH2): c.1590+22A>G	;maf-5-some-pop,maf-5-all-pops	125180	0.385717	U	0.4921	0.443291	13006	0.421498	PASS	1020	8606	0.483500	9206	120172	0.383317	2032	8282	4.81344e-01	18333	93259	3.80152e-01	rs2273940	.	4024	0.513200	-1.403	-0.197	-0.034	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	45296751	45296752	1p34.1	0	normal	.	C	ref	C	GA.GA	het-alt	155	0.53	.	1	.	PASS	603673	P	109400(MK);155255(MK);605462(MK)	AD	Basal cell nevus syndrome	AD	.	Dermatologic; Musculoskeletal; Oncologic	Oncologic	23479190|22670904|22670903|18285427	.	8643	PTCH2	IC5	IVS5	.	.	no-change	NM_001166292.1	NP_001159764.1	-	Y	c.618-37G=	.	.	.	NM_001166292.1(PTCH2): c.618-37G=	;maf-5-some-pop,maf-5-all-pops	102894	0.796859	U	0.2887	0.204473	13002	0.828642	PASS	.	6988	0.722811	30917	97886	0.796927	.	.	.	.	.	.	rs2295998	.	4024	0.742300	-1.046	-0.339	-0.845	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	45296751	45296752	1p34.1	0	normal	.	C	snv	T	GA.GA	het-ref	137	0.47	.	2	.	PASS	603673	P	109400(MK);155255(MK);605462(MK)	AD	Basal cell nevus syndrome	AD	.	Dermatologic; Musculoskeletal; Oncologic	Oncologic	23479190|22670904|22670903|18285427	.	8643	PTCH2	IC5	IVS5	.	.	intron	NM_001166292.1	NP_001159764.1	-	Y	c.618-37G>A	.	.	.	NM_001166292.1(PTCH2): c.618-37G>A	;maf-5-some-pop,maf-5-all-pops	102894	0.203141	U	0.2887	0.204473	13002	0.171358	PASS	228	6988	0.277189	1852	97886	0.203073	559	4303	2.67168e-01	4195	43446	1.92394e-01	rs2295998	.	4024	0.257700	-1.046	-0.339	-0.845	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	45297752	45297753	1p34.1	0	normal	.	A	ref	A	GA.GG	het-alt	247	0.50	.	1	.	PASS	603673	P	109400(MK);155255(MK);605462(MK)	AD	Basal cell nevus syndrome	AD	.	Dermatologic; Musculoskeletal; Oncologic	Oncologic	23479190|22670904|22670903|18285427	.	8643	PTCH2	IC3	IVS3	.	.	no-change	NM_001166292.1	NP_001159764.1	-	Y	c.456-37T=	.	.	.	NM_001166292.1(PTCH2): c.456-37T=	SingleClassTriAllelic;maf-5-some-pop	126328	0.781759	U	0	0.0131789	13006	0.738505	PASS	.	8636	0.741431	37904	121320	0.784899	.	.	.	.	.	.	rs2295999	.	4024	0.741600	-2.463	-0.574	-0.649	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	45297752	45297753	1p34.1	0	normal	.	A	snv	G	GA.GG	het-ref	249	0.50	.	2	.	PASS	603673	P	109400(MK);155255(MK);605462(MK)	AD	Basal cell nevus syndrome	AD	.	Dermatologic; Musculoskeletal; Oncologic	Oncologic	23479190|22670904|22670903|18285427	.	8643	PTCH2	IC3	IVS3	.	.	intron	NM_001166292.1	NP_001159764.1	-	Y	c.456-37T>C	.	.	.	NM_001166292.1(PTCH2): c.456-37T>C	SingleClassTriAllelic;maf-5-some-pop	126328	0.214347	U	0.2887	0.28115	13006	0.261495	PASS	286	8636	0.258569	3148	121320	0.211589	612	4581	2.65658e-01	6013	51247	2.08177e-01	rs2295999	.	4024	0.258400	-2.463	-0.574	-0.649	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	45307505	45307506	1p34.1	0	normal	.	G	ref	G	GT.TC	het-alt	216	0.55	.	1	.	PASS	603673	P	109400(MK);155255(MK);605462(MK)	AD	Basal cell nevus syndrome	AD	.	Dermatologic; Musculoskeletal; Oncologic	Oncologic	23479190|22670904|22670903|18285427	.	8643	PTCH2	IC2	IVS2	.	.	no-change	NM_001166292.1	NP_001159764.1	-	Y	c.265+13C=	.	.	.	NM_001166292.1(PTCH2): c.265+13C=	MixedObserved;maf-5-some-pop,maf-5-all-pops	126362	0.632302	U	0.4454	0.372005	13006	0.660926	PASS	.	8640	0.568866	24663	121354	0.632480	.	.	.	.	.	.	rs3795720	.	4024	0.543500	0.561	1.263	0.562	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	45307505	45307506	1p34.1	1	normal	.	G	snv	A	GT.TC	het-ref	179	0.45	.	2	.	PASS	603673	P	109400(MK);155255(MK);605462(MK)	AD	Basal cell nevus syndrome	AD	.	Dermatologic; Musculoskeletal; Oncologic	Oncologic	23479190|22670904|22670903|18285427	.	8643	PTCH2	IC2	IVS2	.	.	intron	NM_001166292.1	NP_001159764.1	-	Y	c.265+13C>T	.	.	.	NM_001166292.1(PTCH2): c.265+13C>T	MixedObserved;maf-5-some-pop,maf-5-all-pops	126362	0.367698	U	0.4454	0.372005	13006	0.339074	PASS	813	8640	0.431134	8586	121354	0.367520	1648	7488	4.34238e-01	17983	92094	3.74116e-01	rs3795720	.	4024	0.456500	0.561	1.263	0.562	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	45796268	45796269	1p34.1	0	nullSample	.	G	ref	G	TT.CA	homo-ref	.	.	.	0	.	.	604933	P	132600(MK);608456(MK);613659(MK)	NN	Familial adenomatous polyposis, 2; Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas 	AR	.	Dermatologic; Oncologic	Oncologic	22865608|22851115|22744763|22658618|22371070|21696383|21171015|21063410|21061173|15690400|12853198|12606733|12393807|11818965	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HE15;MC58;MH43	4595	MUTYH	IC14	IVS14	.	.	no-change	NM_001128425.1	NP_001121897.1	-	Y	c.1477-40C=	.	.	.	NM_001128425.1(MUTYH): c.1477-40C=	;maf-5-some-pop	89272	0.074928	U	0.9137	0.935304	13004	0.073747	PASS	-282	5798	0.106244	220	84264	0.075536	.	.	.	.	.	.	rs3219493	.	4024	0.147400	-0.215	-0.265	-0.268	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	45796268	45796269	1p34.1	0	normal	.	G	snv	C	TT.CA	hom-alt	326	1.00	.	0	.	PASS	604933	P	132600(MK);608456(MK);613659(MK)	NN	Familial adenomatous polyposis, 2; Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas 	AR	.	Dermatologic; Oncologic	Oncologic	22865608|22851115|22744763|22658618|22371070|21696383|21171015|21063410|21061173|15690400|12853198|12606733|12393807|11818965	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HE15;MC58;MH43	4595	MUTYH	IC14	IVS14	.	.	intron	NM_001128425.1	NP_001121897.1	-	Y	c.1477-40C>G	.	.	.	NM_001128425.1(MUTYH): c.1477-40C>G	;maf-5-some-pop	89272	0.925072	U	0.9137	0.935304	13004	0.926253	PASS	2309	5798	0.893756	35987	84264	0.924464	5908	13290	8.89082e-01	90051	194714	9.24515e-01	rs3219493	.	4024	0.852600	-0.215	-0.265	-0.268	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	439920	criteria_provided,_single_submitter	Benign	Benign
1	45796898	45796899	1p34.1	0	normal	.	C	ref	C	TG.GT	het-alt	373	0.55	.	1	.	PASS	604933	P	132600(MK);608456(MK);613659(MK)	NN	Familial adenomatous polyposis, 2; Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas 	AR	.	Dermatologic; Oncologic	Oncologic	22865608|22851115|22744763|22658618|22371070|21696383|21171015|21063410|21061173|15690400|12853198|12606733|12393807|11818965	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HE15;MC58;MH43	4595	MUTYH	C14	EX14	NUDIX domain	PF14815.1	no-change	NM_001128425.1	NP_001121897.1	-	Y	c.1431G=	.	.	.	NM_001128425.1(MUTYH): c.1431G=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126402	0.994897	U	0.0308	0.0103834	13006	0.995848	PASS	.	8650	0.971908	60112	121394	0.995115	.	.	.	.	.	.	rs74318065	.	4024	0.969900	-1.789	0.428	-0.542	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	45796898	45796899	1p34.1	1	normal	.	C	snv	G	TG.GT	het-ref	304	0.45	.	2	.	PASS	604933	P	132600(MK);608456(MK);613659(MK)	NN	Familial adenomatous polyposis, 2; Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas 	AR	.	Dermatologic; Oncologic	Oncologic	22865608|22851115|22744763|22658618|22371070|21696383|21171015|21063410|21061173|15690400|12853198|12606733|12393807|11818965	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HE15;MC58;MH43	4595	MUTYH	C14	EX14	NUDIX domain	PF14815.1	coding-synon	NM_001128425.1	NP_001121897.1	-	Y	c.1431G>C	p.(T477=) | p.(Thr477=)	ACG=>ACC	.	NM_001128425.1(MUTYH): c.1431G>C (p.(T477=))	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126402	0.005103	U	0.0308	0.0103834	13006	0.004152	PASS	4	8650	0.028092	8	121394	0.004885	7	427	2.47565e-02	13	1120	4.54804e-03	rs74318065	.	4024	0.029800	-1.789	0.428	-0.542	.	.	.	.	.	ENST00000372098: c.1422G>C (p.T474T)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4417650	.	.	.	.	.	no_record	183787	criteria_provided,_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	Certain
1	45797504	45797505	1p34.1	0	nullSample	.	C	ref	C	CA.TG	homo-ref	.	.	.	0	.	.	604933	P	132600(MK);608456(MK);613659(MK)	NN	Familial adenomatous polyposis, 2; Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas 	AR	.	Dermatologic; Oncologic	Oncologic	22865608|22851115|22744763|22658618|22371070|21696383|21171015|21063410|21061173|15690400|12853198|12606733|12393807|11818965	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HE15;MC58;MH43	4595	MUTYH	C12	EX12	.	.	no-change	NM_001128425.1	NP_001121897.1	-	Y	c.1014G=	.	.	.	NM_001128425.1(MUTYH): c.1014G=	MixedObserved;maf-5-some-pop,maf-5-all-pops	102302	0.702498	U	0.3909	0.313498	13002	0.745885	PASS	.	6868	0.569744	24048	97294	0.703322	.	.	.	.	.	.	rs3219489	.	4024	0.623300	-0.140	-0.078	0.240	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	45797504	45797505	1p34.1	1	normal	.	C	snv	G	CA.TG	hom-alt	450	1.00	.	0	.	PASS	604933	P	132600(MK);608456(MK);613659(MK)	NN	Familial adenomatous polyposis, 2; Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas 	AR	.	Dermatologic; Oncologic	Oncologic	22865608|22851115|22744763|22658618|22371070|21696383|21171015|21063410|21061173|15690400|12853198|12606733|12393807|11818965	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HE15;MC58;MH43	4595	MUTYH	C12	EX12	.	.	missense	NM_001128425.1	NP_001121897.1	-	Y	c.1014G>C	p.Q338H | p.Gln338His	CAG=>CAC	P0=>P+	NM_001128425.1(MUTYH): c.1014G>C (p.Q338H)	MixedObserved;maf-5-some-pop,maf-5-all-pops	102302	0.297502	U	0.3909	0.313498	13002	0.254115	PASS	570	6868	0.430256	4266	97294	0.296678	1215	6423	3.96923e-01	10375	65945	2.89123e-01	rs3219489	.	4024	0.376700	-0.140	-0.078	0.240	0.11	0.152	0.315	0.285	neutral	ENST00000372098: c.1005G>C (p.Q335H)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3751252	.	.	.	.	.	no_record	41767	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
1	45798554	45798555	1p34.1	0	normal	.	T	snv	C	AT.GT	hom-alt	547	1.00	.	0	.	PASS	604933	P	132600(MK);608456(MK);613659(MK)	NN	Familial adenomatous polyposis, 2; Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas 	AR	.	Dermatologic; Oncologic	Oncologic	22865608|22851115|22744763|22658618|22371070|21696383|21171015|21063410|21061173|15690400|12853198|12606733|12393807|11818965	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HE15;MC58;MH43	4595	MUTYH	IC6	IVS6	.	.	intron	NM_001128425.1	NP_001121897.1	-	Y	c.504+35A>G	.	.	.	NM_001128425.1(MUTYH): c.504+35A>G	;maf-5-some-pop	126360	0.925973	U	0.9137	0.937101	13006	0.930263	PASS	3419	8654	0.888144	52022	121352	0.925514	6812	15319	8.88264e-01	105531	227721	9.26147e-01	rs3219487	.	4024	0.852600	-1.381	-0.770	-1.063	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	257529	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
1	45798554	45798555	1p34.1	0	nullSample	.	T	ref	T	AT.GT	homo-ref	.	.	.	0	.	.	604933	P	132600(MK);608456(MK);613659(MK)	NN	Familial adenomatous polyposis, 2; Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas 	AR	.	Dermatologic; Oncologic	Oncologic	22865608|22851115|22744763|22658618|22371070|21696383|21171015|21063410|21061173|15690400|12853198|12606733|12393807|11818965	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HE15;MC58;MH43	4595	MUTYH	IC6	IVS6	.	.	no-change	NM_001128425.1	NP_001121897.1	-	Y	c.504+35A=	.	.	.	NM_001128425.1(MUTYH): c.504+35A=	;maf-5-some-pop	126360	0.074027	U	0.9137	0.937101	13006	0.069737	PASS	-424	8654	0.111856	385	121352	0.074486	.	.	.	.	.	.	rs3219487	.	4024	0.147400	-1.381	-0.770	-1.063	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	45805879	45805880	1p34.1	1	normal	.	G	snv	A	AA.TC	het-ref	182	0.49	.	2	.	PASS	604933	P	132600(MK);608456(MK);613659(MK)	NN	Familial adenomatous polyposis, 2; Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas 	AR	.	Dermatologic; Oncologic	Oncologic	22865608|22851115|22744763|22658618|22371070|21696383|21171015|21063410|21061173|15690400|12853198|12606733|12393807|11818965	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HE15;MC58;MH43	4595	MUTYH	IC1	IVS1	.	.	intron	NM_001128425.1	NP_001121897.1	-	Y	c.36+11C>T	.	.	.	NM_001128425.1(MUTYH): c.36+11C>T	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118836	0.003854	U	0.0308	0.00678914	13006	0.000384	PASS	4	8408	0.028782	6	113828	0.003725	7	425	2.47266e-02	9	814	3.32968e-03	rs2275602	.	4024	0.029800	0.655	3.358	2.770	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	138310	criteria_provided,_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	Likely Deleterious
1	45805879	45805880	1p34.1	0	normal	.	G	ref	G	AA.TC	het-alt	193	0.51	.	1	.	PASS	604933	P	132600(MK);608456(MK);613659(MK)	NN	Familial adenomatous polyposis, 2; Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas 	AR	.	Dermatologic; Oncologic	Oncologic	22865608|22851115|22744763|22658618|22371070|21696383|21171015|21063410|21061173|15690400|12853198|12606733|12393807|11818965	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HE15;MC58;MH43	4595	MUTYH	IC1	IVS1	.	.	no-change	NM_001128425.1	NP_001121897.1	-	Y	c.36+11C=	.	.	.	NM_001128425.1(MUTYH): c.36+11C=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118836	0.996146	U	0.0308	0.00678914	13006	0.999616	PASS	-117	8408	0.971218	56496	113828	0.996275	.	.	.	.	.	.	rs2275602	.	4024	0.970200	0.655	3.358	2.770	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	47398742	47398743	1p33	0	nullSample	.	G	ref	G	GA.AG	homo-ref	.	.	.	0	dup	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr1: g.47398742G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	126212	0.303291	U	0.496	0.571486	13006	0.339843	PASS	.	8618	0.480274	6319	121204	0.298117	.	.	.	.	.	.	rs3890011	.	.	.	-0.929	-3.934	-3.776	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	47398742	47398743	1p33	0	normal	.	G	snv	C	GA.AG	hom-alt	419	1.00	.	0	dup	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr1: g.47398742G>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	126212	0.696709	U	0.496	0.571486	13006	0.660157	PASS	1161	8618	0.519726	30788	121204	0.701883	2386	9062	5.25638e-01	63214	173844	7.07747e-01	rs3890011	.	.	.	-0.929	-3.934	-3.776	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	47685454	47685455	1p33	0	nullSample	.	T	ref	T	TG.TT	homo-ref	.	.	.	0	.	.	187040	C	187040(MK)	NN	.	.	.	.	.	.	.	6886	TAL1	C3E	EX4E	.	.	no-change	NM_003189.2	NP_003180.1	-	Y	c.933A=	.	.	.	NM_003189.2(TAL1): c.933A=	SingleClassTriAllelic;	121376	0.000000	U	1	1	.	.	PASS	0	8366	0.000000	0	116368	0.000000	.	.	.	.	.	.	rs927462	.	4024	0.001500	-1.479	0.517	-0.035	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	47685454	47685455	1p33	1	normal	.	T	snv	C	TG.TT	hom-alt	304	1.00	.	0	.	PASS	187040	C	187040(MK)	NN	.	.	.	.	.	.	.	6886	TAL1	C3E	EX4E	.	.	coding-synon	NM_003189.2	NP_003180.1	-	Y	c.933A>G	p.(K311=) | p.(Lys311=)	AAA=>AAG	.	NM_003189.2(TAL1): c.933A>G (p.(K311=))	SingleClassTriAllelic;	121376	0.999992	U	1	1	.	.	PASS	4183	8366	1.000000	58183	116368	0.999991	8507	17014	1.00000e+00	120080	240161	9.99996e-01	rs927462	.	4024	0.998500	-1.479	0.517	-0.035	.	.	.	.	.	ENST00000371884: c.933A>G (p.K311K)	large_intestine [colon|descending|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3751261	.	.	.	.	.	.	.	.	.	Likely Benign
1	51873950	51873951	1p32.3	0	nullSample	.	G	ref	G	TC.TA	homo-ref	.	.	.	0	.	.	600051	P	.	NN	.	.	.	.	.	.	.	2060	EPS15	C15	EX15	.	.	no-change	NM_001981.2	NP_001972.1	-	Y	c.1329C=	.	.	.	NM_001981.2(EPS15): c.1329C=	;maf-5-some-pop	126378	0.261826	U	0.9921	0.822684	13006	0.270721	PASS	-28	8652	0.006472	5039	121370	0.265313	.	.	.	.	.	.	rs1065754	.	4024	0.010200	-0.360	-0.289	-0.339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	51873950	51873951	1p32.3	1	normal	.	G	snv	A	TC.TA	hom-alt	405	1.00	.	0	.	PASS	600051	P	.	NN	.	.	.	.	.	.	.	2060	EPS15	C15	EX15	.	.	coding-synon	NM_001981.2	NP_001972.1	-	Y	c.1329C>T	p.(Y443=) | p.(Tyr443=)	TAC=>TAT	.	NM_001981.2(EPS15): c.1329C>T (p.(Y443=))	;maf-5-some-pop	126378	0.738174	U	0.9921	0.822684	13006	0.729279	PASS	4270	8652	0.993528	33523	121370	0.734687	8505	17127	9.93215e-01	67251	179906	7.30707e-01	rs1065754	.	4024	0.989800	-0.360	-0.289	-0.339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
1	59248812	59248813	1p32.1	0	nullSample	.	G	ref	G	CT.TG	homo-ref	.	.	.	0	.	.	165160	C	.	NN	.	.	.	.	.	.	.	3725	JUN	5U1E	EX1E	.	.	utr-5	NM_002228.3	NP_002219.1	-	Y	c.-71G>C	.	.	.	NM_002228.3(JUN): c.-71G>C	;maf-5-some-pop	5008	0.048123	U	1	0.951877	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2760499	.	.	.	-0.357	0.744	0.444	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	59248812	59248813	1p32.1	0	normal	.	G	snv	C	CT.TG	hom-alt	350	1.00	.	0	.	PASS	165160	C	.	NN	.	.	.	.	.	.	.	3725	JUN	5U1E	EX1E	.	.	no-change	NM_002228.3	NP_002219.1	-	Y	c.-71G=	.	.	.	NM_002228.3(JUN): c.-71G=	;maf-5-some-pop	5008	0.951877	U	1	0.951877	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2760499	.	.	.	-0.357	0.744	0.444	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	65310488	65310489	1p31.3	0	normal	.	T	ref	T	AA.GG	het-alt	282	0.47	.	1	.	PASS	147795	C	.	NN	.	.	.	.	.	.	.	3716	JAK1	C15	EX16	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	no-change	NM_002227.2	NP_002218.2	-	Y	c.2199A=	.	.	.	NM_002227.2(JAK1): c.2199A=	;maf-5-some-pop,genotype-conflict	125712	0.703314	U	0.2996	0.372604	12692	0.650804	PASS	.	8612	0.686368	30918	120704	0.706464	.	.	.	.	.	.	rs2230588	.	4024	0.716500	-2.706	-3.681	-4.134	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	65310488	65310489	1p31.3	1	normal	.	T	snv	C	AA.GG	het-ref	313	0.53	.	2	.	PASS	147795	C	.	NN	.	.	.	.	.	.	.	3716	JAK1	C15	EX16	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_002227.2	NP_002218.2	-	Y	c.2199A>G	p.(P733=) | p.(Pro733=)	CCA=>CCG	.	NM_002227.2(JAK1): c.2199A>G (p.(P733=))	;maf-5-some-pop,genotype-conflict	125712	0.296686	U	0.2996	0.372604	12692	0.349196	PASS	457	8612	0.313632	5997	120704	0.293536	873	5468	3.17022e-01	11906	72460	2.94323e-01	rs2230588	.	4024	0.283500	-2.706	-3.681	-4.134	.	.	.	.	.	ENST00000342505: c.2199A>G (p.P733P)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3751351	.	.	.	.	.	.	.	.	.	Likely Benign
1	65311115	65311116	1p31.3	0	normal	.	G	ref	G	TG.CT	het-alt	99	0.44	.	1	.	PASS	147795	C	.	NN	.	.	.	.	.	.	.	3716	JAK1	IC14	IVS15	.	.	no-change	NM_002227.2	NP_002218.2	-	Y	c.2115+80C=	.	.	.	NM_002227.2(JAK1): c.2115+80C=	MixedObserved;maf-5-some-pop,maf-5-all-pops|MixedObserved;	5008|0	0.629193|0	U	0.2996	0.370807	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2780821|rs370311896	.	4024	0.716900	-1.233	-0.882	-0.501	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	65311115	65311116	1p31.3	0	normal	.	G	snv	C	TG.CT	het-ref	124	0.56	.	2	.	PASS	147795	C	.	NN	.	.	.	.	.	.	.	3716	JAK1	IC14	IVS15	.	.	intron	NM_002227.2	NP_002218.2	-	Y	c.2115+80C>G	.	.	.	NM_002227.2(JAK1): c.2115+80C>G	MixedObserved;maf-5-some-pop,maf-5-all-pops|MixedObserved;	5008|0	0.370807|0	U	0.2996	0.370807	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2780821|rs370311896	.	4024	0.283100	-1.233	-0.882	-0.501	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	65311116	65311117	1p31.3	0	normal	.	C	ref	C	GG.TA	het-alt	101	0.44	.	1	.	PASS	147795	C	.	NN	.	.	.	.	.	.	.	3716	JAK1	IC14	IVS15	.	.	no-change	NM_002227.2	NP_002218.2	-	Y	c.2115+79G=	.	.	.	NM_002227.2(JAK1): c.2115+79G=	MixedObserved;maf-5-some-pop,maf-5-all-pops	4998	0.626851	U	0	0.00199681	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2780896	.	4024	0.716900	0.411	0.528	0.542	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	65311116	65311117	1p31.3	0	normal	.	C	snv	T	GG.TA	het-ref	127	0.56	.	2	.	PASS	147795	C	.	NN	.	.	.	.	.	.	.	3716	JAK1	IC14	IVS15	.	.	intron	NM_002227.2	NP_002218.2	-	Y	c.2115+79G>A	.	.	.	NM_002227.2(JAK1): c.2115+79G>A	MixedObserved;maf-5-some-pop,maf-5-all-pops	4998	0.373149	U	0.2996	0.372404	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2780896	.	4024	0.283100	0.411	0.528	0.542	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	65321387	65321388	1p31.3	1	normal	.	G	snv	A	TC.GG	het-ref	190	0.45	.	2	.	PASS	147795	C	.	NN	.	.	.	.	.	.	.	3716	JAK1	IC9	IVS10	.	.	intron	NM_002227.2	NP_002218.2	-	Y	c.1459-7C>T	.	.	.	NM_002227.2(JAK1): c.1459-7C>T	;maf-5-some-pop,maf-5-all-pops	122370	0.359214	U	0.3065	0.402556	11980	0.380134	PASS	472	8458	0.326437	7970	117362	0.357364	919	5608	3.27417e-01	16690	86661	3.58548e-01	rs310229	.	4024	0.300400	-0.977	0.022	-0.186	.	.	.	.	.	ENST00000342505: c.1459-7C>T (p.?)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	5019821	.	.	.	.	.	.	.	.	.	Benign
1	65321387	65321388	1p31.3	0	normal	.	G	ref	G	TC.GG	het-alt	232	0.55	.	1	.	PASS	147795	C	.	NN	.	.	.	.	.	.	.	3716	JAK1	IC9	IVS10	.	.	no-change	NM_002227.2	NP_002218.2	-	Y	c.1459-7C=	.	.	.	NM_002227.2(JAK1): c.1459-7C=	;maf-5-some-pop,maf-5-all-pops	122370	0.640786	U	0.3065	0.402556	11980	0.619866	PASS	.	8458	0.673563	24710	117362	0.642636	.	.	.	.	.	.	rs310229	.	4024	0.699600	-0.977	0.022	-0.186	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	65325969	65325970	1p31.3	0	normal	.	C	ref	C	CA.GG	het-alt	158	0.52	.	1	.	PASS	147795	C	.	NN	.	.	.	.	.	.	.	3716	JAK1	IC7	IVS8	.	.	no-change	NM_002227.2	NP_002218.2	-	Y	c.1177-25G=	.	.	.	NM_002227.2(JAK1): c.1177-25G=	;maf-5-some-pop,maf-5-all-pops	119446	0.641261	U	0.3065	0.404153	12604	0.617264	PASS	.	8546	0.677393	24290	114438	0.643248	.	.	.	.	.	.	rs310224	.	4024	0.701300	-2.244	-1.628	-1.443	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	65325969	65325970	1p31.3	0	normal	.	C	snv	T	CA.GG	het-ref	143	0.48	.	2	.	PASS	147795	C	.	NN	.	.	.	.	.	.	.	3716	JAK1	IC7	IVS8	.	.	intron	NM_002227.2	NP_002218.2	-	Y	c.1177-25G>A	.	.	.	NM_002227.2(JAK1): c.1177-25G>A	;maf-5-some-pop,maf-5-all-pops	119446	0.358740	U	0.3065	0.404153	12604	0.382736	PASS	472	8546	0.322607	7897	114438	0.356752	904	5504	3.27191e-01	15918	81655	3.62486e-01	rs310224	.	4024	0.298700	-2.244	-1.628	-1.443	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	65330681	65330682	1p31.3	0	normal	.	G	ref	G	GG.TT	het-alt	216	0.54	.	1	.	PASS	147795	C	.	NN	.	.	.	.	.	.	.	3716	JAK1	IC6	IVS7	.	.	no-change	NM_002227.2	NP_002218.2	-	Y	c.991-27C=	.	.	.	NM_002227.2(JAK1): c.991-27C=	;maf-5-some-pop,genotype-conflict	121582	0.698771	U	0.3065	0.367212	11850	0.670127	PASS	-885	8220	0.672749	29328	116574	0.701606	.	.	.	.	.	.	rs2256298	.	4024	0.701800	-0.142	-0.150	-0.146	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	65330681	65330682	1p31.3	0	normal	.	G	snv	A	GG.TT	het-ref	184	0.46	.	2	.	PASS	147795	C	.	NN	.	.	.	.	.	.	.	3716	JAK1	IC6	IVS7	.	.	intron	NM_002227.2	NP_002218.2	-	Y	c.991-27C>T	.	.	.	NM_002227.2(JAK1): c.991-27C>T	;maf-5-some-pop,genotype-conflict	121582	0.301229	U	0.3065	0.367212	11850	0.329873	PASS	460	8220	0.327251	5826	116574	0.298394	898	5498	3.30409e-01	12062	71867	3.02539e-01	rs2256298	.	4024	0.298200	-0.142	-0.150	-0.146	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	70225922	70225923	1p31.1	0	normal	.	G	ref	G	GT.CC	het-alt	315	0.50	.	1	.	PASS	614453	C	.	NN	.	.	.	.	.	.	.	57554	LRRC7	C1	EX1	.	.	no-change	NM_020794.2	NP_065845.1	+	Y	c.36G=	.	.	.	NM_020794.2(LRRC7): c.36G=	;maf-5-some-pop	125186	0.934194	U	0.127	0.0766773	13002	0.953699	PASS	.	8530	0.878898	52542	120178	0.934647	.	.	.	.	.	.	rs1340770	.	4024	0.879000	0.557	2.887	1.450	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	70225922	70225923	1p31.1	1	normal	.	G	snv	A	GT.CC	het-ref	317	0.50	.	2	.	PASS	614453	C	.	NN	.	.	.	.	.	.	.	57554	LRRC7	C1	EX1	.	.	coding-synon	NM_020794.2	NP_065845.1	+	Y	c.36G>A	p.(V12=) | p.(Val12=)	GTG=>GTA	.	NM_020794.2(LRRC7): c.36G>A (p.(V12=))	;maf-5-some-pop	125186	0.065806	U	0.127	0.0766773	13002	0.046301	PASS	76	8530	0.121102	307	120178	0.065353	135	2081	1.21270e-01	738	16737	6.82953e-02	rs1340770	.	4024	0.121000	0.557	2.887	1.450	.	.	.	.	.	ENST00000035383: c.36G>A (p.V12V)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3997651	.	.	.	.	.	.	.	.	.	Likely Benign
1	70226124	70226125	1p31.1	0	normal	.	T	ref	T	AA.TT	het-alt	152	0.49	.	1	.	PASS	614453	C	.	NN	.	.	.	.	.	.	.	57554	LRRC7	IC1	IVS1	.	.	no-change	NM_020794.2	NP_065845.1	+	Y	c.189+49T=	.	.	.	NM_020794.2(LRRC7): c.189+49T=	;maf-5-some-pop,maf-5-all-pops	104204	0.829344	U	0.1419	0.173323	12970	0.840786	PASS	.	5902	0.848018	34064	99196	0.829479	.	.	.	.	.	.	rs12407496	.	4024	0.869500	-1.333	0.217	0.084	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	70226124	70226125	1p31.1	0	normal	.	T	snv	C	AA.TT	het-ref	157	0.51	.	2	.	PASS	614453	C	.	NN	.	.	.	.	.	.	.	57554	LRRC7	IC1	IVS1	.	.	intron	NM_020794.2	NP_065845.1	+	Y	c.189+49T>C	.	.	.	NM_020794.2(LRRC7): c.189+49T>C	;maf-5-some-pop,maf-5-all-pops	104204	0.170656	U	0.1419	0.173323	12970	0.159214	PASS	74	5902	0.151982	1381	99196	0.170521	145	2110	1.41839e-01	2992	36979	1.65862e-01	rs12407496	.	4024	0.130500	-1.333	0.217	0.084	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	78426230	78426231	1p31.1	0	normal	.	A	ref	A	TT.AA	het-alt	204	0.53	.	1	.	PASS	603444	P	.	NN	.	.	.	.	.	.	.	8880	FUBP1	IC14	IVS14	.	.	no-change	NM_003902.3	NP_003893.2	-	Y	c.1345-51T=	.	.	.	NM_003902.3(FUBP1): c.1345-51T=	;maf-5-some-pop	49642	0.904033	U	0.1429	0.113219	12544	0.924904	PASS	.	3204	0.865481	18355	44634	0.905969	.	.	.	.	.	.	rs2296455	.	4024	0.884200	-0.746	-0.433	-0.158	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	78426230	78426231	1p31.1	0	normal	.	A	snv	G	TT.AA	het-ref	180	0.47	.	2	.	PASS	603444	P	.	NN	.	.	.	.	.	.	.	8880	FUBP1	IC14	IVS14	.	.	intron	NM_003902.3	NP_003893.2	-	Y	c.1345-51T>C	.	.	.	NM_003902.3(FUBP1): c.1345-51T>C	;maf-5-some-pop	49642	0.095967	U	0.1429	0.113219	12544	0.075096	PASS	36	3204	0.134519	235	44634	0.094031	88	1266	1.22793e-01	584	11759	7.99878e-02	rs2296455	.	4024	0.115800	-0.746	-0.433	-0.158	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	78430688	78430689	1p31.1	0	nullSample	.	A	ref	A	AA.GA	homo-ref	.	.	.	0	.	.	603444	P	.	NN	.	.	.	.	.	.	.	8880	FUBP1	IC8	IVS8	.	.	no-change	NM_003902.3	NP_003893.2	-	Y	c.637-36T=	.	.	.	NM_003902.3(FUBP1): c.637-36T=	;	13	0.846154	U	1	0.9998	.	.	PASS	.	8654	0.000116	0	121254	0.000091	.	.	.	.	.	.	rs199580605	.	.	.	0.528	1.089	0.359	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	78430689	78430689	1p31.1	0	normal	.	.	ins	G	AA.GA	hom-alt	555	1.00	.	0	.	PASS	603444	P	.	NN	.	.	.	.	.	.	.	8880	FUBP1	IC8	IVS8	.	.	intron	NM_003902.3	NP_003893.2	-	Y	c.637-37_637-36insC	.	.	.	NM_003902.3(FUBP1): c.637-37_637-36insC	;	126260	0.999905	U	1	0.9998	.	.	PASS	4326	8654	0.999884	60614	121254	0.999893	8593	17188	9.99884e-01	122483	244992	9.99894e-01	rs11409017	.	4024	0.998500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	78432502	78432503	1p31.1	0	normal	.	G	ref	G	AG.CT	het-alt	177	0.52	.	1	.	PASS	603444	P	.	NN	.	.	.	.	.	.	.	8880	FUBP1	IC6	IVS6	.	.	no-change	NM_003902.3	NP_003893.2	-	Y	c.415+65C=	.	.	.	NM_003902.3(FUBP1): c.415+65C=	;maf-5-some-pop,maf-5-all-pops	5008	0.664337	U	0.2331	0.335663	4564	0.721297	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3736909	.	4024	0.800000	-0.120	-0.016	0.148	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	78432502	78432503	1p31.1	0	normal	.	G	snv	C	AG.CT	het-ref	162	0.48	.	2	.	PASS	603444	P	.	NN	.	.	.	.	.	.	.	8880	FUBP1	IC6	IVS6	.	.	intron	NM_003902.3	NP_003893.2	-	Y	c.415+65C>G	.	.	.	NM_003902.3(FUBP1): c.415+65C>G	;maf-5-some-pop,maf-5-all-pops	5008	0.335663	U	0.2331	0.335663	4564	0.278703	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3736909	.	4024	0.200000	-0.120	-0.016	0.148	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	78432506	78432507	1p31.1	0	normal	.	A	ref	A	TT.AA	het-alt	176	0.75	.	1	.	PASS	603444	P	.	NN	.	.	.	.	.	.	.	8880	FUBP1	IC6	IVS6	.	.	no-change	NM_003902.3	NP_003893.2	-	Y	c.415+61T=	.	.	.	NM_003902.3(FUBP1): c.415+61T=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.618500	0.157	-0.443	0.159	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	78432506	78432507	1p31.1	0	normal	.	A	del	.	TT.AA	het-ref	58	0.25	.	2	.	PASS	603444	P	.	NN	.	.	.	.	.	.	.	8880	FUBP1	IC6	IVS6	.	.	intron	NM_003902.3	NP_003893.2	-	Y	c.415+61delT	.	.	.	NM_003902.3(FUBP1): c.415+61delT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.381500	0.157	-0.443	0.159	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	78433215	78433216	1p31.1	0	normal	.	C	ref	C	CA.AG	het-alt	121	0.54	.	1	.	PASS	603444	P	.	NN	.	.	.	.	.	.	.	8880	FUBP1	IC4	IVS4	.	.	no-change	NM_003902.3	NP_003893.2	-	Y	c.290+95G=	.	.	.	NM_003902.3(FUBP1): c.290+95G=	.	.	.	.	0.0129	0.00259585	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.650	-0.373	-0.528	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
1	78433216	78433216	1p31.1	0	normal	.	.	ins	AG	AC.AG	het-ref	104	0.46	.	2	.	PASS	603444	P	.	NN	.	.	.	.	.	.	.	8880	FUBP1	IC4	IVS4	.	.	intron	NM_003902.3	NP_003893.2	-	Y	c.290+94_290+95insCT	.	.	.	NM_003902.3(FUBP1): c.290+94_290+95insCT	;	5008	0.002596	U	0.0129	0.00259585	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs531855616	.	4024	0.018400	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
1	78435701	78435702	1p31.1	0	normal	.	A	ref	A	CT.AA	het-alt	192	0.71	.	1	.	PASS	603444	P	.	NN	.	.	.	.	.	.	.	8880	FUBP1	IC1	IVS1	.	.	no-change	NM_003902.3	NP_003893.2	-	Y	c.121-3T=	.	.	.	NM_003902.3(FUBP1): c.121-3T=	MixedObserved;	441	0.988662	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs202224025	.	4024	0.521900	-0.672	0.039	0.423	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	78435701	78435702	1p31.1	1	normal	.	A	del	.	CT.AA	het-ref	77	0.29	.	2	.	PASS	603444	P	.	NN	.	.	.	.	.	.	.	8880	FUBP1	IC1	IVS1	.	.	intron	NM_003902.3	NP_003893.2	-	Y	c.121-3delT	.	.	.	NM_003902.3(FUBP1): c.121-3delT	MixedObserved;	441	0.011338	U	.	.	.	.	InbreedingCoeff_Filter	0	5684	0.341133	0	78662	0.354301	.	.	.	.	.	.	rs202224025	.	4024	0.478100	-0.672	0.039	0.423	.	.	.	.	.	ENST00000370768: c.121-3delT (p.?)	bone [NS|NS|NS]	osteosarcoma [NS|NS|NS]	CSV	3730287	.	.	.	.	.	.	.	.	.	Benign
1	97981241	97981242	1p21.3	0	nullSample	.	T	ref	T	TA.GA	homo-ref	.	.	.	0	.	.	612779	C	274270(MK)	AR	5-fluorouracil toxicity	AD/AR	.	General	Pharmacogenomic	22754590|22410472|21590448|21553285|21420945|20920994|20803296|20544545|19296131|15303009|10071185|10027340|9254861|8051923|7832988|6488556|3335642|2989687	.	1806	DPYD	IC13	IVS13	.	.	no-change	NM_000110.3	NP_000101.2	-	Y	c.1740+40A=	.	.	.	NM_000110.3(DPYD): c.1740+40A=	MixedObserved;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	103214	0.339557	U	0.7341	0.651757	12924	0.400959	PASS	.	6944	0.232575	4854	98206	0.339114	.	.	.	.	.	.	rs2811178	.	.	.	-1.213	-0.243	-0.415	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	97981241	97981242	1p21.3	0	normal	.	T	snv	C	TA.GA	hom-alt	278	1.00	.	0	.	PASS	612779	C	274270(MK)	AR	5-fluorouracil toxicity	AD/AR	.	General	Pharmacogenomic	22754590|22410472|21590448|21553285|21420945|20920994|20803296|20544545|19296131|15303009|10071185|10027340|9254861|8051923|7832988|6488556|3335642|2989687	.	1806	DPYD	IC13	IVS13	.	.	intron	NM_000110.3	NP_000101.2	-	Y	c.1740+40A>G	.	.	.	NM_000110.3(DPYD): c.1740+40A>G	MixedObserved;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	103214	0.660443	U	0.7341	0.651757	12924	0.599041	PASS	1994	6944	0.767425	20654	98206	0.660886	4462	12009	7.45715e-01	46039	144305	6.36086e-01	rs2811178	.	.	.	-1.213	-0.243	-0.415	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	100090	no_assertion_provided	not_provided	Benign
1	110466337	110466338	1p13.3	0	normal	.	C	ref	C	AC.GC	het-alt	103	0.47	.	1	.	PASS	120420	C	.	NN	.	.	.	.	.	.	.	1435	CSF1	C6	EX6	Macrophage colony stimulating factor-1 (CSF-1)	PF05337.6	no-change	NM_000757.5	NP_000748.3	+	Y	c.1095C=	.	.	.	NM_000757.5(CSF1): c.1095C=	;maf-5-some-pop,maf-5-all-pops	125742	0.447750	U	0.4018	0.430112	13006	0.535368	PASS	-1078	8624	0.568414	12787	120734	0.442684	.	.	.	.	.	.	rs333970	.	4024	0.591700	0.467	-0.476	-0.766	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	110466337	110466338	1p13.3	1	normal	.	C	snv	A	AC.GC	het-ref	117	0.53	.	2	.	PASS	120420	C	.	NN	.	.	.	.	.	.	.	1435	CSF1	C6	EX6	Macrophage colony stimulating factor-1 (CSF-1)	PF05337.6	coding-synon	NM_000757.5	NP_000748.3	+	Y	c.1095C>A	p.(T365=) | p.(Thr365=)	ACC=>ACA	.	NM_000757.5(CSF1): c.1095C>A (p.(T365=))	;maf-5-some-pop,maf-5-all-pops	125742	0.552250	U	0.4018	0.430112	13006	0.464632	PASS	783	8624	0.431586	19707	120734	0.557316	1634	7483	4.34049e-01	41212	139145	5.68171e-01	rs333970	.	4024	0.408300	0.467	-0.476	-0.766	.	.	.	.	.	ENST00000369802: c.1095C>A (p.T365T)	large_intestine [colon|descending|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3750219	.	.	.	.	.	.	.	.	.	Likely Benign
1	110466465	110466466	1p13.3	0	normal	.	T	ref	T	AC.GC	het-alt	158	0.54	.	1	.	PASS	120420	C	.	NN	.	.	.	.	.	.	.	1435	CSF1	C6	EX6	Macrophage colony stimulating factor-1 (CSF-1)	PF05337.6	no-change	NM_000757.5	NP_000748.3	+	Y	c.1223T=	.	.	.	NM_000757.5(CSF1): c.1223T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125650	0.616864	U	0.5972	0.421526	13006	0.604490	PASS	.	8622	0.412549	23333	120642	0.618458	.	.	.	.	.	.	rs1058885	.	4024	0.400100	-2.386	-2.085	-2.705	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	110466465	110466466	1p13.3	1	normal	.	T	snv	C	AC.GC	het-ref	135	0.46	.	2	.	PASS	120420	C	.	NN	.	.	.	.	.	.	.	1435	CSF1	C6	EX6	Macrophage colony stimulating factor-1 (CSF-1)	PF05337.6	missense	NM_000757.5	NP_000748.3	+	Y	c.1223T>C	p.L408P | p.Leu408Pro	CTG=>CCG	NP=>NP	NM_000757.5(CSF1): c.1223T>C (p.L408P)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125650	0.383136	U	0.5972	0.421526	13006	0.395510	PASS	1456	8622	0.587451	9042	120642	0.381542	2892	10007	5.80385e-01	17896	91977	3.74533e-01	rs1058885	.	4024	0.599900	-2.386	-2.085	-2.705	.	.	.	.	.	ENST00000369802: c.1223T>C (p.L408P)	liver [NS|NS|NS]	carcinoma [hepatocellular_carcinoma|NS|NS]	CSV	3747493	CM066774	NM_000757.5(CSF1): c.1223T>C (p.L408P)	"Periodontitis, assoc. with ?"	16844084	DP	.	.	.	.	Likely Benign
1	113456545	113456546	1p13.2	0	nullSample	.	A	ref	A	CC.TC	homo-ref	.	.	.	0	.	.	600682	P	245340(MK);610021(MK);616095(MK)	AD	Hyperinsulinemic hypoglycemia, familial, 7; Erythrocyte lactate transporter defect	AD	.	Endocrine; Musculoskeletal; Renal	Endocrine; Musculoskeletal; Renal	17701893|12502513|11207177|10590411|3775384|3395514|3395513|1358043	.	6566	SLC16A1	C4E	EX5E	.	.	no-change	NM_003051.3	NP_003042.3	-	Y	c.1470T=	.	.	.	NM_003051.3(SLC16A1): c.1470T=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	126396	0.399641	U	0.6647	0.676717	13006	0.333769	PASS	-975	8648	0.336725	10445	121388	0.402791	.	.	.	.	.	.	rs1049434	.	4024	0.345900	-0.265	0.490	0.270	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	113456545	113456546	1p13.2	1	normal	.	A	snv	T	CC.TC	hom-alt	302	1.00	.	0	.	PASS	600682	P	245340(MK);610021(MK);616095(MK)	AD	Hyperinsulinemic hypoglycemia, familial, 7; Erythrocyte lactate transporter defect	AD	.	Endocrine; Musculoskeletal; Renal	Endocrine; Musculoskeletal; Renal	17701893|12502513|11207177|10590411|3775384|3395514|3395513|1358043	.	6566	SLC16A1	C4E	EX5E	.	.	missense	NM_003051.3	NP_003042.3	-	Y	c.1470T>A	p.D490E | p.Asp490Glu	GAT=>GAA	P-=>P-	NM_003051.3(SLC16A1): c.1470T>A (p.D490E)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	126396	0.600359	U	0.6647	0.676717	13006	0.666231	PASS	1893	8648	0.663275	22245	121388	0.597209	3873	11544	6.69295e-01	43973	145489	5.90837e-01	rs1049434	.	4024	0.654100	-0.265	0.490	0.270	1	0	0	0.000	neutral	ENST00000369626: c.1470T>A (p.D490E)	pancreas [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	4142166	.	.	.	.	.	no_record	130315	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
1	115256668	115256669	1p13.2	0	nullSample	.	G	ref	G	AT.CA	homo-ref	.	.	.	0	.	.	164790	C	114500(MK);137550(MK);162900(MK);163200(MK);188470(MK);249400(MK);613224(MK);614470(MK)	AD	Autoimmune lymphoproliferative syndrome type IV; Noonan syndrome 6	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Oncologic	22887781|22855653|21901340|20301303|19966803|19775298|17517660	.	4893	NRAS	IC1	IVS2	.	.	no-change	NM_002524.4	NP_002515.1	-	Y	c.112-70C=	.	.	.	NM_002524.4(NRAS): c.112-70C=	;maf-5-some-pop	5008	0.124800	U	0.999	0.8752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs969273	.	4024	0.003200	-2.086	-0.180	0.101	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	115256668	115256669	1p13.2	0	normal	.	G	snv	A	AT.CA	hom-alt	148	1.00	.	0	.	PASS	164790	C	114500(MK);137550(MK);162900(MK);163200(MK);188470(MK);249400(MK);613224(MK);614470(MK)	AD	Autoimmune lymphoproliferative syndrome type IV; Noonan syndrome 6	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Oncologic	22887781|22855653|21901340|20301303|19966803|19775298|17517660	.	4893	NRAS	IC1	IVS2	.	.	intron	NM_002524.4	NP_002515.1	-	Y	c.112-70C>T	.	.	.	NM_002524.4(NRAS): c.112-70C>T	;maf-5-some-pop	5008	0.875200	U	0.999	0.8752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs969273	.	4024	0.996800	-2.086	-0.180	0.101	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	117690271	117690272	1p13.1	0	nullSample	.	G	ref	G	CC.AG	homo-ref	.	.	.	0	.	.	608162	P	.	NN	.	.	.	.	.	.	.	79679	VTCN1	3U1	EX5	.	.	no-change	NM_024626.3	NP_078902.2	-	Y	c.*8C=	.	.	.	NM_024626.3(VTCN1): c.*8C=	;maf-5-some-pop,maf-5-all-pops	126210	0.132969	U	0.9206	0.734625	13006	0.248731	PASS	.	8640	0.106134	2467	121202	0.127498	.	.	.	.	.	.	rs10754339	.	.	.	-0.302	-0.148	-0.036	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	117690271	117690272	1p13.1	0	normal	.	G	snv	A	CC.AG	hom-alt	329	1.00	.	0	.	PASS	608162	P	.	NN	.	.	.	.	.	.	.	79679	VTCN1	3U1	EX5	.	.	utr-3	NM_024626.3	NP_078902.2	-	Y	c.*8C>T	.	.	.	NM_024626.3(VTCN1): c.*8C>T	;maf-5-some-pop,maf-5-all-pops	126210	0.867031	U	0.9206	0.734625	13006	0.751269	PASS	3455	8640	0.893866	47615	121202	0.872502	6818	15243	8.93913e-01	97591	215314	8.85002e-01	rs10754339	.	.	.	-0.302	-0.148	-0.036	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	120478284	120478285	1p12	0	nullSample	.	T	ref	T	CA.GA	homo-ref	.	.	.	0	.	.	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	IC21	IVS21	.	.	no-change	NM_024408.3	NP_077719.2	-	Y	c.3523-58A=	.	.	.	NM_024408.3(NOTCH2): c.3523-58A=	;maf-5-some-pop,maf-5-all-pops	5008	0.395567	U	0.8879	0.604433	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs5025718	.	4024	0.103400	-0.313	-2.229	-2.159	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	120478284	120478285	1p12	0	normal	.	T	snv	C	CA.GA	hom-alt	344	1.00	.	0	.	PASS	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	IC21	IVS21	.	.	intron	NM_024408.3	NP_077719.2	-	Y	c.3523-58A>G	.	.	.	NM_024408.3(NOTCH2): c.3523-58A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.604433	U	0.8879	0.604433	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs5025718	.	4024	0.896600	-0.313	-2.229	-2.159	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	120480393	120480394	1p12	0	nullSample	.	T	ref	T	AT.CC	homo-ref	.	.	.	0	.	.	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	IC20	IVS20	.	.	no-change	NM_024408.3	NP_077719.2	-	Y	c.3337+86A=	.	.	.	NM_024408.3(NOTCH2): c.3337+86A=	;maf-5-some-pop	5008	0.021366	U	1	0.978634	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2453057	.	4024	0.001500	-1.500	-0.193	-0.072	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	120480393	120480394	1p12	0	normal	.	T	snv	C	AT.CC	hom-alt	206	1.00	.	0	.	PASS	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	IC20	IVS20	.	.	intron	NM_024408.3	NP_077719.2	-	Y	c.3337+86A>G	.	.	.	NM_024408.3(NOTCH2): c.3337+86A>G	;maf-5-some-pop	5008	0.978634	U	1	0.978634	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2453057	.	4024	0.998500	-1.500	-0.193	-0.072	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	120508066	120508067	1p12	0	normal	.	G	ref	G	AA.AA	het-alt	195	0.49	.	1	.	PASS	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	IC10	IVS10	.	.	no-change	NM_024408.3	NP_077719.2	-	Y	c.1681+9C=	.	.	.	NM_024408.3(NOTCH2): c.1681+9C=	;	126414	0.999549	U	0.005	0.000998403	.	.	PASS	-26	8650	0.993988	60651	121406	0.999572	.	.	.	.	.	.	rs192886452	.	4024	0.994000	0.557	0.109	-0.354	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	120508066	120508067	1p12	1	normal	.	G	snv	T	AA.AA	het-ref	199	0.51	.	2	.	PASS	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	IC10	IVS10	.	.	intron	NM_024408.3	NP_077719.2	-	Y	c.1681+9C>A	.	.	.	NM_024408.3(NOTCH2): c.1681+9C>A	;	126414	0.000451	U	0.005	0.000998403	.	.	PASS	0	8650	0.006012	0	121406	0.000428	1	123	7.13209e-03	1	125	5.08415e-04	rs192886452	.	4024	0.006000	0.557	0.109	-0.354	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	282715	criteria_provided,_single_submitter	Likely_benign	Likely Benign
1	120512103	120512104	1p12	0	nullSample	.	T	ref	T	CC.GT	homo-ref	.	.	.	0	.	.	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	IC6	IVS6	.	.	no-change	NM_024408.3	NP_077719.2	-	Y	c.1108+30A=	.	.	.	NM_024408.3(NOTCH2): c.1108+30A=	;maf-5-some-pop	115870	0.007716	U	1	0.978634	13006	0.026449	PASS	0	7612	0.000000	15	110862	0.007099	.	.	.	.	.	.	rs2493409	.	4024	0.007000	-2.276	-2.555	-2.346	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	120512103	120512104	1p12	0	normal	.	T	snv	C	CC.GT	hom-alt	310	1.00	.	0	.	PASS	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	IC6	IVS6	.	.	intron	NM_024408.3	NP_077719.2	-	Y	c.1108+30A>G	.	.	.	NM_024408.3(NOTCH2): c.1108+30A>G	;maf-5-some-pop	115870	0.992284	U	1	0.978634	13006	0.973551	PASS	3806	7612	1.000000	54659	110862	0.992901	8217	16434	1.00000e+00	115879	233005	9.94346e-01	rs2493409	.	4024	0.993000	-2.276	-2.555	-2.346	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	120572546	120572547	1p12	0	normal	.	T	ref	T	CA.TG	het-alt	156	0.80	.	1	dup	DUBIOUS	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	C2	EX2	.	.	no-change	NM_024408.3	NP_077719.2	-	Y	c.137A=	.	.	.	NM_024408.3(NOTCH2): c.137A=	;maf-5-some-pop,maf-5-all-pops	18032	0.526398	U	.	.	.	.	InbreedingCoeff_Filter	-279	1158	0.518135	476	18032	0.526398	.	.	.	.	.	.	rs61788900	.	4024	0.544500	0.477	2.519	1.904	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	120572546	120572547	1p12	1	normal	.	T	snv	C	CA.TG	het-ref	39	0.20	.	2	dup	DUBIOUS	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	C2	EX2	.	.	missense	NM_024408.3	NP_077719.2	-	Y	c.137A>G	p.N46S | p.Asn46Ser	AAT=>AGT	P0=>P0	NM_024408.3(NOTCH2): c.137A>G (p.N46S)	;maf-5-some-pop,maf-5-all-pops	18032	0.473602	U	.	.	.	.	InbreedingCoeff_Filter	0	1158	0.481865	0	18032	0.473602	0	3455	4.55324e-01	0	41628	4.40760e-01	rs61788900	.	4024	0.455500	0.477	2.519	1.904	0.18	0.093	0.126	0.063	neutral	ENST00000256646: c.137A>G (p.N46S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3773408	.	.	.	.	.	.	.	.	.	Unknown
1	120572571	120572572	1p12	0	normal	.	C	ref	C	TT.AT	het-alt	136	0.80	.	1	dup	DUBIOUS	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	C2	EX2	.	.	no-change	NM_024408.3	NP_077719.2	-	Y	c.112G=	.	.	.	NM_024408.3(NOTCH2): c.112G=	;maf-5-some-pop,maf-5-all-pops	16954	0.530081	U	.	.	.	.	InbreedingCoeff_Filter	-259	1086	0.523020	510	16954	0.530081	.	.	.	.	.	.	rs61788901	.	4024	0.555200	-0.225	0.502	0.171	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	120572571	120572572	1p12	1	normal	.	C	snv	T	TT.AT	het-ref	33	0.20	.	2	dup	DUBIOUS	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	C2	EX2	.	.	missense	NM_024408.3	NP_077719.2	-	Y	c.112G>A	p.E38K | p.Glu38Lys	GAA=>AAA	P-=>P+	NM_024408.3(NOTCH2): c.112G>A (p.E38K)	;maf-5-some-pop,maf-5-all-pops	16954	0.469919	U	.	.	.	.	InbreedingCoeff_Filter	0	1086	0.476980	0	16954	0.469919	0	3490	4.55971e-01	0	42006	4.43354e-01	rs61788901	.	4024	0.444800	-0.225	0.502	0.171	0.08	0.018	0.01	0.300	neutral	ENST00000256646: c.112G>A (p.E38K)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	CSV	1736165	.	.	.	.	.	.	.	.	.	Unknown
1	120611875	120611876	1p11.2	0	normal	.	C	ref	C	AC.GA	het-alt	310	0.84	.	1	dup	DUBIOUS	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	IC1	IVS1	.	.	no-change	NM_024408.3	NP_077719.2	-	Y	c.73+72G=	.	.	.	NM_024408.3(NOTCH2): c.73+72G=	;maf-5-some-pop,maf-5-all-pops	17486	0.529681	U	.	.	.	.	InbreedingCoeff_Filter	-154	630	0.511111	519	17486	0.529681	.	.	.	.	.	.	rs11801062	.	4024	0.540000	0.298	-2.580	-2.314	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	120611875	120611876	1p11.2	0	normal	.	C	snv	T	AC.GA	het-ref	60	0.16	.	2	dup	DUBIOUS	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	IC1	IVS1	.	.	intron	NM_024408.3	NP_077719.2	-	Y	c.73+72G>A	.	.	.	NM_024408.3(NOTCH2): c.73+72G>A	;maf-5-some-pop,maf-5-all-pops	17486	0.470319	U	.	.	.	.	InbreedingCoeff_Filter	0	630	0.488889	0	17486	0.470319	0	4515	4.55417e-01	1	55210	4.44568e-01	rs11801062	.	4024	0.460000	0.298	-2.580	-2.314	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	120611963	120611964	1p11.2	0	normal	.	G	ref	G	GC.CA	het-alt	564	0.77	.	1	dup	PASS	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	C1	EX1	.	.	no-change	NM_024408.3	NP_077719.2	-	Y	c.57C=	.	.	.	NM_024408.3(NOTCH2): c.57C=	SingleClassTriAllelic;maf-5-some-pop	99638	0.550593	U	.	.	.	.	InbreedingCoeff_Filter	-1806	7660	0.528460	5047	99638	0.550593	.	.	.	.	.	.	rs11810554	.	4024	0.530300	0.184	0.738	1.760	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	120611963	120611964	1p11.2	1	normal	.	G	snv	C	GC.CA	het-ref	164	0.23	.	2	dup	PASS	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	C1	EX1	.	.	missense	NM_024408.3	NP_077719.2	-	Y	c.57C>G	p.C19W | p.Cys19Trp	TGC=>TGG	P0=>NP	NM_024408.3(NOTCH2): c.57C>G (p.C19W)	SingleClassTriAllelic;maf-5-some-pop	99638	0.449317	U	.	.	.	.	InbreedingCoeff_Filter	0	7660	0.471540	3	99638	0.449317	0	7071	4.66979e-01	2	89294	4.43318e-01	rs11810554	.	4024	0.469700	0.184	0.738	1.760	0.18	0.006	0.113	0.056	neutral	ENST00000256646: c.57C>G (p.C19W)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	RSS	132738	.	.	.	.	.	.	.	.	.	Likely Benign
1	120612002	120612004	1p11.2	0	normal	.	GG	ref	GG	GC.GG	het-alt	701	0.84	.	1	dup	PASS	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	C1	EX1	.	.	no-change	NM_024408.3	NP_077719.2	-	Y	c.17_18=	.	.	.	NM_024408.3(NOTCH2): c.17_18=	;maf-5-some-pop,maf-5-all-pops	92738	0.594287	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs372504208	.	4024	0.612300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	120612002	120612004	1p11.2	1	normal	.	GG	del	.	GC.GG	het-ref	133	0.16	.	2	dup	PASS	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	C1	EX1	EGF-like domain;Ankyrin repeat;LNR domain;NOTCH protein;Calcium-binding EGF domain;NOTCH protein;Domain of unknown function (DUF3454);Human growth factor-like EGF;Ankyrin repeats (3 copies);Ankyrin repeat;Ankyrin repeats (many copies);Ankyrin repeats (many copies)	PF00008.22;PF00023.25;PF00066.12;PF06816.8;PF07645.10;PF07684.7;PF11936.3;PF12661.2;PF12796.2;PF13606.1;PF13637.1;PF13857.1	frameshift	NM_024408.3	NP_077719.2	-	Y	c.15C[4>2] (std: c.15C[2] alt: c.17_18delCC )	p.P6Rfs*27 | p.Pro6Argfs*27	.	.	NM_024408.3(NOTCH2): c.15C[2] (p.P6Rfs*27)	;maf-5-some-pop,maf-5-all-pops	92738	0.405713	U	.	.	.	.	InbreedingCoeff_Filter	0	7164	0.370743	0	92738	0.405713	0	1281	1.14212e-01	0	22958	1.79964e-01	rs372504208	.	4024	0.387700	.	.	.	.	.	.	.	.	ENST00000256646: c.17_18delCC (p.P6fs*27)	NS [NS|NS|NS]	malignant_melanoma [NS|NS|NS]	CSV	132830	.	.	.	.	.	no_record	218795	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
1	120612005	120612006	1p11.2	0	normal	.	G	ref	G	GG.CG	het-alt	672	0.80	.	1	dup	PASS	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	C1	EX1	.	.	no-change	NM_024408.3	NP_077719.2	-	Y	c.15C=	.	.	.	NM_024408.3(NOTCH2): c.15C=	SingleClassTriAllelic;maf-5-some-pop	101190	0.534618	U	0.4315	0.39397	.	.	InbreedingCoeff_Filter	-1803	7610	0.521945	3327	96182	0.530900	.	.	.	.	.	.	rs4021006	.	4024	0.525100	0.184	0.742	0.543	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	120612005	120612006	1p11.2	1	normal	.	G	snv	A	GG.CG	het-ref	171	0.20	.	2	dup	PASS	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	C1	EX1	.	.	coding-synon	NM_024408.3	NP_077719.2	-	Y	c.15C>T	p.(R5=) | p.(Arg5=)	CGC=>CGT	.	NM_024408.3(NOTCH2): c.15C>T (p.(R5=))	SingleClassTriAllelic;maf-5-some-pop	101190	0.460302	U	0.4315	0.39397	.	.	InbreedingCoeff_Filter	16	7610	0.478055	259	96182	0.463756	34	6663	4.62708e-01	600	88037	4.51171e-01	rs4021006	.	4024	0.474900	0.184	0.742	0.543	.	.	.	.	.	ENST00000256646: c.15C>T (p.R5R)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	RSS	1320072	.	.	.	.	.	.	.	.	.	Likely Benign
1	120612039	120612040	1p11.2	0	normal	.	T	ref	T	CC.cc	het-alt	393	0.87	.	1	dup	PASS	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	5U1E	EX1	.	.	no-change	NM_024408.3	NP_077719.2	-	Y	c.-20A=	.	.	.	NM_024408.3(NOTCH2): c.-20A=	MixedObserved;	0	0	U	.	.	.	.	PASS	-60	1666	0.927971	9919	25728	0.885533	.	.	.	.	.	.	rs3010135	.	.	.	-2.418	-2.223	-2.418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	120612040	120612040	1p11.2	0	normal	.	.	ins	CCTCCGCCG	CT.cc	het-ref	57	0.13	.	2	dup;(CCG)n|Simple_repeat|Simple_repeat|+|20	PASS	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	5U1E	EX1	.	.	utr-5	NM_024408.3	NP_077719.2	-	Y	c.-21_-20insCGGCGGAGG	.	.	.	NM_024408.3(NOTCH2): c.-21_-20insCGGCGGAGG	ObservedTooLong;rs-cluster-nonoverlapping-alleles	25728	0.083256	U	.	.	.	.	PASS	0	1666	0.058223	0	25728	0.083256	.	.	.	.	.	.	rs782658834	.	4092	0.321600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	120612042	120612043	1p11.2	0	normal	.	G	ref	G	cc.cc	het-alt	392	0.86	.	1	dup;(CCG)n|Simple_repeat|Simple_repeat|+|20	DUBIOUS	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	5U1E	EX1	.	.	no-change	NM_024408.3	NP_077719.2	-	Y	c.-23C=	.	.	.	NM_024408.3(NOTCH2): c.-23C=	;maf-5-some-pop	8564	0.868403	U	.	.	.	.	InbreedingCoeff_Filter	-96	898	0.786192	3155	8564	0.868403	.	.	.	.	.	.	rs57122008	.	.	.	0.064	-0.564	0.064	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	120612042	120612043	1p11.2	0	normal	.	G	snv	T	cc.cc	het-ref	65	0.14	.	2	dup;(CCG)n|Simple_repeat|Simple_repeat|+|20	DUBIOUS	600275	P	102500(MK);610205(MK)	AD	Alagille syndrome 2	AD	Allelic with Hajdu-Cheney syndrome (AD); Serpentine fibula-polycystic kidney syndrome (AD)	Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Gastrointestinal; Renal	24265536|23566664|23401378|23389697|23117206|22488849|22209762|21934706|21793104|21712856|21681853|21378989|21378985|20301450|18918373|17159511|16773578|14303950|11343321|8723560	.	4853	NOTCH2	5U1E	EX1	.	.	utr-5	NM_024408.3	NP_077719.2	-	Y	c.-23C>A	.	.	.	NM_024408.3(NOTCH2): c.-23C>A	;maf-5-some-pop	8564	0.131597	U	.	.	.	.	InbreedingCoeff_Filter	0	898	0.213808	0	8564	0.131597	0	1321	1.74689e-01	0	7269	9.42850e-02	rs57122008	.	.	.	0.064	-0.564	0.064	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	144856887	144856888	1q21.1	0	normal	.	C	ref	C	AG.AG	het-alt	282	0.77	.	1	dup	DUBIOUS	608117	C	.	NN	.	.	.	.	.	.	.	9659	PDE4DIP	C40	EX40	.	.	no-change	NM_001198834.2	NP_001185763.2	-	Y	c.6597G=	.	.	.	NM_001198834.2(PDE4DIP): c.6597G=	;	114824	0.971896	U	.	.	.	.	VQSRTrancheSNP99.60to99.80	-521	8248	0.873666	54185	114824	0.971896	.	.	.	.	.	.	rs3853915	.	4024	0.862300	0.455	0.272	1.042	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	144856887	144856888	1q21.1	1	normal	.	C	snv	T	AG.AG	het-ref	82	0.23	.	2	dup	DUBIOUS	608117	C	.	NN	.	.	.	.	.	.	.	9659	PDE4DIP	C40	EX40	.	.	coding-synon	NM_001198834.2	NP_001185763.2	-	Y	c.6597G>A	p.(L2199=) | p.(Leu2199=)	CTG=>CTA	.	NM_001198834.2(PDE4DIP): c.6597G>A (p.(L2199=))	;	114824	0.028104	U	.	.	.	.	VQSRTrancheSNP99.60to99.80	0	8248	0.126334	0	114824	0.028104	0	1762	1.09632e-01	0	5867	2.44005e-02	rs3853915	.	4024	0.137700	0.455	0.272	1.042	.	.	.	.	.	ENST00000369356: c.6597G>A (p.L2199L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4142479	.	.	.	.	.	.	.	.	.	Unknown
1	144857067	144857068	1q21.1	0	normal	.	A	ref	A	AC.GA	het-alt	196	0.57	.	1	dup	DUBIOUS	608117	C	.	NN	.	.	.	.	.	.	.	9659	PDE4DIP	IC39	IVS39	.	.	no-change	NM_001198834.2	NP_001185763.2	-	Y	c.6443-26T=	.	.	.	NM_001198834.2(PDE4DIP): c.6443-26T=	;maf-5-some-pop,maf-5-all-pops	114706	0.500000	U	.	.	.	.	InbreedingCoeff_Filter	-2058	8234	0.499879	3	114706	0.500000	.	.	.	.	.	.	rs905324	.	4024	0.500700	0.374	-0.361	-0.190	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	144857067	144857068	1q21.1	0	normal	.	A	snv	T	AC.GA	het-ref	146	0.43	.	2	dup	DUBIOUS	608117	C	.	NN	.	.	.	.	.	.	.	9659	PDE4DIP	IC39	IVS39	.	.	intron	NM_001198834.2	NP_001185763.2	-	Y	c.6443-26T>A	.	.	.	NM_001198834.2(PDE4DIP): c.6443-26T>A	;maf-5-some-pop,maf-5-all-pops	114706	0.500000	U	.	.	.	.	InbreedingCoeff_Filter	1	8234	0.500121	3	114706	0.500000	0	8427	5.00000e-01	6	119003	5.00000e-01	rs905324	.	4024	0.499300	0.374	-0.361	-0.190	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	146766068	146766069	1q21.1	0	nullSample	.	C	ref	C	GA.GT	homo-ref	.	.	.	0	.	.	613039	P	.	NN	.	.	.	.	.	.	.	9557	CHD1L	IC21	IVS21	.	.	no-change	NM_004284.4	NP_004275.4	+	Y	c.2507-22C=	.	.	.	NM_004284.4(CHD1L): c.2507-22C=	MixedObserved;	0	0	U	0.9881	0.968051	.	.	PASS	-68	8644	0.015733	77	121012	0.033451	.	.	.	.	.	.	rs201557386	.	.	.	0.462	0.065	0.070	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	146766069	146766069	1q21.1	0	normal	.	.	ins	AT	AC.GT	hom-alt	325	1.00	.	0	.	PASS	613039	P	.	NN	.	.	.	.	.	.	.	9557	CHD1L	IC21	IVS21	.	.	intron	NM_004284.4	NP_004275.4	+	Y	c.2507-22_2507-21insAT	.	.	.	NM_004284.4(CHD1L): c.2507-22_2507-21insAT	MixedObserved;maf-5-some-pop	126020	0.966608	U	0.9881	0.968051	12520	0.954473	PASS	4186	8644	0.984267	56535	121012	0.966549	7798	15867	9.82964e-01	108035	223408	9.66891e-01	rs71083827	.	4024	0.986800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	150549736	150549744	1q21.3	0	normal	.	GCTAGGTT	ref	GCTAGGTT	TG.GC	het-alt	274	0.59	.	1	.	PASS	159552	P	.	NN	.	.	.	.	.	.	.	4170	MCL1	3U1E	EX3E	.	.	no-change	NM_021960.4	NP_068779.1	-	Y	c.*107_*114=	.	.	.	NM_021960.4(MCL1): c.*107_*114=	;maf-5-some-pop	5008	0.973442	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3841831	.	3504	0.858200	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	150549736	150549744	1q21.3	0	normal	.	GCTAGGTT	del	.	TG.GC	het-ref	193	0.41	.	2	.	PASS	159552	P	.	NN	.	.	.	.	.	.	.	4170	MCL1	3U1E	EX3E	.	.	utr-3	NM_021960.4	NP_068779.1	-	Y	c.*107_*114delAACCTAGC	.	.	.	NM_021960.4(MCL1): c.*107_*114delAACCTAGC	;maf-5-some-pop	5008	0.026557	U	0.122	0.0265575	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3841831	.	3504	0.141800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	150550018	150550019	1q21.3	0	nullSample	.	T	ref	T	CT.AC	homo-ref	.	.	.	0	.	.	159552	P	.	NN	.	.	.	.	.	.	.	4170	MCL1	IC2	IVS2	.	.	no-change	NM_021960.4	NP_068779.1	-	Y	c.937-52A=	.	.	.	NM_021960.4(MCL1): c.937-52A=	.	.	.	.	1	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.533	0.727	2.054	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	150550019	150550019	1q21.3	0	normal	.	.	ins	A	TT.AC	hom-alt	391	1.00	.	0	.	PASS	159552	P	.	NN	.	.	.	.	.	.	.	4170	MCL1	IC2	IVS2	.	.	intron	NM_021960.4	NP_068779.1	-	Y	c.937-53_937-52insT	.	.	.	NM_021960.4(MCL1): c.937-53_937-52insT	MixedObserved,InconsistentAlleles;	5008	1.000000	U	1	1	.	.	PASS	4228	8456	1.000000	57425	114866	0.999930	.	.	.	.	.	.	rs11428742	.	4024	0.998500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	152278813	152278814	1q21.3	0	normal	.	C	ref	C	GC.GT	het-alt	862	0.77	.	1	trf;dup	PASS	135940	C	146700(MK);605803(SK)	AD	Icthyosis vulgaris	AD/AR	.	Dermatologic	General	22989708|22962861|22951058|22299762|21790526|21712002|21692775|17291859|17030239|16815158|16550169|16444271|12838398|12473059	.	2312	FLG	C2E	EX3E	Filaggrin	PF03516.8	no-change	NM_002016.1	NP_002007.1	-	Y	c.8548G=	.	.	.	NM_002016.1(FLG): c.8548G=	SingleClassTriAllelic;maf-5-some-pop	90080	0.888499	U	.	.	12886	0.939702	VQSRTrancheSNP99.80to99.90	.	5598	0.650054	34996	90080	0.888499	.	.	.	.	.	.	rs2184952	.	4024	0.596200	0.306	-0.506	-0.915	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	152278813	152278814	1q21.3	1	normal	.	C	snv	T	GC.GT	het-ref	251	0.23	.	2	trf;dup	PASS	135940	C	146700(MK);605803(SK)	AD	Icthyosis vulgaris	AD/AR	.	Dermatologic	General	22989708|22962861|22951058|22299762|21790526|21712002|21692775|17291859|17030239|16815158|16550169|16444271|12838398|12473059	.	2312	FLG	C2E	EX3E	Filaggrin	PF03516.8	missense	NM_002016.1	NP_002007.1	-	Y	c.8548G>A	p.G2850S | p.Gly2850Ser	GGC=>AGC	P0=>P0	NM_002016.1(FLG): c.8548G>A (p.G2850S)	SingleClassTriAllelic;maf-5-some-pop	90080	0.111490	U	.	.	12886	0.060298	VQSRTrancheSNP99.80to99.90	0	5598	0.349946	0	90080	0.111490	0	2076	2.74023e-01	31	11613	7.16127e-02	rs2184952	.	4024	0.403800	0.306	-0.506	-0.915	0.99	1	1	0.500	deleterious	ENST00000368799: c.8548G>A (p.G2850S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4142676	.	.	.	.	.	.	.	.	.	Likely Benign
1	152278855	152278856	1q21.3	0	normal	.	T	ref	T	AC.TC	het-alt	270	0.61	.	1	trf;dup	PASS	135940	C	146700(MK);605803(SK)	AD	Icthyosis vulgaris	AD/AR	.	Dermatologic	General	22989708|22962861|22951058|22299762|21790526|21712002|21692775|17291859|17030239|16815158|16550169|16444271|12838398|12473059	.	2312	FLG	C2E	EX3E	.	.	no-change	NM_002016.1	NP_002007.1	-	Y	c.8506A=	.	.	.	NM_002016.1(FLG): c.8506A=	SingleClassTriAllelic;maf-5-some-pop	120530	0.810653	U	.	.	12928	0.915919	InbreedingCoeff_Filter	-1718	8634	0.602038	37443	120530	0.810653	.	.	.	.	.	.	rs11582087	.	4024	0.591900	0.254	-0.164	-0.204	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	152278855	152278856	1q21.3	1	normal	.	T	snv	G	AC.TC	het-ref	176	0.39	.	2	trf;dup	PASS	135940	C	146700(MK);605803(SK)	AD	Icthyosis vulgaris	AD/AR	.	Dermatologic	General	22989708|22962861|22951058|22299762|21790526|21712002|21692775|17291859|17030239|16815158|16550169|16444271|12838398|12473059	.	2312	FLG	C2E	EX3E	.	.	missense	NM_002016.1	NP_002007.1	-	Y	c.8506A>C	p.S2836R | p.Ser2836Arg	AGT=>CGT	P0=>P+	NM_002016.1(FLG): c.8506A>C (p.S2836R)	SingleClassTriAllelic;maf-5-some-pop	120530	0.189330	U	.	.	12928	0.084081	InbreedingCoeff_Filter	0	8634	0.397846	0	120530	0.189330	0	6485	3.94849e-01	0	40672	1.77547e-01	rs11582087	.	4024	0.408100	0.254	-0.164	-0.204	0.3	0.99	0.998	0.470	deleterious	ENST00000368799: c.8506A>C (p.S2836R)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_leukaemia_of_ambiguous_lineage|NS|NS]	CSV	5803225	.	.	.	.	.	.	.	.	.	Likely Benign
1	156785616	156785617	1q23.1	0	normal	.	G	ref	G	TC.GC	het-alt	258	0.57	.	1	.	PASS	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	5U1E	EX1	.	.	no-change	NM_001007792.1	NP_001007793.1	+	Y	c.-5G=	.	.	.	NM_001007792.1(NTRK1): c.-5G=	;maf-5-some-pop,maf-5-all-pops	126298	0.333798	U	0.8135	0.636981	13006	0.382285	PASS	.	8650	0.178150	7101	121290	0.332591	.	.	.	.	.	.	rs1800601	.	.	.	-1.180	-2.657	-2.944	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	156785616	156785617	1q23.1	0	normal	.	G	snv	A	TC.GC	het-ref	196	0.43	.	2	.	PASS	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	5U1E	EX1	.	.	utr-5	NM_001007792.1	NP_001007793.1	+	Y	c.-5G>A	.	.	.	NM_001007792.1(NTRK1): c.-5G>A	;maf-5-some-pop,maf-5-all-pops	126298	0.666202	U	0.8135	0.636981	13006	0.617715	PASS	2927	8650	0.821850	27406	121290	0.667409	5783	14108	8.18045e-01	56449	165766	6.73681e-01	rs1800601	.	.	.	-1.180	-2.657	-2.944	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	380853	criteria_provided,_single_submitter	Benign	Benign
1	156836837	156836838	1q23.1	0	normal	.	T	ref	T	GT.GG	het-alt	115	0.56	.	1	.	PASS	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	IC5	IVS5	.	.	no-change	NM_001007792.1	NP_001007793.1	+	Y	c.338+68T=	.	.	.	NM_001007792.1(NTRK1): c.338+68T=	;maf-5-some-pop,genotype-conflict	5008	0.845647	U	0.0952	0.154353	4566	0.861586	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2274497	.	4024	0.907600	-1.481	-0.897	-0.894	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	156836837	156836838	1q23.1	0	normal	.	T	ref	T	GT.GG	het-alt	115	0.56	.	1	.	PASS	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	IC4	IVS4	.	.	no-change	NM_001012331.1	NP_001012331.1	+	N	c.428+68T=	.	.	.	NM_001012331.1(NTRK1): c.428+68T=	;maf-5-some-pop,genotype-conflict	5008	0.845647	U	0.0952	0.154353	4566	0.861586	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2274497	.	4024	0.907600	-1.481	-0.897	-0.894	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	156836837	156836838	1q23.1	0	normal	.	T	ref	T	GT.GG	het-alt	115	0.56	.	1	.	PASS	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	IC4	IVS4	.	.	no-change	NM_002529.3	NP_002520.2	+	N	c.428+68T=	.	.	.	NM_002529.3(NTRK1): c.428+68T=	;maf-5-some-pop,genotype-conflict	5008	0.845647	U	0.0952	0.154353	4566	0.861586	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2274497	.	4024	0.907600	-1.481	-0.897	-0.894	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	156836837	156836838	1q23.1	0	normal	.	T	snv	C	GT.GG	het-ref	91	0.44	.	2	.	PASS	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	IC5	IVS5	.	.	intron	NM_001007792.1	NP_001007793.1	+	Y	c.338+68T>C	.	.	.	NM_001007792.1(NTRK1): c.338+68T>C	;maf-5-some-pop,genotype-conflict	5008	0.154353	U	0.0952	0.154353	4566	0.138414	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2274497	.	4024	0.092400	-1.481	-0.897	-0.894	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	156836837	156836838	1q23.1	0	normal	.	T	snv	C	GT.GG	het-ref	91	0.44	.	2	.	PASS	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	IC4	IVS4	.	.	intron	NM_001012331.1	NP_001012331.1	+	N	c.428+68T>C	.	.	.	NM_001012331.1(NTRK1): c.428+68T>C	;maf-5-some-pop,genotype-conflict	5008	0.154353	U	0.0952	0.154353	4566	0.138414	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2274497	.	4024	0.092400	-1.481	-0.897	-0.894	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	156836837	156836838	1q23.1	0	normal	.	T	snv	C	GT.GG	het-ref	91	0.44	.	2	.	PASS	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	IC4	IVS4	.	.	intron	NM_002529.3	NP_002520.2	+	N	c.428+68T>C	.	.	.	NM_002529.3(NTRK1): c.428+68T>C	;maf-5-some-pop,genotype-conflict	5008	0.154353	U	0.0952	0.154353	4566	0.138414	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2274497	.	4024	0.092400	-1.481	-0.897	-0.894	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	156845492	156845496	1q23.1	0	nullSample	.	GTGT	ref	GTGT	GA.gt	homo-ref	.	.	.	0	(TG)n|Simple_repeat|Simple_repeat|+|36;trf	.	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	IC12	IVS12	.	.	no-change	NM_001007792.1	NP_001007793.1	+	Y	c.1393+35_1393+38=	.	.	.	NM_001007792.1(NTRK1): c.1393+35_1393+38=	MixedObserved;	13541	0.880289	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs761074272	.	4030	0.943300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	156845492	156845496	1q23.1	0	nullSample	.	GTGT	ref	GTGT	GA.gt	homo-ref	.	.	.	0	(TG)n|Simple_repeat|Simple_repeat|+|36;trf	.	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	IC11	IVS11	.	.	no-change	NM_001012331.1	NP_001012331.1	+	N	c.1483+35_1483+38=	.	.	.	NM_001012331.1(NTRK1): c.1483+35_1483+38=	MixedObserved;	13541	0.880289	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs761074272	.	4030	0.943300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	156845492	156845496	1q23.1	0	nullSample	.	GTGT	ref	GTGT	GA.gt	homo-ref	.	.	.	0	(TG)n|Simple_repeat|Simple_repeat|+|36;trf	.	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	IC12	IVS12	.	.	no-change	NM_002529.3	NP_002520.2	+	N	c.1501+35_1501+38=	.	.	.	NM_002529.3(NTRK1): c.1501+35_1501+38=	MixedObserved;	13541	0.880289	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs761074272	.	4030	0.943300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	156845492	156845496	1q23.1	0	normal	.	GTGT	del	.	GA.gt	het-alt	14	0.33	.	1	(TG)n|Simple_repeat|Simple_repeat|+|36;trf	PASS	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	IC12	IVS12	.	.	intron	NM_001007792.1	NP_001007793.1	+	Y	c.1393+35_1393+38delGTGT	.	.	.	NM_001007792.1(NTRK1): c.1393+35_1393+38delGTGT	MixedObserved;	13541	0.119711	U	.	.	.	.	PASS	1	3418	0.106495	5	47690	0.033990	.	.	.	.	.	.	rs761074272	.	4030	0.027800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
1	156845492	156845496	1q23.1	0	normal	.	GTGT	del	.	GA.gt	het-alt	14	0.33	.	1	(TG)n|Simple_repeat|Simple_repeat|+|36;trf	PASS	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	IC11	IVS11	.	.	intron	NM_001012331.1	NP_001012331.1	+	N	c.1483+35_1483+38delGTGT	.	.	.	NM_001012331.1(NTRK1): c.1483+35_1483+38delGTGT	MixedObserved;	13541	0.119711	U	.	.	.	.	PASS	1	3418	0.106495	5	47690	0.033990	.	.	.	.	.	.	rs761074272	.	4030	0.027800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
1	156845492	156845496	1q23.1	0	normal	.	GTGT	del	.	GA.gt	het-alt	14	0.33	.	1	(TG)n|Simple_repeat|Simple_repeat|+|36;trf	PASS	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	IC12	IVS12	.	.	intron	NM_002529.3	NP_002520.2	+	N	c.1501+35_1501+38delGTGT	.	.	.	NM_002529.3(NTRK1): c.1501+35_1501+38delGTGT	MixedObserved;	13541	0.119711	U	.	.	.	.	PASS	1	3418	0.106495	5	47690	0.033990	.	.	.	.	.	.	rs761074272	.	4030	0.027800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
1	156845492	156845496	1q23.1	0	normal	.	GTGT	rep	GT	GA.gt	het-alt	24	0.57	.	2	(TG)n|Simple_repeat|Simple_repeat|+|36;trf	PASS	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	IC12	IVS12	.	.	intron	NM_001007792.1	NP_001007793.1	+	Y	c.1393+35GT[2>1] (std: c.1393+35GT[1] alt: c.1393+37_1393+38delGT )	.	.	.	NM_001007792.1(NTRK1): c.1393+35GT[1]	.	.	.	.	.	.	.	.	PASS	62	3418	0.330895	148	47690	0.173328	.	.	.	.	.	.	.	.	4030	0.027300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	156845492	156845496	1q23.1	0	normal	.	GTGT	rep	GT	GA.gt	het-alt	24	0.57	.	2	(TG)n|Simple_repeat|Simple_repeat|+|36;trf	PASS	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	IC11	IVS11	.	.	intron	NM_001012331.1	NP_001012331.1	+	N	c.1483+35GT[2>1] (std: c.1483+35GT[1] alt: c.1483+37_1483+38delGT )	.	.	.	NM_001012331.1(NTRK1): c.1483+35GT[1]	.	.	.	.	.	.	.	.	PASS	62	3418	0.330895	148	47690	0.173328	.	.	.	.	.	.	.	.	4030	0.027300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	156845492	156845496	1q23.1	0	normal	.	GTGT	rep	GT	GA.gt	het-alt	24	0.57	.	2	(TG)n|Simple_repeat|Simple_repeat|+|36;trf	PASS	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	IC12	IVS12	.	.	intron	NM_002529.3	NP_002520.2	+	N	c.1501+35GT[2>1] (std: c.1501+35GT[1] alt: c.1501+37_1501+38delGT )	.	.	.	NM_002529.3(NTRK1): c.1501+35GT[1]	.	.	.	.	.	.	.	.	PASS	62	3418	0.330895	148	47690	0.173328	.	.	.	.	.	.	.	.	4030	0.027300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	156846232	156846233	1q23.1	0	nullSample	.	G	ref	G	CA.CG	homo-ref	.	.	.	0	.	.	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	C14	EX14	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	no-change	NM_001007792.1	NP_001007793.1	+	Y	c.1566G=	.	.	.	NM_001007792.1(NTRK1): c.1566G=	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	125010	0.779962	U	0.3204	0.212859	13006	0.806397	PASS	.	8560	0.644743	36593	120002	0.779662	.	.	.	.	.	.	rs6334	.	4024	0.667700	0.561	0.588	0.773	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	156846232	156846233	1q23.1	0	nullSample	.	G	ref	G	CA.CG	homo-ref	.	.	.	0	.	.	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	C13	EX13	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	no-change	NM_001012331.1	NP_001012331.1	+	N	c.1656G=	.	.	.	NM_001012331.1(NTRK1): c.1656G=	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	125010	0.779962	U	0.3204	0.212859	13006	0.806397	PASS	.	8560	0.644743	36593	120002	0.779662	.	.	.	.	.	.	rs6334	.	4024	0.667700	0.561	0.588	0.773	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	156846232	156846233	1q23.1	0	nullSample	.	G	ref	G	CA.CG	homo-ref	.	.	.	0	.	.	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	C14	EX14	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	no-change	NM_002529.3	NP_002520.2	+	N	c.1674G=	.	.	.	NM_002529.3(NTRK1): c.1674G=	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	125010	0.779962	U	0.3204	0.212859	13006	0.806397	PASS	.	8560	0.644743	36593	120002	0.779662	.	.	.	.	.	.	rs6334	.	4024	0.667700	0.561	0.588	0.773	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	156846232	156846233	1q23.1	1	normal	.	G	snv	A	CA.CG	hom-alt	659	1.00	.	0	.	PASS	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	C14	EX14	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_001007792.1	NP_001007793.1	+	Y	c.1566G>A	p.(Q522=) | p.(Gln522=)	CAG=>CAA	.	NM_001007792.1(NTRK1): c.1566G>A (p.(Q522=))	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	125010	0.220030	U	0.3204	0.212859	13006	0.193603	PASS	545	8560	0.355257	3033	120002	0.220330	1069	6030	3.50459e-01	6246	54107	2.20248e-01	rs6334	.	4024	0.332300	0.561	0.588	0.773	.	.	.	.	.	ENST00000524377: c.1674G>A (p.Q558Q)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3750439	.	.	.	.	.	no_record	292889	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
1	156846232	156846233	1q23.1	1	normal	.	G	snv	A	CA.CG	hom-alt	659	1.00	.	0	.	PASS	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	C13	EX13	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_001012331.1	NP_001012331.1	+	N	c.1656G>A	p.(Q552=) | p.(Gln552=)	CAG=>CAA	.	NM_001012331.1(NTRK1): c.1656G>A (p.(Q552=))	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	125010	0.220030	U	0.3204	0.212859	13006	0.193603	PASS	545	8560	0.355257	3033	120002	0.220330	1069	6030	3.50459e-01	6246	54107	2.20248e-01	rs6334	.	4024	0.332300	0.561	0.588	0.773	.	.	.	.	.	ENST00000524377: c.1674G>A (p.Q558Q)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3750439	.	.	.	.	.	no_record	292889	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
1	156846232	156846233	1q23.1	1	normal	.	G	snv	A	CA.CG	hom-alt	659	1.00	.	0	.	PASS	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	C14	EX14	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_002529.3	NP_002520.2	+	N	c.1674G>A	p.(Q558=) | p.(Gln558=)	CAG=>CAA	.	NM_002529.3(NTRK1): c.1674G>A (p.(Q558=))	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	125010	0.220030	U	0.3204	0.212859	13006	0.193603	PASS	545	8560	0.355257	3033	120002	0.220330	1069	6030	3.50459e-01	6246	54107	2.20248e-01	rs6334	.	4024	0.332300	0.561	0.588	0.773	.	.	.	.	.	ENST00000524377: c.1674G>A (p.Q558Q)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3750439	.	.	.	.	.	no_record	292889	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
1	156848807	156848808	1q23.1	0	nullSample	.	T	ref	T	GG.CC	homo-ref	.	.	.	0	.	.	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	IC14	IVS14	.	.	no-change	NM_001007792.1	NP_001007793.1	+	Y	c.1698-106T=	.	.	.	NM_001007792.1(NTRK1): c.1698-106T=	;maf-5-some-pop,maf-5-all-pops	5008	0.371406	U	0.3522	0.628594	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2768757	.	4020	0.625400	-1.043	-1.183	-0.914	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	156848807	156848808	1q23.1	0	nullSample	.	T	ref	T	GG.CC	homo-ref	.	.	.	0	.	.	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	IC13	IVS13	.	.	no-change	NM_001012331.1	NP_001012331.1	+	N	c.1788-106T=	.	.	.	NM_001012331.1(NTRK1): c.1788-106T=	;maf-5-some-pop,maf-5-all-pops	5008	0.371406	U	0.3522	0.628594	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2768757	.	4020	0.625400	-1.043	-1.183	-0.914	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	156848807	156848808	1q23.1	0	nullSample	.	T	ref	T	GG.CC	homo-ref	.	.	.	0	.	.	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	IC14	IVS14	.	.	no-change	NM_002529.3	NP_002520.2	+	N	c.1806-106T=	.	.	.	NM_002529.3(NTRK1): c.1806-106T=	;maf-5-some-pop,maf-5-all-pops	5008	0.371406	U	0.3522	0.628594	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2768757	.	4020	0.625400	-1.043	-1.183	-0.914	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	156848807	156848808	1q23.1	0	normal	.	T	snv	C	GG.CC	hom-alt	201	1.00	.	0	.	PASS	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	IC14	IVS14	.	.	intron	NM_001007792.1	NP_001007793.1	+	Y	c.1698-106T>C	.	.	.	NM_001007792.1(NTRK1): c.1698-106T>C	;maf-5-some-pop,maf-5-all-pops	5008	0.628594	U	0.3522	0.628594	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2768757	.	4020	0.374600	-1.043	-1.183	-0.914	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	156848807	156848808	1q23.1	0	normal	.	T	snv	C	GG.CC	hom-alt	201	1.00	.	0	.	PASS	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	IC13	IVS13	.	.	intron	NM_001012331.1	NP_001012331.1	+	N	c.1788-106T>C	.	.	.	NM_001012331.1(NTRK1): c.1788-106T>C	;maf-5-some-pop,maf-5-all-pops	5008	0.628594	U	0.3522	0.628594	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2768757	.	4020	0.374600	-1.043	-1.183	-0.914	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	156848807	156848808	1q23.1	0	normal	.	T	snv	C	GG.CC	hom-alt	201	1.00	.	0	.	PASS	191315	C	155240(MK);256800(MK)	AD;AR	Insensitivity to pain, congenital, with anhidrosis	AR	Allelic with Medullary thyroid carcinoma, familial (AD), but the evidence/clinical applicability is unclear	Allergy/Immunology/Infectious; Neurologic	Allergy/Immunology/Infectious; Neurologic	22653642|22032467|20301726|19089473|17915006|16490492|15695606|15534759|12949319|11744315|10861667|10088743|8696348	FC59;H54;H62;H68;HE15;MC58	4914	NTRK1	IC14	IVS14	.	.	intron	NM_002529.3	NP_002520.2	+	N	c.1806-106T>C	.	.	.	NM_002529.3(NTRK1): c.1806-106T>C	;maf-5-some-pop,maf-5-all-pops	5008	0.628594	U	0.3522	0.628594	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2768757	.	4020	0.374600	-1.043	-1.183	-0.914	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	158585229	158585230	1q23.1	0	normal	.	C	ref	C	GC.CA	het-alt	113	0.53	.	1	.	PASS	182860	C	130600(MK);266140(MK);270970(MK)	AD;AR	Spherocytosis, type 3; Pyropoikilocytosis , hereditary; Ellipsocytosis 2	AD/AR	.	Hematologic	Hematologic	21251457|16150946|8941647|8226774|7070419|3785322|3597773|2987946|2794061|2567189|1541680|1191563	.	6708	SPTA1	IC47	IVS47	.	.	no-change	NM_003126.2	NP_003117.2	-	Y	c.6601-37G=	.	.	.	NM_003126.2(SPTA1): c.6601-37G=	;maf-5-some-pop	125452	0.731092	U	0.4306	0.231629	11912	0.789624	PASS	-1049	8570	0.580630	32526	120444	0.729542	.	.	.	.	.	.	rs2518491	.	4024	0.539300	-0.224	-1.065	-0.953	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	158585229	158585230	1q23.1	0	normal	.	C	snv	T	GC.CA	het-ref	101	0.47	.	2	.	PASS	182860	C	130600(MK);266140(MK);270970(MK)	AD;AR	Spherocytosis, type 3; Pyropoikilocytosis , hereditary; Ellipsocytosis 2	AD/AR	.	Hematologic	Hematologic	21251457|16150946|8941647|8226774|7070419|3785322|3597773|2987946|2794061|2567189|1541680|1191563	.	6708	SPTA1	IC47	IVS47	.	.	intron	NM_003126.2	NP_003117.2	-	Y	c.6601-37G>A	.	.	.	NM_003126.2(SPTA1): c.6601-37G>A	;maf-5-some-pop	125452	0.268908	U	0.4306	0.231629	11912	0.210376	PASS	748	8570	0.419370	4879	120444	0.270458	1571	7331	4.25973e-01	10383	67942	2.77500e-01	rs2518491	.	4024	0.460700	-0.224	-1.065	-0.953	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	161293492	161293493	1q23.3	0	normal	.	T	ref	T	ta.tt	het-alt	203	0.86	.	1	AluY|SINE|Alu|-|301	PASS	602413	C	605373(MK);606764(MK);606864(MK)	NN	Paraganglioma and gastric stromal sarcoma; Gastrointestinal stromal tumor; Paragangliomas 3	AD	.	Oncologic	Oncologic	22703879|21348866|21173220|17804857|17667967|16249420|15342702	FC59;FH44;H54;H62;H68;HD31;HD32;HE15;HG15;MC58;MH43	6391	SDHC	IC2	IVS2	.	.	no-change	NM_003001.3	NP_002992.1	+	Y	c.77+33T=	.	.	.	NM_003001.3(SDHC): c.77+33T=	;	65277	0.965914	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs768040867	.	4024	0.981600	0.000	-0.547	-0.529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	161293492	161293493	1q23.3	0	normal	.	T	del	.	ta.tt	het-ref	34	0.14	.	2	AluY|SINE|Alu|-|301	PASS	602413	C	605373(MK);606764(MK);606864(MK)	NN	Paraganglioma and gastric stromal sarcoma; Gastrointestinal stromal tumor; Paragangliomas 3	AD	.	Oncologic	Oncologic	22703879|21348866|21173220|17804857|17667967|16249420|15342702	FC59;FH44;H54;H62;H68;HD31;HD32;HE15;HG15;MC58;MH43	6391	SDHC	IC2	IVS2	.	.	intron	NM_003001.3	NP_002992.1	+	Y	c.77+33delT	.	.	.	NM_003001.3(SDHC): c.77+33delT	;	65277	0.034086	U	.	.	.	.	PASS	0	5994	0.010177	0	74714	0.029780	.	.	.	.	.	.	rs768040867	.	4024	0.018400	0.000	-0.547	-0.529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
1	161332091	161332092	1q23.3	0	normal	.	T	ref	T	CC.TT	het-alt	140	0.59	.	1	.	PASS	602413	C	605373(MK);606764(MK);606864(MK)	NN	Paraganglioma and gastric stromal sarcoma; Gastrointestinal stromal tumor; Paragangliomas 3	AD	.	Oncologic	Oncologic	22703879|21348866|21173220|17804857|17667967|16249420|15342702	FC59;FH44;H54;H62;H68;HD31;HD32;HE15;HG15;MC58;MH43	6391	SDHC	IC5	IVS5	.	.	no-change	NM_003001.3	NP_002992.1	+	Y	c.406-27T=	.	.	.	NM_003001.3(SDHC): c.406-27T=	MixedObserved;|MixedObserved;maf-5-some-pop,maf-5-all-pops	0|5008	0|0.587859	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs200068284|rs535325534	.	4024	0.638200	0.482	0.342	0.075	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	161332091	161332092	1q23.3	0	normal	.	T	del	.	CC.TT	het-ref	96	0.41	.	2	.	PASS	602413	C	605373(MK);606764(MK);606864(MK)	NN	Paraganglioma and gastric stromal sarcoma; Gastrointestinal stromal tumor; Paragangliomas 3	AD	.	Oncologic	Oncologic	22703879|21348866|21173220|17804857|17667967|16249420|15342702	FC59;FH44;H54;H62;H68;HD31;HD32;HE15;HG15;MC58;MH43	6391	SDHC	IC5	IVS5	.	.	intron	NM_003001.3	NP_002992.1	+	Y	c.406-27delT	.	.	.	NM_003001.3(SDHC): c.406-27delT	MixedObserved;|MixedObserved;maf-5-some-pop,maf-5-all-pops	0|5008	0|0.412141	U	0.4206	0.412141	.	.	VQSRTrancheINDEL96.00to97.00	0	3162	0.333966	110	55438	0.397724	.	.	.	.	.	.	rs200068284|rs535325534	.	4024	0.361800	0.482	0.342	0.075	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	161512730	161512731	1q23.3	0	normal	.	G	ref	G	AT.GG	het-alt	278	0.53	.	1	dup	PASS	146740	C	615707(MK)	NN	.	.	.	.	.	.	.	2214	FCGR3A	3U1E	EX6E	.	.	no-change	NM_001127593.1	NP_001121065.1	-	Y	c.*71C=	.	.	.	NM_001127593.1(FCGR3A): c.*71C=	;maf-5-some-pop	5008	0.893371	U	0.0744	0.106629	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7539036	.	.	.	-0.224	-0.051	-0.171	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	161512730	161512731	1q23.3	0	normal	.	G	snv	A	AT.GG	het-ref	251	0.47	.	2	dup	PASS	146740	C	615707(MK)	NN	.	.	.	.	.	.	.	2214	FCGR3A	3U1E	EX6E	.	.	utr-3	NM_001127593.1	NP_001121065.1	-	Y	c.*71C>T	.	.	.	NM_001127593.1(FCGR3A): c.*71C>T	;maf-5-some-pop	5008	0.106629	U	0.0744	0.106629	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7539036	.	.	.	-0.224	-0.051	-0.171	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	161519410	161519411	1q23.3	0	normal	.	C	ref	C	TT.GT	het-alt	141	0.56	.	1	dup	PASS	146740	C	615707(MK)	NN	.	.	.	.	.	.	.	2214	FCGR3A	IC1	IVS2	.	.	no-change	NM_001127593.1	NP_001121065.1	-	Y	c.40+76G=	.	.	.	NM_001127593.1(FCGR3A): c.40+76G=	;maf-5-some-pop,maf-5-all-pops	5008	0.659545	U	0.3651	0.340455	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10917571	.	4024	0.605900	0.591	0.003	0.122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	161519410	161519411	1q23.3	0	normal	.	C	snv	A	TT.GT	het-ref	110	0.44	.	2	dup	PASS	146740	C	615707(MK)	NN	.	.	.	.	.	.	.	2214	FCGR3A	IC1	IVS2	.	.	intron	NM_001127593.1	NP_001121065.1	-	Y	c.40+76G>T	.	.	.	NM_001127593.1(FCGR3A): c.40+76G>T	;maf-5-some-pop,maf-5-all-pops	5008	0.340455	U	0.3651	0.340455	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10917571	.	4024	0.394100	0.591	0.003	0.122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	161645009	161645010	1q23.3	0	normal	.	C	snv	A	AC.GC	het-ref	89	0.49	.	2	dup	PASS	604590	P	152700(SK);611162(SK)	AD	.	.	.	.	.	.	.	2213	FCGR2B	IC5	IVS5	.	.	intron	NM_004001.4	NP_003992.3	+	Y	c.761-37C>A	.	.	.	NM_004001.4(FCGR2B): c.761-37C>A	SingleClassTriAllelic;maf-5-some-pop	94710	0.153205	U	0.251	0.179313	12996	0.154047	PASS	187	7142	0.252030	988	89702	0.151747	380	3387	2.27315e-01	2013	27762	1.28314e-01	rs6427615	.	4024	0.252700	-0.215	1.297	1.144	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	161645009	161645010	1q23.3	0	normal	.	C	ref	C	AC.GC	het-alt	91	0.51	.	1	dup	PASS	604590	P	152700(SK);611162(SK)	AD	.	.	.	.	.	.	.	2213	FCGR2B	IC5	IVS5	.	.	no-change	NM_004001.4	NP_003992.3	+	Y	c.761-37C=	.	.	.	NM_004001.4(FCGR2B): c.761-37C=	SingleClassTriAllelic;maf-5-some-pop	94710	0.840450	U	0.251	0.179313	12996	0.845953	PASS	.	7142	0.746430	31833	89702	0.842345	.	.	.	.	.	.	rs6427615	.	4024	0.746800	-0.215	1.297	1.144	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	162722845	162722846	1q23.3	0	nullSample	.	C	ref	C	AA.CA	homo-ref	.	.	.	0	.	.	191311	P	271665(MK)	AR	Spondylometaepiphyseal dysplasia, short limb-hand type	AR	.	Craniofacial; Musculoskeletal	General	20223752|19110212|8434618	.	4921	DDR2	IC1	IVS4	.	.	no-change	NM_001014796.1	NP_001014796.1	+	Y	c.83-39C=	.	.	.	NM_001014796.1(DDR2): c.83-39C=	;maf-5-some-pop	126174	0.008520	U	1	0.970447	13006	0.026988	PASS	0	8614	0.000000	42	121166	0.007651	.	.	.	.	.	.	rs1632311	.	4024	0.001000	-0.752	-0.073	0.253	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	162722845	162722846	1q23.3	0	normal	.	C	snv	G	AA.CA	hom-alt	306	1.00	.	0	.	PASS	191311	P	271665(MK)	AR	Spondylometaepiphyseal dysplasia, short limb-hand type	AR	.	Craniofacial; Musculoskeletal	General	20223752|19110212|8434618	.	4921	DDR2	IC1	IVS4	.	.	intron	NM_001014796.1	NP_001014796.1	+	Y	c.83-39C>G	.	.	.	NM_001014796.1(DDR2): c.83-39C>G	;maf-5-some-pop	126174	0.991480	U	1	0.970447	13006	0.973012	PASS	4307	8614	1.000000	59698	121166	0.992349	8604	17208	1.00000e+00	121248	243850	9.94008e-01	rs1632311	.	4024	0.999000	-0.752	-0.073	0.253	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	259936	criteria_provided,_single_submitter	Benign	Benign
1	162737115	162737116	1q23.3	0	normal	.	C	ref	C	CT.TG	het-alt	341	0.52	.	1	.	PASS	191311	P	271665(MK)	AR	Spondylometaepiphyseal dysplasia, short limb-hand type	AR	.	Craniofacial; Musculoskeletal	General	20223752|19110212|8434618	.	4921	DDR2	C9	EX12	.	.	no-change	NM_001014796.1	NP_001014796.1	+	Y	c.1260C=	.	.	.	NM_001014796.1(DDR2): c.1260C=	;maf-5-some-pop,maf-5-all-pops	126320	0.770899	U	0.4077	0.348442	13006	0.742734	PASS	-1037	8618	0.595962	37657	121312	0.775826	.	.	.	.	.	.	rs2298258	.	4024	0.588200	0.655	0.027	0.034	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	162737115	162737116	1q23.3	1	normal	.	C	snv	G	CT.TG	het-ref	320	0.48	.	2	.	PASS	191311	P	271665(MK)	AR	Spondylometaepiphyseal dysplasia, short limb-hand type	AR	.	Craniofacial; Musculoskeletal	General	20223752|19110212|8434618	.	4921	DDR2	C9	EX12	.	.	coding-synon	NM_001014796.1	NP_001014796.1	+	Y	c.1260C>G	p.(L420=) | p.(Leu420=)	CTC=>CTG	.	NM_001014796.1(DDR2): c.1260C>G (p.(L420=))	;maf-5-some-pop,maf-5-all-pops	126320	0.229101	U	0.4077	0.348442	13006	0.257266	PASS	704	8618	0.404038	4196	121312	0.224174	1396	6865	3.98294e-01	8513	55460	2.25484e-01	rs2298258	.	4024	0.411800	0.655	0.027	0.034	.	.	.	.	.	ENST00000367922: c.1260C>G (p.L420L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3997042	.	.	.	.	.	no_record	259929	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
1	162740326	162740327	1q23.3	0	nullSample	.	T	ref	T	GG.GT	homo-ref	.	.	.	0	.	.	191311	P	271665(MK)	AR	Spondylometaepiphyseal dysplasia, short limb-hand type	AR	.	Craniofacial; Musculoskeletal	General	20223752|19110212|8434618	.	4921	DDR2	IC10	IVS13	.	.	no-change	NM_001014796.1	NP_001014796.1	+	Y	c.1504+25T=	.	.	.	NM_001014796.1(DDR2): c.1504+25T=	SingleClassTriAllelic;maf-5-some-pop	125718	0.016076	U	1	0.945487	13006	0.052437	PASS	0	8544	0.000000	122	120710	0.014481	.	.	.	.	.	.	rs1780003	.	4024	0.001000	-3.586	-3.909	-3.508	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	162740326	162740327	1q23.3	0	normal	.	T	snv	C	GG.GT	hom-alt	357	1.00	.	0	.	PASS	191311	P	271665(MK)	AR	Spondylometaepiphyseal dysplasia, short limb-hand type	AR	.	Craniofacial; Musculoskeletal	General	20223752|19110212|8434618	.	4921	DDR2	IC10	IVS13	.	.	intron	NM_001014796.1	NP_001014796.1	+	Y	c.1504+25T>C	.	.	.	NM_001014796.1(DDR2): c.1504+25T>C	SingleClassTriAllelic;maf-5-some-pop	125718	0.983916	U	1	0.945487	13006	0.947563	PASS	4271	8544	0.999883	58728	120710	0.985511	8579	17162	9.99767e-01	120020	242513	9.88332e-01	rs1780003	.	4024	0.999000	-3.586	-3.909	-3.508	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	259930	criteria_provided,_single_submitter	Benign	Benign
1	162741793	162741794	1q23.3	0	normal	.	C	ref	C	CT.GT	het-alt	182	0.48	.	1	.	PASS	191311	P	271665(MK)	AR	Spondylometaepiphyseal dysplasia, short limb-hand type	AR	.	Craniofacial; Musculoskeletal	General	20223752|19110212|8434618	.	4921	DDR2	IC10	IVS13	.	.	no-change	NM_001014796.1	NP_001014796.1	+	Y	c.1505-20C=	.	.	.	NM_001014796.1(DDR2): c.1505-20C=	;maf-5-some-pop	44820	0.869433	U	0.2272	0.104832	12994	0.959905	PASS	.	2542	0.635327	14993	39812	0.866196	.	.	.	.	.	.	rs3738807	.	4024	0.758400	-3.583	-1.594	-2.152	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	162741793	162741794	1q23.3	0	normal	.	C	snv	T	CT.GT	het-ref	194	0.52	.	2	.	PASS	191311	P	271665(MK)	AR	Spondylometaepiphyseal dysplasia, short limb-hand type	AR	.	Craniofacial; Musculoskeletal	General	20223752|19110212|8434618	.	4921	DDR2	IC10	IVS13	.	.	intron	NM_001014796.1	NP_001014796.1	+	Y	c.1505-20C>T	.	.	.	NM_001014796.1(DDR2): c.1505-20C>T	;maf-5-some-pop	44820	0.130567	U	0.2272	0.104832	12994	0.040095	PASS	107	2542	0.364673	414	39812	0.133804	318	2865	2.14961e-01	1675	18191	9.33801e-02	rs3738807	.	4024	0.241600	-3.583	-1.594	-2.152	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	259931	criteria_provided,_single_submitter	Benign	Benign
1	162743417	162743418	1q23.3	0	nullSample	.	G	ref	G	TA.GT	homo-ref	.	.	.	0	.	.	191311	P	271665(MK)	AR	Spondylometaepiphyseal dysplasia, short limb-hand type	AR	.	Craniofacial; Musculoskeletal	General	20223752|19110212|8434618	.	4921	DDR2	IC12	IVS15	.	.	no-change	NM_001014796.1	NP_001014796.1	+	Y	c.1856+32G=	.	.	.	NM_001014796.1(DDR2): c.1856+32G=	SingleClassTriAllelic;	126328	0.001623	U	1	0.992412	13006	0.005228	PASS	0	8644	0.000000	1	121320	0.001377	.	.	.	.	.	.	rs1355287	.	4024	0.001000	-0.335	-0.208	-0.370	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	162743417	162743418	1q23.3	0	normal	.	G	snv	T	TA.GT	hom-alt	507	1.00	.	0	.	PASS	191311	P	271665(MK)	AR	Spondylometaepiphyseal dysplasia, short limb-hand type	AR	.	Craniofacial; Musculoskeletal	General	20223752|19110212|8434618	.	4921	DDR2	IC12	IVS15	.	.	intron	NM_001014796.1	NP_001014796.1	+	Y	c.1856+32G>T	.	.	.	NM_001014796.1(DDR2): c.1856+32G>T	SingleClassTriAllelic;	126328	0.998330	U	1	0.992412	13006	0.994772	PASS	4322	8644	1.000000	60488	121320	0.998574	8619	17238	1.00000e+00	122694	245646	9.98935e-01	rs1355287	.	4024	0.999000	-0.335	-0.208	-0.370	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	259932	criteria_provided,_single_submitter	Benign	Benign
1	162748587	162748588	1q23.3	0	nullSample	.	C	ref	C	TG.CT	homo-ref	.	.	.	0	.	.	191311	P	271665(MK)	AR	Spondylometaepiphyseal dysplasia, short limb-hand type	AR	.	Craniofacial; Musculoskeletal	General	20223752|19110212|8434618	.	4921	DDR2	IC15	IVS18	.	.	no-change	NM_001014796.1	NP_001014796.1	+	Y	c.2433+69C=	.	.	.	NM_001014796.1(DDR2): c.2433+69C=	;maf-5-some-pop	5008	0.031150	U	1	0.96885	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs907074	.	4024	0.001000	-0.256	-0.342	-0.420	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	162748587	162748588	1q23.3	0	normal	.	C	snv	A	TG.CT	hom-alt	308	1.00	.	0	.	PASS	191311	P	271665(MK)	AR	Spondylometaepiphyseal dysplasia, short limb-hand type	AR	.	Craniofacial; Musculoskeletal	General	20223752|19110212|8434618	.	4921	DDR2	IC15	IVS18	.	.	intron	NM_001014796.1	NP_001014796.1	+	Y	c.2433+69C>A	.	.	.	NM_001014796.1(DDR2): c.2433+69C>A	;maf-5-some-pop	5008	0.968850	U	1	0.96885	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs907074	.	4024	0.999000	-0.256	-0.342	-0.420	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	179078168	179078169	1q25.2	0	normal	.	A	ref	A	CC.CC	het-alt	93	0.82	.	1	.	PASS	164690	C	164690(MA)	NN	.	.	.	.	.	.	.	27	ABL2	C12E	EX12E	.	.	no-change	NM_007314.3	NP_009298.1	-	Y	c.2233T=	.	.	.	NM_007314.3(ABL2): c.2233T=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs868612829	.	4024	0.988600	0.528	1.264	2.164	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	179078169	179078169	1q25.2	1	normal	.	.	ins	ACCC	CA.CC	het-ref	20	0.18	.	2	.	PASS	164690	C	164690(MA)	NN	.	.	.	.	.	.	.	27	ABL2	C12E	EX12E	F-actin binding	PF08919.5	frameshift	NM_007314.3	NP_009298.1	-	Y	c.2232_2233insGGGT	p.W745Gfs*24 | p.Trp745Glyfs*24	.	.	NM_007314.3(ABL2): c.2232_2233insGGGT (p.W745Gfs*24)	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0.00000e+00	0	0	0.00000e+00	.	.	4024	0.008700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
1	179078172	179078173	1q25.2	0	normal	.	A	ref	A	CC.CC	het-alt	86	0.85	.	1	.	DUBIOUS	164690	C	164690(MA)	NN	.	.	.	.	.	.	.	27	ABL2	C12E	EX12E	.	.	no-change	NM_007314.3	NP_009298.1	-	Y	c.2229T=	.	.	.	NM_007314.3(ABL2): c.2229T=	MixedObserved;	98510|117594	0.996244|0.999991	U	.	.	.	.	VQSRTrancheSNP99.95to100.00	-8	7286	0.997804	48885	98510	0.996244	.	.	.	.	.	.	rs774330058|rs777241613	.	4024	0.839000	-0.321	-1.228	-0.925	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	179078172	179078173	1q25.2	1	normal	.	A	snv	C	CC.CC	het-ref	15	0.15	.	2	.	DUBIOUS	164690	C	164690(MA)	NN	.	.	.	.	.	.	.	27	ABL2	C12E	EX12E	.	.	coding-synon	NM_007314.3	NP_009298.1	-	Y	c.2229T>G	p.(G743=) | p.(Gly743=)	GGT=>GGG	.	NM_007314.3(ABL2): c.2229T>G (p.(G743=))	MixedObserved;	98510	0.003756	U	.	.	.	.	VQSRTrancheSNP99.95to100.00	0	7286	0.002196	0	98510	0.003756	0	33	2.86608e-03	0	1269	7.75426e-03	rs774330058	.	4024	0.111300	-0.321	-1.228	-0.925	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
1	179089474	179089475	1q25.2	0	nullSample	.	C	ref	C	TT.AT	homo-ref	.	.	.	0	.	.	164690	C	164690(MA)	NN	.	.	.	.	.	.	.	27	ABL2	IC5	IVS5	.	.	no-change	NM_007314.3	NP_009298.1	-	Y	c.961-66G=	.	.	.	NM_007314.3(ABL2): c.961-66G=	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	5008	0.370807	U	0.5407	0.629193	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9726961	.	4024	0.470400	-1.536	-0.096	0.022	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	179089474	179089475	1q25.2	0	normal	.	C	snv	G	TT.AT	hom-alt	261	1.00	.	0	.	PASS	164690	C	164690(MA)	NN	.	.	.	.	.	.	.	27	ABL2	IC5	IVS5	.	.	intron	NM_007314.3	NP_009298.1	-	Y	c.961-66G>C	.	.	.	NM_007314.3(ABL2): c.961-66G>C	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	5008	0.629193	U	0.5407	0.629193	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9726961	.	4024	0.529600	-1.536	-0.096	0.022	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	179198301	179198302	1q25.2	0	nullSample	.	T	ref	T	CG.CC	homo-ref	.	.	.	0	.	.	164690	C	164690(MA)	NN	.	.	.	.	.	.	.	27	ABL2	IC1	IVS1	.	.	no-change	NM_007314.3	NP_009298.1	-	Y	c.157+74A=	.	.	.	NM_007314.3(ABL2): c.157+74A=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.541	-0.864	-0.675	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
1	179198301	179198302	1q25.2	0	normal	.	T	snv	G	CG.CC	hom-alt	5	1.00	.	0	.	DUBIOUS	164690	C	164690(MA)	NN	.	.	.	.	.	.	.	27	ABL2	IC1	IVS1	.	.	intron	NM_007314.3	NP_009298.1	-	Y	c.157+74A>C	.	.	.	NM_007314.3(ABL2): c.157+74A>C	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.541	-0.864	-0.675	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
1	179198304	179198305	1q25.2	0	nullSample	.	G	ref	G	CC.CC	homo-ref	.	.	.	0	.	.	164690	C	164690(MA)	NN	.	.	.	.	.	.	.	27	ABL2	IC1	IVS1	.	.	no-change	NM_007314.3	NP_009298.1	-	Y	c.157+71C=	.	.	.	NM_007314.3(ABL2): c.157+71C=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2642	0.930000	-0.390	0.035	-0.082	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	179198304	179198305	1q25.2	0	normal	.	G	snv	C	CC.CC	hom-alt	4	1.00	.	0	.	DUBIOUS	164690	C	164690(MA)	NN	.	.	.	.	.	.	.	27	ABL2	IC1	IVS1	.	.	intron	NM_007314.3	NP_009298.1	-	Y	c.157+71C>G	.	.	.	NM_007314.3(ABL2): c.157+71C>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2642	0.064700	-0.390	0.035	-0.082	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	179198307	179198308	1q25.2	0	nullSample	.	A	ref	A	CC.CC	homo-ref	.	.	.	0	.	.	164690	C	164690(MA)	NN	.	.	.	.	.	.	.	27	ABL2	IC1	IVS1	.	.	no-change	NM_007314.3	NP_009298.1	-	Y	c.157+68T=	.	.	.	NM_007314.3(ABL2): c.157+68T=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1163	0.589800	-0.714	-0.190	-0.264	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	179198307	179198308	1q25.2	0	normal	.	A	snv	C	CC.CC	hom-alt	4	1.00	.	0	.	DUBIOUS	164690	C	164690(MA)	NN	.	.	.	.	.	.	.	27	ABL2	IC1	IVS1	.	.	intron	NM_007314.3	NP_009298.1	-	Y	c.157+68T>G	.	.	.	NM_007314.3(ABL2): c.157+68T>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1163	0.327100	-0.714	-0.190	-0.264	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	179198311	179198312	1q25.2	0	nullSample	.	A	ref	A	CC.CC	homo-ref	.	.	.	0	.	.	164690	C	164690(MA)	NN	.	.	.	.	.	.	.	27	ABL2	IC1	IVS1	.	.	no-change	NM_007314.3	NP_009298.1	-	Y	c.157+64T=	.	.	.	NM_007314.3(ABL2): c.157+64T=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	775	0.291300	0.374	0.236	0.433	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	179198311	179198312	1q25.2	0	normal	.	A	snv	C	CC.CC	hom-alt	4	1.00	.	0	.	DUBIOUS	164690	C	164690(MA)	NN	.	.	.	.	.	.	.	27	ABL2	IC1	IVS1	.	.	intron	NM_007314.3	NP_009298.1	-	Y	c.157+64T>G	.	.	.	NM_007314.3(ABL2): c.157+64T>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	775	0.657800	0.374	0.236	0.433	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	179198316	179198317	1q25.2	0	nullSample	.	G	ref	G	CC.CC	homo-ref	.	.	.	0	.	.	164690	C	164690(MA)	NN	.	.	.	.	.	.	.	27	ABL2	IC1	IVS1	.	.	no-change	NM_007314.3	NP_009298.1	-	Y	c.157+59C=	.	.	.	NM_007314.3(ABL2): c.157+59C=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	628	0.384100	-0.390	-0.138	-0.357	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	179198316	179198317	1q25.2	0	normal	.	G	snv	C	CC.CC	hom-alt	3	1.00	.	0	.	DUBIOUS	164690	C	164690(MA)	NN	.	.	.	.	.	.	.	27	ABL2	IC1	IVS1	.	.	intron	NM_007314.3	NP_009298.1	-	Y	c.157+59C>G	.	.	.	NM_007314.3(ABL2): c.157+59C>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	628	0.601600	-0.390	-0.138	-0.357	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	182551336	182551337	1q25.3	0	nullSample	.	A	ref	A	AG.TC	homo-ref	.	.	.	0	.	.	180435	C	601518(MK)	NN	Prostate cancer, hereditary, 1	AD	.	Oncologic	Oncologic	18575592|17224235|16054567|12915880|12022038|11799394	.	6041	RNASEL	C3	EX4	.	.	no-change	NM_021133.3	NP_066956.1	-	Y	c.1623T=	.	.	.	NM_021133.3(RNASEL): c.1623T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126390	0.464317	U	0.7093	0.479832	13006	0.527833	PASS	-849	8650	0.278382	13473	121382	0.462012	.	.	.	.	.	.	rs627928	.	4024	0.288000	-1.655	-1.926	-1.577	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	182551336	182551337	1q25.3	1	normal	.	A	snv	C	AG.TC	hom-alt	238	1.00	.	0	.	PASS	180435	C	601518(MK)	NN	Prostate cancer, hereditary, 1	AD	.	Oncologic	Oncologic	18575592|17224235|16054567|12915880|12022038|11799394	.	6041	RNASEL	C3	EX4	.	.	missense	NM_021133.3	NP_066956.1	-	Y	c.1623T>G	p.D541E | p.Asp541Glu	GAT=>GAG	P-=>P-	NM_021133.3(RNASEL): c.1623T>G (p.D541E)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126390	0.535683	U	0.7093	0.479832	13006	0.472167	PASS	2272	8650	0.721618	18084	121382	0.537988	4523	12453	7.21997e-01	36337	131423	5.39729e-01	rs627928	.	4024	0.712000	-1.655	-1.926	-1.577	1	0	0	0.000	neutral	.	.	.	.	.	CM034674	NM_021133.3(RNASEL): c.1623T>G (p.D541E)	"Prostate cancer, association with"	12915880	DP	.	.	.	.	Likely Benign
1	182554556	182554557	1q25.3	0	nullSample	.	C	ref	C	TT.GG	homo-ref	.	.	.	0	.	.	180435	C	601518(MK)	NN	Prostate cancer, hereditary, 1	AD	.	Oncologic	Oncologic	18575592|17224235|16054567|12915880|12022038|11799394	.	6041	RNASEL	C1	EX2	Protein kinase domain;Lipopolysaccharide kinase (Kdo/WaaP) family;Protein tyrosine kinase	PF00069.20;PF06293.9;PF07714.12	no-change	NM_021133.3	NP_066956.1	-	Y	c.1385G=	.	.	.	NM_021133.3(RNASEL): c.1385G=	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	126372	0.694181	U	0.2421	0.230631	13006	0.719207	PASS	.	8648	0.770930	29506	121364	0.691078	.	.	.	.	.	.	rs486907	.	4024	0.779600	0.650	0.253	0.102	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	182554556	182554557	1q25.3	1	normal	.	C	snv	T	TT.GG	hom-alt	398	1.00	.	0	.	PASS	180435	C	601518(MK)	NN	Prostate cancer, hereditary, 1	AD	.	Oncologic	Oncologic	18575592|17224235|16054567|12915880|12022038|11799394	.	6041	RNASEL	C1	EX2	Protein kinase domain;Lipopolysaccharide kinase (Kdo/WaaP) family;Protein tyrosine kinase	PF00069.20;PF06293.9;PF07714.12	missense	NM_021133.3	NP_066956.1	-	Y	c.1385G>A	p.R462Q | p.Arg462Gln	CGA=>CAA	P+=>P0	NM_021133.3(RNASEL): c.1385G>A (p.R462Q)	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	126372	0.305819	U	0.2421	0.230631	13006	0.280793	PASS	234	8648	0.229070	6316	121364	0.308922	478	4022	2.33186e-01	12551	75436	3.06593e-01	rs486907	.	4024	0.220400	0.650	0.253	0.102	0.04	0.85	0.998	0.676	deleterious	ENST00000367559: c.1385G>A (p.R462Q)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3750683	CM020962	NM_021133.3(RNASEL): c.1385G>A (p.R462Q)	"Prostate cancer, association with ?"	11941539	DP	no_record	13006	no_assertion_criteria_provided	risk_factor	Likely Benign
1	193094368	193094372	1q31.2	0	nullSample	.	TATC	ref	TATC	CT.TA	homo-ref	.	.	.	0	.	.	607393	C	145000(MK);145001(MK);608266(MK)	AD	Hyperparathyroidism, familial isolated; Hyperparathyroidism-jaw tumor syndrome; Carcinoma, parathyroid	AD	.	Endocrine; Oncologic; Renal	Endocrine; Oncologic	23757631|23652676|22187299|21361849|20301744|17666472|17639062|16720667|15606373|15531515|14985403|14715834|14585940|12434154|11157996|3592449	FC59;H41;H54;H62;H68;HE15;MC58	79577	CDC73	IC2	IVS2	.	.	no-change	NM_024529.4	NP_078805.3	+	Y	c.237+22_237+25=	.	.	.	NM_024529.4(CDC73): c.237+22_237+25=	;maf-5-some-pop	125143	0.920091	U	.	.	12520	0.974681	.	.	.	.	.	.	.	.	.	.	.	.	.	rs71945947	.	4024	0.492500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	193094368	193094372	1q31.2	0	normal	.	TATC	del	.	CT.TA	hom-alt	343	1.00	.	0	.	PASS	607393	C	145000(MK);145001(MK);608266(MK)	AD	Hyperparathyroidism, familial isolated; Hyperparathyroidism-jaw tumor syndrome; Carcinoma, parathyroid	AD	.	Endocrine; Oncologic; Renal	Endocrine; Oncologic	23757631|23652676|22187299|21361849|20301744|17666472|17639062|16720667|15606373|15531515|14985403|14715834|14585940|12434154|11157996|3592449	FC59;H41;H54;H62;H68;HE15;MC58	79577	CDC73	IC2	IVS2	.	.	intron	NM_024529.4	NP_078805.3	+	Y	c.237+22_237+25delTATC	.	.	.	NM_024529.4(CDC73): c.237+22_237+25delTATC	;maf-5-some-pop	125143	0.079909	U	0.4821	0.139177	12520	0.025319	PASS	1015	8482	0.482315	1205	120136	0.077437	2050	8352	4.89451e-01	2490	19998	8.15559e-02	rs71945947	.	4024	0.507500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	21684	no_assertion_criteria_provided	Benign	Benign
1	193111228	193111230	1q31.2	0	normal	.	GA	ref	GA	GT.GA	het-alt	198	0.78	.	1	.	PASS	607393	C	145000(MK);145001(MK);608266(MK)	AD	Hyperparathyroidism, familial isolated; Hyperparathyroidism-jaw tumor syndrome; Carcinoma, parathyroid	AD	.	Endocrine; Oncologic; Renal	Endocrine; Oncologic	23757631|23652676|22187299|21361849|20301744|17666472|17639062|16720667|15606373|15531515|14985403|14715834|14585940|12434154|11157996|3592449	FC59;H41;H54;H62;H68;HE15;MC58	79577	CDC73	IC7	IVS7	.	.	no-change	NM_024529.4	NP_078805.3	+	Y	c.729+33_729+34=	.	.	.	NM_024529.4(CDC73): c.729+33_729+34=	MixedObserved;	8	0.750000	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs147167392	.	4024	0.506500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	193111228	193111230	1q31.2	0	normal	.	GA	del	.	GT.GA	het-ref	56	0.22	.	2	.	PASS	607393	C	145000(MK);145001(MK);608266(MK)	AD	Hyperparathyroidism, familial isolated; Hyperparathyroidism-jaw tumor syndrome; Carcinoma, parathyroid	AD	.	Endocrine; Oncologic; Renal	Endocrine; Oncologic	23757631|23652676|22187299|21361849|20301744|17666472|17639062|16720667|15606373|15531515|14985403|14715834|14585940|12434154|11157996|3592449	FC59;H41;H54;H62;H68;HE15;MC58	79577	CDC73	IC7	IVS7	.	.	intron	NM_024529.4	NP_078805.3	+	Y	c.729+33_729+34delGA	.	.	.	NM_024529.4(CDC73): c.729+33_729+34delGA	MixedObserved;	8	0.250000	U	.	.	.	.	PASS	0	4616	0.344671	13	75930	0.358251	.	.	.	.	.	.	rs147167392	.	4024	0.493500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	21686	no_assertion_criteria_provided	Benign	Benign
1	193116950	193116951	1q31.2	0	normal	.	A	ref	A	CT.TT	het-alt	91	0.44	.	1	.	PASS	607393	C	145000(MK);145001(MK);608266(MK)	AD	Hyperparathyroidism, familial isolated; Hyperparathyroidism-jaw tumor syndrome; Carcinoma, parathyroid	AD	.	Endocrine; Oncologic; Renal	Endocrine; Oncologic	23757631|23652676|22187299|21361849|20301744|17666472|17639062|16720667|15606373|15531515|14985403|14715834|14585940|12434154|11157996|3592449	FC59;H41;H54;H62;H68;HE15;MC58	79577	CDC73	IC7	IVS7	.	.	no-change	NM_024529.4	NP_078805.3	+	Y	c.730-46A=	.	.	.	NM_024529.4(CDC73): c.730-46A=	;	35750	0.997175	U	0.0377	0.00798722	12748	0.999686	PASS	-25	1048	0.948473	15312	30742	0.998016	.	.	.	.	.	.	rs140402302	.	4024	0.963500	-1.411	-0.973	-1.007	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	193116950	193116951	1q31.2	0	normal	.	A	snv	G	CT.TT	het-ref	118	0.56	.	2	.	PASS	607393	C	145000(MK);145001(MK);608266(MK)	AD	Hyperparathyroidism, familial isolated; Hyperparathyroidism-jaw tumor syndrome; Carcinoma, parathyroid	AD	.	Endocrine; Oncologic; Renal	Endocrine; Oncologic	23757631|23652676|22187299|21361849|20301744|17666472|17639062|16720667|15606373|15531515|14985403|14715834|14585940|12434154|11157996|3592449	FC59;H41;H54;H62;H68;HE15;MC58	79577	CDC73	IC7	IVS7	.	.	intron	NM_024529.4	NP_078805.3	+	Y	c.730-46A>G	.	.	.	NM_024529.4(CDC73): c.730-46A>G	;	35750	0.002825	U	0.0377	0.00798722	12748	0.000314	PASS	2	1048	0.051527	2	30742	0.001984	12	436	4.05657e-02	12	452	2.75043e-03	rs140402302	.	4024	0.036500	-1.411	-0.973	-1.007	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
1	201981217	201981218	1q32.1	0	normal	.	C	ref	C	GG.GC	het-alt	256	0.53	.	1	.	PASS	602191	P	.	NN	.	.	.	.	.	.	.	1999	ELF3	C2	EX3	Sterile alpha motif (SAM)/Pointed domain	PF02198.11	no-change	NM_001114309.1	NP_001107781.1	+	Y	c.297C=	.	.	.	NM_001114309.1(ELF3): c.297C=	SingleClassTriAllelic;maf-5-some-pop	126240	0.741698	U	0.3363	0.338259	13006	0.704444	PASS	-984	8624	0.649119	33992	121232	0.745001	.	.	.	.	.	.	rs11543979	.	4024	0.641900	-1.059	-0.361	-0.198	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	201981217	201981218	1q32.1	1	normal	.	C	snv	G	GG.GC	het-ref	225	0.47	.	2	.	PASS	602191	P	.	NN	.	.	.	.	.	.	.	1999	ELF3	C2	EX3	Sterile alpha motif (SAM)/Pointed domain	PF02198.11	coding-synon	NM_001114309.1	NP_001107781.1	+	Y	c.297C>G	p.(G99=) | p.(Gly99=)	GGC=>GGG	.	NM_001114309.1(ELF3): c.297C>G (p.(G99=))	SingleClassTriAllelic;maf-5-some-pop	126240	0.258270	U	0.3363	0.338259	13006	0.295556	PASS	529	8624	0.350881	4290	121232	0.254966	1025	5972	3.46243e-01	8207	60906	2.47408e-01	rs11543979	.	4024	0.358100	-1.059	-0.361	-0.198	.	.	.	.	.	ENST00000359651: c.297C>G (p.G99G)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	146735	.	.	.	.	.	.	.	.	.	Likely Benign
1	203152800	203152801	1q32.1	0	nullSample	.	T	ref	T	TC.CC	homo-ref	.	.	.	0	.	.	601525	C	181500(SK);611960(SK)	AD	.	.	.	.	.	.	.	1116	CHI3L1	C5	EX5	Glycosyl hydrolases family 18	PF00704.23	no-change	NM_001276.2	NP_001267.2	-	Y	c.433A=	.	.	.	NM_001276.2(CHI3L1): c.433A=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126300	0.547981	U	0.3839	0.373003	13006	0.585576	PASS	-989	8594	0.629974	18848	121292	0.544719	.	.	.	.	.	.	rs880633	.	4024	0.638400	0.533	1.732	2.153	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	203152800	203152801	1q32.1	1	normal	.	T	snv	C	TC.CC	hom-alt	377	1.00	.	0	.	PASS	601525	C	181500(SK);611960(SK)	AD	.	.	.	.	.	.	.	1116	CHI3L1	C5	EX5	Glycosyl hydrolases family 18	PF00704.23	missense	NM_001276.2	NP_001267.2	-	Y	c.433A>G	p.R145G | p.Arg145Gly	AGA=>GGA	P+=>P0	NM_001276.2(CHI3L1): c.433A>G (p.R145G)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126300	0.452019	U	0.3839	0.373003	13006	0.414424	PASS	601	8594	0.370026	13424	121292	0.455281	1233	6461	3.74942e-01	26886	111099	4.51369e-01	rs880633	.	4024	0.361600	0.533	1.732	2.153	0	0.155	0.177	0.458	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
1	204429837	204429838	1q32.1	0	nullSample	.	C	ref	C	GG.AA	homo-ref	.	.	.	0	.	.	602838	P	.	NN	.	.	.	.	.	.	.	5287	PIK3C2B	IC4	IVS6	.	.	no-change	NM_002646.3	NP_002637.3	-	Y	c.1311-49G=	.	.	.	NM_002646.3(PIK3C2B): c.1311-49G=	;maf-5-some-pop	121480	0.092402	U	0.8224	0.764377	13006	0.179840	PASS	-684	8182	0.203618	1709	116472	0.086244	.	.	.	.	.	.	rs2271414	.	4024	0.236100	-0.758	-0.158	-0.109	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	204429837	204429838	1q32.1	0	normal	.	C	snv	G	GG.AA	hom-alt	227	1.00	.	0	.	PASS	602838	P	.	NN	.	.	.	.	.	.	.	5287	PIK3C2B	IC4	IVS6	.	.	intron	NM_002646.3	NP_002637.3	-	Y	c.1311-49G>C	.	.	.	NM_002646.3(PIK3C2B): c.1311-49G>C	;maf-5-some-pop	121480	0.907598	U	0.8224	0.764377	13006	0.820160	PASS	2574	8182	0.796382	49900	116472	0.913756	5340	13462	7.95344e-01	103655	220732	9.19471e-01	rs2271414	.	4024	0.763900	-0.758	-0.158	-0.109	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	204494755	204494756	1q32.1	0	normal	.	G	ref	G	TG.tt	het-alt	127	0.82	.	1	.	PASS	602704	P	.	NN	.	.	.	.	.	.	.	4194	MDM4	IC1	IVS2	.	.	no-change	NM_002393.4	NP_002384.2	+	Y	c.78+32G=	.	.	.	NM_002393.4(MDM4): c.78+32G=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.000	-1.231	-1.365	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
1	204494756	204494756	1q32.1	0	normal	.	.	ins	T	GG.tt	het-ref	27	0.18	.	2	AT_rich|Low_complexity|Low_complexity|+|26	PASS	602704	P	.	NN	.	.	.	.	.	.	.	4194	MDM4	IC1	IVS2	.	.	intron	NM_002393.4	NP_002384.2	+	Y	c.78+32_78+33insT	.	.	.	NM_002393.4(MDM4): c.78+32_78+33insT	MixedObserved;	52059	0.178221	U	.	.	.	.	PASS	0	5204	0.337433	0	76862	0.316606	.	.	.	.	.	.	rs368369181	.	4024	0.200500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	204512099	204512100	1q32.1	0	nullSample	.	T	ref	T	GG.TT	homo-ref	.	.	.	0	.	.	602704	P	.	NN	.	.	.	.	.	.	.	4194	MDM4	IC7	IVS8	.	.	no-change	NM_002393.4	NP_002384.2	+	Y	c.672+28T=	.	.	.	NM_002393.4(MDM4): c.672+28T=	MixedObserved;maf-5-some-pop,maf-5-all-pops	125416	0.362274	U	0.7024	0.535144	13006	0.458481	PASS	-943	8614	0.316229	8553	120408	0.358008	.	.	.	.	.	.	rs4252717	.	4024	0.336700	0.533	-0.050	0.054	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	204512099	204512100	1q32.1	0	normal	.	T	snv	C	GG.TT	hom-alt	357	1.00	.	0	.	PASS	602704	P	.	NN	.	.	.	.	.	.	.	4194	MDM4	IC7	IVS8	.	.	intron	NM_002393.4	NP_002384.2	+	Y	c.672+28T>C	.	.	.	NM_002393.4(MDM4): c.672+28T>C	MixedObserved;maf-5-some-pop,maf-5-all-pops	125416	0.637726	U	0.7024	0.535144	13006	0.541519	PASS	2002	8614	0.683771	25650	120408	0.641992	3909	11400	6.88406e-01	50421	150669	6.50069e-01	rs4252717	.	4024	0.663300	0.533	-0.050	0.054	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	204515862	204515863	1q32.1	0	nullSample	.	C	ref	C	TT.AG	homo-ref	.	.	.	0	.	.	602704	P	.	NN	.	.	.	.	.	.	.	4194	MDM4	IC8	IVS9	.	.	no-change	NM_002393.4	NP_002384.2	+	Y	c.823-62C=	.	.	.	NM_002393.4(MDM4): c.823-62C=	;maf-5-some-pop,maf-5-all-pops	5008	0.463259	U	0.7024	0.536741	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2290855	.	4024	0.336700	-0.254	-1.374	-1.138	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	204515862	204515863	1q32.1	0	normal	.	C	snv	T	TT.AG	hom-alt	264	1.00	.	0	.	PASS	602704	P	.	NN	.	.	.	.	.	.	.	4194	MDM4	IC8	IVS9	.	.	intron	NM_002393.4	NP_002384.2	+	Y	c.823-62C>T	.	.	.	NM_002393.4(MDM4): c.823-62C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.536741	U	0.7024	0.536741	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2290855	.	4024	0.663300	-0.254	-1.374	-1.138	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	204516024	204516025	1q32.1	0	nullSample	.	A	ref	A	GA.CT	homo-ref	.	.	.	0	.	.	602704	P	.	NN	.	.	.	.	.	.	.	4194	MDM4	IC9	IVS10	.	.	no-change	NM_002393.4	NP_002384.2	+	Y	c.903+20A=	.	.	.	NM_002393.4(MDM4): c.903+20A=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125664	0.359077	U	0.7024	0.539337	13006	0.446409	PASS	-945	8612	0.315838	8458	120656	0.354860	.	.	.	.	.	.	rs2290854	.	4024	0.336500	-0.128	0.247	0.765	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	204516024	204516025	1q32.1	0	normal	.	A	snv	G	GA.CT	hom-alt	307	1.00	.	0	.	PASS	602704	P	.	NN	.	.	.	.	.	.	.	4194	MDM4	IC9	IVS10	.	.	intron	NM_002393.4	NP_002384.2	+	Y	c.903+20A>G	.	.	.	NM_002393.4(MDM4): c.903+20A>G	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125664	0.640923	U	0.7024	0.539337	13006	0.553591	PASS	2001	8612	0.684162	25970	120656	0.645140	3990	11626	6.86224e-01	52843	157377	6.51594e-01	rs2290854	.	4024	0.663500	-0.128	0.247	0.765	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	204518841	204518842	1q32.1	0	nullSample	.	C	ref	C	TC.GT	homo-ref	.	.	.	0	.	.	602704	P	.	NN	.	.	.	.	.	.	.	4194	MDM4	3U1E	EX11E	.	.	no-change	NM_002393.4	NP_002384.2	+	Y	c.*32C=	.	.	.	NM_002393.4(MDM4): c.*32C=	;maf-5-some-pop,genotype-conflict	108006	0.229848	U	0.9504	0.785942	9358	0.232208	PASS	.	8154	0.032745	2915	102998	0.230616	.	.	.	.	.	.	rs4245739	.	.	.	-0.256	-0.517	-0.450	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	204518841	204518842	1q32.1	0	normal	.	C	snv	A	TC.GT	hom-alt	376	1.00	.	0	.	PASS	602704	P	.	NN	.	.	.	.	.	.	.	4194	MDM4	3U1E	EX11E	.	.	utr-3	NM_002393.4	NP_002384.2	+	Y	c.*32C>A	.	.	.	NM_002393.4(MDM4): c.*32C>A	;maf-5-some-pop,genotype-conflict	108006	0.770152	U	0.9504	0.785942	9358	0.767792	PASS	3815	8154	0.967255	30661	102998	0.769384	6318	13044	9.68806e-01	47757	122706	7.71843e-01	rs4245739	.	.	.	-0.256	-0.517	-0.450	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	206647741	206647742	1q32.1	1	nullSample	.	A	ref	A	CA.GT	homo-ref	.	.	.	0	.	.	605048	P	.	NN	.	.	.	.	.	.	.	9641	IKBKE	C2	EX4	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_014002.3	NP_054721.1	+	Y	c.156G>A	p.(Q52=) | p.(Gln52=)	CAG=>CAA	.	NM_014002.3(IKBKE): c.156G>A (p.(Q52=))	;	126382	0.001345	U	1	0.999401	13006	0.001615	PASS	0	8650	0.000000	3	121374	0.001376	.	.	.	.	.	.	rs1539242	.	.	.	-0.215	0.893	0.598	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
1	206647741	206647742	1q32.1	0	normal	.	A	snv	G	CA.GT	hom-alt	612	1.00	.	0	.	PASS	605048	P	.	NN	.	.	.	.	.	.	.	9641	IKBKE	C2	EX4	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	no-change	NM_014002.3	NP_054721.1	+	Y	c.156G=	.	.	.	NM_014002.3(IKBKE): c.156G=	;	126382	0.998655	U	1	0.999401	13006	0.998385	PASS	4325	8650	1.000000	60523	121374	0.998624	8623	17246	1.00000e+00	122756	245858	9.98570e-01	rs1539242	.	.	.	-0.215	0.893	0.598	.	.	.	.	.	ENST00000367120: c.156A>G (p.Q52Q)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4143277	.	.	.	.	.	.	.	.	.	Benign
1	206647786	206647787	1q32.1	0	nullSample	.	T	ref	T	AT.GT	homo-ref	.	.	.	0	.	.	605048	P	.	NN	.	.	.	.	.	.	.	9641	IKBKE	C2	EX4	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	no-change	NM_014002.3	NP_054721.1	+	Y	c.201T=	.	.	.	NM_014002.3(IKBKE): c.201T=	;maf-5-some-pop,genotype-conflict	125810	0.139305	U	0.9732	0.899161	13006	0.154083	PASS	-95	8640	0.023611	1328	120802	0.140900	.	.	.	.	.	.	rs1539243	.	.	.	-0.974	-0.036	0.005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	206647786	206647787	1q32.1	1	normal	.	T	snv	C	AT.GT	hom-alt	627	1.00	.	0	.	PASS	605048	P	.	NN	.	.	.	.	.	.	.	9641	IKBKE	C2	EX4	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_014002.3	NP_054721.1	+	Y	c.201T>C	p.(I67=) | p.(Ile67=)	ATT=>ATC	.	NM_014002.3(IKBKE): c.201T>C (p.(I67=))	;maf-5-some-pop,genotype-conflict	125810	0.860695	U	0.9732	0.899161	13006	0.845917	PASS	4123	8640	0.976389	44708	120802	0.859100	8228	16833	9.76845e-01	91382	211495	8.61031e-01	rs1539243	.	.	.	-0.974	-0.036	0.005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
1	206648356	206648358	1q32.1	0	normal	.	TG	ref	TG	CC.CC	het-alt	273	0.53	.	1	.	PASS	605048	P	.	NN	.	.	.	.	.	.	.	9641	IKBKE	IC3	IVS5	.	.	no-change	NM_014002.3	NP_054721.1	+	Y	c.358+20_358+21=	.	.	.	NM_014002.3(IKBKE): c.358+20_358+21=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
1	206648356	206648358	1q32.1	0	normal	.	TG	del	.	CC.CC	het-ref	240	0.47	.	2	.	PASS	605048	P	.	NN	.	.	.	.	.	.	.	9641	IKBKE	IC3	IVS5	.	.	intron	NM_014002.3	NP_054721.1	+	Y	c.358+20_358+21delTG	.	.	.	NM_014002.3(IKBKE): c.358+20_358+21delTG	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
1	206648377	206648378	1q32.1	0	normal	.	G	ref	G	GC.GC	het-alt	218	0.49	.	1	.	PASS	605048	P	.	NN	.	.	.	.	.	.	.	9641	IKBKE	IC3	IVS5	.	.	no-change	NM_014002.3	NP_054721.1	+	Y	c.358+41G=	.	.	.	NM_014002.3(IKBKE): c.358+41G=	;maf-5-some-pop,maf-5-all-pops	125208	0.382300	U	0.3532	0.508387	13006	0.402737	PASS	-959	8550	0.653801	9248	120200	0.377745	.	.	.	.	.	.	rs1059704	.	.	.	-0.490	-0.320	-0.445	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	206648377	206648378	1q32.1	0	normal	.	G	snv	A	GC.GC	het-ref	230	0.51	.	2	.	PASS	605048	P	.	NN	.	.	.	.	.	.	.	9641	IKBKE	IC3	IVS5	.	.	intron	NM_014002.3	NP_054721.1	+	Y	c.358+41G>A	.	.	.	NM_014002.3(IKBKE): c.358+41G>A	;maf-5-some-pop,maf-5-all-pops	125208	0.617700	U	0.3532	0.508387	13006	0.597263	PASS	521	8550	0.346199	23943	120200	0.622255	958	5729	3.33858e-01	48787	151788	6.24180e-01	rs1059704	.	.	.	-0.490	-0.320	-0.445	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	206651106	206651107	1q32.1	0	normal	.	G	ref	G	AC.GA	het-alt	217	0.55	.	1	.	PASS	605048	P	.	NN	.	.	.	.	.	.	.	9641	IKBKE	C6	EX8	Protein kinase domain	PF00069.20	no-change	NM_014002.3	NP_054721.1	+	Y	c.717G=	.	.	.	NM_014002.3(IKBKE): c.717G=	;maf-5-some-pop,maf-5-all-pops	32458	0.676597	U	0.6131	0.315495	12912	0.805840	PASS	-249	1900	0.320000	6030	27450	0.675155	.	.	.	.	.	.	rs2297545	.	.	.	-2.447	-4.093	-3.856	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	206651106	206651107	1q32.1	1	normal	.	G	snv	A	AC.GA	het-ref	178	0.45	.	2	.	PASS	605048	P	.	NN	.	.	.	.	.	.	.	9641	IKBKE	C6	EX8	Protein kinase domain	PF00069.20	coding-synon	NM_014002.3	NP_054721.1	+	Y	c.717G>A	p.(T239=) | p.(Thr239=)	ACG=>ACA	.	NM_014002.3(IKBKE): c.717G>A (p.(T239=))	;maf-5-some-pop,maf-5-all-pops	32458	0.323403	U	0.6131	0.315495	12912	0.194160	PASS	397	1900	0.680000	1222	27450	0.324845	2403	7414	6.43241e-01	7109	44421	2.66543e-01	rs2297545	.	.	.	-2.447	-4.093	-3.856	.	.	.	.	.	ENST00000367120: c.717G>A (p.T239T)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	425146	.	.	.	.	.	.	.	.	.	Likely Benign
1	206666733	206666734	1q32.1	0	normal	.	T	ref	T	GG.TG	het-alt	106	0.50	.	1	.	PASS	605048	P	.	NN	.	.	.	.	.	.	.	9641	IKBKE	IC18	IVS20	.	.	no-change	NM_014002.3	NP_054721.1	+	Y	c.2045+23T=	.	.	.	NM_014002.3(IKBKE): c.2045+23T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	123434	0.722945	U	0.244	0.293131	13006	0.695525	PASS	-819	8400	0.743571	31053	118426	0.723625	.	.	.	.	.	.	rs12026566	.	.	.	-0.648	0.483	0.493	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	206666733	206666734	1q32.1	0	normal	.	T	snv	G	GG.TG	het-ref	104	0.50	.	2	.	PASS	605048	P	.	NN	.	.	.	.	.	.	.	9641	IKBKE	IC18	IVS20	.	.	intron	NM_014002.3	NP_054721.1	+	Y	c.2045+23T>G	.	.	.	NM_014002.3(IKBKE): c.2045+23T>G	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	123434	0.277055	U	0.244	0.293131	13006	0.304475	PASS	258	8400	0.256429	4570	118426	0.276375	582	4505	2.62376e-01	9172	66274	2.71252e-01	rs12026566	.	.	.	-0.648	0.483	0.493	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	206669464	206669465	1q32.1	0	normal	.	C	ref	C	AC.TC	het-alt	227	0.53	.	1	.	PASS	605048	P	.	NN	.	.	.	.	.	.	.	9641	IKBKE	C20E	EX22E	.	.	no-change	NM_014002.3	NP_054721.1	+	Y	c.2138C=	.	.	.	NM_014002.3(IKBKE): c.2138C=	;maf-5-some-pop	126360	0.808784	U	0.1935	0.148163	13006	0.840766	PASS	.	8644	0.787020	39844	121352	0.807008	.	.	.	.	.	.	rs3748022	.	.	.	0.655	1.405	1.401	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	206669464	206669465	1q32.1	1	normal	.	C	snv	T	AC.TC	het-ref	205	0.47	.	2	.	PASS	605048	P	.	NN	.	.	.	.	.	.	.	9641	IKBKE	C20E	EX22E	.	.	missense	NM_014002.3	NP_054721.1	+	Y	c.2138C>T	p.P713L | p.Pro713Leu	CCT=>CTT	NP=>NP	NM_014002.3(IKBKE): c.2138C>T (p.P713L)	;maf-5-some-pop	126360	0.191216	U	0.1935	0.148163	13006	0.159234	PASS	193	8644	0.212980	2588	121352	0.192992	388	3726	2.16477e-01	5467	49045	1.99586e-01	rs3748022	.	.	.	0.655	1.405	1.401	0.44	0.008	0.007	0.013	neutral	ENST00000367120: c.2138C>T (p.P713L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	1178403	.	.	.	.	.	.	.	.	.	Likely Benign
1	226550923	226550924	1q42.12	0	normal	.	G	snv	C	TT.AT	het-ref	130	0.56	.	2	.	PASS	173870	C	.	NN	.	.	.	.	.	.	.	142	PARP1	IC20	IVS20	.	.	intron	NM_001618.3	NP_001609.2	-	Y	c.2787-63C>G	.	.	.	NM_001618.3(PARP1): c.2787-63C>G	;maf-5-some-pop,maf-5-all-pops	5008	0.486621	U	0.2054	0.486621	4566	0.603373	.	.	.	.	.	.	.	.	.	.	.	.	.	rs747657	.	.	.	-0.258	0.365	0.136	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	226550923	226550924	1q42.12	0	normal	.	G	ref	G	TT.AT	het-alt	104	0.44	.	1	.	PASS	173870	C	.	NN	.	.	.	.	.	.	.	142	PARP1	IC20	IVS20	.	.	no-change	NM_001618.3	NP_001609.2	-	Y	c.2787-63C=	.	.	.	NM_001618.3(PARP1): c.2787-63C=	;maf-5-some-pop,maf-5-all-pops	5008	0.513379	U	0.2054	0.486621	4566	0.396627	.	.	.	.	.	.	.	.	.	.	.	.	.	rs747657	.	.	.	-0.258	0.365	0.136	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	226555301	226555302	1q42.12	0	normal	.	A	ref	A	CC.CC	het-alt	294	0.50	.	1	.	PASS	173870	C	.	NN	.	.	.	.	.	.	.	142	PARP1	C17	EX17	Poly(ADP-ribose) polymerase, regulatory domain	PF02877.9	no-change	NM_001618.3	NP_001609.2	-	Y	c.2285T=	.	.	.	NM_001618.3(PARP1): c.2285T=	;maf-5-some-pop	126334	0.798415	U	0.4365	0.196885	13006	0.876672	PASS	.	8618	0.562427	39581	121326	0.798221	.	.	.	.	.	.	rs1136410	.	.	.	0.533	5.053	2.122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	226555301	226555302	1q42.12	1	normal	.	A	snv	G	CC.CC	het-ref	290	0.50	.	2	.	PASS	173870	C	.	NN	.	.	.	.	.	.	.	142	PARP1	C17	EX17	Poly(ADP-ribose) polymerase, regulatory domain	PF02877.9	missense	NM_001618.3	NP_001609.2	-	Y	c.2285T>C	p.V762A | p.Val762Ala	GTG=>GCG	NP=>NP	NM_001618.3(PARP1): c.2285T>C (p.V762A)	;maf-5-some-pop	126334	0.201585	U	0.4365	0.196885	13006	0.123328	PASS	833	8618	0.437573	3399	121326	0.201779	1703	7697	4.46358e-01	7526	52358	2.12670e-01	rs1136410	.	.	.	0.533	5.053	2.122	0.05	0.764	0.403	0.629	deleterious	ENST00000366794: c.2285T>C (p.V762A)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3997295	CM042761	NM_001618.3(PARP1): c.2285T>C (p.V762A)	"Prostate cancer, susceptibility, association with"	15342424	DFP	.	.	.	.	Likely Benign
1	226556093	226556094	1q42.12	0	nullSample	.	T	ref	T	TT.TA	homo-ref	.	.	.	0	.	.	173870	C	.	NN	.	.	.	.	.	.	.	142	PARP1	IC15	IVS15	.	.	no-change	NM_001618.3	NP_001609.2	-	Y	c.2155-72A=	.	.	.	NM_001618.3(PARP1): c.2155-72A=	;maf-5-some-pop	5008	0.013578	U	1	0.986422	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1805400	.	.	.	-0.128	-0.088	-0.118	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	226556093	226556094	1q42.12	0	normal	.	T	snv	C	TT.TA	hom-alt	297	1.00	.	0	.	PASS	173870	C	.	NN	.	.	.	.	.	.	.	142	PARP1	IC15	IVS15	.	.	intron	NM_001618.3	NP_001609.2	-	Y	c.2155-72A>G	.	.	.	NM_001618.3(PARP1): c.2155-72A>G	;maf-5-some-pop	5008	0.986422	U	1	0.986422	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1805400	.	.	.	-0.128	-0.088	-0.118	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	226570839	226570840	1q42.12	0	normal	.	T	ref	T	TG.TT	het-alt	305	0.53	.	1	.	PASS	173870	C	.	NN	.	.	.	.	.	.	.	142	PARP1	C8	EX8	.	.	no-change	NM_001618.3	NP_001609.2	-	Y	c.1056A=	.	.	.	NM_001618.3(PARP1): c.1056A=	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	126368	0.206326	U	0.5635	0.789337	13006	0.139935	PASS	-1051	8642	0.435084	3446	121360	0.206147	.	.	.	.	.	.	rs1805415	.	.	.	-0.215	0.129	-0.019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	226570839	226570840	1q42.12	1	normal	.	T	snv	C	TG.TT	het-ref	266	0.47	.	2	.	PASS	173870	C	.	NN	.	.	.	.	.	.	.	142	PARP1	C8	EX8	.	.	coding-synon	NM_001618.3	NP_001609.2	-	Y	c.1056A>G	p.(K352=) | p.(Lys352=)	AAA=>AAG	.	NM_001618.3(PARP1): c.1056A>G (p.(K352=))	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	126368	0.793674	U	0.5635	0.789337	13006	0.860065	PASS	1390	8642	0.564916	39108	121360	0.793853	2635	9562	5.54512e-01	77527	193022	7.83903e-01	rs1805415	.	.	.	-0.215	0.129	-0.019	.	.	.	.	.	ENST00000366794: c.1056A>G (p.K352K)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3746819	.	.	.	.	.	.	.	.	.	Likely Benign
1	226573363	226573364	1q42.12	0	normal	.	A	ref	A	TC.GC	het-alt	292	0.51	.	1	.	PASS	173870	C	.	NN	.	.	.	.	.	.	.	142	PARP1	C7	EX7	PADR1 (NUC008) domain	PF08063.7	no-change	NM_001618.3	NP_001609.2	-	Y	c.852T=	.	.	.	NM_001618.3(PARP1): c.852T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126294	0.573479	U	0.7946	0.516573	13006	0.592265	PASS	.	8642	0.194747	21397	121286	0.577198	.	.	.	.	.	.	rs1805414	.	.	.	-2.070	-1.323	-0.721	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	226573363	226573364	1q42.12	1	normal	.	A	snv	G	TC.GC	het-ref	285	0.49	.	2	.	PASS	173870	C	.	NN	.	.	.	.	.	.	.	142	PARP1	C7	EX7	PADR1 (NUC008) domain	PF08063.7	coding-synon	NM_001618.3	NP_001609.2	-	Y	c.852T>C	p.(A284=) | p.(Ala284=)	GCT=>GCC	.	NM_001618.3(PARP1): c.852T>C (p.(A284=))	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126294	0.426521	U	0.7946	0.516573	13006	0.407735	PASS	2807	8642	0.805253	12034	121286	0.422802	5686	14003	8.12051e-01	24697	104491	4.24557e-01	rs1805414	.	.	.	-2.070	-1.323	-0.721	.	.	.	.	.	ENST00000366794: c.852T>C (p.A284A)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4143411	CM071915	NM_001618.3(PARP1): c.852T>C (p.A284A)	"Colorectal adenoma, assoc. with ?"	17283177	DP	.	.	.	.	Likely Benign
1	226578098	226578099	1q42.12	0	nullSample	.	T	ref	T	AG.GC	homo-ref	.	.	.	0	.	.	173870	C	.	NN	.	.	.	.	.	.	.	142	PARP1	IC4	IVS4	.	.	no-change	NM_001618.3	NP_001609.2	-	Y	c.617+12A=	.	.	.	NM_001618.3(PARP1): c.617+12A=	;maf-5-some-pop	126316	0.192003	U	0.9315	0.857628	13006	0.176688	PASS	.	8640	0.063542	2629	121308	0.194052	.	.	.	.	.	.	rs1805403	.	.	.	-2.128	-0.821	-1.252	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	226578098	226578099	1q42.12	1	normal	.	T	snv	C	AG.GC	hom-alt	324	1.00	.	0	.	PASS	173870	C	.	NN	.	.	.	.	.	.	.	142	PARP1	IC4	IVS4	.	.	intron	NM_001618.3	NP_001609.2	-	Y	c.617+12A>G	.	.	.	NM_001618.3(PARP1): c.617+12A>G	;maf-5-some-pop	126316	0.807997	U	0.9315	0.857628	13006	0.823312	PASS	3784	8640	0.936458	39743	121308	0.805948	7582	16175	9.38334e-01	81393	199100	8.09837e-01	rs1805403	.	.	.	-2.128	-0.821	-1.252	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	226589957	226589958	1q42.12	0	normal	.	G	ref	G	TG.TC	het-alt	258	0.46	.	1	.	PASS	173870	C	.	NN	.	.	.	.	.	.	.	142	PARP1	C2	EX2	Poly(ADP-ribose) polymerase and DNA-Ligase Zn-finger region	PF00645.13	no-change	NM_001618.3	NP_001609.2	-	Y	c.243C=	.	.	.	NM_001618.3(PARP1): c.243C=	;maf-5-some-pop,maf-5-all-pops	126340	0.791072	U	0.4365	0.218251	13006	0.852299	PASS	-1053	8630	0.562457	38859	121332	0.791456	.	.	.	.	.	.	rs1805404	.	.	.	-0.142	1.501	0.547	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	226589957	226589958	1q42.12	1	normal	.	G	snv	A	TG.TC	het-ref	305	0.54	.	2	.	PASS	173870	C	.	NN	.	.	.	.	.	.	.	142	PARP1	C2	EX2	Poly(ADP-ribose) polymerase and DNA-Ligase Zn-finger region	PF00645.13	coding-synon	NM_001618.3	NP_001609.2	-	Y	c.243C>T	p.(D81=) | p.(Asp81=)	GAC=>GAT	.	NM_001618.3(PARP1): c.243C>T (p.(D81=))	;maf-5-some-pop,maf-5-all-pops	126340	0.208928	U	0.4365	0.218251	13006	0.147701	PASS	835	8630	0.437543	3496	121332	0.208544	1703	7701	4.46538e-01	7684	53622	2.17839e-01	rs1805404	.	.	.	-0.142	1.501	0.547	.	.	.	.	.	ENST00000366794: c.243C>T (p.D81D)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3997296	.	.	.	.	.	.	.	.	.	Likely Benign
1	226595402	226595403	1q42.12	0	normal	.	A	ref	A	CG.GG	het-alt	47	0.62	.	1	.	PASS	173870	C	.	NN	.	.	.	.	.	.	.	142	PARP1	IC1	IVS1	.	.	no-change	NM_001618.3	NP_001609.2	-	Y	c.120+108T=	.	.	.	NM_001618.3(PARP1): c.120+108T=	.	.	.	.	0.7857	0.538139	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.240	-0.593	-0.541	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	226595403	226595403	1q42.12	0	normal	.	.	ins	GGGCCC	GA.GG	het-ref	29	0.38	.	2	.	PASS	173870	C	.	NN	.	.	.	.	.	.	.	142	PARP1	IC1	IVS1	.	.	intron	NM_001618.3	NP_001609.2	-	Y	c.120+107_120+108insGGGCCC	.	.	.	NM_001618.3(PARP1): c.120+107_120+108insGGGCCC	InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	5008	0.538139	U	0.7857	0.538139	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs144361550	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	226595646	226595647	1q42.12	0	normal	.	C	ref	C	CG.CA	het-alt	238	0.52	.	1	.	PASS	173870	C	.	NN	.	.	.	.	.	.	.	142	PARP1	5U1E	EX1	.	.	no-change	NM_001618.3	NP_001609.2	-	Y	c.-17G=	.	.	.	NM_001618.3(PARP1): c.-17G=	;maf-5-some-pop	120388	0.796724	U	0.4375	0.199081	12998	0.880905	PASS	.	8342	0.573124	37241	115380	0.796542	.	.	.	.	.	.	rs907187	.	.	.	0.297	1.114	0.894	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	226595646	226595647	1q42.12	0	normal	.	C	snv	G	CG.CA	het-ref	217	0.48	.	2	.	PASS	173870	C	.	NN	.	.	.	.	.	.	.	142	PARP1	5U1E	EX1	.	.	utr-5	NM_001618.3	NP_001609.2	-	Y	c.-17G>C	.	.	.	NM_001618.3(PARP1): c.-17G>C	;maf-5-some-pop	120388	0.203276	U	0.4375	0.199081	12998	0.119095	PASS	742	8342	0.426876	3026	115380	0.203458	1632	7447	4.41906e-01	7359	51382	2.12746e-01	rs907187	.	.	.	0.297	1.114	0.894	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	228612837	228612838	1q42.13	1	normal	.	G	snv	T	CG.AT	het-ref	188	0.45	.	2	.	PASS	602820	P	.	NN	.	.	.	.	.	.	.	8290	HIST3H3	C1E	EX1E	Core histone H2A/H2B/H3/H4	PF00125.19	coding-synon	NM_003493.2	NP_003484.1	-	Y	c.189C>A	p.(I63=) | p.(Ile63=)	ATC=>ATA	.	NM_003493.2(HIST3H3): c.189C>A (p.(I63=))	;maf-5-some-pop,maf-5-all-pops	126386	0.815644	U	0.6895	0.690296	13006	0.726665	PASS	1897	8632	0.661608	42225	121378	0.820816	3772	11369	6.59149e-01	87671	205157	8.33111e-01	rs2230656	.	.	.	-0.150	1.205	-0.047	.	.	.	.	.	ENST00000366696: c.189C>A (p.I63I)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4143485	.	.	.	.	.	.	.	.	.	Likely Benign
1	228612837	228612838	1q42.13	0	normal	.	G	ref	G	CG.AT	het-alt	234	0.55	.	1	.	PASS	602820	P	.	NN	.	.	.	.	.	.	.	8290	HIST3H3	C1E	EX1E	Core histone H2A/H2B/H3/H4	PF00125.19	no-change	NM_003493.2	NP_003484.1	-	Y	c.189C=	.	.	.	NM_003493.2(HIST3H3): c.189C=	;maf-5-some-pop,maf-5-all-pops	126386	0.184356	U	0.6895	0.690296	13006	0.273335	PASS	.	8632	0.338392	3285	121378	0.179184	.	.	.	.	.	.	rs2230656	.	.	.	-0.150	1.205	-0.047	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	237801769	237801770	1q43	0	nullSample	.	T	ref	T	CT.AG	homo-ref	.	.	.	0	.	.	180902	C	600996(MK);604772(MK)	NN	Ventricular tachycardia, catecholaminergic polymorphic, 1; Arrhythmogenic right ventricular dysplasia 2  	AD	.	Cardiovascular	Cardiovascular	20301310|19926015|17875969|11208676|11159936|11157710	.	6262	RYR2	C45	EX45	RIH domain	PF01365.16	no-change	NM_001035.2	NP_001026.2	+	Y	c.6906T=	.	.	.	NM_001035.2(RYR2): c.6906T=	;maf-5-some-pop	125778	0.012943	U	1	0.954872	11938	0.040794	PASS	0	8626	0.000000	90	120770	0.011609	.	.	.	.	.	.	rs707189	.	4024	0.001500	-0.215	0.467	0.281	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	237801769	237801770	1q43	1	normal	.	T	snv	C	CT.AG	hom-alt	349	1.00	.	0	.	PASS	180902	C	600996(MK);604772(MK)	NN	Ventricular tachycardia, catecholaminergic polymorphic, 1; Arrhythmogenic right ventricular dysplasia 2  	AD	.	Cardiovascular	Cardiovascular	20301310|19926015|17875969|11208676|11159936|11157710	.	6262	RYR2	C45	EX45	RIH domain	PF01365.16	coding-synon	NM_001035.2	NP_001026.2	+	Y	c.6906T>C	p.(L2302=) | p.(Leu2302=)	CTT=>CTC	.	NM_001035.2(RYR2): c.6906T>C (p.(L2302=))	;maf-5-some-pop	125778	0.987057	U	1	0.954872	11938	0.959206	PASS	4313	8626	1.000000	59073	120770	0.988391	8624	17248	1.00000e+00	120935	243896	9.90642e-01	rs707189	.	4024	0.998500	-0.215	0.467	0.281	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	43819	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
1	241669248	241669249	1q43	0	normal	.	C	ref	C	TA.AG	het-alt	172	0.48	.	1	.	PASS	136850	C	150800(MK);606812(MK)	AD	Hereditary leiomyomatosis and renal cell cancer	AD	Allelic with Fumarase deficiency (AR)	Biochemical; Dermatologic; Neurologic; Obstetric; Oncologic	Obstetric; Oncologic	24346898|23652956|23612258|23320739|23254734|22069215|21404119|21398687|20618355|20301430|16757530|15937070|13520698|11865300|11248088|8200987|6616883|3807970|3736629	FC59;H41;H54;H62;H68;HR14;MC58	2271	FH	IC6	IVS6	.	.	no-change	NM_000143.3	NP_000134.2	-	Y	c.904+54G=	.	.	.	NM_000143.3(FH): c.904+54G=	;maf-5-some-pop	5008	0.958466	U	0.0952	0.0415335	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12065955	.	4024	0.925700	-1.598	-0.721	-0.767	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	241669248	241669249	1q43	0	normal	.	C	snv	T	TA.AG	het-ref	190	0.52	.	2	.	PASS	136850	C	150800(MK);606812(MK)	AD	Hereditary leiomyomatosis and renal cell cancer	AD	Allelic with Fumarase deficiency (AR)	Biochemical; Dermatologic; Neurologic; Obstetric; Oncologic	Obstetric; Oncologic	24346898|23652956|23612258|23320739|23254734|22069215|21404119|21398687|20618355|20301430|16757530|15937070|13520698|11865300|11248088|8200987|6616883|3807970|3736629	FC59;H41;H54;H62;H68;HR14;MC58	2271	FH	IC6	IVS6	.	.	intron	NM_000143.3	NP_000134.2	-	Y	c.904+54G>A	.	.	.	NM_000143.3(FH): c.904+54G>A	;maf-5-some-pop	5008	0.041533	U	0.0952	0.0415335	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12065955	.	4024	0.074300	-1.598	-0.721	-0.767	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	241682819	241682820	1q43	0	normal	.	G	snv	T	GG.CG	het-ref	152	0.52	.	2	.	PASS	136850	C	150800(MK);606812(MK)	AD	Hereditary leiomyomatosis and renal cell cancer	AD	Allelic with Fumarase deficiency (AR)	Biochemical; Dermatologic; Neurologic; Obstetric; Oncologic	Obstetric; Oncologic	24346898|23652956|23612258|23320739|23254734|22069215|21404119|21398687|20618355|20301430|16757530|15937070|13520698|11865300|11248088|8200987|6616883|3807970|3736629	FC59;H41;H54;H62;H68;HR14;MC58	2271	FH	IC1	IVS1	.	.	intron	NM_000143.3	NP_000134.2	-	Y	c.132+71C>A	.	.	.	NM_000143.3(FH): c.132+71C>A	;maf-5-some-pop	5008	0.037740	U	0.0942	0.0377396	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs111416913	.	4024	0.074100	0.655	0.609	1.099	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	241682819	241682820	1q43	0	normal	.	G	ref	G	GG.CG	het-alt	143	0.48	.	1	.	PASS	136850	C	150800(MK);606812(MK)	AD	Hereditary leiomyomatosis and renal cell cancer	AD	Allelic with Fumarase deficiency (AR)	Biochemical; Dermatologic; Neurologic; Obstetric; Oncologic	Obstetric; Oncologic	24346898|23652956|23612258|23320739|23254734|22069215|21404119|21398687|20618355|20301430|16757530|15937070|13520698|11865300|11248088|8200987|6616883|3807970|3736629	FC59;H41;H54;H62;H68;HR14;MC58	2271	FH	IC1	IVS1	.	.	no-change	NM_000143.3	NP_000134.2	-	Y	c.132+71C=	.	.	.	NM_000143.3(FH): c.132+71C=	;maf-5-some-pop	5008	0.962260	U	0.0942	0.0377396	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs111416913	.	4024	0.925900	0.655	0.609	1.099	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	243736210	243736211	1q44	0	normal	.	T	ref	T	AC.TT	het-alt	129	0.49	.	1	.	PASS	611223	P	615937(MK)	NN	.	.	.	.	.	.	.	10000	AKT3	IC8	IVS8	.	.	no-change	NM_181690.2	NP_859029.1	-	Y	c.819+17A=	.	.	.	NM_181690.2(AKT3): c.819+17A=	MixedObserved;	773	0.943079	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs66631932	.	4024	0.565400	0.240	1.820	0.865	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	243736210	243736211	1q44	1	normal	.	T	del	.	AC.TT	het-ref	136	0.51	.	2	.	PASS	611223	P	615937(MK)	NN	.	.	.	.	.	.	.	10000	AKT3	IC8	IVS8	.	.	intron	NM_181690.2	NP_859029.1	-	Y	c.819+17delA	.	.	.	NM_181690.2(AKT3): c.819+17delA	MixedObserved;	773	0.056921	U	0.498	0.482029	.	.	InbreedingCoeff_Filter	13	6148	0.436727	160	85250	0.435613	.	.	.	.	.	.	rs66631932	.	4024	0.433900	0.240	1.820	0.865	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	243777065	243777066	1q44	0	normal	.	G	ref	G	AT.TT	het-alt	187	0.51	.	1	.	PASS	611223	P	615937(MK)	NN	.	.	.	.	.	.	.	10000	AKT3	IC6	IVS6	.	.	no-change	NM_181690.2	NP_859029.1	-	Y	c.628-25C=	.	.	.	NM_181690.2(AKT3): c.628-25C=	;maf-5-some-pop,maf-5-all-pops	115640	0.785256	U	0.2232	0.2498	12938	0.798037	PASS	-720	7950	0.759497	34207	110632	0.786843	.	.	.	.	.	.	rs2168812	.	4024	0.750700	0.557	-0.079	-0.351	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	243777065	243777066	1q44	0	normal	.	G	snv	A	AT.TT	het-ref	178	0.49	.	2	.	PASS	611223	P	615937(MK)	NN	.	.	.	.	.	.	.	10000	AKT3	IC6	IVS6	.	.	intron	NM_181690.2	NP_859029.1	-	Y	c.628-25C>T	.	.	.	NM_181690.2(AKT3): c.628-25C>T	;maf-5-some-pop,maf-5-all-pops	115640	0.214744	U	0.2232	0.2498	12938	0.201963	PASS	236	7950	0.240503	2473	110632	0.213157	443	3528	2.34481e-01	4688	44672	2.02730e-01	rs2168812	.	4024	0.249300	0.557	-0.079	-0.351	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	248525779	248525780	1q44	0	nullSample	.	C	ref	C	CC.CT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	127074	OR2T4	C1E	EX1E	7 transmembrane receptor (rhodopsin family);Olfactory receptor	PF00001.16;PF13853.1	no-change	NM_001004696.1	NP_001004696.1	+	Y	c.898C=	.	.	.	NM_001004696.1(OR2T4): c.898C=	SingleClassTriAllelic;maf-5-some-pop	126396	0.770222	U	0.4276	0.294329	13006	0.810626	PASS	-1085	8636	0.573414	36730	121388	0.772885	.	.	.	.	.	.	rs28698997	.	4024	0.561400	0.585	-0.160	0.407	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
1	248525779	248525780	1q44	1	normal	.	C	snv	T	CC.CT	hom-alt	401	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	127074	OR2T4	C1E	EX1E	7 transmembrane receptor (rhodopsin family);Olfactory receptor	PF00001.16;PF13853.1	missense	NM_001004696.1	NP_001004696.1	+	Y	c.898C>T	p.P300S | p.Pro300Ser	CCT=>TCT	NP=>P0	NM_001004696.1(OR2T4): c.898C>T (p.P300S)	SingleClassTriAllelic;maf-5-some-pop	126396	0.229770	U	0.4276	0.294329	13006	0.189374	PASS	757	8636	0.426586	3604	121388	0.227106	1608	7479	4.34068e-01	7546	56549	2.29678e-01	rs28698997	.	4024	0.438600	0.585	-0.160	0.407	0.04	0.356	0.36	0.462	neutral	ENST00000366475: c.898C>T (p.P300S)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3751110	.	.	.	.	.	.	.	.	.	Likely Benign
2	25466887	25466888	2p23.3	0	nullSample	.	G	ref	G	CA.CG	homo-ref	.	.	.	0	.	.	602769	P	615879(MK)	NN	.	.	.	.	.	.	.	1788	DNMT3A	IC11	IVS11	.	.	no-change	NM_153759.3	NP_715640.2	-	Y	c.1285-37C=	.	.	.	NM_153759.3(DNMT3A): c.1285-37C=	;maf-5-some-pop	52392	0.284700	U	0.6171	0.60024	12954	0.320519	PASS	-378	2742	0.349380	1246	47384	0.272539	.	.	.	.	.	.	rs2289093	.	4024	0.406800	0.655	-0.009	0.195	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	25466887	25466888	2p23.3	0	nullSample	.	G	ref	G	CA.CG	homo-ref	.	.	.	0	.	.	602769	P	615879(MK)	NN	.	.	.	.	.	.	.	1788	DNMT3A	IC14	IVS15	.	.	no-change	NM_175629.2	NP_783328.1	-	N	c.1852-37C=	.	.	.	NM_175629.2(DNMT3A): c.1852-37C=	;maf-5-some-pop	52392	0.284700	U	0.6171	0.60024	12954	0.320519	PASS	-378	2742	0.349380	1246	47384	0.272539	.	.	.	.	.	.	rs2289093	.	4024	0.406800	0.655	-0.009	0.195	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	25466887	25466888	2p23.3	0	normal	.	G	snv	T	CA.CG	hom-alt	321	1.00	.	0	.	PASS	602769	P	615879(MK)	NN	.	.	.	.	.	.	.	1788	DNMT3A	IC11	IVS11	.	.	intron	NM_153759.3	NP_715640.2	-	Y	c.1285-37C>A	.	.	.	NM_153759.3(DNMT3A): c.1285-37C>A	;maf-5-some-pop	52392	0.715300	U	0.6171	0.60024	12954	0.679481	PASS	514	2742	0.650620	12024	47384	0.727461	2076	7224	5.91065e-01	40739	114537	7.02750e-01	rs2289093	.	4024	0.593200	0.655	-0.009	0.195	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	25466887	25466888	2p23.3	0	normal	.	G	snv	T	CA.CG	hom-alt	321	1.00	.	0	.	PASS	602769	P	615879(MK)	NN	.	.	.	.	.	.	.	1788	DNMT3A	IC14	IVS15	.	.	intron	NM_175629.2	NP_783328.1	-	N	c.1852-37C>A	.	.	.	NM_175629.2(DNMT3A): c.1852-37C>A	;maf-5-some-pop	52392	0.715300	U	0.6171	0.60024	12954	0.679481	PASS	514	2742	0.650620	12024	47384	0.727461	2076	7224	5.91065e-01	40739	114537	7.02750e-01	rs2289093	.	4024	0.593200	0.655	-0.009	0.195	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	25469501	25469502	2p23.3	0	nullSample	.	C	ref	C	TC.AG	homo-ref	.	.	.	0	.	.	602769	P	615879(MK)	NN	.	.	.	.	.	.	.	1788	DNMT3A	C6	EX6	.	.	no-change	NM_153759.3	NP_715640.2	-	Y	c.699G=	.	.	.	NM_153759.3(DNMT3A): c.699G=	;maf-5-some-pop	121896	0.807369	U	0.3204	0.223842	12960	0.795062	PASS	-923	8546	0.685233	38379	116888	0.808706	.	.	.	.	.	.	rs2276598	.	4024	0.677200	-1.551	0.591	0.079	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	25469501	25469502	2p23.3	0	nullSample	.	C	ref	C	TC.AG	homo-ref	.	.	.	0	.	.	602769	P	615879(MK)	NN	.	.	.	.	.	.	.	1788	DNMT3A	C9	EX10	.	.	no-change	NM_175629.2	NP_783328.1	-	N	c.1266G=	.	.	.	NM_175629.2(DNMT3A): c.1266G=	;maf-5-some-pop	121896	0.807369	U	0.3204	0.223842	12960	0.795062	PASS	-923	8546	0.685233	38379	116888	0.808706	.	.	.	.	.	.	rs2276598	.	4024	0.677200	-1.551	0.591	0.079	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	25469501	25469502	2p23.3	1	normal	.	C	snv	T	TC.AG	hom-alt	455	1.00	.	0	.	PASS	602769	P	615879(MK)	NN	.	.	.	.	.	.	.	1788	DNMT3A	C6	EX6	.	.	coding-synon	NM_153759.3	NP_715640.2	-	Y	c.699G>A	p.(L233=) | p.(Leu233=)	CTG=>CTA	.	NM_153759.3(DNMT3A): c.699G>A (p.(L233=))	;maf-5-some-pop	121896	0.192631	U	0.3204	0.223842	12960	0.204938	PASS	422	8546	0.314767	2295	116888	0.191294	859	5411	3.15143e-01	4760	46010	1.89557e-01	rs2276598	.	4024	0.322800	-1.551	0.591	0.079	.	.	.	.	.	ENST00000321117: c.1266G>A (p.L422L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4001621	.	.	.	.	.	.	.	.	.	Likely Benign
2	25469501	25469502	2p23.3	1	normal	.	C	snv	T	TC.AG	hom-alt	455	1.00	.	0	.	PASS	602769	P	615879(MK)	NN	.	.	.	.	.	.	.	1788	DNMT3A	C9	EX10	.	.	coding-synon	NM_175629.2	NP_783328.1	-	N	c.1266G>A	p.(L422=) | p.(Leu422=)	CTG=>CTA	.	NM_175629.2(DNMT3A): c.1266G>A (p.(L422=))	;maf-5-some-pop	121896	0.192631	U	0.3204	0.223842	12960	0.204938	PASS	422	8546	0.314767	2295	116888	0.191294	859	5411	3.15143e-01	4760	46010	1.89557e-01	rs2276598	.	4024	0.322800	-1.551	0.591	0.079	.	.	.	.	.	ENST00000321117: c.1266G>A (p.L422L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4001621	.	.	.	.	.	.	.	.	.	Likely Benign
2	25469912	25469913	2p23.3	0	nullSample	.	C	ref	C	GA.AC	homo-ref	.	.	.	0	.	.	602769	P	615879(MK)	NN	.	.	.	.	.	.	.	1788	DNMT3A	IC5	IVS5	.	.	no-change	NM_153759.3	NP_715640.2	-	Y	c.555+7G=	.	.	.	NM_153759.3(DNMT3A): c.555+7G=	;maf-5-some-pop,maf-5-all-pops	122732	0.287488	U	0.6131	0.614018	13006	0.313701	PASS	-1051	8324	0.391639	4802	117724	0.283298	.	.	.	.	.	.	rs2276599	.	4024	0.407100	-1.581	-0.094	-0.435	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	25469912	25469913	2p23.3	0	nullSample	.	C	ref	C	GA.AC	homo-ref	.	.	.	0	.	.	602769	P	615879(MK)	NN	.	.	.	.	.	.	.	1788	DNMT3A	IC8	IVS9	.	.	no-change	NM_175629.2	NP_783328.1	-	N	c.1122+7G=	.	.	.	NM_175629.2(DNMT3A): c.1122+7G=	;maf-5-some-pop,maf-5-all-pops	122732	0.287488	U	0.6131	0.614018	13006	0.313701	PASS	-1051	8324	0.391639	4802	117724	0.283298	.	.	.	.	.	.	rs2276599	.	4024	0.407100	-1.581	-0.094	-0.435	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	25469912	25469913	2p23.3	1	normal	.	C	snv	T	GA.AC	hom-alt	348	1.00	.	0	.	PASS	602769	P	615879(MK)	NN	.	.	.	.	.	.	.	1788	DNMT3A	IC5	IVS5	.	.	intron	NM_153759.3	NP_715640.2	-	Y	c.555+7G>A	.	.	.	NM_153759.3(DNMT3A): c.555+7G>A	;maf-5-some-pop,maf-5-all-pops	122732	0.712512	U	0.6131	0.614018	13006	0.686299	PASS	1481	8324	0.608361	30313	117724	0.716702	2974	10179	5.96589e-01	62536	173338	7.13249e-01	rs2276599	.	4024	0.592900	-1.581	-0.094	-0.435	.	.	.	.	.	ENST00000321117: c.1122+7G>A (p.?)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5468672	.	.	.	.	.	.	.	.	.	Benign
2	25469912	25469913	2p23.3	1	normal	.	C	snv	T	GA.AC	hom-alt	348	1.00	.	0	.	PASS	602769	P	615879(MK)	NN	.	.	.	.	.	.	.	1788	DNMT3A	IC8	IVS9	.	.	intron	NM_175629.2	NP_783328.1	-	N	c.1122+7G>A	.	.	.	NM_175629.2(DNMT3A): c.1122+7G>A	;maf-5-some-pop,maf-5-all-pops	122732	0.712512	U	0.6131	0.614018	13006	0.686299	PASS	1481	8324	0.608361	30313	117724	0.716702	2974	10179	5.96589e-01	62536	173338	7.13249e-01	rs2276599	.	4024	0.592900	-1.581	-0.094	-0.435	.	.	.	.	.	ENST00000321117: c.1122+7G>A (p.?)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5468672	.	.	.	.	.	.	.	.	.	Benign
2	29381848	29381849	2p23.2	0	nullSample	.	G	ref	G	GC.AC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.29381848G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.514377	U	0.756	0.485623	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6754415	.	.	.	-0.361	-0.178	-0.214	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29381848	29381849	2p23.2	0	normal	.	G	snv	A	GC.AC	hom-alt	157	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.29381848G>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.485623	U	0.756	0.485623	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6754415	.	.	.	-0.361	-0.178	-0.214	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29381918	29381919	2p23.2	0	nullSample	.	C	ref	C	GG.TG	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.29381918C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.516973	U	0.7708	0.483027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10195901	.	.	.	0.655	0.589	0.602	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29381918	29381919	2p23.2	0	normal	.	C	snv	A	GG.TG	hom-alt	316	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.29381918C>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.483027	U	0.7708	0.483027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10195901	.	.	.	0.655	0.589	0.602	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29382037	29382038	2p23.2	0	nullSample	.	C	ref	C	CT.GG	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.29382037C= (intergenic)	;maf-5-some-pop,maf-5-all-pops,microattr-tpa	5008	0.554912	U	0.7708	0.445088	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2123443	.	.	.	-3.506	-1.310	-1.423	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29382037	29382038	2p23.2	0	normal	.	C	snv	T	CT.GG	hom-alt	183	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.29382037C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops,microattr-tpa	5008	0.445088	U	0.7708	0.445088	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2123443	.	.	.	-3.506	-1.310	-1.423	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29388806	29388807	2p23.2	0	nullSample	.	A	ref	A	TA.GG	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.29388806A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.558906	U	0.8016	0.441094	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs13417374	.	.	.	-0.313	1.334	0.992	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29388806	29388807	2p23.2	0	normal	.	A	snv	G	TA.GG	hom-alt	326	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.29388806A>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.441094	U	0.8016	0.441094	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs13417374	.	.	.	-0.313	1.334	0.992	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29388840	29388841	2p23.2	0	normal	.	C	ref	C	TT.AA	het-alt	36	0.26	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.29388840C= (intergenic)	;	0	0	U	0.4683	0.323083	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs868656264	.	.	.	0.000	-0.925	-1.037	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29388841	29388841	2p23.2	0	normal	.	.	ins	A	TC.AA	het-ref	103	0.74	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.29388841_29388842insA (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.323083	U	0.4683	0.323083	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs35611841	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29396504	29396505	2p23.2	0	normal	.	T	snv	A	TT.AA	hom-alt	300	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.29396504T>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.583267	U	0.8978	0.583267	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs34623614	.	.	.	-1.437	-0.821	-0.949	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29396504	29396505	2p23.2	0	nullSample	.	T	ref	T	TT.AA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.29396504T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.416733	U	0.8978	0.583267	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs34623614	.	.	.	-1.437	-0.821	-0.949	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29412716	29412717	2p23.2	0	nullSample	.	G	ref	G	CT.TA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.29412716G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.513778	U	0.7262	0.486222	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7587574	.	.	.	-2.435	-0.496	-0.385	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29412716	29412717	2p23.2	0	normal	.	G	snv	C	CT.TA	hom-alt	341	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.29412716G>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.486222	U	0.7262	0.486222	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7587574	.	.	.	-2.435	-0.496	-0.385	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29416365	29416366	2p23.2	0	nullSample	.	G	ref	G	CT.TC	homo-ref	.	.	.	0	.	.	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C29E	EX29E	.	.	no-change	NM_004304.4	NP_004295.2	-	Y	c.4587C=	.	.	.	NM_004304.4(ALK): c.4587C=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126368	0.535507	U	0.7292	0.572883	13006	0.566508	PASS	-794	8638	0.253531	19049	121360	0.539980	.	.	.	.	.	.	rs1881421	.	4024	0.244000	-0.357	-0.064	-1.464	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29416365	29416366	2p23.2	1	normal	.	G	snv	C	CT.TC	hom-alt	707	1.00	.	0	.	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C29E	EX29E	.	.	missense	NM_004304.4	NP_004295.2	-	Y	c.4587C>G	p.D1529E | p.Asp1529Glu	GAC=>GAG	P-=>P-	NM_004304.4(ALK): c.4587C>G (p.D1529E)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126368	0.464493	U	0.7292	0.572883	13006	0.433492	PASS	2430	8638	0.746469	14197	121360	0.460020	4819	12855	7.45477e-01	29583	115007	4.67736e-01	rs1881421	.	4024	0.756000	-0.357	-0.064	-1.464	1	0	0	0.000	neutral	ENST00000389048: c.4587C>G (p.D1529E)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [diffuse_large_B_cell_lymphoma|NS|NS]	CSV	3758201	.	.	.	.	.	no_record	133476	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
2	29416480	29416481	2p23.2	0	nullSample	.	T	ref	T	CC.TG	homo-ref	.	.	.	0	.	.	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C29E	EX29E	.	.	no-change	NM_004304.4	NP_004295.2	-	Y	c.4472A=	.	.	.	NM_004304.4(ALK): c.4472A=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126400	0.664881	U	0.7312	0.415136	13006	0.776642	PASS	.	8642	0.252372	29066	121392	0.668182	.	.	.	.	.	.	rs1881420	.	4024	0.243800	0.454	0.820	0.089	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29416480	29416481	2p23.2	1	normal	.	T	snv	C	CC.TG	hom-alt	665	1.00	.	0	.	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C29E	EX29E	.	.	missense	NM_004304.4	NP_004295.2	-	Y	c.4472A>G	p.K1491R | p.Lys1491Arg	AAG=>AGG	P+=>P+	NM_004304.4(ALK): c.4472A>G (p.K1491R)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126400	0.335119	U	0.7312	0.415136	13006	0.223358	PASS	2440	8642	0.747628	8650	121392	0.331818	4836	12874	7.46492e-01	18527	84463	3.43097e-01	rs1881420	.	4024	0.756200	0.454	0.820	0.089	0.27	0.005	0.001	0.034	neutral	ENST00000389048: c.4472A>G (p.K1491R)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	1130802	.	.	.	.	.	no_record	133474	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
2	29416571	29416572	2p23.2	0	nullSample	.	T	ref	T	GA.CT	homo-ref	.	.	.	0	.	.	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C29E	EX29E	.	.	no-change	NM_004304.4	NP_004295.2	-	Y	c.4381A=	.	.	.	NM_004304.4(ALK): c.4381A=	;clinically-assoc,submitted-by-lsdb,genotype-conflict	126282	0.003033	U	1	0.992212	13006	0.009688	PASS	0	8654	0.000000	3	121274	0.002837	.	.	.	.	.	.	rs1670283	.	4024	0.001000	-0.224	-0.190	-0.248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29416571	29416572	2p23.2	1	normal	.	T	snv	C	GA.CT	hom-alt	627	1.00	.	0	.	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C29E	EX29E	.	.	missense	NM_004304.4	NP_004295.2	-	Y	c.4381A>G	p.I1461V | p.Ile1461Val	ATC=>GTC	NP=>NP	NM_004304.4(ALK): c.4381A>G (p.I1461V)	;clinically-assoc,submitted-by-lsdb,genotype-conflict	126282	0.996967	U	1	0.992212	13006	0.990312	PASS	4327	8654	1.000000	60296	121274	0.997163	8621	17242	1.00000e+00	122036	244651	9.97558e-01	rs1670283	.	4024	0.999000	-0.224	-0.190	-0.248	1	0	0	0.000	neutral	.	.	.	.	.	.	.	.	.	.	no_record	133472	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
2	29420314	29420315	2p23.2	0	nullSample	.	C	ref	C	CC.CT	homo-ref	.	.	.	0	.	.	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	IC27	IVS27	.	.	no-change	NM_004304.4	NP_004295.2	-	Y	c.4073+93G=	.	.	.	NM_004304.4(ALK): c.4073+93G=	;maf-5-some-pop,maf-5-all-pops	5008	0.606030	U	0.7252	0.39397	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3738870	.	4024	0.245800	0.655	0.028	-0.094	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29420314	29420315	2p23.2	0	normal	.	C	snv	T	CC.CT	hom-alt	353	1.00	.	0	.	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	IC27	IVS27	.	.	intron	NM_004304.4	NP_004295.2	-	Y	c.4073+93G>A	.	.	.	NM_004304.4(ALK): c.4073+93G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.393970	U	0.7252	0.39397	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3738870	.	4024	0.754200	0.655	0.028	-0.094	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29445457	29445458	2p23.2	1	normal	.	G	snv	T	GC.CC	hom-alt	370	1.00	.	0	.	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C21	EX21	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_004304.4	NP_004295.2	-	Y	c.3375C>A	p.(G1125=) | p.(Gly1125=)	GGC=>GGA	.	NM_004304.4(ALK): c.3375C>A (p.(G1125=))	;maf-5-some-pop,maf-5-all-pops	124446	0.330722	U	0.7173	0.415935	13006	0.221436	PASS	2351	8562	0.737795	8232	119438	0.327149	4685	12657	7.36643e-01	17926	82485	3.36333e-01	rs3795850	.	4024	0.742500	0.455	-2.058	-1.829	.	.	.	.	.	ENST00000389048: c.3375C>A (p.G1125G)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [diffuse_large_B_cell_lymphoma|NS|NS]	CSV	5351767	.	.	.	.	.	no_record	335694	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
2	29445457	29445458	2p23.2	0	nullSample	.	G	ref	G	GC.CC	homo-ref	.	.	.	0	.	.	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C21	EX21	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	no-change	NM_004304.4	NP_004295.2	-	Y	c.3375C=	.	.	.	NM_004304.4(ALK): c.3375C=	;maf-5-some-pop,maf-5-all-pops	124446	0.669278	U	0.7173	0.415935	13006	0.778564	PASS	.	8562	0.262205	28877	119438	0.672851	.	.	.	.	.	.	rs3795850	.	4024	0.257500	0.455	-2.058	-1.829	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29446183	29446184	2p23.2	0	nullSample	.	C	ref	C	TC.CA	homo-ref	.	.	.	0	.	.	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	IC20	IVS20	.	.	no-change	NM_004304.4	NP_004295.2	-	Y	c.3359+24G=	.	.	.	NM_004304.4(ALK): c.3359+24G=	SingleClassTriAllelic;maf-5-some-pop	124976	0.665240	U	0.7381	0.420727	13006	0.776565	PASS	-764	8584	0.240913	28783	119968	0.668828	.	.	.	.	.	.	rs2276550	.	4024	0.241300	0.305	-0.438	-0.468	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29446183	29446184	2p23.2	0	normal	.	C	snv	G	TC.CA	hom-alt	348	1.00	.	0	.	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	IC20	IVS20	.	.	intron	NM_004304.4	NP_004295.2	-	Y	c.3359+24G>C	.	.	.	NM_004304.4(ALK): c.3359+24G>C	SingleClassTriAllelic;maf-5-some-pop	124976	0.334752	U	0.7381	0.420727	13006	0.223435	PASS	2494	8584	0.759087	8529	119968	0.331163	4967	13060	7.59479e-01	18414	83306	3.41757e-01	rs2276550	.	4024	0.758700	0.305	-0.438	-0.468	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29446720	29446721	2p23.2	0	nullSample	.	A	ref	A	ag.ag	homo-ref	.	.	.	0	LTR16B2|LTR|ERVL|-|414	.	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	IC19	IVS19	.	.	no-change	NM_004304.4	NP_004295.2	-	Y	c.3173-327T=	.	.	.	NM_004304.4(ALK): c.3173-327T=	;maf-5-some-pop,genotype-conflict	5008	0.145367	U	0.9187	0.854633	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4665447	.	4024	0.075500	-0.385	-0.102	-0.124	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29446720	29446721	2p23.2	0	normal	.	A	snv	G	ag.ag	hom-alt	643	1.00	.	0	LTR16B2|LTR|ERVL|-|414	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	IC19	IVS19	.	.	intron	NM_004304.4	NP_004295.2	-	Y	c.3173-327T>C	.	.	.	NM_004304.4(ALK): c.3173-327T>C	;maf-5-some-pop,genotype-conflict	5008	0.854633	U	0.9187	0.854633	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4665447	.	4024	0.924500	-0.385	-0.102	-0.124	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29447107	29447108	2p23.2	0	nullSample	.	G	ref	G	ct.aa	homo-ref	.	.	.	0	MIRc|SINE|MIR|+|265	.	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	IC19	IVS19	.	.	no-change	NM_004304.4	NP_004295.2	-	Y	c.3173-714C=	.	.	.	NM_004304.4(ALK): c.3173-714C=	;maf-5-some-pop,maf-5-all-pops	5008	0.272564	U	0.755	0.727436	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4387740	.	4024	0.229900	-1.780	-2.194	-2.369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29447107	29447108	2p23.2	0	normal	.	G	snv	A	ct.aa	hom-alt	749	1.00	.	0	MIRc|SINE|MIR|+|265	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	IC19	IVS19	.	.	intron	NM_004304.4	NP_004295.2	-	Y	c.3173-714C>T	.	.	.	NM_004304.4(ALK): c.3173-714C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.727436	U	0.755	0.727436	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4387740	.	4024	0.770100	-1.780	-2.194	-2.369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29447252	29447253	2p23.2	0	nullSample	.	A	ref	A	cc.ct	homo-ref	.	.	.	0	MIRc|SINE|MIR|+|265	.	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	IC19	IVS19	.	.	no-change	NM_004304.4	NP_004295.2	-	Y	c.3173-859T=	.	.	.	NM_004304.4(ALK): c.3173-859T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.370607	U	0.8581	0.629393	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6723311	.	4024	0.117500	-0.475	-1.356	-1.454	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29447252	29447253	2p23.2	0	normal	.	A	snv	G	cc.ct	hom-alt	670	1.00	.	0	MIRc|SINE|MIR|+|265	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	IC19	IVS19	.	.	intron	NM_004304.4	NP_004295.2	-	Y	c.3173-859T>C	.	.	.	NM_004304.4(ALK): c.3173-859T>C	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.629393	U	0.8581	0.629393	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6723311	.	4024	0.882500	-0.475	-1.356	-1.454	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29449525	29449526	2p23.2	0	nullSample	.	C	ref	C	gg.at	homo-ref	.	.	.	0	L3|LINE|CR1|+|240	.	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	IC18	IVS18	.	.	no-change	NM_004304.4	NP_004295.2	-	Y	c.3067+262G=	.	.	.	NM_004304.4(ALK): c.3067+262G=	;maf-5-some-pop,maf-5-all-pops	5008	0.611222	U	0.6855	0.388778	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1881419	.	4024	0.317100	0.313	0.124	0.127	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29449525	29449526	2p23.2	0	normal	.	C	snv	T	gg.at	hom-alt	460	1.00	.	0	L3|LINE|CR1|+|240	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	IC18	IVS18	.	.	intron	NM_004304.4	NP_004295.2	-	Y	c.3067+262G>A	.	.	.	NM_004304.4(ALK): c.3067+262G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.388778	U	0.6855	0.388778	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1881419	.	4024	0.682900	0.313	0.124	0.127	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29451789	29451790	2p23.2	0	normal	.	T	ref	T	CC.CC	het-alt	124	0.81	.	1	.	DUBIOUS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C16	EX16	Glycine rich protein	PF12810.2	no-change	NM_004304.4	NP_004295.2	-	Y	c.2775A=	.	.	.	NM_004304.4(ALK): c.2775A=	;	117088	0.999214	U	.	.	.	.	VQSRTrancheSNP99.90to99.95	.	8558	0.999649	58452	117088	0.999214	.	.	.	.	.	.	rs777406442	.	4024	0.881200	-1.235	-0.395	-1.919	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29451789	29451790	2p23.2	1	normal	.	T	snv	C	CC.CC	het-ref	30	0.19	.	2	.	DUBIOUS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C16	EX16	Glycine rich protein	PF12810.2	coding-synon	NM_004304.4	NP_004295.2	-	Y	c.2775A>G	p.(G925=) | p.(Gly925=)	GGA=>GGG	.	NM_004304.4(ALK): c.2775A>G (p.(G925=))	;	117088	0.000786	U	.	.	.	.	VQSRTrancheSNP99.90to99.95	0	8558	0.000351	0	117088	0.000786	0	544	5.76760e-02	0	4979	2.97598e-02	rs777406442	.	4024	0.118000	-1.235	-0.395	-1.919	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
2	29451792	29451793	2p23.2	0	normal	.	A	ref	A	CC.CC	het-alt	127	0.85	.	1	.	DUBIOUS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C16	EX16	Glycine rich protein	PF12810.2	no-change	NM_004304.4	NP_004295.2	-	Y	c.2772T=	.	.	.	NM_004304.4(ALK): c.2772T=	;	114694	0.998596	U	.	.	.	.	VQSRTrancheSNP99.80to99.90	-2	8490	0.999529	57186	114694	0.998596	.	.	.	.	.	.	rs749286400	.	4024	0.874500	0.459	0.993	0.796	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29451792	29451793	2p23.2	1	normal	.	A	snv	C	CC.CC	het-ref	23	0.15	.	2	.	DUBIOUS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C16	EX16	Glycine rich protein	PF12810.2	coding-synon	NM_004304.4	NP_004295.2	-	Y	c.2772T>G	p.(G924=) | p.(Gly924=)	GGT=>GGG	.	NM_004304.4(ALK): c.2772T>G (p.(G924=))	;	114694	0.001404	U	.	.	.	.	VQSRTrancheSNP99.80to99.90	0	8490	0.000471	0	114694	0.001404	0	1726	1.41568e-01	0	12811	7.04706e-02	rs749286400	.	4024	0.125200	0.459	0.993	0.796	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	239814	criteria_provided,_single_submitter	Benign	Unknown
2	29451798	29451799	2p23.2	0	normal	.	T	ref	T	CC.CC	het-alt	137	0.91	.	1	.	DUBIOUS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C16	EX16	Glycine rich protein	PF12810.2	no-change	NM_004304.4	NP_004295.2	-	Y	c.2766A=	.	.	.	NM_004304.4(ALK): c.2766A=	MixedObserved;	112494	0.999644	U	.	.	.	.	VQSRTrancheSNP99.80to99.90	-1	8488	0.999764	56207	112494	0.999644	.	.	.	.	.	.	rs778543123	.	4024	0.973900	0.459	2.059	1.960	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29451798	29451799	2p23.2	1	normal	.	T	snv	C	CC.CC	het-ref	14	0.09	.	2	.	DUBIOUS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C16	EX16	Glycine rich protein	PF12810.2	coding-synon	NM_004304.4	NP_004295.2	-	Y	c.2766A>G	p.(G922=) | p.(Gly922=)	GGA=>GGG	.	NM_004304.4(ALK): c.2766A>G (p.(G922=))	MixedObserved;	112494	0.000356	U	.	.	.	.	VQSRTrancheSNP99.80to99.90	0	8488	0.000236	0	112494	0.000356	0	830	7.63429e-02	0	6888	4.25411e-02	rs778543123	.	4024	0.026100	0.459	2.059	1.960	.	.	.	.	.	ENST00000389048: c.2766A>G (p.G922G)	prostate [NS|NS|NS]	carcinoma [NS|NS|NS]	CSV	4133808	.	.	.	.	.	.	.	.	.	VUS
2	29455266	29455267	2p23.2	1	normal	.	A	snv	G	CC.CC	het-ref	264	0.45	.	2	.	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C15	EX15	Glycine rich protein	PF12810.2	coding-synon	NM_004304.4	NP_004295.2	-	Y	c.2535T>C	p.(G845=) | p.(Gly845=)	GGT=>GGC	.	NM_004304.4(ALK): c.2535T>C (p.(G845=))	;maf-5-some-pop,maf-5-all-pops	126318	0.607657	U	0.1746	0.5	13006	0.661387	PASS	125	8628	0.174664	24282	121310	0.612101	269	3051	1.76952e-01	48751	149770	6.08322e-01	rs2256740	.	4024	0.171500	-1.007	-0.922	-1.203	.	.	.	.	.	ENST00000389048: c.2535T>C (p.G845G)	bone [femur|NS|NS]	osteosarcoma [NS|NS|NS]	CSV	148825	.	.	.	.	.	no_record	259268	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
2	29455266	29455267	2p23.2	0	normal	.	A	ref	A	CC.CC	het-alt	320	0.55	.	1	.	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C15	EX15	Glycine rich protein	PF12810.2	no-change	NM_004304.4	NP_004295.2	-	Y	c.2535T=	.	.	.	NM_004304.4(ALK): c.2535T=	;maf-5-some-pop,maf-5-all-pops	126318	0.392343	U	0.1746	0.5	13006	0.338613	PASS	.	8628	0.825336	10683	121310	0.387899	.	.	.	.	.	.	rs2256740	.	4024	0.828500	-1.007	-0.922	-1.203	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29498209	29498210	2p23.2	0	nullSample	.	A	ref	A	CA.TG	homo-ref	.	.	.	0	.	.	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	IC10	IVS10	.	.	no-change	NM_004304.4	NP_004295.2	-	Y	c.1912+58T=	.	.	.	NM_004304.4(ALK): c.1912+58T=	;maf-5-some-pop	5008	0.148562	U	0.8006	0.851438	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4589708	.	4024	0.225900	-0.215	-0.330	-0.074	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29498209	29498210	2p23.2	0	normal	.	A	snv	G	CA.TG	hom-alt	419	1.00	.	0	.	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	IC10	IVS10	.	.	intron	NM_004304.4	NP_004295.2	-	Y	c.1912+58T>C	.	.	.	NM_004304.4(ALK): c.1912+58T>C	;maf-5-some-pop	5008	0.851438	U	0.8006	0.851438	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4589708	.	4024	0.774100	-0.215	-0.330	-0.074	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29543513	29543514	2p23.2	0	normal	.	C	ref	C	CC.GA	het-alt	120	0.51	.	1	.	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	IC7	IVS7	.	.	no-change	NM_004304.4	NP_004295.2	-	Y	c.1546+103G=	.	.	.	NM_004304.4(ALK): c.1546+103G=	;maf-5-some-pop	5008	0.927316	U	0.0417	0.0726837	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12151564	.	4020	0.951200	-1.012	-0.435	-0.677	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29543513	29543514	2p23.2	0	normal	.	C	snv	T	CC.GA	het-ref	115	0.49	.	2	.	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	IC7	IVS7	.	.	intron	NM_004304.4	NP_004295.2	-	Y	c.1546+103G>A	.	.	.	NM_004304.4(ALK): c.1546+103G>A	;maf-5-some-pop	5008	0.072684	U	0.0417	0.0726837	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12151564	.	4020	0.048800	-1.012	-0.435	-0.677	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29543662	29543663	2p23.2	0	normal	.	T	ref	T	CA.TG	het-alt	299	0.53	.	1	.	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C7	EX7	MAM domain	PF00629.18	no-change	NM_004304.4	NP_004295.2	-	Y	c.1500A=	.	.	.	NM_004304.4(ALK): c.1500A=	SingleClassTriAllelic;maf-5-some-pop	126410	0.132126	U	0.9206	0.776558	13006	0.209057	PASS	.	8650	0.091908	1771	121402	0.128359	.	.	.	.	.	.	rs2293564	.	4024	0.087500	-0.140	0.058	-0.038	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29543662	29543663	2p23.2	1	normal	.	T	snv	C	CA.TG	het-ref	265	0.47	.	2	.	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C7	EX7	MAM domain	PF00629.18	coding-synon	NM_004304.4	NP_004295.2	-	Y	c.1500A>G	p.(Q500=) | p.(Gln500=)	CAA=>CAG	.	NM_004304.4(ALK): c.1500A>G (p.(Q500=))	SingleClassTriAllelic;maf-5-some-pop	126410	0.867866	U	0.9206	0.776558	13006	0.790943	PASS	3559	8650	0.908092	46888	121402	0.871633	7099	15649	9.07294e-01	96227	216269	8.78278e-01	rs2293564	.	4024	0.912500	-0.140	0.058	-0.038	.	.	.	.	.	ENST00000389048: c.1500A>G (p.Q500Q)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4133810	.	.	.	.	.	no_record	259266	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
2	29917939	29917940	2p23.2	0	nullSample	.	C	ref	C	CC.CC	homo-ref	.	.	.	0	.	.	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	IC2	IVS2	.	.	no-change	NM_004304.4	NP_004295.2	-	Y	c.788-60G=	.	.	.	NM_004304.4(ALK): c.788-60G=	;maf-5-some-pop,maf-5-all-pops	5008	0.392372	U	0.7778	0.607628	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2256376	.	4024	0.236600	-0.181	0.636	0.419	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29917939	29917940	2p23.2	0	normal	.	C	snv	G	CC.CC	hom-alt	237	1.00	.	0	.	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	IC2	IVS2	.	.	intron	NM_004304.4	NP_004295.2	-	Y	c.788-60G>C	.	.	.	NM_004304.4(ALK): c.788-60G>C	;maf-5-some-pop,maf-5-all-pops	5008	0.607628	U	0.7778	0.607628	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2256376	.	4024	0.763200	-0.181	0.636	0.419	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29940528	29940529	2p23.2	0	nullSample	.	A	ref	A	GA.GG	homo-ref	.	.	.	0	.	.	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C2	EX2	.	.	no-change	NM_004304.4	NP_004295.2	-	Y	c.702T=	.	.	.	NM_004304.4(ALK): c.702T=	SingleClassTriAllelic;maf-5-some-pop	126400	0.272168	U	0.7827	0.589257	13006	0.372982	PASS	-772	8646	0.239648	5883	121392	0.266451	.	.	.	.	.	.	rs2246745	.	4024	0.229100	-0.313	0.673	0.148	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	29940528	29940529	2p23.2	1	normal	.	A	snv	T	GA.GG	hom-alt	549	1.00	.	0	.	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C2	EX2	.	.	coding-synon	NM_004304.4	NP_004295.2	-	Y	c.702T>A	p.(P234=) | p.(Pro234=)	CCT=>CCA	.	NM_004304.4(ALK): c.702T>A (p.(P234=))	SingleClassTriAllelic;maf-5-some-pop	126400	0.727753	U	0.7827	0.589257	13006	0.627018	PASS	2515	8646	0.760352	34225	121392	0.733467	4788	12845	7.44983e-01	70228	182599	7.41718e-01	rs2246745	.	4024	0.770900	-0.313	0.673	0.148	.	.	.	.	.	ENST00000389048: c.702T>A (p.P234P)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4416269	.	.	.	.	.	no_record	259274	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
2	30143498	30143499	2p23.1	1	normal	.	G	snv	C	AG.AG	hom-alt	533	1.00	.	0	.	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C1	EX1	.	.	coding-synon	NM_004304.4	NP_004295.2	-	Y	c.27C>G	p.(L9=) | p.(Leu9=)	CTC=>CTG	.	NM_004304.4(ALK): c.27C>G (p.(L9=))	;maf-5-some-pop	27578	0.894735	U	0.998	0.89377	9800	0.909286	PASS	461	922	1.000000	9031	22570	0.894949	5268	10540	9.99621e-01	56407	124133	9.06623e-01	rs4358080	.	4024	0.997300	-0.998	0.508	0.269	.	.	.	.	.	ENST00000389048: c.27C>G (p.L9L)	large_intestine [caecum|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3749653	.	.	.	.	.	no_record	259269	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
2	30143498	30143499	2p23.1	0	nullSample	.	G	ref	G	AG.AG	homo-ref	.	.	.	0	.	.	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	C1	EX1	.	.	no-change	NM_004304.4	NP_004295.2	-	Y	c.27C=	.	.	.	NM_004304.4(ALK): c.27C=	;maf-5-some-pop	27578	0.105265	U	0.998	0.89377	9800	0.090714	PASS	0	922	0.000000	117	22570	0.105051	.	.	.	.	.	.	rs4358080	.	4024	0.002700	-0.998	0.508	0.269	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	30151616	30151617	2p23.1	0	nullSample	.	G	ref	G	GG.TC	homo-ref	.	.	.	0	.	.	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	PROM	.	.	.	no-change	NM_004304.4	NP_004295.2	-	Y	c.-952-u7140C=	.	.	.	NM_004304.4(ALK): c.-952-u7140C=	;maf-5-some-pop,maf-5-all-pops	5008	0.451078	U	0.619	0.548922	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6547983	.	.	.	-1.395	0.092	-0.025	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	30151616	30151617	2p23.1	0	normal	.	G	snv	A	GG.TC	hom-alt	233	1.00	.	0	.	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	PROM	.	.	.	promoter	NM_004304.4	NP_004295.2	-	Y	c.-952-u7140C>T	.	.	.	NM_004304.4(ALK): c.-952-u7140C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.548922	U	0.619	0.548922	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6547983	.	.	.	-1.395	0.092	-0.025	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	30151752	30151753	2p23.1	0	nullSample	.	T	ref	T	TC.CA	homo-ref	.	.	.	0	.	.	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	PROM	.	.	.	no-change	NM_004304.4	NP_004295.2	-	Y	c.-952-u7276A=	.	.	.	NM_004304.4(ALK): c.-952-u7276A=	;maf-5-some-pop,maf-5-all-pops	5008	0.447684	U	0.619	0.552316	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4600601	.	.	.	-2.235	-0.526	-0.598	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	30151752	30151753	2p23.1	0	normal	.	T	snv	C	TC.CA	hom-alt	323	1.00	.	0	.	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	PROM	.	.	.	promoter	NM_004304.4	NP_004295.2	-	Y	c.-952-u7276A>G	.	.	.	NM_004304.4(ALK): c.-952-u7276A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.552316	U	0.619	0.552316	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4600601	.	.	.	-2.235	-0.526	-0.598	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	30151780	30151781	2p23.1	0	nullSample	.	G	ref	G	CC.TC	homo-ref	.	.	.	0	.	.	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	PROM	.	.	.	no-change	NM_004304.4	NP_004295.2	-	Y	c.-952-u7304C=	.	.	.	NM_004304.4(ALK): c.-952-u7304C=	;maf-5-some-pop,maf-5-all-pops	5008	0.448083	U	0.619	0.551917	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4564737	.	.	.	-0.251	-1.116	-1.149	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	30151780	30151781	2p23.1	0	normal	.	G	snv	A	CC.TC	hom-alt	247	1.00	.	0	.	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	PROM	.	.	.	promoter	NM_004304.4	NP_004295.2	-	Y	c.-952-u7304C>T	.	.	.	NM_004304.4(ALK): c.-952-u7304C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.551917	U	0.619	0.551917	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4564737	.	.	.	-0.251	-1.116	-1.149	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	30151810	30151811	2p23.1	0	normal	.	A	snv	G	CT.GG	hom-alt	179	1.00	.	0	.	PASS	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	PROM	.	.	.	promoter	NM_004304.4	NP_004295.2	-	Y	c.-952-u7334T>C	.	.	.	NM_004304.4(ALK): c.-952-u7334T>C	;maf-5-some-pop,maf-5-all-pops	5008	0.551717	U	0.619	0.551717	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7581099	.	.	.	-0.408	-0.444	-0.457	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	30151810	30151811	2p23.1	0	nullSample	.	A	ref	A	CT.GG	homo-ref	.	.	.	0	.	.	105590	C	613014(SK)	NN	Neuroblastoma, susceptibility to, 3	AD	.	Oncologic	Oncologic	20301782|18923523|18724359|18242317	.	238	ALK	PROM	.	.	.	no-change	NM_004304.4	NP_004295.2	-	Y	c.-952-u7334T=	.	.	.	NM_004304.4(ALK): c.-952-u7334T=	;maf-5-some-pop,maf-5-all-pops	5008	0.448283	U	0.619	0.551717	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7581099	.	.	.	-0.408	-0.444	-0.457	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	30157482	30157483	2p23.1	0	nullSample	.	T	ref	T	TC.AT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.30157482T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.454872	U	0.622	0.545128	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10204083	.	.	.	-0.735	-0.324	-0.309	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	30157482	30157483	2p23.1	0	normal	.	T	snv	C	TC.AT	hom-alt	231	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.30157482T>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.545128	U	0.622	0.545128	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10204083	.	.	.	-0.735	-0.324	-0.309	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	30157678	30157679	2p23.1	0	nullSample	.	C	ref	C	AA.GT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.30157678C= (intergenic)	;maf-5-some-pop	5008	0.397165	U	0.622	0.602835	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6719321	.	.	.	-1.077	-0.174	-0.217	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	30157678	30157679	2p23.1	0	normal	.	C	snv	G	AA.GT	hom-alt	128	0.99	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.30157678C>G (intergenic)	;maf-5-some-pop	5008	0.602835	U	0.622	0.602835	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6719321	.	.	.	-1.077	-0.174	-0.217	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	30157691	30157692	2p23.1	0	nullSample	.	T	ref	T	CA.GC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.30157691T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.454872	U	0.622	0.545128	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10204274	.	.	.	-0.253	-0.370	-0.381	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	30157691	30157692	2p23.1	0	normal	.	T	snv	C	CA.GC	hom-alt	123	0.99	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.30157691T>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.545128	U	0.622	0.545128	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10204274	.	.	.	-0.253	-0.370	-0.381	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	30165199	30165200	2p23.1	0	normal	.	C	ref	C	AG.AA	het-alt	201	0.50	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.30165199C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.582268	U	0.5407	0.417732	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs57192518	.	.	.	0.549	2.397	2.418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	30165199	30165200	2p23.1	0	normal	.	C	snv	G	AG.AA	het-ref	205	0.50	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.30165199C>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.417732	U	0.5407	0.417732	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs57192518	.	.	.	0.549	2.397	2.418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	30176032	30176033	2p23.1	0	normal	.	T	ref	T	AA.AC	het-alt	159	0.56	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.30176032T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.541733	U	0.4127	0.458267	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11681977	.	.	.	-0.408	-0.075	-0.115	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	30176032	30176033	2p23.1	0	normal	.	T	snv	C	AA.AC	het-ref	127	0.44	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.30176032T>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.458267	U	0.4127	0.458267	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11681977	.	.	.	-0.408	-0.075	-0.115	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	30191248	30191249	2p23.1	0	normal	.	A	ref	A	AC.CA	het-alt	137	0.46	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.30191248A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.648562	U	0.3313	0.351438	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4546051	.	.	.	0.260	0.574	0.531	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	30191248	30191249	2p23.1	0	normal	.	A	snv	C	AC.CA	het-ref	158	0.54	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.30191248A>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.351438	U	0.3313	0.351438	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4546051	.	.	.	0.260	0.574	0.531	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	38298149	38298150	2p22.2	0	nullSample	.	A	ref	A	CC.TC	homo-ref	.	.	.	0	.	.	601771	C	231300(MK);604229(MK)	AR	Glaucoma, primary open angle, adult-onset; Peters anomaly; Glaucoma 3A, primary congenital; Glaucoma, primary open angle glaucoma, juvenile-onset 	AR	.	Ophthalmologic	Ophthalmologic; Pharmacogenomic	23218701|22128238|21081970|19807744|19643970|17718864|15733270|15342693|12372064|11774072|11730663|11403040|10655546|10227395|9497261|9463332|9097971	.	1545	CYP1B1	C2E	EX3E	Cytochrome P450	PF00067.17	no-change	NM_000104.3	NP_000095.2	-	Y	c.1347T=	.	.	.	NM_000104.3(CYP1B1): c.1347T=	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	126370	0.378033	U	0.9087	0.620208	13006	0.546286	PASS	.	8654	0.100878	10391	121362	0.377960	.	.	.	.	.	.	rs1056837	.	4024	0.122800	-3.074	-2.060	-1.835	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	38298149	38298150	2p22.2	1	normal	.	A	snv	G	CC.TC	hom-alt	206	1.00	.	0	.	PASS	601771	C	231300(MK);604229(MK)	AR	Glaucoma, primary open angle, adult-onset; Peters anomaly; Glaucoma 3A, primary congenital; Glaucoma, primary open angle glaucoma, juvenile-onset 	AR	.	Ophthalmologic	Ophthalmologic; Pharmacogenomic	23218701|22128238|21081970|19807744|19643970|17718864|15733270|15342693|12372064|11774072|11730663|11403040|10655546|10227395|9497261|9463332|9097971	.	1545	CYP1B1	C2E	EX3E	Cytochrome P450	PF00067.17	coding-synon	NM_000104.3	NP_000095.2	-	Y	c.1347T>C	p.(D449=) | p.(Asp449=)	GAT=>GAC	.	NM_000104.3(CYP1B1): c.1347T>C (p.(D449=))	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	126370	0.621967	U	0.9087	0.620208	13006	0.453714	PASS	3502	8654	0.899122	25202	121362	0.622040	7000	15532	9.00510e-01	52574	156172	6.34263e-01	rs1056837	.	4024	0.877200	-3.074	-2.060	-1.835	.	.	.	.	.	ENST00000260630: c.1347T>C (p.D449D)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3758225	.	.	.	.	.	no_record	166970	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
2	38298202	38298203	2p22.2	1	nullSample	.	C	ref	C	CA.TG	homo-ref	.	.	.	0	.	.	601771	C	231300(MK);604229(MK)	AR	Glaucoma, primary open angle, adult-onset; Peters anomaly; Glaucoma 3A, primary congenital; Glaucoma, primary open angle glaucoma, juvenile-onset 	AR	.	Ophthalmologic	Ophthalmologic; Pharmacogenomic	23218701|22128238|21081970|19807744|19643970|17718864|15733270|15342693|12372064|11774072|11730663|11403040|10655546|10227395|9497261|9463332|9097971	.	1545	CYP1B1	C2E	EX3E	Cytochrome P450	PF00067.17	missense	NM_000104.3	NP_000095.2	-	Y	c.1294C>G	p.L432V | p.Leu432Val	CTG=>GTG	NP=>NP	NM_000104.3(CYP1B1): c.1294C>G (p.L432V)	;clinically-assoc,maf-5-some-pop,has-omim-omia,genotype-conflict	126282	0.380719	U	0.9087	0.614816	13006	0.554436	PASS	.	8650	0.103006	10578	121274	0.380535	.	.	.	.	.	.	rs1056836	.	.	.	0.655	1.133	2.824	.	.	.	.	.	.	.	.	.	.	CM004465	NM_000104.3(CYP1B1): c.1294C>G (p.L432V)	"Prostate cancer, association with"	15330195	DFP	.	.	.	.	Likely Benign
2	38298202	38298203	2p22.2	0	normal	.	C	snv	G	CA.TG	hom-alt	323	1.00	.	0	.	PASS	601771	C	231300(MK);604229(MK)	AR	Glaucoma, primary open angle, adult-onset; Peters anomaly; Glaucoma 3A, primary congenital; Glaucoma, primary open angle glaucoma, juvenile-onset 	AR	.	Ophthalmologic	Ophthalmologic; Pharmacogenomic	23218701|22128238|21081970|19807744|19643970|17718864|15733270|15342693|12372064|11774072|11730663|11403040|10655546|10227395|9497261|9463332|9097971	.	1545	CYP1B1	C2E	EX3E	Cytochrome P450	PF00067.17	no-change	NM_000104.3	NP_000095.2	-	Y	c.1294C=	.	.	.	NM_000104.3(CYP1B1): c.1294C=	;clinically-assoc,maf-5-some-pop,has-omim-omia,genotype-conflict	126282	0.619281	U	0.9087	0.614816	13006	0.445564	PASS	3485	8650	0.896994	25066	121274	0.619465	6979	15506	8.99003e-01	52303	155484	6.31925e-01	rs1056836	.	.	.	0.655	1.133	2.824	.	.	.	.	.	ENST00000260630: c.1294G>C (p.V432L)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1408012	.	.	.	.	.	no_record	166971	criteria_provided,_single_submitter	Benign	Benign
2	42501642	42501643	2p21	0	normal	.	C	snv	G	AG.AA	het-ref	235	0.49	.	2	.	PASS	607442	P	.	NN	.	.	.	.	.	.	.	27436	EML4	IC6	IVS6	.	.	intron	NM_019063.3	NP_061936.2	+	Y	c.668-6347C>G	.	.	.	NM_019063.3(EML4): c.668-6347C>G	;maf-5-some-pop	5008	0.244209	U	0.5774	0.244209	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10490559	.	4024	0.536800	-0.975	0.243	0.241	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	42501642	42501643	2p21	0	normal	.	C	ref	C	AG.AA	het-alt	241	0.51	.	1	.	PASS	607442	P	.	NN	.	.	.	.	.	.	.	27436	EML4	IC6	IVS6	.	.	no-change	NM_019063.3	NP_061936.2	+	Y	c.668-6347C=	.	.	.	NM_019063.3(EML4): c.668-6347C=	;maf-5-some-pop	5008	0.755791	U	0.5774	0.244209	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10490559	.	4024	0.463200	-0.975	0.243	0.241	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	42503355	42503356	2p21	0	normal	.	C	ref	C	tt.cc	het-alt	155	0.53	.	1	MER102a|DNA|hAT-Charlie|+|285	PASS	607442	P	.	NN	.	.	.	.	.	.	.	27436	EML4	IC6	IVS6	.	.	no-change	NM_019063.3	NP_061936.2	+	Y	c.668-4634C=	.	.	.	NM_019063.3(EML4): c.668-4634C=	;maf-5-some-pop,maf-5-all-pops	5008	0.766973	U	0.5794	0.233027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs35100043	.	4024	0.459500	-1.910	-0.219	-0.276	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	42503355	42503356	2p21	0	normal	.	C	snv	T	tt.cc	het-ref	140	0.47	.	2	MER102a|DNA|hAT-Charlie|+|285	PASS	607442	P	.	NN	.	.	.	.	.	.	.	27436	EML4	IC6	IVS6	.	.	intron	NM_019063.3	NP_061936.2	+	Y	c.668-4634C>T	.	.	.	NM_019063.3(EML4): c.668-4634C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.233027	U	0.5794	0.233027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs35100043	.	4024	0.540500	-1.910	-0.219	-0.276	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	42522755	42522756	2p21	0	normal	.	A	ref	A	CA.TA	het-alt	187	0.53	.	1	.	PASS	607442	P	.	NN	.	.	.	.	.	.	.	27436	EML4	IC13	IVS13	.	.	no-change	NM_019063.3	NP_061936.2	+	Y	c.1489+100A=	.	.	.	NM_019063.3(EML4): c.1489+100A=	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop	5008	0.756190	U	0.5764	0.24381	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10490555	.	4024	0.463700	0.459	-0.791	-0.735	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	42522755	42522756	2p21	0	normal	.	A	snv	G	CA.TA	het-ref	165	0.47	.	2	.	PASS	607442	P	.	NN	.	.	.	.	.	.	.	27436	EML4	IC13	IVS13	.	.	intron	NM_019063.3	NP_061936.2	+	Y	c.1489+100A>G	.	.	.	NM_019063.3(EML4): c.1489+100A>G	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop	5008	0.243810	U	0.5764	0.24381	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10490555	.	4024	0.536300	0.459	-0.791	-0.735	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	46583234	46583235	2p21	0	nullSample	.	C	ref	C	TC.CA	homo-ref	.	.	.	0	.	.	603349	C	611783(MK)	NN	Erthyrocytosis, familial 4	AD	.	Hematologic; Oncologic	Hematologic; Oncologic	23090011|18456918|18378852|18184961|7747773	.	2034	EPAS1	IC2	IVS2	.	.	no-change	NM_001430.4	NP_001421.2	+	Y	c.218-55C=	.	.	.	NM_001430.4(EPAS1): c.218-55C=	;maf-5-some-pop,maf-5-all-pops	5008	0.262979	U	0.8671	0.737021	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6743991	.	4024	0.117800	-0.363	-0.010	0.059	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	46583234	46583235	2p21	0	normal	.	C	snv	A	TC.CA	hom-alt	288	1.00	.	0	.	PASS	603349	C	611783(MK)	NN	Erthyrocytosis, familial 4	AD	.	Hematologic; Oncologic	Hematologic; Oncologic	23090011|18456918|18378852|18184961|7747773	.	2034	EPAS1	IC2	IVS2	.	.	intron	NM_001430.4	NP_001421.2	+	Y	c.218-55C>A	.	.	.	NM_001430.4(EPAS1): c.218-55C>A	;maf-5-some-pop,maf-5-all-pops	5008	0.737021	U	0.8671	0.737021	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6743991	.	4024	0.882200	-0.363	-0.010	0.059	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	46583277	46583278	2p21	0	nullSample	.	C	ref	C	CC.CC	homo-ref	.	.	.	0	.	.	603349	C	611783(MK)	NN	Erthyrocytosis, familial 4	AD	.	Hematologic; Oncologic	Hematologic; Oncologic	23090011|18456918|18378852|18184961|7747773	.	2034	EPAS1	IC2	IVS2	.	.	no-change	NM_001430.4	NP_001421.2	+	Y	c.218-12C=	.	.	.	NM_001430.4(EPAS1): c.218-12C=	MixedObserved,SingleClassTriAllelic;	74367	0.990910	U	0	0.000199681	.	.	VQSRTrancheINDEL97.00to99.00	.	7376	0.267489	23048	106408	0.645487	.	.	.	.	.	.	rs202210836	.	.	.	0.185	-0.426	-0.422	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	46583278	46583278	2p21	1	normal	.	.	ins	G	CC.CC	hom-alt	305	0.95	.	0	.	PASS	603349	C	611783(MK)	NN	Erthyrocytosis, familial 4	AD	.	Hematologic; Oncologic	Hematologic; Oncologic	23090011|18456918|18378852|18184961|7747773	.	2034	EPAS1	IC2	IVS2	.	.	intron	NM_001430.4	NP_001421.2	+	Y	c.218-12_218-11insG	.	.	.	NM_001430.4(EPAS1): c.218-12_218-11insG	InconsistentAlleles;rs-cluster-nonoverlapping-alleles	105734	0.350256	U	.	.	.	.	VQSRTrancheINDEL97.00to99.00	2017	7376	0.732240	7325	106408	0.348038	.	.	.	.	.	.	rs61586942	.	4024	0.769400	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	46583278	46583279	2p21	0	nullSample	.	C	ref	C	CC.CC	homo-ref	.	.	.	0	.	.	603349	C	611783(MK)	NN	Erthyrocytosis, familial 4	AD	.	Hematologic; Oncologic	Hematologic; Oncologic	23090011|18456918|18378852|18184961|7747773	.	2034	EPAS1	IC2	IVS2	.	.	no-change	NM_001430.4	NP_001421.2	+	Y	c.218-11C=	.	.	.	NM_001430.4(EPAS1): c.218-11C=	SingleClassQuadAllelic;	73037	0.943755	U	0	0.000399361	.	.	VQSRTrancheINDEL95.00to96.00	-711	7550	0.241589	19487	107718	0.596196	.	.	.	.	.	.	rs75591953	.	4024	0.997800	-0.380	0.093	-0.137	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	46583279	46583279	2p21	1	normal	.	.	ins	T	CC.CC	hom-alt	374	1.00	.	0	.	PASS	603349	C	611783(MK)	NN	Erthyrocytosis, familial 4	AD	.	Hematologic; Oncologic	Hematologic; Oncologic	23090011|18456918|18378852|18184961|7747773	.	2034	EPAS1	IC2	IVS2	.	.	intron	NM_001430.4	NP_001421.2	+	Y	c.218-11_218-10insT	.	.	.	NM_001430.4(EPAS1): c.218-11_218-10insT	InconsistentAlleles;rs-cluster-nonoverlapping-alleles	103910	0.381484	U	.	.	.	.	VQSRTrancheINDEL95.00to96.00	2109	7550	0.747417	7704	107718	0.367998	3863	8782	7.74563e-01	15288	52942	3.09407e-01	rs142684263	.	4024	0.763400	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	46583280	46583281	2p21	0	nullSample	.	C	ref	C	CC.CT	homo-ref	.	.	.	0	.	.	603349	C	611783(MK)	NN	Erthyrocytosis, familial 4	AD	.	Hematologic; Oncologic	Hematologic; Oncologic	23090011|18456918|18378852|18184961|7747773	.	2034	EPAS1	IC2	IVS2	.	.	no-change	NM_001430.4	NP_001421.2	+	Y	c.218-9C=	.	.	.	NM_001430.4(EPAS1): c.218-9C=	SingleClassQuadAllelic;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	91771	0.497935	U	0	0.000998403	.	.	PASS	.	8000	0.126125	9860	113276	0.393446	.	.	.	.	.	.	rs75984373	.	4024	0.285000	-0.361	0.826	0.922	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	46583280	46583281	2p21	1	normal	.	C	snv	T	CC.CT	hom-alt	396	1.00	.	0	.	PASS	603349	C	611783(MK)	NN	Erthyrocytosis, familial 4	AD	.	Hematologic; Oncologic	Hematologic; Oncologic	23090011|18456918|18378852|18184961|7747773	.	2034	EPAS1	IC2	IVS2	.	.	intron	NM_001430.4	NP_001421.2	+	Y	c.218-9C>T	.	.	.	NM_001430.4(EPAS1): c.218-9C>T	SingleClassQuadAllelic;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	91771	0.501978	U	0.001	0.0662939	.	.	PASS	2328	8000	0.762750	9868	113276	0.403748	.	.	.	.	.	.	rs75984373	.	4024	0.714200	-0.361	0.826	0.922	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	336246	criteria_provided,_single_submitter	Benign	Benign
2	46596950	46596951	2p21	0	normal	.	T	ref	T	CC.TT	het-alt	148	0.51	.	1	.	PASS	603349	C	611783(MK)	NN	Erthyrocytosis, familial 4	AD	.	Hematologic; Oncologic	Hematologic; Oncologic	23090011|18456918|18378852|18184961|7747773	.	2034	EPAS1	IC6	IVS6	.	.	no-change	NM_001430.4	NP_001421.2	+	Y	c.780-15T=	.	.	.	NM_001430.4(EPAS1): c.780-15T=	MixedObserved;maf-5-some-pop|MixedObserved;	90338|82612	0.951914|0.999988	U	0.0992	0.0794728	13006	0.927956	PASS	.	7144	0.871081	38937	85330	0.953756	.	.	.	.	.	.	rs17035079|rs751271825	.	4024	0.886200	0.533	0.154	0.040	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	46596950	46596951	2p21	1	normal	.	T	snv	A	CC.TT	het-ref	145	0.49	.	2	.	PASS	603349	C	611783(MK)	NN	Erthyrocytosis, familial 4	AD	.	Hematologic; Oncologic	Hematologic; Oncologic	23090011|18456918|18378852|18184961|7747773	.	2034	EPAS1	IC6	IVS6	.	.	intron	NM_001430.4	NP_001421.2	+	Y	c.780-15T>A	.	.	.	NM_001430.4(EPAS1): c.780-15T>A	MixedObserved;maf-5-some-pop	90338	0.048086	U	0.0992	0.0794728	13006	0.072044	PASS	47	7144	0.128919	218	85330	0.046244	105	1818	1.06453e-01	372	7414	3.11165e-02	rs17035079	.	4024	0.113800	0.533	0.154	0.040	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	336252	criteria_provided,_single_submitter	Benign	Benign
2	46605934	46605935	2p21	0	normal	.	T	snv	G	GG.GT	het-ref	126	0.55	.	2	.	PASS	603349	C	611783(MK)	NN	Erthyrocytosis, familial 4	AD	.	Hematologic; Oncologic	Hematologic; Oncologic	23090011|18456918|18378852|18184961|7747773	.	2034	EPAS1	IC11	IVS11	.	.	intron	NM_001430.4	NP_001421.2	+	Y	c.1554+29T>G	.	.	.	NM_001430.4(EPAS1): c.1554+29T>G	;maf-5-some-pop	126232	0.006583	U	0.0754	0.0155751	.	.	PASS	34	8618	0.082038	34	121224	0.006212	66	1372	7.95824e-02	67	1464	5.94643e-03	rs117227021	.	4024	0.095200	0.477	1.490	1.434	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	46605934	46605935	2p21	0	normal	.	T	ref	T	GG.GT	het-alt	103	0.45	.	1	.	PASS	603349	C	611783(MK)	NN	Erthyrocytosis, familial 4	AD	.	Hematologic; Oncologic	Hematologic; Oncologic	23090011|18456918|18378852|18184961|7747773	.	2034	EPAS1	IC11	IVS11	.	.	no-change	NM_001430.4	NP_001421.2	+	Y	c.1554+29T=	.	.	.	NM_001430.4(EPAS1): c.1554+29T=	;maf-5-some-pop	126232	0.993417	U	0.0754	0.0155751	.	.	PASS	.	8618	0.917962	59893	121224	0.993788	.	.	.	.	.	.	rs117227021	.	4024	0.904800	0.477	1.490	1.434	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	46609571	46609572	2p21	0	normal	.	A	ref	A	TC.CC	het-alt	241	0.49	.	1	.	PASS	603349	C	611783(MK)	NN	Erthyrocytosis, familial 4	AD	.	Hematologic; Oncologic	Hematologic; Oncologic	23090011|18456918|18378852|18184961|7747773	.	2034	EPAS1	C15	EX15	.	.	no-change	NM_001430.4	NP_001421.2	+	Y	c.2296A=	.	.	.	NM_001430.4(EPAS1): c.2296A=	;maf-5-some-pop	126316	0.937577	U	0.126	0.163339	13006	0.852222	PASS	.	8646	0.867569	54624	121308	0.941743	.	.	.	.	.	.	rs59901247	.	4024	0.866600	-0.313	-0.199	0.030	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	46609571	46609572	2p21	1	normal	.	A	snv	C	TC.CC	het-ref	253	0.51	.	2	.	PASS	603349	C	611783(MK)	NN	Erthyrocytosis, familial 4	AD	.	Hematologic; Oncologic	Hematologic; Oncologic	23090011|18456918|18378852|18184961|7747773	.	2034	EPAS1	C15	EX15	.	.	missense	NM_001430.4	NP_001421.2	+	Y	c.2296A>C	p.T766P | p.Thr766Pro	ACC=>CCC	P0=>NP	NM_001430.4(EPAS1): c.2296A>C (p.T766P)	;maf-5-some-pop	126316	0.062423	U	0.126	0.163339	13006	0.147778	PASS	78	8646	0.132431	1037	121308	0.058257	168	2280	1.32189e-01	1653	12452	5.05973e-02	rs59901247	.	4024	0.133400	-0.313	-0.199	0.030	0.28	0.003	0.001	0.032	neutral	ENST00000263734: c.2296A>C (p.T766P)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3736259	.	.	.	.	.	no_record	336274	criteria_provided,_single_submitter	Benign	Likely Benign
2	47601105	47601106	2p21	0	nullSample	.	T	ref	T	CA.GT	homo-ref	.	.	.	0	.	.	185535	C	613217(MK);613244(MK)	NN	Colorectal cancer, hereditary nonpolyposis, type 8; Diarrhea 5, with tufting enteropathy, congenital	AD/AR	.	Gastrointestinal; Musculoskeletal; Oncologic	Gastrointestinal; Oncologic	21309036|21227399|20388775|20301390|19820410|19098912|18572020|16951683|8057225|100367	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4072	EPCAM	C3	EX3	Thyroglobulin type-1 repeat	PF00086.13	no-change	NM_002354.2	NP_002345.2	+	Y	c.344T=	.	.	.	NM_002354.2(EPCAM): c.344T=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126358	0.474414	U	0.8323	0.666134	13006	0.433262	PASS	.	8650	0.173295	15303	121350	0.480214	.	.	.	.	.	.	rs1126497	.	4024	0.179700	-0.119	0.245	0.160	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	47601105	47601106	2p21	1	normal	.	T	snv	C	CA.GT	hom-alt	703	1.00	.	0	.	PASS	185535	C	613217(MK);613244(MK)	NN	Colorectal cancer, hereditary nonpolyposis, type 8; Diarrhea 5, with tufting enteropathy, congenital	AD/AR	.	Gastrointestinal; Musculoskeletal; Oncologic	Gastrointestinal; Oncologic	21309036|21227399|20388775|20301390|19820410|19098912|18572020|16951683|8057225|100367	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4072	EPCAM	C3	EX3	Thyroglobulin type-1 repeat	PF00086.13	missense	NM_002354.2	NP_002345.2	+	Y	c.344T>C	p.M115T | p.Met115Thr	ATG=>ACG	NP=>P0	NM_002354.2(EPCAM): c.344T>C (p.M115T)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126358	0.525586	U	0.8323	0.666134	13006	0.566738	PASS	2952	8650	0.826705	17704	121350	0.519786	5973	14345	8.31691e-01	34881	126143	5.12364e-01	rs1126497	.	4024	0.820300	-0.119	0.245	0.160	1	0	0	0.000	neutral	ENST00000263735: c.344T>C (p.M115T)	prostate [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3927762	.	.	.	.	.	no_record	183700	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
2	47601256	47601257	2p21	0	normal	.	T	ref	T	AT.AT	het-alt	181	0.54	.	1	.	PASS	185535	C	613217(MK);613244(MK)	NN	Colorectal cancer, hereditary nonpolyposis, type 8; Diarrhea 5, with tufting enteropathy, congenital	AD/AR	.	Gastrointestinal; Musculoskeletal; Oncologic	Gastrointestinal; Oncologic	21309036|21227399|20388775|20301390|19820410|19098912|18572020|16951683|8057225|100367	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4072	EPCAM	IC3	IVS3	.	.	no-change	NM_002354.2	NP_002345.2	+	Y	c.425+70T=	.	.	.	NM_002354.2(EPCAM): c.425+70T=	;maf-5-some-pop,maf-5-all-pops	5008	0.858027	U	0.2609	0.141973	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4399765	.	4024	0.757700	-0.313	0.263	0.102	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	47601256	47601257	2p21	0	normal	.	T	snv	C	AT.AT	het-ref	157	0.46	.	2	.	PASS	185535	C	613217(MK);613244(MK)	NN	Colorectal cancer, hereditary nonpolyposis, type 8; Diarrhea 5, with tufting enteropathy, congenital	AD/AR	.	Gastrointestinal; Musculoskeletal; Oncologic	Gastrointestinal; Oncologic	21309036|21227399|20388775|20301390|19820410|19098912|18572020|16951683|8057225|100367	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4072	EPCAM	IC3	IVS3	.	.	intron	NM_002354.2	NP_002345.2	+	Y	c.425+70T>C	.	.	.	NM_002354.2(EPCAM): c.425+70T>C	;maf-5-some-pop,maf-5-all-pops	5008	0.141973	U	0.2609	0.141973	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4399765	.	4024	0.242300	-0.313	0.263	0.102	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	47604175	47604176	2p21	0	normal	.	C	ref	C	AA.GC	het-alt	256	0.57	.	1	.	PASS	185535	C	613217(MK);613244(MK)	NN	Colorectal cancer, hereditary nonpolyposis, type 8; Diarrhea 5, with tufting enteropathy, congenital	AD/AR	.	Gastrointestinal; Musculoskeletal; Oncologic	Gastrointestinal; Oncologic	21309036|21227399|20388775|20301390|19820410|19098912|18572020|16951683|8057225|100367	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4072	EPCAM	C5	EX5	.	.	no-change	NM_002354.2	NP_002345.2	+	Y	c.515C=	.	.	.	NM_002354.2(EPCAM): c.515C=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126292	0.994695	U	0.0685	0.0141773	13006	0.999077	PASS	.	8650	0.934451	60061	121284	0.995061	.	.	.	.	.	.	rs74531854	.	4024	0.929900	-0.188	-1.011	-0.534	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	47604175	47604176	2p21	1	normal	.	C	snv	T	AA.GC	het-ref	190	0.43	.	2	.	PASS	185535	C	613217(MK);613244(MK)	NN	Colorectal cancer, hereditary nonpolyposis, type 8; Diarrhea 5, with tufting enteropathy, congenital	AD/AR	.	Gastrointestinal; Musculoskeletal; Oncologic	Gastrointestinal; Oncologic	21309036|21227399|20388775|20301390|19820410|19098912|18572020|16951683|8057225|100367	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4072	EPCAM	C5	EX5	.	.	missense	NM_002354.2	NP_002345.2	+	Y	c.515C>T	p.T172M | p.Thr172Met	ACG=>ATG	P0=>NP	NM_002354.2(EPCAM): c.515C>T (p.T172M)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126292	0.005305	U	0.0685	0.0141773	13006	0.000923	PASS	18	8650	0.065549	18	121284	0.004939	54	1248	7.23730e-02	54	1319	5.35852e-03	rs74531854	.	4024	0.070100	-0.188	-1.011	-0.534	0.07	0.32	0.985	0.419	neutral	ENST00000263735: c.515C>T (p.T172M)	biliary_tract [bile_duct|NS|NS]	carcinoma [NS|NS|NS]	CSV	148851	.	.	.	.	.	no_record	132748	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
2	47612223	47612224	2p21	0	normal	.	C	ref	C	TC.AT	het-alt	106	0.44	.	1	.	PASS	185535	C	613217(MK);613244(MK)	NN	Colorectal cancer, hereditary nonpolyposis, type 8; Diarrhea 5, with tufting enteropathy, congenital	AD/AR	.	Gastrointestinal; Musculoskeletal; Oncologic	Gastrointestinal; Oncologic	21309036|21227399|20388775|20301390|19820410|19098912|18572020|16951683|8057225|100367	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4072	EPCAM	IC7	IVS7	.	.	no-change	NM_002354.2	NP_002345.2	+	Y	c.859-81C=	.	.	.	NM_002354.2(EPCAM): c.859-81C=	;maf-5-some-pop,maf-5-all-pops	5008	0.639177	U	0.5615	0.360823	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7584256	.	4024	0.427700	-0.339	-0.962	-0.611	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	47612223	47612224	2p21	0	normal	.	C	snv	T	TC.AT	het-ref	134	0.56	.	2	.	PASS	185535	C	613217(MK);613244(MK)	NN	Colorectal cancer, hereditary nonpolyposis, type 8; Diarrhea 5, with tufting enteropathy, congenital	AD/AR	.	Gastrointestinal; Musculoskeletal; Oncologic	Gastrointestinal; Oncologic	21309036|21227399|20388775|20301390|19820410|19098912|18572020|16951683|8057225|100367	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4072	EPCAM	IC7	IVS7	.	.	intron	NM_002354.2	NP_002345.2	+	Y	c.859-81C>T	.	.	.	NM_002354.2(EPCAM): c.859-81C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.360823	U	0.5615	0.360823	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7584256	.	4024	0.572300	-0.339	-0.962	-0.611	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	47630549	47630550	2p21	0	nullSample	.	C	ref	C	GC.GG	homo-ref	.	.	.	0	.	.	609309	C	120435(MK);158320(MK);276300(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 1; Endometrial cancer; Mismatch repair cancer syndrome; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	23990280|23891921|23729658|23612316|20591884|20301390|20093870|19419416|17539897|17327285|16807412|16511680|16372347|15937084|15872208|15662714|15520370|15235030|14994245|14871915|14574010|12650804|12549480|11809679|11600610|11112663|10534628|10196371|10190329|9843200|9634524|9593786|9218993|8931714|8484121|8484120|8261515|8252616|8072530|6020987|5684233|4016686|2029018	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4436	MSH2	IC1	IVS1	.	.	no-change	NM_000251.2	NP_000242.1	+	Y	c.211+9C=	.	.	.	NM_000251.2(MSH2): c.211+9C=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	85170	0.488000	U	0.8145	0.628395	12684	0.524125	PASS	.	6418	0.194609	9665	80162	0.495272	.	.	.	.	.	.	rs2303426	.	4024	0.193600	-1.252	-1.260	-1.433	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	47630549	47630550	2p21	1	normal	.	C	snv	G	GC.GG	hom-alt	301	1.00	.	0	.	PASS	609309	C	120435(MK);158320(MK);276300(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 1; Endometrial cancer; Mismatch repair cancer syndrome; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	23990280|23891921|23729658|23612316|20591884|20301390|20093870|19419416|17539897|17327285|16807412|16511680|16372347|15937084|15872208|15662714|15520370|15235030|14994245|14871915|14574010|12650804|12549480|11809679|11600610|11112663|10534628|10196371|10190329|9843200|9634524|9593786|9218993|8931714|8484121|8484120|8261515|8252616|8072530|6020987|5684233|4016686|2029018	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4436	MSH2	IC1	IVS1	.	.	intron	NM_000251.2	NP_000242.1	+	Y	c.211+9C>G	.	.	.	NM_000251.2(MSH2): c.211+9C>G	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	85170	0.511964	U	0.8145	0.628395	12684	0.475875	PASS	2047	6418	0.804924	10041	80162	0.504691	5066	12433	8.15600e-01	25312	98964	4.73557e-01	rs2303426	.	4024	0.806200	-1.252	-1.260	-1.433	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	36573	reviewed_by_expert_panel	Benign	Benign
2	47635523	47635524	2p21	0	normal	.	T	ref	T	AC.TT	het-alt	273	0.78	.	1	.	PASS	609309	C	120435(MK);158320(MK);276300(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 1; Endometrial cancer; Mismatch repair cancer syndrome; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	23990280|23891921|23729658|23612316|20591884|20301390|20093870|19419416|17539897|17327285|16807412|16511680|16372347|15937084|15872208|15662714|15520370|15235030|14994245|14871915|14574010|12650804|12549480|11809679|11600610|11112663|10534628|10196371|10190329|9843200|9634524|9593786|9218993|8931714|8484121|8484120|8261515|8252616|8072530|6020987|5684233|4016686|2029018	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4436	MSH2	IC1	IVS1	.	.	no-change	NM_000251.2	NP_000242.1	+	Y	c.212-16T=	.	.	.	NM_000251.2(MSH2): c.212-16T=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs201372136	.	4024	0.826000	0.383	-0.606	-0.120	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	47635523	47635524	2p21	1	normal	.	T	del	.	AC.TT	het-ref	79	0.22	.	2	.	PASS	609309	C	120435(MK);158320(MK);276300(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 1; Endometrial cancer; Mismatch repair cancer syndrome; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	23990280|23891921|23729658|23612316|20591884|20301390|20093870|19419416|17539897|17327285|16807412|16511680|16372347|15937084|15872208|15662714|15520370|15235030|14994245|14871915|14574010|12650804|12549480|11809679|11600610|11112663|10534628|10196371|10190329|9843200|9634524|9593786|9218993|8931714|8484121|8484120|8261515|8252616|8072530|6020987|5684233|4016686|2029018	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4436	MSH2	IC1	IVS1	.	.	intron	NM_000251.2	NP_000242.1	+	Y	c.212-16delT	.	.	.	NM_000251.2(MSH2): c.212-16delT	MixedObserved;	0	0	U	.	.	.	.	PASS	0	5362	0.121783	0	74540	0.151100	.	.	.	.	.	.	rs201372136	.	4024	0.174000	0.383	-0.606	-0.120	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	183770	criteria_provided,_multiple_submitters,_no_conflicts	Likely_benign	Benign
2	47641559	47641561	2p21	0	normal	.	AA	ref	AA	GT.aa	het-alt	24	0.55	.	1	(A)n|Simple_repeat|Simple_repeat|+|27;trf	PASS	609309	C	120435(MK);158320(MK);276300(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 1; Endometrial cancer; Mismatch repair cancer syndrome; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	23990280|23891921|23729658|23612316|20591884|20301390|20093870|19419416|17539897|17327285|16807412|16511680|16372347|15937084|15872208|15662714|15520370|15235030|14994245|14871915|14574010|12650804|12549480|11809679|11600610|11112663|10534628|10196371|10190329|9843200|9634524|9593786|9218993|8931714|8484121|8484120|8261515|8252616|8072530|6020987|5684233|4016686|2029018	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4436	MSH2	IC5	IVS5	.	.	no-change	NM_000251.2	NP_000242.1	+	Y	c.942+3_942+4=	.	.	.	NM_000251.2(MSH2): c.942+3_942+4=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.951300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	47641559	47641561	2p21	1	normal	.	AA	del	.	GT.aa	het-ref	20	0.45	.	2	(A)n|Simple_repeat|Simple_repeat|+|27;trf	PASS	609309	C	120435(MK);158320(MK);276300(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 1; Endometrial cancer; Mismatch repair cancer syndrome; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	23990280|23891921|23729658|23612316|20591884|20301390|20093870|19419416|17539897|17327285|16807412|16511680|16372347|15937084|15872208|15662714|15520370|15235030|14994245|14871915|14574010|12650804|12549480|11809679|11600610|11112663|10534628|10196371|10190329|9843200|9634524|9593786|9218993|8931714|8484121|8484120|8261515|8252616|8072530|6020987|5684233|4016686|2029018	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4436	MSH2	IC5	IVS5	.	.	intron	NM_000251.2	NP_000242.1	+	Y	c.942+3_942+4delAA	.	.	.	NM_000251.2(MSH2): c.942+3_942+4delAA	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	2.000000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	336427	criteria_provided,_multiple_submitters,_no_conflicts	Uncertain_significance	Benign
2	47641746	47641747	2p21	0	normal	.	T	ref	T	AC.tt	het-alt	72	0.69	.	1	AluSx1|SINE|Alu|-|269	PASS	609309	C	120435(MK);158320(MK);276300(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 1; Endometrial cancer; Mismatch repair cancer syndrome; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	23990280|23891921|23729658|23612316|20591884|20301390|20093870|19419416|17539897|17327285|16807412|16511680|16372347|15937084|15872208|15662714|15520370|15235030|14994245|14871915|14574010|12650804|12549480|11809679|11600610|11112663|10534628|10196371|10190329|9843200|9634524|9593786|9218993|8931714|8484121|8484120|8261515|8252616|8072530|6020987|5684233|4016686|2029018	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4436	MSH2	IC5	IVS5	.	.	no-change	NM_000251.2	NP_000242.1	+	Y	c.942+190T=	.	.	.	NM_000251.2(MSH2): c.942+190T=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.761400	0.338	0.065	0.344	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	47641746	47641747	2p21	0	normal	.	T	del	.	AC.tt	het-ref	33	0.31	.	2	AluSx1|SINE|Alu|-|269	PASS	609309	C	120435(MK);158320(MK);276300(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 1; Endometrial cancer; Mismatch repair cancer syndrome; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	23990280|23891921|23729658|23612316|20591884|20301390|20093870|19419416|17539897|17327285|16807412|16511680|16372347|15937084|15872208|15662714|15520370|15235030|14994245|14871915|14574010|12650804|12549480|11809679|11600610|11112663|10534628|10196371|10190329|9843200|9634524|9593786|9218993|8931714|8484121|8484120|8261515|8252616|8072530|6020987|5684233|4016686|2029018	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4436	MSH2	IC5	IVS5	.	.	intron	NM_000251.2	NP_000242.1	+	Y	c.942+190delT	.	.	.	NM_000251.2(MSH2): c.942+190delT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.238600	0.338	0.065	0.344	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	47642511	47642512	2p21	0	normal	.	T	ref	T	GC.TT	het-alt	38	0.70	.	1	.	PASS	609309	C	120435(MK);158320(MK);276300(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 1; Endometrial cancer; Mismatch repair cancer syndrome; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	23990280|23891921|23729658|23612316|20591884|20301390|20093870|19419416|17539897|17327285|16807412|16511680|16372347|15937084|15872208|15662714|15520370|15235030|14994245|14871915|14574010|12650804|12549480|11809679|11600610|11112663|10534628|10196371|10190329|9843200|9634524|9593786|9218993|8931714|8484121|8484120|8261515|8252616|8072530|6020987|5684233|4016686|2029018	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4436	MSH2	IC5	IVS5	.	.	no-change	NM_000251.2	NP_000242.1	+	Y	c.943-923T=	.	.	.	NM_000251.2(MSH2): c.943-923T=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs756860704	.	4024	0.816400	0.402	0.435	0.413	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	47642511	47642512	2p21	0	normal	.	T	del	.	GC.TT	het-ref	16	0.30	.	2	.	PASS	609309	C	120435(MK);158320(MK);276300(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 1; Endometrial cancer; Mismatch repair cancer syndrome; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	23990280|23891921|23729658|23612316|20591884|20301390|20093870|19419416|17539897|17327285|16807412|16511680|16372347|15937084|15872208|15662714|15520370|15235030|14994245|14871915|14574010|12650804|12549480|11809679|11600610|11112663|10534628|10196371|10190329|9843200|9634524|9593786|9218993|8931714|8484121|8484120|8261515|8252616|8072530|6020987|5684233|4016686|2029018	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4436	MSH2	IC5	IVS5	.	.	intron	NM_000251.2	NP_000242.1	+	Y	c.943-923delT	.	.	.	NM_000251.2(MSH2): c.943-923delT	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs756860704	.	4024	0.183600	0.402	0.435	0.413	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	47643190	47643191	2p21	0	nullSample	.	C	ref	C	gt.ag	homo-ref	.	.	.	0	AluJr|SINE|Alu|+|295	.	609309	C	120435(MK);158320(MK);276300(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 1; Endometrial cancer; Mismatch repair cancer syndrome; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	23990280|23891921|23729658|23612316|20591884|20301390|20093870|19419416|17539897|17327285|16807412|16511680|16372347|15937084|15872208|15662714|15520370|15235030|14994245|14871915|14574010|12650804|12549480|11809679|11600610|11112663|10534628|10196371|10190329|9843200|9634524|9593786|9218993|8931714|8484121|8484120|8261515|8252616|8072530|6020987|5684233|4016686|2029018	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4436	MSH2	IC5	IVS5	.	.	no-change	NM_000251.2	NP_000242.1	+	Y	c.943-244C=	.	.	.	NM_000251.2(MSH2): c.943-244C=	;maf-5-some-pop,maf-5-all-pops	5008	0.326677	U	0.8244	0.673323	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11691516	.	4024	0.186100	-0.352	-0.340	-0.360	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	47643190	47643191	2p21	0	normal	.	C	snv	G	gt.ag	hom-alt	289	1.00	.	0	AluJr|SINE|Alu|+|295	PASS	609309	C	120435(MK);158320(MK);276300(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 1; Endometrial cancer; Mismatch repair cancer syndrome; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	23990280|23891921|23729658|23612316|20591884|20301390|20093870|19419416|17539897|17327285|16807412|16511680|16372347|15937084|15872208|15662714|15520370|15235030|14994245|14871915|14574010|12650804|12549480|11809679|11600610|11112663|10534628|10196371|10190329|9843200|9634524|9593786|9218993|8931714|8484121|8484120|8261515|8252616|8072530|6020987|5684233|4016686|2029018	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4436	MSH2	IC5	IVS5	.	.	intron	NM_000251.2	NP_000242.1	+	Y	c.943-244C>G	.	.	.	NM_000251.2(MSH2): c.943-244C>G	;maf-5-some-pop,maf-5-all-pops	5008	0.673323	U	0.8244	0.673323	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11691516	.	4024	0.813900	-0.352	-0.340	-0.360	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	47693705	47693706	2p21	0	normal	.	G	ref	G	AT.TT	het-alt	146	0.55	.	1	.	PASS	609309	C	120435(MK);158320(MK);276300(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 1; Endometrial cancer; Mismatch repair cancer syndrome; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	23990280|23891921|23729658|23612316|20591884|20301390|20093870|19419416|17539897|17327285|16807412|16511680|16372347|15937084|15872208|15662714|15520370|15235030|14994245|14871915|14574010|12650804|12549480|11809679|11600610|11112663|10534628|10196371|10190329|9843200|9634524|9593786|9218993|8931714|8484121|8484120|8261515|8252616|8072530|6020987|5684233|4016686|2029018	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4436	MSH2	IC9	IVS9	.	.	no-change	NM_000251.2	NP_000242.1	+	Y	c.1511-91G=	.	.	.	NM_000251.2(MSH2): c.1511-91G=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5008	0.516973	U	0.6548	0.483027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3732182	.	4024	0.347200	-0.251	-0.772	-0.704	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	47693705	47693706	2p21	0	normal	.	G	snv	T	AT.TT	het-ref	120	0.45	.	2	.	PASS	609309	C	120435(MK);158320(MK);276300(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 1; Endometrial cancer; Mismatch repair cancer syndrome; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	23990280|23891921|23729658|23612316|20591884|20301390|20093870|19419416|17539897|17327285|16807412|16511680|16372347|15937084|15872208|15662714|15520370|15235030|14994245|14871915|14574010|12650804|12549480|11809679|11600610|11112663|10534628|10196371|10190329|9843200|9634524|9593786|9218993|8931714|8484121|8484120|8261515|8252616|8072530|6020987|5684233|4016686|2029018	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4436	MSH2	IC9	IVS9	.	.	intron	NM_000251.2	NP_000242.1	+	Y	c.1511-91G>T	.	.	.	NM_000251.2(MSH2): c.1511-91G>T	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5008	0.483027	U	0.6548	0.483027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3732182	.	4024	0.652800	-0.251	-0.772	-0.704	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	90689	reviewed_by_expert_panel	Benign	Benign
2	47693958	47693959	2p21	0	normal	.	G	ref	G	TC.TT	het-alt	272	0.53	.	1	.	PASS	609309	C	120435(MK);158320(MK);276300(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 1; Endometrial cancer; Mismatch repair cancer syndrome; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	23990280|23891921|23729658|23612316|20591884|20301390|20093870|19419416|17539897|17327285|16807412|16511680|16372347|15937084|15872208|15662714|15520370|15235030|14994245|14871915|14574010|12650804|12549480|11809679|11600610|11112663|10534628|10196371|10190329|9843200|9634524|9593786|9218993|8931714|8484121|8484120|8261515|8252616|8072530|6020987|5684233|4016686|2029018	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4436	MSH2	IC10	IVS10	.	.	no-change	NM_000251.2	NP_000242.1	+	Y	c.1661+12G=	.	.	.	NM_000251.2(MSH2): c.1661+12G=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126066	0.644559	U	0.6548	0.483427	12998	0.621326	PASS	.	8644	0.342318	26595	121058	0.649854	.	.	.	.	.	.	rs3732183	.	4024	0.346200	-2.737	-0.844	-0.383	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	47693958	47693959	2p21	1	normal	.	G	snv	A	TC.TT	het-ref	240	0.47	.	2	.	PASS	609309	C	120435(MK);158320(MK);276300(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 1; Endometrial cancer; Mismatch repair cancer syndrome; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	23990280|23891921|23729658|23612316|20591884|20301390|20093870|19419416|17539897|17327285|16807412|16511680|16372347|15937084|15872208|15662714|15520370|15235030|14994245|14871915|14574010|12650804|12549480|11809679|11600610|11112663|10534628|10196371|10190329|9843200|9634524|9593786|9218993|8931714|8484121|8484120|8261515|8252616|8072530|6020987|5684233|4016686|2029018	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4436	MSH2	IC10	IVS10	.	.	intron	NM_000251.2	NP_000242.1	+	Y	c.1661+12G>A	.	.	.	NM_000251.2(MSH2): c.1661+12G>A	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126066	0.355441	U	0.6548	0.483427	12998	0.378674	PASS	1861	8644	0.657682	8454	121058	0.350146	3735	11331	6.57251e-01	16411	84217	3.42599e-01	rs3732183	.	4024	0.653800	-2.737	-0.844	-0.383	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	36567	reviewed_by_expert_panel	Benign	Benign
2	47702451	47702452	2p21	0	nullSample	.	T	ref	T	tg.tt	homo-ref	.	.	.	0	(T)n|Simple_repeat|Simple_repeat|+|24	.	609309	C	120435(MK);158320(MK);276300(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 1; Endometrial cancer; Mismatch repair cancer syndrome; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	23990280|23891921|23729658|23612316|20591884|20301390|20093870|19419416|17539897|17327285|16807412|16511680|16372347|15937084|15872208|15662714|15520370|15235030|14994245|14871915|14574010|12650804|12549480|11809679|11600610|11112663|10534628|10196371|10190329|9843200|9634524|9593786|9218993|8931714|8484121|8484120|8261515|8252616|8072530|6020987|5684233|4016686|2029018	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4436	MSH2	IC12	IVS12	.	.	no-change	NM_000251.2	NP_000242.1	+	Y	c.2005+43T=	.	.	.	NM_000251.2(MSH2): c.2005+43T=	MixedObserved;	3117|5008	0.776708|0.999601	U	0.002	0.000399361	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs201305711|rs566000677	.	4024	0.858800	0.172	-0.602	-0.283	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	47702451	47702452	2p21	0	normal	.	T	del	.	tg.tt	het-alt	52	0.40	.	1	(T)n|Simple_repeat|Simple_repeat|+|24	PASS	609309	C	120435(MK);158320(MK);276300(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 1; Endometrial cancer; Mismatch repair cancer syndrome; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	23990280|23891921|23729658|23612316|20591884|20301390|20093870|19419416|17539897|17327285|16807412|16511680|16372347|15937084|15872208|15662714|15520370|15235030|14994245|14871915|14574010|12650804|12549480|11809679|11600610|11112663|10534628|10196371|10190329|9843200|9634524|9593786|9218993|8931714|8484121|8484120|8261515|8252616|8072530|6020987|5684233|4016686|2029018	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4436	MSH2	IC12	IVS12	.	.	intron	NM_000251.2	NP_000242.1	+	Y	c.2005+43delT	.	.	.	NM_000251.2(MSH2): c.2005+43delT	MixedObserved;	3117	0.223292	U	.	.	.	.	PASS	0	1768	0.092760	2	28474	0.085025	.	.	.	.	.	.	rs201305711	.	4024	0.138400	0.172	-0.602	-0.283	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	47702451	47702452	2p21	0	normal	.	T	rep	TT	tg.tt	het-alt	43	0.33	.	2	(T)n|Simple_repeat|Simple_repeat|+|24	PASS	609309	C	120435(MK);158320(MK);276300(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 1; Endometrial cancer; Mismatch repair cancer syndrome; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	23990280|23891921|23729658|23612316|20591884|20301390|20093870|19419416|17539897|17327285|16807412|16511680|16372347|15937084|15872208|15662714|15520370|15235030|14994245|14871915|14574010|12650804|12549480|11809679|11600610|11112663|10534628|10196371|10190329|9843200|9634524|9593786|9218993|8931714|8484121|8484120|8261515|8252616|8072530|6020987|5684233|4016686|2029018	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4436	MSH2	IC12	IVS12	.	.	intron	NM_000251.2	NP_000242.1	+	Y	c.2005+43dupT	.	.	.	NM_000251.2(MSH2): c.2005+43dupT	.	.	.	.	.	.	.	.	PASS	0	1768	0.058824	1	28474	0.041336	.	.	.	.	.	.	.	.	4024	0.002700	0.172	-0.602	-0.283	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
2	47703499	47703500	2p21	0	normal	.	T	ref	T	TT.TG	het-alt	249	0.54	.	1	.	PASS	609309	C	120435(MK);158320(MK);276300(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 1; Endometrial cancer; Mismatch repair cancer syndrome; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	23990280|23891921|23729658|23612316|20591884|20301390|20093870|19419416|17539897|17327285|16807412|16511680|16372347|15937084|15872208|15662714|15520370|15235030|14994245|14871915|14574010|12650804|12549480|11809679|11600610|11112663|10534628|10196371|10190329|9843200|9634524|9593786|9218993|8931714|8484121|8484120|8261515|8252616|8072530|6020987|5684233|4016686|2029018	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4436	MSH2	IC12	IVS12	.	.	no-change	NM_000251.2	NP_000242.1	+	Y	c.2006-6T=	.	.	.	NM_000251.2(MSH2): c.2006-6T=	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	124500	0.883880	U	0.3631	0.131989	13006	0.927418	PASS	-965	8578	0.650035	47071	119492	0.884545	.	.	.	.	.	.	rs2303428	.	4024	0.648900	0.477	1.985	2.330	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	47703499	47703500	2p21	1	normal	.	T	snv	C	TT.TG	het-ref	209	0.46	.	2	.	PASS	609309	C	120435(MK);158320(MK);276300(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 1; Endometrial cancer; Mismatch repair cancer syndrome; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	23990280|23891921|23729658|23612316|20591884|20301390|20093870|19419416|17539897|17327285|16807412|16511680|16372347|15937084|15872208|15662714|15520370|15235030|14994245|14871915|14574010|12650804|12549480|11809679|11600610|11112663|10534628|10196371|10190329|9843200|9634524|9593786|9218993|8931714|8484121|8484120|8261515|8252616|8072530|6020987|5684233|4016686|2029018	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4436	MSH2	IC12	IVS12	.	.	intron	NM_000251.2	NP_000242.1	+	Y	c.2006-6T>C	.	.	.	NM_000251.2(MSH2): c.2006-6T>C	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	124500	0.116120	U	0.3631	0.131989	13006	0.072582	PASS	536	8578	0.349965	1121	119492	0.115455	1091	6106	3.54464e-01	2267	28222	1.14730e-01	rs2303428	.	4024	0.351100	0.477	1.985	2.330	.	.	.	.	.	ENST00000233146: c.2006-6T>C (p.?)	breast [NS|NS|NS]	carcinoma [lobular_carcinoma|tubulo-lobular|NS]	CSV	133154	CS951474	NM_000251.2(MSH2): c.2006-6T>C	"High-grade dysplasia/cancer in ulcerative colitis, association"	7797014	DP	no_record	36571	reviewed_by_expert_panel	Benign	Benign
2	48010487	48010488	2p16.3	0	normal	.	G	ref	G	CG.GG	het-alt	305	0.57	.	1	.	PASS	600678	C	276300(MK);608089(MK);614350(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 5; Mismatch repair cancer syndrome; Endometrial cancer	AD/AR	.	Oncologic	Oncologic	17557300|16283678|16000562|15340263|15098177|12732731|9354786	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	2956	MSH6	C1	EX1	.	.	no-change	NM_000179.2	NP_000170.1	+	Y	c.116G=	.	.	.	NM_000179.2(MSH6): c.116G=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	96138	0.786588	U	0.2758	0.200879	11656	0.820350	PASS	.	6792	0.709511	27948	91130	0.785899	.	.	.	.	.	.	rs1042821	.	4024	0.749500	0.313	0.459	0.838	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	48010487	48010488	2p16.3	1	normal	.	G	snv	A	CG.GG	het-ref	234	0.43	.	2	.	PASS	600678	C	276300(MK);608089(MK);614350(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 5; Mismatch repair cancer syndrome; Endometrial cancer	AD/AR	.	Oncologic	Oncologic	17557300|16283678|16000562|15340263|15098177|12732731|9354786	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	2956	MSH6	C1	EX1	.	.	missense	NM_000179.2	NP_000170.1	+	Y	c.116G>A	p.G39E | p.Gly39Glu	GGG=>GAG	P0=>P-	NM_000179.2(MSH6): c.116G>A (p.G39E)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	96138	0.213402	U	0.2758	0.200879	11656	0.179650	PASS	231	6792	0.290489	1894	91130	0.214090	493	4150	2.52218e-01	3965	41416	1.81453e-01	rs1042821	.	4024	0.250500	0.313	0.459	0.838	1	0.608	0.975	0.210	neutral	ENST00000234420: c.116G>A (p.G39E)	large_intestine [caecum|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3749667	CM092149	NM_000179.2(MSH6): c.116G>A (p.G39E)	"Colorectal cancer, assoc. with ?"	18523027	DP	no_record	36581	reviewed_by_expert_panel	Benign	Likely Benign
2	48022980	48022981	2p16.3	0	normal	.	G	ref	G	ag.cg	het-alt	94	0.49	.	1	AluJo|SINE|Alu|-|77	PASS	600678	C	276300(MK);608089(MK);614350(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 5; Mismatch repair cancer syndrome; Endometrial cancer	AD/AR	.	Oncologic	Oncologic	17557300|16283678|16000562|15340263|15098177|12732731|9354786	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	2956	MSH6	IC2	IVS2	.	.	no-change	NM_000179.2	NP_000170.1	+	Y	c.458-52G=	.	.	.	NM_000179.2(MSH6): c.458-52G=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5008	0.775559	U	0.2718	0.224441	5726	0.773839	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1800934	.	4024	0.749300	0.195	0.200	0.192	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	48022980	48022981	2p16.3	0	normal	.	G	snv	T	ag.cg	het-ref	99	0.51	.	2	AluJo|SINE|Alu|-|77	PASS	600678	C	276300(MK);608089(MK);614350(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 5; Mismatch repair cancer syndrome; Endometrial cancer	AD/AR	.	Oncologic	Oncologic	17557300|16283678|16000562|15340263|15098177|12732731|9354786	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	2956	MSH6	IC2	IVS2	.	.	intron	NM_000179.2	NP_000170.1	+	Y	c.458-52G>T	.	.	.	NM_000179.2(MSH6): c.458-52G>T	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5008	0.224441	U	0.2718	0.224441	5726	0.226161	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1800934	.	4024	0.250700	0.195	0.200	0.192	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	89532	reviewed_by_expert_panel	Benign	Benign
2	48030691	48030692	2p16.3	0	normal	.	T	ref	T	AC.TT	het-alt	387	0.51	.	1	.	PASS	600678	C	276300(MK);608089(MK);614350(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 5; Mismatch repair cancer syndrome; Endometrial cancer	AD/AR	.	Oncologic	Oncologic	17557300|16283678|16000562|15340263|15098177|12732731|9354786	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	2956	MSH6	C5	EX5	MutS domain V	PF00488.16	no-change	NM_000179.2	NP_000170.1	+	Y	c.3306T=	.	.	.	NM_000179.2(MSH6): c.3306T=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126358	0.978418	U	0.2153	0.0493211	13006	0.995541	PASS	.	8632	0.789736	58391	121350	0.979563	.	.	.	.	.	.	rs2020910	.	4024	0.803200	-1.272	-1.311	-2.714	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	48030691	48030692	2p16.3	1	normal	.	T	snv	A	AC.TT	het-ref	376	0.49	.	2	.	PASS	600678	C	276300(MK);608089(MK);614350(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 5; Mismatch repair cancer syndrome; Endometrial cancer	AD/AR	.	Oncologic	Oncologic	17557300|16283678|16000562|15340263|15098177|12732731|9354786	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	2956	MSH6	C5	EX5	MutS domain V	PF00488.16	coding-synon	NM_000179.2	NP_000170.1	+	Y	c.3306T>A	p.(T1102=) | p.(Thr1102=)	ACT=>ACA	.	NM_000179.2(MSH6): c.3306T>A (p.(T1102=))	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126358	0.021582	U	0.2153	0.0493211	13006	0.004459	PASS	189	8632	0.210264	196	121350	0.020437	335	3491	2.02494e-01	349	4857	1.97275e-02	rs2020910	.	4024	0.196800	-1.272	-1.311	-2.714	.	.	.	.	.	ENST00000234420: c.3306T>A (p.T1102T)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5021075	.	.	.	.	.	no_record	36589	reviewed_by_expert_panel	Benign	Likely Benign
2	48030837	48030838	2p16.3	0	normal	.	A	ref	A	TT.AA	het-alt	253	0.50	.	1	.	PASS	600678	C	276300(MK);608089(MK);614350(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 5; Mismatch repair cancer syndrome; Endometrial cancer	AD/AR	.	Oncologic	Oncologic	17557300|16283678|16000562|15340263|15098177|12732731|9354786	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	2956	MSH6	IC5	IVS5	.	.	no-change	NM_000179.2	NP_000170.1	+	Y	c.3438+14A=	.	.	.	NM_000179.2(MSH6): c.3438+14A=	MixedObserved;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125892	0.595868	U	0.619	0.400958	13006	0.685376	PASS	-1010	8628	0.383171	22185	120884	0.595736	.	.	.	.	.	.	rs2020911	.	4025	0.366400	-0.326	-0.353	-0.449	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	48030837	48030838	2p16.3	1	normal	.	A	snv	T	TT.AA	het-ref	248	0.50	.	2	.	PASS	600678	C	276300(MK);608089(MK);614350(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 5; Mismatch repair cancer syndrome; Endometrial cancer	AD/AR	.	Oncologic	Oncologic	17557300|16283678|16000562|15340263|15098177|12732731|9354786	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	2956	MSH6	IC5	IVS5	.	.	intron	NM_000179.2	NP_000170.1	+	Y	c.3438+14A>T	.	.	.	NM_000179.2(MSH6): c.3438+14A>T	MixedObserved;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125892	0.404132	U	0.619	0.400958	13006	0.314624	PASS	1651	8628	0.616829	10612	120884	0.404264	3354	10767	6.24391e-01	22061	101116	4.11134e-01	rs2020911	.	4025	0.633400	-0.326	-0.353	-0.449	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	42471	reviewed_by_expert_panel	Benign	Benign
2	48032740	48032741	2p16.3	0	normal	.	T	ref	T	GA.TT	het-alt	273	0.79	.	1	.	PASS	600678	C	276300(MK);608089(MK);614350(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 5; Mismatch repair cancer syndrome; Endometrial cancer	AD/AR	.	Oncologic	Oncologic	17557300|16283678|16000562|15340263|15098177|12732731|9354786	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	2956	MSH6	IC6	IVS6	.	.	no-change	NM_000179.2	NP_000170.1	+	Y	c.3557-16T=	.	.	.	NM_000179.2(MSH6): c.3557-16T=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs749755872	.	4024	0.696300	0.242	0.285	0.029	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	48032740	48032741	2p16.3	1	normal	.	T	del	.	GA.TT	het-ref	72	0.21	.	2	.	PASS	600678	C	276300(MK);608089(MK);614350(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 5; Mismatch repair cancer syndrome; Endometrial cancer	AD/AR	.	Oncologic	Oncologic	17557300|16283678|16000562|15340263|15098177|12732731|9354786	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	2956	MSH6	IC6	IVS6	.	.	intron	NM_000179.2	NP_000170.1	+	Y	c.3557-16delT	.	.	.	NM_000179.2(MSH6): c.3557-16delT	MixedObserved;	0	0	U	.	.	.	.	PASS	0	5948	0.168628	32	90548	0.138645	.	.	.	.	.	.	rs749755872	.	4024	0.303700	0.242	0.285	0.029	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	89417	reviewed_by_expert_panel	Uncertain_significance	Benign
2	48032874	48032878	2p16.3	0	nullSample	.	CTAT	ref	CTAT	GA.CT	homo-ref	.	.	.	0	.	.	600678	C	276300(MK);608089(MK);614350(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 5; Mismatch repair cancer syndrome; Endometrial cancer	AD/AR	.	Oncologic	Oncologic	17557300|16283678|16000562|15340263|15098177|12732731|9354786	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	2956	MSH6	IC7	IVS7	.	.	no-change	NM_000179.2	NP_000170.1	+	Y	c.3646+29_3646+32=	.	.	.	NM_000179.2(MSH6): c.3646+29_3646+32=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125900	0.304750	U	.	.	12492	0.291947	PASS	0	1534	1.000000	23360	46724	0.999957	.	.	.	.	.	.	rs2234731	.	4024	0.132000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	48032874	48032878	2p16.3	0	normal	.	CTAT	del	.	GA.CT	hom-alt	362	1.00	.	0	.	PASS	600678	C	276300(MK);608089(MK);614350(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 5; Mismatch repair cancer syndrome; Endometrial cancer	AD/AR	.	Oncologic	Oncologic	17557300|16283678|16000562|15340263|15098177|12732731|9354786	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	2956	MSH6	IC7	IVS7	.	.	intron	NM_000179.2	NP_000170.1	+	Y	c.3646+29_3646+32delCTAT	.	.	.	NM_000179.2(MSH6): c.3646+29_3646+32delCTAT	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125900	0.695250	U	0.87	0.762181	12492	0.708053	PASS	3276	8634	0.868311	29410	120892	0.692478	6512	14962	8.69884e-01	58425	167729	6.84061e-01	rs2234731	.	4024	0.868000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	89429	reviewed_by_expert_panel	Benign	Benign
2	48033550	48033551	2p16.3	0	nullSample	.	C	ref	C	CT.TT	homo-ref	.	.	.	0	.	.	600678	C	276300(MK);608089(MK);614350(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 5; Mismatch repair cancer syndrome; Endometrial cancer	AD/AR	.	Oncologic	Oncologic	17557300|16283678|16000562|15340263|15098177|12732731|9354786	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	2956	MSH6	IC8	IVS8	.	.	no-change	NM_000179.2	NP_000170.1	+	Y	c.3802-40C=	.	.	.	NM_000179.2(MSH6): c.3802-40C=	MixedObserved;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126016	0.254714	U	0.8869	0.809105	13004	0.212781	PASS	.	8638	0.118662	4377	121008	0.257355	.	.	.	.	.	.	rs3136367	.	4024	0.119500	-1.315	-0.562	-0.545	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	48033550	48033551	2p16.3	0	normal	.	C	snv	G	CT.TT	hom-alt	686	1.00	.	0	.	PASS	600678	C	276300(MK);608089(MK);614350(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 5; Mismatch repair cancer syndrome; Endometrial cancer	AD/AR	.	Oncologic	Oncologic	17557300|16283678|16000562|15340263|15098177|12732731|9354786	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	2956	MSH6	IC8	IVS8	.	.	intron	NM_000179.2	NP_000170.1	+	Y	c.3802-40C>G	.	.	.	NM_000179.2(MSH6): c.3802-40C>G	MixedObserved;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126016	0.745286	U	0.8869	0.809105	13004	0.787219	PASS	3367	8638	0.881338	33739	121008	0.742645	6711	15205	8.82370e-01	66853	180221	7.33261e-01	rs3136367	.	4024	0.880500	-1.315	-0.562	-0.545	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	36594	reviewed_by_expert_panel	Benign	Benign
2	48033890	48033891	2p16.3	0	normal	.	T	ref	T	ac.tt	het-alt	53	0.30	.	1	AT_rich|Low_complexity|Low_complexity|+|34	PASS	600678	C	276300(MK);608089(MK);614350(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 5; Mismatch repair cancer syndrome; Endometrial cancer	AD/AR	.	Oncologic	Oncologic	17557300|16283678|16000562|15340263|15098177|12732731|9354786	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	2956	MSH6	IC9	IVS9	.	.	no-change	NM_000179.2	NP_000170.1	+	Y	c.4002-27T=	.	.	.	NM_000179.2(MSH6): c.4002-27T=	MixedObserved;	477	0.983229	U	.	.	.	.	PASS	.	188	0.739362	199	540	0.868519	.	.	.	.	.	.	rs774215207	.	4024	0.683400	0.324	-0.535	-0.535	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	48033890	48033891	2p16.3	0	normal	.	T	del	.	ac.tt	het-ref	122	0.70	.	2	AT_rich|Low_complexity|Low_complexity|+|34	PASS	600678	C	276300(MK);608089(MK);614350(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 5; Mismatch repair cancer syndrome; Endometrial cancer	AD/AR	.	Oncologic	Oncologic	17557300|16283678|16000562|15340263|15098177|12732731|9354786	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	2956	MSH6	IC9	IVS9	.	.	intron	NM_000179.2	NP_000170.1	+	Y	c.4002-27delT	.	.	.	NM_000179.2(MSH6): c.4002-27delT	.	.	.	.	.	.	.	.	PASS	4	2382	0.419395	82	58750	0.424477	.	.	.	.	.	.	.	.	4024	0.315100	0.324	-0.535	-0.535	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	89508	reviewed_by_expert_panel	Likely_benign	Benign
2	58386999	58387000	2p16.1	0	normal	.	C	ref	C	TA.TA	het-alt	116	0.42	.	1	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC13	IVS13	.	.	no-change	NM_001114636.1	NP_001108108.1	-	Y	c.1108-65G=	.	.	.	NM_001114636.1(FANCL): c.1108-65G=	;maf-5-some-pop,microattr-tpa	5008	0.555312	U	0.2758	0.444688	4546	0.559613	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3732136	.	.	.	-1.112	-1.347	-0.671	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	58386999	58387000	2p16.1	0	normal	.	C	ref	C	TA.TA	het-alt	116	0.42	.	1	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC13	IVS13	.	.	no-change	NM_018062.3	NP_060532.2	-	N	c.1093-65G=	.	.	.	NM_018062.3(FANCL): c.1093-65G=	;maf-5-some-pop,microattr-tpa	5008	0.555312	U	0.2758	0.444688	4546	0.559613	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3732136	.	.	.	-1.112	-1.347	-0.671	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	58386999	58387000	2p16.1	0	normal	.	C	snv	T	TA.TA	het-ref	161	0.58	.	2	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC13	IVS13	.	.	intron	NM_001114636.1	NP_001108108.1	-	Y	c.1108-65G>A	.	.	.	NM_001114636.1(FANCL): c.1108-65G>A	;maf-5-some-pop,microattr-tpa	5008	0.444688	U	0.2758	0.444688	4546	0.440387	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3732136	.	.	.	-1.112	-1.347	-0.671	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	58386999	58387000	2p16.1	0	normal	.	C	snv	T	TA.TA	het-ref	161	0.58	.	2	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC13	IVS13	.	.	intron	NM_018062.3	NP_060532.2	-	N	c.1093-65G>A	.	.	.	NM_018062.3(FANCL): c.1093-65G>A	;maf-5-some-pop,microattr-tpa	5008	0.444688	U	0.2758	0.444688	4546	0.440387	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3732136	.	.	.	-1.112	-1.347	-0.671	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	58388695	58388696	2p16.1	1	normal	.	A	snv	G	TG.GA	hom-alt	397	1.00	.	0	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	C12	EX12	FANCL C-terminal domain	PF11793.3	coding-synon	NM_001114636.1	NP_001108108.1	-	Y	c.996T>C	p.(S332=) | p.(Ser332=)	TCT=>TCC	.	NM_001114636.1(FANCL): c.996T>C (p.(S332=))	;maf-5-some-pop,microattr-tpa	126060	0.650960	U	0.5883	0.70647	13004	0.704091	PASS	1391	8638	0.564019	25916	121052	0.648663	2745	9633	5.58824e-01	51698	158013	6.43900e-01	rs848291	.	.	.	-0.851	-0.055	-0.713	.	.	.	.	.	ENST00000233741: c.981T>C (p.S327S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4001713	.	.	.	.	.	no_record	257495	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
2	58388695	58388696	2p16.1	1	normal	.	A	snv	G	TG.GA	hom-alt	397	1.00	.	0	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	C12	EX12	FANCL C-terminal domain	PF11793.3	coding-synon	NM_018062.3	NP_060532.2	-	N	c.981T>C	p.(S327=) | p.(Ser327=)	TCT=>TCC	.	NM_018062.3(FANCL): c.981T>C (p.(S327=))	;maf-5-some-pop,microattr-tpa	126060	0.650960	U	0.5883	0.70647	13004	0.704091	PASS	1391	8638	0.564019	25916	121052	0.648663	2745	9633	5.58824e-01	51698	158013	6.43900e-01	rs848291	.	.	.	-0.851	-0.055	-0.713	.	.	.	.	.	ENST00000233741: c.981T>C (p.S327S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4001713	.	.	.	.	.	no_record	257495	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
2	58388695	58388696	2p16.1	0	nullSample	.	A	ref	A	TG.GA	homo-ref	.	.	.	0	.	.	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	C12	EX12	FANCL C-terminal domain	PF11793.3	no-change	NM_001114636.1	NP_001108108.1	-	Y	c.996T=	.	.	.	NM_001114636.1(FANCL): c.996T=	;maf-5-some-pop,microattr-tpa	126060	0.349040	U	0.5883	0.70647	13004	0.295909	PASS	-1045	8638	0.435981	7920	121052	0.351337	.	.	.	.	.	.	rs848291	.	.	.	-0.851	-0.055	-0.713	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	58388695	58388696	2p16.1	0	nullSample	.	A	ref	A	TG.GA	homo-ref	.	.	.	0	.	.	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	C12	EX12	FANCL C-terminal domain	PF11793.3	no-change	NM_018062.3	NP_060532.2	-	N	c.981T=	.	.	.	NM_018062.3(FANCL): c.981T=	;maf-5-some-pop,microattr-tpa	126060	0.349040	U	0.5883	0.70647	13004	0.295909	PASS	-1045	8638	0.435981	7920	121052	0.351337	.	.	.	.	.	.	rs848291	.	.	.	-0.851	-0.055	-0.713	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	58390218	58390219	2p16.1	0	normal	.	A	ref	A	tt.aa	het-alt	242	0.86	.	1	AT_rich|Low_complexity|Low_complexity|+|25	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC9	IVS9	.	.	no-change	NM_001114636.1	NP_001108108.1	-	Y	c.791-10T=	.	.	.	NM_001114636.1(FANCL): c.791-10T=	MixedObserved;	8131|52474	0.998893|0.999981	U	.	.	12118	0.878528	PASS	0	4420	1.000000	26236	52474	0.999981	.	.	.	.	.	.	rs374236117|rs754860957	.	.	.	-1.640	-0.900	-0.622	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	58390218	58390219	2p16.1	0	normal	.	A	ref	A	tt.aa	het-alt	242	0.86	.	1	AT_rich|Low_complexity|Low_complexity|+|25	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC9	IVS9	.	.	no-change	NM_018062.3	NP_060532.2	-	N	c.776-10T=	.	.	.	NM_018062.3(FANCL): c.776-10T=	MixedObserved;	8131|52474	0.998893|0.999981	U	.	.	12118	0.878528	PASS	0	4420	1.000000	26236	52474	0.999981	.	.	.	.	.	.	rs374236117|rs754860957	.	.	.	-1.640	-0.900	-0.622	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	58390218	58390219	2p16.1	1	normal	.	A	del	.	tt.aa	het-ref	41	0.14	.	2	AT_rich|Low_complexity|Low_complexity|+|25	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC9	IVS9	.	.	intron	NM_001114636.1	NP_001108108.1	-	Y	c.791-10delT	.	.	.	NM_001114636.1(FANCL): c.791-10delT	MixedObserved;	8131	0.001107	U	.	.	12118	0.042416	PASS	0	6336	0.066288	0	88224	0.092061	.	.	.	.	.	.	rs374236117	.	.	.	-1.640	-0.900	-0.622	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	58390218	58390219	2p16.1	1	normal	.	A	del	.	tt.aa	het-ref	41	0.14	.	2	AT_rich|Low_complexity|Low_complexity|+|25	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC9	IVS9	.	.	intron	NM_018062.3	NP_060532.2	-	N	c.776-10delT	.	.	.	NM_018062.3(FANCL): c.776-10delT	MixedObserved;	8131	0.001107	U	.	.	12118	0.042416	PASS	0	6336	0.066288	0	88224	0.092061	.	.	.	.	.	.	rs374236117	.	.	.	-1.640	-0.900	-0.622	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	58390678	58390679	2p16.1	0	normal	.	T	ref	T	TT.AG	het-alt	111	0.48	.	1	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC8	IVS8	.	.	no-change	NM_001114636.1	NP_001108108.1	-	Y	c.707-27A=	.	.	.	NM_001114636.1(FANCL): c.707-27A=	SingleClassTriAllelic;maf-5-some-pop	109570	0.885845	U	0.2192	0.109824	13002	0.930549	PASS	.	7154	0.773973	41061	104562	0.885637	.	.	.	.	.	.	rs12624152	.	.	.	0.254	-0.942	-1.248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	58390678	58390679	2p16.1	0	normal	.	T	ref	T	TT.AG	het-alt	111	0.48	.	1	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC8	IVS8	.	.	no-change	NM_018062.3	NP_060532.2	-	N	c.692-27A=	.	.	.	NM_018062.3(FANCL): c.692-27A=	SingleClassTriAllelic;maf-5-some-pop	109570	0.885845	U	0.2192	0.109824	13002	0.930549	PASS	.	7154	0.773973	41061	104562	0.885637	.	.	.	.	.	.	rs12624152	.	.	.	0.254	-0.942	-1.248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	58390678	58390679	2p16.1	0	normal	.	T	snv	G	TT.AG	het-ref	119	0.52	.	2	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC8	IVS8	.	.	intron	NM_001114636.1	NP_001108108.1	-	Y	c.707-27A>C	.	.	.	NM_001114636.1(FANCL): c.707-27A>C	SingleClassTriAllelic;maf-5-some-pop	109570	0.114146	U	0.2192	0.109824	13002	0.069451	PASS	164	7154	0.225888	738	104562	0.114353	324	3277	1.98222e-01	1495	24261	1.02713e-01	rs12624152	.	.	.	0.254	-0.942	-1.248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	58390678	58390679	2p16.1	0	normal	.	T	snv	G	TT.AG	het-ref	119	0.52	.	2	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC8	IVS8	.	.	intron	NM_018062.3	NP_060532.2	-	N	c.692-27A>C	.	.	.	NM_018062.3(FANCL): c.692-27A>C	SingleClassTriAllelic;maf-5-some-pop	109570	0.114146	U	0.2192	0.109824	13002	0.069451	PASS	164	7154	0.225888	738	104562	0.114353	324	3277	1.98222e-01	1495	24261	1.02713e-01	rs12624152	.	.	.	0.254	-0.942	-1.248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	58392788	58392789	2p16.1	0	normal	.	T	ref	T	CA.TG	het-alt	185	0.53	.	1	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC8	IVS8	.	.	no-change	NM_001114636.1	NP_001108108.1	-	Y	c.706+70A=	.	.	.	NM_001114636.1(FANCL): c.706+70A=	;maf-5-some-pop,maf-5-all-pops	5008	0.723243	U	0.2887	0.276757	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs848288	.	.	.	0.482	0.621	1.007	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	58392788	58392789	2p16.1	0	normal	.	T	ref	T	CA.TG	het-alt	185	0.53	.	1	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC8	IVS8	.	.	no-change	NM_018062.3	NP_060532.2	-	N	c.691+70A=	.	.	.	NM_018062.3(FANCL): c.691+70A=	;maf-5-some-pop,maf-5-all-pops	5008	0.723243	U	0.2887	0.276757	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs848288	.	.	.	0.482	0.621	1.007	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	58392788	58392789	2p16.1	0	normal	.	T	snv	C	CA.TG	het-ref	163	0.47	.	2	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC8	IVS8	.	.	intron	NM_001114636.1	NP_001108108.1	-	Y	c.706+70A>G	.	.	.	NM_001114636.1(FANCL): c.706+70A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.276757	U	0.2887	0.276757	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs848288	.	.	.	0.482	0.621	1.007	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	58392788	58392789	2p16.1	0	normal	.	T	snv	C	CA.TG	het-ref	163	0.47	.	2	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC8	IVS8	.	.	intron	NM_018062.3	NP_060532.2	-	N	c.691+70A>G	.	.	.	NM_018062.3(FANCL): c.691+70A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.276757	U	0.2887	0.276757	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs848288	.	.	.	0.482	0.621	1.007	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	58392797	58392800	2p16.1	0	normal	.	TTA	ref	TTA	AT.TT	het-alt	198	0.54	.	1	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC8	IVS8	.	.	no-change	NM_001114636.1	NP_001108108.1	-	Y	c.706+59_706+61=	.	.	.	NM_001114636.1(FANCL): c.706+59_706+61=	DuplicateObserved;maf-5-some-pop	5008	0.747604	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs148383677	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
2	58392797	58392800	2p16.1	0	normal	.	TTA	ref	TTA	AT.TT	het-alt	198	0.54	.	1	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC8	IVS8	.	.	no-change	NM_018062.3	NP_060532.2	-	N	c.691+59_691+61=	.	.	.	NM_018062.3(FANCL): c.691+59_691+61=	DuplicateObserved;maf-5-some-pop	5008	0.747604	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs148383677	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
2	58392797	58392800	2p16.1	0	normal	.	TTA	del	.	AT.TT	het-ref	172	0.46	.	2	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC8	IVS8	.	.	intron	NM_001114636.1	NP_001108108.1	-	Y	c.706+59_706+61delTAA	.	.	.	NM_001114636.1(FANCL): c.706+59_706+61delTAA	DuplicateObserved;maf-5-some-pop	5008	0.252396	U	0.2887	0.252396	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs148383677	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	58392797	58392800	2p16.1	0	normal	.	TTA	del	.	AT.TT	het-ref	172	0.46	.	2	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC8	IVS8	.	.	intron	NM_018062.3	NP_060532.2	-	N	c.691+59_691+61delTAA	.	.	.	NM_018062.3(FANCL): c.691+59_691+61delTAA	DuplicateObserved;maf-5-some-pop	5008	0.252396	U	0.2887	0.252396	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs148383677	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	58431409	58431410	2p16.1	0	normal	.	G	snv	C	GA.AG	het-ref	139	0.50	.	2	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC5	IVS5	.	.	intron	NM_001114636.1	NP_001108108.1	-	Y	c.375-49C>G	.	.	.	NM_001114636.1(FANCL): c.375-49C>G	;maf-5-some-pop,maf-5-all-pops	125710	0.128057	U	0.2192	0.176717	13006	0.147240	PASS	175	8622	0.197866	1151	120702	0.126038	328	3323	1.92861e-01	2097	28971	1.18386e-01	rs1404459	.	.	.	-0.136	-2.779	-2.675	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	257494	criteria_provided,_single_submitter	Benign	Benign
2	58431409	58431410	2p16.1	0	normal	.	G	snv	C	GA.AG	het-ref	139	0.50	.	2	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC5	IVS5	.	.	intron	NM_018062.3	NP_060532.2	-	N	c.375-49C>G	.	.	.	NM_018062.3(FANCL): c.375-49C>G	;maf-5-some-pop,maf-5-all-pops	125710	0.128057	U	0.2192	0.176717	13006	0.147240	PASS	175	8622	0.197866	1151	120702	0.126038	328	3323	1.92861e-01	2097	28971	1.18386e-01	rs1404459	.	.	.	-0.136	-2.779	-2.675	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	257494	criteria_provided,_single_submitter	Benign	Benign
2	58431409	58431410	2p16.1	0	normal	.	G	ref	G	GA.AG	het-alt	141	0.50	.	1	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC5	IVS5	.	.	no-change	NM_001114636.1	NP_001108108.1	-	Y	c.375-49C=	.	.	.	NM_001114636.1(FANCL): c.375-49C=	;maf-5-some-pop,maf-5-all-pops	125710	0.871943	U	0.2192	0.176717	13006	0.852760	PASS	-678	8622	0.802134	46289	120702	0.873962	.	.	.	.	.	.	rs1404459	.	.	.	-0.136	-2.779	-2.675	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	58431409	58431410	2p16.1	0	normal	.	G	ref	G	GA.AG	het-alt	141	0.50	.	1	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC5	IVS5	.	.	no-change	NM_018062.3	NP_060532.2	-	N	c.375-49C=	.	.	.	NM_018062.3(FANCL): c.375-49C=	;maf-5-some-pop,maf-5-all-pops	125710	0.871943	U	0.2192	0.176717	13006	0.852760	PASS	-678	8622	0.802134	46289	120702	0.873962	.	.	.	.	.	.	rs1404459	.	.	.	-0.136	-2.779	-2.675	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	58453842	58453843	2p16.1	0	normal	.	G	ref	G	CA.AA	het-alt	144	0.60	.	1	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC4	IVS4	.	.	no-change	NM_001114636.1	NP_001108108.1	-	Y	c.273+20C=	.	.	.	NM_001114636.1(FANCL): c.273+20C=	.	.	.	.	0.2827	0.259585	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.585	1.000	1.216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	58453842	58453843	2p16.1	0	normal	.	G	ref	G	CA.AA	het-alt	144	0.60	.	1	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC4	IVS4	.	.	no-change	NM_018062.3	NP_060532.2	-	N	c.273+20C=	.	.	.	NM_018062.3(FANCL): c.273+20C=	.	.	.	.	0.2827	0.259585	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.585	1.000	1.216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	58453843	58453843	2p16.1	1	normal	.	.	ins	A	AG.AA	het-ref	96	0.40	.	2	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC4	IVS4	.	.	intron	NM_001114636.1	NP_001108108.1	-	Y	c.273+19_273+20insT	.	.	.	NM_001114636.1(FANCL): c.273+19_273+20insT	MixedObserved;maf-5-some-pop,maf-5-all-pops	13385	0.098394	U	0.2827	0.259585	.	.	PASS	28	6412	0.351216	630	90432	0.367890	.	.	.	.	.	.	rs372101290	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	58453843	58453843	2p16.1	1	normal	.	.	ins	A	AG.AA	het-ref	96	0.40	.	2	.	PASS	608111	P	614083(MK)	NN	Fanconi anemia type L	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22720145|20301575|12973351	.	55120	FANCL	IC4	IVS4	.	.	intron	NM_018062.3	NP_060532.2	-	N	c.273+19_273+20insT	.	.	.	NM_018062.3(FANCL): c.273+19_273+20insT	MixedObserved;maf-5-some-pop,maf-5-all-pops	13385	0.098394	U	0.2827	0.259585	.	.	PASS	28	6412	0.351216	630	90432	0.367890	.	.	.	.	.	.	rs372101290	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	61709747	61709748	2p15	0	normal	.	T	ref	T	tg.tt	het-alt	22	0.13	.	1	AluSx3|SINE|Alu|-|324	PASS	602559	P	.	NN	.	.	.	.	.	.	.	7514	XPO1	IC21	IVS22	.	.	no-change	NM_003400.3	NP_003391.1	-	Y	c.2813-74A=	.	.	.	NM_003400.3(XPO1): c.2813-74A=	MixedObserved;maf-5-some-pop,maf-5-all-pops|MixedObserved;	5008|0	0.410144|0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11360652|rs201346154	.	4024	0.535500	0.092	0.100	0.093	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	61709747	61709748	2p15	0	normal	.	T	del	.	tg.tt	het-ref	143	0.87	.	2	AluSx3|SINE|Alu|-|324	PASS	602559	P	.	NN	.	.	.	.	.	.	.	7514	XPO1	IC21	IVS22	.	.	intron	NM_003400.3	NP_003391.1	-	Y	c.2813-74delA	.	.	.	NM_003400.3(XPO1): c.2813-74delA	MixedObserved;maf-5-some-pop,maf-5-all-pops|MixedObserved;	5008|0	0.589856|0	U	0.6101	0.589856	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11360652|rs201346154	.	4024	0.464200	0.092	0.100	0.093	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	61722518	61722519	2p15	0	nullSample	.	G	ref	G	TA.AA	homo-ref	.	.	.	0	.	.	602559	P	.	NN	.	.	.	.	.	.	.	7514	XPO1	IC10	IVS11	.	.	no-change	NM_003400.3	NP_003391.1	-	Y	c.1047+71C=	.	.	.	NM_003400.3(XPO1): c.1047+71C=	.	.	.	.	0.6677	0.641973	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.474	-0.669	-0.526	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	61722519	61722519	2p15	0	normal	.	.	ins	A	AG.AA	hom-alt	308	1.00	.	0	.	PASS	602559	P	.	NN	.	.	.	.	.	.	.	7514	XPO1	IC10	IVS11	.	.	intron	NM_003400.3	NP_003391.1	-	Y	c.1047+70_1047+71insT	.	.	.	NM_003400.3(XPO1): c.1047+70_1047+71insT	;	5008	0.641973	U	0.6677	0.641973	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs74392163	.	4024	0.648400	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	61729257	61729258	2p15	0	nullSample	.	A	ref	A	AC.GC	homo-ref	.	.	.	0	.	.	602559	P	.	NN	.	.	.	.	.	.	.	7514	XPO1	IC4	IVS5	.	.	no-change	NM_003400.3	NP_003391.1	-	Y	c.364-83T=	.	.	.	NM_003400.3(XPO1): c.364-83T=	;maf-5-some-pop,maf-5-all-pops	5008	0.378195	U	0.6617	0.621805	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2305155	.	4024	0.357900	0.523	0.295	1.565	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	61729257	61729258	2p15	0	normal	.	A	snv	G	AC.GC	hom-alt	397	1.00	.	0	.	PASS	602559	P	.	NN	.	.	.	.	.	.	.	7514	XPO1	IC4	IVS5	.	.	intron	NM_003400.3	NP_003391.1	-	Y	c.364-83T>C	.	.	.	NM_003400.3(XPO1): c.364-83T>C	;maf-5-some-pop,maf-5-all-pops	5008	0.621805	U	0.6617	0.621805	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2305155	.	4024	0.642100	0.523	0.295	1.565	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	61749689	61749690	2p15	0	nullSample	.	C	ref	C	TA.AA	homo-ref	.	.	.	0	.	.	602559	P	.	NN	.	.	.	.	.	.	.	7514	XPO1	IC3	IVS4	.	.	no-change	NM_003400.3	NP_003391.1	-	Y	c.301+56G=	.	.	.	NM_003400.3(XPO1): c.301+56G=	;maf-5-some-pop,maf-5-all-pops	5008	0.394968	U	0.6587	0.605032	4566	0.390714	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3732171	.	4024	0.356600	-0.381	0.137	0.130	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	61749689	61749690	2p15	0	normal	.	C	snv	T	TA.AA	hom-alt	251	1.00	.	0	.	PASS	602559	P	.	NN	.	.	.	.	.	.	.	7514	XPO1	IC3	IVS4	.	.	intron	NM_003400.3	NP_003391.1	-	Y	c.301+56G>A	.	.	.	NM_003400.3(XPO1): c.301+56G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.605032	U	0.6587	0.605032	4566	0.609286	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3732171	.	4024	0.643400	-0.381	0.137	0.130	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	61749715	61749716	2p15	0	nullSample	.	C	ref	C	AA.TC	homo-ref	.	.	.	0	.	.	602559	P	.	NN	.	.	.	.	.	.	.	7514	XPO1	IC3	IVS4	.	.	no-change	NM_003400.3	NP_003391.1	-	Y	c.301+30G=	.	.	.	NM_003400.3(XPO1): c.301+30G=	;maf-5-some-pop,maf-5-all-pops	121760	0.368290	U	0.6587	0.640575	13000	0.360154	PASS	-991	8420	0.348456	7706	116752	0.368670	.	.	.	.	.	.	rs3732170	.	4024	0.356600	-0.381	-0.064	-0.765	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	61749715	61749716	2p15	0	normal	.	C	snv	T	AA.TC	hom-alt	290	1.00	.	0	.	PASS	602559	P	.	NN	.	.	.	.	.	.	.	7514	XPO1	IC3	IVS4	.	.	intron	NM_003400.3	NP_003391.1	-	Y	c.301+30G>A	.	.	.	NM_003400.3(XPO1): c.301+30G>A	;maf-5-some-pop,maf-5-all-pops	121760	0.631710	U	0.6587	0.640575	13000	0.639846	PASS	1752	8420	0.651544	23039	116752	0.631330	3490	10936	6.41558e-01	46109	148812	6.19384e-01	rs3732170	.	4024	0.643400	-0.381	-0.064	-0.765	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	61749836	61749837	2p15	0	normal	.	A	ref	A	AG.AG	het-alt	161	0.55	.	1	.	PASS	602559	P	.	NN	.	.	.	.	.	.	.	7514	XPO1	IC2	IVS3	.	.	no-change	NM_003400.3	NP_003391.1	-	Y	c.229-19T=	.	.	.	NM_003400.3(XPO1): c.229-19T=	;	118862	0.999588	U	0.003	0.000798722	.	.	PASS	.	8324	0.996036	56882	113854	0.999605	.	.	.	.	.	.	rs201554476	.	4024	0.994800	0.455	0.739	0.902	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	61749836	61749837	2p15	1	normal	.	A	snv	G	AG.AG	het-ref	131	0.45	.	2	.	PASS	602559	P	.	NN	.	.	.	.	.	.	.	7514	XPO1	IC2	IVS3	.	.	intron	NM_003400.3	NP_003391.1	-	Y	c.229-19T>C	.	.	.	NM_003400.3(XPO1): c.229-19T>C	;	118862	0.000412	U	0.003	0.000798722	.	.	PASS	0	8324	0.003964	0	113854	0.000395	0	68	3.95395e-03	0	89	3.64990e-04	rs201554476	.	4024	0.005200	0.455	0.739	0.902	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
2	69173519	69173520	2p13.3	0	normal	.	C	ref	C	CA.GT	het-alt	202	0.52	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	200504	GKN2	C5	EX5	BRICHOS domain	PF04089.9	no-change	NM_182536.2	NP_872342.2	-	Y	c.388G=	.	.	.	NM_182536.2(GKN2): c.388G=	;	126322	0.997625	U	0.0228	0.00479233	.	.	PASS	-123	8654	0.970881	60384	121314	0.997725	.	.	.	.	.	.	rs146849599	.	4024	0.968200	-2.110	-0.830	-0.761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	69173519	69173520	2p13.3	1	normal	.	C	snv	T	CA.GT	het-ref	187	0.48	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	200504	GKN2	C5	EX5	BRICHOS domain	PF04089.9	missense	NM_182536.2	NP_872342.2	-	Y	c.388G>A	p.V130M | p.Val130Met	GTG=>ATG	NP=>NP	NM_182536.2(GKN2): c.388G>A (p.V130M)	;	126322	0.002375	U	0.0228	0.00479233	.	.	PASS	3	8654	0.029119	3	121314	0.002275	6	503	2.92000e-02	6	548	2.22659e-03	rs146849599	.	4024	0.031800	-2.110	-0.830	-0.761	0.16	0.018	0.125	0.060	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
2	74140788	74140789	2p13.1	1	normal	.	T	snv	C	TT.CT	het-ref	152	0.49	.	2	.	PASS	102545	C	155310(MK)	AD	.	.	.	.	.	.	.	72	ACTG2	IC5	IVS6	.	.	intron	NM_001615.3	NP_001606.1	+	Y	c.613+16T>C	.	.	.	NM_001615.3(ACTG2): c.613+16T>C	;maf-5-some-pop,maf-5-all-pops	125310	0.647434	U	0.5288	0.60004	13006	0.619637	PASS	1024	8614	0.490597	25801	120302	0.649407	2144	8476	4.96835e-01	53218	158325	6.58420e-01	rs891698	.	4024	0.495000	-0.213	0.501	0.103	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	74140788	74140789	2p13.1	0	normal	.	T	ref	T	TT.CT	het-alt	156	0.51	.	1	.	PASS	102545	C	155310(MK)	AD	.	.	.	.	.	.	.	72	ACTG2	IC5	IVS6	.	.	no-change	NM_001615.3	NP_001606.1	+	Y	c.613+16T=	.	.	.	NM_001615.3(ACTG2): c.613+16T=	;maf-5-some-pop,maf-5-all-pops	125310	0.352566	U	0.5288	0.60004	13006	0.380363	PASS	-1089	8614	0.509403	7827	120302	0.350593	.	.	.	.	.	.	rs891698	.	4024	0.505000	-0.213	0.501	0.103	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	84800604	84800605	2p11.2	0	nullSample	.	C	ref	C	GC.GC	homo-ref	.	.	.	0	.	.	603336	C	.	NN	.	.	.	.	.	.	.	1768	DNAH6	C11	EX12	.	.	no-change	NM_001370.1	NP_001361.1	+	Y	c.1818C=	.	.	.	NM_001370.1(DNAH6): c.1818C=	;maf-5-some-pop	126344	0.054122	U	0.997	0.929712	13006	0.091189	PASS	-9	8652	0.002080	255	121336	0.053455	.	.	.	.	.	.	rs11891970	.	4024	0.003500	-0.494	0.026	0.252	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	84800604	84800605	2p11.2	1	normal	.	C	snv	A	GC.GC	hom-alt	403	1.00	.	0	.	PASS	603336	C	.	NN	.	.	.	.	.	.	.	1768	DNAH6	C11	EX12	.	.	coding-synon	NM_001370.1	NP_001361.1	+	Y	c.1818C>A	p.(A606=) | p.(Ala606=)	GCC=>GCA	.	NM_001370.1(DNAH6): c.1818C>A (p.(A606=))	;maf-5-some-pop	126344	0.945878	U	0.997	0.929712	13006	0.908811	PASS	4308	8652	0.997920	54437	121336	0.946545	7175	14375	9.98264e-01	96759	203641	9.48889e-01	rs11891970	.	4024	0.996500	-0.494	0.026	0.252	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	402734	criteria_provided,_single_submitter	Benign	Likely Benign
2	96920498	96920499	2q11.2	0	normal	.	A	ref	A	CC.CC	het-alt	137	0.68	.	1	.	DUBIOUS	613403	P	171300(SK)	AD	Pheochromocytoma	AD	.	Oncologic	Oncologic	23666964|22419703|20154675	FC59;H54;H62;H68;HE15;MC58	55654	TMEM127	IC2	IVS3	.	.	no-change	NM_017849.3	NP_060319.1	-	Y	c.409+72T=	.	.	.	NM_017849.3(TMEM127): c.409+72T=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.856100	0.533	0.267	0.130	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	96920498	96920499	2q11.2	0	normal	.	A	snv	C	CC.CC	het-ref	64	0.32	.	2	.	DUBIOUS	613403	P	171300(SK)	AD	Pheochromocytoma	AD	.	Oncologic	Oncologic	23666964|22419703|20154675	FC59;H54;H62;H68;HE15;MC58	55654	TMEM127	IC2	IVS3	.	.	intron	NM_017849.3	NP_060319.1	-	Y	c.409+72T>G	.	.	.	NM_017849.3(TMEM127): c.409+72T>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.143900	0.533	0.267	0.130	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	99779130	99779131	2q11.2	0	normal	.	T	ref	T	GC.TA	het-alt	289	0.57	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.99779130T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	126190	0.441485	U	0.6617	0.496805	13006	0.495079	PASS	-967	8636	0.335109	12447	121182	0.438935	.	.	.	.	.	.	rs2516835	.	.	.	0.528	0.317	0.039	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	99779130	99779131	2q11.2	0	normal	.	T	snv	C	GC.TA	het-ref	222	0.43	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.99779130T>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	126190	0.558515	U	0.6617	0.496805	13006	0.504921	PASS	1904	8636	0.664891	19847	121182	0.561065	3903	11608	6.73084e-01	40271	138371	5.62644e-01	rs2516835	.	.	.	0.528	0.317	0.039	.	.	.	.	.	ENST00000393471: c.711T>C (p.A237A)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5008345	.	.	.	.	.	no_record	379992	criteria_provided,_single_submitter	Benign	Benign
2	128015366	128015367	2q14.3	0	nullSample	.	C	ref	C	TA.TT	homo-ref	.	.	.	0	.	.	133510	C	601675(MK);610651(MK)	NN	Xeroderma pigmentosum, complementation group B; Trichothiodystrophy	AR	.	Allergy/Immunology/Infectious; Dermatologic; Endocrine; Genitourinary; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Dermatologic; Oncologic	20301571|16947863|9012405|8783572|6185841|4811796|2189905|2167179	.	2071	ERCC3	IC14	IVS14	.	.	no-change	NM_000122.1	NP_000113.1	-	Y	c.2218-64G=	.	.	.	NM_000122.1(ERCC3): c.2218-64G=	;maf-5-some-pop	5008	0.186302	U	0.999	0.813698	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4662718	.	4024	0.006000	-0.556	-0.198	-0.399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	128015366	128015367	2q14.3	0	normal	.	C	snv	T	TA.TT	hom-alt	428	1.00	.	0	.	PASS	133510	C	601675(MK);610651(MK)	NN	Xeroderma pigmentosum, complementation group B; Trichothiodystrophy	AR	.	Allergy/Immunology/Infectious; Dermatologic; Endocrine; Genitourinary; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Dermatologic; Oncologic	20301571|16947863|9012405|8783572|6185841|4811796|2189905|2167179	.	2071	ERCC3	IC14	IVS14	.	.	intron	NM_000122.1	NP_000113.1	-	Y	c.2218-64G>A	.	.	.	NM_000122.1(ERCC3): c.2218-64G>A	;maf-5-some-pop	5008	0.813698	U	0.999	0.813698	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4662718	.	4024	0.994000	-0.556	-0.198	-0.399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	128029065	128029066	2q14.3	0	normal	.	A	ref	A	GG.AA	het-alt	92	0.48	.	1	.	PASS	133510	C	601675(MK);610651(MK)	NN	Xeroderma pigmentosum, complementation group B; Trichothiodystrophy	AR	.	Allergy/Immunology/Infectious; Dermatologic; Endocrine; Genitourinary; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Dermatologic; Oncologic	20301571|16947863|9012405|8783572|6185841|4811796|2189905|2167179	.	2071	ERCC3	IC11	IVS11	.	.	no-change	NM_000122.1	NP_000113.1	-	Y	c.1828-37T=	.	.	.	NM_000122.1(ERCC3): c.1828-37T=	MixedObserved;|MixedObserved;maf-5-some-pop,maf-5-all-pops	18296|42217	0.999781|0.956368	U	.	.	12514	0.657823	PASS	0	984	1.000000	9144	18296	0.999781	.	.	.	.	.	.	rs112349061|rs11345447	.	4024	0.597400	-3.382	-0.708	-0.570	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	128029065	128029066	2q14.3	0	normal	.	A	del	.	GG.AA	het-ref	101	0.52	.	2	.	PASS	133510	C	601675(MK);610651(MK)	NN	Xeroderma pigmentosum, complementation group B; Trichothiodystrophy	AR	.	Allergy/Immunology/Infectious; Dermatologic; Endocrine; Genitourinary; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Dermatologic; Oncologic	20301571|16947863|9012405|8783572|6185841|4811796|2189905|2167179	.	2071	ERCC3	IC11	IVS11	.	.	intron	NM_000122.1	NP_000113.1	-	Y	c.1828-37delT	.	.	.	NM_000122.1(ERCC3): c.1828-37delT	MixedObserved;maf-5-some-pop,maf-5-all-pops	42217	0.043632	U	0.4008	0.353235	12514	0.324916	PASS	595	7424	0.450970	5340	99436	0.374211	.	.	.	.	.	.	rs11345447	.	4024	0.402100	-3.382	-0.708	-0.570	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141027925	141027926	2q22.1	0	normal	.	A	ref	A	AC.AA	het-alt	200	0.50	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC85	IVS85	.	.	no-change	NM_018557.2	NP_061027.2	-	Y	c.13143-11T=	.	.	.	NM_018557.2(LRP1B): c.13143-11T=	;maf-5-some-pop	124792	0.823659	U	0.3085	0.167732	13006	0.870368	PASS	.	8450	0.669467	40870	119784	0.823299	.	.	.	.	.	.	rs3748865	.	4024	0.670200	-0.262	0.320	0.051	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141027925	141027926	2q22.1	1	normal	.	A	snv	G	AC.AA	het-ref	202	0.50	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC85	IVS85	.	.	intron	NM_018557.2	NP_061027.2	-	Y	c.13143-11T>C	.	.	.	NM_018557.2(LRP1B): c.13143-11T>C	;maf-5-some-pop	124792	0.176341	U	0.3085	0.167732	13006	0.129632	PASS	479	8450	0.330533	2144	119784	0.176701	930	5508	3.22747e-01	4436	44021	1.80694e-01	rs3748865	.	4024	0.329800	-0.262	0.320	0.051	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141032087	141032088	2q22.1	0	normal	.	C	ref	C	CG.GT	het-alt	269	0.50	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	C85	EX85	.	.	no-change	NM_018557.2	NP_061027.2	-	Y	c.13047G=	.	.	.	NM_018557.2(LRP1B): c.13047G=	;maf-5-some-pop,maf-5-all-pops	126080	0.400944	U	0.6508	0.486222	13006	0.468015	PASS	.	8596	0.314216	10588	121072	0.396277	.	.	.	.	.	.	rs1386356	.	4024	0.309400	-0.254	-0.957	-0.237	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141032087	141032088	2q22.1	1	normal	.	C	snv	T	CG.GT	het-ref	264	0.50	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	C85	EX85	.	.	coding-synon	NM_018557.2	NP_061027.2	-	Y	c.13047G>A	p.(T4349=) | p.(Thr4349=)	ACG=>ACA	.	NM_018557.2(LRP1B): c.13047G>A (p.(T4349=))	;maf-5-some-pop,maf-5-all-pops	126080	0.599056	U	0.6508	0.486222	13006	0.531985	PASS	2034	8596	0.685784	23146	121072	0.603723	4096	11810	6.86309e-01	47408	149628	6.09443e-01	rs1386356	.	4024	0.690600	-0.254	-0.957	-0.237	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
2	141260667	141260668	2q22.1	0	normal	.	A	ref	A	CG.TA	het-alt	324	0.51	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	C54	EX54	.	.	no-change	NM_018557.2	NP_061027.2	-	Y	c.8526T=	.	.	.	NM_018557.2(LRP1B): c.8526T=	;maf-5-some-pop,maf-5-all-pops	126248	0.451247	U	0.7222	0.543131	13006	0.467246	PASS	-812	8650	0.248555	12766	121240	0.451015	.	.	.	.	.	.	rs4444457	.	4024	0.258000	-0.131	0.239	0.127	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141260667	141260668	2q22.1	1	normal	.	A	snv	G	CG.TA	het-ref	314	0.49	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	C54	EX54	.	.	coding-synon	NM_018557.2	NP_061027.2	-	Y	c.8526T>C	p.(Y2842=) | p.(Tyr2842=)	TAT=>TAC	.	NM_018557.2(LRP1B): c.8526T>C (p.(Y2842=))	;maf-5-some-pop,maf-5-all-pops	126248	0.548753	U	0.7222	0.543131	13006	0.532754	PASS	2438	8650	0.751445	18705	121240	0.548985	4948	13042	7.56233e-01	37632	134430	5.47639e-01	rs4444457	.	4024	0.742000	-0.131	0.239	0.127	.	.	.	.	.	ENST00000389484: c.8526T>C (p.Y2842Y)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3757652	.	.	.	.	.	.	.	.	.	Likely Benign
2	141274575	141274576	2q22.1	0	normal	.	T	ref	T	TT.TG	het-alt	263	0.56	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	C50	EX50	.	.	no-change	NM_018557.2	NP_061027.2	-	Y	c.8031A=	.	.	.	NM_018557.2(LRP1B): c.8031A=	;maf-5-some-pop,maf-5-all-pops	125986	0.287889	U	0.4167	0.642372	13004	0.253307	PASS	-1028	8622	0.595917	5554	120978	0.285002	.	.	.	.	.	.	rs4954672	.	4024	0.594900	0.460	1.486	1.969	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141274575	141274576	2q22.1	1	normal	.	T	snv	C	TT.TG	het-ref	207	0.44	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	C50	EX50	.	.	coding-synon	NM_018557.2	NP_061027.2	-	Y	c.8031A>G	p.(Q2677=) | p.(Gln2677=)	CAA=>CAG	.	NM_018557.2(LRP1B): c.8031A>G (p.(Q2677=))	;maf-5-some-pop,maf-5-all-pops	125986	0.712111	U	0.4167	0.642372	13004	0.746693	PASS	714	8622	0.404083	31564	120978	0.714998	1398	6941	4.03125e-01	63768	175065	7.13648e-01	rs4954672	.	4024	0.405100	0.460	1.486	1.969	.	.	.	.	.	ENST00000389484: c.8031A>G (p.Q2677Q)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4001201	.	.	.	.	.	.	.	.	.	Likely Benign
2	141274644	141274645	2q22.1	0	normal	.	C	ref	C	AT.AT	het-alt	142	0.48	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC49	IVS49	.	.	no-change	NM_018557.2	NP_061027.2	-	Y	c.8027-65G=	.	.	.	NM_018557.2(LRP1B): c.8027-65G=	;maf-5-some-pop	5008	0.978435	U	0.0933	0.0215655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs76733697	.	4024	0.905300	0.462	-0.170	-0.201	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141274644	141274645	2q22.1	0	normal	.	C	snv	T	AT.AT	het-ref	156	0.52	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC49	IVS49	.	.	intron	NM_018557.2	NP_061027.2	-	Y	c.8027-65G>A	.	.	.	NM_018557.2(LRP1B): c.8027-65G>A	;maf-5-some-pop	5008	0.021566	U	0.0933	0.0215655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs76733697	.	4024	0.094700	0.462	-0.170	-0.201	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141283602	141283603	2q22.1	0	nullSample	.	T	ref	T	TT.CA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC48	IVS48	.	.	no-change	NM_018557.2	NP_061027.2	-	Y	c.7877-41A=	.	.	.	NM_018557.2(LRP1B): c.7877-41A=	;maf-5-some-pop	122198	0.005352	U	1	0.982228	13004	0.018071	PASS	0	8192	0.000000	12	117190	0.004821	.	.	.	.	.	.	rs1352047	.	4024	0.001500	-0.127	-0.002	0.079	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141283602	141283603	2q22.1	0	normal	.	T	snv	G	TT.CA	hom-alt	380	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC48	IVS48	.	.	intron	NM_018557.2	NP_061027.2	-	Y	c.7877-41A>C	.	.	.	NM_018557.2(LRP1B): c.7877-41A>C	;maf-5-some-pop	122198	0.994648	U	1	0.982228	13004	0.981929	PASS	4096	8192	1.000000	58042	117190	0.995179	8436	16872	1.00000e+00	118818	238485	9.96261e-01	rs1352047	.	4024	0.998500	-0.127	-0.002	0.079	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141294285	141294286	2q22.1	0	normal	.	A	ref	A	AG.AA	het-alt	153	0.78	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC45	IVS45	.	.	no-change	NM_018557.2	NP_061027.2	-	Y	c.7514-8T=	.	.	.	NM_018557.2(LRP1B): c.7514-8T=	MixedObserved;	2555	0.969080	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs755359693	.	4024	0.757000	0.000	0.000	0.000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141294285	141294286	2q22.1	1	normal	.	A	del	.	AG.AA	het-ref	43	0.22	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC45	IVS45	.	.	intron	NM_018557.2	NP_061027.2	-	Y	c.7514-8delT	.	.	.	NM_018557.2(LRP1B): c.7514-8delT	MixedObserved;	2555	0.030920	U	.	.	.	.	InbreedingCoeff_Filter	0	6366	0.424599	0	92842	0.405775	.	.	.	.	.	.	rs755359693	.	4024	0.242000	0.000	0.000	0.000	.	.	.	.	.	ENST00000389484: c.7514-8delT (p.?)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [diffuse_large_B_cell_lymphoma|NS|NS]	CSV	1613440	.	.	.	.	.	.	.	.	.	Benign
2	141458272	141458273	2q22.1	0	nullSample	.	T	ref	T	AT.AA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC40	IVS40	.	.	no-change	NM_018557.2	NP_061027.2	-	Y	c.6428-83A=	.	.	.	NM_018557.2(LRP1B): c.6428-83A=	;maf-5-some-pop	5008	0.941693	U	0.2292	0.0583067	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs78366782	.	4024	0.756500	0.477	-0.036	-0.170	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141458272	141458273	2q22.1	0	normal	.	T	snv	G	AT.AA	hom-alt	314	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC40	IVS40	.	.	intron	NM_018557.2	NP_061027.2	-	Y	c.6428-83A>C	.	.	.	NM_018557.2(LRP1B): c.6428-83A>C	;maf-5-some-pop	5008	0.058307	U	0.2292	0.0583067	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs78366782	.	4024	0.243500	0.477	-0.036	-0.170	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141527012	141527013	2q22.1	0	nullSample	.	A	ref	A	TT.TG	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC34	IVS34	.	.	no-change	NM_018557.2	NP_061027.2	-	Y	c.5627-100T=	.	.	.	NM_018557.2(LRP1B): c.5627-100T=	;maf-5-some-pop	5008	0.226038	U	0.9871	0.773962	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs13002947	.	4024	0.010900	0.383	-0.333	-0.282	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141527012	141527013	2q22.1	0	normal	.	A	snv	G	TT.TG	hom-alt	244	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC34	IVS34	.	.	intron	NM_018557.2	NP_061027.2	-	Y	c.5627-100T>C	.	.	.	NM_018557.2(LRP1B): c.5627-100T>C	;maf-5-some-pop	5008	0.773962	U	0.9871	0.773962	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs13002947	.	4024	0.989100	0.383	-0.333	-0.282	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141528434	141528435	2q22.1	0	nullSample	.	T	ref	T	TT.TC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC34	IVS34	.	.	no-change	NM_018557.2	NP_061027.2	-	Y	c.5626+15A=	.	.	.	NM_018557.2(LRP1B): c.5626+15A=	;maf-5-some-pop	124890	0.954192	U	0.1687	0.102037	13006	0.936491	PASS	-588	8638	0.837462	55115	119882	0.956541	.	.	.	.	.	.	rs13382825	.	4024	0.836200	0.477	0.294	0.086	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141528434	141528435	2q22.1	1	normal	.	T	snv	C	TT.TC	hom-alt	488	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC34	IVS34	.	.	intron	NM_018557.2	NP_061027.2	-	Y	c.5626+15A>G	.	.	.	NM_018557.2(LRP1B): c.5626+15A>G	;maf-5-some-pop	124890	0.045808	U	0.1687	0.102037	13006	0.063509	PASS	114	8638	0.162538	384	119882	0.043459	163	1923	1.65633e-01	546	7253	3.84632e-02	rs13382825	.	4024	0.163800	0.477	0.294	0.086	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141528591	141528592	2q22.1	1	normal	.	T	snv	C	AA.GA	hom-alt	504	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC33	IVS33	.	.	intron	NM_018557.2	NP_061027.2	-	Y	c.5501-17A>G	.	.	.	NM_018557.2(LRP1B): c.5501-17A>G	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop	121046	0.872685	U	.	.	13006	0.838382	PASS	4306	8622	0.999420	46312	121046	0.872685	6273	12553	9.99443e-01	74104	168451	8.76245e-01	rs7599219	.	4024	0.997300	-0.220	-0.177	-0.167	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141528591	141528592	2q22.1	0	nullSample	.	T	ref	T	AA.GA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC33	IVS33	.	.	no-change	NM_018557.2	NP_061027.2	-	Y	c.5501-17A=	.	.	.	NM_018557.2(LRP1B): c.5501-17A=	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop	121046	0.127315	U	.	.	13006	0.161618	PASS	.	8622	0.000580	1200	121046	0.127315	.	.	.	.	.	.	rs7599219	.	4024	0.002700	-0.220	-0.177	-0.167	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141533661	141533662	2q22.1	0	nullSample	.	T	ref	T	GA.TT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC33	IVS33	.	.	no-change	NM_018557.2	NP_061027.2	-	Y	c.5500+5A=	.	.	.	NM_018557.2(LRP1B): c.5500+5A=	;maf-5-some-pop	126370	0.127522	U	0.999	0.855232	13006	0.161618	PASS	.	8654	0.000578	1204	121362	0.126811	.	.	.	.	.	.	rs996361	.	4024	0.002700	-0.186	1.003	0.695	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141533661	141533662	2q22.1	1	normal	.	T	snv	C	GA.TT	hom-alt	554	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC33	IVS33	.	.	intron	NM_018557.2	NP_061027.2	-	Y	c.5500+5A>G	.	.	.	NM_018557.2(LRP1B): c.5500+5A>G	;maf-5-some-pop	126370	0.872478	U	0.999	0.855232	13006	0.838382	PASS	4322	8654	0.999422	46495	121362	0.873189	5835	11676	9.99486e-01	76283	173504	8.75787e-01	rs996361	.	4024	0.997300	-0.186	1.003	0.695	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141571328	141571329	2q22.1	0	nullSample	.	T	ref	T	CC.GA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	C32	EX32	.	.	no-change	NM_018557.2	NP_061027.2	-	Y	c.5256A=	.	.	.	NM_018557.2(LRP1B): c.5256A=	SingleClassTriAllelic;maf-5-some-pop	126272	0.130251	U	0.9871	0.845248	13006	0.163002	PASS	.	8652	0.011211	1279	121264	0.129239	.	.	.	.	.	.	rs3749010	.	4024	0.010200	-0.119	-2.302	-3.718	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141571328	141571329	2q22.1	1	normal	.	T	snv	C	CC.GA	hom-alt	549	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	C32	EX32	.	.	coding-synon	NM_018557.2	NP_061027.2	-	Y	c.5256A>G	p.(S1752=) | p.(Ser1752=)	TCA=>TCG	.	NM_018557.2(LRP1B): c.5256A>G (p.(S1752=))	SingleClassTriAllelic;maf-5-some-pop	126272	0.869741	U	0.9871	0.845248	13006	0.836998	PASS	4230	8652	0.988789	46238	121264	0.870753	8425	17044	9.88631e-01	93573	213843	8.70526e-01	rs3749010	.	4024	0.989800	-0.119	-2.302	-3.718	.	.	.	.	.	ENST00000389484: c.5256A>G (p.S1752S)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4133144	.	.	.	.	.	.	.	.	.	Likely Benign
2	141571439	141571440	2q22.1	0	nullSample	.	C	ref	C	CA.CA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC31	IVS31	.	.	no-change	NM_018557.2	NP_061027.2	-	Y	c.5210-65G=	.	.	.	NM_018557.2(LRP1B): c.5210-65G=	;maf-5-some-pop,maf-5-all-pops	5008	0.568291	U	0.6577	0.431709	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17575847	.	4024	0.320300	-0.119	-0.454	-0.540	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141571439	141571440	2q22.1	0	normal	.	C	snv	G	CA.CA	hom-alt	285	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC31	IVS31	.	.	intron	NM_018557.2	NP_061027.2	-	Y	c.5210-65G>C	.	.	.	NM_018557.2(LRP1B): c.5210-65G>C	;maf-5-some-pop,maf-5-all-pops	5008	0.431709	U	0.6577	0.431709	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17575847	.	4024	0.679700	-0.119	-0.454	-0.540	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141571455	141571456	2q22.1	0	nullSample	.	G	ref	G	GG.AA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC31	IVS31	.	.	no-change	NM_018557.2	NP_061027.2	-	Y	c.5210-81C=	.	.	.	NM_018557.2(LRP1B): c.5210-81C=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-1.872	-1.108	-0.706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
2	141571456	141571456	2q22.1	0	normal	.	.	ins	A	GG.AA	hom-alt	231	0.98	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC31	IVS31	.	.	intron	NM_018557.2	NP_061027.2	-	Y	c.5210-82_5210-81insT	.	.	.	NM_018557.2(LRP1B): c.5210-82_5210-81insT	;	0	0	U	0.6577	0.449081	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs60071104	.	4024	0.679200	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141598472	141598473	2q22.1	0	nullSample	.	A	ref	A	AA.AA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC30	IVS30	.	.	no-change	NM_018557.2	NP_061027.2	-	Y	c.5114+14T=	.	.	.	NM_018557.2(LRP1B): c.5114+14T=	MixedObserved;	1043	0.737296	U	0.999	0.977636	.	.	PASS	.	8634	0.000116	20	120584	0.005498	.	.	.	.	.	.	rs78477398	.	.	.	-0.527	2.037	0.912	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141598473	141598473	2q22.1	1	normal	.	.	ins	T	AA.AA	hom-alt	421	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC30	IVS30	.	.	intron	NM_018557.2	NP_061027.2	-	Y	c.5114+13_5114+14insA	.	.	.	NM_018557.2(LRP1B): c.5114+13_5114+14insA	;maf-5-some-pop	125318	0.993864	U	0.999	0.977636	12520	0.978115	PASS	4307	8634	0.998842	59383	120584	0.992279	7541	15100	9.98809e-01	102998	207322	9.93350e-01	rs35745624	.	4024	0.997000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141625630	141625631	2q22.1	0	normal	.	A	ref	A	GT.AA	het-alt	299	0.84	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC26	IVS26	.	.	no-change	NM_018557.2	NP_061027.2	-	Y	c.4334+37T=	.	.	.	NM_018557.2(LRP1B): c.4334+37T=	MixedObserved;	5724	0.997729	U	.	.	12492	0.953250	.	.	.	.	.	.	.	.	.	.	.	.	.	rs770477214	.	4024	0.754000	0.533	0.139	0.467	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141625630	141625631	2q22.1	0	normal	.	A	del	.	GT.AA	het-ref	57	0.16	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC26	IVS26	.	.	intron	NM_018557.2	NP_061027.2	-	Y	c.4334+37delT	.	.	.	NM_018557.2(LRP1B): c.4334+37delT	MixedObserved;	5724	0.002271	U	.	.	12492	0.034102	PASS	0	5244	0.072082	0	71992	0.079328	.	.	.	.	.	.	rs770477214	.	4024	0.246000	0.533	0.139	0.467	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141643776	141643777	2q22.1	0	normal	.	A	ref	A	TG.TT	het-alt	247	0.50	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	C24	EX24	.	.	no-change	NM_018557.2	NP_061027.2	-	Y	c.3894T=	.	.	.	NM_018557.2(LRP1B): c.3894T=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.528	0.804	0.985	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
2	141643776	141643777	2q22.1	1	normal	.	A	snv	C	TG.TT	het-ref	251	0.50	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	C24	EX24	.	.	missense	NM_018557.2	NP_061027.2	-	Y	c.3894T>G	p.N1298K | p.Asn1298Lys	AAT=>AAG	P0=>P+	NM_018557.2(LRP1B): c.3894T>G (p.N1298K)	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.528	0.804	0.985	0.04	0.423	0.706	0.486	deleterious	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
2	141707867	141707868	2q22.1	0	nullSample	.	G	ref	G	CA.GC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	C20	EX20	Low-density lipoprotein receptor domain class A	PF00057.13	no-change	NM_018557.2	NP_061027.2	-	Y	c.3072C=	.	.	.	NM_018557.2(LRP1B): c.3072C=	;maf-5-some-pop,maf-5-all-pops	125844	0.819912	U	0.249	0.275759	13006	0.776795	PASS	.	8538	0.766104	41485	120836	0.823877	.	.	.	.	.	.	rs6748626	.	4024	0.750500	-0.244	0.297	0.700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141707867	141707868	2q22.1	1	normal	.	G	snv	T	CA.GC	hom-alt	607	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	C20	EX20	Low-density lipoprotein receptor domain class A	PF00057.13	coding-synon	NM_018557.2	NP_061027.2	-	Y	c.3072C>A	p.(A1024=) | p.(Ala1024=)	GCC=>GCA	.	NM_018557.2(LRP1B): c.3072C>A (p.(A1024=))	;maf-5-some-pop,maf-5-all-pops	125844	0.180088	U	0.249	0.275759	13006	0.223205	PASS	236	8538	0.233896	2349	120836	0.176123	511	4030	2.36087e-01	4584	42381	1.73182e-01	rs6748626	.	4024	0.249500	-0.244	0.297	0.700	.	.	.	.	.	ENST00000389484: c.3072C>A (p.A1024A)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3757654	.	.	.	.	.	.	.	.	.	Likely Benign
2	141708020	141708021	2q22.1	0	nullSample	.	T	ref	T	AA.TT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC19	IVS19	.	.	no-change	NM_018557.2	NP_061027.2	-	Y	c.2969-50A=	.	.	.	NM_018557.2(LRP1B): c.2969-50A=	;maf-5-some-pop,maf-5-all-pops	117398	0.819793	U	0.249	0.275759	13006	0.784484	PASS	-734	8118	0.767430	38554	112390	0.824050	.	.	.	.	.	.	rs6706503	.	4024	0.750500	-0.364	-2.104	-1.830	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141708020	141708021	2q22.1	0	normal	.	T	snv	A	AA.TT	hom-alt	412	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC19	IVS19	.	.	intron	NM_018557.2	NP_061027.2	-	Y	c.2969-50A>T	.	.	.	NM_018557.2(LRP1B): c.2969-50A>T	;maf-5-some-pop,maf-5-all-pops	117398	0.180208	U	0.249	0.275759	13006	0.215516	PASS	210	8118	0.232570	2134	112390	0.175950	345	2881	2.25678e-01	3034	29096	1.64648e-01	rs6706503	.	4024	0.249500	-0.364	-2.104	-1.830	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141709405	141709406	2q22.1	0	nullSample	.	T	ref	T	TA.AC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC19	IVS19	.	.	no-change	NM_018557.2	NP_061027.2	-	Y	c.2968+23A=	.	.	.	NM_018557.2(LRP1B): c.2968+23A=	;maf-5-some-pop,genotype-conflict	124584	0.901087	U	0.2302	0.157348	13006	0.913117	PASS	-708	8510	0.786369	49094	119576	0.903534	.	.	.	.	.	.	rs1991540	.	4024	0.776600	0.528	0.177	0.240	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141709405	141709406	2q22.1	0	normal	.	T	snv	G	TA.AC	hom-alt	338	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC19	IVS19	.	.	intron	NM_018557.2	NP_061027.2	-	Y	c.2968+23A>C	.	.	.	NM_018557.2(LRP1B): c.2968+23A>C	;maf-5-some-pop,genotype-conflict	124584	0.098913	U	0.2302	0.157348	13006	0.086883	PASS	201	8510	0.213631	841	119576	0.096466	420	3637	2.12243e-01	1817	24036	9.80973e-02	rs1991540	.	4024	0.223400	0.528	0.177	0.240	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141747248	141747249	2q22.1	0	nullSample	.	A	ref	A	AG.TT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC16	IVS16	.	.	no-change	NM_018557.2	NP_061027.2	-	Y	c.2645-23T=	.	.	.	NM_018557.2(LRP1B): c.2645-23T=	SingleClassTriAllelic;maf-5-some-pop	125736	0.579715	U	0.6181	0.527356	13006	0.578964	PASS	-1030	8504	0.392992	21094	120728	0.584156	.	.	.	.	.	.	rs1429365	.	4024	0.384400	-0.257	-1.201	-1.142	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141747248	141747249	2q22.1	0	normal	.	A	snv	T	AG.TT	hom-alt	446	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC16	IVS16	.	.	intron	NM_018557.2	NP_061027.2	-	Y	c.2645-23T>A	.	.	.	NM_018557.2(LRP1B): c.2645-23T>A	SingleClassTriAllelic;maf-5-some-pop	125736	0.420269	U	0.6181	0.527356	13006	0.421036	PASS	1551	8504	0.607008	10933	120728	0.415827	3051	10251	5.99824e-01	21511	99753	4.09156e-01	rs1429365	.	4024	0.615600	-0.257	-1.201	-1.142	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141747292	141747293	2q22.1	0	nullSample	.	T	ref	T	GA.AG	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC16	IVS16	.	.	no-change	NM_018557.2	NP_061027.2	-	Y	c.2645-67A=	.	.	.	NM_018557.2(LRP1B): c.2645-67A=	;maf-5-some-pop,maf-5-all-pops	5008	0.513578	U	0.6032	0.486422	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1429366	.	4024	0.410300	0.524	-1.049	-1.094	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141747292	141747293	2q22.1	0	normal	.	T	snv	C	GA.AG	hom-alt	304	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC16	IVS16	.	.	intron	NM_018557.2	NP_061027.2	-	Y	c.2645-67A>G	.	.	.	NM_018557.2(LRP1B): c.2645-67A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.486422	U	0.6032	0.486422	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1429366	.	4024	0.589700	0.524	-1.049	-1.094	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141751591	141751592	2q22.1	0	nullSample	.	G	ref	G	CC.TC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	C16	EX16	Low-density lipoprotein receptor domain class A	PF00057.13	no-change	NM_018557.2	NP_061027.2	-	Y	c.2616C=	.	.	.	NM_018557.2(LRP1B): c.2616C=	;maf-5-some-pop,maf-5-all-pops	125966	0.607196	U	0.6141	0.509585	13006	0.601261	PASS	.	8556	0.401239	23308	120958	0.612031	.	.	.	.	.	.	rs13007735	.	4024	0.393600	-1.948	-0.410	-1.115	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141751591	141751592	2q22.1	1	normal	.	G	snv	A	CC.TC	hom-alt	615	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	C16	EX16	Low-density lipoprotein receptor domain class A	PF00057.13	coding-synon	NM_018557.2	NP_061027.2	-	Y	c.2616C>T	p.(D872=) | p.(Asp872=)	GAC=>GAT	.	NM_018557.2(LRP1B): c.2616C>T (p.(D872=))	;maf-5-some-pop,maf-5-all-pops	125966	0.392804	U	0.6141	0.509585	13006	0.398739	PASS	1514	8556	0.598761	9757	120958	0.387969	2974	10150	5.91147e-01	19264	93579	3.81799e-01	rs13007735	.	4024	0.606400	-1.948	-0.410	-1.115	.	.	.	.	.	ENST00000389484: c.2616C>T (p.D872D)	pancreas [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	4964776	.	.	.	.	.	.	.	.	.	Likely Benign
2	141812616	141812617	2q22.1	0	normal	.	C	ref	C	TG.TA	het-alt	150	0.51	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC10	IVS10	.	.	no-change	NM_018557.2	NP_061027.2	-	Y	c.1552+68G=	.	.	.	NM_018557.2(LRP1B): c.1552+68G=	;maf-5-some-pop	5008	0.960663	U	0.0516	0.0393371	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs75389026	.	4024	0.954300	0.557	0.193	0.233	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141812616	141812617	2q22.1	0	normal	.	C	snv	T	TG.TA	het-ref	142	0.49	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC10	IVS10	.	.	intron	NM_018557.2	NP_061027.2	-	Y	c.1552+68G>A	.	.	.	NM_018557.2(LRP1B): c.1552+68G>A	;maf-5-some-pop	5008	0.039337	U	0.0516	0.0393371	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs75389026	.	4024	0.045700	0.557	0.193	0.233	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
2	141816620	141816621	2q22.1	0	nullSample	.	A	ref	A	CT.AC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	C9	EX9	.	.	no-change	NM_018557.2	NP_061027.2	-	Y	c.1239T=	.	.	.	NM_018557.2(LRP1B): c.1239T=	;maf-5-some-pop	124672	0.017253	U	1	0.945288	12988	0.059516	PASS	0	8618	0.000000	157	119664	0.015686	.	.	.	.	.	.	rs1525579	.	4024	0.001500	-0.213	-0.430	0.179	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141816620	141816621	2q22.1	1	normal	.	A	snv	G	CT.AC	hom-alt	381	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	C9	EX9	.	.	coding-synon	NM_018557.2	NP_061027.2	-	Y	c.1239T>C	p.(V413=) | p.(Val413=)	GTT=>GTC	.	NM_018557.2(LRP1B): c.1239T>C (p.(V413=))	;maf-5-some-pop	124672	0.982747	U	1	0.945288	12988	0.940484	PASS	4309	8618	1.000000	58112	119664	0.984314	6584	13168	1.00000e+00	97249	196498	9.87844e-01	rs1525579	.	4024	0.998500	-0.213	-0.430	0.179	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
2	141945948	141945949	2q22.1	0	nullSample	.	C	ref	C	AA.GC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC7	IVS7	.	.	no-change	NM_018557.2	NP_061027.2	-	Y	c.1013+41G=	.	.	.	NM_018557.2(LRP1B): c.1013+41G=	;	122886	0.000513	U	1	0.997005	12994	0.001847	PASS	0	8284	0.000000	0	117878	0.000407	.	.	.	.	.	.	rs1249434	.	4024	0.001500	-0.254	-0.248	-0.268	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	141945948	141945949	2q22.1	0	normal	.	C	snv	T	AA.GC	hom-alt	376	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC7	IVS7	.	.	intron	NM_018557.2	NP_061027.2	-	Y	c.1013+41G>A	.	.	.	NM_018557.2(LRP1B): c.1013+41G>A	;	122886	0.999487	U	1	0.997005	12994	0.998153	PASS	4142	8284	1.000000	58891	117878	0.999593	7993	15986	1.00000e+00	113237	226539	9.99713e-01	rs1249434	.	4024	0.998500	-0.254	-0.248	-0.268	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	142012026	142012027	2q22.1	0	normal	.	G	ref	G	CT.CT	het-alt	180	0.52	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC4	IVS4	.	.	no-change	NM_018557.2	NP_061027.2	-	Y	c.463+64C=	.	.	.	NM_018557.2(LRP1B): c.463+64C=	;maf-5-some-pop,maf-5-all-pops	5008	0.786142	U	0.1885	0.213858	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs431809	.	4024	0.794200	-0.520	-0.675	-0.477	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	142012026	142012027	2q22.1	0	normal	.	G	snv	T	CT.CT	het-ref	166	0.48	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC4	IVS4	.	.	intron	NM_018557.2	NP_061027.2	-	Y	c.463+64C>A	.	.	.	NM_018557.2(LRP1B): c.463+64C>A	;maf-5-some-pop,maf-5-all-pops	5008	0.213858	U	0.1885	0.213858	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs431809	.	4024	0.205800	-0.520	-0.675	-0.477	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	142012035	142012036	2q22.1	0	normal	.	T	ref	T	TT.CT	het-alt	177	0.49	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC4	IVS4	.	.	no-change	NM_018557.2	NP_061027.2	-	Y	c.463+55A=	.	.	.	NM_018557.2(LRP1B): c.463+55A=	;maf-5-some-pop,maf-5-all-pops	5008	0.690695	U	0.5655	0.309305	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9973397	.	4024	0.456300	0.383	1.076	0.655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	142012035	142012036	2q22.1	0	normal	.	T	snv	G	TT.CT	het-ref	187	0.51	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC4	IVS4	.	.	intron	NM_018557.2	NP_061027.2	-	Y	c.463+55A>C	.	.	.	NM_018557.2(LRP1B): c.463+55A>C	;maf-5-some-pop,maf-5-all-pops	5008	0.309305	U	0.5655	0.309305	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9973397	.	4024	0.543700	0.383	1.076	0.655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	142012300	142012301	2q22.1	0	normal	.	T	ref	T	CT.GA	het-alt	130	0.54	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC3	IVS3	.	.	no-change	NM_018557.2	NP_061027.2	-	Y	c.344-91A=	.	.	.	NM_018557.2(LRP1B): c.344-91A=	;maf-5-some-pop,maf-5-all-pops	5008	0.785343	U	0.1885	0.214657	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs373757	.	4024	0.794200	-1.839	-0.744	-0.543	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	142012300	142012301	2q22.1	0	normal	.	T	snv	C	CT.GA	het-ref	109	0.46	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC3	IVS3	.	.	intron	NM_018557.2	NP_061027.2	-	Y	c.344-91A>G	.	.	.	NM_018557.2(LRP1B): c.344-91A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.214657	U	0.1885	0.214657	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs373757	.	4024	0.205800	-1.839	-0.744	-0.543	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	142237867	142237868	2q22.2	0	normal	.	G	ref	G	TT.TA	het-alt	127	0.50	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC3	IVS3	.	.	no-change	NM_018557.2	NP_061027.2	-	Y	c.343+97C=	.	.	.	NM_018557.2(LRP1B): c.343+97C=	;maf-5-some-pop,maf-5-all-pops	5008	0.630990	U	0.2827	0.36901	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4264514	.	4020	0.725100	-2.842	-0.278	-0.195	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	142237867	142237868	2q22.2	0	normal	.	G	snv	A	TT.TA	het-ref	126	0.50	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	53353	LRP1B	IC3	IVS3	.	.	intron	NM_018557.2	NP_061027.2	-	Y	c.343+97C>T	.	.	.	NM_018557.2(LRP1B): c.343+97C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.369010	U	0.2827	0.36901	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4264514	.	4020	0.274900	-2.842	-0.278	-0.195	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	170010984	170010985	2q31.1	0	nullSample	.	T	ref	T	CT.GG	homo-ref	.	.	.	0	.	.	600073	C	222448(MK)	AR	Donnai-Barrow syndrome; Faciooculoacousticorenal syndrome	AR	.	Audiologic/Otolaryngologic; Craniofacial; Musculoskeletal; Ophthalmologic; Renal	Audiologic/Otolaryngologic; General	20301732|18553518|17632512|12923867|9475100|8266995	.	4036	LRP2	C66	EX66	.	.	no-change	NM_004525.2	NP_004516.2	-	Y	c.12280A=	.	.	.	NM_004525.2(LRP2): c.12280A=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126266	0.237245	U	0.5208	0.777955	13006	0.198678	PASS	.	8632	0.515871	4082	121258	0.237873	.	.	.	.	.	.	rs2075252	.	4024	0.535300	-0.119	4.492	1.341	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	170010984	170010985	2q31.1	1	normal	.	T	snv	C	CT.GG	hom-alt	409	1.00	.	0	.	PASS	600073	C	222448(MK)	AR	Donnai-Barrow syndrome; Faciooculoacousticorenal syndrome	AR	.	Audiologic/Otolaryngologic; Craniofacial; Musculoskeletal; Ophthalmologic; Renal	Audiologic/Otolaryngologic; General	20301732|18553518|17632512|12923867|9475100|8266995	.	4036	LRP2	C66	EX66	.	.	missense	NM_004525.2	NP_004516.2	-	Y	c.12280A>G	p.K4094E | p.Lys4094Glu	AAG=>GAG	P+=>P-	NM_004525.2(LRP2): c.12280A>G (p.K4094E)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126266	0.762755	U	0.5208	0.777955	13006	0.801322	PASS	1018	8632	0.484129	35867	121258	0.762127	2093	8463	4.91121e-01	72354	187260	7.61343e-01	rs2075252	.	4024	0.464700	-0.119	4.492	1.341	1	0	0	0.000	neutral	ENST00000263816: c.12280A>G (p.K4094E)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4001308	.	.	.	.	.	no_record	129500	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
2	173435578	173435579	2q31.1	0	normal	.	T	ref	T	TC.TT	het-alt	134	0.77	.	1	.	PASS	602524	P	.	NN	.	.	.	.	.	.	.	5163	PDK1	IC8	IVS8	.	.	no-change	NM_002610.3	NP_002601.1	+	Y	c.945+27T=	.	.	.	NM_002610.3(PDK1): c.945+27T=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs777902558	.	4024	0.732600	0.240	0.767	0.215	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	173435578	173435579	2q31.1	0	normal	.	T	del	.	TC.TT	het-ref	41	0.23	.	2	.	PASS	602524	P	.	NN	.	.	.	.	.	.	.	5163	PDK1	IC8	IVS8	.	.	intron	NM_002610.3	NP_002601.1	+	Y	c.945+27delT	.	.	.	NM_002610.3(PDK1): c.945+27delT	MixedObserved;	0	0	U	0.3403	0.261981	.	.	PASS	0	3430	0.268513	1	50104	0.296503	.	.	.	.	.	.	rs777902558	.	4024	0.267400	0.240	0.767	0.215	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	175436939	175436940	2q31.1	0	nullSample	.	G	ref	G	GC.GA	homo-ref	.	.	.	0	.	.	602357	P	614493(MK)	NN	Wiskott-Aldrich syndrome 2	AR	.	Allergy/Immunology/Infectious; Dermatologic; Hematologic 	Allergy/Immunology/Infectious; Hematologic	22231303	.	7456	WIPF1	C4	EX5	.	.	no-change	NM_001077269.1	NP_001070737.1	-	Y	c.593C=	.	.	.	NM_001077269.1(WIPF1): c.593C=	;maf-5-some-pop,genotype-conflict	124926	0.060276	U	0.9881	0.907947	13000	0.077000	PASS	.	8634	0.009382	329	119918	0.058949	.	.	.	.	.	.	rs4972450	.	4024	0.009400	-0.443	1.086	0.765	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	175436939	175436940	2q31.1	1	normal	.	G	snv	A	GC.GA	hom-alt	386	1.00	.	0	.	PASS	602357	P	614493(MK)	NN	Wiskott-Aldrich syndrome 2	AR	.	Allergy/Immunology/Infectious; Dermatologic; Hematologic 	Allergy/Immunology/Infectious; Hematologic	22231303	.	7456	WIPF1	C4	EX5	.	.	missense	NM_001077269.1	NP_001070737.1	-	Y	c.593C>T	p.P198L | p.Pro198Leu	CCG=>CTG	NP=>NP	NM_001077269.1(WIPF1): c.593C>T (p.P198L)	;maf-5-some-pop,genotype-conflict	124926	0.939724	U	0.9881	0.907947	13000	0.923000	PASS	4236	8634	0.990618	53219	119918	0.941051	8486	17103	9.92284e-01	109519	231343	9.44728e-01	rs4972450	.	4024	0.990600	-0.443	1.086	0.765	0.95	0	0	0.000	neutral	.	.	.	.	.	.	.	.	.	.	no_record	403608	criteria_provided,_single_submitter	Benign	Likely Benign
2	178098659	178098660	2q31.2	0	normal	.	C	snv	T	tc.ag	het-ref	181	0.50	.	2	MIRc|SINE|MIR|-|211	PASS	600492	P	.	NN	.	.	.	.	.	.	.	4780	NFE2L2	IC2	IVS2	.	.	intron	NM_006164.4	NP_006155.2	-	Y	c.312+73G>A	.	.	.	NM_006164.4(NFE2L2): c.312+73G>A	;	66450	0.008141	U	0.0456	0.0123802	.	.	PASS	6	4680	0.060256	9	61442	0.007796	24	706	4.74845e-02	31	1128	5.69939e-03	rs151335115	.	.	.	-0.253	-0.126	-0.037	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
2	178098659	178098660	2q31.2	0	normal	.	C	ref	C	tc.ag	het-alt	181	0.50	.	1	MIRc|SINE|MIR|-|211	PASS	600492	P	.	NN	.	.	.	.	.	.	.	4780	NFE2L2	IC2	IVS2	.	.	no-change	NM_006164.4	NP_006155.2	-	Y	c.312+73G=	.	.	.	NM_006164.4(NFE2L2): c.312+73G=	;	66450	0.991859	U	0.0456	0.0123802	.	.	PASS	-135	4680	0.939744	30251	61442	0.992204	.	.	.	.	.	.	rs151335115	.	.	.	-0.253	-0.126	-0.037	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	178129390	178129393	2q31.2	0	normal	.	GGC	ref	GGC	gt.gg	het-alt	45	0.55	.	1	trf;(CGG)n|Simple_repeat|Simple_repeat|+|39	PASS	600492	P	.	NN	.	.	.	.	.	.	.	4780	NFE2L2	5U1E	EX1	.	.	no-change	NM_006164.4	NP_006155.2	-	Y	c.-89_-87=	.	.	.	NM_006164.4(NFE2L2): c.-89_-87=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs143406266	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
2	178129390	178129393	2q31.2	0	normal	.	GGC	del	.	gt.gg	het-ref	37	0.45	.	2	trf;(CGG)n|Simple_repeat|Simple_repeat|+|39	PASS	600492	P	.	NN	.	.	.	.	.	.	.	4780	NFE2L2	5U1E	EX1	.	.	utr-5	NM_006164.4	NP_006155.2	-	Y	c.-101GCC[5>4] (std: c.-101GCC[4] alt: c.-89_-87delGCC )	.	.	.	NM_006164.4(NFE2L2): c.-101GCC[4]	MixedObserved;	0	0	U	0.5843	0.396765	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs143406266	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	191848311	191848312	2q32.2	0	nullSample	.	T	ref	T	AG.GA	homo-ref	.	.	.	0	.	.	600555	P	613796(MK);614162(MK);614892(MK)	NN	Familial Candiasis, 7; STAT1 deficiency; Mycobacterial infection, atypical, familial disseminated 	AD/AR	.	Allergy/Immunology/Infectious; Oncologic	Allergy/Immunology/Infectious; Oncologic	22847544|22748593|22730530|22437822|21727188|21714643|16585605|12590259|11452125	.	6772	STAT1	IC15	IVS17	.	.	no-change	NM_007315.3	NP_009330.1	-	Y	c.1446+56A=	.	.	.	NM_007315.3(STAT1): c.1446+56A=	;	5008	0.000200	U	0.999	0.9998	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12477076	.	4024	0.001500	-0.994	0.579	0.109	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	191848311	191848312	2q32.2	0	normal	.	T	snv	C	AG.GA	hom-alt	207	1.00	.	0	.	PASS	600555	P	613796(MK);614162(MK);614892(MK)	NN	Familial Candiasis, 7; STAT1 deficiency; Mycobacterial infection, atypical, familial disseminated 	AD/AR	.	Allergy/Immunology/Infectious; Oncologic	Allergy/Immunology/Infectious; Oncologic	22847544|22748593|22730530|22437822|21727188|21714643|16585605|12590259|11452125	.	6772	STAT1	IC15	IVS17	.	.	intron	NM_007315.3	NP_009330.1	-	Y	c.1446+56A>G	.	.	.	NM_007315.3(STAT1): c.1446+56A>G	;	5008	0.999800	U	0.999	0.9998	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12477076	.	4024	0.998500	-0.994	0.579	0.109	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	198257651	198257652	2q33.1	0	normal	.	T	ref	T	tt.aa	het-alt	134	0.61	.	1	L1PA8|LINE|L1|+|184	PASS	605590	P	614286(MK)	NN	.	.	.	.	.	.	.	23451	SF3B1	IC24	IVS24	.	.	no-change	NM_012433.2	NP_036565.2	-	Y	c.3756+44A=	.	.	.	NM_012433.2(SF3B1): c.3756+44A=	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs77630471	.	.	.	-0.907	-0.573	-1.262	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
2	198257652	198257652	2q33.1	0	normal	.	.	ins	A	tt.aa	het-ref	84	0.39	.	2	L1PA8|LINE|L1|+|184	PASS	605590	P	614286(MK)	NN	.	.	.	.	.	.	.	23451	SF3B1	IC24	IVS24	.	.	intron	NM_012433.2	NP_036565.2	-	Y	c.3756+43_3756+44insT	.	.	.	NM_012433.2(SF3B1): c.3756+43_3756+44insT	;rs-cluster-nonoverlapping-alleles	66228	0.013408	U	0.497	0.568291	.	.	PASS	210	4314	0.484237	4893	67746	0.527662	.	.	.	.	.	.	rs554235956	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	198257794	198257795	2q33.1	0	normal	.	T	ref	T	AA.AC	het-alt	243	0.51	.	1	.	PASS	605590	P	614286(MK)	NN	.	.	.	.	.	.	.	23451	SF3B1	C24	EX24	.	.	no-change	NM_012433.2	NP_036565.2	-	Y	c.3657A=	.	.	.	NM_012433.2(SF3B1): c.3657A=	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	126306	0.326453	U	0.5218	0.71845	13006	0.264032	PASS	.	8620	0.456729	7322	121298	0.328307	.	.	.	.	.	.	rs4685	.	.	.	-0.320	0.528	0.660	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	198257794	198257795	2q33.1	1	normal	.	T	snv	C	AA.AC	het-ref	233	0.49	.	2	.	PASS	605590	P	614286(MK)	NN	.	.	.	.	.	.	.	23451	SF3B1	C24	EX24	.	.	coding-synon	NM_012433.2	NP_036565.2	-	Y	c.3657A>G	p.(V1219=) | p.(Val1219=)	GTA=>GTG	.	NM_012433.2(SF3B1): c.3657A>G (p.(V1219=))	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	126306	0.673547	U	0.5218	0.71845	13006	0.735968	PASS	1283	8620	0.543271	28148	121298	0.671693	2487	9232	5.35685e-01	54898	161990	6.58410e-01	rs4685	.	.	.	-0.320	0.528	0.660	.	.	.	.	.	ENST00000335508: c.3657A>G (p.V1219V)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	3757859	.	.	.	.	.	.	.	.	.	Likely Benign
2	198263145	198263146	2q33.1	0	normal	.	T	ref	T	AA.TG	het-alt	263	0.50	.	1	.	PASS	605590	P	614286(MK)	NN	.	.	.	.	.	.	.	23451	SF3B1	IC21	IVS21	.	.	no-change	NM_012433.2	NP_036565.2	-	Y	c.3134+39A=	.	.	.	NM_012433.2(SF3B1): c.3134+39A=	;maf-5-some-pop	126112	0.802818	U	0.25	0.157348	13006	0.819468	PASS	.	8624	0.728780	39045	121104	0.801171	.	.	.	.	.	.	rs16865262	.	.	.	-0.313	-1.311	-0.714	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	198263145	198263146	2q33.1	0	normal	.	T	snv	C	AA.TG	het-ref	264	0.50	.	2	.	PASS	605590	P	614286(MK)	NN	.	.	.	.	.	.	.	23451	SF3B1	IC21	IVS21	.	.	intron	NM_012433.2	NP_036565.2	-	Y	c.3134+39A>G	.	.	.	NM_012433.2(SF3B1): c.3134+39A>G	;maf-5-some-pop	126112	0.197182	U	0.25	0.157348	13006	0.180532	PASS	316	8624	0.271220	2572	121104	0.198829	620	4545	2.66882e-01	5268	48631	2.01973e-01	rs16865262	.	.	.	-0.313	-1.311	-0.714	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	198265172	198265173	2q33.1	0	normal	.	T	ref	T	tt.aa	het-alt	234	0.53	.	1	AT_rich|Low_complexity|Low_complexity|+|22	PASS	605590	P	614286(MK)	NN	.	.	.	.	.	.	.	23451	SF3B1	IC18	IVS18	.	.	no-change	NM_012433.2	NP_036565.2	-	Y	c.2719-15A=	.	.	.	NM_012433.2(SF3B1): c.2719-15A=	MixedObserved;maf-5-some-pop,maf-5-all-pops	121847	0.330989	U	0.5169	0.717851	.	.	PASS	.	8456	0.462985	7096	116840	0.333079	.	.	.	.	.	.	rs788017	.	.	.	0.338	-0.162	-0.106	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	198265172	198265173	2q33.1	1	normal	.	T	snv	A	tt.aa	het-ref	205	0.47	.	2	AT_rich|Low_complexity|Low_complexity|+|22	PASS	605590	P	614286(MK)	NN	.	.	.	.	.	.	.	23451	SF3B1	IC18	IVS18	.	.	intron	NM_012433.2	NP_036565.2	-	Y	c.2719-15A>T	.	.	.	NM_012433.2(SF3B1): c.2719-15A>T	MixedObserved;maf-5-some-pop,maf-5-all-pops	121847	0.669011	U	0.5169	0.717851	.	.	PASS	1216	8456	0.537015	26598	116840	0.666912	2184	8297	5.29754e-01	46562	139414	6.54077e-01	rs788017	.	.	.	0.338	-0.162	-0.106	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	198265525	198265526	2q33.1	0	normal	.	A	ref	A	TT.CC	het-alt	302	0.52	.	1	.	PASS	605590	P	614286(MK)	NN	.	.	.	.	.	.	.	23451	SF3B1	C18	EX18	.	.	no-change	NM_012433.2	NP_036565.2	-	Y	c.2631T=	.	.	.	NM_012433.2(SF3B1): c.2631T=	;maf-5-some-pop,maf-5-all-pops	126296	0.327342	U	0.5099	0.716653	13004	0.264918	PASS	-1063	8640	0.463889	7356	121288	0.329159	.	.	.	.	.	.	rs788018	.	.	.	-0.119	0.011	0.337	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	198265525	198265526	2q33.1	1	normal	.	A	snv	G	TT.CC	het-ref	283	0.48	.	2	.	PASS	605590	P	614286(MK)	NN	.	.	.	.	.	.	.	23451	SF3B1	C18	EX18	.	.	coding-synon	NM_012433.2	NP_036565.2	-	Y	c.2631T>C	p.(G877=) | p.(Gly877=)	GGT=>GGC	.	NM_012433.2(SF3B1): c.2631T>C (p.(G877=))	;maf-5-some-pop,maf-5-all-pops	126296	0.672658	U	0.5099	0.716653	13004	0.735082	PASS	1253	8640	0.536111	28077	121288	0.670841	2428	9123	5.29361e-01	54783	161755	6.57872e-01	rs788018	.	.	.	-0.119	0.011	0.337	.	.	.	.	.	ENST00000335508: c.2631T>C (p.G877G)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3757860	.	.	.	.	.	.	.	.	.	Likely Benign
2	198266942	198266943	2q33.1	0	nullSample	.	C	ref	C	TT.AG	homo-ref	.	.	.	0	.	.	605590	P	614286(MK)	NN	.	.	.	.	.	.	.	23451	SF3B1	IC14	IVS14	.	.	no-change	NM_012433.2	NP_036565.2	-	Y	c.2078-89G=	.	.	.	NM_012433.2(SF3B1): c.2078-89G=	;maf-5-some-pop	5008	0.004992	U	1	0.995008	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs788019	.	4024	0.001500	-0.381	0.324	0.959	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	198266942	198266943	2q33.1	0	normal	.	C	snv	T	TT.AG	hom-alt	323	1.00	.	0	.	PASS	605590	P	614286(MK)	NN	.	.	.	.	.	.	.	23451	SF3B1	IC14	IVS14	.	.	intron	NM_012433.2	NP_036565.2	-	Y	c.2078-89G>A	.	.	.	NM_012433.2(SF3B1): c.2078-89G>A	;maf-5-some-pop	5008	0.995008	U	1	0.995008	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs788019	.	4024	0.998500	-0.381	0.324	0.959	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	198267242	198267243	2q33.1	0	normal	.	G	ref	G	aa.aa	het-alt	181	0.83	.	1	FLAM_A|SINE|Alu|+|119	PASS	605590	P	614286(MK)	NN	.	.	.	.	.	.	.	23451	SF3B1	IC14	IVS14	.	.	no-change	NM_012433.2	NP_036565.2	-	Y	c.2077+37C=	.	.	.	NM_012433.2(SF3B1): c.2077+37C=	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs200694304	.	.	.	-0.345	-0.173	-0.239	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
2	198267243	198267243	2q33.1	0	normal	.	.	ins	A	ag.aa	het-ref	38	0.17	.	2	FLAM_A|SINE|Alu|+|119	PASS	605590	P	614286(MK)	NN	.	.	.	.	.	.	.	23451	SF3B1	IC14	IVS14	.	.	intron	NM_012433.2	NP_036565.2	-	Y	c.2077+36_2077+37insT	.	.	.	NM_012433.2(SF3B1): c.2077+36_2077+37insT	;rs-cluster-nonoverlapping-alleles	38825	0.010097	U	.	.	.	.	PASS	0	3402	0.198707	0	48940	0.202942	.	.	.	.	.	.	rs766755045	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	198267769	198267770	2q33.1	0	normal	.	G	ref	G	GA.AA	het-alt	194	0.55	.	1	.	PASS	605590	P	614286(MK)	NN	.	.	.	.	.	.	.	23451	SF3B1	IC12	IVS12	.	.	no-change	NM_012433.2	NP_036565.2	-	Y	c.1720-11C=	.	.	.	NM_012433.2(SF3B1): c.1720-11C=	;	0	0	U	0.5179	0.717452	.	.	PASS	-1044	8298	0.452880	6782	117908	0.325703	.	.	.	.	.	.	rs80128856	.	.	.	-0.982	-1.556	-2.171	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	198267770	198267770	2q33.1	1	normal	.	.	ins	AA	AG.AA	het-ref	160	0.45	.	2	.	PASS	605590	P	614286(MK)	NN	.	.	.	.	.	.	.	23451	SF3B1	IC12	IVS12	.	.	intron	NM_012433.2	NP_036565.2	-	Y	c.1720-12_1720-11insTT	.	.	.	NM_012433.2(SF3B1): c.1720-12_1720-11insTT	;maf-5-some-pop,maf-5-all-pops	122916	0.676055	U	0.5179	0.717452	12518	0.735501	PASS	1226	8298	0.547120	27333	117908	0.674297	.	.	.	.	.	.	rs3217350	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	198283304	198283305	2q33.1	0	normal	.	T	ref	T	GT.TT	het-alt	210	0.55	.	1	.	PASS	605590	P	614286(MK)	NN	.	.	.	.	.	.	.	23451	SF3B1	C5	EX5	.	.	no-change	NM_012433.2	NP_036565.2	-	Y	c.423A=	.	.	.	NM_012433.2(SF3B1): c.423A=	;maf-5-some-pop,maf-5-all-pops	126236	0.325612	U	0.5179	0.720647	13006	0.260649	PASS	-1062	8640	0.461574	7290	121228	0.327523	.	.	.	.	.	.	rs788023	.	.	.	-0.131	2.297	1.509	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	198283304	198283305	2q33.1	1	normal	.	T	snv	C	GT.TT	het-ref	175	0.45	.	2	.	PASS	605590	P	614286(MK)	NN	.	.	.	.	.	.	.	23451	SF3B1	C5	EX5	.	.	coding-synon	NM_012433.2	NP_036565.2	-	Y	c.423A>G	p.(K141=) | p.(Lys141=)	AAA=>AAG	.	NM_012433.2(SF3B1): c.423A>G (p.(K141=))	;maf-5-some-pop,maf-5-all-pops	126236	0.674388	U	0.5179	0.720647	13006	0.739351	PASS	1264	8640	0.538426	28199	121228	0.672477	2442	9113	5.31618e-01	54479	160602	6.58415e-01	rs788023	.	.	.	-0.131	2.297	1.509	.	.	.	.	.	ENST00000335508: c.423A>G (p.K141K)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	1129389	.	.	.	.	.	.	.	.	.	Likely Benign
2	202122994	202122995	2q33.1	0	normal	.	A	snv	G	TA.AA	het-ref	273	0.49	.	2	.	PASS	601763	C	114480(SK);114550(MK);211980(SK);607271(UK)	AD;AR	Caspase 8 defiency	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	21447005|19930184|15459299|12353035	.	841	CASP8	I5U1	IVS2	.	.	intron	NM_001228.4	NP_001219.2	+	Y	c.-26-8189A>G	.	.	.	NM_001228.4(CASP8): c.-26-8189A>G	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125726	0.666465	U	0.6964	0.646366	12126	0.669471	PASS	2175	8608	0.711199	27190	120718	0.667299	4301	12217	7.09054e-01	54237	162482	6.60115e-01	rs3769823	.	4024	0.705800	-0.263	0.935	0.875	.	.	.	.	.	ENST00000358485: c.41A>G (p.K14R)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4133375	.	.	.	.	.	no_record	402492	criteria_provided,_single_submitter	Benign	Benign
2	202122994	202122995	2q33.1	0	normal	.	A	snv	G	TA.AA	het-ref	273	0.49	.	2	.	PASS	601763	C	114480(SK);114550(MK);211980(SK);607271(UK)	AD;AR	Caspase 8 defiency	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	21447005|19930184|15459299|12353035	.	841	CASP8	I5U1	IVS2	.	.	intron	NM_033355.3	NP_203519.1	+	N	c.1-8215A>G	.	.	.	NM_033355.3(CASP8): c.1-8215A>G	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125726	0.666465	U	0.6964	0.646366	12126	0.669471	PASS	2175	8608	0.711199	27190	120718	0.667299	4301	12217	7.09054e-01	54237	162482	6.60115e-01	rs3769823	.	4024	0.705800	-0.263	0.935	0.875	.	.	.	.	.	ENST00000358485: c.41A>G (p.K14R)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4133375	.	.	.	.	.	no_record	402492	criteria_provided,_single_submitter	Benign	Benign
2	202122994	202122995	2q33.1	0	normal	.	A	ref	A	TA.AA	het-alt	283	0.51	.	1	.	PASS	601763	C	114480(SK);114550(MK);211980(SK);607271(UK)	AD;AR	Caspase 8 defiency	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	21447005|19930184|15459299|12353035	.	841	CASP8	I5U1	IVS2	.	.	no-change	NM_001228.4	NP_001219.2	+	Y	c.-26-8189A=	.	.	.	NM_001228.4(CASP8): c.-26-8189A=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125726	0.333535	U	0.6964	0.646366	12126	0.330529	PASS	-886	8608	0.288801	6994	120718	0.332701	.	.	.	.	.	.	rs3769823	.	4024	0.294200	-0.263	0.935	0.875	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	202122994	202122995	2q33.1	0	normal	.	A	ref	A	TA.AA	het-alt	283	0.51	.	1	.	PASS	601763	C	114480(SK);114550(MK);211980(SK);607271(UK)	AD;AR	Caspase 8 defiency	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	21447005|19930184|15459299|12353035	.	841	CASP8	I5U1	IVS2	.	.	no-change	NM_033355.3	NP_203519.1	+	N	c.1-8215A=	.	.	.	NM_033355.3(CASP8): c.1-8215A=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125726	0.333535	U	0.6964	0.646366	12126	0.330529	PASS	-886	8608	0.288801	6994	120718	0.332701	.	.	.	.	.	.	rs3769823	.	4024	0.294200	-0.263	0.935	0.875	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	202151162	202151163	2q33.1	0	normal	.	A	ref	A	AT.TT	het-alt	326	0.54	.	1	.	PASS	601763	C	114480(SK);114550(MK);211980(SK);607271(UK)	AD;AR	Caspase 8 defiency	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	21447005|19930184|15459299|12353035	.	841	CASP8	IC7	IVS9	.	.	no-change	NM_001228.4	NP_001219.2	+	Y	c.1356-19A=	.	.	.	NM_001228.4(CASP8): c.1356-19A=	SingleClassTriAllelic;maf-5-some-pop	126294	0.283719	U	0.6964	0.745208	13006	0.257112	PASS	-902	8632	0.295181	5314	121286	0.284913	.	.	.	.	.	.	rs3769818	.	4024	0.293500	-0.119	0.824	0.651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	202151162	202151163	2q33.1	0	normal	.	A	ref	A	AT.TT	het-alt	326	0.54	.	1	.	PASS	601763	C	114480(SK);114550(MK);211980(SK);607271(UK)	AD;AR	Caspase 8 defiency	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	21447005|19930184|15459299|12353035	.	841	CASP8	IC7	IVS9	.	.	no-change	NM_033355.3	NP_203519.1	+	N	c.1305-19A=	.	.	.	NM_033355.3(CASP8): c.1305-19A=	SingleClassTriAllelic;maf-5-some-pop	126294	0.283719	U	0.6964	0.745208	13006	0.257112	PASS	-902	8632	0.295181	5314	121286	0.284913	.	.	.	.	.	.	rs3769818	.	4024	0.293500	-0.119	0.824	0.651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	202151162	202151163	2q33.1	1	normal	.	A	snv	G	AT.TT	het-ref	273	0.46	.	2	.	PASS	601763	C	114480(SK);114550(MK);211980(SK);607271(UK)	AD;AR	Caspase 8 defiency	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	21447005|19930184|15459299|12353035	.	841	CASP8	IC7	IVS9	.	.	intron	NM_001228.4	NP_001219.2	+	Y	c.1356-19A>G	.	.	.	NM_001228.4(CASP8): c.1356-19A>G	SingleClassTriAllelic;maf-5-some-pop	126294	0.716273	U	0.6964	0.745208	13006	0.742888	PASS	2140	8632	0.704819	31400	121286	0.715078	4230	12119	7.03366e-01	61313	172049	7.01319e-01	rs3769818	.	4024	0.706500	-0.119	0.824	0.651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	202151162	202151163	2q33.1	1	normal	.	A	snv	G	AT.TT	het-ref	273	0.46	.	2	.	PASS	601763	C	114480(SK);114550(MK);211980(SK);607271(UK)	AD;AR	Caspase 8 defiency	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	21447005|19930184|15459299|12353035	.	841	CASP8	IC7	IVS9	.	.	intron	NM_033355.3	NP_203519.1	+	N	c.1305-19A>G	.	.	.	NM_033355.3(CASP8): c.1305-19A>G	SingleClassTriAllelic;maf-5-some-pop	126294	0.716273	U	0.6964	0.745208	13006	0.742888	PASS	2140	8632	0.704819	31400	121286	0.715078	4230	12119	7.03366e-01	61313	172049	7.01319e-01	rs3769818	.	4024	0.706500	-0.119	0.824	0.651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	204824178	204824180	2q33.2	0	normal	.	GT	del	.	ga.gt	het-ref	16	0.18	.	2	trf;(TG)n|Simple_repeat|Simple_repeat|+|57	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.204824179_204824180delGT (intergenic)	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs146016344	.	4022	0.446800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	204824178	204824180	2q33.2	0	normal	.	GT	ref	GT	ga.gt	het-alt	72	0.82	.	1	trf;(TG)n|Simple_repeat|Simple_repeat|+|57	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr2: g.204824178_204824179= (intergenic)	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs146016344	.	4022	0.542800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	209101905	209101906	2q34	0	nullSample	.	A	ref	A	GG.AA	homo-ref	.	.	.	0	.	.	147700	C	137800(SK)	AD	.	.	.	.	.	.	.	3417	IDH1	IC7	IVS9	.	.	no-change	NM_005896.2	NP_005887.2	-	Y	c.1155-13T=	.	.	.	NM_005896.2(IDH1): c.1155-13T=	MixedObserved;|MixedObserved;maf-5-some-pop	0|99835	0|0.949056	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs200686278|rs57383668	.	4024	0.001700	-1.042	-0.803	-1.515	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
2	209101905	209101906	2q34	1	normal	.	A	del	.	GG.AA	hom-alt	225	0.98	.	0	.	PASS	147700	C	137800(SK)	AD	.	.	.	.	.	.	.	3417	IDH1	IC7	IVS9	.	.	intron	NM_005896.2	NP_005887.2	-	Y	c.1155-13delT	.	.	.	NM_005896.2(IDH1): c.1155-13delT	MixedObserved;|MixedObserved;maf-5-some-pop	0|99835	0|0.050944	U	0.999	0.982628	.	.	PASS	3360	6818	0.992813	46845	95642	0.989753	.	.	.	.	.	.	rs200686278|rs57383668	.	4024	0.998300	-1.042	-0.803	-1.515	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	212251863	212251864	2q34	0	normal	.	T	ref	T	TA.AC	het-alt	266	0.51	.	1	.	PASS	600543	P	615515(MK)	NN	Amyotrophic lateral sclerosis 19	AD	.	Neurologic	General	24119685	.	2066	ERBB4	C27	EX27	.	.	no-change	NM_005235.2	NP_005226.1	-	Y	c.3195A=	.	.	.	NM_005235.2(ERBB4): c.3195A=	;maf-5-some-pop	126340	0.707511	U	0.2887	0.223043	13006	0.747270	PASS	.	8638	0.691943	30517	121332	0.704645	.	.	.	.	.	.	rs3748962	.	4024	0.701500	-0.899	-1.087	-1.971	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	212251863	212251864	2q34	1	normal	.	T	snv	C	TA.AC	het-ref	254	0.49	.	2	.	PASS	600543	P	615515(MK)	NN	Amyotrophic lateral sclerosis 19	AD	.	Neurologic	General	24119685	.	2066	ERBB4	C27	EX27	.	.	coding-synon	NM_005235.2	NP_005226.1	-	Y	c.3195A>G	p.(V1065=) | p.(Val1065=)	GTA=>GTG	.	NM_005235.2(ERBB4): c.3195A>G (p.(V1065=))	;maf-5-some-pop	126340	0.292489	U	0.2887	0.223043	13006	0.252730	PASS	399	8638	0.308057	5687	121332	0.295355	881	5367	3.11167e-01	11872	73672	3.00432e-01	rs3748962	.	4024	0.298500	-0.899	-1.087	-1.971	.	.	.	.	.	ENST00000342788: c.3195A>G (p.V1065V)	bone [femur|NS|NS]	osteosarcoma [NS|NS|NS]	CSV	3757923	.	.	.	.	.	.	.	.	.	Likely Benign
2	212285102	212285103	2q34	0	normal	.	T	ref	T	TA.GA	het-alt	153	0.54	.	1	.	PASS	600543	P	615515(MK)	NN	Amyotrophic lateral sclerosis 19	AD	.	Neurologic	General	24119685	.	2066	ERBB4	IC25	IVS25	.	.	no-change	NM_005235.2	NP_005226.1	-	Y	c.3135+63A=	.	.	.	NM_005235.2(ERBB4): c.3135+63A=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.525559	U	0.4306	0.474441	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2289086	.	4024	0.570100	-0.290	-2.001	-2.114	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	212285102	212285103	2q34	0	normal	.	T	snv	C	TA.GA	het-ref	128	0.46	.	2	.	PASS	600543	P	615515(MK)	NN	Amyotrophic lateral sclerosis 19	AD	.	Neurologic	General	24119685	.	2066	ERBB4	IC25	IVS25	.	.	intron	NM_005235.2	NP_005226.1	-	Y	c.3135+63A>G	.	.	.	NM_005235.2(ERBB4): c.3135+63A>G	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.474441	U	0.4306	0.474441	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2289086	.	4024	0.429900	-0.290	-2.001	-2.114	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	212285339	212285343	2q34	0	normal	.	AAAG	ref	AAAG	TA.AA	het-alt	254	0.55	.	1	.	PASS	600543	P	615515(MK)	NN	Amyotrophic lateral sclerosis 19	AD	.	Neurologic	General	24119685	.	2066	ERBB4	IC24	IVS24	.	.	no-change	NM_005235.2	NP_005226.1	-	Y	c.2965-7_2965-4=	.	.	.	NM_005235.2(ERBB4): c.2965-7_2965-4=	MixedObserved;maf-5-some-pop	124550	0.939301	U	.	.	12514	0.870385	.	.	.	.	.	.	.	.	.	.	.	.	.	rs138150601	.	4024	0.914500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	212285339	212285343	2q34	1	normal	.	AAAG	del	.	TA.AA	het-ref	205	0.45	.	2	.	PASS	600543	P	615515(MK)	NN	Amyotrophic lateral sclerosis 19	AD	.	Neurologic	General	24119685	.	2066	ERBB4	IC24	IVS24	.	.	intron	NM_005235.2	NP_005226.1	-	Y	c.2965-7_2965-4delCTTT	.	.	.	NM_005235.2(ERBB4): c.2965-7_2965-4delCTTT	MixedObserved;maf-5-some-pop	124550	0.060699	U	0.0694	0.138379	12514	0.129615	PASS	19	8510	0.080846	758	119542	0.057444	50	1423	8.27518e-02	1222	12845	5.23709e-02	rs138150601	.	4024	0.085500	.	.	.	.	.	.	.	.	ENST00000342788: c.2965-7_2965-4delCTTT (p.?)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5020445	.	.	.	.	.	.	.	.	.	Benign
2	212295874	212295875	2q34	0	normal	.	C	snv	T	TT.CC	het-ref	190	0.54	.	2	.	PASS	600543	P	615515(MK)	NN	Amyotrophic lateral sclerosis 19	AD	.	Neurologic	General	24119685	.	2066	ERBB4	IC20	IVS20	.	.	intron	NM_005235.2	NP_005226.1	-	Y	c.2488-50G>A	.	.	.	NM_005235.2(ERBB4): c.2488-50G>A	;maf-5-some-pop	124596	0.735914	U	0.6954	0.79353	13004	0.782836	PASS	1905	8424	0.671771	32489	119588	0.733502	3850	11378	6.69137e-01	63959	174197	7.27506e-01	rs6710946	.	4024	0.676200	-0.254	0.518	0.329	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	212295874	212295875	2q34	0	normal	.	C	ref	C	TT.CC	het-alt	164	0.46	.	1	.	PASS	600543	P	615515(MK)	NN	Amyotrophic lateral sclerosis 19	AD	.	Neurologic	General	24119685	.	2066	ERBB4	IC20	IVS20	.	.	no-change	NM_005235.2	NP_005226.1	-	Y	c.2488-50G=	.	.	.	NM_005235.2(ERBB4): c.2488-50G=	;maf-5-some-pop	124596	0.264086	U	0.6954	0.79353	13004	0.217164	PASS	.	8424	0.328229	4565	119588	0.266498	.	.	.	.	.	.	rs6710946	.	4024	0.323800	-0.254	0.518	0.329	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	212488828	212488830	2q34	0	normal	.	TC	del	.	tg.tc	het-ref	42	0.15	.	2	(TC)n|Simple_repeat|Simple_repeat|+|32;trf	PASS	600543	P	615515(MK)	NN	Amyotrophic lateral sclerosis 19	AD	.	Neurologic	General	24119685	.	2066	ERBB4	IC17	IVS17	.	.	intron	NM_005235.2	NP_005226.1	-	Y	c.2080-61_2080-60delGA	.	.	.	NM_005235.2(ERBB4): c.2080-61_2080-60delGA	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs146953835	.	4024	0.477900	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	212488828	212488830	2q34	0	normal	.	TC	ref	TC	tg.tc	het-alt	237	0.85	.	1	(TC)n|Simple_repeat|Simple_repeat|+|32;trf	PASS	600543	P	615515(MK)	NN	Amyotrophic lateral sclerosis 19	AD	.	Neurologic	General	24119685	.	2066	ERBB4	IC17	IVS17	.	.	no-change	NM_005235.2	NP_005226.1	-	Y	c.2080-61_2080-60=	.	.	.	NM_005235.2(ERBB4): c.2080-61_2080-60=	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs146953835	.	4024	0.522100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	212488869	212488870	2q34	0	normal	.	G	ref	G	AA.AA	het-alt	151	0.50	.	1	.	PASS	600543	P	615515(MK)	NN	Amyotrophic lateral sclerosis 19	AD	.	Neurologic	General	24119685	.	2066	ERBB4	IC17	IVS17	.	.	no-change	NM_005235.2	NP_005226.1	-	Y	c.2080-101C=	.	.	.	NM_005235.2(ERBB4): c.2080-101C=	MixedObserved;	0	0	U	0.8056	0.852236	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs199609474	.	.	.	-0.867	-0.655	-0.740	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	212488870	212488870	2q34	0	normal	.	.	ins	C	AG.AA	het-ref	151	0.50	.	2	.	PASS	600543	P	615515(MK)	NN	Amyotrophic lateral sclerosis 19	AD	.	Neurologic	General	24119685	.	2066	ERBB4	IC17	IVS17	.	.	intron	NM_005235.2	NP_005226.1	-	Y	c.2080-102_2080-101insG	.	.	.	NM_005235.2(ERBB4): c.2080-102_2080-101insG	;maf-5-some-pop,maf-5-all-pops	5008	0.852236	U	0.8056	0.852236	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs76332141	.	4024	0.833000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	212569982	212569983	2q34	0	normal	.	G	ref	G	TT.TG	het-alt	92	0.47	.	1	.	PASS	600543	P	615515(MK)	NN	Amyotrophic lateral sclerosis 19	AD	.	Neurologic	General	24119685	.	2066	ERBB4	IC10	IVS10	.	.	no-change	NM_005235.2	NP_005226.1	-	Y	c.1198+60C=	.	.	.	NM_005235.2(ERBB4): c.1198+60C=	;maf-5-some-pop,maf-5-all-pops	5008	0.602236	U	0.1012	0.397764	4566	0.427508	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6723705	.	4024	0.881700	-0.524	-0.023	-0.054	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	212569982	212569983	2q34	0	normal	.	G	snv	A	TT.TG	het-ref	102	0.53	.	2	.	PASS	600543	P	615515(MK)	NN	Amyotrophic lateral sclerosis 19	AD	.	Neurologic	General	24119685	.	2066	ERBB4	IC10	IVS10	.	.	intron	NM_005235.2	NP_005226.1	-	Y	c.1198+60C>T	.	.	.	NM_005235.2(ERBB4): c.1198+60C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.397764	U	0.1012	0.397764	4566	0.572492	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6723705	.	4024	0.118300	-0.524	-0.023	-0.054	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	212576979	212576980	2q34	0	normal	.	T	ref	T	AA.AG	het-alt	187	0.48	.	1	.	PASS	600543	P	615515(MK)	NN	Amyotrophic lateral sclerosis 19	AD	.	Neurologic	General	24119685	.	2066	ERBB4	IC8	IVS8	.	.	no-change	NM_005235.2	NP_005226.1	-	Y	c.998-79A=	.	.	.	NM_005235.2(ERBB4): c.998-79A=	;maf-5-some-pop	5008	0.928714	U	0.0794	0.0712859	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12994961	.	4024	0.905800	0.383	0.425	0.153	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	212576979	212576980	2q34	0	normal	.	T	snv	C	AA.AG	het-ref	201	0.52	.	2	.	PASS	600543	P	615515(MK)	NN	Amyotrophic lateral sclerosis 19	AD	.	Neurologic	General	24119685	.	2066	ERBB4	IC8	IVS8	.	.	intron	NM_005235.2	NP_005226.1	-	Y	c.998-79A>G	.	.	.	NM_005235.2(ERBB4): c.998-79A>G	;maf-5-some-pop	5008	0.071286	U	0.0794	0.0712859	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12994961	.	4024	0.094200	0.383	0.425	0.153	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	212578379	212578380	2q34	0	normal	.	A	ref	A	TT.AA	het-alt	109	0.75	.	1	.	PASS	600543	P	615515(MK)	NN	Amyotrophic lateral sclerosis 19	AD	.	Neurologic	General	24119685	.	2066	ERBB4	IC7	IVS7	.	.	no-change	NM_005235.2	NP_005226.1	-	Y	c.884-7T=	.	.	.	NM_005235.2(ERBB4): c.884-7T=	MixedObserved;maf-5-some-pop,maf-5-all-pops|MixedObserved;	5054|2926	0.560942|0.999658	U	.	.	.	.	InbreedingCoeff_Filter	0	288	1.000000	1462	2926	0.999658	.	.	.	.	.	.	rs67894136|rs74499552	.	4024	0.572100	-1.918	-1.161	-1.327	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	212578379	212578380	2q34	1	normal	.	A	del	.	TT.AA	het-ref	36	0.25	.	2	.	PASS	600543	P	615515(MK)	NN	Amyotrophic lateral sclerosis 19	AD	.	Neurologic	General	24119685	.	2066	ERBB4	IC7	IVS7	.	.	intron	NM_005235.2	NP_005226.1	-	Y	c.884-7delT	.	.	.	NM_005235.2(ERBB4): c.884-7delT	MixedObserved;maf-5-some-pop,maf-5-all-pops	5054	0.439058	U	0.4028	0.442891	.	.	InbreedingCoeff_Filter	46	5560	0.439568	990	85506	0.462821	.	.	.	.	.	.	rs67894136	.	4024	0.427900	-1.918	-1.161	-1.327	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	215595163	215595164	2q35	0	normal	.	G	ref	G	GC.TG	het-alt	277	0.54	.	1	.	PASS	601593	C	114480(SK)	AD	.	.	.	.	.	.	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	580	BARD1	C10	EX10	.	.	no-change	NM_000465.2	NP_000456.2	-	Y	c.1972C=	.	.	.	NM_000465.2(BARD1): c.1972C=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	126370	0.992166	U	0.0139	0.00539137	13006	0.994080	PASS	.	8654	0.989254	59722	121362	0.992065	.	.	.	.	.	.	rs3738888	.	4024	0.988100	0.650	5.338	2.728	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	215595163	215595164	2q35	1	normal	.	G	snv	A	GC.TG	het-ref	240	0.46	.	2	.	PASS	601593	C	114480(SK)	AD	.	.	.	.	.	.	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	580	BARD1	C10	EX10	.	.	missense	NM_000465.2	NP_000456.2	-	Y	c.1972C>T	p.R658C | p.Arg658Cys	CGC=>TGC	P+=>P0	NM_000465.2(BARD1): c.1972C>T (p.R658C)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	126370	0.007834	U	0.0139	0.00539137	13006	0.005920	PASS	0	8654	0.010746	4	121362	0.007935	0	192	1.11317e-02	10	2071	8.41384e-03	rs3738888	.	4024	0.011900	0.650	5.338	2.728	0	0.346	0.995	0.554	deleterious	ENST00000260947: c.1972C>T (p.R658C)	pancreas [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	3782109	CM067650	NM_000465.2(BARD1): c.1972C>T (p.R658C)	"Lung cancer, susceptibility to, association with"	16741161	DP	no_record	136500	criteria_provided,_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	Certain
2	215632255	215632256	2q35	0	nullSample	.	A	ref	A	AC.TG	homo-ref	.	.	.	0	.	.	601593	C	114480(SK)	AD	.	.	.	.	.	.	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	580	BARD1	C6	EX6	Ankyrin repeat;Ankyrin repeats (3 copies);Ankyrin repeat;Ankyrin repeats (many copies);Ankyrin repeats (many copies)	PF00023.25;PF12796.2;PF13606.1;PF13637.1;PF13857.1	no-change	NM_000465.2	NP_000456.2	-	Y	c.1518T=	.	.	.	NM_000465.2(BARD1): c.1518T=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126312	0.188280	U	0.9484	0.770567	13006	0.286176	PASS	.	8650	0.046127	2531	121304	0.186581	.	.	.	.	.	.	rs2070093	.	4024	0.060400	-0.212	0.115	-0.323	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	215632255	215632256	2q35	1	normal	.	A	snv	G	AC.TG	hom-alt	624	1.00	.	0	.	PASS	601593	C	114480(SK)	AD	.	.	.	.	.	.	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	580	BARD1	C6	EX6	Ankyrin repeat;Ankyrin repeats (3 copies);Ankyrin repeat;Ankyrin repeats (many copies);Ankyrin repeats (many copies)	PF00023.25;PF12796.2;PF13606.1;PF13637.1;PF13857.1	coding-synon	NM_000465.2	NP_000456.2	-	Y	c.1518T>C	p.(H506=) | p.(His506=)	CAT=>CAC	.	NM_000465.2(BARD1): c.1518T>C (p.(H506=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126312	0.811720	U	0.9484	0.770567	13006	0.713824	PASS	3937	8650	0.953873	40550	121304	0.813419	7825	16435	9.52864e-01	83030	201220	8.17708e-01	rs2070093	.	4024	0.939600	-0.212	0.115	-0.323	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	183704	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
2	215657182	215657183	2q35	0	normal	.	A	ref	A	tt.aa	het-alt	137	0.67	.	1	AT_rich|Low_complexity|Low_complexity|+|28	PASS	601593	C	114480(SK)	AD	.	.	.	.	.	.	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	580	BARD1	IC2	IVS2	.	.	no-change	NM_000465.2	NP_000456.2	-	Y	c.216-14T=	.	.	.	NM_000465.2(BARD1): c.216-14T=	MixedObserved;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb|MixedObserved,SingleClassTriAllelic;	5205|976	0.571182|0.997951	U	.	.	.	.	PASS	0	26	1.000000	486	976	0.997951	.	.	.	.	.	.	rs56130510|rs775103922	.	4024	0.540300	-0.376	-0.395	-0.947	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	215657182	215657183	2q35	1	normal	.	A	del	.	tt.aa	het-ref	69	0.33	.	2	AT_rich|Low_complexity|Low_complexity|+|28	PASS	601593	C	114480(SK)	AD	.	.	.	.	.	.	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	580	BARD1	IC2	IVS2	.	.	intron	NM_000465.2	NP_000456.2	-	Y	c.216-14delT	.	.	.	NM_000465.2(BARD1): c.216-14delT	MixedObserved;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5205	0.428818	U	0.381	0.444888	.	.	PASS	1	834	0.456835	92	30538	0.438437	.	.	.	.	.	.	rs56130510	.	4024	0.458000	-0.376	-0.395	-0.947	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	142007	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
2	215674089	215674090	2q35	0	nullSample	.	T	ref	T	TG.GC	homo-ref	.	.	.	0	.	.	601593	C	114480(SK)	AD	.	.	.	.	.	.	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	580	BARD1	IC1	IVS1	.	.	no-change	NM_000465.2	NP_000456.2	-	Y	c.158+46A=	.	.	.	NM_000465.2(BARD1): c.158+46A=	;maf-5-some-pop,maf-5-all-pops	110084	0.261037	U	0.7847	0.744808	11512	0.253040	PASS	.	7992	0.178554	3583	105076	0.261316	.	.	.	.	.	.	rs35933323	.	4024	0.185100	-0.358	-0.114	-0.142	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	215674089	215674090	2q35	0	normal	.	T	snv	G	TG.GC	hom-alt	394	1.00	.	0	.	PASS	601593	C	114480(SK)	AD	.	.	.	.	.	.	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	580	BARD1	IC1	IVS1	.	.	intron	NM_000465.2	NP_000456.2	-	Y	c.158+46A>C	.	.	.	NM_000465.2(BARD1): c.158+46A>C	;maf-5-some-pop,maf-5-all-pops	110084	0.738963	U	0.7847	0.744808	11512	0.746960	PASS	2674	7992	0.821446	28663	105076	0.738684	5547	13672	8.13229e-01	62885	169036	7.39382e-01	rs35933323	.	4024	0.814900	-0.358	-0.114	-0.142	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	215674322	215674323	2q35	0	nullSample	.	C	ref	C	CG.AG	homo-ref	.	.	.	0	.	.	601593	C	114480(SK)	AD	.	.	.	.	.	.	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	580	BARD1	5U1E	EX1	.	.	no-change	NM_000465.2	NP_000456.2	-	Y	c.-30G=	.	.	.	NM_000465.2(BARD1): c.-30G=	;maf-5-some-pop,maf-5-all-pops	20802	0.283771	U	0.7817	0.744609	11326	0.229119	PASS	-47	532	0.206767	665	15794	0.292769	.	.	.	.	.	.	rs1129804	.	.	.	-2.090	-1.066	-1.293	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	215674322	215674323	2q35	0	normal	.	C	snv	G	CG.AG	hom-alt	458	1.00	.	0	.	PASS	601593	C	114480(SK)	AD	.	.	.	.	.	.	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	580	BARD1	5U1E	EX1	.	.	utr-5	NM_000465.2	NP_000456.2	-	Y	c.-30G>C	.	.	.	NM_000465.2(BARD1): c.-30G>C	;maf-5-some-pop,maf-5-all-pops	20802	0.716229	U	0.7817	0.744609	11326	0.770881	PASS	164	532	0.793233	3938	15794	0.707231	3272	8150	8.03272e-01	36588	98896	7.34031e-01	rs1129804	.	.	.	-2.090	-1.066	-1.293	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	334199	criteria_provided,_single_submitter	Likely_benign	Benign
2	215674340	215674341	2q35	0	normal	.	A	snv	G	GA.GC	hom-alt	471	1.00	.	0	.	PASS	601593	C	114480(SK)	AD	.	.	.	.	.	.	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	580	BARD1	5U1E	EX1	.	.	utr-5	NM_000465.2	NP_000456.2	-	Y	c.-48T>C	.	.	.	NM_000465.2(BARD1): c.-48T>C	;maf-5-some-pop,maf-5-all-pops	18200	0.704780	U	0.7837	0.745008	10716	0.785181	PASS	104	342	0.789474	3139	13192	0.689509	3228	8031	8.04387e-01	35543	96141	7.33464e-01	rs17489363	.	.	.	-2.736	-0.251	-0.251	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	334200	criteria_provided,_single_submitter	Likely_benign	Benign
2	215674340	215674341	2q35	0	nullSample	.	A	ref	A	GA.GC	homo-ref	.	.	.	0	.	.	601593	C	114480(SK)	AD	.	.	.	.	.	.	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	580	BARD1	5U1E	EX1	.	.	no-change	NM_000465.2	NP_000456.2	-	Y	c.-48T=	.	.	.	NM_000465.2(BARD1): c.-48T=	;maf-5-some-pop,maf-5-all-pops	18200	0.295220	U	0.7837	0.745008	10716	0.214819	PASS	-31	342	0.210526	639	13192	0.310491	.	.	.	.	.	.	rs17489363	.	.	.	-2.736	-0.251	-0.251	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	215674370	215674371	2q35	0	nullSample	.	C	ref	C	GG.CA	homo-ref	.	.	.	0	.	.	601593	C	114480(SK)	AD	.	.	.	.	.	.	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	580	BARD1	5U1E	EX1	.	.	no-change	NM_000465.2	NP_000456.2	-	Y	c.-78G=	.	.	.	NM_000465.2(BARD1): c.-78G=	;maf-5-some-pop,maf-5-all-pops	5008	0.341653	U	0.7827	0.658347	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs34732883	.	.	.	0.561	0.591	0.011	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	215674370	215674371	2q35	0	normal	.	C	snv	T	GG.CA	hom-alt	450	1.00	.	0	.	PASS	601593	C	114480(SK)	AD	.	.	.	.	.	.	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	580	BARD1	5U1E	EX1	.	.	utr-5	NM_000465.2	NP_000456.2	-	Y	c.-78G>A	.	.	.	NM_000465.2(BARD1): c.-78G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.658347	U	0.7827	0.658347	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs34732883	.	.	.	0.561	0.591	0.011	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	334201	criteria_provided,_single_submitter	Likely_benign	Benign
2	215674435	215674436	2q35	0	nullSample	.	C	ref	C	gg.gc	homo-ref	.	.	.	0	(CGGGG)n|Simple_repeat|Simple_repeat|+|36	.	601593	C	114480(SK)	AD	.	.	.	.	.	.	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	580	BARD1	PROM	.	.	.	no-change	NM_000465.2	NP_000456.2	-	Y	c.-135-u8G=	.	.	.	NM_000465.2(BARD1): c.-135-u8G=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-3.103	0.071	-0.132	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
2	215674435	215674436	2q35	0	normal	.	C	snv	T	gg.gc	hom-alt	157	1.00	.	0	(CGGGG)n|Simple_repeat|Simple_repeat|+|36	PASS	601593	C	114480(SK)	AD	.	.	.	.	.	.	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	580	BARD1	PROM	.	.	.	promoter	NM_000465.2	NP_000456.2	-	Y	c.-135-u8G>A	.	.	.	NM_000465.2(BARD1): c.-135-u8G>A	MixedObserved,SingleAlleleFreq;	10	1.000000	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs13022992	.	.	.	-3.103	0.071	-0.132	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
2	216212278	216212279	2q35	0	nullSample	.	G	ref	G	AG.CT	homo-ref	.	.	.	0	.	.	601731	P	608688(MK)	NN	AICAR transformylase/IMP cyclohydrolase deficiency	AR	.	Biochemical; Dermatologic; Neurologic; Ophthalmologic	General	15114530	.	471	ATIC	IC14	IVS14	.	.	no-change	NM_004044.6	NP_004035.2	+	Y	c.1503+615G=	.	.	.	NM_004044.6(ATIC): c.1503+615G=	;maf-5-some-pop,genotype-conflict	5008	0.053914	U	1	0.946086	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4673992	.	4024	0.002000	-1.238	-2.549	-2.843	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	216212278	216212279	2q35	0	normal	.	G	snv	C	AG.CT	hom-alt	275	1.00	.	0	.	PASS	601731	P	608688(MK)	NN	AICAR transformylase/IMP cyclohydrolase deficiency	AR	.	Biochemical; Dermatologic; Neurologic; Ophthalmologic	General	15114530	.	471	ATIC	IC14	IVS14	.	.	intron	NM_004044.6	NP_004035.2	+	Y	c.1503+615G>C	.	.	.	NM_004044.6(ATIC): c.1503+615G>C	;maf-5-some-pop,genotype-conflict	5008	0.946086	U	1	0.946086	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4673992	.	4024	0.998000	-1.238	-2.549	-2.843	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	216212338	216212339	2q35	0	normal	.	T	ref	T	TA.TC	het-alt	228	0.51	.	1	.	PASS	601731	P	608688(MK)	NN	AICAR transformylase/IMP cyclohydrolase deficiency	AR	.	Biochemical; Dermatologic; Neurologic; Ophthalmologic	General	15114530	.	471	ATIC	IC14	IVS14	.	.	no-change	NM_004044.6	NP_004035.2	+	Y	c.1503+675T=	.	.	.	NM_004044.6(ATIC): c.1503+675T=	;maf-5-some-pop,maf-5-all-pops	20520	0.630507	U	0.2937	0.285543	.	.	PASS	-19	200	0.700000	2890	15512	0.603404	.	.	.	.	.	.	rs4673993	.	4024	0.710000	-0.621	-0.640	-0.719	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	216212338	216212339	2q35	0	normal	.	T	snv	C	TA.TC	het-ref	222	0.49	.	2	.	PASS	601731	P	608688(MK)	NN	AICAR transformylase/IMP cyclohydrolase deficiency	AR	.	Biochemical; Dermatologic; Neurologic; Ophthalmologic	General	15114530	.	471	ATIC	IC14	IVS14	.	.	intron	NM_004044.6	NP_004035.2	+	Y	c.1503+675T>C	.	.	.	NM_004044.6(ATIC): c.1503+675T>C	;maf-5-some-pop,maf-5-all-pops	20520	0.369493	U	0.2937	0.285543	.	.	PASS	11	200	0.300000	1286	15512	0.396596	474	3062	3.09168e-01	8231	45590	3.41197e-01	rs4673993	.	4024	0.290000	-0.621	-0.640	-0.719	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	225999	reviewed_by_expert_panel	drug_response	Benign
2	225346645	225346646	2q36.2	0	normal	.	T	ref	T	AA.TG	het-alt	330	0.56	.	1	.	PASS	603136	P	614496(MK)	NN	Pseudohypoaldosteronism, type IIE	AD	.	Renal	Renal	22266938	.	8452	CUL3	C14	EX14	Cullin family	PF00888.17	no-change	NM_003590.4	NP_003581.1	-	Y	c.1992A=	.	.	.	NM_003590.4(CUL3): c.1992A=	;maf-5-some-pop,maf-5-all-pops	126256	0.813545	U	0.2401	0.232628	13006	0.825619	PASS	-866	8644	0.721657	40673	121248	0.815453	.	.	.	.	.	.	rs2070127	.	4024	0.739300	-0.766	1.606	0.102	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	225346645	225346646	2q36.2	1	normal	.	T	snv	C	AA.TG	het-ref	263	0.44	.	2	.	PASS	603136	P	614496(MK)	NN	Pseudohypoaldosteronism, type IIE	AD	.	Renal	Renal	22266938	.	8452	CUL3	C14	EX14	Cullin family	PF00888.17	coding-synon	NM_003590.4	NP_003581.1	-	Y	c.1992A>G	p.(Q664=) | p.(Gln664=)	CAA=>CAG	.	NM_003590.4(CUL3): c.1992A>G (p.(Q664=))	;maf-5-some-pop,maf-5-all-pops	126256	0.186455	U	0.2401	0.232628	13006	0.174381	PASS	337	8644	0.278343	2425	121248	0.184547	647	4476	2.76228e-01	4581	42805	1.84114e-01	rs2070127	.	4024	0.260700	-0.766	1.606	0.102	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	259092	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
2	225362477	225362478	2q36.2	0	normal	.	C	ref	C	AA.TG	het-alt	200	0.55	.	1	.	PASS	603136	P	614496(MK)	NN	Pseudohypoaldosteronism, type IIE	AD	.	Renal	Renal	22266938	.	8452	CUL3	C12	EX12	Cullin family	PF00888.17	no-change	NM_003590.4	NP_003581.1	-	Y	c.1699G=	.	.	.	NM_003590.4(CUL3): c.1699G=	;maf-5-some-pop	126222	0.871568	U	0.2391	0.139377	13006	0.928802	PASS	.	8618	0.722790	46482	121214	0.872020	.	.	.	.	.	.	rs3738952	.	4024	0.739800	0.650	3.142	2.937	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	225362477	225362478	2q36.2	1	normal	.	C	snv	T	AA.TG	het-ref	166	0.45	.	2	.	PASS	603136	P	614496(MK)	NN	Pseudohypoaldosteronism, type IIE	AD	.	Renal	Renal	22266938	.	8452	CUL3	C12	EX12	Cullin family	PF00888.17	missense	NM_003590.4	NP_003581.1	-	Y	c.1699G>A	p.V567I | p.Val567Ile	GTT=>ATT	NP=>NP	NM_003590.4(CUL3): c.1699G>A (p.V567I)	;maf-5-some-pop	126222	0.128432	U	0.2391	0.139377	13006	0.071198	PASS	331	8618	0.277210	1388	121214	0.127980	665	4689	2.72205e-01	2841	32304	1.31438e-01	rs3738952	.	4024	0.260200	0.650	3.142	2.937	0.19	0.017	0	0.050	neutral	.	.	.	.	.	.	.	.	.	.	no_record	259091	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
2	225365055	225365056	2q36.2	0	normal	.	A	ref	A	TG.TA	het-alt	260	0.57	.	1	.	PASS	603136	P	614496(MK)	NN	Pseudohypoaldosteronism, type IIE	AD	.	Renal	Renal	22266938	.	8452	CUL3	IC11	IVS11	.	.	no-change	NM_003590.4	NP_003581.1	-	Y	c.1610+24T=	.	.	.	NM_003590.4(CUL3): c.1610+24T=	;maf-5-some-pop,maf-5-all-pops	126224	0.813926	U	0.2401	0.232827	13006	0.825235	PASS	-867	8636	0.722325	40699	121216	0.815858	.	.	.	.	.	.	rs3768889	.	4024	0.739300	0.454	3.169	2.108	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	225365055	225365056	2q36.2	0	normal	.	A	snv	G	TG.TA	het-ref	199	0.43	.	2	.	PASS	603136	P	614496(MK)	NN	Pseudohypoaldosteronism, type IIE	AD	.	Renal	Renal	22266938	.	8452	CUL3	IC11	IVS11	.	.	intron	NM_003590.4	NP_003581.1	-	Y	c.1610+24T>C	.	.	.	NM_003590.4(CUL3): c.1610+24T>C	;maf-5-some-pop,maf-5-all-pops	126224	0.186074	U	0.2401	0.232827	13006	0.174765	PASS	332	8636	0.277675	2412	121216	0.184142	666	4697	2.72669e-01	4815	45286	1.84130e-01	rs3768889	.	4024	0.260700	0.454	3.169	2.108	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	225367668	225367669	2q36.2	0	normal	.	C	ref	C	AA.GC	het-alt	157	0.46	.	1	.	PASS	603136	P	614496(MK)	NN	Pseudohypoaldosteronism, type IIE	AD	.	Renal	Renal	22266938	.	8452	CUL3	IC10	IVS10	.	.	no-change	NM_003590.4	NP_003581.1	-	Y	c.1485+13G=	.	.	.	NM_003590.4(CUL3): c.1485+13G=	;maf-5-some-pop,maf-5-all-pops	126162	0.812471	U	0.2401	0.232628	13006	0.824773	PASS	-865	8638	0.722158	40533	121154	0.814335	.	.	.	.	.	.	rs3754629	.	4024	0.739300	-0.254	-0.376	-0.176	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	225367668	225367669	2q36.2	1	normal	.	C	snv	T	AA.GC	het-ref	182	0.54	.	2	.	PASS	603136	P	614496(MK)	NN	Pseudohypoaldosteronism, type IIE	AD	.	Renal	Renal	22266938	.	8452	CUL3	IC10	IVS10	.	.	intron	NM_003590.4	NP_003581.1	-	Y	c.1485+13G>A	.	.	.	NM_003590.4(CUL3): c.1485+13G>A	;maf-5-some-pop,maf-5-all-pops	126162	0.187529	U	0.2401	0.232628	13006	0.175227	PASS	335	8638	0.277842	2450	121154	0.185665	666	4688	2.72780e-01	4845	45268	1.85403e-01	rs3754629	.	4024	0.260700	-0.254	-0.376	-0.176	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	259090	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
2	225368320	225368321	2q36.2	0	normal	.	A	snv	G	AT.AT	hom-alt	347	1.00	.	0	.	PASS	603136	P	614496(MK)	NN	Pseudohypoaldosteronism, type IIE	AD	.	Renal	Renal	22266938	.	8452	CUL3	IC9	IVS9	.	.	intron	NM_003590.4	NP_003581.1	-	Y	c.1377+48T>C	.	.	.	NM_003590.4(CUL3): c.1377+48T>C	;maf-5-some-pop,maf-5-all-pops	93588	0.519158	U	0.6508	0.539736	12990	0.466205	PASS	1413	7152	0.629474	11754	88580	0.517995	2574	8242	6.21475e-01	19259	75416	5.08167e-01	rs3738951	.	4024	0.594400	-0.226	0.369	0.055	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	225368320	225368321	2q36.2	0	nullSample	.	A	ref	A	AT.AT	homo-ref	.	.	.	0	.	.	603136	P	614496(MK)	NN	Pseudohypoaldosteronism, type IIE	AD	.	Renal	Renal	22266938	.	8452	CUL3	IC9	IVS9	.	.	no-change	NM_003590.4	NP_003581.1	-	Y	c.1377+48T=	.	.	.	NM_003590.4(CUL3): c.1377+48T=	;maf-5-some-pop,maf-5-all-pops	93588	0.480842	U	0.6508	0.539736	12990	0.533795	PASS	-838	7152	0.370526	10160	88580	0.482005	.	.	.	.	.	.	rs3738951	.	4024	0.405600	-0.226	0.369	0.055	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	225376033	225376034	2q36.2	0	normal	.	G	ref	G	GA.TA	het-alt	139	0.48	.	1	.	PASS	603136	P	614496(MK)	NN	Pseudohypoaldosteronism, type IIE	AD	.	Renal	Renal	22266938	.	8452	CUL3	IC6	IVS6	.	.	no-change	NM_003590.4	NP_003581.1	-	Y	c.883+37C=	.	.	.	NM_003590.4(CUL3): c.883+37C=	;maf-5-some-pop,maf-5-all-pops	123706	0.812564	U	0.2401	0.232827	13000	0.825538	PASS	-863	8592	0.722533	39702	118698	0.814479	.	.	.	.	.	.	rs11686067	.	4024	0.739300	-0.550	-0.688	-0.760	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	225376033	225376034	2q36.2	0	normal	.	G	snv	A	GA.TA	het-ref	148	0.52	.	2	.	PASS	603136	P	614496(MK)	NN	Pseudohypoaldosteronism, type IIE	AD	.	Renal	Renal	22266938	.	8452	CUL3	IC6	IVS6	.	.	intron	NM_003590.4	NP_003581.1	-	Y	c.883+37C>T	.	.	.	NM_003590.4(CUL3): c.883+37C>T	;maf-5-some-pop,maf-5-all-pops	123706	0.187436	U	0.2401	0.232827	13000	0.174462	PASS	329	8592	0.277467	2374	118698	0.185521	568	3987	2.70672e-01	3939	37462	1.79646e-01	rs11686067	.	4024	0.260700	-0.550	-0.688	-0.760	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	233194726	233194727	2q37.1	0	normal	.	G	ref	G	TC.GG	het-alt	97	0.49	.	1	dup	PASS	614184	P	267000(MK)	AR	Perlman syndrome	AR	.	Craniofacial; Musculoskeletal;  Neurologic; Oncologic; Renal	Oncologic	23613427|23486540|22705997|22306653|10508986|6093533|4315293|3024486|163679	.	129563	DIS3L2	IC14	IVS15	.	.	no-change	NM_152383.4	NP_689596.4	+	Y	c.1923+21G=	.	.	.	NM_152383.4(DIS3L2): c.1923+21G=	;	120396	0.999859	U	0.002	0.000399361	12032	0.999917	PASS	-4	8546	0.999064	57679	115388	0.999870	.	.	.	.	.	.	rs201288510	.	4024	0.998000	-1.332	-1.175	-1.197	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	233194726	233194727	2q37.1	0	normal	.	G	snv	A	TC.GG	het-ref	101	0.51	.	2	dup	PASS	614184	P	267000(MK)	AR	Perlman syndrome	AR	.	Craniofacial; Musculoskeletal;  Neurologic; Oncologic; Renal	Oncologic	23613427|23486540|22705997|22306653|10508986|6093533|4315293|3024486|163679	.	129563	DIS3L2	IC14	IVS15	.	.	intron	NM_152383.4	NP_689596.4	+	Y	c.1923+21G>A	.	.	.	NM_152383.4(DIS3L2): c.1923+21G>A	;	120396	0.000141	U	0.002	0.000399361	12032	0.000083	PASS	0	8546	0.000936	0	115388	0.000130	0	18	1.12669e-03	0	33	1.43324e-04	rs201288510	.	4024	0.002000	-1.332	-1.175	-1.197	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
2	234669143	234669144	2q37.1	0	normal	.	G	ref	G	AC.GA	het-alt	253	0.54	.	1	.	PASS	191740	C	143500(NK);218800(MK);237900(MK);601816(NK);606785(MK)	AR	Crigler-Najjar syndrome, type I; Crigler-Najjar syndrome, type II; Gilbert syndrome	AD/AR	Allelic with Breast milk jaundice (AD/AR)	Gastrointestinal	Gastrointestinal; Pharmacogenomic	24065680|23992562|23926009|23430851|23403257|23279026|23241680|23162302|23099197|22710376|22676194|18518849|16712705|12983120|11906189|11370628|11316168|11061796|11003624|10412811|9621515|9580649|9413009|8690398|8528206|8276413|7989595|7565971|5685361|3546653|1734381|1531971|805737	.	54658	UGT1A1	C1	EX1	UDP-glucoronosyl and UDP-glucosyl transferase	PF00201.13	no-change	NM_000463.2	NP_000454.1	+	Y	c.211G=	.	.	.	NM_000463.2(UGT1A1): c.211G=	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict	126330	0.978794	U	0.1379	0.034345	13006	0.998693	PASS	.	8642	0.847605	58288	121322	0.979336	.	.	.	.	.	.	rs4148323	.	4024	0.821600	0.650	2.128	2.890	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	234669143	234669144	2q37.1	1	normal	.	G	snv	A	AC.GA	het-ref	213	0.46	.	2	.	PASS	191740	C	143500(NK);218800(MK);237900(MK);601816(NK);606785(MK)	AR	Crigler-Najjar syndrome, type I; Crigler-Najjar syndrome, type II; Gilbert syndrome	AD/AR	Allelic with Breast milk jaundice (AD/AR)	Gastrointestinal	Gastrointestinal; Pharmacogenomic	24065680|23992562|23926009|23430851|23403257|23279026|23241680|23162302|23099197|22710376|22676194|18518849|16712705|12983120|11906189|11370628|11316168|11061796|11003624|10412811|9621515|9580649|9413009|8690398|8528206|8276413|7989595|7565971|5685361|3546653|1734381|1531971|805737	.	54658	UGT1A1	C1	EX1	UDP-glucoronosyl and UDP-glucosyl transferase	PF00201.13	missense	NM_000463.2	NP_000454.1	+	Y	c.211G>A	p.G71R | p.Gly71Arg	GGA=>AGA	P0=>P+	NM_000463.2(UGT1A1): c.211G>A (p.G71R)	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict	126330	0.021206	U	0.1379	0.034345	13006	0.001307	PASS	113	8642	0.152395	134	121322	0.020664	225	2654	1.53873e-01	269	5442	2.21034e-02	rs4148323	.	4024	0.178400	0.650	2.128	2.890	0.13	0.712	0.975	0.510	deleterious	ENST00000305208: c.211G>A (p.G71R)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4415616	CM930722	NM_000463.2(UGT1A1): c.211G>A (p.G71R)	"Hyperbilirubinaemia, association with"	17850628	DFP	no_record	12280	reviewed_by_expert_panel	drug_response	Likely Benign
2	240003869	240003870	2q37.3	1	normal	.	G	snv	A	CT.GG	hom-alt	272	1.00	.	0	.	PASS	605314	P	600430(MK)	NN	Brachydacytly-mental retardation syndrome	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	20691407	.	9759	HDAC4	C20	EX21	Histone deacetylase domain	PF00850.14	coding-synon	NM_006037.3	NP_006028.2	-	Y	c.2565C>T	p.(P855=) | p.(Pro855=)	CCC=>CCT	.	NM_006037.3(HDAC4): c.2565C>T (p.(P855=))	;maf-5-some-pop,maf-5-all-pops	126400	0.535783	U	0.6885	0.595248	13006	0.506074	PASS	2056	8646	0.687717	17909	121392	0.533330	4090	11851	6.87094e-01	36703	132056	5.36255e-01	rs1063639	.	4024	0.732100	0.454	-0.693	-0.680	.	.	.	.	.	ENST00000345617: c.2565C>T (p.P855P)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4133597	.	.	.	.	.	.	.	.	.	Likely Benign
2	240003869	240003870	2q37.3	0	nullSample	.	G	ref	G	CT.GG	homo-ref	.	.	.	0	.	.	605314	P	600430(MK)	NN	Brachydacytly-mental retardation syndrome	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	20691407	.	9759	HDAC4	C20	EX21	Histone deacetylase domain	PF00850.14	no-change	NM_006037.3	NP_006028.2	-	Y	c.2565C=	.	.	.	NM_006037.3(HDAC4): c.2565C=	;maf-5-some-pop,maf-5-all-pops	126400	0.464217	U	0.6885	0.595248	13006	0.493926	PASS	-917	8646	0.312283	13863	121392	0.466670	.	.	.	.	.	.	rs1063639	.	4024	0.267900	0.454	-0.693	-0.680	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	240009198	240009199	2q37.3	0	normal	.	G	ref	G	AA.GG	het-alt	112	0.47	.	1	.	PASS	605314	P	600430(MK)	NN	Brachydacytly-mental retardation syndrome	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	20691407	.	9759	HDAC4	IC18	IVS19	.	.	no-change	NM_006037.3	NP_006028.2	-	Y	c.2429+56C=	.	.	.	NM_006037.3(HDAC4): c.2429+56C=	;maf-5-some-pop	5008	0.929513	U	0.0645	0.0704872	4566	0.936706	.	.	.	.	.	.	.	.	.	.	.	.	.	rs62189546	.	4024	0.911500	0.298	-0.921	-0.755	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	240009198	240009199	2q37.3	0	normal	.	G	snv	A	AA.GG	het-ref	124	0.53	.	2	.	PASS	605314	P	600430(MK)	NN	Brachydacytly-mental retardation syndrome	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	20691407	.	9759	HDAC4	IC18	IVS19	.	.	intron	NM_006037.3	NP_006028.2	-	Y	c.2429+56C>T	.	.	.	NM_006037.3(HDAC4): c.2429+56C>T	;maf-5-some-pop	5008	0.070487	U	0.0645	0.0704872	4566	0.063294	.	.	.	.	.	.	.	.	.	.	.	.	.	rs62189546	.	4024	0.088500	0.298	-0.921	-0.755	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	240011716	240011717	2q37.3	0	normal	.	T	ref	T	CC.GT	het-alt	185	0.57	.	1	.	PASS	605314	P	600430(MK)	NN	Brachydacytly-mental retardation syndrome	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	20691407	.	9759	HDAC4	C17	EX18	Histone deacetylase domain	PF00850.14	no-change	NM_006037.3	NP_006028.2	-	Y	c.2361A=	.	.	.	NM_006037.3(HDAC4): c.2361A=	;maf-5-some-pop	125382	0.952800	U	0.0367	0.033746	13006	0.967323	PASS	-222	8614	0.945670	54628	120374	0.952241	.	.	.	.	.	.	rs61752234	.	4024	0.942800	-1.945	-2.476	-2.670	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	240011716	240011717	2q37.3	1	normal	.	T	snv	C	CC.GT	het-ref	139	0.43	.	2	.	PASS	605314	P	600430(MK)	NN	Brachydacytly-mental retardation syndrome	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	20691407	.	9759	HDAC4	C17	EX18	Histone deacetylase domain	PF00850.14	coding-synon	NM_006037.3	NP_006028.2	-	Y	c.2361A>G	p.(T787=) | p.(Thr787=)	ACA=>ACG	.	NM_006037.3(HDAC4): c.2361A>G (p.(T787=))	;maf-5-some-pop	125382	0.047200	U	0.0367	0.033746	13006	0.032677	PASS	12	8614	0.054330	190	120374	0.047759	30	859	4.98202e-02	445	12296	5.01186e-02	rs61752234	.	4024	0.057200	-1.945	-2.476	-2.670	.	.	.	.	.	ENST00000345617: c.2361A>G (p.T787T)	kidney [NS|NS|NS]	carcinoma [clear_cell_renal_cell_carcinoma|NS|NS]	CSV	3773957	.	.	.	.	.	.	.	.	.	Likely Benign
2	240029735	240029736	2q37.3	0	nullSample	.	T	ref	T	GG.CG	homo-ref	.	.	.	0	.	.	605314	P	600430(MK)	NN	Brachydacytly-mental retardation syndrome	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	20691407	.	9759	HDAC4	IC14	IVS15	.	.	no-change	NM_006037.3	NP_006028.2	-	Y	c.2097+10A=	.	.	.	NM_006037.3(HDAC4): c.2097+10A=	;maf-5-some-pop,maf-5-all-pops	123122	0.166193	U	0.8224	0.838658	12996	0.211065	PASS	-572	8488	0.159284	1823	118114	0.166399	.	.	.	.	.	.	rs7585225	.	4024	0.158100	-0.279	0.141	-0.021	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	240029735	240029736	2q37.3	1	normal	.	T	snv	C	GG.CG	hom-alt	490	1.00	.	0	.	PASS	605314	P	600430(MK)	NN	Brachydacytly-mental retardation syndrome	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	20691407	.	9759	HDAC4	IC14	IVS15	.	.	intron	NM_006037.3	NP_006028.2	-	Y	c.2097+10A>G	.	.	.	NM_006037.3(HDAC4): c.2097+10A>G	;maf-5-some-pop,maf-5-all-pops	123122	0.833807	U	0.8224	0.838658	12996	0.788935	PASS	2996	8488	0.840716	41226	118114	0.833601	5997	14292	8.34618e-01	85625	203501	8.36757e-01	rs7585225	.	4024	0.841900	-0.279	0.141	-0.021	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	240037031	240037032	2q37.3	0	normal	.	G	snv	A	AA.CA	het-ref	217	0.45	.	2	.	PASS	605314	P	600430(MK)	NN	Brachydacytly-mental retardation syndrome	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	20691407	.	9759	HDAC4	IC11	IVS12	.	.	intron	NM_006037.3	NP_006028.2	-	Y	c.1519-26C>T	.	.	.	NM_006037.3(HDAC4): c.1519-26C>T	;maf-5-some-pop	5008	0.079074	U	0.0585	0.0790735	13000	0.065385	PASS	33	8526	0.073422	809	116924	0.097379	65	1233	7.17361e-02	2062	25272	1.06041e-01	rs62190760	.	4024	0.081500	0.591	0.578	0.138	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	240037031	240037032	2q37.3	0	normal	.	G	ref	G	AA.CA	het-alt	263	0.55	.	1	.	PASS	605314	P	600430(MK)	NN	Brachydacytly-mental retardation syndrome	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	20691407	.	9759	HDAC4	IC11	IVS12	.	.	no-change	NM_006037.3	NP_006028.2	-	Y	c.1519-26C=	.	.	.	NM_006037.3(HDAC4): c.1519-26C=	;maf-5-some-pop	5008	0.920927	U	0.0585	0.0790735	13000	0.934615	.	.	.	.	.	.	.	.	.	.	.	.	.	rs62190760	.	4024	0.918500	0.591	0.578	0.138	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	240048480	240048481	2q37.3	0	normal	.	C	snv	T	TG.GC	het-ref	99	0.50	.	2	.	PASS	605314	P	600430(MK)	NN	Brachydacytly-mental retardation syndrome	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	20691407	.	9759	HDAC4	IC10	IVS11	.	.	intron	NM_006037.3	NP_006028.2	-	Y	c.1295-106G>A	.	.	.	NM_006037.3(HDAC4): c.1295-106G>A	;maf-5-some-pop	5008	0.081070	U	0.0446	0.0810703	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs35504237	.	4024	0.052700	-0.300	-0.865	-0.811	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	240048480	240048481	2q37.3	0	normal	.	C	ref	C	TG.GC	het-alt	99	0.50	.	1	.	PASS	605314	P	600430(MK)	NN	Brachydacytly-mental retardation syndrome	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	20691407	.	9759	HDAC4	IC10	IVS11	.	.	no-change	NM_006037.3	NP_006028.2	-	Y	c.1295-106G=	.	.	.	NM_006037.3(HDAC4): c.1295-106G=	;maf-5-some-pop	5008	0.918930	U	0.0446	0.0810703	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs35504237	.	4024	0.947300	-0.300	-0.865	-0.811	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	240055900	240055901	2q37.3	0	normal	.	G	ref	G	CA.CC	het-alt	143	0.50	.	1	.	PASS	605314	P	600430(MK)	NN	Brachydacytly-mental retardation syndrome	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	20691407	.	9759	HDAC4	IC10	IVS11	.	.	no-change	NM_006037.3	NP_006028.2	-	Y	c.1294+40C=	.	.	.	NM_006037.3(HDAC4): c.1294+40C=	;maf-5-some-pop	117088	0.366272	U	0.8562	0.588858	13004	0.526376	PASS	.	8188	0.136908	8555	112080	0.364267	.	.	.	.	.	.	rs2278778	.	4024	0.143100	0.467	0.352	-0.011	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	240055900	240055901	2q37.3	0	normal	.	G	snv	A	CA.CC	het-ref	142	0.50	.	2	.	PASS	605314	P	600430(MK)	NN	Brachydacytly-mental retardation syndrome	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	20691407	.	9759	HDAC4	IC10	IVS11	.	.	intron	NM_006037.3	NP_006028.2	-	Y	c.1294+40C>T	.	.	.	NM_006037.3(HDAC4): c.1294+40C>T	;maf-5-some-pop	117088	0.633729	U	0.8562	0.588858	13004	0.473624	PASS	3041	8188	0.863092	23768	112080	0.635733	6200	14468	8.55892e-01	49112	146895	6.35304e-01	rs2278778	.	4024	0.856900	0.467	0.352	-0.011	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	240111476	240111477	2q37.3	0	normal	.	A	snv	T	GG.GT	het-ref	134	0.51	.	2	.	PASS	605314	P	600430(MK)	NN	Brachydacytly-mental retardation syndrome	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	20691407	.	9759	HDAC4	IC3	IVS4	.	.	intron	NM_006037.3	NP_006028.2	-	Y	c.339+52T>A	.	.	.	NM_006037.3(HDAC4): c.339+52T>A	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.561502	U	0.4216	0.561502	5712	0.594188	.	.	.	.	.	.	.	.	.	.	.	.	.	rs531993	.	4024	0.424700	0.460	0.979	0.470	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	240111476	240111477	2q37.3	0	normal	.	A	ref	A	GG.GT	het-alt	127	0.49	.	1	.	PASS	605314	P	600430(MK)	NN	Brachydacytly-mental retardation syndrome	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	20691407	.	9759	HDAC4	IC3	IVS4	.	.	no-change	NM_006037.3	NP_006028.2	-	Y	c.339+52T=	.	.	.	NM_006037.3(HDAC4): c.339+52T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.438498	U	0.4216	0.561502	5712	0.405812	.	.	.	.	.	.	.	.	.	.	.	.	.	rs531993	.	4024	0.575300	0.460	0.979	0.470	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	242793272	242793273	2q37.3	0	nullSample	.	A	ref	A	TC.GC	homo-ref	.	.	.	0	.	.	600244	C	126200(SK);605218(SK)	NN	.	.	.	.	.	.	.	5133	PDCD1	C5E	EX5E	.	.	no-change	NM_005018.2	NP_005009.2	-	Y	c.804T=	.	.	.	NM_005018.2(PDCD1): c.804T=	SingleClassTriAllelic;maf-5-some-pop	124124	0.370557	U	0	0.000798722	13004	0.413642	PASS	-852	8580	0.275524	8492	119116	0.371369	.	.	.	.	.	.	rs2227981	.	4024	0.244300	-2.293	-3.827	-3.849	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	242793272	242793273	2q37.3	1	normal	.	A	snv	G	TC.GC	hom-alt	523	1.00	.	0	.	PASS	600244	C	126200(SK);605218(SK)	NN	.	.	.	.	.	.	.	5133	PDCD1	C5E	EX5E	.	.	coding-synon	NM_005018.2	NP_005009.2	-	Y	c.804T>C	p.(A268=) | p.(Ala268=)	GCT=>GCC	.	NM_005018.2(PDCD1): c.804T>C (p.(A268=))	SingleClassTriAllelic;maf-5-some-pop	124124	0.629210	U	0.7321	0.647963	13004	0.586358	PASS	2256	8580	0.724476	23802	119116	0.628421	4574	12522	7.27769e-01	49522	154619	6.32559e-01	rs2227981	.	4024	0.755700	-2.293	-3.827	-3.849	.	.	.	.	.	ENST00000334409: c.804T>C (p.A268A)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3758140	.	.	.	.	.	.	.	.	.	Likely Benign
2	242793432	242793433	2q37.3	1	normal	.	G	snv	A	CG.CT	het-ref	255	0.52	.	2	.	PASS	600244	C	126200(SK);605218(SK)	NN	.	.	.	.	.	.	.	5133	PDCD1	C5E	EX5E	.	.	missense	NM_005018.2	NP_005009.2	-	Y	c.644C>T	p.A215V | p.Ala215Val	GCC=>GTC	NP=>NP	NM_005018.2(PDCD1): c.644C>T (p.A215V)	;maf-5-some-pop	122386	0.084912	U	0.4454	0.136781	13006	0.012456	PASS	1049	8590	0.487311	1626	117378	0.082699	2112	8427	4.90227e-01	3634	22273	9.12275e-02	rs2227982	.	4024	0.520600	0.555	1.234	0.892	0.22	0.34	0.894	0.149	neutral	ENST00000334409: c.644C>T (p.A215V)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4989211	.	.	.	.	.	.	.	.	.	Likely Benign
2	242793432	242793433	2q37.3	0	normal	.	G	ref	G	CG.CT	het-alt	237	0.48	.	1	.	PASS	600244	C	126200(SK);605218(SK)	NN	.	.	.	.	.	.	.	5133	PDCD1	C5E	EX5E	.	.	no-change	NM_005018.2	NP_005009.2	-	Y	c.644C=	.	.	.	NM_005018.2(PDCD1): c.644C=	;maf-5-some-pop	122386	0.915088	U	0.4454	0.136781	13006	0.987544	PASS	-1044	8590	0.512689	50608	117378	0.917301	.	.	.	.	.	.	rs2227982	.	4024	0.479400	0.555	1.234	0.892	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	242793558	242793559	2q37.3	0	nullSample	.	T	ref	T	TA.GA	homo-ref	.	.	.	0	.	.	600244	C	126200(SK);605218(SK)	NN	.	.	.	.	.	.	.	5133	PDCD1	IC4	IVS4	.	.	no-change	NM_005018.2	NP_005009.2	-	Y	c.628-110A=	.	.	.	NM_005018.2(PDCD1): c.628-110A=	;maf-5-some-pop,maf-5-all-pops	5008	0.351837	U	0.7321	0.648163	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6705653	.	.	.	-2.202	-0.392	-0.465	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	242793558	242793559	2q37.3	0	normal	.	T	snv	C	TA.GA	hom-alt	163	1.00	.	0	.	PASS	600244	C	126200(SK);605218(SK)	NN	.	.	.	.	.	.	.	5133	PDCD1	IC4	IVS4	.	.	intron	NM_005018.2	NP_005009.2	-	Y	c.628-110A>G	.	.	.	NM_005018.2(PDCD1): c.628-110A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.648163	U	0.7321	0.648163	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6705653	.	.	.	-2.202	-0.392	-0.465	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	242800899	242800900	2q37.3	0	normal	.	G	ref	G	CC.CC	het-alt	168	0.55	.	1	.	PASS	600244	C	126200(SK);605218(SK)	NN	.	.	.	.	.	.	.	5133	PDCD1	IC1	IVS1	.	.	no-change	NM_005018.2	NP_005009.2	-	Y	c.76+15C=	.	.	.	NM_005018.2(PDCD1): c.76+15C=	;maf-5-some-pop	38054	0.848952	U	0.4722	0.152157	12966	0.976323	PASS	-543	3734	0.404928	12344	33046	0.849119	.	.	.	.	.	.	rs35933396	.	.	.	0.305	-0.282	-0.314	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
2	242800899	242800900	2q37.3	1	normal	.	G	snv	A	CC.CC	het-ref	136	0.45	.	2	.	PASS	600244	C	126200(SK);605218(SK)	NN	.	.	.	.	.	.	.	5133	PDCD1	IC1	IVS1	.	.	intron	NM_005018.2	NP_005009.2	-	Y	c.76+15C>T	.	.	.	NM_005018.2(PDCD1): c.76+15C>T	;maf-5-some-pop	38054	0.151049	U	0.4722	0.152157	12966	0.023677	PASS	568	3734	0.595072	807	33046	0.150881	1757	6848	5.03603e-01	2993	18492	9.82019e-02	rs35933396	.	.	.	0.305	-0.282	-0.314	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	10094206	10094207	3p25.3	0	normal	.	T	ref	T	GA.tt	het-alt	110	0.79	.	1	AluSc8|SINE|Alu|-|173	PASS	613984	P	227646(MK)	AR	Fanconi anemia, complementation group D2	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22720145|20301575|17436244	.	2177	FANCD2	IC17	IVS18	.	.	no-change	NM_001018115.1	NP_001018125.1	+	Y	c.1656+26T=	.	.	.	NM_001018115.1(FANCD2): c.1656+26T=	MixedObserved;	21855	0.993640	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs752879499	.	4024	0.621800	0.324	0.679	0.330	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	10094206	10094207	3p25.3	0	normal	.	T	ref	T	GA.tt	het-alt	110	0.79	.	1	AluSc8|SINE|Alu|-|173	PASS	613984	P	227646(MK)	AR	Fanconi anemia, complementation group D2	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22720145|20301575|17436244	.	2177	FANCD2	IC17	IVS18	.	.	no-change	NM_033084.3	NP_149075.2	+	N	c.1656+26T=	.	.	.	NM_033084.3(FANCD2): c.1656+26T=	MixedObserved;	21855	0.993640	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs752879499	.	4024	0.621800	0.324	0.679	0.330	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	10094206	10094207	3p25.3	0	normal	.	T	del	.	GA.tt	het-ref	30	0.21	.	2	AluSc8|SINE|Alu|-|173	PASS	613984	P	227646(MK)	AR	Fanconi anemia, complementation group D2	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22720145|20301575|17436244	.	2177	FANCD2	IC17	IVS18	.	.	intron	NM_001018115.1	NP_001018125.1	+	Y	c.1656+26delT	.	.	.	NM_001018115.1(FANCD2): c.1656+26delT	MixedObserved;	21855	0.006360	U	.	.	.	.	PASS	0	5322	0.346110	0	84416	0.257250	.	.	.	.	.	.	rs752879499	.	4024	0.378200	0.324	0.679	0.330	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	10094206	10094207	3p25.3	0	normal	.	T	del	.	GA.tt	het-ref	30	0.21	.	2	AluSc8|SINE|Alu|-|173	PASS	613984	P	227646(MK)	AR	Fanconi anemia, complementation group D2	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22720145|20301575|17436244	.	2177	FANCD2	IC17	IVS18	.	.	intron	NM_033084.3	NP_149075.2	+	N	c.1656+26delT	.	.	.	NM_033084.3(FANCD2): c.1656+26delT	MixedObserved;	21855	0.006360	U	.	.	.	.	PASS	0	5322	0.346110	0	84416	0.257250	.	.	.	.	.	.	rs752879499	.	4024	0.378200	0.324	0.679	0.330	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	10128965	10128966	3p25.3	0	normal	.	T	ref	T	CC.tt	het-alt	37	0.47	.	1	AT_rich|Low_complexity|Low_complexity|+|22	PASS	613984	P	227646(MK)	AR	Fanconi anemia, complementation group D2	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22720145|20301575|17436244	.	2177	FANCD2	IC33	IVS34	.	.	no-change	NM_001018115.1	NP_001018125.1	+	Y	c.3466+18T=	.	.	.	NM_001018115.1(FANCD2): c.3466+18T=	MixedObserved;maf-5-some-pop,maf-5-all-pops	18072	0.629759	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs535944248	.	4024	0.901600	-0.384	-0.204	-0.210	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	10128965	10128966	3p25.3	0	normal	.	T	ref	T	CC.tt	het-alt	37	0.47	.	1	AT_rich|Low_complexity|Low_complexity|+|22	PASS	613984	P	227646(MK)	AR	Fanconi anemia, complementation group D2	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22720145|20301575|17436244	.	2177	FANCD2	IC33	IVS34	.	.	no-change	NM_033084.3	NP_149075.2	+	N	c.3466+18T=	.	.	.	NM_033084.3(FANCD2): c.3466+18T=	MixedObserved;maf-5-some-pop,maf-5-all-pops	18072	0.629759	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs535944248	.	4024	0.901600	-0.384	-0.204	-0.210	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	10128965	10128966	3p25.3	1	normal	.	T	del	.	CC.tt	het-ref	42	0.53	.	2	AT_rich|Low_complexity|Low_complexity|+|22	PASS	613984	P	227646(MK)	AR	Fanconi anemia, complementation group D2	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22720145|20301575|17436244	.	2177	FANCD2	IC33	IVS34	.	.	intron	NM_001018115.1	NP_001018125.1	+	Y	c.3466+18delT	.	.	.	NM_001018115.1(FANCD2): c.3466+18delT	MixedObserved;maf-5-some-pop,maf-5-all-pops	18072	0.370241	U	0.4296	0.368011	.	.	PASS	0	2350	0.165106	1	38400	0.213958	.	.	.	.	.	.	rs535944248	.	4024	0.095700	-0.384	-0.204	-0.210	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	10128965	10128966	3p25.3	1	normal	.	T	del	.	CC.tt	het-ref	42	0.53	.	2	AT_rich|Low_complexity|Low_complexity|+|22	PASS	613984	P	227646(MK)	AR	Fanconi anemia, complementation group D2	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22720145|20301575|17436244	.	2177	FANCD2	IC33	IVS34	.	.	intron	NM_033084.3	NP_149075.2	+	N	c.3466+18delT	.	.	.	NM_033084.3(FANCD2): c.3466+18delT	MixedObserved;maf-5-some-pop,maf-5-all-pops	18072	0.370241	U	0.4296	0.368011	.	.	PASS	0	2350	0.165106	1	38400	0.213958	.	.	.	.	.	.	rs535944248	.	4024	0.095700	-0.384	-0.204	-0.210	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	10136102	10136103	3p25.3	0	normal	.	T	ref	T	TA.GT	het-alt	94	0.52	.	1	.	PASS	613984	P	227646(MK)	AR	Fanconi anemia, complementation group D2	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22720145|20301575|17436244	.	2177	FANCD2	IC39	IVS40	.	.	no-change	NM_001018115.1	NP_001018125.1	+	Y	c.3963+56T=	.	.	.	NM_001018115.1(FANCD2): c.3963+56T=	;	5008	0.996605	U	0.0169	0.00339457	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs34441486	.	4024	0.982400	-0.352	-3.117	-3.371	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	10136102	10136103	3p25.3	0	normal	.	T	ref	T	TA.GT	het-alt	94	0.52	.	1	.	PASS	613984	P	227646(MK)	AR	Fanconi anemia, complementation group D2	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22720145|20301575|17436244	.	2177	FANCD2	IC39	IVS40	.	.	no-change	NM_033084.3	NP_149075.2	+	N	c.3963+56T=	.	.	.	NM_033084.3(FANCD2): c.3963+56T=	;	5008	0.996605	U	0.0169	0.00339457	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs34441486	.	4024	0.982400	-0.352	-3.117	-3.371	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	10136102	10136103	3p25.3	0	normal	.	T	snv	C	TA.GT	het-ref	86	0.48	.	2	.	PASS	613984	P	227646(MK)	AR	Fanconi anemia, complementation group D2	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22720145|20301575|17436244	.	2177	FANCD2	IC39	IVS40	.	.	intron	NM_001018115.1	NP_001018125.1	+	Y	c.3963+56T>C	.	.	.	NM_001018115.1(FANCD2): c.3963+56T>C	;	5008	0.003395	U	0.0169	0.00339457	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs34441486	.	4024	0.017600	-0.352	-3.117	-3.371	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
3	10136102	10136103	3p25.3	0	normal	.	T	snv	C	TA.GT	het-ref	86	0.48	.	2	.	PASS	613984	P	227646(MK)	AR	Fanconi anemia, complementation group D2	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22720145|20301575|17436244	.	2177	FANCD2	IC39	IVS40	.	.	intron	NM_033084.3	NP_149075.2	+	N	c.3963+56T>C	.	.	.	NM_033084.3(FANCD2): c.3963+56T>C	;	5008	0.003395	U	0.0169	0.00339457	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs34441486	.	4024	0.017600	-0.352	-3.117	-3.371	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
3	10188427	10188428	3p25.3	0	nullSample	.	T	ref	T	CG.TA	homo-ref	.	.	.	0	.	.	608537	C	144700(MK);171300(MK);193300(MK);263400(MK);608537(MK)	AD;AR	Von Hippel Lindau; Erythrocytosis, familial, 2 (Chuvash polycythemia); Pheochromocytoma	AD/AR	.	Cardiovascular; Hematologic; Oncologic	Cardiovascular; Hematologic; Oncologic	23968328|23897319|23827964|23781388|22393103|22265326|21993671|21972040|21713522|21606165|20301636|20151405|19464396|17609489|17311301|17057815|16518846|16210343|15642664|15599750|15190140|14726398|14711727|14695531|14500227|14142412|13494077|12844285|12629069|12415268|11987242|11688380|11106358|11097604|10830910|10697963|10631138|10554035|10408776|9663592|9398721|9329368|9215674|9145719|9058738|8929948|8825918|8592333|8493574|8069305|8059782|7987306|7977949|4453572|3790978|3200963|2897130|2642584|2066108|1673491|1593692|1436350|1347089|573913|449657|431135	FC59;H41;H54;H62;H68;HE15;HR14;MC58	7428	VHL	IC2	IVS2	.	.	no-change	NM_000551.3	NP_000542.1	+	Y	c.463+108T=	.	.	.	NM_000551.3(VHL): c.463+108T=	;maf-5-some-pop	5008	0.150958	U	0.8224	0.849042	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1678607	.	4020	0.094800	-0.371	-1.251	-1.259	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	10188427	10188428	3p25.3	0	normal	.	T	snv	G	CG.TA	hom-alt	203	1.00	.	0	.	PASS	608537	C	144700(MK);171300(MK);193300(MK);263400(MK);608537(MK)	AD;AR	Von Hippel Lindau; Erythrocytosis, familial, 2 (Chuvash polycythemia); Pheochromocytoma	AD/AR	.	Cardiovascular; Hematologic; Oncologic	Cardiovascular; Hematologic; Oncologic	23968328|23897319|23827964|23781388|22393103|22265326|21993671|21972040|21713522|21606165|20301636|20151405|19464396|17609489|17311301|17057815|16518846|16210343|15642664|15599750|15190140|14726398|14711727|14695531|14500227|14142412|13494077|12844285|12629069|12415268|11987242|11688380|11106358|11097604|10830910|10697963|10631138|10554035|10408776|9663592|9398721|9329368|9215674|9145719|9058738|8929948|8825918|8592333|8493574|8069305|8059782|7987306|7977949|4453572|3790978|3200963|2897130|2642584|2066108|1673491|1593692|1436350|1347089|573913|449657|431135	FC59;H41;H54;H62;H68;HE15;HR14;MC58	7428	VHL	IC2	IVS2	.	.	intron	NM_000551.3	NP_000542.1	+	Y	c.463+108T>G	.	.	.	NM_000551.3(VHL): c.463+108T>G	;maf-5-some-pop	5008	0.849042	U	0.8224	0.849042	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1678607	.	4020	0.905200	-0.371	-1.251	-1.259	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	12643143	12643144	3p25.2	0	normal	.	A	ref	A	Ca.tt	het-alt	260	0.50	.	1	AT_rich|Low_complexity|Low_complexity|+|51	PASS	164760	C	611553(MK);611554(MK);615916(MK)	NN	LEOPARD syndrome 2; Noonan syndrome 5	AD	.	Cardiovascular; Craniofacial; Dermatologic; Hematologic; Musculoskeletal; Neurologic; Genitourinary	Cardiovascular; Hematologic	20876176|20602484|20301303|17603483|17603482	.	5894	RAF1	IC6	IVS7	.	.	no-change	NM_002880.3	NP_002871.1	-	Y	c.835-1230T=	.	.	.	NM_002880.3(RAF1): c.835-1230T=	;	5008	0.991613	U	0.0397	0.00838658	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs143147809	.	4024	0.949100	0.459	-0.439	-0.494	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	12643143	12643144	3p25.2	0	normal	.	A	snv	G	Ca.tt	het-ref	260	0.50	.	2	AT_rich|Low_complexity|Low_complexity|+|51	PASS	164760	C	611553(MK);611554(MK);615916(MK)	NN	LEOPARD syndrome 2; Noonan syndrome 5	AD	.	Cardiovascular; Craniofacial; Dermatologic; Hematologic; Musculoskeletal; Neurologic; Genitourinary	Cardiovascular; Hematologic	20876176|20602484|20301303|17603483|17603482	.	5894	RAF1	IC6	IVS7	.	.	intron	NM_002880.3	NP_002871.1	-	Y	c.835-1230T>C	.	.	.	NM_002880.3(RAF1): c.835-1230T>C	;	5008	0.008387	U	0.0397	0.00838658	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs143147809	.	4024	0.050900	0.459	-0.439	-0.494	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	12646749	12646751	3p25.2	0	normal	.	TG	ref	TG	TA.tg	het-alt	147	0.80	.	1	(TG)n|Simple_repeat|Simple_repeat|+|33;trf	PASS	164760	C	611553(MK);611554(MK);615916(MK)	NN	LEOPARD syndrome 2; Noonan syndrome 5	AD	.	Cardiovascular; Craniofacial; Dermatologic; Hematologic; Musculoskeletal; Neurologic; Genitourinary	Cardiovascular; Hematologic	20876176|20602484|20301303|17603483|17603482	.	5894	RAF1	IC5	IVS6	.	.	no-change	NM_002880.3	NP_002871.1	-	Y	c.680+949_680+950=	.	.	.	NM_002880.3(RAF1): c.680+949_680+950=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4027	0.775200	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	12646749	12646751	3p25.2	0	normal	.	TG	del	.	TA.tg	het-ref	36	0.20	.	2	(TG)n|Simple_repeat|Simple_repeat|+|33;trf	PASS	164760	C	611553(MK);611554(MK);615916(MK)	NN	LEOPARD syndrome 2; Noonan syndrome 5	AD	.	Cardiovascular; Craniofacial; Dermatologic; Hematologic; Musculoskeletal; Neurologic; Genitourinary	Cardiovascular; Hematologic	20876176|20602484|20301303|17603483|17603482	.	5894	RAF1	IC5	IVS6	.	.	intron	NM_002880.3	NP_002871.1	-	Y	c.680+949_680+950delCA	.	.	.	NM_002880.3(RAF1): c.680+949_680+950delCA	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4027	0.222600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	12649448	12649451	3p25.2	0	normal	.	AAA	ref	AAA	cc.aa	het-alt	58	0.60	.	1	AluSc|SINE|Alu|+|303	PASS	164760	C	611553(MK);611554(MK);615916(MK)	NN	LEOPARD syndrome 2; Noonan syndrome 5	AD	.	Cardiovascular; Craniofacial; Dermatologic; Hematologic; Musculoskeletal; Neurologic; Genitourinary	Cardiovascular; Hematologic	20876176|20602484|20301303|17603483|17603482	.	5894	RAF1	IC4	IVS5	.	.	no-change	NM_002880.3	NP_002871.1	-	Y	c.581+814_581+816=	.	.	.	NM_002880.3(RAF1): c.581+814_581+816=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.964000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	12649448	12649451	3p25.2	0	normal	.	AAA	del	.	cc.aa	het-ref	38	0.40	.	2	AluSc|SINE|Alu|+|303	PASS	164760	C	611553(MK);611554(MK);615916(MK)	NN	LEOPARD syndrome 2; Noonan syndrome 5	AD	.	Cardiovascular; Craniofacial; Dermatologic; Hematologic; Musculoskeletal; Neurologic; Genitourinary	Cardiovascular; Hematologic	20876176|20602484|20301303|17603483|17603482	.	5894	RAF1	IC4	IVS5	.	.	intron	NM_002880.3	NP_002871.1	-	Y	c.581+814_581+816delTTT	.	.	.	NM_002880.3(RAF1): c.581+814_581+816delTTT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.035800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
3	12650481	12650482	3p25.2	0	nullSample	.	T	ref	T	AC.TC	homo-ref	.	.	.	0	.	.	164760	C	611553(MK);611554(MK);615916(MK)	NN	LEOPARD syndrome 2; Noonan syndrome 5	AD	.	Cardiovascular; Craniofacial; Dermatologic; Hematologic; Musculoskeletal; Neurologic; Genitourinary	Cardiovascular; Hematologic	20876176|20602484|20301303|17603483|17603482	.	5894	RAF1	IC3	IVS4	.	.	no-change	NM_002880.3	NP_002871.1	-	Y	c.424-60A=	.	.	.	NM_002880.3(RAF1): c.424-60A=	;	5008	0.000000	U	1	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2454440	.	4024	0.001500	-1.319	-1.570	-0.687	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	12650481	12650482	3p25.2	0	normal	.	T	snv	A	AC.TC	hom-alt	682	1.00	.	0	.	PASS	164760	C	611553(MK);611554(MK);615916(MK)	NN	LEOPARD syndrome 2; Noonan syndrome 5	AD	.	Cardiovascular; Craniofacial; Dermatologic; Hematologic; Musculoskeletal; Neurologic; Genitourinary	Cardiovascular; Hematologic	20876176|20602484|20301303|17603483|17603482	.	5894	RAF1	IC3	IVS4	.	.	intron	NM_002880.3	NP_002871.1	-	Y	c.424-60A>T	.	.	.	NM_002880.3(RAF1): c.424-60A>T	;	5008	1.000000	U	1	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2454440	.	4024	0.998500	-1.319	-1.570	-0.687	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	30686413	30686414	3p24.1	1	normal	.	A	snv	G	GC.AG	het-ref	226	0.49	.	2	.	PASS	190182	C	133239(MK);610168(MK);614331(MK)	AD	Loeys-Dietz syndrome, type 2B; Loeys-Dietz syndrome, type 1B	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Obstetric	Cardiovascular; Obstetric	19996017|19542084|19006214|16928994|16251899|16027248|15731757|15235604	.	7048	TGFBR2	IC3	IVS3	.	.	intron	NM_001024847.2	NP_001020018.1	+	Y	c.338+7A>G	.	.	.	NM_001024847.2(TGFBR2): c.338+7A>G	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	125728	0.374157	U	0.7054	0.412939	13006	0.321544	PASS	2041	8604	0.689679	8816	120720	0.372548	4147	11929	6.93950e-01	17884	90755	3.69668e-01	rs1155705	.	4024	0.687900	-0.726	-1.327	-1.364	.	.	.	.	.	ENST00000359013: c.338+7A>G (p.?)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019240	.	.	.	.	.	no_record	36867	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
3	30686413	30686414	3p24.1	0	normal	.	A	ref	A	GC.AG	het-alt	237	0.51	.	1	.	PASS	190182	C	133239(MK);610168(MK);614331(MK)	AD	Loeys-Dietz syndrome, type 2B; Loeys-Dietz syndrome, type 1B	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Obstetric	Cardiovascular; Obstetric	19996017|19542084|19006214|16928994|16251899|16027248|15731757|15235604	.	7048	TGFBR2	IC3	IVS3	.	.	no-change	NM_001024847.2	NP_001020018.1	+	Y	c.338+7A=	.	.	.	NM_001024847.2(TGFBR2): c.338+7A=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	125728	0.625843	U	0.7054	0.412939	13006	0.678456	PASS	-926	8604	0.310321	24202	120720	0.627452	.	.	.	.	.	.	rs1155705	.	4024	0.312100	-0.726	-1.327	-1.364	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	30713841	30713842	3p24.1	0	normal	.	C	ref	C	AA.GA	het-alt	326	0.56	.	1	.	PASS	190182	C	133239(MK);610168(MK);614331(MK)	AD	Loeys-Dietz syndrome, type 2B; Loeys-Dietz syndrome, type 1B	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Obstetric	Cardiovascular; Obstetric	19996017|19542084|19006214|16928994|16251899|16027248|15731757|15235604	.	7048	TGFBR2	C5	EX5	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	no-change	NM_001024847.2	NP_001020018.1	+	Y	c.1242C=	.	.	.	NM_001024847.2(TGFBR2): c.1242C=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	125756	0.942985	U	0.2986	0.103435	13006	0.981701	PASS	-919	8642	0.704698	54248	120748	0.944910	.	.	.	.	.	.	rs2228048	.	4024	0.743800	-0.312	-0.997	-1.139	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	30713841	30713842	3p24.1	1	normal	.	C	snv	T	AA.GA	het-ref	261	0.44	.	2	.	PASS	190182	C	133239(MK);610168(MK);614331(MK)	AD	Loeys-Dietz syndrome, type 2B; Loeys-Dietz syndrome, type 1B	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Obstetric	Cardiovascular; Obstetric	19996017|19542084|19006214|16928994|16251899|16027248|15731757|15235604	.	7048	TGFBR2	C5	EX5	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_001024847.2	NP_001020018.1	+	Y	c.1242C>T	p.(N414=) | p.(Asn414=)	AAC=>AAT	.	NM_001024847.2(TGFBR2): c.1242C>T (p.(N414=))	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	125756	0.057015	U	0.2986	0.103435	13006	0.018299	PASS	357	8642	0.295302	526	120748	0.055090	823	5217	3.02575e-01	1169	13292	5.42110e-02	rs2228048	.	4024	0.256200	-0.312	-0.997	-1.139	.	.	.	.	.	ENST00000359013: c.1242C>T (p.N414N)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5020533	.	.	.	.	.	no_record	44652	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
3	37034945	37034946	3p22.2	0	normal	.	G	ref	G	CT.AA	het-alt	157	0.53	.	1	.	PASS	120436	C	158320(MK);276300(MK);609310(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 2; Mismatch repair cancer syndrome; Endometrial cancer; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	20301390|19156169|18457354|17440981|16042583|15662714|15520370|15264268|15235030|15077197|10577927|10072435|9927033|9634524|8751876|8145827|8128251|7815421|7661930|6020987|5684233|4063166	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4292	MLH1	5U1E	EX1	.	.	no-change	NM_000249.3	NP_000240.1	+	Y	c.-93G=	.	.	.	NM_000249.3(MLH1): c.-93G=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	5008	0.679513	U	0.5476	0.320487	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1800734	.	.	.	0.563	-0.077	0.026	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	37034945	37034946	3p22.2	0	normal	.	G	snv	A	CT.AA	het-ref	137	0.47	.	2	.	PASS	120436	C	158320(MK);276300(MK);609310(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 2; Mismatch repair cancer syndrome; Endometrial cancer; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	20301390|19156169|18457354|17440981|16042583|15662714|15520370|15264268|15235030|15077197|10577927|10072435|9927033|9634524|8751876|8145827|8128251|7815421|7661930|6020987|5684233|4063166	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4292	MLH1	5U1E	EX1	.	.	utr-5	NM_000249.3	NP_000240.1	+	Y	c.-93G>A	.	.	.	NM_000249.3(MLH1): c.-93G>A	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	5008	0.320487	U	0.5476	0.320487	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1800734	.	.	.	0.563	-0.077	0.026	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	89600	reviewed_by_expert_panel	Benign	Benign
3	37067239	37067240	3p22.2	0	normal	.	T	ref	T	GG.TC	het-alt	186	0.48	.	1	.	PASS	120436	C	158320(MK);276300(MK);609310(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 2; Mismatch repair cancer syndrome; Endometrial cancer; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	20301390|19156169|18457354|17440981|16042583|15662714|15520370|15264268|15235030|15077197|10577927|10072435|9927033|9634524|8751876|8145827|8128251|7815421|7661930|6020987|5684233|4063166	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4292	MLH1	C12	EX12	.	.	no-change	NM_000249.3	NP_000240.1	+	Y	c.1151T=	.	.	.	NM_000249.3(MLH1): c.1151T=	;clinically-assoc,submitted-by-lsdb	126296	0.997126	U	0.0258	0.00519169	13006	0.999923	PASS	.	8646	0.961485	60310	121288	0.997221	.	.	.	.	.	.	rs63750447	.	4024	0.955800	0.455	4.821	2.158	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	37067239	37067240	3p22.2	1	normal	.	T	snv	A	GG.TC	het-ref	202	0.52	.	2	.	PASS	120436	C	158320(MK);276300(MK);609310(MK)	AD;AR	Colorectal cancer, hereditary nonpolyposis, type 2; Mismatch repair cancer syndrome; Endometrial cancer; Muir-Torre syndrome	AD/AR	.	Dermatologic; Oncologic	Oncologic	20301390|19156169|18457354|17440981|16042583|15662714|15520370|15264268|15235030|15077197|10577927|10072435|9927033|9634524|8751876|8145827|8128251|7815421|7661930|6020987|5684233|4063166	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	4292	MLH1	C12	EX12	.	.	missense	NM_000249.3	NP_000240.1	+	Y	c.1151T>A	p.V384D | p.Val384Asp	GTT=>GAT	NP=>P-	NM_000249.3(MLH1): c.1151T>A (p.V384D)	;clinically-assoc,submitted-by-lsdb	126296	0.002874	U	0.0258	0.00519169	13006	0.000077	PASS	3	8646	0.038515	3	121288	0.002779	7	622	3.60622e-02	7	637	2.58750e-03	rs63750447	.	4024	0.044200	0.455	4.821	2.158	0	0.997	1	0.911	deleterious	ENST00000231790: c.1151T>A (p.V384D)	NS [NS|NS|NS]	malignant_melanoma [NS|NS|NS]	RSS	26085	CM981292	NM_000249.3(MLH1): c.1151T>A (p.V384D)	"Colorectal cancer, non-polyposis ?"	9526167	DM	no_record	41632	reviewed_by_expert_panel	Benign	VUS
3	41279439	41279440	3p22.1	0	normal	.	A	snv	G	AA.TT	het-ref	124	0.51	.	2	.	PASS	116806	C	114500(MK);114550(MK);132600(MK);167000(MK);615075(MK)	AD	Mental retardation, autosomal dominant, 19	AD	.	Neurologic	General	23033978	.	1499	CTNNB1	IC12	IVS13	.	.	intron	NM_001904.3	NP_001895.1	+	Y	c.2077-67A>G	.	.	.	NM_001904.3(CTNNB1): c.2077-67A>G	;maf-5-some-pop	5008	0.232827	U	0.5308	0.232827	4566	0.169295	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4135385	.	4024	0.511700	0.482	-0.818	-1.021	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	41279439	41279440	3p22.1	0	normal	.	A	ref	A	AA.TT	het-alt	119	0.49	.	1	.	PASS	116806	C	114500(MK);114550(MK);132600(MK);167000(MK);615075(MK)	AD	Mental retardation, autosomal dominant, 19	AD	.	Neurologic	General	23033978	.	1499	CTNNB1	IC12	IVS13	.	.	no-change	NM_001904.3	NP_001895.1	+	Y	c.2077-67A=	.	.	.	NM_001904.3(CTNNB1): c.2077-67A=	;maf-5-some-pop	5008	0.767173	U	0.5308	0.232827	4566	0.830705	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4135385	.	4024	0.488300	0.482	-0.818	-1.021	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	41280826	41280827	3p22.1	0	normal	.	C	ref	C	GA.CT	het-alt	238	0.52	.	1	.	PASS	116806	C	114500(MK);114550(MK);132600(MK);167000(MK);615075(MK)	AD	Mental retardation, autosomal dominant, 19	AD	.	Neurologic	General	23033978	.	1499	CTNNB1	C14E	EX15E	.	.	no-change	NM_001904.3	NP_001895.1	+	Y	c.2340C=	.	.	.	NM_001904.3(CTNNB1): c.2340C=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118088	0.971902	U	0.1468	0.043131	13006	0.998155	PASS	.	8142	0.860845	53659	113080	0.972568	.	.	.	.	.	.	rs2293303	.	4024	0.855100	0.557	4.488	2.679	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	41280826	41280827	3p22.1	1	normal	.	C	snv	T	GA.CT	het-ref	222	0.48	.	2	.	PASS	116806	C	114500(MK);114550(MK);132600(MK);167000(MK);615075(MK)	AD	Mental retardation, autosomal dominant, 19	AD	.	Neurologic	General	23033978	.	1499	CTNNB1	C14E	EX15E	.	.	coding-synon	NM_001904.3	NP_001895.1	+	Y	c.2340C>T	p.(D780=) | p.(Asp780=)	GAC=>GAT	.	NM_001904.3(CTNNB1): c.2340C>T (p.(D780=))	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118088	0.028098	U	0.1468	0.043131	13006	0.001845	PASS	75	8142	0.139155	221	113080	0.027432	165	2361	1.37957e-01	572	7641	3.12802e-02	rs2293303	.	4024	0.144900	0.557	4.488	2.679	.	.	.	.	.	ENST00000349496: c.2340C>T (p.D780D)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5008346	.	.	.	.	.	no_record	128869	criteria_provided,_single_submitter	Benign	Likely Benign
3	47079111	47079112	3p21.31	0	normal	.	G	snv	A	AC.GA	hom-alt	273	1.00	.	0	.	PASS	612778	P	.	NN	.	.	.	.	.	.	.	29072	SETD2	IC18	IVS18	.	.	intron	NM_014159.6	NP_054878.5	-	Y	c.7350+44C>T	.	.	.	NM_014159.6(SETD2): c.7350+44C>T	;maf-5-some-pop,maf-5-all-pops	125084	0.634933	U	0.6637	0.677516	13006	0.642703	PASS	2003	8450	0.687929	24229	120076	0.633157	4059	11785	6.86532e-01	50007	155342	6.35309e-01	rs6768722	.	4024	0.689900	-0.488	-0.182	-0.700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	47079111	47079112	3p21.31	0	nullSample	.	G	ref	G	AC.GA	homo-ref	.	.	.	0	.	.	612778	P	.	NN	.	.	.	.	.	.	.	29072	SETD2	IC18	IVS18	.	.	no-change	NM_014159.6	NP_054878.5	-	Y	c.7350+44C=	.	.	.	NM_014159.6(SETD2): c.7350+44C=	;maf-5-some-pop,maf-5-all-pops	125084	0.365067	U	0.6637	0.677516	13006	0.357297	PASS	.	8450	0.312071	8240	120076	0.366843	.	.	.	.	.	.	rs6768722	.	4024	0.310100	-0.488	-0.182	-0.700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	47103861	47103863	3p21.31	0	nullSample	.	TT	ref	TT	TG.TT	homo-ref	.	.	.	0	.	.	612778	P	.	NN	.	.	.	.	.	.	.	29072	SETD2	IC13	IVS13	.	.	no-change	NM_014159.6	NP_054878.5	-	Y	c.6110-27_6110-26=	.	.	.	NM_014159.6(SETD2): c.6110-27_6110-26=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10589946	.	4024	0.327500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	47103861	47103863	3p21.31	0	normal	.	TT	del	.	TG.TT	hom-alt	361	0.99	.	0	.	PASS	612778	P	.	NN	.	.	.	.	.	.	.	29072	SETD2	IC13	IVS13	.	.	intron	NM_014159.6	NP_054878.5	-	Y	c.6110-27_6110-26delAA	.	.	.	NM_014159.6(SETD2): c.6110-27_6110-26delAA	MixedObserved;	0	0	U	0.6448	0.646166	.	.	PASS	1599	7902	0.661098	16259	106370	0.597932	.	.	.	.	.	.	rs10589946	.	4024	0.596900	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	436678	criteria_provided,_single_submitter	Likely_benign	Benign
3	47103866	47103867	3p21.31	0	nullSample	.	T	ref	T	TT.TT	homo-ref	.	.	.	0	.	.	612778	P	.	NN	.	.	.	.	.	.	.	29072	SETD2	IC13	IVS13	.	.	no-change	NM_014159.6	NP_054878.5	-	Y	c.6110-31A=	.	.	.	NM_014159.6(SETD2): c.6110-31A=	;maf-5-some-pop	124774	0.944452	U	0.119	0.0559105	.	.	PASS	-520	8576	0.858675	53745	119766	0.944467	.	.	.	.	.	.	rs200150790	.	4024	0.857600	-2.385	-4.135	-4.336	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	47103866	47103867	3p21.31	0	normal	.	T	snv	G	TT.TT	hom-alt	311	0.98	.	0	.	PASS	612778	P	.	NN	.	.	.	.	.	.	.	29072	SETD2	IC13	IVS13	.	.	intron	NM_014159.6	NP_054878.5	-	Y	c.6110-31A>C	.	.	.	NM_014159.6(SETD2): c.6110-31A>C	;maf-5-some-pop	124774	0.055548	U	0.119	0.0559105	.	.	PASS	86	8576	0.141325	513	119766	0.055533	149	2035	1.38605e-01	869	11158	5.48407e-02	rs200150790	.	4024	0.142400	-2.385	-4.135	-4.336	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	47108653	47108654	3p21.31	0	normal	.	T	ref	T	AA.GG	het-alt	108	0.46	.	1	.	PASS	612778	P	.	NN	.	.	.	.	.	.	.	29072	SETD2	IC12	IVS12	.	.	no-change	NM_014159.6	NP_054878.5	-	Y	c.6061-46A=	.	.	.	NM_014159.6(SETD2): c.6061-46A=	;maf-5-some-pop	126042	0.946066	U	0.125	0.0555112	13004	0.984082	PASS	-516	8626	0.859958	54510	121034	0.946131	.	.	.	.	.	.	rs77252032	.	4024	0.860300	-0.461	-0.551	-0.377	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	47108653	47108654	3p21.31	0	normal	.	T	snv	C	AA.GG	het-ref	126	0.54	.	2	.	PASS	612778	P	.	NN	.	.	.	.	.	.	.	29072	SETD2	IC12	IVS12	.	.	intron	NM_014159.6	NP_054878.5	-	Y	c.6061-46A>G	.	.	.	NM_014159.6(SETD2): c.6061-46A>G	;maf-5-some-pop	126042	0.053934	U	0.125	0.0555112	13004	0.015918	PASS	88	8626	0.140042	513	121034	0.053869	172	2365	1.38175e-01	1218	14728	6.06180e-02	rs77252032	.	4024	0.139700	-0.461	-0.551	-0.377	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	47125384	47125385	3p21.31	0	normal	.	G	ref	G	TG.GC	het-alt	371	0.51	.	1	.	PASS	612778	P	.	NN	.	.	.	.	.	.	.	29072	SETD2	C12	EX12	.	.	no-change	NM_014159.6	NP_054878.5	-	Y	c.5885C=	.	.	.	NM_014159.6(SETD2): c.5885C=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	126382	0.468295	U	0.5327	0.469848	13006	0.528679	PASS	.	8648	0.457562	13622	121374	0.465742	.	.	.	.	.	.	rs4082155	.	4024	0.458500	-0.145	0.765	0.333	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	47125384	47125385	3p21.31	1	normal	.	G	snv	A	TG.GC	het-ref	351	0.49	.	2	.	PASS	612778	P	.	NN	.	.	.	.	.	.	.	29072	SETD2	C12	EX12	.	.	missense	NM_014159.6	NP_054878.5	-	Y	c.5885C>T	p.P1962L | p.Pro1962Leu	CCC=>CTC	NP=>NP	NM_014159.6(SETD2): c.5885C>T (p.P1962L)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	126382	0.531682	U	0.5327	0.469848	13006	0.471321	PASS	1302	8648	0.542438	17779	121374	0.534233	2563	9362	5.42913e-01	36612	132662	5.38978e-01	rs4082155	.	4024	0.541500	-0.145	0.765	0.333	0.34	0	0	0.023	neutral	ENST00000409792: c.5885C>T (p.P1962L)	prostate [NS|NS|NS]	carcinoma [NS|NS|NS]	CSV	149375	.	.	.	.	.	no_record	135202	criteria_provided,_single_submitter	Benign	Likely Benign
3	47125916	47125917	3p21.31	0	normal	.	T	ref	T	AC.tt	het-alt	21	0.24	.	1	trf;AluSz|SINE|Alu|-|298	PASS	612778	P	.	NN	.	.	.	.	.	.	.	29072	SETD2	IC11	IVS11	.	.	no-change	NM_014159.6	NP_054878.5	-	Y	c.5398-45A=	.	.	.	NM_014159.6(SETD2): c.5398-45A=	MixedObserved;maf-5-some-pop,maf-5-all-pops|MixedObserved;	5008|0	0.428914|0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs5848822|rs869293478	.	4024	0.591500	0.254	0.050	-0.126	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	47125916	47125917	3p21.31	0	normal	.	T	del	.	AC.tt	het-ref	65	0.76	.	2	trf;AluSz|SINE|Alu|-|298	PASS	612778	P	.	NN	.	.	.	.	.	.	.	29072	SETD2	IC11	IVS11	.	.	intron	NM_014159.6	NP_054878.5	-	Y	c.5398-45delA	.	.	.	NM_014159.6(SETD2): c.5398-45delA	MixedObserved;maf-5-some-pop,maf-5-all-pops|MixedObserved;	5008|0	0.571086|0	U	0.5764	0.571086	.	.	PASS	8	400	0.440000	148	7268	0.447716	.	.	.	.	.	.	rs5848822|rs869293478	.	4024	0.408300	0.254	0.050	-0.126	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	47129780	47129781	3p21.31	0	normal	.	C	ref	C	AA.AA	het-alt	213	0.82	.	1	.	PASS	612778	P	.	NN	.	.	.	.	.	.	.	29072	SETD2	IC9	IVS9	.	.	no-change	NM_014159.6	NP_054878.5	-	Y	c.5143-44G=	.	.	.	NM_014159.6(SETD2): c.5143-44G=	;	5008	0.993011	U	0.001	0.00698882	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs563758965	.	4024	0.998000	-1.226	-0.990	-1.027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	47129781	47129781	3p21.31	0	normal	.	.	ins	A	AC.AA	het-ref	48	0.18	.	2	.	PASS	612778	P	.	NN	.	.	.	.	.	.	.	29072	SETD2	IC9	IVS9	.	.	intron	NM_014159.6	NP_054878.5	-	Y	c.5143-45_5143-44insT	.	.	.	NM_014159.6(SETD2): c.5143-45_5143-44insT	;	57016	0.116003	U	.	.	.	.	PASS	0	4082	0.116365	2	63628	0.101386	.	.	.	.	.	.	rs777027080	.	4024	0.307400	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	47142907	47142909	3p21.31	0	normal	.	CC	ref	CC	TT.CC	het-alt	108	0.54	.	1	.	PASS	612778	P	.	NN	.	.	.	.	.	.	.	29072	SETD2	IC8	IVS8	.	.	no-change	NM_014159.6	NP_054878.5	-	Y	c.5015+39_5015+40=	.	.	.	NM_014159.6(SETD2): c.5015+39_5015+40=	;maf-5-some-pop,maf-5-all-pops	126060	0.426678	U	.	.	12520	0.392572	.	.	.	.	.	.	.	.	.	.	.	.	.	rs60548476	.	4024	0.457500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	47142907	47142909	3p21.31	0	normal	.	CC	del	.	TT.CC	het-ref	92	0.46	.	2	.	PASS	612778	P	.	NN	.	.	.	.	.	.	.	29072	SETD2	IC8	IVS8	.	.	intron	NM_014159.6	NP_054878.5	-	Y	c.5015+39_5015+40delGG	.	.	.	NM_014159.6(SETD2): c.5015+39_5015+40delGG	;maf-5-some-pop,maf-5-all-pops	126060	0.573322	U	0.5327	0.60024	12520	0.606470	PASS	1300	8650	0.541965	19931	121052	0.572209	2479	9083	5.42010e-01	38844	134907	5.70455e-01	rs60548476	.	4024	0.542500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	47143087	47143091	3p21.31	0	nullSample	.	GTGT	ref	GTGT	TA.gt	homo-ref	.	.	.	0	(TG)n|Simple_repeat|Simple_repeat|+|37;trf	.	612778	P	.	NN	.	.	.	.	.	.	.	29072	SETD2	IC7	IVS7	.	.	no-change	NM_014159.6	NP_054878.5	-	Y	c.4918-46_4918-43=	.	.	.	NM_014159.6(SETD2): c.4918-46_4918-43=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs72231601	.	4024	0.924500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	47143087	47143091	3p21.31	0	normal	.	GTGT	del	.	TA.gt	hom-alt	23	0.92	.	0	(TG)n|Simple_repeat|Simple_repeat|+|37;trf	PASS	612778	P	.	NN	.	.	.	.	.	.	.	29072	SETD2	IC7	IVS7	.	.	intron	NM_014159.6	NP_054878.5	-	Y	c.4918-46_4918-43delACAC	.	.	.	NM_014159.6(SETD2): c.4918-46_4918-43delACAC	MixedObserved;	0	0	U	.	.	.	.	PASS	10	5362	0.148452	78	76158	0.084824	.	.	.	.	.	.	rs72231601	.	4024	0.060900	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	47147393	47147397	3p21.31	0	normal	.	AAAA	ref	AAAA	cc.aa	het-alt	25	0.68	.	1	AluSx1|SINE|Alu|+|282	PASS	612778	P	.	NN	.	.	.	.	.	.	.	29072	SETD2	IC6	IVS6	.	.	no-change	NM_014159.6	NP_054878.5	-	Y	c.4839+90_4839+93=	.	.	.	NM_014159.6(SETD2): c.4839+90_4839+93=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs752575960	.	4024	0.988300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	47147393	47147397	3p21.31	0	normal	.	AAAA	del	.	cc.aa	het-ref	12	0.32	.	2	AluSx1|SINE|Alu|+|282	PASS	612778	P	.	NN	.	.	.	.	.	.	.	29072	SETD2	IC6	IVS6	.	.	intron	NM_014159.6	NP_054878.5	-	Y	c.4839+90_4839+93delTTTT	.	.	.	NM_014159.6(SETD2): c.4839+90_4839+93delTTTT	MixedObserved;	0	0	U	.	.	.	.	PASS	0	2538	0.133964	1	40836	0.120457	.	.	.	.	.	.	rs752575960	.	4024	0.010400	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	47162660	47162661	3p21.31	0	nullSample	.	A	ref	A	CG.TT	homo-ref	.	.	.	0	.	.	612778	P	.	NN	.	.	.	.	.	.	.	29072	SETD2	C3	EX3	.	.	no-change	NM_014159.6	NP_054878.5	-	Y	c.3465T=	.	.	.	NM_014159.6(SETD2): c.3465T=	;maf-5-some-pop,maf-5-all-pops	126204	0.363950	U	0.6577	0.678315	13006	0.355221	PASS	.	8652	0.317961	8365	121196	0.365697	.	.	.	.	.	.	rs6767907	.	4024	0.317600	-0.119	-0.236	-0.591	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	47162660	47162661	3p21.31	1	normal	.	A	snv	G	CG.TT	hom-alt	678	1.00	.	0	.	PASS	612778	P	.	NN	.	.	.	.	.	.	.	29072	SETD2	C3	EX3	.	.	coding-synon	NM_014159.6	NP_054878.5	-	Y	c.3465T>C	p.(N1155=) | p.(Asn1155=)	AAT=>AAC	.	NM_014159.6(SETD2): c.3465T>C (p.(N1155=))	;maf-5-some-pop,maf-5-all-pops	126204	0.636050	U	0.6577	0.678315	13006	0.644779	PASS	2030	8652	0.682039	24642	121196	0.634303	4028	11751	6.81375e-01	50756	156876	6.37459e-01	rs6767907	.	4024	0.682400	-0.119	-0.236	-0.591	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	586533	criteria_provided,_single_submitter	Benign	Likely Benign
3	47162885	47162886	3p21.31	0	normal	.	C	ref	C	TC.AT	het-alt	363	0.49	.	1	.	PASS	612778	P	.	NN	.	.	.	.	.	.	.	29072	SETD2	C3	EX3	.	.	no-change	NM_014159.6	NP_054878.5	-	Y	c.3240G=	.	.	.	NM_014159.6(SETD2): c.3240G=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	125986	0.945899	U	0.124	0.0553115	13006	0.984007	PASS	-517	8612	0.859498	54466	120978	0.945949	.	.	.	.	.	.	rs76208147	.	4024	0.860100	0.585	1.391	2.718	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	47162885	47162886	3p21.31	1	normal	.	C	snv	T	TC.AT	het-ref	371	0.51	.	2	.	PASS	612778	P	.	NN	.	.	.	.	.	.	.	29072	SETD2	C3	EX3	.	.	missense	NM_014159.6	NP_054878.5	-	Y	c.3240G>A	p.M1080I | p.Met1080Ile	ATG=>ATA	NP=>NP	NM_014159.6(SETD2): c.3240G>A (p.M1080I)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	125986	0.054101	U	0.124	0.0553115	13006	0.015993	PASS	88	8612	0.140502	516	120978	0.054051	174	2386	1.38512e-01	1240	14930	6.14798e-02	rs76208147	.	4024	0.139900	0.585	1.391	2.718	0.17	0.035	0.216	0.061	neutral	ENST00000409792: c.3240G>A (p.M1080I)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	149377	.	.	.	.	.	no_record	135235	no_assertion_provided	not_provided	Likely Benign
3	47205502	47205511	3p21.31	0	nullSample	.	GCGGCGGCG	ref	GCGGCGGCG	CC.gc	homo-ref	.	.	.	0	(CGG)n|Simple_repeat|Simple_repeat|+|41;trf	.	612778	P	.	NN	.	.	.	.	.	.	.	29072	SETD2	PROM	.	.	.	no-change	NM_014159.6	NP_054878.5	-	Y	c.-53-u44_-53-u36=	.	.	.	NM_014159.6(SETD2): c.-53-u44_-53-u36=	;maf-5-some-pop	5008	0.177716	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs545985439	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
3	47205502	47205511	3p21.31	0	normal	.	GCGGCGGCG	del	.	CC.gc	hom-alt	182	1.00	.	0	(CGG)n|Simple_repeat|Simple_repeat|+|41;trf	PASS	612778	P	.	NN	.	.	.	.	.	.	.	29072	SETD2	PROM	.	.	.	promoter	NM_014159.6	NP_054878.5	-	Y	c.-53-u44_-53-u36delCGCCGCCGC	.	.	.	NM_014159.6(SETD2): c.-53-u44_-53-u36delCGCCGCCGC	;maf-5-some-pop	5008	0.822284	U	0.6766	0.822284	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs545985439	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	49406079	49406080	3p21.31	0	nullSample	.	T	ref	T	CA.TG	homo-ref	.	.	.	0	trf	.	165390	C	.	NN	.	.	.	.	.	.	.	387	RHOA	IC1	IVS2	.	.	no-change	NM_001664.2	NP_001655.1	-	Y	c.157-99A=	.	.	.	NM_001664.2(RHOA): c.157-99A=	;maf-5-some-pop,maf-5-all-pops	5008	0.416933	U	0.9117	0.583067	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2878298	.	4024	0.082300	0.000	0.000	0.000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	49406079	49406080	3p21.31	0	normal	.	T	snv	C	CA.TG	hom-alt	311	1.00	.	0	trf	PASS	165390	C	.	NN	.	.	.	.	.	.	.	387	RHOA	IC1	IVS2	.	.	intron	NM_001664.2	NP_001655.1	-	Y	c.157-99A>G	.	.	.	NM_001664.2(RHOA): c.157-99A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.583067	U	0.9117	0.583067	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2878298	.	4024	0.917700	0.000	0.000	0.000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	49928162	49928163	3p21.31	0	normal	.	T	ref	T	AA.tt	het-alt	102	0.74	.	1	AluY|SINE|Alu|-|296	PASS	600168	P	.	NN	.	.	.	.	.	.	.	4486	MST1R	IC17	IVS17	.	.	no-change	NM_002447.2	NP_002438.2	-	Y	c.3645-80A=	.	.	.	NM_002447.2(MST1R): c.3645-80A=	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs373581213	.	.	.	0.055	0.058	0.056	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
3	49928162	49928163	3p21.31	0	normal	.	T	del	.	AA.tt	het-ref	35	0.26	.	2	AluY|SINE|Alu|-|296	PASS	600168	P	.	NN	.	.	.	.	.	.	.	4486	MST1R	IC17	IVS17	.	.	intron	NM_002447.2	NP_002438.2	-	Y	c.3645-80delA	.	.	.	NM_002447.2(MST1R): c.3645-80delA	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs373581213	.	.	.	0.055	0.058	0.056	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
3	49928690	49928691	3p21.31	0	normal	.	T	snv	C	GC.GC	hom-alt	440	1.00	.	0	.	PASS	600168	P	.	NN	.	.	.	.	.	.	.	4486	MST1R	C17	EX17	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	no-change	NM_002447.2	NP_002438.2	-	Y	c.3583G=	.	.	.	NM_002447.2(MST1R): c.3583G=	SingleClassTriAllelic,InconsistentAlleles;	126370	0.999984	U	1	1	.	.	PASS	4326	8652	1.000000	60679	121362	0.999984	8624	17248	1.00000e+00	123075	246152	9.99992e-01	rs7433231	.	.	.	-0.131	4.343	1.275	.	.	.	.	.	ENST00000296474: c.3583A>G (p.S1195G)	upper_aerodigestive_tract [head_neck|NS|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	VUO	4590310	.	.	.	.	.	.	.	.	.	Benign
3	49928690	49928691	3p21.31	1	nullSample	.	T	ref	T	GC.GC	homo-ref	.	.	.	0	.	.	600168	P	.	NN	.	.	.	.	.	.	.	4486	MST1R	C17	EX17	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	missense	NM_002447.2	NP_002438.2	-	Y	c.3583G>A	p.G1195S | p.Gly1195Ser	GGC=>AGC	P0=>P0	NM_002447.2(MST1R): c.3583G>A (p.G1195S)	SingleClassTriAllelic,InconsistentAlleles;	126370	0.000016	U	1	1	.	.	PASS	0	8652	0.000000	0	121362	0.000016	.	.	.	.	.	.	rs7433231	.	.	.	-0.131	4.343	1.275	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
3	52676065	52676066	3p21.1	0	normal	.	A	ref	A	AC.AA	het-alt	116	0.69	.	1	.	PASS	606083	P	.	NN	.	.	.	.	.	.	.	55193	PBRM1	IC9	IVS10	.	.	no-change	NM_018313.4	NP_060783.3	-	Y	c.996-5T=	.	.	.	NM_018313.4(PBRM1): c.996-5T=	MixedObserved;|MixedObserved;maf-5-some-pop	182|39794	0.983516|0.788536	U	0.0218	0.0127796	.	.	InbreedingCoeff_Filter	.	2536	0.730678	9042	34786	0.759932	.	.	.	.	.	.	rs376663529|rs576272601	.	4024	0.779300	0.377	0.407	0.383	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	52676065	52676066	3p21.1	1	normal	.	A	del	.	AC.AA	het-ref	53	0.31	.	2	.	PASS	606083	P	.	NN	.	.	.	.	.	.	.	55193	PBRM1	IC9	IVS10	.	.	intron	NM_018313.4	NP_060783.3	-	Y	c.996-5delT	.	.	.	NM_018313.4(PBRM1): c.996-5delT	MixedObserved;	182	0.016484	U	.	.	.	.	PASS	0	8364	0.160091	1	116916	0.189752	.	.	.	.	.	.	rs376663529	.	4024	0.135700	0.377	0.407	0.383	.	.	.	.	.	ENST00000356770: c.900-5delT (p.?)	skin [NS|NS|NS]	carcinoma [basal_cell_carcinoma|NS|NS]	CSV	5943950	.	.	.	.	.	.	.	.	.	Benign
3	52696309	52696310	3p21.1	0	normal	.	G	ref	G	GA.AA	het-alt	216	0.86	.	1	.	PASS	606083	P	.	NN	.	.	.	.	.	.	.	55193	PBRM1	IC3	IVS4	.	.	no-change	NM_018313.4	NP_060783.3	-	Y	c.385-18C=	.	.	.	NM_018313.4(PBRM1): c.385-18C=	;	13006	0.999923	U	.	.	13006	0.999923	.	.	.	.	.	.	.	.	.	.	.	.	.	rs370360003	.	4024	0.974700	-0.143	0.104	0.295	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	52696310	52696310	3p21.1	1	normal	.	.	ins	A	AG.AA	het-ref	34	0.14	.	2	.	PASS	606083	P	.	NN	.	.	.	.	.	.	.	55193	PBRM1	IC3	IVS4	.	.	intron	NM_018313.4	NP_060783.3	-	Y	c.385-19_385-18insT	.	.	.	NM_018313.4(PBRM1): c.385-19_385-18insT	;	60081	0.128809	U	.	.	.	.	PASS	0	4788	0.124896	0	68006	0.115946	.	.	.	.	.	.	rs781206124	.	4024	0.108100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	67548726	67548729	3p14.1	0	normal	.	AAG	ref	AAG	TA.AA	het-alt	87	0.47	.	1	.	PASS	603922	P	.	NN	.	.	.	.	.	.	.	8801	SUCLG2	IC7	IVS7	.	.	no-change	NM_001177599.1	NP_001171070.1	-	Y	c.758-10_758-8=	.	.	.	NM_001177599.1(SUCLG2): c.758-10_758-8=	;maf-5-some-pop	123044	0.876369	U	.	.	11366	0.901021	.	.	.	.	.	.	.	.	.	.	.	.	.	rs150352166	.	1340	0.022400	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	67548726	67548729	3p14.1	1	normal	.	AAG	del	.	TA.AA	het-ref	99	0.53	.	2	.	PASS	603922	P	.	NN	.	.	.	.	.	.	.	8801	SUCLG2	IC7	IVS7	.	.	intron	NM_001177599.1	NP_001171070.1	-	Y	c.758-10_758-8delCTT	.	.	.	NM_001177599.1(SUCLG2): c.758-10_758-8delCTT	;maf-5-some-pop	123044	0.123631	U	0.3006	0.196685	11366	0.098979	PASS	390	8364	0.310378	1292	118036	0.120531	813	5243	3.07579e-01	2830	29501	1.20847e-01	rs150352166	.	1340	0.977600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	257602	criteria_provided,_single_submitter	Benign	Benign
3	70014446	70014447	3p13	0	normal	.	T	ref	T	AT.CG	het-alt	183	0.50	.	1	.	PASS	156845	C	103470(MK);103500(MK);193510(MK);614456(SK)	AD;AR;XL	Waardenburg syndrome, type 2A; Tietz albinism-deafness syndrome	AD	Variants may be associated with Melanoma, cutaneous malignant, susceptibility to, 8 (AD); Renal cell carcinoma with or without malignant melanoma (AD) (The OR of melanoma and/or RCC has been reported as >14 in one study) (AD)	Audiologic/Otolaryngologic; Dermatologic; Ophthalmologic	Audiologic/Otolaryngologic	22080950|22012259|20024939|18510545|13985019|10851256|9158138|8589691|7951321|7874167|7702105|7573125|5006208|666627|331943	.	4286	MITF	3U1E	EX9E	.	.	no-change	NM_000248.3	NP_000239.1	+	Y	c.*48T=	.	.	.	NM_000248.3(MITF): c.*48T=	;maf-5-some-pop	123722	0.909798	U	0.0347	0.101438	13006	0.867676	PASS	-160	8402	0.960962	49280	118714	0.910272	.	.	.	.	.	.	rs9863910	.	.	.	-0.313	-0.344	-0.941	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	70014446	70014447	3p13	0	normal	.	T	snv	C	AT.CG	het-ref	186	0.50	.	2	.	PASS	156845	C	103470(MK);103500(MK);193510(MK);614456(SK)	AD;AR;XL	Waardenburg syndrome, type 2A; Tietz albinism-deafness syndrome	AD	Variants may be associated with Melanoma, cutaneous malignant, susceptibility to, 8 (AD); Renal cell carcinoma with or without malignant melanoma (AD) (The OR of melanoma and/or RCC has been reported as >14 in one study) (AD)	Audiologic/Otolaryngologic; Dermatologic; Ophthalmologic	Audiologic/Otolaryngologic	22080950|22012259|20024939|18510545|13985019|10851256|9158138|8589691|7951321|7874167|7702105|7573125|5006208|666627|331943	.	4286	MITF	3U1E	EX9E	.	.	utr-3	NM_000248.3	NP_000239.1	+	Y	c.*48T>C	.	.	.	NM_000248.3(MITF): c.*48T>C	;maf-5-some-pop	123722	0.090202	U	0.0347	0.101438	13006	0.132324	PASS	4	8402	0.039038	575	118714	0.089728	13	609	3.58531e-02	1130	21082	8.76474e-02	rs9863910	.	.	.	-0.313	-0.344	-0.941	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	346504	criteria_provided,_single_submitter	Benign	Benign
3	71008340	71008341	3p13	0	normal	.	G	ref	G	GT.TT	het-alt	41	0.31	.	1	.	PASS	605515	P	613670(MK)	NN	Mental retardation with language impairment and autistic features	AD	.	Neurologic	General	22521361|21572417|20950788|20571508	.	27086	FOXP1	3U1E	EX21E	.	.	no-change	NM_032682.5	NP_116071.2	-	Y	c.*57C=	.	.	.	NM_032682.5(FOXP1): c.*57C=	;	0	0	U	0.4514	0.319688	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs202147567	.	.	.	0.460	2.131	2.667	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	71008341	71008341	3p13	0	normal	.	.	ins	T	TG.TT	het-ref	92	0.69	.	2	.	PASS	605515	P	613670(MK)	NN	Mental retardation with language impairment and autistic features	AD	.	Neurologic	General	22521361|21572417|20950788|20571508	.	27086	FOXP1	3U1E	EX21E	.	.	utr-3	NM_032682.5	NP_116071.2	-	Y	c.*44A[13>14] (std: c.*56dupA alt: c.*56_*57insA )	.	.	.	NM_032682.5(FOXP1): c.*56dupA	;maf-5-some-pop,maf-5-all-pops	5008	0.319688	U	0.4514	0.319688	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs543490335	.	4024	0.427700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	346639	criteria_provided,_single_submitter	Benign	Benign
3	71015020	71015021	3p13	0	normal	.	G	snv	T	CT.TT	hom-alt	373	1.00	.	0	.	PASS	605515	P	613670(MK)	NN	Mental retardation with language impairment and autistic features	AD	.	Neurologic	General	22521361|21572417|20950788|20571508	.	27086	FOXP1	IC15	IVS20	.	.	intron	NM_032682.5	NP_116071.2	-	Y	c.1889+20C>A	.	.	.	NM_032682.5(FOXP1): c.1889+20C>A	;maf-5-some-pop	126420	0.946346	U	1	0.974641	13006	0.941258	PASS	4326	8654	0.999884	54318	121412	0.945178	8623	17247	9.99942e-01	110135	232746	9.45315e-01	rs7638391	.	4024	0.998000	-1.445	-1.697	-1.327	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	96228	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
3	71015020	71015021	3p13	0	nullSample	.	G	ref	G	CT.TT	homo-ref	.	.	.	0	.	.	605515	P	613670(MK)	NN	Mental retardation with language impairment and autistic features	AD	.	Neurologic	General	22521361|21572417|20950788|20571508	.	27086	FOXP1	IC15	IVS20	.	.	no-change	NM_032682.5	NP_116071.2	-	Y	c.1889+20C=	.	.	.	NM_032682.5(FOXP1): c.1889+20C=	;maf-5-some-pop	126420	0.053654	U	1	0.974641	13006	0.058742	PASS	.	8654	0.000116	268	121412	0.054822	.	.	.	.	.	.	rs7638391	.	4024	0.002000	-1.445	-1.697	-1.327	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	71161837	71161838	3p13	0	normal	.	G	ref	G	GG.AC	het-alt	112	0.52	.	1	.	PASS	605515	P	613670(MK)	NN	Mental retardation with language impairment and autistic features	AD	.	Neurologic	General	22521361|21572417|20950788|20571508	.	27086	FOXP1	IC1	IVS6	.	.	no-change	NM_032682.5	NP_116071.2	-	Y	c.181-50C=	.	.	.	NM_032682.5(FOXP1): c.181-50C=	;maf-5-some-pop	125824	0.969124	U	0.1974	0.0569089	13006	0.995387	PASS	.	8472	0.805123	56995	120816	0.970203	.	.	.	.	.	.	rs17008224	.	4024	0.806400	-0.300	0.467	0.782	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	71161837	71161838	3p13	0	normal	.	G	snv	A	GG.AC	het-ref	104	0.48	.	2	.	PASS	605515	P	613670(MK)	NN	Mental retardation with language impairment and autistic features	AD	.	Neurologic	General	22521361|21572417|20950788|20571508	.	27086	FOXP1	IC1	IVS6	.	.	intron	NM_032682.5	NP_116071.2	-	Y	c.181-50C>T	.	.	.	NM_032682.5(FOXP1): c.181-50C>T	;maf-5-some-pop	125824	0.030876	U	0.1974	0.0569089	13006	0.004613	PASS	152	8472	0.194877	187	120816	0.029797	332	3347	1.95274e-01	416	7643	3.11880e-02	rs17008224	.	4024	0.193600	-0.300	0.467	0.782	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	71247303	71247304	3p13	0	normal	.	A	ref	A	GT.AA	het-alt	168	0.48	.	1	.	PASS	605515	P	613670(MK)	NN	Mental retardation with language impairment and autistic features	AD	.	Neurologic	General	22521361|21572417|20950788|20571508	.	27086	FOXP1	IC1	IVS6	.	.	no-change	NM_032682.5	NP_116071.2	-	Y	c.180+49T=	.	.	.	NM_032682.5(FOXP1): c.180+49T=	MixedObserved;maf-5-some-pop,maf-5-all-pops	125884	0.795852	U	0.4355	0.282348	13006	0.834307	PASS	-1043	8582	0.592403	39507	120876	0.799092	.	.	.	.	.	.	rs2037474	.	4024	0.575300	0.460	-0.555	-0.801	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	71247303	71247304	3p13	0	normal	.	A	snv	G	GT.AA	het-ref	180	0.52	.	2	.	PASS	605515	P	613670(MK)	NN	Mental retardation with language impairment and autistic features	AD	.	Neurologic	General	22521361|21572417|20950788|20571508	.	27086	FOXP1	IC1	IVS6	.	.	intron	NM_032682.5	NP_116071.2	-	Y	c.180+49T>C	.	.	.	NM_032682.5(FOXP1): c.180+49T>C	MixedObserved;maf-5-some-pop,maf-5-all-pops	125884	0.204148	U	0.4355	0.282348	13006	0.165693	PASS	706	8582	0.407597	3354	120876	0.200908	1401	6920	4.01765e-01	7221	51215	2.08401e-01	rs2037474	.	4024	0.424700	0.460	-0.555	-0.801	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	71247571	71247572	3p13	0	normal	.	A	ref	A	GG.GG	het-alt	29	0.63	.	1	.	PASS	605515	P	613670(MK)	NN	Mental retardation with language impairment and autistic features	AD	.	Neurologic	General	22521361|21572417|20950788|20571508	.	27086	FOXP1	I5U1	IVS5	.	.	no-change	NM_032682.5	NP_116071.2	-	Y	c.-11-29T=	.	.	.	NM_032682.5(FOXP1): c.-11-29T=	SingleClassTriAllelic;maf-5-some-pop,maf-5-all-pops|MixedObserved;	92539|111579	0.661256|0.999973	U	0.1062	0.26258	12472	0.722498	PASS	-409	5830	0.842882	17887	87620	0.656231	.	.	.	.	.	.	rs56850311|rs770353752	.	4021	0.907500	-5.177	-1.362	-2.118	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	71247571	71247572	3p13	0	normal	.	A	snv	T	GG.GG	het-ref	17	0.37	.	2	.	PASS	605515	P	613670(MK)	NN	Mental retardation with language impairment and autistic features	AD	.	Neurologic	General	22521361|21572417|20950788|20571508	.	27086	FOXP1	I5U1	IVS5	.	.	intron	NM_032682.5	NP_116071.2	-	Y	c.-11-29T>A	.	.	.	NM_032682.5(FOXP1): c.-11-29T>A	SingleClassTriAllelic;maf-5-some-pop,maf-5-all-pops	92539	0.336410	U	0.1062	0.26258	12472	0.277502	PASS	44	5830	0.153516	4053	87620	0.340288	.	.	.	.	.	.	rs56850311	.	4021	0.090000	-5.177	-1.362	-2.118	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	71247575	71247576	3p13	0	normal	.	A	ref	A	GG.GG	het-alt	8	0.30	.	1	.	PASS	605515	P	613670(MK)	NN	Mental retardation with language impairment and autistic features	AD	.	Neurologic	General	22521361|21572417|20950788|20571508	.	27086	FOXP1	I5U1	IVS5	.	.	no-change	NM_032682.5	NP_116071.2	-	Y	c.-11-33T=	.	.	.	NM_032682.5(FOXP1): c.-11-33T=	MixedObserved;|MixedObserved,SingleClassTriAllelic;maf-5-some-pop,maf-5-all-pops	110345|5008	0.999937|0.287340	U	0.0456	0.0910543	12138	0.336382	.	.	.	.	.	.	.	.	.	.	.	.	.	rs753851345|rs9855825	.	3833	0.325800	-2.675	-1.281	-1.402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	71247575	71247576	3p13	0	normal	.	A	del	.	GG.GG	het-ref	19	0.70	.	2	.	PASS	605515	P	613670(MK)	NN	Mental retardation with language impairment and autistic features	AD	.	Neurologic	General	22521361|21572417|20950788|20571508	.	27086	FOXP1	I5U1	IVS5	.	.	intron	NM_032682.5	NP_116071.2	-	Y	c.-11-33delT	.	.	.	NM_032682.5(FOXP1): c.-11-33delT	MixedObserved;	110345	0.000063	U	.	.	12138	0	VQSRTrancheINDEL95.00to96.00	0	8322	0.000000	0	110382	0.000063	0	0	0.00000e+00	0	8	3.59770e-05	rs753851345	.	3833	0	-2.675	-1.281	-1.402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
3	71247576	71247577	3p13	0	normal	.	G	ref	G	GA.GG	het-alt	6	0.24	.	1	.	DUBIOUS	605515	P	613670(MK)	NN	Mental retardation with language impairment and autistic features	AD	.	Neurologic	General	22521361|21572417|20950788|20571508	.	27086	FOXP1	I5U1	IVS5	.	.	no-change	NM_032682.5	NP_116071.2	-	Y	c.-11-34C=	.	.	.	NM_032682.5(FOXP1): c.-11-34C=	MixedObserved;|MixedObserved,SingleClassTriAllelic;	27207|114414	0.999779|0.999869	U	.	.	.	.	PASS	0	8376	1.000000	57193	114414	0.999869	.	.	.	.	.	.	rs747142970|rs762803844	.	.	.	-0.345	-0.481	-0.504	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	71247576	71247577	3p13	0	normal	.	G	snv	T	GA.GG	het-ref	19	0.76	.	2	.	PASS	605515	P	613670(MK)	NN	Mental retardation with language impairment and autistic features	AD	.	Neurologic	General	22521361|21572417|20950788|20571508	.	27086	FOXP1	I5U1	IVS5	.	.	intron	NM_032682.5	NP_116071.2	-	Y	c.-11-34C>A	.	.	.	NM_032682.5(FOXP1): c.-11-34C>A	MixedObserved,SingleClassTriAllelic;	114414	0.000087	U	.	.	.	.	PASS	0	8376	0.000000	0	114414	0.000087	0	0	0.00000e+00	0	9	4.05427e-05	rs762803844	.	.	.	-0.345	-0.481	-0.504	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
3	105422843	105422844	3q13.11	0	nullSample	.	C	ref	C	CC.GT	homo-ref	.	.	.	0	.	.	604491	P	.	NN	.	.	.	.	.	.	.	868	CBLB	C10	EX11	.	.	no-change	NM_170662.3	NP_733762.2	-	Y	c.1581G=	.	.	.	NM_170662.3(CBLB): c.1581G=	;maf-5-some-pop,maf-5-all-pops	126338	0.268526	U	0.7788	0.750998	13006	0.263109	PASS	-790	8636	0.235757	4603	121330	0.269332	.	.	.	.	.	.	rs2305037	.	4024	0.239300	-1.655	-0.753	-0.818	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	105422843	105422844	3q13.11	1	normal	.	C	snv	T	CC.GT	hom-alt	258	1.00	.	0	.	PASS	604491	P	.	NN	.	.	.	.	.	.	.	868	CBLB	C10	EX11	.	.	coding-synon	NM_170662.3	NP_733762.2	-	Y	c.1581G>A	p.(T527=) | p.(Thr527=)	ACG=>ACA	.	NM_170662.3(CBLB): c.1581G>A (p.(T527=))	;maf-5-some-pop,maf-5-all-pops	126338	0.731474	U	0.7788	0.750998	13006	0.736891	PASS	2510	8636	0.764243	32590	121330	0.730668	4993	13129	7.61543e-01	65450	178805	7.26726e-01	rs2305037	.	4024	0.760700	-1.655	-0.753	-0.818	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
3	119534152	119534153	3q13.33	0	normal	.	C	ref	C	AT.CT	het-alt	231	0.55	.	1	.	PASS	603065	P	.	NN	.	.	.	.	.	.	.	8856	NR1I2	IC5	IVS6	.	.	no-change	NM_003889.3	NP_003880.3	+	Y	c.938-17C=	.	.	.	NM_003889.3(NR1I2): c.938-17C=	SingleClassTriAllelic;maf-5-some-pop	126172	0.752235	U	0	0.00219649	13006	0.757573	PASS	-1094	8628	0.530598	35094	121164	0.755299	.	.	.	.	.	.	rs2276707	.	4024	0.528100	0.561	0.929	0.433	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	119534152	119534153	3q13.33	1	normal	.	C	snv	T	AT.CT	het-ref	190	0.45	.	2	.	PASS	603065	P	.	NN	.	.	.	.	.	.	.	8856	NR1I2	IC5	IVS6	.	.	intron	NM_003889.3	NP_003880.3	+	Y	c.938-17C>T	.	.	.	NM_003889.3(NR1I2): c.938-17C>T	SingleClassTriAllelic;maf-5-some-pop	126172	0.247202	U	0.4663	0.319688	13006	0.242427	PASS	931	8628	0.469402	4137	121164	0.244206	1871	8011	4.64621e-01	7933	58693	2.38545e-01	rs2276707	.	4024	0.471900	0.561	0.929	0.433	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	119537253	119537254	3q13.33	0	normal	.	A	ref	A	TA.GA	het-alt	211	0.59	.	1	.	PASS	603065	P	.	NN	.	.	.	.	.	.	.	8856	NR1I2	3U1E	EX9E	.	.	no-change	NM_003889.3	NP_003880.3	+	Y	c.*1195A=	.	.	.	NM_003889.3(NR1I2): c.*1195A=	;maf-5-some-pop,maf-5-all-pops	5008	0.651957	U	0.4712	0.348043	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3814057	.	.	.	0.482	0.289	0.242	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	119537253	119537254	3q13.33	0	normal	.	A	snv	C	TA.GA	het-ref	146	0.41	.	2	.	PASS	603065	P	.	NN	.	.	.	.	.	.	.	8856	NR1I2	3U1E	EX9E	.	.	utr-3	NM_003889.3	NP_003880.3	+	Y	c.*1195A>C	.	.	.	NM_003889.3(NR1I2): c.*1195A>C	;maf-5-some-pop,maf-5-all-pops	5008	0.348043	U	0.4712	0.348043	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3814057	.	.	.	0.482	0.289	0.242	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	119537290	119537291	3q13.33	0	normal	.	T	ref	T	TG.CA	het-alt	232	0.58	.	1	.	PASS	603065	P	.	NN	.	.	.	.	.	.	.	8856	NR1I2	3U1E	EX9E	.	.	no-change	NM_003889.3	NP_003880.3	+	Y	c.*1232T=	.	.	.	NM_003889.3(NR1I2): c.*1232T=	;maf-5-some-pop,maf-5-all-pops	5008	0.651757	U	0.4722	0.348243	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3814058	.	.	.	0.482	0.829	0.763	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	119537290	119537291	3q13.33	0	normal	.	T	snv	C	TG.CA	het-ref	166	0.42	.	2	.	PASS	603065	P	.	NN	.	.	.	.	.	.	.	8856	NR1I2	3U1E	EX9E	.	.	utr-3	NM_003889.3	NP_003880.3	+	Y	c.*1232T>C	.	.	.	NM_003889.3(NR1I2): c.*1232T>C	;maf-5-some-pop,maf-5-all-pops	5008	0.348243	U	0.4722	0.348243	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3814058	.	.	.	0.482	0.829	0.763	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	119537352	119537353	3q13.33	0	nullSample	.	T	ref	T	GC.TT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr3: g.119537352T= (intergenic)	;	5008	0.006190	U	1	0.99381	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2461826	.	.	.	-0.119	0.007	0.001	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	119537352	119537353	3q13.33	0	normal	.	T	snv	C	GC.TT	hom-alt	229	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr3: g.119537352T>C (intergenic)	;	5008	0.993810	U	1	0.99381	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2461826	.	.	.	-0.119	0.007	0.001	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	121351314	121351315	3q13.33	0	nullSample	.	G	ref	G	tc.gg	homo-ref	.	.	.	0	trf	.	601306	P	.	NN	.	.	.	.	.	.	.	3059	HCLS1	C11	EX12	.	.	no-change	NM_005335.4	NP_005326.2	-	Y	c.1104C=	.	.	.	NM_005335.4(HCLS1): c.1104C=	NonIntegerChromCount;maf-5-some-pop,maf-5-all-pops	392.000016	0.936263	U	0.4563	0.241214	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs80289672	.	.	.	-0.587	-1.536	-1.385	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	121351315	121351315	3q13.33	1	normal	.	.	ins	GGCTCAGGCTCA	cg.gg	hom-alt	238	0.99	.	0	trf	PASS	601306	P	.	NN	.	.	.	.	.	.	.	3059	HCLS1	C11	EX12	.	.	cds-ins	NM_005335.4	NP_005326.2	-	Y	c.1092TGAGCC[2>4] (std: c.1092TGAGCC[4] alt: c.1103_1104insTGAGCCTGAGCC )	p.P364_E365[6>8] (std: p.P364_E365[8] alt: p.E375_N376insPEPE ) | p.Pro364_Glu365[6>8] (std: p.Pro364_Glu365[8] alt: p.Glu375_Asn376insProGluProGlu )	.	.	NM_005335.4(HCLS1): c.1092TGAGCC[4] (p.P364_E365[8])	;maf-5-some-pop,maf-5-all-pops	5008	0.241214	U	0.4563	0.241214	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs150627065	.	4024	0.433200	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	121353253	121353254	3q13.33	0	nullSample	.	T	ref	T	GG.AC	homo-ref	.	.	.	0	.	.	601306	P	.	NN	.	.	.	.	.	.	.	3059	HCLS1	C9	EX10	.	.	no-change	NM_005335.4	NP_005326.2	-	Y	c.703A=	.	.	.	NM_005335.4(HCLS1): c.703A=	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	126146	0.302221	U	0.8492	0.651558	13006	0.288636	PASS	-552	8648	0.150555	6495	121138	0.300310	.	.	.	.	.	.	rs2070179	.	4024	0.155800	-0.197	2.606	1.472	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	121353253	121353254	3q13.33	1	normal	.	T	snv	C	GG.AC	hom-alt	536	1.00	.	0	.	PASS	601306	P	.	NN	.	.	.	.	.	.	.	3059	HCLS1	C9	EX10	.	.	missense	NM_005335.4	NP_005326.2	-	Y	c.703A>G	p.T235A | p.Thr235Ala	ACC=>GCC	P0=>NP	NM_005335.4(HCLS1): c.703A>G (p.T235A)	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	126146	0.697771	U	0.8492	0.651558	13006	0.711364	PASS	3121	8648	0.849445	30684	121138	0.699681	6247	14683	8.51583e-01	60367	168567	6.89526e-01	rs2070179	.	4024	0.844200	-0.197	2.606	1.472	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
3	134514578	134514579	3q22.2	0	nullSample	.	T	ref	T	CT.GG	homo-ref	.	.	.	0	.	.	600600	P	.	NN	.	.	.	.	.	.	.	2047	EPHB1	IC1	IVS1	.	.	no-change	NM_004441.4	NP_004432.1	+	Y	c.58+48T=	.	.	.	NM_004441.4(EPHB1): c.58+48T=	SingleClassTriAllelic;maf-5-some-pop	125154	0.006432	U	1	0.978634	12438	0.019296	PASS	.	8580	0.000117	21	120146	0.005810	.	.	.	.	.	.	rs9852662	.	.	.	-1.295	-0.274	-0.036	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	134514578	134514579	3q22.2	0	normal	.	T	snv	C	CT.GG	hom-alt	176	1.00	.	0	.	PASS	600600	P	.	NN	.	.	.	.	.	.	.	2047	EPHB1	IC1	IVS1	.	.	intron	NM_004441.4	NP_004432.1	+	Y	c.58+48T>C	.	.	.	NM_004441.4(EPHB1): c.58+48T>C	SingleClassTriAllelic;maf-5-some-pop	125154	0.993528	U	1	0.978634	12438	0.980704	PASS	4289	8580	0.999883	59391	120146	0.994149	8174	16348	1.00000e+00	117382	235808	9.95340e-01	rs9852662	.	.	.	-1.295	-0.274	-0.036	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	134670523	134670524	3q22.2	0	normal	.	C	ref	C	AG.TT	het-alt	278	0.48	.	1	.	PASS	600600	P	.	NN	.	.	.	.	.	.	.	2047	EPHB1	C3	EX3	Ephrin receptor ligand binding domain	PF01404.14	no-change	NM_004441.4	NP_004432.1	+	Y	c.435C=	.	.	.	NM_004441.4(EPHB1): c.435C=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125768	0.536488	U	0.2123	0.48143	12368	0.512128	PASS	.	8620	0.811021	18045	120760	0.537231	.	.	.	.	.	.	rs7644369	.	.	.	0.655	3.398	2.578	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	134670523	134670524	3q22.2	1	normal	.	C	snv	T	AG.TT	het-ref	305	0.52	.	2	.	PASS	600600	P	.	NN	.	.	.	.	.	.	.	2047	EPHB1	C3	EX3	Ephrin receptor ligand binding domain	PF01404.14	coding-synon	NM_004441.4	NP_004432.1	+	Y	c.435C>T	p.(S145=) | p.(Ser145=)	AGC=>AGT	.	NM_004441.4(EPHB1): c.435C>T (p.(S145=))	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125768	0.463512	U	0.2123	0.48143	12368	0.487872	PASS	172	8620	0.188979	13549	120760	0.462769	340	3332	1.93182e-01	27050	112946	4.58910e-01	rs7644369	.	.	.	0.655	3.398	2.578	.	.	.	.	.	ENST00000398015: c.435C>T (p.S145S)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3759780	.	.	.	.	.	.	.	.	.	Likely Benign
3	138400782	138400783	3q22.3	0	normal	.	A	ref	A	TG.AA	het-alt	154	0.77	.	1	.	PASS	602925	P	.	NN	.	.	.	.	.	.	.	5291	PIK3CB	IC17	IVS17	.	.	no-change	NM_006219.2	NP_006210.1	-	Y	c.2504+26T=	.	.	.	NM_006219.2(PIK3CB): c.2504+26T=	MixedObserved;	566	0.978799	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs145780817	.	4024	0.839000	0.477	0.762	0.147	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	138400782	138400783	3q22.3	0	normal	.	A	del	.	TG.AA	het-ref	47	0.23	.	2	.	PASS	602925	P	.	NN	.	.	.	.	.	.	.	5291	PIK3CB	IC17	IVS17	.	.	intron	NM_006219.2	NP_006210.1	-	Y	c.2504+26delT	.	.	.	NM_006219.2(PIK3CB): c.2504+26delT	MixedObserved;	566	0.021201	U	.	.	.	.	PASS	0	4284	0.308590	2	64108	0.310694	.	.	.	.	.	.	rs145780817	.	4024	0.161000	0.477	0.762	0.147	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	138403389	138403390	3q22.3	0	nullSample	.	C	ref	C	GG.CC	homo-ref	.	.	.	0	.	.	602925	P	.	NN	.	.	.	.	.	.	.	5291	PIK3CB	IC15	IVS15	.	.	no-change	NM_006219.2	NP_006210.1	-	Y	c.2315+77G=	.	.	.	NM_006219.2(PIK3CB): c.2315+77G=	;maf-5-some-pop	5008	0.421326	U	0.9841	0.578674	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs625468	.	4020	0.010200	0.591	0.668	1.086	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	138403389	138403390	3q22.3	0	normal	.	C	snv	T	GG.CC	hom-alt	283	1.00	.	0	.	PASS	602925	P	.	NN	.	.	.	.	.	.	.	5291	PIK3CB	IC15	IVS15	.	.	intron	NM_006219.2	NP_006210.1	-	Y	c.2315+77G>A	.	.	.	NM_006219.2(PIK3CB): c.2315+77G>A	;maf-5-some-pop	5008	0.578674	U	0.9841	0.578674	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs625468	.	4020	0.989800	0.591	0.668	1.086	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	138417988	138417989	3q22.3	0	nullSample	.	G	ref	G	GC.AA	homo-ref	.	.	.	0	.	.	602925	P	.	NN	.	.	.	.	.	.	.	5291	PIK3CB	IC10	IVS10	.	.	no-change	NM_006219.2	NP_006210.1	-	Y	c.1582-52C=	.	.	.	NM_006219.2(PIK3CB): c.1582-52C=	;maf-5-some-pop	75740	0.356839	U	0.9841	0.703275	6596	0.417829	PASS	-24	5036	0.009531	4864	70732	0.361095	.	.	.	.	.	.	rs361080	.	4024	0.011200	-0.550	0.206	0.325	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	138417988	138417989	3q22.3	0	normal	.	G	snv	A	GC.AA	hom-alt	284	1.00	.	0	.	PASS	602925	P	.	NN	.	.	.	.	.	.	.	5291	PIK3CB	IC10	IVS10	.	.	intron	NM_006219.2	NP_006210.1	-	Y	c.1582-52C>T	.	.	.	NM_006219.2(PIK3CB): c.1582-52C>T	;maf-5-some-pop	75740	0.643161	U	0.9841	0.703275	6596	0.582171	PASS	2470	5036	0.990469	14689	70732	0.638905	3173	6411	9.89657e-01	22302	69908	6.23588e-01	rs361080	.	4024	0.988800	-0.550	0.206	0.325	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	138430998	138430999	3q22.3	0	normal	.	T	ref	T	CA.GC	het-alt	129	0.50	.	1	.	PASS	602925	P	.	NN	.	.	.	.	.	.	.	5291	PIK3CB	IC8	IVS8	.	.	no-change	NM_006219.2	NP_006210.1	-	Y	c.1399+51A=	.	.	.	NM_006219.2(PIK3CB): c.1399+51A=	;	115380	0.999463	U	0.004	0.000798722	.	.	PASS	.	7710	0.993904	55128	110372	0.999475	.	.	.	.	.	.	rs190565424	.	4024	0.988600	0.460	-0.554	-0.219	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	138430998	138430999	3q22.3	0	normal	.	T	snv	C	CA.GC	het-ref	127	0.50	.	2	.	PASS	602925	P	.	NN	.	.	.	.	.	.	.	5291	PIK3CB	IC8	IVS8	.	.	intron	NM_006219.2	NP_006210.1	-	Y	c.1399+51A>G	.	.	.	NM_006219.2(PIK3CB): c.1399+51A>G	;	115380	0.000537	U	0.004	0.000798722	.	.	PASS	0	7710	0.006096	0	110372	0.000525	1	70	5.67261e-03	1	96	4.90918e-04	rs190565424	.	4024	0.011400	0.460	-0.554	-0.219	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
3	138433567	138433568	3q22.3	0	nullSample	.	C	ref	C	AA.GA	homo-ref	.	.	.	0	.	.	602925	P	.	NN	.	.	.	.	.	.	.	5291	PIK3CB	IC6	IVS6	.	.	no-change	NM_006219.2	NP_006210.1	-	Y	c.1051-7G=	.	.	.	NM_006219.2(PIK3CB): c.1051-7G=	;maf-5-some-pop,genotype-conflict	125458	0.374460	U	0.9841	0.701877	13004	0.439711	PASS	-42	8648	0.009713	9688	120450	0.377634	.	.	.	.	.	.	rs497900	.	4024	0.011200	-1.135	-2.169	-1.834	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	138433567	138433568	3q22.3	1	normal	.	C	snv	T	AA.GA	hom-alt	571	1.00	.	0	.	PASS	602925	P	.	NN	.	.	.	.	.	.	.	5291	PIK3CB	IC6	IVS6	.	.	intron	NM_006219.2	NP_006210.1	-	Y	c.1051-7G>A	.	.	.	NM_006219.2(PIK3CB): c.1051-7G>A	;maf-5-some-pop,genotype-conflict	125458	0.625540	U	0.9841	0.701877	13004	0.560289	PASS	4240	8648	0.990287	24427	120450	0.622366	7721	15597	9.90034e-01	44445	135605	6.25288e-01	rs497900	.	4024	0.988800	-1.135	-2.169	-1.834	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	142168330	142168331	3q23	0	nullSample	.	C	ref	C	TC.TG	homo-ref	.	.	.	0	.	.	601215	C	210600(MK);614564(MK)	AR	Cutaneous telangiectasia and cancer syndrome, familial; Seckel syndrome 1	AD/AR	.	Craniofacial; Dental; Dermatologic; Musculoskeletal; Neurologic; Oncologic	Oncologic	22341969|13869653|12640452|10889046|9128935|8358044|8182723|7046443|6022184|4378248	.	545	ATR	C47E	EX47E	FATC domain	PF02260.15	no-change	NM_001184.3	NP_001175.2	-	Y	c.7875G=	.	.	.	NM_001184.3(ATR): c.7875G=	;maf-5-some-pop	126394	0.133345	U	0.9266	0.916334	13006	0.102184	PASS	-276	8654	0.069794	1407	121386	0.135395	.	.	.	.	.	.	rs1802904	.	4024	0.058600	-1.079	0.319	-0.397	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	142168330	142168331	3q23	1	normal	.	C	snv	T	TC.TG	hom-alt	587	1.00	.	0	.	PASS	601215	C	210600(MK);614564(MK)	AR	Cutaneous telangiectasia and cancer syndrome, familial; Seckel syndrome 1	AD/AR	.	Craniofacial; Dental; Dermatologic; Musculoskeletal; Neurologic; Oncologic	Oncologic	22341969|13869653|12640452|10889046|9128935|8358044|8182723|7046443|6022184|4378248	.	545	ATR	C47E	EX47E	FATC domain	PF02260.15	coding-synon	NM_001184.3	NP_001175.2	-	Y	c.7875G>A	p.(Q2625=) | p.(Gln2625=)	CAG=>CAA	.	NM_001184.3(ATR): c.7875G>A (p.(Q2625=))	;maf-5-some-pop	126394	0.866655	U	0.9266	0.916334	13006	0.897816	PASS	3749	8654	0.930206	45665	121386	0.864605	7516	16093	9.33036e-01	91046	211108	8.57410e-01	rs1802904	.	4024	0.941400	-1.079	0.319	-0.397	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	93669	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
3	142241691	142241692	3q23	0	normal	.	G	ref	G	CA.AA	het-alt	138	0.85	.	1	.	PASS	601215	C	210600(MK);614564(MK)	AR	Cutaneous telangiectasia and cancer syndrome, familial; Seckel syndrome 1	AD/AR	.	Craniofacial; Dental; Dermatologic; Musculoskeletal; Neurologic; Oncologic	Oncologic	22341969|13869653|12640452|10889046|9128935|8358044|8182723|7046443|6022184|4378248	.	545	ATR	IC22	IVS22	.	.	no-change	NM_001184.3	NP_001175.2	-	Y	c.4153-9C=	.	.	.	NM_001184.3(ATR): c.4153-9C=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.979400	-1.279	-0.018	-0.031	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	142241692	142241692	3q23	1	normal	.	.	ins	A	AG.AA	het-ref	25	0.15	.	2	.	PASS	601215	C	210600(MK);614564(MK)	AR	Cutaneous telangiectasia and cancer syndrome, familial; Seckel syndrome 1	AD/AR	.	Craniofacial; Dental; Dermatologic; Musculoskeletal; Neurologic; Oncologic	Oncologic	22341969|13869653|12640452|10889046|9128935|8358044|8182723|7046443|6022184|4378248	.	545	ATR	IC22	IVS22	.	.	intron	NM_001184.3	NP_001175.2	-	Y	c.4153-10_4153-9insT	.	.	.	NM_001184.3(ATR): c.4153-10_4153-9insT	MixedObserved;rs-cluster-nonoverlapping-alleles	81661	0.080210	U	.	.	.	.	PASS	0	5816	0.263583	0	81728	0.246011	.	.	.	.	.	.	rs112116713	.	4024	0.207300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	195738	criteria_provided,_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	Likely Benign
3	142259706	142259707	3q23	0	normal	.	A	ref	A	GC.aa	het-alt	207	0.75	.	1	AT_rich|Low_complexity|Low_complexity|+|22	PASS	601215	C	210600(MK);614564(MK)	AR	Cutaneous telangiectasia and cancer syndrome, familial; Seckel syndrome 1	AD/AR	.	Craniofacial; Dental; Dermatologic; Musculoskeletal; Neurologic; Oncologic	Oncologic	22341969|13869653|12640452|10889046|9128935|8358044|8182723|7046443|6022184|4378248	.	545	ATR	IC18	IVS18	.	.	no-change	NM_001184.3	NP_001175.2	-	Y	c.3581+39T=	.	.	.	NM_001184.3(ATR): c.3581+39T=	MixedObserved;	10643	0.974631	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs201551475	.	4024	0.521400	0.240	-0.167	0.243	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	142259706	142259707	3q23	0	normal	.	A	del	.	GC.aa	het-ref	68	0.25	.	2	AT_rich|Low_complexity|Low_complexity|+|22	PASS	601215	C	210600(MK);614564(MK)	AR	Cutaneous telangiectasia and cancer syndrome, familial; Seckel syndrome 1	AD/AR	.	Craniofacial; Dental; Dermatologic; Musculoskeletal; Neurologic; Oncologic	Oncologic	22341969|13869653|12640452|10889046|9128935|8358044|8182723|7046443|6022184|4378248	.	545	ATR	IC18	IVS18	.	.	intron	NM_001184.3	NP_001175.2	-	Y	c.3581+39delT	.	.	.	NM_001184.3(ATR): c.3581+39delT	MixedObserved;	10643	0.025369	U	.	.	.	.	PASS	2	730	0.450685	74	22678	0.457404	.	.	.	.	.	.	rs201551475	.	4024	0.478400	0.240	-0.167	0.243	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	142272275	142272277	3q23	0	normal	.	AC	ref	AC	aa.ac	het-alt	122	0.81	.	1	(CA)n|Simple_repeat|Simple_repeat|+|41;trf	PASS	601215	C	210600(MK);614564(MK)	AR	Cutaneous telangiectasia and cancer syndrome, familial; Seckel syndrome 1	AD/AR	.	Craniofacial; Dental; Dermatologic; Musculoskeletal; Neurologic; Oncologic	Oncologic	22341969|13869653|12640452|10889046|9128935|8358044|8182723|7046443|6022184|4378248	.	545	ATR	IC12	IVS12	.	.	no-change	NM_001184.3	NP_001175.2	-	Y	c.2634-37_2634-36=	.	.	.	NM_001184.3(ATR): c.2634-37_2634-36=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs796162248	.	4024	0.821100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	142272275	142272277	3q23	0	normal	.	AC	del	.	aa.ac	het-ref	29	0.19	.	2	(CA)n|Simple_repeat|Simple_repeat|+|41;trf	PASS	601215	C	210600(MK);614564(MK)	AR	Cutaneous telangiectasia and cancer syndrome, familial; Seckel syndrome 1	AD/AR	.	Craniofacial; Dental; Dermatologic; Musculoskeletal; Neurologic; Oncologic	Oncologic	22341969|13869653|12640452|10889046|9128935|8358044|8182723|7046443|6022184|4378248	.	545	ATR	IC12	IVS12	.	.	intron	NM_001184.3	NP_001175.2	-	Y	c.2634-37_2634-36delGT	.	.	.	NM_001184.3(ATR): c.2634-37_2634-36delGT	MixedObserved;	0	0	U	.	.	.	.	PASS	0	5332	0.128282	1	85026	0.109449	.	.	.	.	.	.	rs796162248	.	4024	0.178700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	155642985	155642986	3q25.31	0	nullSample	.	C	ref	C	AC.TT	homo-ref	.	.	.	0	.	.	600358	C	601626(MK)	NN	.	.	.	.	.	.	.	8833	GMPS	IC11	IVS11	.	.	no-change	NM_003875.2	NP_003866.1	+	Y	c.1435-44C=	.	.	.	NM_003875.2(GMPS): c.1435-44C=	;maf-5-some-pop	124702	0.931252	U	0.1587	0.0816693	11856	0.970057	PASS	-655	8568	0.819328	52115	119694	0.931793	.	.	.	.	.	.	rs76515101	.	4024	0.831300	-0.150	-1.358	-1.097	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	155642985	155642986	3q25.31	0	normal	.	C	snv	T	AC.TT	hom-alt	219	1.00	.	0	.	PASS	600358	C	601626(MK)	NN	.	.	.	.	.	.	.	8833	GMPS	IC11	IVS11	.	.	intron	NM_003875.2	NP_003866.1	+	Y	c.1435-44C>T	.	.	.	NM_003875.2(GMPS): c.1435-44C>T	;maf-5-some-pop	124702	0.068748	U	0.1587	0.0816693	11856	0.029943	PASS	119	8568	0.180672	432	119694	0.068207	254	3006	1.83405e-01	781	15377	6.70069e-02	rs76515101	.	4024	0.168700	-0.150	-1.358	-1.097	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	155643186	155643187	3q25.31	0	nullSample	.	T	ref	T	TA.AC	homo-ref	.	.	.	0	.	.	600358	C	601626(MK)	NN	.	.	.	.	.	.	.	8833	GMPS	IC12	IVS12	.	.	no-change	NM_003875.2	NP_003866.1	+	Y	c.1560+32T=	.	.	.	NM_003875.2(GMPS): c.1560+32T=	;maf-5-some-pop	40824	0.891755	U	0.1587	0.0942492	11900	0.957731	PASS	-163	1604	0.759352	14213	35816	0.889798	.	.	.	.	.	.	rs75611544	.	4024	0.831300	-1.381	-0.763	-1.409	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	155643186	155643187	3q25.31	0	normal	.	T	snv	C	TA.AC	hom-alt	220	1.00	.	0	.	PASS	600358	C	601626(MK)	NN	.	.	.	.	.	.	.	8833	GMPS	IC12	IVS12	.	.	intron	NM_003875.2	NP_003866.1	+	Y	c.1560+32T>C	.	.	.	NM_003875.2(GMPS): c.1560+32T>C	;maf-5-some-pop	40824	0.108245	U	0.1587	0.0942492	11900	0.042269	PASS	30	1604	0.240648	252	35816	0.110202	183	1929	2.06266e-01	670	11870	8.98548e-02	rs75611544	.	4024	0.168700	-1.381	-0.763	-1.409	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	155643189	155643192	3q25.31	0	nullSample	.	TTT	ref	TTT	AC.tt	homo-ref	.	.	.	0	AluSx|SINE|Alu|-|107	.	600358	C	601626(MK)	NN	.	.	.	.	.	.	.	8833	GMPS	IC12	IVS12	.	.	no-change	NM_003875.2	NP_003866.1	+	Y	c.1560+35_1560+37=	.	.	.	NM_003875.2(GMPS): c.1560+35_1560+37=	MixedObserved;maf-5-some-pop	8581	0.942431	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs200488171	.	4024	0.830500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	155643189	155643192	3q25.31	0	normal	.	TTT	del	.	AC.tt	hom-alt	212	1.00	.	0	AluSx|SINE|Alu|-|107	PASS	600358	C	601626(MK)	NN	.	.	.	.	.	.	.	8833	GMPS	IC12	IVS12	.	.	intron	NM_003875.2	NP_003866.1	+	Y	c.1560+35_1560+37delTTT	.	.	.	NM_003875.2(GMPS): c.1560+35_1560+37delTTT	MixedObserved;maf-5-some-pop	8581	0.057569	U	0.1597	0.095647	.	.	PASS	7	804	0.231343	99	18706	0.134716	.	.	.	.	.	.	rs200488171	.	4024	0.162800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	169482334	169482335	3q26.2	0	normal	.	T	ref	T	CA.TG	het-alt	117	0.52	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr3: g.169482334T= (intergenic)	;maf-5-some-pop	5008	0.730232	U	0.5744	0.269768	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2293607	.	.	.	-1.321	-1.980	-1.854	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	169482334	169482335	3q26.2	0	normal	.	T	snv	C	CA.TG	het-ref	109	0.48	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr3: g.169482334T>C (intergenic)	;maf-5-some-pop	5008	0.269768	U	0.5744	0.269768	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2293607	.	.	.	-1.321	-1.980	-1.854	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	440330	criteria_provided,_single_submitter	Benign	Benign
3	178785548	178785549	3q26.32	0	nullSample	.	G	ref	G	GG.AA	homo-ref	.	.	.	0	.	.	606452	P	.	NN	.	.	.	.	.	.	.	64393	ZMAT3	5U1	EX2	.	.	no-change	NM_022470.3	NP_071915.1	-	Y	c.-9C=	.	.	.	NM_022470.3(ZMAT3): c.-9C=	;maf-5-some-pop	126376	0.188865	U	0.9405	0.874601	13006	0.186529	PASS	.	8654	0.056737	2565	121368	0.191484	.	.	.	.	.	.	rs6772028	.	.	.	-0.360	1.717	0.491	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	178785548	178785549	3q26.32	0	normal	.	G	snv	A	GG.AA	hom-alt	477	1.00	.	0	.	PASS	606452	P	.	NN	.	.	.	.	.	.	.	64393	ZMAT3	5U1	EX2	.	.	utr-5	NM_022470.3	NP_071915.1	-	Y	c.-9C>T	.	.	.	NM_022470.3(ZMAT3): c.-9C>T	;maf-5-some-pop	126376	0.811135	U	0.9405	0.874601	13006	0.813471	PASS	3855	8654	0.943263	40009	121368	0.808516	7654	16247	9.41964e-01	80087	197710	8.04235e-01	rs6772028	.	.	.	-0.360	1.717	0.491	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	178919396	178919397	3q26.32	0	normal	.	A	ref	A	GT.tt	het-alt	49	0.59	.	1	.	PASS	171834	P	114480(MK);114500(MK);114550(MK);162900(MK);167000(MK);182000(MK);211980(MK);602501(MK);612918(MK);613659(MK);615108(MK)	AD;AR	Cowden syndrome 5	AD	.	Dermatologic; Endocrine; Oncologic	Oncologic	23246288	.	5290	PIK3CA	IC3	IVS4	.	.	no-change	NM_006218.2	NP_006209.2	+	Y	c.813+69A=	.	.	.	NM_006218.2(PIK3CA): c.813+69A=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.999300	-0.287	0.522	0.078	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	178919397	178919397	3q26.32	0	normal	.	.	ins	T	TA.tt	het-ref	34	0.41	.	2	AluY|SINE|Alu|-|296	PASS	171834	P	114480(MK);114500(MK);114550(MK);162900(MK);167000(MK);182000(MK);211980(MK);602501(MK);612918(MK);613659(MK);615108(MK)	AD;AR	Cowden syndrome 5	AD	.	Dermatologic; Endocrine; Oncologic	Oncologic	23246288	.	5290	PIK3CA	IC3	IVS4	.	.	intron	NM_006218.2	NP_006209.2	+	Y	c.813+69_813+70insT	.	.	.	NM_006218.2(PIK3CA): c.813+69_813+70insT	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs373901635	.	4024	0.078800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	178921638	178921639	3q26.32	0	normal	.	C	ref	C	TG.AC	het-alt	118	0.49	.	1	.	PASS	171834	P	114480(MK);114500(MK);114550(MK);162900(MK);167000(MK);182000(MK);211980(MK);602501(MK);612918(MK);613659(MK);615108(MK)	AD;AR	Cowden syndrome 5	AD	.	Dermatologic; Endocrine; Oncologic	Oncologic	23246288	.	5290	PIK3CA	IC4	IVS5	.	.	no-change	NM_006218.2	NP_006209.2	+	Y	c.1059+62C=	.	.	.	NM_006218.2(PIK3CA): c.1059+62C=	;maf-5-some-pop,maf-5-all-pops	5008	0.482029	U	0.2083	0.517971	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2699895	.	4024	0.780100	-0.363	-0.192	-0.204	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	178921638	178921639	3q26.32	0	normal	.	C	snv	A	TG.AC	het-ref	125	0.51	.	2	.	PASS	171834	P	114480(MK);114500(MK);114550(MK);162900(MK);167000(MK);182000(MK);211980(MK);602501(MK);612918(MK);613659(MK);615108(MK)	AD;AR	Cowden syndrome 5	AD	.	Dermatologic; Endocrine; Oncologic	Oncologic	23246288	.	5290	PIK3CA	IC4	IVS5	.	.	intron	NM_006218.2	NP_006209.2	+	Y	c.1059+62C>A	.	.	.	NM_006218.2(PIK3CA): c.1059+62C>A	;maf-5-some-pop,maf-5-all-pops	5008	0.517971	U	0.2083	0.517971	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2699895	.	4024	0.219900	-0.363	-0.192	-0.204	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	178922273	178922274	3q26.32	0	normal	.	C	ref	C	AC.TA	het-alt	135	0.52	.	1	.	PASS	171834	P	114480(MK);114500(MK);114550(MK);162900(MK);167000(MK);182000(MK);211980(MK);602501(MK);612918(MK);613659(MK);615108(MK)	AD;AR	Cowden syndrome 5	AD	.	Dermatologic; Endocrine; Oncologic	Oncologic	23246288	.	5290	PIK3CA	IC4	IVS5	.	.	no-change	NM_006218.2	NP_006209.2	+	Y	c.1060-17C=	.	.	.	NM_006218.2(PIK3CA): c.1060-17C=	;maf-5-some-pop,maf-5-all-pops	125494	0.437670	U	0.248	0.584665	11872	0.330273	PASS	.	8620	0.746520	12766	120486	0.438599	.	.	.	.	.	.	rs2699896	.	4024	0.725400	-0.256	0.397	0.175	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	178922273	178922274	3q26.32	1	normal	.	C	snv	A	AC.TA	het-ref	125	0.48	.	2	.	PASS	171834	P	114480(MK);114500(MK);114550(MK);162900(MK);167000(MK);182000(MK);211980(MK);602501(MK);612918(MK);613659(MK);615108(MK)	AD;AR	Cowden syndrome 5	AD	.	Dermatologic; Endocrine; Oncologic	Oncologic	23246288	.	5290	PIK3CA	IC4	IVS5	.	.	intron	NM_006218.2	NP_006209.2	+	Y	c.1060-17C>A	.	.	.	NM_006218.2(PIK3CA): c.1060-17C>A	;maf-5-some-pop,maf-5-all-pops	125494	0.562330	U	0.248	0.584665	11872	0.669727	PASS	267	8620	0.253480	20164	120486	0.561401	596	4499	2.62853e-01	39539	135497	5.55106e-01	rs2699896	.	4024	0.274600	-0.256	0.397	0.175	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	259957	criteria_provided,_single_submitter	Benign	Benign
3	178922429	178922430	3q26.32	0	normal	.	A	ref	A	GT.TG	het-alt	106	0.55	.	1	.	PASS	171834	P	114480(MK);114500(MK);114550(MK);162900(MK);167000(MK);182000(MK);211980(MK);602501(MK);612918(MK);613659(MK);615108(MK)	AD;AR	Cowden syndrome 5	AD	.	Dermatologic; Endocrine; Oncologic	Oncologic	23246288	.	5290	PIK3CA	IC5	IVS6	.	.	no-change	NM_006218.2	NP_006209.2	+	Y	c.1145+54A=	.	.	.	NM_006218.2(PIK3CA): c.1145+54A=	;maf-5-some-pop,maf-5-all-pops	5008	0.482029	U	0.2083	0.517971	4566	0.401007	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3729679	.	4024	0.780100	-0.128	-1.444	-1.397	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	178922429	178922430	3q26.32	0	normal	.	A	snv	G	GT.TG	het-ref	87	0.45	.	2	.	PASS	171834	P	114480(MK);114500(MK);114550(MK);162900(MK);167000(MK);182000(MK);211980(MK);602501(MK);612918(MK);613659(MK);615108(MK)	AD;AR	Cowden syndrome 5	AD	.	Dermatologic; Endocrine; Oncologic	Oncologic	23246288	.	5290	PIK3CA	IC5	IVS6	.	.	intron	NM_006218.2	NP_006209.2	+	Y	c.1145+54A>G	.	.	.	NM_006218.2(PIK3CA): c.1145+54A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.517971	U	0.2083	0.517971	4566	0.598993	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3729679	.	4024	0.219900	-0.128	-1.444	-1.397	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	178942430	178942431	3q26.32	0	normal	.	C	snv	G	tt.AG	het-ref	188	0.49	.	2	.	PASS	171834	P	114480(MK);114500(MK);114550(MK);162900(MK);167000(MK);182000(MK);211980(MK);602501(MK);612918(MK);613659(MK);615108(MK)	AD;AR	Cowden syndrome 5	AD	.	Dermatologic; Endocrine; Oncologic	Oncologic	23246288	.	5290	PIK3CA	IC14	IVS15	.	.	intron	NM_006218.2	NP_006209.2	+	Y	c.2295-57C>G	.	.	.	NM_006218.2(PIK3CA): c.2295-57C>G	;maf-5-some-pop	5008	0.629393	U	0.2679	0.629393	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2699889	.	4024	0.300200	-0.120	0.116	0.101	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	178942430	178942431	3q26.32	0	normal	.	C	ref	C	tt.AG	het-alt	192	0.51	.	1	.	PASS	171834	P	114480(MK);114500(MK);114550(MK);162900(MK);167000(MK);182000(MK);211980(MK);602501(MK);612918(MK);613659(MK);615108(MK)	AD;AR	Cowden syndrome 5	AD	.	Dermatologic; Endocrine; Oncologic	Oncologic	23246288	.	5290	PIK3CA	IC14	IVS15	.	.	no-change	NM_006218.2	NP_006209.2	+	Y	c.2295-57C=	.	.	.	NM_006218.2(PIK3CA): c.2295-57C=	;maf-5-some-pop	5008	0.370607	U	0.2679	0.629393	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2699889	.	4024	0.699800	-0.120	0.116	0.101	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	186443017	186443018	3q27.3	0	normal	.	T	snv	C	CA.GC	het-ref	205	0.46	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr3: g.186443017T>C (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126382	0.536738	U	0.3562	0.524161	13006	0.545748	PASS	636	8648	0.384713	17823	121374	0.537257	1203	6456	3.74304e-01	36228	132248	5.37087e-01	rs1656922	.	.	.	-1.983	-0.251	-0.128	.	.	.	.	.	ENST00000287611: c.533T>C (p.M178T)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	149539	.	.	.	.	.	.	.	.	.	Benign
3	186443017	186443018	3q27.3	0	normal	.	T	ref	T	CA.GC	het-alt	244	0.54	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr3: g.186443017T= (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126382	0.463262	U	0.3562	0.524161	13006	0.454252	PASS	.	8648	0.615287	13301	121374	0.462743	.	.	.	.	.	.	rs1656922	.	.	.	-1.983	-0.251	-0.128	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	186504406	186504407	3q27.3	0	normal	.	A	ref	A	AA.CA	het-alt	157	0.54	.	1	.	PASS	601102	P	.	NN	.	.	.	.	.	.	.	1974	EIF4A2	C7	EX7	.	.	no-change	NM_001967.3	NP_001958.2	+	Y	c.744A=	.	.	.	NM_001967.3(EIF4A2): c.744A=	;maf-5-some-pop	126200	0.983637	U	0.0744	0.0299521	13006	0.991312	PASS	-293	8650	0.926243	58724	121192	0.984199	.	.	.	.	.	.	rs11538612	.	.	.	0.528	2.701	2.254	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	186504406	186504407	3q27.3	1	normal	.	A	snv	G	AA.CA	het-ref	134	0.46	.	2	.	PASS	601102	P	.	NN	.	.	.	.	.	.	.	1974	EIF4A2	C7	EX7	.	.	coding-synon	NM_001967.3	NP_001958.2	+	Y	c.744A>G	p.(K248=) | p.(Lys248=)	AAA=>AAG	.	NM_001967.3(EIF4A2): c.744A>G (p.(K248=))	;maf-5-some-pop	126200	0.016363	U	0.0744	0.0299521	13006	0.008688	PASS	26	8650	0.073757	43	121192	0.015801	55	1311	7.60088e-02	91	3732	1.51609e-02	rs11538612	.	.	.	0.528	2.701	2.254	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
3	186504912	186504913	3q27.3	0	normal	.	C	ref	C	TA.AG	het-alt	116	0.48	.	1	.	PASS	601102	P	.	NN	.	.	.	.	.	.	.	1974	EIF4A2	IC7	IVS7	.	.	no-change	NM_001967.3	NP_001958.2	+	Y	c.772-3C=	.	.	.	NM_001967.3(EIF4A2): c.772-3C=	;maf-5-some-pop	126236	0.983642	U	0.0744	0.0299521	13006	0.991312	PASS	-293	8654	0.926277	58742	121228	0.984203	.	.	.	.	.	.	rs75837460	.	.	.	-0.412	0.209	-0.399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	186504912	186504913	3q27.3	1	normal	.	C	snv	T	TA.AG	het-ref	125	0.52	.	2	.	PASS	601102	P	.	NN	.	.	.	.	.	.	.	1974	EIF4A2	IC7	IVS7	.	.	intron	NM_001967.3	NP_001958.2	+	Y	c.772-3C>T	.	.	.	NM_001967.3(EIF4A2): c.772-3C>T	;maf-5-some-pop	126236	0.016358	U	0.0744	0.0299521	13006	0.008688	PASS	26	8654	0.073723	43	121228	0.015797	55	1309	7.58929e-02	91	3728	1.51541e-02	rs75837460	.	.	.	-0.412	0.209	-0.399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
3	187443212	187443213	3q27.3	0	normal	.	T	ref	T	ct.gc	het-alt	135	0.69	.	1	trf;C-rich|Low_complexity|Low_complexity|+|146	PASS	109565	P	109565(ML)	NN	.	.	.	.	.	.	.	604	BCL6	IC6	IVS8	.	.	no-change	NM_001706.4	NP_001697.2	-	Y	c.1839+74A=	.	.	.	NM_001706.4(BCL6): c.1839+74A=	;maf-5-some-pop	5008	0.880192	U	0.0466	0.119808	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9755700	.	.	.	-1.896	-0.060	-1.968	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	187443212	187443213	3q27.3	0	normal	.	T	snv	C	ct.gc	het-ref	61	0.31	.	2	trf;C-rich|Low_complexity|Low_complexity|+|146	PASS	109565	P	109565(ML)	NN	.	.	.	.	.	.	.	604	BCL6	IC6	IVS8	.	.	intron	NM_001706.4	NP_001697.2	-	Y	c.1839+74A>G	.	.	.	NM_001706.4(BCL6): c.1839+74A>G	;maf-5-some-pop	5008	0.119808	U	0.0466	0.119808	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9755700	.	.	.	-1.896	-0.060	-1.968	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	187443249	187443253	3q27.3	0	normal	.	CGCC	ref	CGCC	ct.tg	het-alt	253	0.72	.	1	trf;C-rich|Low_complexity|Low_complexity|+|146	PASS	109565	P	109565(ML)	NN	.	.	.	.	.	.	.	604	BCL6	IC6	IVS8	.	.	no-change	NM_001706.4	NP_001697.2	-	Y	c.1839+34_1839+37=	.	.	.	NM_001706.4(BCL6): c.1839+34_1839+37=	MixedObserved;	111922	0.970578	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs778653664	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
3	187443249	187443253	3q27.3	0	normal	.	CGCC	del	.	ct.tg	het-ref	99	0.28	.	2	trf;C-rich|Low_complexity|Low_complexity|+|146	PASS	109565	P	109565(ML)	NN	.	.	.	.	.	.	.	604	BCL6	IC6	IVS8	.	.	intron	NM_001706.4	NP_001697.2	-	Y	c.1839+34_1839+37delGGCG	.	.	.	NM_001706.4(BCL6): c.1839+34_1839+37delGGCG	MixedObserved;	111922	0.029422	U	.	.	.	.	PASS	0	8228	0.005469	55	111922	0.029422	11	460	2.68065e-02	1868	28013	1.14883e-01	rs778653664	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
3	187443254	187443267	3q27.3	0	normal	.	GCCCGCTCCGCTC	ref	GCCCGCTCCGCTC	ct.gc	het-alt	304	0.75	.	1	trf;C-rich|Low_complexity|Low_complexity|+|146	PASS	109565	P	109565(ML)	NN	.	.	.	.	.	.	.	604	BCL6	IC6	IVS8	.	.	no-change	NM_001706.4	NP_001697.2	-	Y	c.1839+20_1839+32=	.	.	.	NM_001706.4(BCL6): c.1839+20_1839+32=	;	112616	0.970564	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs747298443	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
3	187443254	187443267	3q27.3	0	normal	.	GCCCGCTCCGCTC	del	.	ct.gc	het-ref	99	0.25	.	2	trf;C-rich|Low_complexity|Low_complexity|+|146	PASS	109565	P	109565(ML)	NN	.	.	.	.	.	.	.	604	BCL6	IC6	IVS8	.	.	intron	NM_001706.4	NP_001697.2	-	Y	c.1839+20_1839+32delGAGCGGAGCGGGC	.	.	.	NM_001706.4(BCL6): c.1839+20_1839+32delGAGCGGAGCGGGC	;	112616	0.029436	U	.	.	.	.	VQSRTrancheINDEL99.50to99.90	0	8266	0.005565	55	112616	0.029436	10	458	2.66372e-02	1860	28015	1.14530e-01	rs747298443	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
3	189587090	189587091	3q28	0	normal	.	A	snv	G	AA.CT	het-ref	217	0.51	.	2	.	PASS	603273	C	103285(MK);106260(MK);129400(MK);603543(MK);604292(MK);605289(MK)	AD	Split-hand/foot malformation 4; Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3; Limb-mammary syndrome; Rapp-Hodgkin syndrome; Orofacial cleft 8; ADULT syndrome; Ankyloblepharon-ectodermal defects-cleft lip/palate	AD	.	Audiologic/Otolaryngologic; Craniofacial; Dental; Dermatologic; Gastrointestinal; Genitourinary; Musculoskeletal	General	22740388|22607287|22574117|22430731|22069181|22065614|22065540|21990121|21204238|19697430|19676059|19530185|19353643|19239083|18627043|18603493|17609671|17431922|17041931|16740912|16724007|16688749|15200513|14684701|12939657|12838557|12766194|11929852|11528512|11462173|11159940|10886756|10839977|10535733|9973291|9443880|5713637|3366140|946410	.	8626	TP63	IC8	IVS8	.	.	intron	NM_003722.4	NP_003713.3	+	Y	c.1130-22A>G	.	.	.	NM_003722.4(TP63): c.1130-22A>G	;maf-5-some-pop	125772	0.234305	U	0.1468	0.3123	13006	0.338997	PASS	96	8592	0.152002	4031	120764	0.231071	211	2714	1.57772e-01	7455	54817	2.23080e-01	rs6789961	.	.	.	0.533	1.049	0.519	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	259124	criteria_provided,_single_submitter	Benign	Benign
3	189587090	189587091	3q28	0	normal	.	A	ref	A	AA.CT	het-alt	210	0.49	.	1	.	PASS	603273	C	103285(MK);106260(MK);129400(MK);603543(MK);604292(MK);605289(MK)	AD	Split-hand/foot malformation 4; Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3; Limb-mammary syndrome; Rapp-Hodgkin syndrome; Orofacial cleft 8; ADULT syndrome; Ankyloblepharon-ectodermal defects-cleft lip/palate	AD	.	Audiologic/Otolaryngologic; Craniofacial; Dental; Dermatologic; Gastrointestinal; Genitourinary; Musculoskeletal	General	22740388|22607287|22574117|22430731|22069181|22065614|22065540|21990121|21204238|19697430|19676059|19530185|19353643|19239083|18627043|18603493|17609671|17431922|17041931|16740912|16724007|16688749|15200513|14684701|12939657|12838557|12766194|11929852|11528512|11462173|11159940|10886756|10839977|10535733|9973291|9443880|5713637|3366140|946410	.	8626	TP63	IC8	IVS8	.	.	no-change	NM_003722.4	NP_003713.3	+	Y	c.1130-22A=	.	.	.	NM_003722.4(TP63): c.1130-22A=	;maf-5-some-pop	125772	0.765695	U	0.1468	0.3123	13006	0.661003	PASS	-557	8592	0.847998	36508	120764	0.768929	.	.	.	.	.	.	rs6789961	.	.	.	0.533	1.049	0.519	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	192125767	192125768	3q28	0	nullSample	.	A	ref	A	AA.GA	homo-ref	.	.	.	0	.	.	601513	C	.	NN	.	.	.	.	.	.	.	2257	FGF12	IC1	IVS1	.	.	no-change	NM_021032.4	NP_066360.1	-	Y	c.199+46T=	.	.	.	NM_021032.4(FGF12): c.199+46T=	;maf-5-some-pop,maf-5-all-pops	112924	0.574324	U	0.6409	0.509585	12420	0.592754	PASS	.	8392	0.351644	18615	107916	0.578218	.	.	.	.	.	.	rs2249551	.	.	.	0.454	-0.940	-1.252	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
3	192125767	192125768	3q28	0	normal	.	A	snv	G	AA.GA	hom-alt	226	1.00	.	0	.	PASS	601513	C	.	NN	.	.	.	.	.	.	.	2257	FGF12	IC1	IVS1	.	.	intron	NM_021032.4	NP_066360.1	-	Y	c.199+46T>C	.	.	.	NM_021032.4(FGF12): c.199+46T>C	;maf-5-some-pop,maf-5-all-pops	112924	0.425676	U	0.6409	0.509585	12420	0.407246	PASS	1772	8392	0.648356	10174	107916	0.421782	3303	9976	6.54593e-01	17927	79162	4.24639e-01	rs2249551	.	.	.	0.454	-0.940	-1.252	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1745750	1745751	4p16.3	0	normal	.	A	snv	G	GG.CC	het-ref	135	0.44	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.1745750A>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.766174	U	0.8562	0.766174	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs28521716	.	.	.	-1.439	-2.833	-2.966	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1745750	1745751	4p16.3	0	normal	.	A	ref	A	GG.CC	het-alt	171	0.56	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.1745750A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.233826	U	0.8562	0.766174	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs28521716	.	.	.	-1.439	-2.833	-2.966	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1745815	1745816	4p16.3	0	normal	.	A	snv	C	GC.GC	het-ref	125	0.44	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.1745815A>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.529553	U	0.8373	0.529553	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs34770519	.	.	.	0.000	0.000	0.000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1745815	1745816	4p16.3	0	normal	.	A	ref	A	GC.GC	het-alt	157	0.56	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.1745815A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.470447	U	0.8373	0.529553	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs34770519	.	.	.	0.000	0.000	0.000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1750486	1750487	4p16.3	0	normal	.	T	ref	T	CC.GG	het-alt	206	0.52	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.1750486T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.616813	U	0.6726	0.383187	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7680647	.	.	.	0.330	-0.199	-0.375	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1750486	1750487	4p16.3	0	normal	.	T	snv	C	CC.GG	het-ref	193	0.48	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.1750486T>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.383187	U	0.6726	0.383187	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7680647	.	.	.	0.330	-0.199	-0.375	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1758542	1758543	4p16.3	0	normal	.	C	ref	C	GG.GT	het-alt	222	0.75	.	1	trf	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.1758542C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.305911	U	0.8482	0.694089	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11931099	.	.	.	-1.756	-0.750	-0.815	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1758542	1758543	4p16.3	0	normal	.	C	snv	G	GG.GT	het-ref	75	0.25	.	2	trf	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.1758542C>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.694089	U	0.8482	0.694089	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11931099	.	.	.	-1.756	-0.750	-0.815	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1764514	1764515	4p16.3	0	normal	.	G	ref	G	CC.TG	het-alt	206	0.52	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.1764514G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.795527	U	0.1429	0.204473	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12502758	.	.	.	0.205	-0.058	-0.060	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1764514	1764515	4p16.3	0	normal	.	G	snv	A	CC.TG	het-ref	191	0.48	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.1764514G>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.204473	U	0.1429	0.204473	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12502758	.	.	.	0.205	-0.058	-0.060	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1770356	1770357	4p16.3	0	nullSample	.	T	ref	T	CC.GC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.1770356T= (intergenic)	;maf-5-some-pop,genotype-conflict	5008	0.249601	U	0.9831	0.750399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4865468	.	.	.	0.368	-0.756	-0.883	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1770356	1770357	4p16.3	0	normal	.	T	snv	C	CC.GC	hom-alt	394	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.1770356T>C (intergenic)	;maf-5-some-pop,genotype-conflict	5008	0.750399	U	0.9831	0.750399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4865468	.	.	.	0.368	-0.756	-0.883	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1770444	1770445	4p16.3	0	nullSample	.	T	ref	T	CA.GC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.1770444T= (intergenic)	;maf-5-some-pop	5008	0.124002	U	0.9831	0.875998	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4865469	.	.	.	-1.715	-0.478	-0.657	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1770444	1770445	4p16.3	0	normal	.	T	snv	C	CA.GC	hom-alt	258	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.1770444T>C (intergenic)	;maf-5-some-pop	5008	0.875998	U	0.9831	0.875998	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4865469	.	.	.	-1.715	-0.478	-0.657	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1777408	1777409	4p16.3	0	nullSample	.	T	ref	T	CT.CC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.1777408T= (intergenic)	;maf-5-some-pop	5008	0.063498	U	1	0.936502	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10027677	.	.	.	0.448	-0.983	-1.039	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1777408	1777409	4p16.3	0	normal	.	T	snv	G	CT.CC	hom-alt	179	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.1777408T>G (intergenic)	;maf-5-some-pop	5008	0.936502	U	1	0.936502	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10027677	.	.	.	0.448	-0.983	-1.039	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1782585	1782586	4p16.3	0	normal	.	G	ref	G	CC.TG	het-alt	231	0.53	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.1782585G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.539736	U	0.7371	0.460264	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4865473	.	.	.	0.563	1.260	1.258	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1782585	1782586	4p16.3	0	normal	.	G	snv	A	CC.TG	het-ref	203	0.47	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.1782585G>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.460264	U	0.7371	0.460264	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4865473	.	.	.	0.563	1.260	1.258	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1788993	1788994	4p16.3	0	normal	.	A	ref	A	GA.GC	het-alt	172	0.55	.	1	.	PASS	134934	C	100800(MK);109800(MK);114500(MK);146000(MK);149730(MK);162900(MK);187600(MK);187601(MK);273300(MK);602849(MK);603956(MK);610474(MK);612247(MK)	AD	Camptodactyly, tall stature, and hearing loss (CATSHL) syndrome; Crouzon syndrome with acanthosis nigricans; Muenke syndrome	AD	Allelic with Thanatophoric dysplasia, type I (AD), Thanatophoric dysplasia, type II (AD); Severe achondroplasia with developmental delay and acanthosis nigricans (AD); Lacrimoauriculodentodigital syndrome (which may be recognizable from multisystem involvement) (AD); Hypochondroplasia (AD); Achondroplasia (AD); Homozygous/compound heterozygous mutations have been described	Audiologic/Otolaryngologic; Craniofacial; Dermatologic; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	24168007|23378035|23044018|22565872|22446440|22085076|22038757|21971908|21403567|21403557|21204234|20624921|20301628|20301588|20301540|20301331|19449410|19215249|18266238|18000976|18000903|17935505|17895900|17879967|17764078|17360555|17033969|16912704|16501574|16411219|16353253|15517832|15241680|12116251|11186939|11055896|10777366|10360402|10360393|10360392|10053006|9842995|9797588|9733026|9677066|9600744|9585583|9580776|9525367|9450868|9279764|9279753|9042914|8923856|8880573|8845844|8841188|8834055|8589699|8585566|8078586|7968151|7913883|7847369|7773297|7758520|7670477|7647778|7493034|5783850|4697848|3631079|3228140|2650599|474637	.	2261	FGFR3	PROM	.	.	.	no-change	NM_000142.4	NP_000133.1	+	Y	c.-256-u6045A=	.	.	.	NM_000142.4(FGFR3): c.-256-u6045A=	;maf-5-some-pop,maf-5-all-pops	5008	0.529553	U	0.6171	0.470447	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11248077	.	.	.	-1.633	-0.662	-0.625	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1788993	1788994	4p16.3	0	normal	.	A	snv	G	GA.GC	het-ref	142	0.45	.	2	.	PASS	134934	C	100800(MK);109800(MK);114500(MK);146000(MK);149730(MK);162900(MK);187600(MK);187601(MK);273300(MK);602849(MK);603956(MK);610474(MK);612247(MK)	AD	Camptodactyly, tall stature, and hearing loss (CATSHL) syndrome; Crouzon syndrome with acanthosis nigricans; Muenke syndrome	AD	Allelic with Thanatophoric dysplasia, type I (AD), Thanatophoric dysplasia, type II (AD); Severe achondroplasia with developmental delay and acanthosis nigricans (AD); Lacrimoauriculodentodigital syndrome (which may be recognizable from multisystem involvement) (AD); Hypochondroplasia (AD); Achondroplasia (AD); Homozygous/compound heterozygous mutations have been described	Audiologic/Otolaryngologic; Craniofacial; Dermatologic; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	24168007|23378035|23044018|22565872|22446440|22085076|22038757|21971908|21403567|21403557|21204234|20624921|20301628|20301588|20301540|20301331|19449410|19215249|18266238|18000976|18000903|17935505|17895900|17879967|17764078|17360555|17033969|16912704|16501574|16411219|16353253|15517832|15241680|12116251|11186939|11055896|10777366|10360402|10360393|10360392|10053006|9842995|9797588|9733026|9677066|9600744|9585583|9580776|9525367|9450868|9279764|9279753|9042914|8923856|8880573|8845844|8841188|8834055|8589699|8585566|8078586|7968151|7913883|7847369|7773297|7758520|7670477|7647778|7493034|5783850|4697848|3631079|3228140|2650599|474637	.	2261	FGFR3	PROM	.	.	.	promoter	NM_000142.4	NP_000133.1	+	Y	c.-256-u6045A>G	.	.	.	NM_000142.4(FGFR3): c.-256-u6045A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.470447	U	0.6171	0.470447	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11248077	.	.	.	-1.633	-0.662	-0.625	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1803306	1803307	4p16.3	0	normal	.	T	ref	T	GT.GC	het-alt	293	0.52	.	1	.	PASS	134934	C	100800(MK);109800(MK);114500(MK);146000(MK);149730(MK);162900(MK);187600(MK);187601(MK);273300(MK);602849(MK);603956(MK);610474(MK);612247(MK)	AD	Camptodactyly, tall stature, and hearing loss (CATSHL) syndrome; Crouzon syndrome with acanthosis nigricans; Muenke syndrome	AD	Allelic with Thanatophoric dysplasia, type I (AD), Thanatophoric dysplasia, type II (AD); Severe achondroplasia with developmental delay and acanthosis nigricans (AD); Lacrimoauriculodentodigital syndrome (which may be recognizable from multisystem involvement) (AD); Hypochondroplasia (AD); Achondroplasia (AD); Homozygous/compound heterozygous mutations have been described	Audiologic/Otolaryngologic; Craniofacial; Dermatologic; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	24168007|23378035|23044018|22565872|22446440|22085076|22038757|21971908|21403567|21403557|21204234|20624921|20301628|20301588|20301540|20301331|19449410|19215249|18266238|18000976|18000903|17935505|17895900|17879967|17764078|17360555|17033969|16912704|16501574|16411219|16353253|15517832|15241680|12116251|11186939|11055896|10777366|10360402|10360393|10360392|10053006|9842995|9797588|9733026|9677066|9600744|9585583|9580776|9525367|9450868|9279764|9279753|9042914|8923856|8880573|8845844|8841188|8834055|8589699|8585566|8078586|7968151|7913883|7847369|7773297|7758520|7670477|7647778|7493034|5783850|4697848|3631079|3228140|2650599|474637	.	2261	FGFR3	IC4	IVS5	.	.	no-change	NM_000142.4	NP_000133.1	+	Y	c.616-40T=	.	.	.	NM_000142.4(FGFR3): c.616-40T=	;maf-5-some-pop,maf-5-all-pops	48432	0.759766	U	0.0665	0.223842	12886	0.779606	PASS	.	2526	0.917260	12323	43424	0.757876	.	.	.	.	.	.	rs2305183	.	4024	0.952800	-3.685	-2.563	-2.677	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1803306	1803307	4p16.3	0	normal	.	T	snv	C	GT.GC	het-ref	275	0.48	.	2	.	PASS	134934	C	100800(MK);109800(MK);114500(MK);146000(MK);149730(MK);162900(MK);187600(MK);187601(MK);273300(MK);602849(MK);603956(MK);610474(MK);612247(MK)	AD	Camptodactyly, tall stature, and hearing loss (CATSHL) syndrome; Crouzon syndrome with acanthosis nigricans; Muenke syndrome	AD	Allelic with Thanatophoric dysplasia, type I (AD), Thanatophoric dysplasia, type II (AD); Severe achondroplasia with developmental delay and acanthosis nigricans (AD); Lacrimoauriculodentodigital syndrome (which may be recognizable from multisystem involvement) (AD); Hypochondroplasia (AD); Achondroplasia (AD); Homozygous/compound heterozygous mutations have been described	Audiologic/Otolaryngologic; Craniofacial; Dermatologic; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	24168007|23378035|23044018|22565872|22446440|22085076|22038757|21971908|21403567|21403557|21204234|20624921|20301628|20301588|20301540|20301331|19449410|19215249|18266238|18000976|18000903|17935505|17895900|17879967|17764078|17360555|17033969|16912704|16501574|16411219|16353253|15517832|15241680|12116251|11186939|11055896|10777366|10360402|10360393|10360392|10053006|9842995|9797588|9733026|9677066|9600744|9585583|9580776|9525367|9450868|9279764|9279753|9042914|8923856|8880573|8845844|8841188|8834055|8589699|8585566|8078586|7968151|7913883|7847369|7773297|7758520|7670477|7647778|7493034|5783850|4697848|3631079|3228140|2650599|474637	.	2261	FGFR3	IC4	IVS5	.	.	intron	NM_000142.4	NP_000133.1	+	Y	c.616-40T>C	.	.	.	NM_000142.4(FGFR3): c.616-40T>C	;maf-5-some-pop,maf-5-all-pops	48432	0.240234	U	0.0665	0.223842	12886	0.220394	PASS	5	2526	0.082740	1125	43424	0.242124	9	587	4.24624e-02	2966	29944	1.59609e-01	rs2305183	.	4024	0.047200	-3.685	-2.563	-2.677	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	255343	criteria_provided,_single_submitter	Benign	Benign
4	1803703	1803704	4p16.3	0	normal	.	T	ref	T	AA.GG	het-alt	279	0.53	.	1	.	PASS	134934	C	100800(MK);109800(MK);114500(MK);146000(MK);149730(MK);162900(MK);187600(MK);187601(MK);273300(MK);602849(MK);603956(MK);610474(MK);612247(MK)	AD	Camptodactyly, tall stature, and hearing loss (CATSHL) syndrome; Crouzon syndrome with acanthosis nigricans; Muenke syndrome	AD	Allelic with Thanatophoric dysplasia, type I (AD), Thanatophoric dysplasia, type II (AD); Severe achondroplasia with developmental delay and acanthosis nigricans (AD); Lacrimoauriculodentodigital syndrome (which may be recognizable from multisystem involvement) (AD); Hypochondroplasia (AD); Achondroplasia (AD); Homozygous/compound heterozygous mutations have been described	Audiologic/Otolaryngologic; Craniofacial; Dermatologic; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	24168007|23378035|23044018|22565872|22446440|22085076|22038757|21971908|21403567|21403557|21204234|20624921|20301628|20301588|20301540|20301331|19449410|19215249|18266238|18000976|18000903|17935505|17895900|17879967|17764078|17360555|17033969|16912704|16501574|16411219|16353253|15517832|15241680|12116251|11186939|11055896|10777366|10360402|10360393|10360392|10053006|9842995|9797588|9733026|9677066|9600744|9585583|9580776|9525367|9450868|9279764|9279753|9042914|8923856|8880573|8845844|8841188|8834055|8589699|8585566|8078586|7968151|7913883|7847369|7773297|7758520|7670477|7647778|7493034|5783850|4697848|3631079|3228140|2650599|474637	.	2261	FGFR3	C6	EX7	Immunoglobulin domain;Immunoglobulin I-set domain;Immunoglobulin domain;Immunoglobulin domain	PF00047.20;PF07679.11;PF13895.1;PF13927.1	no-change	NM_000142.4	NP_000133.1	+	Y	c.882T=	.	.	.	NM_000142.4(FGFR3): c.882T=	;maf-5-some-pop	122356	0.829236	U	0.0744	0.207468	13004	0.786066	PASS	.	8478	0.950342	40804	117348	0.830802	.	.	.	.	.	.	rs2234909	.	4024	0.949300	-1.982	-0.914	-1.576	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1803703	1803704	4p16.3	1	normal	.	T	snv	C	AA.GG	het-ref	249	0.47	.	2	.	PASS	134934	C	100800(MK);109800(MK);114500(MK);146000(MK);149730(MK);162900(MK);187600(MK);187601(MK);273300(MK);602849(MK);603956(MK);610474(MK);612247(MK)	AD	Camptodactyly, tall stature, and hearing loss (CATSHL) syndrome; Crouzon syndrome with acanthosis nigricans; Muenke syndrome	AD	Allelic with Thanatophoric dysplasia, type I (AD), Thanatophoric dysplasia, type II (AD); Severe achondroplasia with developmental delay and acanthosis nigricans (AD); Lacrimoauriculodentodigital syndrome (which may be recognizable from multisystem involvement) (AD); Hypochondroplasia (AD); Achondroplasia (AD); Homozygous/compound heterozygous mutations have been described	Audiologic/Otolaryngologic; Craniofacial; Dermatologic; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	24168007|23378035|23044018|22565872|22446440|22085076|22038757|21971908|21403567|21403557|21204234|20624921|20301628|20301588|20301540|20301331|19449410|19215249|18266238|18000976|18000903|17935505|17895900|17879967|17764078|17360555|17033969|16912704|16501574|16411219|16353253|15517832|15241680|12116251|11186939|11055896|10777366|10360402|10360393|10360392|10053006|9842995|9797588|9733026|9677066|9600744|9585583|9580776|9525367|9450868|9279764|9279753|9042914|8923856|8880573|8845844|8841188|8834055|8589699|8585566|8078586|7968151|7913883|7847369|7773297|7758520|7670477|7647778|7493034|5783850|4697848|3631079|3228140|2650599|474637	.	2261	FGFR3	C6	EX7	Immunoglobulin domain;Immunoglobulin I-set domain;Immunoglobulin domain;Immunoglobulin domain	PF00047.20;PF07679.11;PF13895.1;PF13927.1	coding-synon	NM_000142.4	NP_000133.1	+	Y	c.882T>C	p.(N294=) | p.(Asn294=)	AAT=>AAC	.	NM_000142.4(FGFR3): c.882T>C (p.(N294=))	;maf-5-some-pop	122356	0.170764	U	0.0744	0.207468	13004	0.213934	PASS	13	8478	0.049658	1985	117348	0.169198	17	778	4.52483e-02	3747	39074	1.59869e-01	rs2234909	.	4024	0.050700	-1.982	-0.914	-1.576	.	.	.	.	.	ENST00000340107: c.882T>C (p.N294N)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1428695	.	.	.	.	.	no_record	255346	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
4	1803823	1803824	4p16.3	0	normal	.	C	ref	C	TG.GG	het-alt	115	0.54	.	1	.	PASS	134934	C	100800(MK);109800(MK);114500(MK);146000(MK);149730(MK);162900(MK);187600(MK);187601(MK);273300(MK);602849(MK);603956(MK);610474(MK);612247(MK)	AD	Camptodactyly, tall stature, and hearing loss (CATSHL) syndrome; Crouzon syndrome with acanthosis nigricans; Muenke syndrome	AD	Allelic with Thanatophoric dysplasia, type I (AD), Thanatophoric dysplasia, type II (AD); Severe achondroplasia with developmental delay and acanthosis nigricans (AD); Lacrimoauriculodentodigital syndrome (which may be recognizable from multisystem involvement) (AD); Hypochondroplasia (AD); Achondroplasia (AD); Homozygous/compound heterozygous mutations have been described	Audiologic/Otolaryngologic; Craniofacial; Dermatologic; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	24168007|23378035|23044018|22565872|22446440|22085076|22038757|21971908|21403567|21403557|21204234|20624921|20301628|20301588|20301540|20301331|19449410|19215249|18266238|18000976|18000903|17935505|17895900|17879967|17764078|17360555|17033969|16912704|16501574|16411219|16353253|15517832|15241680|12116251|11186939|11055896|10777366|10360402|10360393|10360392|10053006|9842995|9797588|9733026|9677066|9600744|9585583|9580776|9525367|9450868|9279764|9279753|9042914|8923856|8880573|8845844|8841188|8834055|8589699|8585566|8078586|7968151|7913883|7847369|7773297|7758520|7670477|7647778|7493034|5783850|4697848|3631079|3228140|2650599|474637	.	2261	FGFR3	IC6	IVS7	.	.	no-change	NM_000142.4	NP_000133.1	+	Y	c.930+72C=	.	.	.	NM_000142.4(FGFR3): c.930+72C=	;maf-5-some-pop,maf-5-all-pops	5008	0.790535	U	0.0724	0.209465	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2305184	.	4020	0.952500	-0.444	-0.730	-0.861	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1803823	1803824	4p16.3	0	normal	.	C	snv	G	TG.GG	het-ref	99	0.46	.	2	.	PASS	134934	C	100800(MK);109800(MK);114500(MK);146000(MK);149730(MK);162900(MK);187600(MK);187601(MK);273300(MK);602849(MK);603956(MK);610474(MK);612247(MK)	AD	Camptodactyly, tall stature, and hearing loss (CATSHL) syndrome; Crouzon syndrome with acanthosis nigricans; Muenke syndrome	AD	Allelic with Thanatophoric dysplasia, type I (AD), Thanatophoric dysplasia, type II (AD); Severe achondroplasia with developmental delay and acanthosis nigricans (AD); Lacrimoauriculodentodigital syndrome (which may be recognizable from multisystem involvement) (AD); Hypochondroplasia (AD); Achondroplasia (AD); Homozygous/compound heterozygous mutations have been described	Audiologic/Otolaryngologic; Craniofacial; Dermatologic; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	24168007|23378035|23044018|22565872|22446440|22085076|22038757|21971908|21403567|21403557|21204234|20624921|20301628|20301588|20301540|20301331|19449410|19215249|18266238|18000976|18000903|17935505|17895900|17879967|17764078|17360555|17033969|16912704|16501574|16411219|16353253|15517832|15241680|12116251|11186939|11055896|10777366|10360402|10360393|10360392|10053006|9842995|9797588|9733026|9677066|9600744|9585583|9580776|9525367|9450868|9279764|9279753|9042914|8923856|8880573|8845844|8841188|8834055|8589699|8585566|8078586|7968151|7913883|7847369|7773297|7758520|7670477|7647778|7493034|5783850|4697848|3631079|3228140|2650599|474637	.	2261	FGFR3	IC6	IVS7	.	.	intron	NM_000142.4	NP_000133.1	+	Y	c.930+72C>G	.	.	.	NM_000142.4(FGFR3): c.930+72C>G	;maf-5-some-pop,maf-5-all-pops	5008	0.209465	U	0.0724	0.209465	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2305184	.	4020	0.047500	-0.444	-0.730	-0.861	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1805295	1805296	4p16.3	0	nullSample	.	G	ref	G	CG.TG	homo-ref	.	.	.	0	.	.	134934	C	100800(MK);109800(MK);114500(MK);146000(MK);149730(MK);162900(MK);187600(MK);187601(MK);273300(MK);602849(MK);603956(MK);610474(MK);612247(MK)	AD	Camptodactyly, tall stature, and hearing loss (CATSHL) syndrome; Crouzon syndrome with acanthosis nigricans; Muenke syndrome	AD	Allelic with Thanatophoric dysplasia, type I (AD), Thanatophoric dysplasia, type II (AD); Severe achondroplasia with developmental delay and acanthosis nigricans (AD); Lacrimoauriculodentodigital syndrome (which may be recognizable from multisystem involvement) (AD); Hypochondroplasia (AD); Achondroplasia (AD); Homozygous/compound heterozygous mutations have been described	Audiologic/Otolaryngologic; Craniofacial; Dermatologic; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	24168007|23378035|23044018|22565872|22446440|22085076|22038757|21971908|21403567|21403557|21204234|20624921|20301628|20301588|20301540|20301331|19449410|19215249|18266238|18000976|18000903|17935505|17895900|17879967|17764078|17360555|17033969|16912704|16501574|16411219|16353253|15517832|15241680|12116251|11186939|11055896|10777366|10360402|10360393|10360392|10053006|9842995|9797588|9733026|9677066|9600744|9585583|9580776|9525367|9450868|9279764|9279753|9042914|8923856|8880573|8845844|8841188|8834055|8589699|8585566|8078586|7968151|7913883|7847369|7773297|7758520|7670477|7647778|7493034|5783850|4697848|3631079|3228140|2650599|474637	.	2261	FGFR3	IC6	IVS7	.	.	no-change	NM_000142.4	NP_000133.1	+	Y	c.931-123G=	.	.	.	NM_000142.4(FGFR3): c.931-123G=	;maf-5-some-pop	5008	0.075080	U	1	0.92492	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3135883	.	4024	0.001500	0.604	2.655	2.110	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1805295	1805296	4p16.3	0	normal	.	G	snv	A	CG.TG	hom-alt	257	1.00	.	0	.	PASS	134934	C	100800(MK);109800(MK);114500(MK);146000(MK);149730(MK);162900(MK);187600(MK);187601(MK);273300(MK);602849(MK);603956(MK);610474(MK);612247(MK)	AD	Camptodactyly, tall stature, and hearing loss (CATSHL) syndrome; Crouzon syndrome with acanthosis nigricans; Muenke syndrome	AD	Allelic with Thanatophoric dysplasia, type I (AD), Thanatophoric dysplasia, type II (AD); Severe achondroplasia with developmental delay and acanthosis nigricans (AD); Lacrimoauriculodentodigital syndrome (which may be recognizable from multisystem involvement) (AD); Hypochondroplasia (AD); Achondroplasia (AD); Homozygous/compound heterozygous mutations have been described	Audiologic/Otolaryngologic; Craniofacial; Dermatologic; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	24168007|23378035|23044018|22565872|22446440|22085076|22038757|21971908|21403567|21403557|21204234|20624921|20301628|20301588|20301540|20301331|19449410|19215249|18266238|18000976|18000903|17935505|17895900|17879967|17764078|17360555|17033969|16912704|16501574|16411219|16353253|15517832|15241680|12116251|11186939|11055896|10777366|10360402|10360393|10360392|10053006|9842995|9797588|9733026|9677066|9600744|9585583|9580776|9525367|9450868|9279764|9279753|9042914|8923856|8880573|8845844|8841188|8834055|8589699|8585566|8078586|7968151|7913883|7847369|7773297|7758520|7670477|7647778|7493034|5783850|4697848|3631079|3228140|2650599|474637	.	2261	FGFR3	IC6	IVS7	.	.	intron	NM_000142.4	NP_000133.1	+	Y	c.931-123G>A	.	.	.	NM_000142.4(FGFR3): c.931-123G>A	;maf-5-some-pop	5008	0.924920	U	1	0.92492	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3135883	.	4024	0.998500	0.604	2.655	2.110	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1806012	1806013	4p16.3	0	normal	.	G	ref	G	GT.GG	het-alt	89	0.51	.	1	.	PASS	134934	C	100800(MK);109800(MK);114500(MK);146000(MK);149730(MK);162900(MK);187600(MK);187601(MK);273300(MK);602849(MK);603956(MK);610474(MK);612247(MK)	AD	Camptodactyly, tall stature, and hearing loss (CATSHL) syndrome; Crouzon syndrome with acanthosis nigricans; Muenke syndrome	AD	Allelic with Thanatophoric dysplasia, type I (AD), Thanatophoric dysplasia, type II (AD); Severe achondroplasia with developmental delay and acanthosis nigricans (AD); Lacrimoauriculodentodigital syndrome (which may be recognizable from multisystem involvement) (AD); Hypochondroplasia (AD); Achondroplasia (AD); Homozygous/compound heterozygous mutations have been described	Audiologic/Otolaryngologic; Craniofacial; Dermatologic; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	24168007|23378035|23044018|22565872|22446440|22085076|22038757|21971908|21403567|21403557|21204234|20624921|20301628|20301588|20301540|20301331|19449410|19215249|18266238|18000976|18000903|17935505|17895900|17879967|17764078|17360555|17033969|16912704|16501574|16411219|16353253|15517832|15241680|12116251|11186939|11055896|10777366|10360402|10360393|10360392|10053006|9842995|9797588|9733026|9677066|9600744|9585583|9580776|9525367|9450868|9279764|9279753|9042914|8923856|8880573|8845844|8841188|8834055|8589699|8585566|8078586|7968151|7913883|7847369|7773297|7758520|7670477|7647778|7493034|5783850|4697848|3631079|3228140|2650599|474637	.	2261	FGFR3	IC7	IVS8	.	.	no-change	NM_000142.4	NP_000133.1	+	Y	c.1076-44G=	.	.	.	NM_000142.4(FGFR3): c.1076-44G=	MixedObserved;maf-5-some-pop,maf-5-all-pops|MixedObserved,SingleClassQuadAllelic;rs-cluster-nonoverlapping-alleles	49451|1580	0.957594|0.919620	U	.	.	.	.	PASS	0	40	1.000000	663	1580	0.919620	.	.	.	.	.	.	rs377096563|rs780329181	.	4024	0.733800	-0.384	-0.039	-0.193	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1806012	1806013	4p16.3	0	normal	.	G	del	.	GT.GG	het-ref	84	0.49	.	2	.	PASS	134934	C	100800(MK);109800(MK);114500(MK);146000(MK);149730(MK);162900(MK);187600(MK);187601(MK);273300(MK);602849(MK);603956(MK);610474(MK);612247(MK)	AD	Camptodactyly, tall stature, and hearing loss (CATSHL) syndrome; Crouzon syndrome with acanthosis nigricans; Muenke syndrome	AD	Allelic with Thanatophoric dysplasia, type I (AD), Thanatophoric dysplasia, type II (AD); Severe achondroplasia with developmental delay and acanthosis nigricans (AD); Lacrimoauriculodentodigital syndrome (which may be recognizable from multisystem involvement) (AD); Hypochondroplasia (AD); Achondroplasia (AD); Homozygous/compound heterozygous mutations have been described	Audiologic/Otolaryngologic; Craniofacial; Dermatologic; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	24168007|23378035|23044018|22565872|22446440|22085076|22038757|21971908|21403567|21403557|21204234|20624921|20301628|20301588|20301540|20301331|19449410|19215249|18266238|18000976|18000903|17935505|17895900|17879967|17764078|17360555|17033969|16912704|16501574|16411219|16353253|15517832|15241680|12116251|11186939|11055896|10777366|10360402|10360393|10360392|10053006|9842995|9797588|9733026|9677066|9600744|9585583|9580776|9525367|9450868|9279764|9279753|9042914|8923856|8880573|8845844|8841188|8834055|8589699|8585566|8078586|7968151|7913883|7847369|7773297|7758520|7670477|7647778|7493034|5783850|4697848|3631079|3228140|2650599|474637	.	2261	FGFR3	IC7	IVS8	.	.	intron	NM_000142.4	NP_000133.1	+	Y	c.1076-44delG	.	.	.	NM_000142.4(FGFR3): c.1076-44delG	MixedObserved;maf-5-some-pop,maf-5-all-pops	49451	0.042406	U	0.371	0.386981	.	.	InbreedingCoeff_Filter	6	7542	0.477857	368	94722	0.467515	.	.	.	.	.	.	rs377096563	.	4024	0.265700	-0.384	-0.039	-0.193	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1806497	1806498	4p16.3	0	normal	.	C	ref	C	AC.TC	het-alt	111	0.55	.	1	.	PASS	134934	C	100800(MK);109800(MK);114500(MK);146000(MK);149730(MK);162900(MK);187600(MK);187601(MK);273300(MK);602849(MK);603956(MK);610474(MK);612247(MK)	AD	Camptodactyly, tall stature, and hearing loss (CATSHL) syndrome; Crouzon syndrome with acanthosis nigricans; Muenke syndrome	AD	Allelic with Thanatophoric dysplasia, type I (AD), Thanatophoric dysplasia, type II (AD); Severe achondroplasia with developmental delay and acanthosis nigricans (AD); Lacrimoauriculodentodigital syndrome (which may be recognizable from multisystem involvement) (AD); Hypochondroplasia (AD); Achondroplasia (AD); Homozygous/compound heterozygous mutations have been described	Audiologic/Otolaryngologic; Craniofacial; Dermatologic; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	24168007|23378035|23044018|22565872|22446440|22085076|22038757|21971908|21403567|21403557|21204234|20624921|20301628|20301588|20301540|20301331|19449410|19215249|18266238|18000976|18000903|17935505|17895900|17879967|17764078|17360555|17033969|16912704|16501574|16411219|16353253|15517832|15241680|12116251|11186939|11055896|10777366|10360402|10360393|10360392|10053006|9842995|9797588|9733026|9677066|9600744|9585583|9580776|9525367|9450868|9279764|9279753|9042914|8923856|8880573|8845844|8841188|8834055|8589699|8585566|8078586|7968151|7913883|7847369|7773297|7758520|7670477|7647778|7493034|5783850|4697848|3631079|3228140|2650599|474637	.	2261	FGFR3	IC8	IVS9	.	.	no-change	NM_000142.4	NP_000133.1	+	Y	c.1267-53C=	.	.	.	NM_000142.4(FGFR3): c.1267-53C=	;	24876	0.999759	U	0.003	0.000599042	.	.	PASS	-1	614	0.996743	9931	19868	0.999849	.	.	.	.	.	.	rs535725390	.	.	.	-1.461	-0.316	-0.324	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	1806497	1806498	4p16.3	0	normal	.	C	snv	T	AC.TC	het-ref	92	0.45	.	2	.	PASS	134934	C	100800(MK);109800(MK);114500(MK);146000(MK);149730(MK);162900(MK);187600(MK);187601(MK);273300(MK);602849(MK);603956(MK);610474(MK);612247(MK)	AD	Camptodactyly, tall stature, and hearing loss (CATSHL) syndrome; Crouzon syndrome with acanthosis nigricans; Muenke syndrome	AD	Allelic with Thanatophoric dysplasia, type I (AD), Thanatophoric dysplasia, type II (AD); Severe achondroplasia with developmental delay and acanthosis nigricans (AD); Lacrimoauriculodentodigital syndrome (which may be recognizable from multisystem involvement) (AD); Hypochondroplasia (AD); Achondroplasia (AD); Homozygous/compound heterozygous mutations have been described	Audiologic/Otolaryngologic; Craniofacial; Dermatologic; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	24168007|23378035|23044018|22565872|22446440|22085076|22038757|21971908|21403567|21403557|21204234|20624921|20301628|20301588|20301540|20301331|19449410|19215249|18266238|18000976|18000903|17935505|17895900|17879967|17764078|17360555|17033969|16912704|16501574|16411219|16353253|15517832|15241680|12116251|11186939|11055896|10777366|10360402|10360393|10360392|10053006|9842995|9797588|9733026|9677066|9600744|9585583|9580776|9525367|9450868|9279764|9279753|9042914|8923856|8880573|8845844|8841188|8834055|8589699|8585566|8078586|7968151|7913883|7847369|7773297|7758520|7670477|7647778|7493034|5783850|4697848|3631079|3228140|2650599|474637	.	2261	FGFR3	IC8	IVS9	.	.	intron	NM_000142.4	NP_000133.1	+	Y	c.1267-53C>T	.	.	.	NM_000142.4(FGFR3): c.1267-53C>T	;	24876	0.000241	U	0.003	0.000599042	.	.	PASS	0	614	0.003257	0	19868	0.000151	0	11	1.07695e-03	0	15	1.02298e-04	rs535725390	.	.	.	-1.461	-0.316	-0.324	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
4	1807893	1807894	4p16.3	1	nullSample	.	G	ref	G	AC.AC	homo-ref	.	.	.	0	.	.	134934	C	100800(MK);109800(MK);114500(MK);146000(MK);149730(MK);162900(MK);187600(MK);187601(MK);273300(MK);602849(MK);603956(MK);610474(MK);612247(MK)	AD	Camptodactyly, tall stature, and hearing loss (CATSHL) syndrome; Crouzon syndrome with acanthosis nigricans; Muenke syndrome	AD	Allelic with Thanatophoric dysplasia, type I (AD), Thanatophoric dysplasia, type II (AD); Severe achondroplasia with developmental delay and acanthosis nigricans (AD); Lacrimoauriculodentodigital syndrome (which may be recognizable from multisystem involvement) (AD); Hypochondroplasia (AD); Achondroplasia (AD); Homozygous/compound heterozygous mutations have been described	Audiologic/Otolaryngologic; Craniofacial; Dermatologic; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	24168007|23378035|23044018|22565872|22446440|22085076|22038757|21971908|21403567|21403557|21204234|20624921|20301628|20301588|20301540|20301331|19449410|19215249|18266238|18000976|18000903|17935505|17895900|17879967|17764078|17360555|17033969|16912704|16501574|16411219|16353253|15517832|15241680|12116251|11186939|11055896|10777366|10360402|10360393|10360392|10053006|9842995|9797588|9733026|9677066|9600744|9585583|9580776|9525367|9450868|9279764|9279753|9042914|8923856|8880573|8845844|8841188|8834055|8589699|8585566|8078586|7968151|7913883|7847369|7773297|7758520|7670477|7647778|7493034|5783850|4697848|3631079|3228140|2650599|474637	.	2261	FGFR3	C13	EX14	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_000142.4	NP_000133.1	+	Y	c.1953A>G	p.(T651=) | p.(Thr651=)	ACA=>ACG	.	NM_000142.4(FGFR3): c.1953A>G (p.(T651=))	;maf-5-some-pop	124438	0.013951	U	1	0.95607	13002	0.044916	PASS	0	8602	0.000000	89	119430	0.012694	.	.	.	.	.	.	rs7688609	.	.	.	-2.821	0.554	0.049	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
4	1807893	1807894	4p16.3	0	normal	.	G	snv	A	AC.AC	hom-alt	687	1.00	.	0	.	PASS	134934	C	100800(MK);109800(MK);114500(MK);146000(MK);149730(MK);162900(MK);187600(MK);187601(MK);273300(MK);602849(MK);603956(MK);610474(MK);612247(MK)	AD	Camptodactyly, tall stature, and hearing loss (CATSHL) syndrome; Crouzon syndrome with acanthosis nigricans; Muenke syndrome	AD	Allelic with Thanatophoric dysplasia, type I (AD), Thanatophoric dysplasia, type II (AD); Severe achondroplasia with developmental delay and acanthosis nigricans (AD); Lacrimoauriculodentodigital syndrome (which may be recognizable from multisystem involvement) (AD); Hypochondroplasia (AD); Achondroplasia (AD); Homozygous/compound heterozygous mutations have been described	Audiologic/Otolaryngologic; Craniofacial; Dermatologic; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	24168007|23378035|23044018|22565872|22446440|22085076|22038757|21971908|21403567|21403557|21204234|20624921|20301628|20301588|20301540|20301331|19449410|19215249|18266238|18000976|18000903|17935505|17895900|17879967|17764078|17360555|17033969|16912704|16501574|16411219|16353253|15517832|15241680|12116251|11186939|11055896|10777366|10360402|10360393|10360392|10053006|9842995|9797588|9733026|9677066|9600744|9585583|9580776|9525367|9450868|9279764|9279753|9042914|8923856|8880573|8845844|8841188|8834055|8589699|8585566|8078586|7968151|7913883|7847369|7773297|7758520|7670477|7647778|7493034|5783850|4697848|3631079|3228140|2650599|474637	.	2261	FGFR3	C13	EX14	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	no-change	NM_000142.4	NP_000133.1	+	Y	c.1953A=	.	.	.	NM_000142.4(FGFR3): c.1953A=	;maf-5-some-pop	124438	0.986049	U	1	0.95607	13002	0.955084	PASS	4301	8602	1.000000	58288	119430	0.987306	8603	17206	1.00000e+00	120148	242436	9.90052e-01	rs7688609	.	.	.	-2.821	0.554	0.049	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	25666098	25666099	4p15.2	0	normal	.	A	ref	A	ct.tg	het-alt	191	0.53	.	1	MIR3|SINE|MIR|-|138	PASS	604217	C	265100(MK);610441(UK)	AR	Pulmonary alveolar microlithiasis	AR	.	Pulmonary	Pulmonary	22336687|20425862|16960801|12700375|12357485|12210357|11956731|11287838|9258573|9097354|1485012	.	10568	SLC34A2	IC3	IVS4	.	.	no-change	NM_006424.2	NP_006415.2	+	Y	c.379+147A=	.	.	.	NM_006424.2(SLC34A2): c.379+147A=	;maf-5-some-pop,maf-5-all-pops	5008	0.634585	U	0.6081	0.365415	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs13110175	.	.	.	0.459	0.374	0.325	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	25666098	25666099	4p15.2	0	normal	.	A	snv	G	ct.tg	het-ref	170	0.47	.	2	MIR3|SINE|MIR|-|138	PASS	604217	C	265100(MK);610441(UK)	AR	Pulmonary alveolar microlithiasis	AR	.	Pulmonary	Pulmonary	22336687|20425862|16960801|12700375|12357485|12210357|11956731|11287838|9258573|9097354|1485012	.	10568	SLC34A2	IC3	IVS4	.	.	intron	NM_006424.2	NP_006415.2	+	Y	c.379+147A>G	.	.	.	NM_006424.2(SLC34A2): c.379+147A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.365415	U	0.6081	0.365415	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs13110175	.	.	.	0.459	0.374	0.325	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	25678395	25678396	4p15.2	0	normal	.	G	ref	G	AT.GG	het-alt	99	0.52	.	1	.	PASS	604217	C	265100(MK);610441(UK)	AR	Pulmonary alveolar microlithiasis	AR	.	Pulmonary	Pulmonary	22336687|20425862|16960801|12700375|12357485|12210357|11956731|11287838|9258573|9097354|1485012	.	10568	SLC34A2	3U1E	EX13E	.	.	no-change	NM_006424.2	NP_006415.2	+	Y	c.*25G=	.	.	.	NM_006424.2(SLC34A2): c.*25G=	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	124732	0.740243	U	0.5794	0.319888	13006	0.765877	PASS	.	8564	0.424685	33669	119724	0.742758	.	.	.	.	.	.	rs3733545	.	.	.	-2.293	-1.100	-1.722	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	25678395	25678396	4p15.2	0	normal	.	G	snv	T	AT.GG	het-ref	90	0.48	.	2	.	PASS	604217	C	265100(MK);610441(UK)	AR	Pulmonary alveolar microlithiasis	AR	.	Pulmonary	Pulmonary	22336687|20425862|16960801|12700375|12357485|12210357|11956731|11287838|9258573|9097354|1485012	.	10568	SLC34A2	3U1E	EX13E	.	.	utr-3	NM_006424.2	NP_006415.2	+	Y	c.*25G>T	.	.	.	NM_006424.2(SLC34A2): c.*25G>T	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	124732	0.259701	U	0.5794	0.319888	13006	0.234123	PASS	1406	8564	0.575315	4604	119724	0.257183	2846	9829	5.71919e-01	9564	62655	2.56762e-01	rs3733545	.	.	.	-2.293	-1.100	-1.722	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55079491	55079492	4q12	0	nullSample	.	T	ref	T	GG.AA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55079491T= (intergenic)	;	5008	0.002796	U	1	0.997204	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1364988	.	.	.	-0.527	0.101	0.067	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55079491	55079492	4q12	0	normal	.	T	snv	A	GG.AA	hom-alt	297	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55079491T>A (intergenic)	;	5008	0.997204	U	1	0.997204	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1364988	.	.	.	-0.527	0.101	0.067	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55125057	55125058	4q12	0	nullSample	.	A	ref	A	TT.TT	homo-ref	.	.	.	0	.	.	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	IC1	IVS2	.	.	no-change	NM_006206.4	NP_006197.1	+	Y	c.49+74A=	.	.	.	NM_006206.4(PDGFRA): c.49+74A=	;maf-5-some-pop	5008	0.745208	U	0.4861	0.254792	4566	0.779895	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2303430	.	4024	0.516700	0.172	-1.835	-2.181	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55125057	55125058	4q12	0	normal	.	A	snv	T	TT.TT	hom-alt	221	1.00	.	0	.	PASS	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	IC1	IVS2	.	.	intron	NM_006206.4	NP_006197.1	+	Y	c.49+74A>T	.	.	.	NM_006206.4(PDGFRA): c.49+74A>T	;maf-5-some-pop	5008	0.254792	U	0.4861	0.254792	4566	0.220105	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2303430	.	4024	0.483300	0.172	-1.835	-2.181	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55130161	55130162	4q12	0	normal	.	T	del	.	GA.TT	het-ref	35	0.32	.	2	.	PASS	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	IC3	IVS4	.	.	intron	NM_006206.4	NP_006197.1	+	Y	c.628+68delT	.	.	.	NM_006206.4(PDGFRA): c.628+68delT	MixedObserved;	0	0	U	.	.	.	.	PASS	0	1852	0.440065	0	40278	0.435076	.	.	.	.	.	.	rs138257527	.	4024	0.418200	0.459	-0.489	-1.023	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55130161	55130162	4q12	0	normal	.	T	ref	T	GA.TT	het-alt	75	0.68	.	1	.	PASS	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	IC3	IVS4	.	.	no-change	NM_006206.4	NP_006197.1	+	Y	c.628+68T=	.	.	.	NM_006206.4(PDGFRA): c.628+68T=	MixedObserved;	0|1942	0|0.999485	U	.	.	.	.	InbreedingCoeff_Filter	0	68	1.000000	970	1942	0.999485	.	.	.	.	.	.	rs138257527|rs779104255	.	4024	0.581800	0.459	-0.489	-1.023	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55135671	55135673	4q12	0	normal	.	AC	del	.	at.ac	het-ref	68	0.24	.	2	(CA)n|Simple_repeat|Simple_repeat|+|40;trf	PASS	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	IC6	IVS7	.	.	intron	NM_006206.4	NP_006197.1	+	Y	c.1122-1128_1122-1127delAC	.	.	.	NM_006206.4(PDGFRA): c.1122-1128_1122-1127delAC	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.220400	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55135671	55135673	4q12	0	normal	.	AC	ref	AC	at.ac	het-alt	218	0.76	.	1	(CA)n|Simple_repeat|Simple_repeat|+|40;trf	PASS	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	IC6	IVS7	.	.	no-change	NM_006206.4	NP_006197.1	+	Y	c.1122-1128_1122-1127=	.	.	.	NM_006206.4(PDGFRA): c.1122-1128_1122-1127=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.778600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55135777	55135778	4q12	0	normal	.	T	ref	T	TA.TT	het-alt	133	0.85	.	1	.	PASS	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	IC6	IVS7	.	.	no-change	NM_006206.4	NP_006197.1	+	Y	c.1122-1022T=	.	.	.	NM_006206.4(PDGFRA): c.1122-1022T=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.827000	0.303	0.263	0.221	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55135777	55135778	4q12	0	normal	.	T	del	.	TA.TT	het-ref	23	0.15	.	2	.	PASS	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	IC6	IVS7	.	.	intron	NM_006206.4	NP_006197.1	+	Y	c.1122-1022delT	.	.	.	NM_006206.4(PDGFRA): c.1122-1022delT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.173000	0.303	0.263	0.221	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55139977	55139978	4q12	0	nullSample	.	T	ref	T	GT.AT	homo-ref	.	.	.	0	.	.	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	IC9	IVS10	.	.	no-change	NM_006206.4	NP_006197.1	+	Y	c.1558+81T=	.	.	.	NM_006206.4(PDGFRA): c.1558+81T=	;maf-5-some-pop	5008	0.044928	U	1	0.955072	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1492765	.	4024	0.001500	-0.128	-0.215	-0.223	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55139977	55139978	4q12	0	normal	.	T	snv	C	GT.AT	hom-alt	310	1.00	.	0	.	PASS	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	IC9	IVS10	.	.	intron	NM_006206.4	NP_006197.1	+	Y	c.1558+81T>C	.	.	.	NM_006206.4(PDGFRA): c.1558+81T>C	;maf-5-some-pop	5008	0.955072	U	1	0.955072	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1492765	.	4024	0.998500	-0.128	-0.215	-0.223	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55141054	55141055	4q12	0	nullSample	.	A	ref	A	CC.GA	homo-ref	.	.	.	0	.	.	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	C11	EX12	.	.	no-change	NM_006206.4	NP_006197.1	+	Y	c.1701A=	.	.	.	NM_006206.4(PDGFRA): c.1701A=	;maf-5-some-pop,genotype-conflict	126412	0.013163	U	1	0.957668	13006	0.041135	PASS	0	8650	0.000000	62	121404	0.011960	.	.	.	.	.	.	rs1873778	.	4024	0.001000	-4.136	-5.707	-5.312	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55141054	55141055	4q12	1	normal	.	A	snv	G	CC.GA	hom-alt	732	1.00	.	0	.	PASS	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	C11	EX12	.	.	coding-synon	NM_006206.4	NP_006197.1	+	Y	c.1701A>G	p.(P567=) | p.(Pro567=)	CCA=>CCG	.	NM_006206.4(PDGFRA): c.1701A>G (p.(P567=))	;maf-5-some-pop,genotype-conflict	126412	0.986837	U	1	0.957668	13006	0.958865	PASS	4325	8650	1.000000	59312	121404	0.988040	8620	17241	9.99942e-01	120667	243535	9.90278e-01	rs1873778	.	4024	0.999000	-4.136	-5.707	-5.312	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	259949	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
4	55144446	55144447	4q12	0	nullSample	.	T	ref	T	TG.GC	homo-ref	.	.	.	0	.	.	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	IC13	IVS14	.	.	no-change	NM_006206.4	NP_006197.1	+	Y	c.2003-82T=	.	.	.	NM_006206.4(PDGFRA): c.2003-82T=	;maf-5-some-pop	5008	0.047125	U	0.9921	0.952875	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1907820	.	4024	0.074300	-1.741	-1.483	-1.645	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55144446	55144447	4q12	0	normal	.	T	snv	C	TG.GC	hom-alt	218	1.00	.	0	.	PASS	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	IC13	IVS14	.	.	intron	NM_006206.4	NP_006197.1	+	Y	c.2003-82T>C	.	.	.	NM_006206.4(PDGFRA): c.2003-82T>C	;maf-5-some-pop	5008	0.952875	U	0.9921	0.952875	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1907820	.	4024	0.925700	-1.741	-1.483	-1.645	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55146405	55146406	4q12	0	nullSample	.	T	ref	T	CA.AA	homo-ref	.	.	.	0	.	.	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	IC14	IVS15	.	.	no-change	NM_006206.4	NP_006197.1	+	Y	c.2157-77T=	.	.	.	NM_006206.4(PDGFRA): c.2157-77T=	;	0	0	U	1	0.955072	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs76127266	.	.	.	0.459	-0.332	-0.481	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55146406	55146406	4q12	0	normal	.	.	ins	TGTAGGTCCCCCAG	AT.AA	hom-alt	201	1.00	.	0	.	PASS	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	IC14	IVS15	.	.	intron	NM_006206.4	NP_006197.1	+	Y	c.2157-77_2157-76insTGTAGGTCCCCCAG	.	.	.	NM_006206.4(PDGFRA): c.2157-77_2157-76insTGTAGGTCCCCCAG	ObservedTooLong;maf-5-some-pop	5008	0.955072	U	1	0.955072	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6148442	.	4024	0.999000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55151957	55151958	4q12	0	nullSample	.	T	ref	T	TA.TC	homo-ref	.	.	.	0	.	.	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	IC16	IVS17	.	.	no-change	NM_006206.4	NP_006197.1	+	Y	c.2440-50T=	.	.	.	NM_006206.4(PDGFRA): c.2440-50T=	.	.	.	.	0.8224	0.713858	.	.	PASS	.	8626	0.152910	3064	121142	0.196133	.	.	.	.	.	.	.	.	.	.	-0.264	-0.498	-0.448	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55151958	55151958	4q12	0	normal	.	.	ins	A	AT.TC	hom-alt	360	1.00	.	0	.	PASS	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	IC16	IVS17	.	.	intron	NM_006206.4	NP_006197.1	+	Y	c.2440-50_2440-49insA	.	.	.	NM_006206.4(PDGFRA): c.2440-50_2440-49insA	;maf-5-some-pop,maf-5-all-pops	126150	0.800293	U	0.8224	0.713858	12520	0.749681	PASS	3107	8626	0.847090	39875	121142	0.803867	6238	14657	8.50470e-01	80695	197147	8.05615e-01	rs3830355	.	4024	0.851100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55156379	55156380	4q12	0	nullSample	.	G	ref	G	GA.AT	homo-ref	.	.	.	0	.	.	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	IC20	IVS21	.	.	no-change	NM_006206.4	NP_006197.1	+	Y	c.2881-100G=	.	.	.	NM_006206.4(PDGFRA): c.2881-100G=	;maf-5-some-pop	5008	0.043730	U	1	0.95627	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4864506	.	4024	0.001500	-0.352	-0.433	-0.602	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55156379	55156380	4q12	0	normal	.	G	snv	A	GA.AT	hom-alt	243	1.00	.	0	.	PASS	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	IC20	IVS21	.	.	intron	NM_006206.4	NP_006197.1	+	Y	c.2881-100G>A	.	.	.	NM_006206.4(PDGFRA): c.2881-100G>A	;maf-5-some-pop	5008	0.956270	U	1	0.95627	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4864506	.	4024	0.998500	-0.352	-0.433	-0.602	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55156399	55156400	4q12	0	nullSample	.	A	ref	A	AT.GT	homo-ref	.	.	.	0	.	.	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	IC20	IVS21	.	.	no-change	NM_006206.4	NP_006197.1	+	Y	c.2881-80A=	.	.	.	NM_006206.4(PDGFRA): c.2881-80A=	;maf-5-some-pop,maf-5-all-pops	5008	0.299720	U	0.8274	0.70028	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2276948	.	4024	0.141200	-0.361	-1.260	-1.726	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55156399	55156400	4q12	0	normal	.	A	snv	G	AT.GT	hom-alt	282	1.00	.	0	.	PASS	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	IC20	IVS21	.	.	intron	NM_006206.4	NP_006197.1	+	Y	c.2881-80A>G	.	.	.	NM_006206.4(PDGFRA): c.2881-80A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.700280	U	0.8274	0.70028	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2276948	.	4024	0.858800	-0.361	-1.260	-1.726	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55161253	55161254	4q12	0	normal	.	C	snv	T	TG.AG	hom-alt	270	1.00	.	0	.	PASS	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	IC21	IVS22	.	.	intron	NM_006206.4	NP_006197.1	+	Y	c.3123-38C>T	.	.	.	NM_006206.4(PDGFRA): c.3123-38C>T	;maf-5-some-pop,maf-5-all-pops	126288	0.798001	U	0.8274	0.699081	13006	0.735814	PASS	3179	8624	0.856563	39914	121280	0.802086	6360	14797	8.59192e-01	80923	197242	8.04662e-01	rs3733540	.	4024	0.858100	-0.379	-1.642	-1.612	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	259952	criteria_provided,_single_submitter	Benign	Benign
4	55161253	55161254	4q12	0	nullSample	.	C	ref	C	TG.AG	homo-ref	.	.	.	0	.	.	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	IC21	IVS22	.	.	no-change	NM_006206.4	NP_006197.1	+	Y	c.3123-38C=	.	.	.	NM_006206.4(PDGFRA): c.3123-38C=	;maf-5-some-pop,maf-5-all-pops	126288	0.201999	U	0.8274	0.699081	13006	0.264186	PASS	.	8624	0.143437	3277	121280	0.197914	.	.	.	.	.	.	rs3733540	.	4024	0.141900	-0.379	-1.642	-1.612	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55161390	55161391	4q12	0	nullSample	.	T	ref	T	GA.GA	homo-ref	.	.	.	0	.	.	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	C22E	EX23E	.	.	no-change	NM_006206.4	NP_006197.1	+	Y	c.3222T=	.	.	.	NM_006206.4(PDGFRA): c.3222T=	;	126418	0.001084	U	1	0.997204	13006	0.003229	PASS	.	8652	0.000116	0	121410	0.001013	.	.	.	.	.	.	rs7685117	.	4024	0.001500	-0.355	-0.112	-0.918	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55161390	55161391	4q12	1	normal	.	T	snv	C	GA.GA	hom-alt	494	1.00	.	0	.	PASS	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	C22E	EX23E	.	.	coding-synon	NM_006206.4	NP_006197.1	+	Y	c.3222T>C	p.(D1074=) | p.(Asp1074=)	GAT=>GAC	.	NM_006206.4(PDGFRA): c.3222T>C (p.(D1074=))	;	126418	0.998916	U	1	0.997204	13006	0.996771	PASS	4325	8652	0.999884	60582	121410	0.998987	8621	17244	9.99884e-01	122830	245847	9.99232e-01	rs7685117	.	4024	0.998500	-0.355	-0.112	-0.918	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	259953	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
4	55161516	55161517	4q12	0	nullSample	.	A	ref	A	GC.GA	homo-ref	.	.	.	0	.	.	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	3U1E	EX23E	.	.	no-change	NM_006206.4	NP_006197.1	+	Y	c.*78A=	.	.	.	NM_006206.4(PDGFRA): c.*78A=	SingleClassTriAllelic,InconsistentAlleles;	5008	0.002995	U	1	0.997005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7680422	.	.	.	-1.741	0.320	0.113	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55161516	55161517	4q12	0	normal	.	A	snv	G	GC.GA	hom-alt	257	1.00	.	0	.	PASS	173490	C	606764(MK);607685(MK)	NN	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	17087943|14699510	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	5156	PDGFRA	3U1E	EX23E	.	.	utr-3	NM_006206.4	NP_006197.1	+	Y	c.*78A>G	.	.	.	NM_006206.4(PDGFRA): c.*78A>G	SingleClassTriAllelic,InconsistentAlleles;	5008	0.997005	U	1	0.997005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7680422	.	.	.	-1.741	0.320	0.113	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	348913	criteria_provided,_single_submitter	Benign	Benign
4	55174826	55174827	4q12	0	nullSample	.	G	ref	G	TC.TC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55174826G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.554712	U	0.3978	0.445288	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6554168	.	.	.	-0.972	-4.933	-4.649	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55174826	55174827	4q12	0	normal	.	G	snv	A	TC.TC	hom-alt	246	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55174826G>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.445288	U	0.3978	0.445288	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6554168	.	.	.	-0.972	-4.933	-4.649	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55174884	55174885	4q12	0	nullSample	.	C	ref	C	GA.TT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55174884C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.588059	U	0.3978	0.411941	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6554170	.	.	.	-1.126	-0.130	-0.280	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55174884	55174885	4q12	0	normal	.	C	snv	T	GA.TT	hom-alt	256	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55174884C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.411941	U	0.3978	0.411941	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6554170	.	.	.	-1.126	-0.130	-0.280	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55186955	55186956	4q12	0	nullSample	.	C	ref	C	GT.GG	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55186955C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.628994	U	0.3819	0.371006	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2087806	.	.	.	-0.694	-0.101	-0.143	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55186955	55186956	4q12	0	normal	.	C	snv	T	GT.GG	hom-alt	429	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55186955C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.371006	U	0.3819	0.371006	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2087806	.	.	.	-0.694	-0.101	-0.143	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55193346	55193347	4q12	0	nullSample	.	T	ref	T	AC.TA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55193346T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.564297	U	0.3829	0.435703	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4583821	.	.	.	-0.119	-0.245	-0.278	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55193346	55193347	4q12	0	normal	.	T	snv	C	AC.TA	hom-alt	338	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55193346T>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.435703	U	0.3829	0.435703	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4583821	.	.	.	-0.119	-0.245	-0.278	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55199932	55199933	4q12	0	nullSample	.	T	ref	T	GA.CT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55199932T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.553115	U	0.4167	0.446885	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1873774	.	.	.	-0.355	0.384	0.209	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55199932	55199933	4q12	0	normal	.	T	snv	C	GA.CT	hom-alt	186	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55199932T>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.446885	U	0.4167	0.446885	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1873774	.	.	.	-0.355	0.384	0.209	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55200058	55200059	4q12	0	nullSample	.	T	ref	T	TC.GG	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55200058T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.573882	U	0.4167	0.426118	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1873775	.	.	.	-2.401	-0.831	-1.195	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55200058	55200059	4q12	0	normal	.	T	snv	C	TC.GG	hom-alt	271	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55200058T>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.426118	U	0.4167	0.426118	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1873775	.	.	.	-2.401	-0.831	-1.195	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55200113	55200114	4q12	0	nullSample	.	T	ref	T	AG.GC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55200113T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.574081	U	0.4167	0.425919	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1873776	.	.	.	-1.309	-1.220	-1.242	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55200113	55200114	4q12	0	normal	.	T	snv	C	AG.GC	hom-alt	214	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55200113T>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.425919	U	0.4167	0.425919	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1873776	.	.	.	-1.309	-1.220	-1.242	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55481584	55481585	4q12	0	normal	.	C	snv	T	TA.AC	het-ref	162	0.42	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55481584C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.535743	U	0.4226	0.535743	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs987397	.	.	.	-0.521	0.135	0.105	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55481584	55481585	4q12	0	normal	.	C	ref	C	TA.AC	het-alt	220	0.58	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55481584C= (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.464257	U	0.4226	0.535743	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs987397	.	.	.	-0.521	0.135	0.105	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55490809	55490810	4q12	0	normal	.	C	snv	T	CA.AT	hom-alt	349	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55490809C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.216653	U	0.3175	0.216653	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17084534	.	.	.	0.561	0.351	0.172	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55490809	55490810	4q12	0	nullSample	.	C	ref	C	CA.AT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55490809C= (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.783347	U	0.3175	0.216653	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17084534	.	.	.	0.561	0.351	0.172	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55495725	55495726	4q12	0	normal	.	A	snv	T	AC.GG	hom-alt	324	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55495725A>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.256789	U	0.3165	0.256789	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17084550	.	.	.	0.260	-0.205	-0.249	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55495725	55495726	4q12	0	nullSample	.	A	ref	A	AC.GG	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55495725A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.743211	U	0.3165	0.256789	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17084550	.	.	.	0.260	-0.205	-0.249	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55495792	55495793	4q12	0	nullSample	.	T	ref	T	AC.CT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55495792T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.488419	U	0.4196	0.511581	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6815910	.	.	.	-1.602	-2.215	-2.391	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55495792	55495793	4q12	0	normal	.	T	snv	A	AC.CT	hom-alt	339	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55495792T>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.511581	U	0.4196	0.511581	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6815910	.	.	.	-1.602	-2.215	-2.391	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55501194	55501195	4q12	0	nullSample	.	C	ref	C	TC.GT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55501194C= (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.458267	U	0.4286	0.541733	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6554197	.	.	.	-0.361	0.651	0.455	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55501194	55501195	4q12	0	normal	.	C	snv	T	TC.GT	hom-alt	267	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55501194C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.541733	U	0.4286	0.541733	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6554197	.	.	.	-0.361	0.651	0.455	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55510861	55510862	4q12	0	nullSample	.	C	ref	C	AT.AC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55510861C= (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.478035	U	0.4028	0.521965	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10488849	.	.	.	-1.135	-0.063	-0.104	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55510861	55510862	4q12	0	normal	.	C	snv	T	AT.AC	hom-alt	287	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55510861C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.521965	U	0.4028	0.521965	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10488849	.	.	.	-1.135	-0.063	-0.104	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55511007	55511008	4q12	0	nullSample	.	T	ref	T	TA.CC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55511007T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.831270	U	0.2599	0.16873	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs60929191	.	.	.	0.533	0.052	0.019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55511007	55511008	4q12	0	normal	.	T	snv	G	TA.CC	hom-alt	258	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55511007T>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.168730	U	0.2599	0.16873	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs60929191	.	.	.	0.533	0.052	0.019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55511016	55511017	4q12	0	nullSample	.	T	ref	T	TC.CC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55511016T= (intergenic)	;maf-5-some-pop,genotype-conflict	5008	0.095447	U	1	0.904553	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2537864	.	.	.	-1.595	-0.919	-0.944	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55511016	55511017	4q12	0	normal	.	T	snv	C	TC.CC	hom-alt	237	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55511016T>C (intergenic)	;maf-5-some-pop,genotype-conflict	5008	0.904553	U	1	0.904553	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2537864	.	.	.	-1.595	-0.919	-0.944	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55524303	55524304	4q12	0	nullSample	.	T	ref	T	CC.GG	homo-ref	.	.	.	0	.	.	164920	C	154800(MK);172800(MK);273300(MK);601626(MK);606764(MK)	AD	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	22083669|19847891|18724244|18183595|17824795|16185297|16143141|11505412|11073817|9697690	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	3815	KIT	IC1	IVS1	.	.	no-change	NM_000222.2	NP_000213.1	+	Y	c.67+56T=	.	.	.	NM_000222.2(KIT): c.67+56T=	;maf-5-some-pop,maf-5-all-pops	5008	0.442292	U	0.4563	0.557708	4566	0.419623	.	.	.	.	.	.	.	.	.	.	.	.	.	rs999020	.	4024	0.573800	-1.741	-0.204	-0.084	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55524303	55524304	4q12	0	normal	.	T	snv	C	CC.GG	hom-alt	196	1.00	.	0	.	PASS	164920	C	154800(MK);172800(MK);273300(MK);601626(MK);606764(MK)	AD	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	22083669|19847891|18724244|18183595|17824795|16185297|16143141|11505412|11073817|9697690	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	3815	KIT	IC1	IVS1	.	.	intron	NM_000222.2	NP_000213.1	+	Y	c.67+56T>C	.	.	.	NM_000222.2(KIT): c.67+56T>C	;maf-5-some-pop,maf-5-all-pops	5008	0.557708	U	0.4563	0.557708	4566	0.580377	.	.	.	.	.	.	.	.	.	.	.	.	.	rs999020	.	4024	0.426200	-1.741	-0.204	-0.084	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55598211	55598212	4q12	0	normal	.	T	ref	T	ga.tt	het-alt	46	0.53	.	1	(T)n|Simple_repeat|Simple_repeat|+|39;trf	PASS	164920	C	154800(MK);172800(MK);273300(MK);601626(MK);606764(MK)	AD	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	22083669|19847891|18724244|18183595|17824795|16185297|16143141|11505412|11073817|9697690	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	3815	KIT	IC16	IVS16	.	.	no-change	NM_000222.2	NP_000213.1	+	Y	c.2361+48T=	.	.	.	NM_000222.2(KIT): c.2361+48T=	MixedObserved;	0	0	U	.	.	.	.	PASS	0	986	1.000000	7743	15488	0.999935	.	.	.	.	.	.	rs749161019|rs869153101	.	4024	0.945800	0.000	0.549	0.000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55598211	55598212	4q12	0	normal	.	T	del	.	ga.tt	het-ref	40	0.47	.	2	(T)n|Simple_repeat|Simple_repeat|+|39;trf	PASS	164920	C	154800(MK);172800(MK);273300(MK);601626(MK);606764(MK)	AD	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	22083669|19847891|18724244|18183595|17824795|16185297|16143141|11505412|11073817|9697690	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	3815	KIT	IC16	IVS16	.	.	intron	NM_000222.2	NP_000213.1	+	Y	c.2361+48delT	.	.	.	NM_000222.2(KIT): c.2361+48delT	MixedObserved;	0	0	U	.	.	.	.	PASS	0	224	0.174107	8	6584	0.144897	.	.	.	.	.	.	rs749161019|rs869153101	.	4024	0.044700	0.000	0.549	0.000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55599435	55599436	4q12	0	nullSample	.	T	ref	T	GA.TT	homo-ref	.	.	.	0	.	.	164920	C	154800(MK);172800(MK);273300(MK);601626(MK);606764(MK)	AD	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	22083669|19847891|18724244|18183595|17824795|16185297|16143141|11505412|11073817|9697690	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	3815	KIT	IC17	IVS17	.	.	no-change	NM_000222.2	NP_000213.1	+	Y	c.2484+78T=	.	.	.	NM_000222.2(KIT): c.2484+78T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.495208	U	0.6875	0.504792	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1008658	.	4024	0.334000	0.477	-0.107	0.335	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55599435	55599436	4q12	0	normal	.	T	snv	C	GA.TT	hom-alt	321	1.00	.	0	.	PASS	164920	C	154800(MK);172800(MK);273300(MK);601626(MK);606764(MK)	AD	Gastrointestinal stromal tumor	AD	.	Oncologic	Oncologic	22083669|19847891|18724244|18183595|17824795|16185297|16143141|11505412|11073817|9697690	FC59;FH44;H54;H62;H68;HD31;HD32;HG15;MC58;MH43	3815	KIT	IC17	IVS17	.	.	intron	NM_000222.2	NP_000213.1	+	Y	c.2484+78T>C	.	.	.	NM_000222.2(KIT): c.2484+78T>C	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.504792	U	0.6875	0.504792	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1008658	.	4024	0.666000	0.477	-0.107	0.335	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55650766	55650767	4q12	0	normal	.	G	snv	A	TG.TC	het-ref	166	0.48	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55650766G>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.273562	U	0.2976	0.273562	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7686567	.	.	.	0.491	1.600	1.401	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55650766	55650767	4q12	0	normal	.	G	ref	G	TG.TC	het-alt	179	0.52	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55650766G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.726438	U	0.2976	0.273562	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7686567	.	.	.	0.491	1.600	1.401	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55899114	55899115	4q12	0	nullSample	.	C	ref	C	GC.TT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55899114C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.367212	U	0.6687	0.632788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4566712	.	.	.	-0.363	-1.457	-1.645	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55899114	55899115	4q12	0	normal	.	C	snv	A	GC.TT	hom-alt	217	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55899114C>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.632788	U	0.6687	0.632788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4566712	.	.	.	-0.363	-1.457	-1.645	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55899285	55899286	4q12	0	nullSample	.	G	ref	G	CT.TA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55899285G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.367412	U	0.6687	0.632588	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs13142103	.	.	.	0.561	-0.755	-0.817	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55899285	55899286	4q12	0	normal	.	G	snv	A	CT.TA	hom-alt	211	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55899285G>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.632588	U	0.6687	0.632588	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs13142103	.	.	.	0.561	-0.755	-0.817	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55904727	55904728	4q12	0	nullSample	.	C	ref	C	CC.CT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55904727C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.415136	U	0.6696	0.584864	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6554228	.	.	.	-1.996	-1.652	-1.926	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55904727	55904728	4q12	0	normal	.	C	snv	G	CC.CT	hom-alt	255	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55904727C>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.584864	U	0.6696	0.584864	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6554228	.	.	.	-1.996	-1.652	-1.926	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55904740	55904741	4q12	0	nullSample	.	A	ref	A	CT.GA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55904740A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.415136	U	0.6696	0.584864	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6554229	.	.	.	-0.996	0.233	0.395	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55904740	55904741	4q12	0	normal	.	A	snv	G	CT.GA	hom-alt	255	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55904740A>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.584864	U	0.6696	0.584864	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6554229	.	.	.	-0.996	0.233	0.395	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55917807	55917808	4q12	0	nullSample	.	G	ref	G	AT.TG	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55917807G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.647165	U	0.5754	0.352835	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs61158582	.	.	.	0.650	1.555	1.346	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55917807	55917808	4q12	0	normal	.	G	snv	T	AT.TG	hom-alt	274	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55917807G>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.352835	U	0.5754	0.352835	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs61158582	.	.	.	0.650	1.555	1.346	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55917868	55917869	4q12	0	nullSample	.	G	ref	G	GT.TA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55917868G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.417133	U	0.6627	0.582867	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs34227858	.	.	.	0.650	0.869	0.700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55917868	55917869	4q12	0	normal	.	G	snv	T	GT.TA	hom-alt	280	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55917868G>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.582867	U	0.6627	0.582867	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs34227858	.	.	.	0.650	0.869	0.700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55922488	55922489	4q12	0	nullSample	.	A	ref	A	AT.TT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55922488A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.661342	U	0.5784	0.338658	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9998321	.	.	.	0.438	0.610	0.569	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55922488	55922489	4q12	0	normal	.	A	snv	G	AT.TT	hom-alt	211	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55922488A>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.338658	U	0.5784	0.338658	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9998321	.	.	.	0.438	0.610	0.569	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55922601	55922602	4q12	0	normal	.	G	snv	T	AG.CA	hom-alt	209	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55922601G>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.582867	U	0.6647	0.582867	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10008645	.	.	.	-0.335	-0.116	-0.138	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55922601	55922602	4q12	0	nullSample	.	G	ref	G	AG.CA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55922601G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.417133	U	0.6647	0.582867	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10008645	.	.	.	-0.335	-0.116	-0.138	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55938835	55938836	4q12	0	nullSample	.	T	ref	T	TA.TT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55938835T= (intergenic)	DuplicateObserved;maf-5-some-pop,maf-5-all-pops|DuplicateObserved;	5008|0	0.225839|0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs5858310|rs869036045	.	.	.	-0.408	-0.019	-0.023	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
4	55938835	55938836	4q12	0	normal	.	T	del	.	TA.TT	hom-alt	236	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55938836delT (intergenic)	DuplicateObserved;maf-5-some-pop,maf-5-all-pops|DuplicateObserved;	5008|0	0.774161|0	U	0.752	0.774161	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs5858310|rs869036045	.	.	.	-0.408	-0.019	-0.023	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55938913	55938914	4q12	0	normal	.	C	snv	T	CT.TG	hom-alt	390	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55938913C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.794529	U	0.751	0.794529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4254836	.	.	.	-0.797	-0.005	-0.006	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55938913	55938914	4q12	0	nullSample	.	C	ref	C	CT.TG	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.55938913C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.205471	U	0.751	0.794529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4254836	.	.	.	-0.797	-0.005	-0.006	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55946080	55946081	4q12	0	nullSample	.	A	ref	A	CC.GG	homo-ref	.	.	.	0	.	.	191306	C	602089(SK)	NN	.	.	.	.	.	.	.	3791	KDR	3U1E	EX30E	.	.	no-change	NM_002253.2	NP_002244.1	-	Y	c.*27T=	.	.	.	NM_002253.2(KDR): c.*27T=	;maf-5-some-pop	126414	0.003370	U	1	0.992812	13006	0.007996	PASS	0	8654	0.000000	1	121406	0.003212	.	.	.	.	.	.	rs4421048	.	.	.	-0.990	0.533	0.430	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55946080	55946081	4q12	0	normal	.	A	snv	G	CC.GG	hom-alt	258	1.00	.	0	.	PASS	191306	C	602089(SK)	NN	.	.	.	.	.	.	.	3791	KDR	3U1E	EX30E	.	.	utr-3	NM_002253.2	NP_002244.1	-	Y	c.*27T>C	.	.	.	NM_002253.2(KDR): c.*27T>C	;maf-5-some-pop	126414	0.996630	U	1	0.992812	13006	0.992004	PASS	4327	8654	1.000000	60314	121406	0.996788	8624	17248	1.00000e+00	122353	245392	9.97188e-01	rs4421048	.	.	.	-0.990	0.533	0.430	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55948107	55948108	4q12	0	nullSample	.	A	ref	A	AT.TG	homo-ref	.	.	.	0	.	.	191306	C	602089(SK)	NN	.	.	.	.	.	.	.	3791	KDR	IC29	IVS29	.	.	no-change	NM_002253.2	NP_002244.1	-	Y	c.3848+15T=	.	.	.	NM_002253.2(KDR): c.3848+15T=	;	126360	0.001512	U	1	0.996805	13006	0.002384	PASS	0	8650	0.000000	0	121352	0.001442	.	.	.	.	.	.	rs2412617	.	4024	0.001500	-1.102	-0.881	-1.194	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55948107	55948108	4q12	1	normal	.	A	snv	G	AT.TG	hom-alt	332	1.00	.	0	.	PASS	191306	C	602089(SK)	NN	.	.	.	.	.	.	.	3791	KDR	IC29	IVS29	.	.	intron	NM_002253.2	NP_002244.1	-	Y	c.3848+15T>C	.	.	.	NM_002253.2(KDR): c.3848+15T>C	;	126360	0.998488	U	1	0.996805	13006	0.997616	PASS	4325	8650	1.000000	60501	121352	0.998558	8621	17242	1.00000e+00	122527	245393	9.98620e-01	rs2412617	.	4024	0.998500	-1.102	-0.881	-1.194	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	518355	no_assertion_criteria_provided	Benign	Benign
4	55961158	55961159	4q12	0	normal	.	T	ref	T	AA.AC	het-alt	195	0.47	.	1	.	PASS	191306	C	602089(SK)	NN	.	.	.	.	.	.	.	3791	KDR	IC20	IVS20	.	.	no-change	NM_002253.2	NP_002244.1	-	Y	c.2818-37A=	.	.	.	NM_002253.2(KDR): c.2818-37A=	;maf-5-some-pop,maf-5-all-pops	124942	0.776969	U	0.4593	0.220248	13006	0.792711	PASS	-1041	8466	0.539570	36698	119934	0.776852	.	.	.	.	.	.	rs2219471	.	4024	0.518100	-2.292	-1.229	-1.704	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55961158	55961159	4q12	0	normal	.	T	snv	C	AA.AC	het-ref	219	0.53	.	2	.	PASS	191306	C	602089(SK)	NN	.	.	.	.	.	.	.	3791	KDR	IC20	IVS20	.	.	intron	NM_002253.2	NP_002244.1	-	Y	c.2818-37A>G	.	.	.	NM_002253.2(KDR): c.2818-37A>G	;maf-5-some-pop,maf-5-all-pops	124942	0.223031	U	0.4593	0.220248	13006	0.207289	PASS	908	8466	0.460430	3494	119934	0.223148	1976	8132	4.74556e-01	7239	54700	2.24213e-01	rs2219471	.	4024	0.481900	-2.292	-1.229	-1.704	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55962544	55962545	4q12	0	normal	.	T	ref	T	TA.GG	het-alt	135	0.56	.	1	.	PASS	191306	C	602089(SK)	NN	.	.	.	.	.	.	.	3791	KDR	IC18	IVS18	.	.	no-change	NM_002253.2	NP_002244.1	-	Y	c.2615-36A=	.	.	.	NM_002253.2(KDR): c.2615-36A=	.	.	.	.	0.4534	0.241014	.	.	PASS	.	8192	0.539917	33842	114308	0.765887	.	.	.	.	.	.	.	.	.	.	-0.256	-0.957	-1.236	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55962545	55962545	4q12	0	normal	.	.	ins	G	AT.GG	het-ref	105	0.44	.	2	.	PASS	191306	C	602089(SK)	NN	.	.	.	.	.	.	.	3791	KDR	IC18	IVS18	.	.	intron	NM_002253.2	NP_002244.1	-	Y	c.2615-37_2615-36insC	.	.	.	NM_002253.2(KDR): c.2615-37_2615-36insC	;maf-5-some-pop,maf-5-all-pops	119316	0.234403	U	0.4534	0.241014	12518	0.226474	PASS	886	8192	0.460083	3449	114308	0.234113	1946	8012	4.72239e-01	7201	54607	2.29808e-01	rs3214870	.	4024	0.480900	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55968052	55968053	4q12	0	normal	.	A	ref	A	tt.tc	het-alt	213	0.56	.	1	L1PA10|LINE|L1|-|389	PASS	191306	C	602089(SK)	NN	.	.	.	.	.	.	.	3791	KDR	IC15	IVS15	.	.	no-change	NM_002253.2	NP_002244.1	-	Y	c.2266+11T=	.	.	.	NM_002253.2(KDR): c.2266+11T=	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	124900	0.654692	U	0.3135	0.292931	13006	0.717438	PASS	-899	8466	0.680369	26164	119892	0.652504	.	.	.	.	.	.	rs7655964	.	4024	0.708300	-0.686	-1.720	-1.898	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55968052	55968053	4q12	1	normal	.	A	snv	C	tt.tc	het-ref	170	0.44	.	2	L1PA10|LINE|L1|-|389	PASS	191306	C	602089(SK)	NN	.	.	.	.	.	.	.	3791	KDR	IC15	IVS15	.	.	intron	NM_002253.2	NP_002244.1	-	Y	c.2266+11T>G	.	.	.	NM_002253.2(KDR): c.2266+11T>G	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	124900	0.345308	U	0.3135	0.292931	13006	0.282562	PASS	454	8466	0.319631	7880	119892	0.347496	849	5326	3.10048e-01	16976	87427	3.58801e-01	rs7655964	.	4024	0.291700	-0.686	-1.720	-1.898	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55972973	55972974	4q12	0	normal	.	T	ref	T	GC.TG	het-alt	315	0.52	.	1	.	PASS	191306	C	602089(SK)	NN	.	.	.	.	.	.	.	3791	KDR	C11	EX11	Immunoglobulin domain	PF13895.1	no-change	NM_002253.2	NP_002244.1	-	Y	c.1416A=	.	.	.	NM_002253.2(KDR): c.1416A=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126054	0.780491	U	0.4653	0.211861	13006	0.806089	PASS	-1027	8644	0.536326	37434	121046	0.780174	.	.	.	.	.	.	rs1870377	.	4024	0.509700	-0.290	-0.007	-0.160	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55972973	55972974	4q12	1	normal	.	T	snv	A	GC.TG	het-ref	292	0.48	.	2	.	PASS	191306	C	602089(SK)	NN	.	.	.	.	.	.	.	3791	KDR	C11	EX11	Immunoglobulin domain	PF13895.1	missense	NM_002253.2	NP_002244.1	-	Y	c.1416A>T	p.Q472H | p.Gln472His	CAA=>CAT	P0=>P+	NM_002253.2(KDR): c.1416A>T (p.Q472H)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126054	0.219509	U	0.4653	0.211861	13006	0.193911	PASS	977	8644	0.463674	3520	121046	0.219826	2057	8271	4.79756e-01	7252	54567	2.22166e-01	rs1870377	.	4024	0.490300	-0.290	-0.007	-0.160	0.1	0.012	0.011	0.287	neutral	ENST00000263923: c.1416A>T (p.Q472H)	autonomic_ganglia [sinonasal_and_nasal_cavity|NS|NS]	olfactory_neuroblastoma [NS|NS|NS]	CSV	149673	.	.	.	.	.	no_record	134603	no_assertion_provided	not_provided	Likely Benign
4	55976946	55976947	4q12	0	normal	.	T	ref	T	AA.AA	het-alt	48	0.26	.	1	.	PASS	191306	C	602089(SK)	NN	.	.	.	.	.	.	.	3791	KDR	IC7	IVS7	.	.	no-change	NM_002253.2	NP_002244.1	-	Y	c.977-12A=	.	.	.	NM_002253.2(KDR): c.977-12A=	;|DuplicateObserved;	0|109947	0|0.999873	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs76308157|rs781052011	.	4024	0.994500	-0.490	-0.607	-0.511	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55976947	55976947	4q12	1	normal	.	.	ins	A	AT.AA	het-ref	140	0.74	.	2	.	PASS	191306	C	602089(SK)	NN	.	.	.	.	.	.	.	3791	KDR	IC7	IVS7	.	.	intron	NM_002253.2	NP_002244.1	-	Y	c.977-13_977-12insT	.	.	.	NM_002253.2(KDR): c.977-13_977-12insT	;rs-cluster-nonoverlapping-alleles	84506	0.071794	U	.	.	.	.	PASS	88	6550	0.443359	729	94528	0.395047	.	.	.	.	.	.	rs753790740	.	4024	0.443100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55979557	55979558	4q12	0	normal	.	C	ref	C	TA.AC	het-alt	269	0.52	.	1	.	PASS	191306	C	602089(SK)	NN	.	.	.	.	.	.	.	3791	KDR	C7	EX7	Immunoglobulin domain;Immunoglobulin I-set domain;Immunoglobulin V-set domain;Immunoglobulin domain;Immunoglobulin domain	PF00047.20;PF07679.11;PF07686.12;PF13895.1;PF13927.1	no-change	NM_002253.2	NP_002244.1	-	Y	c.889G=	.	.	.	NM_002253.2(KDR): c.889G=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126334	0.889341	U	0.1667	0.152556	13006	0.857297	PASS	-507	8654	0.861105	48330	121326	0.891070	.	.	.	.	.	.	rs2305948	.	4024	0.853400	0.563	3.257	1.298	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55979557	55979558	4q12	1	normal	.	C	snv	T	TA.AC	het-ref	250	0.48	.	2	.	PASS	191306	C	602089(SK)	NN	.	.	.	.	.	.	.	3791	KDR	C7	EX7	Immunoglobulin domain;Immunoglobulin I-set domain;Immunoglobulin V-set domain;Immunoglobulin domain;Immunoglobulin domain	PF00047.20;PF07679.11;PF07686.12;PF13895.1;PF13927.1	missense	NM_002253.2	NP_002244.1	-	Y	c.889G>A	p.V297I | p.Val297Ile	GTA=>ATA	NP=>NP	NM_002253.2(KDR): c.889G>A (p.V297I)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126334	0.110659	U	0.1667	0.152556	13006	0.142703	PASS	94	8654	0.138895	883	121326	0.108930	205	2483	1.43959e-01	1673	25800	1.04825e-01	rs2305948	.	4024	0.146600	0.563	3.257	1.298	0.05	0.999	1	0.836	deleterious	ENST00000263923: c.889G>A (p.V297I)	autonomic_ganglia [sinonasal_and_nasal_cavity|NS|NS]	olfactory_neuroblastoma [NS|NS|NS]	CSV	1131107	CM074307	NM_002253.2(KDR): c.889G>A (p.V297I)	"Coronary heart disease, association with"	17707181	DFP	no_record	134616	no_assertion_provided	not_provided	Likely Benign
4	55980238	55980239	4q12	0	normal	.	C	ref	C	CA.TG	het-alt	141	0.46	.	1	.	PASS	191306	C	602089(SK)	NN	.	.	.	.	.	.	.	3791	KDR	IC6	IVS6	.	.	no-change	NM_002253.2	NP_002244.1	-	Y	c.798+54G=	.	.	.	NM_002253.2(KDR): c.798+54G=	;maf-5-some-pop,maf-5-all-pops	5008	0.455871	U	0.63	0.544129	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7692791	.	4024	0.367000	-0.360	-0.201	-0.173	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55980238	55980239	4q12	0	normal	.	C	snv	T	CA.TG	het-ref	167	0.54	.	2	.	PASS	191306	C	602089(SK)	NN	.	.	.	.	.	.	.	3791	KDR	IC6	IVS6	.	.	intron	NM_002253.2	NP_002244.1	-	Y	c.798+54G>A	.	.	.	NM_002253.2(KDR): c.798+54G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.544129	U	0.63	0.544129	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7692791	.	4024	0.633000	-0.360	-0.201	-0.173	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55980455	55980456	4q12	0	normal	.	C	ref	C	AA.AG	het-alt	250	0.50	.	1	.	PASS	191306	C	602089(SK)	NN	.	.	.	.	.	.	.	3791	KDR	IC5	IVS5	.	.	no-change	NM_002253.2	NP_002244.1	-	Y	c.659-24G=	.	.	.	NM_002253.2(KDR): c.659-24G=	SingleClassTriAllelic;maf-5-some-pop	125652	0.823091	U	0.2004	0.146166	13006	0.828464	PASS	-601	8574	0.826919	40964	120644	0.821815	.	.	.	.	.	.	rs2305949	.	4024	0.813400	-0.140	-0.059	-0.150	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	55980455	55980456	4q12	0	normal	.	C	snv	T	AA.AG	het-ref	246	0.50	.	2	.	PASS	191306	C	602089(SK)	NN	.	.	.	.	.	.	.	3791	KDR	IC5	IVS5	.	.	intron	NM_002253.2	NP_002244.1	-	Y	c.659-24G>A	.	.	.	NM_002253.2(KDR): c.659-24G>A	SingleClassTriAllelic;maf-5-some-pop	125652	0.176901	U	0.2004	0.146166	13006	0.171536	PASS	141	8574	0.173081	2138	120644	0.178177	316	3073	1.78497e-01	4300	43559	1.77721e-01	rs2305949	.	4024	0.186600	-0.140	-0.059	-0.150	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	56002781	56002782	4q12	0	normal	.	G	ref	G	AA.TT	het-alt	128	0.54	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.56002781G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.515775	U	0.6528	0.484225	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1380069	.	.	.	0.305	-0.559	-0.538	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	56002781	56002782	4q12	0	normal	.	G	snv	C	AA.TT	het-ref	107	0.46	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.56002781G>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.484225	U	0.6528	0.484225	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1380069	.	.	.	0.305	-0.559	-0.538	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	56014388	56014389	4q12	0	normal	.	G	ref	G	AT.TT	het-alt	178	0.62	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.56014388G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.524760	U	0.6002	0.47524	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1350543	.	.	.	0.567	0.045	0.021	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	56014388	56014389	4q12	0	normal	.	G	snv	C	AT.TT	het-ref	107	0.38	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.56014388G>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.475240	U	0.6002	0.47524	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1350543	.	.	.	0.567	0.045	0.021	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	56014392	56014393	4q12	0	normal	.	C	ref	C	TG.CA	het-alt	181	0.63	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.56014392C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.503195	U	0.6022	0.496805	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1350542	.	.	.	0.567	0.128	0.097	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	56014392	56014393	4q12	0	normal	.	C	snv	T	TG.CA	het-ref	105	0.37	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.56014392C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.496805	U	0.6022	0.496805	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1350542	.	.	.	0.567	0.128	0.097	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	56014424	56014425	4q12	0	normal	.	C	ref	C	GC.CA	het-alt	164	0.62	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.56014424C= (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.501198	U	0.5992	0.498802	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2219469	.	.	.	0.567	-0.789	-0.831	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	56014424	56014425	4q12	0	normal	.	C	snv	T	GC.CA	het-ref	101	0.38	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.56014424C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.498802	U	0.5992	0.498802	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2219469	.	.	.	0.567	-0.789	-0.831	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	56020938	56020939	4q12	0	normal	.	A	ref	A	AA.GG	het-alt	216	0.55	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.56020938A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.526158	U	0.5972	0.473842	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2125493	.	.	.	0.533	2.886	2.027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	56020938	56020939	4q12	0	normal	.	A	snv	G	AA.GG	het-ref	175	0.45	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.56020938A>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.473842	U	0.5972	0.473842	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2125493	.	.	.	0.533	2.886	2.027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	56024062	56024063	4q12	0	normal	.	G	ref	G	TA.GC	het-alt	99	0.55	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.56024062G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.505591	U	0.5992	0.494409	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17712245	.	.	.	-0.978	-0.664	-0.657	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	56024062	56024063	4q12	0	normal	.	G	snv	C	TA.GC	het-ref	82	0.45	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.56024062G>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.494409	U	0.5992	0.494409	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17712245	.	.	.	-0.978	-0.664	-0.657	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	56024178	56024179	4q12	0	normal	.	A	ref	A	GA.GT	het-alt	131	0.56	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.56024178A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.449081	U	0.5992	0.550919	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17081840	.	.	.	-0.441	0.381	0.332	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	56024178	56024179	4q12	0	normal	.	A	snv	G	GA.GT	het-ref	102	0.44	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.56024178A>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.550919	U	0.5992	0.550919	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17081840	.	.	.	-0.441	0.381	0.332	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	56024198	56024199	4q12	0	normal	.	T	ref	T	CG.CT	het-alt	93	0.54	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.56024198T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.458666	U	0.6002	0.541334	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs62304733	.	.	.	-0.215	-0.174	-0.190	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	56024198	56024199	4q12	0	normal	.	T	snv	C	CG.CT	het-ref	78	0.46	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.56024198T>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.541334	U	0.6002	0.541334	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs62304733	.	.	.	-0.215	-0.174	-0.190	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	56038619	56038620	4q12	0	nullSample	.	C	ref	C	AG.AT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.56038619C= (intergenic)	;maf-5-some-pop	5008	0.117212	U	1	0.882788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1993583	.	.	.	-0.525	0.567	0.528	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	56038619	56038620	4q12	0	normal	.	C	snv	A	AG.AT	hom-alt	303	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.56038619C>A (intergenic)	;maf-5-some-pop	5008	0.882788	U	1	0.882788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1993583	.	.	.	-0.525	0.567	0.528	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	56038713	56038714	4q12	0	nullSample	.	G	ref	G	TA.GA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.56038713G= (intergenic)	;maf-5-some-pop	5008	0.228035	U	0.999	0.771965	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1993584	.	.	.	0.462	-0.036	0.122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	56038713	56038714	4q12	0	normal	.	G	snv	C	TA.GA	hom-alt	357	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.56038713G>C (intergenic)	;maf-5-some-pop	5008	0.771965	U	0.999	0.771965	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1993584	.	.	.	0.462	-0.036	0.122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	56038745	56038746	4q12	0	nullSample	.	A	ref	A	CA.CT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.56038745A= (intergenic)	;maf-5-some-pop	5008	0.226438	U	0.999	0.773562	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1993585	.	.	.	-0.355	-0.040	0.079	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	56038745	56038746	4q12	0	normal	.	A	snv	G	CA.CT	hom-alt	262	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr4: g.56038745A>G (intergenic)	;maf-5-some-pop	5008	0.773562	U	0.999	0.773562	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1993585	.	.	.	-0.355	-0.040	0.079	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	66197803	66197804	4q13.1	0	normal	.	C	ref	C	GC.CC	het-alt	298	0.52	.	1	.	PASS	600004	P	.	NN	.	.	.	.	.	.	.	2044	EPHA5	C17	EX17	.	.	no-change	NM_004439.5	NP_004430.4	-	Y	c.2895G=	.	.	.	NM_004439.5(EPHA5): c.2895G=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125664	0.654253	U	0.4613	0.326677	13006	0.717054	PASS	.	8584	0.580033	26132	120656	0.653461	.	.	.	.	.	.	rs7349683	.	4024	0.576500	0.561	0.921	1.458	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	66197803	66197804	4q13.1	1	normal	.	C	snv	T	GC.CC	het-ref	276	0.48	.	2	.	PASS	600004	P	.	NN	.	.	.	.	.	.	.	2044	EPHA5	C17	EX17	.	.	coding-synon	NM_004439.5	NP_004430.4	-	Y	c.2895G>A	p.(G965=) | p.(Gly965=)	GGG=>GGA	.	NM_004439.5(EPHA5): c.2895G>A (p.(G965=))	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125664	0.345747	U	0.4613	0.326677	13006	0.282946	PASS	742	8584	0.419967	7616	120656	0.346539	1522	7216	4.21397e-01	15317	84521	3.45893e-01	rs7349683	.	4024	0.423500	0.561	0.921	1.458	.	.	.	.	.	ENST00000273854: c.2895G>A (p.G965G)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	5619001	.	.	.	.	.	.	.	.	.	Likely Benign
4	66218727	66218728	4q13.1	0	normal	.	C	snv	T	CA.CT	hom-alt	167	1.00	.	0	.	PASS	600004	P	.	NN	.	.	.	.	.	.	.	2044	EPHA5	IC13	IVS13	.	.	intron	NM_004439.5	NP_004430.4	-	Y	c.2298+32G>A	.	.	.	NM_004439.5(EPHA5): c.2298+32G>A	;maf-5-some-pop,maf-5-all-pops	124366	0.683659	U	0.8194	0.658746	13004	0.623654	PASS	2785	8558	0.806964	28272	119358	0.684705	3702	9246	8.00519e-01	47438	137480	6.82337e-01	rs3792649	.	4024	0.791500	-0.225	0.424	0.576	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	66218727	66218728	4q13.1	0	nullSample	.	C	ref	C	CA.CT	homo-ref	.	.	.	0	.	.	600004	P	.	NN	.	.	.	.	.	.	.	2044	EPHA5	IC13	IVS13	.	.	no-change	NM_004439.5	NP_004430.4	-	Y	c.2298+32G=	.	.	.	NM_004439.5(EPHA5): c.2298+32G=	;maf-5-some-pop,maf-5-all-pops	124366	0.316340	U	0.8194	0.658746	13004	0.376346	PASS	-668	8558	0.193036	6226	119358	0.315295	.	.	.	.	.	.	rs3792649	.	4024	0.208500	-0.225	0.424	0.576	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	66233028	66233029	4q13.1	0	normal	.	A	ref	A	AA.GT	het-alt	141	0.52	.	1	.	PASS	600004	P	.	NN	.	.	.	.	.	.	.	2044	EPHA5	IC10	IVS10	.	.	no-change	NM_004439.5	NP_004430.4	-	Y	c.1924+46T=	.	.	.	NM_004439.5(EPHA5): c.1924+46T=	;maf-5-some-pop	107874	0.562925	U	0.5198	0.360024	12990	0.648114	PASS	.	6626	0.494265	16188	102866	0.559174	.	.	.	.	.	.	rs2198104	.	4024	0.506200	0.377	-0.019	-0.271	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	66233028	66233029	4q13.1	0	normal	.	A	snv	G	AA.GT	het-ref	130	0.48	.	2	.	PASS	600004	P	.	NN	.	.	.	.	.	.	.	2044	EPHA5	IC10	IVS10	.	.	intron	NM_004439.5	NP_004430.4	-	Y	c.1924+46T>C	.	.	.	NM_004439.5(EPHA5): c.1924+46T>C	;maf-5-some-pop	107874	0.437075	U	0.5198	0.360024	12990	0.351886	PASS	822	6626	0.505735	10101	102866	0.440826	1912	7729	4.90606e-01	22621	99044	4.41569e-01	rs2198104	.	4024	0.493800	0.377	-0.019	-0.271	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	66280170	66280171	4q13.1	0	normal	.	C	ref	C	TG.GC	het-alt	297	0.56	.	1	.	PASS	600004	P	.	NN	.	.	.	.	.	.	.	2044	EPHA5	IC6	IVS6	.	.	no-change	NM_004439.5	NP_004430.4	-	Y	c.1528-10G=	.	.	.	NM_004439.5(EPHA5): c.1528-10G=	SingleClassTriAllelic;maf-5-some-pop	126008	0.810853	U	0.2857	0.180911	13006	0.886898	PASS	-888	8572	0.705553	40213	121000	0.810512	.	.	.	.	.	.	rs2305351	.	4024	0.699100	-0.127	1.051	0.043	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	66280170	66280171	4q13.1	1	normal	.	C	snv	T	TG.GC	het-ref	233	0.44	.	2	.	PASS	600004	P	.	NN	.	.	.	.	.	.	.	2044	EPHA5	IC6	IVS6	.	.	intron	NM_004439.5	NP_004430.4	-	Y	c.1528-10G>A	.	.	.	NM_004439.5(EPHA5): c.1528-10G>A	SingleClassTriAllelic;maf-5-some-pop	126008	0.189139	U	0.2857	0.180911	13006	0.113102	PASS	374	8572	0.294447	2641	121000	0.189479	742	5098	2.96706e-01	5673	48449	1.97845e-01	rs2305351	.	4024	0.300900	-0.127	1.051	0.043	.	.	.	.	.	ENST00000273854: c.1528-10G>A (p.?)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	149681	.	.	.	.	.	.	.	.	.	Benign
4	66286087	66286088	4q13.1	0	nullSample	.	G	ref	G	AA.TT	homo-ref	.	.	.	0	.	.	600004	P	.	NN	.	.	.	.	.	.	.	2044	EPHA5	IC6	IVS6	.	.	no-change	NM_004439.5	NP_004430.4	-	Y	c.1527+71C=	.	.	.	NM_004439.5(EPHA5): c.1527+71C=	;maf-5-some-pop	5008	0.032548	U	1	0.967452	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6551921	.	4024	0.002500	-0.516	0.166	-0.018	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	66286087	66286088	4q13.1	0	normal	.	G	snv	A	AA.TT	hom-alt	298	1.00	.	0	.	PASS	600004	P	.	NN	.	.	.	.	.	.	.	2044	EPHA5	IC6	IVS6	.	.	intron	NM_004439.5	NP_004430.4	-	Y	c.1527+71C>T	.	.	.	NM_004439.5(EPHA5): c.1527+71C>T	;maf-5-some-pop	5008	0.967452	U	1	0.967452	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6551921	.	4024	0.997500	-0.516	0.166	-0.018	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	66286099	66286100	4q13.1	0	nullSample	.	T	ref	T	TG.AG	homo-ref	.	.	.	0	.	.	600004	P	.	NN	.	.	.	.	.	.	.	2044	EPHA5	IC6	IVS6	.	.	no-change	NM_004439.5	NP_004430.4	-	Y	c.1527+59A=	.	.	.	NM_004439.5(EPHA5): c.1527+59A=	;maf-5-some-pop	5008	0.110423	U	1	0.889577	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6551922	.	4024	0.001500	-0.349	-0.536	-0.729	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	66286099	66286100	4q13.1	0	normal	.	T	snv	C	TG.AG	hom-alt	291	1.00	.	0	.	PASS	600004	P	.	NN	.	.	.	.	.	.	.	2044	EPHA5	IC6	IVS6	.	.	intron	NM_004439.5	NP_004430.4	-	Y	c.1527+59A>G	.	.	.	NM_004439.5(EPHA5): c.1527+59A>G	;maf-5-some-pop	5008	0.889577	U	1	0.889577	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6551922	.	4024	0.998500	-0.349	-0.536	-0.729	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	66468046	66468047	4q13.1	0	normal	.	A	ref	A	AT.AA	het-alt	165	0.47	.	1	.	PASS	600004	P	.	NN	.	.	.	.	.	.	.	2044	EPHA5	IC2	IVS2	.	.	no-change	NM_004439.5	NP_004430.4	-	Y	c.247-25T=	.	.	.	NM_004439.5(EPHA5): c.247-25T=	MixedObserved;maf-5-some-pop,maf-5-all-pops|MixedObserved;|MixedObserved;	103010|1804|0	0.959363|0.999446|0	U	.	.	11900	0.131008	PASS	.	422	0.997630	901	1804	0.999446	.	.	.	.	.	.	rs5858973|rs774854373|rs869262733	.	4024	0.212700	-0.339	-0.871	-1.012	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	66468046	66468047	4q13.1	0	normal	.	A	del	.	AT.AA	het-ref	188	0.53	.	2	.	PASS	600004	P	.	NN	.	.	.	.	.	.	.	2044	EPHA5	IC2	IVS2	.	.	intron	NM_004439.5	NP_004430.4	-	Y	c.247-25delT	.	.	.	NM_004439.5(EPHA5): c.247-25delT	MixedObserved;maf-5-some-pop,maf-5-all-pops|MixedObserved;	103010|0	0.040637|0	U	0.8135	0.835663	11900	0.868992	PASS	2617	8288	0.790661	43501	110786	0.884597	.	.	.	.	.	.	rs5858973|rs869262733	.	4024	0.787300	-0.339	-0.871	-1.012	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	66509193	66509194	4q13.1	0	normal	.	T	ref	T	AA.AT	het-alt	137	0.51	.	1	.	PASS	600004	P	.	NN	.	.	.	.	.	.	.	2044	EPHA5	IC1	IVS1	.	.	no-change	NM_004439.5	NP_004430.4	-	Y	c.182-49A=	.	.	.	NM_004439.5(EPHA5): c.182-49A=	;maf-5-some-pop,maf-5-all-pops	119040	0.407056	U	0.5972	0.576278	12964	0.407899	PASS	-1011	8188	0.419150	9414	114032	0.406325	.	.	.	.	.	.	rs4343775	.	4024	0.430900	0.383	0.230	0.059	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	66509193	66509194	4q13.1	0	normal	.	T	snv	C	AA.AT	het-ref	131	0.49	.	2	.	PASS	600004	P	.	NN	.	.	.	.	.	.	.	2044	EPHA5	IC1	IVS1	.	.	intron	NM_004439.5	NP_004430.4	-	Y	c.182-49A>G	.	.	.	NM_004439.5(EPHA5): c.182-49A>G	;maf-5-some-pop,maf-5-all-pops	119040	0.592944	U	0.5972	0.576278	12964	0.592101	PASS	1367	8188	0.580850	20096	114032	0.593675	2793	9611	5.77723e-01	42568	140870	6.00003e-01	rs4343775	.	4024	0.569100	0.383	0.230	0.059	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	84383809	84383810	4q21.23	0	nullSample	.	C	ref	C	GG.TT	homo-ref	.	.	.	0	dup	.	611143	P	.	NN	.	.	.	.	.	.	.	84142	FAM175A	C9E	EX9E	.	.	no-change	NM_139076.2	NP_620775.2	-	Y	c.1042G=	.	.	.	NM_139076.2(FAM175A): c.1042G=	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	126400	0.569557	U	0.6756	0.41893	13006	0.672766	PASS	.	8654	0.334527	20663	121392	0.569082	.	.	.	.	.	.	rs12642536	.	4024	0.352600	-0.293	0.821	1.330	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	84383809	84383810	4q21.23	1	normal	.	C	snv	T	GG.TT	hom-alt	711	1.00	.	0	dup	PASS	611143	P	.	NN	.	.	.	.	.	.	.	84142	FAM175A	C9E	EX9E	.	.	missense	NM_139076.2	NP_620775.2	-	Y	c.1042G>A	p.A348T | p.Ala348Thr	GCC=>ACC	NP=>P0	NM_139076.2(FAM175A): c.1042G>A (p.A348T)	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	126400	0.430364	U	0.6756	0.41893	13006	0.327234	PASS	1908	8654	0.664317	12271	121392	0.430836	3871	11510	6.67401e-01	26121	108936	4.42599e-01	rs12642536	.	4024	0.647100	-0.293	0.821	1.330	0.03	0.48	0.844	0.523	deleterious	ENST00000321945: c.1042G>A (p.A348T)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3760790	.	.	.	.	.	.	.	.	.	Likely Benign
4	84393474	84393475	4q21.23	0	nullSample	.	C	ref	C	TA.GC	homo-ref	.	.	.	0	.	.	611143	P	.	NN	.	.	.	.	.	.	.	84142	FAM175A	IC3	IVS3	.	.	no-change	NM_139076.2	NP_620775.2	-	Y	c.216-34G=	.	.	.	NM_139076.2(FAM175A): c.216-34G=	;maf-5-some-pop,maf-5-all-pops	32310	0.397741	U	0.6776	0.684704	10896	0.379130	PASS	-116	986	0.330629	2295	27302	0.412864	.	.	.	.	.	.	rs6535478	.	4024	0.353100	-1.511	-0.394	-0.634	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	84393474	84393475	4q21.23	0	normal	.	C	snv	T	TA.GC	hom-alt	308	1.00	.	0	.	PASS	611143	P	.	NN	.	.	.	.	.	.	.	84142	FAM175A	IC3	IVS3	.	.	intron	NM_139076.2	NP_620775.2	-	Y	c.216-34G>A	.	.	.	NM_139076.2(FAM175A): c.216-34G>A	;maf-5-some-pop,maf-5-all-pops	32310	0.602259	U	0.6776	0.684704	10896	0.620870	PASS	214	986	0.669371	4674	27302	0.587136	1270	3766	6.70345e-01	16724	58659	5.56389e-01	rs6535478	.	4024	0.646900	-1.511	-0.394	-0.634	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	84406090	84406091	4q21.23	0	normal	.	A	ref	A	GC.GG	het-alt	92	0.53	.	1	.	PASS	611143	P	.	NN	.	.	.	.	.	.	.	84142	FAM175A	IC1	IVS1	.	.	no-change	NM_139076.2	NP_620775.2	-	Y	c.87+48T=	.	.	.	NM_139076.2(FAM175A): c.87+48T=	.	.	.	.	0.2798	0.110823	.	.	PASS	-595	5788	0.728749	32705	72410	0.947991	.	.	.	.	.	.	.	.	.	.	-0.619	-3.068	-3.306	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	84406091	84406091	4q21.23	0	normal	.	.	ins	G	CA.GG	het-ref	82	0.47	.	2	.	PASS	611143	P	.	NN	.	.	.	.	.	.	.	84142	FAM175A	IC1	IVS1	.	.	intron	NM_139076.2	NP_620775.2	-	Y	c.87+47_87+48insC	.	.	.	NM_139076.2(FAM175A): c.87+47_87+48insC	;maf-5-some-pop	77418	0.055814	U	0.2798	0.110823	11286	0.039341	PASS	190	5788	0.271251	266	72410	0.052009	340	2514	2.64187e-01	479	6834	4.04135e-02	rs139863124	.	4024	0.268600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	89033602	89033604	4q22.1	0	normal	.	CT	ref	CT	cc.tt	het-alt	162	0.53	.	1	L2a|LINE|L2|+|341	PASS	603756	P	138900(NK);614490(NK)	AD	Blood group, junior system	BG	.	Hematologic	Hematologic	22246507|22246505|20890084|18522708|567888	.	9429	ABCG2	IC8	IVS9	.	.	no-change	NM_004827.2	NP_004818.2	-	Y	c.1194+851_1194+852=	.	.	.	NM_004827.2(ABCG2): c.1194+851_1194+852=	;maf-5-some-pop,maf-5-all-pops	5008	0.844848	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs149926596	.	4024	0.658500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	89033602	89033604	4q22.1	0	normal	.	CT	del	.	cc.tt	het-ref	144	0.47	.	2	L2a|LINE|L2|+|341	PASS	603756	P	138900(NK);614490(NK)	AD	Blood group, junior system	BG	.	Hematologic	Hematologic	22246507|22246505|20890084|18522708|567888	.	9429	ABCG2	IC8	IVS9	.	.	intron	NM_004827.2	NP_004818.2	-	Y	c.1194+851_1194+852delAG	.	.	.	NM_004827.2(ABCG2): c.1194+851_1194+852delAG	;maf-5-some-pop,maf-5-all-pops	5008	0.155152	U	0.3274	0.155152	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs149926596	.	4024	0.341500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	89055484	89055485	4q22.1	0	nullSample	.	A	ref	A	AG.GT	homo-ref	.	.	.	0	.	.	603756	P	138900(NK);614490(NK)	AD	Blood group, junior system	BG	.	Hematologic	Hematologic	22246507|22246505|20890084|18522708|567888	.	9429	ABCG2	IC1	IVS2	.	.	no-change	NM_004827.2	NP_004818.2	-	Y	c.204-1698T=	.	.	.	NM_004827.2(ABCG2): c.204-1698T=	;maf-5-some-pop	5008	0.035343	U	1	0.964657	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2725255	.	4024	0.001500	-0.990	-0.890	-0.884	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	89055484	89055485	4q22.1	0	normal	.	A	snv	G	AG.GT	hom-alt	242	1.00	.	0	.	PASS	603756	P	138900(NK);614490(NK)	AD	Blood group, junior system	BG	.	Hematologic	Hematologic	22246507|22246505|20890084|18522708|567888	.	9429	ABCG2	IC1	IVS2	.	.	intron	NM_004827.2	NP_004818.2	-	Y	c.204-1698T>C	.	.	.	NM_004827.2(ABCG2): c.204-1698T>C	;maf-5-some-pop	5008	0.964657	U	1	0.964657	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2725255	.	4024	0.998500	-0.990	-0.890	-0.884	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	106155184	106155185	4q24	0	nullSample	.	C	ref	C	AC.TC	homo-ref	.	.	.	0	.	.	612839	P	614286(MK)	NN	.	.	.	.	.	.	.	54790	TET2	C1	EX3	.	.	no-change	NM_001127208.2	NP_001120680.1	+	Y	c.86C=	.	.	.	NM_001127208.2(TET2): c.86C=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126018	0.938168	U	0.2093	0.0924521	13006	0.979625	PASS	.	8550	0.792865	53593	121010	0.939435	.	.	.	.	.	.	rs12498609	.	4024	0.786000	0.591	1.982	1.250	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	106155184	106155185	4q24	0	nullSample	.	C	ref	C	AC.TC	homo-ref	.	.	.	0	.	.	612839	P	614286(MK)	NN	.	.	.	.	.	.	.	54790	TET2	C1E	EX3E	.	.	no-change	NM_017628.4	NP_060098.3	+	N	c.86C=	.	.	.	NM_017628.4(TET2): c.86C=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126018	0.938168	U	0.2093	0.0924521	13006	0.979625	PASS	.	8550	0.792865	53593	121010	0.939435	.	.	.	.	.	.	rs12498609	.	4024	0.786000	0.591	1.982	1.250	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	106155184	106155185	4q24	1	normal	.	C	snv	G	AC.TC	hom-alt	643	1.00	.	0	.	PASS	612839	P	614286(MK)	NN	.	.	.	.	.	.	.	54790	TET2	C1	EX3	.	.	missense	NM_001127208.2	NP_001120680.1	+	Y	c.86C>G	p.P29R | p.Pro29Arg	CCT=>CGT	NP=>P+	NM_001127208.2(TET2): c.86C>G (p.P29R)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126018	0.061832	U	0.2093	0.0924521	13006	0.020375	PASS	176	8550	0.207135	417	121010	0.060565	332	3507	2.04323e-01	854	15396	6.26873e-02	rs12498609	.	4024	0.214000	0.591	1.982	1.250	0.01	0.628	0.939	0.625	deleterious	ENST00000305737: c.86C>G (p.P29R)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5020248	.	.	.	.	.	no_record	135316	no_assertion_provided	not_provided	Likely Benign
4	106155184	106155185	4q24	1	normal	.	C	snv	G	AC.TC	hom-alt	643	1.00	.	0	.	PASS	612839	P	614286(MK)	NN	.	.	.	.	.	.	.	54790	TET2	C1E	EX3E	.	.	missense	NM_017628.4	NP_060098.3	+	N	c.86C>G	p.P29R | p.Pro29Arg	CCT=>CGT	NP=>P+	NM_017628.4(TET2): c.86C>G (p.P29R)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126018	0.061832	U	0.2093	0.0924521	13006	0.020375	PASS	176	8550	0.207135	417	121010	0.060565	332	3507	2.04323e-01	854	15396	6.26873e-02	rs12498609	.	4024	0.214000	0.591	1.982	1.250	0.04	0.997	1	0.815	deleterious	ENST00000305737: c.86C>G (p.P29R)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5020248	.	.	.	.	.	no_record	135316	no_assertion_provided	not_provided	Likely Benign
4	106196091	106196092	4q24	0	nullSample	.	C	ref	C	GT.GT	homo-ref	.	.	.	0	.	.	612839	P	614286(MK)	NN	.	.	.	.	.	.	.	54790	TET2	IC8	IVS10	.	.	no-change	NM_001127208.2	NP_001120680.1	+	Y	c.4538-113C=	.	.	.	NM_001127208.2(TET2): c.4538-113C=	;maf-5-some-pop	5008	0.169529	U	0.5804	0.830471	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2647243	.	4024	0.431700	-0.352	-0.090	0.043	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	106196091	106196092	4q24	0	normal	.	C	snv	T	GT.GT	hom-alt	141	1.00	.	0	.	PASS	612839	P	614286(MK)	NN	.	.	.	.	.	.	.	54790	TET2	IC8	IVS10	.	.	intron	NM_001127208.2	NP_001120680.1	+	Y	c.4538-113C>T	.	.	.	NM_001127208.2(TET2): c.4538-113C>T	;maf-5-some-pop	5008	0.830471	U	0.5804	0.830471	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2647243	.	4024	0.568300	-0.352	-0.090	0.043	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	143003154	143003155	4q31.21	0	nullSample	.	G	ref	G	AA.AA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	IC22	IVS26	.	.	no-change	NM_003866.2	NP_003857.2	-	Y	c.2642+29C=	.	.	.	NM_003866.2(INPP4B): c.2642+29C=	;	0	0	U	0.9335	0.874601	.	.	PASS	.	8236	0.060102	507	117340	0.048824	.	.	.	.	.	.	rs374059888	.	.	.	-0.746	-0.266	-0.741	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	143003155	143003155	4q31.21	0	normal	.	.	ins	A	AG.AA	hom-alt	436	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	IC22	IVS26	.	.	intron	NM_003866.2	NP_003857.2	-	Y	c.2642+28_2642+29insT	.	.	.	NM_003866.2(INPP4B): c.2642+28_2642+29insT	;maf-5-some-pop	122348	0.948042	U	0.9335	0.874601	12520	0.887780	PASS	3641	8236	0.939898	53448	117340	0.951176	5625	11968	9.39551e-01	83636	174203	9.53409e-01	rs11446749	.	4024	0.948300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	143007418	143007419	4q31.21	0	normal	.	A	ref	A	GG.AA	het-alt	134	0.49	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	IC20	IVS24	.	.	no-change	NM_003866.2	NP_003857.2	-	Y	c.2375-10T=	.	.	.	NM_003866.2(INPP4B): c.2375-10T=	;maf-5-some-pop,maf-5-all-pops	121938	0.290549	U	0.626	0.604832	12996	0.405125	PASS	-952	8070	0.347955	5068	116930	0.286069	.	.	.	.	.	.	rs336324	.	4024	0.362300	0.533	0.001	-0.091	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	143007418	143007419	4q31.21	1	normal	.	A	snv	G	GG.AA	het-ref	137	0.51	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	IC20	IVS24	.	.	intron	NM_003866.2	NP_003857.2	-	Y	c.2375-10T>C	.	.	.	NM_003866.2(INPP4B): c.2375-10T>C	;maf-5-some-pop,maf-5-all-pops	121938	0.709451	U	0.626	0.604832	12996	0.594875	PASS	1679	8070	0.652045	30083	116930	0.713931	3443	10773	6.42014e-01	62115	171607	7.12399e-01	rs336324	.	4024	0.637700	0.533	0.001	-0.091	.	.	.	.	.	ENST00000513000: c.2375-10T>C (p.?)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4002952	.	.	.	.	.	.	.	.	.	Benign
4	143007459	143007460	4q31.21	0	normal	.	T	ref	T	AT.AA	het-alt	113	0.50	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	IC20	IVS24	.	.	no-change	NM_003866.2	NP_003857.2	-	Y	c.2375-51A=	.	.	.	NM_003866.2(INPP4B): c.2375-51A=	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop	99206	0.295123	U	0.626	0.604832	12964	0.364085	PASS	-713	6096	0.352362	4280	94198	0.289804	.	.	.	.	.	.	rs336323	.	4024	0.362300	0.533	0.080	0.184	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	143007459	143007460	4q31.21	0	normal	.	T	snv	G	AT.AA	het-ref	114	0.50	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	IC20	IVS24	.	.	intron	NM_003866.2	NP_003857.2	-	Y	c.2375-51A>C	.	.	.	NM_003866.2(INPP4B): c.2375-51A>C	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop	99206	0.704877	U	0.626	0.604832	12964	0.635915	PASS	1261	6096	0.647638	24080	94198	0.710196	3018	9431	6.45605e-01	54157	149865	7.13439e-01	rs336323	.	4024	0.637700	0.533	0.080	0.184	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	143029390	143029391	4q31.21	0	normal	.	A	ref	A	CA.AA	het-alt	126	0.51	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	IC19	IVS23	.	.	no-change	NM_003866.2	NP_003857.2	-	Y	c.2277-48T=	.	.	.	NM_003866.2(INPP4B): c.2277-48T=	;maf-5-some-pop	108438	0.868266	U	0.0744	0.102236	12946	0.894330	PASS	.	7348	0.941889	38992	103430	0.866837	.	.	.	.	.	.	rs17383664	.	4024	0.933200	-0.182	-0.284	-0.336	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	143029390	143029391	4q31.21	0	normal	.	A	snv	G	CA.AA	het-ref	120	0.49	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	IC19	IVS23	.	.	intron	NM_003866.2	NP_003857.2	-	Y	c.2277-48T>C	.	.	.	NM_003866.2(INPP4B): c.2277-48T>C	;maf-5-some-pop	108438	0.131734	U	0.0744	0.102236	12946	0.105670	PASS	8	7348	0.058111	1050	103430	0.133163	13	844	5.72436e-02	1985	26930	1.30686e-01	rs17383664	.	4024	0.066800	-0.182	-0.284	-0.336	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	143033777	143033778	4q31.21	0	normal	.	T	ref	T	TG.AG	het-alt	322	0.54	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	C19	EX23	.	.	no-change	NM_003866.2	NP_003857.2	-	Y	c.2193A=	.	.	.	NM_003866.2(INPP4B): c.2193A=	SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop	126230	0.918704	U	0.0764	0.0748802	13006	0.945640	PASS	.	8610	0.940186	51281	121222	0.918439	.	.	.	.	.	.	rs3822141	.	4024	0.934100	-2.252	-1.489	-3.782	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	143033777	143033778	4q31.21	1	normal	.	T	snv	C	TG.AG	het-ref	271	0.46	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	C19	EX23	.	.	coding-synon	NM_003866.2	NP_003857.2	-	Y	c.2193A>G	p.(L731=) | p.(Leu731=)	CTA=>CTG	.	NM_003866.2(INPP4B): c.2193A>G (p.(L731=))	SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop	126230	0.081296	U	0.0764	0.0748802	13006	0.054360	PASS	15	8610	0.059814	557	121222	0.081561	21	1014	5.89603e-02	1059	20380	8.30427e-02	rs3822141	.	4024	0.065900	-2.252	-1.489	-3.782	.	.	.	.	.	ENST00000513000: c.2193A>G (p.L731L)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019421	.	.	.	.	.	.	.	.	.	Likely Benign
4	143043403	143043404	4q31.21	0	normal	.	C	ref	C	AA.AA	het-alt	111	0.42	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	IC17	IVS21	.	.	no-change	NM_003866.2	NP_003857.2	-	Y	c.2018-6G=	.	.	.	NM_003866.2(INPP4B): c.2018-6G=	;maf-5-some-pop	125600	0.873455	U	0.0754	0.100839	13006	0.894280	PASS	.	8524	0.941929	46054	120592	0.872388	.	.	.	.	.	.	rs13133767	.	4024	0.933400	0.585	0.317	0.057	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	143043403	143043404	4q31.21	1	normal	.	C	snv	T	AA.AA	het-ref	156	0.58	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	IC17	IVS21	.	.	intron	NM_003866.2	NP_003857.2	-	Y	c.2018-6G>A	.	.	.	NM_003866.2(INPP4B): c.2018-6G>A	;maf-5-some-pop	125600	0.126545	U	0.0754	0.100839	13006	0.105720	PASS	12	8524	0.058071	1147	120592	0.127612	19	976	5.80538e-02	2234	30842	1.28478e-01	rs13133767	.	4024	0.066600	0.585	0.317	0.057	.	.	.	.	.	ENST00000513000: c.2018-6G>A (p.?)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019492	.	.	.	.	.	.	.	.	.	Benign
4	143044665	143044666	4q31.21	0	nullSample	.	A	ref	A	TT.TC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	IC16	IVS20	.	.	no-change	NM_003866.2	NP_003857.2	-	Y	c.1894-98T=	.	.	.	NM_003866.2(INPP4B): c.1894-98T=	;maf-5-some-pop	5008	0.052516	U	1	0.947484	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2645786	.	4024	0.001500	-0.215	-2.281	-1.894	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	143044665	143044666	4q31.21	0	normal	.	A	snv	C	TT.TC	hom-alt	276	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	IC16	IVS20	.	.	intron	NM_003866.2	NP_003857.2	-	Y	c.1894-98T>G	.	.	.	NM_003866.2(INPP4B): c.1894-98T>G	;maf-5-some-pop	5008	0.947484	U	1	0.947484	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2645786	.	4024	0.998500	-0.215	-2.281	-1.894	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	143067053	143067054	4q31.21	0	normal	.	G	ref	G	CC.CC	het-alt	342	0.53	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	C15	EX19	.	.	no-change	NM_003866.2	NP_003857.2	-	Y	c.1659C=	.	.	.	NM_003866.2(INPP4B): c.1659C=	;maf-5-some-pop	126378	0.882693	U	0.0615	0.0958466	13006	0.908734	PASS	.	8640	0.937384	47379	121370	0.881808	.	.	.	.	.	.	rs35390852	.	4024	0.934900	-0.355	-0.328	-0.385	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	143067053	143067054	4q31.21	1	normal	.	G	snv	A	CC.CC	het-ref	302	0.47	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	C15	EX19	.	.	coding-synon	NM_003866.2	NP_003857.2	-	Y	c.1659C>T	p.(G553=) | p.(Gly553=)	GGC=>GGT	.	NM_003866.2(INPP4B): c.1659C>T (p.(G553=))	;maf-5-some-pop	126378	0.117307	U	0.0615	0.0958466	13006	0.091266	PASS	20	8640	0.062616	1039	121370	0.118192	24	1043	6.05340e-02	2075	29623	1.20379e-01	rs35390852	.	4024	0.065100	-0.355	-0.328	-0.385	.	.	.	.	.	ENST00000513000: c.1659C>T (p.G553G)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3760412	.	.	.	.	.	.	.	.	.	Likely Benign
4	143130033	143130034	4q31.21	0	nullSample	.	A	ref	A	AG.AA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	IC10	IVS14	.	.	no-change	NM_003866.2	NP_003857.2	-	Y	c.967+15T=	.	.	.	NM_003866.2(INPP4B): c.967+15T=	SingleClassTriAllelic;maf-5-some-pop	126216	0.070934	U	0.9683	0.903355	13006	0.098493	PASS	.	8618	0.045834	404	121208	0.069872	.	.	.	.	.	.	rs1907123	.	4024	0.052700	-0.540	-0.336	-0.130	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	143130033	143130034	4q31.21	1	normal	.	A	snv	T	AG.AA	hom-alt	516	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	IC10	IVS14	.	.	intron	NM_003866.2	NP_003857.2	-	Y	c.967+15T>A	.	.	.	NM_003866.2(INPP4B): c.967+15T>A	SingleClassTriAllelic;maf-5-some-pop	126216	0.929058	U	0.9683	0.903355	13006	0.901507	PASS	3925	8618	0.954166	52538	121208	0.930120	6811	14239	9.56665e-01	96476	206380	9.33162e-01	rs1907123	.	4024	0.947300	-0.540	-0.336	-0.130	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	143130218	143130219	4q31.21	0	normal	.	T	ref	T	TC.TA	het-alt	192	0.47	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	IC9	IVS13	.	.	no-change	NM_003866.2	NP_003857.2	-	Y	c.837-40A=	.	.	.	NM_003866.2(INPP4B): c.837-40A=	;maf-5-some-pop	124974	0.367909	U	0.7083	0.50639	13006	0.487083	PASS	-914	8530	0.313482	9450	119966	0.362661	.	.	.	.	.	.	rs1994217	.	4024	0.304900	-0.334	-0.388	-0.614	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	143130218	143130219	4q31.21	0	normal	.	T	snv	A	TC.TA	het-ref	213	0.53	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	IC9	IVS13	.	.	intron	NM_003866.2	NP_003857.2	-	Y	c.837-40A>T	.	.	.	NM_003866.2(INPP4B): c.837-40A>T	;maf-5-some-pop	124974	0.632091	U	0.7083	0.50639	13006	0.512917	PASS	2014	8530	0.686518	25926	119966	0.637339	3908	11268	6.89512e-01	51624	151964	6.47212e-01	rs1994217	.	4024	0.695100	-0.334	-0.388	-0.614	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	143181746	143181748	4q31.21	0	normal	.	AT	ref	AT	aa.tt	het-alt	131	0.82	.	1	AT_rich|Low_complexity|Low_complexity|+|29	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	IC7	IVS11	.	.	no-change	NM_003866.2	NP_003857.2	-	Y	c.616-31_616-30=	.	.	.	NM_003866.2(INPP4B): c.616-31_616-30=	MixedObserved;maf-5-some-pop	72748	0.863543	U	0.4821	0.417732	12418	0.289016	.	.	.	.	.	.	.	.	.	.	.	.	.	rs375337012	.	7513	0.650500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	143181746	143181748	4q31.21	0	normal	.	AT	del	.	aa.tt	het-ref	29	0.18	.	2	AT_rich|Low_complexity|Low_complexity|+|29	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	IC7	IVS11	.	.	intron	NM_003866.2	NP_003857.2	-	Y	c.616-31_616-30delAT	.	.	.	NM_003866.2(INPP4B): c.616-31_616-30delAT	MixedObserved;maf-5-some-pop	72748	0.136457	U	0.0218	0.014976	12418	0.710984	VQSRTrancheINDEL95.00to96.00	2	4072	0.249754	4	67740	0.145438	6	1307	1.74406e-01	19	11715	9.44408e-02	rs375337012	.	7513	0.031600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	143181747	143181748	4q31.21	0	normal	.	T	ref	T	aa.tt	het-alt	96	0.63	.	1	AT_rich|Low_complexity|Low_complexity|+|29	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	IC7	IVS11	.	.	no-change	NM_003866.2	NP_003857.2	-	Y	c.616-31A=	.	.	.	NM_003866.2(INPP4B): c.616-31A=	MixedObserved;maf-5-some-pop,maf-5-all-pops	79934|43797	0.529987|0.952211	U	0.4464	0.402756	12390	0.193947	InbreedingCoeff_Filter	.	4300	0.509070	2166	74926	0.525492	.	.	.	.	.	.	rs1907111|rs66750380	.	4372	0.184500	-0.633	-0.825	-1.065	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	143181747	143181748	4q31.21	0	normal	.	T	ref	T	aa.tt	het-alt	101	0.65	.	1	AT_rich|Low_complexity|Low_complexity|+|29	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	IC7	IVS11	.	.	no-change	NM_003866.2	NP_003857.2	-	Y	c.616-31A=	.	.	.	NM_003866.2(INPP4B): c.616-31A=	MixedObserved;maf-5-some-pop,maf-5-all-pops	79934|43797	0.529987|0.952211	U	0.4464	0.402756	12390	0.193947	InbreedingCoeff_Filter	.	4300	0.509070	2166	74926	0.525492	.	.	.	.	.	.	rs1907111|rs66750380	.	4372	0.184500	-0.633	-0.825	-1.065	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	143181747	143181748	4q31.21	0	normal	.	T	del	.	aa.tt	het-ref	56	0.37	.	2	AT_rich|Low_complexity|Low_complexity|+|29	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	IC7	IVS11	.	.	intron	NM_003866.2	NP_003857.2	-	Y	c.616-31delA	.	.	.	NM_003866.2(INPP4B): c.616-31delA	MixedObserved;maf-5-some-pop,maf-5-all-pops	43797	0.047789	U	0.4821	0.417732	12390	0.806053	InbreedingCoeff_Filter	198	5566	0.516170	1336	84384	0.459661	.	.	.	.	.	.	rs66750380	.	4372	0.341300	-0.633	-0.825	-1.065	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	143181747	143181748	4q31.21	0	normal	.	T	snv	A	aa.tt	het-ref	55	0.35	.	2	AT_rich|Low_complexity|Low_complexity|+|29	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	IC7	IVS11	.	.	intron	NM_003866.2	NP_003857.2	-	Y	c.616-31A>T	.	.	.	NM_003866.2(INPP4B): c.616-31A>T	MixedObserved;maf-5-some-pop,maf-5-all-pops	79934	0.470013	U	0.4464	0.402756	12390	0	InbreedingCoeff_Filter	8	4300	0.490930	256	74926	0.474508	326	5364	4.86575e-01	4167	78952	4.72851e-01	rs1907111	.	4372	0.400400	-0.633	-0.825	-1.065	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	143235864	143235865	4q31.21	0	nullSample	.	C	ref	C	AC.CC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	C5	EX9	.	.	no-change	NM_003866.2	NP_003857.2	-	Y	c.423G=	.	.	.	NM_003866.2(INPP4B): c.423G=	SingleClassTriAllelic;maf-5-some-pop	126340	0.814920	U	0.4623	0.199481	13006	0.911579	PASS	-1099	8638	0.499884	41297	121332	0.815514	.	.	.	.	.	.	rs3756122	.	4024	0.471400	0.561	1.148	2.873	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	143235864	143235865	4q31.21	1	normal	.	C	snv	G	AC.CC	hom-alt	452	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	C5	EX9	.	.	coding-synon	NM_003866.2	NP_003857.2	-	Y	c.423G>C	p.(G141=) | p.(Gly141=)	GGG=>GGC	.	NM_003866.2(INPP4B): c.423G>C (p.(G141=))	SingleClassTriAllelic;maf-5-some-pop	126340	0.185040	U	0.4623	0.199481	13006	0.088421	PASS	1060	8638	0.499537	3014	121332	0.184444	1851	7625	4.85731e-01	5758	43536	1.86105e-01	rs3756122	.	4024	0.528600	0.561	1.148	2.873	.	.	.	.	.	ENST00000513000: c.423G>C (p.G141G)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3760413	.	.	.	.	.	.	.	.	.	Likely Benign
4	143326311	143326312	4q31.21	0	nullSample	.	A	ref	A	gc.ag	homo-ref	.	.	.	0	GA-rich|Low_complexity|Low_complexity|+|56	.	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	IC3	IVS7	.	.	no-change	NM_003866.2	NP_003857.2	-	Y	c.255+47T=	.	.	.	NM_003866.2(INPP4B): c.255+47T=	SingleClassTriAllelic;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs144136838	.	.	.	-0.740	-1.016	-1.140	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
4	143326312	143326312	4q31.21	0	normal	.	.	ins	AGAGAG	ca.ag	het-alt	79	0.73	.	2	GA-rich|Low_complexity|Low_complexity|+|56	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	IC3	IVS7	.	.	intron	NM_003866.2	NP_003857.2	-	Y	c.255+46_255+47insCTCTCT	.	.	.	NM_003866.2(INPP4B): c.255+46_255+47insCTCTCT	InconsistentAlleles;rs-cluster-nonoverlapping-alleles	75052	0.455444	U	.	.	.	.	PASS	223	7456	0.353273	1259	104014	0.244967	.	.	.	.	.	.	rs150473961	.	4025	0.247600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	143326312	143326312	4q31.21	0	normal	.	.	ins	AGAG	ca.ag	het-alt	29	0.27	.	1	GA-rich|Low_complexity|Low_complexity|+|56	PASS	.	.	.	.	.	.	.	.	.	.	.	8821	INPP4B	IC3	IVS7	.	.	intron	NM_003866.2	NP_003857.2	-	Y	c.255+46_255+47insCTCT	.	.	.	NM_003866.2(INPP4B): c.255+46_255+47insCTCT	InconsistentAlleles;rs-cluster-nonoverlapping-alleles	75052	0.072883	U	.	.	.	.	PASS	1	7456	0.062634	6	104014	0.029602	.	.	.	.	.	.	rs150473961	.	4025	0.097400	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	153267967	153267968	4q31.3	0	nullSample	.	A	ref	A	aa.tt	homo-ref	.	.	.	0	L1MB7|LINE|L1|-|371	.	606278	P	.	NN	.	.	.	.	.	.	.	55294	FBXW7	IC3	IVS4	.	.	no-change	NM_033632.3	NP_361014.1	-	Y	c.726+114T=	.	.	.	NM_033632.3(FBXW7): c.726+114T=	;maf-5-some-pop	5008	0.041933	U	1	0.958067	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2714803	.	4024	0.001000	-0.213	0.514	0.627	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	153267967	153267968	4q31.3	0	normal	.	A	snv	G	aa.tt	hom-alt	226	1.00	.	0	L1MB7|LINE|L1|-|371	PASS	606278	P	.	NN	.	.	.	.	.	.	.	55294	FBXW7	IC3	IVS4	.	.	intron	NM_033632.3	NP_361014.1	-	Y	c.726+114T>C	.	.	.	NM_033632.3(FBXW7): c.726+114T>C	;maf-5-some-pop	5008	0.958067	U	1	0.958067	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2714803	.	4024	0.999000	-0.213	0.514	0.627	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	153268227	153268228	4q31.3	0	normal	.	A	ref	A	AC.aa	het-alt	206	0.81	.	1	A-rich|Low_complexity|Low_complexity|+|65	PASS	606278	P	.	NN	.	.	.	.	.	.	.	55294	FBXW7	IC2	IVS3	.	.	no-change	NM_033632.3	NP_361014.1	-	Y	c.585-5T=	.	.	.	NM_033632.3(FBXW7): c.585-5T=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs780809685	.	4024	0.702300	-0.374	0.618	0.325	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	153268227	153268228	4q31.3	1	normal	.	A	del	.	AC.aa	het-ref	48	0.19	.	2	A-rich|Low_complexity|Low_complexity|+|65	PASS	606278	P	.	NN	.	.	.	.	.	.	.	55294	FBXW7	IC2	IVS3	.	.	intron	NM_033632.3	NP_361014.1	-	Y	c.585-5delT	.	.	.	NM_033632.3(FBXW7): c.585-5delT	MixedObserved;	0	0	U	.	.	.	.	PASS	0	4318	0.346920	0	67974	0.364051	.	.	.	.	.	.	rs780809685	.	4024	0.297700	-0.374	0.618	0.325	.	.	.	.	.	ENST00000281708: c.585-5delT (p.?)	skin [NS|NS|NS]	carcinoma [basal_cell_carcinoma|NS|NS]	CSV	5895336	.	.	.	.	.	.	.	.	.	Benign
4	187516879	187516880	4q35.2	0	normal	.	A	ref	A	AG.GA	het-alt	339	0.53	.	1	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C25	EX26	.	.	no-change	NM_005245.3	NP_005236.2	-	Y	c.13101T=	.	.	.	NM_005245.3(FAT1): c.13101T=	;maf-5-some-pop,maf-5-all-pops	125722	0.576009	U	0.5724	0.491813	12458	0.545914	PASS	.	8594	0.372469	21373	120714	0.578823	.	.	.	.	.	.	rs1298865	.	4024	0.382200	-0.128	-0.432	-0.690	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187516879	187516880	4q35.2	1	normal	.	A	snv	G	AG.GA	het-ref	300	0.47	.	2	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C25	EX26	.	.	coding-synon	NM_005245.3	NP_005236.2	-	Y	c.13101T>C	p.(S4367=) | p.(Ser4367=)	TCT=>TCC	.	NM_005245.3(FAT1): c.13101T>C (p.(S4367=))	;maf-5-some-pop,maf-5-all-pops	125722	0.423991	U	0.5724	0.491813	12458	0.454086	PASS	1685	8594	0.627531	11858	120714	0.421177	3344	10703	6.20752e-01	24447	104711	4.25329e-01	rs1298865	.	4024	0.617800	-0.128	-0.432	-0.690	.	.	.	.	.	ENST00000441802: c.13101T>C (p.S4367S)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	4158951	.	.	.	.	.	.	.	.	.	Likely Benign
4	187518975	187518976	4q35.2	0	normal	.	C	ref	C	AC.TC	het-alt	220	0.49	.	1	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	IC22	IVS23	.	.	no-change	NM_005245.3	NP_005236.2	-	Y	c.12258-30G=	.	.	.	NM_005245.3(FAT1): c.12258-30G=	;maf-5-some-pop,maf-5-all-pops	121362	0.637794	U	0.5367	0.31869	12098	0.712928	PASS	-1031	8284	0.409223	24161	116354	0.635921	.	.	.	.	.	.	rs2306990	.	4024	0.419000	0.655	-0.703	-0.261	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187518975	187518976	4q35.2	0	normal	.	C	snv	T	AC.TC	het-ref	230	0.51	.	2	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	IC22	IVS23	.	.	intron	NM_005245.3	NP_005236.2	-	Y	c.12258-30G>A	.	.	.	NM_005245.3(FAT1): c.12258-30G>A	;maf-5-some-pop,maf-5-all-pops	121362	0.362206	U	0.5367	0.31869	12098	0.287072	PASS	1416	8284	0.590777	8346	116354	0.364079	2870	9893	5.80848e-01	18401	90289	3.73824e-01	rs2306990	.	4024	0.581000	0.655	-0.703	-0.261	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187518979	187518980	4q35.2	0	nullSample	.	T	ref	T	CA.GA	homo-ref	.	.	.	0	.	.	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	IC22	IVS23	.	.	no-change	NM_005245.3	NP_005236.2	-	Y	c.12258-34A=	.	.	.	NM_005245.3(FAT1): c.12258-34A=	;maf-5-some-pop	121514	0.191213	U	0.9752	0.883986	12078	0.177678	PASS	.	8252	0.012239	2417	116506	0.194445	.	.	.	.	.	.	rs1280096	.	4024	0.008400	-2.282	-3.647	-2.766	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187518979	187518980	4q35.2	0	normal	.	T	snv	C	CA.GA	hom-alt	454	1.00	.	0	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	IC22	IVS23	.	.	intron	NM_005245.3	NP_005236.2	-	Y	c.12258-34A>G	.	.	.	NM_005245.3(FAT1): c.12258-34A>G	;maf-5-some-pop	121514	0.808787	U	0.9752	0.883986	12078	0.822322	PASS	4027	8252	0.987761	38016	116506	0.805555	8353	16874	9.89910e-01	78295	193700	8.02110e-01	rs1280096	.	4024	0.991600	-2.282	-3.647	-2.766	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187519205	187519206	4q35.2	0	nullSample	.	C	ref	C	GG.TT	homo-ref	.	.	.	0	.	.	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C22	EX23	.	.	no-change	NM_005245.3	NP_005236.2	-	Y	c.12177G=	.	.	.	NM_005245.3(FAT1): c.12177G=	;	125772	0.004580	U	1	0.997404	12102	0.004793	PASS	0	8626	0.000000	2	120764	0.004662	.	.	.	.	.	.	rs1280097	.	4024	0.001500	-1.086	-0.105	-0.151	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187519205	187519206	4q35.2	1	normal	.	C	snv	G	GG.TT	hom-alt	545	1.00	.	0	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C22	EX23	.	.	missense	NM_005245.3	NP_005236.2	-	Y	c.12177G>C	p.K4059N | p.Lys4059Asn	AAG=>AAC	P+=>P0	NM_005245.3(FAT1): c.12177G>C (p.K4059N)	;	125772	0.995420	U	1	0.997404	12102	0.995207	PASS	4313	8626	1.000000	59821	120764	0.995338	8622	17244	1.00000e+00	121963	245049	9.95341e-01	rs1280097	.	4024	0.998500	-1.086	-0.105	-0.151	1	0	0	0.000	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
4	187521036	187521037	4q35.2	0	normal	.	C	ref	C	AA.AT	het-alt	229	0.49	.	1	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	IC21	IVS22	.	.	no-change	NM_005245.3	NP_005236.2	-	Y	c.12103+15G=	.	.	.	NM_005245.3(FAT1): c.12103+15G=	;maf-5-some-pop,maf-5-all-pops	121074	0.679081	U	0.377	0.284744	12088	0.716248	PASS	.	8294	0.589462	26700	116066	0.677520	.	.	.	.	.	.	rs10009030	.	4024	0.603900	-0.123	-0.790	-0.773	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187521036	187521037	4q35.2	1	normal	.	C	snv	A	AA.AT	het-ref	241	0.51	.	2	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	IC21	IVS22	.	.	intron	NM_005245.3	NP_005236.2	-	Y	c.12103+15G>T	.	.	.	NM_005245.3(FAT1): c.12103+15G>T	;maf-5-some-pop,maf-5-all-pops	121074	0.320919	U	0.377	0.284744	12088	0.283752	PASS	673	8294	0.410538	6096	116066	0.322480	1370	6732	3.98249e-01	12544	75617	3.17540e-01	rs10009030	.	4024	0.396100	-0.123	-0.790	-0.773	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187524463	187524464	4q35.2	0	normal	.	G	ref	G	CC.CG	het-alt	359	0.52	.	1	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C18	EX19	.	.	no-change	NM_005245.3	NP_005236.2	-	Y	c.11216C=	.	.	.	NM_005245.3(FAT1): c.11216C=	;maf-5-some-pop	125454	0.978765	U	0.1181	0.0367412	12162	0.999342	PASS	.	8596	0.876803	57903	120446	0.979410	.	.	.	.	.	.	rs74511500	.	4024	0.876500	0.563	2.131	1.122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187524463	187524464	4q35.2	1	normal	.	G	snv	A	CC.CG	het-ref	331	0.48	.	2	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C18	EX19	.	.	missense	NM_005245.3	NP_005236.2	-	Y	c.11216C>T	p.A3739V | p.Ala3739Val	GCG=>GTG	NP=>NP	NM_005245.3(FAT1): c.11216C>T (p.A3739V)	;maf-5-some-pop	125454	0.021235	U	0.1181	0.0367412	12162	0.000658	PASS	66	8596	0.123197	160	120446	0.020590	130	2101	1.21938e-01	360	6062	2.47029e-02	rs74511500	.	4024	0.123500	0.563	2.131	1.122	0.4	0.015	0.062	0.017	neutral	ENST00000441802: c.11216C>T (p.A3739V)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4967292	.	.	.	.	.	.	.	.	.	Likely Benign
4	187525019	187525020	4q35.2	0	normal	.	A	ref	A	AG.GG	het-alt	352	0.55	.	1	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C18	EX19	.	.	no-change	NM_005245.3	NP_005236.2	-	Y	c.10660T=	.	.	.	NM_005245.3(FAT1): c.10660T=	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	125614	0.568941	U	0.5774	0.51278	12114	0.528397	PASS	-1008	8604	0.368201	21089	120606	0.572335	.	.	.	.	.	.	rs2637777	.	4024	0.376700	-0.905	0.568	0.336	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187525019	187525020	4q35.2	1	normal	.	A	snv	C	AG.GG	het-ref	293	0.45	.	2	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C18	EX19	.	.	missense	NM_005245.3	NP_005236.2	-	Y	c.10660T>G	p.S3554A | p.Ser3554Ala	TCT=>GCT	P0=>NP	NM_005245.3(FAT1): c.10660T>G (p.S3554A)	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	125614	0.431043	U	0.5774	0.51278	12114	0.471603	PASS	1710	8604	0.631799	12365	120606	0.427649	3384	10779	6.25450e-01	25285	105950	4.30579e-01	rs2637777	.	4024	0.623300	-0.905	0.568	0.336	0.25	0.002	0	0.037	neutral	ENST00000441802: c.10660T>G (p.S3554A)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [diffuse_large_B_cell_lymphoma|NS|NS]	CSV	4984957	.	.	.	.	.	.	.	.	.	Likely Benign
4	187530312	187530313	4q35.2	0	nullSample	.	C	ref	C	AA.GT	homo-ref	.	.	.	0	.	.	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	IC15	IVS16	.	.	no-change	NM_005245.3	NP_005236.2	-	Y	c.10206+24G=	.	.	.	NM_005245.3(FAT1): c.10206+24G=	;	124810	0.003766	U	1	0.999601	12600	0.003254	PASS	0	8620	0.000000	0	119802	0.003906	.	.	.	.	.	.	rs4862722	.	4024	0.001500	-1.204	-1.651	-1.788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187530312	187530313	4q35.2	0	normal	.	C	snv	T	AA.GT	hom-alt	506	1.00	.	0	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	IC15	IVS16	.	.	intron	NM_005245.3	NP_005236.2	-	Y	c.10206+24G>A	.	.	.	NM_005245.3(FAT1): c.10206+24G>A	;	124810	0.996234	U	1	0.999601	12600	0.996746	PASS	4310	8620	1.000000	59433	119802	0.996094	8547	17094	1.00000e+00	120313	241481	9.96472e-01	rs4862722	.	4024	0.998500	-1.204	-1.651	-1.788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187532694	187532695	4q35.2	0	normal	.	C	ref	C	CA.GG	het-alt	332	0.48	.	1	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C13	EX14	.	.	no-change	NM_005245.3	NP_005236.2	-	Y	c.9698G=	.	.	.	NM_005245.3(FAT1): c.9698G=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.999800	0.650	6.055	2.776	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187532694	187532695	4q35.2	1	normal	.	C	snv	T	CA.GG	het-ref	355	0.52	.	2	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C13	EX14	.	.	missense	NM_005245.3	NP_005236.2	-	Y	c.9698G>A	p.R3233H | p.Arg3233His	CGT=>CAT	P+=>P+	NM_005245.3(FAT1): c.9698G>A (p.R3233H)	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0.00000e+00	0	3	1.21893e-05	.	.	4024	0.000200	0.650	6.055	2.776	0.01	0.961	0.999	0.810	deleterious	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
4	187532981	187532982	4q35.2	0	normal	.	T	ref	T	AC.tt	het-alt	97	0.69	.	1	AluSg4|SINE|Alu|-|281	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	IC12	IVS13	.	.	no-change	NM_005245.3	NP_005236.2	-	Y	c.9464-53A=	.	.	.	NM_005245.3(FAT1): c.9464-53A=	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs753961493	.	4024	0.730400	-0.496	-0.421	-0.211	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187532981	187532982	4q35.2	0	normal	.	T	del	.	AC.tt	het-ref	43	0.31	.	2	AluSg4|SINE|Alu|-|281	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	IC12	IVS13	.	.	intron	NM_005245.3	NP_005236.2	-	Y	c.9464-53delA	.	.	.	NM_005245.3(FAT1): c.9464-53delA	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs753961493	.	4024	0.269600	-0.496	-0.421	-0.211	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187534362	187534363	4q35.2	0	normal	.	G	ref	G	GC.TT	het-alt	312	0.50	.	1	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C12	EX13	.	.	no-change	NM_005245.3	NP_005236.2	-	Y	c.9363C=	.	.	.	NM_005245.3(FAT1): c.9363C=	;maf-5-some-pop,maf-5-all-pops	125706	0.407912	U	0.6657	0.611422	12470	0.377787	PASS	.	8606	0.313386	10535	120698	0.408714	.	.	.	.	.	.	rs2249916	.	4024	0.325500	-2.912	-1.033	-3.183	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187534362	187534363	4q35.2	1	normal	.	G	snv	A	GC.TT	het-ref	308	0.50	.	2	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C12	EX13	.	.	coding-synon	NM_005245.3	NP_005236.2	-	Y	c.9363C>T	p.(N3121=) | p.(Asn3121=)	AAC=>AAT	.	NM_005245.3(FAT1): c.9363C>T (p.(N3121=))	;maf-5-some-pop,maf-5-all-pops	125706	0.592088	U	0.6657	0.611422	12470	0.622213	PASS	2025	8606	0.686614	21553	120698	0.591286	4002	11694	6.78464e-01	44146	145924	5.93472e-01	rs2249916	.	4024	0.674500	-2.912	-1.033	-3.183	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
4	187534374	187534375	4q35.2	0	normal	.	A	ref	A	AC.TC	het-alt	323	0.52	.	1	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C12	EX13	.	.	no-change	NM_005245.3	NP_005236.2	-	Y	c.9351T=	.	.	.	NM_005245.3(FAT1): c.9351T=	;maf-5-some-pop,maf-5-all-pops	125682	0.560136	U	0.2808	0.417931	12468	0.526708	PASS	-855	8602	0.713787	19287	120674	0.559226	.	.	.	.	.	.	rs2249917	.	4024	0.711000	-1.751	-0.691	-1.615	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187534374	187534375	4q35.2	1	normal	.	A	snv	G	AC.TC	het-ref	304	0.48	.	2	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C12	EX13	.	.	coding-synon	NM_005245.3	NP_005236.2	-	Y	c.9351T>C	p.(D3117=) | p.(Asp3117=)	GAT=>GAC	.	NM_005245.3(FAT1): c.9351T>C (p.(D3117=))	;maf-5-some-pop,maf-5-all-pops	125682	0.439864	U	0.2808	0.417931	12468	0.473292	PASS	376	8602	0.286213	12140	120674	0.440774	718	4779	2.77140e-01	24597	108349	4.40586e-01	rs2249917	.	4024	0.289000	-1.751	-0.691	-1.615	.	.	.	.	.	ENST00000441802: c.9351T>C (p.D3117D)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4003024	.	.	.	.	.	.	.	.	.	Likely Benign
4	187534541	187534542	4q35.2	0	normal	.	T	ref	T	AC.TG	het-alt	180	0.50	.	1	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	IC11	IVS12	.	.	no-change	NM_005245.3	NP_005236.2	-	Y	c.9230-46A=	.	.	.	NM_005245.3(FAT1): c.9230-46A=	SingleClassTriAllelic;maf-5-some-pop	121960	0.395712	U	0.3849	0.173123	12224	0.393652	PASS	-905	8290	0.312425	9692	116952	0.397428	.	.	.	.	.	.	rs2249926	.	4024	0.325300	-0.821	0.325	0.210	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187534541	187534542	4q35.2	0	normal	.	T	snv	C	AC.TG	het-ref	178	0.50	.	2	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	IC11	IVS12	.	.	intron	NM_005245.3	NP_005236.2	-	Y	c.9230-46A>G	.	.	.	NM_005245.3(FAT1): c.9230-46A>G	SingleClassTriAllelic;maf-5-some-pop	121960	0.456420	U	0.2808	0.471246	12224	0.606348	PASS	354	8290	0.285283	12716	116952	0.455785	700	4716	2.76761e-01	25786	108963	4.52971e-01	rs2249926	.	4024	0.289000	-0.821	0.325	0.210	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187538132	187538133	4q35.2	0	normal	.	A	ref	A	AC.CA	het-alt	241	0.53	.	1	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	IC10	IVS11	.	.	no-change	NM_005245.3	NP_005236.2	-	Y	c.9075+26T=	.	.	.	NM_005245.3(FAT1): c.9075+26T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	122882	0.389048	U	0.6667	0.648363	12038	0.343329	PASS	-931	8604	0.311715	9419	117874	0.390637	.	.	.	.	.	.	rs1280100	.	4024	0.325500	-1.195	0.118	-0.008	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187538132	187538133	4q35.2	0	normal	.	A	snv	G	AC.CA	het-ref	215	0.47	.	2	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	IC10	IVS11	.	.	intron	NM_005245.3	NP_005236.2	-	Y	c.9075+26T>C	.	.	.	NM_005245.3(FAT1): c.9075+26T>C	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	122882	0.610952	U	0.6667	0.648363	12038	0.656671	PASS	2030	8604	0.688285	22310	117874	0.609363	3885	11348	6.79358e-01	43279	139353	6.04123e-01	rs1280100	.	4024	0.674500	-1.195	0.118	-0.008	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187538329	187538330	4q35.2	0	normal	.	G	ref	G	AC.GC	het-alt	287	0.53	.	1	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C10	EX11	Cadherin domain	PF00028.12	no-change	NM_005245.3	NP_005236.2	-	Y	c.8904C=	.	.	.	NM_005245.3(FAT1): c.8904C=	;maf-5-some-pop	125066	0.561120	U	0.2808	0.416134	11820	0.524535	PASS	.	8576	0.714669	19196	120058	0.560171	.	.	.	.	.	.	rs1280099	.	4024	0.711500	-0.381	0.478	0.024	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187538329	187538330	4q35.2	1	normal	.	G	snv	A	AC.GC	het-ref	251	0.47	.	2	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C10	EX11	Cadherin domain	PF00028.12	coding-synon	NM_005245.3	NP_005236.2	-	Y	c.8904C>T	p.(A2968=) | p.(Ala2968=)	GCC=>GCT	.	NM_005245.3(FAT1): c.8904C>T (p.(A2968=))	;maf-5-some-pop	125066	0.438880	U	0.2808	0.416134	11820	0.475465	PASS	370	8576	0.285331	11972	120058	0.439829	708	4708	2.76551e-01	24044	106017	4.39777e-01	rs1280099	.	4024	0.288500	-0.381	0.478	0.024	.	.	.	.	.	ENST00000441802: c.8904C>T (p.A2968A)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	5425426	.	.	.	.	.	.	.	.	.	Likely Benign
4	187538941	187538942	4q35.2	0	normal	.	T	ref	T	CT.GG	het-alt	320	0.50	.	1	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C9	EX10	Cadherin domain	PF00028.12	no-change	NM_005245.3	NP_005236.2	-	Y	c.8798A=	.	.	.	NM_005245.3(FAT1): c.8798A=	MixedObserved,SingleClassTriAllelic;maf-5-some-pop	125588	0.394942	U	0.0377	0.053115	12110	0.376631	PASS	.	8620	0.311485	10090	120580	0.396608	.	.	.	.	.	.	rs1280098	.	4024	0.324300	-0.127	3.287	0.780	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187538941	187538942	4q35.2	1	normal	.	T	snv	G	CT.GG	het-ref	314	0.50	.	2	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C9	EX10	Cadherin domain	PF00028.12	missense	NM_005245.3	NP_005236.2	-	Y	c.8798A>C	p.Q2933P | p.Gln2933Pro	CAA=>CCA	P0=>NP	NM_005245.3(FAT1): c.8798A>C (p.Q2933P)	MixedObserved,SingleClassTriAllelic;maf-5-some-pop	125588	0.556845	U	0.631	0.592053	12110	0.623369	PASS	1764	8620	0.643735	18985	120580	0.555382	3497	10960	6.35436e-01	38652	136458	5.54937e-01	rs1280098	.	4024	0.636700	-0.127	3.287	0.780	1	0	0	0.000	neutral	ENST00000441802: c.8798A>C (p.Q2933P)	urinary_tract [bladder|NS|NS]	carcinoma [NS|NS|NS]	CSV	4005726	.	.	.	.	.	.	.	.	.	Likely Benign
4	187542426	187542427	4q35.2	1	normal	.	T	snv	C	CC.GT	het-ref	371	0.50	.	2	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C9	EX10	.	.	coding-synon	NM_005245.3	NP_005236.2	-	Y	c.5313A>G	p.(T1771=) | p.(Thr1771=)	ACA=>ACG	.	NM_005245.3(FAT1): c.5313A>G (p.(T1771=))	;	125418	0.000502	U	0.0069	0.00159744	12200	0.000082	PASS	0	8604	0.004998	0	120410	0.000457	0	75	4.35035e-03	0	92	3.74520e-04	rs186222414	.	4024	0.007000	-0.336	-0.418	-1.142	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
4	187542426	187542427	4q35.2	0	normal	.	T	ref	T	CC.GT	het-alt	367	0.50	.	1	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C9	EX10	.	.	no-change	NM_005245.3	NP_005236.2	-	Y	c.5313A=	.	.	.	NM_005245.3(FAT1): c.5313A=	;	125418	0.999498	U	0.0069	0.00159744	12200	0.999918	PASS	.	8604	0.995002	60150	120410	0.999543	.	.	.	.	.	.	rs186222414	.	4024	0.993000	-0.336	-0.418	-1.142	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187557892	187557893	4q35.2	0	normal	.	T	ref	T	CG.GA	het-alt	339	0.49	.	1	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C4	EX5	Cadherin domain	PF00028.12	no-change	NM_005245.3	NP_005236.2	-	Y	c.3818A=	.	.	.	NM_005245.3(FAT1): c.3818A=	;maf-5-some-pop,maf-5-all-pops	125768	0.410073	U	0.6786	0.645767	11954	0.366237	PASS	-934	8626	0.313239	10953	120760	0.412388	.	.	.	.	.	.	rs328418	.	4024	0.328800	-0.215	4.275	1.353	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187557892	187557893	4q35.2	1	normal	.	T	snv	C	CG.GA	het-ref	353	0.51	.	2	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C4	EX5	Cadherin domain	PF00028.12	missense	NM_005245.3	NP_005236.2	-	Y	c.3818A>G	p.H1273R | p.His1273Arg	CAC=>CGC	P+=>P+	NM_005245.3(FAT1): c.3818A>G (p.H1273R)	;maf-5-some-pop,maf-5-all-pops	125768	0.589927	U	0.6786	0.645767	11954	0.633763	PASS	2028	8626	0.686761	21533	120760	0.587612	3964	11664	6.76252e-01	43903	144906	5.88537e-01	rs328418	.	4024	0.671200	-0.215	4.275	1.353	1	0	0	0.000	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
4	187584770	187584771	4q35.2	0	nullSample	.	C	ref	C	TA.AG	homo-ref	.	.	.	0	.	.	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	IC1	IVS2	.	.	no-change	NM_005245.3	NP_005236.2	-	Y	c.3266-4G=	.	.	.	NM_005245.3(FAT1): c.3266-4G=	;maf-5-some-pop	120482	0.032013	U	1	0.983427	12236	0.037512	PASS	.	7826	0.000128	69	115474	0.032683	.	.	.	.	.	.	rs172903	.	4024	0.001700	-0.120	-0.174	-0.187	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187584770	187584771	4q35.2	1	normal	.	C	snv	G	TA.AG	hom-alt	422	1.00	.	0	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	IC1	IVS2	.	.	intron	NM_005245.3	NP_005236.2	-	Y	c.3266-4G>C	.	.	.	NM_005245.3(FAT1): c.3266-4G>C	;maf-5-some-pop	120482	0.967987	U	1	0.983427	12236	0.962488	PASS	3912	7826	0.999872	54032	115474	0.967317	8424	16849	9.99941e-01	108883	224966	9.67696e-01	rs172903	.	4024	0.998300	-0.120	-0.174	-0.187	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187627659	187627660	4q35.2	0	normal	.	A	ref	A	TT.AA	het-alt	85	0.57	.	1	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	IC1	IVS2	.	.	no-change	NM_005245.3	NP_005236.2	-	Y	c.3265+57T=	.	.	.	NM_005245.3(FAT1): c.3265+57T=	;maf-5-some-pop,maf-5-all-pops	5008	0.585463	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs200130748	.	4024	0.634400	-0.829	-0.015	-0.188	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187627659	187627660	4q35.2	0	normal	.	A	del	.	TT.AA	het-ref	65	0.43	.	2	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	IC1	IVS2	.	.	intron	NM_005245.3	NP_005236.2	-	Y	c.3265+57delT	.	.	.	NM_005245.3(FAT1): c.3265+57delT	;maf-5-some-pop,maf-5-all-pops	5008	0.414537	U	0.3363	0.414537	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs200130748	.	4024	0.365600	-0.829	-0.015	-0.188	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187627791	187627792	4q35.2	0	nullSample	.	T	ref	T	TC.GG	homo-ref	.	.	.	0	.	.	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C1	EX2	Cadherin domain	PF00028.12	no-change	NM_005245.3	NP_005236.2	-	Y	c.3190A=	.	.	.	NM_005245.3(FAT1): c.3190A=	;maf-5-some-pop,maf-5-all-pops	125754	0.239698	U	0.5	0.745807	12328	0.172777	PASS	.	8616	0.502205	4053	120746	0.239097	.	.	.	.	.	.	rs11939575	.	4024	0.498000	-0.186	4.093	1.172	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187627791	187627792	4q35.2	1	normal	.	T	snv	C	TC.GG	hom-alt	676	1.00	.	0	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C1	EX2	Cadherin domain	PF00028.12	missense	NM_005245.3	NP_005236.2	-	Y	c.3190A>G	p.R1064G | p.Arg1064Gly	AGA=>GGA	P+=>P0	NM_005245.3(FAT1): c.3190A>G (p.R1064G)	;maf-5-some-pop,maf-5-all-pops	125754	0.760302	U	0.5	0.745807	12328	0.827223	PASS	1068	8616	0.497795	35556	120746	0.760903	2144	8601	4.98667e-01	71292	185929	7.55103e-01	rs11939575	.	4024	0.502000	-0.186	4.093	1.172	1	0	0	0.000	neutral	ENST00000441802: c.3190A>G (p.R1064G)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4003034	.	.	.	.	.	.	.	.	.	Likely Benign
4	187628397	187628398	4q35.2	0	nullSample	.	C	ref	C	AA.AA	homo-ref	.	.	.	0	.	.	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C1	EX2	Cadherin domain	PF00028.12	no-change	NM_005245.3	NP_005236.2	-	Y	c.2584G=	.	.	.	NM_005245.3(FAT1): c.2584G=	SingleClassTriAllelic;maf-5-some-pop	125666	0.256243	U	0.502	0.689097	12420	0.224477	PASS	-1077	8614	0.501974	4417	120658	0.253974	.	.	.	.	.	.	rs1877731	.	4024	0.498300	-0.322	0.799	0.228	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187628397	187628398	4q35.2	1	normal	.	C	snv	G	AA.AA	hom-alt	857	1.00	.	0	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C1	EX2	Cadherin domain	PF00028.12	missense	NM_005245.3	NP_005236.2	-	Y	c.2584G>C	p.V862L | p.Val862Leu	GTT=>CTT	NP=>NP	NM_005245.3(FAT1): c.2584G>C (p.V862L)	SingleClassTriAllelic;maf-5-some-pop	125666	0.743733	U	0.502	0.689097	12420	0.775523	PASS	1068	8614	0.498026	34100	120658	0.746001	2146	8602	4.98956e-01	68753	182599	7.42647e-01	rs1877731	.	4024	0.501700	-0.322	0.799	0.228	1	0.001	0	0.000	neutral	ENST00000441802: c.2584G>C (p.V862L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4003036	.	.	.	.	.	.	.	.	.	Likely Benign
4	187629139	187629140	4q35.2	1	normal	.	G	snv	C	AA.AA	hom-alt	632	1.00	.	0	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C1	EX2	.	.	missense	NM_005245.3	NP_005236.2	-	Y	c.1842C>G	p.F614L | p.Phe614Leu	TTC=>TTG	NP=>NP	NM_005245.3(FAT1): c.1842C>G (p.F614L)	;maf-5-some-pop,genotype-conflict	125636	0.745296	U	0.502	0.690495	11936	0.780077	PASS	1066	8592	0.498603	34215	120628	0.747571	2141	8595	4.98608e-01	69011	183028	7.43786e-01	rs367863	.	4024	0.501000	-0.120	0.600	0.860	0.97	0	0	0.000	neutral	ENST00000441802: c.1842C>G (p.F614L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4003038	.	.	.	.	.	.	.	.	.	Likely Benign
4	187629139	187629140	4q35.2	0	nullSample	.	G	ref	G	AA.AA	homo-ref	.	.	.	0	.	.	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C1	EX2	.	.	no-change	NM_005245.3	NP_005236.2	-	Y	c.1842C=	.	.	.	NM_005245.3(FAT1): c.1842C=	;maf-5-some-pop,genotype-conflict	125636	0.254704	U	0.502	0.690495	11936	0.219923	PASS	-1076	8592	0.501397	4351	120628	0.252429	.	.	.	.	.	.	rs367863	.	4024	0.499000	-0.120	0.600	0.860	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187630589	187630590	4q35.2	0	nullSample	.	G	ref	G	GC.CC	homo-ref	.	.	.	0	.	.	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C1	EX2	.	.	no-change	NM_005245.3	NP_005236.2	-	Y	c.392C=	.	.	.	NM_005245.3(FAT1): c.392C=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125744	0.816953	U	0.2768	0.261382	12572	0.795339	PASS	.	8620	0.732367	41163	120736	0.820203	.	.	.	.	.	.	rs3733415	.	4024	0.718700	0.591	3.013	2.704	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187630589	187630590	4q35.2	1	normal	.	G	snv	A	GC.CC	hom-alt	707	1.00	.	0	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	C1	EX2	.	.	missense	NM_005245.3	NP_005236.2	-	Y	c.392C>T	p.A131V | p.Ala131Val	GCG=>GTG	NP=>NP	NM_005245.3(FAT1): c.392C>T (p.A131V)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125744	0.183047	U	0.2768	0.261382	12572	0.204661	PASS	317	8620	0.267633	2503	120736	0.179797	658	4667	2.70582e-01	4824	43255	1.75705e-01	rs3733415	.	4024	0.281300	0.591	3.013	2.704	0.01	0.565	0.977	0.599	deleterious	ENST00000441802: c.392C>T (p.A131V)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4416272	.	.	.	.	.	.	.	.	.	Likely Benign
4	187630988	187630989	4q35.2	0	nullSample	.	C	ref	C	AA.TG	homo-ref	.	.	.	0	.	.	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	5U1	EX2	.	.	no-change	NM_005245.3	NP_005236.2	-	Y	c.-8G=	.	.	.	NM_005245.3(FAT1): c.-8G=	;maf-5-some-pop,maf-5-all-pops	77432	0.771012	U	0.2758	0.261382	12164	0.796860	PASS	-649	5398	0.678029	21605	72424	0.773252	.	.	.	.	.	.	rs17077740	.	.	.	0.313	1.037	1.064	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
4	187630988	187630989	4q35.2	0	normal	.	C	snv	A	AA.TG	hom-alt	461	1.00	.	0	.	PASS	600976	P	.	NN	.	.	.	.	.	.	.	2195	FAT1	5U1	EX2	.	.	utr-5	NM_005245.3	NP_005236.2	-	Y	c.-8G>T	.	.	.	NM_005245.3(FAT1): c.-8G>T	;maf-5-some-pop,maf-5-all-pops	77432	0.228988	U	0.2758	0.261382	12164	0.203140	PASS	220	5398	0.321971	1815	72424	0.226748	577	4185	2.71084e-01	4152	38013	1.75999e-01	rs17077740	.	.	.	0.313	1.037	1.064	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	218597	218598	5p15.33	0	normal	.	G	ref	G	cg.tc	het-alt	75	0.52	.	1	dup;(CGGGG)n|Simple_repeat|Simple_repeat|+|78	PASS	600857	C	252011(MK);256000(MK);613642(MK);614165(MK)	AR	Paragangliomas 5; Gastrointestinal stromal tumors	AD	Allelic with Cardiomyopathy, dilated, 1GG (AR); Leigh syndrome/Mitochondrial respiratory chain complex II deficiency (AR)	Biochemical; Cardiovascular; Musculoskeletal; Neurologic; Oncologic	Gastrointestinal; Oncologic	22972948|21505157|20551992|20484225|16798039|16737791|12794685|10746566|7550341	FC59;H54;H62;H68;HE15;MC58	6389	SDHA	IC1	IVS1	.	.	no-change	NM_004168.2	NP_004159.2	+	Y	c.63+65G=	.	.	.	NM_004168.2(SDHA): c.63+65G=	;maf-5-some-pop,maf-5-all-pops	5008	0.670128	U	0.2768	0.329872	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2303740	.	4024	0.740600	-0.350	-2.008	-2.418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	218597	218598	5p15.33	0	normal	.	G	snv	A	cg.tc	het-ref	68	0.48	.	2	dup;(CGGGG)n|Simple_repeat|Simple_repeat|+|78	PASS	600857	C	252011(MK);256000(MK);613642(MK);614165(MK)	AR	Paragangliomas 5; Gastrointestinal stromal tumors	AD	Allelic with Cardiomyopathy, dilated, 1GG (AR); Leigh syndrome/Mitochondrial respiratory chain complex II deficiency (AR)	Biochemical; Cardiovascular; Musculoskeletal; Neurologic; Oncologic	Gastrointestinal; Oncologic	22972948|21505157|20551992|20484225|16798039|16737791|12794685|10746566|7550341	FC59;H54;H62;H68;HE15;MC58	6389	SDHA	IC1	IVS1	.	.	intron	NM_004168.2	NP_004159.2	+	Y	c.63+65G>A	.	.	.	NM_004168.2(SDHA): c.63+65G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.329872	U	0.2768	0.329872	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2303740	.	4024	0.259400	-0.350	-2.008	-2.418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	224655	224656	5p15.33	0	normal	.	C	ref	C	CA.TG	het-alt	361	0.84	.	1	dup	DUBIOUS	600857	C	252011(MK);256000(MK);613642(MK);614165(MK)	AR	Paragangliomas 5; Gastrointestinal stromal tumors	AD	Allelic with Cardiomyopathy, dilated, 1GG (AR); Leigh syndrome/Mitochondrial respiratory chain complex II deficiency (AR)	Biochemical; Cardiovascular; Musculoskeletal; Neurologic; Oncologic	Gastrointestinal; Oncologic	22972948|21505157|20551992|20484225|16798039|16737791|12794685|10746566|7550341	FC59;H54;H62;H68;HE15;MC58	6389	SDHA	IC3	IVS3	.	.	no-change	NM_004168.2	NP_004159.2	+	Y	c.312+20C=	.	.	.	NM_004168.2(SDHA): c.312+20C=	;maf-5-some-pop	115982	0.962606	U	.	.	.	.	VQSRTrancheSNP99.80to99.90	.	8088	0.937809	53654	115982	0.962606	.	.	.	.	.	.	rs111533078	.	4024	0.922500	-0.541	-1.501	-1.550	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	224655	224656	5p15.33	0	normal	.	C	snv	T	CA.TG	het-ref	69	0.16	.	2	dup	DUBIOUS	600857	C	252011(MK);256000(MK);613642(MK);614165(MK)	AR	Paragangliomas 5; Gastrointestinal stromal tumors	AD	Allelic with Cardiomyopathy, dilated, 1GG (AR); Leigh syndrome/Mitochondrial respiratory chain complex II deficiency (AR)	Biochemical; Cardiovascular; Musculoskeletal; Neurologic; Oncologic	Gastrointestinal; Oncologic	22972948|21505157|20551992|20484225|16798039|16737791|12794685|10746566|7550341	FC59;H54;H62;H68;HE15;MC58	6389	SDHA	IC3	IVS3	.	.	intron	NM_004168.2	NP_004159.2	+	Y	c.312+20C>T	.	.	.	NM_004168.2(SDHA): c.312+20C>T	;maf-5-some-pop	115982	0.037394	U	.	.	.	.	VQSRTrancheSNP99.80to99.90	0	8088	0.062191	0	115982	0.037394	0	103	6.42786e-03	0	1352	5.84366e-03	rs111533078	.	4024	0.077500	-0.541	-1.501	-1.550	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	225767	225768	5p15.33	0	normal	.	G	ref	G	TG.CA	het-alt	145	0.47	.	1	dup	PASS	600857	C	252011(MK);256000(MK);613642(MK);614165(MK)	AR	Paragangliomas 5; Gastrointestinal stromal tumors	AD	Allelic with Cardiomyopathy, dilated, 1GG (AR); Leigh syndrome/Mitochondrial respiratory chain complex II deficiency (AR)	Biochemical; Cardiovascular; Musculoskeletal; Neurologic; Oncologic	Gastrointestinal; Oncologic	22972948|21505157|20551992|20484225|16798039|16737791|12794685|10746566|7550341	FC59;H54;H62;H68;HE15;MC58	6389	SDHA	IC4	IVS4	.	.	no-change	NM_004168.2	NP_004159.2	+	Y	c.456+91G=	.	.	.	NM_004168.2(SDHA): c.456+91G=	;maf-5-some-pop,maf-5-all-pops	5008	0.670727	U	0.2768	0.329273	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12520059	.	4024	0.741600	-0.874	-0.595	-0.728	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	225767	225768	5p15.33	0	normal	.	G	snv	C	TG.CA	het-ref	162	0.53	.	2	dup	PASS	600857	C	252011(MK);256000(MK);613642(MK);614165(MK)	AR	Paragangliomas 5; Gastrointestinal stromal tumors	AD	Allelic with Cardiomyopathy, dilated, 1GG (AR); Leigh syndrome/Mitochondrial respiratory chain complex II deficiency (AR)	Biochemical; Cardiovascular; Musculoskeletal; Neurologic; Oncologic	Gastrointestinal; Oncologic	22972948|21505157|20551992|20484225|16798039|16737791|12794685|10746566|7550341	FC59;H54;H62;H68;HE15;MC58	6389	SDHA	IC4	IVS4	.	.	intron	NM_004168.2	NP_004159.2	+	Y	c.456+91G>C	.	.	.	NM_004168.2(SDHA): c.456+91G>C	;maf-5-some-pop,maf-5-all-pops	5008	0.329273	U	0.2768	0.329273	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12520059	.	4024	0.258400	-0.874	-0.595	-0.728	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	230979	230980	5p15.33	0	nullSample	.	A	ref	A	CT.TT	homo-ref	.	.	.	0	dup	.	600857	C	252011(MK);256000(MK);613642(MK);614165(MK)	AR	Paragangliomas 5; Gastrointestinal stromal tumors	AD	Allelic with Cardiomyopathy, dilated, 1GG (AR); Leigh syndrome/Mitochondrial respiratory chain complex II deficiency (AR)	Biochemical; Cardiovascular; Musculoskeletal; Neurologic; Oncologic	Gastrointestinal; Oncologic	22972948|21505157|20551992|20484225|16798039|16737791|12794685|10746566|7550341	FC59;H54;H62;H68;HE15;MC58	6389	SDHA	IC6	IVS6	.	.	no-change	NM_004168.2	NP_004159.2	+	Y	c.771-11A=	.	.	.	NM_004168.2(SDHA): c.771-11A=	SingleClassTriAllelic;maf-5-some-pop	126308	0.119842	U	0.628	0.858427	13006	0.087421	PASS	-961	8622	0.335653	1157	121300	0.118945	.	.	.	.	.	.	rs2288461	.	4024	0.311100	-1.009	-0.208	-0.154	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	230979	230980	5p15.33	1	normal	.	A	snv	G	CT.TT	hom-alt	568	1.00	.	0	dup	PASS	600857	C	252011(MK);256000(MK);613642(MK);614165(MK)	AR	Paragangliomas 5; Gastrointestinal stromal tumors	AD	Allelic with Cardiomyopathy, dilated, 1GG (AR); Leigh syndrome/Mitochondrial respiratory chain complex II deficiency (AR)	Biochemical; Cardiovascular; Musculoskeletal; Neurologic; Oncologic	Gastrointestinal; Oncologic	22972948|21505157|20551992|20484225|16798039|16737791|12794685|10746566|7550341	FC59;H54;H62;H68;HE15;MC58	6389	SDHA	IC6	IVS6	.	.	intron	NM_004168.2	NP_004159.2	+	Y	c.771-11A>G	.	.	.	NM_004168.2(SDHA): c.771-11A>G	SingleClassTriAllelic;maf-5-some-pop	126308	0.880142	U	0.628	0.858427	13006	0.912579	PASS	1903	8622	0.664347	47377	121300	0.881039	3787	11387	6.60269e-01	95476	216094	8.77896e-01	rs2288461	.	4024	0.688900	-1.009	-0.208	-0.154	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	259248	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
5	231110	231111	5p15.33	0	normal	.	T	ref	T	CC.AC	het-alt	285	0.52	.	1	dup	PASS	600857	C	252011(MK);256000(MK);613642(MK);614165(MK)	AR	Paragangliomas 5; Gastrointestinal stromal tumors	AD	Allelic with Cardiomyopathy, dilated, 1GG (AR); Leigh syndrome/Mitochondrial respiratory chain complex II deficiency (AR)	Biochemical; Cardiovascular; Musculoskeletal; Neurologic; Oncologic	Gastrointestinal; Oncologic	22972948|21505157|20551992|20484225|16798039|16737791|12794685|10746566|7550341	FC59;H54;H62;H68;HE15;MC58	6389	SDHA	C7	EX7	FAD binding domain	PF00890.19	no-change	NM_004168.2	NP_004159.2	+	Y	c.891T=	.	.	.	NM_004168.2(SDHA): c.891T=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125786	0.294341	U	0.3363	0.653355	13004	0.231313	PASS	-950	8582	0.671871	6099	120778	0.292172	.	.	.	.	.	.	rs1126417	.	4024	0.685600	-0.748	0.363	-0.222	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	231110	231111	5p15.33	1	normal	.	T	snv	C	CC.AC	het-ref	264	0.48	.	2	dup	PASS	600857	C	252011(MK);256000(MK);613642(MK);614165(MK)	AR	Paragangliomas 5; Gastrointestinal stromal tumors	AD	Allelic with Cardiomyopathy, dilated, 1GG (AR); Leigh syndrome/Mitochondrial respiratory chain complex II deficiency (AR)	Biochemical; Cardiovascular; Musculoskeletal; Neurologic; Oncologic	Gastrointestinal; Oncologic	22972948|21505157|20551992|20484225|16798039|16737791|12794685|10746566|7550341	FC59;H54;H62;H68;HE15;MC58	6389	SDHA	C7	EX7	FAD binding domain	PF00890.19	coding-synon	NM_004168.2	NP_004159.2	+	Y	c.891T>C	p.(P297=) | p.(Pro297=)	CCT=>CCC	.	NM_004168.2(SDHA): c.891T>C (p.(P297=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125786	0.705659	U	0.3363	0.653355	13004	0.768687	PASS	458	8582	0.328129	31200	120778	0.707828	877	5508	3.20009e-01	62110	172135	7.01378e-01	rs1126417	.	4024	0.314400	-0.748	0.363	-0.222	.	.	.	.	.	ENST00000264932: c.891T>C (p.P297P)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4159838	.	.	.	.	.	no_record	130283	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
5	256434	256436	5p15.33	0	normal	.	CT	ref	CT	GA.CT	het-alt	302	0.89	.	1	dup	PASS	600857	C	252011(MK);256000(MK);613642(MK);614165(MK)	AR	Paragangliomas 5; Gastrointestinal stromal tumors	AD	Allelic with Cardiomyopathy, dilated, 1GG (AR); Leigh syndrome/Mitochondrial respiratory chain complex II deficiency (AR)	Biochemical; Cardiovascular; Musculoskeletal; Neurologic; Oncologic	Gastrointestinal; Oncologic	22972948|21505157|20551992|20484225|16798039|16737791|12794685|10746566|7550341	FC59;H54;H62;H68;HE15;MC58	6389	SDHA	IC14	IVS14	.	.	no-change	NM_004168.2	NP_004159.2	+	Y	c.1909-14_1909-13=	.	.	.	NM_004168.2(SDHA): c.1909-14_1909-13=	;	121134	0.999992	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs372662724	.	4024	0.690100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	256434	256436	5p15.33	1	normal	.	CT	del	.	GA.CT	het-ref	36	0.11	.	2	dup	PASS	600857	C	252011(MK);256000(MK);613642(MK);614165(MK)	AR	Paragangliomas 5; Gastrointestinal stromal tumors	AD	Allelic with Cardiomyopathy, dilated, 1GG (AR); Leigh syndrome/Mitochondrial respiratory chain complex II deficiency (AR)	Biochemical; Cardiovascular; Musculoskeletal; Neurologic; Oncologic	Gastrointestinal; Oncologic	22972948|21505157|20551992|20484225|16798039|16737791|12794685|10746566|7550341	FC59;H54;H62;H68;HE15;MC58	6389	SDHA	IC14	IVS14	.	.	intron	NM_004168.2	NP_004159.2	+	Y	c.1909-14_1909-13delCT	.	.	.	NM_004168.2(SDHA): c.1909-14_1909-13delCT	;	121134	0.000008	U	.	.	.	.	VQSRTrancheINDEL99.50to99.90	0	8654	0.000000	0	121134	0.000008	0	0	0.00000e+00	0	0	0.00000e+00	rs372662724	.	4024	2.000000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	353206	criteria_provided,_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	Likely Benign
5	256471	256472	5p15.33	1	normal	.	G	snv	A	GT.AT	het-ref	54	0.11	.	2	dup	DUBIOUS	600857	C	252011(MK);256000(MK);613642(MK);614165(MK)	AR	Paragangliomas 5; Gastrointestinal stromal tumors	AD	Allelic with Cardiomyopathy, dilated, 1GG (AR); Leigh syndrome/Mitochondrial respiratory chain complex II deficiency (AR)	Biochemical; Cardiovascular; Musculoskeletal; Neurologic; Oncologic	Gastrointestinal; Oncologic	22972948|21505157|20551992|20484225|16798039|16737791|12794685|10746566|7550341	FC59;H54;H62;H68;HE15;MC58	6389	SDHA	C15E	EX15E	Fumarate reductase flavoprotein C-term	PF02910.15	coding-synon	NM_004168.2	NP_004159.2	+	Y	c.1932G>A	p.(V644=) | p.(Val644=)	GTG=>GTA	.	NM_004168.2(SDHA): c.1932G>A (p.(V644=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	123626	0.178231	U	0.2312	0.335264	13006	0.278256	PASS	17	8310	0.086643	2406	118618	0.171601	32	1040	6.25752e-02	4345	37286	1.55600e-01	rs6961	.	4024	0.303700	-0.893	-1.213	-1.663	.	.	.	.	.	ENST00000264932: c.1932G>A (p.V644V)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4963172	.	.	.	.	.	no_record	130278	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Unknown
5	256471	256472	5p15.33	0	normal	.	G	ref	G	GT.AT	het-alt	420	0.89	.	1	dup	DUBIOUS	600857	C	252011(MK);256000(MK);613642(MK);614165(MK)	AR	Paragangliomas 5; Gastrointestinal stromal tumors	AD	Allelic with Cardiomyopathy, dilated, 1GG (AR); Leigh syndrome/Mitochondrial respiratory chain complex II deficiency (AR)	Biochemical; Cardiovascular; Musculoskeletal; Neurologic; Oncologic	Gastrointestinal; Oncologic	22972948|21505157|20551992|20484225|16798039|16737791|12794685|10746566|7550341	FC59;H54;H62;H68;HE15;MC58	6389	SDHA	C15E	EX15E	Fumarate reductase flavoprotein C-term	PF02910.15	no-change	NM_004168.2	NP_004159.2	+	Y	c.1932G=	.	.	.	NM_004168.2(SDHA): c.1932G=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	123626	0.821769	U	0.2312	0.335264	13006	0.721744	PASS	-343	8310	0.913357	41360	118618	0.828399	.	.	.	.	.	.	rs6961	.	4024	0.696300	-0.893	-1.213	-1.663	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	256483	256485	5p15.33	0	normal	.	TT	ref	TT	AC.TG	het-alt	465	0.91	.	1	dup	PASS	600857	C	252011(MK);256000(MK);613642(MK);614165(MK)	AR	Paragangliomas 5; Gastrointestinal stromal tumors	AD	Allelic with Cardiomyopathy, dilated, 1GG (AR); Leigh syndrome/Mitochondrial respiratory chain complex II deficiency (AR)	Biochemical; Cardiovascular; Musculoskeletal; Neurologic; Oncologic	Gastrointestinal; Oncologic	22972948|21505157|20551992|20484225|16798039|16737791|12794685|10746566|7550341	FC59;H54;H62;H68;HE15;MC58	6389	SDHA	C15E	EX15E	Fumarate reductase flavoprotein C-term	PF02910.15	no-change	NM_004168.2	NP_004159.2	+	Y	c.1944_1945=	.	.	.	NM_004168.2(SDHA): c.1944_1945=	;	120154	0.986501	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs112307877	.	4024	0.769100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	256483	256485	5p15.33	1	normal	.	TT	del	.	AC.TG	het-ref	46	0.09	.	2	dup	PASS	600857	C	252011(MK);256000(MK);613642(MK);614165(MK)	AR	Paragangliomas 5; Gastrointestinal stromal tumors	AD	Allelic with Cardiomyopathy, dilated, 1GG (AR); Leigh syndrome/Mitochondrial respiratory chain complex II deficiency (AR)	Biochemical; Cardiovascular; Musculoskeletal; Neurologic; Oncologic	Gastrointestinal; Oncologic	22972948|21505157|20551992|20484225|16798039|16737791|12794685|10746566|7550341	FC59;H54;H62;H68;HE15;MC58	6389	SDHA	C15E	EX15E	Fumarate reductase flavoprotein C-term	PF02910.15	frameshift	NM_004168.2	NP_004159.2	+	Y	c.1944T[3>1] (std: c.1944T[1] alt: c.1945_1946delTT )	p.L649Efs*4 | p.Leu649Glufs*4	.	.	NM_004168.2(SDHA): c.1944T[1] (p.L649Efs*4)	;	120154	0.013499	U	.	.	.	.	VQSRTrancheINDEL99.50to99.90	0	8146	0.096612	0	120154	0.013499	0	0	0.00000e+00	0	2	8.28096e-06	rs112307877	.	4024	0.230900	.	.	.	.	.	.	.	.	ENST00000264932: c.1944_1945delTT (p.L649fs*4)	NS [NS|NS|NS]	malignant_melanoma [NS|NS|NS]	CSV	111560	.	.	.	.	.	.	.	.	.	Likely Benign
5	256572	256573	5p15.33	0	normal	.	A	ref	A	GT.AT	het-alt	282	0.88	.	1	dup	DUBIOUS	600857	C	252011(MK);256000(MK);613642(MK);614165(MK)	AR	Paragangliomas 5; Gastrointestinal stromal tumors	AD	Allelic with Cardiomyopathy, dilated, 1GG (AR); Leigh syndrome/Mitochondrial respiratory chain complex II deficiency (AR)	Biochemical; Cardiovascular; Musculoskeletal; Neurologic; Oncologic	Gastrointestinal; Oncologic	22972948|21505157|20551992|20484225|16798039|16737791|12794685|10746566|7550341	FC59;H54;H62;H68;HE15;MC58	6389	SDHA	3U1E	EX15E	.	.	no-change	NM_004168.2	NP_004159.2	+	Y	c.*38A=	.	.	.	NM_004168.2(SDHA): c.*38A=	;	105472	0.960881	U	.	.	.	.	PASS	.	7186	0.948094	48610	105472	0.960881	.	.	.	.	.	.	rs780738058	.	.	.	0.254	-0.069	-0.592	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	256572	256573	5p15.33	0	normal	.	A	snv	G	GT.AT	het-ref	39	0.12	.	2	dup	DUBIOUS	600857	C	252011(MK);256000(MK);613642(MK);614165(MK)	AR	Paragangliomas 5; Gastrointestinal stromal tumors	AD	Allelic with Cardiomyopathy, dilated, 1GG (AR); Leigh syndrome/Mitochondrial respiratory chain complex II deficiency (AR)	Biochemical; Cardiovascular; Musculoskeletal; Neurologic; Oncologic	Gastrointestinal; Oncologic	22972948|21505157|20551992|20484225|16798039|16737791|12794685|10746566|7550341	FC59;H54;H62;H68;HE15;MC58	6389	SDHA	3U1E	EX15E	.	.	utr-3	NM_004168.2	NP_004159.2	+	Y	c.*38A>G	.	.	.	NM_004168.2(SDHA): c.*38A>G	;	105472	0.039119	U	.	.	.	.	PASS	0	7186	0.051906	0	105472	0.039119	0	8	5.22193e-04	0	105	4.73041e-04	rs780738058	.	.	.	0.254	-0.069	-0.592	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
5	256577	256578	5p15.33	0	normal	.	T	snv	C	TA.GT	het-ref	47	0.15	.	2	dup	PASS	600857	C	252011(MK);256000(MK);613642(MK);614165(MK)	AR	Paragangliomas 5; Gastrointestinal stromal tumors	AD	Allelic with Cardiomyopathy, dilated, 1GG (AR); Leigh syndrome/Mitochondrial respiratory chain complex II deficiency (AR)	Biochemical; Cardiovascular; Musculoskeletal; Neurologic; Oncologic	Gastrointestinal; Oncologic	22972948|21505157|20551992|20484225|16798039|16737791|12794685|10746566|7550341	FC59;H54;H62;H68;HE15;MC58	6389	SDHA	3U1E	EX15E	.	.	utr-3	NM_004168.2	NP_004159.2	+	Y	c.*43T>C	.	.	.	NM_004168.2(SDHA): c.*43T>C	;	101614	0.041146	U	.	.	.	.	PASS	0	6878	0.054958	0	101614	0.041146	0	13	8.63787e-04	0	254	1.16654e-03	rs150891426	.	.	.	0.254	1.221	0.436	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
5	256577	256578	5p15.33	0	normal	.	T	ref	T	TA.GT	het-alt	275	0.85	.	1	dup	PASS	600857	C	252011(MK);256000(MK);613642(MK);614165(MK)	AR	Paragangliomas 5; Gastrointestinal stromal tumors	AD	Allelic with Cardiomyopathy, dilated, 1GG (AR); Leigh syndrome/Mitochondrial respiratory chain complex II deficiency (AR)	Biochemical; Cardiovascular; Musculoskeletal; Neurologic; Oncologic	Gastrointestinal; Oncologic	22972948|21505157|20551992|20484225|16798039|16737791|12794685|10746566|7550341	FC59;H54;H62;H68;HE15;MC58	6389	SDHA	3U1E	EX15E	.	.	no-change	NM_004168.2	NP_004159.2	+	Y	c.*43T=	.	.	.	NM_004168.2(SDHA): c.*43T=	;	101614	0.958854	U	.	.	.	.	PASS	-189	6878	0.945042	46626	101614	0.958854	.	.	.	.	.	.	rs150891426	.	.	.	0.254	1.221	0.436	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	1295348	1295349	5p15.33	0	normal	.	A	ref	A	GG.AG	het-alt	75	0.52	.	1	.	PASS	187270	C	187270(SK);601626(SK);613989(SK);614742(SK);615134(SK)	NN	Aplastic anemia; Dyskeratosis congenita, autosomal dominant; Dyskeratosis congenita, autosomal recessive; Pulmonary fibrosis and/or bone marrow failure, telomere-related 1	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular; Dental; Dermatologic; Endocrine; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic;  Oncologic; Pulmonary	Allergy/Immunology/Infectious; Hematologic; Oncologic; Pulmonary	22512499|21602826|21436073|20502709|20301779|19760749|18460650|18042801|17785587|17460043|17392301|16890917|16247010|15814878	.	7015	TERT	PROM	.	.	.	no-change	NM_198253.2	NP_937983.2	-	Y	c.-58-u187T=	.	.	.	NM_198253.2(TERT): c.-58-u187T=	;maf-5-some-pop	5008	0.702077	U	0.377	0.297923	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2853669	.	.	.	-1.224	-0.577	-0.453	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	1295348	1295349	5p15.33	0	normal	.	A	snv	G	GG.AG	het-ref	70	0.48	.	2	.	PASS	187270	C	187270(SK);601626(SK);613989(SK);614742(SK);615134(SK)	NN	Aplastic anemia; Dyskeratosis congenita, autosomal dominant; Dyskeratosis congenita, autosomal recessive; Pulmonary fibrosis and/or bone marrow failure, telomere-related 1	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular; Dental; Dermatologic; Endocrine; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic;  Oncologic; Pulmonary	Allergy/Immunology/Infectious; Hematologic; Oncologic; Pulmonary	22512499|21602826|21436073|20502709|20301779|19760749|18460650|18042801|17785587|17460043|17392301|16890917|16247010|15814878	.	7015	TERT	PROM	.	.	.	promoter	NM_198253.2	NP_937983.2	-	Y	c.-58-u187T>C	.	.	.	NM_198253.2(TERT): c.-58-u187T>C	;maf-5-some-pop	5008	0.297923	U	0.377	0.297923	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2853669	.	.	.	-1.224	-0.577	-0.453	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	539240	criteria_provided,_single_submitter	Benign	Benign
5	7889215	7889216	5p15.31	0	normal	.	G	ref	G	TT.CG	het-alt	123	0.53	.	1	.	PASS	602568	P	236270(MK);601634(SK)	AR	Homocystinuria-megaloblastic anemia, cobalamin E type	AR	.	Biochemical; Hematologic; Neurologic; Renal	Biochemical	15979034|15714522|15060097|10444342|9427140|6700644|3812589|2860337	.	4552	MTRR	C8	EX9	FAD binding domain	PF00667.15	no-change	NM_002454.2	NP_002445.2	+	Y	c.1155G=	.	.	.	NM_002454.2(MTRR): c.1155G=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126316	0.943056	U	0.1696	0.0680911	13006	0.972320	PASS	-679	8640	0.813657	54132	121308	0.943516	.	.	.	.	.	.	rs2287779	.	4024	0.839000	0.655	2.040	2.209	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	7889215	7889216	5p15.31	1	normal	.	G	snv	A	TT.CG	het-ref	110	0.47	.	2	.	PASS	602568	P	236270(MK);601634(SK)	AR	Homocystinuria-megaloblastic anemia, cobalamin E type	AR	.	Biochemical; Hematologic; Neurologic; Renal	Biochemical	15979034|15714522|15060097|10444342|9427140|6700644|3812589|2860337	.	4552	MTRR	C8	EX9	FAD binding domain	PF00667.15	coding-synon	NM_002454.2	NP_002445.2	+	Y	c.1155G>A	p.(L385=) | p.(Leu385=)	TTG=>TTA	.	NM_002454.2(MTRR): c.1155G>A (p.(L385=))	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126316	0.056944	U	0.1696	0.0680911	13006	0.027680	PASS	126	8640	0.186343	330	121308	0.056484	258	3158	1.83157e-01	790	15039	6.10870e-02	rs2287779	.	4024	0.161000	0.655	2.040	2.209	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	138292	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
5	7889303	7889304	5p15.31	0	normal	.	C	ref	C	GC.GC	het-alt	244	0.56	.	1	.	PASS	602568	P	236270(MK);601634(SK)	AR	Homocystinuria-megaloblastic anemia, cobalamin E type	AR	.	Biochemical; Hematologic; Neurologic; Renal	Biochemical	15979034|15714522|15060097|10444342|9427140|6700644|3812589|2860337	.	4552	MTRR	C8	EX9	FAD binding domain	PF00667.15	no-change	NM_002454.2	NP_002445.2	+	Y	c.1243C=	.	.	.	NM_002454.2(MTRR): c.1243C=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126394	0.942956	U	0.1696	0.0678914	13006	0.972320	PASS	.	8642	0.812891	54162	121386	0.943404	.	.	.	.	.	.	rs2287780	.	4024	0.839000	0.655	1.083	2.355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	7889303	7889304	5p15.31	1	normal	.	C	snv	T	GC.GC	het-ref	190	0.44	.	2	.	PASS	602568	P	236270(MK);601634(SK)	AR	Homocystinuria-megaloblastic anemia, cobalamin E type	AR	.	Biochemical; Hematologic; Neurologic; Renal	Biochemical	15979034|15714522|15060097|10444342|9427140|6700644|3812589|2860337	.	4552	MTRR	C8	EX9	FAD binding domain	PF00667.15	missense	NM_002454.2	NP_002445.2	+	Y	c.1243C>T	p.R415C | p.Arg415Cys	CGC=>TGC	P+=>P0	NM_002454.2(MTRR): c.1243C>T (p.R415C)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126394	0.057044	U	0.1696	0.0678914	13006	0.027680	PASS	130	8642	0.187109	339	121386	0.056596	262	3166	1.83558e-01	799	15069	6.11964e-02	rs2287780	.	4024	0.161000	0.655	1.083	2.355	0.05	0.913	0.999	0.710	deleterious	.	.	.	.	.	.	.	.	.	.	no_record	138293	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
5	35857176	35857177	5p13.2	0	nullSample	.	G	ref	G	AA.TT	homo-ref	.	.	.	0	.	.	146661	C	608971(MK)	NN	Severe combined immunodeficiency, autosomal recessive, T-cell negative, B-cell positive, NK cell positive	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	21883749|21625022|21184155|17827065|11023514|9843216	.	3575	IL7R	IC1	IVS1	.	.	no-change	NM_002185.3	NP_002176.2	+	Y	c.82+16G=	.	.	.	NM_002185.3(IL7R): c.82+16G=	;maf-5-some-pop	126370	0.360212	U	0.4236	0.647364	13006	0.257189	PASS	-1048	8648	0.580019	8827	121362	0.360525	.	.	.	.	.	.	rs1353252	.	4024	0.590200	-0.120	-1.121	-1.234	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	35857176	35857177	5p13.2	1	normal	.	G	snv	C	AA.TT	hom-alt	238	1.00	.	0	.	PASS	146661	C	608971(MK)	NN	Severe combined immunodeficiency, autosomal recessive, T-cell negative, B-cell positive, NK cell positive	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	21883749|21625022|21184155|17827065|11023514|9843216	.	3575	IL7R	IC1	IVS1	.	.	intron	NM_002185.3	NP_002176.2	+	Y	c.82+16G>C	.	.	.	NM_002185.3(IL7R): c.82+16G>C	;maf-5-some-pop	126370	0.639788	U	0.4236	0.647364	13006	0.742811	PASS	768	8648	0.419981	25754	121362	0.639475	1526	7246	4.20546e-01	49639	152286	6.27239e-01	rs1353252	.	4024	0.409800	-0.120	-1.121	-1.234	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	258579	criteria_provided,_single_submitter	Benign	Benign
5	35861067	35861068	5p13.2	1	normal	.	T	snv	C	CA.CA	hom-alt	455	1.00	.	0	.	PASS	146661	C	608971(MK)	NN	Severe combined immunodeficiency, autosomal recessive, T-cell negative, B-cell positive, NK cell positive	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	21883749|21625022|21184155|17827065|11023514|9843216	.	3575	IL7R	C2	EX2	.	.	missense	NM_002185.3	NP_002176.2	+	Y	c.197T>C	p.I66T | p.Ile66Thr	ATC=>ACC	NP=>P0	NM_002185.3(IL7R): c.197T>C (p.I66T)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	126338	0.626755	U	0.4256	0.59984	13006	0.700907	PASS	774	8632	0.423077	24636	121330	0.627866	1539	7277	4.22345e-01	48639	152154	6.18920e-01	rs1494558	.	4024	0.410500	-2.304	0.130	0.111	0.65	0	0	0.003	neutral	ENST00000303115: c.197T>C (p.I66T)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	RSS	149813	.	.	.	.	.	no_record	14839	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
5	35861067	35861068	5p13.2	0	nullSample	.	T	ref	T	CA.CA	homo-ref	.	.	.	0	.	.	146661	C	608971(MK)	NN	Severe combined immunodeficiency, autosomal recessive, T-cell negative, B-cell positive, NK cell positive	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	21883749|21625022|21184155|17827065|11023514|9843216	.	3575	IL7R	C2	EX2	.	.	no-change	NM_002185.3	NP_002176.2	+	Y	c.197T=	.	.	.	NM_002185.3(IL7R): c.197T=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	126338	0.373245	U	0.4256	0.59984	13006	0.299093	PASS	-1052	8632	0.576923	9122	121330	0.372134	.	.	.	.	.	.	rs1494558	.	4024	0.589500	-2.304	0.130	0.111	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	35861158	35861159	5p13.2	0	nullSample	.	A	ref	A	TA.TA	homo-ref	.	.	.	0	.	.	146661	C	608971(MK)	NN	Severe combined immunodeficiency, autosomal recessive, T-cell negative, B-cell positive, NK cell positive	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	21883749|21625022|21184155|17827065|11023514|9843216	.	3575	IL7R	IC2	IVS2	.	.	no-change	NM_002185.3	NP_002176.2	+	Y	c.221+67A=	.	.	.	NM_002185.3(IL7R): c.221+67A=	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	5008	0.871805	U	0.1528	0.128195	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs969128	.	4024	0.855900	0.533	-0.278	-0.046	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	35861158	35861159	5p13.2	0	normal	.	A	snv	G	TA.TA	hom-alt	271	1.00	.	0	.	PASS	146661	C	608971(MK)	NN	Severe combined immunodeficiency, autosomal recessive, T-cell negative, B-cell positive, NK cell positive	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	21883749|21625022|21184155|17827065|11023514|9843216	.	3575	IL7R	IC2	IVS2	.	.	intron	NM_002185.3	NP_002176.2	+	Y	c.221+67A>G	.	.	.	NM_002185.3(IL7R): c.221+67A>G	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	5008	0.128195	U	0.1528	0.128195	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs969128	.	4024	0.144100	0.533	-0.278	-0.046	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	35871189	35871190	5p13.2	0	nullSample	.	G	ref	G	TC.TC	homo-ref	.	.	.	0	.	.	146661	C	608971(MK)	NN	Severe combined immunodeficiency, autosomal recessive, T-cell negative, B-cell positive, NK cell positive	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	21883749|21625022|21184155|17827065|11023514|9843216	.	3575	IL7R	C4	EX4	Fibronectin type III domain	PF00041.16	no-change	NM_002185.3	NP_002176.2	+	Y	c.412G=	.	.	.	NM_002185.3(IL7R): c.412G=	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict	126280	0.347474	U	0.4812	0.666933	13006	0.254190	PASS	.	8642	0.525920	8126	121272	0.348069	.	.	.	.	.	.	rs1494555	.	4024	0.528300	-1.213	-0.421	-0.900	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	35871189	35871190	5p13.2	1	normal	.	G	snv	A	TC.TC	hom-alt	515	1.00	.	0	.	PASS	146661	C	608971(MK)	NN	Severe combined immunodeficiency, autosomal recessive, T-cell negative, B-cell positive, NK cell positive	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	21883749|21625022|21184155|17827065|11023514|9843216	.	3575	IL7R	C4	EX4	Fibronectin type III domain	PF00041.16	missense	NM_002185.3	NP_002176.2	+	Y	c.412G>A	p.V138I | p.Val138Ile	GTC=>ATC	NP=>NP	NM_002185.3(IL7R): c.412G>A (p.V138I)	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict	126280	0.652526	U	0.4812	0.666933	13006	0.745810	PASS	966	8642	0.474080	26551	121272	0.651931	1927	8173	4.74072e-01	51928	157347	6.39773e-01	rs1494555	.	4024	0.471700	-1.213	-0.421	-0.900	0.52	0	0.001	0.009	neutral	ENST00000303115: c.412G>A (p.V138I)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	RSS	149814	.	.	.	.	.	no_record	14840	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
5	35871272	35871273	5p13.2	0	nullSample	.	C	ref	C	CA.GA	homo-ref	.	.	.	0	.	.	146661	C	608971(MK)	NN	Severe combined immunodeficiency, autosomal recessive, T-cell negative, B-cell positive, NK cell positive	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	21883749|21625022|21184155|17827065|11023514|9843216	.	3575	IL7R	C4	EX4	Fibronectin type III domain	PF00041.16	no-change	NM_002185.3	NP_002176.2	+	Y	c.495C=	.	.	.	NM_002185.3(IL7R): c.495C=	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125760	0.873115	U	0.1528	0.128594	13006	0.864909	PASS	-551	8626	0.846047	46085	120752	0.873186	.	.	.	.	.	.	rs2228141	.	4024	0.855900	-0.812	-0.338	-0.761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	35871272	35871273	5p13.2	1	normal	.	C	snv	T	CA.GA	hom-alt	512	1.00	.	0	.	PASS	146661	C	608971(MK)	NN	Severe combined immunodeficiency, autosomal recessive, T-cell negative, B-cell positive, NK cell positive	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	21883749|21625022|21184155|17827065|11023514|9843216	.	3575	IL7R	C4	EX4	Fibronectin type III domain	PF00041.16	coding-synon	NM_002185.3	NP_002176.2	+	Y	c.495C>T	p.(H165=) | p.(His165=)	CAC=>CAT	.	NM_002185.3(IL7R): c.495C>T (p.(H165=))	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125760	0.126885	U	0.1528	0.128594	13006	0.135091	PASS	113	8626	0.153953	1022	120752	0.126814	211	2630	1.52694e-01	2103	31100	1.26505e-01	rs2228141	.	4024	0.144100	-0.812	-0.338	-0.761	.	.	.	.	.	ENST00000303115: c.495C>T (p.H165H)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3761218	.	.	.	.	.	no_record	137585	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
5	38496636	38496637	5p13.1	0	nullSample	.	C	ref	C	AT.TG	homo-ref	.	.	.	0	.	.	151443	C	601559(MK)	NN	Stuve-Wiedemann syndrome	AR	.	Musculoskeletal; Neurologic	General	20447141|19371797|18546280|14740318|12514358|9674906|9674905|9382147|8728692|4105362	.	3977	LIFR	C12	EX13	.	.	no-change	NM_002310.5	NP_002301.1	-	Y	c.1732G=	.	.	.	NM_002310.5(LIFR): c.1732G=	;maf-5-some-pop	126408	0.977818	U	0.2411	0.052516	13006	0.998616	PASS	.	8648	0.747572	58430	121400	0.979069	.	.	.	.	.	.	rs3729740	.	4024	0.737100	0.563	0.165	0.323	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	38496636	38496637	5p13.1	1	normal	.	C	snv	T	AT.TG	hom-alt	392	1.00	.	0	.	PASS	151443	C	601559(MK)	NN	Stuve-Wiedemann syndrome	AR	.	Musculoskeletal; Neurologic	General	20447141|19371797|18546280|14740318|12514358|9674906|9674905|9382147|8728692|4105362	.	3977	LIFR	C12	EX13	.	.	missense	NM_002310.5	NP_002301.1	-	Y	c.1732G>A	p.D578N | p.Asp578Asn	GAT=>AAT	P-=>P0	NM_002310.5(LIFR): c.1732G>A (p.D578N)	;maf-5-some-pop	126408	0.022182	U	0.2411	0.052516	13006	0.001384	PASS	270	8648	0.252428	271	121400	0.020931	573	4417	2.56117e-01	576	5271	2.14112e-02	rs3729740	.	4024	0.262900	0.563	0.165	0.323	0.44	0	0	0.013	neutral	ENST00000263409: c.1732G>A (p.D578N)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4003522	.	.	.	.	.	no_record	353625	criteria_provided,_single_submitter	Benign	Likely Benign
5	38950775	38950776	5p13.1	0	normal	.	G	snv	A	GT.CT	hom-alt	624	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	253260	RICTOR	C31	EX31	.	.	no-change	NM_152756.3	NP_689969.2	-	Y	c.3174T=	.	.	.	NM_152756.3(RICTOR): c.3174T=	;maf-5-some-pop	125980	0.965185	U	0.9881	0.949481	12998	0.952070	PASS	4250	8636	0.992010	56476	120972	0.965835	8455	17051	9.91683e-01	113909	234869	9.68780e-01	rs2115949	.	.	.	-0.269	-0.215	-0.279	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	38950775	38950776	5p13.1	1	nullSample	.	G	ref	G	GT.CT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	253260	RICTOR	C31	EX31	.	.	coding-synon	NM_152756.3	NP_689969.2	-	Y	c.3174T>C	p.(S1058=) | p.(Ser1058=)	AGT=>AGC	.	NM_152756.3(RICTOR): c.3174T>C (p.(S1058=))	;maf-5-some-pop	125980	0.034815	U	0.9881	0.949481	12998	0.047930	PASS	.	8636	0.007990	123	120972	0.034165	.	.	.	.	.	.	rs2115949	.	.	.	-0.269	-0.215	-0.279	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
5	38953664	38953665	5p13.1	0	nullSample	.	G	ref	G	AA.AA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	253260	RICTOR	IC27	IVS27	.	.	no-change	NM_152756.3	NP_689969.2	-	Y	c.2698-10C=	.	.	.	NM_152756.3(RICTOR): c.2698-10C=	.	.	.	.	0.9881	0.934105	.	.	PASS	-62	8354	0.015083	203	113824	0.059873	.	.	.	.	.	.	.	.	.	.	-1.378	-0.311	-1.012	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	38953665	38953665	5p13.1	1	normal	.	.	ins	A	AG.AA	hom-alt	216	0.97	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	253260	RICTOR	IC27	IVS27	.	.	intron	NM_152756.3	NP_689969.2	-	Y	c.2698-11_2698-10insT	.	.	.	NM_152756.3(RICTOR): c.2698-11_2698-10insT	;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	118832	0.937466	U	0.9881	0.934105	12356	0.892927	PASS	4029	8354	0.982164	50015	113824	0.937614	.	.	.	.	.	.	rs33912683	.	4024	0.987800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	38954993	38954994	5p13.1	0	nullSample	.	T	ref	T	TC.TG	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	253260	RICTOR	IC26	IVS26	.	.	no-change	NM_152756.3	NP_689969.2	-	Y	c.2610-31A=	.	.	.	NM_152756.3(RICTOR): c.2610-31A=	;maf-5-some-pop	125464	0.032177	U	0.9881	0.956669	13006	0.037060	PASS	-33	8600	0.007907	110	120456	0.031713	.	.	.	.	.	.	rs9292726	.	4024	0.006200	-0.197	-0.451	-0.862	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	38954993	38954994	5p13.1	0	normal	.	T	snv	C	TC.TG	hom-alt	275	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	253260	RICTOR	IC26	IVS26	.	.	intron	NM_152756.3	NP_689969.2	-	Y	c.2610-31A>G	.	.	.	NM_152756.3(RICTOR): c.2610-31A>G	;maf-5-some-pop	125464	0.967823	U	0.9881	0.956669	13006	0.962940	PASS	4233	8600	0.992093	56518	120456	0.968287	7358	14830	9.92239e-01	100587	206861	9.71635e-01	rs9292726	.	4024	0.993800	-0.197	-0.451	-0.862	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	38955795	38955796	5p13.1	0	nullSample	.	G	ref	G	TG.AG	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	253260	RICTOR	C26	EX26	Rapamycin-insensitive companion of mTOR RasGEF_N domain	PF14663.1	no-change	NM_152756.3	NP_689969.2	-	Y	c.2510C=	.	.	.	NM_152756.3(RICTOR): c.2510C=	SingleClassTriAllelic;maf-5-some-pop	126154	0.607900	U	0.4494	0.363818	13006	0.638167	PASS	-1063	8620	0.525290	22576	121146	0.606731	.	.	.	.	.	.	rs2043112	.	4024	0.530300	0.650	2.374	1.258	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	38955795	38955796	5p13.1	1	normal	.	G	snv	A	TG.AG	hom-alt	258	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	253260	RICTOR	C26	EX26	Rapamycin-insensitive companion of mTOR RasGEF_N domain	PF14663.1	missense	NM_152756.3	NP_689969.2	-	Y	c.2510C>T	p.S837F | p.Ser837Phe	TCC=>TTC	P0=>NP	NM_152756.3(RICTOR): c.2510C>T (p.S837F)	SingleClassTriAllelic;maf-5-some-pop	126154	0.392092	U	0.4494	0.363818	13006	0.361833	PASS	983	8620	0.474710	9646	121146	0.393261	1923	8095	4.70475e-01	19537	96667	3.94199e-01	rs2043112	.	4024	0.469700	0.650	2.374	1.258	0.69	0.045	0.051	0.005	neutral	ENST00000296782: c.2510C>T (p.S837F)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4003525	.	.	.	.	.	.	.	.	.	Likely Benign
5	38958967	38958968	5p13.1	0	normal	.	A	snv	C	AA.AA	hom-alt	253	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	253260	RICTOR	IC22	IVS22	.	.	intron	NM_152756.3	NP_689969.2	-	Y	c.2179-35T>G	.	.	.	NM_152756.3(RICTOR): c.2179-35T>G	;maf-5-some-pop	76376	0.943490	U	0.8859	0.869209	12812	0.922182	PASS	2062	5096	0.901884	30894	74192	0.912592	2669	6337	8.56351e-01	43222	97520	8.90935e-01	rs6868591	.	4024	0.550900	-0.461	-0.734	-1.283	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	38958967	38958968	5p13.1	0	nullSample	.	A	ref	A	AA.AA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	253260	RICTOR	IC22	IVS22	.	.	no-change	NM_152756.3	NP_689969.2	-	Y	c.2179-35T=	.	.	.	NM_152756.3(RICTOR): c.2179-35T=	;maf-5-some-pop	76376	0.056510	U	0.0724	0.0453275	12812	0.077818	PASS	.	5096	0.040620	173	74192	0.052405	.	.	.	.	.	.	rs6868591	.	4024	0.449100	-0.461	-0.734	-1.283	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	38962277	38962278	5p13.1	0	nullSample	.	T	ref	T	AA.AT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	253260	RICTOR	IC19	IVS19	.	.	no-change	NM_152756.3	NP_689969.2	-	Y	c.1715+139A=	.	.	.	NM_152756.3(RICTOR): c.1715+139A=	MixedObserved;maf-5-some-pop|MixedObserved;|MixedObserved;	5008|0|0	0.050519|0|0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10709459|rs72635274|rs869100015	.	.	.	0.412	-1.085	-1.258	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
5	38962277	38962278	5p13.1	0	normal	.	T	del	.	AA.AT	hom-alt	176	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	253260	RICTOR	IC19	IVS19	.	.	intron	NM_152756.3	NP_689969.2	-	Y	c.1715+139delA	.	.	.	NM_152756.3(RICTOR): c.1715+139delA	MixedObserved;maf-5-some-pop|MixedObserved;|MixedObserved;	5008|0|0	0.949481|0|0	U	0.9881	0.949481	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10709459|rs72635274|rs869100015	.	.	.	0.412	-1.085	-1.258	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	38962542	38962543	5p13.1	0	nullSample	.	A	ref	A	ta.ta	homo-ref	.	.	.	0	AT_rich|Low_complexity|Low_complexity|+|23	.	.	.	.	.	.	.	.	.	.	.	.	253260	RICTOR	IC18	IVS18	.	.	no-change	NM_152756.3	NP_689969.2	-	Y	c.1668+44T=	.	.	.	NM_152756.3(RICTOR): c.1668+44T=	;maf-5-some-pop	119732	0.037041	U	0.9881	0.9375	12820	0.053588	PASS	.	8224	0.007661	132	114724	0.035930	.	.	.	.	.	.	rs7729745	.	4024	0.006200	0.460	0.495	0.078	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	38962542	38962543	5p13.1	0	normal	.	A	snv	G	ta.ta	hom-alt	471	1.00	.	0	AT_rich|Low_complexity|Low_complexity|+|23	PASS	.	.	.	.	.	.	.	.	.	.	.	253260	RICTOR	IC18	IVS18	.	.	intron	NM_152756.3	NP_689969.2	-	Y	c.1668+44T>C	.	.	.	NM_152756.3(RICTOR): c.1668+44T>C	;maf-5-some-pop	119732	0.962959	U	0.9881	0.9375	12820	0.946412	PASS	4050	8224	0.992339	53372	114724	0.964070	7306	14730	9.91919e-01	97802	201927	9.67435e-01	rs7729745	.	4024	0.993800	0.460	0.495	0.078	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	38971911	38971912	5p13.1	0	nullSample	.	T	ref	T	tt.tt	homo-ref	.	.	.	0	AT_rich|Low_complexity|Low_complexity|+|26	.	.	.	.	.	.	.	.	.	.	.	.	253260	RICTOR	IC11	IVS11	.	.	no-change	NM_152756.3	NP_689969.2	-	Y	c.972+67A=	.	.	.	NM_152756.3(RICTOR): c.972+67A=	MixedObserved;maf-5-some-pop	62000	0.040903	U	0.9881	0.941094	.	.	PASS	.	3046	0.008207	85	56992	0.039321	.	.	.	.	.	.	rs7732615	.	4024	0.006200	0.402	0.643	0.339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	38971911	38971912	5p13.1	0	normal	.	T	snv	A	tt.tt	hom-alt	223	1.00	.	0	AT_rich|Low_complexity|Low_complexity|+|26	PASS	.	.	.	.	.	.	.	.	.	.	.	253260	RICTOR	IC11	IVS11	.	.	intron	NM_152756.3	NP_689969.2	-	Y	c.972+67A>T	.	.	.	NM_152756.3(RICTOR): c.972+67A>T	MixedObserved;maf-5-some-pop	62000	0.959097	U	0.9881	0.941094	.	.	PASS	1499	3046	0.991793	26340	56992	0.960679	4629	9335	9.91608e-01	68200	140678	9.68150e-01	rs7732615	.	4024	0.993800	0.402	0.643	0.339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	38978758	38978759	5p13.1	0	normal	.	A	ref	A	TT.AA	het-alt	206	0.85	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	253260	RICTOR	IC8	IVS8	.	.	no-change	NM_152756.3	NP_689969.2	-	Y	c.754-7T=	.	.	.	NM_152756.3(RICTOR): c.754-7T=	MixedObserved;	43674|8756	0.999771|0.993604	U	.	.	12426	0.946966	PASS	0	3504	1.000000	21827	43674	0.999771	.	.	.	.	.	.	rs754049442|rs756295969	.	4024	0.773900	-1.172	0.722	0.028	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	38978758	38978759	5p13.1	1	normal	.	A	del	.	TT.AA	het-ref	36	0.15	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	253260	RICTOR	IC8	IVS8	.	.	intron	NM_152756.3	NP_689969.2	-	Y	c.754-7delT	.	.	.	NM_152756.3(RICTOR): c.754-7delT	MixedObserved;	8756	0.006396	U	.	.	12426	0.043457	PASS	0	4950	0.089293	0	68564	0.126889	.	.	.	.	.	.	rs756295969	.	4024	0.226100	-1.172	0.722	0.028	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	38990956	38990957	5p13.1	0	nullSample	.	T	ref	T	ta.at	homo-ref	.	.	.	0	(TA)n|Simple_repeat|Simple_repeat|+|392;trf	.	.	.	.	.	.	.	.	.	.	.	.	253260	RICTOR	IC7	IVS7	.	.	no-change	NM_152756.3	NP_689969.2	-	Y	c.583+94A=	.	.	.	NM_152756.3(RICTOR): c.583+94A=	;	4	0.500000	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs56213103	.	4058	0.941100	0.063	0.067	0.064	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	38990957	38990957	5p13.1	0	normal	.	.	ins	ATGAGATATATGATATATATATGATAG	at.at	hom-alt	116	1.00	.	0	(TA)n|Simple_repeat|Simple_repeat|+|392;trf	PASS	.	.	.	.	.	.	.	.	.	.	.	253260	RICTOR	IC7	IVS7	.	.	intron	NM_152756.3	NP_689969.2	-	Y	c.583+93_583+94insCTATCATATATATATCATATATCTCAT	.	.	.	NM_152756.3(RICTOR): c.583+93_583+94insCTATCATATATATATCATATATCTCAT	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs143738262	.	4024	0.472400	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	39074295	39074296	5p13.1	0	normal	.	G	snv	C	TT.GC	hom-alt	332	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	253260	RICTOR	IC1	IVS1	.	.	intron	NM_152756.3	NP_689969.2	-	Y	c.50-36C>G	.	.	.	NM_152756.3(RICTOR): c.50-36C>G	;maf-5-some-pop,maf-5-all-pops	120362	0.443695	U	0.4702	0.426717	12998	0.418295	PASS	994	8348	0.490656	11389	115354	0.444432	1698	6948	4.86350e-01	21347	95761	4.40374e-01	rs2303808	.	4024	0.475400	-0.215	0.791	0.775	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	39074295	39074296	5p13.1	0	nullSample	.	G	ref	G	TT.GC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	253260	RICTOR	IC1	IVS1	.	.	no-change	NM_152756.3	NP_689969.2	-	Y	c.50-36C=	.	.	.	NM_152756.3(RICTOR): c.50-36C=	;maf-5-some-pop,maf-5-all-pops	120362	0.556305	U	0.4702	0.426717	12998	0.581705	PASS	-1054	8348	0.509344	17799	115354	0.555568	.	.	.	.	.	.	rs2303808	.	4024	0.524600	-0.215	0.791	0.775	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	40777530	40777531	5p13.1	0	normal	.	T	ref	T	AA.AT	het-alt	175	0.53	.	1	.	PASS	602739	P	.	NN	.	.	.	.	.	.	.	5562	PRKAA1	IC2	IVS2	.	.	no-change	NM_206907.3	NP_996790.3	-	Y	c.269+16A=	.	.	.	NM_206907.3(PRKAA1): c.269+16A=	MixedObserved;	86701	0.999965	U	0	0.000399361	.	.	PASS	-1108	8604	0.448861	29387	120252	0.694367	.	.	.	.	.	.	rs555918218	.	.	.	-0.297	0.189	0.255	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	40777531	40777531	5p13.1	1	normal	.	.	ins	TA	AT.AT	het-ref	154	0.47	.	2	.	PASS	602739	P	.	NN	.	.	.	.	.	.	.	5562	PRKAA1	IC2	IVS2	.	.	intron	NM_206907.3	NP_996790.3	-	Y	c.269+15_269+16insTA	.	.	.	NM_206907.3(PRKAA1): c.269+15_269+16insTA	;maf-5-some-pop,maf-5-all-pops	125257	0.307831	U	0.5536	0.360823	11314	0.289818	PASS	1262	8604	0.551023	6012	120252	0.305617	2508	9131	5.55211e-01	11681	71325	3.01874e-01	rs144157386	.	4024	0.530800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	55252984	55252985	5q11.2	0	normal	.	A	ref	A	tc.aa	het-alt	90	0.67	.	1	AluSc|SINE|Alu|+|294	PASS	600694	C	.	NN	.	.	.	.	.	.	.	3572	IL6ST	IC7	IVS9	.	.	no-change	NM_002184.3	NP_002175.2	-	Y	c.1056+52T=	.	.	.	NM_002184.3(IL6ST): c.1056+52T=	MixedObserved;	2	0.500000	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs80300976	.	4024	0.625700	0.254	0.086	-0.150	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	55252984	55252985	5q11.2	0	normal	.	A	del	.	tc.aa	het-ref	44	0.33	.	2	AluSc|SINE|Alu|+|294	PASS	600694	C	.	NN	.	.	.	.	.	.	.	3572	IL6ST	IC7	IVS9	.	.	intron	NM_002184.3	NP_002175.2	-	Y	c.1056+52delT	.	.	.	NM_002184.3(IL6ST): c.1056+52delT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.374000	0.254	0.086	-0.150	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	55256462	55256463	5q11.2	0	normal	.	C	ref	C	AA.tt	het-alt	92	0.47	.	1	.	PASS	600694	C	.	NN	.	.	.	.	.	.	.	3572	IL6ST	IC5	IVS7	.	.	no-change	NM_002184.3	NP_002175.2	-	Y	c.814-74G=	.	.	.	NM_002184.3(IL6ST): c.814-74G=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.657	-1.523	-1.546	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
5	55256463	55256463	5q11.2	0	normal	.	.	ins	T	AC.tt	het-ref	105	0.53	.	2	AluSx1|SINE|Alu|-|295	PASS	600694	C	.	NN	.	.	.	.	.	.	.	3572	IL6ST	IC5	IVS7	.	.	intron	NM_002184.3	NP_002175.2	-	Y	c.814-75_814-74insA	.	.	.	NM_002184.3(IL6ST): c.814-75_814-74insA	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.004000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
5	56111750	56111751	5q11.2	0	normal	.	G	ref	G	GC.AG	het-alt	221	0.50	.	1	.	PASS	600982	P	613762(MK)	NN	46,XY Sex Reversal 6	AD	.	Endocrine; Genitourinary; Oncologic	Genitourinary; Oncologic	21129722|12476449	.	4214	MAP3K1	C1	EX1	.	.	no-change	NM_005921.1	NP_005912.1	+	Y	c.351G=	.	.	.	NM_005921.1(MAP3K1): c.351G=	;maf-5-some-pop,maf-5-all-pops	6622	0.287526	U	0.5704	0.685703	.	.	PASS	.	10	0.500000	19	1614	0.204461	.	.	.	.	.	.	rs28710284	.	4024	0.424000	0.500	0.953	1.518	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	56111750	56111751	5q11.2	1	normal	.	G	snv	C	GC.AG	het-ref	220	0.50	.	2	.	PASS	600982	P	613762(MK)	NN	46,XY Sex Reversal 6	AD	.	Endocrine; Genitourinary; Oncologic	Genitourinary; Oncologic	21129722|12476449	.	4214	MAP3K1	C1	EX1	.	.	coding-synon	NM_005921.1	NP_005912.1	+	Y	c.351G>C	p.(A117=) | p.(Ala117=)	GCG=>GCC	.	NM_005921.1(MAP3K1): c.351G>C (p.(A117=))	;maf-5-some-pop,maf-5-all-pops	6622	0.712474	U	0.5704	0.685703	.	.	PASS	2	10	0.500000	496	1614	0.795539	8	23	5.75000e-01	2658	6709	7.83579e-01	rs28710284	.	4024	0.576000	0.500	0.953	1.518	.	.	.	.	.	ENST00000399503: c.351G>C (p.A117A)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4159917	.	.	.	.	.	no_record	518361	criteria_provided,_single_submitter	Benign	Likely Benign
5	56111926	56111927	5q11.2	0	normal	.	C	ref	C	GG.AG	het-alt	130	0.50	.	1	.	PASS	600982	P	613762(MK)	NN	46,XY Sex Reversal 6	AD	.	Endocrine; Genitourinary; Oncologic	Genitourinary; Oncologic	21129722|12476449	.	4214	MAP3K1	IC1	IVS1	.	.	no-change	NM_005921.1	NP_005912.1	+	Y	c.482+45C=	.	.	.	NM_005921.1(MAP3K1): c.482+45C=	;maf-5-some-pop,maf-5-all-pops	5010	0.507585	U	0.245	0.492412	.	.	PASS	0	0	0	0	2	0.500000	.	.	.	.	.	.	rs7731700	.	4024	0.774600	-0.309	1.159	0.700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	56111926	56111927	5q11.2	0	normal	.	C	snv	T	GG.AG	het-ref	129	0.50	.	2	.	PASS	600982	P	613762(MK)	NN	46,XY Sex Reversal 6	AD	.	Endocrine; Genitourinary; Oncologic	Genitourinary; Oncologic	21129722|12476449	.	4214	MAP3K1	IC1	IVS1	.	.	intron	NM_005921.1	NP_005912.1	+	Y	c.482+45C>T	.	.	.	NM_005921.1(MAP3K1): c.482+45C>T	;maf-5-some-pop,maf-5-all-pops	5010	0.492415	U	0.245	0.492412	.	.	PASS	0	0	0	0	2	0.500000	0	0	.	1	3	7.50000e-01	rs7731700	.	4024	0.225400	-0.309	1.159	0.700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	56152415	56152416	5q11.2	0	normal	.	C	ref	C	GC.TG	het-alt	242	0.54	.	1	.	PASS	600982	P	613762(MK)	NN	46,XY Sex Reversal 6	AD	.	Endocrine; Genitourinary; Oncologic	Genitourinary; Oncologic	21129722|12476449	.	4214	MAP3K1	IC1	IVS1	.	.	no-change	NM_005921.1	NP_005912.1	+	Y	c.483-11C=	.	.	.	NM_005921.1(MAP3K1): c.483-11C=	;maf-5-some-pop,maf-5-all-pops	125162	0.390278	U	0.245	0.526158	11798	0.301068	PASS	-697	8514	0.791167	10399	120154	0.386795	.	.	.	.	.	.	rs832567	.	4024	0.775300	-0.824	-1.363	-1.859	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	56152415	56152416	5q11.2	1	normal	.	C	snv	A	GC.TG	het-ref	208	0.46	.	2	.	PASS	600982	P	613762(MK)	NN	46,XY Sex Reversal 6	AD	.	Endocrine; Genitourinary; Oncologic	Genitourinary; Oncologic	21129722|12476449	.	4214	MAP3K1	IC1	IVS1	.	.	intron	NM_005921.1	NP_005912.1	+	Y	c.483-11C>A	.	.	.	NM_005921.1(MAP3K1): c.483-11C>A	;maf-5-some-pop,maf-5-all-pops	125162	0.609722	U	0.245	0.526158	11798	0.698932	PASS	192	8514	0.208833	24001	120154	0.613205	386	3565	2.07316e-01	48346	148869	6.06999e-01	rs832567	.	4024	0.224700	-0.824	-1.363	-1.859	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	518362	criteria_provided,_single_submitter	Benign	Benign
5	56161786	56161787	5q11.2	0	normal	.	G	ref	G	AC.TC	het-alt	279	0.50	.	1	.	PASS	600982	P	613762(MK)	NN	46,XY Sex Reversal 6	AD	.	Endocrine; Genitourinary; Oncologic	Genitourinary; Oncologic	21129722|12476449	.	4214	MAP3K1	C6	EX6	.	.	no-change	NM_005921.1	NP_005912.1	+	Y	c.1284G=	.	.	.	NM_005921.1(MAP3K1): c.1284G=	;maf-5-some-pop,genotype-conflict	125626	0.153838	U	0.7183	0.804313	11926	0.146990	PASS	-909	8588	0.296227	1763	120618	0.152100	.	.	.	.	.	.	rs832575	.	4024	0.271900	-0.988	0.707	-0.091	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	56161786	56161787	5q11.2	1	normal	.	G	snv	A	AC.TC	het-ref	279	0.50	.	2	.	PASS	600982	P	613762(MK)	NN	46,XY Sex Reversal 6	AD	.	Endocrine; Genitourinary; Oncologic	Genitourinary; Oncologic	21129722|12476449	.	4214	MAP3K1	C6	EX6	.	.	coding-synon	NM_005921.1	NP_005912.1	+	Y	c.1284G>A	p.(T428=) | p.(Thr428=)	ACG=>ACA	.	NM_005921.1(MAP3K1): c.1284G>A (p.(T428=))	;maf-5-some-pop,genotype-conflict	125626	0.846162	U	0.7183	0.804313	11926	0.853010	PASS	2113	8588	0.703773	43726	120618	0.847900	4257	12124	7.04392e-01	88055	207109	8.42770e-01	rs832575	.	4024	0.728100	-0.988	0.707	-0.091	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	518363	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
5	56177442	56177443	5q11.2	0	normal	.	G	ref	G	TT.AT	het-alt	309	0.52	.	1	.	PASS	600982	P	613762(MK)	NN	46,XY Sex Reversal 6	AD	.	Endocrine; Genitourinary; Oncologic	Genitourinary; Oncologic	21129722|12476449	.	4214	MAP3K1	C14	EX14	.	.	no-change	NM_005921.1	NP_005912.1	+	Y	c.2416G=	.	.	.	NM_005921.1(MAP3K1): c.2416G=	;maf-5-some-pop,genotype-conflict	125656	0.406507	U	0.2431	0.476438	11924	0.349883	PASS	.	8612	0.793428	11286	120648	0.401648	.	.	.	.	.	.	rs702689	.	4024	0.777100	0.655	3.482	2.778	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	56177442	56177443	5q11.2	1	normal	.	G	snv	A	TT.AT	het-ref	290	0.48	.	2	.	PASS	600982	P	613762(MK)	NN	46,XY Sex Reversal 6	AD	.	Endocrine; Genitourinary; Oncologic	Genitourinary; Oncologic	21129722|12476449	.	4214	MAP3K1	C14	EX14	.	.	missense	NM_005921.1	NP_005912.1	+	Y	c.2416G>A	p.D806N | p.Asp806Asn	GAT=>AAT	P-=>P0	NM_005921.1(MAP3K1): c.2416G>A (p.D806N)	;maf-5-some-pop,genotype-conflict	125656	0.593493	U	0.2431	0.476438	11924	0.650117	PASS	196	8612	0.206572	23152	120648	0.598352	381	3548	2.05705e-01	46827	146215	5.95096e-01	rs702689	.	4024	0.222900	0.655	3.482	2.778	0.32	0.111	0.649	0.033	neutral	ENST00000399503: c.2416G>A (p.D806N)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4003564	.	.	.	.	.	no_record	518364	criteria_provided,_single_submitter	Benign	Likely Benign
5	56177742	56177743	5q11.2	0	normal	.	G	ref	G	CA.TC	het-alt	368	0.51	.	1	.	PASS	600982	P	613762(MK)	NN	46,XY Sex Reversal 6	AD	.	Endocrine; Genitourinary; Oncologic	Genitourinary; Oncologic	21129722|12476449	.	4214	MAP3K1	C14	EX14	.	.	no-change	NM_005921.1	NP_005912.1	+	Y	c.2716G=	.	.	.	NM_005921.1(MAP3K1): c.2716G=	;maf-5-some-pop,maf-5-all-pops	125570	0.237453	U	0.5704	0.708267	12028	0.201530	PASS	-1070	8604	0.430033	3801	120562	0.235198	.	.	.	.	.	.	rs832582	.	4024	0.425200	-0.977	0.798	0.764	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	56177742	56177743	5q11.2	1	normal	.	G	snv	A	CA.TC	het-ref	357	0.49	.	2	.	PASS	600982	P	613762(MK)	NN	46,XY Sex Reversal 6	AD	.	Endocrine; Genitourinary; Oncologic	Genitourinary; Oncologic	21129722|12476449	.	4214	MAP3K1	C14	EX14	.	.	missense	NM_005921.1	NP_005912.1	+	Y	c.2716G>A	p.V906I | p.Val906Ile	GTC=>ATC	NP=>NP	NM_005921.1(MAP3K1): c.2716G>A (p.V906I)	;maf-5-some-pop,maf-5-all-pops	125570	0.762547	U	0.5704	0.708267	12028	0.798470	PASS	1382	8604	0.569967	35726	120562	0.764802	2756	9787	5.67889e-01	71723	186262	7.58346e-01	rs832582	.	4024	0.574800	-0.977	0.798	0.764	1	0	0	0.000	neutral	ENST00000399503: c.2716G>A (p.V906I)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4416190	.	.	.	.	.	no_record	518365	criteria_provided,_single_submitter	Benign	Likely Benign
5	56177848	56177851	5q11.2	0	normal	.	CAA	ref	CAA	TT.ca	het-alt	260	0.54	.	1	(CAA)n|Simple_repeat|Simple_repeat|+|26;trf	PASS	600982	P	613762(MK)	NN	46,XY Sex Reversal 6	AD	.	Endocrine; Genitourinary; Oncologic	Genitourinary; Oncologic	21129722|12476449	.	4214	MAP3K1	C14	EX14	.	.	no-change	NM_005921.1	NP_005912.1	+	Y	c.2822_2824=	.	.	.	NM_005921.1(MAP3K1): c.2822_2824=	MixedObserved;	18	0.444444	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs5868032	.	4024	0.434600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	56177848	56177851	5q11.2	1	normal	.	CAA	del	.	TT.ca	het-ref	221	0.46	.	2	(CAA)n|Simple_repeat|Simple_repeat|+|26;trf	PASS	600982	P	613762(MK)	NN	46,XY Sex Reversal 6	AD	.	Endocrine; Genitourinary; Oncologic	Genitourinary; Oncologic	21129722|12476449	.	4214	MAP3K1	C14	EX14	.	.	cds-del	NM_005921.1	NP_005912.1	+	Y	c.2824ACA[8>7] (std: c.2824ACA[7] alt: c.2845_2847delACA )	p.T942[8>7] (std: p.T942[7] alt: p.T949del ) | p.Thr942[8>7] (std: p.Thr942[7] alt: p.Thr949del )	.	.	NM_005921.1(MAP3K1): c.2824ACA[7] (p.T942[7])	MixedObserved;	18	0.555556	U	.	.	.	.	PASS	1185	8360	0.558493	31046	115872	0.739281	.	.	.	.	.	.	rs5868032	.	4024	0.564400	.	.	.	.	.	.	.	.	ENST00000399503: c.2822_2824delCAA (p.T949delT)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	VUO	4594439	.	.	.	.	.	no_record	435819	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
5	56178216	56178217	5q11.2	0	normal	.	A	ref	A	CT.GA	het-alt	320	0.50	.	1	.	PASS	600982	P	613762(MK)	NN	46,XY Sex Reversal 6	AD	.	Endocrine; Genitourinary; Oncologic	Genitourinary; Oncologic	21129722|12476449	.	4214	MAP3K1	C14	EX14	.	.	no-change	NM_005921.1	NP_005912.1	+	Y	c.3190A=	.	.	.	NM_005921.1(MAP3K1): c.3190A=	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	125622	0.236989	U	0.5704	0.708267	11978	0.200534	PASS	-1069	8600	0.428837	3793	120614	0.234716	.	.	.	.	.	.	rs832583	.	4024	0.425200	-0.121	3.377	1.503	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	56178216	56178217	5q11.2	1	normal	.	A	snv	C	CT.GA	het-ref	316	0.50	.	2	.	PASS	600982	P	613762(MK)	NN	46,XY Sex Reversal 6	AD	.	Endocrine; Genitourinary; Oncologic	Genitourinary; Oncologic	21129722|12476449	.	4214	MAP3K1	C14	EX14	.	.	coding-synon	NM_005921.1	NP_005912.1	+	Y	c.3190A>C	p.(R1064=) | p.(Arg1064=)	AGA=>CGA	.	NM_005921.1(MAP3K1): c.3190A>C (p.(R1064=))	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	125622	0.763003	U	0.5704	0.708267	11978	0.799466	PASS	1387	8600	0.571163	35789	120614	0.765276	2759	9792	5.68047e-01	71789	186340	7.58689e-01	rs832583	.	4024	0.574800	-0.121	3.377	1.503	.	.	.	.	.	ENST00000399503: c.3190A>C (p.R1064R)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4159918	.	.	.	.	.	no_record	518366	criteria_provided,_single_submitter	Benign	Likely Benign
5	67522721	67522722	5q13.1	0	nullSample	.	C	ref	C	TA.GT	homo-ref	.	.	.	0	.	.	171833	P	269880(MK);615214(UK);616005(MK)	AD	Agammaglobulinemia 7, autosomal recessive	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	22351933|7705412	.	5295	PIK3R1	C1	EX2	Variant SH3 domain	PF07653.12	no-change	NM_181523.2	NP_852664.1	+	Y	c.219C=	.	.	.	NM_181523.2(PIK3R1): c.219C=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	125828	0.682829	U	0.6746	0.419329	13006	0.706674	PASS	-882	8634	0.298819	29540	120820	0.687063	.	.	.	.	.	.	rs706713	.	4024	0.298200	-1.062	-1.908	-2.419	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	67522721	67522722	5q13.1	1	normal	.	C	snv	T	TA.GT	hom-alt	642	1.00	.	0	.	PASS	171833	P	269880(MK);615214(UK);616005(MK)	AD	Agammaglobulinemia 7, autosomal recessive	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	22351933|7705412	.	5295	PIK3R1	C1	EX2	Variant SH3 domain	PF07653.12	coding-synon	NM_181523.2	NP_852664.1	+	Y	c.219C>T	p.(Y73=) | p.(Tyr73=)	TAC=>TAT	.	NM_181523.2(PIK3R1): c.219C>T (p.(Y73=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	125828	0.317171	U	0.6746	0.419329	13006	0.293326	PASS	2145	8634	0.701181	6939	120820	0.312937	4255	12096	7.01787e-01	14130	77153	3.13528e-01	rs706713	.	4024	0.701800	-1.062	-1.908	-2.419	.	.	.	.	.	ENST00000521381: c.219C>T (p.Y73Y)	liver [NS|NS|NS]	carcinoma [hepatocellular_carcinoma|NS|NS]	CSV	4407349	.	.	.	.	.	no_record	159722	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
5	67522850	67522851	5q13.1	1	normal	.	A	snv	C	TA.GT	hom-alt	420	1.00	.	0	.	PASS	171833	P	269880(MK);615214(UK);616005(MK)	AD	Agammaglobulinemia 7, autosomal recessive	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	22351933|7705412	.	5295	PIK3R1	IC1	IVS2	.	.	intron	NM_181523.2	NP_852664.1	+	Y	c.334+14A>C	.	.	.	NM_181523.2(PIK3R1): c.334+14A>C	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	121068	0.335572	U	0.7034	0.42492	13002	0.293878	PASS	2273	8580	0.727506	7273	116060	0.331716	4135	11432	7.24461e-01	13204	71127	3.22817e-01	rs706714	.	4024	0.719200	0.533	0.075	0.475	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	159723	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
5	67522850	67522851	5q13.1	0	nullSample	.	A	ref	A	TA.GT	homo-ref	.	.	.	0	.	.	171833	P	269880(MK);615214(UK);616005(MK)	AD	Agammaglobulinemia 7, autosomal recessive	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	22351933|7705412	.	5295	PIK3R1	IC1	IVS2	.	.	no-change	NM_181523.2	NP_852664.1	+	Y	c.334+14A=	.	.	.	NM_181523.2(PIK3R1): c.334+14A=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	121068	0.664428	U	0.7034	0.42492	13002	0.706122	PASS	-848	8580	0.272494	26804	116060	0.668284	.	.	.	.	.	.	rs706714	.	4024	0.280800	0.533	0.075	0.475	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	67576330	67576331	5q13.1	0	normal	.	T	ref	T	TC.TT	het-alt	100	0.65	.	1	.	PASS	171833	P	269880(MK);615214(UK);616005(MK)	AD	Agammaglobulinemia 7, autosomal recessive	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	22351933|7705412	.	5295	PIK3R1	IC4	IVS5	.	.	no-change	NM_181523.2	NP_852664.1	+	Y	c.635-25T=	.	.	.	NM_181523.2(PIK3R1): c.635-25T=	MixedObserved;	2|579	0.500000|0.975820	U	.	.	12304	0.618986	.	.	.	.	.	.	.	.	.	.	.	.	.	rs75408171|rs758333098	.	4024	0.580300	-0.952	-3.230	-2.909	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	67576330	67576331	5q13.1	0	normal	.	T	del	.	TC.TT	het-ref	54	0.35	.	2	.	PASS	171833	P	269880(MK);615214(UK);616005(MK)	AD	Agammaglobulinemia 7, autosomal recessive	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	22351933|7705412	.	5295	PIK3R1	IC4	IVS5	.	.	intron	NM_181523.2	NP_852664.1	+	Y	c.635-25delT	.	.	.	NM_181523.2(PIK3R1): c.635-25delT	MixedObserved;	579	0.024180	U	.	.	12304	0.248456	InbreedingCoeff_Filter	0	7816	0.429376	2	108598	0.444225	.	.	.	.	.	.	rs758333098	.	4024	0.419700	-0.952	-3.230	-2.909	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	67588147	67588148	5q13.1	0	normal	.	G	ref	G	AT.TC	het-alt	196	0.53	.	1	.	PASS	171833	P	269880(MK);615214(UK);616005(MK)	AD	Agammaglobulinemia 7, autosomal recessive	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	22351933|7705412	.	5295	PIK3R1	C7	EX8	.	.	no-change	NM_181523.2	NP_852664.1	+	Y	c.978G=	.	.	.	NM_181523.2(PIK3R1): c.978G=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126396	0.823974	U	0.1657	0.220447	13006	0.761725	PASS	-613	8652	0.830097	41830	121388	0.825807	.	.	.	.	.	.	rs3730089	.	4024	0.810600	0.563	2.948	1.498	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	67588147	67588148	5q13.1	1	normal	.	G	snv	A	AT.TC	het-ref	174	0.47	.	2	.	PASS	171833	P	269880(MK);615214(UK);616005(MK)	AD	Agammaglobulinemia 7, autosomal recessive	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	22351933|7705412	.	5295	PIK3R1	C7	EX8	.	.	missense	NM_181523.2	NP_852664.1	+	Y	c.978G>A	p.M326I | p.Met326Ile	ATG=>ATA	NP=>NP	NM_181523.2(PIK3R1): c.978G>A (p.M326I)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126396	0.176026	U	0.1657	0.220447	13006	0.238275	PASS	122	8652	0.169903	2281	121388	0.174193	252	3000	1.74115e-01	4710	43538	1.77051e-01	rs3730089	.	4024	0.189400	0.563	2.948	1.498	0.47	0	0	0.011	neutral	ENST00000521381: c.978G>A (p.M326I)	skin [NS|NS|NS]	malignant_melanoma [NS|NS|NS]	CSV	3727824	CM080497	NM_181523.2(PIK3R1): c.978G>A (p.M326I)	"Colon cancer, incr. risk, association with"	18245521	DFP	no_record	135039	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
5	79950511	79950512	5q14.1	0	normal	.	A	snv	G	CC.GG	hom-alt	154	1.00	.	0	.	PASS	600887	P	600887(MK)	NN	Endometrial carcinoma	AD	.	Oncologic	Oncologic	21128252|8782829	C1021;FC59;FH44;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	4437	MSH3	5U1E	EX1	.	.	utr-5	NM_002439.4	NP_002430.3	+	Y	c.-35A>G	.	.	.	NM_002439.4(MSH3): c.-35A>G	MixedObserved;maf-5-some-pop	103400	0.675861	U	0.4008	0.704273	12628	0.760849	PASS	507	6932	0.421235	22308	98392	0.674415	784	4430	3.60104e-01	41823	126286	6.37782e-01	rs1105524	.	.	.	-0.349	-0.263	-0.257	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	79950511	79950512	5q14.1	0	nullSample	.	A	ref	A	CC.GG	homo-ref	.	.	.	0	.	.	600887	P	600887(MK)	NN	Endometrial carcinoma	AD	.	Oncologic	Oncologic	21128252|8782829	C1021;FC59;FH44;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	4437	MSH3	5U1E	EX1	.	.	no-change	NM_002439.4	NP_002430.3	+	Y	c.-35A=	.	.	.	NM_002439.4(MSH3): c.-35A=	MixedObserved;maf-5-some-pop|MixedObserved;	103400|85458	0.324139|0.999977	U	0.4008	0.704273	12628	0.239151	PASS	-953	6932	0.578765	5147	98392	0.325585	.	.	.	.	.	.	rs1105524|rs765543063	.	.	.	-0.349	-0.263	-0.257	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	79950723	79950724	5q14.1	0	nullSample	.	G	ref	G	cg.cc	homo-ref	.	.	.	0	trf	.	600887	P	600887(MK)	NN	Endometrial carcinoma	AD	.	Oncologic	Oncologic	21128252|8782829	C1021;FC59;FH44;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	4437	MSH3	C1	EX1	.	.	no-change	NM_002439.4	NP_002430.3	+	Y	c.178G=	.	.	.	NM_002439.4(MSH3): c.178G=	;maf-5-some-pop	43613	0.986197	U	0.001	0.0207668	.	.	PASS	-72	1928	0.902490	18031	40412	0.942962	.	.	.	.	.	.	rs2001675	.	4024	0.998000	0.000	-0.265	-0.480	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	79950724	79950724	5q14.1	1	normal	.	.	ins	CCGCAGCGC	gg.cc	hom-alt	312	0.99	.	0	trf	PASS	600887	P	600887(MK)	NN	Endometrial carcinoma	AD	.	Oncologic	Oncologic	21128252|8782829	C1021;FC59;FH44;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	4437	MSH3	C1	EX1	.	.	cds-ins	NM_002439.4	NP_002430.3	+	Y	c.181_189dupGCAGCGCCC	p.A61_P63dup (alt: p.P63_P64insAAP ) | p.Ala61_Pro63dup (alt: p.Pro63_Pro64insAlaAlaPro )	.	.	NM_002439.4(MSH3): c.181_189dupGCAGCGCCC (p.A61_P63dup)	ObservedTooLong;rs-cluster-nonoverlapping-alleles	39914	0.043243	U	.	.	.	.	PASS	19	1928	0.092842	95	40412	0.042710	30	362	5.12748e-02	261	4988	4.41502e-02	rs758718643	.	4024	0.263700	.	.	.	.	.	.	.	.	ENST00000265081: c.178_179insCCGCAGCGC (p.P63_P64insAAP)	adrenal_gland [adrenal_gland|NS|NS]	adrenal_cortical_adenoma [cortisol_producing|NS|NS]	CSV	5061231	.	.	.	.	.	no_record	518369	no_assertion_criteria_provided	Benign	Benign
5	80149980	80149981	5q14.1	1	normal	.	A	snv	G	AC.GA	hom-alt	623	1.00	.	0	.	PASS	600887	P	600887(MK)	NN	Endometrial carcinoma	AD	.	Oncologic	Oncologic	21128252|8782829	C1021;FC59;FH44;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	4437	MSH3	C21	EX21	MutS domain V	PF00488.16	missense	NM_002439.4	NP_002430.3	+	Y	c.2846A>G	p.Q949R | p.Gln949Arg	CAG=>CGG	P0=>P+	NM_002439.4(MSH3): c.2846A>G (p.Q949R)	;maf-5-some-pop,genotype-conflict	126232	0.874255	U	1	0.902157	13006	0.855221	PASS	4312	8636	0.999305	46317	121224	0.873103	8602	17215	9.99361e-01	93891	214386	8.73327e-01	rs184967	.	4024	0.997800	-0.119	0.470	-0.255	1	0.001	0	0.000	neutral	ENST00000265081: c.2846A>G (p.Q949R)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4160036	.	.	.	.	.	.	.	.	.	Likely Benign
5	80149980	80149981	5q14.1	0	nullSample	.	A	ref	A	AC.GA	homo-ref	.	.	.	0	.	.	600887	P	600887(MK)	NN	Endometrial carcinoma	AD	.	Oncologic	Oncologic	21128252|8782829	C1021;FC59;FH44;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	4437	MSH3	C21	EX21	MutS domain V	PF00488.16	no-change	NM_002439.4	NP_002430.3	+	Y	c.2846A=	.	.	.	NM_002439.4(MSH3): c.2846A=	;maf-5-some-pop,genotype-conflict	126232	0.125745	U	1	0.902157	13006	0.144779	PASS	-3	8636	0.000695	1088	121224	0.126897	.	.	.	.	.	.	rs184967	.	4024	0.002200	-0.119	0.470	-0.255	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	112111309	112111310	5q22.2	0	normal	.	A	ref	A	tt.aa	het-alt	185	0.77	.	1	AT_rich|Low_complexity|Low_complexity|+|22	PASS	611731	C	114500(MK);114550(MK);135290(MK);175100(MK);611731(MK);613659(MK)	AD	Familial adenomatous polyposis; Gardner syndrome; Desmoid disease, hereditary	AD	.	Dental; Dermatologic; Musculoskeletal; Oncologic; Ophthalmologic	Oncologic	22886683|22773231|22305464|20400027|20301519|20105204|19793053|18395100|17135589|14933371|14902760|14136536|13946545|13891268|13707264|12621137|11932472|10874062|10815155|10782927|10504375|10077730|9585611|9215849|8968744|8940264|8940262|8826936|8385741|8281160|8276387|8244107|8105087|8064829|8037405|7661930|7446647|7296952|7172944|7067564|6887943|6690356|6129922|6121129|5660317|5660235|5644968|5443116|4853059|4739325|3821797|3800608|3354603|3338026|3033343|2896968|2848134|2827474|2435780|2156161|1658283|1651563|1651174|1544113|1329510|1324223|1317264|1316858|1316610|1314729|1111674|880737|856075|758668|739523	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	324	APC	IC3	IVS5	.	.	no-change	NM_001127510.2	NP_001120982.1	+	Y	c.423-16A=	.	.	.	NM_001127510.2(APC): c.423-16A=	MixedObserved;|MixedObserved;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	40|22312	0.975000|0.986375	U	0.003	0.023762	.	.	PASS	.	1020	0.993137	8467	17304	0.989309	.	.	.	.	.	.	rs775769881|rs78919815	.	4024	0.599900	0.000	0.000	0.000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	112111309	112111310	5q22.2	1	normal	.	A	del	.	tt.aa	het-ref	56	0.23	.	2	AT_rich|Low_complexity|Low_complexity|+|22	PASS	611731	C	114500(MK);114550(MK);135290(MK);175100(MK);611731(MK);613659(MK)	AD	Familial adenomatous polyposis; Gardner syndrome; Desmoid disease, hereditary	AD	.	Dental; Dermatologic; Musculoskeletal; Oncologic; Ophthalmologic	Oncologic	22886683|22773231|22305464|20400027|20301519|20105204|19793053|18395100|17135589|14933371|14902760|14136536|13946545|13891268|13707264|12621137|11932472|10874062|10815155|10782927|10504375|10077730|9585611|9215849|8968744|8940264|8940262|8826936|8385741|8281160|8276387|8244107|8105087|8064829|8037405|7661930|7446647|7296952|7172944|7067564|6887943|6690356|6129922|6121129|5660317|5660235|5644968|5443116|4853059|4739325|3821797|3800608|3354603|3338026|3033343|2896968|2848134|2827474|2435780|2156161|1658283|1651563|1651174|1544113|1329510|1324223|1317264|1316858|1316610|1314729|1111674|880737|856075|758668|739523	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	324	APC	IC3	IVS5	.	.	intron	NM_001127510.2	NP_001120982.1	+	Y	c.423-16delA	.	.	.	NM_001127510.2(APC): c.423-16delA	MixedObserved;	40	0.025000	U	.	.	.	.	PASS	0	5066	0.227201	15	74382	0.260184	.	.	.	.	.	.	rs775769881	.	4024	0.400100	0.000	0.000	0.000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	181781	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
5	112162853	112162854	5q22.2	0	nullSample	.	T	ref	T	TA.GG	homo-ref	.	.	.	0	.	.	611731	C	114500(MK);114550(MK);135290(MK);175100(MK);611731(MK);613659(MK)	AD	Familial adenomatous polyposis; Gardner syndrome; Desmoid disease, hereditary	AD	.	Dental; Dermatologic; Musculoskeletal; Oncologic; Ophthalmologic	Oncologic	22886683|22773231|22305464|20400027|20301519|20105204|19793053|18395100|17135589|14933371|14902760|14136536|13946545|13891268|13707264|12621137|11932472|10874062|10815155|10782927|10504375|10077730|9585611|9215849|8968744|8940264|8940262|8826936|8385741|8281160|8276387|8244107|8105087|8064829|8037405|7661930|7446647|7296952|7172944|7067564|6887943|6690356|6129922|6121129|5660317|5660235|5644968|5443116|4853059|4739325|3821797|3800608|3354603|3338026|3033343|2896968|2848134|2827474|2435780|2156161|1658283|1651563|1651174|1544113|1329510|1324223|1317264|1316858|1316610|1314729|1111674|880737|856075|758668|739523	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	324	APC	C11	EX13	.	.	no-change	NM_001127510.2	NP_001120982.1	+	Y	c.1458T=	.	.	.	NM_001127510.2(APC): c.1458T=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	126126	0.424718	U	0.6647	0.509984	13004	0.537835	PASS	-944	8602	0.320856	11810	121118	0.422018	.	.	.	.	.	.	rs2229992	.	4024	0.359800	0.533	0.491	0.135	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	112162853	112162854	5q22.2	1	normal	.	T	snv	C	TA.GG	hom-alt	544	1.00	.	0	.	PASS	611731	C	114500(MK);114550(MK);135290(MK);175100(MK);611731(MK);613659(MK)	AD	Familial adenomatous polyposis; Gardner syndrome; Desmoid disease, hereditary	AD	.	Dental; Dermatologic; Musculoskeletal; Oncologic; Ophthalmologic	Oncologic	22886683|22773231|22305464|20400027|20301519|20105204|19793053|18395100|17135589|14933371|14902760|14136536|13946545|13891268|13707264|12621137|11932472|10874062|10815155|10782927|10504375|10077730|9585611|9215849|8968744|8940264|8940262|8826936|8385741|8281160|8276387|8244107|8105087|8064829|8037405|7661930|7446647|7296952|7172944|7067564|6887943|6690356|6129922|6121129|5660317|5660235|5644968|5443116|4853059|4739325|3821797|3800608|3354603|3338026|3033343|2896968|2848134|2827474|2435780|2156161|1658283|1651563|1651174|1544113|1329510|1324223|1317264|1316858|1316610|1314729|1111674|880737|856075|758668|739523	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	324	APC	C11	EX13	.	.	coding-synon	NM_001127510.2	NP_001120982.1	+	Y	c.1458T>C	p.(Y486=) | p.(Tyr486=)	TAT=>TAC	.	NM_001127510.2(APC): c.1458T>C (p.(Y486=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	126126	0.575282	U	0.6647	0.509984	13004	0.462165	PASS	1977	8602	0.679144	21255	121118	0.577982	3926	11602	6.73986e-01	43904	143908	5.85411e-01	rs2229992	.	4024	0.640200	0.533	0.491	0.135	.	.	.	.	.	ENST00000457016: c.1458T>C (p.Y486Y)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1432175	.	.	.	.	.	no_record	42238	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
5	112164560	112164561	5q22.2	0	nullSample	.	G	ref	G	GC.AG	homo-ref	.	.	.	0	.	.	611731	C	114500(MK);114550(MK);135290(MK);175100(MK);611731(MK);613659(MK)	AD	Familial adenomatous polyposis; Gardner syndrome; Desmoid disease, hereditary	AD	.	Dental; Dermatologic; Musculoskeletal; Oncologic; Ophthalmologic	Oncologic	22886683|22773231|22305464|20400027|20301519|20105204|19793053|18395100|17135589|14933371|14902760|14136536|13946545|13891268|13707264|12621137|11932472|10874062|10815155|10782927|10504375|10077730|9585611|9215849|8968744|8940264|8940262|8826936|8385741|8281160|8276387|8244107|8105087|8064829|8037405|7661930|7446647|7296952|7172944|7067564|6887943|6690356|6129922|6121129|5660317|5660235|5644968|5443116|4853059|4739325|3821797|3800608|3354603|3338026|3033343|2896968|2848134|2827474|2435780|2156161|1658283|1651563|1651174|1544113|1329510|1324223|1317264|1316858|1316610|1314729|1111674|880737|856075|758668|739523	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	324	APC	C13	EX15	.	.	no-change	NM_001127510.2	NP_001120982.1	+	Y	c.1635G=	.	.	.	NM_001127510.2(APC): c.1635G=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	126154	0.351174	U	0.8165	0.666134	13004	0.413565	PASS	.	8606	0.176970	7975	121146	0.351889	.	.	.	.	.	.	rs351771	.	4024	0.198600	-0.254	1.170	0.422	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	112164560	112164561	5q22.2	1	normal	.	G	snv	A	GC.AG	hom-alt	414	1.00	.	0	.	PASS	611731	C	114500(MK);114550(MK);135290(MK);175100(MK);611731(MK);613659(MK)	AD	Familial adenomatous polyposis; Gardner syndrome; Desmoid disease, hereditary	AD	.	Dental; Dermatologic; Musculoskeletal; Oncologic; Ophthalmologic	Oncologic	22886683|22773231|22305464|20400027|20301519|20105204|19793053|18395100|17135589|14933371|14902760|14136536|13946545|13891268|13707264|12621137|11932472|10874062|10815155|10782927|10504375|10077730|9585611|9215849|8968744|8940264|8940262|8826936|8385741|8281160|8276387|8244107|8105087|8064829|8037405|7661930|7446647|7296952|7172944|7067564|6887943|6690356|6129922|6121129|5660317|5660235|5644968|5443116|4853059|4739325|3821797|3800608|3354603|3338026|3033343|2896968|2848134|2827474|2435780|2156161|1658283|1651563|1651174|1544113|1329510|1324223|1317264|1316858|1316610|1314729|1111674|880737|856075|758668|739523	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	324	APC	C13	EX15	.	.	coding-synon	NM_001127510.2	NP_001120982.1	+	Y	c.1635G>A	p.(A545=) | p.(Ala545=)	GCG=>GCA	.	NM_001127510.2(APC): c.1635G>A (p.(A545=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	126154	0.648826	U	0.8165	0.666134	13004	0.586435	PASS	2910	8606	0.823030	25918	121146	0.648111	5806	14130	8.21798e-01	52792	159619	6.49301e-01	rs351771	.	4024	0.801400	-0.254	1.170	0.422	.	.	.	.	.	ENST00000457016: c.1635G>A (p.A545A)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3760868	.	.	.	.	.	no_record	42239	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
5	112175769	112175770	5q22.2	0	nullSample	.	G	ref	G	AC.GA	homo-ref	.	.	.	0	.	.	611731	C	114500(MK);114550(MK);135290(MK);175100(MK);611731(MK);613659(MK)	AD	Familial adenomatous polyposis; Gardner syndrome; Desmoid disease, hereditary	AD	.	Dental; Dermatologic; Musculoskeletal; Oncologic; Ophthalmologic	Oncologic	22886683|22773231|22305464|20400027|20301519|20105204|19793053|18395100|17135589|14933371|14902760|14136536|13946545|13891268|13707264|12621137|11932472|10874062|10815155|10782927|10504375|10077730|9585611|9215849|8968744|8940264|8940262|8826936|8385741|8281160|8276387|8244107|8105087|8064829|8037405|7661930|7446647|7296952|7172944|7067564|6887943|6690356|6129922|6121129|5660317|5660235|5644968|5443116|4853059|4739325|3821797|3800608|3354603|3338026|3033343|2896968|2848134|2827474|2435780|2156161|1658283|1651563|1651174|1544113|1329510|1324223|1317264|1316858|1316610|1314729|1111674|880737|856075|758668|739523	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	324	APC	C15E	EX17E	.	.	no-change	NM_001127510.2	NP_001120982.1	+	Y	c.4479G=	.	.	.	NM_001127510.2(APC): c.4479G=	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict	126062	0.350756	U	0.8165	0.665535	13002	0.413782	PASS	.	8648	0.177266	7948	121054	0.351430	.	.	.	.	.	.	rs41115	.	4024	0.198300	-1.128	0.417	0.212	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	112175769	112175770	5q22.2	1	normal	.	G	snv	A	AC.GA	hom-alt	708	1.00	.	0	.	PASS	611731	C	114500(MK);114550(MK);135290(MK);175100(MK);611731(MK);613659(MK)	AD	Familial adenomatous polyposis; Gardner syndrome; Desmoid disease, hereditary	AD	.	Dental; Dermatologic; Musculoskeletal; Oncologic; Ophthalmologic	Oncologic	22886683|22773231|22305464|20400027|20301519|20105204|19793053|18395100|17135589|14933371|14902760|14136536|13946545|13891268|13707264|12621137|11932472|10874062|10815155|10782927|10504375|10077730|9585611|9215849|8968744|8940264|8940262|8826936|8385741|8281160|8276387|8244107|8105087|8064829|8037405|7661930|7446647|7296952|7172944|7067564|6887943|6690356|6129922|6121129|5660317|5660235|5644968|5443116|4853059|4739325|3821797|3800608|3354603|3338026|3033343|2896968|2848134|2827474|2435780|2156161|1658283|1651563|1651174|1544113|1329510|1324223|1317264|1316858|1316610|1314729|1111674|880737|856075|758668|739523	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	324	APC	C15E	EX17E	.	.	coding-synon	NM_001127510.2	NP_001120982.1	+	Y	c.4479G>A	p.(T1493=) | p.(Thr1493=)	ACG=>ACA	.	NM_001127510.2(APC): c.4479G>A (p.(T1493=))	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict	126062	0.649244	U	0.8165	0.665535	13002	0.586218	PASS	2924	8648	0.822734	25933	121054	0.648570	5824	14170	8.21735e-01	52779	159537	6.49581e-01	rs41115	.	4024	0.801700	-1.128	0.417	0.212	.	.	.	.	.	ENST00000457016: c.4479G>A (p.T1493T)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	3760869	.	.	.	.	.	no_record	42242	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
5	112176324	112176325	5q22.2	0	nullSample	.	G	ref	G	GG.GC	homo-ref	.	.	.	0	.	.	611731	C	114500(MK);114550(MK);135290(MK);175100(MK);611731(MK);613659(MK)	AD	Familial adenomatous polyposis; Gardner syndrome; Desmoid disease, hereditary	AD	.	Dental; Dermatologic; Musculoskeletal; Oncologic; Ophthalmologic	Oncologic	22886683|22773231|22305464|20400027|20301519|20105204|19793053|18395100|17135589|14933371|14902760|14136536|13946545|13891268|13707264|12621137|11932472|10874062|10815155|10782927|10504375|10077730|9585611|9215849|8968744|8940264|8940262|8826936|8385741|8281160|8276387|8244107|8105087|8064829|8037405|7661930|7446647|7296952|7172944|7067564|6887943|6690356|6129922|6121129|5660317|5660235|5644968|5443116|4853059|4739325|3821797|3800608|3354603|3338026|3033343|2896968|2848134|2827474|2435780|2156161|1658283|1651563|1651174|1544113|1329510|1324223|1317264|1316858|1316610|1314729|1111674|880737|856075|758668|739523	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	324	APC	C15E	EX17E	.	.	no-change	NM_001127510.2	NP_001120982.1	+	Y	c.5034G=	.	.	.	NM_001127510.2(APC): c.5034G=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125824	0.347994	U	0.8165	0.666733	13004	0.409874	PASS	-630	8594	0.176402	7760	120816	0.348604	.	.	.	.	.	.	rs42427	.	4024	0.198100	-0.127	0.011	-0.040	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	112176324	112176325	5q22.2	1	normal	.	G	snv	A	GG.GC	hom-alt	640	1.00	.	0	.	PASS	611731	C	114500(MK);114550(MK);135290(MK);175100(MK);611731(MK);613659(MK)	AD	Familial adenomatous polyposis; Gardner syndrome; Desmoid disease, hereditary	AD	.	Dental; Dermatologic; Musculoskeletal; Oncologic; Ophthalmologic	Oncologic	22886683|22773231|22305464|20400027|20301519|20105204|19793053|18395100|17135589|14933371|14902760|14136536|13946545|13891268|13707264|12621137|11932472|10874062|10815155|10782927|10504375|10077730|9585611|9215849|8968744|8940264|8940262|8826936|8385741|8281160|8276387|8244107|8105087|8064829|8037405|7661930|7446647|7296952|7172944|7067564|6887943|6690356|6129922|6121129|5660317|5660235|5644968|5443116|4853059|4739325|3821797|3800608|3354603|3338026|3033343|2896968|2848134|2827474|2435780|2156161|1658283|1651563|1651174|1544113|1329510|1324223|1317264|1316858|1316610|1314729|1111674|880737|856075|758668|739523	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	324	APC	C15E	EX17E	.	.	coding-synon	NM_001127510.2	NP_001120982.1	+	Y	c.5034G>A	p.(G1678=) | p.(Gly1678=)	GGG=>GGA	.	NM_001127510.2(APC): c.5034G>A (p.(G1678=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125824	0.652006	U	0.8165	0.666733	13004	0.590126	PASS	2909	8594	0.823598	26051	120816	0.651396	5806	14128	8.21873e-01	53006	159652	6.52440e-01	rs42427	.	4024	0.801900	-0.127	0.011	-0.040	.	.	.	.	.	ENST00000457016: c.5034G>A (p.G1678G)	large_intestine [colon|descending|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3760870	.	.	.	.	.	no_record	42243	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
5	112176558	112176559	5q22.2	0	nullSample	.	T	ref	T	TC.TC	homo-ref	.	.	.	0	.	.	611731	C	114500(MK);114550(MK);135290(MK);175100(MK);611731(MK);613659(MK)	AD	Familial adenomatous polyposis; Gardner syndrome; Desmoid disease, hereditary	AD	.	Dental; Dermatologic; Musculoskeletal; Oncologic; Ophthalmologic	Oncologic	22886683|22773231|22305464|20400027|20301519|20105204|19793053|18395100|17135589|14933371|14902760|14136536|13946545|13891268|13707264|12621137|11932472|10874062|10815155|10782927|10504375|10077730|9585611|9215849|8968744|8940264|8940262|8826936|8385741|8281160|8276387|8244107|8105087|8064829|8037405|7661930|7446647|7296952|7172944|7067564|6887943|6690356|6129922|6121129|5660317|5660235|5644968|5443116|4853059|4739325|3821797|3800608|3354603|3338026|3033343|2896968|2848134|2827474|2435780|2156161|1658283|1651563|1651174|1544113|1329510|1324223|1317264|1316858|1316610|1314729|1111674|880737|856075|758668|739523	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	324	APC	C15E	EX17E	.	.	no-change	NM_001127510.2	NP_001120982.1	+	Y	c.5268T=	.	.	.	NM_001127510.2(APC): c.5268T=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	125798	0.348543	U	0.8165	0.666933	13002	0.412014	PASS	-633	8634	0.177206	7822	120790	0.349185	.	.	.	.	.	.	rs866006	.	4024	0.197600	-2.343	-0.899	-1.028	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	112176558	112176559	5q22.2	1	normal	.	T	snv	G	TC.TC	hom-alt	616	1.00	.	0	.	PASS	611731	C	114500(MK);114550(MK);135290(MK);175100(MK);611731(MK);613659(MK)	AD	Familial adenomatous polyposis; Gardner syndrome; Desmoid disease, hereditary	AD	.	Dental; Dermatologic; Musculoskeletal; Oncologic; Ophthalmologic	Oncologic	22886683|22773231|22305464|20400027|20301519|20105204|19793053|18395100|17135589|14933371|14902760|14136536|13946545|13891268|13707264|12621137|11932472|10874062|10815155|10782927|10504375|10077730|9585611|9215849|8968744|8940264|8940262|8826936|8385741|8281160|8276387|8244107|8105087|8064829|8037405|7661930|7446647|7296952|7172944|7067564|6887943|6690356|6129922|6121129|5660317|5660235|5644968|5443116|4853059|4739325|3821797|3800608|3354603|3338026|3033343|2896968|2848134|2827474|2435780|2156161|1658283|1651563|1651174|1544113|1329510|1324223|1317264|1316858|1316610|1314729|1111674|880737|856075|758668|739523	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	324	APC	C15E	EX17E	.	.	coding-synon	NM_001127510.2	NP_001120982.1	+	Y	c.5268T>G	p.(S1756=) | p.(Ser1756=)	TCT=>TCG	.	NM_001127510.2(APC): c.5268T>G (p.(S1756=))	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	125798	0.651409	U	0.8165	0.666933	13002	0.587986	PASS	2915	8634	0.822330	26034	120790	0.650766	5813	14155	8.21342e-01	52989	159750	6.51318e-01	rs866006	.	4024	0.802400	-2.343	-0.899	-1.028	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	42245	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
5	112176755	112176756	5q22.2	1	normal	.	T	snv	A	GG.CT	hom-alt	730	1.00	.	0	.	PASS	611731	C	114500(MK);114550(MK);135290(MK);175100(MK);611731(MK);613659(MK)	AD	Familial adenomatous polyposis; Gardner syndrome; Desmoid disease, hereditary	AD	.	Dental; Dermatologic; Musculoskeletal; Oncologic; Ophthalmologic	Oncologic	22886683|22773231|22305464|20400027|20301519|20105204|19793053|18395100|17135589|14933371|14902760|14136536|13946545|13891268|13707264|12621137|11932472|10874062|10815155|10782927|10504375|10077730|9585611|9215849|8968744|8940264|8940262|8826936|8385741|8281160|8276387|8244107|8105087|8064829|8037405|7661930|7446647|7296952|7172944|7067564|6887943|6690356|6129922|6121129|5660317|5660235|5644968|5443116|4853059|4739325|3821797|3800608|3354603|3338026|3033343|2896968|2848134|2827474|2435780|2156161|1658283|1651563|1651174|1544113|1329510|1324223|1317264|1316858|1316610|1314729|1111674|880737|856075|758668|739523	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	324	APC	C15E	EX17E	.	.	missense	NM_001127510.2	NP_001120982.1	+	Y	c.5465T>A	p.V1822D | p.Val1822Asp	GTC=>GAC	NP=>P-	NM_001127510.2(APC): c.5465T>A (p.V1822D)	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict	125952	0.800781	U	0.9008	0.865415	13002	0.826257	PASS	3507	8638	0.901829	38872	120944	0.798105	7017	15562	9.02982e-01	77927	194769	7.93764e-01	rs459552	.	4024	0.902600	-0.265	1.161	0.139	0.37	0	0	0.019	neutral	ENST00000457016: c.5465T>A (p.V1822D)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3760871	.	.	.	.	.	no_record	21030	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
5	112176755	112176756	5q22.2	0	nullSample	.	T	ref	T	GG.CT	homo-ref	.	.	.	0	.	.	611731	C	114500(MK);114550(MK);135290(MK);175100(MK);611731(MK);613659(MK)	AD	Familial adenomatous polyposis; Gardner syndrome; Desmoid disease, hereditary	AD	.	Dental; Dermatologic; Musculoskeletal; Oncologic; Ophthalmologic	Oncologic	22886683|22773231|22305464|20400027|20301519|20105204|19793053|18395100|17135589|14933371|14902760|14136536|13946545|13891268|13707264|12621137|11932472|10874062|10815155|10782927|10504375|10077730|9585611|9215849|8968744|8940264|8940262|8826936|8385741|8281160|8276387|8244107|8105087|8064829|8037405|7661930|7446647|7296952|7172944|7067564|6887943|6690356|6129922|6121129|5660317|5660235|5644968|5443116|4853059|4739325|3821797|3800608|3354603|3338026|3033343|2896968|2848134|2827474|2435780|2156161|1658283|1651563|1651174|1544113|1329510|1324223|1317264|1316858|1316610|1314729|1111674|880737|856075|758668|739523	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	324	APC	C15E	EX17E	.	.	no-change	NM_001127510.2	NP_001120982.1	+	Y	c.5465T=	.	.	.	NM_001127510.2(APC): c.5465T=	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict	125952	0.199219	U	0.9008	0.865415	13002	0.173743	PASS	-388	8638	0.098171	2818	120944	0.201895	.	.	.	.	.	.	rs459552	.	4024	0.097400	-0.265	1.161	0.139	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	112177170	112177171	5q22.2	0	nullSample	.	G	ref	G	CC.GT	homo-ref	.	.	.	0	.	.	611731	C	114500(MK);114550(MK);135290(MK);175100(MK);611731(MK);613659(MK)	AD	Familial adenomatous polyposis; Gardner syndrome; Desmoid disease, hereditary	AD	.	Dental; Dermatologic; Musculoskeletal; Oncologic; Ophthalmologic	Oncologic	22886683|22773231|22305464|20400027|20301519|20105204|19793053|18395100|17135589|14933371|14902760|14136536|13946545|13891268|13707264|12621137|11932472|10874062|10815155|10782927|10504375|10077730|9585611|9215849|8968744|8940264|8940262|8826936|8385741|8281160|8276387|8244107|8105087|8064829|8037405|7661930|7446647|7296952|7172944|7067564|6887943|6690356|6129922|6121129|5660317|5660235|5644968|5443116|4853059|4739325|3821797|3800608|3354603|3338026|3033343|2896968|2848134|2827474|2435780|2156161|1658283|1651563|1651174|1544113|1329510|1324223|1317264|1316858|1316610|1314729|1111674|880737|856075|758668|739523	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	324	APC	C15E	EX17E	.	.	no-change	NM_001127510.2	NP_001120982.1	+	Y	c.5880G=	.	.	.	NM_001127510.2(APC): c.5880G=	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict	126022	0.350486	U	0.8165	0.666534	13002	0.413090	PASS	-633	8628	0.177561	7915	121014	0.351191	.	.	.	.	.	.	rs465899	.	4024	0.197600	-0.269	-0.566	-0.820	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	112177170	112177171	5q22.2	1	normal	.	G	snv	A	CC.GT	hom-alt	844	1.00	.	0	.	PASS	611731	C	114500(MK);114550(MK);135290(MK);175100(MK);611731(MK);613659(MK)	AD	Familial adenomatous polyposis; Gardner syndrome; Desmoid disease, hereditary	AD	.	Dental; Dermatologic; Musculoskeletal; Oncologic; Ophthalmologic	Oncologic	22886683|22773231|22305464|20400027|20301519|20105204|19793053|18395100|17135589|14933371|14902760|14136536|13946545|13891268|13707264|12621137|11932472|10874062|10815155|10782927|10504375|10077730|9585611|9215849|8968744|8940264|8940262|8826936|8385741|8281160|8276387|8244107|8105087|8064829|8037405|7661930|7446647|7296952|7172944|7067564|6887943|6690356|6129922|6121129|5660317|5660235|5644968|5443116|4853059|4739325|3821797|3800608|3354603|3338026|3033343|2896968|2848134|2827474|2435780|2156161|1658283|1651563|1651174|1544113|1329510|1324223|1317264|1316858|1316610|1314729|1111674|880737|856075|758668|739523	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	324	APC	C15E	EX17E	.	.	coding-synon	NM_001127510.2	NP_001120982.1	+	Y	c.5880G>A	p.(P1960=) | p.(Pro1960=)	CCG=>CCA	.	NM_001127510.2(APC): c.5880G>A (p.(P1960=))	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict	126022	0.649514	U	0.8165	0.666534	13002	0.586910	PASS	2915	8628	0.822439	25923	121014	0.648809	5814	14150	8.21814e-01	52777	159530	6.49732e-01	rs465899	.	4024	0.802400	-0.269	-0.566	-0.820	.	.	.	.	.	ENST00000457016: c.5880G>A (p.P1960P)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	3760872	.	.	.	.	.	no_record	42247	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
5	112213678	112213692	5q22.2	0	nullSample	.	TGTGTGTGTGTGTG	ref	TGTGTGTGTGTGTG	TC.tg	homo-ref	.	.	.	0	(TG)n|Simple_repeat|Simple_repeat|+|41;trf	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr5: g.112213678_112213691= (intergenic)	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.578500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	112213678	112213692	5q22.2	0	normal	.	TGTGTGTGTGTGTG	del	.	TC.tg	het-alt	90	0.27	.	1	(TG)n|Simple_repeat|Simple_repeat|+|41;trf	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr5: g.112213679_112213692delTGTGTGTGTGTGTG (intergenic)	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.211000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	112213678	112213692	5q22.2	0	normal	.	TGTGTGTGTGTGTG	rep	TG	TC.tg	het-alt	240	0.71	.	2	(TG)n|Simple_repeat|Simple_repeat|+|41;trf	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr5: g.112213679TG[1] (intergenic)	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.209000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	112213747	112213751	5q22.2	0	nullSample	.	TAAC	ref	TAAC	AG.TA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr5: g.112213747_112213750= (intergenic)	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs72124463	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
5	112213747	112213751	5q22.2	0	normal	.	TAAC	del	.	AG.TA	hom-alt	413	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr5: g.112213748_112213751delTAAC (intergenic)	MixedObserved;	0	0	U	0.8194	0.625998	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs72124463	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	112213804	112213805	5q22.2	0	nullSample	.	C	ref	C	TA.GG	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr5: g.112213804C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.312101	U	0.8214	0.687899	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2545166	.	.	.	-0.120	0.496	0.482	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	112213804	112213805	5q22.2	0	normal	.	C	snv	G	TA.GG	hom-alt	394	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr5: g.112213804C>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.687899	U	0.8214	0.687899	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2545166	.	.	.	-0.120	0.496	0.482	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	131892978	131892979	5q31.1	0	nullSample	.	G	ref	G	GG.CT	homo-ref	.	.	.	0	.	.	604040	P	613078(MK)	NN	Nijmegen breakage syndrome-like disorder	AR	.	Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Ophthalmologic	General	19409520|1887849	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	10111	RAD50	5U1E	EX1	.	.	utr-5	NM_005732.3	NP_005723.2	+	Y	c.-38A>G	.	.	.	NM_005732.3(RAD50): c.-38A>G	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126398	0.026765	U	0.999	0.92492	13006	0.081270	PASS	0	8652	0.000000	300	121390	0.024771	.	.	.	.	.	.	rs4526098	.	.	.	0.655	1.434	1.220	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	131892978	131892979	5q31.1	0	normal	.	G	snv	A	GG.CT	hom-alt	256	1.00	.	0	.	PASS	604040	P	613078(MK)	NN	Nijmegen breakage syndrome-like disorder	AR	.	Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Ophthalmologic	General	19409520|1887849	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	10111	RAD50	5U1E	EX1	.	.	no-change	NM_005732.3	NP_005723.2	+	Y	c.-38A=	.	.	.	NM_005732.3(RAD50): c.-38A=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126398	0.973235	U	0.999	0.92492	13006	0.918730	PASS	4326	8652	1.000000	57988	121390	0.975229	8623	17247	9.99942e-01	118616	241246	9.79711e-01	rs4526098	.	.	.	0.655	1.434	1.220	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	131927515	131927516	5q31.1	0	normal	.	T	ref	T	GA.AT	het-alt	118	0.50	.	1	.	PASS	604040	P	613078(MK)	NN	Nijmegen breakage syndrome-like disorder	AR	.	Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Ophthalmologic	General	19409520|1887849	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	10111	RAD50	IC10	IVS10	.	.	no-change	NM_005732.3	NP_005723.2	+	Y	c.1636-53T=	.	.	.	NM_005732.3(RAD50): c.1636-53T=	;	5008	0.999201	U	0.004	0.000798722	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs561752193	.	4024	0.991800	0.533	0.279	0.961	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	131927515	131927516	5q31.1	0	normal	.	T	snv	C	GA.AT	het-ref	119	0.50	.	2	.	PASS	604040	P	613078(MK)	NN	Nijmegen breakage syndrome-like disorder	AR	.	Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Ophthalmologic	General	19409520|1887849	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	10111	RAD50	IC10	IVS10	.	.	intron	NM_005732.3	NP_005723.2	+	Y	c.1636-53T>C	.	.	.	NM_005732.3(RAD50): c.1636-53T>C	;	5008	0.000799	U	0.004	0.000798722	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs561752193	.	4024	0.008200	0.533	0.279	0.961	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
5	131972953	131972954	5q31.1	0	normal	.	A	ref	A	TT.TG	het-alt	85	0.45	.	1	.	PASS	604040	P	613078(MK)	NN	Nijmegen breakage syndrome-like disorder	AR	.	Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Ophthalmologic	General	19409520|1887849	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	10111	RAD50	IC22	IVS22	.	.	no-change	NM_005732.3	NP_005723.2	+	Y	c.3475+62A=	.	.	.	NM_005732.3(RAD50): c.3475+62A=	;maf-5-some-pop	5008	0.961062	U	0.1815	0.0389377	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17166112	.	4024	0.850900	0.443	0.370	0.141	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	131972953	131972954	5q31.1	0	normal	.	A	snv	G	TT.TG	het-ref	103	0.55	.	2	.	PASS	604040	P	613078(MK)	NN	Nijmegen breakage syndrome-like disorder	AR	.	Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Ophthalmologic	General	19409520|1887849	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	10111	RAD50	IC22	IVS22	.	.	intron	NM_005732.3	NP_005723.2	+	Y	c.3475+62A>G	.	.	.	NM_005732.3(RAD50): c.3475+62A>G	;maf-5-some-pop	5008	0.038938	U	0.1815	0.0389377	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17166112	.	4024	0.149100	0.443	0.370	0.141	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	138160146	138160147	5q31.2	0	normal	.	A	ref	A	TT.CC	het-alt	166	0.47	.	1	.	PASS	116805	C	.	NN	Hereditary diffuse gastric cancer, familial	AD	.	Oncologic	Oncologic	23208944	.	1495	CTNNA1	IC4	IVS5	.	.	no-change	NM_001903.2	NP_001894.2	+	Y	c.589-72A=	.	.	.	NM_001903.2(CTNNA1): c.589-72A=	;	5008	0.993810	U	0.0308	0.0061901	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs28363405	.	4024	0.943300	0.482	1.958	0.797	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	138160146	138160147	5q31.2	0	normal	.	A	snv	G	TT.CC	het-ref	186	0.53	.	2	.	PASS	116805	C	.	NN	Hereditary diffuse gastric cancer, familial	AD	.	Oncologic	Oncologic	23208944	.	1495	CTNNA1	IC4	IVS5	.	.	intron	NM_001903.2	NP_001894.2	+	Y	c.589-72A>G	.	.	.	NM_001903.2(CTNNA1): c.589-72A>G	;	5008	0.006190	U	0.0308	0.0061901	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs28363405	.	4024	0.056700	0.482	1.958	0.797	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	223733	no_assertion_criteria_provided	Likely_benign	Benign
5	149433595	149433596	5q32	0	normal	.	T	ref	T	TG.GG	het-alt	136	0.48	.	1	.	PASS	164770	C	221820(MK)	AD	Leukoencephalopathy, diffuse hereditary, with spheroids	AD	.	Neurologic	General	23698128|22843259|22197934|19153373|16523341	.	1436	CSF1R	3U1E	EX22E	.	.	no-change	NM_005211.3	NP_005202.2	-	Y	c.*36A=	.	.	.	NM_005211.3(CSF1R): c.*36A=	MixedObserved;maf-5-some-pop	118980	0.223735	U	0.7153	0.796725	13006	0.519222	PASS	.	8118	0.273343	2814	113972	0.224634	.	.	.	.	.	.	rs2066934	.	.	.	-4.641	-0.408	-0.372	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	149433595	149433596	5q32	0	normal	.	T	snv	G	TG.GG	het-ref	150	0.52	.	2	.	PASS	164770	C	221820(MK)	AD	Leukoencephalopathy, diffuse hereditary, with spheroids	AD	.	Neurologic	General	23698128|22843259|22197934|19153373|16523341	.	1436	CSF1R	3U1E	EX22E	.	.	utr-3	NM_005211.3	NP_005202.2	-	Y	c.*36A>C	.	.	.	NM_005211.3(CSF1R): c.*36A>C	MixedObserved;maf-5-some-pop	118980	0.776265	U	0.7153	0.796725	13006	0.480778	PASS	2103	8118	0.726657	34198	113972	0.775366	4530	12350	7.34769e-01	71208	183882	7.70025e-01	rs2066934	.	.	.	-4.641	-0.408	-0.372	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	352120	criteria_provided,_single_submitter	Benign	Benign
5	149433596	149433597	5q32	0	normal	.	G	snv	A	GT.GG	het-ref	152	0.52	.	2	.	PASS	164770	C	221820(MK)	AD	Leukoencephalopathy, diffuse hereditary, with spheroids	AD	.	Neurologic	General	23698128|22843259|22197934|19153373|16523341	.	1436	CSF1R	3U1E	EX22E	.	.	utr-3	NM_005211.3	NP_005202.2	-	Y	c.*35C>T	.	.	.	NM_005211.3(CSF1R): c.*35C>T	;maf-5-some-pop	119476	0.775386	U	0.7113	0.795927	13006	0.495925	PASS	2073	8152	0.719823	34289	114468	0.774487	4448	12252	7.27553e-01	71276	184153	7.69375e-01	rs2066933	.	.	.	-1.204	0.180	-0.054	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	352121	criteria_provided,_single_submitter	Benign	Benign
5	149433596	149433597	5q32	0	normal	.	G	ref	G	GT.GG	het-alt	140	0.48	.	1	.	PASS	164770	C	221820(MK)	AD	Leukoencephalopathy, diffuse hereditary, with spheroids	AD	.	Neurologic	General	23698128|22843259|22197934|19153373|16523341	.	1436	CSF1R	3U1E	EX22E	.	.	no-change	NM_005211.3	NP_005202.2	-	Y	c.*35C=	.	.	.	NM_005211.3(CSF1R): c.*35C=	;maf-5-some-pop	119476	0.224614	U	0.7113	0.795927	13006	0.504075	PASS	-861	8152	0.280177	2869	114468	0.225513	.	.	.	.	.	.	rs2066933	.	.	.	-1.204	0.180	-0.054	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	149435758	149435759	5q32	0	normal	.	G	ref	G	TG.CC	het-alt	318	0.56	.	1	.	PASS	164770	C	221820(MK)	AD	Leukoencephalopathy, diffuse hereditary, with spheroids	AD	.	Neurologic	General	23698128|22843259|22197934|19153373|16523341	.	1436	CSF1R	IC17	IVS18	.	.	no-change	NM_005211.3	NP_005202.2	-	Y	c.2442+23C=	.	.	.	NM_005211.3(CSF1R): c.2442+23C=	;maf-5-some-pop,maf-5-all-pops	126382	0.474617	U	0.4593	0.394169	13006	0.540674	PASS	-1086	8630	0.547625	14604	121374	0.469203	.	.	.	.	.	.	rs216136	.	4024	0.559900	0.407	-0.229	-0.575	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	149435758	149435759	5q32	0	normal	.	G	snv	A	TG.CC	het-ref	254	0.44	.	2	.	PASS	164770	C	221820(MK)	AD	Leukoencephalopathy, diffuse hereditary, with spheroids	AD	.	Neurologic	General	23698128|22843259|22197934|19153373|16523341	.	1436	CSF1R	IC17	IVS18	.	.	intron	NM_005211.3	NP_005202.2	-	Y	c.2442+23C>T	.	.	.	NM_005211.3(CSF1R): c.2442+23C>T	;maf-5-some-pop,maf-5-all-pops	126382	0.525383	U	0.4593	0.394169	13006	0.459326	PASS	866	8630	0.452375	18342	121374	0.530797	1863	8025	4.65271e-01	36715	130574	5.30491e-01	rs216136	.	4024	0.440100	0.407	-0.229	-0.575	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	149437189	149437190	5q32	0	normal	.	C	ref	C	CA.TC	het-alt	115	0.57	.	1	.	PASS	164770	C	221820(MK)	AD	Leukoencephalopathy, diffuse hereditary, with spheroids	AD	.	Neurologic	General	23698128|22843259|22197934|19153373|16523341	.	1436	CSF1R	IC14	IVS15	.	.	no-change	NM_005211.3	NP_005202.2	-	Y	c.2133-35G=	.	.	.	NM_005211.3(CSF1R): c.2133-35G=	MixedObserved;maf-5-some-pop	124440	0.228648	U	0.7083	0.791933	13006	0.178841	PASS	.	8460	0.279078	3369	119432	0.229511	.	.	.	.	.	.	rs216138	.	4024	0.286000	-0.216	0.507	0.890	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	149437189	149437190	5q32	0	normal	.	C	snv	G	CA.TC	het-ref	86	0.43	.	2	.	PASS	164770	C	221820(MK)	AD	Leukoencephalopathy, diffuse hereditary, with spheroids	AD	.	Neurologic	General	23698128|22843259|22197934|19153373|16523341	.	1436	CSF1R	IC14	IVS15	.	.	intron	NM_005211.3	NP_005202.2	-	Y	c.2133-35G>C	.	.	.	NM_005211.3(CSF1R): c.2133-35G>C	MixedObserved;maf-5-some-pop	124440	0.771352	U	0.7083	0.791933	13006	0.821159	PASS	2188	8460	0.720922	35674	119432	0.770489	4546	12469	7.27904e-01	71983	186453	7.66061e-01	rs216138	.	4024	0.714000	-0.216	0.507	0.890	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	149441022	149441023	5q32	0	normal	.	A	ref	A	CC.TC	het-alt	35	0.76	.	1	.	PASS	164770	C	221820(MK)	AD	Leukoencephalopathy, diffuse hereditary, with spheroids	AD	.	Neurologic	General	23698128|22843259|22197934|19153373|16523341	.	1436	CSF1R	IC12	IVS13	.	.	no-change	NM_005211.3	NP_005202.2	-	Y	c.1858+31T=	.	.	.	NM_005211.3(CSF1R): c.1858+31T=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.443	0.325	0.145	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
5	149441022	149441023	5q32	0	normal	.	A	del	.	CC.TC	het-ref	11	0.24	.	2	.	PASS	164770	C	221820(MK)	AD	Leukoencephalopathy, diffuse hereditary, with spheroids	AD	.	Neurologic	General	23698128|22843259|22197934|19153373|16523341	.	1436	CSF1R	IC12	IVS13	.	.	intron	NM_005211.3	NP_005202.2	-	Y	c.1858+31delT	.	.	.	NM_005211.3(CSF1R): c.1858+31delT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	8	5.59675e-04	0	98	5.48921e-04	.	.	.	.	0.443	0.325	0.145	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
5	149450131	149450132	5q32	0	normal	.	T	ref	T	TG.GC	het-alt	145	0.56	.	1	.	PASS	164770	C	221820(MK)	AD	Leukoencephalopathy, diffuse hereditary, with spheroids	AD	.	Neurologic	General	23698128|22843259|22197934|19153373|16523341	.	1436	CSF1R	C7	EX8	.	.	no-change	NM_005211.3	NP_005202.2	-	Y	c.1085A=	.	.	.	NM_005211.3(CSF1R): c.1085A=	;maf-5-some-pop	19928	0.872190	U	0.381	0.153355	12606	0.926226	PASS	-87	686	0.635569	5787	14920	0.880764	.	.	.	.	.	.	rs10079250	.	4024	0.640900	0.459	0.969	2.123	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	149450131	149450132	5q32	1	normal	.	T	snv	C	TG.GC	het-ref	112	0.44	.	2	.	PASS	164770	C	221820(MK)	AD	Leukoencephalopathy, diffuse hereditary, with spheroids	AD	.	Neurologic	General	23698128|22843259|22197934|19153373|16523341	.	1436	CSF1R	C7	EX8	.	.	missense	NM_005211.3	NP_005202.2	-	Y	c.1085A>G	p.H362R | p.His362Arg	CAC=>CGC	P+=>P+	NM_005211.3(CSF1R): c.1085A>G (p.H362R)	;maf-5-some-pop	19928	0.127810	U	0.381	0.153355	12606	0.073774	PASS	38	686	0.364431	106	14920	0.119236	681	3460	3.89903e-01	1051	11670	9.75198e-02	rs10079250	.	4024	0.359100	0.459	0.969	2.123	0.05	0.09	0.074	0.352	neutral	ENST00000286301: c.1085A>G (p.H362R)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5020476	.	.	.	.	.	no_record	352157	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
5	149452792	149452793	5q32	0	normal	.	C	ref	C	AG.GT	het-alt	118	0.51	.	1	.	PASS	164770	C	221820(MK)	AD	Leukoencephalopathy, diffuse hereditary, with spheroids	AD	.	Neurologic	General	23698128|22843259|22197934|19153373|16523341	.	1436	CSF1R	IC6	IVS7	.	.	no-change	NM_005211.3	NP_005202.2	-	Y	c.1082+71G=	.	.	.	NM_005211.3(CSF1R): c.1082+71G=	;maf-5-some-pop,maf-5-all-pops	5008	0.699281	U	0.5139	0.300719	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10044553	.	4020	0.506500	-0.254	-0.509	-0.575	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	149452792	149452793	5q32	0	normal	.	C	snv	T	AG.GT	het-ref	114	0.49	.	2	.	PASS	164770	C	221820(MK)	AD	Leukoencephalopathy, diffuse hereditary, with spheroids	AD	.	Neurologic	General	23698128|22843259|22197934|19153373|16523341	.	1436	CSF1R	IC6	IVS7	.	.	intron	NM_005211.3	NP_005202.2	-	Y	c.1082+71G>A	.	.	.	NM_005211.3(CSF1R): c.1082+71G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.300719	U	0.5139	0.300719	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10044553	.	4020	0.493500	-0.254	-0.509	-0.575	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	149495536	149495537	5q32	0	normal	.	G	ref	G	GG.CT	het-alt	180	0.53	.	1	.	PASS	173410	C	131440(MC);228550(MK);615007(MK)	AD	Basal ganglia calcification, idiopathic, 4 	AD	.	Neurologic	General	23255827	.	5159	PDGFRB	IC21	IVS22	.	.	no-change	NM_002609.3	NP_002600.1	-	Y	c.3138-28C=	.	.	.	NM_002609.3(PDGFRB): c.3138-28C=	;maf-5-some-pop	26602	0.967747	U	0.1696	0.0577077	12578	0.978454	PASS	.	780	0.814103	10252	21594	0.973650	.	.	.	.	.	.	rs75732095	.	4024	0.813100	0.462	-0.180	0.011	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	149495536	149495537	5q32	0	normal	.	G	ref	G	GG.CT	het-alt	180	0.53	.	1	.	PASS	164770	C	221820(MK)	AD	Leukoencephalopathy, diffuse hereditary, with spheroids	AD	.	Neurologic	General	23698128|22843259|22197934|19153373|16523341	.	1436	CSF1R	PROM	.	.	.	no-change	NM_005211.3	NP_005202.2	-	N	c.-292-u2602C=	.	.	.	NM_005211.3(CSF1R): c.-292-u2602C=	;maf-5-some-pop	26602	0.967747	U	0.1696	0.0577077	12578	0.978454	PASS	.	780	0.814103	10252	21594	0.973650	.	.	.	.	.	.	rs75732095	.	4024	0.813100	0.462	-0.180	0.011	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	149495536	149495537	5q32	0	normal	.	G	snv	A	GG.CT	het-ref	161	0.47	.	2	.	PASS	173410	C	131440(MC);228550(MK);615007(MK)	AD	Basal ganglia calcification, idiopathic, 4 	AD	.	Neurologic	General	23255827	.	5159	PDGFRB	IC21	IVS22	.	.	intron	NM_002609.3	NP_002600.1	-	Y	c.3138-28C>T	.	.	.	NM_002609.3(PDGFRB): c.3138-28C>T	;maf-5-some-pop	26602	0.032253	U	0.1696	0.0577077	12578	0.021546	PASS	12	780	0.185897	24	21594	0.026350	167	1854	1.87235e-01	194	3665	2.58372e-02	rs75732095	.	4024	0.186900	0.462	-0.180	0.011	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	149495536	149495537	5q32	0	normal	.	G	snv	A	GG.CT	het-ref	161	0.47	.	2	.	PASS	164770	C	221820(MK)	AD	Leukoencephalopathy, diffuse hereditary, with spheroids	AD	.	Neurologic	General	23698128|22843259|22197934|19153373|16523341	.	1436	CSF1R	PROM	.	.	.	promoter	NM_005211.3	NP_005202.2	-	N	c.-292-u2602C>T	.	.	.	NM_005211.3(CSF1R): c.-292-u2602C>T	;maf-5-some-pop	26602	0.032253	U	0.1696	0.0577077	12578	0.021546	PASS	12	780	0.185897	24	21594	0.026350	167	1854	1.87235e-01	194	3665	2.58372e-02	rs75732095	.	4024	0.186900	0.462	-0.180	0.011	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	149497132	149497133	5q32	0	normal	.	A	ref	A	ac.ca	het-alt	63	0.50	.	1	(CA)n|Simple_repeat|Simple_repeat|+|35;trf	PASS	173410	C	131440(MC);228550(MK);615007(MK)	AD	Basal ganglia calcification, idiopathic, 4 	AD	.	Neurologic	General	23255827	.	5159	PDGFRB	IC21	IVS22	.	.	no-change	NM_002609.3	NP_002600.1	-	Y	c.3137+48T=	.	.	.	NM_002609.3(PDGFRB): c.3137+48T=	MixedObserved;maf-5-some-pop	117880	0.945521	U	0.0099	0.0623003	13004	0.951400	PASS	-30	8582	0.992776	50533	112872	0.945868	.	.	.	.	.	.	rs41289061	.	4024	0.993000	-0.250	-0.539	-0.477	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	149497132	149497133	5q32	0	normal	.	A	ref	A	ac.ca	het-alt	63	0.50	.	1	(CA)n|Simple_repeat|Simple_repeat|+|35;trf	PASS	164770	C	221820(MK)	AD	Leukoencephalopathy, diffuse hereditary, with spheroids	AD	.	Neurologic	General	23698128|22843259|22197934|19153373|16523341	.	1436	CSF1R	PROM	.	.	.	no-change	NM_005211.3	NP_005202.2	-	N	c.-292-u4198T=	.	.	.	NM_005211.3(CSF1R): c.-292-u4198T=	MixedObserved;maf-5-some-pop	117880	0.945521	U	0.0099	0.0623003	13004	0.951400	PASS	-30	8582	0.992776	50533	112872	0.945868	.	.	.	.	.	.	rs41289061	.	4024	0.993000	-0.250	-0.539	-0.477	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	149497132	149497133	5q32	0	normal	.	A	snv	G	ac.ca	het-ref	64	0.50	.	2	(CA)n|Simple_repeat|Simple_repeat|+|35;trf	PASS	173410	C	131440(MC);228550(MK);615007(MK)	AD	Basal ganglia calcification, idiopathic, 4 	AD	.	Neurologic	General	23255827	.	5159	PDGFRB	IC21	IVS22	.	.	intron	NM_002609.3	NP_002600.1	-	Y	c.3137+48T>C	.	.	.	NM_002609.3(PDGFRB): c.3137+48T>C	MixedObserved;maf-5-some-pop	117880	0.054479	U	0.0099	0.0623003	13004	0.048600	PASS	1	8582	0.007224	207	112872	0.054132	0	119	7.03892e-03	382	11530	5.21790e-02	rs41289061	.	4024	0.007000	-0.250	-0.539	-0.477	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	149497132	149497133	5q32	0	normal	.	A	snv	G	ac.ca	het-ref	64	0.50	.	2	(CA)n|Simple_repeat|Simple_repeat|+|35;trf	PASS	164770	C	221820(MK)	AD	Leukoencephalopathy, diffuse hereditary, with spheroids	AD	.	Neurologic	General	23698128|22843259|22197934|19153373|16523341	.	1436	CSF1R	PROM	.	.	.	promoter	NM_005211.3	NP_005202.2	-	N	c.-292-u4198T>C	.	.	.	NM_005211.3(CSF1R): c.-292-u4198T>C	MixedObserved;maf-5-some-pop	117880	0.054479	U	0.0099	0.0623003	13004	0.048600	PASS	1	8582	0.007224	207	112872	0.054132	0	119	7.03892e-03	382	11530	5.21790e-02	rs41289061	.	4024	0.007000	-0.250	-0.539	-0.477	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	149501688	149501692	5q32	0	normal	.	CTCA	ref	CTCA	CT.CT	het-alt	112	0.49	.	1	.	PASS	173410	C	131440(MC);228550(MK);615007(MK)	AD	Basal ganglia calcification, idiopathic, 4 	AD	.	Neurologic	General	23255827	.	5159	PDGFRB	IC14	IVS15	.	.	no-change	NM_002609.3	NP_002600.1	-	Y	c.2184-89_2184-86=	.	.	.	NM_002609.3(PDGFRB): c.2184-89_2184-86=	;maf-5-some-pop	5008	0.915935	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs56202461	.	4020	0.991300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	149501688	149501692	5q32	0	normal	.	CTCA	del	.	CT.CT	het-ref	118	0.51	.	2	.	PASS	173410	C	131440(MC);228550(MK);615007(MK)	AD	Basal ganglia calcification, idiopathic, 4 	AD	.	Neurologic	General	23255827	.	5159	PDGFRB	IC14	IVS15	.	.	intron	NM_002609.3	NP_002600.1	-	Y	c.2184-89_2184-86delTGAG	.	.	.	NM_002609.3(PDGFRB): c.2184-89_2184-86delTGAG	;maf-5-some-pop	5008	0.084065	U	0.0099	0.0840655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs56202461	.	4020	0.008700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	149509269	149509270	5q32	0	nullSample	.	A	ref	A	GG.TT	homo-ref	.	.	.	0	.	.	173410	C	131440(MC);228550(MK);615007(MK)	AD	Basal ganglia calcification, idiopathic, 4 	AD	.	Neurologic	General	23255827	.	5159	PDGFRB	IC9	IVS10	.	.	no-change	NM_002609.3	NP_002600.1	-	Y	c.1579+50T=	.	.	.	NM_002609.3(PDGFRB): c.1579+50T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	113110	0.282318	U	0.8492	0.805312	13002	0.292647	PASS	.	8044	0.153282	4858	108102	0.286378	.	.	.	.	.	.	rs1864972	.	4024	0.138200	-1.460	-0.767	-0.773	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	149509269	149509270	5q32	0	normal	.	A	snv	G	GG.TT	hom-alt	324	1.00	.	0	.	PASS	173410	C	131440(MC);228550(MK);615007(MK)	AD	Basal ganglia calcification, idiopathic, 4 	AD	.	Neurologic	General	23255827	.	5159	PDGFRB	IC9	IVS10	.	.	intron	NM_002609.3	NP_002600.1	-	Y	c.1579+50T>C	.	.	.	NM_002609.3(PDGFRB): c.1579+50T>C	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	113110	0.717682	U	0.8492	0.805312	13002	0.707353	PASS	2876	8044	0.846718	27951	108102	0.713622	5964	14125	8.45201e-01	57511	158178	7.13349e-01	rs1864972	.	4024	0.861800	-1.460	-0.767	-0.773	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	149513071	149513072	5q32	0	nullSample	.	A	ref	A	TC.CT	homo-ref	.	.	.	0	.	.	173410	C	131440(MC);228550(MK);615007(MK)	AD	Basal ganglia calcification, idiopathic, 4 	AD	.	Neurologic	General	23255827	.	5159	PDGFRB	IC5	IVS6	.	.	no-change	NM_002609.3	NP_002600.1	-	Y	c.934+77T=	.	.	.	NM_002609.3(PDGFRB): c.934+77T=	;maf-5-some-pop,maf-5-all-pops	5008	0.439497	U	0.5913	0.560503	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2240780	.	4020	0.420100	0.055	-0.119	0.056	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	149513071	149513072	5q32	0	normal	.	A	snv	G	TC.CT	hom-alt	321	1.00	.	0	.	PASS	173410	C	131440(MC);228550(MK);615007(MK)	AD	Basal ganglia calcification, idiopathic, 4 	AD	.	Neurologic	General	23255827	.	5159	PDGFRB	IC5	IVS6	.	.	intron	NM_002609.3	NP_002600.1	-	Y	c.934+77T>C	.	.	.	NM_002609.3(PDGFRB): c.934+77T>C	;maf-5-some-pop,maf-5-all-pops	5008	0.560503	U	0.5913	0.560503	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2240780	.	4020	0.579900	0.055	-0.119	0.056	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	149515073	149515074	5q32	0	normal	.	G	ref	G	TT.AC	het-alt	140	0.51	.	1	.	PASS	173410	C	131440(MC);228550(MK);615007(MK)	AD	Basal ganglia calcification, idiopathic, 4 	AD	.	Neurologic	General	23255827	.	5159	PDGFRB	IC2	IVS3	.	.	no-change	NM_002609.3	NP_002600.1	-	Y	c.364+44C=	.	.	.	NM_002609.3(PDGFRB): c.364+44C=	;maf-5-some-pop,maf-5-all-pops	116536	0.476479	U	0.4306	0.459864	13006	0.540597	PASS	-1022	8532	0.596812	13173	111528	0.473621	.	.	.	.	.	.	rs740750	.	4024	0.607400	0.561	0.124	0.167	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	149515073	149515074	5q32	0	normal	.	G	snv	A	TT.AC	het-ref	136	0.49	.	2	.	PASS	173410	C	131440(MC);228550(MK);615007(MK)	AD	Basal ganglia calcification, idiopathic, 4 	AD	.	Neurologic	General	23255827	.	5159	PDGFRB	IC2	IVS3	.	.	intron	NM_002609.3	NP_002600.1	-	Y	c.364+44C>T	.	.	.	NM_002609.3(PDGFRB): c.364+44C>T	;maf-5-some-pop,maf-5-all-pops	116536	0.523521	U	0.4306	0.459864	13006	0.459403	PASS	698	8532	0.403188	16115	111528	0.526379	1250	6192	3.98404e-01	27343	98977	5.28763e-01	rs740750	.	4024	0.392600	0.561	0.124	0.167	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	150886724	150886725	5q33.1	0	nullSample	.	G	ref	G	TC.CT	homo-ref	.	.	.	0	.	.	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C22	EX22	.	.	no-change	NM_001447.2	NP_001438.1	-	Y	c.12507C=	.	.	.	NM_001447.2(FAT2): c.12507C=	;maf-5-some-pop	119104	0.137225	U	0.9643	0.911941	13006	0.147701	PASS	-98	8596	0.022801	1327	114096	0.139383	.	.	.	.	.	.	rs7723266	.	4024	0.024600	-0.137	-1.819	-1.469	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	150886724	150886725	5q33.1	1	normal	.	G	snv	A	TC.CT	hom-alt	379	1.00	.	0	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C22	EX22	.	.	coding-synon	NM_001447.2	NP_001438.1	-	Y	c.12507C>T	p.(S4169=) | p.(Ser4169=)	AGC=>AGT	.	NM_001447.2(FAT2): c.12507C>T (p.(S4169=))	;maf-5-some-pop	119104	0.862775	U	0.9643	0.911941	13006	0.852299	PASS	4102	8596	0.977199	42472	114096	0.860617	8139	16682	9.75670e-01	83086	191835	8.61460e-01	rs7723266	.	4024	0.975400	-0.137	-1.819	-1.469	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
5	150886881	150886882	5q33.1	0	nullSample	.	G	ref	G	CC.GT	homo-ref	.	.	.	0	.	.	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C22	EX22	.	.	no-change	NM_001447.2	NP_001438.1	-	Y	c.12350C=	.	.	.	NM_001447.2(FAT2): c.12350C=	;maf-5-some-pop	126398	0.331271	U	0.8244	0.776957	13006	0.346379	PASS	-579	8646	0.154291	7736	121390	0.335736	.	.	.	.	.	.	rs1105168	.	4024	0.153100	-0.150	0.224	-0.078	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	150886881	150886882	5q33.1	1	normal	.	G	snv	A	CC.GT	hom-alt	745	1.00	.	0	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C22	EX22	.	.	missense	NM_001447.2	NP_001438.1	-	Y	c.12350C>T	p.P4117L | p.Pro4117Leu	CCG=>CTG	NP=>NP	NM_001447.2(FAT2): c.12350C>T (p.P4117L)	;maf-5-some-pop	126398	0.668729	U	0.8244	0.776957	13006	0.653621	PASS	3077	8646	0.845709	27676	121390	0.664264	6153	14564	8.44388e-01	55139	162213	6.58696e-01	rs1105168	.	4024	0.846900	-0.150	0.224	-0.078	0.41	0	0	0.015	neutral	ENST00000261800: c.12350C>T (p.P4117L)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3761045	.	.	.	.	.	.	.	.	.	Likely Benign
5	150887183	150887184	5q33.1	0	nullSample	.	G	ref	G	CA.AG	homo-ref	.	.	.	0	.	.	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	IC21	IVS21	.	.	no-change	NM_001447.2	NP_001438.1	-	Y	c.12060-12C=	.	.	.	NM_001447.2(FAT2): c.12060-12C=	.	.	.	.	0.9653	0.903355	.	.	PASS	-95	8506	0.022337	1428	111676	0.154939	.	.	.	.	.	.	.	.	.	.	0.655	1.110	1.296	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	150887184	150887184	5q33.1	1	normal	.	.	ins	AGA	AG.AG	hom-alt	306	1.00	.	0	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	IC21	IVS21	.	.	intron	NM_001447.2	NP_001438.1	-	Y	c.12060-13_12060-12insTCT	.	.	.	NM_001447.2(FAT2): c.12060-13_12060-12insTCT	InconsistentAlleles;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	116684	0.847554	U	0.9653	0.903355	12450	0.833655	PASS	4063	8506	0.977663	39962	111676	0.845052	8098	16578	9.76670e-01	80159	188616	8.44834e-01	rs75548276	.	4024	0.975600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	150889804	150889805	5q33.1	0	nullSample	.	A	ref	A	AG.CT	homo-ref	.	.	.	0	.	.	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	IC20	IVS20	.	.	no-change	NM_001447.2	NP_001438.1	-	Y	c.11906-70T=	.	.	.	NM_001447.2(FAT2): c.11906-70T=	;maf-5-some-pop,maf-5-all-pops	5008	0.445487	U	0.8165	0.554513	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6870300	.	4024	0.148600	-0.313	-0.532	-0.856	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	150889804	150889805	5q33.1	0	normal	.	A	snv	T	AG.CT	hom-alt	298	1.00	.	0	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	IC20	IVS20	.	.	intron	NM_001447.2	NP_001438.1	-	Y	c.11906-70T>A	.	.	.	NM_001447.2(FAT2): c.11906-70T>A	;maf-5-some-pop,maf-5-all-pops	5008	0.554513	U	0.8165	0.554513	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6870300	.	4024	0.851400	-0.313	-0.532	-0.856	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	150891662	150891663	5q33.1	0	normal	.	T	snv	C	GC.TT	hom-alt	259	1.00	.	0	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	IC20	IVS20	.	.	intron	NM_001447.2	NP_001438.1	-	Y	c.11905+63A>G	.	.	.	NM_001447.2(FAT2): c.11905+63A>G	MixedObserved;maf-5-some-pop	5008	0.798722	U	0.9494	0.798722	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6862750	.	4020	0.972100	-0.119	0.824	0.951	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	150891662	150891663	5q33.1	0	nullSample	.	T	ref	T	GC.TT	homo-ref	.	.	.	0	.	.	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	IC20	IVS20	.	.	no-change	NM_001447.2	NP_001438.1	-	Y	c.11905+63A=	.	.	.	NM_001447.2(FAT2): c.11905+63A=	MixedObserved;maf-5-some-pop	5008	0.201278	U	0.9494	0.798722	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6862750	.	4020	0.027900	-0.119	0.824	0.951	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	150891732	150891733	5q33.1	0	nullSample	.	A	ref	A	CC.TG	homo-ref	.	.	.	0	.	.	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C20	EX20	.	.	no-change	NM_001447.2	NP_001438.1	-	Y	c.11898T=	.	.	.	NM_001447.2(FAT2): c.11898T=	;maf-5-some-pop	126104	0.227241	U	0.9494	0.799521	13006	0.292173	PASS	-120	8652	0.028433	3610	121096	0.228348	.	.	.	.	.	.	rs2304028	.	4024	0.028800	-3.729	-5.246	-4.887	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	150891732	150891733	5q33.1	1	normal	.	A	snv	G	CC.TG	hom-alt	434	1.00	.	0	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C20	EX20	.	.	coding-synon	NM_001447.2	NP_001438.1	-	Y	c.11898T>C	p.(H3966=) | p.(His3966=)	CAT=>CAC	.	NM_001447.2(FAT2): c.11898T>C (p.(H3966=))	;maf-5-some-pop	126104	0.772759	U	0.9494	0.799521	13006	0.707827	PASS	4083	8652	0.971567	36506	121096	0.771652	8130	16744	9.70779e-01	74519	189939	7.74212e-01	rs2304028	.	4024	0.971200	-3.729	-5.246	-4.887	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
5	150901110	150901111	5q33.1	0	nullSample	.	A	ref	A	AC.TC	homo-ref	.	.	.	0	.	.	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C18	EX18	.	.	no-change	NM_001447.2	NP_001438.1	-	Y	c.11043T=	.	.	.	NM_001447.2(FAT2): c.11043T=	;maf-5-some-pop	126196	0.233747	U	0.9494	0.779553	13006	0.303937	PASS	-119	8652	0.028202	3807	121188	0.234297	.	.	.	.	.	.	rs3822699	.	4024	0.029100	-0.215	-1.506	-2.542	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	150901110	150901111	5q33.1	1	normal	.	A	snv	G	AC.TC	hom-alt	762	1.00	.	0	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C18	EX18	.	.	coding-synon	NM_001447.2	NP_001438.1	-	Y	c.11043T>C	p.(D3681=) | p.(Asp3681=)	GAT=>GAC	.	NM_001447.2(FAT2): c.11043T>C (p.(D3681=))	;maf-5-some-pop	126196	0.766253	U	0.9494	0.779553	13006	0.696063	PASS	4085	8652	0.971798	36007	121188	0.765703	8131	16746	9.70895e-01	73896	189366	7.69712e-01	rs3822699	.	4024	0.970900	-0.215	-1.506	-2.542	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
5	150901260	150901261	5q33.1	0	nullSample	.	C	ref	C	CA.AT	homo-ref	.	.	.	0	.	.	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C18	EX18	.	.	no-change	NM_001447.2	NP_001438.1	-	Y	c.10893G=	.	.	.	NM_001447.2(FAT2): c.10893G=	;maf-5-some-pop	124974	0.237257	U	0.9494	0.76897	13006	0.316316	PASS	-117	8624	0.027829	3885	119966	0.237517	.	.	.	.	.	.	rs6650971	.	4024	0.029300	0.563	0.242	0.346	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	150901260	150901261	5q33.1	1	normal	.	C	snv	T	CA.AT	hom-alt	663	1.00	.	0	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C18	EX18	.	.	missense	NM_001447.2	NP_001438.1	-	Y	c.10893G>A	p.M3631I | p.Met3631Ile	ATG=>ATA	NP=>NP	NM_001447.2(FAT2): c.10893G>A (p.M3631I)	;maf-5-some-pop	124974	0.762743	U	0.9494	0.76897	13006	0.683684	PASS	4075	8624	0.972171	35374	119966	0.762483	8123	16727	9.71032e-01	73001	187599	7.66724e-01	rs6650971	.	4024	0.970700	0.563	0.242	0.346	0.76	0.003	0.002	0.001	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
5	150901299	150901300	5q33.1	0	nullSample	.	G	ref	G	AC.TA	homo-ref	.	.	.	0	.	.	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C18	EX18	.	.	no-change	NM_001447.2	NP_001438.1	-	Y	c.10854C=	.	.	.	NM_001447.2(FAT2): c.10854C=	;maf-5-some-pop	125330	0.238139	U	0.9484	0.764577	13006	0.319237	PASS	.	8628	0.028164	3940	120322	0.238252	.	.	.	.	.	.	rs3734046	.	4024	0.029600	0.563	-0.554	-1.719	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	150901299	150901300	5q33.1	1	normal	.	G	snv	A	AC.TA	hom-alt	648	1.00	.	0	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C18	EX18	.	.	coding-synon	NM_001447.2	NP_001438.1	-	Y	c.10854C>T	p.(Y3618=) | p.(Tyr3618=)	TAC=>TAT	.	NM_001447.2(FAT2): c.10854C>T (p.(Y3618=))	;maf-5-some-pop	125330	0.761861	U	0.9484	0.764577	13006	0.680763	PASS	4074	8628	0.971836	35434	120322	0.761748	8121	16726	9.70749e-01	73014	187733	7.66170e-01	rs3734046	.	4024	0.970400	0.563	-0.554	-1.719	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
5	150901612	150901613	5q33.1	0	nullSample	.	A	ref	A	TC.AA	homo-ref	.	.	.	0	.	.	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C18	EX18	Cadherin domain	PF00028.12	no-change	NM_001447.2	NP_001438.1	-	Y	c.10541T=	.	.	.	NM_001447.2(FAT2): c.10541T=	;maf-5-some-pop,genotype-conflict	124380	0.233615	U	0.9494	0.775759	13006	0.310011	PASS	.	8594	0.029905	3604	119372	0.234008	.	.	.	.	.	.	rs2053028	.	4024	0.029300	-0.213	0.431	0.036	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	150901612	150901613	5q33.1	1	normal	.	A	snv	G	TC.AA	hom-alt	517	1.00	.	0	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C18	EX18	Cadherin domain	PF00028.12	missense	NM_001447.2	NP_001438.1	-	Y	c.10541T>C	p.L3514S | p.Leu3514Ser	TTG=>TCG	NP=>P0	NM_001447.2(FAT2): c.10541T>C (p.L3514S)	;maf-5-some-pop,genotype-conflict	124380	0.766385	U	0.9494	0.775759	13006	0.689989	PASS	4044	8594	0.970095	35356	119372	0.765992	8078	16660	9.69394e-01	72477	185822	7.68870e-01	rs2053028	.	4024	0.970700	-0.213	0.431	0.036	0.47	0.007	0	0.011	neutral	ENST00000261800: c.10541T>C (p.L3514S)	large_intestine [colon|ascending|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	292313	.	.	.	.	.	.	.	.	.	Likely Benign
5	150914183	150914184	5q33.1	0	nullSample	.	A	ref	A	GC.GT	homo-ref	.	.	.	0	.	.	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C12	EX12	Cadherin domain	PF00028.12	no-change	NM_001447.2	NP_001438.1	-	Y	c.9213T=	.	.	.	NM_001447.2(FAT2): c.9213T=	;maf-5-some-pop,genotype-conflict	126306	0.408231	U	0.8085	0.632788	13006	0.478318	PASS	-569	8634	0.156590	10886	121298	0.409924	.	.	.	.	.	.	rs1432643	.	4024	0.164800	-0.364	-0.769	-0.198	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	150914183	150914184	5q33.1	1	normal	.	A	snv	T	GC.GT	hom-alt	421	1.00	.	0	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C12	EX12	Cadherin domain	PF00028.12	coding-synon	NM_001447.2	NP_001438.1	-	Y	c.9213T>A	p.(T3071=) | p.(Thr3071=)	ACT=>ACA	.	NM_001447.2(FAT2): c.9213T>A (p.(T3071=))	;maf-5-some-pop,genotype-conflict	126306	0.591769	U	0.8085	0.632788	13006	0.521682	PASS	3072	8634	0.843410	21812	121298	0.590076	6048	14431	8.37162e-01	44868	145977	5.94781e-01	rs1432643	.	4024	0.835200	-0.364	-0.769	-0.198	.	.	.	.	.	ENST00000261800: c.9213T>A (p.T3071T)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3761048	.	.	.	.	.	.	.	.	.	Likely Benign
5	150920107	150920108	5q33.1	0	normal	.	A	snv	G	CC.CC	het-ref	148	0.45	.	2	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	IC10	IVS10	.	.	intron	NM_001447.2	NP_001438.1	-	Y	c.9039+20T>C	.	.	.	NM_001447.2(FAT2): c.9039+20T>C	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	114288	0.092031	U	0.1319	0.122204	13006	0.103798	PASS	73	8268	0.140300	458	109280	0.090648	140	2281	1.34019e-01	854	19294	8.14526e-02	rs2288777	.	4024	0.146600	-1.212	-0.844	-0.227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	150920107	150920108	5q33.1	0	normal	.	A	ref	A	CC.CC	het-alt	181	0.55	.	1	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	IC10	IVS10	.	.	no-change	NM_001447.2	NP_001438.1	-	Y	c.9039+20T=	.	.	.	NM_001447.2(FAT2): c.9039+20T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	114288	0.907969	U	0.1319	0.122204	13006	0.896202	PASS	-507	8268	0.859700	45192	109280	0.909352	.	.	.	.	.	.	rs2288777	.	4024	0.853400	-1.212	-0.844	-0.227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	150921804	150921805	5q33.1	0	normal	.	G	ref	G	TC.AT	het-alt	165	0.50	.	1	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	IC9	IVS9	.	.	no-change	NM_001447.2	NP_001438.1	-	Y	c.8842+41C=	.	.	.	NM_001447.2(FAT2): c.8842+41C=	;maf-5-some-pop,maf-5-all-pops	116030	0.375489	U	0.6815	0.607827	13006	0.391435	PASS	-952	8532	0.315049	7937	111022	0.374737	.	.	.	.	.	.	rs6579879	.	4024	0.323800	-1.179	0.165	-0.173	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	150921804	150921805	5q33.1	0	normal	.	G	snv	A	TC.AT	het-ref	163	0.50	.	2	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	IC9	IVS9	.	.	intron	NM_001447.2	NP_001438.1	-	Y	c.8842+41C>T	.	.	.	NM_001447.2(FAT2): c.8842+41C>T	;maf-5-some-pop,maf-5-all-pops	116030	0.624511	U	0.6815	0.607827	13006	0.608565	PASS	1970	8532	0.684951	21844	111022	0.625263	3603	10563	6.88772e-01	35655	112279	6.28753e-01	rs6579879	.	4024	0.676200	-1.179	0.165	-0.173	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	150923404	150923405	5q33.1	0	nullSample	.	A	ref	A	TG.AG	homo-ref	.	.	.	0	.	.	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C9	EX9	Cadherin domain	PF00028.12	no-change	NM_001447.2	NP_001438.1	-	Y	c.7283T=	.	.	.	NM_001447.2(FAT2): c.7283T=	;	126352	0.003237	U	1	0.997604	13006	0.003306	PASS	0	8646	0.000000	2	121344	0.003272	.	.	.	.	.	.	rs6892335	.	4024	0.001500	-0.215	0.824	1.375	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	150923404	150923405	5q33.1	1	normal	.	A	snv	G	TG.AG	hom-alt	775	1.00	.	0	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C9	EX9	Cadherin domain	PF00028.12	missense	NM_001447.2	NP_001438.1	-	Y	c.7283T>C	p.F2428S | p.Phe2428Ser	TTC=>TCC	NP=>P0	NM_001447.2(FAT2): c.7283T>C (p.F2428S)	;	126352	0.996763	U	1	0.997604	13006	0.996694	PASS	4323	8646	1.000000	60277	121344	0.996728	8622	17244	1.00000e+00	122272	245329	9.96810e-01	rs6892335	.	4024	0.998500	-0.215	0.824	1.375	0.63	0	0	0.004	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
5	150925143	150925144	5q33.1	0	nullSample	.	A	ref	A	AC.GG	homo-ref	.	.	.	0	.	.	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C9	EX9	Cadherin domain	PF00028.12	no-change	NM_001447.2	NP_001438.1	-	Y	c.5544T=	.	.	.	NM_001447.2(FAT2): c.5544T=	;maf-5-some-pop	126370	0.190401	U	0.7302	0.815695	13006	0.133323	PASS	-871	8646	0.265788	2538	121362	0.190653	.	.	.	.	.	.	rs3797875	.	4024	0.262400	-0.349	-0.182	-0.047	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	150925143	150925144	5q33.1	1	normal	.	A	snv	G	AC.GG	hom-alt	741	1.00	.	0	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C9	EX9	Cadherin domain	PF00028.12	coding-synon	NM_001447.2	NP_001438.1	-	Y	c.5544T>C	p.(P1848=) | p.(Pro1848=)	CCT=>CCC	.	NM_001447.2(FAT2): c.5544T>C (p.(P1848=))	;maf-5-some-pop	126370	0.809599	U	0.7302	0.815695	13006	0.866677	PASS	2303	8646	0.734212	40081	121362	0.809347	4689	12762	7.39912e-01	80982	198795	8.08484e-01	rs3797875	.	4024	0.737600	-0.349	-0.182	-0.047	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
5	150930185	150930186	5q33.1	0	normal	.	C	ref	C	GC.GA	het-alt	293	0.49	.	1	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C7	EX7	Cadherin domain	PF00028.12	no-change	NM_001447.2	NP_001438.1	-	Y	c.4543G=	.	.	.	NM_001447.2(FAT2): c.4543G=	;maf-5-some-pop,genotype-conflict	126340	0.900989	U	0.2083	0.116014	13006	0.945794	PASS	-707	8640	0.793750	50071	121332	0.901691	.	.	.	.	.	.	rs2278370	.	4024	0.795200	-0.834	0.331	-0.574	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	150930185	150930186	5q33.1	1	normal	.	C	snv	T	GC.GA	het-ref	307	0.51	.	2	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C7	EX7	Cadherin domain	PF00028.12	missense	NM_001447.2	NP_001438.1	-	Y	c.4543G>A	p.G1515S | p.Gly1515Ser	GGC=>AGC	P0=>P0	NM_001447.2(FAT2): c.4543G>A (p.G1515S)	;maf-5-some-pop,genotype-conflict	126340	0.099011	U	0.2083	0.116014	13006	0.054206	PASS	184	8640	0.206250	1333	121332	0.098309	345	3571	2.07087e-01	3282	27261	1.10970e-01	rs2278370	.	4024	0.204800	-0.834	0.331	-0.574	0.2	0.009	0.006	0.050	neutral	ENST00000261800: c.4543G>A (p.G1515S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	150002	.	.	.	.	.	.	.	.	.	Likely Benign
5	150930344	150930345	5q33.1	0	normal	.	C	ref	C	CA.GG	het-alt	315	0.50	.	1	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C7	EX7	Cadherin domain	PF00028.12	no-change	NM_001447.2	NP_001438.1	-	Y	c.4384G=	.	.	.	NM_001447.2(FAT2): c.4384G=	;maf-5-some-pop,genotype-conflict	126174	0.899068	U	0.2272	0.122404	13006	0.944795	PASS	.	8612	0.782745	49807	121166	0.899955	.	.	.	.	.	.	rs2278371	.	4024	0.784800	-0.147	0.668	0.153	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	150930344	150930345	5q33.1	1	normal	.	C	snv	T	CA.GG	het-ref	317	0.50	.	2	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C7	EX7	Cadherin domain	PF00028.12	missense	NM_001447.2	NP_001438.1	-	Y	c.4384G>A	p.V1462M | p.Val1462Met	GTG=>ATG	NP=>NP	NM_001447.2(FAT2): c.4384G>A (p.V1462M)	;maf-5-some-pop,genotype-conflict	126174	0.100932	U	0.2272	0.122404	13006	0.055205	PASS	201	8612	0.217255	1346	121166	0.100045	381	3749	2.17560e-01	3319	27693	1.12672e-01	rs2278371	.	4024	0.215200	-0.147	0.668	0.153	0.19	0.152	0.787	0.063	neutral	ENST00000261800: c.4384G>A (p.V1462M)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	150003	.	.	.	.	.	.	.	.	.	Likely Benign
5	150942918	150942919	5q33.1	0	nullSample	.	A	ref	A	GT.GT	homo-ref	.	.	.	0	.	.	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C2	EX2	Cadherin domain	PF00028.12	no-change	NM_001447.2	NP_001438.1	-	Y	c.3541T=	.	.	.	NM_001447.2(FAT2): c.3541T=	;	126420	0.003069	U	1	0.998403	13006	0.003921	PASS	0	8654	0.000000	3	121412	0.003130	.	.	.	.	.	.	rs6872614	.	4024	0.001500	-0.215	0.696	0.204	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	150942918	150942919	5q33.1	1	normal	.	A	snv	G	GT.GT	hom-alt	522	1.00	.	0	.	PASS	604269	P	.	NN	.	.	.	.	.	.	.	2196	FAT2	C2	EX2	Cadherin domain	PF00028.12	missense	NM_001447.2	NP_001438.1	-	Y	c.3541T>C	p.Y1181H | p.Tyr1181His	TAC=>CAC	P0=>P+	NM_001447.2(FAT2): c.3541T>C (p.Y1181H)	;	126420	0.996931	U	1	0.998403	13006	0.996079	PASS	4327	8654	1.000000	60329	121412	0.996870	8624	17248	1.00000e+00	122214	245225	9.96736e-01	rs6872614	.	4024	0.998500	-0.215	0.696	0.204	0.43	0	0	0.013	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
5	161128760	161128761	5q34	0	nullSample	.	C	ref	C	GT.AG	homo-ref	.	.	.	0	.	.	137143	C	.	NN	.	.	.	.	.	.	.	2559	GABRA6	C9E	EX9E	.	.	no-change	NM_000811.2	NP_000802.2	+	Y	c.1344C=	.	.	.	NM_000811.2(GABRA6): c.1344C=	MixedObserved,SingleClassTriAllelic;maf-5-some-pop|MixedObserved;	121386|121364	0.010693|0.999992	U	.	.	13006	0.037982	PASS	0	8652	0.000000	70	121386	0.010693	.	.	.	.	.	.	rs4277944|rs750093869	.	4024	0.001500	-0.120	0.504	0.227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
5	161128760	161128761	5q34	1	normal	.	C	snv	G	GT.AG	hom-alt	289	1.00	.	0	.	PASS	137143	C	.	NN	.	.	.	.	.	.	.	2559	GABRA6	C9E	EX9E	.	.	coding-synon	NM_000811.2	NP_000802.2	+	Y	c.1344C>G	p.(V448=) | p.(Val448=)	GTC=>GTG	.	NM_000811.2(GABRA6): c.1344C>G (p.(V448=))	MixedObserved,SingleClassTriAllelic;maf-5-some-pop	121386	0.989299	U	.	.	13006	0.962018	PASS	4326	8652	1.000000	59464	121386	0.989299	8620	17240	1.00000e+00	121099	244031	9.91690e-01	rs4277944	.	4024	0.998500	-0.120	0.504	0.227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
5	170815065	170815066	5q35.1	0	normal	.	T	ref	T	GG.GG	het-alt	29	0.72	.	1	.	DUBIOUS	164040	P	164040(MK);601626(MK)	NN	.	.	.	.	.	.	.	4869	NPM1	IC1	IVS1	.	.	no-change	NM_002520.6	NP_002511.1	+	Y	c.58+56T=	.	.	.	NM_002520.6(NPM1): c.58+56T=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3968	0.999500	-0.282	-0.727	-0.815	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	170815065	170815066	5q35.1	0	normal	.	T	snv	G	GG.GG	het-ref	11	0.28	.	2	.	DUBIOUS	164040	P	164040(MK);601626(MK)	NN	.	.	.	.	.	.	.	4869	NPM1	IC1	IVS1	.	.	intron	NM_002520.6	NP_002511.1	+	Y	c.58+56T>G	.	.	.	NM_002520.6(NPM1): c.58+56T>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3968	0.000500	-0.282	-0.727	-0.815	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
5	170819886	170819887	5q35.1	0	nullSample	.	G	ref	G	TT.TT	homo-ref	.	.	.	0	.	.	164040	P	164040(MK);601626(MK)	NN	.	.	.	.	.	.	.	4869	NPM1	IC5	IVS5	.	.	no-change	NM_002520.6	NP_002511.1	+	Y	c.460-31G=	.	.	.	NM_002520.6(NPM1): c.460-31G=	;maf-5-some-pop,maf-5-all-pops	126228	0.584783	U	0.5268	0.457468	13004	0.606659	PASS	.	8654	0.454241	21008	121220	0.586529	.	.	.	.	.	.	rs3830035	.	4024	0.430400	0.484	1.048	0.718	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	170819886	170819887	5q35.1	0	normal	.	G	snv	A	TT.TT	hom-alt	702	1.00	.	0	.	PASS	164040	P	164040(MK);601626(MK)	NN	.	.	.	.	.	.	.	4869	NPM1	IC5	IVS5	.	.	intron	NM_002520.6	NP_002511.1	+	Y	c.460-31G>A	.	.	.	NM_002520.6(NPM1): c.460-31G>A	;maf-5-some-pop,maf-5-all-pops	126228	0.415217	U	0.5268	0.457468	13004	0.393341	PASS	1276	8654	0.545759	10519	121220	0.413471	2576	9408	5.45518e-01	21241	101097	4.10993e-01	rs3830035	.	4024	0.569600	0.484	1.048	0.718	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	170820023	170820024	5q35.1	0	nullSample	.	G	ref	G	TT.AC	homo-ref	.	.	.	0	.	.	164040	P	164040(MK);601626(MK)	NN	.	.	.	.	.	.	.	4869	NPM1	IC6	IVS6	.	.	no-change	NM_002520.6	NP_002511.1	+	Y	c.524+42G=	.	.	.	NM_002520.6(NPM1): c.524+42G=	;maf-5-some-pop,maf-5-all-pops	90520	0.577331	U	0.5268	0.457468	12964	0.609534	PASS	.	5584	0.454334	13988	85512	0.579369	.	.	.	.	.	.	rs3830036	.	4024	0.430400	-0.893	-0.790	-0.861	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	170820023	170820024	5q35.1	0	normal	.	G	snv	A	TT.AC	hom-alt	487	1.00	.	0	.	PASS	164040	P	164040(MK);601626(MK)	NN	.	.	.	.	.	.	.	4869	NPM1	IC6	IVS6	.	.	intron	NM_002520.6	NP_002511.1	+	Y	c.524+42G>A	.	.	.	NM_002520.6(NPM1): c.524+42G>A	;maf-5-some-pop,maf-5-all-pops	90520	0.422669	U	0.5268	0.457468	12964	0.390466	PASS	792	5584	0.545666	7201	85512	0.420631	2140	7914	5.44741e-01	17319	84173	4.12084e-01	rs3830036	.	4024	0.569600	-0.893	-0.790	-0.861	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	170827310	170827311	5q35.1	0	nullSample	.	T	ref	T	TG.GG	homo-ref	.	.	.	0	.	.	164040	P	164040(MK);601626(MK)	NN	.	.	.	.	.	.	.	4869	NPM1	IC7	IVS7	.	.	no-change	NM_002520.6	NP_002511.1	+	Y	c.582+97T=	.	.	.	NM_002520.6(NPM1): c.582+97T=	;	0	0	U	0.5268	0.457668	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs78849100	.	.	.	0.533	0.501	0.442	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	170827311	170827311	5q35.1	0	normal	.	.	ins	GGGAGATCATCTCATACTGA	GT.GG	hom-alt	176	1.00	.	0	.	PASS	164040	P	164040(MK);601626(MK)	NN	.	.	.	.	.	.	.	4869	NPM1	IC7	IVS7	.	.	intron	NM_002520.6	NP_002511.1	+	Y	c.582+97_582+98insGGGAGATCATCTCATACTGA	.	.	.	NM_002520.6(NPM1): c.582+97_582+98insGGGAGATCATCTCATACTGA	;maf-5-some-pop,maf-5-all-pops	5008	0.457668	U	0.5268	0.457668	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs139696681	.	4024	0.567600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	170837513	170837514	5q35.1	0	normal	.	T	ref	T	TC.TT	het-alt	150	0.52	.	1	.	PASS	164040	P	164040(MK);601626(MK)	NN	.	.	.	.	.	.	.	4869	NPM1	IC10	IVS10	.	.	no-change	NM_002520.6	NP_002511.1	+	Y	c.847-17T=	.	.	.	NM_002520.6(NPM1): c.847-17T=	MixedObserved;	699|2840	0.919886|0.998944	U	.	.	.	.	InbreedingCoeff_Filter	0	98	1.000000	1417	2840	0.998944	.	.	.	.	.	.	rs34323200|rs778609783	.	4024	0.739300	-0.346	0.314	-0.102	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	170837513	170837514	5q35.1	1	normal	.	T	del	.	TC.TT	het-ref	138	0.48	.	2	.	PASS	164040	P	164040(MK);601626(MK)	NN	.	.	.	.	.	.	.	4869	NPM1	IC10	IVS10	.	.	intron	NM_002520.6	NP_002511.1	+	Y	c.847-17delT	.	.	.	NM_002520.6(NPM1): c.847-17delT	MixedObserved;	699	0.080114	U	.	.	.	.	InbreedingCoeff_Filter	6	6608	0.373789	57	87784	0.337829	.	.	.	.	.	.	rs34323200	.	4024	0.260200	-0.346	0.314	-0.102	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	176516630	176516631	5q35.2	0	normal	.	G	ref	G	GG.TC	het-alt	186	0.51	.	1	.	PASS	134935	C	134935(SK)	NN	.	.	.	.	.	.	.	2264	FGFR4	C1	EX2	.	.	no-change	NM_213647.1	NP_998812.1	+	Y	c.28G=	.	.	.	NM_213647.1(FGFR4): c.28G=	;maf-5-some-pop,genotype-conflict	122524	0.759672	U	0.5069	0.228834	13006	0.829233	PASS	-1098	8540	0.476581	34393	117516	0.759182	.	.	.	.	.	.	rs1966265	.	4024	0.471900	-1.652	-0.523	-0.406	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	176516630	176516631	5q35.2	1	normal	.	G	snv	A	GG.TC	het-ref	179	0.49	.	2	.	PASS	134935	C	134935(SK)	NN	.	.	.	.	.	.	.	2264	FGFR4	C1	EX2	.	.	missense	NM_213647.1	NP_998812.1	+	Y	c.28G>A	p.V10I | p.Val10Ile	GTC=>ATC	NP=>NP	NM_213647.1(FGFR4): c.28G>A (p.V10I)	;maf-5-some-pop,genotype-conflict	122524	0.240328	U	0.5069	0.228834	13006	0.170767	PASS	1137	8540	0.523419	3935	117516	0.240818	2303	8908	5.18027e-01	8595	60028	2.45654e-01	rs1966265	.	4024	0.528100	-1.652	-0.523	-0.406	0.62	0.004	0.016	0.004	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
5	176517325	176517326	5q35.2	0	nullSample	.	T	ref	T	CT.TG	homo-ref	.	.	.	0	.	.	134935	C	134935(SK)	NN	.	.	.	.	.	.	.	2264	FGFR4	IC1	IVS2	.	.	no-change	NM_213647.1	NP_998812.1	+	Y	c.92-65T=	.	.	.	NM_213647.1(FGFR4): c.92-65T=	;maf-5-some-pop,genotype-conflict	119188	0.167332	U	1	0.853035	.	.	PASS	.	8358	0.000359	1873	114180	0.168226	.	.	.	.	.	.	rs422421	.	4024	0.002200	-0.642	0.185	0.176	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	176517325	176517326	5q35.2	0	normal	.	T	snv	C	CT.TG	hom-alt	373	1.00	.	0	.	PASS	134935	C	134935(SK)	NN	.	.	.	.	.	.	.	2264	FGFR4	IC1	IVS2	.	.	intron	NM_213647.1	NP_998812.1	+	Y	c.92-65T>C	.	.	.	NM_213647.1(FGFR4): c.92-65T>C	;maf-5-some-pop,genotype-conflict	119188	0.832668	U	1	0.853035	.	.	PASS	4176	8358	0.999641	39755	114180	0.831774	8497	17001	9.99588e-01	79823	190209	8.32804e-01	rs422421	.	4024	0.997800	-0.642	0.185	0.176	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	176517460	176517461	5q35.2	0	nullSample	.	T	ref	T	CG.CT	homo-ref	.	.	.	0	.	.	134935	C	134935(SK)	NN	.	.	.	.	.	.	.	2264	FGFR4	C2	EX3	.	.	no-change	NM_213647.1	NP_998812.1	+	Y	c.162T=	.	.	.	NM_213647.1(FGFR4): c.162T=	MixedObserved;maf-5-some-pop	123186	0.234872	U	0.9772	0.775958	13000	0.316769	PASS	.	8580	0.027389	3853	118178	0.235331	.	.	.	.	.	.	rs446382	.	4024	0.030800	-0.648	-0.068	-0.467	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	176517460	176517461	5q35.2	1	normal	.	T	snv	G	CG.CT	hom-alt	587	1.00	.	0	.	PASS	134935	C	134935(SK)	NN	.	.	.	.	.	.	.	2264	FGFR4	C2	EX3	.	.	coding-synon	NM_213647.1	NP_998812.1	+	Y	c.162T>G	p.(R54=) | p.(Arg54=)	CGT=>CGG	.	NM_213647.1(FGFR4): c.162T>G (p.(R54=))	MixedObserved;maf-5-some-pop	123186	0.765128	U	0.9772	0.775958	13000	0.683231	PASS	4058	8580	0.972611	35131	118178	0.764669	8107	16687	9.71756e-01	71639	182693	7.71260e-01	rs446382	.	4024	0.969200	-0.648	-0.068	-0.467	.	.	.	.	.	ENST00000292408: c.162T>G (p.R54R)	large_intestine [colon|descending|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3761131	.	.	.	.	.	.	.	.	.	Likely Benign
5	176517796	176517797	5q35.2	0	nullSample	.	C	ref	C	CC.CT	homo-ref	.	.	.	0	.	.	134935	C	134935(SK)	NN	.	.	.	.	.	.	.	2264	FGFR4	C3	EX4	.	.	no-change	NM_213647.1	NP_998812.1	+	Y	c.407C=	.	.	.	NM_213647.1(FGFR4): c.407C=	;maf-5-some-pop,genotype-conflict	126326	0.204526	U	1	0.807308	13006	0.278948	PASS	-2	8654	0.000462	3056	121318	0.205015	.	.	.	.	.	.	rs376618	.	4024	0.002500	0.313	1.259	1.120	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	176517796	176517797	5q35.2	1	normal	.	C	snv	T	CC.CT	hom-alt	552	1.00	.	0	.	PASS	134935	C	134935(SK)	NN	.	.	.	.	.	.	.	2264	FGFR4	C3	EX4	.	.	missense	NM_213647.1	NP_998812.1	+	Y	c.407C>T	p.P136L | p.Pro136Leu	CCC=>CTC	NP=>NP	NM_213647.1(FGFR4): c.407C>T (p.P136L)	;maf-5-some-pop,genotype-conflict	126326	0.795474	U	1	0.807308	13006	0.721052	PASS	4323	8654	0.999538	38843	121318	0.794985	8613	17236	9.99420e-01	79772	196915	8.00754e-01	rs376618	.	4024	0.997500	0.313	1.259	1.120	0.32	0.019	0.008	0.025	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
5	176518783	176518784	5q35.2	1	normal	.	C	snv	T	CG.TA	hom-alt	451	1.00	.	0	.	PASS	134935	C	134935(SK)	NN	.	.	.	.	.	.	.	2264	FGFR4	C5	EX6	.	.	coding-synon	NM_213647.1	NP_998812.1	+	Y	c.702C>T	p.(R234=) | p.(Arg234=)	CGC=>CGT	.	NM_213647.1(FGFR4): c.702C>T (p.(R234=))	;maf-5-some-pop	126400	0.795340	U	1	0.807109	13006	0.721129	PASS	4322	8652	0.999538	38863	121392	0.794855	8613	17236	9.99420e-01	79841	197096	8.00702e-01	rs452885	.	4024	0.997500	-0.448	0.008	-0.073	.	.	.	.	.	ENST00000292408: c.702C>T (p.R234R)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4159758	.	.	.	.	.	.	.	.	.	Likely Benign
5	176518783	176518784	5q35.2	0	nullSample	.	C	ref	C	CG.TA	homo-ref	.	.	.	0	.	.	134935	C	134935(SK)	NN	.	.	.	.	.	.	.	2264	FGFR4	C5	EX6	.	.	no-change	NM_213647.1	NP_998812.1	+	Y	c.702C=	.	.	.	NM_213647.1(FGFR4): c.702C=	;maf-5-some-pop	126400	0.204660	U	1	0.807109	13006	0.278871	PASS	-2	8652	0.000462	3070	121392	0.205145	.	.	.	.	.	.	rs452885	.	4024	0.002500	-0.448	0.008	-0.073	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	176519286	176519287	5q35.2	0	nullSample	.	G	ref	G	CC.GT	homo-ref	.	.	.	0	.	.	134935	C	134935(SK)	NN	.	.	.	.	.	.	.	2264	FGFR4	IC5	IVS6	.	.	no-change	NM_213647.1	NP_998812.1	+	Y	c.728-35G=	.	.	.	NM_213647.1(FGFR4): c.728-35G=	;maf-5-some-pop	112110	0.155240	U	1	0.899361	12990	0.179754	PASS	-1	8450	0.000237	1515	107102	0.157794	.	.	.	.	.	.	rs393923	.	4024	0.002200	-1.327	-1.377	-1.841	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	176519286	176519287	5q35.2	0	normal	.	G	snv	A	CC.GT	hom-alt	337	1.00	.	0	.	PASS	134935	C	134935(SK)	NN	.	.	.	.	.	.	.	2264	FGFR4	IC5	IVS6	.	.	intron	NM_213647.1	NP_998812.1	+	Y	c.728-35G>A	.	.	.	NM_213647.1(FGFR4): c.728-35G>A	;maf-5-some-pop	112110	0.844760	U	1	0.899361	12990	0.820246	PASS	4223	8450	0.999763	38166	107102	0.842206	7270	14545	9.99656e-01	62189	146701	8.42151e-01	rs393923	.	4024	0.997800	-1.327	-1.377	-1.841	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	176520242	176520243	5q35.2	0	normal	.	G	ref	G	CC.GG	het-alt	298	0.52	.	1	.	PASS	134935	C	134935(SK)	NN	.	.	.	.	.	.	.	2264	FGFR4	C8	EX9	.	.	no-change	NM_213647.1	NP_998812.1	+	Y	c.1162G=	.	.	.	NM_213647.1(FGFR4): c.1162G=	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	123448	0.679890	U	0.4633	0.299521	13000	0.757692	PASS	.	8496	0.550494	27668	118440	0.679019	.	.	.	.	.	.	rs351855	.	4024	0.566400	0.561	3.818	2.233	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	176520242	176520243	5q35.2	1	normal	.	G	snv	A	CC.GG	het-ref	277	0.48	.	2	.	PASS	134935	C	134935(SK)	NN	.	.	.	.	.	.	.	2264	FGFR4	C8	EX9	.	.	missense	NM_213647.1	NP_998812.1	+	Y	c.1162G>A	p.G388R | p.Gly388Arg	GGG=>AGG	P0=>P+	NM_213647.1(FGFR4): c.1162G>A (p.G388R)	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	123448	0.320110	U	0.4633	0.299521	13000	0.242308	PASS	835	8496	0.449506	6465	118440	0.320981	1714	7695	4.48531e-01	13760	79372	3.26989e-01	rs351855	.	4024	0.433600	0.561	3.818	2.233	0.35	0.515	0.98	0.194	neutral	ENST00000292408: c.1162G>A (p.G388R)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1567768	CM023917	NM_002011.3(FGFR4): c.1162G>A (p.G388R)	"Cancer, accelerated progression, association with"	11830541	DP	no_record	16326	no_assertion_criteria_provided	Pathogenic	Likely Benign
5	176522727	176522728	5q35.2	0	nullSample	.	C	ref	C	TA.AG	homo-ref	.	.	.	0	.	.	134935	C	134935(SK)	NN	.	.	.	.	.	.	.	2264	FGFR4	IC12	IVS13	.	.	no-change	NM_213647.1	NP_998812.1	+	Y	c.1821+4C=	.	.	.	NM_213647.1(FGFR4): c.1821+4C=	;maf-5-some-pop	102172	0.273323	U	0.9742	0.701877	13006	0.401584	PASS	.	7510	0.028362	3699	97164	0.272045	.	.	.	.	.	.	rs42409	.	4024	0.031100	-1.036	-3.249	-3.220	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	176522727	176522728	5q35.2	1	normal	.	C	snv	T	TA.AG	hom-alt	471	1.00	.	0	.	PASS	134935	C	134935(SK)	NN	.	.	.	.	.	.	.	2264	FGFR4	IC12	IVS13	.	.	intron	NM_213647.1	NP_998812.1	+	Y	c.1821+4C>T	.	.	.	NM_213647.1(FGFR4): c.1821+4C>T	;maf-5-some-pop	102172	0.726677	U	0.9742	0.701877	13006	0.598416	PASS	3547	7510	0.971638	25848	97164	0.727955	7560	15579	9.70533e-01	58623	156575	7.29233e-01	rs42409	.	4024	0.968900	-1.036	-3.249	-3.220	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	176523561	176523562	5q35.2	0	nullSample	.	C	ref	C	GT.GG	homo-ref	.	.	.	0	.	.	134935	C	134935(SK)	NN	.	.	.	.	.	.	.	2264	FGFR4	IC14	IVS15	.	.	no-change	NM_213647.1	NP_998812.1	+	Y	c.2016-43C=	.	.	.	NM_213647.1(FGFR4): c.2016-43C=	;maf-5-some-pop	124794	0.171755	U	1	0.852835	13006	0.227895	PASS	-2	8646	0.000463	2145	119786	0.172783	.	.	.	.	.	.	rs31777	.	4024	0.002200	-0.374	-0.443	-0.220	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	176523561	176523562	5q35.2	0	normal	.	C	snv	A	GT.GG	hom-alt	377	1.00	.	0	.	PASS	134935	C	134935(SK)	NN	.	.	.	.	.	.	.	2264	FGFR4	IC14	IVS15	.	.	intron	NM_213647.1	NP_998812.1	+	Y	c.2016-43C>A	.	.	.	NM_213647.1(FGFR4): c.2016-43C>A	;maf-5-some-pop	124794	0.828245	U	1	0.852835	13006	0.772105	PASS	4319	8646	0.999537	41341	119786	0.827217	8588	17184	9.99535e-01	83733	199819	8.31477e-01	rs31777	.	4024	0.997800	-0.374	-0.443	-0.220	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	176523596	176523597	5q35.2	0	nullSample	.	A	ref	A	CT.CC	homo-ref	.	.	.	0	.	.	134935	C	134935(SK)	NN	.	.	.	.	.	.	.	2264	FGFR4	IC14	IVS15	.	.	no-change	NM_213647.1	NP_998812.1	+	Y	c.2016-8A=	.	.	.	NM_213647.1(FGFR4): c.2016-8A=	;maf-5-some-pop	126036	0.234885	U	0.9762	0.785343	13006	0.311087	PASS	.	8648	0.027405	4006	121028	0.235722	.	.	.	.	.	.	rs31776	.	4024	0.030800	-1.195	-1.715	-0.839	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	176523596	176523597	5q35.2	1	normal	.	A	snv	G	CT.CC	hom-alt	483	1.00	.	0	.	PASS	134935	C	134935(SK)	NN	.	.	.	.	.	.	.	2264	FGFR4	IC14	IVS15	.	.	intron	NM_213647.1	NP_998812.1	+	Y	c.2016-8A>G	.	.	.	NM_213647.1(FGFR4): c.2016-8A>G	;maf-5-some-pop	126036	0.765115	U	0.9762	0.785343	13006	0.688913	PASS	4090	8648	0.972595	35991	121028	0.764278	8141	16758	9.71704e-01	73986	188955	7.70999e-01	rs31776	.	4024	0.969200	-1.195	-1.715	-0.839	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	176636881	176636882	5q35.3	0	nullSample	.	C	ref	C	TG.GC	homo-ref	.	.	.	0	.	.	606681	C	117550(MK);130650(MK);601626(MA)	AD	Sotos syndrome; Weaver syndrome; Beckwith-Wiedemann syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Cardiovascular; Oncologic; Renal	22012791|21834047|21738022|21677402|21342349|20420030|20301652|20101679|19914434|18304174|17825104|17480008|17420391|16780628|16329110|16222665|16170239|16010674|15942875|15852475|15455365|15452385|15365454|15362962|15125616|14997421|14571271|14517949|14148233|12525543|12464997|11896389|11813184|11146472|11078573|10507738|10434127|6324572|4366187|3565472|2319581|1552397	.	64324	NSD1	C4	EX5	.	.	no-change	NM_022455.4	NP_071900.2	+	Y	c.1482C=	.	.	.	NM_022455.4(NSD1): c.1482C=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126176	0.693420	U	0.5298	0.468051	13006	0.645856	PASS	-1103	8634	0.468612	31172	121168	0.700094	.	.	.	.	.	.	rs1363405	.	4024	0.466200	-0.332	1.213	0.891	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	176636881	176636882	5q35.3	1	normal	.	C	snv	T	TG.GC	hom-alt	785	1.00	.	0	.	PASS	606681	C	117550(MK);130650(MK);601626(MA)	AD	Sotos syndrome; Weaver syndrome; Beckwith-Wiedemann syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Cardiovascular; Oncologic; Renal	22012791|21834047|21738022|21677402|21342349|20420030|20301652|20101679|19914434|18304174|17825104|17480008|17420391|16780628|16329110|16222665|16170239|16010674|15942875|15852475|15455365|15452385|15365454|15362962|15125616|14997421|14571271|14517949|14148233|12525543|12464997|11896389|11813184|11146472|11078573|10507738|10434127|6324572|4366187|3565472|2319581|1552397	.	64324	NSD1	C4	EX5	.	.	coding-synon	NM_022455.4	NP_071900.2	+	Y	c.1482C>T	p.(C494=) | p.(Cys494=)	TGC=>TGT	.	NM_022455.4(NSD1): c.1482C>T (p.(C494=))	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126176	0.306580	U	0.5298	0.468051	13006	0.354144	PASS	1191	8634	0.531388	6927	121168	0.299906	2503	9256	5.36953e-01	12984	71578	2.91373e-01	rs1363405	.	4024	0.533800	-0.332	1.213	0.891	.	.	.	.	.	ENST00000439151: c.1482C>T (p.C494C)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4419701	.	.	.	.	.	no_record	96035	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
5	176637148	176637149	5q35.3	0	nullSample	.	G	ref	G	GA.AC	homo-ref	.	.	.	0	.	.	606681	C	117550(MK);130650(MK);601626(MA)	AD	Sotos syndrome; Weaver syndrome; Beckwith-Wiedemann syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Cardiovascular; Oncologic; Renal	22012791|21834047|21738022|21677402|21342349|20420030|20301652|20101679|19914434|18304174|17825104|17480008|17420391|16780628|16329110|16222665|16170239|16010674|15942875|15852475|15455365|15452385|15365454|15362962|15125616|14997421|14571271|14517949|14148233|12525543|12464997|11896389|11813184|11146472|11078573|10507738|10434127|6324572|4366187|3565472|2319581|1552397	.	64324	NSD1	C4	EX5	.	.	no-change	NM_022455.4	NP_071900.2	+	Y	c.1749G=	.	.	.	NM_022455.4(NSD1): c.1749G=	;maf-5-some-pop,maf-5-all-pops	120172	0.823536	U	.	.	12994	0.899569	PASS	-1105	8632	0.487720	41566	120172	0.823536	.	.	.	.	.	.	rs3733874	.	4024	0.482900	0.591	2.319	1.382	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	176637148	176637149	5q35.3	1	normal	.	G	snv	A	GA.AC	hom-alt	793	1.00	.	0	.	PASS	606681	C	117550(MK);130650(MK);601626(MA)	AD	Sotos syndrome; Weaver syndrome; Beckwith-Wiedemann syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Cardiovascular; Oncologic; Renal	22012791|21834047|21738022|21677402|21342349|20420030|20301652|20101679|19914434|18304174|17825104|17480008|17420391|16780628|16329110|16222665|16170239|16010674|15942875|15852475|15455365|15452385|15365454|15362962|15125616|14997421|14571271|14517949|14148233|12525543|12464997|11896389|11813184|11146472|11078573|10507738|10434127|6324572|4366187|3565472|2319581|1552397	.	64324	NSD1	C4	EX5	.	.	coding-synon	NM_022455.4	NP_071900.2	+	Y	c.1749G>A	p.(E583=) | p.(Glu583=)	GAG=>GAA	.	NM_022455.4(NSD1): c.1749G>A (p.(E583=))	;maf-5-some-pop,maf-5-all-pops	120172	0.176464	U	.	.	12994	0.100431	PASS	1106	8632	0.512280	2686	120172	0.176464	2280	8838	5.16118e-01	5470	43608	1.78261e-01	rs3733874	.	4024	0.517100	0.591	2.319	1.382	.	.	.	.	.	ENST00000439151: c.1749G>A (p.E583E)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4419034	.	.	.	.	.	no_record	96038	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
5	176637239	176637240	5q35.3	0	nullSample	.	G	ref	G	TG.TG	homo-ref	.	.	.	0	.	.	606681	C	117550(MK);130650(MK);601626(MA)	AD	Sotos syndrome; Weaver syndrome; Beckwith-Wiedemann syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Cardiovascular; Oncologic; Renal	22012791|21834047|21738022|21677402|21342349|20420030|20301652|20101679|19914434|18304174|17825104|17480008|17420391|16780628|16329110|16222665|16170239|16010674|15942875|15852475|15455365|15452385|15365454|15362962|15125616|14997421|14571271|14517949|14148233|12525543|12464997|11896389|11813184|11146472|11078573|10507738|10434127|6324572|4366187|3565472|2319581|1552397	.	64324	NSD1	C4	EX5	.	.	no-change	NM_022455.4	NP_071900.2	+	Y	c.1840G=	.	.	.	NM_022455.4(NSD1): c.1840G=	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	123456	0.821629	U	0.5119	0.228634	13006	0.900661	PASS	-1104	8628	0.487714	40982	118448	0.823754	.	.	.	.	.	.	rs3733875	.	4024	0.482900	-2.213	-0.524	-0.383	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	176637239	176637240	5q35.3	1	normal	.	G	snv	T	TG.TG	hom-alt	786	1.00	.	0	.	PASS	606681	C	117550(MK);130650(MK);601626(MA)	AD	Sotos syndrome; Weaver syndrome; Beckwith-Wiedemann syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Cardiovascular; Oncologic; Renal	22012791|21834047|21738022|21677402|21342349|20420030|20301652|20101679|19914434|18304174|17825104|17480008|17420391|16780628|16329110|16222665|16170239|16010674|15942875|15852475|15455365|15452385|15365454|15362962|15125616|14997421|14571271|14517949|14148233|12525543|12464997|11896389|11813184|11146472|11078573|10507738|10434127|6324572|4366187|3565472|2319581|1552397	.	64324	NSD1	C4	EX5	.	.	missense	NM_022455.4	NP_071900.2	+	Y	c.1840G>T	p.V614L | p.Val614Leu	GTG=>TTG	NP=>NP	NM_022455.4(NSD1): c.1840G>T (p.V614L)	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	123456	0.178363	U	0.5119	0.228634	13006	0.099339	PASS	1106	8628	0.512286	2633	118448	0.176238	2255	8724	5.16641e-01	5248	41802	1.77970e-01	rs3733875	.	4024	0.517100	-2.213	-0.524	-0.383	0.57	0.001	0.001	0.006	neutral	ENST00000439151: c.1840G>T (p.V614L)	oesophagus [NS|NS|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	CSV	4987203	.	.	.	.	.	no_record	96042	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
5	176637575	176637576	5q35.3	0	nullSample	.	T	ref	T	CG.CT	homo-ref	.	.	.	0	.	.	606681	C	117550(MK);130650(MK);601626(MA)	AD	Sotos syndrome; Weaver syndrome; Beckwith-Wiedemann syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Cardiovascular; Oncologic; Renal	22012791|21834047|21738022|21677402|21342349|20420030|20301652|20101679|19914434|18304174|17825104|17480008|17420391|16780628|16329110|16222665|16170239|16010674|15942875|15852475|15455365|15452385|15365454|15362962|15125616|14997421|14571271|14517949|14148233|12525543|12464997|11896389|11813184|11146472|11078573|10507738|10434127|6324572|4366187|3565472|2319581|1552397	.	64324	NSD1	C4	EX5	.	.	no-change	NM_022455.4	NP_071900.2	+	Y	c.2176T=	.	.	.	NM_022455.4(NSD1): c.2176T=	;maf-5-some-pop,maf-5-all-pops	126332	0.799291	U	0.5119	0.249601	13006	0.873674	PASS	-1103	8640	0.487500	39693	121324	0.801309	.	.	.	.	.	.	rs28932178	.	4024	0.482600	0.533	0.216	0.130	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	176637575	176637576	5q35.3	1	normal	.	T	snv	C	CG.CT	hom-alt	698	1.00	.	0	.	PASS	606681	C	117550(MK);130650(MK);601626(MA)	AD	Sotos syndrome; Weaver syndrome; Beckwith-Wiedemann syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Cardiovascular; Oncologic; Renal	22012791|21834047|21738022|21677402|21342349|20420030|20301652|20101679|19914434|18304174|17825104|17480008|17420391|16780628|16329110|16222665|16170239|16010674|15942875|15852475|15455365|15452385|15365454|15362962|15125616|14997421|14571271|14517949|14148233|12525543|12464997|11896389|11813184|11146472|11078573|10507738|10434127|6324572|4366187|3565472|2319581|1552397	.	64324	NSD1	C4	EX5	.	.	missense	NM_022455.4	NP_071900.2	+	Y	c.2176T>C	p.S726P | p.Ser726Pro	TCT=>CCT	P0=>NP	NM_022455.4(NSD1): c.2176T>C (p.S726P)	;maf-5-some-pop,maf-5-all-pops	126332	0.200709	U	0.5119	0.249601	13006	0.126326	PASS	1111	8640	0.512500	3137	121324	0.198691	2311	8922	5.17517e-01	6433	49713	2.01939e-01	rs28932178	.	4024	0.517400	0.533	0.216	0.130	0.17	0.89	0.998	0.409	neutral	ENST00000439151: c.2176T>C (p.S726P)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4418708	.	.	.	.	.	no_record	96043	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
5	176639216	176639217	5q35.3	0	normal	.	T	ref	T	GA.AA	het-alt	44	0.20	.	1	.	PASS	606681	C	117550(MK);130650(MK);601626(MA)	AD	Sotos syndrome; Weaver syndrome; Beckwith-Wiedemann syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Cardiovascular; Oncologic; Renal	22012791|21834047|21738022|21677402|21342349|20420030|20301652|20101679|19914434|18304174|17825104|17480008|17420391|16780628|16329110|16222665|16170239|16010674|15942875|15852475|15455365|15452385|15365454|15362962|15125616|14997421|14571271|14517949|14148233|12525543|12464997|11896389|11813184|11146472|11078573|10507738|10434127|6324572|4366187|3565472|2319581|1552397	.	64324	NSD1	IC4	IVS5	.	.	no-change	NM_022455.4	NP_071900.2	+	Y	c.3796+21T=	.	.	.	NM_022455.4(NSD1): c.3796+21T=	.	.	.	.	0.3889	0.246805	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.459	0.293	0.242	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	176639217	176639217	5q35.3	0	normal	.	.	ins	A	AT.AA	het-ref	176	0.80	.	2	.	PASS	606681	C	117550(MK);130650(MK);601626(MA)	AD	Sotos syndrome; Weaver syndrome; Beckwith-Wiedemann syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Cardiovascular; Oncologic; Renal	22012791|21834047|21738022|21677402|21342349|20420030|20301652|20101679|19914434|18304174|17825104|17480008|17420391|16780628|16329110|16222665|16170239|16010674|15942875|15852475|15455365|15452385|15365454|15362962|15125616|14997421|14571271|14517949|14148233|12525543|12464997|11896389|11813184|11146472|11078573|10507738|10434127|6324572|4366187|3565472|2319581|1552397	.	64324	NSD1	IC4	IVS5	.	.	intron	NM_022455.4	NP_071900.2	+	Y	c.3796+21_3796+22insA	.	.	.	NM_022455.4(NSD1): c.3796+21_3796+22insA	MixedObserved,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops,rs-cluster-nonoverlapping-alleles	63040	0.077030	U	0.3889	0.246805	.	.	PASS	144	4332	0.458910	408	58722	0.309254	.	.	.	.	.	.	rs35159794	.	4024	0.474700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	176721943	176721944	5q35.3	0	normal	.	C	ref	C	GA.CC	het-alt	370	0.50	.	1	.	PASS	606681	C	117550(MK);130650(MK);601626(MA)	AD	Sotos syndrome; Weaver syndrome; Beckwith-Wiedemann syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Cardiovascular; Oncologic; Renal	22012791|21834047|21738022|21677402|21342349|20420030|20301652|20101679|19914434|18304174|17825104|17480008|17420391|16780628|16329110|16222665|16170239|16010674|15942875|15852475|15455365|15452385|15365454|15362962|15125616|14997421|14571271|14517949|14148233|12525543|12464997|11896389|11813184|11146472|11078573|10507738|10434127|6324572|4366187|3565472|2319581|1552397	.	64324	NSD1	C22E	EX23E	.	.	no-change	NM_022455.4	NP_071900.2	+	Y	c.7575C=	.	.	.	NM_022455.4(NSD1): c.7575C=	;	125890	0.998785	U	0	0.000199681	13006	0.999308	PASS	0	8628	1.000000	60291	120882	0.998743	.	.	.	.	.	.	rs148891711	.	.	.	0.462	0.277	0.641	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	176721943	176721944	5q35.3	1	normal	.	C	snv	T	GA.CC	het-ref	369	0.50	.	2	.	PASS	606681	C	117550(MK);130650(MK);601626(MA)	AD	Sotos syndrome; Weaver syndrome; Beckwith-Wiedemann syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Cardiovascular; Oncologic; Renal	22012791|21834047|21738022|21677402|21342349|20420030|20301652|20101679|19914434|18304174|17825104|17480008|17420391|16780628|16329110|16222665|16170239|16010674|15942875|15852475|15455365|15452385|15365454|15362962|15125616|14997421|14571271|14517949|14148233|12525543|12464997|11896389|11813184|11146472|11078573|10507738|10434127|6324572|4366187|3565472|2319581|1552397	.	64324	NSD1	C22E	EX23E	.	.	coding-synon	NM_022455.4	NP_071900.2	+	Y	c.7575C>T	p.(D2525=) | p.(Asp2525=)	GAC=>GAT	.	NM_022455.4(NSD1): c.7575C>T (p.(D2525=))	;	125890	0.001215	U	0	0.000199681	13006	0.000692	PASS	0	8628	0.000000	2	120882	0.001257	0	0	0.00000e+00	3	406	1.65023e-03	rs148891711	.	.	.	0.462	0.277	0.641	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	352893	criteria_provided,_single_submitter	Likely_benign	VUS
5	180038247	180038248	5q35.3	0	normal	.	T	ref	T	TT.CC	het-alt	104	0.54	.	1	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC27	IVS27	.	.	no-change	NM_182925.4	NP_891555.2	-	Y	c.3686+83A=	.	.	.	NM_182925.4(FLT4): c.3686+83A=	;	2	0.500000	U	0.5238	0.575479	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs75065961	.	.	.	-1.442	0.386	0.160	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180038248	180038248	5q35.3	0	normal	.	.	ins	C	TT.CC	het-ref	89	0.46	.	2	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC27	IVS27	.	.	intron	NM_182925.4	NP_891555.2	-	Y	c.3686+82_3686+83insG	.	.	.	NM_182925.4(FLT4): c.3686+82_3686+83insG	;maf-5-some-pop,maf-5-all-pops	5008	0.575479	U	0.5238	0.575479	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs35683852	.	4024	0.501200	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180038525	180038582	5q35.3	0	normal	.	GCCCTCAGCCCTCGCCCCCACCCTCAGCCCTCACCCCCGCCCTCAGCCCTCACCCCC	del	.	CT.gc	het-ref	9	0.07	.	2	trf;C-rich|Low_complexity|Low_complexity|+|98	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC26	IVS26	.	.	intron	NM_182925.4	NP_891555.2	-	Y	c.3538-103_3538-47del	.	.	.	NM_182925.4(FLT4): c.3538-103_3538-47del	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4080	0.074100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180038525	180038582	5q35.3	0	normal	.	GCCCTCAGCCCTCGCCCCCACCCTCAGCCCTCACCCCCGCCCTCAGCCCTCACCCCC	ref	GCCCTCAGCCCTCGCCCCCACCCTCAGCCCTCACCCCCGCCCTCAGCCCTCACCCCC	CT.gc	het-alt	123	0.93	.	1	trf;C-rich|Low_complexity|Low_complexity|+|98	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC26	IVS26	.	.	no-change	NM_182925.4	NP_891555.2	-	Y	c.3538-103_3538-47=	.	.	.	NM_182925.4(FLT4): c.3538-103_3538-47=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4080	0.779500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180041207	180041208	5q35.3	0	nullSample	.	T	ref	T	CG.GG	homo-ref	.	.	.	0	trf	.	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC23	IVS23	.	.	no-change	NM_182925.4	NP_891555.2	-	Y	c.3220-29A=	.	.	.	NM_182925.4(FLT4): c.3220-29A=	;maf-5-some-pop,maf-5-all-pops	108884	0.304462	U	0.5784	0.671925	13006	0.319007	PASS	-883	7614	0.447334	5598	103876	0.303323	.	.	.	.	.	.	rs659268	.	4025	0.467000	-2.075	-0.698	-1.451	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180041207	180041208	5q35.3	0	normal	.	T	snv	C	CG.GG	hom-alt	209	1.00	.	0	trf	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC23	IVS23	.	.	intron	NM_182925.4	NP_891555.2	-	Y	c.3220-29A>G	.	.	.	NM_182925.4(FLT4): c.3220-29A>G	;maf-5-some-pop,maf-5-all-pops	108884	0.695538	U	0.5784	0.671925	13006	0.680993	PASS	1221	7614	0.552666	26028	103876	0.696677	2454	8122	5.71891e-01	55324	149605	7.21753e-01	rs659268	.	4025	0.532800	-2.075	-0.698	-1.451	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	263049	criteria_provided,_single_submitter	Benign	Benign
5	180043329	180043330	5q35.3	0	normal	.	C	ref	C	TC.GC	het-alt	207	0.50	.	1	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC23	IVS23	.	.	no-change	NM_182925.4	NP_891555.2	-	Y	c.3219+37G=	.	.	.	NM_182925.4(FLT4): c.3219+37G=	SingleClassTriAllelic;maf-5-some-pop	126024	0.959055	U	0.0853	0.0349441	13006	0.962633	PASS	.	8638	0.912132	55670	121016	0.958807	.	.	.	.	.	.	rs55657009	.	4024	0.921200	-4.349	-2.602	-4.076	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180043329	180043330	5q35.3	0	normal	.	C	snv	G	TC.GC	het-ref	206	0.50	.	2	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC23	IVS23	.	.	intron	NM_182925.4	NP_891555.2	-	Y	c.3219+37G>C	.	.	.	NM_182925.4(FLT4): c.3219+37G>C	SingleClassTriAllelic;maf-5-some-pop	126024	0.040905	U	0.0853	0.0349441	13006	0.037367	PASS	35	8638	0.087868	147	121016	0.041152	73	1532	8.88528e-02	317	10458	4.25644e-02	rs55657009	.	4024	0.078800	-4.349	-2.602	-4.076	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	263045	criteria_provided,_single_submitter	Benign	Benign
5	180045699	180045700	5q35.3	0	nullSample	.	G	ref	G	CT.GG	homo-ref	.	.	.	0	.	.	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC21	IVS21	.	.	no-change	NM_182925.4	NP_891555.2	-	Y	c.3001+70C=	.	.	.	NM_182925.4(FLT4): c.3001+70C=	MixedObserved;	0	0	U	0.5665	0.640176	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs199584124|rs762872051	.	4024	0.999500	0.555	-1.043	-1.259	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180045700	180045700	5q35.3	0	normal	.	.	ins	GGTTACCCTA	TG.GG	hom-alt	233	1.00	.	0	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC21	IVS21	.	.	intron	NM_182925.4	NP_891555.2	-	Y	c.3001+69_3001+70insTAGGGTAACC	.	.	.	NM_182925.4(FLT4): c.3001+69_3001+70insTAGGGTAACC	InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	5008	0.640176	U	0.5665	0.640176	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3214903	.	4024	0.535300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180045967	180045968	5q35.3	0	normal	.	G	ref	G	CA.AG	het-alt	194	0.49	.	1	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC20	IVS20	.	.	no-change	NM_182925.4	NP_891555.2	-	Y	c.2851-48C=	.	.	.	NM_182925.4(FLT4): c.2851-48C=	;	15866	0.999748	U	.	.	.	.	PASS	-2	728	0.994505	7929	15866	0.999748	.	.	.	.	.	.	rs772658558	.	4024	0.996800	-0.300	0.123	0.079	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180045967	180045968	5q35.3	0	normal	.	G	snv	A	CA.AG	het-ref	203	0.51	.	2	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC20	IVS20	.	.	intron	NM_182925.4	NP_891555.2	-	Y	c.2851-48C>T	.	.	.	NM_182925.4(FLT4): c.2851-48C>T	;	15866	0.000252	U	.	.	.	.	PASS	0	728	0.005495	0	15866	0.000252	0	18	1.64835e-03	0	19	1.29624e-04	rs772658558	.	4024	0.003200	-0.300	0.123	0.079	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
5	180046208	180046209	5q35.3	0	nullSample	.	C	ref	C	cc.gc	homo-ref	.	.	.	0	GC_rich|Low_complexity|Low_complexity|+|39	.	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC19	IVS19	.	.	no-change	NM_182925.4	NP_891555.2	-	Y	c.2761+44G=	.	.	.	NM_182925.4(FLT4): c.2761+44G=	SingleClassTriAllelic;maf-5-some-pop	70420	0.287532	U	0.5139	0.631789	12294	0.321376	PASS	.	3682	0.413634	2032	65412	0.281355	.	.	.	.	.	.	rs446003	.	4024	0.527100	-3.023	-0.844	-1.527	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180046208	180046209	5q35.3	0	normal	.	C	snv	T	cc.gc	hom-alt	234	1.00	.	0	GC_rich|Low_complexity|Low_complexity|+|39	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC19	IVS19	.	.	intron	NM_182925.4	NP_891555.2	-	Y	c.2761+44G>A	.	.	.	NM_182925.4(FLT4): c.2761+44G>A	SingleClassTriAllelic;maf-5-some-pop	70420	0.712454	U	0.5139	0.631789	12294	0.678624	PASS	556	3682	0.586366	16333	65412	0.718630	911	3223	5.60327e-01	33036	92549	7.11040e-01	rs446003	.	4024	0.472900	-3.023	-0.844	-1.527	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	263040	criteria_provided,_single_submitter	Benign	Benign
5	180046343	180046344	5q35.3	0	normal	.	G	ref	G	CG.TG	het-alt	168	0.55	.	1	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	C19	EX19	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	no-change	NM_182925.4	NP_891555.2	-	Y	c.2670C=	.	.	.	NM_182925.4(FLT4): c.2670C=	;maf-5-some-pop,maf-5-all-pops	122620	0.376978	U	0.497	0.582668	12988	0.402987	PASS	-1053	8430	0.513642	8602	117612	0.375259	.	.	.	.	.	.	rs448012	.	4024	0.520600	0.455	1.588	0.126	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180046343	180046344	5q35.3	1	normal	.	G	snv	C	CG.TG	het-ref	136	0.45	.	2	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	C19	EX19	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	missense	NM_182925.4	NP_891555.2	-	Y	c.2670C>G	p.H890Q | p.His890Gln	CAC=>CAG	P+=>P0	NM_182925.4(FLT4): c.2670C>G (p.H890Q)	;maf-5-some-pop,maf-5-all-pops	122620	0.623022	U	0.497	0.582668	12988	0.597013	PASS	997	8430	0.486358	23273	117612	0.624741	2078	8368	4.88785e-01	48517	151327	6.30130e-01	rs448012	.	4024	0.479400	0.455	1.588	0.126	0.04	0.32	0.243	0.449	neutral	ENST00000393347: c.2670C>G (p.H890Q)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	1486680	.	.	.	.	.	no_record	263039	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
5	180047739	180047741	5q35.3	0	normal	.	GT	ref	GT	GC.GT	het-alt	227	0.88	.	1	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC15	IVS15	.	.	no-change	NM_182925.4	NP_891555.2	-	Y	c.2300-26_2300-25=	.	.	.	NM_182925.4(FLT4): c.2300-26_2300-25=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs796540739	.	4024	0.658100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180047739	180047741	5q35.3	0	normal	.	GT	del	.	GC.GT	het-ref	30	0.12	.	2	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC15	IVS15	.	.	intron	NM_182925.4	NP_891555.2	-	Y	c.2300-26_2300-25delAC	.	.	.	NM_182925.4(FLT4): c.2300-26_2300-25delAC	MixedObserved;	0	0	U	.	.	.	.	PASS	0	6180	0.069579	0	92160	0.064084	.	.	.	.	.	.	rs796540739	.	4024	0.341900	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180047862	180047863	5q35.3	0	nullSample	.	C	ref	C	AG.CT	homo-ref	.	.	.	0	.	.	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC15	IVS15	.	.	no-change	NM_182925.4	NP_891555.2	-	Y	c.2299+13G=	.	.	.	NM_182925.4(FLT4): c.2299+13G=	;maf-5-some-pop	121966	0.013537	U	1	0.960064	12996	0.046861	PASS	0	8506	0.000000	93	116958	0.012406	.	.	.	.	.	.	rs423086	.	4024	0.001500	-0.371	-0.991	-1.048	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180047862	180047863	5q35.3	1	normal	.	C	snv	G	AG.CT	hom-alt	513	1.00	.	0	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC15	IVS15	.	.	intron	NM_182925.4	NP_891555.2	-	Y	c.2299+13G>C	.	.	.	NM_182925.4(FLT4): c.2299+13G>C	;maf-5-some-pop	121966	0.986463	U	1	0.960064	12996	0.953139	PASS	4253	8506	1.000000	57121	116958	0.987594	8558	17116	1.00000e+00	118724	239454	9.90617e-01	rs423086	.	4024	0.998500	-0.371	-0.991	-1.048	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	263036	criteria_provided,_single_submitter	Benign	Benign
5	180048985	180048986	5q35.3	0	nullSample	.	G	ref	G	CT.CC	homo-ref	.	.	.	0	.	.	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC12	IVS12	.	.	no-change	NM_182925.4	NP_891555.2	-	Y	c.1658-82C=	.	.	.	NM_182925.4(FLT4): c.1658-82C=	;	5008	0.999002	U	0.8095	0.745208	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs555031641	.	.	.	-2.505	-0.789	-1.082	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180048986	180048986	5q35.3	0	normal	.	.	ins	CCTC	TG.CC	hom-alt	161	0.98	.	0	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC12	IVS12	.	.	intron	NM_182925.4	NP_891555.2	-	Y	c.1658-83_1658-82insGAGG	.	.	.	NM_182925.4(FLT4): c.1658-83_1658-82insGAGG	;maf-5-some-pop,maf-5-all-pops	5008	0.745208	U	0.8095	0.745208	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10635355	.	4024	0.813900	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180051117	180051118	5q35.3	0	normal	.	A	snv	T	AC.TG	het-ref	143	0.50	.	2	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC10	IVS10	.	.	intron	NM_182925.4	NP_891555.2	-	Y	c.1422-57T>A	.	.	.	NM_182925.4(FLT4): c.1422-57T>A	;maf-5-some-pop	5008	0.115615	U	0.3135	0.115615	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs728986	.	4024	0.322800	-1.919	-2.418	-2.629	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180051117	180051118	5q35.3	0	normal	.	A	ref	A	AC.TG	het-alt	145	0.50	.	1	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC10	IVS10	.	.	no-change	NM_182925.4	NP_891555.2	-	Y	c.1422-57T=	.	.	.	NM_182925.4(FLT4): c.1422-57T=	;maf-5-some-pop	5008	0.884385	U	0.3135	0.115615	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs728986	.	4024	0.677200	-1.919	-2.418	-2.629	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180052816	180052817	5q35.3	0	normal	.	G	ref	G	CT.AG	het-alt	122	0.50	.	1	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC10	IVS10	.	.	no-change	NM_182925.4	NP_891555.2	-	Y	c.1421+52C=	.	.	.	NM_182925.4(FLT4): c.1421+52C=	;maf-5-some-pop	5008	0.965855	U	0.1052	0.0341454	5696	0.973666	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3736063	.	4024	0.906100	0.561	-0.501	-0.331	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180052816	180052817	5q35.3	0	normal	.	G	snv	A	CT.AG	het-ref	124	0.50	.	2	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC10	IVS10	.	.	intron	NM_182925.4	NP_891555.2	-	Y	c.1421+52C>T	.	.	.	NM_182925.4(FLT4): c.1421+52C>T	;maf-5-some-pop	5008	0.034145	U	0.1052	0.0341454	5696	0.026334	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3736063	.	4024	0.093900	0.561	-0.501	-0.331	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180052945	180052946	5q35.3	0	normal	.	G	ref	G	CC.TA	het-alt	262	0.47	.	1	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	C10	EX10	Immunoglobulin domain	PF13895.1	no-change	NM_182925.4	NP_891555.2	-	Y	c.1344C=	.	.	.	NM_182925.4(FLT4): c.1344C=	;maf-5-some-pop	124266	0.969581	U	0.1052	0.0341454	12994	0.973680	PASS	.	8602	0.893164	56113	119258	0.969738	.	.	.	.	.	.	rs3736062	.	4024	0.906100	-0.347	-0.215	-0.786	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180052945	180052946	5q35.3	1	normal	.	G	snv	A	CC.TA	het-ref	299	0.53	.	2	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	C10	EX10	Immunoglobulin domain	PF13895.1	coding-synon	NM_182925.4	NP_891555.2	-	Y	c.1344C>T	p.(Y448=) | p.(Tyr448=)	TAC=>TAT	.	NM_182925.4(FLT4): c.1344C>T (p.(Y448=))	;maf-5-some-pop	124266	0.030419	U	0.1052	0.0341454	12994	0.026320	PASS	52	8602	0.106836	93	119258	0.030262	119	1887	1.09506e-01	218	7651	3.13836e-02	rs3736062	.	4024	0.093900	-0.347	-0.215	-0.786	.	.	.	.	.	ENST00000261937: c.1344C>T (p.Y448Y)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019233	.	.	.	.	.	no_record	263024	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
5	180053306	180053307	5q35.3	0	nullSample	.	A	ref	A	CC.CA	homo-ref	.	.	.	0	.	.	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC8	IVS8	.	.	no-change	NM_182925.4	NP_891555.2	-	Y	c.1104-42T=	.	.	.	NM_182925.4(FLT4): c.1104-42T=	;maf-5-some-pop	124546	0.020482	U	1	0.941494	13000	0.069615	PASS	0	8612	0.000000	236	119538	0.018889	.	.	.	.	.	.	rs402647	.	4024	0.001500	-3.077	-0.762	-0.596	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180053306	180053307	5q35.3	0	normal	.	A	snv	G	CC.CA	hom-alt	255	1.00	.	0	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC8	IVS8	.	.	intron	NM_182925.4	NP_891555.2	-	Y	c.1104-42T>C	.	.	.	NM_182925.4(FLT4): c.1104-42T>C	;maf-5-some-pop	124546	0.979518	U	1	0.941494	13000	0.930385	PASS	4306	8612	1.000000	57747	119538	0.981111	8609	17218	1.00000e+00	115780	234495	9.84661e-01	rs402647	.	4024	0.998500	-3.077	-0.762	-0.596	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	263020	criteria_provided,_single_submitter	Benign	Benign
5	180055861	180055862	5q35.3	0	nullSample	.	T	ref	T	GG.GG	homo-ref	.	.	.	0	.	.	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC8	IVS8	.	.	no-change	NM_182925.4	NP_891555.2	-	Y	c.1103+20A=	.	.	.	NM_182925.4(FLT4): c.1103+20A=	MixedObserved;|MixedObserved,SingleClassTriAllelic;maf-5-some-pop	0|114356	0|0.324968	U	0.124	0.0537141	12958	0.586279	PASS	-233	8258	0.060790	5909	109348	0.326206	.	.	.	.	.	.	rs201452968|rs383985	.	4024	0.063100	-4.079	-4.382	-4.126	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180055861	180055862	5q35.3	0	normal	.	T	snv	C	GG.GG	het-alt	104	0.44	.	1	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC8	IVS8	.	.	intron	NM_182925.4	NP_891555.2	-	Y	c.1103+20A>G	.	.	.	NM_182925.4(FLT4): c.1103+20A>G	MixedObserved;|MixedObserved,SingleClassTriAllelic;maf-5-some-pop	0|114356	0|0.071356	U	0.124	0.0537141	12958	0	PASS	59	8258	0.121942	368	109348	0.072164	128	2085	1.22820e-01	772	16240	7.25998e-02	rs201452968|rs383985	.	4024	0.108100	-4.079	-4.382	-4.126	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	263018	criteria_provided,_single_submitter	Benign	Benign
5	180055861	180055862	5q35.3	0	normal	.	T	snv	G	GG.GG	het-alt	134	0.56	.	2	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC8	IVS8	.	.	intron	NM_182925.4	NP_891555.2	-	Y	c.1103+20A>C	.	.	.	NM_182925.4(FLT4): c.1103+20A>C	MixedObserved;|MixedObserved,SingleClassTriAllelic;maf-5-some-pop	0|114356	0|0.603676	U	0.8224	0.648363	12958	0.413721	PASS	2767	8258	0.817268	19847	109348	0.601630	5771	13967	8.22750e-01	42474	136951	6.12230e-01	rs201452968|rs383985	.	4024	0.828800	-4.079	-4.382	-4.126	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	263017	criteria_provided,_single_submitter	Benign	Benign
5	180055863	180055864	5q35.3	1	normal	.	G	snv	A	TG.GG	het-ref	138	0.56	.	2	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC8	IVS8	.	.	intron	NM_182925.4	NP_891555.2	-	Y	c.1103+18C>T	.	.	.	NM_182925.4(FLT4): c.1103+18C>T	;maf-5-some-pop,maf-5-all-pops	115551	0.470589	U	0.3115	0.458466	12964	0.029235	PASS	323	8186	0.299902	11878	110544	0.471134	785	5164	3.04015e-01	24665	106257	4.71018e-01	rs438464	.	4024	0.319300	0.561	0.337	0.090	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	263016	criteria_provided,_single_submitter	Benign	Benign
5	180055863	180055864	5q35.3	0	normal	.	G	ref	G	TG.GG	het-alt	107	0.44	.	1	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC8	IVS8	.	.	no-change	NM_182925.4	NP_891555.2	-	Y	c.1103+18C=	.	.	.	NM_182925.4(FLT4): c.1103+18C=	;maf-5-some-pop,maf-5-all-pops	115551	0.529411	U	0.3115	0.458466	12964	0.970765	PASS	.	8186	0.700098	15068	110544	0.528857	.	.	.	.	.	.	rs438464	.	4024	0.680700	0.561	0.337	0.090	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180056191	180056192	5q35.3	0	normal	.	T	snv	C	GC.CA	het-ref	135	0.53	.	2	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC7	IVS7	.	.	intron	NM_182925.4	NP_891555.2	-	Y	c.985+67A>G	.	.	.	NM_182925.4(FLT4): c.985+67A>G	SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops,rs-cluster-nonoverlapping-alleles	5008	0.466853	U	0.3155	0.466853	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs399108	.	4024	0.321600	-0.441	-1.700	-1.947	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180056191	180056192	5q35.3	0	normal	.	T	ref	T	GC.CA	het-alt	121	0.47	.	1	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC7	IVS7	.	.	no-change	NM_182925.4	NP_891555.2	-	Y	c.985+67A=	.	.	.	NM_182925.4(FLT4): c.985+67A=	SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops,rs-cluster-nonoverlapping-alleles	5008	0.533147	U	0.3155	0.466853	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs399108	.	4024	0.678400	-0.441	-1.700	-1.947	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180056619	180056620	5q35.3	0	nullSample	.	G	ref	G	AC.CG	homo-ref	.	.	.	0	.	.	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC6	IVS6	.	.	no-change	NM_182925.4	NP_891555.2	-	Y	c.816+76C=	.	.	.	NM_182925.4(FLT4): c.816+76C=	;maf-5-some-pop	5008	0.066094	U	1	0.933906	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs414348	.	4024	0.001500	-0.443	0.078	-0.076	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180056619	180056620	5q35.3	0	normal	.	G	snv	A	AC.CG	hom-alt	400	1.00	.	0	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC6	IVS6	.	.	intron	NM_182925.4	NP_891555.2	-	Y	c.816+76C>T	.	.	.	NM_182925.4(FLT4): c.816+76C>T	;maf-5-some-pop	5008	0.933906	U	1	0.933906	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs414348	.	4024	0.998500	-0.443	0.078	-0.076	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180057230	180057231	5q35.3	0	normal	.	C	ref	C	CG.AG	het-alt	205	0.54	.	1	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	C4	EX4	.	.	no-change	NM_182925.4	NP_891555.2	-	Y	c.507G=	.	.	.	NM_182925.4(FLT4): c.507G=	;maf-5-some-pop	124330	0.926011	U	0.123	0.0593051	12998	0.938683	PASS	.	8596	0.883550	51156	119322	0.925395	.	.	.	.	.	.	rs3736061	.	4024	0.896100	-0.314	0.349	1.411	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180057230	180057231	5q35.3	1	normal	.	C	snv	A	CG.AG	het-ref	174	0.46	.	2	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	C4	EX4	.	.	coding-synon	NM_182925.4	NP_891555.2	-	Y	c.507G>T	p.(L169=) | p.(Leu169=)	CTG=>CTT	.	NM_182925.4(FLT4): c.507G>T (p.(L169=))	;maf-5-some-pop	124330	0.073989	U	0.123	0.0593051	12998	0.061317	PASS	52	8596	0.116450	397	119322	0.074605	115	2024	1.17497e-01	870	18745	7.64596e-02	rs3736061	.	4024	0.103900	-0.314	0.349	1.411	.	.	.	.	.	ENST00000261937: c.507G>T (p.L169L)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	3721831	.	.	.	.	.	no_record	263064	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
5	180057355	180057356	5q35.3	0	normal	.	C	ref	C	AG.TG	het-alt	151	0.45	.	1	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC3	IVS3	.	.	no-change	NM_182925.4	NP_891555.2	-	Y	c.401-19G=	.	.	.	NM_182925.4(FLT4): c.401-19G=	;maf-5-some-pop,maf-5-all-pops	122216	0.868307	U	0.5317	0.171725	12988	0.909994	PASS	-1068	8494	0.434189	45229	117208	0.870017	.	.	.	.	.	.	rs56188706	.	4024	0.451500	-1.169	-0.313	-1.229	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180057355	180057356	5q35.3	1	normal	.	C	snv	G	AG.TG	het-ref	181	0.55	.	2	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC3	IVS3	.	.	intron	NM_182925.4	NP_891555.2	-	Y	c.401-19G>C	.	.	.	NM_182925.4(FLT4): c.401-19G>C	;maf-5-some-pop,maf-5-all-pops	122216	0.131693	U	0.5317	0.171725	12988	0.090006	PASS	1335	8494	0.565811	1860	117208	0.129983	2712	9603	5.60399e-01	3842	31027	1.29881e-01	rs56188706	.	4024	0.548500	-1.169	-0.313	-1.229	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	263060	criteria_provided,_single_submitter	Benign	Benign
5	180057875	180057876	5q35.3	0	normal	.	C	ref	C	GC.GA	het-alt	150	0.47	.	1	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC2	IVS2	.	.	no-change	NM_182925.4	NP_891555.2	-	Y	c.156-77G=	.	.	.	NM_182925.4(FLT4): c.156-77G=	;maf-5-some-pop,maf-5-all-pops	240	0.883333	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6859866	.	4024	0.908100	-1.402	-0.611	-0.712	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
5	180057875	180057876	5q35.3	0	normal	.	C	snv	T	GC.GA	het-ref	169	0.53	.	2	.	PASS	136352	C	153100(MK);602089(MK)	AD	Lymphedema, hereditary I (Milory disease)	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular	Allergy/Immunology/Infectious	22768468|20301417|19289394|19002718|16965327|16924388|15689446|14295660|12960217|10835628|9817924	.	2324	FLT4	IC2	IVS2	.	.	intron	NM_182925.4	NP_891555.2	-	Y	c.156-77G>A	.	.	.	NM_182925.4(FLT4): c.156-77G>A	;maf-5-some-pop,maf-5-all-pops	240	0.116667	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6859866	.	4024	0.091700	-1.402	-0.611	-0.712	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	348079	348080	6p25.3	0	normal	.	A	snv	G	AC.TG	hom-alt	463	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	56940	DUSP22	IC5	IVS5	.	.	intron	NM_020185.3	NP_064570.1	+	Y	c.264-23A>G	.	.	.	NM_020185.3(DUSP22): c.264-23A>G	SingleClassTriAllelic;	126274	0.998765	U	1	0.997005	13006	0.997078	PASS	4327	8654	1.000000	60492	121266	0.998837	8621	17243	9.99942e-01	122362	244948	9.99086e-01	rs2797333	.	4024	0.998000	-1.073	-2.356	-2.150	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	348079	348080	6p25.3	0	nullSample	.	A	ref	A	AC.TG	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	56940	DUSP22	IC5	IVS5	.	.	no-change	NM_020185.3	NP_064570.1	+	Y	c.264-23A=	.	.	.	NM_020185.3(DUSP22): c.264-23A=	SingleClassTriAllelic;	126274	0.001220	U	1	0.997005	13006	0.002922	PASS	0	8654	0.000000	0	121266	0.001146	.	.	.	.	.	.	rs2797333	.	4024	0.002000	-1.073	-2.356	-2.150	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	26031867	26031868	6p22.2	0	normal	.	G	ref	G	GT.AC	het-alt	144	0.46	.	1	.	PASS	602819	P	.	NN	.	.	.	.	.	.	.	8358	HIST1H3B	3U1E	EX1E	.	.	no-change	NM_003537.3	NP_003528.1	-	Y	c.*10C=	.	.	.	NM_003537.3(HIST1H3B): c.*10C=	;maf-5-some-pop	126258	0.293368	U	0.8581	0.78115	13006	0.239428	PASS	-455	8618	0.120910	5844	121250	0.296445	.	.	.	.	.	.	rs2213284	.	.	.	-0.361	-1.904	-1.785	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	26031867	26031868	6p22.2	0	normal	.	G	snv	A	GT.AC	het-ref	167	0.54	.	2	.	PASS	602819	P	.	NN	.	.	.	.	.	.	.	8358	HIST1H3B	3U1E	EX1E	.	.	utr-3	NM_003537.3	NP_003528.1	-	Y	c.*10C>T	.	.	.	NM_003537.3(HIST1H3B): c.*10C>T	;maf-5-some-pop	126258	0.706632	U	0.8581	0.78115	13006	0.760572	PASS	3333	8618	0.879090	30525	121250	0.703555	6395	14710	8.67949e-01	60646	170158	7.02198e-01	rs2213284	.	.	.	-0.361	-1.904	-1.785	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	26045736	26045737	6p22.2	0	normal	.	C	ref	C	AC.GG	het-alt	143	0.56	.	1	.	PASS	602812	P	.	NN	.	.	.	.	.	.	.	8352	HIST1H3C	C1E	EX1E	.	.	no-change	NM_003531.2	NP_003522.1	+	Y	c.99C=	.	.	.	NM_003531.2(HIST1H3C): c.99C=	;maf-5-some-pop,maf-5-all-pops	125454	0.851523	U	0.5149	0.216853	13004	0.924792	PASS	-1078	8620	0.463573	45030	120446	0.854366	.	.	.	.	.	.	rs3752418	.	.	.	-4.293	-1.780	-4.367	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	26045736	26045737	6p22.2	1	normal	.	C	snv	G	AC.GG	het-ref	113	0.44	.	2	.	PASS	602812	P	.	NN	.	.	.	.	.	.	.	8352	HIST1H3C	C1E	EX1E	.	.	coding-synon	NM_003531.2	NP_003522.1	+	Y	c.99C>G	p.(T33=) | p.(Thr33=)	ACC=>ACG	.	NM_003531.2(HIST1H3C): c.99C>G (p.(T33=))	;maf-5-some-pop,maf-5-all-pops	125454	0.148477	U	0.5149	0.216853	13004	0.075208	PASS	1234	8620	0.536427	2348	120446	0.145634	2445	9169	5.33702e-01	5003	37012	1.50886e-01	rs3752418	.	.	.	-4.293	-1.780	-4.367	.	.	.	.	.	ENST00000540144: c.99C>G (p.T33T)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3761735	.	.	.	.	.	.	.	.	.	Likely Benign
6	26271300	26271301	6p22.2	0	normal	.	G	ref	G	AA.AG	het-alt	168	0.52	.	1	.	PASS	602815	P	.	NN	.	.	.	.	.	.	.	8355	HIST1H3G	C1E	EX1E	.	.	no-change	NM_003534.2	NP_003525.1	-	Y	c.312C=	.	.	.	NM_003534.2(HIST1H3G): c.312C=	;	126376	0.998853	U	0.006	0.00119808	13006	0.999846	PASS	.	8646	0.987393	60545	121368	0.998855	.	.	.	.	.	.	rs144684800	.	.	.	-0.300	-0.847	-1.614	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	26271300	26271301	6p22.2	1	normal	.	G	snv	A	AA.AG	het-ref	156	0.48	.	2	.	PASS	602815	P	.	NN	.	.	.	.	.	.	.	8355	HIST1H3G	C1E	EX1E	.	.	coding-synon	NM_003534.2	NP_003525.1	-	Y	c.312C>T	p.(L104=) | p.(Leu104=)	CTC=>CTT	.	NM_003534.2(HIST1H3G): c.312C>T (p.(L104=))	;	126376	0.001147	U	0.006	0.00119808	13006	0.000154	PASS	0	8646	0.012607	0	121368	0.001145	2	204	1.18275e-02	2	263	1.06796e-03	rs144684800	.	.	.	-0.300	-0.847	-1.614	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
6	27114424	27114425	6p22.1	0	normal	.	G	ref	G	TC.GG	het-alt	345	0.79	.	1	.	DUBIOUS	615045	P	.	NN	.	.	.	.	.	.	.	85236	HIST1H2BK	C1E	EX1	Core histone H2A/H2B/H3/H4;Histone-like transcription factor (CBF/NF-Y) and archaeal histone	PF00125.19;PF00808.18	no-change	NM_080593.2	NP_542160.1	-	Y	c.153C=	.	.	.	NM_080593.2(HIST1H2BK): c.153C=	SingleClassQuadAllelic;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	102250	0.758200	U	.	.	.	.	VQSRTrancheSNP99.80to99.90	-1296	7436	0.651425	26401	102250	0.758200	.	.	.	.	.	.	rs202101103	.	4024	0.704500	-0.188	0.150	-1.001	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	27114424	27114425	6p22.1	1	normal	.	G	snv	A	TC.GG	het-ref	91	0.21	.	2	.	DUBIOUS	615045	P	.	NN	.	.	.	.	.	.	.	85236	HIST1H2BK	C1E	EX1	Core histone H2A/H2B/H3/H4;Histone-like transcription factor (CBF/NF-Y) and archaeal histone	PF00125.19;PF00808.18	coding-synon	NM_080593.2	NP_542160.1	-	Y	c.153C>T	p.(P51=) | p.(Pro51=)	CCC=>CCT	.	NM_080593.2(HIST1H2BK): c.153C>T (p.(P51=))	SingleClassQuadAllelic;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	102250	0.241780	U	.	.	.	.	VQSRTrancheSNP99.80to99.90	0	7436	0.348575	0	102250	0.241780	0	761	6.01011e-02	0	7954	4.67855e-02	rs202101103	.	4024	0.295500	-0.188	0.150	-1.001	.	.	.	.	.	ENST00000356950: c.153C>T (p.P51P)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	RSS	1487539	.	.	.	.	.	.	.	.	.	Unknown
6	29910236	29910237	6p22.1	0	normal	.	C	ref	C	GT.GG	het-alt	233	0.78	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	PROM	.	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.-84-u10C=	.	.	.	NM_001242758.1(HLA-A): c.-84-u10C=	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs796126528	.	.	.	-3.260	-1.521	-1.981	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	29910236	29910237	6p22.1	0	normal	.	C	snv	T	GT.GG	het-ref	66	0.22	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	PROM	.	.	.	promoter	NM_001242758.1	NP_001229687.1	+	Y	c.-84-u10C>T	.	.	.	NM_001242758.1(HLA-A): c.-84-u10C>T	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs796126528	.	.	.	-3.260	-1.521	-1.981	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	29910244	29910245	6p22.1	0	normal	.	C	ref	C	TC.AG	het-alt	244	0.77	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	PROM	.	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.-84-u2C=	.	.	.	NM_001242758.1(HLA-A): c.-84-u2C=	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs796742140	.	.	.	-2.292	-0.727	-0.506	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	29910244	29910245	6p22.1	0	normal	.	C	snv	T	TC.AG	het-ref	71	0.23	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	PROM	.	.	.	promoter	NM_001242758.1	NP_001229687.1	+	Y	c.-84-u2C>T	.	.	.	NM_001242758.1(HLA-A): c.-84-u2C>T	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs796742140	.	.	.	-2.292	-0.727	-0.506	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	29910264	29910265	6p22.1	0	normal	.	G	ref	G	TC.TC	het-alt	276	0.82	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	5U1E	EX1	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.-66G=	.	.	.	NM_001242758.1(HLA-A): c.-66G=	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	5008	0.898163	U	0.2629	0.101837	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs41545520	.	.	.	-3.550	-5.731	-5.735	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910264	29910265	6p22.1	0	normal	.	G	snv	A	TC.TC	het-ref	59	0.18	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	5U1E	EX1	.	.	utr-5	NM_001242758.1	NP_001229687.1	+	Y	c.-66G>A	.	.	.	NM_001242758.1(HLA-A): c.-66G>A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-3.550	-5.731	-5.735	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	29910273	29910274	6p22.1	0	normal	.	G	ref	G	TC.CT	het-alt	302	0.86	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	5U1E	EX1	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.-57G=	.	.	.	NM_001242758.1(HLA-A): c.-57G=	;maf-5-some-pop	5008	0.969050	U	0.0208	0.0309505	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs529070997	.	.	.	-0.355	0.118	0.369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	29910273	29910274	6p22.1	0	normal	.	G	snv	C	TC.CT	het-ref	48	0.14	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	5U1E	EX1	.	.	utr-5	NM_001242758.1	NP_001229687.1	+	Y	c.-57G>C	.	.	.	NM_001242758.1(HLA-A): c.-57G>C	;maf-5-some-pop	5008	0.030950	U	0.0208	0.0309505	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs529070997	.	.	.	-0.355	0.118	0.369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	29910275	29910276	6p22.1	0	normal	.	T	snv	G	GC.GT	het-ref	209	0.56	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	5U1E	EX1	.	.	utr-5	NM_001242758.1	NP_001229687.1	+	Y	c.-55T>G	.	.	.	NM_001242758.1(HLA-A): c.-55T>G	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5008	0.533347	U	0.4851	0.533347	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs41560714	.	.	.	-0.349	-0.204	-0.024	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910275	29910276	6p22.1	0	normal	.	T	ref	T	GC.GT	het-alt	166	0.44	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	5U1E	EX1	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.-55T=	.	.	.	NM_001242758.1(HLA-A): c.-55T=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5008	0.466653	U	0.4851	0.533347	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs41560714	.	.	.	-0.349	-0.204	-0.024	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910285	29910286	6p22.1	0	normal	.	C	snv	T	AG.CC	het-ref	234	0.55	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	5U1E	EX1	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.-45T=	.	.	.	NM_001242758.1(HLA-A): c.-45T=	MixedObserved;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	116360	0.847508	U	0.9692	0.873003	12978	0.818539	PASS	3971	8520	0.965962	39873	111352	0.846361	7189	14861	9.67765e-01	69620	164046	8.46567e-01	rs2916801	.	.	.	-0.534	-2.083	-1.869	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910285	29910286	6p22.1	0	normal	.	C	ref	C	AG.CC	het-alt	189	0.45	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	5U1E	EX1	.	.	utr-5	NM_001242758.1	NP_001229687.1	+	Y	c.-45T>C	.	.	.	NM_001242758.1(HLA-A): c.-45T>C	MixedObserved;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	116360	0.152492	U	0.9692	0.873003	12978	0.181461	PASS	-144	8520	0.034038	1305	111352	0.153639	.	.	.	.	.	.	rs2916801	.	.	.	-0.534	-2.083	-1.869	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910288	29910289	6p22.1	0	normal	.	G	ref	G	CC.CA	het-alt	384	0.89	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	5U1E	EX1	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.-42G=	.	.	.	NM_001242758.1(HLA-A): c.-42G=	;maf-5-some-pop	108702	0.933699	U	.	.	.	.	VQSRTrancheSNP99.80to99.90	.	8238	0.891843	47144	108702	0.933699	.	.	.	.	.	.	rs199780123	.	.	.	-0.355	-0.959	-1.202	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910288	29910289	6p22.1	0	normal	.	G	snv	C	CC.CA	het-ref	48	0.11	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	5U1E	EX1	.	.	utr-5	NM_001242758.1	NP_001229687.1	+	Y	c.-42G>C	.	.	.	NM_001242758.1(HLA-A): c.-42G>C	;maf-5-some-pop	108702	0.066300	U	.	.	.	.	VQSRTrancheSNP99.80to99.90	0	8238	0.108157	0	108702	0.066301	0	149	1.12981e-02	0	1895	1.07970e-02	rs199780123	.	.	.	-0.355	-0.959	-1.202	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910293	29910294	6p22.1	0	normal	.	C	ref	C	CG.AC	het-alt	421	0.90	.	1	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	5U1E	EX1	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.-37C=	.	.	.	NM_001242758.1(HLA-A): c.-37C=	;maf-5-some-pop	108786	0.933631	U	.	.	.	.	VQSRTrancheSNP99.80to99.90	.	8268	0.891993	47173	108786	0.933631	.	.	.	.	.	.	rs200736475	.	.	.	-1.706	-2.795	-2.632	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910293	29910294	6p22.1	0	normal	.	C	snv	A	CG.AC	het-ref	46	0.10	.	2	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	5U1E	EX1	.	.	utr-5	NM_001242758.1	NP_001229687.1	+	Y	c.-37C>A	.	.	.	NM_001242758.1(HLA-A): c.-37C>A	;maf-5-some-pop	108786	0.066369	U	.	.	.	.	VQSRTrancheSNP99.80to99.90	0	8268	0.108007	0	108786	0.066369	0	155	1.17176e-02	0	1977	1.12179e-02	rs200736475	.	.	.	-1.706	-2.795	-2.632	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910301	29910302	6p22.1	0	normal	.	G	ref	G	CC.GG	het-alt	458	0.91	.	1	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	5U1E	EX1	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.-29G=	.	.	.	NM_001242758.1(HLA-A): c.-29G=	;maf-5-some-pop	107892	0.932692	U	.	.	.	.	VQSRTrancheSNP99.60to99.80	.	8076	0.888930	46684	107892	0.932692	.	.	.	.	.	.	rs201399357	.	.	.	-2.989	-0.555	-0.811	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910301	29910302	6p22.1	0	normal	.	G	snv	C	CC.GG	het-ref	47	0.09	.	2	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	5U1E	EX1	.	.	utr-5	NM_001242758.1	NP_001229687.1	+	Y	c.-29G>C	.	.	.	NM_001242758.1(HLA-A): c.-29G>C	;maf-5-some-pop	107892	0.067308	U	.	.	.	.	VQSRTrancheSNP99.60to99.80	0	8076	0.111070	0	107892	0.067308	0	216	1.63910e-02	0	2586	1.46204e-02	rs201399357	.	.	.	-2.989	-0.555	-0.811	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910335	29910336	6p22.1	0	normal	.	C	ref	C	GC.GT	het-alt	616	0.83	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C1	EX1	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.6C=	.	.	.	NM_001242758.1(HLA-A): c.6C=	SingleClassTriAllelic;maf-5-some-pop	111092	0.907698	U	.	.	.	.	PASS	-655	8380	0.843675	45292	111092	0.907698	.	.	.	.	.	.	rs113772324	.	.	.	-0.355	-0.075	-0.075	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910335	29910336	6p22.1	1	normal	.	C	snv	G	GC.GT	het-ref	124	0.17	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C1	EX1	.	.	coding-synon	NM_001242758.1	NP_001229687.1	+	Y	c.6C>G	p.(A2=) | p.(Ala2=)	GCC=>GCG	.	NM_001242758.1(HLA-A): c.6C>G (p.(A2=))	SingleClassTriAllelic;maf-5-some-pop	111092	0.092293	U	.	.	.	.	PASS	0	8380	0.156325	0	111092	0.092293	0	582	4.29457e-02	0	7123	3.74800e-02	rs113772324	.	.	.	-0.355	-0.075	-0.075	.	.	.	.	.	ENST00000396634: c.6C>G (p.A2A)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4160500	.	.	.	.	.	.	.	.	.	Likely Benign
6	29910339	29910340	6p22.1	1	normal	.	A	snv	G	TC.TG	het-ref	139	0.18	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C1	EX1	.	.	missense	NM_001242758.1	NP_001229687.1	+	Y	c.10A>G	p.M4V | p.Met4Val	ATG=>GTG	NP=>NP	NM_001242758.1(HLA-A): c.10A>G (p.M4V)	;maf-5-some-pop	111270	0.092460	U	.	.	.	.	PASS	0	8394	0.155945	0	111270	0.092460	0	647	4.69999e-02	0	7767	3.97675e-02	rs79326316	.	.	.	-0.537	-1.517	-1.630	0.09	0.001	0	0.296	neutral	ENST00000396634: c.10A>G (p.M4V)	central_nervous_system [spinal_cord|NS|NS]	glioma [astrocytoma_Grade_II|fibrillary|NS]	RSS	4160501	.	.	.	.	.	.	.	.	.	Likely Benign
6	29910339	29910340	6p22.1	0	normal	.	A	ref	A	TC.TG	het-alt	628	0.82	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C1	EX1	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.10A=	.	.	.	NM_001242758.1(HLA-A): c.10A=	;maf-5-some-pop	111270	0.907540	U	.	.	.	.	PASS	.	8394	0.844055	45347	111270	0.907540	.	.	.	.	.	.	rs79326316	.	.	.	-0.537	-1.517	-1.630	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910370	29910371	6p22.1	0	normal	.	C	ref	C	CT.GG	het-alt	516	0.59	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C1	EX1	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.41C=	.	.	.	NM_001242758.1(HLA-A): c.41C=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	114364	0.878493	U	.	.	12994	0.873942	PASS	.	8526	0.845531	43592	114364	0.878493	.	.	.	.	.	.	rs2230954	.	.	.	0.478	-0.297	-0.164	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910370	29910371	6p22.1	1	normal	.	C	snv	T	CT.GG	het-ref	357	0.41	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C1	EX1	.	.	missense	NM_001242758.1	NP_001229687.1	+	Y	c.41C>T	p.S14L | p.Ser14Leu	TCG=>TTG	P0=>NP	NM_001242758.1(HLA-A): c.41C>T (p.S14L)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	114364	0.121507	U	.	.	12994	0.126058	PASS	0	8526	0.154469	306	114364	0.121507	73	2554	1.55732e-01	888	27385	1.23539e-01	rs2230954	.	.	.	0.478	-0.297	-0.164	0.1	0.003	0.001	0.286	neutral	ENST00000396634: c.41C>T (p.S14L)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4407066	.	.	.	.	.	.	.	.	.	Likely Benign
6	29910418	29910419	6p22.1	0	normal	.	G	ref	G	CG.GA	het-alt	528	0.61	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.73+16G=	.	.	.	NM_001242758.1(HLA-A): c.73+16G=	MixedObserved;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	115034	0.880592	U	0.1349	0.147364	.	.	PASS	-627	8354	0.849892	42266	110026	0.881864	.	.	.	.	.	.	rs9260122	.	.	.	0.478	0.662	0.307	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910418	29910419	6p22.1	1	normal	.	G	snv	T	CG.GA	het-ref	341	0.39	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.73+16G>T	.	.	.	NM_001242758.1(HLA-A): c.73+16G>T	MixedObserved;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	115034	0.119408	U	0.1349	0.147364	.	.	PASS	0	8354	0.150108	251	110026	0.118136	82	2488	1.48591e-01	861	26360	1.18526e-01	rs9260122	.	.	.	0.478	0.662	0.307	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910420	29910421	6p22.1	0	normal	.	A	ref	A	GG.GG	het-alt	518	0.61	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.73+18A=	.	.	.	NM_001242758.1(HLA-A): c.73+18A=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	114662	0.880292	U	.	.	12416	0.875483	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9278464	.	.	.	0.391	-0.610	-0.744	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910420	29910421	6p22.1	1	normal	.	A	del	.	GG.GG	het-ref	335	0.39	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.73+18delA	.	.	.	NM_001242758.1(HLA-A): c.73+18delA	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	114662	0.119708	U	0.1349	0.147364	12416	0.124517	VQSRTrancheINDEL97.00to99.00	0	8350	0.149940	250	109654	0.118445	82	2484	1.50327e-01	860	26348	1.20826e-01	rs9278464	.	.	.	0.391	-0.610	-0.744	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910438	29910439	6p22.1	0	normal	.	G	ref	G	CG.GG	het-alt	672	0.86	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.73+36G=	.	.	.	NM_001242758.1(HLA-A): c.73+36G=	;maf-5-some-pop,maf-5-all-pops	103668	0.938525	U	.	.	.	.	PASS	-445	7734	0.884924	45461	103668	0.938525	.	.	.	.	.	.	rs188678899	.	.	.	-0.346	0.241	-0.008	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910438	29910439	6p22.1	0	normal	.	G	snv	A	CG.GG	het-ref	111	0.14	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.73+36G>A	.	.	.	NM_001242758.1(HLA-A): c.73+36G>A	;maf-5-some-pop,maf-5-all-pops	103668	0.061475	U	.	.	.	.	PASS	0	7734	0.115076	0	103668	0.061475	0	863	5.60171e-02	0	7301	3.52739e-02	rs188678899	.	.	.	-0.346	0.241	-0.008	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910443	29910444	6p22.1	0	normal	.	A	snv	G	AG.AG	het-ref	94	0.12	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.73+41A>G	.	.	.	NM_001242758.1(HLA-A): c.73+41A>G	;maf-5-some-pop,maf-5-all-pops	103332	0.061046	U	.	.	.	.	PASS	0	7800	0.113077	0	103332	0.061046	0	759	5.02982e-02	0	6409	3.14302e-02	rs192596431	.	.	.	-0.401	0.005	0.013	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910443	29910444	6p22.1	0	normal	.	A	ref	A	AG.AG	het-alt	687	0.88	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.73+41A=	.	.	.	NM_001242758.1(HLA-A): c.73+41A=	;maf-5-some-pop,maf-5-all-pops	103332	0.938954	U	.	.	.	.	PASS	-441	7800	0.886923	45358	103332	0.938954	.	.	.	.	.	.	rs192596431	.	.	.	-0.401	0.005	0.013	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910447	29910449	6p22.1	0	normal	.	AA	ref	AA	GC.GG	het-alt	721	0.90	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.73+45_73+46=	.	.	.	NM_001242758.1(HLA-A): c.73+45_73+46=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs760402696	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	29910447	29910449	6p22.1	0	normal	.	AA	del	.	GC.GG	het-ref	76	0.10	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.73+45_73+46delAA	.	.	.	NM_001242758.1(HLA-A): c.73+45_73+46delAA	MixedObserved;	0	0	U	.	.	.	.	VQSRTrancheINDEL99.00to99.50	0	7898	0.105596	0	103362	0.058513	.	.	.	.	.	.	rs760402696	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910450	29910451	6p22.1	0	normal	.	G	ref	G	AG.GG	het-alt	688	0.91	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.73+48G=	.	.	.	NM_001242758.1(HLA-A): c.73+48G=	.	.	.	.	.	.	.	.	VQSRTrancheINDEL99.00to99.50	-412	7634	0.892062	44256	100450	0.940577	.	.	.	.	.	.	.	.	.	.	-0.373	0.182	0.222	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910451	29910451	6p22.1	0	normal	.	.	ins	GC	GG.GG	het-ref	71	0.09	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.73+48_73+49insGC	.	.	.	NM_001242758.1(HLA-A): c.73+48_73+49insGC	MixedObserved;maf-5-some-pop,maf-5-all-pops	100450	0.059423	U	.	.	.	.	VQSRTrancheINDEL99.00to99.50	0	7634	0.107938	0	100450	0.059423	0	592	3.93669e-02	0	4790	2.35268e-02	rs753355820	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910456	29910457	6p22.1	0	normal	.	T	ref	T	CC.CC	het-alt	366	0.50	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.73+54T=	.	.	.	NM_001242758.1(HLA-A): c.73+54T=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	105326	0.378406	U	0.6855	0.682508	.	.	PASS	-905	7652	0.338996	6810	100318	0.381447	.	.	.	.	.	.	rs9260125	.	.	.	-1.683	0.049	-0.192	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910456	29910457	6p22.1	0	normal	.	T	snv	G	CC.CC	het-ref	360	0.50	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.73+54T>G	.	.	.	NM_001242758.1(HLA-A): c.73+54T>G	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	105326	0.621594	U	0.6855	0.682508	.	.	PASS	1624	7652	0.661004	18703	100318	0.618553	3740	10636	6.83109e-01	44106	133119	6.40920e-01	rs9260125	.	.	.	-1.683	0.049	-0.192	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910459	29910460	6p22.1	0	normal	.	T	ref	T	CC.GG	het-alt	368	0.51	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.73+57T=	.	.	.	NM_001242758.1(HLA-A): c.73+57T=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	102802	0.759022	U	0.1964	0.292332	.	.	PASS	.	7378	0.793575	28225	97794	0.761652	.	.	.	.	.	.	rs9260126	.	.	.	-1.690	-1.057	-1.074	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910459	29910460	6p22.1	0	normal	.	T	snv	C	CC.GG	het-ref	352	0.49	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.73+57T>C	.	.	.	NM_001242758.1(HLA-A): c.73+57T>C	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	102802	0.240978	U	0.1964	0.292332	.	.	PASS	153	7378	0.206425	2637	97794	0.238348	355	3271	2.03724e-01	6660	50191	2.37834e-01	rs9260126	.	.	.	-1.690	-1.057	-1.074	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910477	29910478	6p22.1	0	normal	.	G	snv	C	CC.GG	het-ref	281	0.44	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.74-56G>C	.	.	.	NM_001242758.1(HLA-A): c.74-56G>C	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	93450	0.550498	U	0.6587	0.648562	.	.	PASS	926	6488	0.565814	12131	88442	0.544945	2770	8917	6.26986e-01	32681	109716	5.86579e-01	rs9260127	.	.	.	-4.053	-0.459	-0.278	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910477	29910478	6p22.1	0	normal	.	G	ref	G	CC.GG	het-alt	362	0.56	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.74-56G=	.	.	.	NM_001242758.1(HLA-A): c.74-56G=	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	93450	0.449492	U	0.6587	0.648562	.	.	PASS	-909	6488	0.434032	8156	88442	0.455044	.	.	.	.	.	.	rs9260127	.	.	.	-4.053	-0.459	-0.278	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910481	29910482	6p22.1	0	normal	.	G	ref	G	GG.AG	het-alt	365	0.56	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.74-52G=	.	.	.	NM_001242758.1(HLA-A): c.74-52G=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	91758	0.455524	U	0.5397	0.508986	.	.	PASS	-867	6300	0.439683	8441	86750	0.461533	.	.	.	.	.	.	rs9256980	.	.	.	-1.379	-0.370	-0.964	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910481	29910482	6p22.1	0	normal	.	G	snv	T	GG.AG	het-ref	286	0.44	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.74-52G>T	.	.	.	NM_001242758.1(HLA-A): c.74-52G>T	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	91758	0.093006	U	0.119	0.139577	.	.	PASS	6	6300	0.097302	240	86750	0.090317	114	1944	1.40584e-01	878	20032	1.09265e-01	rs9256980	.	.	.	-1.379	-0.370	-0.964	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910495	29910496	6p22.1	0	normal	.	C	ref	C	GA.GA	het-alt	373	0.54	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.74-38C=	.	.	.	NM_001242758.1(HLA-A): c.74-38C=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	92732	0.156019	U	0.9841	0.926917	11002	0.163607	PASS	.	6470	0.034158	1506	87724	0.160754	.	.	.	.	.	.	rs2904759	.	.	.	-0.348	-0.183	-0.132	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910495	29910496	6p22.1	0	normal	.	C	snv	G	GA.GA	het-ref	312	0.46	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.74-38C>G	.	.	.	NM_001242758.1(HLA-A): c.74-38C>G	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	92732	0.843959	U	0.9841	0.926917	11002	0.836393	PASS	3020	6470	0.965842	31264	87724	0.839223	7557	15260	9.90395e-01	78122	174854	8.72865e-01	rs2904759	.	.	.	-0.348	-0.183	-0.132	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910507	29910508	6p22.1	0	normal	.	A	ref	A	GC.GG	het-alt	392	0.55	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.74-26A=	.	.	.	NM_001242758.1(HLA-A): c.74-26A=	MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	90660	0.446360	U	0.6905	0.687101	.	.	PASS	.	6208	0.418653	8877	85652	0.454163	.	.	.	.	.	.	rs9260129	.	.	.	-0.345	-1.937	-1.639	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910507	29910508	6p22.1	0	normal	.	A	snv	G	GC.GG	het-ref	325	0.45	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.74-26A>G	.	.	.	NM_001242758.1(HLA-A): c.74-26A>G	MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	90660	0.553629	U	0.6905	0.687101	.	.	PASS	1028	6208	0.581186	12803	85652	0.545825	3264	9224	6.63120e-01	39452	115256	6.15342e-01	rs9260129	.	.	.	-0.345	-1.937	-1.639	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910509	29910510	6p22.1	0	normal	.	G	snv	A	AG.TC	het-ref	300	0.41	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.74-24G>A	.	.	.	NM_001242758.1(HLA-A): c.74-24G>A	;clinically-assoc,submitted-by-lsdb	89109	0.047459	U	.	.	.	.	VQSRTrancheINDEL99.50to99.90	4	6228	0.096500	58	89110	0.047458	84	1852	1.22115e-01	278	11199	5.23930e-02	rs41541212	.	.	.	0.478	-0.213	-0.100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	29910509	29910510	6p22.1	0	normal	.	G	ref	G	AG.TC	het-alt	425	0.59	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.74-24G=	.	.	.	NM_001242758.1(HLA-A): c.74-24G=	;clinically-assoc,submitted-by-lsdb	89109	0.952541	U	.	.	.	.	VQSRTrancheINDEL99.50to99.90	.	6228	0.903500	40383	89110	0.952531	.	.	.	.	.	.	rs41541212	.	.	.	0.478	-0.213	-0.100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910521	29910522	6p22.1	1	normal	.	G	snv	C	CT.CT	het-ref	348	0.48	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.74-12G>C	.	.	.	NM_001242758.1(HLA-A): c.74-12G>C	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	99524	0.581980	U	0.6925	0.688498	.	.	PASS	1211	7020	0.607835	14897	94516	0.576336	3505	9949	6.77448e-01	43945	128952	6.43409e-01	rs9260130	.	.	.	-1.723	-1.691	-1.216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910521	29910522	6p22.1	0	normal	.	G	ref	G	CT.CT	het-alt	375	0.52	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC1	IVS1	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.74-12G=	.	.	.	NM_001242758.1(HLA-A): c.74-12G=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	99524	0.418020	U	0.6925	0.688498	.	.	PASS	.	7020	0.392165	7682	94516	0.423664	.	.	.	.	.	.	rs9260130	.	.	.	-1.723	-1.691	-1.216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910556	29910557	6p22.1	1	normal	.	T	snv	A	TC.TC	het-ref	454	0.46	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_001242758.1	NP_001229687.1	+	Y	c.97T>A	p.F33I | p.Phe33Ile	TTC=>ATC	NP=>NP	NM_001242758.1(HLA-A): c.97T>A (p.F33I)	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	114528	0.091908	U	0.12	0.106829	.	.	PASS	23	8020	0.157107	199	109520	0.091225	45	2441	1.44695e-01	386	20900	8.72433e-02	rs1136659	.	.	.	-0.712	-2.503	-2.974	0.25	0.105	0.059	0.045	neutral	ENST00000396634: c.97T>A (p.F33I)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4596306	.	.	.	.	.	.	.	.	.	Likely Benign
6	29910556	29910557	6p22.1	0	normal	.	T	ref	T	TC.TC	het-alt	536	0.54	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.97T=	.	.	.	NM_001242758.1(HLA-A): c.97T=	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	114528	0.908092	U	0.12	0.106829	.	.	PASS	-607	8020	0.842893	44968	109520	0.908775	.	.	.	.	.	.	rs1136659	.	.	.	-0.712	-2.503	-2.974	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910557	29910558	6p22.1	0	normal	.	T	ref	T	CT.CA	het-alt	449	0.45	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.98T=	.	.	.	NM_001242758.1(HLA-A): c.98T=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	115384	0.508485	U	0.3333	0.220248	12890	0.650737	PASS	.	8152	0.280790	14811	110376	0.513055	.	.	.	.	.	.	rs2075684	.	.	.	-4.308	-0.649	-0.931	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910557	29910558	6p22.1	1	normal	.	T	snv	C	CT.CA	het-ref	550	0.55	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_001242758.1	NP_001229687.1	+	Y	c.98T>C	p.F33S | p.Phe33Ser	TTC=>TCC	NP=>P0	NM_001242758.1(HLA-A): c.98T>C (p.F33S)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	115384	0.298118	U	0.375	0.372005	12890	0.349263	PASS	660	8152	0.408611	4520	110376	0.294765	1208	6102	3.72755e-01	9151	62364	2.82609e-01	rs2075684	.	.	.	-4.308	-0.649	-0.931	0.49	0.004	0	0.011	neutral	ENST00000396634: c.98T>C (p.F33S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [diffuse_large_B_cell_lymphoma|NS|NS]	CSV	330510	.	.	.	.	.	.	.	.	.	Likely Benign
6	29910580	29910581	6p22.1	0	normal	.	C	ref	C	GC.GC	het-alt	906	0.87	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.121C=	.	.	.	NM_001242758.1(HLA-A): c.121C=	MixedObserved,SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118106	0.936726	U	0.1042	0.124401	.	.	PASS	-260	7962	0.933685	49793	113098	0.939433	.	.	.	.	.	.	rs1059423	.	.	.	0.478	0.397	0.232	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910580	29910581	6p22.1	1	normal	.	C	snv	A	GC.GC	het-ref	134	0.13	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_001242758.1	NP_001229687.1	+	Y	c.121C>A	p.R41S | p.Arg41Ser	CGC=>AGC	P+=>P0	NM_001242758.1(HLA-A): c.121C>A (p.R41S)	MixedObserved,SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118106	0.063248	U	0.1042	0.124401	.	.	PASS	4	7962	0.066315	94	113098	0.060540	4	455	3.14270e-02	195	8769	3.99448e-02	rs1059423	.	.	.	0.478	0.397	0.232	0.04	0.002	0	0.349	neutral	ENST00000396634: c.121C>A (p.R41S)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4594190	.	.	.	.	.	.	.	.	.	Likely Benign
6	29910582	29910583	6p22.1	0	normal	.	C	ref	C	CG.GG	het-alt	900	0.87	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.123C=	.	.	.	NM_001242758.1(HLA-A): c.123C=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118444	0.936839	U	0.1042	0.124401	.	.	PASS	.	8012	0.934224	49957	113436	0.939543	.	.	.	.	.	.	rs1059426	.	.	.	-0.346	-0.114	-0.257	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910582	29910583	6p22.1	1	normal	.	C	snv	T	CG.GG	het-ref	137	0.13	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_001242758.1	NP_001229687.1	+	Y	c.123C>T	p.(R41=) | p.(Arg41=)	CGC=>CGT	.	NM_001242758.1(HLA-A): c.123C>T (p.(R41=))	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118444	0.063161	U	0.1042	0.124401	.	.	PASS	4	8012	0.065776	97	113436	0.060457	4	451	3.11034e-02	193	8651	3.93979e-02	rs1059426	.	.	.	-0.346	-0.114	-0.257	.	.	.	.	.	ENST00000396634: c.123C>T (p.R41R)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4594167	.	.	.	.	.	.	.	.	.	Likely Benign
6	29910585	29910586	6p22.1	0	normal	.	G	ref	G	GG.GA	het-alt	917	0.87	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.126G=	.	.	.	NM_001242758.1(HLA-A): c.126G=	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118216	0.933926	U	0.131	0.136182	.	.	PASS	-296	7826	0.923332	49569	113208	0.937027	.	.	.	.	.	.	rs12721672	.	.	.	0.478	0.156	0.043	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910585	29910586	6p22.1	1	normal	.	G	snv	A	GG.GA	het-ref	140	0.13	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_001242758.1	NP_001229687.1	+	Y	c.126G>A	p.(G42=) | p.(Gly42=)	GGG=>GGA	.	NM_001242758.1(HLA-A): c.126G>A (p.(G42=))	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118216	0.066074	U	0.131	0.136182	.	.	PASS	4	7826	0.076668	94	113208	0.062973	4	462	3.31754e-02	194	8710	4.01612e-02	rs12721672	.	.	.	0.478	0.156	0.043	.	.	.	.	.	ENST00000396634: c.126G>A (p.G42G)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4594279	.	.	.	.	.	.	.	.	.	Likely Benign
6	29910603	29910604	6p22.1	0	normal	.	C	ref	C	GC.GT	het-alt	906	0.85	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.144C=	.	.	.	NM_001242758.1(HLA-A): c.144C=	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	115760	0.614288	U	0.3899	0.382388	.	.	PASS	-1283	7678	0.562907	18001	110752	0.614138	.	.	.	.	.	.	rs12721675	.	.	.	-1.251	-0.938	-1.250	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910603	29910604	6p22.1	1	normal	.	C	snv	A	GC.GT	het-ref	160	0.15	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_001242758.1	NP_001229687.1	+	Y	c.144C>A	p.(A48=) | p.(Ala48=)	GCC=>GCA	.	NM_001242758.1(HLA-A): c.144C>A (p.(A48=))	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	115760	0.385669	U	0.3899	0.382388	.	.	PASS	395	7678	0.437093	5356	110752	0.385817	801	5879	3.91777e-01	10300	79139	3.63160e-01	rs12721675	.	.	.	-1.251	-0.938	-1.250	.	.	.	.	.	ENST00000396634: c.144C>A (p.A48A)	breast [NS|NS|NS]	carcinoma [NS|NS|NS]	CSV	451147	.	.	.	.	.	.	.	.	.	Likely Benign
6	29910697	29910698	6p22.1	1	normal	.	G	snv	A	AG.GG	het-ref	440	0.45	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_001242758.1	NP_001229687.1	+	Y	c.238G>A	p.G80R | p.Gly80Arg	GGG=>AGG	P0=>P+	NM_001242758.1(HLA-A): c.238G>A (p.G80R)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	125062	0.062721	U	0.0506	0.0808706	13006	0.079348	PASS	7	8610	0.051336	117	120054	0.061964	12	820	4.76467e-02	353	14969	6.10272e-02	rs1059449	.	.	.	0.478	1.102	0.889	0.05	0.014	0.003	0.346	neutral	ENST00000396634: c.238G>A (p.G80R)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019429	.	.	.	.	.	.	.	.	.	Likely Benign
6	29910697	29910698	6p22.1	0	normal	.	G	ref	G	AG.GG	het-alt	532	0.55	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.238G=	.	.	.	NM_001242758.1(HLA-A): c.238G=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	125062	0.937279	U	0.0506	0.0808706	13006	0.920652	PASS	-214	8610	0.948664	52705	120054	0.938036	.	.	.	.	.	.	rs1059449	.	.	.	0.478	1.102	0.889	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910702	29910703	6p22.1	0	normal	.	G	ref	G	CC.GA	het-alt	525	0.54	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.243G=	.	.	.	NM_001242758.1(HLA-A): c.243G=	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	124686	0.937106	U	0.0506	0.0808706	13006	0.919883	PASS	.	8578	0.948823	52519	119678	0.937858	.	.	.	.	.	.	rs41541222	.	.	.	0.478	-0.864	-1.171	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910702	29910703	6p22.1	1	normal	.	G	snv	T	CC.GA	het-ref	442	0.46	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_001242758.1	NP_001229687.1	+	Y	c.243G>T	p.(P81=) | p.(Pro81=)	CCG=>CCT	.	NM_001242758.1(HLA-A): c.243G>T (p.(P81=))	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	124686	0.062894	U	0.0506	0.0808706	13006	0.080117	PASS	7	8578	0.051177	117	119678	0.062142	11	815	4.73947e-02	371	15003	6.12182e-02	rs41541222	.	.	.	0.478	-0.864	-1.171	.	.	.	.	.	ENST00000396634: c.243G>T (p.P81P)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5021059	.	.	.	.	.	.	.	.	.	Likely Benign
6	29910741	29910742	6p22.1	1	normal	.	G	ref	G	CA.TC	het-alt	496	0.54	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_001242758.1	NP_001229687.1	+	Y	c.282C>G	p.H94Q | p.His94Gln	CAC=>CAG	P+=>P0	NM_001242758.1(HLA-A): c.282C>G (p.H94Q)	MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	121864	0.341545	U	0.6706	0.680711	12982	0.361732	PASS	-1089	8312	0.372714	5805	116856	0.342498	.	.	.	.	.	.	rs78306866	.	.	.	-1.243	-0.383	-0.256	0.35	0.002	0	0.021	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	29910741	29910742	6p22.1	0	normal	.	G	snv	C	CA.TC	het-ref	427	0.46	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.282C=	.	.	.	NM_001242758.1(HLA-A): c.282C=	MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	121864	0.658447	U	0.6706	0.680711	12982	0.638268	PASS	1518	8312	0.627286	24209	116856	0.657493	3877	10997	6.80423e-01	58061	164119	7.01855e-01	rs78306866	.	.	.	-1.243	-0.383	-0.256	.	.	.	.	.	ENST00000396634: c.282G>C (p.Q94H)	liver [NS|NS|NS]	carcinoma [hepatocellular_carcinoma|NS|NS]	CSV	1730558	.	.	.	.	.	.	.	.	.	Benign
6	29910749	29910750	6p22.1	0	normal	.	C	ref	C	GA.TG	het-alt	493	0.52	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.290C=	.	.	.	NM_001242758.1(HLA-A): c.290C=	MixedObserved;clinically-assoc,submitted-by-lsdb|MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	0|123198	0|0.914081	U	0.1379	0.124201	12980	0.950154	PASS	.	8484	0.835101	49744	118190	0.915704	.	.	.	.	.	.	rs199474456|rs199474457	.	.	.	-3.060	-2.369	-2.264	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910749	29910750	6p22.1	1	normal	.	C	snv	T	GA.TG	het-ref	453	0.48	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_001242758.1	NP_001229687.1	+	Y	c.290C>T	p.T97I | p.Thr97Ile	ACT=>ATT	P0=>NP	NM_001242758.1(HLA-A): c.290C>T (p.T97I)	MixedObserved;clinically-assoc,submitted-by-lsdb|MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	0|123198	0|0.085919	U	0.1379	0.124201	12980	0.049846	PASS	108	8484	0.164899	612	118190	0.084296	221	2596	1.53901e-01	1182	18091	7.68789e-02	rs199474456|rs199474457	.	.	.	-3.060	-2.369	-2.264	0.33	0.006	0.001	0.024	neutral	ENST00000396634: c.290C>T (p.T97I)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4160508	.	.	.	.	.	.	.	.	.	Likely Benign
6	29910815	29910816	6p22.1	0	normal	.	G	ref	G	CC.GC	het-alt	380	0.51	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC2	IVS2	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.343+13G=	.	.	.	NM_001242758.1(HLA-A): c.343+13G=	MixedObserved;clinically-assoc,maf-5-some-pop,submitted-by-lsdb|MixedObserved;	117188|112290	0.934362|0.999982	U	0.1181	0.0866613	12912	0.959495	PASS	-578	8226	0.851204	49042	112180	0.935300	.	.	.	.	.	.	rs41562315|rs768097668	.	.	.	0.478	1.490	1.471	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910815	29910816	6p22.1	1	normal	.	G	snv	A	CC.GC	het-ref	362	0.49	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC2	IVS2	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.343+13G>A	.	.	.	NM_001242758.1(HLA-A): c.343+13G>A	MixedObserved;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	117188	0.065638	U	0.1181	0.0866613	12912	0.040505	PASS	34	8226	0.148796	210	112180	0.064700	111	2414	1.42773e-01	429	14556	6.29863e-02	rs41562315	.	.	.	0.478	1.490	1.471	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910819	29910820	6p22.1	0	normal	.	G	ref	G	CC.GG	het-alt	358	0.52	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC2	IVS2	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.343+17G=	.	.	.	NM_001242758.1(HLA-A): c.343+17G=	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	117532	0.164925	U	0.9683	0.854832	12910	0.248567	PASS	-163	8354	0.040938	1635	112524	0.165805	.	.	.	.	.	.	rs9260142	.	.	.	-0.721	-0.432	-0.455	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910819	29910820	6p22.1	1	normal	.	G	snv	C	CC.GG	het-ref	335	0.48	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC2	IVS2	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.343+17G>C	.	.	.	NM_001242758.1(HLA-A): c.343+17G>C	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	117532	0.835049	U	0.9683	0.854832	12910	0.751433	PASS	3842	8354	0.958942	39238	112524	0.834169	7964	16430	9.69550e-01	82170	192948	8.46724e-01	rs9260142	.	.	.	-0.721	-0.432	-0.455	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910833	29910834	6p22.1	0	normal	.	G	ref	G	CA.GA	het-alt	365	0.53	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC2	IVS2	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.343+31G=	.	.	.	NM_001242758.1(HLA-A): c.343+31G=	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	114140	0.132513	U	0.9841	0.908746	12864	0.163790	PASS	-72	8190	0.017582	1060	109132	0.134406	.	.	.	.	.	.	rs63225861	.	.	.	-0.721	0.171	0.167	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910833	29910834	6p22.1	0	normal	.	G	snv	C	CA.GA	het-ref	330	0.47	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC2	IVS2	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.343+31G>C	.	.	.	NM_001242758.1(HLA-A): c.343+31G>C	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	114140	0.867487	U	0.9841	0.908746	12864	0.836210	PASS	3951	8190	0.982418	40958	109132	0.865594	8267	16687	9.90914e-01	85604	194450	8.75467e-01	rs63225861	.	.	.	-0.721	0.171	0.167	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910838	29910839	6p22.1	0	normal	.	C	ref	C	CC.CT	het-alt	359	0.53	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC2	IVS2	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.343+36C=	.	.	.	NM_001242758.1(HLA-A): c.343+36C=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	105980	0.613059	U	.	.	.	.	PASS	-1110	7886	0.572660	19430	105980	0.613059	.	.	.	.	.	.	rs9260144	.	.	.	0.420	0.533	0.535	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910838	29910839	6p22.1	0	normal	.	C	snv	T	CC.CT	het-ref	323	0.47	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC2	IVS2	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.343+36C>T	.	.	.	NM_001242758.1(HLA-A): c.343+36C>T	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	105980	0.386941	U	.	.	.	.	PASS	575	7886	0.427340	7448	105980	0.386941	1003	6670	4.12543e-01	13701	80811	3.75715e-01	rs9260144	.	.	.	0.420	0.533	0.535	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910865	29910866	6p22.1	0	normal	.	G	ref	G	TC.CC	het-alt	419	0.57	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC2	IVS2	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.343+63G=	.	.	.	NM_001242758.1(HLA-A): c.343+63G=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	5008	0.915335	U	0.1161	0.0846645	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs41543916	.	.	.	0.420	-0.016	-0.154	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910865	29910866	6p22.1	0	normal	.	G	snv	A	TC.CC	het-ref	320	0.43	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC2	IVS2	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.343+63G>A	.	.	.	NM_001242758.1(HLA-A): c.343+63G>A	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	5008	0.084665	U	0.1161	0.0846645	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs41543916	.	.	.	0.420	-0.016	-0.154	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910922	29910923	6p22.1	0	normal	.	C	ref	C	TG.CC	het-alt	807	0.79	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC2	IVS2	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.343+120C=	.	.	.	NM_001242758.1(HLA-A): c.343+120C=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5008	0.768970	U	0.1399	0.141374	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9260147	.	.	.	-1.588	-1.275	-1.228	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910922	29910923	6p22.1	0	normal	.	C	snv	A	TG.CC	het-ref	210	0.21	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC2	IVS2	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.343+120C>A	.	.	.	NM_001242758.1(HLA-A): c.343+120C>A	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5008	0.141374	U	0.1399	0.141374	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9260147	.	.	.	-1.588	-1.275	-1.228	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910969	29910970	6p22.1	0	normal	.	G	ref	G	TA.GC	het-alt	710	0.86	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC2	IVS2	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.344-75G=	.	.	.	NM_001242758.1(HLA-A): c.344-75G=	;maf-5-some-pop,maf-5-all-pops	238	0.882353	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs72498368	.	.	.	0.420	1.011	0.788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	29910969	29910970	6p22.1	0	normal	.	G	snv	A	TA.GC	het-ref	116	0.14	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC2	IVS2	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.344-75G>A	.	.	.	NM_001242758.1(HLA-A): c.344-75G>A	;maf-5-some-pop,maf-5-all-pops	238	0.117647	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs72498368	.	.	.	0.420	1.011	0.788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	29910983	29910984	6p22.1	0	normal	.	C	ref	C	CC.CG	het-alt	686	0.88	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC2	IVS2	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.344-61C=	.	.	.	NM_001242758.1(HLA-A): c.344-61C=	;	120	0.966667	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs117114904	.	.	.	-1.378	-1.436	-1.567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	29910983	29910984	6p22.1	0	normal	.	C	snv	G	CC.CG	het-ref	94	0.12	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC2	IVS2	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.344-61C>G	.	.	.	NM_001242758.1(HLA-A): c.344-61C>G	;	120	0.033333	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs117114904	.	.	.	-1.378	-1.436	-1.567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	29910999	29911000	6p22.1	0	normal	.	T	ref	T	GC.GG	het-alt	325	0.47	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC2	IVS2	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.344-45T=	.	.	.	NM_001242758.1(HLA-A): c.344-45T=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	68348	0.160092	U	0.6012	0.410743	.	.	PASS	-99	5214	0.038358	892	63340	0.162899	.	.	.	.	.	.	rs9256982	.	.	.	-3.941	-0.341	-0.599	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29910999	29911000	6p22.1	0	normal	.	T	snv	C	GC.GG	het-ref	363	0.53	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC2	IVS2	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.344-45T>C	.	.	.	NM_001242758.1(HLA-A): c.344-45T>C	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	68348	0.470343	U	0.6012	0.410743	.	.	PASS	1250	5214	0.718067	7353	63340	0.475055	2238	7586	6.23644e-01	12594	62959	3.81912e-01	rs9256982	.	.	.	-3.941	-0.341	-0.599	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911002	29911003	6p22.1	0	normal	.	G	ref	G	GG.CG	het-alt	362	0.49	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC2	IVS2	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.344-42G=	.	.	.	NM_001242758.1(HLA-A): c.344-42G=	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	68542	0.811036	U	0.1379	0.161542	.	.	PASS	.	5258	0.782237	21090	63534	0.808874	.	.	.	.	.	.	rs9260148	.	.	.	0.420	-0.887	-0.710	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911002	29911003	6p22.1	0	normal	.	G	snv	A	GG.CG	het-ref	373	0.51	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC2	IVS2	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.344-42G>A	.	.	.	NM_001242758.1(HLA-A): c.344-42G>A	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	68542	0.188964	U	0.1379	0.161542	.	.	PASS	88	5258	0.217763	1466	63534	0.191126	83	2380	1.66085e-01	1822	26481	1.45203e-01	rs9260148	.	.	.	0.420	-0.887	-0.710	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911029	29911030	6p22.1	0	normal	.	C	ref	C	CG.GG	het-alt	340	0.48	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC2	IVS2	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.344-15C=	.	.	.	NM_001242758.1(HLA-A): c.344-15C=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	77278	0.785541	U	0.1508	0.178714	8048	0.818837	PASS	.	5830	0.740480	24146	72270	0.783064	.	.	.	.	.	.	rs9260151	.	.	.	0.478	-0.051	-0.168	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911029	29911030	6p22.1	1	normal	.	C	snv	T	CG.GG	het-ref	374	0.52	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC2	IVS2	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.344-15C>T	.	.	.	NM_001242758.1(HLA-A): c.344-15C>T	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	77278	0.214459	U	0.1508	0.178714	8048	0.181163	PASS	378	5830	0.259520	3689	72270	0.216936	511	2867	1.88942e-01	5461	31624	1.61771e-01	rs9260151	.	.	.	0.478	-0.051	-0.168	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911063	29911064	6p22.1	0	normal	.	A	ref	A	AT.AT	het-alt	436	0.51	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.363A=	.	.	.	NM_001242758.1(HLA-A): c.363A=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	93144	0.440168	U	0.6865	0.661142	8228	0.513612	PASS	-561	6584	0.390644	10853	88136	0.445924	.	.	.	.	.	.	rs1136695	.	.	.	-0.389	-1.762	-1.641	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911063	29911064	6p22.1	1	normal	.	A	snv	G	AT.AT	het-ref	418	0.49	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_001242758.1	NP_001229687.1	+	Y	c.363A>G	p.I121M | p.Ile121Met	ATA=>ATG	NP=>NP	NM_001242758.1(HLA-A): c.363A>G (p.I121M)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	93144	0.559832	U	0.6865	0.661142	8228	0.486388	PASS	1445	6584	0.609356	15619	88136	0.554076	3506	9599	6.48406e-01	41234	116795	5.95972e-01	rs1136695	.	.	.	-0.389	-1.762	-1.641	0.23	0.007	0	0.042	neutral	ENST00000396634: c.363A>G (p.I121M)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	4160516	.	.	.	.	.	.	.	.	.	Likely Benign
6	29911113	29911114	6p22.1	0	normal	.	G	ref	G	CC.GC	het-alt	483	0.52	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.413G=	.	.	.	NM_001242758.1(HLA-A): c.413G=	MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	110554	0.432268	U	0.6766	0.64976	8366	0.495697	PASS	.	7750	0.342581	10724	105546	0.436161	.	.	.	.	.	.	rs3173420	.	.	.	-1.798	-1.623	-2.037	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911113	29911114	6p22.1	1	normal	.	G	snv	A	CC.GC	het-ref	447	0.48	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_001242758.1	NP_001229687.1	+	Y	c.413G>A	p.R138Q | p.Arg138Gln	CGG=>CAG	P+=>P0	NM_001242758.1(HLA-A): c.413G>A (p.R138Q)	MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	110554	0.549424	U	0.6766	0.64976	8366	0.504303	PASS	1669	7750	0.641161	16255	105546	0.544663	3651	10124	6.76919e-01	37303	115121	5.76759e-01	rs3173420	.	.	.	-1.798	-1.623	-2.037	0.31	0.014	0.002	0.028	neutral	ENST00000396634: c.413G>A (p.R138Q)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5019450	.	.	.	.	.	.	.	.	.	Likely Benign
6	29911148	29911149	6p22.1	0	normal	.	C	ref	C	CC.TG	het-alt	457	0.48	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.448C=	.	.	.	NM_001242758.1(HLA-A): c.448C=	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	116760	0.865510	U	0.1438	0.15635	8426	0.862094	PASS	-589	8156	0.824179	42143	111752	0.866490	.	.	.	.	.	.	rs1059506	.	.	.	-0.330	0.923	0.941	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911148	29911149	6p22.1	1	normal	.	C	snv	T	CC.TG	het-ref	499	0.52	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_001242758.1	NP_001229687.1	+	Y	c.448C>T	p.(L150=) | p.(Leu150=)	CTG=>TTG	.	NM_001242758.1(HLA-A): c.448C>T (p.(L150=))	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	116760	0.134490	U	0.1438	0.15635	8426	0.137906	PASS	128	8156	0.175821	1187	111752	0.133510	251	2767	1.62918e-01	2292	30536	1.27816e-01	rs1059506	.	.	.	-0.330	0.923	0.941	.	.	.	.	.	ENST00000396634: c.448C>T (p.L150L)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019453	.	.	.	.	.	.	.	.	.	Likely Benign
6	29911202	29911203	6p22.1	0	normal	.	A	ref	A	CC.AG	het-alt	448	0.49	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.502A=	.	.	.	NM_001242758.1(HLA-A): c.502A=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118856	0.755873	U	0.2143	0.339058	.	.	PASS	-736	8402	0.769579	33403	113848	0.760048	.	.	.	.	.	.	rs1059517	.	.	.	-2.126	-0.019	-0.300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911202	29911203	6p22.1	1	normal	.	A	snv	C	CC.AG	het-ref	471	0.51	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_001242758.1	NP_001229687.1	+	Y	c.502A>C	p.K168Q | p.Lys168Gln	AAG=>CAG	P+=>P0	NM_001242758.1(HLA-A): c.502A>C (p.K168Q)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118856	0.244102	U	0.2143	0.339058	.	.	PASS	232	8402	0.230421	3796	113848	0.239925	442	3766	2.26513e-01	7976	56166	2.43465e-01	rs1059517	.	.	.	-2.126	-0.019	-0.300	1	0.002	0	0.000	neutral	ENST00000396634: c.502A>C (p.K168Q)	upper_aerodigestive_tract [head_neck|NS|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	VUO	4593597	.	.	.	.	.	.	.	.	.	Likely Benign
6	29911224	29911225	6p22.1	1	normal	.	A	snv	G	CC.TG	het-ref	442	0.53	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_001242758.1	NP_001229687.1	+	Y	c.524A>G	p.H175R | p.His175Arg	CAT=>CGT	P+=>P+	NM_001242758.1(HLA-A): c.524A>G (p.H175R)	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	119217	0.180402	U	0.1617	0.25639	.	.	VQSRTrancheINDEL99.00to99.50	145	8370	0.192115	2241	114210	0.177069	296	3116	1.83316e-01	4538	41273	1.74223e-01	rs1059536	.	.	.	-1.697	0.215	0.063	0.22	0	0	0.042	neutral	ENST00000396634: c.524A>G (p.H175R)	upper_aerodigestive_tract [head_neck|NS|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	VUO	4594067	.	.	.	.	.	.	.	.	.	Likely Benign
6	29911224	29911225	6p22.1	0	normal	.	A	ref	A	CC.TG	het-alt	393	0.47	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.524A=	.	.	.	NM_001242758.1(HLA-A): c.524A=	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	119217	0.819598	U	0.1617	0.25639	.	.	VQSRTrancheINDEL99.00to99.50	-659	8370	0.807885	39122	114210	0.822923	.	.	.	.	.	.	rs1059536	.	.	.	-1.697	0.215	0.063	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911227	29911228	6p22.1	1	normal	.	A	ref	A	TG.GG	het-alt	400	0.47	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_001242758.1	NP_001229687.1	+	Y	c.527C>A	p.A176E | p.Ala176Glu	GCG=>GAG	NP=>P-	NM_001242758.1(HLA-A): c.527C>A (p.A176E)	MixedObserved;observed-mismatch|MixedObserved,SingleClassQuadAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	111223|116680	0.999991|0.250051	U	0.2817	0.189497	.	.	PASS	-539	8282	0.141753	2209	111672	0.254236	.	.	.	.	.	.	rs748036658|rs9256983	.	.	.	-7.138	-7.497	-7.540	0.41	0.003	0	0.015	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	29911227	29911228	6p22.1	1	normal	.	A	snv	T	TG.GG	het-ref	452	0.53	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_001242758.1	NP_001229687.1	+	Y	c.527C>T	p.A176V | p.Ala176Val	GCG=>GTG	NP=>NP	NM_001242758.1(HLA-A): c.527C>T (p.A176V)	MixedObserved,SingleClassQuadAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	116680	0.538036	U	0.5893	0.598043	.	.	PASS	1301	8282	0.577638	13809	111672	0.535345	2752	9560	5.75211e-01	34280	127661	5.65713e-01	rs9256983	.	.	.	-7.138	-7.497	-7.540	0.6	0.001	0	0.004	neutral	ENST00000396634: c.527A>T (p.E176V)	central_nervous_system [spinal_cord|NS|NS]	glioma [astrocytoma_Grade_II|fibrillary|NS]	RSS	3733674	.	.	.	.	.	.	.	.	.	Likely Benign
6	29911306	29911307	6p22.1	0	normal	.	G	ref	G	AC.CT	het-alt	779	0.90	.	1	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.606G=	.	.	.	NM_001242758.1(HLA-A): c.606G=	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	114464	0.980046	U	.	.	.	.	PASS	.	8306	0.944980	54948	114464	0.980046	.	.	.	.	.	.	rs199474578	.	.	.	-0.346	-1.992	-1.291	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911306	29911307	6p22.1	1	normal	.	G	snv	A	AC.CT	het-ref	87	0.10	.	2	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_001242758.1	NP_001229687.1	+	Y	c.606G>A	p.(T202=) | p.(Thr202=)	ACG=>ACA	.	NM_001242758.1(HLA-A): c.606G>A (p.(T202=))	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	114464	0.019954	U	.	.	.	.	PASS	0	8306	0.055020	0	114464	0.019954	0	82	5.20173e-03	0	325	1.41200e-03	rs199474578	.	.	.	-0.346	-1.992	-1.291	.	.	.	.	.	ENST00000396634: c.606G>A (p.T202T)	central_nervous_system [brain|NS|NS]	primitive_neuroectodermal_tumour-medulloblastoma [NS|NS|NS]	RSS	307018	.	.	.	.	.	.	.	.	.	VUS
6	29911318	29911319	6p22.1	0	normal	.	G	ref	G	AC.GG	het-alt	742	0.88	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C3	EX3	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.618G=	.	.	.	NM_001242758.1(HLA-A): c.618G=	MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles|MixedObserved;	108798|114804	0.626850|0.991760	U	.	.	.	.	InbreedingCoeff_Filter	-1107	8168	0.728942	13801	108798	0.626850	.	.	.	.	.	.	rs41554520|rs776875561	.	.	.	0.485	1.825	0.549	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911318	29911319	6p22.1	1	normal	.	G	snv	T	AC.GG	het-ref	105	0.12	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C3	EX3	.	.	coding-synon	NM_001242758.1	NP_001229687.1	+	Y	c.618G>T	p.(T206=) | p.(Thr206=)	ACG=>ACT	.	NM_001242758.1(HLA-A): c.618G>T (p.(T206=))	MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	108798	0.373141	U	.	.	.	.	InbreedingCoeff_Filter	0	8168	0.271058	0	108798	0.373141	0	1493	1.23757e-01	0	42779	2.69037e-01	rs41554520	.	.	.	0.485	1.825	0.549	.	.	.	.	.	ENST00000396634: c.618G>T (p.T206T)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3761773	.	.	.	.	.	.	.	.	.	Likely Benign
6	29911328	29911329	6p22.1	0	normal	.	G	ref	G	GG.GC	het-alt	741	0.86	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.619+9G=	.	.	.	NM_001242758.1(HLA-A): c.619+9G=	;	113926	0.977178	U	.	.	.	.	PASS	.	8278	0.938753	54363	113926	0.977178	.	.	.	.	.	.	rs200281525	.	.	.	0.485	0.624	0.330	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911328	29911329	6p22.1	1	normal	.	G	snv	A	GG.GC	het-ref	118	0.14	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.619+9G>A	.	.	.	NM_001242758.1(HLA-A): c.619+9G>A	;	113926	0.022822	U	.	.	.	.	PASS	0	8278	0.061247	0	113926	0.022822	0	102	6.58915e-03	0	569	2.51037e-03	rs200281525	.	.	.	0.485	0.624	0.330	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	29911456	29911457	6p22.1	0	normal	.	G	ref	G	GG.TT	het-alt	260	0.49	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.619+137G=	.	.	.	NM_001242758.1(HLA-A): c.619+137G=	;	0	0	U	0.9821	0.925319	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs199610249	.	.	.	0.485	0.278	0.227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911457	29911457	6p22.1	0	normal	.	.	ins	T	GG.TT	het-ref	270	0.51	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.619+137_619+138insT	.	.	.	NM_001242758.1(HLA-A): c.619+137_619+138insT	;maf-5-some-pop	5008	0.925319	U	0.9821	0.925319	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs140855897	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911504	29911505	6p22.1	0	normal	.	C	ref	C	CT.TG	het-alt	299	0.54	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.619+185C=	.	.	.	NM_001242758.1(HLA-A): c.619+185C=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	5008	0.910743	U	0.121	0.0892572	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs41543412	.	.	.	0.485	0.961	1.737	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911504	29911505	6p22.1	0	normal	.	C	snv	G	CT.TG	het-ref	255	0.46	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.619+185C>G	.	.	.	NM_001242758.1(HLA-A): c.619+185C>G	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	5008	0.089257	U	0.121	0.0892572	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs41543412	.	.	.	0.485	0.961	1.737	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911537	29911538	6p22.1	0	normal	.	G	ref	G	GA.TG	het-alt	366	0.59	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.619+218G=	.	.	.	NM_001242758.1(HLA-A): c.619+218G=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5008	0.316893	U	0.6875	0.683107	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2735111	.	.	.	-0.503	-0.427	-0.475	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911537	29911538	6p22.1	0	normal	.	G	snv	A	GA.TG	het-ref	252	0.41	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.619+218G>A	.	.	.	NM_001242758.1(HLA-A): c.619+218G>A	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5008	0.683107	U	0.6875	0.683107	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2735111	.	.	.	-0.503	-0.427	-0.475	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911582	29911583	6p22.1	0	normal	.	G	ref	G	TT.AC	het-alt	280	0.56	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.619+263G=	.	.	.	NM_001242758.1(HLA-A): c.619+263G=	.	.	.	.	0.2024	0.293331	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.485	0.214	0.365	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911583	29911583	6p22.1	0	normal	.	.	ins	ACAC	TG.AC	het-ref	217	0.44	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.619+263_619+264insACAC	.	.	.	NM_001242758.1(HLA-A): c.619+263_619+264insACAC	;maf-5-some-pop,maf-5-all-pops	5008	0.293331	U	0.2024	0.293331	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs139109856	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911789	29911790	6p22.1	0	normal	.	T	ref	T	TC.CT	het-alt	322	0.65	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.620-109T=	.	.	.	NM_001242758.1(HLA-A): c.620-109T=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5008	0.490615	U	0.4752	0.509385	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9260166	.	.	.	-2.425	-1.452	-1.571	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911789	29911790	6p22.1	0	normal	.	T	snv	C	TC.CT	het-ref	177	0.35	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.620-109T>C	.	.	.	NM_001242758.1(HLA-A): c.620-109T>C	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5008	0.509385	U	0.4752	0.509385	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9260166	.	.	.	-2.425	-1.452	-1.571	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911802	29911803	6p22.1	0	normal	.	G	ref	G	CC.GG	het-alt	316	0.63	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.620-96G=	.	.	.	NM_001242758.1(HLA-A): c.620-96G=	;clinically-assoc,submitted-by-lsdb	2	0.500000	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9260167	.	.	.	-3.149	-4.104	-4.379	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	29911802	29911803	6p22.1	0	normal	.	G	snv	A	CC.GG	het-ref	187	0.37	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.620-96G>A	.	.	.	NM_001242758.1(HLA-A): c.620-96G>A	;clinically-assoc,submitted-by-lsdb	2	0.500000	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9260167	.	.	.	-3.149	-4.104	-4.379	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	29911826	29911827	6p22.1	0	normal	.	G	ref	G	AT.GC	het-alt	335	0.71	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.620-72G=	.	.	.	NM_001242758.1(HLA-A): c.620-72G=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	4	0.500000	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9260168	.	.	.	-0.667	1.108	0.893	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	29911826	29911827	6p22.1	0	normal	.	G	snv	A	AT.GC	het-ref	136	0.29	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.620-72G>A	.	.	.	NM_001242758.1(HLA-A): c.620-72G>A	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	4	0.500000	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9260168	.	.	.	-0.667	1.108	0.893	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	29911835	29911836	6p22.1	0	normal	.	C	ref	C	TG.GT	het-alt	321	0.73	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.620-63C=	.	.	.	NM_001242758.1(HLA-A): c.620-63C=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	4	0.500000	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9260169	.	.	.	-3.428	-1.737	-1.535	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	29911835	29911836	6p22.1	0	normal	.	C	snv	T	TG.GT	het-ref	116	0.27	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.620-63C>T	.	.	.	NM_001242758.1(HLA-A): c.620-63C>T	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	4	0.500000	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9260169	.	.	.	-3.428	-1.737	-1.535	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	29911843	29911844	6p22.1	0	normal	.	T	ref	T	GG.GG	het-alt	327	0.77	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.620-55T=	.	.	.	NM_001242758.1(HLA-A): c.620-55T=	MixedObserved;maf-5-some-pop,maf-5-all-pops	4	0.500000	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9260170	.	.	.	-2.326	-0.340	-0.254	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	29911843	29911844	6p22.1	0	normal	.	T	snv	A	GG.GG	het-ref	99	0.23	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.620-55T>A	.	.	.	NM_001242758.1(HLA-A): c.620-55T>A	MixedObserved;maf-5-some-pop,maf-5-all-pops	4	0.500000	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9260170	.	.	.	-2.326	-0.340	-0.254	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	29911856	29911857	6p22.1	0	normal	.	G	ref	G	AT.AC	het-alt	320	0.73	.	1	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.620-42G=	.	.	.	NM_001242758.1(HLA-A): c.620-42G=	;clinically-assoc,submitted-by-lsdb	116084	0.999630	U	.	.	.	.	VQSRTrancheSNP99.80to99.90	-3	8440	0.999289	58000	116084	0.999630	.	.	.	.	.	.	rs70944751	.	.	.	-0.494	-0.883	-1.270	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911856	29911857	6p22.1	0	normal	.	G	snv	T	AT.AC	het-ref	118	0.27	.	2	dup	PASS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.620-42G>T	.	.	.	NM_001242758.1(HLA-A): c.620-42G>T	;clinically-assoc,submitted-by-lsdb	116084	0.000370	U	.	.	.	.	VQSRTrancheSNP99.80to99.90	0	8440	0.000711	1	116084	0.000370	50	345	2.17364e-02	114	1165	4.99554e-03	rs70944751	.	.	.	-0.494	-0.883	-1.270	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	29911878	29911879	6p22.1	0	normal	.	T	ref	T	AT.TT	het-alt	250	0.59	.	1	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.620-20T=	.	.	.	NM_001242758.1(HLA-A): c.620-20T=	MixedObserved;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	121328	0.993728	U	0.1498	0.103035	.	.	VQSRTrancheSNP99.60to99.80	.	8458	0.997044	57918	116320	0.997894	.	.	.	.	.	.	rs9260171	.	.	.	-0.509	-0.588	-0.543	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911878	29911879	6p22.1	0	normal	.	T	snv	G	AT.TT	het-ref	175	0.41	.	2	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.620-20T>G	.	.	.	NM_001242758.1(HLA-A): c.620-20T>G	MixedObserved;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	121328	0.006272	U	0.1498	0.103035	.	.	VQSRTrancheSNP99.60to99.80	0	8458	0.002956	3	116320	0.002106	50	1141	8.16400e-02	127	7714	3.61355e-02	rs9260171	.	.	.	-0.509	-0.588	-0.543	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911892	29911893	6p22.1	1	normal	.	C	snv	T	CC.GT	het-ref	215	0.51	.	2	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.620-6C>T	.	.	.	NM_001242758.1(HLA-A): c.620-6C>T	MixedObserved;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	122902	0.376739	U	0.4514	0.386182	8430	0.327758	PASS	905	8466	0.444248	9511	117894	0.376338	1881	7354	4.67633e-01	19261	89870	3.88113e-01	rs9260172	.	.	.	-0.706	0.531	0.334	.	.	.	.	.	ENST00000396634: c.620-6C>T (p.?)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019213	.	.	.	.	.	.	.	.	.	Benign
6	29911892	29911893	6p22.1	0	normal	.	C	ref	C	CC.GT	het-alt	208	0.49	.	1	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.620-6C=	.	.	.	NM_001242758.1(HLA-A): c.620-6C=	MixedObserved;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	122902	0.623261	U	0.4514	0.386182	8430	0.672242	PASS	.	8466	0.555752	24090	117894	0.623662	.	.	.	.	.	.	rs9260172	.	.	.	-0.706	0.531	0.334	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911894	29911895	6p22.1	0	normal	.	T	ref	T	CG.CA	het-alt	201	0.49	.	1	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.620-4T=	.	.	.	NM_001242758.1(HLA-A): c.620-4T=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	117804	0.997980	U	.	.	.	.	PASS	.	8492	0.997292	58666	117804	0.997980	.	.	.	.	.	.	rs9260173	.	.	.	-0.512	-0.148	-0.133	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911894	29911895	6p22.1	1	normal	.	T	snv	A	CG.CA	het-ref	211	0.51	.	2	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	IC3	IVS3	.	.	intron	NM_001242758.1	NP_001229687.1	+	Y	c.620-4T>A	.	.	.	NM_001242758.1(HLA-A): c.620-4T>A	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	117804	0.002020	U	.	.	.	.	PASS	0	8492	0.002708	2	117804	0.002020	47	1117	7.99227e-02	122	7484	3.44016e-02	rs9260173	.	.	.	-0.512	-0.148	-0.133	.	.	.	.	.	ENST00000396634: c.620-4T>A (p.?)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3948956	.	.	.	.	.	.	.	.	.	Unknown
6	29911911	29911912	6p22.1	0	normal	.	A	ref	A	AC.CA	het-alt	168	0.44	.	1	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C4	EX4	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.633A=	.	.	.	NM_001242758.1(HLA-A): c.633A=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	122750	0.992073	U	0.1815	0.131589	.	.	VQSRTrancheSNP99.60to99.80	-13	8496	0.996940	58557	117742	0.997333	.	.	.	.	.	.	rs1136749	.	.	.	-0.706	-0.727	-0.626	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911911	29911912	6p22.1	1	normal	.	A	snv	G	AC.CA	het-ref	213	0.56	.	2	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C4	EX4	.	.	coding-synon	NM_001242758.1	NP_001229687.1	+	Y	c.633A>G	p.(T211=) | p.(Thr211=)	ACA=>ACG	.	NM_001242758.1(HLA-A): c.633A>G (p.(T211=))	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	122750	0.007927	U	0.1815	0.131589	.	.	VQSRTrancheSNP99.60to99.80	0	8496	0.003060	0	117742	0.002667	0	1136	8.15272e-02	1	7786	3.61390e-02	rs1136749	.	.	.	-0.706	-0.727	-0.626	.	.	.	.	.	ENST00000396634: c.633A>G (p.T211T)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4160525	.	.	.	.	.	.	.	.	.	Unknown
6	29911920	29911921	6p22.1	0	normal	.	C	ref	C	AC.CA	het-alt	152	0.44	.	1	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C4	EX4	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.642C=	.	.	.	NM_001242758.1(HLA-A): c.642C=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	117460	0.997182	U	.	.	.	.	VQSRTrancheSNP99.60to99.80	.	8500	0.996353	58399	117460	0.997182	.	.	.	.	.	.	rs1136754	.	.	.	-1.400	0.119	0.057	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911920	29911921	6p22.1	1	normal	.	C	snv	T	AC.CA	het-ref	192	0.56	.	2	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C4	EX4	.	.	coding-synon	NM_001242758.1	NP_001229687.1	+	Y	c.642C>T	p.(T214=) | p.(Thr214=)	ACC=>ACT	.	NM_001242758.1(HLA-A): c.642C>T (p.(T214=))	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	117460	0.002818	U	.	.	.	.	VQSRTrancheSNP99.60to99.80	0	8500	0.003647	0	117460	0.002818	0	1097	8.00029e-02	1	7658	3.62859e-02	rs1136754	.	.	.	-1.400	0.119	0.057	.	.	.	.	.	ENST00000396634: c.642C>T (p.T214T)	skin [NS|NS|NS]	carcinoma [NS|NS|NS]	CSV	4160526	.	.	.	.	.	.	.	.	.	VUS
6	29911927	29911928	6p22.1	0	normal	.	C	ref	C	AC.CC	het-alt	157	0.47	.	1	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C4	EX4	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.649C=	.	.	.	NM_001242758.1(HLA-A): c.649C=	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	117336	0.997162	U	.	.	.	.	VQSRTrancheSNP99.60to99.80	.	8498	0.996352	58335	117336	0.997162	.	.	.	.	.	.	rs1059563	.	.	.	0.485	-0.003	0.334	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911927	29911928	6p22.1	1	normal	.	C	snv	G	AC.CC	het-ref	179	0.53	.	2	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C4	EX4	.	.	missense	NM_001242758.1	NP_001229687.1	+	Y	c.649C>G	p.P217A | p.Pro217Ala	CCC=>GCC	NP=>NP	NM_001242758.1(HLA-A): c.649C>G (p.P217A)	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	117336	0.002838	U	.	.	.	.	VQSRTrancheSNP99.60to99.80	0	8498	0.003648	0	117336	0.002838	0	1118	8.20009e-02	1	8145	3.93874e-02	rs1059563	.	.	.	0.485	-0.003	0.334	0.04	0.001	0	0.349	neutral	ENST00000396634: c.649C>G (p.P217A)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3948957	.	.	.	.	.	.	.	.	.	VUS
6	29911929	29911930	6p22.1	0	normal	.	C	ref	C	CC.AT	het-alt	155	0.47	.	1	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C4	EX4	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.651C=	.	.	.	NM_001242758.1(HLA-A): c.651C=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	117088	0.997130	U	.	.	.	.	VQSRTrancheSNP99.60to99.80	-16	8490	0.996231	58208	117088	0.997130	.	.	.	.	.	.	rs1059564	.	.	.	-0.330	-0.054	-0.266	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911929	29911930	6p22.1	1	normal	.	C	snv	T	CC.AT	het-ref	177	0.53	.	2	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C4	EX4	.	.	coding-synon	NM_001242758.1	NP_001229687.1	+	Y	c.651C>T	p.(P217=) | p.(Pro217=)	CCC=>CCT	.	NM_001242758.1(HLA-A): c.651C>T (p.(P217=))	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	117088	0.002870	U	.	.	.	.	VQSRTrancheSNP99.60to99.80	0	8490	0.003769	0	117088	0.002870	0	1114	8.26409e-02	1	8136	3.98273e-02	rs1059564	.	.	.	-0.330	-0.054	-0.266	.	.	.	.	.	ENST00000396634: c.651C>T (p.P217P)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3948958	.	.	.	.	.	.	.	.	.	VUS
6	29911930	29911931	6p22.1	0	normal	.	A	ref	A	CC.TC	het-alt	154	0.47	.	1	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C4	EX4	.	.	no-change	NM_001242758.1	NP_001229687.1	+	Y	c.652A=	.	.	.	NM_001242758.1(HLA-A): c.652A=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	117034	0.997155	U	.	.	.	.	VQSRTrancheSNP99.60to99.80	-16	8488	0.996230	58184	117034	0.997155	.	.	.	.	.	.	rs9260179	.	.	.	-2.420	-1.653	-1.507	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	29911930	29911931	6p22.1	1	normal	.	A	snv	G	CC.TC	het-ref	172	0.53	.	2	dup	DUBIOUS	142800	C	608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	21428769|21428768|21149285|17258541|15743917	.	3105	HLA-A	C4	EX4	.	.	missense	NM_001242758.1	NP_001229687.1	+	Y	c.652A>G	p.I218V | p.Ile218Val	ATC=>GTC	NP=>NP	NM_001242758.1(HLA-A): c.652A>G (p.I218V)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	117034	0.002845	U	.	.	.	.	VQSRTrancheSNP99.60to99.80	0	8488	0.003770	0	117034	0.002845	0	1197	8.84962e-02	1	9000	4.41661e-02	rs9260179	.	.	.	-2.420	-1.653	-1.507	0.57	0.001	0	0.006	neutral	ENST00000396634: c.652A>G (p.I218V)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4160527	.	.	.	.	.	.	.	.	.	VUS
6	30860999	30861000	6p21.33	0	normal	.	C	ref	C	CT.GG	het-alt	328	0.51	.	1	.	PASS	600408	P	.	NN	.	.	.	.	.	.	.	780	DDR1	IC8	IVS11	.	.	no-change	NM_001954.4	NP_001945.3	+	Y	c.1196-49C=	.	.	.	NM_001954.4(DDR1): c.1196-49C=	;maf-5-some-pop,maf-5-all-pops	121060	0.679225	U	0.248	0.222843	13002	0.708199	PASS	.	8522	0.712391	26881	116052	0.674999	.	.	.	.	.	.	rs1264320	.	4024	0.744000	0.561	0.689	0.441	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	30860999	30861000	6p21.33	0	normal	.	C	snv	T	CT.GG	het-ref	319	0.49	.	2	.	PASS	600408	P	.	NN	.	.	.	.	.	.	.	780	DDR1	IC8	IVS11	.	.	intron	NM_001954.4	NP_001945.3	+	Y	c.1196-49C>T	.	.	.	NM_001954.4(DDR1): c.1196-49C>T	;maf-5-some-pop,maf-5-all-pops	121060	0.320775	U	0.248	0.222843	13002	0.291801	PASS	342	8522	0.287609	6572	116052	0.325001	715	4890	2.85731e-01	12285	72866	3.16193e-01	rs1264320	.	4024	0.256000	0.561	0.689	0.441	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	30864699	30864700	6p21.33	0	normal	.	C	ref	C	TG.GC	het-alt	298	0.49	.	1	.	PASS	600408	P	.	NN	.	.	.	.	.	.	.	780	DDR1	IC11	IVS14	.	.	no-change	NM_001954.4	NP_001945.3	+	Y	c.1758+58C=	.	.	.	NM_001954.4(DDR1): c.1758+58C=	;maf-5-some-pop,maf-5-all-pops	5008	0.777157	U	0.251	0.222843	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1264317	.	4024	0.741800	-0.258	-0.123	-0.390	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	30864699	30864700	6p21.33	0	normal	.	C	snv	T	TG.GC	het-ref	312	0.51	.	2	.	PASS	600408	P	.	NN	.	.	.	.	.	.	.	780	DDR1	IC11	IVS14	.	.	intron	NM_001954.4	NP_001945.3	+	Y	c.1758+58C>T	.	.	.	NM_001954.4(DDR1): c.1758+58C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.222843	U	0.251	0.222843	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1264317	.	4024	0.258200	-0.258	-0.123	-0.390	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31238376	31238377	6p21.33	0	nullSample	.	G	ref	G	CA.AG	homo-ref	.	.	.	0	dup	.	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	IC3	IVS3	.	.	no-change	NM_002117.5	NP_002108.4	-	Y	c.620-115C=	.	.	.	NM_002117.5(HLA-C): c.620-115C=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	79156	0.096733	U	0.9722	0.956669	.	.	PASS	.	4438	0.023209	366	74148	0.100340	.	.	.	.	.	.	rs9264641	.	.	.	-0.807	-0.126	-0.127	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31238376	31238377	6p21.33	0	normal	.	G	snv	C	CA.AG	hom-alt	801	1.00	.	0	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	IC3	IVS3	.	.	intron	NM_002117.5	NP_002108.4	-	Y	c.620-115C>G	.	.	.	NM_002117.5(HLA-C): c.620-115C>G	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	79156	0.903254	U	0.9722	0.956669	.	.	PASS	2118	4438	0.976791	29999	74148	0.899647	6720	13612	9.86949e-01	83210	181888	9.10943e-01	rs9264641	.	.	.	-0.807	-0.126	-0.127	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31238665	31238666	6p21.33	0	normal	.	T	ref	T	AC.TC	het-alt	727	0.92	.	1	dup	DUBIOUS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	IC3	IVS3	.	.	no-change	NM_002117.5	NP_002108.4	-	Y	c.619+184A=	.	.	.	NM_002117.5(HLA-C): c.619+184A=	;maf-5-some-pop,maf-5-all-pops	5008	0.717053	U	0.2778	0.282947	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs113436248	.	.	.	-0.856	-1.161	-1.324	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31238665	31238666	6p21.33	0	normal	.	T	snv	G	AC.TC	het-ref	59	0.08	.	2	dup	DUBIOUS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	IC3	IVS3	.	.	intron	NM_002117.5	NP_002108.4	-	Y	c.619+184A>C	.	.	.	NM_002117.5(HLA-C): c.619+184A>C	;maf-5-some-pop,maf-5-all-pops	5008	0.282947	U	0.2778	0.282947	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs113436248	.	.	.	-0.856	-1.161	-1.324	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31238690	31238691	6p21.33	0	normal	.	C	ref	C	AG.AG	het-alt	735	0.89	.	1	dup	DUBIOUS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	IC3	IVS3	.	.	no-change	NM_002117.5	NP_002108.4	-	Y	c.619+159G=	.	.	.	NM_002117.5(HLA-C): c.619+159G=	;	2	0.500000	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs111585150	.	.	.	0.298	-0.689	-0.677	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
6	31238690	31238691	6p21.33	0	normal	.	C	snv	A	AG.AG	het-ref	88	0.11	.	2	dup	DUBIOUS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	IC3	IVS3	.	.	intron	NM_002117.5	NP_002108.4	-	Y	c.619+159G>T	.	.	.	NM_002117.5(HLA-C): c.619+159G>T	;	2	0.500000	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs111585150	.	.	.	0.298	-0.689	-0.677	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
6	31238850	31238851	6p21.33	0	normal	.	T	ref	T	CC.GC	het-alt	771	0.78	.	1	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	.	.	no-change	NM_002117.5	NP_002108.4	-	Y	c.618A=	.	.	.	NM_002117.5(HLA-C): c.618A=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	120344	0.236231	U	.	.	13004	0.265764	PASS	.	8606	0.171160	2195	120344	0.236231	.	.	.	.	.	.	rs2308604	.	.	.	-1.840	0.427	-0.004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31238850	31238851	6p21.33	1	normal	.	T	snv	C	CC.GC	het-ref	214	0.22	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	.	.	coding-synon	NM_002117.5	NP_002108.4	-	Y	c.618A>G	p.(A206=) | p.(Ala206=)	GCA=>GCG	.	NM_002117.5(HLA-C): c.618A>G (p.(A206=))	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	120344	0.763727	U	.	.	13004	0.734236	PASS	2873	8606	0.828840	33934	120344	0.763727	5674	13818	8.30908e-01	68310	181959	7.66795e-01	rs2308604	.	.	.	-1.840	0.427	-0.004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	31238908	31238909	6p21.33	0	normal	.	G	ref	G	AC.TG	het-alt	751	0.81	.	1	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_002117.5	NP_002108.4	-	Y	c.560C=	.	.	.	NM_002117.5(HLA-C): c.560C=	SingleClassQuadAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	113032	0.650718	U	0.3641	0.378794	.	.	InbreedingCoeff_Filter	.	7892	0.630132	17719	108024	0.653614	.	.	.	.	.	.	rs1050686	.	.	.	-4.896	-5.366	-5.533	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31238908	31238909	6p21.33	1	normal	.	G	snv	A	AC.TG	het-ref	176	0.19	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_002117.5	NP_002108.4	-	Y	c.560C>T	p.T187M | p.Thr187Met	ACG=>ATG	P0=>NP	NM_002117.5(HLA-C): c.560C>T (p.T187M)	SingleClassQuadAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	113032	0.317521	U	0.3641	0.378794	.	.	InbreedingCoeff_Filter	110	7892	0.348834	561	108024	0.314680	267	3475	2.91282e-01	1218	49716	2.99288e-01	rs1050686	.	.	.	-4.896	-5.366	-5.533	0.08	0.599	0.646	0.507	deleterious	ENST00000376228: c.560C>T (p.T187M)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3722064	.	.	.	.	.	.	.	.	.	Likely Benign
6	31238909	31238910	6p21.33	1	normal	.	T	snv	G	CG.GC	het-ref	174	0.19	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_002117.5	NP_002108.4	-	Y	c.559A>C	p.T187P | p.Thr187Pro	ACG=>CCG	P0=>NP	NM_002117.5(HLA-C): c.559A>C (p.T187P)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5008	0.378794	U	0.3641	0.378794	.	.	VQSRTrancheINDEL96.00to97.00	110	7900	0.355570	570	108348	0.316268	273	3519	2.92421e-01	1236	49557	2.98864e-01	rs1050685	.	.	.	-4.761	-3.834	-4.140	0.25	0.443	0.12	0.181	neutral	ENST00000376228: c.559A>C (p.T187P)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3722061	.	.	.	.	.	.	.	.	.	Likely Benign
6	31238909	31238910	6p21.33	0	normal	.	T	ref	T	CG.GC	het-alt	746	0.81	.	1	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_002117.5	NP_002108.4	-	Y	c.559A=	.	.	.	NM_002117.5(HLA-C): c.559A=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5008	0.588259	U	0.0109	0.0329473	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1050685	.	.	.	-4.761	-3.834	-4.140	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	31238941	31238942	6p21.33	0	normal	.	G	ref	G	CC.CA	het-alt	751	0.86	.	1	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_002117.5	NP_002108.4	-	Y	c.527C=	.	.	.	NM_002117.5(HLA-C): c.527C=	SingleClassQuadAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	112202	0.319397	U	0.244	0.296725	12920	0.394040	PASS	.	7920	0.289520	4549	107194	0.321511	.	.	.	.	.	.	rs2308590	.	.	.	-3.123	-4.116	-4.565	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31238941	31238942	6p21.33	1	normal	.	G	snv	T	CC.CA	het-ref	123	0.14	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_002117.5	NP_002108.4	-	Y	c.527C>A	p.A176E | p.Ala176Glu	GCG=>GAG	NP=>P-	NM_002117.5(HLA-C): c.527C>A (p.A176E)	SingleClassQuadAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	112202	0.405875	U	0.4921	0.429113	12920	0.605960	PASS	466	7920	0.408460	5638	107194	0.404789	1273	6336	4.82927e-01	12214	78566	4.22389e-01	rs2308590	.	.	.	-3.123	-4.116	-4.565	0.43	0.003	0	0.013	neutral	ENST00000376228: c.527C>A (p.A176E)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4160739	.	.	.	.	.	.	.	.	.	Likely Benign
6	31238956	31238957	6p21.33	0	normal	.	A	ref	A	CC.AC	het-alt	782	0.86	.	1	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_002117.5	NP_002108.4	-	Y	c.512T=	.	.	.	NM_002117.5(HLA-C): c.512T=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	105806	0.315039	U	.	.	.	.	PASS	.	7716	0.243520	4423	105806	0.315039	.	.	.	.	.	.	rs1050366	.	.	.	-2.460	0.369	-0.049	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31238956	31238957	6p21.33	1	normal	.	A	snv	C	CC.AC	het-ref	127	0.14	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_002117.5	NP_002108.4	-	Y	c.512T>G	p.L171W | p.Leu171Trp	TTG=>TGG	NP=>NP	NM_002117.5(HLA-C): c.512T>G (p.L171W)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	105806	0.684952	U	.	.	.	.	PASS	2090	7716	0.756480	23992	105806	0.684952	4928	12225	8.07250e-01	54448	149041	7.21064e-01	rs1050366	.	.	.	-2.460	0.369	-0.049	1	0	0	0.000	neutral	ENST00000376228: c.512T>G (p.L171W)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4160742	.	.	.	.	.	.	.	.	.	Likely Benign
6	31238991	31238992	6p21.33	0	normal	.	G	ref	G	GC.GC	het-alt	816	0.85	.	1	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_002117.5	NP_002108.4	-	Y	c.477C=	.	.	.	NM_002117.5(HLA-C): c.477C=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	110428	0.597376	U	0.0407	0.0247604	.	.	InbreedingCoeff_Filter	.	7518	0.633014	11160	105420	0.598662	.	.	.	.	.	.	rs41550715	.	.	.	0.305	-0.451	-0.382	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31238991	31238992	6p21.33	1	normal	.	G	snv	C	GC.GC	het-ref	142	0.15	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_002117.5	NP_002108.4	-	Y	c.477C>G	p.(A159=) | p.(Ala159=)	GCC=>GCG	.	NM_002117.5(HLA-C): c.477C>G (p.(A159=))	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	110428	0.389964	U	0.3621	0.404952	.	.	InbreedingCoeff_Filter	8	7518	0.344507	263	105420	0.389253	21	3380	2.58055e-01	1194	66848	3.48996e-01	rs41550715	.	.	.	0.305	-0.451	-0.382	.	.	.	.	.	ENST00000376228: c.477C>G (p.A159A)	breast [NS|NS|NS]	carcinoma [NS|NS|NS]	CSV	3830080	.	.	.	.	.	.	.	.	.	Likely Benign
6	31239005	31239006	6p21.33	0	normal	.	G	ref	G	GC.CA	het-alt	800	0.85	.	1	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_002117.5	NP_002108.4	-	Y	c.463C=	.	.	.	NM_002117.5(HLA-C): c.463C=	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	104534	0.653749	U	.	.	.	.	InbreedingCoeff_Filter	.	7360	0.666168	16096	104534	0.653749	.	.	.	.	.	.	rs76907552	.	.	.	-0.692	-0.027	0.025	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31239005	31239006	6p21.33	1	normal	.	G	snv	T	GC.CA	het-ref	136	0.15	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_002117.5	NP_002108.4	-	Y	c.463C>A	p.R155S | p.Arg155Ser	CGC=>AGC	P+=>P0	NM_002117.5(HLA-C): c.463C>A (p.R155S)	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	104534	0.346251	U	.	.	.	.	InbreedingCoeff_Filter	2	7360	0.333832	24	104534	0.346251	6	2958	2.39088e-01	495	56250	3.06196e-01	rs76907552	.	.	.	-0.692	-0.027	0.025	0.12	0.998	0.992	0.735	deleterious	ENST00000376228: c.463C>A (p.R155S)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	RSS	232488	.	.	.	.	.	.	.	.	.	Likely Benign
6	31239048	31239049	6p21.33	0	normal	.	G	ref	G	GC.GA	het-alt	772	0.83	.	1	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_002117.5	NP_002108.4	-	Y	c.420C=	.	.	.	NM_002117.5(HLA-C): c.420C=	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	118744	0.943408	U	0.0377	0.0539137	.	.	PASS	.	8288	0.957650	50526	113736	0.943290	.	.	.	.	.	.	rs1065406	.	.	.	-1.236	-0.750	-0.884	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31239048	31239049	6p21.33	1	normal	.	G	snv	T	GC.GA	het-ref	162	0.17	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_002117.5	NP_002108.4	-	Y	c.420C>A	p.(S140=) | p.(Ser140=)	TCC=>TCA	.	NM_002117.5(HLA-C): c.420C>A (p.(S140=))	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	118744	0.056592	U	0.0377	0.0539137	.	.	PASS	5	8288	0.042350	108	113736	0.056710	11	561	3.63342e-02	227	8267	3.67618e-02	rs1065406	.	.	.	-1.236	-0.750	-0.884	.	.	.	.	.	ENST00000376228: c.420C>A (p.S140S)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4160745	.	.	.	.	.	.	.	.	.	Likely Benign
6	31239049	31239050	6p21.33	0	normal	.	G	ref	G	CG.AC	het-alt	772	0.82	.	1	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_002117.5	NP_002108.4	-	Y	c.419C=	.	.	.	NM_002117.5(HLA-C): c.419C=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	115162	0.540595	U	0.2242	0.325879	12858	0.655623	PASS	-1076	8040	0.467164	13552	110154	0.541369	.	.	.	.	.	.	rs713032	.	.	.	-4.240	-5.547	-6.427	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31239049	31239050	6p21.33	1	normal	.	G	snv	A	CG.AC	het-ref	165	0.18	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_002117.5	NP_002108.4	-	Y	c.419C>T	p.S140F | p.Ser140Phe	TCC=>TTC	P0=>NP	NM_002117.5(HLA-C): c.419C>T (p.S140F)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	115162	0.317961	U	0.2242	0.325879	12858	0.344377	PASS	133	8040	0.231095	2890	110154	0.317601	284	3395	2.31836e-01	5239	63831	3.15870e-01	rs713032	.	.	.	-4.240	-5.547	-6.427	0.82	0.032	0.004	0.002	neutral	ENST00000376228: c.419C>T (p.S140F)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4160748	.	.	.	.	.	.	.	.	.	Likely Benign
6	31239056	31239057	6p21.33	0	normal	.	C	ref	C	GT.AT	het-alt	778	0.80	.	1	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_002117.5	NP_002108.4	-	Y	c.412G=	.	.	.	NM_002117.5(HLA-C): c.412G=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118798	0.740787	U	0.1627	0.256789	12852	0.719810	PASS	.	8286	0.819575	29114	113790	0.740680	.	.	.	.	.	.	rs2308575	.	.	.	-3.984	-8.217	-8.536	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31239056	31239057	6p21.33	1	normal	.	C	snv	T	GT.AT	het-ref	189	0.20	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_002117.5	NP_002108.4	-	Y	c.412G>A	p.D138N | p.Asp138Asn	GAC=>AAC	P-=>P0	NM_002117.5(HLA-C): c.412G>A (p.D138N)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118798	0.259163	U	0.1627	0.256789	12852	0.280190	PASS	81	8286	0.180425	1726	113790	0.259267	164	2821	1.79476e-01	3132	55940	2.50830e-01	rs2308575	.	.	.	-3.984	-8.217	-8.536	0.33	0.003	0	0.024	neutral	ENST00000376228: c.412G>A (p.D138N)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4160751	.	.	.	.	.	.	.	.	.	Likely Benign
6	31239100	31239101	6p21.33	0	normal	.	G	ref	G	CA.AC	het-alt	352	0.37	.	1	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_002117.5	NP_002108.4	-	Y	c.368C=	.	.	.	NM_002117.5(HLA-C): c.368C=	SingleClassQuadAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118274	0.145899	U	0.121	0.171925	12730	0.143676	PASS	-607	8196	0.187653	1433	113266	0.147255	.	.	.	.	.	.	rs1131115	.	.	.	-2.586	-5.358	-6.089	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31239100	31239101	6p21.33	1	normal	.	G	snv	T	CA.AC	het-ref	589	0.63	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_002117.5	NP_002108.4	-	Y	c.368C>A	p.S123Y | p.Ser123Tyr	TCT=>TAT	P0=>P0	NM_002117.5(HLA-C): c.368C>A (p.S123Y)	SingleClassQuadAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118274	0.655503	U	0.5179	0.64377	12730	0.856324	PASS	985	8196	0.492435	24258	113266	0.656022	2056	8010	5.05044e-01	49141	149306	6.59957e-01	rs1131115	.	.	.	-2.586	-5.358	-6.089	1	0.001	0	0.000	neutral	ENST00000376228: c.368C>A (p.S123Y)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4160754	.	.	.	.	.	.	.	.	.	Likely Benign
6	31239110	31239111	6p21.33	0	normal	.	G	ref	G	CT.GA	het-alt	751	0.87	.	1	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_002117.5	NP_002108.4	-	Y	c.358C=	.	.	.	NM_002117.5(HLA-C): c.358C=	.	.	.	.	.	.	.	.	VQSRTrancheINDEL99.50to99.90	.	8070	0.998389	54981	110794	0.996245	.	.	.	.	.	.	.	.	.	.	0.305	3.033	1.886	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31239111	31239111	6p21.33	1	normal	.	.	ins	CC	TG.GA	het-ref	114	0.13	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2;MHC_I C-terminus;Immunoglobulin C1-set domain	PF00129.13;PF06623.6;PF07654.10	frameshift	NM_002117.5	NP_002108.4	-	Y	c.357_358insGG	p.Q120Gfs*32 | p.Gln120Glyfs*32	.	.	NM_002117.5(HLA-C): c.357_358insGG (p.Q120Gfs*32)	MixedObserved;	110794	0.003737	U	.	.	.	.	VQSRTrancheINDEL99.50to99.90	0	8070	0.001611	0	110794	0.003737	0	46	2.86783e-03	0	249	1.08259e-03	rs748394002	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
6	31239111	31239112	6p21.33	0	normal	.	G	ref	G	TG.AG	het-alt	757	0.88	.	1	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_002117.5	NP_002108.4	-	Y	c.357C=	.	.	.	NM_002117.5(HLA-C): c.357C=	MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	109950	0.996262	U	.	.	.	.	PASS	.	8028	0.998381	54564	109950	0.996262	.	.	.	.	.	.	rs201441823	.	.	.	0.305	0.640	0.709	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31239111	31239112	6p21.33	1	normal	.	G	snv	A	TG.AG	het-ref	107	0.12	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_002117.5	NP_002108.4	-	Y	c.357C>T	p.(L119=) | p.(Leu119=)	CTC=>CTT	.	NM_002117.5(HLA-C): c.357C>T (p.(L119=))	MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	109950	0.003738	U	.	.	.	.	PASS	0	8028	0.001619	0	109950	0.003738	0	46	2.91545e-03	0	242	1.07886e-03	rs201441823	.	.	.	0.305	0.640	0.709	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
6	31239113	31239115	6p21.33	0	normal	.	GG	ref	GG	GA.GT	het-alt	777	0.88	.	1	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_002117.5	NP_002108.4	-	Y	c.354_355=	.	.	.	NM_002117.5(HLA-C): c.354_355=	MixedObserved;observed-mismatch	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs778339286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	31239113	31239115	6p21.33	1	normal	.	GG	del	.	GA.GT	het-ref	102	0.12	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2;MHC_I C-terminus;Immunoglobulin C1-set domain	PF00129.13;PF06623.6;PF07654.10	frameshift	NM_002117.5	NP_002108.4	-	Y	c.353C[3>1] (std: c.353C[1] alt: c.354_355delCC )	p.L119Pfs*19 | p.Leu119Profs*19	.	.	NM_002117.5(HLA-C): c.353C[1] (p.L119Pfs*19)	MixedObserved;observed-mismatch	0	0	U	.	.	.	.	VQSRTrancheINDEL99.50to99.90	0	8026	0.001620	0	109878	0.003731	.	.	.	.	.	.	rs778339286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
6	31239305	31239306	6p21.33	0	normal	.	T	ref	T	TC.GG	het-alt	359	0.51	.	1	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	IC2	IVS2	.	.	no-change	NM_002117.5	NP_002108.4	-	Y	c.343+70A=	.	.	.	NM_002117.5(HLA-C): c.343+70A=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	5008	0.111222	U	0.8294	0.888778	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7383157	.	.	.	-0.703	-1.348	-1.384	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31239305	31239306	6p21.33	0	normal	.	T	snv	G	TC.GG	het-ref	343	0.49	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	IC2	IVS2	.	.	intron	NM_002117.5	NP_002108.4	-	Y	c.343+70A>C	.	.	.	NM_002117.5(HLA-C): c.343+70A>C	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	5008	0.888778	U	0.8294	0.888778	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7383157	.	.	.	-0.703	-1.348	-1.384	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31239448	31239449	6p21.33	0	normal	.	C	ref	C	TA.TT	het-alt	399	0.49	.	1	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_002117.5	NP_002108.4	-	Y	c.270G=	.	.	.	NM_002117.5(HLA-C): c.270G=	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125850	0.839913	U	0.0516	0.141773	8440	0.829739	PASS	.	8630	0.945886	42713	120842	0.839154	.	.	.	.	.	.	rs28626310	.	.	.	-3.594	-5.643	-6.044	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31239448	31239449	6p21.33	1	normal	.	C	snv	G	TA.TT	het-ref	419	0.51	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_002117.5	NP_002108.4	-	Y	c.270G>C	p.K90N | p.Lys90Asn	AAG=>AAC	P+=>P0	NM_002117.5(HLA-C): c.270G>C (p.K90N)	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125850	0.160087	U	0.0516	0.141773	8440	0.170261	PASS	17	8630	0.054114	1729	120842	0.160846	26	901	5.22986e-02	3469	38859	1.58721e-01	rs28626310	.	.	.	-3.594	-5.643	-6.044	0.33	0.028	0.007	0.026	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	31239721	31239722	6p21.33	0	normal	.	A	ref	A	GG.GG	het-alt	398	0.52	.	1	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	IC1	IVS1	.	.	no-change	NM_002117.5	NP_002108.4	-	Y	c.73+54T=	.	.	.	NM_002117.5(HLA-C): c.73+54T=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	99536	0.138513	U	0.8214	0.870008	.	.	PASS	-476	6724	0.158537	733	94528	0.138964	.	.	.	.	.	.	rs9264670	.	.	.	-0.677	-1.548	-1.566	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31239721	31239722	6p21.33	0	normal	.	A	snv	C	GG.GG	het-ref	369	0.48	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	IC1	IVS1	.	.	intron	NM_002117.5	NP_002108.4	-	Y	c.73+54T>G	.	.	.	NM_002117.5(HLA-C): c.73+54T>G	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	99536	0.861487	U	0.8214	0.870008	.	.	PASS	2353	6724	0.841463	34861	94528	0.861036	5324	12938	8.22087e-01	80186	188016	8.50482e-01	rs9264670	.	.	.	-0.677	-1.548	-1.566	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31240352	31240353	6p21.33	0	normal	.	A	ref	A	GA.AC	het-alt	359	0.52	.	1	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	PROM	.	.	.	no-change	NM_002117.5	NP_002108.4	-	Y	c.-65-u440T=	.	.	.	NM_002117.5(HLA-C): c.-65-u440T=	;maf-5-some-pop	5008	0.110823	U	0.8294	0.889177	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs28498059	.	.	.	-2.030	-1.871	-1.996	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31240352	31240353	6p21.33	0	normal	.	A	snv	C	GA.AC	het-ref	331	0.48	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	PROM	.	.	.	promoter	NM_002117.5	NP_002108.4	-	Y	c.-65-u440T>G	.	.	.	NM_002117.5(HLA-C): c.-65-u440T>G	;maf-5-some-pop	5008	0.889177	U	0.8294	0.889177	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs28498059	.	.	.	-2.030	-1.871	-1.996	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31240662	31240663	6p21.33	0	normal	.	T	ref	T	GG.TC	het-alt	336	0.50	.	1	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	PROM	.	.	.	no-change	NM_002117.5	NP_002108.4	-	Y	c.-65-u750A=	.	.	.	NM_002117.5(HLA-C): c.-65-u750A=	;maf-5-some-pop	5008	0.110423	U	0.8294	0.889577	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9264679	.	.	.	-0.906	-1.451	-1.495	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31240662	31240663	6p21.33	0	normal	.	T	snv	A	GG.TC	het-ref	339	0.50	.	2	dup	PASS	142840	C	177900(SK);609423(SK)	NN	.	.	.	.	.	.	.	3107	HLA-C	PROM	.	.	.	promoter	NM_002117.5	NP_002108.4	-	Y	c.-65-u750A>T	.	.	.	NM_002117.5(HLA-C): c.-65-u750A>T	;maf-5-some-pop	5008	0.889577	U	0.8294	0.889577	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9264679	.	.	.	-0.906	-1.451	-1.495	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31323295	31323296	6p21.33	0	normal	.	A	ref	A	AA.CC	het-alt	124	0.49	.	1	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C4	EX4	Immunoglobulin C1-set domain	PF07654.10	no-change	NM_005514.6	NP_005505.2	-	Y	c.693T=	.	.	.	NM_005514.6(HLA-B): c.693T=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126174	0.149968	U	0.8284	0.877196	13000	0.163769	PASS	.	8610	0.186876	1545	121166	0.151090	.	.	.	.	.	.	rs1050747	.	.	.	-0.391	-0.019	-0.113	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31323295	31323296	6p21.33	1	normal	.	A	snv	G	AA.CC	het-ref	127	0.51	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C4	EX4	Immunoglobulin C1-set domain	PF07654.10	coding-synon	NM_005514.6	NP_005505.2	-	Y	c.693T>C	p.(G231=) | p.(Gly231=)	GGT=>GGC	.	NM_005514.6(HLA-B): c.693T>C (p.(G231=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126174	0.850033	U	0.8284	0.877196	13000	0.836231	PASS	2815	8610	0.813124	43821	121166	0.848910	5594	13893	8.10371e-01	89539	209317	8.53282e-01	rs1050747	.	.	.	-0.391	-0.019	-0.113	.	.	.	.	.	ENST00000412585: c.693T>C (p.G231G)	kidney [NS|NS|NS]	carcinoma [clear_cell_renal_cell_carcinoma|NS|NS]	CSV	3774227	.	.	.	.	.	.	.	.	.	Likely Benign
6	31323352	31323353	6p21.33	0	normal	.	G	ref	G	AC.TG	het-alt	202	0.52	.	1	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C4	EX4	.	.	no-change	NM_005514.6	NP_005505.2	-	Y	c.636C=	.	.	.	NM_005514.6(HLA-B): c.636C=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126199	0.603008	U	0.4018	0.40016	13006	0.578656	PASS	-1022	8636	0.640574	22157	121192	0.603134	.	.	.	.	.	.	rs2257269	.	.	.	-2.627	-2.865	-2.511	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31323352	31323353	6p21.33	1	normal	.	G	snv	A	AC.TG	het-ref	188	0.48	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C4	EX4	.	.	coding-synon	NM_005514.6	NP_005505.2	-	Y	c.636C>T	p.(H212=) | p.(His212=)	CAC=>CAT	.	NM_005514.6(HLA-B): c.636C>T (p.(H212=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126199	0.396992	U	0.4018	0.40016	13006	0.421344	PASS	530	8636	0.359426	9657	121192	0.396858	1095	6285	3.64432e-01	19973	98004	3.98873e-01	rs2257269	.	.	.	-2.627	-2.865	-2.511	.	.	.	.	.	ENST00000412585: c.636C>T (p.H212H)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3761863	.	.	.	.	.	.	.	.	.	Likely Benign
6	31323408	31323409	6p21.33	0	normal	.	T	ref	T	CT.TC	het-alt	289	0.51	.	1	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC3	IVS3	.	.	no-change	NM_005514.6	NP_005505.2	-	Y	c.620-40A=	.	.	.	NM_005514.6(HLA-B): c.620-40A=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125838	0.152267	U	0.8185	0.872604	13006	0.163771	PASS	.	8640	0.192014	1747	120830	0.153298	.	.	.	.	.	.	rs2523605	.	.	.	-0.380	-0.780	-1.123	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31323408	31323409	6p21.33	0	normal	.	T	snv	C	CT.TC	het-ref	274	0.49	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC3	IVS3	.	.	intron	NM_005514.6	NP_005505.2	-	Y	c.620-40A>G	.	.	.	NM_005514.6(HLA-B): c.620-40A>G	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125838	0.847733	U	0.8185	0.872604	13006	0.836229	PASS	2813	8640	0.807986	43639	120830	0.846702	5591	13883	8.06026e-01	88994	207992	8.50342e-01	rs2523605	.	.	.	-0.380	-0.780	-1.123	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31323556	31323557	6p21.33	0	normal	.	C	ref	C	AG.GG	het-alt	316	0.47	.	1	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC3	IVS3	.	.	no-change	NM_005514.6	NP_005505.2	-	Y	c.620-188G=	.	.	.	NM_005514.6(HLA-B): c.620-188G=	;clinically-assoc,submitted-by-lsdb	26058	0.986223	U	0	0.0151757	.	.	PASS	.	800	0.998750	10245	21050	0.986556	.	.	.	.	.	.	rs2394985	.	.	.	-0.778	-0.749	-0.589	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31323556	31323557	6p21.33	0	normal	.	C	snv	T	AG.GG	het-ref	353	0.53	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC3	IVS3	.	.	intron	NM_005514.6	NP_005505.2	-	Y	c.620-188G>A	.	.	.	NM_005514.6(HLA-B): c.620-188G>A	;clinically-assoc,submitted-by-lsdb	26058	0.013777	U	0	0.0151757	.	.	PASS	0	800	0.001250	3	21050	0.013444	0	1	9.49307e-05	27	1918	1.26969e-02	rs2394985	.	.	.	-0.778	-0.749	-0.589	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	31323765	31323766	6p21.33	0	normal	.	T	ref	T	AT.CC	het-alt	373	0.58	.	1	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC3	IVS3	.	.	no-change	NM_005514.6	NP_005505.2	-	Y	c.619+178A=	.	.	.	NM_005514.6(HLA-B): c.619+178A=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5008	0.127796	U	0.8175	0.872204	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2523604	.	.	.	-0.695	-1.303	-1.303	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31323765	31323766	6p21.33	0	normal	.	T	snv	C	AT.CC	het-ref	267	0.42	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC3	IVS3	.	.	intron	NM_005514.6	NP_005505.2	-	Y	c.619+178A>G	.	.	.	NM_005514.6(HLA-B): c.619+178A>G	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5008	0.872204	U	0.8175	0.872204	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2523604	.	.	.	-0.695	-1.303	-1.303	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31323775	31323776	6p21.33	0	normal	.	T	ref	T	TG.CT	het-alt	368	0.59	.	1	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC3	IVS3	.	.	no-change	NM_005514.6	NP_005505.2	-	Y	c.619+168A=	.	.	.	NM_005514.6(HLA-B): c.619+168A=	;clinically-assoc,submitted-by-lsdb	0	0	U	0.8115	0.805911	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs151341336	.	.	.	0.247	0.658	0.455	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31323776	31323776	6p21.33	0	normal	.	.	ins	C	GT.CT	het-ref	258	0.41	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC3	IVS3	.	.	intron	NM_005514.6	NP_005505.2	-	Y	c.619+167_619+168insG	.	.	.	NM_005514.6(HLA-B): c.619+167_619+168insG	;maf-5-some-pop,maf-5-all-pops	5008	0.805911	U	0.8115	0.805911	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11423052	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31323837	31323838	6p21.33	0	normal	.	C	ref	C	AA.GG	het-alt	442	0.56	.	1	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC3	IVS3	.	.	no-change	NM_005514.6	NP_005505.2	-	Y	c.619+106G=	.	.	.	NM_005514.6(HLA-B): c.619+106G=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	38402	0.168377	U	0.8185	0.872604	.	.	PASS	-148	1308	0.262997	301	33394	0.174522	.	.	.	.	.	.	rs2596494	.	.	.	-0.699	-1.337	-1.449	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31323837	31323838	6p21.33	0	normal	.	C	snv	G	AA.GG	het-ref	342	0.44	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC3	IVS3	.	.	intron	NM_005514.6	NP_005505.2	-	Y	c.619+106G>C	.	.	.	NM_005514.6(HLA-B): c.619+106G>C	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	38402	0.831623	U	0.8185	0.872604	.	.	PASS	334	1308	0.737003	11170	33394	0.825478	3355	8364	7.93247e-01	53709	125322	8.45331e-01	rs2596494	.	.	.	-0.699	-1.337	-1.449	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31323944	31323945	6p21.33	0	normal	.	A	ref	A	CC.GC	het-alt	392	0.81	.	1	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	.	.	no-change	NM_005514.6	NP_005505.2	-	Y	c.618T=	.	.	.	NM_005514.6(HLA-B): c.618T=	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	107236	0.193321	U	0.8204	0.873802	.	.	PASS	-670	7268	0.261420	2877	102228	0.196610	.	.	.	.	.	.	rs2596493	.	.	.	-2.465	-0.230	-0.650	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31323944	31323945	6p21.33	1	normal	.	A	snv	C	CC.GC	het-ref	94	0.19	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	.	.	coding-synon	NM_005514.6	NP_005505.2	-	Y	c.618T>G	p.(A206=) | p.(Ala206=)	GCT=>GCG	.	NM_005514.6(HLA-B): c.618T>G (p.(A206=))	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	107236	0.806641	U	0.8204	0.873802	.	.	PASS	2014	7268	0.738580	33888	102228	0.803351	4861	11184	8.11965e-01	76685	169181	8.48714e-01	rs2596493	.	.	.	-2.465	-0.230	-0.650	.	.	.	.	.	ENST00000412585: c.618T>G (p.A206A)	skin [NS|NS|NS]	carcinoma [basal_cell_carcinoma|NS|NS]	CSV	4006326	.	.	.	.	.	.	.	.	.	Likely Benign
6	31323952	31323953	6p21.33	0	normal	.	C	ref	C	CT.CA	het-alt	395	0.86	.	1	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	.	.	no-change	NM_005514.6	NP_005505.2	-	Y	c.610G=	.	.	.	NM_005514.6(HLA-B): c.610G=	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	97138	0.337911	U	0.8165	0.810903	.	.	PASS	-646	6586	0.296994	6894	92130	0.346000	.	.	.	.	.	.	rs1131285	.	.	.	-0.699	0.340	0.204	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31323952	31323953	6p21.33	1	normal	.	C	snv	G	CT.CA	het-ref	64	0.14	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	.	.	missense	NM_005514.6	NP_005505.2	-	Y	c.610G>C	p.E204Q | p.Glu204Gln	GAG=>CAG	P-=>P0	NM_005514.6(HLA-B): c.610G>C (p.E204Q)	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	97138	0.662089	U	0.8165	0.810903	.	.	PASS	1669	6586	0.703006	21082	92130	0.654000	4409	10020	7.98406e-01	52908	123330	7.25087e-01	rs1131285	.	.	.	-0.699	0.340	0.204	1	0	0	0.000	neutral	ENST00000412585: c.610G>C (p.E204Q)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4006327	.	.	.	.	.	.	.	.	.	Likely Benign
6	31323957	31323958	6p21.33	0	normal	.	T	ref	T	GC.TG	het-alt	403	0.87	.	1	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.605A=	.	.	.	NM_005514.6(HLA-B): c.605A=	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	88726	0.251009	U	0.8075	0.866014	12214	0.291305	PASS	-576	5800	0.354138	4431	83718	0.258009	.	.	.	.	.	.	rs1131279	.	.	.	-0.700	0.251	0.205	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31323957	31323958	6p21.33	1	normal	.	T	snv	G	GC.TG	het-ref	60	0.13	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.605A>C	p.K202T | p.Lys202Thr	AAG=>ACG	P+=>P0	NM_005514.6(HLA-B): c.605A>C (p.K202T)	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	88726	0.748991	U	0.8075	0.866014	12214	0.708695	PASS	1297	5800	0.645862	24690	83718	0.741991	4000	9064	7.73247e-01	62658	137465	8.13046e-01	rs1131279	.	.	.	-0.700	0.251	0.205	1	0	0	0.000	neutral	ENST00000412585: c.605A>C (p.K202T)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3734024	.	.	.	.	.	.	.	.	.	Likely Benign
6	31323959	31323960	6p21.33	0	normal	.	G	ref	G	TT.TC	het-alt	400	0.87	.	1	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.603C=	.	.	.	NM_005514.6(HLA-B): c.603C=	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	82477	0.409375	U	0.8036	0.802316	12210	0.532432	VQSRTrancheINDEL99.00to99.50	-548	5368	0.383756	8388	77470	0.423054	.	.	.	.	.	.	rs1131275	.	.	.	-0.699	0.283	-0.082	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31323959	31323960	6p21.33	1	normal	.	G	snv	C	TT.TC	het-ref	58	0.13	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.603C>G	p.D201E | p.Asp201Glu	GAC=>GAG	P-=>P-	NM_005514.6(HLA-B): c.603C>G (p.D201E)	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	82477	0.590625	U	0.8036	0.802316	12210	0.467568	VQSRTrancheINDEL99.00to99.50	1106	5368	0.616244	14349	77470	0.576933	3792	8608	7.60290e-01	43174	101235	6.75332e-01	rs1131275	.	.	.	-0.699	0.283	-0.082	1	0	0	0.000	neutral	ENST00000412585: c.603C>G (p.D201E)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [NS|NS|NS]	CSV	3734025	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324002	31324003	6p21.33	0	normal	.	T	ref	T	AC.CG	het-alt	411	0.74	.	1	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.560A=	.	.	.	NM_005514.6(HLA-B): c.560A=	MixedObserved,SingleClassQuadAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	106302	0.302167	U	0.5218	0.485024	12624	0.509902	PASS	.	7252	0.375483	4701	101294	0.304441	.	.	.	.	.	.	rs2308466	.	.	.	-3.687	-4.258	-4.771	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324002	31324003	6p21.33	1	normal	.	T	snv	A	AC.CG	het-ref	145	0.26	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.560A>T	p.E187V | p.Glu187Val	GAG=>GTG	P-=>NP	NM_005514.6(HLA-B): c.560A>T (p.E187V)	MixedObserved,SingleClassQuadAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	106302	0.381611	U	0.5218	0.485024	12624	0.490098	PASS	355	7252	0.435604	3699	101294	0.376498	989	5416	4.79462e-01	6631	63536	3.81492e-01	rs2308466	.	.	.	-3.687	-4.258	-4.771	0.23	0.049	0.004	0.045	neutral	ENST00000412585: c.560A>T (p.E187V)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3733865	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324003	31324004	6p21.33	0	normal	.	C	ref	C	CT.GC	het-alt	408	0.74	.	1	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.559G=	.	.	.	NM_005514.6(HLA-B): c.559G=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	106500	0.300770	U	0.5218	0.485024	12636	0.511159	PASS	-891	7244	0.372998	4641	101492	0.302970	.	.	.	.	.	.	rs2523600	.	.	.	-2.049	-1.058	-1.312	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324003	31324004	6p21.33	1	normal	.	C	snv	G	CT.GC	het-ref	146	0.26	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.559G>C	p.E187Q | p.Glu187Gln	GAG=>CAG	P-=>P0	NM_005514.6(HLA-B): c.559G>C (p.E187Q)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	106500	0.382366	U	0.5218	0.485024	12636	0.488841	PASS	356	7244	0.437327	3744	101492	0.377301	982	5455	4.81125e-01	6625	64029	3.82724e-01	rs2523600	.	.	.	-2.049	-1.058	-1.312	0.45	0.329	0.197	0.115	neutral	ENST00000412585: c.559G>C (p.E187Q)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3733866	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324023	31324024	6p21.33	0	nullSample	.	C	ref	C	TC.GC	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.539G=	.	.	.	NM_005514.6(HLA-B): c.539G=	MixedObserved,SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	99494	0.491688	U	0.5655	0.4998	.	.	InbreedingCoeff_Filter	-1173	7798	0.395742	4645	94486	0.496264	.	.	.	.	.	.	rs697742	.	.	.	-0.891	-1.411	-1.333	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324023	31324024	6p21.33	1	normal	.	C	snv	A	TC.GC	hom-alt	565	0.99	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.539G>T	p.R180L | p.Arg180Leu	CGG=>CTG	P+=>NP	NM_005514.6(HLA-B): c.539G>T (p.R180L)	MixedObserved,SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	99494	0.502422	U	0.5655	0.4998	.	.	InbreedingCoeff_Filter	1183	7798	0.604258	4917	94486	0.502561	2723	9753	6.42236e-01	10710	91275	4.66455e-01	rs697742	.	.	.	-0.891	-1.411	-1.333	0.66	0.03	0.002	0.004	neutral	ENST00000412585: c.539G>T (p.R180L)	large_intestine [colon|descending|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3761864	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324035	31324036	6p21.33	0	normal	.	T	ref	T	CC.CA	het-alt	174	0.32	.	1	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.527A=	.	.	.	NM_005514.6(HLA-B): c.527A=	SingleClassTriAllelic;maf-5-some-pop	110618	0.581054	U	0.3839	0.425519	.	.	InbreedingCoeff_Filter	.	7558	0.606113	10650	105610	0.581365	.	.	.	.	.	.	rs151341293	.	.	.	-2.615	-6.462	-6.376	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324035	31324036	6p21.33	1	normal	.	T	snv	A	CC.CA	het-ref	373	0.68	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.527A>T	p.E176V | p.Glu176Val	GAG=>GTG	P-=>NP	NM_005514.6(HLA-B): c.527A>T (p.E176V)	SingleClassTriAllelic;maf-5-some-pop	110618	0.416831	U	0.3839	0.425519	.	.	InbreedingCoeff_Filter	163	7558	0.393226	1944	105610	0.416419	584	6088	4.26869e-01	4877	83475	4.19009e-01	rs151341293	.	.	.	-2.615	-6.462	-6.376	0.6	0.016	0.001	0.005	neutral	ENST00000412585: c.527A>T (p.E176V)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4160793	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324050	31324051	6p21.33	0	normal	.	C	ref	C	CC.AC	het-alt	171	0.31	.	1	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.512G=	.	.	.	NM_005514.6(HLA-B): c.512G=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118628	0.935993	U	0.12	0.0678914	12752	0.955301	VQSRTrancheSNP99.60to99.80	-629	8280	0.837198	49605	113620	0.936164	.	.	.	.	.	.	rs41551018	.	.	.	-0.898	1.459	0.177	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324050	31324051	6p21.33	1	normal	.	C	snv	A	CC.AC	het-ref	378	0.69	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.512G>T	p.W171L | p.Trp171Leu	TGG=>TTG	NP=>NP	NM_005514.6(HLA-B): c.512G>T (p.W171L)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118628	0.063990	U	0.12	0.0678914	12752	0.044699	VQSRTrancheSNP99.60to99.80	45	8280	0.162802	48	113620	0.063818	130	2847	1.67234e-01	158	13405	5.65297e-02	rs41551018	.	.	.	-0.898	1.459	0.177	0.1	0.284	0.847	0.373	neutral	ENST00000412585: c.512G>T (p.W171L)	kidney [NS|NS|NS]	carcinoma [clear_cell_renal_cell_carcinoma|NS|NS]	CSV	3774228	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324063	31324064	6p21.33	0	normal	.	T	ref	T	GG.GA	het-alt	157	0.29	.	1	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.499A=	.	.	.	NM_005514.6(HLA-B): c.499A=	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118748	0.934854	U	0.12	0.0682907	12720	0.949214	PASS	.	8308	0.836904	49526	113740	0.934992	.	.	.	.	.	.	rs41541519	.	.	.	-2.763	0.150	-0.714	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324063	31324064	6p21.33	1	normal	.	T	snv	A	GG.GA	het-ref	386	0.71	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.499A>T	p.T167S | p.Thr167Ser	ACC=>TCC	P0=>P0	NM_005514.6(HLA-B): c.499A>T (p.T167S)	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118748	0.065146	U	0.12	0.0682907	12720	0.050786	PASS	44	8308	0.163096	50	113740	0.065008	131	2849	1.67352e-01	152	13663	5.75323e-02	rs41541519	.	.	.	-2.763	0.150	-0.714	0.19	0.003	0.001	0.050	neutral	ENST00000412585: c.499A>T (p.T167S)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4006328	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324076	31324077	6p21.33	0	normal	.	C	ref	C	GC.GT	het-alt	386	0.73	.	1	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.486G=	.	.	.	NM_005514.6(HLA-B): c.486G=	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	113740	0.597864	U	0.3373	0.393371	.	.	InbreedingCoeff_Filter	-1147	7784	0.682682	12829	108732	0.597460	.	.	.	.	.	.	rs709053	.	.	.	-2.220	-1.378	-0.809	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324076	31324077	6p21.33	1	normal	.	C	snv	G	GC.GT	het-ref	143	0.27	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_005514.6	NP_005505.2	-	Y	c.486G>C	p.(T162=) | p.(Thr162=)	ACG=>ACC	.	NM_005514.6(HLA-B): c.486G>C (p.(T162=))	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	113740	0.386953	U	0.3373	0.393371	.	.	InbreedingCoeff_Filter	88	7784	0.315391	1959	108732	0.386657	220	4254	3.29155e-01	4836	73607	3.94777e-01	rs709053	.	.	.	-2.220	-1.378	-0.809	.	.	.	.	.	ENST00000412585: c.486G>C (p.T162T)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4160794	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324085	31324086	6p21.33	0	normal	.	G	ref	G	GC.GC	het-alt	404	0.74	.	1	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.477C=	.	.	.	NM_005514.6(HLA-B): c.477C=	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	116896	0.535536	U	0.0198	0.0161741	.	.	InbreedingCoeff_Filter	-1599	8122	0.562423	7714	111888	0.537296	.	.	.	.	.	.	rs709054	.	.	.	-3.946	-1.261	-1.174	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324085	31324086	6p21.33	1	normal	.	G	snv	C	GC.GC	het-ref	140	0.26	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_005514.6	NP_005505.2	-	Y	c.477C>G	p.(A159=) | p.(Ala159=)	GCC=>GCG	.	NM_005514.6(HLA-B): c.477C>G (p.(A159=))	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	116896	0.450708	U	0.4742	0.48762	.	.	InbreedingCoeff_Filter	93	8122	0.416523	2456	111888	0.449056	365	6630	4.61378e-01	6245	94100	4.67383e-01	rs709054	.	.	.	-3.946	-1.261	-1.174	.	.	.	.	.	ENST00000412585: c.477C>G (p.A159A)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4160795	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324099	31324100	6p21.33	1	normal	.	G	snv	T	GC.CA	het-ref	143	0.25	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.463C>A	p.R155S | p.Arg155Ser	CGC=>AGC	P+=>P0	NM_005514.6(HLA-B): c.463C>A (p.R155S)	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	110432	0.413204	U	.	.	.	.	InbreedingCoeff_Filter	125	8060	0.437097	1033	110432	0.413205	400	7017	4.71573e-01	2544	85474	4.24568e-01	rs1050654	.	.	.	-2.445	-0.762	-0.595	0.12	0.005	0	0.261	neutral	ENST00000412585: c.463C>A (p.R155S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4006329	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324099	31324100	6p21.33	0	normal	.	G	ref	G	GC.CA	het-alt	420	0.75	.	1	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.463C=	.	.	.	NM_005514.6(HLA-B): c.463C=	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	110432	0.586796	U	.	.	.	.	InbreedingCoeff_Filter	.	8060	0.562903	10618	110432	0.586795	.	.	.	.	.	.	rs1050654	.	.	.	-2.445	-0.762	-0.595	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324150	31324151	6p21.33	0	nullSample	.	C	ref	C	GT.AT	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.412G=	.	.	.	NM_005514.6(HLA-B): c.412G=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	109082	0.510258	U	0.0149	0.0263578	12502	0.563510	PASS	.	7696	0.479080	11911	104074	0.510300	.	.	.	.	.	.	rs709055	.	.	.	-0.712	-4.124	-4.183	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324150	31324151	6p21.33	1	normal	.	C	snv	T	GT.AT	hom-alt	443	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.412G>A	p.D138N | p.Asp138Asn	GAC=>AAC	P-=>P0	NM_005514.6(HLA-B): c.412G>A (p.D138N)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	109082	0.454493	U	0.4792	0.464257	12502	0.436490	PASS	720	7696	0.497531	9368	104074	0.454023	1335	7483	4.89661e-01	17894	93874	4.62179e-01	rs709055	.	.	.	-0.712	-4.124	-4.183	0.34	0.002	0.001	0.023	neutral	ENST00000412585: c.412G>A (p.D138N)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	4006331	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324199	31324200	6p21.33	0	nullSample	.	G	ref	G	AT.CT	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.363C=	.	.	.	NM_005514.6(HLA-B): c.363C=	MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	89200	0.306883	U	0.0169	0.01877	11524	0.402551	PASS	-238	6614	0.110372	6590	84192	0.314305	.	.	.	.	.	.	rs1140412	.	.	.	-1.868	-1.001	-0.787	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324199	31324200	6p21.33	1	normal	.	G	snv	C	AT.CT	hom-alt	393	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C3	EX3	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.363C>G	p.S121R | p.Ser121Arg	AGC=>AGG	P0=>P+	NM_005514.6(HLA-B): c.363C>G (p.S121R)	MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	89200	0.661536	U	0.8681	0.799121	11524	0.597449	PASS	2528	6614	0.856819	20470	84192	0.653352	6028	13103	9.03905e-01	49733	122687	7.07603e-01	rs1140412	.	.	.	-1.868	-1.001	-0.787	0.46	0.003	0.007	0.012	neutral	ENST00000412585: c.363C>G (p.S121R)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4160800	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324253	31324254	6p21.33	0	normal	.	A	ref	A	CG.GC	het-alt	234	0.83	.	1	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC2	IVS2	.	.	no-change	NM_005514.6	NP_005505.2	-	Y	c.344-35T=	.	.	.	NM_005514.6(HLA-B): c.344-35T=	.	.	.	.	.	.	.	.	VQSRTrancheINDEL99.50to99.90	0	2512	1.000000	13244	26512	0.999547	.	.	.	.	.	.	.	.	.	.	0.232	-0.081	-0.001	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324254	31324254	6p21.33	0	normal	.	.	ins	GCCCC	GA.GC	het-ref	47	0.17	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC2	IVS2	.	.	intron	NM_005514.6	NP_005505.2	-	Y	c.344-36_344-35insGGGGC	.	.	.	NM_005514.6(HLA-B): c.344-36_344-35insGGGGC	;	26512	0.000453	U	.	.	4706	0.004037	VQSRTrancheINDEL99.50to99.90	0	2512	0.000000	0	26512	0.000453	.	.	.	.	.	.	rs766362414	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324372	31324373	6p21.33	0	nullSample	.	A	ref	A	GG.GG	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC2	IVS2	.	.	no-change	NM_005514.6	NP_005505.2	-	Y	c.343+92T=	.	.	.	NM_005514.6(HLA-B): c.343+92T=	MixedObserved;maf-5-some-pop,maf-5-all-pops,observed-mismatch|MixedObserved;maf-5-some-pop,maf-5-all-pops	5008	0.853035|0.638578	U	0.4623	0.361422	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs151341211|rs4999718	.	.	.	-0.695	1.039	0.603	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324372	31324373	6p21.33	0	normal	.	A	snv	G	GG.GG	hom-alt	618	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC2	IVS2	.	.	intron	NM_005514.6	NP_005505.2	-	Y	c.343+92T>C	.	.	.	NM_005514.6(HLA-B): c.343+92T>C	MixedObserved;maf-5-some-pop,maf-5-all-pops	5008	0.361422	U	0.4623	0.361422	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4999718	.	.	.	-0.695	1.039	0.603	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324374	31324375	6p21.33	0	normal	.	G	ref	G	AG.CG	het-alt	270	0.44	.	1	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC2	IVS2	.	.	no-change	NM_005514.6	NP_005505.2	-	Y	c.343+90C=	.	.	.	NM_005514.6(HLA-B): c.343+90C=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	5008	0.962061	U	0.1071	0.0379393	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs41563615	.	.	.	0.297	0.215	0.012	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324374	31324375	6p21.33	0	normal	.	G	snv	T	AG.CG	het-ref	347	0.56	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC2	IVS2	.	.	intron	NM_005514.6	NP_005505.2	-	Y	c.343+90C>A	.	.	.	NM_005514.6(HLA-B): c.343+90C>A	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	5008	0.037939	U	0.1071	0.0379393	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs41563615	.	.	.	0.297	0.215	0.012	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324487	31324488	6p21.33	0	normal	.	C	ref	C	AG.CG	het-alt	422	0.90	.	1	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.320G=	.	.	.	NM_005514.6(HLA-B): c.320G=	SingleClassQuadAllelic;clinically-assoc,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	0	0	U	.	.	.	.	VQSRTrancheINDEL99.00to99.50	.	7604	0.816281	36867	105042	0.837484	.	.	.	.	.	.	rs41552715	.	.	.	0.448	1.349	0.699	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324488	31324488	6p21.33	1	normal	.	.	ins	GGAG	GC.CG	het-ref	49	0.10	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2;MHC_I C-terminus;Immunoglobulin C1-set domain	PF00129.13;PF06623.6;PF07654.10	frameshift	NM_005514.6	NP_005505.2	-	Y	c.319_320insCTCC	p.G107Afs*33 | p.Gly107Alafs*33	.	.	NM_005514.6(HLA-B): c.319_320insCTCC (p.G107Afs*33)	ObservedTooLong;rs-cluster-nonoverlapping-alleles	105042	0.133328	U	.	.	12214	0	VQSRTrancheINDEL99.00to99.50	42	7604	0.129406	1206	105042	0.133328	147	1478	1.04202e-01	2706	18997	9.69848e-02	rs375356947	.	.	.	.	.	.	.	.	.	.	.	ENST00000412585: c.319_320insCTCC (p.G107fs*33)	thyroid [NS|NS|NS]	carcinoma [NS|NS|NS]	CSV	5957933	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324492	31324493	6p21.33	0	normal	.	C	ref	C	CG.AG	het-alt	437	0.91	.	1	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.315G=	.	.	.	NM_005514.6(HLA-B): c.315G=	MixedObserved,SingleClassTriAllelic;clinically-assoc,submitted-by-lsdb|MixedObserved;maf-5-some-pop,maf-5-all-pops	0|105704	0|0.870175	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs41549513|rs749699159	.	.	.	0.448	0.307	0.207	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324492	31324493	6p21.33	1	normal	.	C	del	.	CG.AG	het-ref	43	0.09	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2;MHC_I C-terminus;Immunoglobulin C1-set domain	PF00129.13;PF06623.6;PF07654.10	frameshift	NM_005514.6	NP_005505.2	-	Y	c.315delG	p.R106Afs*45 | p.Arg106Alafs*45	.	.	NM_005514.6(HLA-B): c.315delG (p.R106Afs*45)	MixedObserved,SingleClassTriAllelic;clinically-assoc,submitted-by-lsdb|MixedObserved;maf-5-some-pop,maf-5-all-pops	0|105704	0|0.129825	U	.	.	.	.	VQSRTrancheINDEL99.00to99.50	35	7588	0.126911	1083	105704	0.129825	100	1218	8.41276e-02	2098	16403	8.09026e-02	rs41549513|rs749699159	.	.	.	0.448	0.307	0.207	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324494	31324497	6p21.33	0	normal	.	GGT	ref	GGT	CA.TC	het-alt	458	0.91	.	1	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.311_313=	.	.	.	NM_005514.6(HLA-B): c.311_313=	MixedObserved;observed-mismatch	93420	0.853929	U	0.0913	0.0658946	.	.	VQSRTrancheINDEL99.00to99.50	.	5722	0.927123	36661	79106	0.962734	.	.	.	.	.	.	rs770563406	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324494	31324497	6p21.33	1	normal	.	GGT	del	.	CA.TC	het-ref	43	0.09	.	2	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	cds-indel	NM_005514.6	NP_005505.2	-	Y	c.311_313delACC	p.N104_L105delinsM | p.Asn104_Leu105delinsMet	.	.	NM_005514.6(HLA-B): c.311_313delACC (p.N104_L105delinsM)	MixedObserved;observed-mismatch	93420	0.146072	U	.	.	.	.	VQSRTrancheINDEL99.00to99.50	29	6316	0.150412	1022	93428	0.146059	95	1187	9.55101e-02	2049	16172	9.14240e-02	rs770563406	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324515	31324516	6p21.33	0	nullSample	.	C	ref	C	GT.AG	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.292G=	.	.	.	NM_005514.6(HLA-B): c.292G=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	107498	0.401635	U	0.6419	0.703874	12594	0.518342	PASS	-811	6904	0.360950	9974	102490	0.406791	.	.	.	.	.	.	rs1131215	.	.	.	-6.206	-2.257	-2.027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324515	31324516	6p21.33	1	normal	.	C	snv	A	GT.AG	hom-alt	499	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.292G>T	p.D98Y | p.Asp98Tyr	GAC=>TAC	P-=>P0	NM_005514.6(HLA-B): c.292G>T (p.D98Y)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	107498	0.598272	U	0.6419	0.703874	12594	0.481658	PASS	1395	6904	0.639050	19517	102490	0.593112	3222	8750	6.74946e-01	42997	113568	6.15071e-01	rs1131215	.	.	.	-6.206	-2.257	-2.027	0.49	0.15	0.05	0.024	neutral	ENST00000412585: c.292G>T (p.D98Y)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1443267	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324524	31324526	6p21.33	0	nullSample	.	CC	ref	CC	TG.TG	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.282_283=	.	.	.	NM_005514.6(HLA-B): c.282_283=	MixedObserved;maf-5-some-pop,maf-5-all-pops,observed-mismatch	105006	0.303497	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs750527298	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324524	31324526	6p21.33	1	normal	.	CC	del	.	TG.TG	hom-alt	502	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2;MHC_I C-terminus;Immunoglobulin C1-set domain	PF00129.13;PF06623.6;PF07654.10	frameshift	NM_005514.6	NP_005505.2	-	Y	c.282_283delGG	p.Q94Hfs*4 | p.Gln94Hisfs*4	.	.	NM_005514.6(HLA-B): c.282_283delGG (p.Q94Hfs*4)	MixedObserved;maf-5-some-pop,maf-5-all-pops,observed-mismatch	105006	0.696503	U	.	.	.	.	VQSRTrancheINDEL99.50to99.90	1363	6816	0.627494	27072	105006	0.696503	3100	8499	6.44743e-01	60831	145444	7.30852e-01	rs750527298	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324527	31324528	6p21.33	0	nullSample	.	G	ref	G	CT.GG	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.280C=	.	.	.	NM_005514.6(HLA-B): c.280C=	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	30895	0.730830	U	0.0565	0.0758786	12332	0.872040	VQSRTrancheINDEL99.50to99.90	-568	6376	0.260979	3736	101688	0.213063	.	.	.	.	.	.	rs1071817	.	.	.	-4.899	-4.847	-5.592	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324528	31324528	6p21.33	1	normal	.	.	ins	TT	TG.GG	hom-alt	498	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2;MHC_I C-terminus;Immunoglobulin C1-set domain	PF00129.13;PF06623.6;PF07654.10	frameshift	NM_005514.6	NP_005505.2	-	Y	c.279_280insAA	p.Q94Nfs*58 | p.Gln94Asnfs*58	.	.	NM_005514.6(HLA-B): c.279_280insAA (p.Q94Nfs*58)	;	97467	0.735900	U	.	.	.	.	VQSRTrancheINDEL99.50to99.90	1315	6376	0.634881	26638	101688	0.705354	3189	8314	6.92256e-01	61835	144766	7.67208e-01	rs749557905	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324530	31324531	6p21.33	0	nullSample	.	C	ref	C	GG.CT	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.277G=	.	.	.	NM_005514.6(HLA-B): c.277G=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	106466	0.293991	U	0.1111	0.0223642	12278	0.352256	PASS	-661	6204	0.343005	5799	101458	0.295285	.	.	.	.	.	.	rs1131204	.	.	.	-1.745	-0.169	-0.875	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324530	31324531	6p21.33	1	normal	.	C	snv	T	GG.CT	hom-alt	505	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.277G>A	p.A93T | p.Ala93Thr	GCC=>ACC	NP=>P0	NM_005514.6(HLA-B): c.277G>A (p.A93T)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	106466	0.703999	U	0.6389	0.709864	12278	0.647744	PASS	1304	6204	0.640716	26495	101458	0.703710	3400	8376	7.21074e-01	63780	147513	7.67122e-01	rs1131204	.	.	.	-1.745	-0.169	-0.875	0.54	0.016	0.001	0.008	neutral	ENST00000412585: c.277G>A (p.A93T)	bone [femur|NS|NS]	osteosarcoma [NS|NS|NS]	CSV	5021513	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324535	31324536	6p21.33	0	nullSample	.	T	ref	T	TG.AG	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.272A=	.	.	.	NM_005514.6(HLA-B): c.272A=	SingleClassQuadAllelic;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5008	0.188898	U	0.1736	0.346046	12432	0.460746	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1071816	.	.	.	-1.502	-0.795	-1.353	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324535	31324536	6p21.33	1	normal	.	T	snv	G	TG.AG	hom-alt	508	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.272A>C	p.Y91S | p.Tyr91Ser	TAC=>TCC	P0=>P0	NM_005514.6(HLA-B): c.272A>C (p.Y91S)	SingleClassQuadAllelic;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5008	0.366813	U	0.4345	0.366813	12432	0	PASS	583	6140	0.408306	6090	100234	0.313427	1753	5344	4.80662e-01	16199	58940	3.38701e-01	rs1071816	.	.	.	-1.502	-0.795	-1.353	0.19	0.001	0	0.050	neutral	ENST00000412585: c.272A>C (p.Y91S)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4160817	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324546	31324547	6p21.33	0	nullSample	.	G	ref	G	GT.TT	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.261C=	.	.	.	NM_005514.6(HLA-B): c.261C=	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	102320	0.654320	U	0.5853	0.454872	12530	0.794812	PASS	.	5820	0.534192	21740	97312	0.659939	.	.	.	.	.	.	rs1065386	.	.	.	-1.610	-0.549	-0.885	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324546	31324547	6p21.33	1	normal	.	G	snv	C	GT.TT	hom-alt	540	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.261C>G	p.N87K | p.Asn87Lys	AAC=>AAG	P0=>P+	NM_005514.6(HLA-B): c.261C>G (p.N87K)	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	102320	0.345670	U	0.5853	0.454872	12530	0.205188	PASS	637	5820	0.465636	6175	97312	0.340051	2164	5845	5.46160e-01	17697	60311	3.41226e-01	rs1065386	.	.	.	-1.610	-0.549	-0.885	0.04	0.101	0.047	0.356	neutral	ENST00000412585: c.261C>G (p.N87K)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [plasma_cell_myeloma|NS|NS]	RSS	329391	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324548	31324549	6p21.33	0	nullSample	.	T	ref	T	GT.CC	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.259A=	.	.	.	NM_005514.6(HLA-B): c.259A=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	102256	0.655257	U	0.5853	0.454872	12534	0.811473	PASS	.	5802	0.534126	21809	97248	0.660929	.	.	.	.	.	.	rs1050570	.	.	.	-3.744	-3.846	-3.541	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324548	31324549	6p21.33	1	normal	.	T	snv	C	GT.CC	hom-alt	547	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.259A>G	p.N87D | p.Asn87Asp	AAC=>GAC	P0=>P-	NM_005514.6(HLA-B): c.259A>G (p.N87D)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	102256	0.344743	U	0.5853	0.454872	12534	0.188527	PASS	640	5802	0.465874	6159	97248	0.339071	2163	5823	5.46350e-01	17658	60057	3.39904e-01	rs1050570	.	.	.	-3.744	-3.846	-3.541	0.05	0.03	0.004	0.347	neutral	ENST00000412585: c.259A>G (p.N87D)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [plasma_cell_myeloma|NS|NS]	RSS	329392	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324585	31324586	6p21.33	0	nullSample	.	C	ref	C	CA.GG	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.222G=	.	.	.	NM_005514.6(HLA-B): c.222G=	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	83616	0.688588	U	0.7133	0.641174	12584	0.672362	PASS	-316	4272	0.655899	22294	78608	0.709597	.	.	.	.	.	.	rs1050556	.	.	.	-0.379	-1.128	-0.813	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324585	31324586	6p21.33	1	normal	.	C	snv	T	CA.GG	hom-alt	678	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_005514.6	NP_005505.2	-	Y	c.222G>A	p.(P74=) | p.(Pro74=)	CCG=>CCA	.	NM_005514.6(HLA-B): c.222G>A (p.(P74=))	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	83616	0.311412	U	0.7133	0.641174	12584	0.327638	PASS	419	4272	0.344101	5818	78608	0.290403	1641	3610	4.25607e-01	19189	46031	3.07974e-01	rs1050556	.	.	.	-0.379	-1.128	-0.813	.	.	.	.	.	ENST00000412585: c.222G>A (p.P74P)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4006338	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324602	31324603	6p21.33	0	nullSample	.	C	ref	C	CT.TC	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.205G=	.	.	.	NM_005514.6(HLA-B): c.205G=	MixedObserved;observed-mismatch|MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	61261|5008	0.999967|0.515176	U	0.4256	0.484824	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs779396259|rs9266178	.	.	.	-0.833	-2.372	-3.012	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324602	31324603	6p21.33	1	normal	.	C	snv	T	CT.TC	hom-alt	695	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.205G>A	p.E69K | p.Glu69Lys	GAG=>AAG	P-=>P+	NM_005514.6(HLA-B): c.205G>A (p.E69K)	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5008	0.484824	U	0.4256	0.484824	.	.	PASS	51	3866	0.111743	998	73910	0.095995	896	2216	2.79445e-01	6025	19115	1.35398e-01	rs9266178	.	.	.	-0.833	-2.372	-3.012	0.08	0	0	0.300	neutral	ENST00000412585: c.205G>A (p.E69K)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4160819	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324603	31324604	6p21.33	0	nullSample	.	T	ref	T	TC.CT	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.204A=	.	.	.	NM_005514.6(HLA-B): c.204A=	MixedObserved;observed-mismatch|MixedObserved,SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	66814|55046	0.805550|0.869709	U	.	.	12070	0.557581	PASS	-171	2776	0.840058	21334	55046	0.869709	.	.	.	.	.	.	rs200186034|rs9266179	.	.	.	-0.525	0.109	-0.418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324603	31324604	6p21.33	1	normal	.	T	snv	C	TC.CT	hom-alt	695	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_005514.6	NP_005505.2	-	Y	c.204A>G	p.(R68=) | p.(Arg68=)	AGA=>AGG	.	NM_005514.6(HLA-B): c.204A>G (p.(R68=))	MixedObserved,SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	55046	0.130273	U	.	.	12070	0	PASS	51	2776	0.159942	983	55046	0.130273	879	2332	2.90918e-01	5796	19629	1.40059e-01	rs9266179	.	.	.	-0.525	0.109	-0.418	.	.	.	.	.	ENST00000412585: c.204A>G (p.R68R)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4160820	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324614	31324615	6p21.33	0	nullSample	.	C	ref	C	CG.GG	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.193G=	.	.	.	NM_005514.6(HLA-B): c.193G=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	91460	0.894566	U	0.256	0.211262	12694	0.913502	PASS	-276	4886	0.866148	35360	86452	0.900696	.	.	.	.	.	.	rs1050529	.	.	.	0.448	-0.314	-0.088	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324614	31324615	6p21.33	1	normal	.	C	snv	T	CG.GG	hom-alt	702	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.193G>A	p.A65T | p.Ala65Thr	GCG=>ACG	NP=>P0	NM_005514.6(HLA-B): c.193G>A (p.A65T)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	91460	0.105434	U	0.256	0.211262	12694	0.086498	PASS	51	4886	0.133852	719	86452	0.099304	604	2300	2.00035e-01	4255	21080	1.12126e-01	rs1050529	.	.	.	0.448	-0.314	-0.088	0.12	0.987	0.998	0.697	deleterious	ENST00000412585: c.193G>A (p.A65T)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4160821	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324640	31324641	6p21.33	0	nullSample	.	T	ref	T	AC.GG	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.167A=	.	.	.	NM_005514.6(HLA-B): c.167A=	MixedObserved;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	103338	0.893553	U	0.2054	0.198682	12604	0.938591	PASS	.	6422	0.897695	40331	98330	0.898251	.	.	.	.	.	.	rs1050518	.	.	.	0.368	0.891	1.476	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324640	31324641	6p21.33	1	normal	.	T	snv	A	AC.GG	hom-alt	645	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.167A>T	p.Q56L | p.Gln56Leu	CAG=>CTG	P0=>NP	NM_005514.6(HLA-B): c.167A>T (p.Q56L)	MixedObserved;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	103338	0.106447	U	0.2054	0.198682	12604	0.061409	PASS	65	6422	0.102305	1171	98330	0.101749	421	2450	1.73907e-01	4891	26128	1.29120e-01	rs1050518	.	.	.	0.368	0.891	1.476	0.01	0.983	0.998	0.835	deleterious	ENST00000412585: c.167A>T (p.Q56L)	biliary_tract [bile_duct|NS|NS]	carcinoma [NS|NS|NS]	CSV	4160822	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324642	31324643	6p21.33	0	nullSample	.	G	ref	G	TG.GT	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.165C=	.	.	.	NM_005514.6(HLA-B): c.165C=	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	103894	0.621316	U	0.3631	0.375799	12602	0.657118	PASS	.	6254	0.672370	21651	98886	0.621170	.	.	.	.	.	.	rs1050517	.	.	.	-0.382	-0.080	-0.055	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324642	31324643	6p21.33	1	normal	.	G	snv	C	TG.GT	hom-alt	634	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_005514.6	NP_005505.2	-	Y	c.165C>G	p.(T55=) | p.(Thr55=)	ACC=>ACG	.	NM_005514.6(HLA-B): c.165C>G (p.(T55=))	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	103894	0.378684	U	0.3631	0.375799	12602	0.342882	PASS	473	6254	0.327630	9669	98886	0.378830	1620	5770	4.20186e-01	24566	86628	4.19165e-01	rs1050517	.	.	.	-0.382	-0.080	-0.055	.	.	.	.	.	ENST00000412585: c.165C>G (p.T55T)	biliary_tract [bile_duct|NS|NS]	carcinoma [NS|NS|NS]	CSV	4160823	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324663	31324664	6p21.33	0	nullSample	.	T	ref	T	AC.GA	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.144A=	.	.	.	NM_005514.6(HLA-B): c.144A=	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	106726	0.869207	U	0.2629	0.22524	12492	0.966218	PASS	.	7194	0.843064	39451	101718	0.873857	.	.	.	.	.	.	rs9266184	.	.	.	-0.424	-0.788	-0.875	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324663	31324664	6p21.33	1	normal	.	T	snv	G	AC.GA	hom-alt	629	1.00	.	0	dup	DUBIOUS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	coding-synon	NM_005514.6	NP_005505.2	-	Y	c.144A>C	p.(S48=) | p.(Ser48=)	TCA=>TCC	.	NM_005514.6(HLA-B): c.144A>C (p.(S48=))	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	106726	0.130793	U	0.2629	0.22524	12492	0.033782	PASS	112	7194	0.156936	1423	101718	0.126143	450	2800	2.02079e-01	4833	27034	1.37491e-01	rs9266184	.	.	.	-0.424	-0.788	-0.875	.	.	.	.	.	ENST00000412585: c.144A>C (p.S48S)	urinary_tract [bladder|NS|NS]	carcinoma [NS|NS|NS]	CSV	4006339	.	.	.	.	.	.	.	.	.	Unknown
6	31324665	31324666	6p21.33	0	nullSample	.	A	ref	A	TG.GA	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.142T=	.	.	.	NM_005514.6(HLA-B): c.142T=	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	109620	0.404096	U	0.5724	0.496406	12476	0.587688	PASS	-446	7596	0.179305	11885	104612	0.408787	.	.	.	.	.	.	rs713031	.	.	.	-3.242	-3.083	-2.734	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324665	31324666	6p21.33	1	normal	.	A	snv	T	TG.GA	hom-alt	623	1.00	.	0	dup	DUBIOUS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.142T>A	p.S48T | p.Ser48Thr	TCA=>ACA	P0=>P0	NM_005514.6(HLA-B): c.142T>A (p.S48T)	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	109620	0.127431	U	0.245	0.197484	12476	0	PASS	113	7596	0.152054	1434	104612	0.124078	452	2743	2.04457e-01	4866	26810	1.43020e-01	rs713031	.	.	.	-3.242	-3.083	-2.734	0.18	0.001	0	0.056	neutral	ENST00000412585: c.142T>A (p.S48T)	upper_aerodigestive_tract [head_neck|NS|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	VUO	3253076	.	.	.	.	.	.	.	.	.	Unknown
6	31324701	31324702	6p21.33	0	nullSample	.	C	ref	C	CA.GG	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.106G=	.	.	.	NM_005514.6(HLA-B): c.106G=	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	98452	0.495053	U	0.6994	0.676518	12186	0.550796	PASS	.	7194	0.436058	10809	93444	0.504249	.	.	.	.	.	.	rs1050486	.	.	.	0.448	1.274	0.660	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324701	31324702	6p21.33	1	normal	.	C	snv	T	CA.GG	hom-alt	662	1.00	.	0	dup	DUBIOUS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.106G>A	p.V36M | p.Val36Met	GTG=>ATG	NP=>NP	NM_005514.6(HLA-B): c.106G>A (p.V36M)	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	98452	0.504947	U	0.6994	0.676518	12186	0.449204	PASS	868	7194	0.563942	10412	93444	0.495751	3277	9519	6.90183e-01	30808	101936	5.49348e-01	rs1050486	.	.	.	0.448	1.274	0.660	0.09	0.101	0.434	0.304	neutral	ENST00000412585: c.106G>A (p.V36M)	large_intestine [colon|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3761868	.	.	.	.	.	.	.	.	.	Unknown
6	31324704	31324705	6p21.33	0	nullSample	.	A	ref	A	GG.GG	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.103T=	.	.	.	NM_005514.6(HLA-B): c.103T=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	96382	0.428254	U	0.7312	0.705072	12082	0.451829	PASS	.	6930	0.325397	8568	91374	0.435562	.	.	.	.	.	.	rs1131170	.	.	.	-4.197	-0.541	-0.833	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324704	31324705	6p21.33	1	normal	.	A	snv	C	GG.GG	hom-alt	667	1.00	.	0	dup	DUBIOUS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.103T>G	p.S35A | p.Ser35Ala	TCC=>GCC	P0=>NP	NM_005514.6(HLA-B): c.103T>G (p.S35A)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	96382	0.571735	U	0.7312	0.705072	12082	0.548171	PASS	1523	6930	0.674459	14455	91374	0.564428	4209	10465	7.70732e-01	40080	114822	6.23870e-01	rs1131170	.	.	.	-4.197	-0.541	-0.833	1	0.003	0	0.000	neutral	ENST00000412585: c.103T>G (p.S35A)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3761869	.	.	.	.	.	.	.	.	.	Unknown
6	31324710	31324711	6p21.33	0	nullSample	.	A	ref	A	GT.GA	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	no-change	NM_005514.6	NP_005505.2	-	Y	c.97T=	.	.	.	NM_005514.6(HLA-B): c.97T=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	90342	0.786932	U	0.002	0.0317492	12070	0.892875	PASS	.	6320	0.888766	26888	85334	0.785584	.	.	.	.	.	.	rs2596492	.	.	.	-3.831	-7.550	-7.871	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324710	31324711	6p21.33	1	normal	.	A	snv	G	GT.GA	hom-alt	690	1.00	.	0	dup	DUBIOUS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C2	EX2	Class I Histocompatibility antigen, domains alpha 1 and 2	PF00129.13	missense	NM_005514.6	NP_005505.2	-	Y	c.97T>C	p.Y33H | p.Tyr33His	TAC=>CAC	P0=>P+	NM_005514.6(HLA-B): c.97T>C (p.Y33H)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	90342	0.167574	U	0.1647	0.158347	12070	0.107125	PASS	51	6320	0.109810	1701	85334	0.168116	284	2312	1.59514e-01	3886	32152	1.65325e-01	rs2596492	.	.	.	-3.831	-7.550	-7.871	0.55	0.837	0.921	0.327	neutral	ENST00000412585: c.97T>C (p.Y33H)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5019352	.	.	.	.	.	.	.	.	.	Unknown
6	31324741	31324742	6p21.33	0	nullSample	.	T	ref	T	GG.GA	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC1	IVS1	.	.	no-change	NM_005514.6	NP_005505.2	-	Y	c.74-8A=	.	.	.	NM_005514.6(HLA-B): c.74-8A=	MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	78328	0.176297	U	0.9266	0.894169	.	.	PASS	-146	5198	0.074259	1883	73320	0.181110	.	.	.	.	.	.	rs147324178	.	.	.	-2.049	-0.571	-0.821	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324741	31324742	6p21.33	1	normal	.	T	snv	C	GG.GA	hom-alt	592	1.00	.	0	dup	DUBIOUS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC1	IVS1	.	.	intron	NM_005514.6	NP_005505.2	-	Y	c.74-8A>G	.	.	.	NM_005514.6(HLA-B): c.74-8A>G	MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	78328	0.823537	U	0.9266	0.894169	.	.	PASS	2260	5198	0.925741	25251	73320	0.818712	6210	12769	9.55620e-01	68246	152786	8.46816e-01	rs147324178	.	.	.	-2.049	-0.571	-0.821	.	.	.	.	.	ENST00000412585: c.74-8A>G (p.?)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4160824	.	.	.	.	.	.	.	.	.	Benign
6	31324749	31324750	6p21.33	0	normal	.	G	ref	G	GG.GC	het-alt	332	0.50	.	1	dup	DUBIOUS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC1	IVS1	.	.	no-change	NM_005514.6	NP_005505.2	-	Y	c.74-16C=	.	.	.	NM_005514.6(HLA-B): c.74-16C=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	69590	0.984581	U	0.1071	0.0453275	.	.	VQSRTrancheSNP99.80to99.90	-56	3836	0.969760	31455	64582	0.986900	.	.	.	.	.	.	rs41558815	.	.	.	0.435	2.058	1.799	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324749	31324750	6p21.33	1	normal	.	G	snv	A	GG.GC	het-ref	338	0.50	.	2	dup	DUBIOUS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC1	IVS1	.	.	intron	NM_005514.6	NP_005505.2	-	Y	c.74-16C>T	.	.	.	NM_005514.6(HLA-B): c.74-16C>T	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	69590	0.015419	U	0.1071	0.0453275	.	.	VQSRTrancheSNP99.80to99.90	2	3836	0.030240	10	64582	0.013100	122	1257	9.67370e-02	238	4684	2.41329e-02	rs41558815	.	.	.	0.435	2.058	1.799	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
6	31324787	31324788	6p21.33	0	nullSample	.	T	ref	T	CC.CA	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC1	IVS1	.	.	no-change	NM_005514.6	NP_005505.2	-	Y	c.74-54A=	.	.	.	NM_005514.6(HLA-B): c.74-54A=	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	49080	0.697800	U	0.6478	0.497204	.	.	PASS	.	2240	0.593304	11320	44072	0.719958	.	.	.	.	.	.	rs9266193	.	.	.	-0.319	-0.243	-0.402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324787	31324788	6p21.33	0	normal	.	T	snv	C	CC.CA	hom-alt	780	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC1	IVS1	.	.	intron	NM_005514.6	NP_005505.2	-	Y	c.74-54A>G	.	.	.	NM_005514.6(HLA-B): c.74-54A>G	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	49080	0.302200	U	0.6478	0.497204	.	.	PASS	156	2240	0.406696	1626	44072	0.280042	2204	6075	6.15128e-01	13970	47536	3.44259e-01	rs9266193	.	.	.	-0.319	-0.243	-0.402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324789	31324790	6p21.33	0	nullSample	.	A	ref	A	TC.GG	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC1	IVS1	.	.	no-change	NM_005514.6	NP_005505.2	-	Y	c.74-56T=	.	.	.	NM_005514.6(HLA-B): c.74-56T=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	49314	0.692521	U	0.6468	0.496805	.	.	PASS	-308	2298	0.580505	11213	44306	0.713921	.	.	.	.	.	.	rs9266194	.	.	.	-1.511	-0.494	-0.278	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324789	31324790	6p21.33	0	normal	.	A	snv	G	TC.GG	hom-alt	792	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC1	IVS1	.	.	intron	NM_005514.6	NP_005505.2	-	Y	c.74-56T>C	.	.	.	NM_005514.6(HLA-B): c.74-56T>C	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	49314	0.307479	U	0.6468	0.496805	.	.	PASS	174	2298	0.419495	1735	44306	0.286079	2222	6130	6.15091e-01	14102	48066	3.46302e-01	rs9266194	.	.	.	-1.511	-0.494	-0.278	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324828	31324829	6p21.33	0	nullSample	.	G	ref	G	CC.GC	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC1	IVS1	.	.	no-change	NM_005514.6	NP_005505.2	-	Y	c.73+34C=	.	.	.	NM_005514.6(HLA-B): c.73+34C=	MixedObserved,SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	62834	0.364723	U	0.8403	0.753594	.	.	PASS	-323	4232	0.182892	4659	57826	0.378567	.	.	.	.	.	.	rs9266196	.	.	.	-0.801	0.592	0.593	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324828	31324829	6p21.33	0	normal	.	G	snv	C	CC.GC	hom-alt	898	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC1	IVS1	.	.	intron	NM_005514.6	NP_005505.2	-	Y	c.73+34C>G	.	.	.	NM_005514.6(HLA-B): c.73+34C>G	MixedObserved,SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	62834	0.621829	U	0.8403	0.753594	.	.	PASS	1402	4232	0.815690	11238	57826	0.610417	4851	10355	8.87318e-01	38035	93374	6.37191e-01	rs9266196	.	.	.	-0.801	0.592	0.593	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324829	31324830	6p21.33	0	nullSample	.	G	ref	G	CG.CA	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC1	IVS1	.	.	no-change	NM_005514.6	NP_005505.2	-	Y	c.73+33C=	.	.	.	NM_005514.6(HLA-B): c.73+33C=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	62786	0.368729	U	0.8502	0.792332	.	.	PASS	.	4240	0.184670	4778	57778	0.382689	.	.	.	.	.	.	rs9266197	.	.	.	-0.387	-0.082	-0.085	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324829	31324830	6p21.33	0	normal	.	G	snv	A	CG.CA	hom-alt	894	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC1	IVS1	.	.	intron	NM_005514.6	NP_005505.2	-	Y	c.73+33C>T	.	.	.	NM_005514.6(HLA-B): c.73+33C>T	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	62786	0.631271	U	0.8502	0.792332	.	.	PASS	1405	4240	0.815330	11556	57778	0.617311	4844	10325	8.86266e-01	40212	95588	6.49013e-01	rs9266197	.	.	.	-0.387	-0.082	-0.085	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324846	31324847	6p21.33	0	nullSample	.	C	ref	C	CT.CC	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC1	IVS1	.	.	no-change	NM_005514.6	NP_005505.2	-	Y	c.73+16G=	.	.	.	NM_005514.6(HLA-B): c.73+16G=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	58128	0.739437	U	0.4196	0.331869	.	.	PASS	-508	4334	0.601292	15191	53120	0.746160	.	.	.	.	.	.	rs9266198	.	.	.	0.448	0.819	0.614	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324846	31324847	6p21.33	1	normal	.	C	snv	G	CT.CC	hom-alt	804	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	IC1	IVS1	.	.	intron	NM_005514.6	NP_005505.2	-	Y	c.73+16G>C	.	.	.	NM_005514.6(HLA-B): c.73+16G>C	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	58128	0.260563	U	0.4196	0.331869	.	.	PASS	356	4334	0.398708	2115	53120	0.253840	1220	4757	4.29487e-01	7532	34839	2.51956e-01	rs9266198	.	.	.	0.448	0.819	0.614	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324920	31324921	6p21.33	0	nullSample	.	C	ref	C	GG.GC	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C1	EX1	.	.	no-change	NM_005514.6	NP_005505.2	-	Y	c.15G=	.	.	.	NM_005514.6(HLA-B): c.15G=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	81330	0.847535	U	0.1895	0.158946	12346	0.881743	PASS	.	5550	0.733514	28226	76322	0.847960	.	.	.	.	.	.	rs1050459	.	.	.	-0.497	-1.090	-1.376	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324920	31324921	6p21.33	1	normal	.	C	snv	T	GG.GC	hom-alt	618	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C1	EX1	.	.	coding-synon	NM_005514.6	NP_005505.2	-	Y	c.15G>A	p.(A5=) | p.(Ala5=)	GCG=>GCA	.	NM_005514.6(HLA-B): c.15G>A (p.(A5=))	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	81330	0.152465	U	0.1895	0.158946	12346	0.118257	PASS	240	5550	0.266486	1669	76322	0.152040	702	3293	2.59741e-01	4411	23509	1.29649e-01	rs1050459	.	.	.	-0.497	-1.090	-1.376	.	.	.	.	.	ENST00000412585: c.15G>A (p.A5A)	upper_aerodigestive_tract [mouth|NS|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	CSV	3722060	.	.	.	.	.	.	.	.	.	Likely Benign
6	31324924	31324925	6p21.33	0	nullSample	.	A	ref	A	CC.TG	homo-ref	.	.	.	0	dup	.	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C1	EX1	.	.	no-change	NM_005514.6	NP_005505.2	-	Y	c.11T=	.	.	.	NM_005514.6(HLA-B): c.11T=	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	82180	0.398126	U	0.8452	0.792332	.	.	PASS	.	5936	0.187163	8001	77172	0.410486	.	.	.	.	.	.	rs1050458	.	.	.	-1.590	-0.068	-0.217	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	31324924	31324925	6p21.33	1	normal	.	A	snv	G	CC.TG	hom-alt	587	1.00	.	0	dup	PASS	142830	C	106300(SK);142830(SK);608579(SK)	NN	Drug-induced toxicity, susceptibility to	AD	.	General	Pharmacogenomic	203459391|22348435|22348415|21676164|21428768|21244392|19933789|17258541|16538176|16415921|3477129	.	3106	HLA-B	C1	EX1	.	.	missense	NM_005514.6	NP_005505.2	-	Y	c.11T>C	p.M4T | p.Met4Thr	ATG=>ACG	NP=>P0	NM_005514.6(HLA-B): c.11T>C (p.M4T)	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,rs-cluster-nonoverlapping-alleles	82180	0.601862	U	0.8452	0.792332	.	.	PASS	2030	5936	0.812837	14909	77172	0.589501	4762	10065	8.63208e-01	37736	87304	6.02188e-01	rs1050458	.	.	.	-1.590	-0.068	-0.217	0.12	0	0	0.261	neutral	ENST00000412585: c.11T>C (p.M4T)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [diffuse_large_B_cell_lymphoma|NS|NS]	CSV	3722059	.	.	.	.	.	.	.	.	.	Likely Benign
6	32170432	32170433	6p21.32	0	normal	.	C	ref	C	TC.AT	het-alt	164	0.49	.	1	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	IC20	IVS20	.	.	no-change	NM_004557.3	NP_004548.3	-	Y	c.3232-57G=	.	.	.	NM_004557.3(NOTCH4): c.3232-57G=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.557109	U	0.38	0.442891	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2071287	.	4024	0.625500	-0.339	-0.238	-0.384	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32170432	32170433	6p21.32	0	normal	.	C	snv	T	TC.AT	het-ref	171	0.51	.	2	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	IC20	IVS20	.	.	intron	NM_004557.3	NP_004548.3	-	Y	c.3232-57G>A	.	.	.	NM_004557.3(NOTCH4): c.3232-57G>A	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.442891	U	0.38	0.442891	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2071287	.	4024	0.374500	-0.339	-0.238	-0.384	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32170464	32170465	6p21.32	0	normal	.	G	ref	G	ca.ag	het-alt	122	0.49	.	1	MIR3|SINE|MIR|-|75	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	IC20	IVS20	.	.	no-change	NM_004557.3	NP_004548.3	-	Y	c.3232-89C=	.	.	.	NM_004557.3(NOTCH4): c.3232-89C=	;	5008	0.557109	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs35083974	.	.	.	-0.258	1.321	1.352	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	32170464	32170465	6p21.32	0	normal	.	G	del	.	ca.ag	het-ref	128	0.51	.	2	MIR3|SINE|MIR|-|75	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	IC20	IVS20	.	.	intron	NM_004557.3	NP_004548.3	-	Y	c.3232-89delC	.	.	.	NM_004557.3(NOTCH4): c.3232-89delC	;	5008	0.442891	U	0.379	0.442891	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs35083974	.	.	.	-0.258	1.321	1.352	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32172064	32172065	6p21.32	0	nullSample	.	T	ref	T	AA.CC	homo-ref	.	.	.	0	.	.	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	C19	EX19	EGF-like domain	PF00008.22	no-change	NM_004557.3	NP_004548.3	-	Y	c.2967A=	.	.	.	NM_004557.3(NOTCH4): c.2967A=	;maf-5-some-pop,genotype-conflict	121246	0.081586	U	0.9921	0.963259	8434	0.096633	PASS	.	8520	0.002465	626	116238	0.083518	.	.	.	.	.	.	rs1044506	.	4024	0.007700	-0.121	-0.242	-0.232	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32172064	32172065	6p21.32	1	normal	.	T	snv	G	AA.CC	hom-alt	234	1.00	.	0	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	C19	EX19	EGF-like domain	PF00008.22	coding-synon	NM_004557.3	NP_004548.3	-	Y	c.2967A>C	p.(G989=) | p.(Gly989=)	GGA=>GGC	.	NM_004557.3(NOTCH4): c.2967A>C (p.(G989=))	;maf-5-some-pop,genotype-conflict	121246	0.918414	U	0.9921	0.963259	8434	0.903367	PASS	4239	8520	0.997535	49037	116238	0.916482	8531	17097	9.97957e-01	101467	220711	9.15570e-01	rs1044506	.	4024	0.992300	-0.121	-0.242	-0.232	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	32180430	32180431	6p21.32	0	normal	.	A	ref	A	GC.GG	het-alt	189	0.53	.	1	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	IC16	IVS16	.	.	no-change	NM_004557.3	NP_004548.3	-	Y	c.2527-27T=	.	.	.	NM_004557.3(NOTCH4): c.2527-27T=	;maf-5-some-pop	114682	0.931349	U	0.2054	0.0832668	8438	0.944418	PASS	.	8468	0.825579	47697	109674	0.932017	.	.	.	.	.	.	rs2071285	.	4024	0.801700	-0.398	-0.346	-0.197	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32180430	32180431	6p21.32	0	normal	.	A	snv	T	GC.GG	het-ref	165	0.47	.	2	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	IC16	IVS16	.	.	intron	NM_004557.3	NP_004548.3	-	Y	c.2527-27T>A	.	.	.	NM_004557.3(NOTCH4): c.2527-27T>A	;maf-5-some-pop	114682	0.068651	U	0.2054	0.0832668	8438	0.055582	PASS	121	8468	0.174421	316	109674	0.067983	253	2998	1.77103e-01	686	15355	6.96593e-02	rs2071285	.	4024	0.198300	-0.398	-0.346	-0.197	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32184704	32184705	6p21.32	0	nullSample	.	G	ref	G	CA.TG	homo-ref	.	.	.	0	.	.	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	IC11	IVS11	.	.	no-change	NM_004557.3	NP_004548.3	-	Y	c.1861+17C=	.	.	.	NM_004557.3(NOTCH4): c.1861+17C=	;maf-5-some-pop,maf-5-all-pops	121300	0.225540	U	0.9137	0.824481	8440	0.230332	PASS	-390	8524	0.103003	3582	116292	0.227694	.	.	.	.	.	.	rs3134798	.	4024	0.102400	-0.521	-0.405	-0.657	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32184704	32184705	6p21.32	1	normal	.	G	snv	A	CA.TG	hom-alt	500	1.00	.	0	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	IC11	IVS11	.	.	intron	NM_004557.3	NP_004548.3	-	Y	c.1861+17C>T	.	.	.	NM_004557.3(NOTCH4): c.1861+17C>T	;maf-5-some-pop,maf-5-all-pops	121300	0.774460	U	0.9137	0.824481	8440	0.769668	PASS	3433	8524	0.896997	35249	116292	0.772306	6868	15339	8.95238e-01	71651	184229	7.64214e-01	rs3134798	.	4024	0.897600	-0.521	-0.405	-0.657	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32185922	32185924	6p21.32	0	normal	.	AG	ref	AG	CC.GT	het-alt	105	0.53	.	1	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	IC8	IVS8	.	.	no-change	NM_004557.3	NP_004548.3	-	Y	c.1511-39_1511-38=	.	.	.	NM_004557.3(NOTCH4): c.1511-39_1511-38=	MixedObserved;maf-5-some-pop,maf-5-all-pops	71104	0.574497	U	.	.	12500	0.600800	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9279512	.	4024	0.769900	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32185922	32185924	6p21.32	0	normal	.	AG	del	.	CC.GT	het-ref	93	0.47	.	2	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	IC8	IVS8	.	.	intron	NM_004557.3	NP_004548.3	-	Y	c.1511-39_1511-38delCT	.	.	.	NM_004557.3(NOTCH4): c.1511-39_1511-38delCT	MixedObserved;maf-5-some-pop,maf-5-all-pops	71104	0.425503	U	0.2153	0.342452	12500	0.399200	PASS	80	3684	0.223127	5859	66096	0.431796	234	2519	1.86289e-01	16999	79849	4.07963e-01	rs9279512	.	4024	0.230100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32187604	32187605	6p21.32	0	normal	.	A	ref	A	GC.GG	het-alt	137	0.53	.	1	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	IC7	IVS7	.	.	no-change	NM_004557.3	NP_004548.3	-	Y	c.1316-42T=	.	.	.	NM_004557.3(NOTCH4): c.1316-42T=	;maf-5-some-pop,maf-5-all-pops	83138	0.423657	U	0.7083	0.577875	8432	0.461456	PASS	-652	5610	0.318717	6467	78130	0.423755	.	.	.	.	.	.	rs1109771	.	4024	0.290800	-0.374	-1.510	-0.953	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32187604	32187605	6p21.32	0	normal	.	A	snv	G	GC.GG	het-ref	121	0.47	.	2	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	IC7	IVS7	.	.	intron	NM_004557.3	NP_004548.3	-	Y	c.1316-42T>C	.	.	.	NM_004557.3(NOTCH4): c.1316-42T>C	;maf-5-some-pop,maf-5-all-pops	83138	0.576343	U	0.7083	0.577875	8432	0.538544	PASS	1259	5610	0.681283	12424	78130	0.576245	3317	9914	6.75617e-01	31416	111611	5.66082e-01	rs1109771	.	4024	0.709200	-0.374	-1.510	-0.953	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32187835	32187836	6p21.32	0	normal	.	G	ref	G	CT.CC	het-alt	184	0.53	.	1	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	IC7	IVS7	.	.	no-change	NM_004557.3	NP_004548.3	-	Y	c.1315+70C=	.	.	.	NM_004557.3(NOTCH4): c.1315+70C=	.	.	.	.	0.1845	0.26258	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.305	0.337	0.684	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32187836	32187836	6p21.32	0	normal	.	.	ins	CC	TG.CC	het-ref	161	0.47	.	2	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	IC7	IVS7	.	.	intron	NM_004557.3	NP_004548.3	-	Y	c.1315+69_1315+70insGG	.	.	.	NM_004557.3(NOTCH4): c.1315+69_1315+70insGG	;maf-5-some-pop,maf-5-all-pops	5008	0.262580	U	0.1845	0.26258	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3216791	.	4024	0.145900	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32188098	32188099	6p21.32	0	normal	.	C	ref	C	CA.TT	het-alt	266	0.51	.	1	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	IC6	IVS6	.	.	no-change	NM_004557.3	NP_004548.3	-	Y	c.1160-38G=	.	.	.	NM_004557.3(NOTCH4): c.1160-38G=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125720	0.751623	U	0.1339	0.182708	13006	0.782254	PASS	.	8648	0.898821	34304	120712	0.748898	.	.	.	.	.	.	rs430916	.	4024	0.901300	0.313	0.252	0.907	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32188098	32188099	6p21.32	0	normal	.	C	snv	T	CA.TT	het-ref	251	0.49	.	2	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	IC6	IVS6	.	.	intron	NM_004557.3	NP_004548.3	-	Y	c.1160-38G>A	.	.	.	NM_004557.3(NOTCH4): c.1160-38G>A	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125720	0.248377	U	0.1339	0.182708	13006	0.217746	PASS	46	8648	0.101179	4259	120712	0.251102	85	1693	9.82703e-02	8706	61673	2.53525e-01	rs430916	.	4024	0.098700	0.313	0.252	0.907	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32188296	32188297	6p21.32	0	normal	.	G	ref	G	CC.CC	het-alt	290	0.56	.	1	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	C6	EX6	Calcium-binding EGF domain	PF07645.10	no-change	NM_004557.3	NP_004548.3	-	Y	c.1044C=	.	.	.	NM_004557.3(NOTCH4): c.1044C=	MixedObserved,SingleClassTriAllelic;maf-5-some-pop|MixedObserved;	118848|116619	0.680903|0.999983	U	0.002	0.000599042	.	.	PASS	.	8434	0.797131	26614	113840	0.680982	.	.	.	.	.	.	rs423023|rs753855314	.	4024	0.812900	-2.269	-1.291	-1.465	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32188296	32188297	6p21.32	1	normal	.	G	snv	C	CC.CC	het-ref	224	0.44	.	2	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	C6	EX6	Calcium-binding EGF domain	PF07645.10	coding-synon	NM_004557.3	NP_004548.3	-	Y	c.1044C>G	p.(G348=) | p.(Gly348=)	GGC=>GGG	.	NM_004557.3(NOTCH4): c.1044C>G (p.(G348=))	MixedObserved,SingleClassTriAllelic;maf-5-some-pop	118848	0.318928	U	0.2976	0.320288	.	.	PASS	161	8434	0.201684	6007	113840	0.318869	322	3296	1.92771e-01	12414	74890	3.13781e-01	rs423023	.	4024	0.186100	-2.269	-1.291	-1.465	.	.	.	.	.	ENST00000375023: c.1044C>G (p.G348G)	breast [NS|NS|NS]	carcinoma [NS|NS|NS]	CSV	3830202	.	.	.	.	.	.	.	.	.	Likely Benign
6	32188382	32188383	6p21.32	0	normal	.	T	ref	T	GG.CT	het-alt	293	0.52	.	1	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	C6	EX6	Calcium-binding EGF domain	PF07645.10	no-change	NM_004557.3	NP_004548.3	-	Y	c.958A=	.	.	.	NM_004557.3(NOTCH4): c.958A=	;maf-5-some-pop,maf-5-all-pops,microattr-tpa,genotype-conflict	122656	0.598927	U	0.2212	0.343051	8440	0.599763	PASS	.	8528	0.826806	21584	117648	0.596457	.	.	.	.	.	.	rs422951	.	4024	0.789500	-1.194	-0.142	-1.001	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32188382	32188383	6p21.32	1	normal	.	T	snv	C	GG.CT	het-ref	269	0.48	.	2	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	C6	EX6	Calcium-binding EGF domain	PF07645.10	missense	NM_004557.3	NP_004548.3	-	Y	c.958A>G	p.T320A | p.Thr320Ala	ACC=>GCC	P0=>NP	NM_004557.3(NOTCH4): c.958A>G (p.T320A)	;maf-5-some-pop,maf-5-all-pops,microattr-tpa,genotype-conflict	122656	0.401073	U	0.2212	0.343051	8440	0.400237	PASS	134	8528	0.173194	10236	117648	0.403543	264	2879	1.67598e-01	21043	97403	4.01414e-01	rs422951	.	4024	0.210500	-1.194	-0.142	-1.001	0.49	0.003	0	0.011	neutral	ENST00000375023: c.958A>G (p.T320A)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	451253	.	.	.	.	.	.	.	.	.	Likely Benign
6	32188602	32188603	6p21.32	0	normal	.	C	ref	C	CA.TG	het-alt	339	0.53	.	1	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	C5	EX5	EGF-like domain	PF00008.22	no-change	NM_004557.3	NP_004548.3	-	Y	c.852G=	.	.	.	NM_004557.3(NOTCH4): c.852G=	SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126360	0.695513	U	0.1935	0.267772	13006	0.715900	PASS	-523	8648	0.859621	29699	121352	0.693998	.	.	.	.	.	.	rs520803	.	4024	0.850600	-1.656	-1.906	-0.977	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32188602	32188603	6p21.32	1	normal	.	C	snv	T	CA.TG	het-ref	295	0.47	.	2	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	C5	EX5	EGF-like domain	PF00008.22	coding-synon	NM_004557.3	NP_004548.3	-	Y	c.852G>A	p.(Q284=) | p.(Gln284=)	CAG=>CAA	.	NM_004557.3(NOTCH4): c.852G>A (p.(Q284=))	SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126360	0.304487	U	0.1935	0.267772	13006	0.284100	PASS	84	8648	0.140379	6157	121352	0.306002	172	2350	1.36248e-01	12563	75439	3.06513e-01	rs520803	.	4024	0.149400	-1.656	-1.906	-0.977	.	.	.	.	.	ENST00000375023: c.852G>A (p.Q284Q)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4003968	.	.	.	.	.	.	.	.	.	Likely Benign
6	32188639	32188640	6p21.32	0	normal	.	T	ref	T	AG.CT	het-alt	345	0.54	.	1	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	C5	EX5	Human growth factor-like EGF	PF12661.2	no-change	NM_004557.3	NP_004548.3	-	Y	c.815A=	.	.	.	NM_004557.3(NOTCH4): c.815A=	MixedObserved;maf-5-some-pop,maf-5-all-pops	125970	0.695705	U	0.1935	0.267772	13006	0.717131	PASS	-524	8636	0.859889	29571	120962	0.694193	.	.	.	.	.	.	rs520692	.	4024	0.850900	0.402	2.812	0.865	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32188639	32188640	6p21.32	1	normal	.	T	snv	C	AG.CT	het-ref	290	0.46	.	2	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	C5	EX5	Human growth factor-like EGF	PF12661.2	missense	NM_004557.3	NP_004548.3	-	Y	c.815A>G	p.D272G | p.Asp272Gly	GAC=>GGC	P-=>P0	NM_004557.3(NOTCH4): c.815A>G (p.D272G)	MixedObserved;maf-5-some-pop,maf-5-all-pops	125970	0.304295	U	0.1935	0.267772	13006	0.282869	PASS	81	8636	0.140111	6081	120962	0.305807	170	2346	1.36063e-01	12445	75114	3.05804e-01	rs520692	.	4024	0.149100	0.402	2.812	0.865	0.34	0.001	0.001	0.023	neutral	ENST00000375023: c.815A>G (p.D272G)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4003969	.	.	.	.	.	.	.	.	.	Likely Benign
6	32188641	32188642	6p21.32	0	normal	.	T	ref	T	TC.GG	het-alt	349	0.54	.	1	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	C5	EX5	EGF-like domain;Human growth factor-like EGF	PF00008.22;PF12661.2	no-change	NM_004557.3	NP_004548.3	-	Y	c.813A=	.	.	.	NM_004557.3(NOTCH4): c.813A=	;maf-5-some-pop	125940	0.690360	U	0.2421	0.280152	13006	0.716592	PASS	.	8636	0.799792	29070	120932	0.689139	.	.	.	.	.	.	rs520688	.	4024	0.812600	-4.087	-1.224	-1.539	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32188641	32188642	6p21.32	1	normal	.	T	snv	C	TC.GG	het-ref	294	0.46	.	2	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	C5	EX5	EGF-like domain;Human growth factor-like EGF	PF00008.22;PF12661.2	coding-synon	NM_004557.3	NP_004548.3	-	Y	c.813A>G	p.(P271=) | p.(Pro271=)	CCA=>CCG	.	NM_004557.3(NOTCH4): c.813A>G (p.(P271=))	;maf-5-some-pop	125940	0.309640	U	0.2421	0.280152	13006	0.283408	PASS	164	8636	0.200208	6197	120932	0.310861	325	3324	1.92785e-01	12640	76188	3.10298e-01	rs520688	.	4024	0.187400	-4.087	-1.224	-1.539	.	.	.	.	.	ENST00000375023: c.813A>G (p.P271P)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3722800	.	.	.	.	.	.	.	.	.	Likely Benign
6	32189031	32189032	6p21.32	0	normal	.	T	ref	T	TA.GT	het-alt	353	0.56	.	1	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	C4	EX4	.	.	no-change	NM_004557.3	NP_004548.3	-	Y	c.522A=	.	.	.	NM_004557.3(NOTCH4): c.522A=	;maf-5-some-pop,maf-5-all-pops	121084	0.690017	U	0.2421	0.279952	8438	0.716521	PASS	.	8494	0.800918	27911	116076	0.688721	.	.	.	.	.	.	rs415929	.	4024	0.812100	-2.250	-3.742	-4.223	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32189031	32189032	6p21.32	1	normal	.	T	snv	C	TA.GT	het-ref	279	0.44	.	2	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	C4	EX4	.	.	coding-synon	NM_004557.3	NP_004548.3	-	Y	c.522A>G	p.(T174=) | p.(Thr174=)	ACA=>ACG	.	NM_004557.3(NOTCH4): c.522A>G (p.(T174=))	;maf-5-some-pop,maf-5-all-pops	121084	0.309983	U	0.2421	0.279952	8438	0.283479	PASS	158	8494	0.199082	6005	116076	0.311279	320	3295	1.92330e-01	12363	74226	3.10975e-01	rs415929	.	4024	0.187900	-2.250	-3.742	-4.223	.	.	.	.	.	ENST00000375023: c.522A>G (p.T174T)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019317	.	.	.	.	.	.	.	.	.	Likely Benign
6	32190216	32190217	6p21.32	0	normal	.	T	ref	T	TC.AT	het-alt	117	0.45	.	1	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	IC3	IVS3	.	.	no-change	NM_004557.3	NP_004548.3	-	Y	c.451+71A=	.	.	.	NM_004557.3(NOTCH4): c.451+71A=	;maf-5-some-pop,maf-5-all-pops	5008	0.595048	U	0.5397	0.404952	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs915895	.	4024	0.467900	-0.974	-1.054	-1.099	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32190216	32190217	6p21.32	0	normal	.	T	snv	C	TC.AT	het-ref	144	0.55	.	2	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	IC3	IVS3	.	.	intron	NM_004557.3	NP_004548.3	-	Y	c.451+71A>G	.	.	.	NM_004557.3(NOTCH4): c.451+71A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.404952	U	0.5397	0.404952	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs915895	.	4024	0.532100	-0.974	-1.054	-1.099	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32190389	32190390	6p21.32	0	normal	.	T	ref	T	CT.GG	het-alt	189	0.50	.	1	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	C3	EX3	.	.	no-change	NM_004557.3	NP_004548.3	-	Y	c.349A=	.	.	.	NM_004557.3(NOTCH4): c.349A=	;maf-5-some-pop	125848	0.639962	U	0.5109	0.398762	13006	0.627787	PASS	-1072	8630	0.537659	25086	120840	0.641567	.	.	.	.	.	.	rs915894	.	4024	0.486800	-0.217	1.853	0.361	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32190389	32190390	6p21.32	1	normal	.	T	snv	G	CT.GG	het-ref	186	0.50	.	2	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	C3	EX3	.	.	missense	NM_004557.3	NP_004548.3	-	Y	c.349A>C	p.K117Q | p.Lys117Gln	AAG=>CAG	P+=>P0	NM_004557.3(NOTCH4): c.349A>C (p.K117Q)	;maf-5-some-pop	125848	0.360038	U	0.5109	0.398762	13006	0.372213	PASS	923	8630	0.462341	7979	120840	0.358433	1758	7576	4.62289e-01	15010	82535	3.51497e-01	rs915894	.	4024	0.513200	-0.217	1.853	0.361	0.51	0	0	0.009	neutral	ENST00000375023: c.349A>C (p.K117Q)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	4417696	.	.	.	.	.	.	.	.	.	Likely Benign
6	32190405	32190406	6p21.32	0	nullSample	.	A	ref	A	TC.CC	homo-ref	.	.	.	0	.	.	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	C3	EX3	Human growth factor-like EGF	PF12661.2	no-change	NM_004557.3	NP_004548.3	-	Y	c.333T=	.	.	.	NM_004557.3(NOTCH4): c.333T=	;maf-5-some-pop,maf-5-all-pops,microattr-tpa,genotype-conflict	126224	0.616436	U	0.5615	0.460663	13006	0.596033	PASS	-1081	8640	0.501157	23740	121216	0.619621	.	.	.	.	.	.	rs443198	.	4024	0.453800	-3.068	-2.396	-3.487	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32190405	32190406	6p21.32	1	normal	.	A	snv	G	TC.CC	hom-alt	372	1.00	.	0	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	C3	EX3	Human growth factor-like EGF	PF12661.2	coding-synon	NM_004557.3	NP_004548.3	-	Y	c.333T>C	p.(G111=) | p.(Gly111=)	GGT=>GGC	.	NM_004557.3(NOTCH4): c.333T>C (p.(G111=))	;maf-5-some-pop,maf-5-all-pops,microattr-tpa,genotype-conflict	126224	0.383564	U	0.5615	0.460663	13006	0.403967	PASS	1074	8640	0.498843	9240	121216	0.380379	2076	8305	4.98260e-01	17670	89388	3.74937e-01	rs443198	.	4024	0.546200	-3.068	-2.396	-3.487	.	.	.	.	.	ENST00000375023: c.333T>C (p.G111G)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4417276	CM030916	NM_004557.3(NOTCH4): c.333T>C (p.G111G)	"Alopecia universalis, association with ?"	12589427	DP	.	.	.	.	Likely Benign
6	32190619	32190620	6p21.32	0	nullSample	.	T	ref	T	GG.cc	homo-ref	.	.	.	0	C-rich|Low_complexity|Low_complexity|+|146	.	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	IC2	IVS2	.	.	no-change	NM_004557.3	NP_004548.3	-	Y	c.156-37A=	.	.	.	NM_004557.3(NOTCH4): c.156-37A=	;maf-5-some-pop,maf-5-all-pops,microattr-tpa,genotype-conflict	125044	0.640359	U	0.5952	0.454273	13004	0.642956	PASS	-1087	8540	0.453630	25482	120036	0.644307	.	.	.	.	.	.	rs3134931	.	4024	0.410300	-1.252	-0.579	-0.544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32190619	32190620	6p21.32	0	normal	.	T	snv	C	GG.cc	hom-alt	404	1.00	.	0	C-rich|Low_complexity|Low_complexity|+|146	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	IC2	IVS2	.	.	intron	NM_004557.3	NP_004548.3	-	Y	c.156-37A>G	.	.	.	NM_004557.3(NOTCH4): c.156-37A>G	;maf-5-some-pop,maf-5-all-pops,microattr-tpa,genotype-conflict	125044	0.359641	U	0.5952	0.454273	13004	0.357044	PASS	1246	8540	0.546370	8160	120036	0.355693	2549	9245	5.49905e-01	15760	83487	3.50815e-01	rs3134931	.	4024	0.589700	-1.252	-0.579	-0.544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32190870	32190871	6p21.32	0	normal	.	T	ref	T	GG.GG	het-alt	131	0.53	.	1	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	IC1	IVS1	.	.	no-change	NM_004557.3	NP_004548.3	-	Y	c.74-8A=	.	.	.	NM_004557.3(NOTCH4): c.74-8A=	;maf-5-some-pop,maf-5-all-pops	126138	0.924955	U	0.1339	0.11262	13006	0.919652	PASS	-564	8618	0.845904	52202	121130	0.926509	.	.	.	.	.	.	rs2854049	.	4024	0.861300	-0.542	0.325	0.028	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32190870	32190871	6p21.32	1	normal	.	T	snv	A	GG.GG	het-ref	114	0.47	.	2	.	PASS	164951	C	.	NN	.	.	.	.	.	.	.	4855	NOTCH4	IC1	IVS1	.	.	intron	NM_004557.3	NP_004548.3	-	Y	c.74-8A>T	.	.	.	NM_004557.3(NOTCH4): c.74-8A>T	;maf-5-some-pop,maf-5-all-pops	126138	0.075045	U	0.1339	0.11262	13006	0.080348	PASS	100	8618	0.154096	539	121130	0.073491	209	2667	1.54680e-01	982	17283	7.02807e-02	rs2854049	.	4024	0.138700	-0.542	0.325	0.028	.	.	.	.	.	ENST00000375023: c.74-8A>T (p.?)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019502	.	.	.	.	.	.	.	.	.	Benign
6	32943978	32943979	6p21.32	0	normal	.	C	ref	C	AA.TA	het-alt	374	0.50	.	1	.	PASS	601540	P	.	NN	.	.	.	.	.	.	.	6046	BRD2	IC4	IVS4	.	.	no-change	NM_001199455.1	NP_001186384.1	+	Y	c.610+33C=	.	.	.	NM_001199455.1(BRD2): c.610+33C=	MixedObserved;	60718	0.999984	U	0.376	0.455471	.	.	PASS	.	8472	0.649079	16229	115742	0.524589	.	.	.	.	.	.	rs780113744	.	.	.	0.643	-0.099	0.039	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32943979	32943979	6p21.32	0	normal	.	.	ins	T	AC.TA	het-ref	369	0.50	.	2	.	PASS	601540	P	.	NN	.	.	.	.	.	.	.	6046	BRD2	IC4	IVS4	.	.	intron	NM_001199455.1	NP_001186384.1	+	Y	c.610+33_610+34insT	.	.	.	NM_001199455.1(BRD2): c.610+33_610+34insT	;maf-5-some-pop,maf-5-all-pops	120749	0.474580	U	0.376	0.455471	10476	0.512887	PASS	488	8472	0.350921	13382	115742	0.475402	1019	5945	3.47701e-01	27327	112893	4.71216e-01	rs2066741	.	4024	0.324300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32944093	32944094	6p21.32	0	normal	.	G	ref	G	CT.TA	het-alt	277	0.51	.	1	.	PASS	601540	P	.	NN	.	.	.	.	.	.	.	6046	BRD2	C5	EX5	.	.	no-change	NM_001199455.1	NP_001186384.1	+	Y	c.678G=	.	.	.	NM_001199455.1(BRD2): c.678G=	;maf-5-some-pop	121342	0.935538	U	0.0208	0.0477236	8440	0.943009	PASS	-107	8518	0.973468	50854	116334	0.934817	.	.	.	.	.	.	rs15912	.	4024	0.982100	0.643	0.679	0.141	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32944093	32944094	6p21.32	1	normal	.	G	snv	C	CT.TA	het-ref	270	0.49	.	2	.	PASS	601540	P	.	NN	.	.	.	.	.	.	.	6046	BRD2	C5	EX5	.	.	coding-synon	NM_001199455.1	NP_001186384.1	+	Y	c.678G>C	p.(L226=) | p.(Leu226=)	CTG=>CTC	.	NM_001199455.1(BRD2): c.678G>C (p.(L226=))	;maf-5-some-pop	121342	0.064462	U	0.0208	0.0477236	8440	0.056991	PASS	6	8518	0.026532	270	116334	0.065183	8	384	2.24142e-02	617	15786	6.54380e-02	rs15912	.	4024	0.017900	0.643	0.679	0.141	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	32945529	32945530	6p21.32	0	nullSample	.	G	ref	G	TT.TA	homo-ref	.	.	.	0	.	.	601540	P	.	NN	.	.	.	.	.	.	.	6046	BRD2	IC7	IVS7	.	.	no-change	NM_001199455.1	NP_001186384.1	+	Y	c.1330-4G=	.	.	.	NM_001199455.1(BRD2): c.1330-4G=	SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop,microattr-tpa,rs-cluster-nonoverlapping-alleles	121070	0.047625	U	0.995	0.979832	8434	0.059521	PASS	.	8512	0.005052	207	116062	0.048810	.	.	.	.	.	.	rs3097644	.	4024	0.009400	-2.938	-0.354	-0.633	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32945529	32945530	6p21.32	1	normal	.	G	snv	C	TT.TA	hom-alt	658	1.00	.	0	.	PASS	601540	P	.	NN	.	.	.	.	.	.	.	6046	BRD2	IC7	IVS7	.	.	intron	NM_001199455.1	NP_001186384.1	+	Y	c.1330-4G>C	.	.	.	NM_001199455.1(BRD2): c.1330-4G>C	SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop,microattr-tpa,rs-cluster-nonoverlapping-alleles	121070	0.952366	U	0.995	0.979832	8434	0.940479	PASS	4213	8512	0.994948	52573	116062	0.951181	8459	17021	9.93985e-01	108682	228287	9.50594e-01	rs3097644	.	4024	0.990600	-2.938	-0.354	-0.633	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	95242	criteria_provided,_single_submitter	Benign	Benign
6	32948425	32948426	6p21.32	0	normal	.	C	ref	C	TC.AG	het-alt	370	0.49	.	1	.	PASS	601540	P	.	NN	.	.	.	.	.	.	.	6046	BRD2	C13E	EX13E	.	.	no-change	NM_001199455.1	NP_001186384.1	+	Y	c.2442C=	.	.	.	NM_001199455.1(BRD2): c.2442C=	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,genotype-conflict	121264	0.930383	U	0.0397	0.0605032	8440	0.936611	PASS	-167	8518	0.958676	50282	116256	0.929991	.	.	.	.	.	.	rs2071876	.	4024	0.970900	0.643	2.007	0.871	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	32948425	32948426	6p21.32	1	normal	.	C	snv	T	TC.AG	het-ref	384	0.51	.	2	.	PASS	601540	P	.	NN	.	.	.	.	.	.	.	6046	BRD2	C13E	EX13E	.	.	coding-synon	NM_001199455.1	NP_001186384.1	+	Y	c.2442C>T	p.(S814=) | p.(Ser814=)	TCC=>TCT	.	NM_001199455.1(BRD2): c.2442C>T (p.(S814=))	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,genotype-conflict	121264	0.069617	U	0.0397	0.0605032	8440	0.063389	PASS	9	8518	0.041324	293	116256	0.070009	17	597	3.48389e-02	675	16755	6.94692e-02	rs2071876	.	4024	0.029100	0.643	2.007	0.871	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	33288270	33288271	6p21.32	0	normal	.	A	ref	A	GC.TA	het-alt	328	0.56	.	1	.	PASS	603186	P	.	NN	.	.	.	.	.	.	.	1616	DAXX	C4	EX4	Daxx Family	PF03344.10	no-change	NM_001141970.1	NP_001135442.1	-	Y	c.1173T=	.	.	.	NM_001141970.1(DAXX): c.1173T=	;maf-5-some-pop	126212	0.707508	U	0.2619	0.220847	13006	0.781101	PASS	-805	8610	0.755865	30592	121204	0.704548	.	.	.	.	.	.	rs1059231	.	4024	0.748800	0.523	0.230	0.277	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	33288270	33288271	6p21.32	1	normal	.	A	snv	G	GC.TA	het-ref	255	0.44	.	2	.	PASS	603186	P	.	NN	.	.	.	.	.	.	.	1616	DAXX	C4	EX4	Daxx Family	PF03344.10	coding-synon	NM_001141970.1	NP_001135442.1	-	Y	c.1173T>C	p.(Y391=) | p.(Tyr391=)	TAT=>TAC	.	NM_001141970.1(DAXX): c.1173T>C (p.(Y391=))	;maf-5-some-pop	126212	0.292492	U	0.2619	0.220847	13006	0.218899	PASS	246	8610	0.244135	5800	121204	0.295452	552	4322	2.50667e-01	11892	73597	2.99058e-01	rs1059231	.	4024	0.251200	0.523	0.230	0.277	.	.	.	.	.	ENST00000266000: c.1137T>C (p.Y379Y)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	5019618	.	.	.	.	.	.	.	.	.	Likely Benign
6	35420266	35420267	6p21.31	0	normal	.	C	ref	C	GC.TC	het-alt	173	0.51	.	1	.	PASS	613976	P	600901(MK)	NN	Fanconi anemia, complementation group E	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22778927|20301575|17924555|11001585	.	2178	FANCE	5U1E	EX1	.	.	no-change	NM_021922.2	NP_068741.1	+	Y	c.-56C=	.	.	.	NM_021922.2(FANCE): c.-56C=	;maf-5-some-pop	5008	0.970647	U	0.0546	0.029353	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4713866	.	.	.	-0.314	-0.008	-0.391	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	35420266	35420267	6p21.31	0	normal	.	C	snv	T	GC.TC	het-ref	169	0.49	.	2	.	PASS	613976	P	600901(MK)	NN	Fanconi anemia, complementation group E	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22778927|20301575|17924555|11001585	.	2178	FANCE	5U1E	EX1	.	.	utr-5	NM_021922.2	NP_068741.1	+	Y	c.-56C>T	.	.	.	NM_021922.2(FANCE): c.-56C>T	;maf-5-some-pop	5008	0.029353	U	0.0546	0.029353	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4713866	.	.	.	-0.314	-0.008	-0.391	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	356439	criteria_provided,_single_submitter	Likely_benign	Likely Benign
6	35420627	35420628	6p21.31	0	normal	.	A	ref	A	GA.CG	het-alt	113	0.49	.	1	.	PASS	613976	P	600901(MK)	NN	Fanconi anemia, complementation group E	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22778927|20301575|17924555|11001585	.	2178	FANCE	IC1	IVS1	.	.	no-change	NM_021922.2	NP_068741.1	+	Y	c.248+58A=	.	.	.	NM_021922.2(FANCE): c.248+58A=	;maf-5-some-pop,maf-5-all-pops	5008	0.382788	U	0.5238	0.617212	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9470029	.	.	.	-2.308	-1.234	-1.247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	35420627	35420628	6p21.31	0	normal	.	A	snv	C	GA.CG	het-ref	119	0.51	.	2	.	PASS	613976	P	600901(MK)	NN	Fanconi anemia, complementation group E	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22778927|20301575|17924555|11001585	.	2178	FANCE	IC1	IVS1	.	.	intron	NM_021922.2	NP_068741.1	+	Y	c.248+58A>C	.	.	.	NM_021922.2(FANCE): c.248+58A>C	;maf-5-some-pop,maf-5-all-pops	5008	0.617212	U	0.5238	0.617212	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9470029	.	.	.	-2.308	-1.234	-1.247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	35423488	35423489	6p21.31	0	normal	.	A	snv	G	CA.AC	hom-alt	358	1.00	.	0	.	PASS	613976	P	600901(MK)	NN	Fanconi anemia, complementation group E	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22778927|20301575|17924555|11001585	.	2178	FANCE	IC1	IVS1	.	.	intron	NM_021922.2	NP_068741.1	+	Y	c.249-35A>G	.	.	.	NM_021922.2(FANCE): c.249-35A>G	;maf-5-some-pop,maf-5-all-pops	126356	0.722332	U	0.7123	0.776558	13006	0.734123	PASS	2032	8636	0.683650	31745	121348	0.720094	4025	11778	6.83020e-01	63958	175880	7.20666e-01	rs7757405	.	.	.	-0.355	0.988	1.055	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	261434	criteria_provided,_single_submitter	Benign	Benign
6	35423488	35423489	6p21.31	0	nullSample	.	A	ref	A	CA.AC	homo-ref	.	.	.	0	.	.	613976	P	600901(MK)	NN	Fanconi anemia, complementation group E	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22778927|20301575|17924555|11001585	.	2178	FANCE	IC1	IVS1	.	.	no-change	NM_021922.2	NP_068741.1	+	Y	c.249-35A=	.	.	.	NM_021922.2(FANCE): c.249-35A=	;maf-5-some-pop,maf-5-all-pops	126356	0.277668	U	0.7123	0.776558	13006	0.265877	PASS	-920	8636	0.316350	5037	121348	0.279906	.	.	.	.	.	.	rs7757405	.	.	.	-0.355	0.988	1.055	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	35423540	35423541	6p21.31	0	normal	.	G	ref	G	GC.AT	het-alt	275	0.53	.	1	.	PASS	613976	P	600901(MK)	NN	Fanconi anemia, complementation group E	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22778927|20301575|17924555|11001585	.	2178	FANCE	C2	EX2	.	.	no-change	NM_021922.2	NP_068741.1	+	Y	c.266G=	.	.	.	NM_021922.2(FANCE): c.266G=	SingleClassTriAllelic;clinically-assoc,submitted-by-lsdb	126400	0.998964	U	0.0149	0.00359425	.	.	PASS	.	8650	0.989249	60584	121392	0.999069	.	.	.	.	.	.	rs45600543	.	.	.	0.561	0.230	0.560	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	35423540	35423541	6p21.31	1	normal	.	G	snv	T	GC.AT	het-ref	240	0.47	.	2	.	PASS	613976	P	600901(MK)	NN	Fanconi anemia, complementation group E	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22778927|20301575|17924555|11001585	.	2178	FANCE	C2	EX2	.	.	missense	NM_021922.2	NP_068741.1	+	Y	c.266G>T	p.R89L | p.Arg89Leu	CGA=>CTA	P+=>NP	NM_021922.2(FANCE): c.266G>T (p.R89L)	SingleClassTriAllelic;clinically-assoc,submitted-by-lsdb	126400	0.001028	U	0.0149	0.00359425	.	.	PASS	1	8650	0.010751	1	121392	0.000923	2	186	1.07839e-02	2	232	9.42492e-04	rs45600543	.	.	.	0.561	0.230	0.560	1	0.084	0.52	0.006	neutral	.	.	.	.	.	.	.	.	.	.	no_record	134334	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	VUS
6	35423661	35423662	6p21.31	0	nullSample	.	A	ref	A	CC.GA	homo-ref	.	.	.	0	.	.	613976	P	600901(MK)	NN	Fanconi anemia, complementation group E	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22778927|20301575|17924555|11001585	.	2178	FANCE	C2	EX2	.	.	no-change	NM_021922.2	NP_068741.1	+	Y	c.387A=	.	.	.	NM_021922.2(FANCE): c.387A=	SingleClassTriAllelic;maf-5-some-pop	126212	0.276392	U	0.7133	0.777955	13006	0.264340	PASS	.	8638	0.316161	4977	121204	0.278638	.	.	.	.	.	.	rs4713867	.	.	.	-1.389	-1.018	-0.891	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	35423661	35423662	6p21.31	1	normal	.	A	snv	C	CC.GA	hom-alt	608	1.00	.	0	.	PASS	613976	P	600901(MK)	NN	Fanconi anemia, complementation group E	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22778927|20301575|17924555|11001585	.	2178	FANCE	C2	EX2	.	.	coding-synon	NM_021922.2	NP_068741.1	+	Y	c.387A>C	p.(P129=) | p.(Pro129=)	CCA=>CCC	.	NM_021922.2(FANCE): c.387A>C (p.(P129=))	SingleClassTriAllelic;maf-5-some-pop	126212	0.723394	U	0.7133	0.777955	13006	0.735660	PASS	2035	8638	0.683839	31791	121204	0.721140	4023	11776	6.83142e-01	64526	177387	7.21009e-01	rs4713867	.	.	.	-1.389	-1.018	-0.891	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	261435	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
6	35424187	35424188	6p21.31	0	nullSample	.	A	ref	A	CC.TG	homo-ref	.	.	.	0	.	.	613976	P	600901(MK)	NN	Fanconi anemia, complementation group E	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22778927|20301575|17924555|11001585	.	2178	FANCE	IC2	IVS2	.	.	no-change	NM_021922.2	NP_068741.1	+	Y	c.855+58A=	.	.	.	NM_021922.2(FANCE): c.855+58A=	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	5008	0.280950	U	0.5446	0.71905	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3800377	.	.	.	-4.022	-3.284	-3.395	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	35424187	35424188	6p21.31	0	normal	.	A	snv	G	CC.TG	hom-alt	345	1.00	.	0	.	PASS	613976	P	600901(MK)	NN	Fanconi anemia, complementation group E	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22778927|20301575|17924555|11001585	.	2178	FANCE	IC2	IVS2	.	.	intron	NM_021922.2	NP_068741.1	+	Y	c.855+58A>G	.	.	.	NM_021922.2(FANCE): c.855+58A>G	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	5008	0.719050	U	0.5446	0.71905	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3800377	.	.	.	-4.022	-3.284	-3.395	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	35424203	35424204	6p21.31	0	normal	.	G	ref	G	TT.GG	het-alt	134	0.47	.	1	.	PASS	613976	P	600901(MK)	NN	Fanconi anemia, complementation group E	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22778927|20301575|17924555|11001585	.	2178	FANCE	IC2	IVS2	.	.	no-change	NM_021922.2	NP_068741.1	+	Y	c.855+74G=	.	.	.	NM_021922.2(FANCE): c.855+74G=	;	5008	0.996406	U	0.0149	0.00359425	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs118179009	.	.	.	-0.291	0.961	0.973	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	35424203	35424204	6p21.31	0	normal	.	G	snv	A	TT.GG	het-ref	149	0.53	.	2	.	PASS	613976	P	600901(MK)	NN	Fanconi anemia, complementation group E	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22778927|20301575|17924555|11001585	.	2178	FANCE	IC2	IVS2	.	.	intron	NM_021922.2	NP_068741.1	+	Y	c.855+74G>A	.	.	.	NM_021922.2(FANCE): c.855+74G>A	;	5008	0.003594	U	0.0149	0.00359425	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs118179009	.	.	.	-0.291	0.961	0.973	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	35426246	35426247	6p21.31	0	normal	.	C	ref	C	GC.AA	het-alt	176	0.49	.	1	.	PASS	613976	P	600901(MK)	NN	Fanconi anemia, complementation group E	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22778927|20301575|17924555|11001585	.	2178	FANCE	IC5	IVS5	.	.	no-change	NM_021922.2	NP_068741.1	+	Y	c.1113+30C=	.	.	.	NM_021922.2(FANCE): c.1113+30C=	;	126398	0.998979	U	0.0149	0.00359425	13006	0.999923	PASS	-45	8650	0.989364	60585	121390	0.999086	.	.	.	.	.	.	rs117881500	.	.	.	0.561	-0.059	0.212	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	35426246	35426247	6p21.31	0	normal	.	C	snv	T	GC.AA	het-ref	182	0.51	.	2	.	PASS	613976	P	600901(MK)	NN	Fanconi anemia, complementation group E	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22778927|20301575|17924555|11001585	.	2178	FANCE	IC5	IVS5	.	.	intron	NM_021922.2	NP_068741.1	+	Y	c.1113+30C>T	.	.	.	NM_021922.2(FANCE): c.1113+30C>T	;	126398	0.001021	U	0.0149	0.00359425	13006	0.000077	PASS	1	8650	0.010636	1	121390	0.000914	2	185	1.07259e-02	2	231	9.38940e-04	rs117881500	.	.	.	0.561	-0.059	0.212	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	35427423	35427424	6p21.31	0	normal	.	C	ref	C	TC.CC	het-alt	126	0.49	.	1	.	PASS	613976	P	600901(MK)	NN	Fanconi anemia, complementation group E	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22778927|20301575|17924555|11001585	.	2178	FANCE	IC6	IVS6	.	.	no-change	NM_021922.2	NP_068741.1	+	Y	c.1238-35C=	.	.	.	NM_021922.2(FANCE): c.1238-35C=	SingleClassTriAllelic;maf-5-some-pop	126374	0.998979	U	0.0149	0.00359425	.	.	PASS	-45	8652	0.989367	60573	121366	0.999085	.	.	.	.	.	.	rs45571538	.	.	.	-1.827	-0.320	-0.567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	35427423	35427424	6p21.31	0	normal	.	C	snv	A	TC.CC	het-ref	130	0.51	.	2	.	PASS	613976	P	600901(MK)	NN	Fanconi anemia, complementation group E	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22778927|20301575|17924555|11001585	.	2178	FANCE	IC6	IVS6	.	.	intron	NM_021922.2	NP_068741.1	+	Y	c.1238-35C>A	.	.	.	NM_021922.2(FANCE): c.1238-35C>A	SingleClassTriAllelic;maf-5-some-pop	126374	0.001013	U	0.0149	0.00359425	.	.	PASS	1	8652	0.010518	1	121366	0.000906	2	184	1.06679e-02	2	231	9.38742e-04	rs45571538	.	.	.	-1.827	-0.320	-0.567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	35430499	35430500	6p21.31	0	normal	.	A	snv	C	cc.gg	het-ref	153	0.51	.	2	MIRb|SINE|MIR|-|188	PASS	613976	P	600901(MK)	NN	Fanconi anemia, complementation group E	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22778927|20301575|17924555|11001585	.	2178	FANCE	IC8	IVS8	.	.	intron	NM_021922.2	NP_068741.1	+	Y	c.1384-66A>C	.	.	.	NM_021922.2(FANCE): c.1384-66A>C	;	5008	0.003594	U	0.0149	0.00359425	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs145176801	.	.	.	-0.441	0.049	0.012	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	35430499	35430500	6p21.31	0	normal	.	A	ref	A	cc.gg	het-alt	145	0.49	.	1	MIRb|SINE|MIR|-|188	PASS	613976	P	600901(MK)	NN	Fanconi anemia, complementation group E	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22778927|20301575|17924555|11001585	.	2178	FANCE	IC8	IVS8	.	.	no-change	NM_021922.2	NP_068741.1	+	Y	c.1384-66A=	.	.	.	NM_021922.2(FANCE): c.1384-66A=	;	5008	0.996406	U	0.0149	0.00359425	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs145176801	.	.	.	-0.441	0.049	0.012	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	36651970	36651971	6p21.2	0	normal	.	C	ref	C	AG.CG	het-alt	319	0.49	.	1	.	PASS	116899	C	.	NN	.	.	.	.	.	.	.	1026	CDKN1A	C1	EX3	.	.	no-change	NM_078467.2	NP_510867.1	+	Y	c.93C=	.	.	.	NM_078467.2(CDKN1A): c.93C=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	124792	0.847747	U	0.4881	0.25619	13006	0.872443	PASS	.	8574	0.515629	44672	119784	0.852092	.	.	.	.	.	.	rs1801270	.	4024	0.511400	-1.383	-0.583	-0.519	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	36651970	36651971	6p21.2	1	normal	.	C	snv	A	AG.CG	het-ref	328	0.51	.	2	.	PASS	116899	C	.	NN	.	.	.	.	.	.	.	1026	CDKN1A	C1	EX3	.	.	missense	NM_078467.2	NP_510867.1	+	Y	c.93C>A	p.S31R | p.Ser31Arg	AGC=>AGA	P0=>P+	NM_078467.2(CDKN1A): c.93C>A (p.S31R)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	124792	0.152213	U	0.4881	0.25619	13006	0.127557	PASS	1039	8574	0.484371	2497	119784	0.147866	2115	8446	4.90818e-01	5396	37219	1.52389e-01	rs1801270	.	4024	0.488600	-1.383	-0.583	-0.519	1	0.001	0	0.000	neutral	ENST00000244741: c.93C>A (p.S31R)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3762017	CM940226	NM_078467.2(CDKN1A): c.93C>A (p.S31R)	"Cancer, association with"	7655464	DFP	no_record	17565	no_assertion_criteria_provided	Benign	Likely Benign
6	36652338	36652339	6p21.2	0	nullSample	.	C	ref	C	CA.GG	homo-ref	.	.	.	0	.	.	116899	C	.	NN	.	.	.	.	.	.	.	1026	CDKN1A	IC1	IVS3	.	.	no-change	NM_078467.2	NP_510867.1	+	Y	c.445+16C=	.	.	.	NM_078467.2(CDKN1A): c.445+16C=	SingleClassTriAllelic;maf-5-some-pop	124556	0.627806	U	0.6121	0.503594	13006	0.612179	PASS	-1011	8542	0.403418	25112	119548	0.633310	.	.	.	.	.	.	rs3176352	.	4024	0.417000	-0.216	0.976	0.746	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	36652338	36652339	6p21.2	1	normal	.	C	snv	G	CA.GG	hom-alt	344	1.00	.	0	.	PASS	116899	C	.	NN	.	.	.	.	.	.	.	1026	CDKN1A	IC1	IVS3	.	.	intron	NM_078467.2	NP_510867.1	+	Y	c.445+16C>G	.	.	.	NM_078467.2(CDKN1A): c.445+16C>G	SingleClassTriAllelic;maf-5-some-pop	124556	0.372162	U	0.6121	0.503594	13006	0.387821	PASS	1536	8542	0.596465	9174	119548	0.366656	3119	10255	5.97611e-01	18481	88744	3.64117e-01	rs3176352	.	4024	0.583000	-0.216	0.976	0.746	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	36653596	36653597	6p21.2	0	normal	.	C	ref	C	TG.AG	het-alt	165	0.56	.	1	.	PASS	116899	C	.	NN	.	.	.	.	.	.	.	1026	CDKN1A	3U1E	EX4E	.	.	no-change	NM_078467.2	NP_510867.1	+	Y	c.*20C=	.	.	.	NM_078467.2(CDKN1A): c.*20C=	;maf-5-some-pop	126246	0.857469	U	0.4782	0.231829	13006	0.895510	PASS	-1052	8628	0.523412	46076	121238	0.861157	.	.	.	.	.	.	rs1059234	.	.	.	-0.258	-0.846	-1.225	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	36653596	36653597	6p21.2	0	normal	.	C	snv	T	TG.AG	het-ref	132	0.44	.	2	.	PASS	116899	C	.	NN	.	.	.	.	.	.	.	1026	CDKN1A	3U1E	EX4E	.	.	utr-3	NM_078467.2	NP_510867.1	+	Y	c.*20C>T	.	.	.	NM_078467.2(CDKN1A): c.*20C>T	;maf-5-some-pop	126246	0.142531	U	0.4782	0.231829	13006	0.104490	PASS	1004	8628	0.476588	2290	121238	0.138843	2020	8297	4.81209e-01	5035	35799	1.45451e-01	rs1059234	.	.	.	-0.258	-0.846	-1.225	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	41903781	41903782	6p21.1	0	normal	.	A	ref	A	AG.GG	het-alt	243	0.52	.	1	.	PASS	123834	C	.	NN	.	.	.	.	.	.	.	896	CCND3	C5E	EX5E	Cyclin, C-terminal domain	PF02984.14	no-change	NM_001760.3	NP_001751.1	-	Y	c.775T=	.	.	.	NM_001760.3(CCND3): c.775T=	MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop	124610	0.453720	U	0.504	0.592452	13006	0.375673	PASS	.	8536	0.469892	12712	119602	0.455653	.	.	.	.	.	.	rs1051130	.	4024	0.442100	-0.352	-0.033	-0.245	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	41903781	41903782	6p21.1	1	normal	.	A	snv	C	AG.GG	het-ref	223	0.48	.	2	.	PASS	123834	C	.	NN	.	.	.	.	.	.	.	896	CCND3	C5E	EX5E	Cyclin, C-terminal domain	PF02984.14	missense	NM_001760.3	NP_001751.1	-	Y	c.775T>G	p.S259A | p.Ser259Ala	TCT=>GCT	P0=>NP	NM_001760.3(CCND3): c.775T>G (p.S259A)	MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop	124610	0.546272	U	0.504	0.592452	13006	0.624327	PASS	1175	8536	0.529991	18016	119602	0.544339	2412	9098	5.29693e-01	36046	131230	5.37405e-01	rs1051130	.	4024	0.557700	-0.352	-0.033	-0.245	0.41	0.001	0	0.015	neutral	ENST00000372991: c.775T>G (p.S259A)	pancreas [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	451455	.	.	.	.	.	.	.	.	.	Likely Benign
6	41905173	41905174	6p21.1	0	nullSample	.	T	ref	T	AG.GA	homo-ref	.	.	.	0	.	.	123834	C	.	NN	.	.	.	.	.	.	.	896	CCND3	IC2	IVS2	.	.	no-change	NM_001760.3	NP_001751.1	-	Y	c.415-42A=	.	.	.	NM_001760.3(CCND3): c.415-42A=	;maf-5-some-pop	125440	0.212213	U	0.8978	0.863618	13006	0.199908	PASS	-348	8604	0.091585	3213	120432	0.215366	.	.	.	.	.	.	rs2479717	.	4024	0.081000	-1.429	-0.105	0.330	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	41905173	41905174	6p21.1	0	normal	.	T	snv	A	AG.GA	hom-alt	317	1.00	.	0	.	PASS	123834	C	.	NN	.	.	.	.	.	.	.	896	CCND3	IC2	IVS2	.	.	intron	NM_001760.3	NP_001751.1	-	Y	c.415-42A>T	.	.	.	NM_001760.3(CCND3): c.415-42A>T	;maf-5-some-pop	125440	0.787787	U	0.8978	0.863618	13006	0.800092	PASS	3560	8604	0.908415	37492	120432	0.784634	7142	15669	9.10459e-01	76034	191533	7.85293e-01	rs2479717	.	4024	0.919000	-1.429	-0.105	0.330	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	43748399	43748400	6p21.1	0	normal	.	A	ref	A	CC.CC	het-alt	10	0.48	.	1	.	PASS	192240	C	603933(SK)	NN	.	.	.	.	.	.	.	7422	VEGFA	IC5	IVS5	.	.	no-change	NM_001025366.2	NP_001020537.2	+	Y	c.963-69A=	.	.	.	NM_001025366.2(VEGFA): c.963-69A=	.	.	.	.	0	0.000998403	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4020	0.991300	-0.393	-0.397	-0.249	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	43748399	43748400	6p21.1	0	normal	.	A	snv	C	CC.CC	het-ref	11	0.52	.	2	.	PASS	192240	C	603933(SK)	NN	.	.	.	.	.	.	.	7422	VEGFA	IC5	IVS5	.	.	intron	NM_001025366.2	NP_001020537.2	+	Y	c.963-69A>C	.	.	.	NM_001025366.2(VEGFA): c.963-69A>C	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4020	0.008700	-0.393	-0.397	-0.249	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	43748642	43748643	6p21.1	0	normal	.	T	snv	C	cc.tc	hom-alt	309	1.00	.	0	C-rich|Low_complexity|Low_complexity|+|74	PASS	192240	C	603933(SK)	NN	.	.	.	.	.	.	.	7422	VEGFA	IC6	IVS6	.	.	intron	NM_001025366.2	NP_001020537.2	+	Y	c.1085+52T>C	.	.	.	NM_001025366.2(VEGFA): c.1085+52T>C	;	126322	0.978990	U	1	0.989018	7272	0.976898	PASS	4322	8646	0.999884	58099	121314	0.978576	8621	17243	9.99942e-01	117420	240058	9.77905e-01	rs3025052	.	4024	0.998300	-1.464	-0.323	-0.109	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	43748642	43748643	6p21.1	0	nullSample	.	T	ref	T	cc.tc	homo-ref	.	.	.	0	C-rich|Low_complexity|Low_complexity|+|74	.	192240	C	603933(SK)	NN	.	.	.	.	.	.	.	7422	VEGFA	IC6	IVS6	.	.	no-change	NM_001025366.2	NP_001020537.2	+	Y	c.1085+52T=	.	.	.	NM_001025366.2(VEGFA): c.1085+52T=	;	126322	0.021010	U	1	0.989018	7272	0.023102	PASS	.	8646	0.000116	41	121314	0.021424	.	.	.	.	.	.	rs3025052	.	4024	0.001700	-1.464	-0.323	-0.109	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	51890822	51890823	6p12.2	0	normal	.	G	ref	G	GA.CG	het-alt	197	0.54	.	1	.	PASS	606702	C	263200(MK)	AR	Polycystic kidney disease, autosomal recessive	AR	.	Allergy/Immunology/Infectious; Endocrine; Gastrointestinal; Renal	Allergy/Immunology/Infectious; Gastrointestinal; Pulmonary; Pharmacogenomic; Renal	24162162|24114580|23941846|23041322|22882926|22464505|21896375|21046169|20301501|16523049|15706593|15108277|13764315|12728091|12506140|11919560|7554350|4688793|2702087	.	5314	PKHD1	C31	EX32	.	.	no-change	NM_138694.3	NP_619639.3	-	Y	c.3785C=	.	.	.	NM_138694.3(PKHD1): c.3785C=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125640	0.534830	U	0.381	0.354633	13006	0.607643	PASS	-970	8576	0.643657	18016	120632	0.530241	.	.	.	.	.	.	rs9296669	.	4024	0.673500	0.655	-0.049	-0.700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	51890822	51890823	6p12.2	1	normal	.	G	snv	A	GA.CG	het-ref	167	0.46	.	2	.	PASS	606702	C	263200(MK)	AR	Polycystic kidney disease, autosomal recessive	AR	.	Allergy/Immunology/Infectious; Endocrine; Gastrointestinal; Renal	Allergy/Immunology/Infectious; Gastrointestinal; Pulmonary; Pharmacogenomic; Renal	24162162|24114580|23941846|23041322|22882926|22464505|21896375|21046169|20301501|16523049|15706593|15108277|13764315|12728091|12506140|11919560|7554350|4688793|2702087	.	5314	PKHD1	C31	EX32	.	.	missense	NM_138694.3	NP_619639.3	-	Y	c.3785C>T	p.A1262V | p.Ala1262Val	GCT=>GTT	NP=>NP	NM_138694.3(PKHD1): c.3785C>T (p.A1262V)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125640	0.465170	U	0.381	0.354633	13006	0.392357	PASS	558	8576	0.356343	14368	120632	0.469759	1100	6129	3.56586e-01	30218	117708	4.79928e-01	rs9296669	.	4024	0.326500	0.655	-0.049	-0.700	0.68	0.001	0	0.002	neutral	ENST00000371117: c.3785C>T (p.A1262V)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4004072	.	.	.	.	.	no_record	96399	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
6	55216004	55216005	6p12.1	0	normal	.	G	ref	G	CA.CT	het-alt	150	0.52	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	389400	GFRAL	IC4	IVS4	.	.	no-change	NM_207410.2	NP_997293.2	+	Y	c.371-46G=	.	.	.	NM_207410.2(GFRAL): c.371-46G=	;maf-5-some-pop,maf-5-all-pops	115636	0.491534	U	0.5397	0.435503	13006	0.520913	PASS	-1059	8508	0.489187	13715	110628	0.488231	.	.	.	.	.	.	rs870806	.	4024	0.482400	0.655	0.379	0.247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	55216004	55216005	6p12.1	0	normal	.	G	snv	A	CA.CT	het-ref	136	0.48	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	389400	GFRAL	IC4	IVS4	.	.	intron	NM_207410.2	NP_997293.2	+	Y	c.371-46G>A	.	.	.	NM_207410.2(GFRAL): c.371-46G>A	;maf-5-some-pop,maf-5-all-pops	115636	0.508466	U	0.5397	0.435503	13006	0.479087	PASS	1114	8508	0.510813	15017	110628	0.511769	2082	8034	5.12438e-01	24606	93577	5.04719e-01	rs870806	.	4024	0.517600	0.655	0.379	0.247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	93956646	93956647	6q16.1	0	normal	.	A	ref	A	CC.GC	het-alt	146	0.52	.	1	.	PASS	602190	P	.	NN	.	.	.	.	.	.	.	2045	EPHA7	C15	EX15	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	no-change	NM_004440.3	NP_004431.1	-	Y	c.2589T=	.	.	.	NM_004440.3(EPHA7): c.2589T=	;	126272	0.999279	U	0.004	0.000798722	.	.	PASS	.	8636	0.989926	60546	121264	0.999283	.	.	.	.	.	.	rs55780501	.	4024	0.991800	0.482	0.496	1.056	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	93956646	93956647	6q16.1	1	normal	.	A	snv	T	CC.GC	het-ref	137	0.48	.	2	.	PASS	602190	P	.	NN	.	.	.	.	.	.	.	2045	EPHA7	C15	EX15	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_004440.3	NP_004431.1	-	Y	c.2589T>A	p.(A863=) | p.(Ala863=)	GCT=>GCA	.	NM_004440.3(EPHA7): c.2589T>A (p.(A863=))	;	126272	0.000721	U	0.004	0.000798722	.	.	PASS	1	8636	0.010074	1	121264	0.000717	0	191	1.10815e-02	0	191	7.76322e-04	rs55780501	.	4024	0.008200	0.482	0.496	1.056	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
6	106534483	106534484	6q21	0	normal	.	A	ref	A	GA.TT	het-alt	222	0.85	.	1	.	PASS	603423	P	.	NN	.	.	.	.	.	.	.	639	PRDM1	IC1	IVS1	.	.	no-change	NM_001198.3	NP_001189.2	+	Y	c.42+14A=	.	.	.	NM_001198.3(PRDM1): c.42+14A=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.456	-0.674	-0.455	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	106534484	106534484	6q21	1	normal	.	.	ins	T	AA.TT	het-ref	39	0.15	.	2	.	PASS	603423	P	.	NN	.	.	.	.	.	.	.	639	PRDM1	IC1	IVS1	.	.	intron	NM_001198.3	NP_001189.2	+	Y	c.42+14_42+15insT	.	.	.	NM_001198.3(PRDM1): c.42+14_42+15insT	DuplicateObserved;	17073	0.933052	U	.	.	.	.	VQSRTrancheINDEL97.00to99.00	0	712	0.064607	0	19402	0.120039	.	.	.	.	.	.	rs760651087	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	106553434	106553435	6q21	0	normal	.	C	ref	C	CC.GA	het-alt	341	0.51	.	1	.	PASS	603423	P	.	NN	.	.	.	.	.	.	.	639	PRDM1	C5	EX5	.	.	no-change	NM_001198.3	NP_001189.2	+	Y	c.1400C=	.	.	.	NM_001198.3(PRDM1): c.1400C=	;clinically-assoc,submitted-by-lsdb	125284	0.999481	U	0.006	0.00119808	.	.	PASS	.	8616	0.994081	60079	120276	0.999509	.	.	.	.	.	.	rs77256382	.	.	.	0.655	6.103	2.715	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	106553434	106553435	6q21	1	normal	.	C	snv	T	CC.GA	het-ref	330	0.49	.	2	.	PASS	603423	P	.	NN	.	.	.	.	.	.	.	639	PRDM1	C5	EX5	.	.	missense	NM_001198.3	NP_001189.2	+	Y	c.1400C>T	p.P467L | p.Pro467Leu	CCG=>CTG	NP=>NP	NM_001198.3(PRDM1): c.1400C>T (p.P467L)	;clinically-assoc,submitted-by-lsdb	125284	0.000519	U	0.006	0.00119808	.	.	PASS	0	8616	0.005919	0	120276	0.000491	1	113	6.55757e-03	1	123	5.01145e-04	rs77256382	.	.	.	0.655	6.103	2.715	0.06	0.887	0.999	0.669	deleterious	.	.	.	.	.	.	.	.	.	.	no_record	135084	no_assertion_provided	not_provided	VUS
6	110777961	110777962	6q21	0	normal	.	A	ref	A	TT.TT	het-alt	276	0.54	.	1	.	PASS	608276	C	.	NN	.	.	.	.	.	.	.	85413	SLC22A16	C2	EX2	.	.	no-change	NM_033125.3	NP_149116.2	-	Y	c.312T=	.	.	.	NM_033125.3(SLC22A16): c.312T=	;maf-5-some-pop,maf-5-all-pops	126384	0.743433	U	0.4107	0.314097	13006	0.729586	PASS	-1026	8626	0.581962	34055	121376	0.745806	.	.	.	.	.	.	rs6907567	.	4024	0.549000	-1.096	-0.175	-0.211	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	110777961	110777962	6q21	1	normal	.	A	snv	G	TT.TT	het-ref	236	0.46	.	2	.	PASS	608276	C	.	NN	.	.	.	.	.	.	.	85413	SLC22A16	C2	EX2	.	.	coding-synon	NM_033125.3	NP_149116.2	-	Y	c.312T>C	p.(N104=) | p.(Asn104=)	AAT=>AAC	.	NM_033125.3(SLC22A16): c.312T>C (p.(N104=))	;maf-5-some-pop,maf-5-all-pops	126384	0.256567	U	0.4107	0.314097	13006	0.270414	PASS	777	8626	0.418038	4220	121376	0.254194	1512	7171	4.15758e-01	8304	61775	2.50914e-01	rs6907567	.	4024	0.451000	-1.096	-0.175	-0.211	.	.	.	.	.	ENST00000368919: c.312T>C (p.N104N)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3761423	.	.	.	.	.	.	.	.	.	Likely Benign
6	110778127	110778128	6q21	0	normal	.	T	ref	T	GA.GA	het-alt	264	0.49	.	1	.	PASS	608276	C	.	NN	.	.	.	.	.	.	.	85413	SLC22A16	C2	EX2	.	.	no-change	NM_033125.3	NP_149116.2	-	Y	c.146A=	.	.	.	NM_033125.3(SLC22A16): c.146A=	;maf-5-some-pop,maf-5-all-pops	125030	0.741542	U	0.4097	0.313898	13006	0.729586	PASS	-1025	8626	0.582193	33474	120022	0.743855	.	.	.	.	.	.	rs714368	.	4024	0.549000	-1.875	0.507	-0.837	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	110778127	110778128	6q21	1	normal	.	T	snv	C	GA.GA	het-ref	270	0.51	.	2	.	PASS	608276	C	.	NN	.	.	.	.	.	.	.	85413	SLC22A16	C2	EX2	.	.	missense	NM_033125.3	NP_149116.2	-	Y	c.146A>G	p.H49R | p.His49Arg	CAT=>CGT	P+=>P+	NM_033125.3(SLC22A16): c.146A>G (p.H49R)	;maf-5-some-pop,maf-5-all-pops	125030	0.258458	U	0.4097	0.313898	13006	0.270414	PASS	777	8626	0.417807	4206	120022	0.256145	1509	7157	4.15621e-01	8240	61391	2.50471e-01	rs714368	.	4024	0.451000	-1.875	0.507	-0.837	0.25	0	0	0.037	neutral	ENST00000368919: c.146A>G (p.H49R)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3761426	.	.	.	.	.	.	.	.	.	Likely Benign
6	117631462	117631463	6q22.1	0	normal	.	T	ref	T	AT.ta	het-alt	109	0.57	.	1	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC39	IVS39	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.6234-19A=	.	.	.	NM_002944.2(ROS1): c.6234-19A=	.	.	.	.	0.0774	0.0283546	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.533	0.623	0.960	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	117631463	117631463	6q22.1	1	normal	.	.	ins	TAA	TT.ta	het-ref	81	0.43	.	2	(TAA)n|Simple_repeat|Simple_repeat|+|27	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC39	IVS39	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.6234-20_6234-19insTTA	.	.	.	NM_002944.2(ROS1): c.6234-20_6234-19insTTA	MixedObserved,FlankMismatchGenomeLonger;|MixedObserved;maf-5-some-pop	0|98251	0|0.741977	U	0.0774	0.0283546	.	.	PASS	150	5012	0.225060	1446	93256	0.176289	.	.	.	.	.	.	rs2243387|rs71554877	.	4024	0.413800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117641015	117641016	6q22.1	0	normal	.	G	ref	G	TC.AA	het-alt	310	0.52	.	1	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC36	IVS36	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.5940+15C=	.	.	.	NM_002944.2(ROS1): c.5940+15C=	;maf-5-some-pop	125454	0.976653	U	0.0496	0.0375399	13006	0.984546	PASS	-286	8636	0.930292	57582	120446	0.977243	.	.	.	.	.	.	rs2071974	.	4024	0.931900	-2.366	-0.259	-0.303	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117641015	117641016	6q22.1	1	normal	.	G	snv	A	TC.AA	het-ref	282	0.48	.	2	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC36	IVS36	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.5940+15C>T	.	.	.	NM_002944.2(ROS1): c.5940+15C>T	;maf-5-some-pop	125454	0.023347	U	0.0496	0.0375399	13006	0.015454	PASS	15	8636	0.069708	100	120446	0.022757	37	1180	6.84375e-02	219	5769	2.35646e-02	rs2071974	.	4024	0.068100	-2.366	-0.259	-0.303	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117642417	117642418	6q22.1	0	normal	.	A	ref	A	AC.TA	het-alt	356	0.51	.	1	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC35	IVS35	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.5777+4T=	.	.	.	NM_002944.2(ROS1): c.5777+4T=	SingleClassTriAllelic;maf-5-some-pop	126006	0.976723	U	0.0496	0.0375399	13006	0.984546	PASS	-286	8646	0.930372	57854	120998	0.977314	.	.	.	.	.	.	rs55708202	.	4024	0.931700	-0.119	-2.631	-2.490	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117642417	117642418	6q22.1	1	normal	.	A	snv	C	AC.TA	het-ref	344	0.49	.	2	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC35	IVS35	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.5777+4T>G	.	.	.	NM_002944.2(ROS1): c.5777+4T>G	SingleClassTriAllelic;maf-5-some-pop	126006	0.023269	U	0.0496	0.0375399	13006	0.015454	PASS	15	8646	0.069628	100	120998	0.022678	36	1177	6.85099e-02	219	5732	2.34166e-02	rs55708202	.	4024	0.068300	-0.119	-2.631	-2.490	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117643432	117643433	6q22.1	0	normal	.	T	ref	T	TC.CA	het-alt	393	0.53	.	1	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC34	IVS34	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.5642-876A=	.	.	.	NM_002944.2(ROS1): c.5642-876A=	;maf-5-some-pop	5008	0.874401	U	0.1528	0.125599	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs492132	.	4024	0.815100	0.496	0.074	0.041	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117643432	117643433	6q22.1	0	normal	.	T	snv	C	TC.CA	het-ref	345	0.47	.	2	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC34	IVS34	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.5642-876A>G	.	.	.	NM_002944.2(ROS1): c.5642-876A>G	;maf-5-some-pop	5008	0.125599	U	0.1528	0.125599	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs492132	.	4024	0.184900	0.496	0.074	0.041	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117643658	117643659	6q22.1	0	normal	.	C	ref	C	gt.tt	het-alt	383	0.49	.	1	L2b|LINE|L2|+|109	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC34	IVS34	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.5642-1102G=	.	.	.	NM_002944.2(ROS1): c.5642-1102G=	;maf-5-some-pop,maf-5-all-pops	5008	0.875200	U	0.1528	0.1248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs489576	.	4024	0.815400	0.591	2.649	2.671	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117643658	117643659	6q22.1	0	normal	.	C	snv	G	gt.tt	het-ref	404	0.51	.	2	L2b|LINE|L2|+|109	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC34	IVS34	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.5642-1102G>C	.	.	.	NM_002944.2(ROS1): c.5642-1102G>C	;maf-5-some-pop,maf-5-all-pops	5008	0.124800	U	0.1528	0.1248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs489576	.	4024	0.184600	0.591	2.649	2.671	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117644840	117644841	6q22.1	0	normal	.	C	ref	C	CC.TT	het-alt	297	0.51	.	1	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC34	IVS34	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.5641+654G=	.	.	.	NM_002944.2(ROS1): c.5641+654G=	;maf-5-some-pop,maf-5-all-pops	5008	0.875399	U	0.1528	0.124601	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs568514	.	4024	0.816100	-0.308	0.329	0.277	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117644840	117644841	6q22.1	0	normal	.	C	snv	T	CC.TT	het-ref	280	0.49	.	2	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC34	IVS34	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.5641+654G>A	.	.	.	NM_002944.2(ROS1): c.5641+654G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.124601	U	0.1528	0.124601	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs568514	.	4024	0.183900	-0.308	0.329	0.277	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117644865	117644866	6q22.1	0	normal	.	T	ref	T	AT.AT	het-alt	288	0.51	.	1	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC34	IVS34	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.5641+629A=	.	.	.	NM_002944.2(ROS1): c.5641+629A=	;maf-5-some-pop,maf-5-all-pops	5008	0.807109	U	0.1964	0.192891	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs546631	.	4024	0.780800	-0.119	0.048	0.052	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117644865	117644866	6q22.1	0	normal	.	T	snv	C	AT.AT	het-ref	277	0.49	.	2	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC34	IVS34	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.5641+629A>G	.	.	.	NM_002944.2(ROS1): c.5641+629A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.192891	U	0.1964	0.192891	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs546631	.	4024	0.219200	-0.119	0.048	0.052	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117645040	117645041	6q22.1	0	normal	.	C	ref	C	TA.TC	het-alt	362	0.54	.	1	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC34	IVS34	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.5641+454G=	.	.	.	NM_002944.2(ROS1): c.5641+454G=	;maf-5-some-pop	5008	0.875399	U	0.1528	0.124601	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs545537	.	4024	0.815900	0.655	0.720	0.726	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117645040	117645041	6q22.1	0	normal	.	C	snv	T	TA.TC	het-ref	309	0.46	.	2	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC34	IVS34	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.5641+454G>A	.	.	.	NM_002944.2(ROS1): c.5641+454G>A	;maf-5-some-pop	5008	0.124601	U	0.1528	0.124601	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs545537	.	4024	0.184100	0.655	0.720	0.726	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117645603	117645604	6q22.1	0	normal	.	A	ref	A	AA.TT	het-alt	368	0.54	.	1	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC33	IVS33	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.5558-26T=	.	.	.	NM_002944.2(ROS1): c.5558-26T=	;maf-5-some-pop	87160	0.969929	U	0.0496	0.0375399	12880	0.986102	PASS	.	5518	0.906307	38733	82152	0.970384	.	.	.	.	.	.	rs3822950	.	4024	0.931700	0.528	0.792	0.977	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117645603	117645604	6q22.1	0	normal	.	A	snv	T	AA.TT	het-ref	317	0.46	.	2	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC33	IVS33	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.5558-26T>A	.	.	.	NM_002944.2(ROS1): c.5558-26T>A	;maf-5-some-pop	87160	0.030071	U	0.0496	0.0375399	12880	0.013898	PASS	12	5518	0.093693	90	82152	0.029616	29	1006	7.19908e-02	170	4575	2.26982e-02	rs3822950	.	4024	0.068300	0.528	0.792	0.977	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117645781	117645782	6q22.1	0	normal	.	T	ref	T	tt.tt	het-alt	336	0.51	.	1	MER63B|DNA|hAT-Blackjack|+|88	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC33	IVS33	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.5558-204A=	.	.	.	NM_002944.2(ROS1): c.5558-204A=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.528	-0.898	-0.974	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	117645782	117645782	6q22.1	0	normal	.	.	ins	C	tt.tt	het-ref	319	0.49	.	2	MER63B|DNA|hAT-Blackjack|+|88	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC33	IVS33	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.5558-205_5558-204insG	.	.	.	NM_002944.2(ROS1): c.5558-205_5558-204insG	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs150636655	.	4024	0.068300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117646379	117646380	6q22.1	0	normal	.	A	snv	C	TA.GG	het-ref	337	0.44	.	2	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC33	IVS33	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.5558-802T>G	.	.	.	NM_002944.2(ROS1): c.5558-802T>G	;maf-5-some-pop	5008	0.037540	U	0.0496	0.0375399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs35134954	.	4024	0.068300	0.533	0.231	0.190	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117646379	117646380	6q22.1	0	normal	.	A	ref	A	TA.GG	het-alt	433	0.56	.	1	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC33	IVS33	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.5558-802T=	.	.	.	NM_002944.2(ROS1): c.5558-802T=	;maf-5-some-pop	5008	0.962460	U	0.0496	0.0375399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs35134954	.	4024	0.931700	0.533	0.231	0.190	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117646771	117646772	6q22.1	0	normal	.	T	snv	C	AG.CA	het-ref	366	0.48	.	2	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC33	IVS33	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.5557+615A>G	.	.	.	NM_002944.2(ROS1): c.5557+615A>G	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.186701	U	0.1964	0.186701	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs508278	.	4024	0.218900	-0.733	-2.131	-2.141	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117646771	117646772	6q22.1	0	normal	.	T	ref	T	AG.CA	het-alt	390	0.52	.	1	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC33	IVS33	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.5557+615A=	.	.	.	NM_002944.2(ROS1): c.5557+615A=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.813299	U	0.1964	0.186701	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs508278	.	4024	0.781100	-0.733	-2.131	-2.141	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117647252	117647257	6q22.1	0	normal	.	ATTAT	ref	ATTAT	AG.at	het-alt	82	0.51	.	1	(TA)n|Simple_repeat|Simple_repeat|+|36;trf	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC33	IVS33	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.5557+130_5557+134=	.	.	.	NM_002944.2(ROS1): c.5557+130_5557+134=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4992	0.647800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117647252	117647257	6q22.1	0	normal	.	ATTAT	del	.	AG.at	het-ref	78	0.49	.	2	(TA)n|Simple_repeat|Simple_repeat|+|36;trf	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC33	IVS33	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.5557+130_5557+134delATAAT	.	.	.	NM_002944.2(ROS1): c.5557+130_5557+134delATAAT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4992	0.012000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	117647254	117647258	6q22.1	0	normal	.	TATA	ref	TATA	AT.ta	het-alt	99	0.81	.	1	(TA)n|Simple_repeat|Simple_repeat|+|36;trf	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC33	IVS33	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.5557+129_5557+132=	.	.	.	NM_002944.2(ROS1): c.5557+129_5557+132=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs71767528	.	4636	0.719100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117647254	117647258	6q22.1	0	normal	.	TATA	del	.	AT.ta	het-ref	23	0.19	.	2	(TA)n|Simple_repeat|Simple_repeat|+|36;trf	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC33	IVS33	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.5557+129_5557+132delTATA	.	.	.	NM_002944.2(ROS1): c.5557+129_5557+132delTATA	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs71767528	.	4636	0.108300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117648891	117648892	6q22.1	0	normal	.	A	ref	A	tt.at	het-alt	339	0.49	.	1	MLT1C|LTR|ERVL-MaLR|+|425	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC32	IVS32	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.5367-1315T=	.	.	.	NM_002944.2(ROS1): c.5367-1315T=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.334	1.462	1.421	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	117648891	117648892	6q22.1	0	normal	.	A	snv	C	tt.at	het-ref	349	0.51	.	2	MLT1C|LTR|ERVL-MaLR|+|425	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC32	IVS32	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.5367-1315T>G	.	.	.	NM_002944.2(ROS1): c.5367-1315T>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.334	1.462	1.421	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	117649987	117649988	6q22.1	0	normal	.	T	ref	T	CA.TG	het-alt	331	0.51	.	1	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC32	IVS32	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.5366+504A=	.	.	.	NM_002944.2(ROS1): c.5366+504A=	;maf-5-some-pop	120074	0.858529	U	0.1528	0.149361	5734	0.857517	PASS	.	8476	0.807574	42490	115066	0.858872	.	.	.	.	.	.	rs581235	.	4024	0.816100	-0.119	-1.075	-0.936	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117649987	117649988	6q22.1	0	normal	.	T	snv	C	CA.TG	het-ref	314	0.49	.	2	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC32	IVS32	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.5366+504A>G	.	.	.	NM_002944.2(ROS1): c.5366+504A>G	;maf-5-some-pop	120074	0.141471	U	0.1528	0.149361	5734	0.142483	PASS	162	8476	0.192426	1196	115066	0.141128	320	3212	1.87529e-01	2502	33640	1.41295e-01	rs581235	.	4024	0.183900	-0.119	-1.075	-0.936	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117650799	117650800	6q22.1	0	normal	.	G	ref	G	ga.tc	het-alt	337	0.49	.	1	L1PA8A|LINE|L1|+|6420	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC31	IVS31	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.5249-191C=	.	.	.	NM_002944.2(ROS1): c.5249-191C=	;maf-5-some-pop,maf-5-all-pops	5008	0.814696	U	0.1964	0.185304	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs584647	.	4024	0.781300	-0.817	-0.737	-0.796	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117650799	117650800	6q22.1	0	normal	.	G	snv	A	ga.tc	het-ref	356	0.51	.	2	L1PA8A|LINE|L1|+|6420	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC31	IVS31	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.5249-191C>T	.	.	.	NM_002944.2(ROS1): c.5249-191C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.185304	U	0.1964	0.185304	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs584647	.	4024	0.218700	-0.817	-0.737	-0.796	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117651054	117651055	6q22.1	0	normal	.	C	ref	C	aa.cc	het-alt	382	0.53	.	1	L1PA8A|LINE|L1|+|6420	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC31	IVS31	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.5249-446G=	.	.	.	NM_002944.2(ROS1): c.5249-446G=	;maf-5-some-pop	5008	0.962460	U	0.0496	0.0375399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6914365	.	4024	0.931900	0.313	0.317	0.308	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117651054	117651055	6q22.1	0	normal	.	C	snv	T	aa.cc	het-ref	343	0.47	.	2	L1PA8A|LINE|L1|+|6420	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC31	IVS31	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.5249-446G>A	.	.	.	NM_002944.2(ROS1): c.5249-446G>A	;maf-5-some-pop	5008	0.037540	U	0.0496	0.0375399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6914365	.	4024	0.068100	0.313	0.317	0.308	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117653329	117653331	6q22.1	0	normal	.	AA	ref	AA	gc.aa	het-alt	273	0.72	.	1	L1PA8A|LINE|L1|+|6420	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC31	IVS31	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.5249-2722_5249-2721=	.	.	.	NM_002944.2(ROS1): c.5249-2722_5249-2721=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.845900	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117653329	117653331	6q22.1	0	normal	.	AA	del	.	gc.aa	het-ref	107	0.28	.	2	L1PA8A|LINE|L1|+|6420	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC31	IVS31	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.5249-2722_5249-2721delTT	.	.	.	NM_002944.2(ROS1): c.5249-2722_5249-2721delTT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.152800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117653746	117653747	6q22.1	0	normal	.	C	ref	C	ca.at	het-alt	348	0.50	.	1	L1PA8A|LINE|L1|+|6420	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC31	IVS31	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.5249-3138G=	.	.	.	NM_002944.2(ROS1): c.5249-3138G=	;maf-5-some-pop	5008	0.959864	U	0.0615	0.0401358	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9387465	.	4024	0.920200	-0.680	-0.672	-0.694	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117653746	117653747	6q22.1	0	normal	.	C	snv	T	ca.at	het-ref	352	0.50	.	2	L1PA8A|LINE|L1|+|6420	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC31	IVS31	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.5249-3138G>A	.	.	.	NM_002944.2(ROS1): c.5249-3138G>A	;maf-5-some-pop	5008	0.040136	U	0.0615	0.0401358	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9387465	.	4024	0.079800	-0.680	-0.672	-0.694	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117654710	117654711	6q22.1	0	nullSample	.	T	ref	T	tt.gg	homo-ref	.	.	.	0	L1PA8A|LINE|L1|+|6420	.	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC31	IVS31	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.5248+3624A=	.	.	.	NM_002944.2(ROS1): c.5248+3624A=	;	5008	0.000000	U	1	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2095283	.	4024	0.002000	-0.711	-0.687	-0.717	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117654710	117654711	6q22.1	0	normal	.	T	snv	C	tt.gg	hom-alt	747	1.00	.	0	L1PA8A|LINE|L1|+|6420	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC31	IVS31	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.5248+3624A>G	.	.	.	NM_002944.2(ROS1): c.5248+3624A>G	;	5008	1.000000	U	1	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2095283	.	4024	0.998000	-0.711	-0.687	-0.717	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117656338	117656339	6q22.1	0	normal	.	G	ref	G	gg.ca	het-alt	336	0.51	.	1	L1PA8A|LINE|L1|+|6420	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC31	IVS31	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.5248+1996C=	.	.	.	NM_002944.2(ROS1): c.5248+1996C=	;maf-5-some-pop,maf-5-all-pops	5008	0.811102	U	0.2083	0.188898	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9481702	.	4024	0.769400	-2.194	-2.108	-2.160	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117656338	117656339	6q22.1	0	normal	.	G	snv	A	gg.ca	het-ref	318	0.49	.	2	L1PA8A|LINE|L1|+|6420	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC31	IVS31	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.5248+1996C>T	.	.	.	NM_002944.2(ROS1): c.5248+1996C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.188898	U	0.2083	0.188898	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9481702	.	4024	0.230600	-2.194	-2.108	-2.160	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117656554	117656555	6q22.1	0	normal	.	T	ref	T	gg.aa	het-alt	353	0.52	.	1	L1PA8A|LINE|L1|+|6420	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC31	IVS31	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.5248+1780A=	.	.	.	NM_002944.2(ROS1): c.5248+1780A=	;maf-5-some-pop,maf-5-all-pops	5008	0.242013	U	0.5694	0.757987	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9385006	.	4024	0.412800	-0.703	-0.686	-0.712	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117656554	117656555	6q22.1	0	normal	.	T	snv	G	gg.aa	het-ref	323	0.48	.	2	L1PA8A|LINE|L1|+|6420	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC31	IVS31	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.5248+1780A>C	.	.	.	NM_002944.2(ROS1): c.5248+1780A>C	;maf-5-some-pop,maf-5-all-pops	5008	0.757987	U	0.5694	0.757987	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9385006	.	4024	0.587200	-0.703	-0.686	-0.712	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117657498	117657499	6q22.1	0	normal	.	T	ref	T	cc.ga	het-alt	206	0.53	.	1	L1PA10|LINE|L1|-|581	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC31	IVS31	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.5248+836A=	.	.	.	NM_002944.2(ROS1): c.5248+836A=	;	5008	0.977037	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs145989639	.	4024	0.931900	0.225	0.242	0.228	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117657498	117657499	6q22.1	0	normal	.	T	del	.	cc.ga	het-ref	181	0.47	.	2	L1PA10|LINE|L1|-|581	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC31	IVS31	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.5248+836delA	.	.	.	NM_002944.2(ROS1): c.5248+836delA	;	5008	0.022963	U	0.0496	0.0229633	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs145989639	.	4024	0.068100	0.225	0.242	0.228	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117657566	117657567	6q22.1	0	normal	.	T	ref	T	tg.aa	het-alt	341	0.52	.	1	L1PA10|LINE|L1|-|581	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC31	IVS31	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.5248+768A=	.	.	.	NM_002944.2(ROS1): c.5248+768A=	;maf-5-some-pop	5008	0.957867	U	0.0496	0.0421326	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs150097079	.	4024	0.931900	0.254	0.274	0.257	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117657566	117657567	6q22.1	0	normal	.	T	snv	C	tg.aa	het-ref	310	0.48	.	2	L1PA10|LINE|L1|-|581	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC31	IVS31	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.5248+768A>G	.	.	.	NM_002944.2(ROS1): c.5248+768A>G	;maf-5-some-pop	5008	0.042133	U	0.0496	0.0421326	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs150097079	.	4024	0.068100	0.254	0.274	0.257	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117662681	117662682	6q22.1	1	normal	.	A	snv	G	CA.CT	het-ref	326	0.51	.	2	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	C29	EX29	.	.	coding-synon	NM_002944.2	NP_002935.2	-	Y	c.4783T>C	p.(L1595=) | p.(Leu1595=)	TTG=>CTG	.	NM_002944.2(ROS1): c.4783T>C (p.(L1595=))	;maf-5-some-pop	126246	0.024151	U	0.0615	0.0401358	13006	0.015224	PASS	24	8638	0.081153	110	121238	0.023491	53	1403	8.14088e-02	237	6011	2.44330e-02	rs3752564	.	4024	0.081300	-0.290	-1.888	-1.788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	117662681	117662682	6q22.1	0	normal	.	A	ref	A	CA.CT	het-alt	310	0.49	.	1	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	C29	EX29	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.4783T=	.	.	.	NM_002944.2(ROS1): c.4783T=	;maf-5-some-pop	126246	0.975849	U	0.0615	0.0401358	13006	0.984776	PASS	.	8638	0.918847	57881	121238	0.976509	.	.	.	.	.	.	rs3752564	.	4024	0.918700	-0.290	-1.888	-1.788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117678082	117678083	6q22.1	0	nullSample	.	A	ref	A	AT.GA	homo-ref	.	.	.	0	.	.	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC24	IVS24	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.3855-5T=	.	.	.	NM_002944.2(ROS1): c.3855-5T=	;maf-5-some-pop,maf-5-all-pops	125590	0.537169	U	0.4762	0.394569	13006	0.574581	PASS	.	8598	0.544662	17593	120582	0.534333	.	.	.	.	.	.	rs2243384	.	4024	0.542500	-0.400	0.054	0.057	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117678082	117678083	6q22.1	1	normal	.	A	snv	G	AT.GA	hom-alt	608	1.00	.	0	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC24	IVS24	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.3855-5T>C	.	.	.	NM_002944.2(ROS1): c.3855-5T>C	;maf-5-some-pop,maf-5-all-pops	125590	0.462831	U	0.4762	0.394569	13006	0.425419	PASS	866	8598	0.455338	13453	120582	0.465667	1714	7629	4.51313e-01	26712	111997	4.69101e-01	rs2243384	.	4024	0.457500	-0.400	0.054	0.057	.	.	.	.	.	ENST00000368508: c.3855-5T>C (p.?)	lung [NS|NS|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	CSV	3726793	.	.	.	.	.	.	.	.	.	Benign
6	117681436	117681444	6q22.1	0	normal	.	ACACACAC	ref	ACACACAC	GG.ac	het-alt	82	0.49	.	1	(CA)n|Simple_repeat|Simple_repeat|+|26;trf	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC22	IVS22	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.3445+61_3445+68=	.	.	.	NM_002944.2(ROS1): c.3445+61_3445+68=	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs369921974	.	4020	0.938600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117681436	117681444	6q22.1	0	normal	.	ACACACAC	del	.	GG.ac	het-ref	84	0.51	.	2	(CA)n|Simple_repeat|Simple_repeat|+|26;trf	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC22	IVS22	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.3445+61_3445+68delGTGTGTGT	.	.	.	NM_002944.2(ROS1): c.3445+61_3445+68delGTGTGTGT	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs369921974	.	4020	0.040500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	117708970	117708971	6q22.1	0	normal	.	C	ref	C	GG.TC	het-alt	338	0.53	.	1	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	C13	EX13	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.1986G=	.	.	.	NM_002944.2(ROS1): c.1986G=	;maf-5-some-pop	126232	0.934224	U	0.0308	0.0644968	13006	0.937875	PASS	-84	8654	0.979663	53006	121224	0.934171	.	.	.	.	.	.	rs9489143	.	4024	0.987600	0.561	0.123	-0.084	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117708970	117708971	6q22.1	1	normal	.	C	snv	T	GG.TC	het-ref	300	0.47	.	2	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	C13	EX13	.	.	coding-synon	NM_002944.2	NP_002935.2	-	Y	c.1986G>A	p.(E662=) | p.(Glu662=)	GAG=>GAA	.	NM_002944.2(ROS1): c.1986G>A (p.(E662=))	;maf-5-some-pop	126232	0.065776	U	0.0308	0.0644968	13006	0.062125	PASS	4	8654	0.020337	374	121224	0.065829	7	378	2.19156e-02	718	16335	6.64516e-02	rs9489143	.	4024	0.012400	0.561	0.123	-0.084	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	117718302	117718303	6q22.1	0	normal	.	A	ref	A	TA.TG	het-alt	175	0.52	.	1	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC6	IVS6	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.578-24T=	.	.	.	NM_002944.2(ROS1): c.578-24T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125354	0.742888	U	0.2708	0.351238	13006	0.688836	PASS	.	8608	0.709689	34011	120346	0.746805	.	.	.	.	.	.	rs9401003	.	4024	0.740300	-0.790	-0.579	-0.304	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117718302	117718303	6q22.1	0	normal	.	A	snv	G	TA.TG	het-ref	161	0.48	.	2	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC6	IVS6	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.578-24T>C	.	.	.	NM_002944.2(ROS1): c.578-24T>C	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125354	0.257112	U	0.2708	0.351238	13006	0.311164	PASS	371	8608	0.290311	4309	120346	0.253195	755	4985	2.96021e-01	8016	58795	2.52803e-01	rs9401003	.	4024	0.259700	-0.790	-0.579	-0.304	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117724461	117724462	6q22.1	0	normal	.	C	snv	A	AT.AT	het-ref	223	0.50	.	2	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC5	IVS5	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.439-22G>T	.	.	.	NM_002944.2(ROS1): c.439-22G>T	;maf-5-some-pop,genotype-conflict	123060	0.551186	U	0.5575	0.669329	13006	0.594264	PASS	1260	8400	0.562857	18334	118052	0.546175	2575	9340	5.63737e-01	34647	124890	5.27746e-01	rs2243379	.	4024	0.537800	-0.256	-0.299	-0.167	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117724461	117724462	6q22.1	0	normal	.	C	ref	C	AT.AT	het-alt	220	0.50	.	1	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC5	IVS5	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.439-22G=	.	.	.	NM_002944.2(ROS1): c.439-22G=	;maf-5-some-pop,genotype-conflict	123060	0.448814	U	0.5575	0.669329	13006	0.405736	PASS	-1104	8400	0.437143	12883	118052	0.453825	.	.	.	.	.	.	rs2243379	.	4024	0.462200	-0.256	-0.299	-0.167	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117724498	117724499	6q22.1	0	normal	.	A	ref	A	CT.AA	het-alt	156	0.51	.	1	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC5	IVS5	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.439-59T=	.	.	.	NM_002944.2(ROS1): c.439-59T=	;maf-5-some-pop	5008	0.325280	U	0.5585	0.67472	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1407179	.	4024	0.460000	-1.087	-0.672	-0.671	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117724498	117724499	6q22.1	0	normal	.	A	snv	C	CT.AA	het-ref	148	0.49	.	2	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC5	IVS5	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.439-59T>G	.	.	.	NM_002944.2(ROS1): c.439-59T>G	;maf-5-some-pop	5008	0.674720	U	0.5585	0.67472	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1407179	.	4024	0.540000	-1.087	-0.672	-0.671	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117725383	117725384	6q22.1	0	normal	.	A	ref	A	tc.aa	het-alt	134	0.71	.	1	AluY|SINE|Alu|+|281	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC5	IVS5	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.438+59T=	.	.	.	NM_002944.2(ROS1): c.438+59T=	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs373760201	.	4024	0.708000	0.102	-0.667	-0.773	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117725383	117725384	6q22.1	0	normal	.	A	del	.	tc.aa	het-ref	56	0.29	.	2	AluY|SINE|Alu|+|281	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC5	IVS5	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.438+59delT	.	.	.	NM_002944.2(ROS1): c.438+59delT	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs373760201	.	4024	0.292000	0.102	-0.667	-0.773	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117725577	117725578	6q22.1	0	normal	.	T	ref	T	GG.AG	het-alt	296	0.51	.	1	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	C5	EX5	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.303A=	.	.	.	NM_002944.2(ROS1): c.303A=	;maf-5-some-pop	126366	0.445341	U	0.5675	0.67512	13006	0.400815	PASS	-1094	8650	0.422428	13394	121358	0.450312	.	.	.	.	.	.	rs2243378	.	4024	0.437400	-1.231	-1.117	-0.837	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117725577	117725578	6q22.1	1	normal	.	T	snv	A	GG.AG	het-ref	290	0.49	.	2	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	C5	EX5	.	.	coding-synon	NM_002944.2	NP_002935.2	-	Y	c.303A>T	p.(L101=) | p.(Leu101=)	CTA=>CTT	.	NM_002944.2(ROS1): c.303A>T (p.(L101=))	;maf-5-some-pop	126366	0.554659	U	0.5675	0.67512	13006	0.599185	PASS	1404	8650	0.577572	19424	121358	0.549688	2913	10070	5.85329e-01	37471	132275	5.38632e-01	rs2243378	.	4024	0.562600	-1.231	-1.117	-0.837	.	.	.	.	.	ENST00000368508: c.303A>T (p.L101L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3761460	.	.	.	.	.	.	.	.	.	Likely Benign
6	117730818	117730819	6q22.1	0	normal	.	G	ref	G	AG.GA	het-alt	194	0.51	.	1	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC3	IVS3	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.229-14C=	.	.	.	NM_002944.2(ROS1): c.229-14C=	;maf-5-some-pop,maf-5-all-pops	125928	0.717299	U	0.2738	0.360224	13006	0.683377	PASS	-854	8612	0.733163	32052	120920	0.720509	.	.	.	.	.	.	rs2273601	.	4024	0.736600	-1.975	-0.169	-0.164	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117730818	117730819	6q22.1	1	normal	.	G	snv	A	AG.GA	het-ref	188	0.49	.	2	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC3	IVS3	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.229-14C>T	.	.	.	NM_002944.2(ROS1): c.229-14C>T	;maf-5-some-pop,maf-5-all-pops	125928	0.282701	U	0.2738	0.360224	13006	0.316623	PASS	295	8612	0.266837	5388	120920	0.279491	631	4676	2.71639e-01	10201	66099	2.68936e-01	rs2273601	.	4024	0.263400	-1.975	-0.169	-0.164	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117737389	117737390	6q22.1	0	normal	.	G	ref	G	CA.TA	het-alt	114	0.53	.	1	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC3	IVS3	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.228+31C=	.	.	.	NM_002944.2(ROS1): c.228+31C=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	118684	0.640230	U	0.4395	0.457069	13002	0.632903	PASS	.	8048	0.562003	23959	113676	0.644516	.	.	.	.	.	.	rs2243	.	4024	0.585200	-0.741	-1.696	-1.739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117737389	117737390	6q22.1	0	normal	.	G	snv	A	CA.TA	het-ref	103	0.47	.	2	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC3	IVS3	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.228+31C>T	.	.	.	NM_002944.2(ROS1): c.228+31C>T	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	118684	0.359770	U	0.4395	0.457069	13002	0.367097	PASS	710	8048	0.437997	7531	113676	0.355484	1515	7272	4.31932e-01	14857	80958	3.38055e-01	rs2243	.	4024	0.414800	-0.741	-1.696	-1.739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117739547	117739548	6q22.1	0	normal	.	T	ref	T	TG.GA	het-alt	98	0.43	.	1	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC2	IVS2	.	.	no-change	NM_002944.2	NP_002935.2	-	Y	c.168+77A=	.	.	.	NM_002944.2(ROS1): c.168+77A=	;	5008	0.997804	U	0	0.00219649	4566	0.997153	.	.	.	.	.	.	.	.	.	.	.	.	.	rs146943638	.	.	.	-0.417	-0.259	-0.330	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	117739547	117739548	6q22.1	0	normal	.	T	snv	A	TG.GA	het-ref	128	0.57	.	2	.	PASS	165020	C	.	NN	.	.	.	.	.	.	.	6098	ROS1	IC2	IVS2	.	.	intron	NM_002944.2	NP_002935.2	-	Y	c.168+77A>T	.	.	.	NM_002944.2(ROS1): c.168+77A>T	;	5008	0.002196	U	0	0.00219649	4566	0.002847	.	.	.	.	.	.	.	.	.	.	.	.	.	rs146943638	.	.	.	-0.417	-0.259	-0.330	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	127476515	127476516	6q22.33	0	normal	.	G	ref	G	CT.TG	het-alt	157	0.58	.	1	.	PASS	610574	P	.	NN	.	.	.	.	.	.	.	84870	RSPO3	C4	EX4	Thrombospondin type 1 domain	PF00090.14	no-change	NM_032784.3	NP_116173.2	+	Y	c.567G=	.	.	.	NM_032784.3(RSPO3): c.567G=	;maf-5-some-pop,maf-5-all-pops	126120	0.461925	U	0.494	0.532748	13006	0.446640	PASS	.	8590	0.449709	13074	121112	0.461705	.	.	.	.	.	.	rs1892172	.	4024	0.466200	-0.224	1.152	1.352	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	127476515	127476516	6q22.33	1	normal	.	G	snv	A	CT.TG	het-ref	116	0.42	.	2	.	PASS	610574	P	.	NN	.	.	.	.	.	.	.	84870	RSPO3	C4	EX4	Thrombospondin type 1 domain	PF00090.14	coding-synon	NM_032784.3	NP_116173.2	+	Y	c.567G>A	p.(L189=) | p.(Leu189=)	CTG=>CTA	.	NM_032784.3(RSPO3): c.567G>A (p.(L189=))	;maf-5-some-pop,maf-5-all-pops	126120	0.538075	U	0.494	0.532748	13006	0.553360	PASS	1330	8590	0.550291	17712	121112	0.538295	2675	9561	5.55678e-01	35279	131031	5.33544e-01	rs1892172	.	4024	0.533800	-0.224	1.152	1.352	.	.	.	.	.	ENST00000356698: c.567G>A (p.L189L)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	1568095	.	.	.	.	.	.	.	.	.	Likely Benign
6	137519587	137519588	6q23.3	0	nullSample	.	A	ref	A	CT.GA	homo-ref	.	.	.	0	.	.	107470	C	209950(MK);600263(SK);607948(SK);610424(SK);615978(MK)	AR	Mycobacterial infection, atypical, familial disseminated; BCG infection, generalized familial 	AD/AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	10192386|9389728|8960475|8960473	.	3459	IFNGR1	C7E	EX7E	.	.	no-change	NM_000416.2	NP_000407.1	-	Y	c.1050T=	.	.	.	NM_000416.2(IFNGR1): c.1050T=	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	126328	0.869776	U	0.1062	0.0940495	13006	0.871367	PASS	.	8648	0.879857	45903	121320	0.868282	.	.	.	.	.	.	rs11914	.	4024	0.883400	-1.264	-1.353	-1.543	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	137519587	137519588	6q23.3	1	normal	.	A	snv	C	CT.GA	hom-alt	713	1.00	.	0	.	PASS	107470	C	209950(MK);600263(SK);607948(SK);610424(SK);615978(MK)	AR	Mycobacterial infection, atypical, familial disseminated; BCG infection, generalized familial 	AD/AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	10192386|9389728|8960475|8960473	.	3459	IFNGR1	C7E	EX7E	.	.	coding-synon	NM_000416.2	NP_000407.1	-	Y	c.1050T>G	p.(S350=) | p.(Ser350=)	TCT=>TCG	.	NM_000416.2(IFNGR1): c.1050T>G (p.(S350=))	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	126328	0.130217	U	0.1062	0.0940495	13006	0.128633	PASS	61	8648	0.120143	1223	121320	0.131710	121	2124	1.23145e-01	2415	32382	1.31564e-01	rs11914	.	4024	0.116600	-1.264	-1.353	-1.543	.	.	.	.	.	ENST00000367739: c.1050T>G (p.S350S)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3761497	.	.	.	.	.	no_record	355554	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
6	137524870	137524872	6q23.3	0	nullSample	.	AA	ref	AA	TG.AA	homo-ref	.	.	.	0	.	.	107470	C	209950(MK);600263(SK);607948(SK);610424(SK);615978(MK)	AR	Mycobacterial infection, atypical, familial disseminated; BCG infection, generalized familial 	AD/AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	10192386|9389728|8960475|8960473	.	3459	IFNGR1	IC4	IVS4	.	.	no-change	NM_000416.2	NP_000407.1	-	Y	c.547-50_547-49=	.	.	.	NM_000416.2(IFNGR1): c.547-50_547-49=	MixedObserved;maf-5-some-pop	3608	0.869457	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs35560055	.	4024	0.859100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	137524870	137524872	6q23.3	0	normal	.	AA	del	.	TG.AA	hom-alt	140	0.97	.	0	.	PASS	107470	C	209950(MK);600263(SK);607948(SK);610424(SK);615978(MK)	AR	Mycobacterial infection, atypical, familial disseminated; BCG infection, generalized familial 	AD/AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	10192386|9389728|8960475|8960473	.	3459	IFNGR1	IC4	IVS4	.	.	intron	NM_000416.2	NP_000407.1	-	Y	c.547-50_547-49delTT	.	.	.	NM_000416.2(IFNGR1): c.547-50_547-49delTT	MixedObserved;maf-5-some-pop	3608	0.130543	U	0.1062	0.0940495	.	.	PASS	19	2516	0.162560	387	49816	0.161534	.	.	.	.	.	.	rs35560055	.	4024	0.104400	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	137540369	137540370	6q23.3	1	normal	.	A	snv	G	GA.CG	hom-alt	267	1.00	.	0	.	PASS	107470	C	209950(MK);600263(SK);607948(SK);610424(SK);615978(MK)	AR	Mycobacterial infection, atypical, familial disseminated; BCG infection, generalized familial 	AD/AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	10192386|9389728|8960475|8960473	.	3459	IFNGR1	IC1	IVS1	.	.	intron	NM_000416.2	NP_000407.1	-	Y	c.85+10T>C	.	.	.	NM_000416.2(IFNGR1): c.85+10T>C	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	93842	0.484389	U	0.5873	0.502396	12996	0.428209	PASS	1109	6804	0.591270	9469	88834	0.483373	2612	9134	5.74177e-01	21649	96262	4.29987e-01	rs7749390	.	4024	0.584500	-0.981	0.565	0.569	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	355562	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
6	137540369	137540370	6q23.3	0	nullSample	.	A	ref	A	GA.CG	homo-ref	.	.	.	0	.	.	107470	C	209950(MK);600263(SK);607948(SK);610424(SK);615978(MK)	AR	Mycobacterial infection, atypical, familial disseminated; BCG infection, generalized familial 	AD/AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	10192386|9389728|8960475|8960473	.	3459	IFNGR1	IC1	IVS1	.	.	no-change	NM_000416.2	NP_000407.1	-	Y	c.85+10T=	.	.	.	NM_000416.2(IFNGR1): c.85+10T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	93842	0.515611	U	0.5873	0.502396	12996	0.571791	PASS	.	6804	0.408730	10946	88834	0.516627	.	.	.	.	.	.	rs7749390	.	4024	0.415500	-0.981	0.565	0.569	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	137540519	137540520	6q23.3	0	nullSample	.	A	ref	A	GC.CT	homo-ref	.	.	.	0	.	.	107470	C	209950(MK);600263(SK);607948(SK);610424(SK);615978(MK)	AR	Mycobacterial infection, atypical, familial disseminated; BCG infection, generalized familial 	AD/AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	10192386|9389728|8960475|8960473	.	3459	IFNGR1	5U1E	EX1	.	.	no-change	NM_000416.2	NP_000407.1	-	Y	c.-56T=	.	.	.	NM_000416.2(IFNGR1): c.-56T=	;maf-5-some-pop,maf-5-all-pops	5008	0.497604	U	0.5873	0.502396	4566	0.575558	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2234711	.	.	.	-0.733	-0.131	-0.134	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	137540519	137540520	6q23.3	0	normal	.	A	snv	G	GC.CT	hom-alt	155	1.00	.	0	.	PASS	107470	C	209950(MK);600263(SK);607948(SK);610424(SK);615978(MK)	AR	Mycobacterial infection, atypical, familial disseminated; BCG infection, generalized familial 	AD/AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	10192386|9389728|8960475|8960473	.	3459	IFNGR1	5U1E	EX1	.	.	utr-5	NM_000416.2	NP_000407.1	-	Y	c.-56T>C	.	.	.	NM_000416.2(IFNGR1): c.-56T>C	;maf-5-some-pop,maf-5-all-pops	5008	0.502396	U	0.5873	0.502396	4566	0.424442	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2234711	.	.	.	-0.733	-0.131	-0.134	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	355565	criteria_provided,_single_submitter	Benign	Benign
6	138195961	138195964	6q23.3	0	nullSample	.	CTC	ref	CTC	TT.CT	homo-ref	.	.	.	0	.	.	191163	P	.	NN	.	.	.	.	.	.	.	7128	TNFAIP3	IC1	IVS2	.	.	no-change	NM_006290.3	NP_006281.1	+	Y	c.296-20_296-18=	.	.	.	NM_006290.3(TNFAIP3): c.296-20_296-18=	MixedObserved;maf-5-some-pop,maf-5-all-pops	125226	0.392522	U	.	.	12518	0.517495	.	.	.	.	.	.	.	.	.	.	.	.	.	rs71670547	.	4033	0.146700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	138195961	138195964	6q23.3	1	normal	.	CTC	del	.	TT.CT	hom-alt	348	1.00	.	0	.	PASS	191163	P	.	NN	.	.	.	.	.	.	.	7128	TNFAIP3	IC1	IVS2	.	.	intron	NM_006290.3	NP_006281.1	+	Y	c.296-20_296-18delCTC	.	.	.	NM_006290.3(TNFAIP3): c.296-20_296-18delCTC	MixedObserved;maf-5-some-pop,maf-5-all-pops	125226	0.607478	U	0.8482	0.533946	12518	0.482505	PASS	3069	8596	0.846208	23626	120218	0.610541	6201	14502	8.52557e-01	47851	148396	6.15991e-01	rs71670547	.	4033	0.851100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	138197330	138197331	6q23.3	0	nullSample	.	A	ref	A	CT.TA	homo-ref	.	.	.	0	.	.	191163	P	.	NN	.	.	.	.	.	.	.	7128	TNFAIP3	IC4	IVS5	.	.	no-change	NM_006290.3	NP_006281.1	+	Y	c.805+28A=	.	.	.	NM_006290.3(TNFAIP3): c.805+28A=	;maf-5-some-pop,genotype-conflict	125784	0.390797	U	0.8492	0.533546	13006	0.515993	PASS	-559	8646	0.151284	10422	120776	0.387660	.	.	.	.	.	.	rs661561	.	4024	0.143600	-2.300	-1.850	-1.822	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	138197330	138197331	6q23.3	0	normal	.	A	snv	C	CT.TA	hom-alt	422	1.00	.	0	.	PASS	191163	P	.	NN	.	.	.	.	.	.	.	7128	TNFAIP3	IC4	IVS5	.	.	intron	NM_006290.3	NP_006281.1	+	Y	c.805+28A>C	.	.	.	NM_006290.3(TNFAIP3): c.805+28A>C	;maf-5-some-pop,genotype-conflict	125784	0.609203	U	0.8492	0.533546	13006	0.484007	PASS	3110	8646	0.848716	23990	120776	0.612340	6139	14334	8.54435e-01	47404	146058	6.20573e-01	rs661561	.	4024	0.856400	-2.300	-1.850	-1.822	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	152129076	152129077	6q25.1	0	normal	.	T	ref	T	TC.GG	het-alt	223	0.52	.	1	.	PASS	133430	C	114480(SA);133430(SK);157300(SK);608446(SK);615363(MK)	AD	Estrogen resistance	AR	.	Endocrine	General	23841731|18505767|9396482|8961262|8090165	.	2099	ESR1	C1	EX3	.	.	no-change	NM_001122742.1	NP_001116214.1	+	Y	c.30T=	.	.	.	NM_001122742.1(ESR1): c.30T=	SingleClassTriAllelic;maf-5-some-pop	124498	0.534563	U	0.378	0.466454	13006	0.521144	PASS	-1002	8538	0.636683	17072	119490	0.534605	.	.	.	.	.	.	rs2077647	.	4024	0.604900	-1.096	-1.304	-1.276	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	152129076	152129077	6q25.1	1	normal	.	T	snv	C	TC.GG	het-ref	207	0.48	.	2	.	PASS	133430	C	114480(SA);133430(SK);157300(SK);608446(SK);615363(MK)	AD	Estrogen resistance	AR	.	Endocrine	General	23841731|18505767|9396482|8961262|8090165	.	2099	ESR1	C1	EX3	.	.	coding-synon	NM_001122742.1	NP_001116214.1	+	Y	c.30T>C	p.(S10=) | p.(Ser10=)	TCT=>TCC	.	NM_001122742.1(ESR1): c.30T>C (p.(S10=))	SingleClassTriAllelic;maf-5-some-pop	124498	0.465421	U	0.378	0.466454	13006	0.478856	PASS	549	8538	0.363317	12936	119490	0.465378	1130	6239	3.63282e-01	25995	111995	4.62106e-01	rs2077647	.	4024	0.395100	-1.096	-1.304	-1.276	.	.	.	.	.	ENST00000440973: c.30T>C (p.S10S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3761554	.	.	.	.	.	.	.	.	.	Likely Benign
6	152163334	152163335	6q25.1	0	normal	.	T	snv	C	GC.GT	het-ref	135	0.44	.	2	.	PASS	133430	C	114480(SA);133430(SK);157300(SK);608446(SK);615363(MK)	AD	Estrogen resistance	AR	.	Endocrine	General	23841731|18505767|9396482|8961262|8090165	.	2099	ESR1	IC1	IVS3	.	.	intron	NM_001122742.1	NP_001116214.1	+	Y	c.453-397T>C	.	.	.	NM_001122742.1(ESR1): c.453-397T>C	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia	5008	0.446286	U	0.3998	0.446286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2234693	.	4024	0.409000	-1.073	0.554	0.120	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	152163334	152163335	6q25.1	0	normal	.	T	ref	T	GC.GT	het-alt	169	0.56	.	1	.	PASS	133430	C	114480(SA);133430(SK);157300(SK);608446(SK);615363(MK)	AD	Estrogen resistance	AR	.	Endocrine	General	23841731|18505767|9396482|8961262|8090165	.	2099	ESR1	IC1	IVS3	.	.	no-change	NM_001122742.1	NP_001116214.1	+	Y	c.453-397T=	.	.	.	NM_001122742.1(ESR1): c.453-397T=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia	5008	0.553714	U	0.3998	0.446286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2234693	.	4024	0.591000	-1.073	0.554	0.120	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	152201874	152201875	6q25.1	0	normal	.	T	snv	C	CG.AA	hom-alt	299	1.00	.	0	.	PASS	133430	C	114480(SA);133430(SK);157300(SK);608446(SK);615363(MK)	AD	Estrogen resistance	AR	.	Endocrine	General	23841731|18505767|9396482|8961262|8090165	.	2099	ESR1	C3	EX5	.	.	no-change	NM_001122742.1	NP_001116214.1	+	Y	c.729C=	.	.	.	NM_001122742.1(ESR1): c.729C=	SingleClassTriAllelic,InconsistentAlleles;	126386	0.971286	U	1	0.985623	13006	0.970783	PASS	4321	8648	0.999653	57200	121378	0.970695	8617	17238	9.99768e-01	115825	238757	9.69910e-01	rs4986934	.	.	.	-0.119	-0.073	0.222	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	152201874	152201875	6q25.1	1	nullSample	.	T	ref	T	CG.AA	homo-ref	.	.	.	0	.	.	133430	C	114480(SA);133430(SK);157300(SK);608446(SK);615363(MK)	AD	Estrogen resistance	AR	.	Endocrine	General	23841731|18505767|9396482|8961262|8090165	.	2099	ESR1	C3	EX5	.	.	coding-synon	NM_001122742.1	NP_001116214.1	+	Y	c.729C>T	p.(R243=) | p.(Arg243=)	CGC=>CGT	.	NM_001122742.1(ESR1): c.729C>T (p.(R243=))	SingleClassTriAllelic,InconsistentAlleles;	126386	0.028714	U	1	0.985623	13006	0.029217	PASS	.	8648	0.000347	68	121378	0.029305	.	.	.	.	.	.	rs4986934	.	.	.	-0.119	-0.073	0.222	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	152265281	152265282	6q25.1	0	normal	.	A	ref	A	TA.TT	het-alt	127	0.50	.	1	.	PASS	133430	C	114480(SA);133430(SK);157300(SK);608446(SK);615363(MK)	AD	Estrogen resistance	AR	.	Endocrine	General	23841731|18505767|9396482|8961262|8090165	.	2099	ESR1	IC3	IVS5	.	.	no-change	NM_001122742.1	NP_001116214.1	+	Y	c.761-26A=	.	.	.	NM_001122742.1(ESR1): c.761-26A=	MixedObserved;	0	0	U	0.2927	0.384585	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs764597452	.	.	.	-0.327	-0.294	-0.363	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	152265282	152265282	6q25.1	0	normal	.	.	ins	T	AA.TT	het-ref	125	0.50	.	2	.	PASS	133430	C	114480(SA);133430(SK);157300(SK);608446(SK);615363(MK)	AD	Estrogen resistance	AR	.	Endocrine	General	23841731|18505767|9396482|8961262|8090165	.	2099	ESR1	IC3	IVS5	.	.	intron	NM_001122742.1	NP_001116214.1	+	Y	c.761-26_761-25insT	.	.	.	NM_001122742.1(ESR1): c.761-26_761-25insT	MixedObserved;maf-5-some-pop,maf-5-all-pops	116271	0.417017	U	0.2927	0.384585	.	.	PASS	387	7886	0.327796	19482	111360	0.580810	.	.	.	.	.	.	rs55740371	.	4024	0.324300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	152265521	152265522	6q25.1	1	nullSample	.	G	ref	G	CC.AT	homo-ref	.	.	.	0	.	.	133430	C	114480(SA);133430(SK);157300(SK);608446(SK);615363(MK)	AD	Estrogen resistance	AR	.	Endocrine	General	23841731|18505767|9396482|8961262|8090165	.	2099	ESR1	C4	EX6	.	.	coding-synon	NM_001122742.1	NP_001116214.1	+	Y	c.975C>G	p.(P325=) | p.(Pro325=)	CCC=>CCG	.	NM_001122742.1(ESR1): c.975C>G (p.(P325=))	;maf-5-some-pop	126364	0.264537	U	0.498	0.717652	13006	0.185607	PASS	-1075	8618	0.489905	4971	121356	0.263802	.	.	.	.	.	.	rs1801132	.	.	.	-1.737	-1.355	-0.415	.	.	.	.	.	.	.	.	.	.	CM016108	NM_000125.3(ESR1): c.975C>G (p.P325P)	"Lower femoral neck BMD, association with"	11530279	DP	.	.	.	.	Likely Benign
6	152265521	152265522	6q25.1	0	normal	.	G	snv	C	CC.AT	hom-alt	582	1.00	.	0	.	PASS	133430	C	114480(SA);133430(SK);157300(SK);608446(SK);615363(MK)	AD	Estrogen resistance	AR	.	Endocrine	General	23841731|18505767|9396482|8961262|8090165	.	2099	ESR1	C4	EX6	.	.	no-change	NM_001122742.1	NP_001116214.1	+	Y	c.975C=	.	.	.	NM_001122742.1(ESR1): c.975C=	;maf-5-some-pop	126364	0.735463	U	0.498	0.717652	13006	0.814393	PASS	1123	8618	0.510095	33635	121356	0.736198	2277	8818	5.11604e-01	66934	179736	7.30296e-01	rs1801132	.	.	.	-1.737	-1.355	-0.415	.	.	.	.	.	ENST00000440973: c.975G>C (p.P325P)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4003740	.	.	.	.	.	.	.	.	.	Benign
6	152420094	152420095	6q25.1	0	normal	.	G	ref	G	AC.GT	het-alt	198	0.53	.	1	.	PASS	133430	C	114480(SA);133430(SK);157300(SK);608446(SK);615363(MK)	AD	Estrogen resistance	AR	.	Endocrine	General	23841731|18505767|9396482|8961262|8090165	.	2099	ESR1	C8E	EX10E	.	.	no-change	NM_001122742.1	NP_001116214.1	+	Y	c.1782G=	.	.	.	NM_001122742.1(ESR1): c.1782G=	;maf-5-some-pop,genotype-conflict	124824	0.810742	U	0.2014	0.188698	13006	0.828002	PASS	-702	8546	0.788439	39465	119816	0.810718	.	.	.	.	.	.	rs2228480	.	4024	0.770600	-0.269	-1.214	-3.007	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	152420094	152420095	6q25.1	1	normal	.	G	snv	A	AC.GT	het-ref	177	0.47	.	2	.	PASS	133430	C	114480(SA);133430(SK);157300(SK);608446(SK);615363(MK)	AD	Estrogen resistance	AR	.	Endocrine	General	23841731|18505767|9396482|8961262|8090165	.	2099	ESR1	C8E	EX10E	.	.	coding-synon	NM_001122742.1	NP_001116214.1	+	Y	c.1782G>A	p.(T594=) | p.(Thr594=)	ACG=>ACA	.	NM_001122742.1(ESR1): c.1782G>A (p.(T594=))	;maf-5-some-pop,genotype-conflict	124824	0.189258	U	0.2014	0.188698	13006	0.171998	PASS	202	8546	0.211561	2236	119816	0.189282	418	3775	2.19349e-01	4843	47531	1.93849e-01	rs2228480	.	4024	0.229400	-0.269	-1.214	-3.007	.	.	.	.	.	ENST00000440973: c.1782G>A (p.T594T)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3761556	.	.	.	.	.	.	.	.	.	Likely Benign
6	152716745	152716746	6q25.2	0	normal	.	A	ref	A	GT.TT	het-alt	218	0.56	.	1	.	PASS	608441	C	610743(MK);612998(MK)	NN	Emery-Dreifuss muscular dystrophy 4, autosomal dominant; Spinocerebellar ataxia, autosomal recessive 8	AD/AR	.	Cardiovascular; Musculoskeletal	Cardiovascular	20301609|20301553|19542096|17761684|17503513|17159980	.	23345	SYNE1	C50	EX51	.	.	no-change	NM_033071.3	NP_149062.1	-	Y	c.7638T=	.	.	.	NM_033071.3(SYNE1): c.7638T=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.533	-0.038	-0.489	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	152716745	152716746	6q25.2	0	normal	.	A	ref	A	GT.TT	het-alt	218	0.56	.	1	.	PASS	608441	C	610743(MK);612998(MK)	NN	Emery-Dreifuss muscular dystrophy 4, autosomal dominant; Spinocerebellar ataxia, autosomal recessive 8	AD/AR	.	Cardiovascular; Musculoskeletal	Cardiovascular	20301609|20301553|19542096|17761684|17503513|17159980	.	23345	SYNE1	C49	EX51	.	.	no-change	NM_182961.3	NP_892006.3	-	N	c.7617T=	.	.	.	NM_182961.3(SYNE1): c.7617T=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.533	-0.038	-0.489	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	152716745	152716746	6q25.2	1	normal	.	A	snv	G	GT.TT	het-ref	171	0.44	.	2	.	PASS	608441	C	610743(MK);612998(MK)	NN	Emery-Dreifuss muscular dystrophy 4, autosomal dominant; Spinocerebellar ataxia, autosomal recessive 8	AD/AR	.	Cardiovascular; Musculoskeletal	Cardiovascular	20301609|20301553|19542096|17761684|17503513|17159980	.	23345	SYNE1	C50	EX51	.	.	coding-synon	NM_033071.3	NP_149062.1	-	Y	c.7638T>C	p.(N2546=) | p.(Asn2546=)	AAT=>AAC	.	NM_033071.3(SYNE1): c.7638T>C (p.(N2546=))	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.533	-0.038	-0.489	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
6	152716745	152716746	6q25.2	1	normal	.	A	snv	G	GT.TT	het-ref	171	0.44	.	2	.	PASS	608441	C	610743(MK);612998(MK)	NN	Emery-Dreifuss muscular dystrophy 4, autosomal dominant; Spinocerebellar ataxia, autosomal recessive 8	AD/AR	.	Cardiovascular; Musculoskeletal	Cardiovascular	20301609|20301553|19542096|17761684|17503513|17159980	.	23345	SYNE1	C49	EX51	.	.	coding-synon	NM_182961.3	NP_892006.3	-	N	c.7617T>C	p.(N2539=) | p.(Asn2539=)	AAT=>AAC	.	NM_182961.3(SYNE1): c.7617T>C (p.(N2539=))	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.533	-0.038	-0.489	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
6	157405760	157405761	6q25.3	0	normal	.	G	ref	G	AC.TG	het-alt	223	0.55	.	1	.	PASS	614556	C	614562(MK)	NN	Mental retardation, autosomal dominant, 12; Coffin-Siris syndrome	AD	.	Craniofacial; Dermatologic; Musculoskeletal; Neurologic	General	22426309|22426308|22405089	.	57492	ARID1B	IC5	IVS5	.	.	no-change	NM_020732.3	NP_065783.3	+	Y	c.2038-35G=	.	.	.	NM_020732.3(ARID1B): c.2038-35G=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	124666	0.478085	U	0.5903	0.502396	13006	0.529294	PASS	.	8536	0.426078	14018	119658	0.477269	.	.	.	.	.	.	rs3734440	.	4024	0.457300	-1.314	-0.760	-0.826	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	157405760	157405761	6q25.3	0	normal	.	G	snv	A	AC.TG	het-ref	183	0.45	.	2	.	PASS	614556	C	614562(MK)	NN	Mental retardation, autosomal dominant, 12; Coffin-Siris syndrome	AD	.	Craniofacial; Dermatologic; Musculoskeletal; Neurologic	General	22426309|22426308|22405089	.	57492	ARID1B	IC5	IVS5	.	.	intron	NM_020732.3	NP_065783.3	+	Y	c.2038-35G>A	.	.	.	NM_020732.3(ARID1B): c.2038-35G>A	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	124666	0.521915	U	0.5903	0.502396	13006	0.470706	PASS	1390	8536	0.573922	16738	119658	0.522731	2781	9716	5.70992e-01	33444	124600	5.24146e-01	rs3734440	.	4024	0.542700	-1.314	-0.760	-0.826	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	126319	no_assertion_criteria_provided	Likely_benign	Benign
6	157405929	157405930	6q25.3	0	normal	.	G	ref	G	GC.TC	het-alt	327	0.50	.	1	.	PASS	614556	C	614562(MK)	NN	Mental retardation, autosomal dominant, 12; Coffin-Siris syndrome	AD	.	Craniofacial; Dermatologic; Musculoskeletal; Neurologic	General	22426309|22426308|22405089	.	57492	ARID1B	C6	EX6	.	.	no-change	NM_020732.3	NP_065783.3	+	Y	c.2172G=	.	.	.	NM_020732.3(ARID1B): c.2172G=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126358	0.481901	U	0.5734	0.495208	13006	0.527372	PASS	-1080	8632	0.445783	14467	121350	0.480956	.	.	.	.	.	.	rs3734441	.	4024	0.475400	-0.808	-2.570	-3.111	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	157405929	157405930	6q25.3	1	normal	.	G	snv	A	GC.TC	het-ref	327	0.50	.	2	.	PASS	614556	C	614562(MK)	NN	Mental retardation, autosomal dominant, 12; Coffin-Siris syndrome	AD	.	Craniofacial; Dermatologic; Musculoskeletal; Neurologic	General	22426309|22426308|22405089	.	57492	ARID1B	C6	EX6	.	.	coding-synon	NM_020732.3	NP_065783.3	+	Y	c.2172G>A	p.(A724=) | p.(Ala724=)	GCG=>GCA	.	NM_020732.3(ARID1B): c.2172G>A (p.(A724=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126358	0.518099	U	0.5734	0.495208	13006	0.472628	PASS	1312	8632	0.554217	16778	121350	0.519044	2612	9461	5.48846e-01	34393	128607	5.22746e-01	rs3734441	.	4024	0.524600	-0.808	-2.570	-3.111	.	.	.	.	.	ENST00000346085: c.2172G>A (p.A724A)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1487405	.	.	.	.	.	no_record	126320	criteria_provided,_single_submitter	Benign	Likely Benign
6	160670281	160670282	6q25.3	0	nullSample	.	A	ref	A	AG.AA	homo-ref	.	.	.	0	.	.	602608	P	.	NN	.	.	.	.	.	.	.	6582	SLC22A2	C4	EX4	Sugar (and other) transporter;Major Facilitator Superfamily	PF00083.19;PF07690.11	no-change	NM_003058.3	NP_003049.2	-	Y	c.808T=	.	.	.	NM_003058.3(SLC22A2): c.808T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126394	0.107901	U	0.8641	0.86262	13006	0.120867	PASS	-475	8650	0.123699	779	121386	0.106684	.	.	.	.	.	.	rs316019	.	4024	0.126700	-2.734	0.184	-0.415	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	160670281	160670282	6q25.3	1	normal	.	A	snv	C	AG.AA	hom-alt	395	1.00	.	0	.	PASS	602608	P	.	NN	.	.	.	.	.	.	.	6582	SLC22A2	C4	EX4	Sugar (and other) transporter;Major Facilitator Superfamily	PF00083.19;PF07690.11	missense	NM_003058.3	NP_003049.2	-	Y	c.808T>G	p.S270A | p.Ser270Ala	TCT=>GCT	P0=>NP	NM_003058.3(SLC22A2): c.808T>G (p.S270A)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126394	0.892099	U	0.8641	0.86262	13006	0.879133	PASS	3315	8650	0.876301	48522	121386	0.893316	6425	14716	8.72732e-01	96928	215240	8.98916e-01	rs316019	.	4024	0.873300	-2.734	0.184	-0.415	0.01	0.394	0.267	0.532	deleterious	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	161990482	161990483	6q26	0	normal	.	C	ref	C	CA.TT	het-alt	131	0.48	.	1	.	PASS	602544	C	167000(MK);211980(MK);600116(MK);607572(SK)	AD;AR	Parkinson disease 2, autosomal recessive juvenile	AR	.	Neurologic	General	20876472|20837857|20558392|20182943|17187375|16328510|16130111|15642918|15266615|12891670|12730996|12629236|12056932|11552035|11487568|10894217|9560156	.	5071	PARK2	IC7	IVS7	.	.	no-change	NM_004562.2	NP_004553.2	-	Y	c.872-35G=	.	.	.	NM_004562.2(PARK2): c.872-35G=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125464	0.445969	U	0.7083	0.578075	13006	0.454252	PASS	.	8548	0.300772	12319	120456	0.446968	.	.	.	.	.	.	rs3765474	.	.	.	-0.268	-0.340	-0.141	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	161990482	161990483	6q26	0	normal	.	C	snv	T	CA.TT	het-ref	142	0.52	.	2	.	PASS	602544	C	167000(MK);211980(MK);600116(MK);607572(SK)	AD;AR	Parkinson disease 2, autosomal recessive juvenile	AR	.	Neurologic	General	20876472|20837857|20558392|20182943|17187375|16328510|16130111|15642918|15266615|12891670|12730996|12629236|12056932|11552035|11487568|10894217|9560156	.	5071	PARK2	IC7	IVS7	.	.	intron	NM_004562.2	NP_004553.2	-	Y	c.872-35G>A	.	.	.	NM_004562.2(PARK2): c.872-35G>A	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125464	0.554031	U	0.7083	0.578075	13006	0.545748	PASS	2095	8548	0.699228	18707	120456	0.553032	4187	11957	6.95417e-01	37499	134347	5.48297e-01	rs3765474	.	.	.	-0.268	-0.340	-0.141	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	161990515	161990516	6q26	0	normal	.	G	ref	G	CA.AG	het-alt	106	0.49	.	1	.	PASS	602544	C	167000(MK);211980(MK);600116(MK);607572(SK)	AD;AR	Parkinson disease 2, autosomal recessive juvenile	AR	.	Neurologic	General	20876472|20837857|20558392|20182943|17187375|16328510|16130111|15642918|15266615|12891670|12730996|12629236|12056932|11552035|11487568|10894217|9560156	.	5071	PARK2	IC7	IVS7	.	.	no-change	NM_004562.2	NP_004553.2	-	Y	c.872-68C=	.	.	.	NM_004562.2(PARK2): c.872-68C=	;maf-5-some-pop,genotype-conflict	5008	0.310503	U	0.7113	0.689497	4566	0.327201	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3765475	.	.	.	-0.132	0.282	0.329	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	161990515	161990516	6q26	0	normal	.	G	snv	C	CA.AG	het-ref	110	0.51	.	2	.	PASS	602544	C	167000(MK);211980(MK);600116(MK);607572(SK)	AD;AR	Parkinson disease 2, autosomal recessive juvenile	AR	.	Neurologic	General	20876472|20837857|20558392|20182943|17187375|16328510|16130111|15642918|15266615|12891670|12730996|12629236|12056932|11552035|11487568|10894217|9560156	.	5071	PARK2	IC7	IVS7	.	.	intron	NM_004562.2	NP_004553.2	-	Y	c.872-68C>G	.	.	.	NM_004562.2(PARK2): c.872-68C>G	;maf-5-some-pop,genotype-conflict	5008	0.689497	U	0.7113	0.689497	4566	0.672799	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3765475	.	.	.	-0.132	0.282	0.329	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	162622196	162622197	6q26	0	normal	.	C	ref	C	TG.TG	het-alt	283	0.51	.	1	.	PASS	602544	C	167000(MK);211980(MK);600116(MK);607572(SK)	AD;AR	Parkinson disease 2, autosomal recessive juvenile	AR	.	Neurologic	General	20876472|20837857|20558392|20182943|17187375|16328510|16130111|15642918|15266615|12891670|12730996|12629236|12056932|11552035|11487568|10894217|9560156	.	5071	PARK2	C4	EX4	.	.	no-change	NM_004562.2	NP_004553.2	-	Y	c.500G=	.	.	.	NM_004562.2(PARK2): c.500G=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	126396	0.930441	U	0.3393	0.117412	13006	0.960787	PASS	-993	8630	0.600463	53442	121388	0.932415	.	.	.	.	.	.	rs1801474	.	.	.	-0.152	1.216	0.769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	162622196	162622197	6q26	1	normal	.	C	snv	T	TG.TG	het-ref	274	0.49	.	2	.	PASS	602544	C	167000(MK);211980(MK);600116(MK);607572(SK)	AD;AR	Parkinson disease 2, autosomal recessive juvenile	AR	.	Neurologic	General	20876472|20837857|20558392|20182943|17187375|16328510|16130111|15642918|15266615|12891670|12730996|12629236|12056932|11552035|11487568|10894217|9560156	.	5071	PARK2	C4	EX4	.	.	missense	NM_004562.2	NP_004553.2	-	Y	c.500G>A	p.S167N | p.Ser167Asn	AGC=>AAC	P0=>P0	NM_004562.2(PARK2): c.500G>A (p.S167N)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	126396	0.069559	U	0.3393	0.117412	13006	0.039213	PASS	731	8630	0.399537	952	121388	0.067585	1370	6758	3.91814e-01	1882	17204	6.99338e-02	rs1801474	.	.	.	-0.152	1.216	0.769	0.41	0.012	0.004	0.015	neutral	ENST00000366898: c.500G>A (p.S167N)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3761635	CM992652	NM_004562.2(PARK2): c.500G>A (p.S167N)	"Parkinson disease, in heterozygosity, association"	10511432	DP	no_record	41223	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
6	162622303	162622304	6q26	0	normal	.	A	snv	G	GA.GA	hom-alt	424	1.00	.	0	.	PASS	602544	C	167000(MK);211980(MK);600116(MK);607572(SK)	AD;AR	Parkinson disease 2, autosomal recessive juvenile	AR	.	Neurologic	General	20876472|20837857|20558392|20182943|17187375|16328510|16130111|15642918|15266615|12891670|12730996|12629236|12056932|11552035|11487568|10894217|9560156	.	5071	PARK2	IC3	IVS3	.	.	intron	NM_004562.2	NP_004553.2	-	Y	c.413-20T>C	.	.	.	NM_004562.2(PARK2): c.413-20T>C	;maf-5-some-pop	126364	0.933612	U	0.9881	0.950479	13006	0.940335	PASS	4236	8652	0.989367	52883	121356	0.932916	8417	17038	9.87939e-01	107265	229436	9.33874e-01	rs4709583	.	.	.	-1.591	0.101	-0.126	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	259433	criteria_provided,_single_submitter	Benign	Benign
6	162622303	162622304	6q26	0	nullSample	.	A	ref	A	GA.GA	homo-ref	.	.	.	0	.	.	602544	C	167000(MK);211980(MK);600116(MK);607572(SK)	AD;AR	Parkinson disease 2, autosomal recessive juvenile	AR	.	Neurologic	General	20876472|20837857|20558392|20182943|17187375|16328510|16130111|15642918|15266615|12891670|12730996|12629236|12056932|11552035|11487568|10894217|9560156	.	5071	PARK2	IC3	IVS3	.	.	no-change	NM_004562.2	NP_004553.2	-	Y	c.413-20T=	.	.	.	NM_004562.2(PARK2): c.413-20T=	;maf-5-some-pop	126364	0.066388	U	0.9881	0.950479	13006	0.059665	PASS	-44	8652	0.010633	346	121356	0.067084	.	.	.	.	.	.	rs4709583	.	.	.	-1.591	0.101	-0.126	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	162683814	162683816	6q26	0	normal	.	AA	ref	AA	GT.aa	het-alt	54	0.56	.	1	(A)n|Simple_repeat|Simple_repeat|+|26	PASS	602544	C	167000(MK);211980(MK);600116(MK);607572(SK)	AD;AR	Parkinson disease 2, autosomal recessive juvenile	AR	.	Neurologic	General	20876472|20837857|20558392|20182943|17187375|16328510|16130111|15642918|15266615|12891670|12730996|12629236|12056932|11552035|11487568|10894217|9560156	.	5071	PARK2	IC2	IVS2	.	.	no-change	NM_004562.2	NP_004553.2	-	Y	c.172-19_172-18=	.	.	.	NM_004562.2(PARK2): c.172-19_172-18=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs776185117	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
6	162683814	162683816	6q26	1	normal	.	AA	del	.	GT.aa	het-ref	42	0.44	.	2	(A)n|Simple_repeat|Simple_repeat|+|26	PASS	602544	C	167000(MK);211980(MK);600116(MK);607572(SK)	AD;AR	Parkinson disease 2, autosomal recessive juvenile	AR	.	Neurologic	General	20876472|20837857|20558392|20182943|17187375|16328510|16130111|15642918|15266615|12891670|12730996|12629236|12056932|11552035|11487568|10894217|9560156	.	5071	PARK2	IC2	IVS2	.	.	intron	NM_004562.2	NP_004553.2	-	Y	c.172-19_172-18delTT	.	.	.	NM_004562.2(PARK2): c.172-19_172-18delTT	MixedObserved;	0	0	U	.	.	.	.	PASS	0	1058	0.096408	1	19070	0.121342	.	.	.	.	.	.	rs776185117	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	162683875	162683876	6q26	0	normal	.	C	ref	C	TG.CC	het-alt	109	0.47	.	1	.	PASS	602544	C	167000(MK);211980(MK);600116(MK);607572(SK)	AD;AR	Parkinson disease 2, autosomal recessive juvenile	AR	.	Neurologic	General	20876472|20837857|20558392|20182943|17187375|16328510|16130111|15642918|15266615|12891670|12730996|12629236|12056932|11552035|11487568|10894217|9560156	.	5071	PARK2	IC2	IVS2	.	.	no-change	NM_004562.2	NP_004553.2	-	Y	c.172-79G=	.	.	.	NM_004562.2(PARK2): c.172-79G=	;maf-5-some-pop,maf-5-all-pops	5008	0.508586	U	0.379	0.491414	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7744798	.	.	.	-0.361	-0.032	-0.345	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
6	162683875	162683876	6q26	0	normal	.	C	snv	T	TG.CC	het-ref	124	0.53	.	2	.	PASS	602544	C	167000(MK);211980(MK);600116(MK);607572(SK)	AD;AR	Parkinson disease 2, autosomal recessive juvenile	AR	.	Neurologic	General	20876472|20837857|20558392|20182943|17187375|16328510|16130111|15642918|15266615|12891670|12730996|12629236|12056932|11552035|11487568|10894217|9560156	.	5071	PARK2	IC2	IVS2	.	.	intron	NM_004562.2	NP_004553.2	-	Y	c.172-79G>A	.	.	.	NM_004562.2(PARK2): c.172-79G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.491414	U	0.379	0.491414	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7744798	.	.	.	-0.361	-0.032	-0.345	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	2946460	2946461	7p22.2	0	normal	.	T	ref	T	GG.CG	het-alt	218	0.54	.	1	.	PASS	607210	P	606445(MK);615206(MK)	NN	Congenital B cell lymphocytosis; Immunodeficiency 11	AD/AR	.	Allergy/Immunology/Infectious; Oncologic	Allergy/Immunology/Infectious; Oncologic	23561803|23374270	.	84433	CARD11	C24E	EX25E	.	.	no-change	NM_032415.4	NP_115791.3	-	Y	c.3276A=	.	.	.	NM_032415.4(CARD11): c.3276A=	;maf-5-some-pop,maf-5-all-pops	122026	0.480406	U	0.6508	0.596446	13006	0.453406	PASS	.	8486	0.352699	13750	117018	0.483695	.	.	.	.	.	.	rs1124581	.	4024	0.377700	-1.183	0.454	0.161	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	2946460	2946461	7p22.2	1	normal	.	T	snv	C	GG.CG	het-ref	184	0.46	.	2	.	PASS	607210	P	606445(MK);615206(MK)	NN	Congenital B cell lymphocytosis; Immunodeficiency 11	AD/AR	.	Allergy/Immunology/Infectious; Oncologic	Allergy/Immunology/Infectious; Oncologic	23561803|23374270	.	84433	CARD11	C24E	EX25E	.	.	coding-synon	NM_032415.4	NP_115791.3	-	Y	c.3276A>G	p.(R1092=) | p.(Arg1092=)	CGA=>CGG	.	NM_032415.4(CARD11): c.3276A>G (p.(R1092=))	;maf-5-some-pop,maf-5-all-pops	122026	0.519594	U	0.6508	0.596446	13006	0.546594	PASS	1760	8486	0.647301	15658	117018	0.516305	3525	11034	6.43757e-01	31951	123594	5.08982e-01	rs1124581	.	4024	0.622300	-1.183	0.454	0.161	.	.	.	.	.	ENST00000396946: c.3276A>G (p.R1092R)	large_intestine [colon|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3762618	.	.	.	.	.	no_record	402477	criteria_provided,_single_submitter	Benign	Likely Benign
7	2954800	2954801	7p22.2	0	nullSample	.	T	ref	T	CC.CC	homo-ref	.	.	.	0	.	.	607210	P	606445(MK);615206(MK)	NN	Congenital B cell lymphocytosis; Immunodeficiency 11	AD/AR	.	Allergy/Immunology/Infectious; Oncologic	Allergy/Immunology/Infectious; Oncologic	23561803|23374270	.	84433	CARD11	IC20	IVS21	.	.	no-change	NM_032415.4	NP_115791.3	-	Y	c.2839+70A=	.	.	.	NM_032415.4(CARD11): c.2839+70A=	;	5008	0.001597	U	1	0.998403	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1182157	.	.	.	-1.929	-4.104	-4.226	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	2954800	2954801	7p22.2	0	normal	.	T	snv	C	CC.CC	hom-alt	304	1.00	.	0	.	PASS	607210	P	606445(MK);615206(MK)	NN	Congenital B cell lymphocytosis; Immunodeficiency 11	AD/AR	.	Allergy/Immunology/Infectious; Oncologic	Allergy/Immunology/Infectious; Oncologic	23561803|23374270	.	84433	CARD11	IC20	IVS21	.	.	intron	NM_032415.4	NP_115791.3	-	Y	c.2839+70A>G	.	.	.	NM_032415.4(CARD11): c.2839+70A>G	;	5008	0.998403	U	1	0.998403	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1182157	.	.	.	-1.929	-4.104	-4.226	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	2962752	2962753	7p22.2	1	normal	.	G	snv	A	CC.CC	hom-alt	400	1.00	.	0	.	PASS	607210	P	606445(MK);615206(MK)	NN	Congenital B cell lymphocytosis; Immunodeficiency 11	AD/AR	.	Allergy/Immunology/Infectious; Oncologic	Allergy/Immunology/Infectious; Oncologic	23561803|23374270	.	84433	CARD11	IC15	IVS16	.	.	intron	NM_032415.4	NP_115791.3	-	Y	c.2142+13C>T	.	.	.	NM_032415.4(CARD11): c.2142+13C>T	;maf-5-some-pop,maf-5-all-pops	121946	0.672355	U	0.3849	0.505391	12990	0.634642	PASS	613	8422	0.395156	28093	116938	0.679505	1229	6529	3.82439e-01	57016	161338	6.78278e-01	rs2527509	.	.	.	-1.242	0.351	0.362	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	402479	criteria_provided,_single_submitter	Benign	Benign
7	2962752	2962753	7p22.2	0	nullSample	.	G	ref	G	CC.CC	homo-ref	.	.	.	0	.	.	607210	P	606445(MK);615206(MK)	NN	Congenital B cell lymphocytosis; Immunodeficiency 11	AD/AR	.	Allergy/Immunology/Infectious; Oncologic	Allergy/Immunology/Infectious; Oncologic	23561803|23374270	.	84433	CARD11	IC15	IVS16	.	.	no-change	NM_032415.4	NP_115791.3	-	Y	c.2142+13C=	.	.	.	NM_032415.4(CARD11): c.2142+13C=	;maf-5-some-pop,maf-5-all-pops	121946	0.327645	U	0.3849	0.505391	12990	0.365358	PASS	-1051	8422	0.604844	7102	116938	0.320495	.	.	.	.	.	.	rs2527509	.	.	.	-1.242	0.351	0.362	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	2985361	2985365	7p22.2	0	nullSample	.	ACAC	ref	ACAC	GG.ac	homo-ref	.	.	.	0	(CA)n|Simple_repeat|Simple_repeat|+|44;trf	.	607210	P	606445(MK);615206(MK)	NN	Congenital B cell lymphocytosis; Immunodeficiency 11	AD/AR	.	Allergy/Immunology/Infectious; Oncologic	Allergy/Immunology/Infectious; Oncologic	23561803|23374270	.	84433	CARD11	IC3	IVS4	.	.	no-change	NM_032415.4	NP_115791.3	-	Y	c.358+88_358+91=	.	.	.	NM_032415.4(CARD11): c.358+88_358+91=	MixedObserved;maf-5-some-pop	5008	0.978035	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs113659658	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
7	2985361	2985365	7p22.2	0	normal	.	ACAC	del	.	GG.ac	het-alt	15	0.29	.	1	(CA)n|Simple_repeat|Simple_repeat|+|44;trf	PASS	607210	P	606445(MK);615206(MK)	NN	Congenital B cell lymphocytosis; Immunodeficiency 11	AD/AR	.	Allergy/Immunology/Infectious; Oncologic	Allergy/Immunology/Infectious; Oncologic	23561803|23374270	.	84433	CARD11	IC3	IVS4	.	.	intron	NM_032415.4	NP_115791.3	-	Y	c.358+88_358+91delGTGT	.	.	.	NM_032415.4(CARD11): c.358+88_358+91delGTGT	MixedObserved;maf-5-some-pop	5008	0.021965	U	0.002	0.0219649	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs113659658	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
7	2985361	2985365	7p22.2	0	normal	.	ACAC	rep	AC	GG.ac	het-alt	33	0.63	.	2	(CA)n|Simple_repeat|Simple_repeat|+|44;trf	PASS	607210	P	606445(MK);615206(MK)	NN	Congenital B cell lymphocytosis; Immunodeficiency 11	AD/AR	.	Allergy/Immunology/Infectious; Oncologic	Allergy/Immunology/Infectious; Oncologic	23561803|23374270	.	84433	CARD11	IC3	IVS4	.	.	intron	NM_032415.4	NP_115791.3	-	Y	c.358+88GT[2>1] (std: c.358+88GT[1] alt: c.358+90_358+91delGT )	.	.	.	NM_032415.4(CARD11): c.358+88GT[1]	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
7	6022625	6022626	7p22.1	0	nullSample	.	C	ref	C	TG.AG	homo-ref	.	.	.	0	dup	.	600259	C	276300(MK);614337(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 4; Mismatch repair cancer syndrome 	AD/AR	.	Dermatologic; Oncologic	Oncologic	22933731|22577899|22461402|20587412|20301390|19851131|17557300|15077197|8072530|7661930|4574005	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	5395	PMS2	IC11	IVS11	.	.	no-change	NM_000535.5	NP_000526.1	-	Y	c.2007-4G=	.	.	.	NM_000535.5(PMS2): c.2007-4G=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	34370	0.844050	U	0.2778	0.16274	.	.	PASS	.	1654	0.743047	10429	29362	0.845208	.	.	.	.	.	.	rs140788589	.	4024	0.676900	0.561	0.601	-0.063	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	6022625	6022626	7p22.1	1	normal	.	C	snv	T	TG.AG	hom-alt	133	0.99	.	0	dup	DUBIOUS	600259	C	276300(MK);614337(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 4; Mismatch repair cancer syndrome 	AD/AR	.	Dermatologic; Oncologic	Oncologic	22933731|22577899|22461402|20587412|20301390|19851131|17557300|15077197|8072530|7661930|4574005	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	5395	PMS2	IC11	IVS11	.	.	intron	NM_000535.5	NP_000526.1	-	Y	c.2007-4G>A	.	.	.	NM_000535.5(PMS2): c.2007-4G>A	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	34370	0.155950	U	0.2778	0.16274	.	.	PASS	44	1654	0.256953	293	29362	0.154792	434	3080	2.86992e-01	1952	24029	1.60084e-01	rs140788589	.	4024	0.323100	0.561	0.601	-0.063	.	.	.	.	.	ENST00000265849: c.2007-4G>A (p.?)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	5020045	.	.	.	.	.	no_record	91327	reviewed_by_expert_panel	Benign	Benign
7	6026774	6026775	7p22.1	1	nullSample	.	T	ref	T	TT.AG	homo-ref	.	.	.	0	dup	.	600259	C	276300(MK);614337(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 4; Mismatch repair cancer syndrome 	AD/AR	.	Dermatologic; Oncologic	Oncologic	22933731|22577899|22461402|20587412|20301390|19851131|17557300|15077197|8072530|7661930|4574005	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	5395	PMS2	C11	EX11	.	.	missense	NM_000535.5	NP_000526.1	-	Y	c.1621G>A	p.E541K | p.Glu541Lys	GAA=>AAA	P-=>P+	NM_000535.5(PMS2): c.1621G>A (p.E541K)	;maf-5-some-pop	125594	0.147340	U	0.878	0.883187	13000	0.129615	PASS	.	8650	0.076185	1682	120586	0.148608	.	.	.	.	.	.	rs2228006	.	.	.	-0.124	2.038	0.737	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
7	6026774	6026775	7p22.1	0	normal	.	T	snv	C	TT.AG	hom-alt	463	1.00	.	0	dup	PASS	600259	C	276300(MK);614337(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 4; Mismatch repair cancer syndrome 	AD/AR	.	Dermatologic; Oncologic	Oncologic	22933731|22577899|22461402|20587412|20301390|19851131|17557300|15077197|8072530|7661930|4574005	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	5395	PMS2	C11	EX11	.	.	no-change	NM_000535.5	NP_000526.1	-	Y	c.1621G=	.	.	.	NM_000535.5(PMS2): c.1621G=	;maf-5-some-pop	125594	0.852660	U	0.878	0.883187	13000	0.870385	PASS	3687	8650	0.923815	44055	120586	0.851392	7345	15926	9.23461e-01	87611	206446	8.40736e-01	rs2228006	.	.	.	-0.124	2.038	0.737	.	.	.	.	.	ENST00000265849: c.1621A>G (p.K541E)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4162329	.	.	.	.	.	no_record	135065	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
7	6026987	6026988	7p22.1	0	nullSample	.	G	ref	G	AG.TC	homo-ref	.	.	.	0	dup	.	600259	C	276300(MK);614337(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 4; Mismatch repair cancer syndrome 	AD/AR	.	Dermatologic; Oncologic	Oncologic	22933731|22577899|22461402|20587412|20301390|19851131|17557300|15077197|8072530|7661930|4574005	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	5395	PMS2	C11	EX11	.	.	no-change	NM_000535.5	NP_000526.1	-	Y	c.1408C=	.	.	.	NM_000535.5(PMS2): c.1408C=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126388	0.615683	U	0.3601	0.358227	13006	0.626173	PASS	-1014	8634	0.622655	23097	121380	0.614607	.	.	.	.	.	.	rs1805321	.	4024	0.599900	-0.145	-0.011	0.386	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	6026987	6026988	7p22.1	1	normal	.	G	snv	A	AG.TC	hom-alt	676	1.00	.	0	dup	PASS	600259	C	276300(MK);614337(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 4; Mismatch repair cancer syndrome 	AD/AR	.	Dermatologic; Oncologic	Oncologic	22933731|22577899|22461402|20587412|20301390|19851131|17557300|15077197|8072530|7661930|4574005	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	5395	PMS2	C11	EX11	.	.	missense	NM_000535.5	NP_000526.1	-	Y	c.1408C>T	p.P470S | p.Pro470Ser	CCT=>TCT	NP=>P0	NM_000535.5(PMS2): c.1408C>T (p.P470S)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126388	0.384317	U	0.3601	0.358227	13006	0.373827	PASS	615	8634	0.377345	9186	121380	0.385393	1261	6490	3.76276e-01	18823	95521	3.87906e-01	rs1805321	.	4024	0.400100	-0.145	-0.011	0.386	.	.	.	.	.	ENST00000265849: c.1408C>T (p.P470S)	skin [NS|NS|NS]	malignant_melanoma [NS|NS|NS]	CSV	3736445	.	.	.	.	.	no_record	36685	reviewed_by_expert_panel	Benign	Likely Benign
7	6036979	6036980	7p22.1	0	nullSample	.	G	ref	G	TC.GA	homo-ref	.	.	.	0	.	.	600259	C	276300(MK);614337(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 4; Mismatch repair cancer syndrome 	AD/AR	.	Dermatologic; Oncologic	Oncologic	22933731|22577899|22461402|20587412|20301390|19851131|17557300|15077197|8072530|7661930|4574005	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	5395	PMS2	C7	EX7	.	.	no-change	NM_000535.5	NP_000526.1	-	Y	c.780C=	.	.	.	NM_000535.5(PMS2): c.780C=	MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb|MixedObserved;clinically-assoc,submitted-by-lsdb	125626|0	0.188321|0	U	0.879	0.83127	13006	0.176226	PASS	-315	8640	0.078009	2411	120618	0.189134	.	.	.	.	.	.	rs1805319|rs587779344	.	4024	0.071100	-2.835	-4.664	-5.634	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	6036979	6036980	7p22.1	1	normal	.	G	snv	C	TC.GA	hom-alt	471	1.00	.	0	.	PASS	600259	C	276300(MK);614337(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 4; Mismatch repair cancer syndrome 	AD/AR	.	Dermatologic; Oncologic	Oncologic	22933731|22577899|22461402|20587412|20301390|19851131|17557300|15077197|8072530|7661930|4574005	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	5395	PMS2	C7	EX7	.	.	coding-synon	NM_000535.5	NP_000526.1	-	Y	c.780C>G	p.(S260=) | p.(Ser260=)	TCC=>TCG	.	NM_000535.5(PMS2): c.780C>G (p.(S260=))	MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb|MixedObserved;clinically-assoc,submitted-by-lsdb	125626|0	0.811671|0	U	0.879	0.83127	13006	0.823774	PASS	3667	8640	0.921875	39906	120618	0.810857	7328	15897	9.23064e-01	79497	196619	8.01512e-01	rs1805319|rs587779344	.	4024	0.928900	-2.835	-4.664	-5.634	.	.	.	.	.	ENST00000265849: c.780C>G (p.S260S)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4162330	.	.	.	.	.	no_record	36693	reviewed_by_expert_panel	Benign	Likely Benign
7	6037057	6037059	7p22.1	0	nullSample	.	AA	ref	AA	TG.AA	homo-ref	.	.	.	0	.	.	600259	C	276300(MK);614337(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 4; Mismatch repair cancer syndrome 	AD/AR	.	Dermatologic; Oncologic	Oncologic	22933731|22577899|22461402|20587412|20301390|19851131|17557300|15077197|8072530|7661930|4574005	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	5395	PMS2	IC6	IVS6	.	.	no-change	NM_000535.5	NP_000526.1	-	Y	c.706-5_706-4=	.	.	.	NM_000535.5(PMS2): c.706-5_706-4=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs776641246	.	4024	0.920500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	6037057	6037059	7p22.1	1	normal	.	AA	del	.	TG.AA	het-alt	40	0.35	.	1	.	PASS	600259	C	276300(MK);614337(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 4; Mismatch repair cancer syndrome 	AD/AR	.	Dermatologic; Oncologic	Oncologic	22933731|22577899|22461402|20587412|20301390|19851131|17557300|15077197|8072530|7661930|4574005	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	5395	PMS2	IC6	IVS6	.	.	intron	NM_000535.5	NP_000526.1	-	Y	c.706-5_706-4delTT	.	.	.	NM_000535.5(PMS2): c.706-5_706-4delTT	MixedObserved;	0	0	U	0.125	0.0916534	.	.	PASS	0	4704	0.255952	0	62852	0.146312	.	.	.	.	.	.	rs776641246	.	4024	2.000000	.	.	.	.	.	.	.	.	ENST00000265849: c.706-5_706-4delTT (p.?)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_III|anaplastic|NS]	CSV	1735836	.	.	.	.	.	no_record	218462	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
7	6037057	6037059	7p22.1	1	normal	.	AA	rep	A	TG.AA	het-alt	54	0.48	.	2	.	PASS	600259	C	276300(MK);614337(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 4; Mismatch repair cancer syndrome 	AD/AR	.	Dermatologic; Oncologic	Oncologic	22933731|22577899|22461402|20587412|20301390|19851131|17557300|15077197|8072530|7661930|4574005	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	5395	PMS2	IC6	IVS6	.	.	intron	NM_000535.5	NP_000526.1	-	Y	c.706-5T[2>1] (std: c.706-5T[1] alt: c.706-4delT )	.	.	.	NM_000535.5(PMS2): c.706-5T[1]	MixedObserved;	0	0	U	0.4931	0.453075	.	.	InbreedingCoeff_Filter	0	4	1.000000	89	180	0.994444	.	.	.	.	.	.	rs776641246	.	4024	2.000000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	6038721	6038722	7p22.1	1	normal	.	T	snv	C	AG.AA	hom-alt	379	1.00	.	0	.	PASS	600259	C	276300(MK);614337(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 4; Mismatch repair cancer syndrome 	AD/AR	.	Dermatologic; Oncologic	Oncologic	22933731|22577899|22461402|20587412|20301390|19851131|17557300|15077197|8072530|7661930|4574005	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	5395	PMS2	IC6	IVS6	.	.	intron	NM_000535.5	NP_000526.1	-	Y	c.705+17A>G	.	.	.	NM_000535.5(PMS2): c.705+17A>G	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126376	0.366090	U	0.3591	0.325679	13006	0.343918	PASS	575	8640	0.365509	8511	121368	0.367758	1182	6306	3.65608e-01	17259	90720	3.68445e-01	rs62456182	.	4024	2.000000	0.477	0.170	-0.080	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	36692	reviewed_by_expert_panel	Benign	Benign
7	6038721	6038722	7p22.1	0	nullSample	.	T	ref	T	AG.AA	homo-ref	.	.	.	0	.	.	600259	C	276300(MK);614337(MK)	AR	Colorectal cancer, hereditary nonpolyposis type 4; Mismatch repair cancer syndrome 	AD/AR	.	Dermatologic; Oncologic	Oncologic	22933731|22577899|22461402|20587412|20301390|19851131|17557300|15077197|8072530|7661930|4574005	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HR14;LS5;MC58;MH43	5395	PMS2	IC6	IVS6	.	.	no-change	NM_000535.5	NP_000526.1	-	Y	c.705+17A=	.	.	.	NM_000535.5(PMS2): c.705+17A=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126376	0.633910	U	0.3591	0.325679	13006	0.656082	PASS	-1004	8640	0.634491	24561	121368	0.632242	.	.	.	.	.	.	rs62456182	.	4024	0.608100	0.477	0.170	-0.080	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	6426940	6426941	7p22.1	0	nullSample	.	C	ref	C	AC.TG	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	5879	RAC1	IC2	IVS2	.	.	no-change	NM_018890.3	NP_061485.1	+	Y	c.107+27C=	.	.	.	NM_018890.3(RAC1): c.107+27C=	MixedObserved;maf-5-some-pop,maf-5-all-pops	126114	0.424465	U	0.9018	0.720847	13004	0.423485	PASS	-366	8650	0.093179	12813	121106	0.430474	.	.	.	.	.	.	rs702483	.	4024	0.104900	-0.254	1.082	0.401	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	6426940	6426941	7p22.1	0	normal	.	C	snv	T	AC.TG	hom-alt	248	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	5879	RAC1	IC2	IVS2	.	.	intron	NM_018890.3	NP_061485.1	+	Y	c.107+27C>T	.	.	.	NM_018890.3(RAC1): c.107+27C>T	MixedObserved;maf-5-some-pop,maf-5-all-pops	126114	0.575535	U	0.9018	0.720847	13004	0.576515	PASS	3556	8650	0.906821	21233	121106	0.569526	5194	11490	9.02451e-01	32532	110712	5.40935e-01	rs702483	.	4024	0.895100	-0.254	1.082	0.401	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	6426953	6426954	7p22.1	0	normal	.	G	snv	A	AC.GG	het-ref	127	0.51	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	5879	RAC1	IC2	IVS2	.	.	intron	NM_018890.3	NP_061485.1	+	Y	c.107+40G>A	.	.	.	NM_018890.3(RAC1): c.107+40G>A	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	125742	0.189825	U	0.2629	0.161142	13004	0.173716	PASS	238	8624	0.227853	2492	120734	0.191015	284	2619	2.13308e-01	3705	36289	1.81863e-01	rs3729790	.	4024	0.221400	-0.137	-1.325	-0.718	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	6426953	6426954	7p22.1	0	normal	.	G	ref	G	AC.GG	het-alt	123	0.49	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	5879	RAC1	IC2	IVS2	.	.	no-change	NM_018890.3	NP_061485.1	+	Y	c.107+40G=	.	.	.	NM_018890.3(RAC1): c.107+40G=	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	125742	0.810167	U	0.2629	0.161142	13004	0.826284	PASS	.	8624	0.772147	39796	120734	0.808977	.	.	.	.	.	.	rs3729790	.	4024	0.778600	-0.137	-1.325	-0.718	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	6426986	6426987	7p22.1	0	normal	.	G	ref	G	CT.TA	het-alt	131	0.57	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	5879	RAC1	IC2	IVS2	.	.	no-change	NM_018890.3	NP_061485.1	+	Y	c.107+73G=	.	.	.	NM_018890.3(RAC1): c.107+73G=	;	5008	0.999201	U	0.003	0.000798722	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs34816204	.	4024	0.993500	-1.710	-2.757	-2.862	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	6426986	6426987	7p22.1	0	normal	.	G	snv	C	CT.TA	het-ref	100	0.43	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	5879	RAC1	IC2	IVS2	.	.	intron	NM_018890.3	NP_061485.1	+	Y	c.107+73G>C	.	.	.	NM_018890.3(RAC1): c.107+73G>C	;	5008	0.000799	U	0.003	0.000798722	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs34816204	.	4024	0.006500	-1.710	-2.757	-2.862	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
7	6431689	6431690	7p22.1	0	nullSample	.	C	ref	C	GA.TT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	5879	RAC1	IC3	IVS3	.	.	no-change	NM_018890.3	NP_061485.1	+	Y	c.225+18C=	.	.	.	NM_018890.3(RAC1): c.225+18C=	;maf-5-some-pop,genotype-conflict	126402	0.434495	U	0.9008	0.691494	13006	0.457481	PASS	-365	8652	0.092695	13138	121394	0.439692	.	.	.	.	.	.	rs836478	.	.	.	-0.381	0.080	0.200	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	6431689	6431690	7p22.1	1	normal	.	C	snv	T	GA.TT	hom-alt	247	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	5879	RAC1	IC3	IVS3	.	.	intron	NM_018890.3	NP_061485.1	+	Y	c.225+18C>T	.	.	.	NM_018890.3(RAC1): c.225+18C>T	;maf-5-some-pop,genotype-conflict	126402	0.565505	U	0.9008	0.691494	13006	0.542519	PASS	3560	8652	0.907305	20459	121394	0.560308	7162	15706	9.10810e-01	41438	137817	5.60122e-01	rs836478	.	.	.	-0.381	0.080	0.200	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	6441687	6441688	7p22.1	0	normal	.	T	ref	T	CT.GT	het-alt	212	0.51	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	5879	RAC1	IC6	IVS6	.	.	no-change	NM_018890.3	NP_061485.1	+	Y	c.505+30T=	.	.	.	NM_018890.3(RAC1): c.505+30T=	;maf-5-some-pop	122452	0.884200	U	0.4821	0.18151	13006	0.960172	PASS	.	8640	0.495949	47150	117444	0.887001	.	.	.	.	.	.	rs2303364	.	.	.	0.496	1.282	0.239	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	6441687	6441688	7p22.1	0	normal	.	T	snv	C	CT.GT	het-ref	202	0.49	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	5879	RAC1	IC6	IVS6	.	.	intron	NM_018890.3	NP_061485.1	+	Y	c.505+30T>C	.	.	.	NM_018890.3(RAC1): c.505+30T>C	;maf-5-some-pop	122452	0.115800	U	0.4821	0.18151	13006	0.039828	PASS	1089	8640	0.504051	1699	117444	0.112999	2206	8686	5.06118e-01	3480	27330	1.16298e-01	rs2303364	.	.	.	0.496	1.282	0.239	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	6442155	6442156	7p22.1	0	nullSample	.	C	ref	C	aa.aa	homo-ref	.	.	.	0	(A)n|Simple_repeat|Simple_repeat|+|35;trf	.	.	.	.	.	.	.	.	.	.	.	.	5879	RAC1	3U1E	EX7E	.	.	no-change	NM_018890.3	NP_061485.1	+	Y	c.*79C=	.	.	.	NM_018890.3(RAC1): c.*79C=	MixedObserved;maf-5-some-pop,maf-5-all-pops|MixedObserved;maf-5-some-pop	5008	0.293331|0.139776	U	0.8849	0.706669	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2303367|rs61124997	.	.	.	-1.549	-1.473	-1.539	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	6442155	6442156	7p22.1	0	normal	.	C	snv	A	aa.aa	hom-alt	30	1.00	.	0	(A)n|Simple_repeat|Simple_repeat|+|35;trf	PASS	.	.	.	.	.	.	.	.	.	.	.	5879	RAC1	3U1E	EX7E	.	.	utr-3	NM_018890.3	NP_061485.1	+	Y	c.*79C>A	.	.	.	NM_018890.3(RAC1): c.*79C>A	MixedObserved;maf-5-some-pop,maf-5-all-pops	5008	0.706669	U	0.8849	0.706669	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2303367	.	.	.	-1.549	-1.473	-1.539	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	31735262	31735263	7p14.3	0	nullSample	.	G	ref	G	CT.TA	homo-ref	.	.	.	0	.	.	604088	P	143890(SK)	AD	.	.	.	.	.	.	.	10842	PPP1R17	IC2	IVS3	.	.	no-change	NM_006658.4	NP_006649.2	+	Y	c.235+28G=	.	.	.	NM_006658.4(PPP1R17): c.235+28G=	;maf-5-some-pop,genotype-conflict	125390	0.298230	U	0.8502	0.776558	13006	0.242427	PASS	-506	8640	0.136111	6051	120382	0.301341	.	.	.	.	.	.	rs34173	.	4024	0.137400	-1.780	-0.321	-0.465	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	31735262	31735263	7p14.3	0	normal	.	G	snv	C	CT.TA	hom-alt	267	1.00	.	0	.	PASS	604088	P	143890(SK)	AD	.	.	.	.	.	.	.	10842	PPP1R17	IC2	IVS3	.	.	intron	NM_006658.4	NP_006649.2	+	Y	c.235+28G>C	.	.	.	NM_006658.4(PPP1R17): c.235+28G>C	;maf-5-some-pop,genotype-conflict	125390	0.701770	U	0.8502	0.776558	13006	0.757573	PASS	3226	8640	0.863889	29966	120382	0.698659	6076	14074	8.62483e-01	56493	159866	6.98038e-01	rs34173	.	4024	0.862600	-1.780	-0.321	-0.465	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	47968926	47968927	7p12.3	0	normal	.	C	snv	A	AA.AC	hom-alt	360	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.47968926C>A (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126418	0.488324	U	0.5089	0.484824	13006	0.492234	PASS	1238	8652	0.541378	14672	121410	0.488469	2501	9286	5.38381e-01	30217	120930	4.91054e-01	rs2686817	.	.	.	0.579	0.564	0.395	.	.	.	.	.	ENST00000289672: c.934G>T (p.V312F)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3762699	.	.	.	.	.	.	.	.	.	Benign
7	47968926	47968927	7p12.3	0	nullSample	.	C	ref	C	AA.AC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.47968926C= (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126418	0.511676	U	0.5089	0.484824	13006	0.507766	PASS	-1104	8652	0.458622	16072	121410	0.511531	.	.	.	.	.	.	rs2686817	.	.	.	0.579	0.564	0.395	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	50467940	50467941	7p12.2	0	normal	.	C	ref	C	AA.AG	het-alt	340	0.46	.	1	.	PASS	603023	P	603023(MK)	NN	.	.	.	.	.	.	.	10320	IKZF1	C7E	EX8E	.	.	no-change	NM_006060.4	NP_006051.1	+	Y	c.1176C=	.	.	.	NM_006060.4(IKZF1): c.1176C=	;maf-5-some-pop	81600	0.920833	U	0.1091	0.0589058	12762	0.951575	PASS	.	5314	0.842868	32314	76592	0.919509	.	.	.	.	.	.	rs61731356	.	.	.	0.585	3.410	1.385	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	50467940	50467941	7p12.2	1	normal	.	C	snv	T	AA.AG	het-ref	394	0.54	.	2	.	PASS	603023	P	603023(MK)	NN	.	.	.	.	.	.	.	10320	IKZF1	C7E	EX8E	.	.	coding-synon	NM_006060.4	NP_006051.1	+	Y	c.1176C>T	p.(N392=) | p.(Asn392=)	AAC=>AAT	.	NM_006060.4(IKZF1): c.1176C>T (p.(N392=))	;maf-5-some-pop	81600	0.079167	U	0.1091	0.0589058	12762	0.048425	PASS	40	5314	0.157132	183	76592	0.080491	81	1665	9.90718e-02	386	12551	5.28023e-02	rs61731356	.	.	.	0.585	3.410	1.385	.	.	.	.	.	ENST00000331340_v65: c.1176C>T (p.N392N)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	4162286	.	.	.	.	.	.	.	.	.	Likely Benign
7	50468333	50468334	7p12.2	0	normal	.	C	ref	C	CC.GC	het-alt	131	0.47	.	1	.	PASS	603023	P	603023(MK)	NN	.	.	.	.	.	.	.	10320	IKZF1	3U1E	EX8E	.	.	no-change	NM_006060.4	NP_006051.1	+	Y	c.*9C=	.	.	.	NM_006060.4(IKZF1): c.*9C=	SingleClassTriAllelic;maf-5-some-pop	94074	0.930002	U	0.1081	0.0591054	12398	0.951444	PASS	-374	6174	0.863946	38452	89066	0.929389	.	.	.	.	.	.	rs72645704	.	.	.	0.467	0.109	-0.343	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	50468333	50468334	7p12.2	0	normal	.	C	snv	T	CC.GC	het-ref	146	0.53	.	2	.	PASS	603023	P	603023(MK)	NN	.	.	.	.	.	.	.	10320	IKZF1	3U1E	EX8E	.	.	utr-3	NM_006060.4	NP_006051.1	+	Y	c.*9C>T	.	.	.	NM_006060.4(IKZF1): c.*9C>T	SingleClassTriAllelic;maf-5-some-pop	94074	0.069987	U	0.1081	0.0591054	12398	0.048556	PASS	46	6174	0.136054	208	89066	0.070599	88	1669	1.02242e-01	384	12110	5.37420e-02	rs72645704	.	.	.	0.467	0.109	-0.343	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	53103945	53103946	7p12.1	0	normal	.	G	ref	G	GG.CC	het-alt	169	0.52	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	285877	POM121L12	C1E	EX1E	POM121 family	PF15229.1	no-change	NM_182595.3	NP_872401.3	+	Y	c.582G=	.	.	.	NM_182595.3(POM121L12): c.582G=	SingleClassTriAllelic;maf-5-some-pop	125242	0.566368	U	0.3026	0.328874	12226	0.591772	PASS	.	8540	0.719321	19683	120234	0.562004	.	.	.	.	.	.	rs12113170	.	4024	0.718400	0.561	-1.653	-1.678	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	53103945	53103946	7p12.1	1	normal	.	G	snv	C	GG.CC	het-ref	157	0.48	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	285877	POM121L12	C1E	EX1E	POM121 family	PF15229.1	coding-synon	NM_182595.3	NP_872401.3	+	Y	c.582G>C	p.(G194=) | p.(Gly194=)	GGG=>GGC	.	NM_182595.3(POM121L12): c.582G>C (p.(G194=))	SingleClassTriAllelic;maf-5-some-pop	125242	0.433625	U	0.3026	0.328874	12226	0.408228	PASS	330	8540	0.280679	12228	120234	0.437988	645	4746	2.75578e-01	25539	109069	4.43991e-01	rs12113170	.	4024	0.281600	0.561	-1.653	-1.678	.	.	.	.	.	ENST00000408890: c.582G>C (p.G194G)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4162293	.	.	.	.	.	.	.	.	.	Likely Benign
7	55037761	55037762	7p11.2	0	nullSample	.	T	ref	T	TG.AA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55037761T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.425519	U	0.744	0.574481	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4947958	.	.	.	0.254	-0.429	-0.487	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55037761	55037762	7p11.2	0	normal	.	T	snv	C	TG.AA	hom-alt	356	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55037761T>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.574481	U	0.744	0.574481	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4947958	.	.	.	0.254	-0.429	-0.487	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55051330	55051331	7p11.2	0	normal	.	G	snv	T	AA.TC	hom-alt	350	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55051330G>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.654353	U	0.9226	0.654353	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6943639	.	.	.	-0.256	-0.017	-0.051	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55051330	55051331	7p11.2	0	nullSample	.	G	ref	G	AA.TC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55051330G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.345647	U	0.9226	0.654353	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6943639	.	.	.	-0.256	-0.017	-0.051	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55058005	55058006	7p11.2	0	nullSample	.	T	ref	T	AA.TC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55058005T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.442891	U	0.744	0.557109	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4947960	.	.	.	-1.163	-0.651	-0.741	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55058005	55058006	7p11.2	0	normal	.	T	snv	C	AA.TC	hom-alt	426	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55058005T>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.557109	U	0.744	0.557109	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4947960	.	.	.	-1.163	-0.651	-0.741	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55062207	55062208	7p11.2	0	nullSample	.	G	ref	G	TC.CA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55062207G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.452476	U	0.7401	0.547524	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2330947	.	.	.	-0.383	0.115	0.079	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55062207	55062208	7p11.2	0	normal	.	G	snv	A	TC.CA	hom-alt	243	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55062207G>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.547524	U	0.7401	0.547524	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2330947	.	.	.	-0.383	0.115	0.079	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55069620	55069621	7p11.2	0	nullSample	.	G	ref	G	AA.AC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55069620G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.452077	U	0.7401	0.547923	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1158657	.	.	.	-0.525	-0.074	-0.106	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55069620	55069621	7p11.2	0	normal	.	G	snv	T	AA.AC	hom-alt	280	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55069620G>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.547923	U	0.7401	0.547923	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1158657	.	.	.	-0.525	-0.074	-0.106	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55069646	55069647	7p11.2	0	normal	.	G	snv	A	AT.GG	hom-alt	250	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55069646G>A (intergenic)	;maf-5-some-pop	5008	0.331869	U	0.6548	0.331869	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1158658	.	.	.	0.462	0.412	0.410	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55069646	55069647	7p11.2	0	nullSample	.	G	ref	G	AT.GG	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55069646G= (intergenic)	;maf-5-some-pop	5008	0.668131	U	0.6548	0.331869	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1158658	.	.	.	0.462	0.412	0.410	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55069690	55069692	7p11.2	0	nullSample	.	AT	ref	AT	AA.AT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55069690_55069691= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.452276	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs58647989	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
7	55069690	55069692	7p11.2	0	normal	.	AT	del	.	AA.AT	hom-alt	199	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55069691_55069692delAT (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.547724	U	0.7391	0.547724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs58647989	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55221654	55221655	7p11.2	0	normal	.	G	snv	A	GC.CT	hom-alt	382	1.00	.	0	.	PASS	131550	C	211980(SK);616069(UK)	AR	Acute myeloid leukemia, familial; Lung cancer, familial, susceptibilty to	AD	.	Oncologic	Oncologic	16258541|10686940	.	1956	EGFR	IC6	IVS6	.	.	intron	NM_005228.3	NP_005219.2	+	Y	c.748-49G>A	.	.	.	NM_005228.3(EGFR): c.748-49G>A	;maf-5-some-pop,genotype-conflict	126260	0.302907	U	0.6498	0.320687	13006	0.217438	PASS	1726	8620	0.631671	6312	121252	0.302172	3481	10963	6.35979e-01	13049	75264	3.06088e-01	rs4947986	.	4024	0.592900	-0.499	-0.592	-0.669	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55221654	55221655	7p11.2	0	nullSample	.	G	ref	G	GC.CT	homo-ref	.	.	.	0	.	.	131550	C	211980(SK);616069(UK)	AR	Acute myeloid leukemia, familial; Lung cancer, familial, susceptibilty to	AD	.	Oncologic	Oncologic	16258541|10686940	.	1956	EGFR	IC6	IVS6	.	.	no-change	NM_005228.3	NP_005219.2	+	Y	c.748-49G=	.	.	.	NM_005228.3(EGFR): c.748-49G=	;maf-5-some-pop,genotype-conflict	126260	0.697093	U	0.6498	0.320687	13006	0.782562	PASS	.	8620	0.368329	30299	121252	0.697828	.	.	.	.	.	.	rs4947986	.	4024	0.407100	-0.499	-0.592	-0.669	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55228052	55228053	7p11.2	0	nullSample	.	A	ref	A	TT.GT	homo-ref	.	.	.	0	.	.	131550	C	211980(SK);616069(UK)	AR	Acute myeloid leukemia, familial; Lung cancer, familial, susceptibilty to	AD	.	Oncologic	Oncologic	16258541|10686940	.	1956	EGFR	IC12	IVS12	.	.	no-change	NM_005228.3	NP_005219.2	+	Y	c.1498+22A=	.	.	.	NM_005228.3(EGFR): c.1498+22A=	MixedObserved,SingleClassQuadAllelic;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	123208	0.230099	U	0.997	0.773363	12990	0.336567	PASS	.	8398	0.002501	3802	118200	0.230245	.	.	.	.	.	.	rs1558544	.	4024	0.004500	-0.265	0.053	-0.233	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55228052	55228053	7p11.2	0	normal	.	A	snv	T	TT.GT	hom-alt	375	1.00	.	0	.	PASS	131550	C	211980(SK);616069(UK)	AR	Acute myeloid leukemia, familial; Lung cancer, familial, susceptibilty to	AD	.	Oncologic	Oncologic	16258541|10686940	.	1956	EGFR	IC12	IVS12	.	.	intron	NM_005228.3	NP_005219.2	+	Y	c.1498+22A>T	.	.	.	NM_005228.3(EGFR): c.1498+22A>T	MixedObserved,SingleClassQuadAllelic;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	123208	0.769885	U	0.997	0.773363	12990	0.663433	PASS	4177	8398	0.997380	35685	118200	0.769738	8455	16980	9.95894e-01	73887	186645	7.76213e-01	rs1558544	.	4024	0.995500	-0.265	0.053	-0.233	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55229254	55229255	7p11.2	0	nullSample	.	G	ref	G	CA.GG	homo-ref	.	.	.	0	.	.	131550	C	211980(SK);616069(UK)	AR	Acute myeloid leukemia, familial; Lung cancer, familial, susceptibilty to	AD	.	Oncologic	Oncologic	16258541|10686940	.	1956	EGFR	C13	EX13	Growth factor receptor domain IV	PF14843.1	no-change	NM_005228.3	NP_005219.2	+	Y	c.1562G=	.	.	.	NM_005228.3(EGFR): c.1562G=	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126372	0.712832	U	0.5238	0.292133	13006	0.797324	PASS	.	8638	0.464112	31462	121364	0.713037	.	.	.	.	.	.	rs2227983	.	4024	0.489100	-0.165	-1.137	-1.106	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55229254	55229255	7p11.2	1	normal	.	G	snv	A	CA.GG	hom-alt	522	1.00	.	0	.	PASS	131550	C	211980(SK);616069(UK)	AR	Acute myeloid leukemia, familial; Lung cancer, familial, susceptibilty to	AD	.	Oncologic	Oncologic	16258541|10686940	.	1956	EGFR	C13	EX13	Growth factor receptor domain IV	PF14843.1	missense	NM_005228.3	NP_005219.2	+	Y	c.1562G>A	p.R521K | p.Arg521Lys	AGG=>AAG	P+=>P+	NM_005228.3(EGFR): c.1562G>A (p.R521K)	SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126372	0.287168	U	0.5238	0.292133	13006	0.202676	PASS	1228	8638	0.535888	5607	121364	0.286963	2409	9192	5.32993e-01	11551	71955	2.92248e-01	rs2227983	.	4024	0.510900	-0.165	-1.137	-1.106	0.49	0	0	0.011	neutral	ENST00000275493: c.1562G>A (p.R521K)	autonomic_ganglia [sinonasal_and_nasal_cavity|NS|NS]	olfactory_neuroblastoma [NS|NS|NS]	CSV	3721608	CM942312	NM_005228.3(EGFR): c.1562G>A (p.R521K)	"Altered transmembrane signaling, association with ?"	7937865	DP	no_record	134021	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
7	55238267	55238268	7p11.2	0	nullSample	.	G	ref	G	CC.CT	homo-ref	.	.	.	0	.	.	131550	C	211980(SK);616069(UK)	AR	Acute myeloid leukemia, familial; Lung cancer, familial, susceptibilty to	AD	.	Oncologic	Oncologic	16258541|10686940	.	1956	EGFR	IC15	IVS15	.	.	no-change	NM_005228.3	NP_005219.2	+	Y	c.1881-600G=	.	.	.	NM_005228.3(EGFR): c.1881-600G=	SingleClassTriAllelic;maf-5-some-pop	126360	0.632574	U	0.5357	0.376198	13006	0.694910	PASS	-1092	8630	0.457937	24755	121352	0.632936	.	.	.	.	.	.	rs10228436	.	4024	0.482400	-1.512	-3.124	-3.278	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55238267	55238268	7p11.2	0	normal	.	G	snv	A	CC.CT	hom-alt	275	1.00	.	0	.	PASS	131550	C	211980(SK);616069(UK)	AR	Acute myeloid leukemia, familial; Lung cancer, familial, susceptibilty to	AD	.	Oncologic	Oncologic	16258541|10686940	.	1956	EGFR	IC15	IVS15	.	.	intron	NM_005228.3	NP_005219.2	+	Y	c.1881-600G>A	.	.	.	NM_005228.3(EGFR): c.1881-600G>A	SingleClassTriAllelic;maf-5-some-pop	126360	0.367387	U	0.5357	0.376198	13006	0.305090	PASS	1247	8630	0.542063	8623	121352	0.367023	2489	9342	5.41628e-01	17479	90430	3.70099e-01	rs10228436	.	4024	0.517600	-1.512	-3.124	-3.278	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55238873	55238874	7p11.2	0	nullSample	.	T	ref	T	AC.GG	homo-ref	.	.	.	0	.	.	131550	C	211980(SK);616069(UK)	AR	Acute myeloid leukemia, familial; Lung cancer, familial, susceptibilty to	AD	.	Oncologic	Oncologic	16258541|10686940	.	1956	EGFR	C16	EX16	Growth factor receptor domain IV	PF14843.1	no-change	NM_005228.3	NP_005219.2	+	Y	c.1887T=	.	.	.	NM_005228.3(EGFR): c.1887T=	SingleClassTriAllelic;maf-5-some-pop	126352	0.625332	U	0.5347	0.390375	13006	0.677533	PASS	-1091	8644	0.458815	24159	121344	0.625981	.	.	.	.	.	.	rs2227984	.	4024	0.482400	-0.379	-1.067	-0.735	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55238873	55238874	7p11.2	1	normal	.	T	snv	A	AC.GG	hom-alt	345	1.00	.	0	.	PASS	131550	C	211980(SK);616069(UK)	AR	Acute myeloid leukemia, familial; Lung cancer, familial, susceptibilty to	AD	.	Oncologic	Oncologic	16258541|10686940	.	1956	EGFR	C16	EX16	Growth factor receptor domain IV	PF14843.1	coding-synon	NM_005228.3	NP_005219.2	+	Y	c.1887T>A	p.(T629=) | p.(Thr629=)	ACT=>ACA	.	NM_005228.3(EGFR): c.1887T>A (p.(T629=))	SingleClassTriAllelic;maf-5-some-pop	126352	0.374660	U	0.5347	0.390375	13006	0.322467	PASS	1248	8644	0.541185	8872	121344	0.374011	2482	9331	5.40990e-01	18027	92507	3.75797e-01	rs2227984	.	4024	0.517600	-0.379	-1.067	-0.735	.	.	.	.	.	ENST00000275493: c.1887T>A (p.T629T)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3762772	.	.	.	.	.	no_record	259677	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
7	55242608	55242609	7p11.2	0	nullSample	.	A	ref	A	TC.TC	homo-ref	.	.	.	0	.	.	131550	C	211980(SK);616069(UK)	AR	Acute myeloid leukemia, familial; Lung cancer, familial, susceptibilty to	AD	.	Oncologic	Oncologic	16258541|10686940	.	1956	EGFR	IC19	IVS19	.	.	no-change	NM_005228.3	NP_005219.2	+	Y	c.2283+96A=	.	.	.	NM_005228.3(EGFR): c.2283+96A=	;maf-5-some-pop	5008	0.670527	U	0.6181	0.329473	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2017000	.	4024	0.431400	-0.396	-0.136	-0.201	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55242608	55242609	7p11.2	0	normal	.	A	snv	G	TC.TC	hom-alt	460	1.00	.	0	.	PASS	131550	C	211980(SK);616069(UK)	AR	Acute myeloid leukemia, familial; Lung cancer, familial, susceptibilty to	AD	.	Oncologic	Oncologic	16258541|10686940	.	1956	EGFR	IC19	IVS19	.	.	intron	NM_005228.3	NP_005219.2	+	Y	c.2283+96A>G	.	.	.	NM_005228.3(EGFR): c.2283+96A>G	;maf-5-some-pop	5008	0.329473	U	0.6181	0.329473	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2017000	.	4024	0.568600	-0.396	-0.136	-0.201	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55266416	55266417	7p11.2	0	normal	.	T	snv	C	AC.GT	hom-alt	587	1.00	.	0	.	PASS	131550	C	211980(SK);616069(UK)	AR	Acute myeloid leukemia, familial; Lung cancer, familial, susceptibilty to	AD	.	Oncologic	Oncologic	16258541|10686940	.	1956	EGFR	C23	EX23	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	no-change	NM_005228.3	NP_005219.2	+	Y	c.2709C=	.	.	.	NM_005228.3(EGFR): c.2709C=	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	126416	0.896508	U	0.9196	0.916733	13006	0.889051	PASS	3720	8652	0.926607	48811	121408	0.895674	7395	15971	9.25962e-01	98645	220261	8.94468e-01	rs1140475	.	.	.	-0.355	-2.688	-1.919	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55266416	55266417	7p11.2	1	nullSample	.	T	ref	T	AC.GT	homo-ref	.	.	.	0	.	.	131550	C	211980(SK);616069(UK)	AR	Acute myeloid leukemia, familial; Lung cancer, familial, susceptibilty to	AD	.	Oncologic	Oncologic	16258541|10686940	.	1956	EGFR	C23	EX23	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_005228.3	NP_005219.2	+	Y	c.2709C>T	p.(T903=) | p.(Thr903=)	ACC=>ACT	.	NM_005228.3(EGFR): c.2709C>T (p.(T903=))	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	126416	0.103484	U	0.9196	0.916733	13006	0.110949	PASS	.	8652	0.073393	773	121408	0.104318	.	.	.	.	.	.	rs1140475	.	.	.	-0.355	-2.688	-1.919	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
7	55268915	55268916	7p11.2	0	normal	.	C	ref	C	GA.TC	het-alt	426	0.55	.	1	.	PASS	131550	C	211980(SK);616069(UK)	AR	Acute myeloid leukemia, familial; Lung cancer, familial, susceptibilty to	AD	.	Oncologic	Oncologic	16258541|10686940	.	1956	EGFR	C25	EX25	.	.	no-change	NM_005228.3	NP_005219.2	+	Y	c.2982C=	.	.	.	NM_005228.3(EGFR): c.2982C=	;maf-5-some-pop	126396	0.865969	U	0.247	0.141773	13006	0.929571	PASS	.	8648	0.722364	45911	121388	0.866288	.	.	.	.	.	.	rs2293347	.	4024	0.728100	-0.127	1.189	0.855	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55268915	55268916	7p11.2	1	normal	.	C	snv	T	GA.TC	het-ref	347	0.45	.	2	.	PASS	131550	C	211980(SK);616069(UK)	AR	Acute myeloid leukemia, familial; Lung cancer, familial, susceptibilty to	AD	.	Oncologic	Oncologic	16258541|10686940	.	1956	EGFR	C25	EX25	.	.	coding-synon	NM_005228.3	NP_005219.2	+	Y	c.2982C>T	p.(D994=) | p.(Asp994=)	GAC=>GAT	.	NM_005228.3(EGFR): c.2982C>T (p.(D994=))	;maf-5-some-pop	126396	0.134031	U	0.247	0.141773	13006	0.070429	PASS	351	8648	0.277636	1448	121388	0.133712	657	4736	2.74614e-01	2944	34020	1.38144e-01	rs2293347	.	4024	0.271900	-0.127	1.189	0.855	.	.	.	.	.	ENST00000275493: c.2982C>T (p.D994D)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3762773	.	.	.	.	.	no_record	259679	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
7	55277963	55277964	7p11.2	0	normal	.	G	ref	G	CA.TA	het-alt	135	0.50	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55277963G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.494808	U	0.7192	0.505192	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6593211	.	.	.	-3.067	-2.548	-2.752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55277963	55277964	7p11.2	0	normal	.	G	snv	A	CA.TA	het-ref	135	0.50	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55277963G>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.505192	U	0.7192	0.505192	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6593211	.	.	.	-3.067	-2.548	-2.752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55291055	55291056	7p11.2	0	normal	.	C	ref	C	GC.GT	het-alt	173	0.56	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55291055C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.721046	U	0.1429	0.278954	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12531491	.	.	.	0.431	0.892	0.899	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55291055	55291056	7p11.2	0	normal	.	C	snv	T	GC.GT	het-ref	136	0.44	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55291055C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.278954	U	0.1429	0.278954	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12531491	.	.	.	0.431	0.892	0.899	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55291078	55291079	7p11.2	0	normal	.	A	ref	A	AG.GC	het-alt	197	0.52	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55291078A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.702276	U	0.1429	0.297724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12534147	.	.	.	0.353	0.385	0.364	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55291078	55291079	7p11.2	0	normal	.	A	snv	C	AG.GC	het-ref	179	0.48	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55291078A>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.297724	U	0.1429	0.297724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12534147	.	.	.	0.353	0.385	0.364	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55301245	55301246	7p11.2	0	normal	.	T	ref	T	CC.AC	het-alt	108	0.51	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55301245T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.830471	U	0.2847	0.169529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs73139007	.	.	.	-0.166	-0.055	-0.070	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55301245	55301246	7p11.2	0	normal	.	T	snv	C	CC.AC	het-ref	104	0.49	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55301245T>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.169529	U	0.2847	0.169529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs73139007	.	.	.	-0.166	-0.055	-0.070	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55301303	55301304	7p11.2	0	normal	.	G	snv	C	AA.CC	het-ref	140	0.43	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55301303G>C (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.634984	U	0.7768	0.634984	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6952602	.	.	.	-1.206	-2.724	-2.992	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55301303	55301304	7p11.2	0	normal	.	G	ref	G	AA.CC	het-alt	184	0.57	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55301303G= (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.365016	U	0.7768	0.634984	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6952602	.	.	.	-1.206	-2.724	-2.992	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55306578	55306579	7p11.2	0	normal	.	A	snv	G	AT.AA	het-ref	76	0.29	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55306578A>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.611022	U	0.7718	0.611022	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2037701	.	.	.	0.533	1.736	1.653	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55306578	55306579	7p11.2	0	normal	.	A	ref	A	AT.AA	het-alt	185	0.71	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55306578A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.388978	U	0.7718	0.611022	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2037701	.	.	.	0.533	1.736	1.653	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55306598	55306599	7p11.2	0	normal	.	T	ref	T	AA.GC	het-alt	176	0.73	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55306598T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.437500	U	0.7738	0.5625	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2037700	.	.	.	0.533	-0.106	-0.153	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55306598	55306599	7p11.2	0	normal	.	T	snv	A	AA.GC	het-ref	64	0.27	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55306598T>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.562500	U	0.7738	0.5625	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2037700	.	.	.	0.533	-0.106	-0.153	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55306611	55306612	7p11.2	0	normal	.	A	ref	A	GT.TT	het-alt	158	0.71	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55306611A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.376997	U	0.7728	0.623003	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2037699	.	.	.	-0.462	-0.145	-0.192	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55306611	55306612	7p11.2	0	normal	.	A	snv	G	GT.TT	het-ref	66	0.29	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55306611A>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.623003	U	0.7728	0.623003	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2037699	.	.	.	-0.462	-0.145	-0.192	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55306624	55306625	7p11.2	0	nullSample	.	T	ref	T	TG.GA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55306624T= (intergenic)	;maf-5-some-pop	5008	0.081869	U	0.9167	0.918131	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2037698	.	.	.	-2.208	-0.056	-0.102	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55306624	55306625	7p11.2	0	normal	.	T	snv	C	TG.GA	hom-alt	203	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55306624T>C (intergenic)	;maf-5-some-pop	5008	0.918131	U	0.9167	0.918131	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2037698	.	.	.	-2.208	-0.056	-0.102	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55313227	55313228	7p11.2	0	normal	.	T	ref	T	TA.AG	het-alt	105	0.55	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55313227T= (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.783147	U	0.3016	0.216853	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11982525	.	.	.	-0.505	-0.804	-0.861	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55313227	55313228	7p11.2	0	normal	.	T	snv	C	TA.AG	het-ref	86	0.45	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55313227T>C (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.216853	U	0.3016	0.216853	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11982525	.	.	.	-0.505	-0.804	-0.861	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55313349	55313350	7p11.2	0	normal	.	G	ref	G	CC.CA	het-alt	120	0.52	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55313349G= (intergenic)	;maf-5-some-pop	5008	0.873802	U	0.2986	0.126198	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17673576	.	.	.	-0.492	-0.129	-0.172	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	55313349	55313350	7p11.2	0	normal	.	G	snv	A	CC.CA	het-ref	109	0.48	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.55313349G>A (intergenic)	;maf-5-some-pop	5008	0.126198	U	0.2986	0.126198	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17673576	.	.	.	-0.492	-0.129	-0.172	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	81346684	81346685	7q21.11	0	normal	.	T	ref	T	TG.GG	het-alt	297	0.52	.	1	.	PASS	142409	C	608265(MK)	NN	Deafness, autosomal recessive 39	AR	.	Audiologic/Otolaryngologic	Audiologic/Otolaryngologic	19576567|14512973	.	3082	HGF	IC10	IVS10	.	.	no-change	NM_000601.4	NP_000592.3	-	Y	c.1272-4A=	.	.	.	NM_000601.4(HGF): c.1272-4A=	SingleClassTriAllelic;maf-5-some-pop	126380	0.194881	U	0.8839	0.798323	13006	0.246963	PASS	-523	8650	0.145896	2553	121372	0.194600	.	.	.	.	.	.	rs1800793	.	4024	0.139700	-1.819	-0.165	-0.280	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	81346684	81346685	7q21.11	1	normal	.	T	snv	C	TG.GG	het-ref	277	0.48	.	2	.	PASS	142409	C	608265(MK)	NN	Deafness, autosomal recessive 39	AR	.	Audiologic/Otolaryngologic	Audiologic/Otolaryngologic	19576567|14512973	.	3082	HGF	IC10	IVS10	.	.	intron	NM_000601.4	NP_000592.3	-	Y	c.1272-4A>G	.	.	.	NM_000601.4(HGF): c.1272-4A>G	SingleClassTriAllelic;maf-5-some-pop	126380	0.805017	U	0.8839	0.798323	13006	0.753037	PASS	3171	8650	0.854104	39611	121372	0.805293	6303	14721	8.53688e-01	81524	199842	8.12207e-01	rs1800793	.	4024	0.860300	-1.819	-0.165	-0.280	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	43607	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
7	81350207	81350208	7q21.11	0	normal	.	A	ref	A	GC.GA	het-alt	143	0.54	.	1	.	PASS	142409	C	608265(MK)	NN	Deafness, autosomal recessive 39	AR	.	Audiologic/Otolaryngologic	Audiologic/Otolaryngologic	19576567|14512973	.	3082	HGF	IC9	IVS9	.	.	no-change	NM_000601.4	NP_000592.3	-	Y	c.1169-45T=	.	.	.	NM_000601.4(HGF): c.1169-45T=	;maf-5-some-pop	115772	0.163546	U	0.8839	0.884784	13000	0.149231	PASS	-485	7842	0.145116	1582	110764	0.165731	.	.	.	.	.	.	rs12536657	.	4024	0.142600	-3.228	-3.035	-2.436	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	81350207	81350208	7q21.11	0	normal	.	A	snv	G	GC.GA	het-ref	121	0.46	.	2	.	PASS	142409	C	608265(MK)	NN	Deafness, autosomal recessive 39	AR	.	Audiologic/Otolaryngologic	Audiologic/Otolaryngologic	19576567|14512973	.	3082	HGF	IC9	IVS9	.	.	intron	NM_000601.4	NP_000592.3	-	Y	c.1169-45T>C	.	.	.	NM_000601.4(HGF): c.1169-45T>C	;maf-5-some-pop	115772	0.836454	U	0.8839	0.884784	13000	0.850769	PASS	2867	7842	0.854884	38607	110764	0.834269	6069	14214	8.52976e-01	82397	197002	8.34733e-01	rs12536657	.	4024	0.857400	-3.228	-3.035	-2.436	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	81359116	81359117	7q21.11	0	normal	.	A	del	.	AC.AA	het-ref	173	0.48	.	2	.	PASS	142409	C	608265(MK)	NN	Deafness, autosomal recessive 39	AR	.	Audiologic/Otolaryngologic	Audiologic/Otolaryngologic	19576567|14512973	.	3082	HGF	IC7	IVS7	.	.	intron	NM_000601.4	NP_000592.3	-	Y	c.866-22delT	.	.	.	NM_000601.4(HGF): c.866-22delT	MixedObserved;maf-5-some-pop	102003	0.042538	U	0.8621	0.862819	.	.	PASS	2993	8486	0.839383	39368	119964	0.808384	.	.	.	.	.	.	rs5745686	.	4025	0.838800	0.338	0.602	0.264	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	81359116	81359117	7q21.11	0	normal	.	A	ref	A	AC.AA	het-alt	189	0.52	.	1	.	PASS	142409	C	608265(MK)	NN	Deafness, autosomal recessive 39	AR	.	Audiologic/Otolaryngologic	Audiologic/Otolaryngologic	19576567|14512973	.	3082	HGF	IC7	IVS7	.	.	no-change	NM_000601.4	NP_000592.3	-	Y	c.866-22T=	.	.	.	NM_000601.4(HGF): c.866-22T=	MixedObserved;maf-5-some-pop|MixedObserved;	102003|4804	0.957462|0.999584	U	.	.	.	.	PASS	0	228	1.000000	2400	4804	0.999584	.	.	.	.	.	.	rs5745686|rs775640197	.	4025	0.161000	0.338	0.602	0.264	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	81372155	81372156	7q21.11	0	normal	.	A	snv	G	TA.AG	het-ref	123	0.53	.	2	.	PASS	142409	C	608265(MK)	NN	Deafness, autosomal recessive 39	AR	.	Audiologic/Otolaryngologic	Audiologic/Otolaryngologic	19576567|14512973	.	3082	HGF	IC7	IVS7	.	.	intron	NM_000601.4	NP_000592.3	-	Y	c.865+513T>C	.	.	.	NM_000601.4(HGF): c.865+513T>C	;maf-5-some-pop	5008	0.863618	U	0.8621	0.863618	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs5745676	.	4024	0.839700	-0.119	-0.745	-0.973	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	81372155	81372156	7q21.11	0	normal	.	A	ref	A	TA.AG	het-alt	111	0.47	.	1	.	PASS	142409	C	608265(MK)	NN	Deafness, autosomal recessive 39	AR	.	Audiologic/Otolaryngologic	Audiologic/Otolaryngologic	19576567|14512973	.	3082	HGF	IC7	IVS7	.	.	no-change	NM_000601.4	NP_000592.3	-	Y	c.865+513T=	.	.	.	NM_000601.4(HGF): c.865+513T=	;maf-5-some-pop	5008	0.136382	U	0.8621	0.863618	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs5745676	.	4024	0.160300	-0.119	-0.745	-0.973	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	81374499	81374500	7q21.11	0	nullSample	.	G	ref	G	TT.CA	homo-ref	.	.	.	0	.	.	142409	C	608265(MK)	NN	Deafness, autosomal recessive 39	AR	.	Audiologic/Otolaryngologic	Audiologic/Otolaryngologic	19576567|14512973	.	3082	HGF	IC5	IVS5	.	.	no-change	NM_000601.4	NP_000592.3	-	Y	c.626-64C=	.	.	.	NM_000601.4(HGF): c.626-64C=	;maf-5-some-pop	5008	0.016174	U	0.998	0.983826	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4732406	.	4024	0.002500	-0.120	0.014	0.296	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	81374499	81374500	7q21.11	0	normal	.	G	snv	C	TT.CA	hom-alt	381	1.00	.	0	.	PASS	142409	C	608265(MK)	NN	Deafness, autosomal recessive 39	AR	.	Audiologic/Otolaryngologic	Audiologic/Otolaryngologic	19576567|14512973	.	3082	HGF	IC5	IVS5	.	.	intron	NM_000601.4	NP_000592.3	-	Y	c.626-64C>G	.	.	.	NM_000601.4(HGF): c.626-64C>G	;maf-5-some-pop	5008	0.983826	U	0.998	0.983826	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4732406	.	4024	0.997500	-0.120	0.014	0.296	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	83590851	83590852	7q21.11	0	normal	.	T	ref	T	AT.GT	het-alt	213	0.50	.	1	.	PASS	603961	P	614897(SK)	NN	Hypogonadotropic hypogonadism 16 with or without anosmia	AD	.	Endocrine; Genitourinary; Neurologic	Endocrine	22416012	.	10371	SEMA3A	C17E	EX17E	.	.	no-change	NM_006080.2	NP_006071.1	-	Y	c.2151A=	.	.	.	NM_006080.2(SEMA3A): c.2151A=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126374	0.386844	U	0.6915	0.612021	13006	0.416423	PASS	-890	8640	0.296991	9300	121366	0.386797	.	.	.	.	.	.	rs797821	.	4024	0.296000	-1.617	-1.352	-2.812	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	83590851	83590852	7q21.11	1	normal	.	T	snv	C	AT.GT	het-ref	213	0.50	.	2	.	PASS	603961	P	614897(SK)	NN	Hypogonadotropic hypogonadism 16 with or without anosmia	AD	.	Endocrine; Genitourinary; Neurologic	Endocrine	22416012	.	10371	SEMA3A	C17E	EX17E	.	.	coding-synon	NM_006080.2	NP_006071.1	-	Y	c.2151A>G	p.(T717=) | p.(Thr717=)	ACA=>ACG	.	NM_006080.2(SEMA3A): c.2151A>G (p.(T717=))	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126374	0.613156	U	0.6915	0.612021	13006	0.583577	PASS	2147	8640	0.703009	23039	121366	0.613203	4303	12162	7.05289e-01	47112	151581	6.15872e-01	rs797821	.	4024	0.704000	-1.617	-1.352	-2.812	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	194754	criteria_provided,_single_submitter	Benign	Likely Benign
7	87138644	87138645	7q21.12	0	normal	.	A	ref	A	AC.AT	het-alt	318	0.55	.	1	.	PASS	171050	C	120080(SK);612244(SK)	NN	Colchicine metabolism, association with	AD	.	General	Pharmacogenomic	21851199|18973929|17259950|7188928|7129432	.	5243	ABCB1	C25	EX27	ABC transporter;Predicted ATPase of the ABC class	PF00005.22;PF09818.4	no-change	NM_000927.4	NP_000918.2	-	Y	c.3435T=	.	.	.	NM_000927.4(ABCB1): c.3435T=	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,has-omim-omia,genotype-conflict	126374	0.492546	U	0.6022	0.604832	13006	0.423343	PASS	.	8632	0.375463	15945	121366	0.496564	.	.	.	.	.	.	rs1045642	.	4024	0.398900	-0.716	-1.682	-1.747	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	87138644	87138645	7q21.12	1	normal	.	A	snv	G	AC.AT	het-ref	257	0.45	.	2	.	PASS	171050	C	120080(SK);612244(SK)	NN	Colchicine metabolism, association with	AD	.	General	Pharmacogenomic	21851199|18973929|17259950|7188928|7129432	.	5243	ABCB1	C25	EX27	ABC transporter;Predicted ATPase of the ABC class	PF00005.22;PF09818.4	coding-synon	NM_000927.4	NP_000918.2	-	Y	c.3435T>C	p.(I1145=) | p.(Ile1145=)	ATT=>ATC	.	NM_000927.4(ABCB1): c.3435T>C (p.(I1145=))	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,has-omim-omia,genotype-conflict	126374	0.507454	U	0.6022	0.604832	13006	0.576657	PASS	1695	8632	0.624537	16362	121366	0.503436	3496	10906	6.32745e-01	32702	123561	5.02154e-01	rs1045642	.	4024	0.601100	-0.716	-1.682	-1.747	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	225939	reviewed_by_expert_panel	drug_response	Likely Benign
7	87160617	87160618	7q21.12	0	normal	.	A	ref	A	AG.AC	het-alt	174	0.53	.	1	.	PASS	171050	C	120080(SK);612244(SK)	NN	Colchicine metabolism, association with	AD	.	General	Pharmacogenomic	21851199|18973929|17259950|7188928|7129432	.	5243	ABCB1	C20	EX22	ABC transporter transmembrane region	PF00664.18	no-change	NM_000927.4	NP_000918.2	-	Y	c.2677T=	.	.	.	NM_000927.4(ABCB1): c.2677T=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict	126142	0.416245	U	0.4683	0.617013	13006	0.321928	PASS	-1023	8638	0.395462	11671	121134	0.419634	.	.	.	.	.	.	rs2032582	.	4024	0.415000	-0.187	2.078	0.319	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	87160617	87160618	7q21.12	1	normal	.	A	snv	C	AG.AC	het-ref	156	0.47	.	2	.	PASS	171050	C	120080(SK);612244(SK)	NN	Colchicine metabolism, association with	AD	.	General	Pharmacogenomic	21851199|18973929|17259950|7188928|7129432	.	5243	ABCB1	C20	EX22	ABC transporter transmembrane region	PF00664.18	missense	NM_000927.4	NP_000918.2	-	Y	c.2677T>G	p.S893A | p.Ser893Ala	TCT=>GCT	P0=>NP	NM_000927.4(ABCB1): c.2677T>G (p.S893A)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict	126142	0.546162	U	0.4683	0.617013	13006	0.678072	PASS	929	8638	0.465270	19017	121134	0.543233	1970	8191	4.75337e-01	37325	131738	5.36834e-01	rs2032582	.	4024	0.442800	-0.187	2.078	0.319	1	0.01	0	0.001	neutral	.	.	.	.	.	CM033585	NM_000927.4(ABCB1): c.2677T>G (p.S893A)	"Inflammatory bowel disease, association with"	14610718	DP	no_record	166622	reviewed_by_expert_panel	drug_response	Likely Benign
7	87229500	87229501	7q21.12	0	nullSample	.	T	ref	T	AT.CC	homo-ref	.	.	.	0	.	.	171050	C	120080(SK);612244(SK)	NN	Colchicine metabolism, association with	AD	.	General	Pharmacogenomic	21851199|18973929|17259950|7188928|7129432	.	5243	ABCB1	5U1	EX3	.	.	no-change	NM_000927.4	NP_000918.2	-	Y	c.-1A=	.	.	.	NM_000927.4(ABCB1): c.-1A=	;maf-5-some-pop	126148	0.054246	U	1	0.97524	13006	0.059357	PASS	.	8650	0.000116	259	121140	0.055465	.	.	.	.	.	.	rs2214102	.	.	.	-0.808	-0.962	-0.960	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	87229500	87229501	7q21.12	0	normal	.	T	snv	C	AT.CC	hom-alt	232	1.00	.	0	.	PASS	171050	C	120080(SK);612244(SK)	NN	Colchicine metabolism, association with	AD	.	General	Pharmacogenomic	21851199|18973929|17259950|7188928|7129432	.	5243	ABCB1	5U1	EX3	.	.	utr-5	NM_000927.4	NP_000918.2	-	Y	c.-1A>G	.	.	.	NM_000927.4(ABCB1): c.-1A>G	;maf-5-some-pop	126148	0.945754	U	1	0.97524	13006	0.940643	PASS	4324	8650	0.999884	54110	121140	0.944535	8620	17242	9.99884e-01	110305	232789	9.46343e-01	rs2214102	.	.	.	-0.808	-0.962	-0.960	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	88956698	88956699	7q21.13	0	normal	.	A	ref	A	GT.GC	het-alt	137	0.45	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	219578	ZNF804B	C3	EX3	.	.	no-change	NM_181646.2	NP_857597.1	+	Y	c.291A=	.	.	.	NM_181646.2(ZNF804B): c.291A=	;maf-5-some-pop,genotype-conflict	125774	0.765913	U	0.6716	0.30631	13002	0.820874	PASS	.	8620	0.295940	37020	120766	0.768908	.	.	.	.	.	.	rs38971	.	4024	0.290300	0.528	-0.146	-0.110	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	88956698	88956699	7q21.13	1	normal	.	A	snv	G	GT.GC	het-ref	169	0.55	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	219578	ZNF804B	C3	EX3	.	.	coding-synon	NM_181646.2	NP_857597.1	+	Y	c.291A>G	p.(V97=) | p.(Val97=)	GTA=>GTG	.	NM_181646.2(ZNF804B): c.291A>G (p.(V97=))	;maf-5-some-pop,genotype-conflict	125774	0.234087	U	0.6716	0.30631	13002	0.179126	PASS	2136	8620	0.704060	4545	120766	0.231092	4129	11832	6.99539e-01	9243	56932	2.34392e-01	rs38971	.	4024	0.709700	0.528	-0.146	-0.110	.	.	.	.	.	ENST00000333190: c.291A>G (p.V97V)	prostate [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4966403	.	.	.	.	.	.	.	.	.	Likely Benign
7	99270538	99270539	7q22.1	0	normal	.	C	snv	T	TA.TG	het-ref	169	0.45	.	2	.	PASS	605325	C	145500(SK)	NN	Drug metabolism, CYP3A5-related	AD	.	General	Pharmacogenomic	23033116|22875663|22706623|22407409|22304537|22210422|22015057|21412232|20212519|15284534|12065767|11740341	.	1577	CYP3A5	IC3	IVS3	.	.	intron	NM_000777.3	NP_000768.1	-	Y	c.219-237G>A	.	.	.	NM_000777.3(CYP3A5): c.219-237G>A	;maf-5-some-pop	5008	0.378594	U	0.2867	0.378594	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs776746	.	4024	0.275600	-0.521	-0.014	-0.049	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	226021	reviewed_by_expert_panel	drug_response	Benign
7	99270538	99270539	7q22.1	0	normal	.	C	ref	C	TA.TG	het-alt	206	0.55	.	1	.	PASS	605325	C	145500(SK)	NN	Drug metabolism, CYP3A5-related	AD	.	General	Pharmacogenomic	23033116|22875663|22706623|22407409|22304537|22210422|22015057|21412232|20212519|15284534|12065767|11740341	.	1577	CYP3A5	IC3	IVS3	.	.	no-change	NM_000777.3	NP_000768.1	-	Y	c.219-237G=	.	.	.	NM_000777.3(CYP3A5): c.219-237G=	;maf-5-some-pop	5008	0.621406	U	0.2867	0.378594	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs776746	.	4024	0.724400	-0.521	-0.014	-0.049	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	99382095	99382096	7q22.1	0	normal	.	C	snv	T	tc.tg	hom-alt	270	1.00	.	0	dup;L2c|LINE|L2|+|387	PASS	124010	C	.	NN	Drug metabolism, CYP3A4-related	AD	.	General	Pharmacogenomic	21946898|21903774|21902502|21902501|21047202|20440227|20437462|20386561|19907160|19802823|19337788|18973929|9789061	.	1576	CYP3A4	PROM	.	.	.	promoter	NM_017460.5	NP_059488.2	-	Y	c.-107-u285G>A	.	.	.	NM_017460.5(CYP3A4): c.-107-u285G>A	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	5008	0.769169	U	0.996	0.769169	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2740574	.	.	.	0.563	0.848	0.845	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	16916	reviewed_by_expert_panel	drug_response	Benign
7	99382095	99382096	7q22.1	0	nullSample	.	C	ref	C	tc.tg	homo-ref	.	.	.	0	dup;L2c|LINE|L2|+|387	.	124010	C	.	NN	Drug metabolism, CYP3A4-related	AD	.	General	Pharmacogenomic	21946898|21903774|21902502|21902501|21047202|20440227|20437462|20386561|19907160|19802823|19337788|18973929|9789061	.	1576	CYP3A4	PROM	.	.	.	no-change	NM_017460.5	NP_059488.2	-	Y	c.-107-u285G=	.	.	.	NM_017460.5(CYP3A4): c.-107-u285G=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	5008	0.230831	U	0.996	0.769169	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2740574	.	.	.	0.563	0.848	0.845	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	106508977	106508978	7q22.3	0	normal	.	A	snv	G	CC.CT	hom-alt	642	1.00	.	0	.	PASS	601232	C	.	NN	.	.	.	.	.	.	.	5294	PIK3CG	C1	EX2	.	.	no-change	NM_002649.2	NP_002640.2	+	Y	c.972G=	.	.	.	NM_002649.2(PIK3CG): c.972G=	SingleClassTriAllelic;maf-5-some-pop	126192	0.948634	U	0.995	0.939497	13006	0.917423	PASS	4310	8650	0.998266	54628	121184	0.949011	8588	17211	9.97971e-01	111636	234273	9.52167e-01	rs849389	.	.	.	-0.908	-4.142	-3.605	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	106508977	106508978	7q22.3	1	nullSample	.	A	ref	A	CC.CT	homo-ref	.	.	.	0	.	.	601232	C	.	NN	.	.	.	.	.	.	.	5294	PIK3CG	C1	EX2	.	.	coding-synon	NM_002649.2	NP_002640.2	+	Y	c.972G>A	p.(P324=) | p.(Pro324=)	CCG=>CCA	.	NM_002649.2(PIK3CG): c.972G>A (p.(P324=))	SingleClassTriAllelic;maf-5-some-pop	126192	0.051342	U	0.995	0.939497	13006	0.082577	PASS	-6	8650	0.001387	215	121184	0.050964	.	.	.	.	.	.	rs849389	.	.	.	-0.908	-4.142	-3.605	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
7	106508986	106508987	7q22.3	0	nullSample	.	T	ref	T	GA.GA	homo-ref	.	.	.	0	.	.	601232	C	.	NN	.	.	.	.	.	.	.	5294	PIK3CG	C1	EX2	.	.	no-change	NM_002649.2	NP_002640.2	+	Y	c.981T=	.	.	.	NM_002649.2(PIK3CG): c.981T=	;maf-5-some-pop	126166	0.050196	U	0.997	0.940895	13006	0.081270	PASS	-5	8644	0.001157	209	121158	0.049827	.	.	.	.	.	.	rs849390	.	4024	0.003000	-3.265	0.015	-0.779	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	106508986	106508987	7q22.3	1	normal	.	T	snv	C	GA.GA	hom-alt	661	1.00	.	0	.	PASS	601232	C	.	NN	.	.	.	.	.	.	.	5294	PIK3CG	C1	EX2	.	.	coding-synon	NM_002649.2	NP_002640.2	+	Y	c.981T>C	p.(D327=) | p.(Asp327=)	GAT=>GAC	.	NM_002649.2(PIK3CG): c.981T>C (p.(D327=))	;maf-5-some-pop	126166	0.949804	U	0.997	0.940895	13006	0.918730	PASS	4312	8644	0.998843	54751	121158	0.950173	8591	17211	9.98318e-01	111895	234544	9.53315e-01	rs849390	.	4024	0.997000	-3.265	0.015	-0.779	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
7	106519942	106519943	7q22.3	0	nullSample	.	T	ref	T	AA.AT	homo-ref	.	.	.	0	.	.	601232	C	.	NN	.	.	.	.	.	.	.	5294	PIK3CG	IC4	IVS5	.	.	no-change	NM_002649.2	NP_002640.2	+	Y	c.2392-21T=	.	.	.	NM_002649.2(PIK3CG): c.2392-21T=	;maf-5-some-pop	126392	0.051918	U	0.997	0.940695	13006	0.079194	PASS	-5	8654	0.001156	224	121384	0.051613	.	.	.	.	.	.	rs849370	.	4024	0.003000	-0.733	-0.404	0.009	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	106519942	106519943	7q22.3	0	normal	.	T	snv	C	AA.AT	hom-alt	428	1.00	.	0	.	PASS	601232	C	.	NN	.	.	.	.	.	.	.	5294	PIK3CG	IC4	IVS5	.	.	intron	NM_002649.2	NP_002640.2	+	Y	c.2392-21T>C	.	.	.	NM_002649.2(PIK3CG): c.2392-21T>C	;maf-5-some-pop	126392	0.948082	U	0.997	0.940695	13006	0.920806	PASS	4317	8654	0.998844	54651	121384	0.948387	8592	17213	9.98318e-01	111381	233957	9.51354e-01	rs849370	.	4024	0.997000	-0.733	-0.404	0.009	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	106522591	106522592	7q22.3	0	normal	.	A	ref	A	AG.CT	het-alt	238	0.56	.	1	.	PASS	601232	C	.	NN	.	.	.	.	.	.	.	5294	PIK3CG	C6	EX7	Phosphatidylinositol 3- and 4-kinase	PF00454.22	no-change	NM_002649.2	NP_002640.2	+	Y	c.2569A=	.	.	.	NM_002649.2(PIK3CG): c.2569A=	;maf-5-some-pop	126292	0.944177	U	0.0317	0.063099	13006	0.946563	PASS	-132	8652	0.967638	54174	121284	0.944477	.	.	.	.	.	.	rs28763991	.	4024	0.966900	0.533	0.905	1.015	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	106522591	106522592	7q22.3	1	normal	.	A	snv	G	AG.CT	het-ref	190	0.44	.	2	.	PASS	601232	C	.	NN	.	.	.	.	.	.	.	5294	PIK3CG	C6	EX7	Phosphatidylinositol 3- and 4-kinase	PF00454.22	missense	NM_002649.2	NP_002640.2	+	Y	c.2569A>G	p.T857A | p.Thr857Ala	ACT=>GCT	P0=>NP	NM_002649.2(PIK3CG): c.2569A>G (p.T857A)	;maf-5-some-pop	126292	0.055823	U	0.0317	0.063099	13006	0.053437	PASS	8	8652	0.032362	266	121284	0.055523	8	402	2.74628e-02	455	11729	5.25022e-02	rs28763991	.	4024	0.033100	0.533	0.905	1.015	0.49	0.002	0.001	0.011	neutral	ENST00000440650: c.2569A>G (p.T857A)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3762311	.	.	.	.	.	.	.	.	.	Likely Benign
7	116284568	116284569	7q31.2	0	normal	.	C	snv	T	TC.TT	het-ref	86	0.39	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.116284568C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.305711	U	0.1984	0.305711	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10215678	.	.	.	-0.269	0.250	0.225	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116284568	116284569	7q31.2	0	normal	.	C	ref	C	TC.TT	het-alt	134	0.61	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.116284568C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.694289	U	0.1984	0.305711	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10215678	.	.	.	-0.269	0.250	0.225	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116288117	116288118	7q31.2	0	normal	.	A	ref	A	TA.GG	het-alt	229	0.57	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.116288117A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.696086	U	0.2004	0.303914	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1002397	.	.	.	0.528	-0.247	-0.309	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116288117	116288118	7q31.2	0	normal	.	A	snv	G	TA.GG	het-ref	176	0.43	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.116288117A>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.303914	U	0.2004	0.303914	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1002397	.	.	.	0.528	-0.247	-0.309	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116296895	116296896	7q31.2	0	normal	.	C	ref	C	GT.AG	het-alt	195	0.57	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.116296895C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.446286	U	0.6895	0.553714	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs437	.	.	.	0.407	0.718	0.350	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116296895	116296896	7q31.2	0	normal	.	C	snv	T	GT.AG	het-ref	145	0.43	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.116296895C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.553714	U	0.6895	0.553714	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs437	.	.	.	0.407	0.718	0.350	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116304524	116304525	7q31.2	0	nullSample	.	C	ref	C	TG.CC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.116304524C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.131789	U	0.8849	0.868211	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs38834	.	.	.	-0.150	-0.808	-0.795	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116304524	116304525	7q31.2	0	normal	.	C	snv	T	TG.CC	hom-alt	304	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.116304524C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.868211	U	0.8849	0.868211	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs38834	.	.	.	-0.150	-0.808	-0.795	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116304537	116304538	7q31.2	0	nullSample	.	C	ref	C	AG.AG	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.116304537C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.131390	U	0.8849	0.86861	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs38835	.	.	.	0.655	0.594	0.598	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116304537	116304538	7q31.2	0	normal	.	C	snv	A	AG.AG	hom-alt	301	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.116304537C>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.868610	U	0.8849	0.86861	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs38835	.	.	.	0.655	0.594	0.598	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116314595	116314596	7q31.2	0	nullSample	.	T	ref	T	GA.CT	homo-ref	.	.	.	0	.	.	164860	C	114550(MK);605074(MK)	AD	Renal cell carcinoma, papillary	AD	.	Oncologic	Oncologic	22717761|19402075|9731534|9563489|9140397	FC59;H41;H54;H62;H68;HR14;MC58	4233	MET	I5U1	IVS1	.	.	no-change	NM_001127500.1	NP_001120972.1	+	Y	c.-15+1965T=	.	.	.	NM_001127500.1(MET): c.-15+1965T=	;maf-5-some-pop,maf-5-all-pops	5008	0.757188	U	0.2252	0.242812	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs60600263	.	.	.	-4.177	-0.752	-0.595	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116314595	116314596	7q31.2	0	normal	.	T	snv	A	GA.CT	hom-alt	176	1.00	.	0	.	PASS	164860	C	114550(MK);605074(MK)	AD	Renal cell carcinoma, papillary	AD	.	Oncologic	Oncologic	22717761|19402075|9731534|9563489|9140397	FC59;H41;H54;H62;H68;HR14;MC58	4233	MET	I5U1	IVS1	.	.	intron	NM_001127500.1	NP_001120972.1	+	Y	c.-15+1965T>A	.	.	.	NM_001127500.1(MET): c.-15+1965T>A	;maf-5-some-pop,maf-5-all-pops	5008	0.242812	U	0.2252	0.242812	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs60600263	.	.	.	-4.177	-0.752	-0.595	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116381121	116381123	7q31.2	0	normal	.	TT	del	.	tg.tt	het-ref	24	0.14	.	2	T-rich|Low_complexity|Low_complexity|+|58	PASS	164860	C	114550(MK);605074(MK)	AD	Renal cell carcinoma, papillary	AD	.	Oncologic	Oncologic	22717761|19402075|9731534|9563489|9140397	FC59;H41;H54;H62;H68;HR14;MC58	4233	MET	IC4	IVS5	.	.	intron	NM_001127500.1	NP_001120972.1	+	Y	c.1701+43_1701+44delTT	.	.	.	NM_001127500.1(MET): c.1701+43_1701+44delTT	MixedObserved;	0	0	U	.	.	.	.	VQSRTrancheINDEL99.00to99.50	0	3910	0.033504	0	59918	0.032311	.	.	.	.	.	.	rs796745354	.	4024	0.008900	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
7	116381121	116381123	7q31.2	0	normal	.	TT	ref	TT	tg.tt	het-alt	142	0.86	.	1	T-rich|Low_complexity|Low_complexity|+|58	PASS	164860	C	114550(MK);605074(MK)	AD	Renal cell carcinoma, papillary	AD	.	Oncologic	Oncologic	22717761|19402075|9731534|9563489|9140397	FC59;H41;H54;H62;H68;HR14;MC58	4233	MET	IC4	IVS5	.	.	no-change	NM_001127500.1	NP_001120972.1	+	Y	c.1701+43_1701+44=	.	.	.	NM_001127500.1(MET): c.1701+43_1701+44=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs796745354	.	4024	0.991100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116397571	116397572	7q31.2	0	normal	.	A	ref	A	CA.TA	het-alt	249	0.50	.	1	.	PASS	164860	C	114550(MK);605074(MK)	AD	Renal cell carcinoma, papillary	AD	.	Oncologic	Oncologic	22717761|19402075|9731534|9563489|9140397	FC59;H41;H54;H62;H68;HR14;MC58	4233	MET	C6	EX7	IPT/TIG domain	PF01833.19	no-change	NM_001127500.1	NP_001120972.1	+	Y	c.1944A=	.	.	.	NM_001127500.1(MET): c.1944A=	;maf-5-some-pop,maf-5-all-pops	125542	0.812182	U	0.2728	0.187899	11896	0.831288	PASS	-901	8612	0.699489	39947	120534	0.812186	.	.	.	.	.	.	rs13223756	.	4024	0.695600	0.477	-0.346	-1.499	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116397571	116397572	7q31.2	1	normal	.	A	snv	G	CA.TA	het-ref	245	0.50	.	2	.	PASS	164860	C	114550(MK);605074(MK)	AD	Renal cell carcinoma, papillary	AD	.	Oncologic	Oncologic	22717761|19402075|9731534|9563489|9140397	FC59;H41;H54;H62;H68;HR14;MC58	4233	MET	C6	EX7	IPT/TIG domain	PF01833.19	coding-synon	NM_001127500.1	NP_001120972.1	+	Y	c.1944A>G	p.(Q648=) | p.(Gln648=)	CAA=>CAG	.	NM_001127500.1(MET): c.1944A>G (p.(Q648=))	;maf-5-some-pop,maf-5-all-pops	125542	0.187818	U	0.2728	0.187899	11896	0.168712	PASS	393	8612	0.300511	2318	120534	0.187814	740	5066	2.93715e-01	4493	44933	1.82698e-01	rs13223756	.	4024	0.304400	0.477	-0.346	-1.499	.	.	.	.	.	ENST00000318493: c.1944A>G (p.Q648Q)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4419559	.	.	.	.	.	no_record	93569	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
7	116409675	116409676	7q31.2	0	normal	.	T	ref	T	CC.TT	het-alt	193	0.69	.	1	.	PASS	164860	C	114550(MK);605074(MK)	AD	Renal cell carcinoma, papillary	AD	.	Oncologic	Oncologic	22717761|19402075|9731534|9563489|9140397	FC59;H41;H54;H62;H68;HR14;MC58	4233	MET	IC10	IVS11	.	.	no-change	NM_001127500.1	NP_001120972.1	+	Y	c.2638-23T=	.	.	.	NM_001127500.1(MET): c.2638-23T=	MixedObserved;	5226|2	0.983927|0.500000	U	0	0.000599042	.	.	InbreedingCoeff_Filter	0	6	1.000000	28	218	0.628440	.	.	.	.	.	.	rs201491944|rs72220100	.	4024	0.569600	-0.460	0.503	0.374	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116409675	116409676	7q31.2	0	normal	.	T	del	.	CC.TT	het-ref	88	0.31	.	2	.	PASS	164860	C	114550(MK);605074(MK)	AD	Renal cell carcinoma, papillary	AD	.	Oncologic	Oncologic	22717761|19402075|9731534|9563489|9140397	FC59;H41;H54;H62;H68;HR14;MC58	4233	MET	IC10	IVS11	.	.	intron	NM_001127500.1	NP_001120972.1	+	Y	c.2638-23delT	.	.	.	NM_001127500.1(MET): c.2638-23delT	MixedObserved;	2	0.500000	U	.	.	.	.	InbreedingCoeff_Filter	0	6936	0.383795	107	101418	0.434972	.	.	.	.	.	.	rs72220100	.	4024	0.430200	-0.460	0.503	0.374	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116435767	116435768	7q31.2	0	normal	.	C	ref	C	GA.GT	het-alt	307	0.51	.	1	.	PASS	164860	C	114550(MK);605074(MK)	AD	Renal cell carcinoma, papillary	AD	.	Oncologic	Oncologic	22717761|19402075|9731534|9563489|9140397	FC59;H41;H54;H62;H68;HR14;MC58	4233	MET	C19	EX20	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	no-change	NM_001127500.1	NP_001120972.1	+	Y	c.3912C=	.	.	.	NM_001127500.1(MET): c.3912C=	;maf-5-some-pop	125744	0.579972	U	0.4673	0.352236	11994	0.676505	PASS	.	8612	0.543776	20827	120736	0.577160	.	.	.	.	.	.	rs41736	.	4024	0.551400	-1.616	-1.191	-3.368	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116435767	116435768	7q31.2	1	normal	.	C	snv	T	GA.GT	het-ref	297	0.49	.	2	.	PASS	164860	C	114550(MK);605074(MK)	AD	Renal cell carcinoma, papillary	AD	.	Oncologic	Oncologic	22717761|19402075|9731534|9563489|9140397	FC59;H41;H54;H62;H68;HR14;MC58	4233	MET	C19	EX20	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_001127500.1	NP_001120972.1	+	Y	c.3912C>T	p.(D1304=) | p.(Asp1304=)	GAC=>GAT	.	NM_001127500.1(MET): c.3912C>T (p.(D1304=))	;maf-5-some-pop	125744	0.420028	U	0.4673	0.352236	11994	0.323495	PASS	884	8612	0.456224	11511	120736	0.422840	1800	7913	4.58831e-01	24180	106398	4.32284e-01	rs41736	.	4024	0.448600	-1.616	-1.191	-3.368	.	.	.	.	.	ENST00000318493: c.3912C>T (p.D1304D)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	150377	.	.	.	.	.	no_record	93574	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
7	116436021	116436022	7q31.2	0	normal	.	G	ref	G	GC.AT	het-alt	317	0.53	.	1	.	PASS	164860	C	114550(MK);605074(MK)	AD	Renal cell carcinoma, papillary	AD	.	Oncologic	Oncologic	22717761|19402075|9731534|9563489|9140397	FC59;H41;H54;H62;H68;HR14;MC58	4233	MET	C20E	EX21E	.	.	no-change	NM_001127500.1	NP_001120972.1	+	Y	c.4071G=	.	.	.	NM_001127500.1(MET): c.4071G=	SingleClassTriAllelic;maf-5-some-pop	125738	0.578266	U	0.4673	0.353834	12220	0.677496	PASS	.	8606	0.543690	20718	120730	0.575449	.	.	.	.	.	.	rs2023748	.	4024	0.551400	-0.844	-2.469	-3.546	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116436021	116436022	7q31.2	1	normal	.	G	snv	A	GC.AT	het-ref	284	0.47	.	2	.	PASS	164860	C	114550(MK);605074(MK)	AD	Renal cell carcinoma, papillary	AD	.	Oncologic	Oncologic	22717761|19402075|9731534|9563489|9140397	FC59;H41;H54;H62;H68;HR14;MC58	4233	MET	C20E	EX21E	.	.	coding-synon	NM_001127500.1	NP_001120972.1	+	Y	c.4071G>A	p.(A1357=) | p.(Ala1357=)	GCG=>GCA	.	NM_001127500.1(MET): c.4071G>A (p.(A1357=))	SingleClassTriAllelic;maf-5-some-pop	125738	0.421710	U	0.4673	0.353834	12220	0.322504	PASS	884	8606	0.456310	11606	120730	0.424526	1800	7910	4.58923e-01	24363	106754	4.34048e-01	rs2023748	.	4024	0.448600	-0.844	-2.469	-3.546	.	.	.	.	.	ENST00000318493: c.4071G>A (p.A1357A)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	150378	.	.	.	.	.	no_record	93575	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
7	116436096	116436097	7q31.2	0	normal	.	G	ref	G	CC.TA	het-alt	314	0.54	.	1	.	PASS	164860	C	114550(MK);605074(MK)	AD	Renal cell carcinoma, papillary	AD	.	Oncologic	Oncologic	22717761|19402075|9731534|9563489|9140397	FC59;H41;H54;H62;H68;HR14;MC58	4233	MET	C20E	EX21E	.	.	no-change	NM_001127500.1	NP_001120972.1	+	Y	c.4146G=	.	.	.	NM_001127500.1(MET): c.4146G=	;maf-5-some-pop	125738	0.578011	U	0.4673	0.354633	12400	0.678952	PASS	-1080	8598	0.543150	20691	120730	0.575217	.	.	.	.	.	.	rs41737	.	4024	0.551400	-0.254	-0.042	-0.723	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116436096	116436097	7q31.2	1	normal	.	G	snv	A	CC.TA	het-ref	268	0.46	.	2	.	PASS	164860	C	114550(MK);605074(MK)	AD	Renal cell carcinoma, papillary	AD	.	Oncologic	Oncologic	22717761|19402075|9731534|9563489|9140397	FC59;H41;H54;H62;H68;HR14;MC58	4233	MET	C20E	EX21E	.	.	coding-synon	NM_001127500.1	NP_001120972.1	+	Y	c.4146G>A	p.(P1382=) | p.(Pro1382=)	CCG=>CCA	.	NM_001127500.1(MET): c.4146G>A (p.(P1382=))	;maf-5-some-pop	125738	0.421989	U	0.4673	0.354633	12400	0.321048	PASS	884	8598	0.456850	11610	120730	0.424783	1800	7912	4.58826e-01	24372	106783	4.34250e-01	rs41737	.	4024	0.448600	-0.254	-0.042	-0.723	.	.	.	.	.	ENST00000318493: c.4146G>A (p.P1382P)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	150379	.	.	.	.	.	no_record	93576	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
7	116441588	116441589	7q31.2	0	normal	.	A	ref	A	TT.AC	het-alt	109	0.50	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.116441588A= (intergenic)	;maf-5-some-pop,genotype-conflict	5008	0.644569	U	0.4673	0.355431	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs42336	.	.	.	-0.128	1.913	1.435	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116441588	116441589	7q31.2	0	normal	.	A	snv	G	TT.AC	het-ref	111	0.50	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.116441588A>G (intergenic)	;maf-5-some-pop,genotype-conflict	5008	0.355431	U	0.4673	0.355431	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs42336	.	.	.	-0.128	1.913	1.435	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116448802	116448803	7q31.2	0	nullSample	.	C	ref	C	TG.TT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.116448802C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.635184	U	0.5079	0.364816	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs56355906	.	.	.	0.650	-0.377	-0.407	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116448802	116448803	7q31.2	0	normal	.	C	snv	T	TG.TT	hom-alt	227	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.116448802C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.364816	U	0.5079	0.364816	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs56355906	.	.	.	0.650	-0.377	-0.407	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116448999	116449000	7q31.2	0	nullSample	.	G	ref	G	CC.CA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.116448999G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.291733	U	0.8968	0.708267	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs41750	.	.	.	-1.103	0.157	0.139	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116448999	116449000	7q31.2	0	normal	.	G	snv	A	CC.CA	hom-alt	181	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.116448999G>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.708267	U	0.8968	0.708267	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs41750	.	.	.	-1.103	0.157	0.139	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116456017	116456018	7q31.2	0	nullSample	.	G	ref	G	AC.TT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.116456017G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.631190	U	0.5129	0.36881	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs41756	.	.	.	-0.434	-0.105	-0.150	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116456017	116456018	7q31.2	0	normal	.	G	snv	A	AC.TT	hom-alt	207	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.116456017G>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.368810	U	0.5129	0.36881	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs41756	.	.	.	-0.434	-0.105	-0.150	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116456122	116456123	7q31.2	0	normal	.	A	snv	G	AA.TT	hom-alt	210	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.116456122A>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.368810	U	0.5129	0.36881	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs41757	.	.	.	0.443	0.568	0.518	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116456122	116456123	7q31.2	0	nullSample	.	A	ref	A	AA.TT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.116456122A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.631190	U	0.5129	0.36881	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs41757	.	.	.	0.443	0.568	0.518	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116468913	116468914	7q31.2	0	normal	.	G	snv	A	TA.CA	hom-alt	362	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.116468913G>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.597843	U	0.8006	0.597843	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs41770	.	.	.	-0.802	-0.111	-0.123	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116468913	116468914	7q31.2	0	nullSample	.	G	ref	G	TA.CA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.116468913G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.402157	U	0.8006	0.597843	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs41770	.	.	.	-0.802	-0.111	-0.123	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116479773	116479774	7q31.2	0	normal	.	A	snv	G	GA.GT	hom-alt	360	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.116479773A>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.724042	U	0.9087	0.724042	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs41776	.	.	.	-1.163	-0.346	-0.391	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116479773	116479774	7q31.2	0	nullSample	.	A	ref	A	GA.GT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.116479773A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.275958	U	0.9087	0.724042	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs41776	.	.	.	-1.163	-0.346	-0.391	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116484275	116484276	7q31.2	0	normal	.	G	snv	A	AC.CA	hom-alt	271	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.116484275G>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.721645	U	0.9087	0.721645	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs41783	.	.	.	-1.369	-0.157	-0.198	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	116484275	116484276	7q31.2	0	nullSample	.	G	ref	G	AC.CA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr7: g.116484275G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.278355	U	0.9087	0.721645	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs41783	.	.	.	-1.369	-0.157	-0.198	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	124475295	124475296	7q31.33	0	nullSample	.	T	ref	T	aa.aa	homo-ref	.	.	.	0	L1PA7|LINE|L1|+|1323	.	606478	P	615848(SK)	NN	.	.	.	.	.	.	.	25913	POT1	IC11	IVS15	.	.	no-change	NM_015450.2	NP_056265.2	-	Y	c.1505+37A=	.	.	.	NM_015450.2(POT1): c.1505+37A=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.172	1.080	0.485	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
7	124475296	124475296	7q31.33	0	normal	.	.	ins	AAACA	at.aa	hom-alt	237	1.00	.	0	L1PA7|LINE|L1|+|1323;trf	PASS	606478	P	615848(SK)	NN	.	.	.	.	.	.	.	25913	POT1	IC11	IVS15	.	.	intron	NM_015450.2	NP_056265.2	-	Y	c.1505+36_1505+37insTGTTT	.	.	.	NM_015450.2(POT1): c.1505+36_1505+37insTGTTT	MixedObserved,InconsistentAlleles;rs-cluster-nonoverlapping-alleles	48099	0.002807	U	.	.	.	.	PASS	326	8312	0.284288	3090	117752	0.225406	.	.	.	.	.	.	rs369649621	.	4024	0.141700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	124486979	124486980	7q31.33	0	nullSample	.	T	ref	T	AA.GA	homo-ref	.	.	.	0	.	.	606478	P	615848(SK)	NN	.	.	.	.	.	.	.	25913	POT1	IC8	IVS12	.	.	no-change	NM_015450.2	NP_056265.2	-	Y	c.1006+16A=	.	.	.	NM_015450.2(POT1): c.1006+16A=	;maf-5-some-pop,maf-5-all-pops	126166	0.303917	U	0.7986	0.721845	13006	0.289559	PASS	-681	8626	0.197774	5752	121158	0.304982	.	.	.	.	.	.	rs7794637	.	4024	0.201000	-2.871	-1.723	-1.794	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	124486979	124486980	7q31.33	1	normal	.	T	snv	C	AA.GA	hom-alt	284	1.00	.	0	.	PASS	606478	P	615848(SK)	NN	.	.	.	.	.	.	.	25913	POT1	IC8	IVS12	.	.	intron	NM_015450.2	NP_056265.2	-	Y	c.1006+16A>G	.	.	.	NM_015450.2(POT1): c.1006+16A>G	;maf-5-some-pop,maf-5-all-pops	126166	0.696083	U	0.7986	0.721845	13006	0.710441	PASS	2779	8626	0.802226	29380	121158	0.695018	5482	13719	7.98824e-01	59030	169672	6.92895e-01	rs7794637	.	4024	0.799000	-2.871	-1.723	-1.794	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	516585	criteria_provided,_single_submitter	Benign	Benign
7	124499001	124499002	7q31.33	0	nullSample	.	A	ref	A	CT.TA	homo-ref	.	.	.	0	.	.	606478	P	615848(SK)	NN	.	.	.	.	.	.	.	25913	POT1	IC5	IVS9	.	.	no-change	NM_015450.2	NP_056265.2	-	Y	c.702+9T=	.	.	.	NM_015450.2(POT1): c.702+9T=	MixedObserved;maf-5-some-pop,maf-5-all-pops	125756	0.410056	U	0.5089	0.582069	13006	0.902430	PASS	.	8598	0.503954	10152	120748	0.409729	.	.	.	.	.	.	rs6977407	.	4024	0.503500	-1.294	-1.697	-1.537	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	124499001	124499002	7q31.33	1	normal	.	A	snv	C	CT.TA	hom-alt	402	1.00	.	0	.	PASS	606478	P	615848(SK)	NN	.	.	.	.	.	.	.	25913	POT1	IC5	IVS9	.	.	intron	NM_015450.2	NP_056265.2	-	Y	c.702+9T>G	.	.	.	NM_015450.2(POT1): c.702+9T>G	MixedObserved;maf-5-some-pop,maf-5-all-pops	125756	0.589944	U	0.5089	0.582069	13006	0.097570	PASS	1053	8598	0.496046	21052	120748	0.590271	2033	8175	4.95515e-01	39733	135284	5.82809e-01	rs6977407	.	4024	0.496500	-1.294	-1.697	-1.537	.	.	.	.	.	ENST00000357628: c.702+9T>G (p.?)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	5428438	.	.	.	.	.	no_record	516584	criteria_provided,_single_submitter	Benign	Benign
7	124499002	124499003	7q31.33	0	nullSample	.	T	ref	T	TA.AC	homo-ref	.	.	.	0	.	.	606478	P	615848(SK)	NN	.	.	.	.	.	.	.	25913	POT1	IC5	IVS9	.	.	no-change	NM_015450.2	NP_056265.2	-	Y	c.702+8A=	.	.	.	NM_015450.2(POT1): c.702+8A=	MixedObserved;|MixedObserved;maf-5-some-pop,maf-5-all-pops	0|125804	0|0.410225	U	0.5099	0.582468	13006	0.849300	PASS	-1079	8600	0.503953	10173	120796	0.409923	.	.	.	.	.	.	rs201732238|rs6959712	.	4024	0.503500	-0.522	-0.261	0.113	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	124499002	124499003	7q31.33	1	normal	.	T	snv	A	TA.AC	hom-alt	407	1.00	.	0	.	PASS	606478	P	615848(SK)	NN	.	.	.	.	.	.	.	25913	POT1	IC5	IVS9	.	.	intron	NM_015450.2	NP_056265.2	-	Y	c.702+8A>T	.	.	.	NM_015450.2(POT1): c.702+8A>T	MixedObserved;|MixedObserved;maf-5-some-pop,maf-5-all-pops	0|125804	0|0.589775	U	0.5099	0.582468	13006	0.150700	PASS	1054	8600	0.496047	21054	120796	0.590077	2034	8179	4.94977e-01	39722	135266	5.82405e-01	rs201732238|rs6959712	.	4024	0.496500	-0.522	-0.261	0.113	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	516583	criteria_provided,_single_submitter	Benign	Benign
7	124537277	124537281	7q31.33	0	normal	.	AAAG	ref	AAAG	AA.AA	het-alt	118	0.52	.	1	.	PASS	606478	P	615848(SK)	NN	.	.	.	.	.	.	.	25913	POT1	I5U1	IVS4	.	.	no-change	NM_015450.2	NP_056265.2	-	Y	c.-39-15_-39-12=	.	.	.	NM_015450.2(POT1): c.-39-15_-39-12=	;	116456	0.998471	U	.	.	12364	0.999596	.	.	.	.	.	.	.	.	.	.	.	.	.	rs199955944	.	4024	0.973200	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	124537277	124537281	7q31.33	1	normal	.	AAAG	del	.	AA.AA	het-ref	111	0.48	.	2	.	PASS	606478	P	615848(SK)	NN	.	.	.	.	.	.	.	25913	POT1	I5U1	IVS4	.	.	intron	NM_015450.2	NP_056265.2	-	Y	c.-39-15_-39-12delCTTT	.	.	.	NM_015450.2(POT1): c.-39-15_-39-12delCTTT	;	116456	0.001528	U	.	.	12364	0.000404	PASS	1	8362	0.018775	1	116456	0.001528	2	275	1.95507e-02	2	311	1.56046e-03	rs199955944	.	4024	0.026800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	516603	criteria_provided,_single_submitter	Likely_benign	Likely Benign
7	128843168	128843169	7q32.1	0	normal	.	C	ref	C	TG.GT	het-alt	96	0.47	.	1	.	PASS	601500	P	601500(MK)	NN	.	.	.	.	.	.	.	6608	SMO	IC1	IVS1	.	.	no-change	NM_005631.4	NP_005622.1	+	Y	c.332-56C=	.	.	.	NM_005631.4(SMO): c.332-56C=	;maf-5-some-pop,maf-5-all-pops	5008	0.538538	U	0.4206	0.461462	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2566871	.	4024	0.611800	-0.360	-1.854	-1.582	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	128843168	128843169	7q32.1	0	normal	.	C	snv	T	TG.GT	het-ref	109	0.53	.	2	.	PASS	601500	P	601500(MK)	NN	.	.	.	.	.	.	.	6608	SMO	IC1	IVS1	.	.	intron	NM_005631.4	NP_005622.1	+	Y	c.332-56C>T	.	.	.	NM_005631.4(SMO): c.332-56C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.461462	U	0.4206	0.461462	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2566871	.	4024	0.388200	-0.360	-1.854	-1.582	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	128843428	128843429	7q32.1	0	normal	.	C	ref	C	CA.GG	het-alt	167	0.51	.	1	.	PASS	601500	P	601500(MK)	NN	.	.	.	.	.	.	.	6608	SMO	C2	EX2	.	.	no-change	NM_005631.4	NP_005622.1	+	Y	c.536C=	.	.	.	NM_005631.4(SMO): c.536C=	;	86376	0.999062	U	0.0069	0.00139776	.	.	PASS	-31	6420	0.990343	40610	81368	0.999091	.	.	.	.	.	.	rs115491500	.	4024	0.991100	0.563	3.779	2.584	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	128843428	128843429	7q32.1	1	normal	.	C	snv	T	CA.GG	het-ref	158	0.49	.	2	.	PASS	601500	P	601500(MK)	NN	.	.	.	.	.	.	.	6608	SMO	C2	EX2	.	.	missense	NM_005631.4	NP_005622.1	+	Y	c.536C>T	p.T179M | p.Thr179Met	ACG=>ATG	P0=>NP	NM_005631.4(SMO): c.536C>T (p.T179M)	;	86376	0.000938	U	0.0069	0.00139776	.	.	PASS	0	6420	0.009657	0	81368	0.000909	1	140	8.31255e-03	1	157	7.00887e-04	rs115491500	.	4024	0.008900	0.563	3.779	2.584	0.09	0.856	0.996	0.627	deleterious	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
7	128845017	128845018	7q32.1	0	nullSample	.	C	ref	C	CA.CG	homo-ref	.	.	.	0	.	.	601500	P	601500(MK)	NN	.	.	.	.	.	.	.	6608	SMO	IC2	IVS2	.	.	no-change	NM_005631.4	NP_005622.1	+	Y	c.538-26C=	.	.	.	NM_005631.4(SMO): c.538-26C=	;maf-5-some-pop,maf-5-all-pops	125980	0.205771	U	0.756	0.752396	13006	0.212056	PASS	-795	8608	0.242100	2758	120972	0.204039	.	.	.	.	.	.	rs2703091	.	4024	0.252200	0.555	-0.210	-0.569	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	128845017	128845018	7q32.1	0	normal	.	C	snv	T	CA.CG	hom-alt	313	1.00	.	0	.	PASS	601500	P	601500(MK)	NN	.	.	.	.	.	.	.	6608	SMO	IC2	IVS2	.	.	intron	NM_005631.4	NP_005622.1	+	Y	c.538-26C>T	.	.	.	NM_005631.4(SMO): c.538-26C>T	;maf-5-some-pop,maf-5-all-pops	125980	0.794229	U	0.756	0.752396	13006	0.787944	PASS	2467	8608	0.757900	38561	120972	0.795961	4957	13034	7.57350e-01	78391	195332	7.96682e-01	rs2703091	.	4024	0.747800	0.555	-0.210	-0.569	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	128845276	128845277	7q32.1	0	nullSample	.	G	ref	G	CC.GG	homo-ref	.	.	.	0	.	.	601500	P	601500(MK)	NN	.	.	.	.	.	.	.	6608	SMO	IC3	IVS3	.	.	no-change	NM_005631.4	NP_005622.1	+	Y	c.747+24G=	.	.	.	NM_005631.4(SMO): c.747+24G=	MixedObserved,SingleClassQuadAllelic;maf-5-some-pop,rs-cluster-nonoverlapping-alleles|MixedObserved;	100298|89050	0.200752|0.999989	U	0.756	0.751997	12954	0.209433	PASS	.	6232	0.234435	1801	95290	0.198268	.	.	.	.	.	.	rs2075777|rs773968967	.	4024	0.252000	0.511	-2.898	-2.950	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	128845276	128845277	7q32.1	0	normal	.	G	snv	C	CC.GG	hom-alt	358	1.00	.	0	.	PASS	601500	P	601500(MK)	NN	.	.	.	.	.	.	.	6608	SMO	IC3	IVS3	.	.	intron	NM_005631.4	NP_005622.1	+	Y	c.747+24G>C	.	.	.	NM_005631.4(SMO): c.747+24G>C	MixedObserved,SingleClassQuadAllelic;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	100298	0.798790	U	0.756	0.751997	12954	0.790567	PASS	1797	6232	0.765565	30520	95290	0.801249	4451	11706	7.58259e-01	70411	175800	7.96383e-01	rs2075777	.	4024	0.747500	0.511	-2.898	-2.950	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	128845701	128845702	7q32.1	0	nullSample	.	C	ref	C	TG.GT	homo-ref	.	.	.	0	.	.	601500	P	601500(MK)	NN	.	.	.	.	.	.	.	6608	SMO	IC4	IVS4	.	.	no-change	NM_005631.4	NP_005622.1	+	Y	c.920+79C=	.	.	.	NM_005631.4(SMO): c.920+79C=	;maf-5-some-pop,maf-5-all-pops	5008	0.247204	U	0.756	0.752796	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2075778	.	4024	0.252700	0.491	0.103	0.488	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	128845701	128845702	7q32.1	0	normal	.	C	snv	T	TG.GT	hom-alt	237	1.00	.	0	.	PASS	601500	P	601500(MK)	NN	.	.	.	.	.	.	.	6608	SMO	IC4	IVS4	.	.	intron	NM_005631.4	NP_005622.1	+	Y	c.920+79C>T	.	.	.	NM_005631.4(SMO): c.920+79C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.752796	U	0.756	0.752796	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2075778	.	4024	0.747300	0.491	0.103	0.488	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	128846327	128846328	7q32.1	0	nullSample	.	G	ref	G	GG.AT	homo-ref	.	.	.	0	.	.	601500	P	601500(MK)	NN	.	.	.	.	.	.	.	6608	SMO	C6	EX6	Frizzled/Smoothened family membrane region;Slime mold cyclic AMP receptor	PF01534.12;PF05462.6	no-change	NM_005631.4	NP_005622.1	+	Y	c.1164G=	.	.	.	NM_005631.4(SMO): c.1164G=	;maf-5-some-pop,maf-5-all-pops	126402	0.204150	U	0.7718	0.75619	13006	0.210364	PASS	-773	8650	0.230520	2749	121394	0.202514	.	.	.	.	.	.	rs2228617	.	4024	0.244500	-0.216	2.176	1.256	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	128846327	128846328	7q32.1	1	normal	.	G	snv	C	GG.AT	hom-alt	592	1.00	.	0	.	PASS	601500	P	601500(MK)	NN	.	.	.	.	.	.	.	6608	SMO	C6	EX6	Frizzled/Smoothened family membrane region;Slime mold cyclic AMP receptor	PF01534.12;PF05462.6	coding-synon	NM_005631.4	NP_005622.1	+	Y	c.1164G>C	p.(G388=) | p.(Gly388=)	GGG=>GGC	.	NM_005631.4(SMO): c.1164G>C (p.(G388=))	;maf-5-some-pop,maf-5-all-pops	126402	0.795850	U	0.7718	0.75619	13006	0.789636	PASS	2555	8650	0.769480	38862	121394	0.797486	5130	13273	7.69538e-01	79023	196537	7.98172e-01	rs2228617	.	4024	0.755500	-0.216	2.176	1.256	.	.	.	.	.	ENST00000249373: c.1164G>C (p.G388G)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4004294	.	.	.	.	.	no_record	403462	criteria_provided,_single_submitter	Benign	Likely Benign
7	128846468	128846469	7q32.1	0	nullSample	.	A	ref	A	AT.TA	homo-ref	.	.	.	0	.	.	601500	P	601500(MK)	NN	.	.	.	.	.	.	.	6608	SMO	IC6	IVS6	.	.	no-change	NM_005631.4	NP_005622.1	+	Y	c.1264+41A=	.	.	.	NM_005631.4(SMO): c.1264+41A=	;maf-5-some-pop,maf-5-all-pops	125250	0.204639	U	0.756	0.753195	13006	0.210518	PASS	.	8638	0.240218	2720	120242	0.202883	.	.	.	.	.	.	rs2735842	.	4024	0.252500	-1.050	-0.175	0.017	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	128846468	128846469	7q32.1	0	normal	.	A	snv	G	AT.TA	hom-alt	331	1.00	.	0	.	PASS	601500	P	601500(MK)	NN	.	.	.	.	.	.	.	6608	SMO	IC6	IVS6	.	.	intron	NM_005631.4	NP_005622.1	+	Y	c.1264+41A>G	.	.	.	NM_005631.4(SMO): c.1264+41A>G	;maf-5-some-pop,maf-5-all-pops	125250	0.795361	U	0.756	0.753195	13006	0.789482	PASS	2490	8638	0.759782	38446	120242	0.797117	4972	13059	7.57834e-01	77393	192776	7.97036e-01	rs2735842	.	4024	0.747500	-1.050	-0.175	0.017	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	138189189	138189192	7q33	0	normal	.	CTC	del	.	AG.tt	het-ref	36	0.36	.	2	.	PASS	603406	P	188550(MK)	AD	.	.	.	.	.	.	.	8805	TRIM24	IC2	IVS2	.	.	intron	NM_015905.2	NP_056989.2	+	Y	c.483+37_483+39delCTC	.	.	.	NM_015905.2(TRIM24): c.483+37_483+39delCTC	MixedObserved,AlleleFreqSumNot1;maf-5-some-pop	161	0.043338	U	0.0317	0.0321486	.	.	PASS	584	6888	0.380952	2609	90152	0.214504	.	.	.	.	.	.	rs148040062	.	4036	0.289900	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	138189189	138189192	7q33	0	normal	.	CTC	ref	CTC	AG.tt	het-alt	64	0.64	.	1	.	PASS	603406	P	188550(MK)	AD	.	.	.	.	.	.	.	8805	TRIM24	IC2	IVS2	.	.	no-change	NM_015905.2	NP_056989.2	+	Y	c.483+37_483+39=	.	.	.	NM_015905.2(TRIM24): c.483+37_483+39=	.	.	.	.	.	.	.	.	VQSRTrancheINDEL97.00to99.00	0	1084	0.998155	15206	30426	0.999704	.	.	.	.	.	.	.	.	4036	0.706700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140434596	140434597	7q34	0	nullSample	.	G	ref	G	aa.aa	homo-ref	.	.	.	0	trf;(A)n|Simple_repeat|Simple_repeat|+|82	.	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC17	IVS17	.	.	no-change	NM_004333.4	NP_004324.2	-	Y	c.2128-27C=	.	.	.	NM_004333.4(BRAF): c.2128-27C=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs200465027|rs374747052	.	4067	0.986600	-0.856	-0.801	-0.847	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140434597	140434597	7q34	0	normal	.	.	ins	A	ag.aa	hom-alt	89	0.93	.	0	trf;(A)n|Simple_repeat|Simple_repeat|+|82	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC17	IVS17	.	.	intron	NM_004333.4	NP_004324.2	-	Y	c.2128-28_2128-27insT	.	.	.	NM_004333.4(BRAF): c.2128-28_2128-27insT	MixedObserved,ObservedTooLong;rs-cluster-nonoverlapping-alleles	2	0.500000	U	.	.	.	.	PASS	1230	2930	0.918089	22155	58378	0.874165	.	.	.	.	.	.	rs60814637	.	4024	0.670000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	359047	criteria_provided,_single_submitter	Uncertain_significance	Benign
7	140434619	140434620	7q34	0	normal	.	A	ref	A	aa.aa	het-alt	78	0.53	.	1	trf;(A)n|Simple_repeat|Simple_repeat|+|82	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC17	IVS17	.	.	no-change	NM_004333.4	NP_004324.2	-	Y	c.2128-50T=	.	.	.	NM_004333.4(BRAF): c.2128-50T=	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs55806659	.	4018	0.929800	-0.359	0.471	0.313	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140434620	140434620	7q34	0	normal	.	.	ins	AAAG	aa.aa	het-ref	69	0.47	.	2	trf;(A)n|Simple_repeat|Simple_repeat|+|82	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC17	IVS17	.	.	intron	NM_004333.4	NP_004324.2	-	Y	c.2128-51_2128-50insCTTT	.	.	.	NM_004333.4(BRAF): c.2128-51_2128-50insCTTT	InconsistentAlleles;rs-cluster-nonoverlapping-alleles	38623	1.000000	U	.	.	.	.	PASS	0	1348	0.016320	60	41088	0.042543	.	.	.	.	.	.	rs145368076	.	4018	0.085600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140449070	140449071	7q34	0	normal	.	C	ref	C	GA.GT	het-alt	254	0.55	.	1	.	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC16	IVS16	.	.	no-change	NM_004333.4	NP_004324.2	-	Y	c.1992+16G=	.	.	.	NM_004333.4(BRAF): c.1992+16G=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	125764	0.784247	U	0.1825	0.348043	13006	0.684069	PASS	-641	8612	0.819322	39144	120756	0.789733	.	.	.	.	.	.	rs3789806	.	4024	0.815900	-0.322	0.210	0.392	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140449070	140449071	7q34	1	normal	.	C	snv	G	GA.GT	het-ref	210	0.45	.	2	.	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC16	IVS16	.	.	intron	NM_004333.4	NP_004324.2	-	Y	c.1992+16G>C	.	.	.	NM_004333.4(BRAF): c.1992+16G>C	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	125764	0.214974	U	0.1825	0.348043	13006	0.315931	PASS	137	8612	0.180330	4146	120756	0.209455	308	3199	1.85794e-01	7371	48649	1.98481e-01	rs3789806	.	4024	0.183900	-0.322	0.210	0.392	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	40393	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
7	140449149	140449150	7q34	0	normal	.	T	ref	T	AT.CC	het-alt	273	0.54	.	1	.	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	C16	EX16	Protein kinase domain;Protein tyrosine kinase;Kinase-like	PF00069.20;PF07714.12;PF14531.1	no-change	NM_004333.4	NP_004324.2	-	Y	c.1929A=	.	.	.	NM_004333.4(BRAF): c.1929A=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125844	0.782119	U	0.1825	0.351038	13006	0.679994	PASS	.	8628	0.818846	39017	120836	0.787638	.	.	.	.	.	.	rs9648696	.	4024	0.815900	-0.355	1.139	-0.010	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140449149	140449150	7q34	1	normal	.	T	snv	C	AT.CC	het-ref	233	0.46	.	2	.	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	C16	EX16	Protein kinase domain;Protein tyrosine kinase;Kinase-like	PF00069.20;PF07714.12;PF14531.1	coding-synon	NM_004333.4	NP_004324.2	-	Y	c.1929A>G	p.(G643=) | p.(Gly643=)	GGA=>GGG	.	NM_004333.4(BRAF): c.1929A>G (p.(G643=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125844	0.217881	U	0.1825	0.351038	13006	0.320006	PASS	139	8628	0.181154	4260	120836	0.212362	310	3220	1.86753e-01	7554	49388	2.01162e-01	rs9648696	.	4024	0.184100	-0.355	1.139	-0.010	.	.	.	.	.	ENST00000288602: c.1929A>G (p.G643G)	kidney [NS|NS|NS]	Wilms_tumour [NS|NS|NS]	CSV	4161857	.	.	.	.	.	no_record	40391	reviewed_by_expert_panel	Benign	Likely Benign
7	140482262	140482263	7q34	0	normal	.	C	ref	C	TC.AA	het-alt	131	0.64	.	1	.	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC10	IVS10	.	.	no-change	NM_004333.4	NP_004324.2	-	Y	c.1314+558G=	.	.	.	NM_004333.4(BRAF): c.1314+558G=	.	.	.	.	0.1111	0.210663	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.973400	-1.637	-2.201	-2.744	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140482263	140482263	7q34	0	normal	.	.	ins	AA	CC.AA	het-ref	73	0.36	.	2	.	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC10	IVS10	.	.	intron	NM_004333.4	NP_004324.2	-	Y	c.1314+557_1314+558insTT	.	.	.	NM_004333.4(BRAF): c.1314+557_1314+558insTT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.061100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140482426	140482427	7q34	0	normal	.	T	ref	T	ca.ac	het-alt	260	0.52	.	1	L1PA8|LINE|L1|-|88	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC10	IVS10	.	.	no-change	NM_004333.4	NP_004324.2	-	Y	c.1314+394A=	.	.	.	NM_004333.4(BRAF): c.1314+394A=	;maf-5-some-pop	5008	0.871406	U	0.0962	0.128594	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1267642	.	4024	0.910000	-1.677	-1.782	-1.623	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140482426	140482427	7q34	0	normal	.	T	snv	C	ca.ac	het-ref	238	0.48	.	2	L1PA8|LINE|L1|-|88	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC10	IVS10	.	.	intron	NM_004333.4	NP_004324.2	-	Y	c.1314+394A>G	.	.	.	NM_004333.4(BRAF): c.1314+394A>G	;maf-5-some-pop	5008	0.128594	U	0.0962	0.128594	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1267642	.	4024	0.090000	-1.677	-1.782	-1.623	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140483399	140483400	7q34	0	normal	.	T	ref	T	AA.CC	het-alt	308	0.53	.	1	.	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC9	IVS9	.	.	no-change	NM_004333.4	NP_004324.2	-	Y	c.1178-443A=	.	.	.	NM_004333.4(BRAF): c.1178-443A=	;maf-5-some-pop	5008	0.652556	U	0.1825	0.347444	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1267643	.	4024	0.816400	-3.154	-0.617	-0.655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140483399	140483400	7q34	0	normal	.	T	snv	C	AA.CC	het-ref	272	0.47	.	2	.	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC9	IVS9	.	.	intron	NM_004333.4	NP_004324.2	-	Y	c.1178-443A>G	.	.	.	NM_004333.4(BRAF): c.1178-443A>G	;maf-5-some-pop	5008	0.347444	U	0.1825	0.347444	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1267643	.	4024	0.183600	-3.154	-0.617	-0.655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140483604	140483605	7q34	0	normal	.	C	ref	C	GC.GG	het-alt	372	0.53	.	1	.	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC9	IVS9	.	.	no-change	NM_004333.4	NP_004324.2	-	Y	c.1178-648G=	.	.	.	NM_004333.4(BRAF): c.1178-648G=	;maf-5-some-pop	5008	0.870407	U	0.0952	0.129593	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1267644	.	4024	0.909800	-0.309	-0.321	-0.326	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140483604	140483605	7q34	0	normal	.	C	snv	T	GC.GG	het-ref	333	0.47	.	2	.	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC9	IVS9	.	.	intron	NM_004333.4	NP_004324.2	-	Y	c.1178-648G>A	.	.	.	NM_004333.4(BRAF): c.1178-648G>A	;maf-5-some-pop	5008	0.129593	U	0.0952	0.129593	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1267644	.	4024	0.090200	-0.309	-0.321	-0.326	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140484450	140484451	7q34	0	normal	.	T	ref	T	ac.tt	het-alt	133	0.83	.	1	AluSx1|SINE|Alu|-|303	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC9	IVS9	.	.	no-change	NM_004333.4	NP_004324.2	-	Y	c.1178-1494A=	.	.	.	NM_004333.4(BRAF): c.1178-1494A=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.849200	0.383	0.589	0.554	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140484450	140484451	7q34	0	normal	.	T	del	.	ac.tt	het-ref	27	0.17	.	2	AluSx1|SINE|Alu|-|303	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC9	IVS9	.	.	intron	NM_004333.4	NP_004324.2	-	Y	c.1178-1494delA	.	.	.	NM_004333.4(BRAF): c.1178-1494delA	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.150800	0.383	0.589	0.554	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140485334	140485335	7q34	0	normal	.	T	ref	T	CG.AC	het-alt	373	0.52	.	1	.	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC9	IVS9	.	.	no-change	NM_004333.4	NP_004324.2	-	Y	c.1177+2013A=	.	.	.	NM_004333.4(BRAF): c.1177+2013A=	;maf-5-some-pop,maf-5-all-pops	5008	0.652955	U	0.1796	0.347045	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1267645	.	4024	0.816800	-0.128	2.085	1.402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140485334	140485335	7q34	0	normal	.	T	snv	C	CG.AC	het-ref	348	0.48	.	2	.	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC9	IVS9	.	.	intron	NM_004333.4	NP_004324.2	-	Y	c.1177+2013A>G	.	.	.	NM_004333.4(BRAF): c.1177+2013A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.347045	U	0.1796	0.347045	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1267645	.	4024	0.183200	-0.128	2.085	1.402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140485689	140485690	7q34	0	normal	.	C	ref	C	AA.AA	het-alt	400	0.52	.	1	.	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC9	IVS9	.	.	no-change	NM_004333.4	NP_004324.2	-	Y	c.1177+1658G=	.	.	.	NM_004333.4(BRAF): c.1177+1658G=	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	5008	0.652955	U	0.1796	0.347045	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1267646	.	4024	0.817300	-1.044	0.811	0.045	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140485689	140485690	7q34	0	normal	.	C	snv	T	AA.AA	het-ref	374	0.48	.	2	.	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC9	IVS9	.	.	intron	NM_004333.4	NP_004324.2	-	Y	c.1177+1658G>A	.	.	.	NM_004333.4(BRAF): c.1177+1658G>A	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	5008	0.347045	U	0.1796	0.347045	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1267646	.	4024	0.182700	-1.044	0.811	0.045	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140486287	140486288	7q34	0	normal	.	C	ref	C	GA.AG	het-alt	366	0.52	.	1	.	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC9	IVS9	.	.	no-change	NM_004333.4	NP_004324.2	-	Y	c.1177+1060G=	.	.	.	NM_004333.4(BRAF): c.1177+1060G=	;maf-5-some-pop	5008	0.652955	U	0.1796	0.347045	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1267647	.	4024	0.816800	-1.177	-1.984	-1.630	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140486287	140486288	7q34	0	normal	.	C	snv	T	GA.AG	het-ref	333	0.48	.	2	.	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC9	IVS9	.	.	intron	NM_004333.4	NP_004324.2	-	Y	c.1177+1060G>A	.	.	.	NM_004333.4(BRAF): c.1177+1060G>A	;maf-5-some-pop	5008	0.347045	U	0.1796	0.347045	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1267647	.	4024	0.183200	-1.177	-1.984	-1.630	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140486742	140486743	7q34	0	normal	.	T	ref	T	ca.cc	het-alt	164	0.51	.	1	5S|rRNA|rRNA|+|51	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC9	IVS9	.	.	no-change	NM_004333.4	NP_004324.2	-	Y	c.1177+605A=	.	.	.	NM_004333.4(BRAF): c.1177+605A=	;maf-5-some-pop,maf-5-all-pops	5008	0.871206	U	0.0952	0.128794	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1270193	.	4024	0.910000	0.260	0.022	0.263	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140486742	140486743	7q34	0	normal	.	T	snv	C	ca.cc	het-ref	155	0.49	.	2	5S|rRNA|rRNA|+|51	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC9	IVS9	.	.	intron	NM_004333.4	NP_004324.2	-	Y	c.1177+605A>G	.	.	.	NM_004333.4(BRAF): c.1177+605A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.128794	U	0.0952	0.128794	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1270193	.	4024	0.090000	0.260	0.022	0.263	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140487201	140487202	7q34	0	normal	.	C	ref	C	AA.AC	het-alt	269	0.53	.	1	.	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC9	IVS9	.	.	no-change	NM_004333.4	NP_004324.2	-	Y	c.1177+146G=	.	.	.	NM_004333.4(BRAF): c.1177+146G=	;maf-5-some-pop,maf-5-all-pops	5008	0.652955	U	0.1796	0.347045	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1267632	.	4024	0.817100	-0.360	0.071	-0.127	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140487201	140487202	7q34	0	normal	.	C	snv	T	AA.AC	het-ref	239	0.47	.	2	.	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC9	IVS9	.	.	intron	NM_004333.4	NP_004324.2	-	Y	c.1177+146G>A	.	.	.	NM_004333.4(BRAF): c.1177+146G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.347045	U	0.1796	0.347045	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1267632	.	4024	0.182900	-0.360	0.071	-0.127	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	561364	criteria_provided,_single_submitter	Benign	Benign
7	140488155	140488156	7q34	0	normal	.	T	ref	T	at.tc	het-alt	231	0.53	.	1	L1ME4a|LINE|L1|+|243	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC8	IVS8	.	.	no-change	NM_004333.4	NP_004324.2	-	Y	c.1141-772A=	.	.	.	NM_004333.4(BRAF): c.1141-772A=	;maf-5-some-pop,maf-5-all-pops	5008	0.871206	U	0.0962	0.128794	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1267633	.	4024	0.910000	0.421	0.703	0.651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140488155	140488156	7q34	0	normal	.	T	snv	G	at.tc	het-ref	207	0.47	.	2	L1ME4a|LINE|L1|+|243	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC8	IVS8	.	.	intron	NM_004333.4	NP_004324.2	-	Y	c.1141-772A>C	.	.	.	NM_004333.4(BRAF): c.1141-772A>C	;maf-5-some-pop,maf-5-all-pops	5008	0.128794	U	0.0962	0.128794	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1267633	.	4024	0.090000	0.421	0.703	0.651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140489018	140489019	7q34	0	normal	.	C	ref	C	aa.aa	het-alt	105	0.44	.	1	AluSg|SINE|Alu|+|300	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC8	IVS8	.	.	no-change	NM_004333.4	NP_004324.2	-	Y	c.1141-1635G=	.	.	.	NM_004333.4(BRAF): c.1141-1635G=	;	0	0	U	0.1071	0.150559	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs199996153	.	.	.	-1.601	-1.147	-1.204	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140489019	140489019	7q34	0	normal	.	.	ins	A	ac.aa	het-ref	134	0.56	.	2	AluSg|SINE|Alu|+|300	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC8	IVS8	.	.	intron	NM_004333.4	NP_004324.2	-	Y	c.1141-1636_1141-1635insT	.	.	.	NM_004333.4(BRAF): c.1141-1636_1141-1635insT	InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	5008	0.150559	U	0.1071	0.150559	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs201489839	.	4024	0.207000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140490381	140490382	7q34	0	normal	.	C	ref	C	GG.AA	het-alt	370	0.54	.	1	.	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC8	IVS8	.	.	no-change	NM_004333.4	NP_004324.2	-	Y	c.1141-2998G=	.	.	.	NM_004333.4(BRAF): c.1141-2998G=	;maf-5-some-pop,maf-5-all-pops	5008	0.652756	U	0.1796	0.347244	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1267634	.	4024	0.817300	-0.490	-1.437	-1.524	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140490381	140490382	7q34	0	normal	.	C	snv	T	GG.AA	het-ref	319	0.46	.	2	.	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC8	IVS8	.	.	intron	NM_004333.4	NP_004324.2	-	Y	c.1141-2998G>A	.	.	.	NM_004333.4(BRAF): c.1141-2998G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.347244	U	0.1796	0.347244	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1267634	.	4024	0.182700	-0.490	-1.437	-1.524	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140490927	140490928	7q34	0	normal	.	C	ref	C	aa.cc	het-alt	176	0.50	.	1	AluSx|SINE|Alu|+|322	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC8	IVS8	.	.	no-change	NM_004333.4	NP_004324.2	-	Y	c.1140+3180G=	.	.	.	NM_004333.4(BRAF): c.1140+3180G=	;maf-5-some-pop,maf-5-all-pops	5008	0.652756	U	0.1796	0.347244	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs986050	.	4020	0.816900	-1.241	-1.145	-1.216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140490927	140490928	7q34	0	normal	.	C	snv	A	aa.cc	het-ref	173	0.50	.	2	AluSx|SINE|Alu|+|322	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC8	IVS8	.	.	intron	NM_004333.4	NP_004324.2	-	Y	c.1140+3180G>T	.	.	.	NM_004333.4(BRAF): c.1140+3180G>T	;maf-5-some-pop,maf-5-all-pops	5008	0.347244	U	0.1796	0.347244	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs986050	.	4020	0.183100	-1.241	-1.145	-1.216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140491677	140491678	7q34	0	normal	.	G	ref	G	gt.ta	het-alt	348	0.49	.	1	MIR|SINE|MIR|+|243	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC8	IVS8	.	.	no-change	NM_004333.4	NP_004324.2	-	Y	c.1140+2430C=	.	.	.	NM_004333.4(BRAF): c.1140+2430C=	;maf-5-some-pop,maf-5-all-pops	5008	0.652756	U	0.1796	0.347244	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1267635	.	4024	0.817100	-1.298	-0.011	-0.045	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140491677	140491678	7q34	0	normal	.	G	snv	A	gt.ta	het-ref	357	0.51	.	2	MIR|SINE|MIR|+|243	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC8	IVS8	.	.	intron	NM_004333.4	NP_004324.2	-	Y	c.1140+2430C>T	.	.	.	NM_004333.4(BRAF): c.1140+2430C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.347244	U	0.1796	0.347244	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1267635	.	4024	0.182900	-1.298	-0.011	-0.045	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140492038	140492039	7q34	0	normal	.	T	ref	T	ta.tg	het-alt	401	0.50	.	1	L2b|LINE|L2|+|719	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC8	IVS8	.	.	no-change	NM_004333.4	NP_004324.2	-	Y	c.1140+2069A=	.	.	.	NM_004333.4(BRAF): c.1140+2069A=	;maf-5-some-pop	5008	0.858626	U	0.0962	0.141374	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1267636	.	4024	0.910000	0.260	-1.866	-1.991	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140492038	140492039	7q34	0	normal	.	T	snv	C	ta.tg	het-ref	406	0.50	.	2	L2b|LINE|L2|+|719	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC8	IVS8	.	.	intron	NM_004333.4	NP_004324.2	-	Y	c.1140+2069A>G	.	.	.	NM_004333.4(BRAF): c.1140+2069A>G	;maf-5-some-pop	5008	0.141374	U	0.0962	0.141374	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1267636	.	4024	0.090000	0.260	-1.866	-1.991	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140493350	140493351	7q34	0	normal	.	T	ref	T	ta.at	het-alt	63	0.50	.	1	AT_rich|Low_complexity|Low_complexity|+|92	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC8	IVS8	.	.	no-change	NM_004333.4	NP_004324.2	-	Y	c.1140+757A=	.	.	.	NM_004333.4(BRAF): c.1140+757A=	;maf-5-some-pop	5008	0.890775	U	0.1627	0.109225	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs56306802	.	3968	0.818800	0.377	-0.000	-0.036	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140493350	140493351	7q34	0	normal	.	T	snv	C	ta.at	het-ref	62	0.50	.	2	AT_rich|Low_complexity|Low_complexity|+|92	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC8	IVS8	.	.	intron	NM_004333.4	NP_004324.2	-	Y	c.1140+757A>G	.	.	.	NM_004333.4(BRAF): c.1140+757A>G	;maf-5-some-pop	5008	0.109225	U	0.1627	0.109225	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs56306802	.	3968	0.181200	0.377	-0.000	-0.036	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140495572	140495573	7q34	0	nullSample	.	T	ref	T	TA.TA	homo-ref	.	.	.	0	.	.	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC7	IVS7	.	.	no-change	NM_004333.4	NP_004324.2	-	Y	c.981-1306A=	.	.	.	NM_004333.4(BRAF): c.981-1306A=	;maf-5-some-pop	5008	0.016773	U	1	0.983227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1733826	.	4024	0.001700	-1.764	-3.006	-2.998	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140495572	140495573	7q34	0	normal	.	T	snv	C	TA.TA	hom-alt	554	1.00	.	0	.	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC7	IVS7	.	.	intron	NM_004333.4	NP_004324.2	-	Y	c.981-1306A>G	.	.	.	NM_004333.4(BRAF): c.981-1306A>G	;maf-5-some-pop	5008	0.983227	U	1	0.983227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1733826	.	4024	0.998300	-1.764	-3.006	-2.998	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140496148	140496149	7q34	0	normal	.	A	ref	A	tt.aa	het-alt	93	0.53	.	1	AluSx1|SINE|Alu|+|296	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC7	IVS7	.	.	no-change	NM_004333.4	NP_004324.2	-	Y	c.981-1882T=	.	.	.	NM_004333.4(BRAF): c.981-1882T=	DuplicateObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs777861140	.	4024	0.574800	0.148	0.671	0.645	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140496148	140496149	7q34	0	normal	.	A	del	.	tt.aa	het-ref	82	0.47	.	2	AluSx1|SINE|Alu|+|296	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC7	IVS7	.	.	intron	NM_004333.4	NP_004324.2	-	Y	c.981-1882delT	.	.	.	NM_004333.4(BRAF): c.981-1882delT	DuplicateObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs777861140	.	4024	0.425200	0.148	0.671	0.645	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140496562	140496563	7q34	0	normal	.	T	ref	T	ca.tg	het-alt	250	0.51	.	1	MamRep605|Unknown|Unknown|+|195	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC7	IVS7	.	.	no-change	NM_004333.4	NP_004324.2	-	Y	c.981-2296A=	.	.	.	NM_004333.4(BRAF): c.981-2296A=	;maf-5-some-pop	5008	0.871406	U	0.0952	0.128594	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1639675	.	4024	0.909800	-0.327	-0.100	-0.147	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140496562	140496563	7q34	0	normal	.	T	snv	C	ca.tg	het-ref	245	0.49	.	2	MamRep605|Unknown|Unknown|+|195	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC7	IVS7	.	.	intron	NM_004333.4	NP_004324.2	-	Y	c.981-2296A>G	.	.	.	NM_004333.4(BRAF): c.981-2296A>G	;maf-5-some-pop	5008	0.128594	U	0.0952	0.128594	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1639675	.	4024	0.090200	-0.327	-0.100	-0.147	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140497260	140497262	7q34	0	normal	.	AA	ref	AA	GC.AA	het-alt	344	0.53	.	1	.	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC7	IVS7	.	.	no-change	NM_004333.4	NP_004324.2	-	Y	c.980+2900_980+2901=	.	.	.	NM_004333.4(BRAF): c.980+2900_980+2901=	;maf-5-some-pop	5008	0.907947	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs141654482	.	4024	0.832800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140497260	140497262	7q34	0	normal	.	AA	del	.	GC.AA	het-ref	303	0.47	.	2	.	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC7	IVS7	.	.	intron	NM_004333.4	NP_004324.2	-	Y	c.980+2900_980+2901delTT	.	.	.	NM_004333.4(BRAF): c.980+2900_980+2901delTT	;maf-5-some-pop	5008	0.092053	U	0.1528	0.0920527	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs141654482	.	4024	0.167200	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140497585	140497586	7q34	0	normal	.	A	ref	A	GC.TC	het-alt	376	0.49	.	1	.	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC7	IVS7	.	.	no-change	NM_004333.4	NP_004324.2	-	Y	c.980+2576T=	.	.	.	NM_004333.4(BRAF): c.980+2576T=	;maf-5-some-pop,maf-5-all-pops	5008	0.859026	U	0.0952	0.140974	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs73491871	.	4024	0.910000	0.455	-0.210	-0.436	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140497585	140497586	7q34	0	normal	.	A	snv	T	GC.TC	het-ref	393	0.51	.	2	.	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC7	IVS7	.	.	intron	NM_004333.4	NP_004324.2	-	Y	c.980+2576T>A	.	.	.	NM_004333.4(BRAF): c.980+2576T>A	;maf-5-some-pop,maf-5-all-pops	5008	0.140974	U	0.0952	0.140974	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs73491871	.	4024	0.090000	0.455	-0.210	-0.436	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140498359	140498360	7q34	0	normal	.	T	ref	T	cc.tt	het-alt	16	0.57	.	1	(T)n|Simple_repeat|Simple_repeat|+|21	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC7	IVS7	.	.	no-change	NM_004333.4	NP_004324.2	-	Y	c.980+1802A=	.	.	.	NM_004333.4(BRAF): c.980+1802A=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.901100	0.055	0.058	0.056	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	140498359	140498360	7q34	0	normal	.	T	del	.	cc.tt	het-ref	12	0.43	.	2	(T)n|Simple_repeat|Simple_repeat|+|21	PASS	164757	C	115150(MK);164757(MK);211980(MK);613706(MK);613707(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome; LEOPARD syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic;	Cardiovascular; Hematologic; Oncologic	21495173|21349766|20523244|20301365|20301303|19206169|19047498|18456719|18413255|18042262|17551924|17483702|16474404|16439621	.	673	BRAF	IC7	IVS7	.	.	intron	NM_004333.4	NP_004324.2	-	Y	c.980+1802delA	.	.	.	NM_004333.4(BRAF): c.980+1802delA	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.098900	0.055	0.058	0.056	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	148504716	148504717	7q36.1	0	normal	.	G	ref	G	GA.GG	het-alt	131	0.47	.	1	.	PASS	601573	C	277590(MK)	AD	Weaver syndrome 2	AD	.	Audiologic/Otolaryngologic; Craniofacial; Musculoskeletal; Neurologic	General	22177091|4366187	.	2146	EZH2	3U1E	EX20E	.	.	no-change	NM_004456.4	NP_004447.2	-	Y	c.*21C=	.	.	.	NM_004456.4(EZH2): c.*21C=	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;|MixedObserved;maf-5-some-pop	5960|75272	0.999664|0.304868	U	.	.	12518	0.230628	PASS	0	560	1.000000	2978	5960	0.999664	.	.	.	.	.	.	rs201597962|rs3217095	.	.	.	0.637	0.541	0.076	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	148504716	148504717	7q36.1	0	normal	.	G	del	.	GA.GG	het-ref	149	0.53	.	2	.	PASS	601573	C	277590(MK)	AD	Weaver syndrome 2	AD	.	Audiologic/Otolaryngologic; Craniofacial; Musculoskeletal; Neurologic	General	22177091|4366187	.	2146	EZH2	3U1E	EX20E	.	.	utr-3	NM_004456.4	NP_004447.2	-	Y	c.*16C[6>5] (std: c.*16C[5] alt: c.*21delC )	.	.	.	NM_004456.4(EZH2): c.*16C[5]	MixedObserved;maf-5-some-pop	75272	0.695132	U	0.7024	0.770966	12518	0.769372	PASS	1103	5460	0.650549	16297	70266	0.689708	3084	9565	6.46371e-01	47122	136317	6.82547e-01	rs3217095	.	.	.	0.637	0.541	0.076	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	259400	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
7	148504853	148504854	7q36.1	0	normal	.	A	ref	A	TG.GA	het-alt	126	0.50	.	1	.	PASS	601573	C	277590(MK)	AD	Weaver syndrome 2	AD	.	Audiologic/Otolaryngologic; Craniofacial; Musculoskeletal; Neurologic	General	22177091|4366187	.	2146	EZH2	IC18	IVS19	.	.	no-change	NM_004456.4	NP_004447.2	-	Y	c.2196-56T=	.	.	.	NM_004456.4(EZH2): c.2196-56T=	.	.	.	.	0.7014	0.694888	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.519	0.146	0.062	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	148504854	148504854	7q36.1	0	normal	.	.	ins	GACTT	GA.GA	het-ref	126	0.50	.	2	.	PASS	601573	C	277590(MK)	AD	Weaver syndrome 2	AD	.	Audiologic/Otolaryngologic; Craniofacial; Musculoskeletal; Neurologic	General	22177091|4366187	.	2146	EZH2	IC18	IVS19	.	.	intron	NM_004456.4	NP_004447.2	-	Y	c.2196-57_2196-56insAAGTC	.	.	.	NM_004456.4(EZH2): c.2196-57_2196-56insAAGTC	InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	5008	0.694888	U	0.7014	0.694888	12452	0.649695	.	.	.	.	.	.	.	.	.	.	.	.	.	rs560966145	.	4024	0.666000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	148508832	148508833	7q36.1	0	normal	.	A	ref	A	TC.CA	het-alt	152	0.56	.	1	.	PASS	601573	C	277590(MK)	AD	Weaver syndrome 2	AD	.	Audiologic/Otolaryngologic; Craniofacial; Musculoskeletal; Neurologic	General	22177091|4366187	.	2146	EZH2	IC14	IVS15	.	.	no-change	NM_004456.4	NP_004447.2	-	Y	c.1852-21T=	.	.	.	NM_004456.4(EZH2): c.1852-21T=	;maf-5-some-pop,maf-5-all-pops	122928	0.330820	U	0.7024	0.690695	13006	0.317700	PASS	.	8318	0.326401	6450	117920	0.331733	.	.	.	.	.	.	rs2072407	.	4024	0.330800	0.533	-0.245	0.208	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	148508832	148508833	7q36.1	0	normal	.	A	snv	G	TC.CA	het-ref	118	0.44	.	2	.	PASS	601573	C	277590(MK)	AD	Weaver syndrome 2	AD	.	Audiologic/Otolaryngologic; Craniofacial; Musculoskeletal; Neurologic	General	22177091|4366187	.	2146	EZH2	IC14	IVS15	.	.	intron	NM_004456.4	NP_004447.2	-	Y	c.1852-21T>C	.	.	.	NM_004456.4(EZH2): c.1852-21T>C	;maf-5-some-pop,maf-5-all-pops	122928	0.669180	U	0.7024	0.690695	13006	0.682300	PASS	1876	8318	0.673599	26292	117920	0.668267	3767	11335	6.67079e-01	53276	159049	6.67690e-01	rs2072407	.	4024	0.669200	0.533	-0.245	0.208	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	148543524	148543525	7q36.1	0	normal	.	A	snv	G	AG.TG	het-ref	159	0.46	.	2	.	PASS	601573	C	277590(MK)	AD	Weaver syndrome 2	AD	.	Audiologic/Otolaryngologic; Craniofacial; Musculoskeletal; Neurologic	General	22177091|4366187	.	2146	EZH2	IC2	IVS3	.	.	intron	NM_004456.4	NP_004447.2	-	Y	c.246+37T>C	.	.	.	NM_004456.4(EZH2): c.246+37T>C	MixedObserved;maf-5-some-pop	126116	0.706683	U	0.7014	0.770367	13006	0.771259	PASS	1918	8632	0.665083	30526	121108	0.704049	3706	11180	6.63344e-01	58904	165660	7.01373e-01	rs10274535	.	4024	0.660000	-0.716	0.407	0.570	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	148543524	148543525	7q36.1	0	normal	.	A	ref	A	AG.TG	het-alt	183	0.54	.	1	.	PASS	601573	C	277590(MK)	AD	Weaver syndrome 2	AD	.	Audiologic/Otolaryngologic; Craniofacial; Musculoskeletal; Neurologic	General	22177091|4366187	.	2146	EZH2	IC2	IVS3	.	.	no-change	NM_004456.4	NP_004447.2	-	Y	c.246+37T=	.	.	.	NM_004456.4(EZH2): c.246+37T=	MixedObserved;maf-5-some-pop	126116	0.293317	U	0.7014	0.770367	13006	0.228741	PASS	.	8632	0.334917	5814	121108	0.295951	.	.	.	.	.	.	rs10274535	.	4024	0.340000	-0.716	0.407	0.570	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	148543693	148543694	7q36.1	0	normal	.	A	ref	A	TT.AA	het-alt	179	0.47	.	1	.	PASS	601573	C	277590(MK)	AD	Weaver syndrome 2	AD	.	Audiologic/Otolaryngologic; Craniofacial; Musculoskeletal; Neurologic	General	22177091|4366187	.	2146	EZH2	IC1	IVS2	.	.	no-change	NM_004456.4	NP_004447.2	-	Y	c.118-4T=	.	.	.	NM_004456.4(EZH2): c.118-4T=	MixedObserved;maf-5-some-pop|MixedObserved;	79605|4862	0.942893|0.999589	U	.	.	.	.	PASS	0	440	1.000000	2429	4862	0.999589	.	.	.	.	.	.	rs3214332|rs758924977	.	4024	0.314900	0.219	-0.498	-0.627	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	148543693	148543694	7q36.1	1	normal	.	A	del	.	TT.AA	het-ref	205	0.53	.	2	.	PASS	601573	C	277590(MK)	AD	Weaver syndrome 2	AD	.	Audiologic/Otolaryngologic; Craniofacial; Musculoskeletal; Neurologic	General	22177091|4366187	.	2146	EZH2	IC1	IVS2	.	.	intron	NM_004456.4	NP_004447.2	-	Y	c.118-4delT	.	.	.	NM_004456.4(EZH2): c.118-4delT	MixedObserved;maf-5-some-pop	79605	0.057107	U	0.6974	0.761182	.	.	PASS	1582	7292	0.683077	24796	103532	0.713432	.	.	.	.	.	.	rs3214332	.	4024	0.685100	0.219	-0.498	-0.627	.	.	.	.	.	ENST00000320356: c.118-4delT (p.?)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_III|anaplastic|NS]	CSV	1735880	.	.	.	.	.	no_record	210966	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
7	150696007	150696008	7q36.1	0	normal	.	A	snv	G	AG.AC	het-ref	44	0.64	.	2	.	PASS	163729	C	104300(SK);145500(SK);163729(SK);189800(SK);601367(SK)	AD	.	.	.	.	.	.	.	4846	NOS3	IC6	IVS7	.	.	intron	NM_000603.4	NP_000594.2	+	Y	c.817-26A>G	.	.	.	NM_000603.4(NOS3): c.817-26A>G	;maf-5-some-pop,maf-5-all-pops	118994	0.446132	U	0.4633	0.459065	12948	0.479920	PASS	1147	8436	0.525367	11691	113986	0.445563	2225	8608	5.20247e-01	22454	99302	4.30498e-01	rs1007311	.	4024	0.477600	-1.256	-1.660	-2.050	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	150696007	150696008	7q36.1	0	normal	.	A	ref	A	AG.AC	het-alt	25	0.36	.	1	.	PASS	163729	C	104300(SK);145500(SK);163729(SK);189800(SK);601367(SK)	AD	.	.	.	.	.	.	.	4846	NOS3	IC6	IVS7	.	.	no-change	NM_000603.4	NP_000594.2	+	Y	c.817-26A=	.	.	.	NM_000603.4(NOS3): c.817-26A=	;maf-5-some-pop,maf-5-all-pops	118994	0.553868	U	0.4633	0.459065	12948	0.520080	PASS	-1069	8436	0.474633	17896	113986	0.554437	.	.	.	.	.	.	rs1007311	.	4024	0.522400	-1.256	-1.660	-2.050	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	150696110	150696111	7q36.1	0	nullSample	.	T	ref	T	GA.CC	homo-ref	.	.	.	0	.	.	163729	C	104300(SK);145500(SK);163729(SK);189800(SK);601367(SK)	AD	.	.	.	.	.	.	.	4846	NOS3	C7	EX8	Nitric oxide synthase, oxygenase domain	PF02898.10	no-change	NM_000603.4	NP_000594.2	+	Y	c.894T=	.	.	.	NM_000603.4(NOS3): c.894T=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	124906	0.244152	U	0.87	0.823682	12992	0.253387	PASS	.	8614	0.103436	4231	119898	0.246985	.	.	.	.	.	.	rs1799983	.	4024	0.118300	-0.143	-0.073	0.032	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	150696110	150696111	7q36.1	1	normal	.	T	snv	G	GA.CC	hom-alt	377	0.99	.	0	.	PASS	163729	C	104300(SK);145500(SK);163729(SK);189800(SK);601367(SK)	AD	.	.	.	.	.	.	.	4846	NOS3	C7	EX8	Nitric oxide synthase, oxygenase domain	PF02898.10	missense	NM_000603.4	NP_000594.2	+	Y	c.894T>G	p.D298E | p.Asp298Glu	GAT=>GAG	P-=>P-	NM_000603.4(NOS3): c.894T>G (p.D298E)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	124906	0.755848	U	0.87	0.823682	12992	0.746613	PASS	3464	8614	0.896564	34567	119898	0.753015	6865	15358	8.92181e-01	70003	183717	7.49706e-01	rs1799983	.	4024	0.881700	-0.143	-0.073	0.032	1	0.003	0	0.000	neutral	.	.	.	.	.	.	.	.	.	.	no_record	14015	criteria_provided,_single_submitter	Benign	Likely Benign
7	150704249	150704250	7q36.1	0	normal	.	C	ref	C	GC.GT	het-alt	204	0.52	.	1	.	PASS	163729	C	104300(SK);145500(SK);163729(SK);189800(SK);601367(SK)	AD	.	.	.	.	.	.	.	4846	NOS3	C16	EX17	Flavodoxin	PF00258.20	no-change	NM_000603.4	NP_000594.2	+	Y	c.1998C=	.	.	.	NM_000603.4(NOS3): c.1998C=	SingleClassTriAllelic;maf-5-some-pop	125966	0.655002	U	0.3909	0.43131	13006	0.666846	PASS	-978	8590	0.636088	27232	120958	0.658576	.	.	.	.	.	.	rs2566514	.	4024	0.642100	-0.293	-0.136	0.179	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	150704249	150704250	7q36.1	1	normal	.	C	snv	G	GC.GT	het-ref	191	0.48	.	2	.	PASS	163729	C	104300(SK);145500(SK);163729(SK);189800(SK);601367(SK)	AD	.	.	.	.	.	.	.	4846	NOS3	C16	EX17	Flavodoxin	PF00258.20	coding-synon	NM_000603.4	NP_000594.2	+	Y	c.1998C>G	p.(A666=) | p.(Ala666=)	GCC=>GCG	.	NM_000603.4(NOS3): c.1998C>G (p.(A666=))	SingleClassTriAllelic;maf-5-some-pop	125966	0.344990	U	0.3909	0.43131	13006	0.333154	PASS	585	8590	0.363912	8051	120958	0.341416	1140	6201	3.59770e-01	16646	84686	3.44813e-01	rs2566514	.	4024	0.357900	-0.293	-0.136	0.179	.	.	.	.	.	ENST00000297494: c.1998C>G (p.A666A)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4415182	.	.	.	.	.	no_record	403249	criteria_provided,_single_submitter	Benign	Likely Benign
7	151164347	151164348	7q36.1	0	normal	.	G	ref	G	CC.AG	het-alt	95	0.47	.	1	.	PASS	601293	P	.	NN	.	.	.	.	.	.	.	6009	RHEB	IC7	IVS7	.	.	no-change	NM_005614.3	NP_005605.1	-	Y	c.463-51C=	.	.	.	NM_005614.3(RHEB): c.463-51C=	;maf-5-some-pop,maf-5-all-pops	114140	0.541134	U	0.4395	0.385982	13006	0.621175	PASS	.	7466	0.548486	16373	109132	0.537789	.	.	.	.	.	.	rs17635434	.	4024	0.550200	-0.254	0.008	0.149	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151164347	151164348	7q36.1	0	normal	.	G	snv	A	CC.AG	het-ref	105	0.53	.	2	.	PASS	601293	P	.	NN	.	.	.	.	.	.	.	6009	RHEB	IC7	IVS7	.	.	intron	NM_005614.3	NP_005605.1	-	Y	c.463-51C>T	.	.	.	NM_005614.3(RHEB): c.463-51C>T	;maf-5-some-pop,maf-5-all-pops	114140	0.458866	U	0.4395	0.385982	13006	0.378825	PASS	764	7466	0.451514	12249	109132	0.462211	1670	7423	4.51191e-01	26720	109272	4.66269e-01	rs17635434	.	4024	0.449800	-0.254	0.008	0.149	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151842396	151842397	7q36.1	1	normal	.	C	snv	T	AG.AG	het-ref	182	0.44	.	2	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC53	IVS53	.	.	intron	NM_170606.2	NP_733751.2	-	Y	c.14032-17G>A	.	.	.	NM_170606.2(MLL3): c.14032-17G>A	;maf-5-some-pop	124222	0.074834	U	0.1577	0.158347	13006	0.116638	PASS	125	8606	0.164885	779	119214	0.071326	246	2868	1.66589e-01	1351	16553	6.78407e-02	rs2240819	.	4024	0.186600	-1.781	-3.923	-4.626	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151842396	151842397	7q36.1	0	normal	.	C	ref	C	AG.AG	het-alt	233	0.56	.	1	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC53	IVS53	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.14032-17G=	.	.	.	NM_170606.2(MLL3): c.14032-17G=	;maf-5-some-pop	124222	0.925166	U	0.1577	0.158347	13006	0.883362	PASS	.	8606	0.835115	51883	119214	0.928674	.	.	.	.	.	.	rs2240819	.	4024	0.813400	-1.781	-3.923	-4.626	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151847945	151847946	7q36.1	0	normal	.	G	ref	G	TC.TT	het-alt	94	0.41	.	1	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC51	IVS51	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.12774+39C=	.	.	.	NM_170606.2(MLL3): c.12774+39C=	;maf-5-some-pop	122116	0.947280	U	0.1558	0.0896565	13006	0.956712	PASS	.	8224	0.831590	52891	117108	0.948859	.	.	.	.	.	.	rs3757422	.	4024	0.814100	0.305	-0.357	-0.814	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151847945	151847946	7q36.1	0	normal	.	G	snv	A	TC.TT	het-ref	136	0.59	.	2	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC51	IVS51	.	.	intron	NM_170606.2	NP_733751.2	-	Y	c.12774+39C>T	.	.	.	NM_170606.2(MLL3): c.12774+39C>T	;maf-5-some-pop	122116	0.052720	U	0.1558	0.0896565	13006	0.043288	PASS	120	8224	0.168410	326	117108	0.051141	243	2822	1.65902e-01	631	12421	5.12270e-02	rs3757422	.	4024	0.185900	0.305	-0.357	-0.814	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151859224	151859225	7q36.1	0	normal	.	T	ref	T	CT.CT	het-alt	313	0.50	.	1	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C43	EX43	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.11437A=	.	.	.	NM_170606.2(MLL3): c.11437A=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.528	4.704	2.095	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
7	151859224	151859225	7q36.1	1	normal	.	T	snv	C	CT.CT	het-ref	314	0.50	.	2	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C43	EX43	.	.	missense	NM_170606.2	NP_733751.2	-	Y	c.11437A>G	p.K3813E | p.Lys3813Glu	AAG=>GAG	P+=>P-	NM_170606.2(MLL3): c.11437A>G (p.K3813E)	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.528	4.704	2.095	0.39	0.086	0.25	0.022	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
7	151860762	151860763	7q36.1	0	normal	.	C	ref	C	GG.TC	het-alt	289	0.49	.	1	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C43	EX43	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.9899G=	.	.	.	NM_170606.2(MLL3): c.9899G=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.655	0.694	1.159	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
7	151860762	151860763	7q36.1	1	normal	.	C	snv	T	GG.TC	het-ref	297	0.51	.	2	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C43	EX43	.	.	missense	NM_170606.2	NP_733751.2	-	Y	c.9899G>A	p.S3300N | p.Ser3300Asn	AGC=>AAC	P0=>P0	NM_170606.2(MLL3): c.9899G>A (p.S3300N)	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.655	0.694	1.159	0.65	0.001	0	0.003	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
7	151866389	151866390	7q36.1	0	normal	.	A	ref	A	GG.AA	het-alt	88	0.47	.	1	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC40	IVS40	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.9454-56T=	.	.	.	NM_170606.2(MLL3): c.9454-56T=	MixedObserved;|MixedObserved;maf-5-some-pop	2|5008	0.500000|0.908147	U	.	.	12492	0.953330	.	.	.	.	.	.	.	.	.	.	.	.	.	rs113769327|rs3837083	.	4024	0.811400	0.528	0.016	-0.122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151866389	151866390	7q36.1	0	normal	.	A	del	.	GG.AA	het-ref	98	0.53	.	2	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC40	IVS40	.	.	intron	NM_170606.2	NP_733751.2	-	Y	c.9454-56delT	.	.	.	NM_170606.2(MLL3): c.9454-56delT	MixedObserved;maf-5-some-pop	5008	0.091853	U	0.1597	0.091853	12492	0.046670	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3837083	.	4024	0.188600	0.528	0.016	-0.122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151873852	151873853	7q36.1	0	normal	.	C	ref	C	GC.TG	het-alt	374	0.52	.	1	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C38	EX38	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.8685G=	.	.	.	NM_170606.2(MLL3): c.8685G=	;maf-5-some-pop,maf-5-all-pops	126286	0.745348	U	0.3016	0.382788	13006	0.658773	PASS	-921	8642	0.684332	35552	121278	0.750639	.	.	.	.	.	.	rs6464211	.	4024	0.664000	-1.256	-0.689	-1.511	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151873852	151873853	7q36.1	1	normal	.	C	snv	T	GC.TG	het-ref	339	0.48	.	2	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C38	EX38	.	.	coding-synon	NM_170606.2	NP_733751.2	-	Y	c.8685G>A	p.(Q2895=) | p.(Gln2895=)	CAG=>CAA	.	NM_170606.2(MLL3): c.8685G>A (p.(Q2895=))	;maf-5-some-pop,maf-5-all-pops	126286	0.254652	U	0.3016	0.382788	13006	0.341227	PASS	443	8642	0.315668	5155	121278	0.249361	871	5506	3.19337e-01	9403	59209	2.41132e-01	rs6464211	.	4024	0.336000	-1.256	-0.689	-1.511	.	.	.	.	.	ENST00000355193: c.8685G>A (p.Q2895Q)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3762511	.	.	.	.	.	.	.	.	.	Likely Benign
7	151874497	151874498	7q36.1	0	normal	.	C	ref	C	GG.TG	het-alt	399	0.53	.	1	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C38	EX38	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.8040G=	.	.	.	NM_170606.2(MLL3): c.8040G=	;maf-5-some-pop	126226	0.925998	U	0.1587	0.158147	13006	0.883515	PASS	-588	8648	0.833950	52851	121218	0.929474	.	.	.	.	.	.	rs10252263	.	4024	0.809400	-1.859	0.157	-0.689	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151874497	151874498	7q36.1	1	normal	.	C	snv	T	GG.TG	het-ref	349	0.47	.	2	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C38	EX38	.	.	coding-synon	NM_170606.2	NP_733751.2	-	Y	c.8040G>A	p.(Q2680=) | p.(Gln2680=)	CAG=>CAA	.	NM_170606.2(MLL3): c.8040G>A (p.(Q2680=))	;maf-5-some-pop	126226	0.074002	U	0.1587	0.158147	13006	0.116485	PASS	130	8648	0.166050	791	121218	0.070526	253	2891	1.67633e-01	1363	16630	6.76242e-02	rs10252263	.	4024	0.190600	-1.859	0.157	-0.689	.	.	.	.	.	ENST00000355193: c.8040G>A (p.Q2680Q)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5009479	.	.	.	.	.	.	.	.	.	Likely Benign
7	151875159	151875160	7q36.1	0	normal	.	G	ref	G	AA.TT	het-alt	110	0.70	.	1	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC37	IVS37	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.7443-65C=	.	.	.	NM_170606.2(MLL3): c.7443-65C=	;maf-5-some-pop	5008	0.911941	U	0.1577	0.0880591	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3778918	.	4026	0.811600	-0.745	-0.980	-0.511	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151875159	151875160	7q36.1	0	normal	.	G	snv	C	AA.TT	het-ref	48	0.30	.	2	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC37	IVS37	.	.	intron	NM_170606.2	NP_733751.2	-	Y	c.7443-65C>G	.	.	.	NM_170606.2(MLL3): c.7443-65C>G	;maf-5-some-pop	5008	0.088059	U	0.1577	0.0880591	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3778918	.	4026	0.187900	-0.745	-0.980	-0.511	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151882656	151882657	7q36.1	0	normal	.	T	ref	T	TC.TT	het-alt	424	0.82	.	1	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C34	EX34	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.5068A=	.	.	.	NM_170606.2(MLL3): c.5068A=	;maf-5-some-pop	120386	0.915065	U	.	.	.	.	PASS	.	8498	0.803365	49968	120386	0.915065	.	.	.	.	.	.	rs78697077	.	4024	0.974700	0.523	4.843	1.889	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151882656	151882657	7q36.1	1	normal	.	T	snv	G	TC.TT	het-ref	91	0.18	.	2	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C34	EX34	.	.	coding-synon	NM_170606.2	NP_733751.2	-	Y	c.5068A>C	p.(R1690=) | p.(Arg1690=)	AGA=>CGA	.	NM_170606.2(MLL3): c.5068A>C (p.(R1690=))	;maf-5-some-pop	120386	0.084935	U	.	.	.	.	PASS	0	8498	0.196635	0	120386	0.084935	0	830	5.92519e-02	0	7027	3.17412e-02	rs78697077	.	4024	0.025300	0.523	4.843	1.889	.	.	.	.	.	ENST00000262189: c.5068A>C (p.R1690R)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|M2|NS]	CSV	150424	.	.	.	.	.	.	.	.	.	Likely Benign
7	151884606	151884607	7q36.1	0	normal	.	C	ref	C	TT.TT	het-alt	210	0.48	.	1	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC32	IVS32	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.4794-46G=	.	.	.	NM_170606.2(MLL3): c.4794-46G=	;maf-5-some-pop	119312	0.926479	U	0.1587	0.159145	12920	0.892647	PASS	.	7888	0.832784	49893	114304	0.930230	.	.	.	.	.	.	rs3800834	.	4024	0.811900	-1.223	-1.439	-1.233	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151884606	151884607	7q36.1	0	normal	.	C	snv	T	TT.TT	het-ref	223	0.52	.	2	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC32	IVS32	.	.	intron	NM_170606.2	NP_733751.2	-	Y	c.4794-46G>A	.	.	.	NM_170606.2(MLL3): c.4794-46G>A	;maf-5-some-pop	119312	0.073522	U	0.1587	0.159145	12920	0.107353	PASS	120	7888	0.167216	716	114304	0.069770	241	2756	1.66929e-01	1295	15959	6.76441e-02	rs3800834	.	4024	0.188100	-1.223	-1.439	-1.233	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151891358	151891359	7q36.1	1	normal	.	A	del	.	TT.AA	het-ref	61	0.17	.	2	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC29	IVS29	.	.	intron	NM_170606.2	NP_733751.2	-	Y	c.4508-13delT	.	.	.	NM_170606.2(MLL3): c.4508-13delT	MixedObserved;	8569	0.004318	U	.	.	11922	0.084717	PASS	0	2416	0.157285	0	45112	0.189129	.	.	.	.	.	.	rs755118430	.	4024	0.430900	-1.335	-1.207	-1.290	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151891358	151891359	7q36.1	0	normal	.	A	ref	A	TT.AA	het-alt	292	0.83	.	1	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC29	IVS29	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.4508-13T=	.	.	.	NM_170606.2(MLL3): c.4508-13T=	MixedObserved;	29274|8569	0.996755|0.995682	U	0	0.00199681	11922	0.875524	PASS	0	1558	1.000000	12048	24266	0.996497	.	.	.	.	.	.	rs199917150|rs755118430	.	4024	0.568800	-1.335	-1.207	-1.290	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151896572	151896573	7q36.1	0	normal	.	G	ref	G	AT.GT	het-alt	136	0.50	.	1	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC26	IVS26	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.4093-29C=	.	.	.	NM_170606.2(MLL3): c.4093-29C=	.	.	.	.	0.1637	0.159744	.	.	PASS	.	8298	0.831405	47944	109986	0.929573	.	.	.	.	.	.	.	.	.	.	0.555	-0.924	-1.178	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151896573	151896573	7q36.1	0	normal	.	.	ins	GTTA	TG.GT	het-ref	137	0.50	.	2	.	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC26	IVS26	.	.	intron	NM_170606.2	NP_733751.2	-	Y	c.4093-30_4093-29insTAAC	.	.	.	NM_170606.2(MLL3): c.4093-30_4093-29insTAAC	;maf-5-some-pop	114994	0.074317	U	0.1637	0.159744	12458	0.116231	PASS	120	8298	0.168595	697	109986	0.070427	145	1717	1.66279e-01	798	9486	5.88447e-02	rs3837082	.	4024	0.189400	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151902342	151902343	7q36.1	0	normal	.	G	ref	G	AA.TA	het-alt	233	0.52	.	1	dup	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC24	IVS24	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.3842-33C=	.	.	.	NM_170606.2(MLL3): c.3842-33C=	;maf-5-some-pop	125682	0.926402	U	0.1577	0.157947	13006	0.883746	PASS	.	8584	0.836789	52649	120674	0.929902	.	.	.	.	.	.	rs10265729	.	4024	0.811600	-1.017	-0.512	-0.785	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151902342	151902343	7q36.1	0	normal	.	G	snv	A	AA.TA	het-ref	218	0.48	.	2	dup	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC24	IVS24	.	.	intron	NM_170606.2	NP_733751.2	-	Y	c.3842-33C>T	.	.	.	NM_170606.2(MLL3): c.3842-33C>T	;maf-5-some-pop	125682	0.073598	U	0.1577	0.157947	13006	0.116254	PASS	119	8584	0.163211	771	120674	0.070098	241	2840	1.65733e-01	1348	16486	6.73717e-02	rs10265729	.	4024	0.188400	-1.017	-0.512	-0.785	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151921036	151921037	7q36.1	0	normal	.	G	ref	G	TT.TT	het-alt	159	0.85	.	1	dup	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC20	IVS20	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.3323+63C=	.	.	.	NM_170606.2(MLL3): c.3323+63C=	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs59239049	.	4024	0.999500	0.000	0.013	-0.000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151921037	151921037	7q36.1	0	normal	.	.	ins	T	TG.TT	het-ref	28	0.15	.	2	dup	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC20	IVS20	.	.	intron	NM_170606.2	NP_733751.2	-	Y	c.3323+62_3323+63insA	.	.	.	NM_170606.2(MLL3): c.3323+62_3323+63insA	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.087200	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151926976	151926977	7q36.1	0	normal	.	A	ref	A	AC.TA	het-alt	295	0.61	.	1	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC18	IVS18	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.2976+31T=	.	.	.	NM_170606.2(MLL3): c.2976+31T=	;maf-5-some-pop,maf-5-all-pops	109614	0.509944	U	.	.	.	.	InbreedingCoeff_Filter	.	8482	0.504008	1092	109614	0.509944	.	.	.	.	.	.	rs62481501	.	4024	0.521100	0.377	0.437	-0.328	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151926976	151926977	7q36.1	0	normal	.	A	snv	G	AC.TA	het-ref	192	0.39	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC18	IVS18	.	.	intron	NM_170606.2	NP_733751.2	-	Y	c.2976+31T>C	.	.	.	NM_170606.2(MLL3): c.2976+31T>C	;maf-5-some-pop,maf-5-all-pops	109614	0.490056	U	.	.	.	.	InbreedingCoeff_Filter	0	8482	0.495992	2	109614	0.490056	0	5246	4.48529e-01	2	73002	4.58336e-01	rs62481501	.	4024	0.478900	0.377	0.437	-0.328	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151927020	151927021	7q36.1	0	normal	.	C	ref	C	CA.AG	het-alt	521	0.85	.	1	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C18	EX18	PHD-finger	PF00628.24	no-change	NM_170606.2	NP_733751.2	-	Y	c.2963G=	.	.	.	NM_170606.2(MLL3): c.2963G=	SingleClassQuadAllelic;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	103606	0.893452	U	.	.	.	.	PASS	-453	7906	0.885403	40764	103606	0.893452	.	.	.	.	.	.	rs28522267	.	4024	0.508700	0.460	5.761	2.303	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151927020	151927021	7q36.1	1	normal	.	C	snv	A	CA.AG	het-ref	92	0.15	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C18	EX18	PHD-finger	PF00628.24	missense	NM_170606.2	NP_733751.2	-	Y	c.2963G>T	p.C988F | p.Cys988Phe	TGT=>TTT	P0=>NP	NM_170606.2(MLL3): c.2963G>T (p.C988F)	SingleClassQuadAllelic;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	103606	0.106529	U	.	.	.	.	PASS	0	7906	0.114470	0	103606	0.106529	0	2285	2.28181e-01	0	25316	1.85210e-01	rs28522267	.	4024	0.491300	0.460	5.761	2.303	0	1	1	0.945	deleterious	ENST00000262189: c.2963G>T (p.C988F)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	RSS	150426	.	.	.	.	.	no_record	403019	criteria_provided,_single_submitter	Benign	Unknown
7	151927024	151927025	7q36.1	0	normal	.	A	ref	A	GT.TG	het-alt	391	0.62	.	1	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C18	EX18	PHD-finger	PF00628.24	no-change	NM_170606.2	NP_733751.2	-	Y	c.2959T=	.	.	.	NM_170606.2(MLL3): c.2959T=	;maf-5-some-pop,maf-5-all-pops	108266	0.527155	U	.	.	.	.	InbreedingCoeff_Filter	.	8474	0.511329	2940	108266	0.527155	.	.	.	.	.	.	rs183684706	.	4024	0.535000	0.377	4.756	1.866	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151927024	151927025	7q36.1	1	normal	.	A	snv	G	GT.TG	het-ref	240	0.38	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C18	EX18	PHD-finger	PF00628.24	missense	NM_170606.2	NP_733751.2	-	Y	c.2959T>C	p.Y987H | p.Tyr987His	TAC=>CAC	P0=>P+	NM_170606.2(MLL3): c.2959T>C (p.Y987H)	;maf-5-some-pop,maf-5-all-pops	108266	0.472845	U	.	.	.	.	InbreedingCoeff_Filter	0	8474	0.488671	0	108266	0.472845	0	4494	4.02616e-01	0	60602	4.11816e-01	rs183684706	.	4024	0.465000	0.377	4.756	1.866	0	1	1	0.945	deleterious	ENST00000262189: c.2959T>C (p.Y987H)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	RSS	253767	.	.	.	.	.	.	.	.	.	Unknown
7	151927025	151927026	7q36.1	0	normal	.	T	ref	T	TA.GG	het-alt	543	0.85	.	1	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C18	EX18	PHD-finger	PF00628.24	no-change	NM_170606.2	NP_733751.2	-	Y	c.2958A=	.	.	.	NM_170606.2(MLL3): c.2958A=	;maf-5-some-pop,maf-5-all-pops	95384	0.884352	U	.	.	.	.	PASS	.	7574	0.880512	36661	95384	0.884352	.	.	.	.	.	.	rs28439884	.	4024	0.511400	0.377	-1.001	-0.745	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151927025	151927026	7q36.1	1	normal	.	T	snv	C	TA.GG	het-ref	95	0.15	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C18	EX18	PHD-finger	PF00628.24	coding-synon	NM_170606.2	NP_733751.2	-	Y	c.2958A>G	p.(P986=) | p.(Pro986=)	CCA=>CCG	.	NM_170606.2(MLL3): c.2958A>G (p.(P986=))	;maf-5-some-pop,maf-5-all-pops	95384	0.115648	U	.	.	.	.	PASS	0	7574	0.119488	0	95384	0.115648	0	2245	2.31110e-01	0	25476	1.92769e-01	rs28439884	.	4024	0.488600	0.377	-1.001	-0.745	.	.	.	.	.	ENST00000262189: c.2958A>G (p.P986P)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	RSS	150428	.	.	.	.	.	.	.	.	.	Unknown
7	151927088	151927089	7q36.1	1	normal	.	A	snv	G	AA.CT	het-ref	102	0.11	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C18	EX18	PHD-finger	PF00628.24	coding-synon	NM_170606.2	NP_733751.2	-	Y	c.2895T>C	p.(S965=) | p.(Ser965=)	AGT=>AGC	.	NM_170606.2(MLL3): c.2895T>C (p.(S965=))	SingleClassTriAllelic;	114050	0.017711	U	.	.	.	.	VQSRTrancheSNP99.60to99.80	0	7932	0.103505	0	114050	0.017712	0	163	1.14050e-02	0	431	1.87154e-03	rs775426786	.	4024	0.035800	0.377	0.535	0.265	.	.	.	.	.	ENST00000355193: c.2895T>C (p.S965S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3304339	.	.	.	.	.	.	.	.	.	VUS
7	151927088	151927089	7q36.1	0	normal	.	A	ref	A	AA.CT	het-alt	786	0.89	.	1	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C18	EX18	PHD-finger	PF00628.24	no-change	NM_170606.2	NP_733751.2	-	Y	c.2895T=	.	.	.	NM_170606.2(MLL3): c.2895T=	SingleClassTriAllelic;	114050	0.982262	U	.	.	.	.	VQSRTrancheSNP99.60to99.80	.	7932	0.896495	55002	114050	0.982262	.	.	.	.	.	.	rs775426786	.	4024	0.964200	0.377	0.535	0.265	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151927126	151927127	7q36.1	0	normal	.	A	ref	A	AA.CA	het-alt	393	0.72	.	1	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC17	IVS17	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.2872-15T=	.	.	.	NM_170606.2(MLL3): c.2872-15T=	;maf-5-some-pop,maf-5-all-pops	96180	0.510709	U	.	.	.	.	InbreedingCoeff_Filter	.	7968	0.506903	1031	96180	0.510709	.	.	.	.	.	.	rs62481502	.	4024	0.506500	0.377	3.234	0.763	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151927126	151927127	7q36.1	1	normal	.	A	snv	G	AA.CA	het-ref	151	0.28	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC17	IVS17	.	.	intron	NM_170606.2	NP_733751.2	-	Y	c.2872-15T>C	.	.	.	NM_170606.2(MLL3): c.2872-15T>C	;maf-5-some-pop,maf-5-all-pops	96180	0.489291	U	.	.	.	.	InbreedingCoeff_Filter	0	7968	0.493097	1	96180	0.489291	0	4204	4.27496e-01	1	60196	4.58930e-01	rs62481502	.	4024	0.493500	0.377	3.234	0.763	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151932964	151932965	7q36.1	0	normal	.	C	ref	C	CC.GA	het-alt	529	0.87	.	1	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C16	EX16	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.2706G=	.	.	.	NM_170606.2(MLL3): c.2706G=	SingleClassTriAllelic;maf-5-some-pop	99684	0.678845	U	.	.	.	.	InbreedingCoeff_Filter	-920	7006	0.737368	17828	99684	0.678845	.	.	.	.	.	.	rs142922667	.	4024	0.533300	-0.482	-1.147	-1.421	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151932964	151932965	7q36.1	1	normal	.	C	snv	T	CC.GA	het-ref	79	0.13	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C16	EX16	.	.	coding-synon	NM_170606.2	NP_733751.2	-	Y	c.2706G>A	p.(S902=) | p.(Ser902=)	TCG=>TCA	.	NM_170606.2(MLL3): c.2706G>A (p.(S902=))	SingleClassTriAllelic;maf-5-some-pop	99684	0.321125	U	.	.	.	.	InbreedingCoeff_Filter	0	7006	0.262632	0	99684	0.321125	0	500	4.76644e-02	0	17413	1.40167e-01	rs142922667	.	4024	0.466700	-0.482	-1.147	-1.421	.	.	.	.	.	ENST00000355193: c.2706G>A (p.S902S)	biliary_tract [gallbladder|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4161999	.	.	.	.	.	.	.	.	.	Unknown
7	151932996	151932997	7q36.1	0	normal	.	C	ref	C	TC.TG	het-alt	438	0.92	.	1	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C16	EX16	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.2674G=	.	.	.	NM_170606.2(MLL3): c.2674G=	;maf-5-some-pop	98998	0.730712	U	.	.	.	.	InbreedingCoeff_Filter	.	7144	0.704787	22840	98998	0.730712	.	.	.	.	.	.	rs199831680	.	4024	0.929200	0.650	5.608	2.530	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151932996	151932997	7q36.1	1	normal	.	C	snv	T	TC.TG	het-ref	40	0.08	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C16	EX16	.	.	missense	NM_170606.2	NP_733751.2	-	Y	c.2674G>A	p.G892R | p.Gly892Arg	GGA=>AGA	P0=>P+	NM_170606.2(MLL3): c.2674G>A (p.G892R)	;maf-5-some-pop	98998	0.269288	U	.	.	.	.	InbreedingCoeff_Filter	0	7144	0.295213	0	98998	0.269288	0	450	4.32859e-02	0	5144	3.49262e-02	rs199831680	.	4024	0.070800	0.650	5.608	2.530	0	0.999	1	0.935	deleterious	ENST00000355193: c.2674G>A (p.G892R)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	RSS	396784	.	.	.	.	.	.	.	.	.	Unknown
7	151933032	151933033	7q36.1	0	normal	.	G	ref	G	TT.GG	het-alt	289	0.89	.	1	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC15	IVS15	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.2653-15C=	.	.	.	NM_170606.2(MLL3): c.2653-15C=	SingleClassTriAllelic;maf-5-some-pop	87100	0.825488	U	.	.	.	.	PASS	-454	6476	0.859790	28350	87100	0.825488	.	.	.	.	.	.	rs113470386	.	4024	0.681400	-0.269	-1.269	-1.736	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151933032	151933033	7q36.1	1	normal	.	G	snv	A	TT.GG	het-ref	35	0.11	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC15	IVS15	.	.	intron	NM_170606.2	NP_733751.2	-	Y	c.2653-15C>T	.	.	.	NM_170606.2(MLL3): c.2653-15C>T	SingleClassTriAllelic;maf-5-some-pop	87100	0.174501	U	.	.	.	.	PASS	0	6476	0.140210	0	87100	0.174501	0	274	2.70697e-02	0	5852	4.47011e-02	rs113470386	.	4024	0.318600	-0.269	-1.269	-1.736	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151935830	151935831	7q36.1	1	normal	.	G	snv	A	CT.GG	het-ref	69	0.12	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C15	EX15	.	.	coding-synon	NM_170606.2	NP_733751.2	-	Y	c.2613C>T	p.(P871=) | p.(Pro871=)	CCC=>CCT	.	NM_170606.2(MLL3): c.2613C>T (p.(P871=))	;	106380	0.031294	U	.	.	.	.	VQSRTrancheSNP99.80to99.90	0	7692	0.023141	0	106380	0.031293	0	22	1.52060e-03	0	316	1.53050e-03	rs62478303	.	4024	0.109800	0.650	4.054	2.749	.	.	.	.	.	ENST00000355193: c.2613C>T (p.P871P)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	5426312	.	.	.	.	.	.	.	.	.	Unknown
7	151935830	151935831	7q36.1	0	normal	.	G	ref	G	CT.GG	het-alt	485	0.88	.	1	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C15	EX15	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.2613C=	.	.	.	NM_170606.2(MLL3): c.2613C=	;	106380	0.968707	U	.	.	.	.	VQSRTrancheSNP99.80to99.90	-89	7692	0.976859	49861	106380	0.968707	.	.	.	.	.	.	rs62478303	.	4024	0.890200	0.650	4.054	2.749	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151935852	151935853	7q36.1	0	normal	.	T	ref	T	CT.CT	het-alt	472	0.92	.	1	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C15	EX15	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.2591A=	.	.	.	NM_170606.2(MLL3): c.2591A=	;maf-5-some-pop,maf-5-all-pops	93196	0.855777	U	.	.	.	.	VQSRTrancheSNP99.80to99.90	.	6838	0.894560	33157	93196	0.855777	.	.	.	.	.	.	rs4024420	.	4024	0.764700	0.528	4.771	2.219	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151935852	151935853	7q36.1	1	normal	.	T	snv	C	CT.CT	het-ref	40	0.08	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C15	EX15	.	.	missense	NM_170606.2	NP_733751.2	-	Y	c.2591A>G	p.E864G | p.Glu864Gly	GAA=>GGA	P-=>P0	NM_170606.2(MLL3): c.2591A>G (p.E864G)	;maf-5-some-pop,maf-5-all-pops	93196	0.144223	U	.	.	.	.	VQSRTrancheSNP99.80to99.90	0	6838	0.105440	0	93196	0.144223	0	199	1.88091e-02	0	5776	3.94913e-02	rs4024420	.	4024	0.235300	0.528	4.771	2.219	0.23	0.376	0.746	0.162	neutral	ENST00000355193: c.2591A>G (p.E864G)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4594559	.	.	.	.	.	.	.	.	.	Unknown
7	151935991	151935992	7q36.1	0	normal	.	A	ref	A	AG.AC	het-alt	220	0.77	.	1	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC14	IVS14	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.2533-81T=	.	.	.	NM_170606.2(MLL3): c.2533-81T=	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2360904	.	4024	0.511900	0.528	2.203	0.401	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151935991	151935992	7q36.1	0	normal	.	A	snv	G	AG.AC	het-ref	64	0.23	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC14	IVS14	.	.	intron	NM_170606.2	NP_733751.2	-	Y	c.2533-81T>C	.	.	.	NM_170606.2(MLL3): c.2533-81T>C	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2360904	.	4024	0.488100	0.528	2.203	0.401	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151944960	151944961	7q36.1	0	normal	.	T	ref	T	TC.GT	het-alt	802	0.89	.	1	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC14	IVS14	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.2532+26A=	.	.	.	NM_170606.2(MLL3): c.2532+26A=	;maf-5-some-pop	108962	0.897212	U	.	.	.	.	PASS	.	8228	0.958556	43281	108962	0.897212	.	.	.	.	.	.	rs1623137	.	4024	0.966900	0.528	0.101	-0.010	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151944960	151944961	7q36.1	0	normal	.	T	snv	A	TC.GT	het-ref	102	0.11	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC14	IVS14	.	.	intron	NM_170606.2	NP_733751.2	-	Y	c.2532+26A>T	.	.	.	NM_170606.2(MLL3): c.2532+26A>T	;maf-5-some-pop	108962	0.102788	U	.	.	.	.	PASS	0	8228	0.041444	0	108962	0.102788	0	59	3.90160e-03	0	3875	2.06431e-02	rs1623137	.	4024	0.033100	0.528	0.101	-0.010	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151944980	151944981	7q36.1	0	normal	.	C	ref	C	CA.CC	het-alt	870	0.84	.	1	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC14	IVS14	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.2532+6G=	.	.	.	NM_170606.2(MLL3): c.2532+6G=	SingleClassTriAllelic;maf-5-some-pop	103254	0.784628	U	0	0.000798722	.	.	InbreedingCoeff_Filter	-575	6812	0.831180	26889	98246	0.773691	.	.	.	.	.	.	rs3888468	.	4024	0.550400	-0.894	-0.629	-0.179	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151944980	151944981	7q36.1	1	normal	.	C	snv	A	CA.CC	het-ref	168	0.16	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC14	IVS14	.	.	intron	NM_170606.2	NP_733751.2	-	Y	c.2532+6G>T	.	.	.	NM_170606.2(MLL3): c.2532+6G>T	SingleClassTriAllelic;maf-5-some-pop	103254	0.214616	U	.	.	.	.	InbreedingCoeff_Filter	0	6812	0.168820	0	98246	0.225556	0	565	4.34615e-02	0	20371	1.20504e-01	rs3888468	.	4024	0.449600	-0.894	-0.629	-0.179	.	.	.	.	.	ENST00000355193: c.2532+6G>T (p.?)	bone [femur|NS|NS]	osteosarcoma [NS|NS|NS]	CSV	5021551	.	.	.	.	.	no_record	218853	criteria_provided,_single_submitter	Benign	Benign
7	151945006	151945007	7q36.1	0	normal	.	C	ref	C	AC.AG	het-alt	755	0.48	.	1	dup	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C14	EX14	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.2512G=	.	.	.	NM_170606.2(MLL3): c.2512G=	;maf-5-some-pop,maf-5-all-pops	120998	0.505554	U	.	.	.	.	InbreedingCoeff_Filter	.	8628	0.502202	672	120998	0.505554	.	.	.	.	.	.	rs2479172	.	4024	0.502000	0.650	5.750	2.658	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151945006	151945007	7q36.1	1	normal	.	C	snv	T	AC.AG	het-ref	813	0.52	.	2	dup	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C14	EX14	.	.	missense	NM_170606.2	NP_733751.2	-	Y	c.2512G>A	p.G838S | p.Gly838Ser	GGT=>AGT	P0=>P0	NM_170606.2(MLL3): c.2512G>A (p.G838S)	;maf-5-some-pop,maf-5-all-pops	120998	0.494446	U	.	.	.	.	InbreedingCoeff_Filter	0	8628	0.497798	0	120998	0.494446	0	8265	4.98132e-01	0	114143	4.94053e-01	rs2479172	.	4024	0.498000	0.650	5.750	2.658	0.01	0.997	1	0.872	deleterious	ENST00000355193: c.2512G>A (p.G838S)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4591269	.	.	.	.	.	.	.	.	.	Likely Benign
7	151945070	151945071	7q36.1	0	normal	.	G	ref	G	AT.TA	het-alt	1880	0.81	.	1	dup	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C14	EX14	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.2448C=	.	.	.	NM_170606.2(MLL3): c.2448C=	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;	59992	0.999967	U	.	.	.	.	InbreedingCoeff_Filter	-2115	8492	0.501884	1166	117648	0.509911	.	.	.	.	.	.	rs202184064	.	.	.	-0.157	0.529	0.745	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151945071	151945071	7q36.1	1	normal	.	.	ins	T	TG.TA	het-ref	430	0.19	.	2	dup	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C14	EX14	PHD-finger;SET domain;F/Y-rich N-terminus;F/Y rich C-terminus;PHD-like zinc-binding domain;PHD-zinc-finger like domain	PF00628.24;PF00856.23;PF05964.9;PF05965.9;PF13771.1;PF13832.1	frameshift	NM_170606.2	NP_733751.2	-	Y	c.2447dupA	p.Y816*fs*1 | p.Tyr816*fs*1	.	.	NM_170606.2(MLL3): c.2447dupA (p.Y816*fs*1)	;	117646	0.490080	U	.	.	.	.	InbreedingCoeff_Filter	0	8492	0.498116	0	117648	0.490072	0	5743	4.98524e-01	0	80185	4.87453e-01	rs150073007	.	4024	0.499000	.	.	.	.	.	.	.	.	ENST00000262189: c.2447_2448insA (p.Y816fs*1)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	RSS	289942	.	.	.	.	.	no_record	403020	criteria_provided,_single_submitter	Benign	Likely Benign
7	151945100	151945101	7q36.1	1	normal	.	G	snv	C	GA.GA	het-ref	299	0.14	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C14	EX14	.	.	coding-synon	NM_170606.2	NP_733751.2	-	Y	c.2418C>G	p.(S806=) | p.(Ser806=)	TCC=>TCG	.	NM_170606.2(MLL3): c.2418C>G (p.(S806=))	MixedObserved;maf-5-some-pop,maf-5-all-pops	100712	0.415869	U	.	.	.	.	InbreedingCoeff_Filter	0	6446	0.407540	0	100712	0.415869	0	1593	1.35000e-01	0	38873	2.55256e-01	rs3896406	.	4024	0.434900	-0.806	-0.308	-0.402	.	.	.	.	.	ENST00000355193: c.2418C>G (p.S806S)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	RSS	1496553	.	.	.	.	.	.	.	.	.	Unknown
7	151945100	151945101	7q36.1	0	normal	.	G	ref	G	GA.GA	het-alt	1871	0.86	.	1	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C14	EX14	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.2418C=	.	.	.	NM_170606.2(MLL3): c.2418C=	MixedObserved;maf-5-some-pop,maf-5-all-pops	100712	0.584131	U	.	.	.	.	InbreedingCoeff_Filter	.	6446	0.592460	8473	100712	0.584131	.	.	.	.	.	.	rs3896406	.	4024	0.565100	-0.806	-0.308	-0.402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151945139	151945140	7q36.1	0	normal	.	C	ref	C	TG.GA	het-alt	1463	0.65	.	1	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C14	EX14	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.2379G=	.	.	.	NM_170606.2(MLL3): c.2379G=	SingleClassTriAllelic;maf-5-some-pop	108468	0.543552	U	.	.	.	.	InbreedingCoeff_Filter	.	7976	0.521690	4724	108468	0.543552	.	.	.	.	.	.	rs2537263	.	4024	0.534500	-0.312	-0.036	-0.077	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151945139	151945140	7q36.1	1	normal	.	C	snv	T	TG.GA	het-ref	772	0.35	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C14	EX14	.	.	coding-synon	NM_170606.2	NP_733751.2	-	Y	c.2379G>A	p.(S793=) | p.(Ser793=)	TCG=>TCA	.	NM_170606.2(MLL3): c.2379G>A (p.(S793=))	SingleClassTriAllelic;maf-5-some-pop	108468	0.456439	U	.	.	.	.	InbreedingCoeff_Filter	0	7976	0.478310	0	108468	0.456439	0	6057	4.66929e-01	0	73639	4.32463e-01	rs2537263	.	4024	0.465500	-0.312	-0.036	-0.077	.	.	.	.	.	ENST00000355193: c.2379G>A (p.S793S)	breast [NS|NS|NS]	carcinoma [NS|NS|NS]	CSV	452727	.	.	.	.	.	.	.	.	.	Unknown
7	151945166	151945167	7q36.1	0	normal	.	G	ref	G	GG.GA	het-alt	1124	0.60	.	1	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C14	EX14	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.2352C=	.	.	.	NM_170606.2(MLL3): c.2352C=	SingleClassTriAllelic;maf-5-some-pop	115256	0.522368	U	.	.	.	.	InbreedingCoeff_Filter	.	8302	0.512045	2578	115256	0.522368	.	.	.	.	.	.	rs2537264	.	4024	0.512400	-0.300	-0.990	-1.541	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151945166	151945167	7q36.1	1	normal	.	G	snv	T	GG.GA	het-ref	741	0.40	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C14	EX14	.	.	coding-synon	NM_170606.2	NP_733751.2	-	Y	c.2352C>A	p.(S784=) | p.(Ser784=)	TCC=>TCA	.	NM_170606.2(MLL3): c.2352C>A (p.(S784=))	SingleClassTriAllelic;maf-5-some-pop	115256	0.477580	U	.	.	.	.	InbreedingCoeff_Filter	0	8302	0.487955	0	115256	0.477580	0	6948	4.87921e-01	0	93792	4.77085e-01	rs2537264	.	4024	0.487600	-0.300	-0.990	-1.541	.	.	.	.	.	ENST00000355193: c.2352C>A (p.S784S)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4162015	.	.	.	.	.	.	.	.	.	Unknown
7	151945203	151945204	7q36.1	0	normal	.	G	ref	G	AT.AT	het-alt	710	0.63	.	1	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C14	EX14	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.2315C=	.	.	.	NM_170606.2(MLL3): c.2315C=	;maf-5-some-pop,maf-5-all-pops	119336	0.513935	U	.	.	.	.	InbreedingCoeff_Filter	-2007	8294	0.516036	1663	119336	0.513935	.	.	.	.	.	.	rs4024453	.	4024	0.500700	0.650	4.467	2.672	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151945203	151945204	7q36.1	1	normal	.	G	snv	A	AT.AT	het-ref	413	0.37	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C14	EX14	.	.	missense	NM_170606.2	NP_733751.2	-	Y	c.2315C>T	p.S772L | p.Ser772Leu	TCA=>TTA	P0=>NP	NM_170606.2(MLL3): c.2315C>T (p.S772L)	;maf-5-some-pop,maf-5-all-pops	119336	0.486065	U	.	.	.	.	InbreedingCoeff_Filter	0	8294	0.483964	0	119336	0.486065	0	7821	4.96445e-01	0	100683	4.93157e-01	rs4024453	.	4024	0.499300	0.650	4.467	2.672	0.35	0.34	0.696	0.128	neutral	ENST00000355193: c.2315C>T (p.S772L)	bone [femur|NS|NS]	osteosarcoma [NS|NS|NS]	CSV	4162017	.	.	.	.	.	.	.	.	.	Unknown
7	151945333	151945334	7q36.1	0	normal	.	T	ref	T	AT.TT	het-alt	725	0.85	.	1	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C14	EX14	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.2185A=	.	.	.	NM_170606.2(MLL3): c.2185A=	;	108580	0.955194	U	.	.	.	.	VQSRTrancheSNP99.80to99.90	.	7896	0.972011	49425	108580	0.955194	.	.	.	.	.	.	rs4639425	.	4024	0.567100	-0.321	0.440	-0.168	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151945333	151945334	7q36.1	1	normal	.	T	snv	C	AT.TT	het-ref	128	0.15	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C14	EX14	.	.	missense	NM_170606.2	NP_733751.2	-	Y	c.2185A>G	p.N729D | p.Asn729Asp	AAT=>GAT	P0=>P-	NM_170606.2(MLL3): c.2185A>G (p.N729D)	;	108580	0.044806	U	.	.	.	.	VQSRTrancheSNP99.80to99.90	0	7896	0.027989	0	108580	0.044806	0	1569	1.51888e-01	0	10784	6.74953e-02	rs4639425	.	4024	0.432900	-0.321	0.440	-0.168	0.5	0.019	0.066	0.011	neutral	ENST00000355193: c.2185A>G (p.N729D)	liver [NS|NS|NS]	carcinoma [NS|NS|NS]	RSS	1635197	.	.	.	.	.	.	.	.	.	Unknown
7	151962054	151962055	7q36.1	0	normal	.	C	ref	C	AC.TT	het-alt	319	0.87	.	1	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC8	IVS8	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.1184+68G=	.	.	.	NM_170606.2(MLL3): c.1184+68G=	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs115431229	.	4024	0.990600	-0.384	-0.114	-0.292	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151962054	151962055	7q36.1	0	normal	.	C	snv	T	AC.TT	het-ref	49	0.13	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC8	IVS8	.	.	intron	NM_170606.2	NP_733751.2	-	Y	c.1184+68G>A	.	.	.	NM_170606.2(MLL3): c.1184+68G>A	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs115431229	.	4024	0.009400	-0.384	-0.114	-0.292	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
7	151962067	151962068	7q36.1	0	normal	.	T	ref	T	AG.AA	het-alt	342	0.71	.	1	dup	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC8	IVS8	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.1184+55A=	.	.	.	NM_170606.2(MLL3): c.1184+55A=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.837000	0.377	-0.049	0.036	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151962067	151962068	7q36.1	0	normal	.	T	snv	C	AG.AA	het-ref	140	0.29	.	2	dup	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC8	IVS8	.	.	intron	NM_170606.2	NP_733751.2	-	Y	c.1184+55A>G	.	.	.	NM_170606.2(MLL3): c.1184+55A>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.163000	0.377	-0.049	0.036	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151962076	151962077	7q36.1	0	normal	.	C	snv	G	GT.CC	het-ref	191	0.34	.	2	dup	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC8	IVS8	.	.	intron	NM_170606.2	NP_733751.2	-	Y	c.1184+46G>C	.	.	.	NM_170606.2(MLL3): c.1184+46G>C	MixedObserved;maf-5-some-pop,maf-5-all-pops	46838	0.482941	U	.	.	.	.	InbreedingCoeff_Filter	0	2138	0.476146	0	46838	0.482941	0	2699	2.85427e-01	0	52027	3.87313e-01	rs62478355	.	4024	0.119000	0.460	1.242	2.206	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151962076	151962077	7q36.1	0	normal	.	C	ref	C	GT.CC	het-alt	374	0.66	.	1	dup	PASS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC8	IVS8	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.1184+46G=	.	.	.	NM_170606.2(MLL3): c.1184+46G=	MixedObserved;maf-5-some-pop,maf-5-all-pops	46838	0.517059	U	.	.	.	.	InbreedingCoeff_Filter	-509	2138	0.523854	799	46838	0.517059	.	.	.	.	.	.	rs62478355	.	4024	0.881000	0.460	1.242	2.206	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151962175	151962176	7q36.1	0	normal	.	T	ref	T	AA.GG	het-alt	1281	0.86	.	1	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C8	EX8	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.1131A=	.	.	.	NM_170606.2(MLL3): c.1131A=	;maf-5-some-pop,maf-5-all-pops	117236	0.544628	U	.	.	.	.	InbreedingCoeff_Filter	.	8030	0.558531	5232	117236	0.544628	.	.	.	.	.	.	rs62478356	.	4024	0.606600	-0.472	0.452	0.708	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151962175	151962176	7q36.1	1	normal	.	T	snv	A	AA.GG	het-ref	203	0.14	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C8	EX8	.	.	coding-synon	NM_170606.2	NP_733751.2	-	Y	c.1131A>T	p.(P377=) | p.(Pro377=)	CCA=>CCT	.	NM_170606.2(MLL3): c.1131A>T (p.(P377=))	;maf-5-some-pop,maf-5-all-pops	117236	0.455372	U	.	.	.	.	InbreedingCoeff_Filter	0	8030	0.441469	0	117236	0.455372	0	2972	2.92175e-01	0	70970	4.08188e-01	rs62478356	.	4024	0.393400	-0.472	0.452	0.708	.	.	.	.	.	ENST00000355193: c.1131A>T (p.P377P)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4162021	.	.	.	.	.	.	.	.	.	Unknown
7	151970855	151970856	7q36.1	0	normal	.	T	ref	T	GG.GC	het-alt	456	0.53	.	1	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C7	EX7	PHD-like zinc-binding domain;PHD-zinc-finger like domain	PF13771.1;PF13832.1	no-change	NM_170606.2	NP_733751.2	-	Y	c.946A=	.	.	.	NM_170606.2(MLL3): c.946A=	;maf-5-some-pop,maf-5-all-pops	119650	0.472394	U	.	.	.	.	InbreedingCoeff_Filter	.	8528	0.464235	0	119650	0.472394	.	.	.	.	.	.	rs10454320	.	4024	0.500700	0.528	3.302	0.824	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151970855	151970856	7q36.1	1	normal	.	T	snv	A	GG.GC	het-ref	412	0.47	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	C7	EX7	PHD-like zinc-binding domain;PHD-zinc-finger like domain	PF13771.1;PF13832.1	missense	NM_170606.2	NP_733751.2	-	Y	c.946A>T	p.T316S | p.Thr316Ser	ACC=>TCC	P0=>P0	NM_170606.2(MLL3): c.946A>T (p.T316S)	;maf-5-some-pop,maf-5-all-pops	119650	0.527606	U	.	.	.	.	InbreedingCoeff_Filter	305	8528	0.535765	3303	119650	0.527606	27	8634	5.01568e-01	379	123240	5.01542e-01	rs10454320	.	4024	0.499300	0.528	3.302	0.824	0.52	0.378	0.705	0.129	neutral	ENST00000355193: c.946A>T (p.T316S)	bone [femur|NS|NS]	osteosarcoma [NS|NS|NS]	CSV	4162023	.	.	.	.	.	.	.	.	.	Unknown
7	151970976	151970977	7q36.1	0	normal	.	C	ref	C	AT.TC	het-alt	521	0.78	.	1	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC6	IVS6	.	.	no-change	NM_170606.2	NP_733751.2	-	Y	c.850-25G=	.	.	.	NM_170606.2(MLL3): c.850-25G=	;maf-5-some-pop,maf-5-all-pops	109914	0.846735	U	.	.	.	.	PASS	.	8190	0.928571	38111	109914	0.846735	.	.	.	.	.	.	rs200020144	.	4024	0.875000	-0.142	-1.012	-0.550	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	151970976	151970977	7q36.1	0	normal	.	C	snv	A	AT.TC	het-ref	144	0.22	.	2	dup	DUBIOUS	606833	P	.	NN	.	.	.	.	.	.	.	58508	MLL3	IC6	IVS6	.	.	intron	NM_170606.2	NP_733751.2	-	Y	c.850-25G>T	.	.	.	NM_170606.2(MLL3): c.850-25G>T	;maf-5-some-pop,maf-5-all-pops	109914	0.153265	U	.	.	.	.	PASS	0	8190	0.071429	0	109914	0.153265	0	389	2.69316e-02	0	14802	8.46913e-02	rs200020144	.	4024	0.125000	-0.142	-1.012	-0.550	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	152373232	152373233	7q36.1	0	normal	.	A	ref	A	AG.CT	het-alt	64	0.45	.	1	.	PASS	600375	C	.	NN	.	.	.	.	.	.	FC59;FH44;H68;HBO28;MC58;MH43	7516	XRCC2	5U1E	EX1	.	.	no-change	NM_005431.1	NP_005422.1	-	Y	c.-69T=	.	.	.	NM_005431.1(XRCC2): c.-69T=	;maf-5-some-pop	5008	0.914337	U	0.1548	0.0856629	4566	0.947876	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3218385	.	.	.	-0.516	-1.945	-1.726	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
7	152373232	152373233	7q36.1	0	normal	.	A	snv	C	AG.CT	het-ref	79	0.55	.	2	.	PASS	600375	C	.	NN	.	.	.	.	.	.	FC59;FH44;H68;HBO28;MC58;MH43	7516	XRCC2	5U1E	EX1	.	.	utr-5	NM_005431.1	NP_005422.1	-	Y	c.-69T>G	.	.	.	NM_005431.1(XRCC2): c.-69T>G	;maf-5-some-pop	5008	0.085663	U	0.1548	0.0856629	4566	0.052124	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3218385	.	.	.	-0.516	-1.945	-1.726	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	2832138	2832139	8p23.2	0	normal	.	C	ref	C	CA.GA	het-alt	117	0.48	.	1	.	PASS	608397	P	.	NN	.	.	.	.	.	.	.	64478	CSMD1	C56	EX56	.	.	no-change	NM_033225.5	NP_150094.5	-	Y	c.8574G=	.	.	.	NM_033225.5(CSMD1): c.8574G=	;maf-5-some-pop,maf-5-all-pops	105460	0.208657	U	0.8046	0.750998	12098	0.200281	PASS	-516	6942	0.168827	1696	100452	0.206646	.	.	.	.	.	.	rs667595	.	4024	0.162500	-2.245	-4.205	-5.474	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	2832138	2832139	8p23.2	1	normal	.	C	snv	G	CA.GA	het-ref	125	0.52	.	2	.	PASS	608397	P	.	NN	.	.	.	.	.	.	.	64478	CSMD1	C56	EX56	.	.	coding-synon	NM_033225.5	NP_150094.5	-	Y	c.8574G>C	p.(S2858=) | p.(Ser2858=)	TCG=>TCC	.	NM_033225.5(CSMD1): c.8574G>C (p.(S2858=))	;maf-5-some-pop,maf-5-all-pops	105460	0.791343	U	0.8046	0.750998	12098	0.799719	PASS	2369	6942	0.831173	31164	100452	0.793354	5346	13010	8.23418e-01	69551	176638	7.84256e-01	rs667595	.	4024	0.837500	-2.245	-4.205	-5.474	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
8	15508199	15508200	8p22	0	normal	.	T	ref	T	CT.AT	het-alt	166	0.50	.	1	.	PASS	601385	C	611093(MK)	NN	Mental retardation, autosomal recessive 7	AR	.	Neurologic	General	21739581|18455129|18452889	.	7991	TUSC3	IC2	IVS2	.	.	no-change	NM_006765.3	NP_006756.2	+	Y	c.309-6T=	.	.	.	NM_006765.3(TUSC3): c.309-6T=	;maf-5-some-pop,maf-5-all-pops	126392	0.663800	U	0.4276	0.293131	13006	0.692834	PASS	.	8636	0.574456	26988	121384	0.662023	.	.	.	.	.	.	rs1035972	.	4024	0.550400	-0.256	0.171	0.081	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	15508199	15508200	8p22	1	normal	.	T	snv	C	CT.AT	het-ref	166	0.50	.	2	.	PASS	601385	C	611093(MK)	NN	Mental retardation, autosomal recessive 7	AR	.	Neurologic	General	21739581|18455129|18452889	.	7991	TUSC3	IC2	IVS2	.	.	intron	NM_006765.3	NP_006756.2	+	Y	c.309-6T>C	.	.	.	NM_006765.3(TUSC3): c.309-6T>C	;maf-5-some-pop,maf-5-all-pops	126392	0.336200	U	0.4276	0.293131	13006	0.307166	PASS	749	8636	0.425544	7321	121384	0.337977	1522	7355	4.26476e-01	15295	84843	3.44725e-01	rs1035972	.	4024	0.449600	-0.256	0.171	0.081	.	.	.	.	.	ENST00000503731: c.309-6T>C (p.?)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3982433	.	.	.	.	.	no_record	95430	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
8	20110640	20110641	8p21.3	1	normal	.	C	snv	T	TG.TC	het-ref	103	0.58	.	2	.	PASS	606551	P	133239(MK)	AD	.	.	.	.	.	.	.	11178	LZTS1	C2	EX2	.	.	coding-synon	NM_021020.2	NP_066300.1	-	Y	c.801G>A	p.(E267=) | p.(Glu267=)	GAG=>GAA	.	NM_021020.2(LZTS1): c.801G>A (p.(E267=))	;maf-5-some-pop,maf-5-all-pops	122520	0.350278	U	0.4623	0.358626	12978	0.365233	PASS	816	8544	0.440309	7521	117512	0.349922	1672	7598	4.42104e-01	14827	82924	3.41766e-01	rs2645386	.	4024	0.460700	0.561	3.158	2.659	.	.	.	.	.	ENST00000381569: c.801G>A (p.E267E)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3982461	.	.	.	.	.	.	.	.	.	Likely Benign
8	20110640	20110641	8p21.3	0	normal	.	C	ref	C	TG.TC	het-alt	74	0.42	.	1	.	PASS	606551	P	133239(MK)	AD	.	.	.	.	.	.	.	11178	LZTS1	C2	EX2	.	.	no-change	NM_021020.2	NP_066300.1	-	Y	c.801G=	.	.	.	NM_021020.2(LZTS1): c.801G=	;maf-5-some-pop,maf-5-all-pops	122520	0.649723	U	0.4623	0.358626	12978	0.634767	PASS	-1065	8544	0.559691	25157	117512	0.650078	.	.	.	.	.	.	rs2645386	.	4024	0.539300	0.561	3.158	2.659	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	30916084	30916085	8p12	0	nullSample	.	T	ref	T	TT.GG	homo-ref	.	.	.	0	.	.	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	IC1	IVS2	.	.	no-change	NM_000553.4	NP_000544.2	+	Y	c.96+26T=	.	.	.	NM_000553.4(WRN): c.96+26T=	;maf-5-some-pop,genotype-conflict	122922	0.013228	U	1	0.96266	13002	0.040532	PASS	0	8448	0.000000	59	117914	0.012204	.	.	.	.	.	.	rs2737316	.	.	.	-0.894	-1.036	-0.521	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	30916084	30916085	8p12	0	normal	.	T	snv	C	TT.GG	hom-alt	281	1.00	.	0	.	PASS	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	IC1	IVS2	.	.	intron	NM_000553.4	NP_000544.2	+	Y	c.96+26T>C	.	.	.	NM_000553.4(WRN): c.96+26T>C	;maf-5-some-pop,genotype-conflict	122922	0.986772	U	1	0.96266	13002	0.959468	PASS	4224	8448	1.000000	57577	117914	0.987796	8532	17064	1.00000e+00	118718	239651	9.89786e-01	rs2737316	.	.	.	-0.894	-1.036	-0.521	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	30922345	30922346	8p12	0	nullSample	.	C	ref	C	TA.AC	homo-ref	.	.	.	0	.	.	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	IC3	IVS4	.	.	no-change	NM_000553.4	NP_000544.2	+	Y	c.356-85C=	.	.	.	NM_000553.4(WRN): c.356-85C=	;maf-5-some-pop,genotype-conflict	5008	0.042133	U	1	0.957867	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2725346	.	.	.	-1.062	0.047	0.070	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	30922345	30922346	8p12	0	normal	.	C	snv	T	TA.AC	hom-alt	283	1.00	.	0	.	PASS	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	IC3	IVS4	.	.	intron	NM_000553.4	NP_000544.2	+	Y	c.356-85C>T	.	.	.	NM_000553.4(WRN): c.356-85C>T	;maf-5-some-pop,genotype-conflict	5008	0.957867	U	1	0.957867	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2725346	.	.	.	-1.062	0.047	0.070	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	30924556	30924557	8p12	0	nullSample	.	C	ref	C	TG.AC	homo-ref	.	.	.	0	.	.	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	C5	EX6	3'-5' exonuclease	PF01612.15	no-change	NM_000553.4	NP_000544.2	+	Y	c.513C=	.	.	.	NM_000553.4(WRN): c.513C=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126282	0.297453	U	0.87	0.6873	13006	0.346302	PASS	-527	8646	0.139486	5797	121274	0.296824	.	.	.	.	.	.	rs1800389	.	.	.	-0.490	0.337	-0.091	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	30924556	30924557	8p12	1	normal	.	C	snv	T	TG.AC	hom-alt	515	1.00	.	0	.	PASS	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	C5	EX6	3'-5' exonuclease	PF01612.15	coding-synon	NM_000553.4	NP_000544.2	+	Y	c.513C>T	p.(C171=) | p.(Cys171=)	TGC=>TGT	.	NM_000553.4(WRN): c.513C>T (p.(C171=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126282	0.702547	U	0.87	0.6873	13006	0.653698	PASS	3193	8646	0.860514	30437	121274	0.703176	6447	14917	8.65356e-01	63212	175211	7.12819e-01	rs1800389	.	.	.	-0.490	0.337	-0.091	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	130763	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
8	30933816	30933817	8p12	0	normal	.	T	ref	T	CC.TT	het-alt	161	0.75	.	1	.	PASS	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	IC7	IVS8	.	.	no-change	NM_000553.4	NP_000544.2	+	Y	c.839+14T=	.	.	.	NM_000553.4(WRN): c.839+14T=	MixedObserved;	285|11102	0.992982|0.999910	U	.	.	.	.	PASS	0	878	1.000000	5550	11102	0.999910	.	.	.	.	.	.	rs370040831|rs762466968	.	.	.	-0.394	0.873	0.318	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	30933816	30933817	8p12	1	normal	.	T	del	.	CC.TT	het-ref	53	0.25	.	2	.	PASS	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	IC7	IVS8	.	.	intron	NM_000553.4	NP_000544.2	+	Y	c.839+14delT	.	.	.	NM_000553.4(WRN): c.839+14delT	MixedObserved;	285	0.007018	U	.	.	.	.	InbreedingCoeff_Filter	0	5408	0.386095	1	83326	0.403668	.	.	.	.	.	.	rs370040831	.	.	.	-0.394	0.873	0.318	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	30933848	30933849	8p12	0	normal	.	A	ref	A	TT.TT	het-alt	123	0.62	.	1	.	PASS	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	IC7	IVS8	.	.	no-change	NM_000553.4	NP_000544.2	+	Y	c.839+46A=	.	.	.	NM_000553.4(WRN): c.839+46A=	MixedObserved;maf-5-some-pop|MixedObserved,NonIntegerChromCount;	88292|580.000005	0.979862|0.998500	U	.	.	12320	0.995698	.	.	.	.	.	.	.	.	.	.	.	.	.	rs199946539|rs200909903	.	.	.	-1.693	-1.654	-1.218	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	30933848	30933849	8p12	0	normal	.	A	del	.	TT.TT	het-ref	75	0.38	.	2	.	PASS	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	IC7	IVS8	.	.	intron	NM_000553.4	NP_000544.2	+	Y	c.839+46delA	.	.	.	NM_000553.4(WRN): c.839+46delA	MixedObserved;maf-5-some-pop	88292	0.020138	U	0.0804	0.0365415	12320	0.004302	PASS	24	4290	0.109790	49	83284	0.019151	41	1262	9.45743e-02	75	3660	1.75348e-02	rs199946539	.	.	.	-1.693	-1.654	-1.218	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
8	30941316	30941317	8p12	0	normal	.	T	ref	T	AA.AT	het-alt	201	0.87	.	1	dup	DUBIOUS	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	IC9	IVS10	.	.	no-change	NM_000553.4	NP_000544.2	+	Y	c.1350+22T=	.	.	.	NM_000553.4(WRN): c.1350+22T=	;maf-5-some-pop,maf-5-all-pops	121322	0.445319	U	0.5784	0.486222	12942	0.490728	PASS	.	8330	0.438295	11936	116314	0.442372	.	.	.	.	.	.	rs2737325	.	.	.	-1.232	-0.352	-0.518	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	30941316	30941317	8p12	0	normal	.	T	snv	C	AA.AT	het-ref	30	0.13	.	2	dup	DUBIOUS	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	IC9	IVS10	.	.	intron	NM_000553.4	NP_000544.2	+	Y	c.1350+22T>C	.	.	.	NM_000553.4(WRN): c.1350+22T>C	;maf-5-some-pop,maf-5-all-pops	121322	0.554681	U	0.5784	0.486222	12942	0.509272	PASS	1317	8330	0.561705	18639	116314	0.557628	2719	9584	5.66363e-01	39579	135228	5.65708e-01	rs2737325	.	.	.	-1.232	-0.352	-0.518	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	30948071	30948072	8p12	0	normal	.	T	snv	A	CC.AA	het-ref	152	0.51	.	2	.	PASS	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	IC13	IVS14	.	.	intron	NM_000553.4	NP_000544.2	+	Y	c.1720+24T>A	.	.	.	NM_000553.4(WRN): c.1720+24T>A	;maf-5-some-pop,genotype-conflict	125072	0.070319	U	0.2738	0.110024	12980	0.025732	PASS	337	8628	0.273644	827	120064	0.068663	675	4789	2.79242e-01	1889	18632	7.67204e-02	rs2247189	.	.	.	0.528	0.479	0.959	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	30948071	30948072	8p12	0	normal	.	T	ref	T	CC.AA	het-alt	147	0.49	.	1	.	PASS	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	IC13	IVS14	.	.	no-change	NM_000553.4	NP_000544.2	+	Y	c.1720+24T=	.	.	.	NM_000553.4(WRN): c.1720+24T=	;maf-5-some-pop,genotype-conflict	125072	0.929681	U	0.2738	0.110024	12980	0.974268	PASS	.	8628	0.726356	52615	120064	0.931337	.	.	.	.	.	.	rs2247189	.	.	.	0.528	0.479	0.959	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	30958353	30958354	8p12	0	nullSample	.	T	ref	T	TC.TT	homo-ref	.	.	.	0	.	.	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	IC16	IVS17	.	.	no-change	NM_000553.4	NP_000544.2	+	Y	c.1982-11T=	.	.	.	NM_000553.4(WRN): c.1982-11T=	MixedObserved;|MixedObserved;maf-5-some-pop	0|125872	0|0.006189	U	.	.	12518	0.021649	.	.	.	.	.	.	.	.	.	.	.	.	.	rs200855118|rs3087419	.	.	.	0.482	-1.258	-0.828	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
8	30958353	30958354	8p12	1	normal	.	T	del	.	TC.TT	hom-alt	265	1.00	.	0	.	PASS	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	IC16	IVS17	.	.	intron	NM_000553.4	NP_000544.2	+	Y	c.1982-11delT	.	.	.	NM_000553.4(WRN): c.1982-11delT	MixedObserved;|MixedObserved;maf-5-some-pop	0|125872	0|0.993811	U	1	0.98123	12518	0.978351	PASS	4287	8574	1.000000	59768	120864	0.994332	8597	17194	1.00000e+00	121778	244546	9.95700e-01	rs200855118|rs3087419	.	.	.	0.482	-1.258	-0.828	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	256707	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
8	30969355	30969356	8p12	0	normal	.	T	ref	T	CC.TT	het-alt	182	0.77	.	1	.	PASS	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	IC18	IVS19	.	.	no-change	NM_000553.4	NP_000544.2	+	Y	c.2273+41T=	.	.	.	NM_000553.4(WRN): c.2273+41T=	;	2	0.500000	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs111854110	.	.	.	0.366	0.395	0.372	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
8	30969355	30969356	8p12	0	normal	.	T	del	.	CC.TT	het-ref	55	0.23	.	2	.	PASS	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	IC18	IVS19	.	.	intron	NM_000553.4	NP_000544.2	+	Y	c.2273+41delT	.	.	.	NM_000553.4(WRN): c.2273+41delT	;	2	0.500000	U	.	.	.	.	PASS	0	3878	0.252450	60	61446	0.283468	.	.	.	.	.	.	rs111854110	.	.	.	0.366	0.395	0.372	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	30973956	30973957	8p12	0	nullSample	.	G	ref	G	CT.AA	homo-ref	.	.	.	0	.	.	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	C19	EX20	Helicase conserved C-terminal domain	PF00271.26	no-change	NM_000553.4	NP_000544.2	+	Y	c.2361G=	.	.	.	NM_000553.4(WRN): c.2361G=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126340	0.552398	U	0.624	0.471246	13006	0.551822	PASS	.	8634	0.379778	19078	121332	0.553374	.	.	.	.	.	.	rs1800392	.	.	.	-0.312	0.450	0.735	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	30973956	30973957	8p12	1	normal	.	G	snv	T	CT.AA	hom-alt	548	1.00	.	0	.	PASS	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	C19	EX20	Helicase conserved C-terminal domain	PF00271.26	coding-synon	NM_000553.4	NP_000544.2	+	Y	c.2361G>T	p.(L787=) | p.(Leu787=)	CTG=>CTT	.	NM_000553.4(WRN): c.2361G>T (p.(L787=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126340	0.447602	U	0.624	0.471246	13006	0.448178	PASS	1654	8634	0.620222	12602	121332	0.446626	3430	10849	6.29365e-01	26162	111383	4.52872e-01	rs1800392	.	.	.	-0.312	0.450	0.735	.	.	.	.	.	ENST00000298139: c.2361G>T (p.L787L)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3763318	.	.	.	.	.	no_record	130758	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
8	30977716	30977717	8p12	0	normal	.	T	snv	C	TC.GC	hom-alt	340	1.00	.	0	.	PASS	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	IC19	IVS20	.	.	intron	NM_000553.4	NP_000544.2	+	Y	c.2449-42T>C	.	.	.	NM_000553.4(WRN): c.2449-42T>C	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126106	0.451810	U	0.625	0.480232	13004	0.459166	PASS	1654	8624	0.620710	12767	121098	0.450635	3427	10842	6.29324e-01	26383	111647	4.56302e-01	rs2725352	.	.	.	-1.139	-0.190	-0.158	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	30977716	30977717	8p12	0	nullSample	.	T	ref	T	TC.GC	homo-ref	.	.	.	0	.	.	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	IC19	IVS20	.	.	no-change	NM_000553.4	NP_000544.2	+	Y	c.2449-42T=	.	.	.	NM_000553.4(WRN): c.2449-42T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126106	0.548190	U	0.625	0.480232	13004	0.540834	PASS	.	8624	0.379290	18745	121098	0.549365	.	.	.	.	.	.	rs2725352	.	.	.	-1.139	-0.190	-0.158	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	30990109	30990110	8p12	0	nullSample	.	G	ref	G	TA.CT	homo-ref	.	.	.	0	.	.	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	IC23	IVS24	.	.	no-change	NM_000553.4	NP_000544.2	+	Y	c.2967+88G=	.	.	.	NM_000553.4(WRN): c.2967+88G=	;maf-5-some-pop,maf-5-all-pops	5008	0.558706	U	0.6429	0.441294	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2252480	.	.	.	-0.218	0.113	0.208	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	30990109	30990110	8p12	0	normal	.	G	snv	A	TA.CT	hom-alt	310	1.00	.	0	.	PASS	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	IC23	IVS24	.	.	intron	NM_000553.4	NP_000544.2	+	Y	c.2967+88G>A	.	.	.	NM_000553.4(WRN): c.2967+88G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.441294	U	0.6429	0.441294	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2252480	.	.	.	-0.218	0.113	0.208	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	30999122	30999123	8p12	0	nullSample	.	G	ref	G	AC.GT	homo-ref	.	.	.	0	.	.	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	IC24	IVS25	.	.	no-change	NM_000553.4	NP_000544.2	+	Y	c.3138+7G=	.	.	.	NM_000553.4(WRN): c.3138+7G=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126296	0.550239	U	0.6419	0.494808	13006	0.533984	PASS	.	8632	0.367586	18974	121288	0.552099	.	.	.	.	.	.	rs2737335	.	.	.	-0.269	-1.083	-1.220	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	30999122	30999123	8p12	1	normal	.	G	snv	A	AC.GT	hom-alt	641	1.00	.	0	.	PASS	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	IC24	IVS25	.	.	intron	NM_000553.4	NP_000544.2	+	Y	c.3138+7G>A	.	.	.	NM_000553.4(WRN): c.3138+7G>A	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126296	0.449761	U	0.6419	0.494808	13006	0.466016	PASS	1727	8632	0.632414	12655	121288	0.447901	3564	11050	6.40803e-01	26164	111361	4.52382e-01	rs2737335	.	.	.	-0.269	-1.083	-1.220	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	130755	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
8	30999279	30999280	8p12	0	nullSample	.	G	ref	G	TT.CT	homo-ref	.	.	.	0	.	.	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	C25	EX26	.	.	no-change	NM_000553.4	NP_000544.2	+	Y	c.3222G=	.	.	.	NM_000553.4(WRN): c.3222G=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	125878	0.548960	U	0.6419	0.496006	13006	0.533062	PASS	-1001	8618	0.367835	18797	120870	0.550823	.	.	.	.	.	.	rs1801195	.	.	.	-0.256	-0.190	0.093	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	30999279	30999280	8p12	1	normal	.	G	snv	T	TT.CT	hom-alt	465	1.00	.	0	.	PASS	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	C25	EX26	.	.	missense	NM_000553.4	NP_000544.2	+	Y	c.3222G>T	p.L1074F | p.Leu1074Phe	TTG=>TTT	NP=>NP	NM_000553.4(WRN): c.3222G>T (p.L1074F)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	125878	0.451040	U	0.6419	0.496006	13006	0.466938	PASS	1723	8618	0.632165	12654	120870	0.449177	3556	11029	6.40774e-01	26195	111370	4.53173e-01	rs1801195	.	.	.	-0.256	-0.190	0.093	0.88	0	0	0.000	neutral	ENST00000298139: c.3222G>T (p.L1074F)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [diffuse_large_B_cell_lymphoma|NS|NS]	CSV	3763319	.	.	.	.	.	no_record	130759	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
8	31000242	31000243	8p12	0	nullSample	.	T	ref	T	GA.TT	homo-ref	.	.	.	0	.	.	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	IC26	IVS27	.	.	no-change	NM_000553.4	NP_000544.2	+	Y	c.3309+26T=	.	.	.	NM_000553.4(WRN): c.3309+26T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125402	0.608411	U	0.6419	0.439097	12946	0.619033	PASS	.	8612	0.367046	23010	120394	0.610388	.	.	.	.	.	.	rs2725365	.	.	.	0.383	0.185	0.447	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	31000242	31000243	8p12	0	normal	.	T	snv	C	GA.TT	hom-alt	265	1.00	.	0	.	PASS	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	IC26	IVS27	.	.	intron	NM_000553.4	NP_000544.2	+	Y	c.3309+26T>C	.	.	.	NM_000553.4(WRN): c.3309+26T>C	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125402	0.391589	U	0.6419	0.439097	12946	0.380967	PASS	1723	8612	0.632954	9720	120394	0.389612	3399	10600	6.37556e-01	19600	93467	3.93837e-01	rs2725365	.	.	.	0.383	0.185	0.447	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	31005016	31005017	8p12	0	nullSample	.	T	ref	T	TC.AT	homo-ref	.	.	.	0	.	.	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	IC29	IVS30	.	.	no-change	NM_000553.4	NP_000544.2	+	Y	c.3572+25T=	.	.	.	NM_000553.4(WRN): c.3572+25T=	.	.	.	.	1	0.976238	.	.	PASS	0	8618	0.000000	37	120924	0.007228	.	.	.	.	.	.	.	.	.	.	-1.140	-0.000	0.166	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	31005017	31005017	8p12	0	normal	.	.	ins	C	CT.AT	hom-alt	316	1.00	.	0	.	PASS	604611	C	277700(MK)	AR	Werner syndrome	AR	.	Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Obstetric; Oncologic; Ophthalmologic	Cardiovascular; Endocrine; Obstetric; Oncologic	23936869|23849162|23552003|23524889|22654791|20443122|20301687|18205852|17476199|16786514|14042963|10220139|9253306|9048918|9012406|8968742|8722214|8602509|7460386	.	7486	WRN	IC29	IVS30	.	.	intron	NM_000553.4	NP_000544.2	+	Y	c.3572+25_3572+26insC	.	.	.	NM_000553.4(WRN): c.3572+25_3572+26insC	MixedObserved;maf-5-some-pop	125932	0.992115	U	1	0.976238	12518	0.972599	PASS	4309	8618	1.000000	59625	120924	0.992772	8608	17216	1.00000e+00	121564	244391	9.94357e-01	rs3087415	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	37693301	37693302	8p11.23	0	nullSample	.	T	ref	T	AA.TC	homo-ref	.	.	.	0	.	.	606823	P	.	NN	.	.	.	.	.	.	.	25960	GPR124	IC13	IVS13	.	.	no-change	NM_032777.9	NP_116166.9	+	Y	c.2050+14T=	.	.	.	NM_032777.9(GPR124): c.2050+14T=	;maf-5-some-pop	123282	0.045092	U	0.999	0.978834	12994	0.047868	PASS	-2	8590	0.000466	183	118274	0.046105	.	.	.	.	.	.	rs10101560	.	4024	0.002200	-0.733	-0.403	-0.119	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	37693301	37693302	8p11.23	1	normal	.	T	snv	C	AA.TC	hom-alt	212	1.00	.	0	.	PASS	606823	P	.	NN	.	.	.	.	.	.	.	25960	GPR124	IC13	IVS13	.	.	intron	NM_032777.9	NP_116166.9	+	Y	c.2050+14T>C	.	.	.	NM_032777.9(GPR124): c.2050+14T>C	;maf-5-some-pop	123282	0.954908	U	0.999	0.978834	12994	0.952132	PASS	4291	8590	0.999534	53867	118274	0.953895	8597	17200	9.99651e-01	110556	231498	9.54379e-01	rs10101560	.	4024	0.997800	-0.733	-0.403	-0.119	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38226276	38226277	8p11.23	0	normal	.	A	ref	A	CC.CT	het-alt	187	0.57	.	1	.	PASS	607083	P	601626(MK)	NN	.	.	.	.	.	.	.	54904	WHSC1L1	I5U1	IVS1	.	.	no-change	NM_023034.1	NP_075447.1	-	Y	c.-45+13040T=	.	.	.	NM_023034.1(WHSC1L1): c.-45+13040T=	;maf-5-some-pop,maf-5-all-pops	5008	0.786542	U	0.3185	0.213458	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs16887343	.	.	.	0.533	2.494	2.193	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38226276	38226277	8p11.23	0	normal	.	A	snv	G	CC.CT	het-ref	143	0.43	.	2	.	PASS	607083	P	601626(MK)	NN	.	.	.	.	.	.	.	54904	WHSC1L1	I5U1	IVS1	.	.	intron	NM_023034.1	NP_075447.1	-	Y	c.-45+13040T>C	.	.	.	NM_023034.1(WHSC1L1): c.-45+13040T>C	;maf-5-some-pop,maf-5-all-pops	5008	0.213458	U	0.3185	0.213458	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs16887343	.	.	.	0.533	2.494	2.193	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38232737	38232738	8p11.23	0	normal	.	G	ref	G	TT.CT	het-alt	165	0.59	.	1	.	PASS	607083	P	601626(MK)	NN	.	.	.	.	.	.	.	54904	WHSC1L1	I5U1	IVS1	.	.	no-change	NM_023034.1	NP_075447.1	-	Y	c.-45+6579C=	.	.	.	NM_023034.1(WHSC1L1): c.-45+6579C=	;maf-5-some-pop,maf-5-all-pops	5008	0.784345	U	0.3194	0.215655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10107763	.	.	.	-0.494	0.766	0.706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38232737	38232738	8p11.23	0	normal	.	G	snv	T	TT.CT	het-ref	113	0.41	.	2	.	PASS	607083	P	601626(MK)	NN	.	.	.	.	.	.	.	54904	WHSC1L1	I5U1	IVS1	.	.	intron	NM_023034.1	NP_075447.1	-	Y	c.-45+6579C>A	.	.	.	NM_023034.1(WHSC1L1): c.-45+6579C>A	;maf-5-some-pop,maf-5-all-pops	5008	0.215655	U	0.3194	0.215655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10107763	.	.	.	-0.494	0.766	0.706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38232845	38232846	8p11.23	0	normal	.	T	ref	T	TC.AA	het-alt	61	0.57	.	1	.	PASS	607083	P	601626(MK)	NN	.	.	.	.	.	.	.	54904	WHSC1L1	I5U1	IVS1	.	.	no-change	NM_023034.1	NP_075447.1	-	Y	c.-45+6471A=	.	.	.	NM_023034.1(WHSC1L1): c.-45+6471A=	.	.	.	.	0.3194	0.19988	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.260	-0.086	-0.135	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38232846	38232846	8p11.23	0	normal	.	.	ins	A	CT.AA	het-ref	46	0.43	.	2	.	PASS	607083	P	601626(MK)	NN	.	.	.	.	.	.	.	54904	WHSC1L1	I5U1	IVS1	.	.	intron	NM_023034.1	NP_075447.1	-	Y	c.-45+6470_-45+6471insT	.	.	.	NM_023034.1(WHSC1L1): c.-45+6470_-45+6471insT	;maf-5-some-pop,maf-5-all-pops	5008	0.199880	U	0.3194	0.19988	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs144443116	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38236812	38236813	8p11.23	0	normal	.	T	ref	T	TC.TT	het-alt	75	0.65	.	1	.	PASS	607083	P	601626(MK)	NN	.	.	.	.	.	.	.	54904	WHSC1L1	I5U1	IVS1	.	.	no-change	NM_023034.1	NP_075447.1	-	Y	c.-45+2504A=	.	.	.	NM_023034.1(WHSC1L1): c.-45+2504A=	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs570499053	.	.	.	0.260	0.281	0.263	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
8	38236812	38236813	8p11.23	0	normal	.	T	del	.	TC.TT	het-ref	40	0.35	.	2	.	PASS	607083	P	601626(MK)	NN	.	.	.	.	.	.	.	54904	WHSC1L1	I5U1	IVS1	.	.	intron	NM_023034.1	NP_075447.1	-	Y	c.-45+2504delA	.	.	.	NM_023034.1(WHSC1L1): c.-45+2504delA	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs570499053	.	.	.	0.260	0.281	0.263	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
8	38236889	38236890	8p11.23	0	normal	.	G	ref	G	TT.CA	het-alt	181	0.53	.	1	.	PASS	607083	P	601626(MK)	NN	.	.	.	.	.	.	.	54904	WHSC1L1	I5U1	IVS1	.	.	no-change	NM_023034.1	NP_075447.1	-	Y	c.-45+2427C=	.	.	.	NM_023034.1(WHSC1L1): c.-45+2427C=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.788339	U	0.3194	0.211661	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10095753	.	.	.	-1.659	-0.140	-0.183	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38236889	38236890	8p11.23	0	normal	.	G	snv	A	TT.CA	het-ref	159	0.47	.	2	.	PASS	607083	P	601626(MK)	NN	.	.	.	.	.	.	.	54904	WHSC1L1	I5U1	IVS1	.	.	intron	NM_023034.1	NP_075447.1	-	Y	c.-45+2427C>T	.	.	.	NM_023034.1(WHSC1L1): c.-45+2427C>T	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.211661	U	0.3194	0.211661	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10095753	.	.	.	-1.659	-0.140	-0.183	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38243864	38243865	8p11.23	0	normal	.	T	ref	T	TG.AA	het-alt	196	0.49	.	1	.	PASS	607083	P	601626(MK)	NN	.	.	.	.	.	.	.	54904	WHSC1L1	PROM	.	.	.	no-change	NM_023034.1	NP_075447.1	-	Y	c.-518-u4075A=	.	.	.	NM_023034.1(WHSC1L1): c.-518-u4075A=	;maf-5-some-pop,maf-5-all-pops	5008	0.783546	U	0.3204	0.216454	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6996860	.	.	.	-0.121	-0.918	-1.214	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38243864	38243865	8p11.23	0	normal	.	T	snv	G	TG.AA	het-ref	207	0.51	.	2	.	PASS	607083	P	601626(MK)	NN	.	.	.	.	.	.	.	54904	WHSC1L1	PROM	.	.	.	promoter	NM_023034.1	NP_075447.1	-	Y	c.-518-u4075A>C	.	.	.	NM_023034.1(WHSC1L1): c.-518-u4075A>C	;maf-5-some-pop,maf-5-all-pops	5008	0.216454	U	0.3204	0.216454	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6996860	.	.	.	-0.121	-0.918	-1.214	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38259480	38259481	8p11.23	0	normal	.	T	ref	T	CC.TT	het-alt	204	0.57	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr8: g.38259480T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.774960	U	0.3512	0.22504	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11986274	.	.	.	-0.939	0.563	0.368	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38259480	38259481	8p11.23	0	normal	.	T	snv	C	CC.TT	het-ref	154	0.43	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr8: g.38259480T>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.225040	U	0.3512	0.22504	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11986274	.	.	.	-0.939	0.563	0.368	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38284010	38284011	8p11.23	0	normal	.	C	snv	T	TC.GG	het-ref	407	0.51	.	2	.	PASS	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	IC4	IVS5	.	.	intron	NM_023110.2	NP_075598.2	-	Y	c.622-248G>A	.	.	.	NM_023110.2(FGFR1): c.622-248G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.183706	U	0.3194	0.183706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2293971	.	4024	0.305200	-1.287	-0.183	-0.229	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38284010	38284011	8p11.23	0	normal	.	C	ref	C	TC.GG	het-alt	391	0.49	.	1	.	PASS	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	IC4	IVS5	.	.	no-change	NM_023110.2	NP_075598.2	-	Y	c.622-248G=	.	.	.	NM_023110.2(FGFR1): c.622-248G=	;maf-5-some-pop,maf-5-all-pops	5008	0.816294	U	0.3194	0.183706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2293971	.	4024	0.694800	-1.287	-0.183	-0.229	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38287554	38287555	8p11.23	0	normal	.	C	ref	C	TA.GC	het-alt	88	0.44	.	1	.	PASS	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	IC1	IVS2	.	.	no-change	NM_023110.2	NP_075598.2	-	Y	c.92-89G=	.	.	.	NM_023110.2(FGFR1): c.92-89G=	;maf-5-some-pop	5008	0.814497	U	0.3155	0.185503	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4647907	.	4020	0.695300	-1.469	-0.776	-0.936	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38287554	38287555	8p11.23	0	normal	.	C	snv	T	TA.GC	het-ref	111	0.56	.	2	.	PASS	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	IC1	IVS2	.	.	intron	NM_023110.2	NP_075598.2	-	Y	c.92-89G>A	.	.	.	NM_023110.2(FGFR1): c.92-89G>A	;maf-5-some-pop	5008	0.185503	U	0.3155	0.185503	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4647907	.	4020	0.304700	-1.469	-0.776	-0.936	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38316848	38316849	8p11.22	0	normal	.	C	ref	C	TG.TG	het-alt	313	0.48	.	1	.	PASS	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	I5U1	IVS1	.	.	no-change	NM_023110.2	NP_075598.2	-	Y	c.-88-1797G=	.	.	.	NM_023110.2(FGFR1): c.-88-1797G=	;maf-5-some-pop	5008	0.801717	U	0.3889	0.198283	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3758102	.	4024	0.617300	0.563	0.338	0.507	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38316848	38316849	8p11.22	0	normal	.	C	snv	T	TG.TG	het-ref	344	0.52	.	2	.	PASS	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	I5U1	IVS1	.	.	intron	NM_023110.2	NP_075598.2	-	Y	c.-88-1797G>A	.	.	.	NM_023110.2(FGFR1): c.-88-1797G>A	;maf-5-some-pop	5008	0.198283	U	0.3889	0.198283	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3758102	.	4024	0.382700	0.563	0.338	0.507	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38317397	38317398	8p11.22	0	nullSample	.	T	ref	T	CA.TG	homo-ref	.	.	.	0	.	.	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	I5U1	IVS1	.	.	no-change	NM_023110.2	NP_075598.2	-	Y	c.-88-2346A=	.	.	.	NM_023110.2(FGFR1): c.-88-2346A=	;maf-5-some-pop,genotype-conflict	5008	0.423722	U	0.6577	0.576278	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7012413	.	4024	0.354900	0.455	-0.389	-0.433	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38317397	38317398	8p11.22	0	normal	.	T	snv	C	CA.TG	hom-alt	453	1.00	.	0	.	PASS	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	I5U1	IVS1	.	.	intron	NM_023110.2	NP_075598.2	-	Y	c.-88-2346A>G	.	.	.	NM_023110.2(FGFR1): c.-88-2346A>G	;maf-5-some-pop,genotype-conflict	5008	0.576278	U	0.6577	0.576278	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7012413	.	4024	0.645100	0.455	-0.389	-0.433	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38317475	38317476	8p11.22	0	nullSample	.	A	ref	A	gg.gt	homo-ref	.	.	.	0	AluSx|SINE|Alu|+|281	.	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	I5U1	IVS1	.	.	no-change	NM_023110.2	NP_075598.2	-	Y	c.-88-2424T=	.	.	.	NM_023110.2(FGFR1): c.-88-2424T=	;maf-5-some-pop,maf-5-all-pops	5008	0.297923	U	0.7034	0.702077	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3758101	.	4024	0.292700	-2.208	-2.127	-2.206	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38317475	38317476	8p11.22	0	normal	.	A	snv	C	gg.gt	hom-alt	241	1.00	.	0	AluSx|SINE|Alu|+|281	PASS	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	I5U1	IVS1	.	.	intron	NM_023110.2	NP_075598.2	-	Y	c.-88-2424T>G	.	.	.	NM_023110.2(FGFR1): c.-88-2424T>G	;maf-5-some-pop,maf-5-all-pops	5008	0.702077	U	0.7034	0.702077	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3758101	.	4024	0.707300	-2.208	-2.127	-2.206	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38318336	38318337	8p11.22	0	normal	.	G	ref	G	CT.CT	het-alt	377	0.48	.	1	.	PASS	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	I5U1	IVS1	.	.	no-change	NM_023110.2	NP_075598.2	-	Y	c.-88-3285C=	.	.	.	NM_023110.2(FGFR1): c.-88-3285C=	;maf-5-some-pop,maf-5-all-pops	5008	0.593650	U	0.4782	0.40635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs13275043	.	4024	0.511200	-0.120	-0.083	-0.200	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38318336	38318337	8p11.22	0	normal	.	G	snv	C	CT.CT	het-ref	404	0.52	.	2	.	PASS	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	I5U1	IVS1	.	.	intron	NM_023110.2	NP_075598.2	-	Y	c.-88-3285C>G	.	.	.	NM_023110.2(FGFR1): c.-88-3285C>G	;maf-5-some-pop,maf-5-all-pops	5008	0.406350	U	0.4782	0.40635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs13275043	.	4024	0.488800	-0.120	-0.083	-0.200	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38321552	38321553	8p11.22	0	nullSample	.	T	ref	T	gg.ca	homo-ref	.	.	.	0	AluSz|SINE|Alu|+|303	.	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	I5U1	IVS1	.	.	no-change	NM_023110.2	NP_075598.2	-	Y	c.-89+3946A=	.	.	.	NM_023110.2(FGFR1): c.-89+3946A=	;maf-5-some-pop	5008	0.075879	U	1	0.924121	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4733948	.	4024	0.001500	-1.692	-1.637	-1.828	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38321552	38321553	8p11.22	0	normal	.	T	snv	C	gg.ca	hom-alt	268	1.00	.	0	AluSz|SINE|Alu|+|303	PASS	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	I5U1	IVS1	.	.	intron	NM_023110.2	NP_075598.2	-	Y	c.-89+3946A>G	.	.	.	NM_023110.2(FGFR1): c.-89+3946A>G	;maf-5-some-pop	5008	0.924121	U	1	0.924121	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4733948	.	4024	0.998500	-1.692	-1.637	-1.828	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38321829	38321830	8p11.22	0	normal	.	C	ref	C	ct.aa	het-alt	20	0.31	.	1	AluSz|SINE|Alu|+|303	PASS	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	I5U1	IVS1	.	.	no-change	NM_023110.2	NP_075598.2	-	Y	c.-89+3669G=	.	.	.	NM_023110.2(FGFR1): c.-89+3669G=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.395	0.012	0.020	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
8	38321830	38321830	8p11.22	0	normal	.	.	ins	AAAAAA	tc.aa	het-ref	44	0.69	.	2	AluSz|SINE|Alu|+|303	PASS	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	I5U1	IVS1	.	.	intron	NM_023110.2	NP_075598.2	-	Y	c.-89+3668_-89+3669insTTTTTT	.	.	.	NM_023110.2(FGFR1): c.-89+3668_-89+3669insTTTTTT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.032800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
8	38322345	38322346	8p11.22	0	normal	.	A	ref	A	CT.TA	het-alt	386	0.53	.	1	.	PASS	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	I5U1	IVS1	.	.	no-change	NM_023110.2	NP_075598.2	-	Y	c.-89+3153T=	.	.	.	NM_023110.2(FGFR1): c.-89+3153T=	;maf-5-some-pop,maf-5-all-pops	5008	0.347244	U	0.6012	0.652756	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6996321	.	4024	0.404800	-2.576	-0.227	-0.285	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38322345	38322346	8p11.22	0	normal	.	A	snv	G	CT.TA	het-ref	346	0.47	.	2	.	PASS	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	I5U1	IVS1	.	.	intron	NM_023110.2	NP_075598.2	-	Y	c.-89+3153T>C	.	.	.	NM_023110.2(FGFR1): c.-89+3153T>C	;maf-5-some-pop,maf-5-all-pops	5008	0.652756	U	0.6012	0.652756	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6996321	.	4024	0.595200	-2.576	-0.227	-0.285	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38324340	38324341	8p11.22	0	normal	.	G	ref	G	AA.GC	het-alt	102	0.45	.	1	.	PASS	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	I5U1	IVS1	.	.	no-change	NM_023110.2	NP_075598.2	-	Y	c.-89+1158C=	.	.	.	NM_023110.2(FGFR1): c.-89+1158C=	;maf-5-some-pop	5008	0.817891	U	0.1538	0.182109	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17182127	.	4024	0.841500	-0.485	0.408	0.102	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38324340	38324341	8p11.22	0	normal	.	G	snv	A	AA.GC	het-ref	125	0.55	.	2	.	PASS	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	I5U1	IVS1	.	.	intron	NM_023110.2	NP_075598.2	-	Y	c.-89+1158C>T	.	.	.	NM_023110.2(FGFR1): c.-89+1158C>T	;maf-5-some-pop	5008	0.182109	U	0.1538	0.182109	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17182127	.	4024	0.158500	-0.485	0.408	0.102	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38324412	38324413	8p11.22	0	normal	.	A	ref	A	CC.CC	het-alt	118	0.71	.	1	.	PASS	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	I5U1	IVS1	.	.	no-change	NM_023110.2	NP_075598.2	-	Y	c.-89+1086T=	.	.	.	NM_023110.2(FGFR1): c.-89+1086T=	MixedObserved;maf-5-some-pop|MixedObserved;	5008|0	0.764776|0	U	0.1935	0.235224	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17182120|rs759264601	.	4065	0.860400	-1.890	-1.761	-1.839	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38324412	38324413	8p11.22	0	normal	.	A	del	.	CC.CC	het-ref	48	0.29	.	2	.	PASS	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	I5U1	IVS1	.	.	intron	NM_023110.2	NP_075598.2	-	Y	c.-89+1086delT	.	.	.	NM_023110.2(FGFR1): c.-89+1086delT	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs759264601	.	4065	0.128300	-1.890	-1.761	-1.839	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38324413	38324414	8p11.22	0	normal	.	C	ref	C	CA.CC	het-alt	109	0.57	.	1	.	PASS	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	I5U1	IVS1	.	.	no-change	NM_023110.2	NP_075598.2	-	Y	c.-89+1085G=	.	.	.	NM_023110.2(FGFR1): c.-89+1085G=	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs35393411	.	4025	0.434700	0.121	0.122	0.119	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38324413	38324414	8p11.22	0	normal	.	C	del	.	CA.CC	het-ref	82	0.43	.	2	.	PASS	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	I5U1	IVS1	.	.	intron	NM_023110.2	NP_075598.2	-	Y	c.-89+1085delG	.	.	.	NM_023110.2(FGFR1): c.-89+1085delG	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs35393411	.	4025	0.560900	0.121	0.122	0.119	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38324615	38324616	8p11.22	0	nullSample	.	G	ref	G	GA.TG	homo-ref	.	.	.	0	.	.	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	I5U1	IVS1	.	.	no-change	NM_023110.2	NP_075598.2	-	Y	c.-89+883C=	.	.	.	NM_023110.2(FGFR1): c.-89+883C=	;maf-5-some-pop,maf-5-all-pops	5008	0.570687	U	0.5526	0.429313	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6994556	.	4024	0.436900	0.305	0.371	0.152	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38324615	38324616	8p11.22	0	normal	.	G	snv	A	GA.TG	hom-alt	614	1.00	.	0	.	PASS	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	I5U1	IVS1	.	.	intron	NM_023110.2	NP_075598.2	-	Y	c.-89+883C>T	.	.	.	NM_023110.2(FGFR1): c.-89+883C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.429313	U	0.5526	0.429313	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6994556	.	4024	0.563100	0.305	0.371	0.152	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38325130	38325131	8p11.22	0	normal	.	G	ref	G	CA.TC	het-alt	327	0.51	.	1	.	PASS	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	I5U1	IVS1	.	.	no-change	NM_023110.2	NP_075598.2	-	Y	c.-89+368C=	.	.	.	NM_023110.2(FGFR1): c.-89+368C=	;maf-5-some-pop	5008	0.752995	U	0.3998	0.247005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17175708	.	4024	0.595900	0.436	0.183	0.183	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38325130	38325131	8p11.22	0	normal	.	G	snv	A	CA.TC	het-ref	319	0.49	.	2	.	PASS	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	I5U1	IVS1	.	.	intron	NM_023110.2	NP_075598.2	-	Y	c.-89+368C>T	.	.	.	NM_023110.2(FGFR1): c.-89+368C>T	;maf-5-some-pop	5008	0.247005	U	0.3998	0.247005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17175708	.	4024	0.404100	0.436	0.183	0.183	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38332094	38332095	8p11.22	0	normal	.	G	ref	G	CG.AT	het-alt	93	0.48	.	1	.	PASS	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	PROM	.	.	.	no-change	NM_023110.2	NP_075598.2	-	Y	c.-942-u5743C=	.	.	.	NM_023110.2(FGFR1): c.-942-u5743C=	;maf-5-some-pop,maf-5-all-pops	5008	0.813698	U	0.1518	0.186302	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7829058	.	.	.	0.563	1.071	1.084	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38332094	38332095	8p11.22	0	normal	.	G	snv	C	CG.AT	het-ref	100	0.52	.	2	.	PASS	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	PROM	.	.	.	promoter	NM_023110.2	NP_075598.2	-	Y	c.-942-u5743C>G	.	.	.	NM_023110.2(FGFR1): c.-942-u5743C>G	;maf-5-some-pop,maf-5-all-pops	5008	0.186302	U	0.1518	0.186302	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7829058	.	.	.	0.563	1.071	1.084	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38332297	38332298	8p11.22	0	normal	.	A	ref	A	AT.GT	het-alt	100	0.50	.	1	.	PASS	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	PROM	.	.	.	no-change	NM_023110.2	NP_075598.2	-	Y	c.-942-u5946T=	.	.	.	NM_023110.2(FGFR1): c.-942-u5946T=	;maf-5-some-pop,maf-5-all-pops	5008	0.809704	U	0.1508	0.190296	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs881300	.	.	.	-0.374	0.113	0.084	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38332297	38332298	8p11.22	0	normal	.	A	snv	C	AT.GT	het-ref	101	0.50	.	2	.	PASS	136350	C	101600(MK);123150(MK);147950(MK);166250(MK);190440(MK);615465(MK)	AD	Hypogonadotropic hypogonadism 2 with our without anosmia; Trigonocephaly 1; Jackson-Weiss syndrome; Pfeiffer syndrome	AD/Digenic/Multigenic	Allelic with Hartsfield syndrome (AD/AR); Osteoglophonic dysplasia (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Genitourinary; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic; Endocrine	23812909|23643382|22035731|21700882|20301509|17959774|17360555|17235395|16606836|16470795|16418210|15625620|14564217|14316612|11420131|11297579|11173846|10861678|9475589|8939381|7874169|7422392|6881209|2627230	.	2260	FGFR1	PROM	.	.	.	promoter	NM_023110.2	NP_075598.2	-	Y	c.-942-u5946T>G	.	.	.	NM_023110.2(FGFR1): c.-942-u5946T>G	;maf-5-some-pop,maf-5-all-pops	5008	0.190296	U	0.1508	0.190296	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs881300	.	.	.	-0.374	0.113	0.084	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38361378	38361379	8p11.22	0	normal	.	C	ref	C	CG.TC	het-alt	198	0.52	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr8: g.38361378C= (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.473043	U	0.5784	0.526957	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs328294	.	.	.	0.542	-0.656	-0.517	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38361378	38361379	8p11.22	0	normal	.	C	snv	T	CG.TC	het-ref	181	0.48	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr8: g.38361378C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.526957	U	0.5784	0.526957	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs328294	.	.	.	0.542	-0.656	-0.517	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38361429	38361430	8p11.22	0	nullSample	.	A	ref	A	CC.AG	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr8: g.38361429A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.249800	U	0.75	0.7502	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs328293	.	.	.	-1.007	-0.350	-0.621	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38361429	38361430	8p11.22	0	normal	.	A	snv	G	CC.AG	hom-alt	297	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr8: g.38361429A>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.750200	U	0.75	0.7502	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs328293	.	.	.	-1.007	-0.350	-0.621	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38368728	38368729	8p11.22	0	nullSample	.	T	ref	T	TC.TG	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr8: g.38368728T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.456669	U	0.5833	0.543331	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs34503346	.	.	.	-0.124	0.052	0.052	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38368728	38368729	8p11.22	0	normal	.	T	snv	C	TC.TG	hom-alt	388	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr8: g.38368728T>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.543331	U	0.5833	0.543331	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs34503346	.	.	.	-0.124	0.052	0.052	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	38368751	38368752	8p11.22	0	normal	.	C	ref	C	GC.GG	het-alt	176	0.51	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr8: g.38368751C= (intergenic)	;maf-5-some-pop	5008	0.981430	U	0.0883	0.0185703	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs80038579	.	.	.	-0.842	-1.867	-1.946	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
8	38368751	38368752	8p11.22	0	normal	.	C	snv	T	GC.GG	het-ref	166	0.49	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr8: g.38368751C>T (intergenic)	;maf-5-some-pop	5008	0.018570	U	0.0883	0.0185703	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs80038579	.	.	.	-0.842	-1.867	-1.946	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
8	68995467	68995468	8q13.2	1	normal	.	C	snv	T	CT.TC	het-ref	177	0.50	.	2	.	PASS	612139	C	.	NN	.	.	.	.	.	.	.	80243	PREX2	IC17	IVS17	.	.	intron	NM_024870.2	NP_079146.2	+	Y	c.1879-7C>T	.	.	.	NM_024870.2(PREX2): c.1879-7C>T	;maf-5-some-pop,maf-5-all-pops	125616	0.525244	U	0.4732	0.522165	13004	0.541218	PASS	886	8614	0.458208	16678	120608	0.525371	1692	7537	4.58790e-01	31716	121111	5.18917e-01	rs1030752	.	4024	0.438400	0.655	0.030	-0.328	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	68995467	68995468	8q13.2	0	normal	.	C	ref	C	CT.TC	het-alt	180	0.50	.	1	.	PASS	612139	C	.	NN	.	.	.	.	.	.	.	80243	PREX2	IC17	IVS17	.	.	no-change	NM_024870.2	NP_079146.2	+	Y	c.1879-7C=	.	.	.	NM_024870.2(PREX2): c.1879-7C=	;maf-5-some-pop,maf-5-all-pops	125616	0.474756	U	0.4732	0.522165	13004	0.458782	PASS	.	8614	0.541792	13618	120608	0.474629	.	.	.	.	.	.	rs1030752	.	4024	0.561600	0.655	0.030	-0.328	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	68995632	68995633	8q13.2	0	normal	.	A	ref	A	GT.TG	het-alt	161	0.52	.	1	.	PASS	612139	C	.	NN	.	.	.	.	.	.	.	80243	PREX2	IC18	IVS18	.	.	no-change	NM_024870.2	NP_079146.2	+	Y	c.2027+10A=	.	.	.	NM_024870.2(PREX2): c.2027+10A=	;maf-5-some-pop,maf-5-all-pops	126016	0.474940	U	0.4732	0.522165	13006	0.457866	PASS	-1087	8602	0.540572	13708	121008	0.474820	.	.	.	.	.	.	rs1030753	.	4024	0.561400	0.533	0.027	0.137	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	68995632	68995633	8q13.2	1	normal	.	A	snv	G	GT.TG	het-ref	147	0.48	.	2	.	PASS	612139	C	.	NN	.	.	.	.	.	.	.	80243	PREX2	IC18	IVS18	.	.	intron	NM_024870.2	NP_079146.2	+	Y	c.2027+10A>G	.	.	.	NM_024870.2(PREX2): c.2027+10A>G	;maf-5-some-pop,maf-5-all-pops	126016	0.525060	U	0.4732	0.522165	13006	0.542134	PASS	889	8602	0.459428	16755	121008	0.525180	1731	7659	4.61052e-01	32376	123116	5.21108e-01	rs1030753	.	4024	0.438600	0.533	0.027	0.137	.	.	.	.	.	ENST00000288368: c.2027+10A>G (p.?)	biliary_tract [gallbladder|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4767791	.	.	.	.	.	.	.	.	.	Benign
8	69020495	69020496	8q13.2	0	normal	.	T	ref	T	AG.GC	het-alt	179	0.55	.	1	.	PASS	612139	C	.	NN	.	.	.	.	.	.	.	80243	PREX2	C24	EX24	.	.	no-change	NM_024870.2	NP_079146.2	+	Y	c.2868T=	.	.	.	NM_024870.2(PREX2): c.2868T=	;maf-5-some-pop,maf-5-all-pops	126210	0.550440	U	0.4663	0.479832	13006	0.556128	PASS	.	8614	0.535988	18646	121202	0.551691	.	.	.	.	.	.	rs4260880	.	4024	0.543500	-0.256	0.001	-0.732	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	69020495	69020496	8q13.2	1	normal	.	T	snv	C	AG.GC	het-ref	147	0.45	.	2	.	PASS	612139	C	.	NN	.	.	.	.	.	.	.	80243	PREX2	C24	EX24	.	.	coding-synon	NM_024870.2	NP_079146.2	+	Y	c.2868T>C	p.(S956=) | p.(Ser956=)	AGT=>AGC	.	NM_024870.2(PREX2): c.2868T>C (p.(S956=))	;maf-5-some-pop,maf-5-all-pops	126210	0.449560	U	0.4663	0.479832	13006	0.443872	PASS	917	8614	0.464012	12381	121202	0.448309	1867	8001	4.64688e-01	24786	109585	4.45641e-01	rs4260880	.	4024	0.456500	-0.256	0.001	-0.732	.	.	.	.	.	ENST00000288368: c.2868T>C (p.S956S)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	3763384	.	.	.	.	.	.	.	.	.	Likely Benign
8	69389216	69389217	8q13.2	0	nullSample	.	C	ref	C	gc.ct	homo-ref	.	.	.	0	LTR51|LTR|ERV1|-|656	.	.	.	.	.	.	.	.	.	.	.	.	116328	C8orf34	IC4	IVS4	.	.	no-change	NM_052958.2	NP_443190.2	+	Y	c.736+8162C=	.	.	.	NM_052958.2(C8orf34): c.736+8162C=	;maf-5-some-pop,genotype-conflict	5008	0.316494	U	0.878	0.683506	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1517114	.	4024	0.112800	-1.373	-1.282	-1.351	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	69389216	69389217	8q13.2	0	normal	.	C	snv	G	gc.ct	hom-alt	286	1.00	.	0	LTR51|LTR|ERV1|-|656	PASS	.	.	.	.	.	.	.	.	.	.	.	116328	C8orf34	IC4	IVS4	.	.	intron	NM_052958.2	NP_443190.2	+	Y	c.736+8162C>G	.	.	.	NM_052958.2(C8orf34): c.736+8162C>G	;maf-5-some-pop,genotype-conflict	5008	0.683506	U	0.878	0.683506	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1517114	.	4024	0.887200	-1.373	-1.282	-1.351	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	225954	reviewed_by_expert_panel	drug_response	Benign
8	95419697	95419698	8q22.1	0	normal	.	A	ref	A	CA.TT	het-alt	228	0.55	.	1	.	PASS	604289	P	114500(MK);605027(MK)	AD	.	.	.	.	.	.	.	25788	RAD54B	C4	EX5	.	.	no-change	NM_012415.3	NP_036547.1	-	Y	c.750T=	.	.	.	NM_012415.3(RAD54B): c.750T=	;maf-5-some-pop,maf-5-all-pops	126212	0.587266	U	0.4663	0.418131	13006	0.638859	PASS	.	8636	0.532770	21348	121204	0.587489	.	.	.	.	.	.	rs2291439	.	4024	0.520100	0.528	1.448	0.398	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	95419697	95419698	8q22.1	1	normal	.	A	snv	G	CA.TT	het-ref	184	0.45	.	2	.	PASS	604289	P	114500(MK);605027(MK)	AD	.	.	.	.	.	.	.	25788	RAD54B	C4	EX5	.	.	coding-synon	NM_012415.3	NP_036547.1	-	Y	c.750T>C	p.(N250=) | p.(Asn250=)	AAT=>AAC	.	NM_012415.3(RAD54B): c.750T>C (p.(N250=))	;maf-5-some-pop,maf-5-all-pops	126212	0.412734	U	0.4663	0.418131	13006	0.361141	PASS	936	8636	0.467230	10744	121204	0.412511	1890	8110	4.70691e-01	22607	103071	4.19616e-01	rs2291439	.	4024	0.479900	0.528	1.448	0.398	.	.	.	.	.	ENST00000336148: c.750T>C (p.N250N)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3763459	.	.	.	.	.	.	.	.	.	Likely Benign
8	108970366	108970367	8q23.1	0	nullSample	.	A	ref	A	AC.GT	homo-ref	.	.	.	0	.	.	610575	P	.	NN	.	.	.	.	.	.	.	340419	RSPO2	C4	EX5	.	.	no-change	NM_178565.4	NP_848660.3	-	Y	c.557T=	.	.	.	NM_178565.4(RSPO2): c.557T=	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	126360	0.425111	U	0.6885	0.490216	13006	0.527141	PASS	.	8630	0.317149	11919	121352	0.421616	.	.	.	.	.	.	rs601558	.	4024	0.316100	-0.213	3.232	1.487	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	108970366	108970367	8q23.1	1	normal	.	A	snv	G	AC.GT	hom-alt	392	1.00	.	0	.	PASS	610575	P	.	NN	.	.	.	.	.	.	.	340419	RSPO2	C4	EX5	.	.	missense	NM_178565.4	NP_848660.3	-	Y	c.557T>C	p.L186P | p.Leu186Pro	CTG=>CCG	NP=>NP	NM_178565.4(RSPO2): c.557T>C (p.L186P)	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	126360	0.574881	U	0.6885	0.490216	13006	0.472859	PASS	1999	8630	0.682851	21431	121352	0.578375	4099	11877	6.88921e-01	44379	144550	5.87989e-01	rs601558	.	4024	0.683900	-0.213	3.232	1.487	0.38	0	0	0.018	neutral	ENST00000276659: c.557T>C (p.L186P)	skin [NS|NS|NS]	carcinoma [basal_cell_carcinoma|NS|NS]	CSV	5904899	.	.	.	.	.	.	.	.	.	Likely Benign
8	109094971	109094972	8q23.1	0	normal	.	C	snv	T	GA.TC	het-ref	137	0.50	.	2	.	PASS	610575	P	.	NN	.	.	.	.	.	.	.	340419	RSPO2	5U1	EX2	.	.	utr-5	NM_178565.4	NP_848660.3	-	Y	c.-106G>A	.	.	.	NM_178565.4(RSPO2): c.-106G>A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.479	0.294	0.546	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
8	109094971	109094972	8q23.1	0	normal	.	C	ref	C	GA.TC	het-alt	137	0.50	.	1	.	PASS	610575	P	.	NN	.	.	.	.	.	.	.	340419	RSPO2	5U1	EX2	.	.	no-change	NM_178565.4	NP_848660.3	-	Y	c.-106G=	.	.	.	NM_178565.4(RSPO2): c.-106G=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.479	0.294	0.546	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
8	117868531	117868533	8q24.11	1	normal	.	AA	del	.	GT.aa	het-ref	19	0.66	.	2	(A)n|Simple_repeat|Simple_repeat|+|23	PASS	606462	C	614701(MK)	NN	Cornelia de Lange syndrome 	AD	.	Cardiovascular; Craniofacial; Dental; Gastrointestinal; Neurologic	General	22633399	.	5885	RAD21	IC6	IVS7	.	.	intron	NM_006265.2	NP_006256.1	-	Y	c.815-6_815-5delTT	.	.	.	NM_006265.2(RAD21): c.815-6_815-5delTT	MixedObserved;	0	0	U	.	.	.	.	PASS	0	3052	0.053080	0	36104	0.058498	.	.	.	.	.	.	rs754557045	.	4025	0.069500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	117868531	117868533	8q24.11	0	normal	.	AA	ref	AA	GT.aa	het-alt	10	0.34	.	1	(A)n|Simple_repeat|Simple_repeat|+|23	PASS	606462	C	614701(MK)	NN	Cornelia de Lange syndrome 	AD	.	Cardiovascular; Craniofacial; Dental; Gastrointestinal; Neurologic	General	22633399	.	5885	RAD21	IC6	IVS7	.	.	no-change	NM_006265.2	NP_006256.1	-	Y	c.815-6_815-5=	.	.	.	NM_006265.2(RAD21): c.815-6_815-5=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs754557045	.	4025	0.929700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	128749022	128749023	8q24.21	0	normal	.	G	snv	T	GG.TA	het-ref	260	0.55	.	2	.	PASS	190080	C	113970(MK)	NN	.	.	.	.	.	.	.	4609	MYC	IC1	IVS1	.	.	intron	NM_002467.4	NP_002458.2	+	Y	c.30+154G>T	.	.	.	NM_002467.4(MYC): c.30+154G>T	;maf-5-some-pop	5008	0.127796	U	0.1974	0.127796	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2071346	.	4024	0.207300	-1.367	-2.054	-2.472	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	128749022	128749023	8q24.21	0	normal	.	G	ref	G	GG.TA	het-alt	217	0.45	.	1	.	PASS	190080	C	113970(MK)	NN	.	.	.	.	.	.	.	4609	MYC	IC1	IVS1	.	.	no-change	NM_002467.4	NP_002458.2	+	Y	c.30+154G=	.	.	.	NM_002467.4(MYC): c.30+154G=	;maf-5-some-pop	5008	0.872204	U	0.1974	0.127796	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2071346	.	4024	0.792700	-1.367	-2.054	-2.472	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	128750138	128750139	8q24.21	0	nullSample	.	T	ref	T	GT.TT	homo-ref	.	.	.	0	.	.	190080	C	113970(MK)	NN	.	.	.	.	.	.	.	4609	MYC	IC1	IVS1	.	.	no-change	NM_002467.4	NP_002458.2	+	Y	c.31-355T=	.	.	.	NM_002467.4(MYC): c.31-355T=	;maf-5-some-pop,genotype-conflict	5008	0.599840	U	0.4038	0.40016	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3891248	.	4024	0.579300	-0.448	-0.849	-0.740	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	128750138	128750139	8q24.21	0	normal	.	T	snv	A	GT.TT	hom-alt	645	1.00	.	0	.	PASS	190080	C	113970(MK)	NN	.	.	.	.	.	.	.	4609	MYC	IC1	IVS1	.	.	intron	NM_002467.4	NP_002458.2	+	Y	c.31-355T>A	.	.	.	NM_002467.4(MYC): c.31-355T>A	;maf-5-some-pop,genotype-conflict	5008	0.400160	U	0.4038	0.40016	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3891248	.	4024	0.420700	-0.448	-0.849	-0.740	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	128750259	128750260	8q24.21	0	normal	.	C	ref	C	GG.GG	het-alt	273	0.54	.	1	.	PASS	190080	C	113970(MK)	NN	.	.	.	.	.	.	.	4609	MYC	IC1	IVS1	.	.	no-change	NM_002467.4	NP_002458.2	+	Y	c.31-234C=	.	.	.	NM_002467.4(MYC): c.31-234C=	;maf-5-some-pop	5008	0.927516	U	0.0724	0.072484	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4645957	.	4024	0.919000	-0.254	-1.159	-0.851	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	128750259	128750260	8q24.21	0	normal	.	C	snv	T	GG.GG	het-ref	229	0.46	.	2	.	PASS	190080	C	113970(MK)	NN	.	.	.	.	.	.	.	4609	MYC	IC1	IVS1	.	.	intron	NM_002467.4	NP_002458.2	+	Y	c.31-234C>T	.	.	.	NM_002467.4(MYC): c.31-234C>T	;maf-5-some-pop	5008	0.072484	U	0.0724	0.072484	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4645957	.	4024	0.081000	-0.254	-1.159	-0.851	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	128751200	128751201	8q24.21	0	normal	.	G	ref	G	CC.CA	het-alt	281	0.51	.	1	.	PASS	190080	C	113970(MK)	NN	.	.	.	.	.	.	.	4609	MYC	C2	EX2	Myc amino-terminal region	PF01056.13	no-change	NM_002467.4	NP_002458.2	+	Y	c.738G=	.	.	.	NM_002467.4(MYC): c.738G=	SingleClassTriAllelic;maf-5-some-pop	108174	0.956718	U	0.0734	0.0625	12110	0.961602	PASS	.	7978	0.917398	47341	103166	0.957651	.	.	.	.	.	.	rs2070582	.	4024	0.919000	0.561	-1.583	-1.277	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	128751200	128751201	8q24.21	1	normal	.	G	snv	A	CC.CA	het-ref	266	0.49	.	2	.	PASS	190080	C	113970(MK)	NN	.	.	.	.	.	.	.	4609	MYC	C2	EX2	Myc amino-terminal region	PF01056.13	coding-synon	NM_002467.4	NP_002458.2	+	Y	c.738G>A	p.(P246=) | p.(Pro246=)	CCG=>CCA	.	NM_002467.4(MYC): c.738G>A (p.(P246=))	SingleClassTriAllelic;maf-5-some-pop	108174	0.043273	U	0.0734	0.0625	12110	0.038398	PASS	29	7978	0.082602	127	103166	0.042340	49	1260	7.68761e-02	212	8156	3.73607e-02	rs2070582	.	4024	0.081000	0.561	-1.583	-1.277	.	.	.	.	.	ENST00000377970: c.738G>A (p.P246P)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019468	.	.	.	.	.	.	.	.	.	Likely Benign
8	128751325	128751326	8q24.21	0	normal	.	T	snv	C	CA.TG	het-ref	186	0.48	.	2	.	PASS	190080	C	113970(MK)	NN	.	.	.	.	.	.	.	4609	MYC	IC2	IVS2	.	.	intron	NM_002467.4	NP_002458.2	+	Y	c.802+61T>C	.	.	.	NM_002467.4(MYC): c.802+61T>C	;maf-5-some-pop	5008	0.023163	U	0.0367	0.0231629	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4645962	.	4024	0.035000	0.260	-0.277	-0.112	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
8	128751325	128751326	8q24.21	0	normal	.	T	ref	T	CA.TG	het-alt	200	0.52	.	1	.	PASS	190080	C	113970(MK)	NN	.	.	.	.	.	.	.	4609	MYC	IC2	IVS2	.	.	no-change	NM_002467.4	NP_002458.2	+	Y	c.802+61T=	.	.	.	NM_002467.4(MYC): c.802+61T=	;maf-5-some-pop	5008	0.976837	U	0.0367	0.0231629	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4645962	.	4024	0.965000	0.260	-0.277	-0.112	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	143310814	143310815	8q24.3	0	nullSample	.	G	ref	G	AC.GG	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr8: g.143310814G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	126018	0.501881	U	0.495	0.535144	13006	0.527064	PASS	-1073	8618	0.488977	15737	121010	0.503413	.	.	.	.	.	.	rs11167136	.	.	.	0.457	1.928	1.300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	143310814	143310815	8q24.3	0	normal	.	G	snv	A	AC.GG	hom-alt	403	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr8: g.143310814G>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	126018	0.498119	U	0.495	0.535144	13006	0.472936	PASS	1129	8618	0.511023	15324	121010	0.496587	2226	8733	5.07025e-01	31235	122259	4.97587e-01	rs11167136	.	.	.	0.457	1.928	1.300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	144940266	144940267	8q24.3	0	normal	.	G	snv	A	AA.CC	het-ref	163	0.18	.	2	.	PASS	607553	P	.	NN	.	.	.	.	.	.	.	83481	EPPK1	C1E	EX1E	.	.	no-change	NM_031308.1	NP_112598.2	-	Y	c.7155T=	.	.	.	NM_031308.1(EPPK1): c.7155T=	;maf-5-some-pop	115380	0.126443	U	.	.	.	.	PASS	0	8234	0.163590	0	115380	0.126443	0	685	5.63972e-02	0	4328	2.36749e-02	rs28441354	.	.	.	0.591	1.614	2.455	.	.	.	.	.	ENST00000525985: c.7155C>T (p.G2385G)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3785904	.	.	.	.	.	.	.	.	.	Benign
8	144940266	144940267	8q24.3	1	normal	.	G	ref	G	AA.CC	het-alt	724	0.82	.	1	.	PASS	607553	P	.	NN	.	.	.	.	.	.	.	83481	EPPK1	C1E	EX1E	.	.	coding-synon	NM_031308.1	NP_112598.2	-	Y	c.7155T>C	p.(G2385=) | p.(Gly2385=)	GGT=>GGC	.	NM_031308.1(EPPK1): c.7155T>C (p.(G2385=))	;maf-5-some-pop	115380	0.873557	U	.	.	.	.	PASS	.	8234	0.836410	43101	115380	0.873557	.	.	.	.	.	.	rs28441354	.	.	.	0.591	1.614	2.455	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
8	144940299	144940300	8q24.3	1	normal	.	G	ref	G	AC.CG	het-alt	468	0.34	.	1	.	PASS	607553	P	.	NN	.	.	.	.	.	.	.	83481	EPPK1	C1E	EX1E	Plectin repeat	PF00681.15	coding-synon	NM_031308.1	NP_112598.2	-	Y	c.7122T>C	p.(R2374=) | p.(Arg2374=)	CGT=>CGC	.	NM_031308.1(EPPK1): c.7122T>C (p.(R2374=))	;maf-5-some-pop,maf-5-all-pops	120552	0.495620	U	.	.	.	.	InbreedingCoeff_Filter	-2135	8610	0.495935	2	120552	0.495620	.	.	.	.	.	.	rs4977191	.	.	.	0.591	0.776	0.591	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
8	144940299	144940300	8q24.3	0	normal	.	G	snv	A	AC.CG	het-ref	904	0.66	.	2	.	PASS	607553	P	.	NN	.	.	.	.	.	.	.	83481	EPPK1	C1E	EX1E	Plectin repeat	PF00681.15	no-change	NM_031308.1	NP_112598.2	-	Y	c.7122T=	.	.	.	NM_031308.1(EPPK1): c.7122T=	;maf-5-some-pop,maf-5-all-pops	120552	0.504380	U	.	.	.	.	InbreedingCoeff_Filter	35	8610	0.504065	530	120552	0.504380	3	8624	5.00174e-01	632	123598	5.02488e-01	rs4977191	.	.	.	0.591	0.776	0.591	.	.	.	.	.	ENST00000525985: c.7122C>T (p.R2374R)	breast [NS|NS|NS]	carcinoma [NS|NS|NS]	CSV	3834213	.	.	.	.	.	.	.	.	.	Benign
8	145737039	145737040	8q24.3	0	normal	.	C	ref	C	AG.GG	het-alt	206	0.49	.	1	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	IC20	IVS20	.	.	no-change	NM_004260.3	NP_004251.3	-	Y	c.3502+24G=	.	.	.	NM_004260.3(RECQL4): c.3502+24G=	;maf-5-some-pop,maf-5-all-pops	121772	0.538950	U	0.5248	0.393171	12052	0.653999	PASS	-1045	8426	0.513411	17470	116764	0.536039	.	.	.	.	.	.	rs2279243	.	.	.	-1.598	-2.707	-2.260	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	145737039	145737040	8q24.3	0	normal	.	C	snv	T	AG.GG	het-ref	214	0.51	.	2	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	IC20	IVS20	.	.	intron	NM_004260.3	NP_004251.3	-	Y	c.3502+24G>A	.	.	.	NM_004260.3(RECQL4): c.3502+24G>A	;maf-5-some-pop,maf-5-all-pops	121772	0.461050	U	0.5248	0.393171	12052	0.346001	PASS	1005	8426	0.486589	13262	116764	0.463961	2036	8268	4.82718e-01	28382	114437	4.71054e-01	rs2279243	.	.	.	-1.598	-2.707	-2.260	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	145737285	145737286	8q24.3	0	normal	.	G	ref	G	CT.CA	het-alt	268	0.48	.	1	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	IC19	IVS19	.	.	no-change	NM_004260.3	NP_004251.3	-	Y	c.3393+8C=	.	.	.	NM_004260.3(RECQL4): c.3393+8C=	;maf-5-some-pop,genotype-conflict	123206	0.535737	U	0.5357	0.400559	12804	0.650031	PASS	-1058	8528	0.509615	17416	118198	0.533038	.	.	.	.	.	.	rs756627	.	.	.	0.462	-0.363	-0.373	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	145737285	145737286	8q24.3	1	normal	.	G	snv	A	CT.CA	het-ref	291	0.52	.	2	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	IC19	IVS19	.	.	intron	NM_004260.3	NP_004251.3	-	Y	c.3393+8C>T	.	.	.	NM_004260.3(RECQL4): c.3393+8C>T	;maf-5-some-pop,genotype-conflict	123206	0.464263	U	0.5357	0.400559	12804	0.349969	PASS	1033	8528	0.490385	13511	118198	0.466962	2121	8440	4.91155e-01	28758	115517	4.75735e-01	rs756627	.	.	.	0.462	-0.363	-0.373	.	.	.	.	.	ENST00000617875: c.3393+8C>T (p.?)	central_nervous_system [brain|NS|NS]	primitive_neuroectodermal_tumour-medulloblastoma [NS|NS|NS]	CSV	3765393	.	.	.	.	.	no_record	94894	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
8	145737513	145737514	8q24.3	0	normal	.	G	ref	G	CC.CC	het-alt	316	0.48	.	1	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	IC18	IVS18	.	.	no-change	NM_004260.3	NP_004251.3	-	Y	c.3236+13C=	.	.	.	NM_004260.3(RECQL4): c.3236+13C=	;maf-5-some-pop,maf-5-all-pops	102454	0.497228	U	0.503	0.433307	12140	0.606755	PASS	-929	7154	0.525301	11474	97446	0.493658	.	.	.	.	.	.	rs4244610	.	.	.	-0.459	-1.019	-1.277	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	145737513	145737514	8q24.3	1	normal	.	G	snv	A	CC.CC	het-ref	339	0.52	.	2	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	IC18	IVS18	.	.	intron	NM_004260.3	NP_004251.3	-	Y	c.3236+13C>T	.	.	.	NM_004260.3(RECQL4): c.3236+13C>T	;maf-5-some-pop,maf-5-all-pops	102454	0.502772	U	0.503	0.433307	12140	0.393245	PASS	769	7154	0.474699	12092	97446	0.506342	1780	7553	4.63545e-01	27759	111263	4.90081e-01	rs4244610	.	.	.	-0.459	-1.019	-1.277	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	94893	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
8	145737635	145737636	8q24.3	1	normal	.	A	ref	A	CA.GT	het-alt	360	0.51	.	1	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	C18	EX18	.	.	coding-synon	NM_004260.3	NP_004251.3	-	Y	c.3127C>T	p.(L1043=) | p.(Leu1043=)	CTG=>TTG	.	NM_004260.3(RECQL4): c.3127C>T (p.(L1043=))	;maf-5-some-pop	123980	0.028255	U	0.7966	0.946086	12546	0.001594	PASS	-715	8568	0.219421	287	118972	0.027174	.	.	.	.	.	.	rs4925828	.	.	.	-0.215	1.854	0.271	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
8	145737635	145737636	8q24.3	0	normal	.	A	snv	G	CA.GT	het-ref	348	0.49	.	2	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	C18	EX18	.	.	no-change	NM_004260.3	NP_004251.3	-	Y	c.3127C=	.	.	.	NM_004260.3(RECQL4): c.3127C=	;maf-5-some-pop	123980	0.971745	U	0.7966	0.946086	12546	0.998406	PASS	2629	8568	0.780579	56540	118972	0.972826	5315	13507	7.84470e-01	115853	237845	9.70075e-01	rs4925828	.	.	.	-0.215	1.854	0.271	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	167573	criteria_provided,_single_submitter	Benign	Benign
8	145737815	145737816	8q24.3	0	normal	.	C	ref	C	CC.GC	het-alt	308	0.49	.	1	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	C17	EX17	.	.	no-change	NM_004260.3	NP_004251.3	-	Y	c.3014G=	.	.	.	NM_004260.3(RECQL4): c.3014G=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	120368	0.541996	U	0.4762	0.384385	12708	0.658089	PASS	-1043	8386	0.558788	17264	115360	0.538800	.	.	.	.	.	.	rs4251691	.	.	.	0.561	1.201	-0.271	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	145737815	145737816	8q24.3	1	normal	.	C	snv	T	CC.GC	het-ref	324	0.51	.	2	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	C17	EX17	.	.	missense	NM_004260.3	NP_004251.3	-	Y	c.3014G>A	p.R1005Q | p.Arg1005Gln	CGG=>CAG	P+=>P0	NM_004260.3(RECQL4): c.3014G>A (p.R1005Q)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	120368	0.458004	U	0.4762	0.384385	12708	0.341911	PASS	807	8386	0.441212	12788	115360	0.461200	1675	7509	4.39277e-01	27626	112838	4.67211e-01	rs4251691	.	.	.	0.561	1.201	-0.271	.	.	.	.	.	ENST00000617875: c.3014G>A (p.R1005Q)	large_intestine [colon|ascending|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1569133	.	.	.	.	.	no_record	94891	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
8	145738581	145738583	8q24.3	0	normal	.	GG	ref	GG	GT.GG	het-alt	44	0.28	.	1	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	IC14	IVS14	.	.	no-change	NM_004260.3	NP_004251.3	-	Y	c.2463+18_2463+19=	.	.	.	NM_004260.3(RECQL4): c.2463+18_2463+19=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs796885693	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
8	145738581	145738583	8q24.3	1	normal	.	GG	del	.	GT.GG	het-ref	114	0.72	.	2	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	IC14	IVS14	.	.	intron	NM_004260.3	NP_004251.3	-	Y	c.2463+18_2463+19delCC	.	.	.	NM_004260.3(RECQL4): c.2463+18_2463+19delCC	MixedObserved;	0	0	U	0.6349	0.539537	.	.	VQSRTrancheINDEL99.50to99.90	93	2674	0.366866	1356	32094	0.412133	.	.	.	.	.	.	rs796885693	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	145738767	145738768	8q24.3	1	nullSample	.	G	ref	G	CC.GC	homo-ref	.	.	.	0	.	.	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	C14	EX14	Helicase conserved C-terminal domain	PF00271.26	frameshift	NM_004260.3	NP_004251.3	-	Y	c.2296dupC	p.R766Pfs*43 | p.Arg766Profs*43	.	.	NM_004260.3(RECQL4): c.2296dupC (p.R766Pfs*43)	MixedObserved;|MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	120606|154	0.000124|0.915584	U	.	.	.	.	PASS	0	12	1.000000	64	154	0.915584	.	.	.	.	.	.	rs11342077|rs199605511	.	.	.	0.000	-0.525	-0.525	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
8	145738767	145738768	8q24.3	0	normal	.	G	del	.	CC.GC	hom-alt	570	1.00	.	0	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	C14	EX14	Helicase conserved C-terminal domain	PF00271.26	no-change	NM_004260.3	NP_004251.3	-	Y	c.=	.	.	.	NM_004260.3(RECQL4): c.=	MixedObserved;	120606	0.999876	U	1	1	.	.	VQSRTrancheINDEL99.00to99.50	4224	8448	1.000000	57784	115598	0.999870	8542	17087	9.99824e-01	118519	237068	9.99873e-01	rs11342077	.	.	.	0.000	-0.525	-0.525	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	145739923	145739924	8q24.3	0	normal	.	G	ref	G	GA.CG	het-alt	193	0.56	.	1	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	IC9	IVS9	.	.	no-change	NM_004260.3	NP_004251.3	-	Y	c.1621-15C=	.	.	.	NM_004260.3(RECQL4): c.1621-15C=	;maf-5-some-pop	112884	0.523635	U	0.503	0.394569	12584	0.649476	PASS	-1032	8078	0.525378	14670	107876	0.519838	.	.	.	.	.	.	rs4244611	.	.	.	0.462	-0.172	-0.167	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	145739923	145739924	8q24.3	1	normal	.	G	snv	A	GA.CG	het-ref	149	0.44	.	2	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	IC9	IVS9	.	.	intron	NM_004260.3	NP_004251.3	-	Y	c.1621-15C>T	.	.	.	NM_004260.3(RECQL4): c.1621-15C>T	;maf-5-some-pop	112884	0.476365	U	0.503	0.394569	12584	0.350524	PASS	885	8078	0.474622	12530	107876	0.480162	1887	7925	4.66891e-01	27923	112697	4.76835e-01	rs4244611	.	.	.	0.462	-0.172	-0.167	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	94886	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
8	145741129	145741130	8q24.3	0	normal	.	C	ref	C	CT.CA	het-alt	243	0.52	.	1	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	IC6	IVS6	.	.	no-change	NM_004260.3	NP_004251.3	-	Y	c.1258+18G=	.	.	.	NM_004260.3(RECQL4): c.1258+18G=	;maf-5-some-pop,maf-5-all-pops	118700	0.531424	U	0.501	0.400958	12330	0.635036	PASS	.	8316	0.536436	16127	113692	0.528445	.	.	.	.	.	.	rs4251689	.	.	.	0.651	2.129	1.555	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	145741129	145741130	8q24.3	1	normal	.	C	snv	T	CT.CA	het-ref	227	0.48	.	2	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	IC6	IVS6	.	.	intron	NM_004260.3	NP_004251.3	-	Y	c.1258+18G>A	.	.	.	NM_004260.3(RECQL4): c.1258+18G>A	;maf-5-some-pop,maf-5-all-pops	118700	0.468576	U	0.501	0.400958	12330	0.364964	PASS	886	8316	0.463564	12893	113692	0.471555	1886	7926	4.65523e-01	28289	114749	4.75336e-01	rs4251689	.	.	.	0.651	2.129	1.555	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	94884	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
8	145741701	145741702	8q24.3	0	normal	.	C	ref	C	GG.TC	het-alt	312	0.47	.	1	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	C5	EX5	.	.	no-change	NM_004260.3	NP_004251.3	-	Y	c.801G=	.	.	.	NM_004260.3(RECQL4): c.801G=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	116754	0.561865	U	0.4821	0.447684	12244	0.608135	PASS	-1002	8040	0.554229	17483	111746	0.562293	.	.	.	.	.	.	rs4244612	.	.	.	0.655	-0.454	-0.467	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	145741701	145741702	8q24.3	1	normal	.	C	snv	G	GG.TC	het-ref	348	0.53	.	2	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	C5	EX5	.	.	missense	NM_004260.3	NP_004251.3	-	Y	c.801G>C	p.E267D | p.Glu267Asp	GAG=>GAC	P-=>P-	NM_004260.3(RECQL4): c.801G>C (p.E267D)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	116754	0.438135	U	0.4821	0.447684	12244	0.391865	PASS	790	8040	0.445771	10522	111746	0.437707	1738	7557	4.47796e-01	23036	104414	4.37446e-01	rs4244612	.	.	.	0.655	-0.454	-0.467	.	.	.	.	.	ENST00000617875: c.801G>C (p.E267D)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3763202	.	.	.	.	.	no_record	94898	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
8	145741764	145741765	8q24.3	0	normal	.	G	ref	G	AT.CT	het-alt	360	0.56	.	1	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	C5	EX5	.	.	no-change	NM_004260.3	NP_004251.3	-	Y	c.738C=	.	.	.	NM_004260.3(RECQL4): c.738C=	;maf-5-some-pop	119532	0.563481	U	0.4831	0.370008	12348	0.660836	PASS	.	8312	0.554981	18298	114524	0.560572	.	.	.	.	.	.	rs4244613	.	.	.	-1.047	-3.879	-3.985	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	145741764	145741765	8q24.3	1	normal	.	G	snv	A	AT.CT	het-ref	279	0.44	.	2	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	C5	EX5	.	.	coding-synon	NM_004260.3	NP_004251.3	-	Y	c.738C>T	p.(S246=) | p.(Ser246=)	AGC=>AGT	.	NM_004260.3(RECQL4): c.738C>T (p.(S246=))	;maf-5-some-pop	119532	0.436519	U	0.4831	0.370008	12348	0.339164	PASS	827	8312	0.445019	11361	114524	0.439428	1783	7680	4.50229e-01	24752	106867	4.43992e-01	rs4244613	.	.	.	-1.047	-3.879	-3.985	.	.	.	.	.	ENST00000617875: c.738C>T (p.S246S)	large_intestine [caecum|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3763203	.	.	.	.	.	no_record	94897	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
8	145742513	145742514	8q24.3	1	normal	.	A	ref	A	AG.CT	het-alt	226	0.53	.	1	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	C4	EX4	.	.	missense	NM_004260.3	NP_004251.3	-	Y	c.274C>T	p.P92S | p.Pro92Ser	CCT=>TCT	NP=>P0	NM_004260.3(RECQL4): c.274C>T (p.P92S)	;maf-5-some-pop,genotype-conflict	121992	0.027912	U	0.8065	0.943291	12204	0.004834	PASS	-670	8428	0.197437	210	116984	0.026679	.	.	.	.	.	.	rs2721190	.	.	.	-0.124	0.235	-0.117	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
8	145742513	145742514	8q24.3	0	normal	.	A	snv	G	AG.CT	het-ref	202	0.47	.	2	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	C4	EX4	.	.	no-change	NM_004260.3	NP_004251.3	-	Y	c.274C=	.	.	.	NM_004260.3(RECQL4): c.274C=	;maf-5-some-pop,genotype-conflict	121992	0.972088	U	0.8065	0.943291	12204	0.995166	PASS	2712	8428	0.802563	55581	116984	0.973321	5509	13736	8.02149e-01	114863	235947	9.70209e-01	rs2721190	.	.	.	-0.124	0.235	-0.117	.	.	.	.	.	ENST00000617875: c.274T>C (p.S92P)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5482487	.	.	.	.	.	no_record	135161	criteria_provided,_single_submitter	Benign	Benign
8	145742878	145742879	8q24.3	0	normal	.	T	ref	T	TA.TC	het-alt	189	0.49	.	1	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	C3	EX3	DNA replication and checkpoint protein	PF11719.3	no-change	NM_004260.3	NP_004251.3	-	Y	c.132A=	.	.	.	NM_004260.3(RECQL4): c.132A=	;maf-5-some-pop,maf-5-all-pops	90532	0.443677	U	0.5238	0.57508	10692	0.449308	PASS	.	6716	0.502829	7600	85524	0.444776	.	.	.	.	.	.	rs2306386	.	.	.	-0.854	-0.127	0.090	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
8	145742878	145742879	8q24.3	1	normal	.	T	snv	C	TA.TC	het-ref	197	0.51	.	2	.	PASS	603780	P	218600(MK);266280(MK);268400(MK)	AR	Baller-Gerold syndrome; RAPADILINO syndrome; Rothmund-Thomson syndrome	AR	.	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Oncologic; Renal	Oncologic	21872685|21143835|20618321|20503338|20113479|19990626|18716613|15964893|13669699|12952869|12838562|12734318|11471165|11102924|11045594|10678659|10319867|8737976|8436644|7315870|2801769|1583650	.	9401	RECQL4	C3	EX3	DNA replication and checkpoint protein	PF11719.3	coding-synon	NM_004260.3	NP_004251.3	-	Y	c.132A>G	p.(E44=) | p.(Glu44=)	GAA=>GAG	.	NM_004260.3(RECQL4): c.132A>G (p.(E44=))	;maf-5-some-pop,maf-5-all-pops	90532	0.556323	U	0.5238	0.57508	10692	0.550692	PASS	768	6716	0.497171	12323	85524	0.555224	1889	7678	4.83989e-01	30107	110211	5.36510e-01	rs2306386	.	.	.	-0.854	-0.127	0.090	.	.	.	.	.	ENST00000617875: c.132A>G (p.E44E)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5452655	.	.	.	.	.	no_record	94885	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
9	5050705	5050706	9p24.1	0	normal	.	C	ref	C	CA.GG	het-alt	330	0.54	.	1	.	PASS	147796	P	133100(MK);254450(MK);263300(MK);600880(SK);601626(MK);614521(MK)	AD	Thrombocythemia 3	AD	Variants may be involved in predisposition to and pathogenesis of oncologic processes (AD)	Hematologic	Hematologic	22696908|22571758|22397670|19847199|19338077|19287385|19287384|19036091|17989398|16762626|16707754	.	3717	JAK2	C4	EX6	.	.	no-change	NM_004972.3	NP_004963.1	+	Y	c.489C=	.	.	.	NM_004972.3(JAK2): c.489C=	;maf-5-some-pop,maf-5-all-pops	126140	0.673014	U	0.2708	0.358227	13006	0.643549	PASS	.	8630	0.729200	27760	121132	0.674306	.	.	.	.	.	.	rs2230722	.	4024	0.737300	-0.521	-0.024	-0.438	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5050705	5050706	9p24.1	1	normal	.	C	snv	T	CA.GG	het-ref	280	0.46	.	2	.	PASS	147796	P	133100(MK);254450(MK);263300(MK);600880(SK);601626(MK);614521(MK)	AD	Thrombocythemia 3	AD	Variants may be involved in predisposition to and pathogenesis of oncologic processes (AD)	Hematologic	Hematologic	22696908|22571758|22397670|19847199|19338077|19287385|19287384|19036091|17989398|16762626|16707754	.	3717	JAK2	C4	EX6	.	.	coding-synon	NM_004972.3	NP_004963.1	+	Y	c.489C>T	p.(H163=) | p.(His163=)	CAC=>CAT	.	NM_004972.3(JAK2): c.489C>T (p.(H163=))	;maf-5-some-pop,maf-5-all-pops	126140	0.326986	U	0.2708	0.358227	13006	0.356451	PASS	321	8630	0.270800	6646	121132	0.325694	660	4710	2.73742e-01	13013	79153	3.22297e-01	rs2230722	.	4024	0.262700	-0.521	-0.024	-0.438	.	.	.	.	.	ENST00000381652: c.489C>T (p.H163H)	oesophagus [lower_third|NS|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	CSV	4432269	.	.	.	.	.	no_record	367122	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
9	5069836	5069837	9p24.1	0	normal	.	G	ref	G	AC.TA	het-alt	120	0.53	.	1	.	PASS	147796	P	133100(MK);254450(MK);263300(MK);600880(SK);601626(MK);614521(MK)	AD	Thrombocythemia 3	AD	Variants may be involved in predisposition to and pathogenesis of oncologic processes (AD)	Hematologic	Hematologic	22696908|22571758|22397670|19847199|19338077|19287385|19287384|19036091|17989398|16762626|16707754	.	3717	JAK2	IC9	IVS11	.	.	no-change	NM_004972.3	NP_004963.1	+	Y	c.1514-88G=	.	.	.	NM_004972.3(JAK2): c.1514-88G=	;maf-5-some-pop	5008	0.384984	U	0.4454	0.615016	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7869668	.	4024	0.569600	-0.556	-0.697	-0.876	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5069836	5069837	9p24.1	0	normal	.	G	snv	A	AC.TA	het-ref	108	0.47	.	2	.	PASS	147796	P	133100(MK);254450(MK);263300(MK);600880(SK);601626(MK);614521(MK)	AD	Thrombocythemia 3	AD	Variants may be involved in predisposition to and pathogenesis of oncologic processes (AD)	Hematologic	Hematologic	22696908|22571758|22397670|19847199|19338077|19287385|19287384|19036091|17989398|16762626|16707754	.	3717	JAK2	IC9	IVS11	.	.	intron	NM_004972.3	NP_004963.1	+	Y	c.1514-88G>A	.	.	.	NM_004972.3(JAK2): c.1514-88G>A	;maf-5-some-pop	5008	0.615016	U	0.4454	0.615016	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7869668	.	4024	0.430400	-0.556	-0.697	-0.876	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5081779	5081780	9p24.1	0	normal	.	G	ref	G	CT.GG	het-alt	238	0.53	.	1	.	PASS	147796	P	133100(MK);254450(MK);263300(MK);600880(SK);601626(MK);614521(MK)	AD	Thrombocythemia 3	AD	Variants may be involved in predisposition to and pathogenesis of oncologic processes (AD)	Hematologic	Hematologic	22696908|22571758|22397670|19847199|19338077|19287385|19287384|19036091|17989398|16762626|16707754	.	3717	JAK2	C17	EX19	.	.	no-change	NM_004972.3	NP_004963.1	+	Y	c.2490G=	.	.	.	NM_004972.3(JAK2): c.2490G=	;maf-5-some-pop,genotype-conflict	126370	0.463915	U	0.4395	0.616813	13006	0.375750	PASS	-1066	8646	0.566273	14116	121362	0.467247	.	.	.	.	.	.	rs2230724	.	4024	0.575800	-0.254	-0.459	-0.826	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5081779	5081780	9p24.1	1	normal	.	G	snv	A	CT.GG	het-ref	211	0.47	.	2	.	PASS	147796	P	133100(MK);254450(MK);263300(MK);600880(SK);601626(MK);614521(MK)	AD	Thrombocythemia 3	AD	Variants may be involved in predisposition to and pathogenesis of oncologic processes (AD)	Hematologic	Hematologic	22696908|22571758|22397670|19847199|19338077|19287385|19287384|19036091|17989398|16762626|16707754	.	3717	JAK2	C17	EX19	.	.	coding-synon	NM_004972.3	NP_004963.1	+	Y	c.2490G>A	p.(L830=) | p.(Leu830=)	CTG=>CTA	.	NM_004972.3(JAK2): c.2490G>A (p.(L830=))	;maf-5-some-pop,genotype-conflict	126370	0.536085	U	0.4395	0.616813	13006	0.624250	PASS	809	8646	0.433727	18091	121362	0.532753	1667	7546	4.38262e-01	35390	129563	5.26508e-01	rs2230724	.	4024	0.424200	-0.254	-0.459	-0.826	.	.	.	.	.	ENST00000381652: c.2490G>A (p.L830L)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3763953	.	.	.	.	.	no_record	367129	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
9	5090933	5090934	9p24.1	0	normal	.	A	ref	A	TA.AT	het-alt	210	0.53	.	1	.	PASS	147796	P	133100(MK);254450(MK);263300(MK);600880(SK);601626(MK);614521(MK)	AD	Thrombocythemia 3	AD	Variants may be involved in predisposition to and pathogenesis of oncologic processes (AD)	Hematologic	Hematologic	22696908|22571758|22397670|19847199|19338077|19287385|19287384|19036091|17989398|16762626|16707754	.	3717	JAK2	IC20	IVS22	.	.	no-change	NM_004972.3	NP_004963.1	+	Y	c.3059+23A=	.	.	.	NM_004972.3(JAK2): c.3059+23A=	;maf-5-some-pop,maf-5-all-pops	121366	0.721833	U	0.2639	0.241214	12974	0.773624	PASS	-821	8474	0.732830	30307	116358	0.720243	.	.	.	.	.	.	rs2274649	.	4024	0.749000	0.477	1.392	2.178	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5090933	5090934	9p24.1	0	normal	.	A	snv	T	TA.AT	het-ref	184	0.47	.	2	.	PASS	147796	P	133100(MK);254450(MK);263300(MK);600880(SK);601626(MK);614521(MK)	AD	Thrombocythemia 3	AD	Variants may be involved in predisposition to and pathogenesis of oncologic processes (AD)	Hematologic	Hematologic	22696908|22571758|22397670|19847199|19338077|19287385|19287384|19036091|17989398|16762626|16707754	.	3717	JAK2	IC20	IVS22	.	.	intron	NM_004972.3	NP_004963.1	+	Y	c.3059+23A>T	.	.	.	NM_004972.3(JAK2): c.3059+23A>T	;maf-5-some-pop,maf-5-all-pops	121366	0.278167	U	0.2639	0.241214	12974	0.226376	PASS	311	8474	0.267170	4680	116358	0.279757	494	3491	2.62877e-01	7694	53039	2.78473e-01	rs2274649	.	4024	0.251000	0.477	1.392	2.178	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5090966	5090969	9p24.1	0	normal	.	TTG	ref	TTG	TA.TT	het-alt	155	0.56	.	1	.	PASS	147796	P	133100(MK);254450(MK);263300(MK);600880(SK);601626(MK);614521(MK)	AD	Thrombocythemia 3	AD	Variants may be involved in predisposition to and pathogenesis of oncologic processes (AD)	Hematologic	Hematologic	22696908|22571758|22397670|19847199|19338077|19287385|19287384|19036091|17989398|16762626|16707754	.	3717	JAK2	IC20	IVS22	.	.	no-change	NM_004972.3	NP_004963.1	+	Y	c.3059+56_3059+58=	.	.	.	NM_004972.3(JAK2): c.3059+56_3059+58=	;maf-5-some-pop,maf-5-all-pops	5008	0.758986	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs146385350	.	4024	0.752000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5090966	5090969	9p24.1	0	normal	.	TTG	del	.	TA.TT	het-ref	122	0.44	.	2	.	PASS	147796	P	133100(MK);254450(MK);263300(MK);600880(SK);601626(MK);614521(MK)	AD	Thrombocythemia 3	AD	Variants may be involved in predisposition to and pathogenesis of oncologic processes (AD)	Hematologic	Hematologic	22696908|22571758|22397670|19847199|19338077|19287385|19287384|19036091|17989398|16762626|16707754	.	3717	JAK2	IC20	IVS22	.	.	intron	NM_004972.3	NP_004963.1	+	Y	c.3059+56_3059+58delTTG	.	.	.	NM_004972.3(JAK2): c.3059+56_3059+58delTTG	;maf-5-some-pop,maf-5-all-pops	5008	0.241014	U	0.2639	0.241014	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs146385350	.	4024	0.248000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5430244	5430245	9p24.1	0	normal	.	A	ref	A	cc.ga	het-alt	146	0.54	.	1	LTR40a|LTR|ERVL|+|285	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.5430244A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.554313	U	0.5655	0.445687	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10815222	.	.	.	0.482	0.182	0.166	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5430244	5430245	9p24.1	0	normal	.	A	snv	G	cc.ga	het-ref	126	0.46	.	2	LTR40a|LTR|ERVL|+|285	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.5430244A>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.445687	U	0.5655	0.445687	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10815222	.	.	.	0.482	0.182	0.166	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5430340	5430341	9p24.1	0	normal	.	T	ref	T	GA.AG	het-alt	161	0.50	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.5430340T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.405152	U	0.7083	0.594848	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10815223	.	.	.	-0.930	-0.151	-0.176	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5430340	5430341	9p24.1	0	normal	.	T	snv	C	GA.AG	het-ref	162	0.50	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.5430340T>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.594848	U	0.7083	0.594848	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10815223	.	.	.	-0.930	-0.151	-0.176	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5436460	5436461	9p24.1	0	normal	.	C	ref	C	TT.AA	het-alt	186	0.54	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.5436460C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.406749	U	0.6647	0.593251	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2295870	.	.	.	-1.185	-0.213	-0.261	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5436460	5436461	9p24.1	0	normal	.	C	snv	A	TT.AA	het-ref	157	0.46	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.5436460C>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.593251	U	0.6647	0.593251	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2295870	.	.	.	-1.185	-0.213	-0.261	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5443889	5443890	9p24.1	0	normal	.	A	ref	A	GC.TA	het-alt	283	0.54	.	1	.	PASS	605402	C	.	NN	.	.	.	.	.	.	.	29126	CD274	PROM	.	.	.	no-change	NM_014143.3	NP_054862.1	+	Y	c.-108-u6613A=	.	.	.	NM_014143.3(CD274): c.-108-u6613A=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.629393	U	0.2421	0.370607	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs849676	.	.	.	-0.394	-0.246	-0.309	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5443889	5443890	9p24.1	0	normal	.	A	snv	G	GC.TA	het-ref	242	0.46	.	2	.	PASS	605402	C	.	NN	.	.	.	.	.	.	.	29126	CD274	PROM	.	.	.	promoter	NM_014143.3	NP_054862.1	+	Y	c.-108-u6613A>G	.	.	.	NM_014143.3(CD274): c.-108-u6613A>G	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.370607	U	0.2421	0.370607	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs849676	.	.	.	-0.394	-0.246	-0.309	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5448689	5448690	9p24.1	0	normal	.	G	ref	G	CA.CA	het-alt	266	0.50	.	1	.	PASS	605402	C	.	NN	.	.	.	.	.	.	.	29126	CD274	PROM	.	.	.	no-change	NM_014143.3	NP_054862.1	+	Y	c.-108-u1813G=	.	.	.	NM_014143.3(CD274): c.-108-u1813G=	;maf-5-some-pop,maf-5-all-pops	5008	0.647364	U	0.2589	0.352636	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs822336	.	.	.	0.455	-0.657	-0.697	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5448689	5448690	9p24.1	0	normal	.	G	snv	C	CA.CA	het-ref	267	0.50	.	2	.	PASS	605402	C	.	NN	.	.	.	.	.	.	.	29126	CD274	PROM	.	.	.	promoter	NM_014143.3	NP_054862.1	+	Y	c.-108-u1813G>C	.	.	.	NM_014143.3(CD274): c.-108-u1813G>C	;maf-5-some-pop,maf-5-all-pops	5008	0.352636	U	0.2589	0.352636	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs822336	.	.	.	0.455	-0.657	-0.697	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5467954	5467955	9p24.1	0	nullSample	.	G	ref	G	GG.CC	homo-ref	.	.	.	0	.	.	605402	C	.	NN	.	.	.	.	.	.	.	29126	CD274	3U1E	EX7E	.	.	no-change	NM_014143.3	NP_054862.1	+	Y	c.*93G=	.	.	.	NM_014143.3(CD274): c.*93G=	;maf-5-some-pop,maf-5-all-pops	5008	0.331470	U	0.8105	0.66853	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2297136	.	.	.	0.491	2.814	2.392	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5467954	5467955	9p24.1	0	normal	.	G	snv	A	GG.CC	hom-alt	171	1.00	.	0	.	PASS	605402	C	.	NN	.	.	.	.	.	.	.	29126	CD274	3U1E	EX7E	.	.	utr-3	NM_014143.3	NP_054862.1	+	Y	c.*93G>A	.	.	.	NM_014143.3(CD274): c.*93G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.668530	U	0.8105	0.66853	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2297136	.	.	.	0.491	2.814	2.392	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5470496	5470497	9p24.1	0	normal	.	A	snv	G	CC.GC	hom-alt	271	1.00	.	0	.	PASS	605402	C	.	NN	.	.	.	.	.	.	.	29126	CD274	3U1E	EX7E	.	.	utr-3	NM_014143.3	NP_054862.1	+	Y	c.*2635A>G	.	.	.	NM_014143.3(CD274): c.*2635A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.290136	U	0.5357	0.290136	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4742098	.	.	.	0.528	-0.257	-0.320	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5470496	5470497	9p24.1	0	nullSample	.	A	ref	A	CC.GC	homo-ref	.	.	.	0	.	.	605402	C	.	NN	.	.	.	.	.	.	.	29126	CD274	3U1E	EX7E	.	.	no-change	NM_014143.3	NP_054862.1	+	Y	c.*2635A=	.	.	.	NM_014143.3(CD274): c.*2635A=	;maf-5-some-pop,maf-5-all-pops	5008	0.709864	U	0.5357	0.290136	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4742098	.	.	.	0.528	-0.257	-0.320	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5479639	5479640	9p24.1	0	nullSample	.	T	ref	T	AG.CA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.5479639T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.697484	U	0.5079	0.302516	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10815230	.	.	.	-0.225	-0.357	-0.347	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5479639	5479640	9p24.1	0	normal	.	T	snv	G	AG.CA	hom-alt	211	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.5479639T>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.302516	U	0.5079	0.302516	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10815230	.	.	.	-0.225	-0.357	-0.347	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5479752	5479753	9p24.1	0	nullSample	.	A	ref	A	GG.AA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.5479752A= (intergenic)	MixedObserved;|MixedObserved;maf-5-some-pop	0|5008	0|0.749002	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs199565195|rs75762486	.	.	.	0.225	0.032	0.009	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
9	5479752	5479753	9p24.1	0	normal	.	A	del	.	GG.AA	hom-alt	251	0.97	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.5479753delA (intergenic)	MixedObserved;|MixedObserved;maf-5-some-pop	0|5008	0|0.250998	U	0.503	0.250998	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs199565195|rs75762486	.	.	.	0.225	0.032	0.009	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5479821	5479822	9p24.1	0	nullSample	.	A	ref	A	CC.AA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.5479821A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.697284	U	0.5079	0.302716	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7043593	.	.	.	-1.230	-1.140	-1.210	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5479821	5479822	9p24.1	0	normal	.	A	snv	G	CC.AA	hom-alt	123	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.5479821A>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.302716	U	0.5079	0.302716	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7043593	.	.	.	-1.230	-1.140	-1.210	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5483362	5483363	9p24.1	0	nullSample	.	A	ref	A	GT.TA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.5483362A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.598243	U	0.4048	0.401757	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7037352	.	.	.	-1.831	-3.753	-3.958	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5483362	5483363	9p24.1	0	normal	.	A	snv	G	GT.TA	hom-alt	329	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.5483362A>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.401757	U	0.4048	0.401757	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7037352	.	.	.	-1.831	-3.753	-3.958	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5485112	5485113	9p24.1	0	nullSample	.	G	ref	G	ca.gc	homo-ref	.	.	.	0	MER58A|DNA|hAT-Charlie|-|141	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.5485112G= (intergenic)	;maf-5-some-pop	5008	0.955671	U	0.121	0.0443291	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10975132	.	.	.	0.449	-0.809	-0.865	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
9	5485112	5485113	9p24.1	0	normal	.	G	snv	C	ca.gc	hom-alt	163	1.00	.	0	MER58A|DNA|hAT-Charlie|-|141	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.5485112G>C (intergenic)	;maf-5-some-pop	5008	0.044329	U	0.121	0.0443291	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10975132	.	.	.	0.449	-0.809	-0.865	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
9	5485124	5485125	9p24.1	0	nullSample	.	A	ref	A	ta.at	homo-ref	.	.	.	0	MER58A|DNA|hAT-Charlie|-|141	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.5485124A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.387181	U	0.7768	0.612819	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10122681	.	.	.	-0.383	0.332	0.328	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5485124	5485125	9p24.1	0	normal	.	A	snv	G	ta.at	hom-alt	176	1.00	.	0	MER58A|DNA|hAT-Charlie|-|141	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.5485124A>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.612819	U	0.7768	0.612819	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10122681	.	.	.	-0.383	0.332	0.328	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5485165	5485166	9p24.1	0	nullSample	.	A	ref	A	AC.TG	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.5485165A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.528554	U	0.622	0.471446	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10815237	.	.	.	0.369	1.128	1.078	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5485165	5485166	9p24.1	0	normal	.	A	snv	G	AC.TG	hom-alt	217	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.5485165A>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.471446	U	0.622	0.471446	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10815237	.	.	.	0.369	1.128	1.078	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5485240	5485241	9p24.1	0	nullSample	.	A	ref	A	TA.TG	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.5485240A= (intergenic)	;maf-5-some-pop,genotype-conflict	5008	0.935703	U	0.1171	0.0642971	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10122714	.	.	.	0.369	1.241	1.187	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5485240	5485241	9p24.1	0	normal	.	A	snv	G	TA.TG	hom-alt	176	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.5485240A>G (intergenic)	;maf-5-some-pop,genotype-conflict	5008	0.064297	U	0.1171	0.0642971	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10122714	.	.	.	0.369	1.241	1.187	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5485263	5485264	9p24.1	0	nullSample	.	C	ref	C	TA.AC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.5485263C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.450080	U	0.7292	0.54992	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10119533	.	.	.	-2.552	-1.206	-1.313	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5485263	5485264	9p24.1	0	normal	.	C	snv	T	TA.AC	hom-alt	166	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.5485263C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.549920	U	0.7292	0.54992	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10119533	.	.	.	-2.552	-1.206	-1.313	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5485306	5485307	9p24.1	0	nullSample	.	G	ref	G	TC.TC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.5485306G= (intergenic)	;maf-5-some-pop	5008	0.952077	U	0.1151	0.0479233	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10125503	.	.	.	-0.634	-0.609	-0.668	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
9	5485306	5485307	9p24.1	0	normal	.	G	snv	A	TC.TC	hom-alt	142	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.5485306G>A (intergenic)	;maf-5-some-pop	5008	0.047923	U	0.1151	0.0479233	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10125503	.	.	.	-0.634	-0.609	-0.668	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
9	5497345	5497346	9p24.1	0	nullSample	.	G	ref	G	AT.TG	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.5497345G= (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.350439	U	0.7837	0.649561	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10815239	.	.	.	-2.210	-2.631	-2.858	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5497345	5497346	9p24.1	0	normal	.	G	snv	T	AT.TG	hom-alt	252	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.5497345G>T (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.649561	U	0.7837	0.649561	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10815239	.	.	.	-2.210	-2.631	-2.858	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5557671	5557672	9p24.1	0	nullSample	.	T	ref	T	CT.CT	homo-ref	.	.	.	0	.	.	605723	P	.	NN	.	.	.	.	.	.	.	80380	PDCD1LG2	C4	EX5	.	.	no-change	NM_025239.3	NP_079515.2	+	Y	c.686T=	.	.	.	NM_025239.3(PDCD1LG2): c.686T=	;genotype-conflict	126402	0.000894	U	1	0.997804	13006	0.001230	PASS	0	8652	0.000000	0	121394	0.000840	.	.	.	.	.	.	rs7854303	.	4024	0.001500	-0.119	-0.103	-0.005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	5557671	5557672	9p24.1	1	normal	.	T	snv	C	CT.CT	hom-alt	512	1.00	.	0	.	PASS	605723	P	.	NN	.	.	.	.	.	.	.	80380	PDCD1LG2	C4	EX5	.	.	missense	NM_025239.3	NP_079515.2	+	Y	c.686T>C	p.F229S | p.Phe229Ser	TTC=>TCC	NP=>P0	NM_025239.3(PDCD1LG2): c.686T>C (p.F229S)	;genotype-conflict	126402	0.999106	U	1	0.997804	13006	0.998770	PASS	4326	8652	1.000000	60595	121394	0.999160	8623	17246	1.00000e+00	122800	245824	9.99073e-01	rs7854303	.	4024	0.998500	-0.119	-0.103	-0.005	0.47	0	0	0.011	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
9	8338846	8338847	9p24.1	0	nullSample	.	C	ref	C	CC.AG	homo-ref	.	.	.	0	.	.	601598	C	.	NN	.	.	.	.	.	.	.	5789	PTPRD	IC32	IVS43	.	.	no-change	NM_002839.3	NP_002830.1	-	Y	c.5379+75G=	.	.	.	NM_002839.3(PTPRD): c.5379+75G=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.650	1.516	0.907	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
9	8338847	8338847	9p24.1	0	normal	.	.	ins	AGAGAGAGAGAGAG	CC.AG	het-alt	33	0.40	.	1	.	PASS	601598	C	.	NN	.	.	.	.	.	.	.	5789	PTPRD	IC32	IVS43	.	.	intron	NM_002839.3	NP_002830.1	-	Y	c.5379+74_5379+75insCTCTCTCTCTCTCT	.	.	.	NM_002839.3(PTPRD): c.5379+74_5379+75insCTCTCTCTCTCTCT	MixedObserved,ObservedTooLong;rs-cluster-nonoverlapping-alleles	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs143960430	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
9	8338847	8338847	9p24.1	0	normal	.	.	ins	AGAGAGAGAGAGAGAG	CC.AG	het-alt	40	0.49	.	2	.	PASS	601598	C	.	NN	.	.	.	.	.	.	.	5789	PTPRD	IC32	IVS43	.	.	intron	NM_002839.3	NP_002830.1	-	Y	c.5379+74_5379+75insCTCTCTCTCTCTCTCT	.	.	.	NM_002839.3(PTPRD): c.5379+74_5379+75insCTCTCTCTCTCTCTCT	MixedObserved,ObservedTooLong;rs-cluster-nonoverlapping-alleles	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs143960430	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
9	8389363	8389364	9p24.1	0	normal	.	C	ref	C	TA.CC	het-alt	301	0.52	.	1	.	PASS	601598	C	.	NN	.	.	.	.	.	.	.	5789	PTPRD	C26	EX37	Protein-tyrosine phosphatase	PF00102.22	no-change	NM_002839.3	NP_002830.1	-	Y	c.4254G=	.	.	.	NM_002839.3(PTPRD): c.4254G=	;maf-5-some-pop,maf-5-all-pops	126198	0.498566	U	0.6329	0.55631	13006	0.515301	PASS	-946	8642	0.340199	15547	121190	0.500833	.	.	.	.	.	.	rs2279776	.	4024	0.317800	-1.197	0.022	-0.464	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	8389363	8389364	9p24.1	1	normal	.	C	snv	G	TA.CC	het-ref	283	0.48	.	2	.	PASS	601598	C	.	NN	.	.	.	.	.	.	.	5789	PTPRD	C26	EX37	Protein-tyrosine phosphatase	PF00102.22	coding-synon	NM_002839.3	NP_002830.1	-	Y	c.4254G>C	p.(G1418=) | p.(Gly1418=)	GGG=>GGC	.	NM_002839.3(PTPRD): c.4254G>C (p.(G1418=))	;maf-5-some-pop,maf-5-all-pops	126198	0.501434	U	0.6329	0.55631	13006	0.484699	PASS	1905	8642	0.659801	15446	121190	0.499167	3942	11541	6.72788e-01	30762	121095	4.95057e-01	rs2279776	.	4024	0.682200	-1.197	0.022	-0.464	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
9	8436702	8436703	9p24.1	0	normal	.	C	ref	C	AG.AA	het-alt	128	0.49	.	1	.	PASS	601598	C	.	NN	.	.	.	.	.	.	.	5789	PTPRD	IC23	IVS34	.	.	no-change	NM_002839.3	NP_002830.1	-	Y	c.3989-14G=	.	.	.	NM_002839.3(PTPRD): c.3989-14G=	;maf-5-some-pop,maf-5-all-pops	125550	0.396718	U	0.6329	0.622404	13004	0.411412	PASS	-1010	8542	0.356123	9747	120542	0.397513	.	.	.	.	.	.	rs1359118	.	.	.	-0.225	0.638	0.202	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	8436702	8436703	9p24.1	1	normal	.	C	snv	G	AG.AA	het-ref	132	0.51	.	2	.	PASS	601598	C	.	NN	.	.	.	.	.	.	.	5789	PTPRD	IC23	IVS34	.	.	intron	NM_002839.3	NP_002830.1	-	Y	c.3989-14G>C	.	.	.	NM_002839.3(PTPRD): c.3989-14G>C	;maf-5-some-pop,maf-5-all-pops	125550	0.603282	U	0.6329	0.622404	13004	0.588588	PASS	1740	8542	0.643877	22101	120542	0.602487	3512	10996	6.42065e-01	43877	145059	5.98107e-01	rs1359118	.	.	.	-0.225	0.638	0.202	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	8437140	8437141	9p24.1	0	normal	.	G	ref	G	AA.AG	het-alt	112	0.52	.	1	.	PASS	601598	C	.	NN	.	.	.	.	.	.	.	5789	PTPRD	IC23	IVS34	.	.	no-change	NM_002839.3	NP_002830.1	-	Y	c.3989-452C=	.	.	.	NM_002839.3(PTPRD): c.3989-452C=	;maf-5-some-pop,genotype-conflict	5008	0.854633	U	0.2391	0.145367	4566	0.931669	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10977104	.	.	.	0.650	1.315	2.880	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	8437140	8437141	9p24.1	0	normal	.	G	snv	C	AA.AG	het-ref	103	0.48	.	2	.	PASS	601598	C	.	NN	.	.	.	.	.	.	.	5789	PTPRD	IC23	IVS34	.	.	intron	NM_002839.3	NP_002830.1	-	Y	c.3989-452C>G	.	.	.	NM_002839.3(PTPRD): c.3989-452C>G	;maf-5-some-pop,genotype-conflict	5008	0.145367	U	0.2391	0.145367	4566	0.068331	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10977104	.	.	.	0.650	1.315	2.880	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	8437287	8437288	9p24.1	0	normal	.	C	ref	C	TT.AA	het-alt	84	0.49	.	1	.	PASS	601598	C	.	NN	.	.	.	.	.	.	.	5789	PTPRD	IC23	IVS34	.	.	no-change	NM_002839.3	NP_002830.1	-	Y	c.3989-599G=	.	.	.	NM_002839.3(PTPRD): c.3989-599G=	;	5008	0.978634	U	0.0437	0.0213658	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs183488291	.	.	.	-0.441	-1.687	-1.915	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
9	8437288	8437288	9p24.1	0	normal	.	.	ins	AAAA	TC.AA	het-ref	89	0.51	.	2	.	PASS	601598	C	.	NN	.	.	.	.	.	.	.	5789	PTPRD	IC23	IVS34	.	.	intron	NM_002839.3	NP_002830.1	-	Y	c.3989-600_3989-599insTTTT	.	.	.	NM_002839.3(PTPRD): c.3989-600_3989-599insTTTT	;rs-cluster-nonoverlapping-alleles	13927	0.007252	U	.	.	.	.	PASS	3	250	0.200000	97	13996	0.120249	.	.	.	.	.	.	rs576027545	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	8454565	8454566	9p24.1	0	normal	.	T	ref	T	GT.CT	het-alt	215	0.58	.	1	.	PASS	601598	C	.	NN	.	.	.	.	.	.	.	5789	PTPRD	IC22	IVS33	.	.	no-change	NM_002839.3	NP_002830.1	-	Y	c.3876-4729A=	.	.	.	NM_002839.3(PTPRD): c.3876-4729A=	;maf-5-some-pop,maf-5-all-pops	122492	0.576829	U	0.3671	0.502995	11794	0.541970	PASS	.	8346	0.613827	19971	117484	0.580232	.	.	.	.	.	.	rs7031287	.	.	.	0.482	0.765	0.022	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	8454565	8454566	9p24.1	0	normal	.	T	snv	C	GT.CT	het-ref	157	0.42	.	2	.	PASS	601598	C	.	NN	.	.	.	.	.	.	.	5789	PTPRD	IC22	IVS33	.	.	intron	NM_002839.3	NP_002830.1	-	Y	c.3876-4729A>G	.	.	.	NM_002839.3(PTPRD): c.3876-4729A>G	;maf-5-some-pop,maf-5-all-pops	122492	0.423171	U	0.3671	0.502995	11794	0.458030	PASS	596	8346	0.386173	10545	117484	0.419768	1193	6487	3.79135e-01	21179	100234	4.10778e-01	rs7031287	.	.	.	0.482	0.765	0.022	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	8518051	8518052	9p24.1	0	normal	.	G	ref	G	CT.TC	het-alt	318	0.46	.	1	.	PASS	601598	C	.	NN	.	.	.	.	.	.	.	5789	PTPRD	C10	EX21	Fibronectin type III domain	PF00041.16	no-change	NM_002839.3	NP_002830.1	-	Y	c.1339C=	.	.	.	NM_002839.3(PTPRD): c.1339C=	;maf-5-some-pop,genotype-conflict	126410	0.953675	U	0.121	0.0509185	13006	0.967630	PASS	.	8650	0.871329	55298	121402	0.953864	.	.	.	.	.	.	rs10977171	.	4024	0.856100	0.467	5.996	2.484	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	8518051	8518052	9p24.1	1	normal	.	G	snv	C	CT.TC	het-ref	376	0.54	.	2	.	PASS	601598	C	.	NN	.	.	.	.	.	.	.	5789	PTPRD	C10	EX21	Fibronectin type III domain	PF00041.16	missense	NM_002839.3	NP_002830.1	-	Y	c.1339C>G	p.Q447E | p.Gln447Glu	CAG=>GAG	P0=>P-	NM_002839.3(PTPRD): c.1339C>G (p.Q447E)	;maf-5-some-pop,genotype-conflict	126410	0.046325	U	0.121	0.0509185	13006	0.032370	PASS	67	8650	0.128671	198	121402	0.046136	146	2246	1.30218e-01	390	11117	4.51914e-02	rs10977171	.	4024	0.143900	0.467	5.996	2.484	0.35	0.07	0.025	0.026	neutral	ENST00000381196: c.1339C>G (p.Q447E)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	150577	.	.	.	.	.	.	.	.	.	Likely Benign
9	21929589	21929590	9p21.3	0	nullSample	.	G	ref	G	AT.TA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.21929589G= (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.474241	U	0.4782	0.525759	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2188125	.	.	.	0.297	0.300	0.292	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	21929589	21929590	9p21.3	0	normal	.	G	snv	T	AT.TA	hom-alt	422	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.21929589G>T (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.525759	U	0.4782	0.525759	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2188125	.	.	.	0.297	0.300	0.292	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	21929665	21929666	9p21.3	0	nullSample	.	G	ref	G	GA.TT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.21929665G= (intergenic)	;maf-5-some-pop,genotype-conflict	5008	0.239816	U	0.5357	0.760184	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2518713	.	.	.	-0.891	-0.798	-0.863	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	21929665	21929666	9p21.3	0	normal	.	G	snv	A	GA.TT	hom-alt	263	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.21929665G>A (intergenic)	;maf-5-some-pop,genotype-conflict	5008	0.760184	U	0.5357	0.760184	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2518713	.	.	.	-0.891	-0.798	-0.863	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	21956077	21956078	9p21.3	0	normal	.	A	ref	A	tt.tt	het-alt	110	0.51	.	1	MER63C|DNA|hAT-Blackjack|+|905	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.21956077A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.198083	U	0.7996	0.801917	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2027938	.	.	.	-3.523	-2.886	-2.883	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	21956077	21956078	9p21.3	0	normal	.	A	snv	G	tt.tt	het-ref	107	0.49	.	2	MER63C|DNA|hAT-Blackjack|+|905	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.21956077A>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.801917	U	0.7996	0.801917	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2027938	.	.	.	-3.523	-2.886	-2.883	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	21961865	21961866	9p21.3	0	normal	.	C	snv	A	AA.AG	het-ref	146	0.43	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.21961865C>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.292732	U	0.499	0.292732	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7041637	.	.	.	-0.327	-1.154	-1.218	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	21961865	21961866	9p21.3	0	normal	.	C	ref	C	AA.AG	het-alt	196	0.57	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.21961865C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.707268	U	0.499	0.292732	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7041637	.	.	.	-0.327	-1.154	-1.218	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	21968198	21968199	9p21.3	0	nullSample	.	C	ref	C	CC.GA	homo-ref	.	.	.	0	.	.	600160	C	155601(SK);155755(MK);600160(MK);606719(MK)	AD	Melanoma, familial; Melanoma-pancreatic cancer syndrome	AD	.	Dermatologic; Oncologic	Dermatologic; Oncologic	22636603|22368299|21895773|21801156|21625824|21614589|21570156|21570154|21325014|21150883|20653773|20574843|20132244|18178632|17492760|16822996|15577313|12700603|12556369|12019208|11815963|11807902|11726555|11506491|10956390|10874641|9916806|9699728|9603434|9516223|9425228|9328469|8653684|8153634|7987388|7987387|7666917|7666916|1579459	FC59;FH44;H41;H54;H62;H68;HD31;HD32;HP16;MC58;MH43	1029	CDKN2A	3U1E	EX3E	.	.	no-change	NM_000077.4	NP_000068.1	-	Y	c.*29G=	.	.	.	NM_000077.4(CDKN2A): c.*29G=	;maf-5-some-pop	126334	0.118891	U	0.9812	0.902157	13006	0.150853	PASS	.	8648	0.023242	1046	121326	0.119760	.	.	.	.	.	.	rs11515	.	.	.	-1.916	-1.903	-1.985	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	21968198	21968199	9p21.3	0	nullSample	.	C	ref	C	CC.GA	homo-ref	.	.	.	0	.	.	600160	C	155601(SK);155755(MK);600160(MK);606719(MK)	AD	Melanoma, familial; Melanoma-pancreatic cancer syndrome	AD	.	Dermatologic; Oncologic	Dermatologic; Oncologic	22636603|22368299|21895773|21801156|21625824|21614589|21570156|21570154|21325014|21150883|20653773|20574843|20132244|18178632|17492760|16822996|15577313|12700603|12556369|12019208|11815963|11807902|11726555|11506491|10956390|10874641|9916806|9699728|9603434|9516223|9425228|9328469|8653684|8153634|7987388|7987387|7666917|7666916|1579459	FC59;FH44;H41;H54;H62;H68;HD31;HD32;HP16;MC58;MH43	1029	CDKN2A	3U2E	EX3E	.	.	no-change	NM_058195.3	NP_478102.2	-	N	c.*144G=	.	.	.	NM_058195.3(CDKN2A): c.*144G=	;maf-5-some-pop	126334	0.118891	U	0.9812	0.902157	13006	0.150853	PASS	.	8648	0.023242	1046	121326	0.119760	.	.	.	.	.	.	rs11515	.	.	.	-1.916	-1.903	-1.985	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	21968198	21968199	9p21.3	0	normal	.	C	snv	G	CC.GA	hom-alt	196	1.00	.	0	.	PASS	600160	C	155601(SK);155755(MK);600160(MK);606719(MK)	AD	Melanoma, familial; Melanoma-pancreatic cancer syndrome	AD	.	Dermatologic; Oncologic	Dermatologic; Oncologic	22636603|22368299|21895773|21801156|21625824|21614589|21570156|21570154|21325014|21150883|20653773|20574843|20132244|18178632|17492760|16822996|15577313|12700603|12556369|12019208|11815963|11807902|11726555|11506491|10956390|10874641|9916806|9699728|9603434|9516223|9425228|9328469|8653684|8153634|7987388|7987387|7666917|7666916|1579459	FC59;FH44;H41;H54;H62;H68;HD31;HD32;HP16;MC58;MH43	1029	CDKN2A	3U1E	EX3E	.	.	utr-3	NM_000077.4	NP_000068.1	-	Y	c.*29G>C	.	.	.	NM_000077.4(CDKN2A): c.*29G>C	;maf-5-some-pop	126334	0.881109	U	0.9812	0.902157	13006	0.849147	PASS	4125	8648	0.976758	47179	121326	0.880240	8248	16866	9.77966e-01	95916	216920	8.81416e-01	rs11515	.	.	.	-1.916	-1.903	-1.985	.	.	.	.	.	ENST00000304494: c.471+29G>C (p.?)	oesophagus [NS|NS|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	CSV	14251	.	.	.	.	.	.	.	.	.	Benign
9	21968198	21968199	9p21.3	0	normal	.	C	snv	G	CC.GA	hom-alt	196	1.00	.	0	.	PASS	600160	C	155601(SK);155755(MK);600160(MK);606719(MK)	AD	Melanoma, familial; Melanoma-pancreatic cancer syndrome	AD	.	Dermatologic; Oncologic	Dermatologic; Oncologic	22636603|22368299|21895773|21801156|21625824|21614589|21570156|21570154|21325014|21150883|20653773|20574843|20132244|18178632|17492760|16822996|15577313|12700603|12556369|12019208|11815963|11807902|11726555|11506491|10956390|10874641|9916806|9699728|9603434|9516223|9425228|9328469|8653684|8153634|7987388|7987387|7666917|7666916|1579459	FC59;FH44;H41;H54;H62;H68;HD31;HD32;HP16;MC58;MH43	1029	CDKN2A	3U2E	EX3E	.	.	utr-3	NM_058195.3	NP_478102.2	-	N	c.*144G>C	.	.	.	NM_058195.3(CDKN2A): c.*144G>C	;maf-5-some-pop	126334	0.881109	U	0.9812	0.902157	13006	0.849147	PASS	4125	8648	0.976758	47179	121326	0.880240	8248	16866	9.77966e-01	95916	216920	8.81416e-01	rs11515	.	.	.	-1.916	-1.903	-1.985	.	.	.	.	.	ENST00000304494: c.471+29G>C (p.?)	oesophagus [NS|NS|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	CSV	14251	.	.	.	.	.	.	.	.	.	Benign
9	21968711	21968712	9p21.3	0	normal	.	C	ref	C	AT.CC	het-alt	198	0.57	.	1	.	PASS	600160	C	155601(SK);155755(MK);600160(MK);606719(MK)	AD	Melanoma, familial; Melanoma-pancreatic cancer syndrome	AD	.	Dermatologic; Oncologic	Dermatologic; Oncologic	22636603|22368299|21895773|21801156|21625824|21614589|21570156|21570154|21325014|21150883|20653773|20574843|20132244|18178632|17492760|16822996|15577313|12700603|12556369|12019208|11815963|11807902|11726555|11506491|10956390|10874641|9916806|9699728|9603434|9516223|9425228|9328469|8653684|8153634|7987388|7987387|7666917|7666916|1579459	FC59;FH44;H41;H54;H62;H68;HD31;HD32;HP16;MC58;MH43	1029	CDKN2A	IC2	IVS2	.	.	no-change	NM_000077.4	NP_000068.1	-	Y	c.458-471G=	.	.	.	NM_000077.4(CDKN2A): c.458-471G=	;maf-5-some-pop	17104	0.957846	U	0.1786	0.0495208	.	.	PASS	.	194	0.798969	5598	12096	0.960896	.	.	.	.	.	.	rs34011899	.	4024	0.804200	0.484	-0.098	-0.110	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	21968711	21968712	9p21.3	0	normal	.	C	ref	C	AT.CC	het-alt	198	0.57	.	1	.	PASS	600160	C	155601(SK);155755(MK);600160(MK);606719(MK)	AD	Melanoma, familial; Melanoma-pancreatic cancer syndrome	AD	.	Dermatologic; Oncologic	Dermatologic; Oncologic	22636603|22368299|21895773|21801156|21625824|21614589|21570156|21570154|21325014|21150883|20653773|20574843|20132244|18178632|17492760|16822996|15577313|12700603|12556369|12019208|11815963|11807902|11726555|11506491|10956390|10874641|9916806|9699728|9603434|9516223|9425228|9328469|8653684|8153634|7987388|7987387|7666917|7666916|1579459	FC59;FH44;H41;H54;H62;H68;HD31;HD32;HP16;MC58;MH43	1029	CDKN2A	I3U1	IVS2	.	.	no-change	NM_058195.3	NP_478102.2	-	N	c.*102-471G=	.	.	.	NM_058195.3(CDKN2A): c.*102-471G=	;maf-5-some-pop	17104	0.957846	U	0.1786	0.0495208	.	.	PASS	.	194	0.798969	5598	12096	0.960896	.	.	.	.	.	.	rs34011899	.	4024	0.804200	0.484	-0.098	-0.110	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	21968711	21968712	9p21.3	0	normal	.	C	snv	A	AT.CC	het-ref	152	0.43	.	2	.	PASS	600160	C	155601(SK);155755(MK);600160(MK);606719(MK)	AD	Melanoma, familial; Melanoma-pancreatic cancer syndrome	AD	.	Dermatologic; Oncologic	Dermatologic; Oncologic	22636603|22368299|21895773|21801156|21625824|21614589|21570156|21570154|21325014|21150883|20653773|20574843|20132244|18178632|17492760|16822996|15577313|12700603|12556369|12019208|11815963|11807902|11726555|11506491|10956390|10874641|9916806|9699728|9603434|9516223|9425228|9328469|8653684|8153634|7987388|7987387|7666917|7666916|1579459	FC59;FH44;H41;H54;H62;H68;HD31;HD32;HP16;MC58;MH43	1029	CDKN2A	IC2	IVS2	.	.	intron	NM_000077.4	NP_000068.1	-	Y	c.458-471G>T	.	.	.	NM_000077.4(CDKN2A): c.458-471G>T	;maf-5-some-pop	17104	0.042154	U	0.1786	0.0495208	.	.	PASS	5	194	0.201031	23	12096	0.039104	199	1940	1.95762e-01	261	3431	2.64493e-02	rs34011899	.	4024	0.195800	0.484	-0.098	-0.110	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	21968711	21968712	9p21.3	0	normal	.	C	snv	A	AT.CC	het-ref	152	0.43	.	2	.	PASS	600160	C	155601(SK);155755(MK);600160(MK);606719(MK)	AD	Melanoma, familial; Melanoma-pancreatic cancer syndrome	AD	.	Dermatologic; Oncologic	Dermatologic; Oncologic	22636603|22368299|21895773|21801156|21625824|21614589|21570156|21570154|21325014|21150883|20653773|20574843|20132244|18178632|17492760|16822996|15577313|12700603|12556369|12019208|11815963|11807902|11726555|11506491|10956390|10874641|9916806|9699728|9603434|9516223|9425228|9328469|8653684|8153634|7987388|7987387|7666917|7666916|1579459	FC59;FH44;H41;H54;H62;H68;HD31;HD32;HP16;MC58;MH43	1029	CDKN2A	I3U1	IVS2	.	.	intron	NM_058195.3	NP_478102.2	-	N	c.*102-471G>T	.	.	.	NM_058195.3(CDKN2A): c.*102-471G>T	;maf-5-some-pop	17104	0.042154	U	0.1786	0.0495208	.	.	PASS	5	194	0.201031	23	12096	0.039104	199	1940	1.95762e-01	261	3431	2.64493e-02	rs34011899	.	4024	0.195800	0.484	-0.098	-0.110	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	21975016	21975017	9p21.3	0	normal	.	C	ref	C	GC.GT	het-alt	164	0.50	.	1	.	PASS	600160	C	155601(SK);155755(MK);600160(MK);606719(MK)	AD	Melanoma, familial; Melanoma-pancreatic cancer syndrome	AD	.	Dermatologic; Oncologic	Dermatologic; Oncologic	22636603|22368299|21895773|21801156|21625824|21614589|21570156|21570154|21325014|21150883|20653773|20574843|20132244|18178632|17492760|16822996|15577313|12700603|12556369|12019208|11815963|11807902|11726555|11506491|10956390|10874641|9916806|9699728|9603434|9516223|9425228|9328469|8653684|8153634|7987388|7987387|7666917|7666916|1579459	FC59;FH44;H41;H54;H62;H68;HD31;HD32;HP16;MC58;MH43	1029	CDKN2A	5U1E	EX1	.	.	no-change	NM_000077.4	NP_000068.1	-	Y	c.-191G=	.	.	.	NM_000077.4(CDKN2A): c.-191G=	SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops,rs-cluster-nonoverlapping-alleles	5008	0.512181	U	0.6657	0.487819	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3814960	.	.	.	-0.266	-0.091	0.062	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	21975016	21975017	9p21.3	0	normal	.	C	ref	C	GC.GT	het-alt	164	0.50	.	1	.	PASS	600160	C	155601(SK);155755(MK);600160(MK);606719(MK)	AD	Melanoma, familial; Melanoma-pancreatic cancer syndrome	AD	.	Dermatologic; Oncologic	Dermatologic; Oncologic	22636603|22368299|21895773|21801156|21625824|21614589|21570156|21570154|21325014|21150883|20653773|20574843|20132244|18178632|17492760|16822996|15577313|12700603|12556369|12019208|11815963|11807902|11726555|11506491|10956390|10874641|9916806|9699728|9603434|9516223|9425228|9328469|8653684|8153634|7987388|7987387|7666917|7666916|1579459	FC59;FH44;H41;H54;H62;H68;HD31;HD32;HP16;MC58;MH43	1029	CDKN2A	IC1	IVS1	.	.	no-change	NM_058195.3	NP_478102.2	-	N	c.194-3810G=	.	.	.	NM_058195.3(CDKN2A): c.194-3810G=	SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops,rs-cluster-nonoverlapping-alleles	5008	0.512181	U	0.6657	0.487819	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3814960	.	.	.	-0.266	-0.091	0.062	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	21975016	21975017	9p21.3	0	normal	.	C	snv	T	GC.GT	het-ref	164	0.50	.	2	.	PASS	600160	C	155601(SK);155755(MK);600160(MK);606719(MK)	AD	Melanoma, familial; Melanoma-pancreatic cancer syndrome	AD	.	Dermatologic; Oncologic	Dermatologic; Oncologic	22636603|22368299|21895773|21801156|21625824|21614589|21570156|21570154|21325014|21150883|20653773|20574843|20132244|18178632|17492760|16822996|15577313|12700603|12556369|12019208|11815963|11807902|11726555|11506491|10956390|10874641|9916806|9699728|9603434|9516223|9425228|9328469|8653684|8153634|7987388|7987387|7666917|7666916|1579459	FC59;FH44;H41;H54;H62;H68;HD31;HD32;HP16;MC58;MH43	1029	CDKN2A	5U1E	EX1	.	.	utr-5	NM_000077.4	NP_000068.1	-	Y	c.-191G>A	.	.	.	NM_000077.4(CDKN2A): c.-191G>A	SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops,rs-cluster-nonoverlapping-alleles	5008	0.487819	U	0.6657	0.487819	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3814960	.	.	.	-0.266	-0.091	0.062	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	21975016	21975017	9p21.3	0	normal	.	C	snv	T	GC.GT	het-ref	164	0.50	.	2	.	PASS	600160	C	155601(SK);155755(MK);600160(MK);606719(MK)	AD	Melanoma, familial; Melanoma-pancreatic cancer syndrome	AD	.	Dermatologic; Oncologic	Dermatologic; Oncologic	22636603|22368299|21895773|21801156|21625824|21614589|21570156|21570154|21325014|21150883|20653773|20574843|20132244|18178632|17492760|16822996|15577313|12700603|12556369|12019208|11815963|11807902|11726555|11506491|10956390|10874641|9916806|9699728|9603434|9516223|9425228|9328469|8653684|8153634|7987388|7987387|7666917|7666916|1579459	FC59;FH44;H41;H54;H62;H68;HD31;HD32;HP16;MC58;MH43	1029	CDKN2A	IC1	IVS1	.	.	intron	NM_058195.3	NP_478102.2	-	N	c.194-3810G>A	.	.	.	NM_058195.3(CDKN2A): c.194-3810G>A	SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops,rs-cluster-nonoverlapping-alleles	5008	0.487819	U	0.6657	0.487819	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3814960	.	.	.	-0.266	-0.091	0.062	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	21997871	21997872	9p21.3	0	normal	.	G	ref	G	GG.TT	het-alt	101	0.52	.	1	.	PASS	600160	C	155601(SK);155755(MK);600160(MK);606719(MK)	AD	Melanoma, familial; Melanoma-pancreatic cancer syndrome	AD	.	Dermatologic; Oncologic	Dermatologic; Oncologic	22636603|22368299|21895773|21801156|21625824|21614589|21570156|21570154|21325014|21150883|20653773|20574843|20132244|18178632|17492760|16822996|15577313|12700603|12556369|12019208|11815963|11807902|11726555|11506491|10956390|10874641|9916806|9699728|9603434|9516223|9425228|9328469|8653684|8153634|7987388|7987387|7666917|7666916|1579459	FC59;FH44;H41;H54;H62;H68;HD31;HD32;HP16;MC58;MH43	1029	CDKN2A	PROM	.	.	.	no-change	NM_058195.3	NP_478102.2	-	Y	c.-160-u3382C=	.	.	.	NM_058195.3(CDKN2A): c.-160-u3382C=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.654752	U	0.5099	0.345248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3218020	.	.	.	0.455	0.004	0.010	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	21997871	21997872	9p21.3	0	normal	.	G	snv	A	GG.TT	het-ref	94	0.48	.	2	.	PASS	600160	C	155601(SK);155755(MK);600160(MK);606719(MK)	AD	Melanoma, familial; Melanoma-pancreatic cancer syndrome	AD	.	Dermatologic; Oncologic	Dermatologic; Oncologic	22636603|22368299|21895773|21801156|21625824|21614589|21570156|21570154|21325014|21150883|20653773|20574843|20132244|18178632|17492760|16822996|15577313|12700603|12556369|12019208|11815963|11807902|11726555|11506491|10956390|10874641|9916806|9699728|9603434|9516223|9425228|9328469|8653684|8153634|7987388|7987387|7666917|7666916|1579459	FC59;FH44;H41;H54;H62;H68;HD31;HD32;HP16;MC58;MH43	1029	CDKN2A	PROM	.	.	.	promoter	NM_058195.3	NP_478102.2	-	Y	c.-160-u3382C>T	.	.	.	NM_058195.3(CDKN2A): c.-160-u3382C>T	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.345248	U	0.5099	0.345248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3218020	.	.	.	0.455	0.004	0.010	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	21998034	21998035	9p21.3	0	normal	.	G	ref	G	AG.AT	het-alt	89	0.49	.	1	.	PASS	600160	C	155601(SK);155755(MK);600160(MK);606719(MK)	AD	Melanoma, familial; Melanoma-pancreatic cancer syndrome	AD	.	Dermatologic; Oncologic	Dermatologic; Oncologic	22636603|22368299|21895773|21801156|21625824|21614589|21570156|21570154|21325014|21150883|20653773|20574843|20132244|18178632|17492760|16822996|15577313|12700603|12556369|12019208|11815963|11807902|11726555|11506491|10956390|10874641|9916806|9699728|9603434|9516223|9425228|9328469|8653684|8153634|7987388|7987387|7666917|7666916|1579459	FC59;FH44;H41;H54;H62;H68;HD31;HD32;HP16;MC58;MH43	1029	CDKN2A	PROM	.	.	.	no-change	NM_058195.3	NP_478102.2	-	Y	c.-160-u3545C=	.	.	.	NM_058195.3(CDKN2A): c.-160-u3545C=	;maf-5-some-pop,maf-5-all-pops	5008	0.160144	U	0.7917	0.839856	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2811712	.	.	.	0.455	-0.218	-0.212	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	21998034	21998035	9p21.3	0	normal	.	G	snv	A	AG.AT	het-ref	91	0.51	.	2	.	PASS	600160	C	155601(SK);155755(MK);600160(MK);606719(MK)	AD	Melanoma, familial; Melanoma-pancreatic cancer syndrome	AD	.	Dermatologic; Oncologic	Dermatologic; Oncologic	22636603|22368299|21895773|21801156|21625824|21614589|21570156|21570154|21325014|21150883|20653773|20574843|20132244|18178632|17492760|16822996|15577313|12700603|12556369|12019208|11815963|11807902|11726555|11506491|10956390|10874641|9916806|9699728|9603434|9516223|9425228|9328469|8653684|8153634|7987388|7987387|7666917|7666916|1579459	FC59;FH44;H41;H54;H62;H68;HD31;HD32;HP16;MC58;MH43	1029	CDKN2A	PROM	.	.	.	promoter	NM_058195.3	NP_478102.2	-	Y	c.-160-u3545C>T	.	.	.	NM_058195.3(CDKN2A): c.-160-u3545C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.839856	U	0.7917	0.839856	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2811712	.	.	.	0.455	-0.218	-0.212	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	22003222	22003223	9p21.3	0	normal	.	C	ref	C	TT.AA	het-alt	207	0.58	.	1	.	PASS	600431	P	.	NN	.	.	.	.	.	.	.	1030	CDKN2B	3U2E	EX2E	.	.	no-change	NM_078487.2	NP_511042.1	-	Y	c.*3066G=	.	.	.	NM_078487.2(CDKN2B): c.*3066G=	;maf-5-some-pop,maf-5-all-pops	5008	0.651757	U	0.5248	0.348243	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3217992	.	.	.	0.557	0.015	0.003	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	22003222	22003223	9p21.3	0	normal	.	C	snv	T	TT.AA	het-ref	151	0.42	.	2	.	PASS	600431	P	.	NN	.	.	.	.	.	.	.	1030	CDKN2B	3U2E	EX2E	.	.	utr-3	NM_078487.2	NP_511042.1	-	Y	c.*3066G>A	.	.	.	NM_078487.2(CDKN2B): c.*3066G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.348243	U	0.5248	0.348243	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3217992	.	.	.	0.557	0.015	0.003	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	22003297	22003298	9p21.3	0	normal	.	C	ref	C	AA.AA	het-alt	97	0.50	.	1	.	PASS	600431	P	.	NN	.	.	.	.	.	.	.	1030	CDKN2B	3U2E	EX2E	.	.	no-change	NM_078487.2	NP_511042.1	-	Y	c.*2991G=	.	.	.	NM_078487.2(CDKN2B): c.*2991G=	.	.	.	.	0.5258	0.352236	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.447	0.612	0.600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	22003298	22003298	9p21.3	0	normal	.	.	ins	A	AC.AA	het-ref	97	0.50	.	2	.	PASS	600431	P	.	NN	.	.	.	.	.	.	.	1030	CDKN2B	3U2E	EX2E	.	.	utr-3	NM_078487.2	NP_511042.1	-	Y	c.*2983T[8>9] (std: c.*2990dupT alt: c.*2990_*2991insT )	.	.	.	NM_078487.2(CDKN2B): c.*2990dupT	InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	5008	0.352236	U	0.5258	0.352236	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3217991	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	22017549	22017550	9p21.3	0	normal	.	A	ref	A	TC.TT	het-alt	127	0.56	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.22017549A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.351637	U	0.6984	0.648363	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2106119	.	.	.	0.477	0.029	-0.013	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	22017549	22017550	9p21.3	0	normal	.	A	snv	G	TC.TT	het-ref	98	0.44	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.22017549A>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.648363	U	0.6984	0.648363	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2106119	.	.	.	0.477	0.029	-0.013	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	22029444	22029445	9p21.3	0	normal	.	G	snv	A	AC.AC	het-ref	179	0.44	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.22029444G>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	120062	0.532508	U	0.7014	0.540735	5734	0.447855	PASS	1896	8476	0.668712	17292	115054	0.532150	3835	11418	6.66861e-01	37778	131287	5.45910e-01	rs10965215	.	.	.	0.563	-0.519	-0.550	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	22029444	22029445	9p21.3	0	normal	.	G	ref	G	AC.AC	het-alt	225	0.56	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.22029444G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	120062	0.467492	U	0.7014	0.540735	5734	0.552145	PASS	-938	8476	0.331288	13593	115054	0.467850	.	.	.	.	.	.	rs10965215	.	.	.	0.563	-0.519	-0.550	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	22041442	22041443	9p21.3	0	normal	.	T	ref	T	AG.AC	het-alt	224	0.53	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.22041442T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.322284	U	0.7282	0.677716	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1360590	.	.	.	-0.263	0.033	-0.011	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	22041442	22041443	9p21.3	0	normal	.	T	snv	C	AG.AC	het-ref	196	0.47	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.22041442T>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.677716	U	0.7282	0.677716	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1360590	.	.	.	-0.263	0.033	-0.011	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	22048341	22048342	9p21.3	0	normal	.	G	ref	G	AT.AT	het-alt	113	0.40	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.22048341G= (intergenic)	;maf-5-some-pop	5008	0.954673	U	0.1647	0.0453275	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs74400540	.	.	.	-0.708	-1.742	-1.511	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
9	22048341	22048342	9p21.3	0	normal	.	G	snv	A	AT.AT	het-ref	167	0.60	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.22048341G>A (intergenic)	;maf-5-some-pop	5008	0.045327	U	0.1647	0.0453275	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs74400540	.	.	.	-0.708	-1.742	-1.511	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
9	22048390	22048391	9p21.3	0	normal	.	C	ref	C	TG.TC	het-alt	213	0.62	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.22048390C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.421526	U	0.7272	0.578474	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7027950	.	.	.	-0.665	-0.056	-0.208	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	22048390	22048391	9p21.3	0	normal	.	C	snv	T	TG.TC	het-ref	132	0.38	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.22048390C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.578474	U	0.7272	0.578474	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7027950	.	.	.	-0.665	-0.056	-0.208	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	22048413	22048414	9p21.3	0	normal	.	G	ref	G	CC.TG	het-alt	202	0.63	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.22048413G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.629992	U	0.624	0.370008	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7028268	.	.	.	-0.794	-0.234	-0.056	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	22048413	22048414	9p21.3	0	normal	.	G	snv	A	CC.TG	het-ref	120	0.37	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.22048413G>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.370008	U	0.624	0.370008	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7028268	.	.	.	-0.794	-0.234	-0.056	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	22053686	22053687	9p21.3	0	normal	.	A	ref	A	AC.TT	het-alt	191	0.70	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.22053686A= (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.332668	U	0.7292	0.667332	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10965219	.	.	.	-1.186	-0.361	-0.596	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	22053686	22053687	9p21.3	0	normal	.	A	snv	G	AC.TT	het-ref	83	0.30	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.22053686A>G (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.667332	U	0.7292	0.667332	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10965219	.	.	.	-1.186	-0.361	-0.596	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	22053708	22053709	9p21.3	0	normal	.	A	ref	A	AC.TA	het-alt	182	0.71	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.22053708A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.333466	U	0.7292	0.666534	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7027048	.	.	.	-3.809	-5.167	-5.625	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	22053708	22053709	9p21.3	0	normal	.	A	snv	G	AC.TA	het-ref	76	0.29	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.22053708A>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.666534	U	0.7292	0.666534	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7027048	.	.	.	-3.809	-5.167	-5.625	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	32631368	32631369	9p21.1	0	nullSample	.	C	ref	C	AG.GT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	138474	TAF1L	C1E	EX1E	.	.	no-change	NM_153809.2	NP_722516.1	-	Y	c.4209G=	.	.	.	NM_153809.2(TAF1L): c.4209G=	SingleClassTriAllelic;maf-5-some-pop	126390	0.867656	U	0.3095	0.161542	13006	0.902583	PASS	.	8626	0.695456	46071	121382	0.868860	.	.	.	.	.	.	rs10971047	.	4024	0.693300	0.195	-1.376	-0.367	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	32631368	32631369	9p21.1	1	normal	.	C	snv	T	AG.GT	hom-alt	357	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	138474	TAF1L	C1E	EX1E	.	.	coding-synon	NM_153809.2	NP_722516.1	-	Y	c.4209G>A	p.(T1403=) | p.(Thr1403=)	ACG=>ACA	.	NM_153809.2(TAF1L): c.4209G>A (p.(T1403=))	SingleClassTriAllelic;maf-5-some-pop	126390	0.132305	U	0.3095	0.161542	13006	0.097417	PASS	416	8626	0.303965	1297	121382	0.131099	789	5175	3.00035e-01	2579	32327	1.31284e-01	rs10971047	.	4024	0.305200	0.195	-1.376	-0.367	.	.	.	.	.	ENST00000242310: c.4209G>A (p.T1403T)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5009670	.	.	.	.	.	.	.	.	.	Likely Benign
9	35077440	35077441	9p13.3	0	normal	.	T	snv	C	CC.CG	het-ref	152	0.45	.	2	.	PASS	602956	C	614082(MK)	NN	Fanconi anemia type G	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	20301575|9806548	.	2189	FANCG	IC4	IVS4	.	.	intron	NM_004629.1	NP_004620.1	-	Y	c.511-45A>G	.	.	.	NM_004629.1(FANCG): c.511-45A>G	;maf-5-some-pop,maf-5-all-pops	126250	0.744127	U	0.4534	0.701478	13006	0.761879	PASS	960	8594	0.465325	34313	121242	0.745888	1793	7782	4.51759e-01	69925	183937	7.48034e-01	rs554098	.	4024	0.456300	-0.733	0.379	0.356	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	259478	criteria_provided,_single_submitter	Benign	Benign
9	35077440	35077441	9p13.3	0	normal	.	T	ref	T	CC.CG	het-alt	184	0.55	.	1	.	PASS	602956	C	614082(MK)	NN	Fanconi anemia type G	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	20301575|9806548	.	2189	FANCG	IC4	IVS4	.	.	no-change	NM_004629.1	NP_004620.1	-	Y	c.511-45A=	.	.	.	NM_004629.1(FANCG): c.511-45A=	;maf-5-some-pop,maf-5-all-pops	126250	0.255873	U	0.4534	0.701478	13006	0.238121	PASS	.	8594	0.534675	4501	121242	0.254112	.	.	.	.	.	.	rs554098	.	4024	0.543700	-0.733	0.379	0.356	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	36840622	36840623	9p13.2	0	nullSample	.	G	ref	G	TA.TA	homo-ref	.	.	.	0	.	.	167414	C	615545(SK)	NN	Pre-B cell acute lymphoblastic leukemia	AD	.	Oncologic	Oncologic	24013638	.	5079	PAX5	C10E	EX10E	Paired-box protein 2 C terminal	PF12403.3	no-change	NM_016734.1	NP_057953.1	-	Y	c.1110C=	.	.	.	NM_016734.1(PAX5): c.1110C=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	56300	0.142593	U	0.8899	0.742013	12918	0.236879	PASS	-212	3988	0.117352	913	51292	0.131327	.	.	.	.	.	.	rs3780135	.	4024	0.128000	0.563	0.612	0.617	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	36840622	36840623	9p13.2	1	normal	.	G	snv	A	TA.TA	hom-alt	349	1.00	.	0	.	PASS	167414	C	615545(SK)	NN	Pre-B cell acute lymphoblastic leukemia	AD	.	Oncologic	Oncologic	24013638	.	5079	PAX5	C10E	EX10E	Paired-box protein 2 C terminal	PF12403.3	coding-synon	NM_016734.1	NP_057953.1	-	Y	c.1110C>T	p.(Y370=) | p.(Tyr370=)	TAC=>TAT	.	NM_016734.1(PAX5): c.1110C>T (p.(Y370=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	56300	0.857407	U	0.8899	0.742013	12918	0.763121	PASS	1548	3988	0.882648	19823	51292	0.868673	5112	11629	8.78721e-01	69303	153983	8.79853e-01	rs3780135	.	4024	0.872000	0.563	0.612	0.617	.	.	.	.	.	ENST00000358127: c.1110C>T (p.Y370Y)	liver [NS|NS|NS]	carcinoma [hepatocellular_carcinoma|NS|NS]	CSV	4163845	.	.	.	.	.	no_record	134998	no_assertion_provided	not_provided	Likely Benign
9	37034094	37034095	9p13.2	0	nullSample	.	C	ref	C	tt.tt	homo-ref	.	.	.	0	(T)n|Simple_repeat|Simple_repeat|+|38;trf	.	167414	C	615545(SK)	NN	Pre-B cell acute lymphoblastic leukemia	AD	.	Oncologic	Oncologic	24013638	.	5079	PAX5	5U1E	EX1	.	.	no-change	NM_016734.1	NP_057953.1	-	Y	c.-67G=	.	.	.	NM_016734.1(PAX5): c.-67G=	MixedObserved;maf-5-some-pop,maf-5-all-pops|MixedObserved;	5005|5008	0.503097|0.999401	U	0	0.000599042	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs143723948|rs372827136	.	.	.	0.134	-0.245	-0.269	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
9	37034095	37034095	9p13.2	0	normal	.	.	ins	TTTTTTT	tc.tt	hom-alt	.	.	.	0	(T)n|Simple_repeat|Simple_repeat|+|38;trf	.	167414	C	615545(SK)	NN	Pre-B cell acute lymphoblastic leukemia	AD	.	Oncologic	Oncologic	24013638	.	5079	PAX5	5U1E	EX1	.	.	utr-5	NM_016734.1	NP_057953.1	-	Y	c.-95A[28>35] (std: c.-95A[35] alt: c.-68_-67insAAAAAAA )	.	.	.	NM_016734.1(PAX5): c.-95A[35]	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
9	80343586	80343587	9q21.2	0	normal	.	G	ref	G	TG.AA	het-alt	72	0.30	.	1	.	PASS	600998	P	163000(MK);185300(MK)	AD	.	.	.	.	.	.	.	2776	GNAQ	IC5	IVS5	.	.	no-change	NM_002072.3	NP_002063.2	-	Y	c.736-4C=	.	.	.	NM_002072.3(GNAQ): c.736-4C=	;maf-5-some-pop,maf-5-all-pops	2826	0.723284	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs371357756	.	.	.	-0.216	-0.567	-1.254	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
9	80343587	80343587	9q21.2	1	normal	.	.	ins	A	GG.AA	het-ref	168	0.70	.	2	.	PASS	600998	P	163000(MK);185300(MK)	AD	.	.	.	.	.	.	.	2776	GNAQ	IC5	IVS5	.	.	intron	NM_002072.3	NP_002063.2	-	Y	c.736-5_736-4insT	.	.	.	NM_002072.3(GNAQ): c.736-5_736-4insT	MixedObserved;rs-cluster-nonoverlapping-alleles	112374	0.061811	U	0.38	0.372005	.	.	InbreedingCoeff_Filter	4	8148	0.345729	172	113738	0.441409	.	.	.	.	.	.	rs5898555	.	4024	0.334000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	80409344	80409345	9q21.2	0	normal	.	A	snv	G	AA.TG	hom-alt	436	1.00	.	0	.	PASS	600998	P	163000(MK);185300(MK)	AD	.	.	.	.	.	.	.	2776	GNAQ	IC5	IVS5	.	.	intron	NM_002072.3	NP_002063.2	-	Y	c.735+34T>C	.	.	.	NM_002072.3(GNAQ): c.735+34T>C	;maf-5-some-pop,genotype-conflict	122966	0.471431	U	0.2321	0.302915	13004	0.439634	PASS	216	8582	0.227569	14638	117958	0.478586	410	3482	2.28388e-01	27091	104228	4.83047e-01	rs1328529	.	4024	0.224400	0.455	-0.087	-0.159	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	80409344	80409345	9q21.2	0	nullSample	.	A	ref	A	AA.TG	homo-ref	.	.	.	0	.	.	600998	P	163000(MK);185300(MK)	AD	.	.	.	.	.	.	.	2776	GNAQ	IC5	IVS5	.	.	no-change	NM_002072.3	NP_002063.2	-	Y	c.735+34T=	.	.	.	NM_002072.3(GNAQ): c.735+34T=	;maf-5-some-pop,genotype-conflict	122966	0.528569	U	0.2321	0.302915	13004	0.560366	PASS	.	8582	0.772431	17164	117958	0.521414	.	.	.	.	.	.	rs1328529	.	4024	0.775600	0.455	-0.087	-0.159	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	87285914	87285915	9q21.33	0	nullSample	.	C	ref	C	CC.TA	homo-ref	.	.	.	0	.	.	600456	C	613886(UK)	NN	Obesity, hyperphagia, and developmental delay	AD	.	Endocrine; Neurologic	General	15494731	.	4915	NTRK2	IC1	IVS4	.	.	no-change	NM_006180.3	NP_006171.2	+	Y	c.212+40C=	.	.	.	NM_006180.3(NTRK2): c.212+40C=	;maf-5-some-pop,maf-5-all-pops	116108	0.246512	U	0.7609	0.709065	13006	0.283023	PASS	-734	7580	0.243272	3157	111100	0.244509	.	.	.	.	.	.	rs1187326	.	.	.	0.561	-0.047	-0.190	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	87285914	87285915	9q21.33	0	normal	.	C	snv	T	CC.TA	hom-alt	204	1.00	.	0	.	PASS	600456	C	613886(UK)	NN	Obesity, hyperphagia, and developmental delay	AD	.	Endocrine; Neurologic	General	15494731	.	4915	NTRK2	IC1	IVS4	.	.	intron	NM_006180.3	NP_006171.2	+	Y	c.212+40C>T	.	.	.	NM_006180.3(NTRK2): c.212+40C>T	;maf-5-some-pop,maf-5-all-pops	116108	0.753488	U	0.7609	0.709065	13006	0.716977	PASS	2134	7580	0.756728	31542	111100	0.755491	4930	12832	7.72547e-01	64660	170650	7.58242e-01	rs1187326	.	.	.	0.561	-0.047	-0.190	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	87358663	87358664	9q21.33	0	nullSample	.	T	ref	T	AA.GA	homo-ref	.	.	.	0	.	.	600456	C	613886(UK)	NN	Obesity, hyperphagia, and developmental delay	AD	.	Endocrine; Neurologic	General	15494731	.	4915	NTRK2	IC9	IVS12	.	.	no-change	NM_006180.3	NP_006171.2	+	Y	c.1196-1224T=	.	.	.	NM_006180.3(NTRK2): c.1196-1224T=	;maf-5-some-pop	5008	0.489217	U	0.6766	0.510783	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11140746	.	4024	0.324100	0.528	0.467	0.525	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	87358663	87358664	9q21.33	0	normal	.	T	snv	C	AA.GA	hom-alt	719	1.00	.	0	.	PASS	600456	C	613886(UK)	NN	Obesity, hyperphagia, and developmental delay	AD	.	Endocrine; Neurologic	General	15494731	.	4915	NTRK2	IC9	IVS12	.	.	intron	NM_006180.3	NP_006171.2	+	Y	c.1196-1224T>C	.	.	.	NM_006180.3(NTRK2): c.1196-1224T>C	;maf-5-some-pop	5008	0.510783	U	0.6766	0.510783	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11140746	.	4024	0.675900	0.528	0.467	0.525	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	87482372	87482373	9q21.33	0	normal	.	T	ref	T	TG.CC	het-alt	165	0.48	.	1	.	PASS	600456	C	613886(UK)	NN	Obesity, hyperphagia, and developmental delay	AD	.	Endocrine; Neurologic	General	15494731	.	4915	NTRK2	IC13	IVS16	.	.	no-change	NM_006180.3	NP_006171.2	+	Y	c.1633+27T=	.	.	.	NM_006180.3(NTRK2): c.1633+27T=	;maf-5-some-pop	125424	0.992410	U	0.0169	0.0133786	13006	0.999000	PASS	-49	8584	0.988583	59356	120416	0.992650	.	.	.	.	.	.	rs76282563	.	.	.	-0.249	-0.030	0.066	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	87482372	87482373	9q21.33	0	normal	.	T	snv	A	TG.CC	het-ref	177	0.52	.	2	.	PASS	600456	C	613886(UK)	NN	Obesity, hyperphagia, and developmental delay	AD	.	Endocrine; Neurologic	General	15494731	.	4915	NTRK2	IC13	IVS16	.	.	intron	NM_006180.3	NP_006171.2	+	Y	c.1633+27T>A	.	.	.	NM_006180.3(NTRK2): c.1633+27T>A	;maf-5-some-pop	125424	0.007590	U	0.0169	0.0133786	13006	0.001000	PASS	0	8584	0.011417	33	120416	0.007350	1	160	9.30774e-03	83	2314	9.50074e-03	rs76282563	.	.	.	-0.249	-0.030	0.066	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
9	87563369	87563370	9q21.33	0	normal	.	T	ref	T	CA.CC	het-alt	227	0.53	.	1	.	PASS	600456	C	613886(UK)	NN	Obesity, hyperphagia, and developmental delay	AD	.	Endocrine; Neurologic	General	15494731	.	4915	NTRK2	IC14	IVS17	.	.	no-change	NM_006180.3	NP_006171.2	+	Y	c.1765-7T=	.	.	.	NM_006180.3(NTRK2): c.1765-7T=	;maf-5-some-pop	122892	0.936611	U	0.1389	0.0870607	13006	0.953867	PASS	.	8492	0.877885	51977	117884	0.937617	.	.	.	.	.	.	rs2289658	.	.	.	-1.617	-0.763	-0.848	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	87563369	87563370	9q21.33	1	normal	.	T	snv	C	CA.CC	het-ref	202	0.47	.	2	.	PASS	600456	C	613886(UK)	NN	Obesity, hyperphagia, and developmental delay	AD	.	Endocrine; Neurologic	General	15494731	.	4915	NTRK2	IC14	IVS17	.	.	intron	NM_006180.3	NP_006171.2	+	Y	c.1765-7T>C	.	.	.	NM_006180.3(NTRK2): c.1765-7T>C	;maf-5-some-pop	122892	0.063389	U	0.1389	0.0870607	13006	0.046133	PASS	53	8492	0.122115	389	117884	0.062383	129	2132	1.23838e-01	884	15963	6.49785e-02	rs2289658	.	.	.	-1.617	-0.763	-0.848	.	.	.	.	.	ENST00000376214: c.1765-7T>C (p.?)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019229	.	.	.	.	.	.	.	.	.	Benign
9	87563459	87563460	9q21.33	0	normal	.	C	ref	C	AT.GT	het-alt	288	0.50	.	1	.	PASS	600456	C	613886(UK)	NN	Obesity, hyperphagia, and developmental delay	AD	.	Endocrine; Neurologic	General	15494731	.	4915	NTRK2	C15	EX18	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	no-change	NM_006180.3	NP_006171.2	+	Y	c.1848C=	.	.	.	NM_006180.3(NTRK2): c.1848C=	;maf-5-some-pop	126138	0.952782	U	0.0784	0.058107	13006	0.955867	PASS	.	8636	0.936429	55107	121130	0.953232	.	.	.	.	.	.	rs2289657	.	.	.	-0.812	-0.388	-1.760	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	87563459	87563460	9q21.33	1	normal	.	C	snv	A	AT.GT	het-ref	290	0.50	.	2	.	PASS	600456	C	613886(UK)	NN	Obesity, hyperphagia, and developmental delay	AD	.	Endocrine; Neurologic	General	15494731	.	4915	NTRK2	C15	EX18	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_006180.3	NP_006171.2	+	Y	c.1848C>A	p.(I616=) | p.(Ile616=)	ATC=>ATA	.	NM_006180.3(NTRK2): c.1848C>A (p.(I616=))	;maf-5-some-pop	126138	0.047218	U	0.0784	0.058107	13006	0.044133	PASS	18	8636	0.063571	207	121130	0.046768	42	1151	6.67633e-02	427	12012	4.87967e-02	rs2289657	.	.	.	-0.812	-0.388	-1.760	.	.	.	.	.	ENST00000376214: c.1848C>A (p.I616I)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	5019069	.	.	.	.	.	.	.	.	.	Likely Benign
9	93629346	93629347	9q22.2	0	nullSample	.	G	ref	G	TC.TG	homo-ref	.	.	.	0	.	.	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	IC5	IVS6	.	.	no-change	NM_003177.5	NP_003168.2	+	Y	c.847-66G=	.	.	.	NM_003177.5(SYK): c.847-66G=	;maf-5-some-pop	5008	0.106030	U	0.9673	0.89397	4566	0.173237	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1760124	.	4024	0.039300	-1.305	-2.681	-2.539	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	93629346	93629347	9q22.2	0	normal	.	G	snv	A	TC.TG	hom-alt	223	1.00	.	0	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	IC5	IVS6	.	.	intron	NM_003177.5	NP_003168.2	+	Y	c.847-66G>A	.	.	.	NM_003177.5(SYK): c.847-66G>A	;maf-5-some-pop	5008	0.893970	U	0.9673	0.89397	4566	0.826763	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1760124	.	4024	0.960700	-1.305	-2.681	-2.539	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	93637014	93637015	9q22.2	0	normal	.	C	ref	C	CC.GA	het-alt	263	0.50	.	1	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	C8	EX9	.	.	no-change	NM_003177.5	NP_003168.2	+	Y	c.1065C=	.	.	.	NM_003177.5(SYK): c.1065C=	SingleClassTriAllelic;maf-5-some-pop	126406	0.816211	U	0.2321	0.195887	13006	0.835922	PASS	-749	8650	0.773410	41095	121398	0.816710	.	.	.	.	.	.	rs2290890	.	4024	0.779800	-1.149	-2.907	-2.770	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	93637014	93637015	9q22.2	1	normal	.	C	snv	T	CC.GA	het-ref	264	0.50	.	2	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	C8	EX9	.	.	coding-synon	NM_003177.5	NP_003168.2	+	Y	c.1065C>T	p.(P355=) | p.(Pro355=)	CCC=>CCT	.	NM_003177.5(SYK): c.1065C>T (p.(P355=))	SingleClassTriAllelic;maf-5-some-pop	126406	0.183781	U	0.2321	0.195887	13006	0.164078	PASS	231	8650	0.226590	2647	121398	0.183281	459	4018	2.32955e-01	5981	47632	1.93459e-01	rs2290890	.	4024	0.220200	-1.149	-2.907	-2.770	.	.	.	.	.	ENST00000375754: c.1065C>T (p.P355P)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4419974	.	.	.	.	.	.	.	.	.	Likely Benign
9	93639802	93639803	9q22.2	0	normal	.	A	snv	G	TA.AA	hom-alt	229	1.00	.	0	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	IC8	IVS9	.	.	intron	NM_003177.5	NP_003168.2	+	Y	c.1182-50A>G	.	.	.	NM_003177.5(SYK): c.1182-50A>G	SingleClassTriAllelic;	120008	0.999950	U	1	1	.	.	PASS	3966	7932	1.000000	57494	115000	0.999948	8357	16714	1.00000e+00	119382	238771	9.99971e-01	rs1760132	.	4024	0.998500	-0.119	-0.393	-0.353	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	93639802	93639803	9q22.2	0	nullSample	.	A	ref	A	TA.AA	homo-ref	.	.	.	0	.	.	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	IC8	IVS9	.	.	no-change	NM_003177.5	NP_003168.2	+	Y	c.1182-50A=	.	.	.	NM_003177.5(SYK): c.1182-50A=	SingleClassTriAllelic;	120008	0.000000	U	1	1	.	.	PASS	0	7932	0.000000	0	115000	0.000000	.	.	.	.	.	.	rs1760132	.	4024	0.001500	-0.119	-0.393	-0.353	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	93639845	93639846	9q22.2	0	normal	.	C	ref	C	CT.TT	het-alt	186	0.50	.	1	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	IC8	IVS9	.	.	no-change	NM_003177.5	NP_003168.2	+	Y	c.1182-7C=	.	.	.	NM_003177.5(SYK): c.1182-7C=	SingleClassTriAllelic;maf-5-some-pop	125404	0.743190	U	0	0.0135783	13006	0.793095	PASS	-1065	8596	0.444625	34045	120396	0.745614	.	.	.	.	.	.	rs290223	.	4024	0.433200	-0.345	0.399	-0.246	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	93639845	93639846	9q22.2	1	normal	.	C	snv	G	CT.TT	het-ref	184	0.50	.	2	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	IC8	IVS9	.	.	intron	NM_003177.5	NP_003168.2	+	Y	c.1182-7C>G	.	.	.	NM_003177.5(SYK): c.1182-7C>G	SingleClassTriAllelic;maf-5-some-pop	125404	0.252424	U	0.5625	0.301518	13006	0.206905	PASS	1322	8596	0.555375	4341	120396	0.250382	2564	9442	5.48507e-01	8696	60752	2.47130e-01	rs290223	.	4024	0.566800	-0.345	0.399	-0.246	.	.	.	.	.	ENST00000375754: c.1182-7C>G (p.?)	liver [NS|NS|NS]	carcinoma [hepatocellular_carcinoma|NS|NS]	CSV	4407231	.	.	.	.	.	.	.	.	.	Benign
9	93639972	93639973	9q22.2	0	normal	.	G	ref	G	CG.AT	het-alt	302	0.53	.	1	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	C9	EX10	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	no-change	NM_003177.5	NP_003168.2	+	Y	c.1302G=	.	.	.	NM_003177.5(SYK): c.1302G=	;maf-5-some-pop,maf-5-all-pops	126366	0.815995	U	0.2321	0.196486	13006	0.834769	PASS	.	8626	0.773360	41053	121358	0.816510	.	.	.	.	.	.	rs2290888	.	4024	0.779600	-0.704	-1.053	-0.381	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	93639972	93639973	9q22.2	1	normal	.	G	snv	C	CG.AT	het-ref	264	0.47	.	2	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	C9	EX10	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_003177.5	NP_003168.2	+	Y	c.1302G>C	p.(R434=) | p.(Arg434=)	CGG=>CGC	.	NM_003177.5(SYK): c.1302G>C (p.(R434=))	;maf-5-some-pop,maf-5-all-pops	126366	0.184005	U	0.2321	0.196486	13006	0.165231	PASS	226	8626	0.226640	2642	121358	0.183490	457	4017	2.32924e-01	5982	47673	1.93604e-01	rs2290888	.	4024	0.220400	-0.704	-1.053	-0.381	.	.	.	.	.	ENST00000375754: c.1302G>C (p.R434R)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3764050	.	.	.	.	.	.	.	.	.	Likely Benign
9	93640008	93640009	9q22.2	0	normal	.	G	ref	G	CT.GT	het-alt	335	0.54	.	1	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	C9	EX10	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	no-change	NM_003177.5	NP_003168.2	+	Y	c.1338G=	.	.	.	NM_003177.5(SYK): c.1338G=	SingleClassTriAllelic;maf-5-some-pop	126392	0.816151	U	0.2321	0.196086	13006	0.835230	PASS	.	8646	0.773653	41079	121384	0.816656	.	.	.	.	.	.	rs2290887	.	4024	0.779600	0.655	0.951	2.566	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	93640008	93640009	9q22.2	1	normal	.	G	snv	A	CT.GT	het-ref	283	0.46	.	2	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	C9	EX10	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_003177.5	NP_003168.2	+	Y	c.1338G>A	p.(L446=) | p.(Leu446=)	CTG=>CTA	.	NM_003177.5(SYK): c.1338G>A (p.(L446=))	SingleClassTriAllelic;maf-5-some-pop	126392	0.183833	U	0.2321	0.196086	13006	0.164770	PASS	228	8646	0.226347	2642	121384	0.183327	458	4018	2.32955e-01	5986	47656	1.93528e-01	rs2290887	.	4024	0.220400	0.655	0.951	2.566	.	.	.	.	.	ENST00000375754: c.1338G>A (p.L446L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3764052	.	.	.	.	.	.	.	.	.	Likely Benign
9	93640119	93640120	9q22.2	0	normal	.	C	ref	C	CC.CT	het-alt	111	0.50	.	1	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	IC9	IVS10	.	.	no-change	NM_003177.5	NP_003168.2	+	Y	c.1391+58C=	.	.	.	NM_003177.5(SYK): c.1391+58C=	;maf-5-some-pop,maf-5-all-pops	5008	0.801717	U	0.2321	0.198283	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2290886	.	4024	0.780800	-3.629	-4.335	-4.415	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	93640119	93640120	9q22.2	0	normal	.	C	snv	T	CC.CT	het-ref	110	0.50	.	2	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	IC9	IVS10	.	.	intron	NM_003177.5	NP_003168.2	+	Y	c.1391+58C>T	.	.	.	NM_003177.5(SYK): c.1391+58C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.198283	U	0.2321	0.198283	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2290886	.	4024	0.219200	-3.629	-4.335	-4.415	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	93641150	93641151	9q22.2	0	normal	.	T	ref	T	AA.GT	het-alt	206	0.45	.	1	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	C10	EX11	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	no-change	NM_003177.5	NP_003168.2	+	Y	c.1497T=	.	.	.	NM_003177.5(SYK): c.1497T=	;maf-5-some-pop	126388	0.959355	U	0.2321	0.0720847	13006	0.989928	PASS	-766	8632	0.764829	56271	121380	0.960652	.	.	.	.	.	.	rs2306042	.	4024	0.768900	-0.250	-0.262	-0.898	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	93641150	93641151	9q22.2	1	normal	.	T	snv	C	AA.GT	het-ref	250	0.55	.	2	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	C10	EX11	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_003177.5	NP_003168.2	+	Y	c.1497T>C	p.(N499=) | p.(Asn499=)	AAT=>AAC	.	NM_003177.5(SYK): c.1497T>C (p.(N499=))	;maf-5-some-pop	126388	0.040645	U	0.2321	0.0720847	13006	0.010072	PASS	249	8632	0.235171	357	121380	0.039348	462	4041	2.34288e-01	642	9248	3.75620e-02	rs2306042	.	4024	0.231100	-0.250	-0.262	-0.898	.	.	.	.	.	ENST00000375751: c.1428T>C (p.N476N)	liver [NS|NS|NS]	carcinoma [hepatocellular_carcinoma|NS|NS]	CSV	150631	.	.	.	.	.	.	.	.	.	Likely Benign
9	93641174	93641175	9q22.2	0	normal	.	C	ref	C	TA.GC	het-alt	243	0.52	.	1	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	C10	EX11	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	no-change	NM_003177.5	NP_003168.2	+	Y	c.1521C=	.	.	.	NM_003177.5(SYK): c.1521C=	;maf-5-some-pop,maf-5-all-pops	126392	0.815083	U	0.2321	0.198283	13006	0.832154	PASS	-750	8644	0.773484	40982	121384	0.815635	.	.	.	.	.	.	rs2306041	.	4024	0.780100	-0.340	-0.054	-0.688	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	93641174	93641175	9q22.2	1	normal	.	C	snv	T	TA.GC	het-ref	222	0.48	.	2	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	C10	EX11	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_003177.5	NP_003168.2	+	Y	c.1521C>T	p.(Y507=) | p.(Tyr507=)	TAC=>TAT	.	NM_003177.5(SYK): c.1521C>T (p.(Y507=))	;maf-5-some-pop,maf-5-all-pops	126392	0.184917	U	0.2321	0.198283	13006	0.167846	PASS	229	8644	0.226516	2669	121384	0.184365	459	4019	2.33013e-01	6033	47865	1.94436e-01	rs2306041	.	4024	0.219900	-0.340	-0.054	-0.688	.	.	.	.	.	ENST00000375754: c.1521C>T (p.Y507Y)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3764054	.	.	.	.	.	.	.	.	.	Likely Benign
9	93641198	93641199	9q22.2	0	normal	.	T	ref	T	CT.TC	het-alt	233	0.52	.	1	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	C10	EX11	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	no-change	NM_003177.5	NP_003168.2	+	Y	c.1545T=	.	.	.	NM_003177.5(SYK): c.1545T=	;maf-5-some-pop	126334	0.889420	U	0.2321	0.130791	13006	0.933415	PASS	.	8646	0.774115	48833	121326	0.890254	.	.	.	.	.	.	rs2306040	.	4024	0.780800	0.459	0.338	0.499	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	93641198	93641199	9q22.2	1	normal	.	T	snv	C	CT.TC	het-ref	215	0.48	.	2	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	C10	EX11	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_003177.5	NP_003168.2	+	Y	c.1545T>C	p.(L515=) | p.(Leu515=)	CTT=>CTC	.	NM_003177.5(SYK): c.1545T>C (p.(L515=))	;maf-5-some-pop	126334	0.110580	U	0.2321	0.130791	13006	0.066585	PASS	227	8646	0.225885	1485	121326	0.109746	452	3999	2.31853e-01	3513	29933	1.21603e-01	rs2306040	.	4024	0.219200	0.459	0.338	0.499	.	.	.	.	.	ENST00000375754: c.1545T>C (p.L515L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4419827	.	.	.	.	.	.	.	.	.	Likely Benign
9	93641281	93641282	9q22.2	0	normal	.	G	ref	G	AT.CA	het-alt	147	0.52	.	1	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	IC10	IVS11	.	.	no-change	NM_003177.5	NP_003168.2	+	Y	c.1581+47G=	.	.	.	NM_003177.5(SYK): c.1581+47G=	;maf-5-some-pop,maf-5-all-pops	123654	0.815582	U	0.2321	0.198283	13006	0.833154	PASS	.	8550	0.773684	40067	118646	0.816167	.	.	.	.	.	.	rs2306039	.	4024	0.780100	-2.516	-1.194	-1.470	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	93641281	93641282	9q22.2	0	normal	.	G	snv	A	AT.CA	het-ref	138	0.48	.	2	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	IC10	IVS11	.	.	intron	NM_003177.5	NP_003168.2	+	Y	c.1581+47G>A	.	.	.	NM_003177.5(SYK): c.1581+47G>A	;maf-5-some-pop,maf-5-all-pops	123654	0.184418	U	0.2321	0.198283	13006	0.166846	PASS	223	8550	0.226316	2555	118646	0.183833	405	3608	2.25924e-01	4516	39982	1.82062e-01	rs2306039	.	4024	0.219900	-2.516	-1.194	-1.470	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	93650758	93650759	9q22.2	0	normal	.	A	ref	A	TT.AA	het-alt	90	0.44	.	1	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	IC11	IVS12	.	.	no-change	NM_003177.5	NP_003168.2	+	Y	c.1723-38A=	.	.	.	NM_003177.5(SYK): c.1723-38A=	MixedObserved;	4901|0	0.989798|0	U	.	.	12466	0.812450	.	.	.	.	.	.	.	.	.	.	.	.	.	rs199586721|rs200077655	.	4024	0.578800	-1.682	0.021	-0.237	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	93650758	93650759	9q22.2	0	normal	.	A	del	.	TT.AA	het-ref	114	0.56	.	2	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	IC11	IVS12	.	.	intron	NM_003177.5	NP_003168.2	+	Y	c.1723-38delA	.	.	.	NM_003177.5(SYK): c.1723-38delA	MixedObserved;	4901|0	0.010202|0	U	.	.	12466	0.143671	PASS	53	1598	0.431164	68	17572	0.276064	.	.	.	.	.	.	rs199586721|rs200077655	.	4024	0.421200	-1.682	0.021	-0.237	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	93657760	93657761	9q22.2	0	nullSample	.	A	ref	A	CA.TT	homo-ref	.	.	.	0	.	.	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	IC12	IVS13	.	.	no-change	NM_003177.5	NP_003168.2	+	Y	c.1836-49A=	.	.	.	NM_003177.5(SYK): c.1836-49A=	MixedObserved;maf-5-some-pop,maf-5-all-pops	125744	0.433221	U	0.4097	0.595647	13006	0.407735	PASS	.	8580	0.584965	11743	120736	0.434419	.	.	.	.	.	.	rs158689	.	4024	0.589700	-1.330	-1.592	-1.895	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	93657760	93657761	9q22.2	0	normal	.	A	snv	T	CA.TT	hom-alt	245	1.00	.	0	.	PASS	600085	P	.	NN	.	.	.	.	.	.	.	6850	SYK	IC12	IVS13	.	.	intron	NM_003177.5	NP_003168.2	+	Y	c.1836-49A>T	.	.	.	NM_003177.5(SYK): c.1836-49A>T	MixedObserved;maf-5-some-pop,maf-5-all-pops	125744	0.566779	U	0.4097	0.595647	13006	0.592265	PASS	749	8580	0.415035	19661	120736	0.565581	1445	7012	4.07864e-01	39123	136260	5.63967e-01	rs158689	.	4024	0.410300	-1.330	-1.592	-1.895	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	97873434	97873435	9q22.32	0	normal	.	G	ref	G	GA.GA	het-alt	146	0.47	.	1	.	PASS	613899	C	227645(MK)	AR	Fanconi anemia, complementation group C	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23028338|22701786|22160080|20301575|10431244|9272737|1574115	FC59;FH44;H68;HBO28;MC58;MH43	2176	FANCC	IC12	IVS13	.	.	no-change	NM_000136.2	NP_000127.2	-	Y	c.1329+310C=	.	.	.	NM_000136.2(FANCC): c.1329+310C=	;maf-5-some-pop,maf-5-all-pops	17398	0.598287	U	0.5873	0.411142	.	.	PASS	-29	218	0.440367	2259	12390	0.602098	.	.	.	.	.	.	rs2404457	.	4024	0.426700	0.563	1.263	1.257	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	97873434	97873435	9q22.32	0	normal	.	G	snv	A	GA.GA	het-ref	165	0.53	.	2	.	PASS	613899	C	227645(MK)	AR	Fanconi anemia, complementation group C	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23028338|22701786|22160080|20301575|10431244|9272737|1574115	FC59;FH44;H68;HBO28;MC58;MH43	2176	FANCC	IC12	IVS13	.	.	intron	NM_000136.2	NP_000127.2	-	Y	c.1329+310C>T	.	.	.	NM_000136.2(FANCC): c.1329+310C>T	;maf-5-some-pop,maf-5-all-pops	17398	0.401713	U	0.5873	0.411142	.	.	PASS	32	218	0.559633	994	12390	0.397902	1633	5681	5.71990e-01	12981	56669	4.36883e-01	rs2404457	.	4024	0.573300	0.563	1.263	1.257	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	97873956	97873957	9q22.32	0	normal	.	A	ref	A	CT.AA	het-alt	163	0.47	.	1	.	PASS	613899	C	227645(MK)	AR	Fanconi anemia, complementation group C	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23028338|22701786|22160080|20301575|10431244|9272737|1574115	FC59;FH44;H68;HBO28;MC58;MH43	2176	FANCC	IC11	IVS12	.	.	no-change	NM_000136.2	NP_000127.2	-	Y	c.1155-38T=	.	.	.	NM_000136.2(FANCC): c.1155-38T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125696	0.523493	U	0.6339	0.541334	13006	0.536214	PASS	.	8594	0.379916	17096	120688	0.526183	.	.	.	.	.	.	rs4647534	.	4024	0.375000	-0.733	-1.606	-1.368	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	97873956	97873957	9q22.32	0	normal	.	A	snv	G	CT.AA	het-ref	187	0.53	.	2	.	PASS	613899	C	227645(MK)	AR	Fanconi anemia, complementation group C	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23028338|22701786|22160080|20301575|10431244|9272737|1574115	FC59;FH44;H68;HBO28;MC58;MH43	2176	FANCC	IC11	IVS12	.	.	intron	NM_000136.2	NP_000127.2	-	Y	c.1155-38T>C	.	.	.	NM_000136.2(FANCC): c.1155-38T>C	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125696	0.476507	U	0.6339	0.541334	13006	0.463786	PASS	1665	8594	0.620084	13936	120688	0.473817	3390	10749	6.24506e-01	28309	115676	4.72954e-01	rs4647534	.	4024	0.625000	-0.733	-1.606	-1.368	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	255273	criteria_provided,_single_submitter	Benign	Benign
9	98209155	98209156	9q22.32	0	normal	.	T	ref	T	GC.CT	het-alt	146	0.49	.	1	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	I3U1	IVS23	.	.	no-change	NM_000264.3	NP_000255.2	-	Y	c.*1+37A=	.	.	.	NM_000264.3(PTCH1): c.*1+37A=	;maf-5-some-pop	126048	0.979087	U	0.1181	0.0295527	13006	0.999077	PASS	-465	8632	0.874652	58142	121040	0.979445	.	.	.	.	.	.	rs56237839	.	4024	0.861300	0.260	0.456	0.437	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	98209155	98209156	9q22.32	0	normal	.	T	ref	T	GC.CT	het-alt	146	0.49	.	1	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	I3U1	IVS23	.	.	no-change	NM_001083602.1	NP_001077071.1	-	N	c.*1+37A=	.	.	.	NM_001083602.1(PTCH1): c.*1+37A=	;maf-5-some-pop	126048	0.979087	U	0.1181	0.0295527	13006	0.999077	PASS	-465	8632	0.874652	58142	121040	0.979445	.	.	.	.	.	.	rs56237839	.	4024	0.861300	0.260	0.456	0.437	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	98209155	98209156	9q22.32	0	normal	.	T	snv	C	GC.CT	het-ref	150	0.51	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	I3U1	IVS23	.	.	intron	NM_000264.3	NP_000255.2	-	Y	c.*1+37A>G	.	.	.	NM_000264.3(PTCH1): c.*1+37A>G	;maf-5-some-pop	126048	0.020913	U	0.1181	0.0295527	13006	0.000923	PASS	76	8632	0.125348	110	121040	0.020555	121	2025	1.17459e-01	206	5431	2.22214e-02	rs56237839	.	4024	0.138700	0.260	0.456	0.437	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	98209155	98209156	9q22.32	0	normal	.	T	snv	C	GC.CT	het-ref	150	0.51	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	I3U1	IVS23	.	.	intron	NM_001083602.1	NP_001077071.1	-	N	c.*1+37A>G	.	.	.	NM_001083602.1(PTCH1): c.*1+37A>G	;maf-5-some-pop	126048	0.020913	U	0.1181	0.0295527	13006	0.000923	PASS	76	8632	0.125348	110	121040	0.020555	121	2025	1.17459e-01	206	5431	2.22214e-02	rs56237839	.	4024	0.138700	0.260	0.456	0.437	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	98209593	98209594	9q22.32	0	normal	.	G	ref	G	AG.GG	het-alt	234	0.41	.	1	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	C23E	EX23	.	.	no-change	NM_000264.3	NP_000255.2	-	Y	c.3944C=	.	.	.	NM_000264.3(PTCH1): c.3944C=	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	121042	0.614060	U	0.5863	0.396765	12568	0.700748	PASS	-1028	8498	0.433278	22415	116034	0.614527	.	.	.	.	.	.	rs357564	.	4024	0.451300	0.655	5.147	2.506	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	98209593	98209594	9q22.32	0	normal	.	G	ref	G	AG.GG	het-alt	234	0.41	.	1	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	C23E	EX23	.	.	no-change	NM_001083602.1	NP_001077071.1	-	N	c.3746C=	.	.	.	NM_001083602.1(PTCH1): c.3746C=	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	121042	0.614060	U	0.5863	0.396765	12568	0.700748	PASS	-1028	8498	0.433278	22415	116034	0.614527	.	.	.	.	.	.	rs357564	.	4024	0.451300	0.655	5.147	2.506	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	98209593	98209594	9q22.32	1	normal	.	G	snv	A	AG.GG	het-ref	342	0.59	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	C23E	EX23	.	.	missense	NM_000264.3	NP_000255.2	-	Y	c.3944C>T	p.P1315L | p.Pro1315Leu	CCC=>CTC	NP=>NP	NM_000264.3(PTCH1): c.3944C>T (p.P1315L)	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	121042	0.385932	U	0.5863	0.396765	12568	0.299252	PASS	1380	8498	0.566722	9126	116034	0.385465	2725	9657	5.63682e-01	19289	94062	3.88850e-01	rs357564	.	4024	0.548700	0.655	5.147	2.506	0.02	0.642	0.994	0.608	deleterious	ENST00000331920: c.3944C>T (p.P1315L)	bone [fibula|NS|NS]	chondrosarcoma [central|NS|NS]	CSV	1638394	.	.	.	.	.	no_record	41663	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
9	98209593	98209594	9q22.32	1	normal	.	G	snv	A	AG.GG	het-ref	342	0.59	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	C23E	EX23	.	.	missense	NM_001083602.1	NP_001077071.1	-	N	c.3746C>T	p.P1249L | p.Pro1249Leu	CCC=>CTC	NP=>NP	NM_001083602.1(PTCH1): c.3746C>T (p.P1249L)	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	121042	0.385932	U	0.5863	0.396765	12568	0.299252	PASS	1380	8498	0.566722	9126	116034	0.385465	2725	9657	5.63682e-01	19289	94062	3.88850e-01	rs357564	.	4024	0.548700	0.655	5.147	2.506	0.02	0.804	0.993	0.685	deleterious	ENST00000331920: c.3944C>T (p.P1315L)	bone [fibula|NS|NS]	chondrosarcoma [central|NS|NS]	CSV	1638394	.	.	.	.	.	no_record	41663	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
9	98211571	98211572	9q22.32	0	normal	.	T	ref	T	TG.GG	het-alt	347	0.52	.	1	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	C22	EX22	.	.	no-change	NM_000264.3	NP_000255.2	-	Y	c.3583A=	.	.	.	NM_000264.3(PTCH1): c.3583A=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	28304	0.941210	U	0.1419	0.0784744	12868	0.958269	PASS	-84	1088	0.823529	10428	23296	0.945441	.	.	.	.	.	.	rs2236405	.	4024	0.867000	0.459	2.171	2.224	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	98211571	98211572	9q22.32	0	normal	.	T	ref	T	TG.GG	het-alt	347	0.52	.	1	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	C22	EX22	.	.	no-change	NM_001083602.1	NP_001077071.1	-	N	c.3385A=	.	.	.	NM_001083602.1(PTCH1): c.3385A=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	28304	0.941210	U	0.1419	0.0784744	12868	0.958269	PASS	-84	1088	0.823529	10428	23296	0.945441	.	.	.	.	.	.	rs2236405	.	4024	0.867000	0.459	2.171	2.224	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	98211571	98211572	9q22.32	1	normal	.	T	snv	A	TG.GG	het-ref	319	0.48	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	C22	EX22	.	.	missense	NM_000264.3	NP_000255.2	-	Y	c.3583A>T	p.T1195S | p.Thr1195Ser	ACA=>TCA	P0=>P0	NM_000264.3(PTCH1): c.3583A>T (p.T1195S)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	28304	0.058790	U	0.1419	0.0784744	12868	0.041731	PASS	12	1088	0.176471	51	23296	0.054559	92	1445	1.30675e-01	212	5218	3.35774e-02	rs2236405	.	4024	0.133000	0.459	2.171	2.224	0.36	0.002	0.012	0.020	neutral	ENST00000331920: c.3583A>T (p.T1195S)	large_intestine [colon|ascending|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1463812	CM032347	NM_000264.3(PTCH1): c.3583A>T (p.T1195S)	Nevoid basal cell carcinoma syndrome	12925203	DM	no_record	135100	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
9	98211571	98211572	9q22.32	1	normal	.	T	snv	A	TG.GG	het-ref	319	0.48	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	C22	EX22	.	.	missense	NM_001083602.1	NP_001077071.1	-	N	c.3385A>T	p.T1129S | p.Thr1129Ser	ACA=>TCA	P0=>P0	NM_001083602.1(PTCH1): c.3385A>T (p.T1129S)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	28304	0.058790	U	0.1419	0.0784744	12868	0.041731	PASS	12	1088	0.176471	51	23296	0.054559	92	1445	1.30675e-01	212	5218	3.35774e-02	rs2236405	.	4024	0.133000	0.459	2.171	2.224	0.32	0.085	0.291	0.030	neutral	ENST00000331920: c.3583A>T (p.T1195S)	large_intestine [colon|ascending|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1463812	.	.	.	.	.	no_record	135100	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
9	98215967	98215968	9q22.32	0	normal	.	C	ref	C	GT.CT	het-alt	156	0.49	.	1	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC19	IVS19	.	.	no-change	NM_000264.3	NP_000255.2	-	Y	c.3307-66G=	.	.	.	NM_000264.3(PTCH1): c.3307-66G=	;maf-5-some-pop	5008	0.921725	U	0.1409	0.0782748	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2274690	.	4024	0.866100	-0.797	0.317	0.163	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	98215967	98215968	9q22.32	0	normal	.	C	ref	C	GT.CT	het-alt	156	0.49	.	1	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC19	IVS19	.	.	no-change	NM_001083602.1	NP_001077071.1	-	N	c.3109-66G=	.	.	.	NM_001083602.1(PTCH1): c.3109-66G=	;maf-5-some-pop	5008	0.921725	U	0.1409	0.0782748	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2274690	.	4024	0.866100	-0.797	0.317	0.163	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	98215967	98215968	9q22.32	0	normal	.	C	snv	G	GT.CT	het-ref	164	0.51	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC19	IVS19	.	.	intron	NM_000264.3	NP_000255.2	-	Y	c.3307-66G>C	.	.	.	NM_000264.3(PTCH1): c.3307-66G>C	;maf-5-some-pop	5008	0.078275	U	0.1409	0.0782748	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2274690	.	4024	0.133900	-0.797	0.317	0.163	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	98215967	98215968	9q22.32	0	normal	.	C	snv	G	GT.CT	het-ref	164	0.51	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC19	IVS19	.	.	intron	NM_001083602.1	NP_001077071.1	-	N	c.3109-66G>C	.	.	.	NM_001083602.1(PTCH1): c.3109-66G>C	;maf-5-some-pop	5008	0.078275	U	0.1409	0.0782748	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2274690	.	4024	0.133900	-0.797	0.317	0.163	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	98218473	98218474	9q22.32	0	normal	.	G	ref	G	AT.CA	het-alt	107	0.41	.	1	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC19	IVS19	.	.	no-change	NM_000264.3	NP_000255.2	-	Y	c.3306+84C=	.	.	.	NM_000264.3(PTCH1): c.3306+84C=	.	.	.	.	0.3433	0.409345	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-1.193	-2.946	-2.904	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	98218473	98218474	9q22.32	0	normal	.	G	ref	G	AT.CA	het-alt	107	0.41	.	1	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC19	IVS19	.	.	no-change	NM_001083602.1	NP_001077071.1	-	N	c.3108+84C=	.	.	.	NM_001083602.1(PTCH1): c.3108+84C=	.	.	.	.	0.3433	0.409345	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-1.193	-2.946	-2.904	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	98218474	98218474	9q22.32	0	normal	.	.	ins	C	TG.CA	het-ref	151	0.59	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC19	IVS19	.	.	intron	NM_000264.3	NP_000255.2	-	Y	c.3306+83_3306+84insG	.	.	.	NM_000264.3(PTCH1): c.3306+83_3306+84insG	;maf-5-some-pop,maf-5-all-pops	5008	0.409345	U	0.3433	0.409345	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs531236471	.	4024	0.365100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	98218474	98218474	9q22.32	0	normal	.	.	ins	C	TG.CA	het-ref	151	0.59	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC19	IVS19	.	.	intron	NM_001083602.1	NP_001077071.1	-	N	c.3108+83_3108+84insG	.	.	.	NM_001083602.1(PTCH1): c.3108+83_3108+84insG	;maf-5-some-pop,maf-5-all-pops	5008	0.409345	U	0.3433	0.409345	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs531236471	.	4024	0.365100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	98220321	98220322	9q22.32	0	normal	.	A	ref	A	AG.AG	het-alt	316	0.53	.	1	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	C18	EX18	Patched family	PF02460.13	no-change	NM_000264.3	NP_000255.2	-	Y	c.3141T=	.	.	.	NM_000264.3(PTCH1): c.3141T=	SingleClassTriAllelic;maf-5-some-pop	125866	0.974314	U	0.1101	0.067492	13006	0.964170	PASS	-385	8626	0.900533	57670	120858	0.976046	.	.	.	.	.	.	rs2066835	.	4024	0.906800	0.533	-0.097	-0.441	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	98220321	98220322	9q22.32	0	normal	.	A	ref	A	AG.AG	het-alt	316	0.53	.	1	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	C18	EX18	Patched family	PF02460.13	no-change	NM_001083602.1	NP_001077071.1	-	N	c.2943T=	.	.	.	NM_001083602.1(PTCH1): c.2943T=	SingleClassTriAllelic;maf-5-some-pop	125866	0.974314	U	0.1101	0.067492	13006	0.964170	PASS	-385	8626	0.900533	57670	120858	0.976046	.	.	.	.	.	.	rs2066835	.	4024	0.906800	0.533	-0.097	-0.441	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	98220321	98220322	9q22.32	1	normal	.	A	snv	C	AG.AG	het-ref	285	0.47	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	C18	EX18	Patched family	PF02460.13	coding-synon	NM_000264.3	NP_000255.2	-	Y	c.3141T>G	p.(L1047=) | p.(Leu1047=)	CTT=>CTG	.	NM_000264.3(PTCH1): c.3141T>G (p.(L1047=))	SingleClassTriAllelic;maf-5-some-pop	125866	0.025678	U	0.1101	0.067492	13006	0.035830	PASS	44	8626	0.099467	136	120858	0.023945	81	1719	9.96868e-02	231	5157	2.09627e-02	rs2066835	.	4024	0.093200	0.533	-0.097	-0.441	.	.	.	.	.	ENST00000331920: c.3141T>G (p.L1047L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4419987	.	.	.	.	.	no_record	255681	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
9	98220321	98220322	9q22.32	1	normal	.	A	snv	C	AG.AG	het-ref	285	0.47	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	C18	EX18	Patched family	PF02460.13	coding-synon	NM_001083602.1	NP_001077071.1	-	N	c.2943T>G	p.(L981=) | p.(Leu981=)	CTT=>CTG	.	NM_001083602.1(PTCH1): c.2943T>G (p.(L981=))	SingleClassTriAllelic;maf-5-some-pop	125866	0.025678	U	0.1101	0.067492	13006	0.035830	PASS	44	8626	0.099467	136	120858	0.023945	81	1719	9.96868e-02	231	5157	2.09627e-02	rs2066835	.	4024	0.093200	0.533	-0.097	-0.441	.	.	.	.	.	ENST00000331920: c.3141T>G (p.L1047L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4419987	.	.	.	.	.	no_record	255681	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
9	98221860	98221861	9q22.32	0	normal	.	T	ref	T	CC.CC	het-alt	153	0.57	.	1	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC17	IVS17	.	.	no-change	NM_000264.3	NP_000255.2	-	Y	c.2887+21A=	.	.	.	NM_000264.3(PTCH1): c.2887+21A=	MixedObserved;maf-5-some-pop,maf-5-all-pops|MixedObserved;	126148|121208	0.642261|0.999992	U	0.3433	0.392572	13006	0.544057	PASS	-972	8622	0.652981	25926	121140	0.643702	.	.	.	.	.	.	rs2236406|rs750412889	.	4024	0.634700	-1.302	-0.411	-0.198	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	98221860	98221861	9q22.32	0	normal	.	T	ref	T	CC.CC	het-alt	153	0.57	.	1	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC17	IVS17	.	.	no-change	NM_001083602.1	NP_001077071.1	-	N	c.2689+21A=	.	.	.	NM_001083602.1(PTCH1): c.2689+21A=	MixedObserved;maf-5-some-pop,maf-5-all-pops|MixedObserved;	126148|121208	0.642261|0.999992	U	0.3433	0.392572	13006	0.544057	PASS	-972	8622	0.652981	25926	121140	0.643702	.	.	.	.	.	.	rs2236406|rs750412889	.	4024	0.634700	-1.302	-0.411	-0.198	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	98221860	98221861	9q22.32	0	normal	.	T	snv	C	CC.CC	het-ref	115	0.43	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC17	IVS17	.	.	intron	NM_000264.3	NP_000255.2	-	Y	c.2887+21A>G	.	.	.	NM_000264.3(PTCH1): c.2887+21A>G	MixedObserved;maf-5-some-pop,maf-5-all-pops	126148	0.357739	U	0.3433	0.392572	13006	0.455943	PASS	524	8622	0.347019	8518	121140	0.356298	1058	6043	3.50644e-01	16079	84563	3.43869e-01	rs2236406	.	4024	0.365300	-1.302	-0.411	-0.198	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	255678	criteria_provided,_single_submitter	Benign	Benign
9	98221860	98221861	9q22.32	0	normal	.	T	snv	C	CC.CC	het-ref	115	0.43	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC17	IVS17	.	.	intron	NM_001083602.1	NP_001077071.1	-	N	c.2689+21A>G	.	.	.	NM_001083602.1(PTCH1): c.2689+21A>G	MixedObserved;maf-5-some-pop,maf-5-all-pops	126148	0.357739	U	0.3433	0.392572	13006	0.455943	PASS	524	8622	0.347019	8518	121140	0.356298	1058	6043	3.50644e-01	16079	84563	3.43869e-01	rs2236406	.	4024	0.365300	-1.302	-0.411	-0.198	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	255678	criteria_provided,_single_submitter	Benign	Benign
9	98224359	98224360	9q22.32	0	normal	.	C	ref	C	GA.TG	het-alt	117	0.54	.	1	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC15	IVS15	.	.	no-change	NM_000264.3	NP_000255.2	-	Y	c.2561-80G=	.	.	.	NM_000264.3(PTCH1): c.2561-80G=	;maf-5-some-pop,maf-5-all-pops	5008	0.598642	U	0.3433	0.401358	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2274692	.	4024	0.633700	-0.978	-0.412	-0.283	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	98224359	98224360	9q22.32	0	normal	.	C	ref	C	GA.TG	het-alt	117	0.54	.	1	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC15	IVS15	.	.	no-change	NM_001083602.1	NP_001077071.1	-	N	c.2363-80G=	.	.	.	NM_001083602.1(PTCH1): c.2363-80G=	;maf-5-some-pop,maf-5-all-pops	5008	0.598642	U	0.3433	0.401358	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2274692	.	4024	0.633700	-0.978	-0.412	-0.283	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	98224359	98224360	9q22.32	0	normal	.	C	snv	G	GA.TG	het-ref	101	0.46	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC15	IVS15	.	.	intron	NM_000264.3	NP_000255.2	-	Y	c.2561-80G>C	.	.	.	NM_000264.3(PTCH1): c.2561-80G>C	;maf-5-some-pop,maf-5-all-pops	5008	0.401358	U	0.3433	0.401358	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2274692	.	4024	0.366300	-0.978	-0.412	-0.283	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	98224359	98224360	9q22.32	0	normal	.	C	snv	G	GA.TG	het-ref	101	0.46	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC15	IVS15	.	.	intron	NM_001083602.1	NP_001077071.1	-	N	c.2363-80G>C	.	.	.	NM_001083602.1(PTCH1): c.2363-80G>C	;maf-5-some-pop,maf-5-all-pops	5008	0.401358	U	0.3433	0.401358	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2274692	.	4024	0.366300	-0.978	-0.412	-0.283	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	98229388	98229389	9q22.32	0	normal	.	C	ref	C	CG.CG	het-alt	259	0.54	.	1	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC15	IVS15	.	.	no-change	NM_000264.3	NP_000255.2	-	Y	c.2560+9G=	.	.	.	NM_000264.3(PTCH1): c.2560+9G=	MixedObserved;maf-5-some-pop,maf-5-all-pops	125894	0.640420	U	0.3383	0.390575	13006	0.546056	PASS	.	8550	0.658596	25621	120886	0.641704	.	.	.	.	.	.	rs2066829	.	4024	0.642600	-0.187	-0.361	-0.278	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	98229388	98229389	9q22.32	0	normal	.	C	ref	C	CG.CG	het-alt	259	0.54	.	1	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC15	IVS15	.	.	no-change	NM_001083602.1	NP_001077071.1	-	N	c.2362+9G=	.	.	.	NM_001083602.1(PTCH1): c.2362+9G=	MixedObserved;maf-5-some-pop,maf-5-all-pops	125894	0.640420	U	0.3383	0.390575	13006	0.546056	PASS	.	8550	0.658596	25621	120886	0.641704	.	.	.	.	.	.	rs2066829	.	4024	0.642600	-0.187	-0.361	-0.278	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	98229388	98229389	9q22.32	1	normal	.	C	snv	G	CG.CG	het-ref	225	0.46	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC15	IVS15	.	.	intron	NM_000264.3	NP_000255.2	-	Y	c.2560+9G>C	.	.	.	NM_000264.3(PTCH1): c.2560+9G>C	MixedObserved;maf-5-some-pop,maf-5-all-pops	125894	0.359580	U	0.3383	0.390575	13006	0.453944	PASS	496	8550	0.341404	8491	120886	0.358296	1045	5967	3.46677e-01	16169	85078	3.46440e-01	rs2066829	.	4024	0.357400	-0.187	-0.361	-0.278	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	255677	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
9	98229388	98229389	9q22.32	1	normal	.	C	snv	G	CG.CG	het-ref	225	0.46	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC15	IVS15	.	.	intron	NM_001083602.1	NP_001077071.1	-	N	c.2362+9G>C	.	.	.	NM_001083602.1(PTCH1): c.2362+9G>C	MixedObserved;maf-5-some-pop,maf-5-all-pops	125894	0.359580	U	0.3383	0.390575	13006	0.453944	PASS	496	8550	0.341404	8491	120886	0.358296	1045	5967	3.46677e-01	16169	85078	3.46440e-01	rs2066829	.	4024	0.357400	-0.187	-0.361	-0.278	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	255677	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
9	98239146	98239147	9q22.32	0	normal	.	A	ref	A	GC.AA	het-alt	168	0.51	.	1	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC10	IVS10	.	.	no-change	NM_000264.3	NP_000255.2	-	Y	c.1504-8T=	.	.	.	NM_000264.3(PTCH1): c.1504-8T=	;maf-5-some-pop,genotype-conflict	115884	0.949890	U	0.1429	0.105032	13006	0.926188	PASS	.	7850	0.848790	50486	110876	0.952370	.	.	.	.	.	.	rs2277184	.	4024	0.862800	-0.417	-0.091	-0.539	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	98239146	98239147	9q22.32	0	normal	.	A	ref	A	GC.AA	het-alt	168	0.51	.	1	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC10	IVS10	.	.	no-change	NM_001083602.1	NP_001077071.1	-	N	c.1306-8T=	.	.	.	NM_001083602.1(PTCH1): c.1306-8T=	;maf-5-some-pop,genotype-conflict	115884	0.949890	U	0.1429	0.105032	13006	0.926188	PASS	.	7850	0.848790	50486	110876	0.952370	.	.	.	.	.	.	rs2277184	.	4024	0.862800	-0.417	-0.091	-0.539	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	98239146	98239147	9q22.32	1	normal	.	A	snv	G	GC.AA	het-ref	162	0.49	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC10	IVS10	.	.	intron	NM_000264.3	NP_000255.2	-	Y	c.1504-8T>C	.	.	.	NM_000264.3(PTCH1): c.1504-8T>C	;maf-5-some-pop,genotype-conflict	115884	0.050110	U	0.1429	0.105032	13006	0.073812	PASS	85	7850	0.151210	329	110876	0.047630	166	2372	1.38406e-01	565	9766	3.99248e-02	rs2277184	.	4024	0.137200	-0.417	-0.091	-0.539	.	.	.	.	.	ENST00000331920: c.1504-8T>C (p.?)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	17610	.	.	.	.	.	no_record	255669	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
9	98239146	98239147	9q22.32	1	normal	.	A	snv	G	GC.AA	het-ref	162	0.49	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC10	IVS10	.	.	intron	NM_001083602.1	NP_001077071.1	-	N	c.1306-8T>C	.	.	.	NM_001083602.1(PTCH1): c.1306-8T>C	;maf-5-some-pop,genotype-conflict	115884	0.050110	U	0.1429	0.105032	13006	0.073812	PASS	85	7850	0.151210	329	110876	0.047630	166	2372	1.38406e-01	565	9766	3.99248e-02	rs2277184	.	4024	0.137200	-0.417	-0.091	-0.539	.	.	.	.	.	ENST00000331920: c.1504-8T>C (p.?)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	17610	.	.	.	.	.	no_record	255669	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
9	98278643	98278644	9q22.32	0	normal	.	C	snv	A	CT.CG	het-ref	103	0.55	.	2	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC1	IVS1	.	.	intron	NM_001083602.1	NP_001077071.1	-	Y	c.3+107G>T	.	.	.	NM_001083602.1(PTCH1): c.3+107G>T	;maf-5-some-pop,maf-5-all-pops	5008	0.324481	U	0.3026	0.324481	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs28591501	.	4020	0.325900	0.297	0.322	0.130	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	98278643	98278644	9q22.32	0	normal	.	C	ref	C	CT.CG	het-alt	84	0.45	.	1	.	PASS	601309	C	109400(MK);605462(MK);610828(MK)	AD	Basal cell nevus syndrome	AD	Variants may also be associated with Holoprosencephaly (AD), though evidence for pathogenicity is mixed (individuals with holoprosencephaly can manifest with endocrine anomalies such as diabetes insipidus, but the efficacy of early diagnosis is unclear)	Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Oncologic	23677114|22844361|22670904|22670903|22565648|22007994|21368767|19557015|19439922|16906569|13851319|11941477|11382639|9096762|9096761|8981943|8326488	GO2	5727	PTCH1	IC1	IVS1	.	.	no-change	NM_001083602.1	NP_001077071.1	-	Y	c.3+107G=	.	.	.	NM_001083602.1(PTCH1): c.3+107G=	;maf-5-some-pop,maf-5-all-pops	5008	0.675519	U	0.3026	0.324481	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs28591501	.	4020	0.674100	0.297	0.322	0.130	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	101585530	101585531	9q22.33	0	normal	.	T	ref	T	TA.TT	het-alt	248	0.54	.	1	.	PASS	610290	P	608812(SK)	NN	Colorectal cancer, susceptibility to, 1	AD	.	Oncologic	Oncologic	22461326|19617566	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	79695	GALNT12	IC1	IVS1	.	.	no-change	NM_024642.4	NP_078918.3	+	Y	c.372-7T=	.	.	.	NM_024642.4(GALNT12): c.372-7T=	;maf-5-some-pop	126374	0.993060	U	0.0685	0.0155751	13006	0.999539	PASS	-311	8646	0.920194	59918	121366	0.993417	.	.	.	.	.	.	rs2295923	.	4024	0.908300	0.533	0.823	2.005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	101585530	101585531	9q22.33	1	normal	.	T	snv	A	TA.TT	het-ref	208	0.46	.	2	.	PASS	610290	P	608812(SK)	NN	Colorectal cancer, susceptibility to, 1	AD	.	Oncologic	Oncologic	22461326|19617566	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	79695	GALNT12	IC1	IVS1	.	.	intron	NM_024642.4	NP_078918.3	+	Y	c.372-7T>A	.	.	.	NM_024642.4(GALNT12): c.372-7T>A	;maf-5-some-pop	126374	0.006940	U	0.0685	0.0155751	13006	0.000461	PASS	34	8646	0.079806	34	121366	0.006583	66	1387	8.04151e-02	66	1668	6.77371e-03	rs2295923	.	4024	0.091700	0.533	0.823	2.005	.	.	.	.	.	ENST00000375011: c.372-7T>A (p.?)	stomach [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	VUO	150648	.	.	.	.	.	no_record	416211	criteria_provided,_single_submitter	Benign	Benign
9	101589210	101589211	9q22.33	0	normal	.	C	ref	C	GC.GC	het-alt	242	0.50	.	1	.	PASS	610290	P	608812(SK)	NN	Colorectal cancer, susceptibility to, 1	AD	.	Oncologic	Oncologic	22461326|19617566	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	79695	GALNT12	C3	EX3	Glycosyl transferase family 2;Glycosyltransferase like family 2;Glycosyltransferase like family 2	PF00535.21;PF10111.4;PF13641.1	no-change	NM_024642.4	NP_078918.3	+	Y	c.719C=	.	.	.	NM_024642.4(GALNT12): c.719C=	;	31320	0.999202	U	0.0109	0.00219649	.	.	PASS	.	1200	0.990833	13142	26312	0.999468	.	.	.	.	.	.	rs59362219	.	4024	0.989800	0.655	5.721	2.757	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	101589210	101589211	9q22.33	1	normal	.	C	snv	T	GC.GC	het-ref	245	0.50	.	2	.	PASS	610290	P	608812(SK)	NN	Colorectal cancer, susceptibility to, 1	AD	.	Oncologic	Oncologic	22461326|19617566	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	79695	GALNT12	C3	EX3	Glycosyl transferase family 2;Glycosyltransferase like family 2;Glycosyltransferase like family 2	PF00535.21;PF10111.4;PF13641.1	missense	NM_024642.4	NP_078918.3	+	Y	c.719C>T	p.P240L | p.Pro240Leu	CCG=>CTG	NP=>NP	NM_024642.4(GALNT12): c.719C>T (p.P240L)	;	31320	0.000798	U	0.0109	0.00219649	.	.	PASS	0	1200	0.009167	0	26312	0.000532	1	83	7.32827e-03	1	88	5.46312e-04	rs59362219	.	4024	0.010200	0.655	5.721	2.757	0	0.927	0.999	0.820	deleterious	.	.	.	.	.	.	.	.	.	.	no_record	410589	criteria_provided,_multiple_submitters,_no_conflicts	Uncertain_significance	VUS
9	101611334	101611335	9q22.33	0	nullSample	.	G	ref	G	TC.GA	homo-ref	.	.	.	0	.	.	610290	P	608812(SK)	NN	Colorectal cancer, susceptibility to, 1	AD	.	Oncologic	Oncologic	22461326|19617566	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	79695	GALNT12	C10E	EX10E	Ricin-type beta-trefoil lectin domain	PF00652.17	no-change	NM_024642.4	NP_078918.3	+	Y	c.1707G=	.	.	.	NM_024642.4(GALNT12): c.1707G=	SingleClassTriAllelic;maf-5-some-pop	126392	0.909520	U	0	0.000399361	13006	0.916808	PASS	.	8642	0.719394	50684	121384	0.911644	.	.	.	.	.	.	rs2273846	.	4024	0.707000	-1.202	-2.662	-2.515	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	101611334	101611335	9q22.33	1	normal	.	G	snv	C	TC.GA	hom-alt	566	1.00	.	0	.	PASS	610290	P	608812(SK)	NN	Colorectal cancer, susceptibility to, 1	AD	.	Oncologic	Oncologic	22461326|19617566	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	79695	GALNT12	C10E	EX10E	Ricin-type beta-trefoil lectin domain	PF00652.17	coding-synon	NM_024642.4	NP_078918.3	+	Y	c.1707G>C	p.(S569=) | p.(Ser569=)	TCG=>TCC	.	NM_024642.4(GALNT12): c.1707G>C (p.(S569=))	SingleClassTriAllelic;maf-5-some-pop	126392	0.090370	U	0.2391	0.141573	13006	0.083192	PASS	321	8642	0.280606	715	121384	0.088257	685	4846	2.80993e-01	1379	21200	8.61110e-02	rs2273846	.	4024	0.293000	-1.202	-2.662	-2.515	.	.	.	.	.	ENST00000375011: c.1707G>C (p.S569S)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3763482	.	.	.	.	.	no_record	485634	criteria_provided,_single_submitter	Benign	Likely Benign
9	101900409	101900410	9q22.33	0	normal	.	A	ref	A	CA.GA	het-alt	145	0.52	.	1	.	PASS	190181	C	132800(SK);609192(MK)	AD	Loeys-Dietz syndrome, type 1A; Loeys-Dietz syndrome, type 2A	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Obstetric	Cardiovascular; Obstetric	21358634|20301312|19542084|16928994|15731757|5173258|3565476	.	7046	TGFBR1	IC4	IVS4	.	.	no-change	NM_004612.2	NP_004603.1	+	Y	c.805+39A=	.	.	.	NM_004612.2(TGFBR1): c.805+39A=	;maf-5-some-pop	122166	0.935661	U	0.4097	0.125599	13006	0.996848	PASS	.	8246	0.572520	52302	117158	0.938280	.	.	.	.	.	.	rs11568778	.	4024	0.585700	0.460	0.440	0.470	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	101900409	101900410	9q22.33	0	normal	.	A	snv	G	CA.GA	het-ref	132	0.48	.	2	.	PASS	190181	C	132800(SK);609192(MK)	AD	Loeys-Dietz syndrome, type 1A; Loeys-Dietz syndrome, type 2A	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Obstetric	Cardiovascular; Obstetric	21358634|20301312|19542084|16928994|15731757|5173258|3565476	.	7046	TGFBR1	IC4	IVS4	.	.	intron	NM_004612.2	NP_004603.1	+	Y	c.805+39A>G	.	.	.	NM_004612.2(TGFBR1): c.805+39A>G	;maf-5-some-pop	122166	0.064339	U	0.4097	0.125599	13006	0.003152	PASS	726	8246	0.427480	954	117158	0.061720	1542	7286	4.29295e-01	2092	15829	6.54534e-02	rs11568778	.	4024	0.414300	0.460	0.440	0.470	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	259453	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
9	101908914	101908915	9q22.33	0	normal	.	G	ref	G	CA.TA	het-alt	263	0.52	.	1	.	PASS	190181	C	132800(SK);609192(MK)	AD	Loeys-Dietz syndrome, type 1A; Loeys-Dietz syndrome, type 2A	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Obstetric	Cardiovascular; Obstetric	21358634|20301312|19542084|16928994|15731757|5173258|3565476	.	7046	TGFBR1	IC7	IVS7	.	.	no-change	NM_004612.2	NP_004603.1	+	Y	c.1255+24G=	.	.	.	NM_004612.2(TGFBR1): c.1255+24G=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126372	0.778622	U	0.4296	0.269968	13006	0.782254	PASS	.	8636	0.560560	37240	121364	0.780627	.	.	.	.	.	.	rs334354	.	4024	0.581800	-1.901	-0.853	-1.149	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	101908914	101908915	9q22.33	0	normal	.	G	snv	A	CA.TA	het-ref	242	0.48	.	2	.	PASS	190181	C	132800(SK);609192(MK)	AD	Loeys-Dietz syndrome, type 1A; Loeys-Dietz syndrome, type 2A	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Obstetric	Cardiovascular; Obstetric	21358634|20301312|19542084|16928994|15731757|5173258|3565476	.	7046	TGFBR1	IC7	IVS7	.	.	intron	NM_004612.2	NP_004603.1	+	Y	c.1255+24G>A	.	.	.	NM_004612.2(TGFBR1): c.1255+24G>A	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126372	0.221378	U	0.4296	0.269968	13006	0.217746	PASS	823	8636	0.439440	3182	121364	0.219373	1676	7629	4.42826e-01	6519	53914	2.19400e-01	rs334354	.	4024	0.418200	-1.901	-0.853	-1.149	.	.	.	.	.	.	.	.	.	.	CS045221	NM_004612.2(TGFBR1): c.1255+24G>A	"Cancer, risk, association with ?"	15382067	DP	no_record	259451	criteria_provided,_single_submitter	Benign	Benign
9	116356372	116356373	9q32	0	nullSample	.	G	ref	G	CT.TC	homo-ref	.	.	.	0	.	.	602189	P	.	NN	.	.	.	.	.	.	.	5998	RGS3	IC21	IVS22	.	.	no-change	NM_144488.4	NP_652759.3	+	Y	c.3081-337G=	.	.	.	NM_144488.4(RGS3): c.3081-337G=	SingleClassTriAllelic;maf-5-some-pop	125514	0.274941	U	0.879	0.742212	13000	0.316692	PASS	.	8632	0.128707	4887	120506	0.275654	.	.	.	.	.	.	rs12350531	.	4024	0.139400	0.650	2.084	1.294	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	116356372	116356373	9q32	0	normal	.	G	snv	C	CT.TC	hom-alt	403	1.00	.	0	.	PASS	602189	P	.	NN	.	.	.	.	.	.	.	5998	RGS3	IC21	IVS22	.	.	intron	NM_144488.4	NP_652759.3	+	Y	c.3081-337G>C	.	.	.	NM_144488.4(RGS3): c.3081-337G>C	SingleClassTriAllelic;maf-5-some-pop	125514	0.724963	U	0.879	0.742212	13000	0.683308	PASS	3283	8632	0.871293	31913	120506	0.724246	6564	15033	8.72186e-01	66243	179396	7.30702e-01	rs12350531	.	4024	0.860600	0.650	2.084	1.294	.	.	.	.	.	ENST00000462403: c.174G>C (p.L58L)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	455194	.	.	.	.	.	.	.	.	.	Benign
9	125424506	125424507	9q33.2	0	normal	.	A	ref	A	TC.AA	het-alt	254	0.52	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.125424506A= (intergenic)	;maf-5-some-pop	126380	0.691739	U	0.5089	0.44988	13006	0.647317	PASS	.	8622	0.483531	31076	121372	0.697583	.	.	.	.	.	.	rs70156	.	.	.	-0.648	-0.276	-0.815	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	125424506	125424507	9q33.2	0	normal	.	A	snv	C	TC.AA	het-ref	236	0.48	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr9: g.125424506A>C (intergenic)	;maf-5-some-pop	126380	0.308261	U	0.5089	0.44988	13006	0.352683	PASS	1170	8622	0.516469	7095	121372	0.302417	2235	8808	5.10727e-01	13468	73377	2.98285e-01	rs70156	.	.	.	-0.648	-0.276	-0.815	.	.	.	.	.	ENST00000373686: c.663A>C (p.S221S)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3763606	.	.	.	.	.	.	.	.	.	Benign
9	133710803	133710804	9q34.12	0	nullSample	.	T	ref	T	GG.TC	homo-ref	.	.	.	0	.	.	189980	C	189980(MK)	NN	.	.	.	.	.	.	.	25	ABL1	PROM	.	.	.	no-change	NM_005157.4	NP_005148.2	+	N	c.-3-u27T=	.	.	.	NM_005157.4(ABL1): c.-3-u27T=	;	25916	0.006444	U	1	0.996805	12110	0.008092	PASS	0	826	0.000000	0	20908	0.007222	.	.	.	.	.	.	rs7866590	.	.	.	-0.971	-1.210	-1.414	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	133710803	133710804	9q34.12	0	nullSample	.	T	ref	T	GG.TC	homo-ref	.	.	.	0	.	.	189980	C	189980(MK)	NN	.	.	.	.	.	.	.	25	ABL1	IC1	IVS1	.	.	no-change	NM_007313.2	NP_009297.2	+	Y	c.137-18647T=	.	.	.	NM_007313.2(ABL1): c.137-18647T=	;	25916	0.006444	U	1	0.996805	12110	0.008092	PASS	0	826	0.000000	0	20908	0.007222	.	.	.	.	.	.	rs7866590	.	.	.	-0.971	-1.210	-1.414	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	133710803	133710804	9q34.12	0	normal	.	T	snv	C	GG.TC	hom-alt	149	1.00	.	0	.	PASS	189980	C	189980(MK)	NN	.	.	.	.	.	.	.	25	ABL1	PROM	.	.	.	promoter	NM_005157.4	NP_005148.2	+	N	c.-3-u27T>C	.	.	.	NM_005157.4(ABL1): c.-3-u27T>C	;	25916	0.993556	U	1	0.996805	12110	0.991908	PASS	413	826	1.000000	10303	20908	0.992778	5091	10182	1.00000e+00	70845	143006	9.90827e-01	rs7866590	.	.	.	-0.971	-1.210	-1.414	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	133710803	133710804	9q34.12	0	normal	.	T	snv	C	GG.TC	hom-alt	149	1.00	.	0	.	PASS	189980	C	189980(MK)	NN	.	.	.	.	.	.	.	25	ABL1	IC1	IVS1	.	.	intron	NM_007313.2	NP_009297.2	+	Y	c.137-18647T>C	.	.	.	NM_007313.2(ABL1): c.137-18647T>C	;	25916	0.993556	U	1	0.996805	12110	0.991908	PASS	413	826	1.000000	10303	20908	0.992778	5091	10182	1.00000e+00	70845	143006	9.90827e-01	rs7866590	.	.	.	-0.971	-1.210	-1.414	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	133710818	133710819	9q34.12	0	nullSample	.	T	ref	T	CG.GC	homo-ref	.	.	.	0	.	.	189980	C	189980(MK)	NN	.	.	.	.	.	.	.	25	ABL1	PROM	.	.	.	no-change	NM_005157.4	NP_005148.2	+	N	c.-3-u12T=	.	.	.	NM_005157.4(ABL1): c.-3-u12T=	;	0	0	U	1	1	.	.	PASS	0	1676	0.000000	0	25802	0.000039	.	.	.	.	.	.	rs563529313	.	.	.	0.172	-0.519	-0.558	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	133710818	133710819	9q34.12	0	nullSample	.	T	ref	T	CG.GC	homo-ref	.	.	.	0	.	.	189980	C	189980(MK)	NN	.	.	.	.	.	.	.	25	ABL1	IC1	IVS1	.	.	no-change	NM_007313.2	NP_009297.2	+	Y	c.137-18632T=	.	.	.	NM_007313.2(ABL1): c.137-18632T=	;	0	0	U	1	1	.	.	PASS	0	1676	0.000000	0	25802	0.000039	.	.	.	.	.	.	rs563529313	.	.	.	0.172	-0.519	-0.558	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	133710819	133710819	9q34.12	0	normal	.	.	ins	C	GT.GC	hom-alt	204	1.00	.	0	.	PASS	189980	C	189980(MK)	NN	.	.	.	.	.	.	.	25	ABL1	PROM	.	.	.	promoter	NM_005157.4	NP_005148.2	+	N	c.-3-u12_-3-u11insC	.	.	.	NM_005157.4(ABL1): c.-3-u12_-3-u11insC	;	30810	0.999968	U	1	1	.	.	PASS	838	1676	1.000000	12900	25802	0.999961	.	.	.	.	.	.	rs11433463	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	133710819	133710819	9q34.12	0	normal	.	.	ins	C	GT.GC	hom-alt	204	1.00	.	0	.	PASS	189980	C	189980(MK)	NN	.	.	.	.	.	.	.	25	ABL1	IC1	IVS1	.	.	intron	NM_007313.2	NP_009297.2	+	Y	c.137-18632_137-18631insC	.	.	.	NM_007313.2(ABL1): c.137-18632_137-18631insC	;	30810	0.999968	U	1	1	.	.	PASS	838	1676	1.000000	12900	25802	0.999961	.	.	.	.	.	.	rs11433463	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	133761000	133761001	9q34.12	0	nullSample	.	A	ref	A	CC.GC	homo-ref	.	.	.	0	.	.	189980	C	189980(MK)	NN	.	.	.	.	.	.	.	25	ABL1	C11E	EX11E	F-actin binding	PF08919.5	no-change	NM_005157.4	NP_005148.2	+	Y	c.3324A=	.	.	.	NM_005157.4(ABL1): c.3324A=	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	125362	0.446834	U	0.5952	0.654153	13006	0.415116	PASS	-1028	8602	0.402697	12961	120354	0.451036	.	.	.	.	.	.	rs1056171	.	4024	0.406800	-1.204	-1.907	-2.191	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	133761000	133761001	9q34.12	0	nullSample	.	A	ref	A	CC.GC	homo-ref	.	.	.	0	.	.	189980	C	189980(MK)	NN	.	.	.	.	.	.	.	25	ABL1	C11E	EX11E	F-actin binding	PF08919.5	no-change	NM_007313.2	NP_009297.2	+	N	c.3381A=	.	.	.	NM_007313.2(ABL1): c.3381A=	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	125362	0.446834	U	0.5952	0.654153	13006	0.415116	PASS	-1028	8602	0.402697	12961	120354	0.451036	.	.	.	.	.	.	rs1056171	.	4024	0.406800	-1.204	-1.907	-2.191	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	133761000	133761001	9q34.12	1	normal	.	A	snv	G	CC.GC	hom-alt	655	1.00	.	0	.	PASS	189980	C	189980(MK)	NN	.	.	.	.	.	.	.	25	ABL1	C11E	EX11E	F-actin binding	PF08919.5	coding-synon	NM_005157.4	NP_005148.2	+	Y	c.3324A>G	p.(P1108=) | p.(Pro1108=)	CCA=>CCG	.	NM_005157.4(ABL1): c.3324A>G (p.(P1108=))	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	125362	0.553158	U	0.5952	0.654153	13006	0.584884	PASS	1541	8602	0.597303	18853	120354	0.548956	3154	10381	6.02566e-01	38686	134979	5.49531e-01	rs1056171	.	4024	0.593200	-1.204	-1.907	-2.191	.	.	.	.	.	ENST00000372348: c.3381A>G (p.P1127P)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [diffuse_large_B_cell_lymphoma|NS|NS]	CSV	5019120	.	.	.	.	.	.	.	.	.	Likely Benign
9	133761000	133761001	9q34.12	1	normal	.	A	snv	G	CC.GC	hom-alt	655	1.00	.	0	.	PASS	189980	C	189980(MK)	NN	.	.	.	.	.	.	.	25	ABL1	C11E	EX11E	F-actin binding	PF08919.5	coding-synon	NM_007313.2	NP_009297.2	+	N	c.3381A>G	p.(P1127=) | p.(Pro1127=)	CCA=>CCG	.	NM_007313.2(ABL1): c.3381A>G (p.(P1127=))	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	125362	0.553158	U	0.5952	0.654153	13006	0.584884	PASS	1541	8602	0.597303	18853	120354	0.548956	3154	10381	6.02566e-01	38686	134979	5.49531e-01	rs1056171	.	4024	0.593200	-1.204	-1.907	-2.191	.	.	.	.	.	ENST00000372348: c.3381A>G (p.P1127P)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [diffuse_large_B_cell_lymphoma|NS|NS]	CSV	5019120	.	.	.	.	.	.	.	.	.	Likely Benign
9	135772999	135773000	9q34.13	0	normal	.	G	ref	G	CT.AA	het-alt	34	0.58	.	1	.	PASS	605284	C	191100(MK);606690(MK);607341(MK)	AD	Tuberous sclerosis; Lymphangioleiomyomatosis	AD	Allelic with Focal cortical dysplasia of Taylor (AD)	Cardiovascular; Dental; Dermatologic; Neurologic; Oncologic; Ophthalmologic; Pulmonary; Renal	Cardiovascular; Neurologic; Oncologic; Pulmonary; Renal	23909960|23852707|23851963|23846400|23845174|23796861|23743818|23158522|22490766|22189265|22161988|21813552|21266383|20301399|19419980|19332694|18722871|18032745|17304050|17005952|17003820|15955990|15257730|14985384|14421523|12112044|11829138|9924605|9863590|9579160|9242607|9132502|8782048|8592324|8534286|3210031|2823681|2706800	H62;H68;HT2	7248	TSC1	IC18	IVS20	.	.	no-change	NM_000368.4	NP_000359.1	-	Y	c.2626-3C=	.	.	.	NM_000368.4(TSC1): c.2626-3C=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4025	0.931900	-4.597	-2.390	-2.479	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	135773000	135773000	9q34.13	1	normal	.	.	ins	AA	TG.AA	het-ref	25	0.42	.	2	.	PASS	605284	C	191100(MK);606690(MK);607341(MK)	AD	Tuberous sclerosis; Lymphangioleiomyomatosis	AD	Allelic with Focal cortical dysplasia of Taylor (AD)	Cardiovascular; Dental; Dermatologic; Neurologic; Oncologic; Ophthalmologic; Pulmonary; Renal	Cardiovascular; Neurologic; Oncologic; Pulmonary; Renal	23909960|23852707|23851963|23846400|23845174|23796861|23743818|23158522|22490766|22189265|22161988|21813552|21266383|20301399|19419980|19332694|18722871|18032745|17304050|17005952|17003820|15955990|15257730|14985384|14421523|12112044|11829138|9924605|9863590|9579160|9242607|9132502|8782048|8592324|8534286|3210031|2823681|2706800	H62;H68;HT2	7248	TSC1	IC18	IVS20	.	.	intron	NM_000368.4	NP_000359.1	-	Y	c.2626-4_2626-3insTT	.	.	.	NM_000368.4(TSC1): c.2626-4_2626-3insTT	MixedObserved;clinically-assoc,has-omim-omia,submitted-by-lsdb|MixedObserved;rs-cluster-nonoverlapping-alleles	0|51608	0|0.439292	U	.	.	.	.	PASS	10	5654	0.138486	278	80186	0.153269	.	.	.	.	.	.	rs397514773|rs5901000	.	4024	0.103100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	495837	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
9	135776033	135776034	9q34.13	0	normal	.	C	ref	C	TG.GG	het-alt	191	0.49	.	1	.	PASS	605284	C	191100(MK);606690(MK);607341(MK)	AD	Tuberous sclerosis; Lymphangioleiomyomatosis	AD	Allelic with Focal cortical dysplasia of Taylor (AD)	Cardiovascular; Dental; Dermatologic; Neurologic; Oncologic; Ophthalmologic; Pulmonary; Renal	Cardiovascular; Neurologic; Oncologic; Pulmonary; Renal	23909960|23852707|23851963|23846400|23845174|23796861|23743818|23158522|22490766|22189265|22161988|21813552|21266383|20301399|19419980|19332694|18722871|18032745|17304050|17005952|17003820|15955990|15257730|14985384|14421523|12112044|11829138|9924605|9863590|9579160|9242607|9132502|8782048|8592324|8534286|3210031|2823681|2706800	H62;H68;HT2	7248	TSC1	IC18	IVS20	.	.	no-change	NM_000368.4	NP_000359.1	-	Y	c.2625+68G=	.	.	.	NM_000368.4(TSC1): c.2625+68G=	;maf-5-some-pop,microattr-tpa,genotype-conflict	5008	0.587660	U	0.5585	0.41234	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1076160	.	4024	0.457500	0.563	-0.007	0.122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	135776033	135776034	9q34.13	0	normal	.	C	snv	T	TG.GG	het-ref	199	0.51	.	2	.	PASS	605284	C	191100(MK);606690(MK);607341(MK)	AD	Tuberous sclerosis; Lymphangioleiomyomatosis	AD	Allelic with Focal cortical dysplasia of Taylor (AD)	Cardiovascular; Dental; Dermatologic; Neurologic; Oncologic; Ophthalmologic; Pulmonary; Renal	Cardiovascular; Neurologic; Oncologic; Pulmonary; Renal	23909960|23852707|23851963|23846400|23845174|23796861|23743818|23158522|22490766|22189265|22161988|21813552|21266383|20301399|19419980|19332694|18722871|18032745|17304050|17005952|17003820|15955990|15257730|14985384|14421523|12112044|11829138|9924605|9863590|9579160|9242607|9132502|8782048|8592324|8534286|3210031|2823681|2706800	H62;H68;HT2	7248	TSC1	IC18	IVS20	.	.	intron	NM_000368.4	NP_000359.1	-	Y	c.2625+68G>A	.	.	.	NM_000368.4(TSC1): c.2625+68G>A	;maf-5-some-pop,microattr-tpa,genotype-conflict	5008	0.412340	U	0.5585	0.41234	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1076160	.	4024	0.542500	0.563	-0.007	0.122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	135776924	135776925	9q34.13	0	normal	.	T	ref	T	AA.GT	het-alt	121	0.47	.	1	.	PASS	605284	C	191100(MK);606690(MK);607341(MK)	AD	Tuberous sclerosis; Lymphangioleiomyomatosis	AD	Allelic with Focal cortical dysplasia of Taylor (AD)	Cardiovascular; Dental; Dermatologic; Neurologic; Oncologic; Ophthalmologic; Pulmonary; Renal	Cardiovascular; Neurologic; Oncologic; Pulmonary; Renal	23909960|23852707|23851963|23846400|23845174|23796861|23743818|23158522|22490766|22189265|22161988|21813552|21266383|20301399|19419980|19332694|18722871|18032745|17304050|17005952|17003820|15955990|15257730|14985384|14421523|12112044|11829138|9924605|9863590|9579160|9242607|9132502|8782048|8592324|8534286|3210031|2823681|2706800	H62;H68;HT2	7248	TSC1	IC17	IVS19	.	.	no-change	NM_000368.4	NP_000359.1	-	Y	c.2502+51A=	.	.	.	NM_000368.4(TSC1): c.2502+51A=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126318	0.928561	U	0.1984	0.0794728	13006	0.963786	PASS	.	8608	0.801464	52479	121310	0.928893	.	.	.	.	.	.	rs75802666	.	4024	0.811100	-1.447	-1.777	-2.024	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	135776924	135776925	9q34.13	0	normal	.	T	snv	C	AA.GT	het-ref	137	0.53	.	2	.	PASS	605284	C	191100(MK);606690(MK);607341(MK)	AD	Tuberous sclerosis; Lymphangioleiomyomatosis	AD	Allelic with Focal cortical dysplasia of Taylor (AD)	Cardiovascular; Dental; Dermatologic; Neurologic; Oncologic; Ophthalmologic; Pulmonary; Renal	Cardiovascular; Neurologic; Oncologic; Pulmonary; Renal	23909960|23852707|23851963|23846400|23845174|23796861|23743818|23158522|22490766|22189265|22161988|21813552|21266383|20301399|19419980|19332694|18722871|18032745|17304050|17005952|17003820|15955990|15257730|14985384|14421523|12112044|11829138|9924605|9863590|9579160|9242607|9132502|8782048|8592324|8534286|3210031|2823681|2706800	H62;H68;HT2	7248	TSC1	IC17	IVS19	.	.	intron	NM_000368.4	NP_000359.1	-	Y	c.2502+51A>G	.	.	.	NM_000368.4(TSC1): c.2502+51A>G	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126318	0.071439	U	0.1984	0.0794728	13006	0.036214	PASS	167	8608	0.198536	450	121310	0.071107	331	3388	1.96565e-01	935	17635	7.25732e-02	rs75802666	.	4024	0.188900	-1.447	-1.777	-2.024	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	64749	no_assertion_provided	not_provided	Benign
9	136913567	136913568	9q34.2	0	normal	.	G	ref	G	AC.CC	het-alt	268	0.51	.	1	.	PASS	601541	P	.	NN	.	.	.	.	.	.	.	8019	BRD3	C5	EX6	.	.	no-change	NM_007371.3	NP_031397.1	-	Y	c.723C=	.	.	.	NM_007371.3(BRD3): c.723C=	;	122534	0.991888	U	0.005	0.00559105	13004	0.999000	PASS	.	8326	0.990992	57836	117526	0.991781	.	.	.	.	.	.	rs150276875	.	4024	0.982600	0.561	-0.191	-0.140	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	136913567	136913568	9q34.2	1	normal	.	G	snv	A	AC.CC	het-ref	260	0.49	.	2	.	PASS	601541	P	.	NN	.	.	.	.	.	.	.	8019	BRD3	C5	EX6	.	.	coding-synon	NM_007371.3	NP_031397.1	-	Y	c.723C>T	p.(G241=) | p.(Gly241=)	GGC=>GGT	.	NM_007371.3(BRD3): c.723C>T (p.(G241=))	;	122534	0.008112	U	0.005	0.00559105	13004	0.001000	PASS	1	8326	0.009008	39	117526	0.008219	1	151	8.86566e-03	91	2466	1.05247e-02	rs150276875	.	4024	0.017400	0.561	-0.191	-0.140	.	.	.	.	.	ENST00000303407: c.723C>T (p.G241G)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3982765	.	.	.	.	.	.	.	.	.	VUS
9	136915507	136915508	9q34.2	0	normal	.	C	ref	C	GG.GG	het-alt	161	0.55	.	1	.	PASS	601541	P	.	NN	.	.	.	.	.	.	.	8019	BRD3	C4	EX5	.	.	no-change	NM_007371.3	NP_031397.1	-	Y	c.702G=	.	.	.	NM_007371.3(BRD3): c.702G=	;maf-5-some-pop	123650	0.902491	U	0.1339	0.0902556	13004	0.924331	PASS	.	8536	0.872423	48340	118642	0.902185	.	.	.	.	.	.	rs2301576	.	4024	0.890900	-0.658	-0.779	-0.277	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	136915507	136915508	9q34.2	1	normal	.	C	snv	T	GG.GG	het-ref	134	0.45	.	2	.	PASS	601541	P	.	NN	.	.	.	.	.	.	.	8019	BRD3	C4	EX5	.	.	coding-synon	NM_007371.3	NP_031397.1	-	Y	c.702G>A	p.(P234=) | p.(Pro234=)	CCG=>CCA	.	NM_007371.3(BRD3): c.702G>A (p.(P234=))	;maf-5-some-pop	123650	0.097509	U	0.1339	0.0902556	13004	0.075669	PASS	48	8536	0.127577	624	118642	0.097815	137	2248	1.30819e-01	1377	24359	1.00216e-01	rs2301576	.	4024	0.109100	-0.658	-0.779	-0.277	.	.	.	.	.	ENST00000303407: c.702G>A (p.P234P)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4163509	.	.	.	.	.	.	.	.	.	Likely Benign
9	139391635	139391636	9q34.3	0	nullSample	.	G	ref	G	CC.TC	homo-ref	.	.	.	0	.	.	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	C34E	EX34E	.	.	no-change	NM_017617.3	NP_060087.3	-	Y	c.6555C=	.	.	.	NM_017617.3(NOTCH1): c.6555C=	;maf-5-some-pop,genotype-conflict	124060	0.378188	U	0.9494	0.695088	12908	0.418733	PASS	.	8574	0.052601	9446	119052	0.381270	.	.	.	.	.	.	rs2229974	.	4024	0.043000	0.561	-0.114	-0.091	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139391635	139391636	9q34.3	1	normal	.	G	snv	A	CC.TC	hom-alt	725	1.00	.	0	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	C34E	EX34E	.	.	coding-synon	NM_017617.3	NP_060087.3	-	Y	c.6555C>T	p.(D2185=) | p.(Asp2185=)	GAC=>GAT	.	NM_017617.3(NOTCH1): c.6555C>T (p.(D2185=))	;maf-5-some-pop,genotype-conflict	124060	0.621812	U	0.9494	0.695088	12908	0.581267	PASS	3851	8574	0.947399	23581	119052	0.618730	7776	16355	9.50430e-01	49065	152091	6.21211e-01	rs2229974	.	4024	0.957000	0.561	-0.114	-0.091	.	.	.	.	.	ENST00000277541: c.6555C>T (p.D2185D)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	3763781	.	.	.	.	.	no_record	286141	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
9	139392042	139392043	9q34.3	0	normal	.	G	snv	C	GG.CC	het-ref	38	0.37	.	2	.	DUBIOUS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC33	IVS33	.	.	intron	NM_017617.3	NP_060087.3	-	Y	c.6181-33C>G	.	.	.	NM_017617.3(NOTCH1): c.6181-33C>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.003000	-0.367	-0.871	-0.983	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
9	139392042	139392043	9q34.3	0	normal	.	G	ref	G	GG.CC	het-alt	66	0.63	.	1	.	DUBIOUS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC33	IVS33	.	.	no-change	NM_017617.3	NP_060087.3	-	Y	c.6181-33C=	.	.	.	NM_017617.3(NOTCH1): c.6181-33C=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.997000	-0.367	-0.871	-0.983	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139392116	139392117	9q34.3	0	normal	.	T	ref	T	GG.GG	het-alt	46	0.63	.	1	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC33	IVS33	.	.	no-change	NM_017617.3	NP_060087.3	-	Y	c.6181-107A=	.	.	.	NM_017617.3(NOTCH1): c.6181-107A=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4018	0.876600	-0.558	-0.918	-1.758	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139392116	139392117	9q34.3	0	normal	.	T	snv	G	GG.GG	het-ref	27	0.37	.	2	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC33	IVS33	.	.	intron	NM_017617.3	NP_060087.3	-	Y	c.6181-107A>C	.	.	.	NM_017617.3(NOTCH1): c.6181-107A>C	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4018	0.123400	-0.558	-0.918	-1.758	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139396407	139396408	9q34.3	0	nullSample	.	A	ref	A	GC.GC	homo-ref	.	.	.	0	.	.	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC29	IVS29	.	.	no-change	NM_017617.3	NP_060087.3	-	Y	c.5473-43T=	.	.	.	NM_017617.3(NOTCH1): c.5473-43T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	123814	0.401909	U	0.9226	0.741613	12122	0.388962	PASS	-329	8504	0.086548	11169	118806	0.407959	.	.	.	.	.	.	rs3124594	.	4024	0.086200	-1.379	-1.148	-0.884	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139396407	139396408	9q34.3	0	normal	.	A	snv	G	GC.GC	hom-alt	557	1.00	.	0	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC29	IVS29	.	.	intron	NM_017617.3	NP_060087.3	-	Y	c.5473-43T>C	.	.	.	NM_017617.3(NOTCH1): c.5473-43T>C	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	123814	0.598091	U	0.9226	0.741613	12122	0.611038	PASS	3555	8504	0.913452	22104	118806	0.592041	7189	15705	9.15316e-01	45294	144406	5.91537e-01	rs3124594	.	4024	0.913800	-1.379	-1.148	-0.884	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139396689	139396690	9q34.3	0	nullSample	.	C	ref	C	AC.GG	homo-ref	.	.	.	0	.	.	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC28	IVS28	.	.	no-change	NM_017617.3	NP_060087.3	-	Y	c.5384+34G=	.	.	.	NM_017617.3(NOTCH1): c.5384+34G=	;maf-5-some-pop	98638	0.883199	U	0.5982	0.161741	11828	0.966097	PASS	.	6984	0.344359	37844	93630	0.885603	.	.	.	.	.	.	rs75842134	.	4024	0.338200	0.205	0.210	0.202	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139396689	139396690	9q34.3	0	normal	.	C	snv	T	AC.GG	hom-alt	349	1.00	.	0	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC28	IVS28	.	.	intron	NM_017617.3	NP_060087.3	-	Y	c.5384+34G>A	.	.	.	NM_017617.3(NOTCH1): c.5384+34G>A	;maf-5-some-pop	98638	0.116801	U	0.5982	0.161741	11828	0.033903	PASS	1437	6984	0.655641	1740	93630	0.114397	3199	10230	6.31715e-01	4067	24916	1.10740e-01	rs75842134	.	4024	0.661800	0.205	0.210	0.202	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139397706	139397707	9q34.3	0	nullSample	.	G	ref	G	AC.TC	homo-ref	.	.	.	0	.	.	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	C27	EX27	NOTCH protein	PF07684.7	no-change	NM_017617.3	NP_060087.3	-	Y	c.5094C=	.	.	.	NM_017617.3(NOTCH1): c.5094C=	;maf-5-some-pop	124206	0.551342	U	0.9018	0.553514	12788	0.591961	PASS	.	8584	0.114049	19719	119198	0.555748	.	.	.	.	.	.	rs10521	.	4024	0.103400	-0.258	-0.389	-0.816	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139397706	139397707	9q34.3	1	normal	.	G	snv	A	AC.TC	hom-alt	512	1.00	.	0	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	C27	EX27	NOTCH protein	PF07684.7	coding-synon	NM_017617.3	NP_060087.3	-	Y	c.5094C>T	p.(D1698=) | p.(Asp1698=)	GAC=>GAT	.	NM_017617.3(NOTCH1): c.5094C>T (p.(D1698=))	;maf-5-some-pop	124206	0.448658	U	0.9018	0.553514	12788	0.408039	PASS	3374	8584	0.885951	13074	119198	0.444252	6797	15297	8.88328e-01	27451	109894	4.48181e-01	rs10521	.	4024	0.896600	-0.258	-0.389	-0.816	.	.	.	.	.	ENST00000277541: c.5094C>T (p.D1698D)	large_intestine [caecum|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1461158	.	.	.	.	.	no_record	384696	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
9	139401503	139401504	9q34.3	0	nullSample	.	G	ref	G	AC.AG	homo-ref	.	.	.	0	.	.	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC22	IVS22	.	.	no-change	NM_017617.3	NP_060087.3	-	Y	c.3644-79C=	.	.	.	NM_017617.3(NOTCH1): c.3644-79C=	;maf-5-some-pop,maf-5-all-pops	5008	0.316094	U	0.9067	0.683906	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3124596	.	4024	0.099400	-0.361	-0.639	-0.944	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139401503	139401504	9q34.3	0	normal	.	G	snv	A	AC.AG	hom-alt	292	1.00	.	0	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC22	IVS22	.	.	intron	NM_017617.3	NP_060087.3	-	Y	c.3644-79C>T	.	.	.	NM_017617.3(NOTCH1): c.3644-79C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.683906	U	0.9067	0.683906	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3124596	.	4024	0.900600	-0.361	-0.639	-0.944	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139402662	139402663	9q34.3	0	nullSample	.	T	ref	T	GC.GG	homo-ref	.	.	.	0	.	.	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC20	IVS20	.	.	no-change	NM_017617.3	NP_060087.3	-	Y	c.3325+21A=	.	.	.	NM_017617.3(NOTCH1): c.3325+21A=	;maf-5-some-pop	122408	0.359462	U	0.9137	0.767173	12572	0.341632	PASS	-388	8508	0.104372	8638	117400	0.364864	.	.	.	.	.	.	rs3124597	.	4024	0.095400	-1.427	-0.525	-0.517	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139402662	139402663	9q34.3	0	normal	.	T	snv	C	GC.GG	hom-alt	597	1.00	.	0	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC20	IVS20	.	.	intron	NM_017617.3	NP_060087.3	-	Y	c.3325+21A>G	.	.	.	NM_017617.3(NOTCH1): c.3325+21A>G	;maf-5-some-pop	122408	0.640538	U	0.9137	0.767173	12572	0.658368	PASS	3422	8508	0.895628	24503	117400	0.635136	6939	15420	8.98497e-01	50245	152983	6.32355e-01	rs3124597	.	4024	0.904600	-1.427	-0.525	-0.517	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139402907	139402908	9q34.3	0	nullSample	.	T	ref	T	TC.GC	homo-ref	.	.	.	0	.	.	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC19	IVS19	.	.	no-change	NM_017617.3	NP_060087.3	-	Y	c.3172-71A=	.	.	.	NM_017617.3(NOTCH1): c.3172-71A=	;maf-5-some-pop	5008	0.238618	U	0.9147	0.761382	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3812603	.	4024	0.097400	-2.444	-3.108	-2.542	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139402907	139402908	9q34.3	0	normal	.	T	snv	C	TC.GC	hom-alt	213	1.00	.	0	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC19	IVS19	.	.	intron	NM_017617.3	NP_060087.3	-	Y	c.3172-71A>G	.	.	.	NM_017617.3(NOTCH1): c.3172-71A>G	;maf-5-some-pop	5008	0.761382	U	0.9147	0.761382	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3812603	.	4024	0.902600	-2.444	-3.108	-2.542	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139403267	139403268	9q34.3	0	nullSample	.	T	ref	T	GG.AG	homo-ref	.	.	.	0	.	.	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC19	IVS19	.	.	no-change	NM_017617.3	NP_060087.3	-	Y	c.3171+54A=	.	.	.	NM_017617.3(NOTCH1): c.3171+54A=	MixedObserved;maf-5-some-pop	5008	0.238019	U	0.9147	0.761981	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3125000	.	4024	0.096900	-0.642	-3.278	-3.876	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139403267	139403268	9q34.3	0	normal	.	T	snv	C	GG.AG	hom-alt	221	1.00	.	0	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC19	IVS19	.	.	intron	NM_017617.3	NP_060087.3	-	Y	c.3171+54A>G	.	.	.	NM_017617.3(NOTCH1): c.3171+54A>G	MixedObserved;maf-5-some-pop	5008	0.761981	U	0.9147	0.761981	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3125000	.	4024	0.903100	-0.642	-3.278	-3.876	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139403553	139403554	9q34.3	0	nullSample	.	T	ref	T	AG.GG	homo-ref	.	.	.	0	.	.	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC18	IVS18	.	.	no-change	NM_017617.3	NP_060087.3	-	Y	c.2970-31A=	.	.	.	NM_017617.3(NOTCH1): c.2970-31A=	;maf-5-some-pop	22114	0.314190	U	0.9167	0.764776	11448	0.330975	PASS	-33	698	0.100287	1011	17106	0.337309	.	.	.	.	.	.	rs3124598	.	4022	0.096500	-4.619	-4.619	-4.482	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139403553	139403554	9q34.3	0	normal	.	T	snv	C	AG.GG	hom-alt	177	1.00	.	0	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC18	IVS18	.	.	intron	NM_017617.3	NP_060087.3	-	Y	c.2970-31A>G	.	.	.	NM_017617.3(NOTCH1): c.2970-31A>G	;maf-5-some-pop	22114	0.685810	U	0.9167	0.764776	11448	0.669025	PASS	281	698	0.899713	3794	17106	0.662691	4182	9262	9.02377e-01	30407	91857	6.39076e-01	rs3124598	.	4022	0.903500	-4.619	-4.619	-4.482	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139405260	139405261	9q34.3	0	nullSample	.	C	ref	C	TG.GG	homo-ref	.	.	.	0	.	.	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC16	IVS16	.	.	no-change	NM_017617.3	NP_060087.3	-	Y	c.2588-4G=	.	.	.	NM_017617.3(NOTCH1): c.2588-4G=	SingleClassTriAllelic;maf-5-some-pop	121654	0.522811	U	0.872	0.585463	12200	0.545082	PASS	-476	8450	0.129231	17502	116646	0.527459	.	.	.	.	.	.	rs3125001	.	4024	0.124500	0.561	-0.369	-0.082	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139405260	139405261	9q34.3	1	normal	.	C	snv	T	TG.GG	hom-alt	447	1.00	.	0	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC16	IVS16	.	.	intron	NM_017617.3	NP_060087.3	-	Y	c.2588-4G>A	.	.	.	NM_017617.3(NOTCH1): c.2588-4G>A	SingleClassTriAllelic;maf-5-some-pop	121654	0.477181	U	0.872	0.585463	12200	0.454918	PASS	3203	8450	0.870769	14299	116646	0.472532	6518	14939	8.73728e-01	29398	112366	4.74370e-01	rs3125001	.	4024	0.875500	0.561	-0.369	-0.082	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	281108	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
9	139405500	139405501	9q34.3	0	nullSample	.	A	ref	A	CC.GC	homo-ref	.	.	.	0	.	.	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC16	IVS16	.	.	no-change	NM_017617.3	NP_060087.3	-	Y	c.2587+103T=	.	.	.	NM_017617.3(NOTCH1): c.2587+103T=	;maf-5-some-pop	5008	0.249601	U	0.8978	0.750399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9411206	.	4024	0.107100	-1.879	-1.304	-1.387	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139405500	139405501	9q34.3	0	normal	.	A	snv	G	CC.GC	hom-alt	290	1.00	.	0	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC16	IVS16	.	.	intron	NM_017617.3	NP_060087.3	-	Y	c.2587+103T>C	.	.	.	NM_017617.3(NOTCH1): c.2587+103T>C	;maf-5-some-pop	5008	0.750399	U	0.8978	0.750399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9411206	.	4024	0.892900	-1.879	-1.304	-1.387	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139407451	139407452	9q34.3	0	nullSample	.	C	ref	C	CA.AG	homo-ref	.	.	.	0	trf	.	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC15	IVS15	.	.	no-change	NM_017617.3	NP_060087.3	-	Y	c.2467+21G=	.	.	.	NM_017617.3(NOTCH1): c.2467+21G=	;maf-5-some-pop	73038	0.367343	U	0.8671	0.697284	11862	0.418479	PASS	-298	5808	0.117424	5137	68030	0.372101	.	.	.	.	.	.	rs3812608	.	3275	0.707800	-2.597	1.086	0.331	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139407451	139407452	9q34.3	0	normal	.	C	snv	T	CA.AG	hom-alt	50	1.00	.	0	trf	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC15	IVS15	.	.	intron	NM_017617.3	NP_060087.3	-	Y	c.2467+21G>A	.	.	.	NM_017617.3(NOTCH1): c.2467+21G>A	;maf-5-some-pop	73038	0.632657	U	0.8671	0.697284	11862	0.581521	PASS	2265	5808	0.882576	13838	68030	0.627899	5791	13453	8.61930e-01	36965	121928	5.76999e-01	rs3812608	.	3275	0.290100	-2.597	1.086	0.331	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139407931	139407932	9q34.3	0	nullSample	.	A	ref	A	TC.TT	homo-ref	.	.	.	0	.	.	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	C14	EX14	.	.	no-change	NM_017617.3	NP_060087.3	-	Y	c.2265T=	.	.	.	NM_017617.3(NOTCH1): c.2265T=	MixedObserved;maf-5-some-pop,maf-5-all-pops,genotype-conflict	123826	0.597039	U	0.7768	0.527756	12932	0.602536	PASS	.	8568	0.204832	23252	118818	0.602299	.	.	.	.	.	.	rs2229971	.	4024	0.203500	-4.386	-0.216	-1.247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139407931	139407932	9q34.3	1	normal	.	A	snv	G	TC.TT	hom-alt	488	1.00	.	0	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	C14	EX14	.	.	coding-synon	NM_017617.3	NP_060087.3	-	Y	c.2265T>C	p.(N755=) | p.(Asn755=)	AAT=>AAC	.	NM_017617.3(NOTCH1): c.2265T>C (p.(N755=))	MixedObserved;maf-5-some-pop,maf-5-all-pops,genotype-conflict	123826	0.402961	U	0.7768	0.527756	12932	0.397464	PASS	2709	8568	0.795168	11097	118818	0.397701	5413	13661	7.94429e-01	23151	98027	4.00074e-01	rs2229971	.	4024	0.796500	-4.386	-0.216	-1.247	.	.	.	.	.	ENST00000277541: c.2265T>C (p.N755N)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3763787	.	.	.	.	.	no_record	384703	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
9	139410176	139410177	9q34.3	0	nullSample	.	T	ref	T	CG.GG	homo-ref	.	.	.	0	.	.	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC10	IVS10	.	.	no-change	NM_017617.3	NP_060087.3	-	Y	c.1670-9A=	.	.	.	NM_017617.3(NOTCH1): c.1670-9A=	;maf-5-some-pop,maf-5-all-pops	23532	0.531702	U	0.8323	0.58726	11712	0.603911	PASS	-51	572	0.199301	3045	18524	0.563863	.	.	.	.	.	.	rs3124603	.	4020	0.133100	-2.525	-0.289	-1.098	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139410176	139410177	9q34.3	1	normal	.	T	snv	C	CG.GG	hom-alt	316	1.00	.	0	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC10	IVS10	.	.	intron	NM_017617.3	NP_060087.3	-	Y	c.1670-9A>G	.	.	.	NM_017617.3(NOTCH1): c.1670-9A>G	;maf-5-some-pop,maf-5-all-pops	23532	0.468298	U	0.8323	0.58726	11712	0.396089	PASS	178	572	0.800699	1862	18524	0.436137	3683	8686	8.50735e-01	16164	61973	4.62685e-01	rs3124603	.	4020	0.866900	-2.525	-0.289	-1.098	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	288086	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
9	139410423	139410424	9q34.3	0	nullSample	.	A	ref	A	CC.GC	homo-ref	.	.	.	0	.	.	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC10	IVS10	.	.	no-change	NM_017617.3	NP_060087.3	-	Y	c.1669+9T=	.	.	.	NM_017617.3(NOTCH1): c.1669+9T=	;maf-5-some-pop	121834	0.129028	U	0.9147	0.883986	12320	0.126705	PASS	.	8456	0.061850	1092	116826	0.129586	.	.	.	.	.	.	rs3125006	.	4024	0.064100	-4.193	-3.361	-3.952	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139410423	139410424	9q34.3	1	normal	.	A	snv	G	CC.GC	hom-alt	228	1.00	.	0	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC10	IVS10	.	.	intron	NM_017617.3	NP_060087.3	-	Y	c.1669+9T>C	.	.	.	NM_017617.3(NOTCH1): c.1669+9T>C	;maf-5-some-pop	121834	0.870972	U	0.9147	0.883986	12320	0.873295	PASS	3717	8456	0.938150	44366	116826	0.870414	7458	15987	9.33493e-01	91728	209670	8.71628e-01	rs3125006	.	4024	0.935900	-4.193	-3.361	-3.952	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	383780	criteria_provided,_single_submitter	Benign	Benign
9	139410588	139410589	9q34.3	0	nullSample	.	A	ref	A	GC.CT	homo-ref	.	.	.	0	.	.	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC9	IVS9	.	.	no-change	NM_017617.3	NP_060087.3	-	Y	c.1556-43T=	.	.	.	NM_017617.3(NOTCH1): c.1556-43T=	SingleClassTriAllelic;maf-5-some-pop	112118	0.360745	U	0.8651	0.686701	12304	0.375569	PASS	-411	7828	0.115738	7226	107110	0.362963	.	.	.	.	.	.	rs4880099	.	4018	0.126200	-0.468	-1.250	-1.171	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139410588	139410589	9q34.3	0	normal	.	A	snv	G	GC.CT	hom-alt	124	1.00	.	0	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC9	IVS9	.	.	intron	NM_017617.3	NP_060087.3	-	Y	c.1556-43T>C	.	.	.	NM_017617.3(NOTCH1): c.1556-43T>C	SingleClassTriAllelic;maf-5-some-pop	112118	0.639246	U	0.8651	0.686701	12304	0.624431	PASS	3050	7828	0.884262	21903	107110	0.637027	6401	14606	8.78821e-01	46907	144153	6.37631e-01	rs4880099	.	4018	0.873800	-0.468	-1.250	-1.171	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139411713	139411714	9q34.3	0	nullSample	.	T	ref	T	GG.GG	homo-ref	.	.	.	0	.	.	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC9	IVS9	.	.	no-change	NM_017617.3	NP_060087.3	-	Y	c.1555+10A=	.	.	.	NM_017617.3(NOTCH1): c.1555+10A=	;maf-5-some-pop,maf-5-all-pops	64294	0.447398	U	0.8353	0.605431	12236	0.572001	PASS	-320	5550	0.122523	5751	59286	0.451860	.	.	.	.	.	.	rs11145767	.	4014	0.127300	-0.971	-1.620	-1.708	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139411713	139411714	9q34.3	1	normal	.	T	snv	C	GG.GG	hom-alt	219	1.00	.	0	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC9	IVS9	.	.	intron	NM_017617.3	NP_060087.3	-	Y	c.1555+10A>G	.	.	.	NM_017617.3(NOTCH1): c.1555+10A>G	;maf-5-some-pop,maf-5-all-pops	64294	0.552602	U	0.8353	0.605431	12236	0.427999	PASS	2115	5550	0.877477	8605	59286	0.548140	5365	12544	8.59767e-01	23340	90202	4.52558e-01	rs11145767	.	4014	0.872700	-0.971	-1.620	-1.708	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	286181	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
9	139411879	139411880	9q34.3	0	nullSample	.	G	ref	G	CA.TG	homo-ref	.	.	.	0	.	.	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC8	IVS8	.	.	no-change	NM_017617.3	NP_060087.3	-	Y	c.1442-43C=	.	.	.	NM_017617.3(NOTCH1): c.1442-43C=	;maf-5-some-pop,maf-5-all-pops	29744	0.553658	U	0.8353	0.525559	12260	0.638010	PASS	-85	1164	0.164948	4143	24736	0.569696	.	.	.	.	.	.	rs9411254	.	4010	0.128400	-0.310	-0.373	-0.340	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139411879	139411880	9q34.3	0	normal	.	G	snv	A	CA.TG	hom-alt	182	1.00	.	0	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC8	IVS8	.	.	intron	NM_017617.3	NP_060087.3	-	Y	c.1442-43C>T	.	.	.	NM_017617.3(NOTCH1): c.1442-43C>T	;maf-5-some-pop,maf-5-all-pops	29744	0.446342	U	0.8353	0.525559	12260	0.361990	PASS	401	1164	0.835052	2419	24736	0.430304	3895	9169	8.55477e-01	16373	66336	4.36456e-01	rs9411254	.	4010	0.871600	-0.310	-0.373	-0.340	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139412196	139412197	9q34.3	0	nullSample	.	G	ref	G	CC.AC	homo-ref	.	.	.	0	.	.	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC8	IVS8	.	.	no-change	NM_017617.3	NP_060087.3	-	Y	c.1441+7C=	.	.	.	NM_017617.3(NOTCH1): c.1441+7C=	;maf-5-some-pop	123228	0.418322	U	0.9286	0.696286	12456	0.445568	PASS	-285	8546	0.073251	11873	118220	0.423177	.	.	.	.	.	.	rs9411208	.	4024	0.064400	-1.324	0.119	0.004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139412196	139412197	9q34.3	1	normal	.	G	snv	A	CC.AC	hom-alt	297	1.00	.	0	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	IC8	IVS8	.	.	intron	NM_017617.3	NP_060087.3	-	Y	c.1441+7C>T	.	.	.	NM_017617.3(NOTCH1): c.1441+7C>T	;maf-5-some-pop	123228	0.581678	U	0.9286	0.696286	12456	0.554432	PASS	3675	8546	0.926749	20955	118220	0.576823	7372	15924	9.26568e-01	43069	140254	5.76356e-01	rs9411208	.	4024	0.935600	-1.324	0.119	0.004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	384693	criteria_provided,_single_submitter	Benign	Benign
9	139418259	139418260	9q34.3	0	nullSample	.	A	ref	A	GC.TT	homo-ref	.	.	.	0	.	.	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	C3	EX3	.	.	no-change	NM_017617.3	NP_060087.3	-	Y	c.312T=	.	.	.	NM_017617.3(NOTCH1): c.312T=	;maf-5-some-pop	115890	0.396773	U	0.8363	0.740016	12782	0.391332	PASS	-509	8232	0.143586	9860	110882	0.402951	.	.	.	.	.	.	rs4489420	.	4024	0.157100	-1.983	-0.457	-1.160	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139418259	139418260	9q34.3	1	normal	.	A	snv	G	GC.TT	hom-alt	520	1.00	.	0	.	PASS	190198	C	109730(MK);616028(MK)	AD	Aortic valve disease	AD	.	Cardiovascular	Cardiovascular	23578328|23102684|18593716|16025100	.	4851	NOTCH1	C3	EX3	.	.	coding-synon	NM_017617.3	NP_060087.3	-	Y	c.312T>C	p.(N104=) | p.(Asn104=)	AAT=>AAC	.	NM_017617.3(NOTCH1): c.312T>C (p.(N104=))	;maf-5-some-pop	115890	0.603227	U	0.8363	0.740016	12782	0.608668	PASS	3016	8232	0.856414	20621	110882	0.597049	6069	14333	8.46604e-01	43574	140189	5.87179e-01	rs4489420	.	4024	0.842900	-1.983	-0.457	-1.160	.	.	.	.	.	ENST00000277541: c.312T>C (p.N104N)	urinary_tract [bladder|NS|NS]	carcinoma [NS|NS|NS]	CSV	1756049	.	.	.	.	.	no_record	286142	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
9	139563143	139563144	9q34.3	0	normal	.	C	ref	C	AC.GA	het-alt	100	0.53	.	1	.	PASS	608582	P	.	NN	.	.	.	.	.	.	.	51162	EGFL7	IC2	IVS5	.	.	no-change	NM_016215.4	NP_057299.1	+	Y	c.197+19C=	.	.	.	NM_016215.4(EGFL7): c.197+19C=	;maf-5-some-pop,maf-5-all-pops	122586	0.819849	U	0.1379	0.151158	12986	0.813953	PASS	-418	8426	0.887491	39555	117578	0.818614	.	.	.	.	.	.	rs2297535	.	.	.	0.407	-1.080	-1.098	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
9	139563143	139563144	9q34.3	1	normal	.	C	snv	A	AC.GA	het-ref	90	0.47	.	2	.	PASS	608582	P	.	NN	.	.	.	.	.	.	.	51162	EGFL7	IC2	IVS5	.	.	intron	NM_016215.4	NP_057299.1	+	Y	c.197+19C>A	.	.	.	NM_016215.4(EGFL7): c.197+19C>A	;maf-5-some-pop,maf-5-all-pops	122586	0.180151	U	0.1379	0.151158	12986	0.186047	PASS	56	8426	0.112509	2093	117578	0.181386	89	1854	1.08408e-01	4089	42403	1.81770e-01	rs2297535	.	.	.	0.407	-1.080	-1.098	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	8111408	8111409	10p14	0	nullSample	.	C	ref	C	TT.AC	homo-ref	.	.	.	0	.	.	131320	C	146255(MK)	AD	Hypoparathyroidism, sensorineural deafness, and renal dysplasia	AD	.	Audiologic/Otolaryngologic; Endocrine; Renal	Audiologic/Otolaryngologic; Endocrine; Renal	21834031|21399899|21242646|21157112|21120445|19248180|17309062|11389161|10935639|9253381	.	2625	GATA3	IC3	IVS4	.	.	no-change	NM_001002295.1	NP_001002295.1	+	Y	c.925-27C=	.	.	.	NM_001002295.1(GATA3): c.925-27C=	;maf-5-some-pop	126352	0.196578	U	0.9544	0.826877	13006	0.246502	PASS	-198	8644	0.048589	2626	121344	0.197546	.	.	.	.	.	.	rs422628	.	4024	0.048200	-2.611	-1.949	-2.699	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	8111408	8111409	10p14	0	normal	.	C	snv	T	TT.AC	hom-alt	386	1.00	.	0	.	PASS	131320	C	146255(MK)	AD	Hypoparathyroidism, sensorineural deafness, and renal dysplasia	AD	.	Audiologic/Otolaryngologic; Endocrine; Renal	Audiologic/Otolaryngologic; Endocrine; Renal	21834031|21399899|21242646|21157112|21120445|19248180|17309062|11389161|10935639|9253381	.	2625	GATA3	IC3	IVS4	.	.	intron	NM_001002295.1	NP_001002295.1	+	Y	c.925-27C>T	.	.	.	NM_001002295.1(GATA3): c.925-27C>T	;maf-5-some-pop	126352	0.803422	U	0.9544	0.826877	13006	0.753498	PASS	3914	8644	0.951411	39327	121344	0.802454	7819	16419	9.52157e-01	80223	197993	8.05413e-01	rs422628	.	4024	0.951800	-2.611	-1.949	-2.699	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	8111620	8111621	10p14	0	nullSample	.	C	ref	C	AG.GT	homo-ref	.	.	.	0	.	.	131320	C	146255(MK)	AD	Hypoparathyroidism, sensorineural deafness, and renal dysplasia	AD	.	Audiologic/Otolaryngologic; Endocrine; Renal	Audiologic/Otolaryngologic; Endocrine; Renal	21834031|21399899|21242646|21157112|21120445|19248180|17309062|11389161|10935639|9253381	.	2625	GATA3	IC4	IVS5	.	.	no-change	NM_001002295.1	NP_001002295.1	+	Y	c.1050+60C=	.	.	.	NM_001002295.1(GATA3): c.1050+60C=	;maf-5-some-pop,maf-5-all-pops	5008	0.728634	U	0.251	0.271366	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs406103	.	4024	0.724200	-0.215	-0.119	-0.428	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	8111620	8111621	10p14	0	normal	.	C	snv	T	AG.GT	hom-alt	329	1.00	.	0	.	PASS	131320	C	146255(MK)	AD	Hypoparathyroidism, sensorineural deafness, and renal dysplasia	AD	.	Audiologic/Otolaryngologic; Endocrine; Renal	Audiologic/Otolaryngologic; Endocrine; Renal	21834031|21399899|21242646|21157112|21120445|19248180|17309062|11389161|10935639|9253381	.	2625	GATA3	IC4	IVS5	.	.	intron	NM_001002295.1	NP_001002295.1	+	Y	c.1050+60C>T	.	.	.	NM_001002295.1(GATA3): c.1050+60C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.271366	U	0.251	0.271366	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs406103	.	4024	0.275800	-0.215	-0.119	-0.428	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	8115668	8115669	10p14	0	normal	.	A	ref	A	gt.aa	het-alt	88	0.59	.	1	(A)n|Simple_repeat|Simple_repeat|+|26	PASS	131320	C	146255(MK)	AD	Hypoparathyroidism, sensorineural deafness, and renal dysplasia	AD	.	Audiologic/Otolaryngologic; Endocrine; Renal	Audiologic/Otolaryngologic; Endocrine; Renal	21834031|21399899|21242646|21157112|21120445|19248180|17309062|11389161|10935639|9253381	.	2625	GATA3	IC4	IVS5	.	.	no-change	NM_001002295.1	NP_001002295.1	+	Y	c.1051-33A=	.	.	.	NM_001002295.1(GATA3): c.1051-33A=	MixedObserved;maf-5-some-pop,maf-5-all-pops	7313	0.720088	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs373223232	.	4024	0.582500	0.358	-0.106	-0.117	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	8115668	8115669	10p14	0	normal	.	A	del	.	gt.aa	het-ref	60	0.41	.	2	(A)n|Simple_repeat|Simple_repeat|+|26	PASS	131320	C	146255(MK)	AD	Hypoparathyroidism, sensorineural deafness, and renal dysplasia	AD	.	Audiologic/Otolaryngologic; Endocrine; Renal	Audiologic/Otolaryngologic; Endocrine; Renal	21834031|21399899|21242646|21157112|21120445|19248180|17309062|11389161|10935639|9253381	.	2625	GATA3	IC4	IVS5	.	.	intron	NM_001002295.1	NP_001002295.1	+	Y	c.1051-33delA	.	.	.	NM_001002295.1(GATA3): c.1051-33delA	MixedObserved;maf-5-some-pop,maf-5-all-pops	7313	0.279912	U	0.4306	0.395367	.	.	PASS	1	1460	0.410274	3	40680	0.423402	.	.	.	.	.	.	rs373223232	.	4024	0.417500	0.358	-0.106	-0.117	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43595835	43595836	10q11.21	0	normal	.	A	ref	A	tg.tt	het-alt	110	0.63	.	1	AT_rich|Low_complexity|Low_complexity|+|30	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC1	IVS1	.	.	no-change	NM_020630.4	NP_065681.1	+	Y	c.74-71A=	.	.	.	NM_020630.4(RET): c.74-71A=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.533	-0.171	-0.539	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
10	43595835	43595836	10q11.21	0	normal	.	A	ref	A	tg.tt	het-alt	110	0.63	.	1	AT_rich|Low_complexity|Low_complexity|+|30	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC1	IVS1	.	.	no-change	NM_020975.4	NP_066124.1	+	N	c.74-71A=	.	.	.	NM_020975.4(RET): c.74-71A=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.533	-0.171	-0.539	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
10	43595836	43595836	10q11.21	0	normal	.	.	ins	T	ga.tt	het-ref	64	0.37	.	2	AT_rich|Low_complexity|Low_complexity|+|30	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC1	IVS1	.	.	intron	NM_020630.4	NP_065681.1	+	Y	c.74-71_74-70insT	.	.	.	NM_020630.4(RET): c.74-71_74-70insT	;	0	0	U	0.3204	0.261182	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs557798883	.	4024	0.278800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43595836	43595836	10q11.21	0	normal	.	.	ins	T	ga.tt	het-ref	64	0.37	.	2	AT_rich|Low_complexity|Low_complexity|+|30	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC1	IVS1	.	.	intron	NM_020975.4	NP_066124.1	+	N	c.74-71_74-70insT	.	.	.	NM_020975.4(RET): c.74-71_74-70insT	;	0	0	U	0.3204	0.261182	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs557798883	.	4024	0.278800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43595967	43595968	10q11.21	1	normal	.	A	ref	A	GC.GC	het-alt	296	0.54	.	1	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	C2	EX2	.	.	coding-synon	NM_020630.4	NP_065681.1	+	Y	c.135G>A	p.(A45=) | p.(Ala45=)	GCG=>GCA	.	NM_020630.4(RET): c.135G>A (p.(A45=))	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	125932	0.262793	U	0.5268	0.753594	13006	0.190835	PASS	.	8612	0.450882	4598	120924	0.263471	.	.	.	.	.	.	rs1800858	.	.	.	-1.551	-1.845	-1.168	.	.	.	.	.	.	.	.	.	.	CM020759	NM_020975.4(RET): c.135G>A (p.A45A)	"Hirschsprung disease, association with"	10528857	DP	.	.	.	.	Likely Benign
10	43595967	43595968	10q11.21	1	normal	.	A	ref	A	GC.GC	het-alt	296	0.54	.	1	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	C2	EX2	.	.	coding-synon	NM_020975.4	NP_066124.1	+	N	c.135G>A	p.(A45=) | p.(Ala45=)	GCG=>GCA	.	NM_020975.4(RET): c.135G>A (p.(A45=))	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	125932	0.262793	U	0.5268	0.753594	13006	0.190835	PASS	.	8612	0.450882	4598	120924	0.263471	.	.	.	.	.	.	rs1800858	.	.	.	-1.551	-1.845	-1.168	.	.	.	.	.	.	.	.	.	.	CM020759	NM_020975.4(RET): c.135G>A (p.A45A)	"Hirschsprung disease, association with"	10528857	DP	.	.	.	.	Likely Benign
10	43595967	43595968	10q11.21	0	normal	.	A	snv	G	GC.GC	het-ref	256	0.46	.	2	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	C2	EX2	.	.	no-change	NM_020630.4	NP_065681.1	+	Y	c.135G=	.	.	.	NM_020630.4(RET): c.135G=	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	125932	0.737207	U	0.5268	0.753594	13006	0.809165	PASS	1303	8612	0.549118	33200	120924	0.736529	2611	9504	5.51532e-01	66092	178746	7.30852e-01	rs1800858	.	.	.	-1.551	-1.845	-1.168	.	.	.	.	.	ENST00000355710: c.135A>G (p.A45A)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	4144677	.	.	.	.	.	no_record	167589	criteria_provided,_single_submitter	Benign	Benign
10	43595967	43595968	10q11.21	0	normal	.	A	snv	G	GC.GC	het-ref	256	0.46	.	2	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	C2	EX2	.	.	no-change	NM_020975.4	NP_066124.1	+	N	c.135G=	.	.	.	NM_020975.4(RET): c.135G=	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	125932	0.737207	U	0.5268	0.753594	13006	0.809165	PASS	1303	8612	0.549118	33200	120924	0.736529	2611	9504	5.51532e-01	66092	178746	7.30852e-01	rs1800858	.	.	.	-1.551	-1.845	-1.168	.	.	.	.	.	ENST00000355710: c.135A>G (p.A45A)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	4144677	.	.	.	.	.	no_record	167589	criteria_provided,_single_submitter	Benign	Benign
10	43600688	43600689	10q11.21	0	normal	.	A	snv	G	CC.CA	het-ref	172	0.44	.	2	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC4	IVS4	.	.	intron	NM_020630.4	NP_065681.1	+	Y	c.867+48A>G	.	.	.	NM_020630.4(RET): c.867+48A>G	;maf-5-some-pop,maf-5-all-pops	120798	0.425918	U	0.4206	0.390974	12982	0.372978	PASS	778	8414	0.430711	10696	115790	0.427429	1589	7358	4.31960e-01	22174	101719	4.28774e-01	rs2435352	.	4024	0.453300	-0.224	-0.295	-0.364	.	.	.	.	.	.	.	.	.	.	CS032425	NM_020975.4(RET): c.867+48A>G	"Hirschsprung disease, association with"	12872262	DP	no_record	261398	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
10	43600688	43600689	10q11.21	0	normal	.	A	snv	G	CC.CA	het-ref	172	0.44	.	2	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC4	IVS4	.	.	intron	NM_020975.4	NP_066124.1	+	N	c.867+48A>G	.	.	.	NM_020975.4(RET): c.867+48A>G	;maf-5-some-pop,maf-5-all-pops	120798	0.425918	U	0.4206	0.390974	12982	0.372978	PASS	778	8414	0.430711	10696	115790	0.427429	1589	7358	4.31960e-01	22174	101719	4.28774e-01	rs2435352	.	4024	0.453300	-0.224	-0.295	-0.364	.	.	.	.	.	.	.	.	.	.	CS032425	NM_020975.4(RET): c.867+48A>G	"Hirschsprung disease, association with"	12872262	DP	no_record	261398	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
10	43600688	43600689	10q11.21	0	normal	.	A	ref	A	CC.CA	het-alt	218	0.56	.	1	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC4	IVS4	.	.	no-change	NM_020630.4	NP_065681.1	+	Y	c.867+48A=	.	.	.	NM_020630.4(RET): c.867+48A=	;maf-5-some-pop,maf-5-all-pops	120798	0.574082	U	0.4206	0.390974	12982	0.627022	PASS	-1034	8414	0.569289	19099	115790	0.572571	.	.	.	.	.	.	rs2435352	.	4024	0.546700	-0.224	-0.295	-0.364	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43600688	43600689	10q11.21	0	normal	.	A	ref	A	CC.CA	het-alt	218	0.56	.	1	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC4	IVS4	.	.	no-change	NM_020975.4	NP_066124.1	+	N	c.867+48A=	.	.	.	NM_020975.4(RET): c.867+48A=	;maf-5-some-pop,maf-5-all-pops	120798	0.574082	U	0.4206	0.390974	12982	0.627022	PASS	-1034	8414	0.569289	19099	115790	0.572571	.	.	.	.	.	.	rs2435352	.	4024	0.546700	-0.224	-0.295	-0.364	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43606686	43606687	10q11.21	0	nullSample	.	A	ref	A	GC.TT	homo-ref	.	.	.	0	.	.	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	C7	EX7	.	.	no-change	NM_020630.4	NP_065681.1	+	Y	c.1296A=	.	.	.	NM_020630.4(RET): c.1296A=	;maf-5-some-pop,maf-5-all-pops	126342	0.291194	U	0.8006	0.77516	13006	0.251422	PASS	.	8638	0.192521	5692	121334	0.293932	.	.	.	.	.	.	rs1800860	.	4024	0.200300	-0.215	-0.011	0.030	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43606686	43606687	10q11.21	0	nullSample	.	A	ref	A	GC.TT	homo-ref	.	.	.	0	.	.	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	C7	EX7	.	.	no-change	NM_020975.4	NP_066124.1	+	N	c.1296A=	.	.	.	NM_020975.4(RET): c.1296A=	;maf-5-some-pop,maf-5-all-pops	126342	0.291194	U	0.8006	0.77516	13006	0.251422	PASS	.	8638	0.192521	5692	121334	0.293932	.	.	.	.	.	.	rs1800860	.	4024	0.200300	-0.215	-0.011	0.030	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43606686	43606687	10q11.21	1	normal	.	A	snv	G	GC.TT	hom-alt	532	1.00	.	0	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	C7	EX7	.	.	coding-synon	NM_020630.4	NP_065681.1	+	Y	c.1296A>G	p.(A432=) | p.(Ala432=)	GCA=>GCG	.	NM_020630.4(RET): c.1296A>G (p.(A432=))	;maf-5-some-pop,maf-5-all-pops	126342	0.708806	U	0.8006	0.77516	13006	0.748578	PASS	2814	8638	0.807479	30695	121334	0.706068	5528	13805	8.00568e-01	60395	171112	6.95594e-01	rs1800860	.	4024	0.799700	-0.215	-0.011	0.030	.	.	.	.	.	ENST00000355710: c.1296A>G (p.A432A)	upper_aerodigestive_tract [mouth|tongue|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	CSV	5983420	CM033447	NM_020975.4(RET): c.1296A>G (p.A432A)	"Hirschsprung disease, assoc. with"	14627689	DP	no_record	95995	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
10	43606686	43606687	10q11.21	1	normal	.	A	snv	G	GC.TT	hom-alt	532	1.00	.	0	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	C7	EX7	.	.	coding-synon	NM_020975.4	NP_066124.1	+	N	c.1296A>G	p.(A432=) | p.(Ala432=)	GCA=>GCG	.	NM_020975.4(RET): c.1296A>G (p.(A432=))	;maf-5-some-pop,maf-5-all-pops	126342	0.708806	U	0.8006	0.77516	13006	0.748578	PASS	2814	8638	0.807479	30695	121334	0.706068	5528	13805	8.00568e-01	60395	171112	6.95594e-01	rs1800860	.	4024	0.799700	-0.215	-0.011	0.030	.	.	.	.	.	ENST00000355710: c.1296A>G (p.A432A)	upper_aerodigestive_tract [mouth|tongue|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	CSV	5983420	CM033447	NM_020975.4(RET): c.1296A>G (p.A432A)	"Hirschsprung disease, assoc. with"	14627689	DP	no_record	95995	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
10	43607755	43607756	10q11.21	0	normal	.	G	ref	G	GG.TG	het-alt	346	0.52	.	1	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC8	IVS8	.	.	no-change	NM_020630.4	NP_065681.1	+	Y	c.1648+84G=	.	.	.	NM_020630.4(RET): c.1648+84G=	;maf-5-some-pop,maf-5-all-pops	5008	0.298323	U	0.496	0.701677	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3026750	.	4024	0.466500	-0.357	-0.721	-0.754	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43607755	43607756	10q11.21	0	normal	.	G	ref	G	GG.TG	het-alt	346	0.52	.	1	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC8	IVS8	.	.	no-change	NM_020975.4	NP_066124.1	+	N	c.1648+84G=	.	.	.	NM_020975.4(RET): c.1648+84G=	;maf-5-some-pop,maf-5-all-pops	5008	0.298323	U	0.496	0.701677	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3026750	.	4024	0.466500	-0.357	-0.721	-0.754	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43607755	43607756	10q11.21	0	normal	.	G	snv	A	GG.TG	het-ref	321	0.48	.	2	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC8	IVS8	.	.	intron	NM_020630.4	NP_065681.1	+	Y	c.1648+84G>A	.	.	.	NM_020630.4(RET): c.1648+84G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.701677	U	0.496	0.701677	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3026750	.	4024	0.533500	-0.357	-0.721	-0.754	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43607755	43607756	10q11.21	0	normal	.	G	snv	A	GG.TG	het-ref	321	0.48	.	2	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC8	IVS8	.	.	intron	NM_020975.4	NP_066124.1	+	N	c.1648+84G>A	.	.	.	NM_020975.4(RET): c.1648+84G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.701677	U	0.496	0.701677	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3026750	.	4024	0.533500	-0.357	-0.721	-0.754	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43607759	43607760	10q11.21	0	normal	.	C	ref	C	GG.TC	het-alt	351	0.53	.	1	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC8	IVS8	.	.	no-change	NM_020630.4	NP_065681.1	+	Y	c.1648+88C=	.	.	.	NM_020630.4(RET): c.1648+88C=	MixedObserved;|MixedObserved;maf-5-some-pop,maf-5-all-pops|MixedObserved;	0|5008|0	0|0.299920|0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs111463326|rs34827976|rs869106918	.	4024	0.466200	-0.490	-0.730	-0.781	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43607759	43607760	10q11.21	0	normal	.	C	ref	C	GG.TC	het-alt	351	0.53	.	1	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC8	IVS8	.	.	no-change	NM_020975.4	NP_066124.1	+	N	c.1648+88C=	.	.	.	NM_020975.4(RET): c.1648+88C=	MixedObserved;|MixedObserved;maf-5-some-pop,maf-5-all-pops|MixedObserved;	0|5008|0	0|0.299920|0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs111463326|rs34827976|rs869106918	.	4024	0.466200	-0.490	-0.730	-0.781	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43607759	43607760	10q11.21	0	normal	.	C	del	.	GG.TC	het-ref	308	0.47	.	2	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC8	IVS8	.	.	intron	NM_020630.4	NP_065681.1	+	Y	c.1648+88delC	.	.	.	NM_020630.4(RET): c.1648+88delC	MixedObserved;|MixedObserved;maf-5-some-pop,maf-5-all-pops|MixedObserved;	0|5008|0	0|0.700080|0	U	0.4911	0.70008	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs111463326|rs34827976|rs869106918	.	4024	0.533800	-0.490	-0.730	-0.781	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43607759	43607760	10q11.21	0	normal	.	C	del	.	GG.TC	het-ref	308	0.47	.	2	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC8	IVS8	.	.	intron	NM_020975.4	NP_066124.1	+	N	c.1648+88delC	.	.	.	NM_020975.4(RET): c.1648+88delC	MixedObserved;|MixedObserved;maf-5-some-pop,maf-5-all-pops|MixedObserved;	0|5008|0	0|0.700080|0	U	0.4911	0.70008	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs111463326|rs34827976|rs869106918	.	4024	0.533800	-0.490	-0.730	-0.781	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43609477	43609478	10q11.21	0	normal	.	G	ref	G	CA.GG	het-alt	373	0.51	.	1	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC10	IVS10	.	.	no-change	NM_020630.4	NP_065681.1	+	Y	c.1879+355G=	.	.	.	NM_020630.4(RET): c.1879+355G=	;	5008	0.998602	U	0.0069	0.00139776	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs534767762	.	4024	0.992000	0.563	-0.142	-0.147	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43609477	43609478	10q11.21	0	normal	.	G	ref	G	CA.GG	het-alt	373	0.51	.	1	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC10	IVS10	.	.	no-change	NM_020975.4	NP_066124.1	+	N	c.1879+355G=	.	.	.	NM_020975.4(RET): c.1879+355G=	;	5008	0.998602	U	0.0069	0.00139776	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs534767762	.	4024	0.992000	0.563	-0.142	-0.147	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43609477	43609478	10q11.21	0	normal	.	G	snv	A	CA.GG	het-ref	352	0.49	.	2	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC10	IVS10	.	.	intron	NM_020630.4	NP_065681.1	+	Y	c.1879+355G>A	.	.	.	NM_020630.4(RET): c.1879+355G>A	;	5008	0.001398	U	0.0069	0.00139776	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs534767762	.	4024	0.008000	0.563	-0.142	-0.147	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
10	43609477	43609478	10q11.21	0	normal	.	G	snv	A	CA.GG	het-ref	352	0.49	.	2	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC10	IVS10	.	.	intron	NM_020975.4	NP_066124.1	+	N	c.1879+355G>A	.	.	.	NM_020975.4(RET): c.1879+355G>A	;	5008	0.001398	U	0.0069	0.00139776	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs534767762	.	4024	0.008000	0.563	-0.142	-0.147	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
10	43610365	43610366	10q11.21	0	normal	.	G	ref	G	CT.TG	het-alt	274	0.51	.	1	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC11	IVS11	.	.	no-change	NM_020630.4	NP_065681.1	+	Y	c.2136+182G=	.	.	.	NM_020630.4(RET): c.2136+182G=	;maf-5-some-pop,maf-5-all-pops	5008	0.250200	U	0.4742	0.7498	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1864400	.	4024	0.457500	-1.844	-1.598	-1.652	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43610365	43610366	10q11.21	0	normal	.	G	ref	G	CT.TG	het-alt	274	0.51	.	1	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC11	IVS11	.	.	no-change	NM_020975.4	NP_066124.1	+	N	c.2136+182G=	.	.	.	NM_020975.4(RET): c.2136+182G=	;maf-5-some-pop,maf-5-all-pops	5008	0.250200	U	0.4742	0.7498	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1864400	.	4024	0.457500	-1.844	-1.598	-1.652	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43610365	43610366	10q11.21	0	normal	.	G	snv	A	CT.TG	het-ref	266	0.49	.	2	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC11	IVS11	.	.	intron	NM_020630.4	NP_065681.1	+	Y	c.2136+182G>A	.	.	.	NM_020630.4(RET): c.2136+182G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.749800	U	0.4742	0.7498	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1864400	.	4024	0.542500	-1.844	-1.598	-1.652	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43610365	43610366	10q11.21	0	normal	.	G	snv	A	CT.TG	het-ref	266	0.49	.	2	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC11	IVS11	.	.	intron	NM_020975.4	NP_066124.1	+	N	c.2136+182G>A	.	.	.	NM_020975.4(RET): c.2136+182G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.749800	U	0.4742	0.7498	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1864400	.	4024	0.542500	-1.844	-1.598	-1.652	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43610454	43610455	10q11.21	0	normal	.	T	ref	T	AC.GA	het-alt	202	0.46	.	1	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC11	IVS11	.	.	no-change	NM_020630.4	NP_065681.1	+	Y	c.2136+271T=	.	.	.	NM_020630.4(RET): c.2136+271T=	;maf-5-some-pop,maf-5-all-pops	5008	0.282149	U	0.4871	0.717851	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1864399	.	4024	0.449100	0.533	-1.274	-1.340	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43610454	43610455	10q11.21	0	normal	.	T	ref	T	AC.GA	het-alt	202	0.46	.	1	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC11	IVS11	.	.	no-change	NM_020975.4	NP_066124.1	+	N	c.2136+271T=	.	.	.	NM_020975.4(RET): c.2136+271T=	;maf-5-some-pop,maf-5-all-pops	5008	0.282149	U	0.4871	0.717851	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1864399	.	4024	0.449100	0.533	-1.274	-1.340	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43610454	43610455	10q11.21	0	normal	.	T	snv	C	AC.GA	het-ref	239	0.54	.	2	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC11	IVS11	.	.	intron	NM_020630.4	NP_065681.1	+	Y	c.2136+271T>C	.	.	.	NM_020630.4(RET): c.2136+271T>C	;maf-5-some-pop,maf-5-all-pops	5008	0.717851	U	0.4871	0.717851	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1864399	.	4024	0.550900	0.533	-1.274	-1.340	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43610454	43610455	10q11.21	0	normal	.	T	snv	C	AC.GA	het-ref	239	0.54	.	2	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC11	IVS11	.	.	intron	NM_020975.4	NP_066124.1	+	N	c.2136+271T>C	.	.	.	NM_020975.4(RET): c.2136+271T>C	;maf-5-some-pop,maf-5-all-pops	5008	0.717851	U	0.4871	0.717851	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1864399	.	4024	0.550900	0.533	-1.274	-1.340	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43610557	43610558	10q11.21	0	normal	.	C	ref	C	CC.GG	het-alt	306	0.53	.	1	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC11	IVS11	.	.	no-change	NM_020630.4	NP_065681.1	+	Y	c.2136+374C=	.	.	.	NM_020630.4(RET): c.2136+374C=	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	5008	0.287540	U	0.4742	0.71246	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2742233	.	4024	0.460500	-0.331	-0.206	-0.233	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43610557	43610558	10q11.21	0	normal	.	C	ref	C	CC.GG	het-alt	306	0.53	.	1	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC11	IVS11	.	.	no-change	NM_020975.4	NP_066124.1	+	N	c.2136+374C=	.	.	.	NM_020975.4(RET): c.2136+374C=	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	5008	0.287540	U	0.4742	0.71246	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2742233	.	4024	0.460500	-0.331	-0.206	-0.233	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43610557	43610558	10q11.21	0	normal	.	C	snv	T	CC.GG	het-ref	275	0.47	.	2	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC11	IVS11	.	.	intron	NM_020630.4	NP_065681.1	+	Y	c.2136+374C>T	.	.	.	NM_020630.4(RET): c.2136+374C>T	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	5008	0.712460	U	0.4742	0.71246	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2742233	.	4024	0.539500	-0.331	-0.206	-0.233	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43610557	43610558	10q11.21	0	normal	.	C	snv	T	CC.GG	het-ref	275	0.47	.	2	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC11	IVS11	.	.	intron	NM_020975.4	NP_066124.1	+	N	c.2136+374C>T	.	.	.	NM_020975.4(RET): c.2136+374C>T	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	5008	0.712460	U	0.4742	0.71246	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2742233	.	4024	0.539500	-0.331	-0.206	-0.233	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43611707	43611708	10q11.21	0	normal	.	A	ref	A	TC.GA	het-alt	270	0.53	.	1	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC11	IVS11	.	.	no-change	NM_020630.4	NP_065681.1	+	Y	c.2137-324A=	.	.	.	NM_020630.4(RET): c.2137-324A=	;maf-5-some-pop,maf-5-all-pops	5008	0.247005	U	0.4742	0.752995	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs741968	.	4024	0.456300	-2.477	-2.500	-2.838	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43611707	43611708	10q11.21	0	normal	.	A	ref	A	TC.GA	het-alt	270	0.53	.	1	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC11	IVS11	.	.	no-change	NM_020975.4	NP_066124.1	+	N	c.2137-324A=	.	.	.	NM_020975.4(RET): c.2137-324A=	;maf-5-some-pop,maf-5-all-pops	5008	0.247005	U	0.4742	0.752995	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs741968	.	4024	0.456300	-2.477	-2.500	-2.838	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43611707	43611708	10q11.21	0	normal	.	A	snv	G	TC.GA	het-ref	242	0.47	.	2	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC11	IVS11	.	.	intron	NM_020630.4	NP_065681.1	+	Y	c.2137-324A>G	.	.	.	NM_020630.4(RET): c.2137-324A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.752995	U	0.4742	0.752995	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs741968	.	4024	0.543700	-2.477	-2.500	-2.838	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43611707	43611708	10q11.21	0	normal	.	A	snv	G	TC.GA	het-ref	242	0.47	.	2	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC11	IVS11	.	.	intron	NM_020975.4	NP_066124.1	+	N	c.2137-324A>G	.	.	.	NM_020975.4(RET): c.2137-324A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.752995	U	0.4742	0.752995	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs741968	.	4024	0.543700	-2.477	-2.500	-2.838	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43613842	43613843	10q11.21	1	normal	.	G	ref	G	CT.CG	het-alt	250	0.50	.	1	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	C13	EX13	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_020630.4	NP_065681.1	+	Y	c.2307T>G	p.(L769=) | p.(Leu769=)	CTT=>CTG	.	NM_020630.4(RET): c.2307T>G (p.(L769=))	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125900	0.259261	U	0.4742	0.71246	13006	0.197370	PASS	-1094	8586	0.500116	4524	120892	0.258090	.	.	.	.	.	.	rs1800861	.	.	.	0.655	1.069	1.339	.	.	.	.	.	.	.	.	.	.	CM014825	NM_020975.4(RET): c.2307T>G (p.L769L)	"Hirschsprung disease, association with"	10528857	DP	.	.	.	.	Likely Benign
10	43613842	43613843	10q11.21	1	normal	.	G	ref	G	CT.CG	het-alt	250	0.50	.	1	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	C13	EX13	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_020975.4	NP_066124.1	+	N	c.2307T>G	p.(L769=) | p.(Leu769=)	CTT=>CTG	.	NM_020975.4(RET): c.2307T>G (p.(L769=))	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125900	0.259261	U	0.4742	0.71246	13006	0.197370	PASS	-1094	8586	0.500116	4524	120892	0.258090	.	.	.	.	.	.	rs1800861	.	.	.	0.655	1.069	1.339	.	.	.	.	.	.	.	.	.	.	CM014825	NM_020975.4(RET): c.2307T>G (p.L769L)	"Hirschsprung disease, association with"	10528857	DP	.	.	.	.	Likely Benign
10	43613842	43613843	10q11.21	0	normal	.	G	snv	T	CT.CG	het-ref	251	0.50	.	2	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	C13	EX13	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	no-change	NM_020630.4	NP_065681.1	+	Y	c.2307T=	.	.	.	NM_020630.4(RET): c.2307T=	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125900	0.740739	U	0.4742	0.71246	13006	0.802630	PASS	1052	8586	0.499884	33769	120892	0.741910	2200	8723	5.07328e-01	68119	181651	7.39176e-01	rs1800861	.	.	.	0.655	1.069	1.339	.	.	.	.	.	ENST00000355710: c.2307G>T (p.L769L)	biliary_tract [gallbladder|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4418405	.	.	.	.	.	no_record	167590	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
10	43613842	43613843	10q11.21	0	normal	.	G	snv	T	CT.CG	het-ref	251	0.50	.	2	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	C13	EX13	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	no-change	NM_020975.4	NP_066124.1	+	N	c.2307T=	.	.	.	NM_020975.4(RET): c.2307T=	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125900	0.740739	U	0.4742	0.71246	13006	0.802630	PASS	1052	8586	0.499884	33769	120892	0.741910	2200	8723	5.07328e-01	68119	181651	7.39176e-01	rs1800861	.	.	.	0.655	1.069	1.339	.	.	.	.	.	ENST00000355710: c.2307G>T (p.L769L)	biliary_tract [gallbladder|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4418405	.	.	.	.	.	no_record	167590	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
10	43622216	43622217	10q11.21	0	normal	.	T	ref	T	CT.TG	het-alt	220	0.52	.	1	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	3U1E	EX19E	.	.	utr-3	NM_020630.4	NP_065681.1	+	Y	c.*15C>T	.	.	.	NM_020630.4(RET): c.*15C>T	;maf-5-some-pop	108870	0.199118	U	0.4762	0.754992	13002	0.146670	PASS	-894	6472	0.464771	1980	103862	0.196906	.	.	.	.	.	.	rs2075912	.	.	.	-0.226	2.175	1.101	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43622216	43622217	10q11.21	0	normal	.	T	ref	T	CT.TG	het-alt	220	0.52	.	1	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC19	IVS19	.	.	no-change	NM_020975.4	NP_066124.1	+	N	c.3187+47T=	.	.	.	NM_020975.4(RET): c.3187+47T=	;maf-5-some-pop	108870	0.199118	U	0.4762	0.754992	13002	0.146670	PASS	-894	6472	0.464771	1980	103862	0.196906	.	.	.	.	.	.	rs2075912	.	.	.	-0.226	2.175	1.101	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	43622216	43622217	10q11.21	0	normal	.	T	snv	C	CT.TG	het-ref	204	0.48	.	2	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	3U1E	EX19E	.	.	no-change	NM_020630.4	NP_065681.1	+	Y	c.*15C=	.	.	.	NM_020630.4(RET): c.*15C=	;maf-5-some-pop	108870	0.800882	U	0.4762	0.754992	13002	0.853330	PASS	838	6472	0.535229	33460	103862	0.803094	2057	8181	5.13430e-01	72912	182343	7.90877e-01	rs2075912	.	.	.	-0.226	2.175	1.101	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	165056	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
10	43622216	43622217	10q11.21	0	normal	.	T	snv	C	CT.TG	het-ref	204	0.48	.	2	.	PASS	164761	C	142623(SK);155240(MK);162300(MK);171300(MK);171400(MK);191830(MK);209880(MK)	AD;AR	Multiple endocrine neoplasia, type IIA; Multiple endocrine neoplasia IIB; Medullary thyroid carcinoma, familial; Pheochromocytoma; Hirschsprung disease, susceptibility to	AD/AR	Allelic with Renal agenesis (AD); Central hypoventilation syndrome (AD), though the data are mixed (eg, one reported patient was later found to have a mutation in a gene with more evidence for involvement in the condition)	Endocrine; Gastrointestinal; Neurologic; Oncologic; Renal	Endocrine; Gastrointestinal; Oncologic	23114404|22715565|20598273|20301434|19856714|19469690|18273880|18252215|17898100|17895320|17167516|17108762|16986122|16443855|16205644|16162881|16091499|15870131|15829955|15827097|15805159|15759212|15741265|15240649|15138456|14602786|14600022|14561794|12788868|12466368|12355085|12214285|12116277|12086152|12000816|11953745|11932300|11815959|11788682|11753660|11739416|11502806|11436122|11238493|11232007|11103773|10982477|10922382|10777380|10528857|10522989|10521317|10458491|10323403|10090908|9824583|9760196|9621513|9506724|9497256|9384613|9111992|9097963|9090527|8981969|8852653|8826440|8825918|8757765|8114938|8103403|8099202|8094268|7977365|7915165|7914213|7911697|7907913|7906866|7906417|7845675|7815416|7784092|7633441|7581377|6047980|5844561|5637238|4968712|4957444|4695886|4386574|3697657|2904651|2563193|1110583|1063979|980061|554522	FC59;H41;H54;H62;H68;HE15;MC58	5979	RET	IC19	IVS19	.	.	intron	NM_020975.4	NP_066124.1	+	N	c.3187+47T>C	.	.	.	NM_020975.4(RET): c.3187+47T>C	;maf-5-some-pop	108870	0.800882	U	0.4762	0.754992	13002	0.853330	PASS	838	6472	0.535229	33460	103862	0.803094	2057	8181	5.13430e-01	72912	182343	7.90877e-01	rs2075912	.	.	.	-0.226	2.175	1.101	.	.	.	.	.	.	.	.	.	.	CS032426	NM_020975.4(RET): c.3187+47T>C	"Hirschsprung disease, association with"	12872262	DP	no_record	165056	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
10	51583018	51583021	10q11.23	0	normal	.	ATT	ref	ATT	TC.GT	het-alt	114	0.52	.	1	.	PASS	601984	C	188550(MK)	AD	.	.	.	.	.	.	.	8031	NCOA4	IC7	IVS8	.	.	no-change	NM_001145260.1	NP_001138732.1	+	Y	c.762+80_762+82=	.	.	.	NM_001145260.1(NCOA4): c.762+80_762+82=	MixedObserved;maf-5-some-pop,maf-5-all-pops	5008	0.703674	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs34542065	.	4024	0.579500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	51583018	51583021	10q11.23	0	normal	.	ATT	del	.	TC.GT	het-ref	106	0.48	.	2	.	PASS	601984	C	188550(MK)	AD	.	.	.	.	.	.	.	8031	NCOA4	IC7	IVS8	.	.	intron	NM_001145260.1	NP_001138732.1	+	Y	c.762+80_762+82delATT	.	.	.	NM_001145260.1(NCOA4): c.762+80_762+82delATT	MixedObserved;maf-5-some-pop,maf-5-all-pops	5008	0.296326	U	0.4216	0.296326	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs34542065	.	4024	0.420500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	72358576	72358577	10q22.1	0	nullSample	.	G	ref	G	GA.TG	homo-ref	.	.	.	0	.	.	170280	C	603553(MK);605027(MK)	NN	Hemophagocytic lymphohistiocytosis, familial, 2; Lymphoma, non-Hodgkin; Aplastic anemia, adult-onset 	AR	.	Allergy/Immunology/Infectious; Hematologic; Oncologic	Allergy/Immunology/Infectious; Hematologic; Oncologic	23443029|22359105|22186995|22029169|21959744|21936944|17873118|17311987|15728124|15659737|14757862|12358924|12229880|10583959	.	5551	PRF1	C2E	EX3E	.	.	no-change	NM_001083116.1	NP_001076585.1	-	Y	c.900C=	.	.	.	NM_001083116.1(PRF1): c.900C=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126364	0.361962	U	0.7341	0.695887	13006	0.337613	PASS	.	8644	0.235192	8474	121356	0.364350	.	.	.	.	.	.	rs885822	.	4024	0.267900	-1.062	-3.744	-3.441	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	72358576	72358577	10q22.1	1	normal	.	G	snv	A	GA.TG	hom-alt	427	1.00	.	0	.	PASS	170280	C	603553(MK);605027(MK)	NN	Hemophagocytic lymphohistiocytosis, familial, 2; Lymphoma, non-Hodgkin; Aplastic anemia, adult-onset 	AR	.	Allergy/Immunology/Infectious; Hematologic; Oncologic	Allergy/Immunology/Infectious; Hematologic; Oncologic	23443029|22359105|22186995|22029169|21959744|21936944|17873118|17311987|15728124|15659737|14757862|12358924|12229880|10583959	.	5551	PRF1	C2E	EX3E	.	.	coding-synon	NM_001083116.1	NP_001076585.1	-	Y	c.900C>T	p.(H300=) | p.(His300=)	CAC=>CAT	.	NM_001083116.1(PRF1): c.900C>T (p.(H300=))	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126364	0.638038	U	0.7341	0.695887	13006	0.662387	PASS	2531	8644	0.764808	24936	121356	0.635650	5032	13167	7.63393e-01	50565	156635	6.36200e-01	rs885822	.	4024	0.732100	-1.062	-3.744	-3.441	.	.	.	.	.	ENST00000373209: c.900C>T (p.H300H)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3765513	.	.	.	.	.	no_record	257409	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
10	73326578	73326579	10q22.1	0	normal	.	C	ref	C	TC.TT	het-alt	334	0.52	.	1	.	PASS	605516	C	601067(MK);601386(MK)	NN	Deafness, autosomal recessive 12; Usher syndrome, type 1D; Usher syndrome, type 1D /F digenic	AR	.	Audiologic/Otolaryngologic; Ophthalmologic	Audiologic/Otolaryngologic	17850630|15537665|11138009|11138008|11090341	.	64072	CDH23	C6	EX7	Cadherin domain	PF00028.12	no-change	NM_022124.5	NP_071407.4	+	Y	c.510C=	.	.	.	NM_022124.5(CDH23): c.510C=	;	125190	0.997236	U	0.0327	0.00658946	12446	0.999920	PASS	.	8608	0.972235	59780	120182	0.997396	.	.	.	.	.	.	rs143341423	.	4024	0.972700	-0.254	0.445	0.286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	73326578	73326579	10q22.1	1	normal	.	C	snv	T	TC.TT	het-ref	313	0.48	.	2	.	PASS	605516	C	601067(MK);601386(MK)	NN	Deafness, autosomal recessive 12; Usher syndrome, type 1D; Usher syndrome, type 1D /F digenic	AR	.	Audiologic/Otolaryngologic; Ophthalmologic	Audiologic/Otolaryngologic	17850630|15537665|11138009|11138008|11090341	.	64072	CDH23	C6	EX7	Cadherin domain	PF00028.12	coding-synon	NM_022124.5	NP_071407.4	+	Y	c.510C>T	p.(S170=) | p.(Ser170=)	TCC=>TCT	.	NM_022124.5(CDH23): c.510C>T (p.(S170=))	;	125190	0.002764	U	0.0327	0.00658946	12446	0.000080	PASS	2	8608	0.027765	2	120182	0.002604	5	457	2.65050e-02	5	679	2.75913e-03	rs143341423	.	4024	0.027300	-0.254	0.445	0.286	.	.	.	.	.	ENST00000398809: c.510C>T (p.S170S)	skin [head_neck|NS|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	CSV	4498031	.	.	.	.	.	no_record	45966	criteria_provided,_single_submitter	Benign	VUS
10	73326756	73326757	10q22.1	0	nullSample	.	C	ref	C	GA.GG	homo-ref	.	.	.	0	.	.	605516	C	601067(MK);601386(MK)	NN	Deafness, autosomal recessive 12; Usher syndrome, type 1D; Usher syndrome, type 1D /F digenic	AR	.	Audiologic/Otolaryngologic; Ophthalmologic	Audiologic/Otolaryngologic	17850630|15537665|11138009|11138008|11090341	.	64072	CDH23	IC6	IVS7	.	.	no-change	NM_022124.5	NP_071407.4	+	Y	c.624+64C=	.	.	.	NM_022124.5(CDH23): c.624+64C=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.592252	U	0.5109	0.407748	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7087735	.	4024	0.467900	-1.322	-1.154	-1.688	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	73326756	73326757	10q22.1	0	normal	.	C	snv	T	GA.GG	hom-alt	342	1.00	.	0	.	PASS	605516	C	601067(MK);601386(MK)	NN	Deafness, autosomal recessive 12; Usher syndrome, type 1D; Usher syndrome, type 1D /F digenic	AR	.	Audiologic/Otolaryngologic; Ophthalmologic	Audiologic/Otolaryngologic	17850630|15537665|11138009|11138008|11090341	.	64072	CDH23	IC6	IVS7	.	.	intron	NM_022124.5	NP_071407.4	+	Y	c.624+64C>T	.	.	.	NM_022124.5(CDH23): c.624+64C>T	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.407748	U	0.5109	0.407748	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7087735	.	4024	0.532100	-1.322	-1.154	-1.688	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	73434887	73434888	10q22.1	0	nullSample	.	G	ref	G	AG.CA	homo-ref	.	.	.	0	.	.	605516	C	601067(MK);601386(MK)	NN	Deafness, autosomal recessive 12; Usher syndrome, type 1D; Usher syndrome, type 1D /F digenic	AR	.	Audiologic/Otolaryngologic; Ophthalmologic	Audiologic/Otolaryngologic	17850630|15537665|11138009|11138008|11090341	.	64072	CDH23	C14	EX15	Cadherin domain	PF00028.12	no-change	NM_022124.5	NP_071407.4	+	Y	c.1469G=	.	.	.	NM_022124.5(CDH23): c.1469G=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	125496	0.800775	U	0.2887	0.185304	12674	0.878807	PASS	.	8600	0.688721	38946	120488	0.800196	.	.	.	.	.	.	rs1227049	.	4024	0.696800	0.655	5.548	2.693	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	73434887	73434888	10q22.1	1	normal	.	G	snv	C	AG.CA	hom-alt	397	1.00	.	0	.	PASS	605516	C	601067(MK);601386(MK)	NN	Deafness, autosomal recessive 12; Usher syndrome, type 1D; Usher syndrome, type 1D /F digenic	AR	.	Audiologic/Otolaryngologic; Ophthalmologic	Audiologic/Otolaryngologic	17850630|15537665|11138009|11138008|11090341	.	64072	CDH23	C14	EX15	Cadherin domain	PF00028.12	missense	NM_022124.5	NP_071407.4	+	Y	c.1469G>C	p.G490A | p.Gly490Ala	GGC=>GCC	P0=>NP	NM_022124.5(CDH23): c.1469G>C (p.G490A)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	125496	0.199225	U	0.2887	0.185304	12674	0.121193	PASS	394	8600	0.311279	2776	120488	0.199804	776	5195	3.01509e-01	5856	49484	2.01184e-01	rs1227049	.	4024	0.303200	0.655	5.548	2.693	.	.	.	.	.	ENST00000398860: c.1484G>C (p.G495A)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3998079	.	.	.	.	.	no_record	45872	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
10	73439100	73439101	10q22.1	0	normal	.	T	snv	C	AG.CT	hom-alt	87	1.00	.	0	.	PASS	605516	C	601067(MK);601386(MK)	NN	Deafness, autosomal recessive 12; Usher syndrome, type 1D; Usher syndrome, type 1D /F digenic	AR	.	Audiologic/Otolaryngologic; Ophthalmologic	Audiologic/Otolaryngologic	17850630|15537665|11138009|11138008|11090341	.	64072	CDH23	IC15	IVS16	.	.	intron	NM_022124.5	NP_071407.4	+	Y	c.1753-43T>C	.	.	.	NM_022124.5(CDH23): c.1753-43T>C	;maf-5-some-pop	90084	0.959771	U	0.999	0.915136	12126	0.928418	PASS	2816	5650	0.998407	39454	85076	0.962398	7421	14865	9.98455e-01	97043	202493	9.55751e-01	rs1227042	.	4024	0.985300	-0.994	-3.446	-3.502	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	261543	criteria_provided,_single_submitter	Benign	Benign
10	73439100	73439101	10q22.1	0	nullSample	.	T	ref	T	AG.CT	homo-ref	.	.	.	0	.	.	605516	C	601067(MK);601386(MK)	NN	Deafness, autosomal recessive 12; Usher syndrome, type 1D; Usher syndrome, type 1D /F digenic	AR	.	Audiologic/Otolaryngologic; Ophthalmologic	Audiologic/Otolaryngologic	17850630|15537665|11138009|11138008|11090341	.	64072	CDH23	IC15	IVS16	.	.	no-change	NM_022124.5	NP_071407.4	+	Y	c.1753-43T=	.	.	.	NM_022124.5(CDH23): c.1753-43T=	;maf-5-some-pop	90084	0.040229	U	0.999	0.915136	12126	0.071582	PASS	.	5650	0.001593	115	85076	0.037602	.	.	.	.	.	.	rs1227042	.	4024	0.014700	-0.994	-3.446	-3.502	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	73450206	73450207	10q22.1	0	normal	.	A	ref	A	CC.CC	het-alt	35	0.61	.	1	.	DUBIOUS	605516	C	601067(MK);601386(MK)	NN	Deafness, autosomal recessive 12; Usher syndrome, type 1D; Usher syndrome, type 1D /F digenic	AR	.	Audiologic/Otolaryngologic; Ophthalmologic	Audiologic/Otolaryngologic	17850630|15537665|11138009|11138008|11090341	.	64072	CDH23	IC18	IVS19	.	.	no-change	NM_022124.5	NP_071407.4	+	Y	c.2060-18A=	.	.	.	NM_022124.5(CDH23): c.2060-18A=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4012	0.971300	-1.491	-1.639	-1.286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	73450206	73450207	10q22.1	1	normal	.	A	snv	C	CC.CC	het-ref	22	0.39	.	2	.	DUBIOUS	605516	C	601067(MK);601386(MK)	NN	Deafness, autosomal recessive 12; Usher syndrome, type 1D; Usher syndrome, type 1D /F digenic	AR	.	Audiologic/Otolaryngologic; Ophthalmologic	Audiologic/Otolaryngologic	17850630|15537665|11138009|11138008|11090341	.	64072	CDH23	IC18	IVS19	.	.	intron	NM_022124.5	NP_071407.4	+	Y	c.2060-18A>C	.	.	.	NM_022124.5(CDH23): c.2060-18A>C	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4012	0.028700	-1.491	-1.639	-1.286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
10	76781905	76781908	10q22.2	0	nullSample	.	GAA	ref	GAA	ag.ga	homo-ref	.	.	.	0	GA-rich|Low_complexity|Low_complexity|+|105;trf	.	605880	P	603736(MK);606170(MK)	NN	Ohdo syndrome, SBBYS variant; Genitopatellar syndrome	AD	.	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Audiologic/Otolaryngologic; Endocrine	23236640|22265014|22077973|21412151|16761293|12949978|12210330|12210329	.	23522	KAT6B	C14	EX16	.	.	no-change	NM_012330.3	NP_036462.2	+	Y	c.3289_3291=	.	.	.	NM_012330.3(KAT6B): c.3289_3291=	MixedObserved;maf-5-some-pop,maf-5-all-pops	4997	0.540324	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs71929101	.	4024	0.644400	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	76781905	76781908	10q22.2	1	normal	.	GAA	del	.	ag.ga	hom-alt	321	1.00	.	0	GA-rich|Low_complexity|Low_complexity|+|105;trf	PASS	605880	P	603736(MK);606170(MK)	NN	Ohdo syndrome, SBBYS variant; Genitopatellar syndrome	AD	.	Audiologic/Otolaryngologic; Craniofacial; Dental; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Audiologic/Otolaryngologic; Endocrine	23236640|22265014|22077973|21412151|16761293|12949978|12210330|12210329	.	23522	KAT6B	C14	EX16	.	.	cds-del	NM_012330.3	NP_036462.2	+	Y	c.3289GAA[8>7] (std: c.3289GAA[7] alt: c.3310_3312delGAA )	p.E1091[14>13] (std: p.E1091[13] alt: p.E1104del ) | p.Glu1091[14>13] (std: p.Glu1091[13] alt: p.Glu1104del )	.	.	NM_012330.3(KAT6B): c.3289GAA[7] (p.E1091[13])	MixedObserved;maf-5-some-pop,maf-5-all-pops	4997	0.459676	U	0.373	0.458666	.	.	VQSRTrancheINDEL95.00to96.00	482	8232	0.365525	5316	113476	0.250670	.	.	.	.	.	.	rs71929101	.	4024	0.355600	.	.	.	.	.	.	.	.	ENST00000287239: c.3289_3291delGAA (p.E1097delE)	breast [NS|NS|NS]	carcinoma [ER-positive_carcinoma|NS|NS]	CSV	111693	.	.	.	.	.	no_record	211214	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
10	88635778	88635779	10q23.2	0	nullSample	.	C	ref	C	TG.CT	homo-ref	.	.	.	0	.	.	601299	C	174900(MK);610069(MK)	AD	Polyposis syndrome, hereditary mixed, 2; Polyposis, juvenile intestinal	AD	.	Oncologic	Oncologic	22810475|22171123|20843829|17873119|16525031|16152648|15235019|12136244|11381269|8037173|7582207|7059958|5483654|4544011|3707330	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	657	BMPR1A	C1	EX3	.	.	no-change	NM_004329.2	NP_004320.2	+	Y	c.4C=	.	.	.	NM_004329.2(BMPR1A): c.4C=	;maf-5-some-pop,maf-5-all-pops	126306	0.638473	U	0.7093	0.4998	13006	0.610487	PASS	-858	8646	0.280592	26649	121298	0.644182	.	.	.	.	.	.	rs11528010	.	4024	0.254000	-0.374	1.784	0.956	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	88635778	88635779	10q23.2	1	normal	.	C	snv	A	TG.CT	hom-alt	244	1.00	.	0	.	DUBIOUS	601299	C	174900(MK);610069(MK)	AD	Polyposis syndrome, hereditary mixed, 2; Polyposis, juvenile intestinal	AD	.	Oncologic	Oncologic	22810475|22171123|20843829|17873119|16525031|16152648|15235019|12136244|11381269|8037173|7582207|7059958|5483654|4544011|3707330	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	657	BMPR1A	C1	EX3	.	.	missense	NM_004329.2	NP_004320.2	+	Y	c.4C>A	p.P2T | p.Pro2Thr	CCT=>ACT	NP=>P0	NM_004329.2(BMPR1A): c.4C>A (p.P2T)	;maf-5-some-pop,maf-5-all-pops	126306	0.361527	U	0.7093	0.4998	13006	0.389513	PASS	2252	8646	0.719408	9160	121298	0.355818	4502	12432	7.21114e-01	18261	87521	3.55904e-01	rs11528010	.	4024	0.746000	-0.374	1.784	0.956	1	0	0	0.000	neutral	ENST00000224764: c.4C>A (p.P2T)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3752019	.	.	.	.	.	Paralog	41782	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Unknown
10	88649762	88649763	10q23.2	0	nullSample	.	C	ref	C	CA.GA	homo-ref	.	.	.	0	.	.	601299	C	174900(MK);610069(MK)	AD	Polyposis syndrome, hereditary mixed, 2; Polyposis, juvenile intestinal	AD	.	Oncologic	Oncologic	22810475|22171123|20843829|17873119|16525031|16152648|15235019|12136244|11381269|8037173|7582207|7059958|5483654|4544011|3707330	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	657	BMPR1A	IC1	IVS3	.	.	no-change	NM_004329.2	NP_004320.2	+	Y	c.68-56C=	.	.	.	NM_004329.2(BMPR1A): c.68-56C=	;maf-5-some-pop,maf-5-all-pops	5008	0.468850	U	0.7153	0.53115	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7087358	.	4024	0.246300	-0.269	0.023	0.126	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	88649762	88649763	10q23.2	0	normal	.	C	snv	T	CA.GA	hom-alt	312	1.00	.	0	.	PASS	601299	C	174900(MK);610069(MK)	AD	Polyposis syndrome, hereditary mixed, 2; Polyposis, juvenile intestinal	AD	.	Oncologic	Oncologic	22810475|22171123|20843829|17873119|16525031|16152648|15235019|12136244|11381269|8037173|7582207|7059958|5483654|4544011|3707330	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	657	BMPR1A	IC1	IVS3	.	.	intron	NM_004329.2	NP_004320.2	+	Y	c.68-56C>T	.	.	.	NM_004329.2(BMPR1A): c.68-56C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.531150	U	0.7153	0.53115	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7087358	.	4024	0.753700	-0.269	0.023	0.126	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	88683121	88683122	10q23.2	0	nullSample	.	T	ref	T	CA.TC	homo-ref	.	.	.	0	.	.	601299	C	174900(MK);610069(MK)	AD	Polyposis syndrome, hereditary mixed, 2; Polyposis, juvenile intestinal	AD	.	Oncologic	Oncologic	22810475|22171123|20843829|17873119|16525031|16152648|15235019|12136244|11381269|8037173|7582207|7059958|5483654|4544011|3707330	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	657	BMPR1A	IC9	IVS11	.	.	no-change	NM_004329.2	NP_004320.2	+	Y	c.1343-11T=	.	.	.	NM_004329.2(BMPR1A): c.1343-11T=	;maf-5-some-pop,maf-5-all-pops	126294	0.640577	U	0.7004	0.496605	13006	0.610180	PASS	.	8630	0.280070	26812	121286	0.646241	.	.	.	.	.	.	rs7074064	.	4024	0.254500	-0.181	-0.292	-0.146	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	88683121	88683122	10q23.2	1	normal	.	T	snv	C	CA.TC	hom-alt	557	1.00	.	0	.	PASS	601299	C	174900(MK);610069(MK)	AD	Polyposis syndrome, hereditary mixed, 2; Polyposis, juvenile intestinal	AD	.	Oncologic	Oncologic	22810475|22171123|20843829|17873119|16525031|16152648|15235019|12136244|11381269|8037173|7582207|7059958|5483654|4544011|3707330	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	657	BMPR1A	IC9	IVS11	.	.	intron	NM_004329.2	NP_004320.2	+	Y	c.1343-11T>C	.	.	.	NM_004329.2(BMPR1A): c.1343-11T>C	;maf-5-some-pop,maf-5-all-pops	126294	0.359423	U	0.7004	0.496605	13006	0.389820	PASS	2247	8630	0.719930	9075	121286	0.353759	4499	12429	7.20940e-01	17968	86793	3.52616e-01	rs7074064	.	4024	0.745500	-0.181	-0.292	-0.146	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	259286	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
10	89623715	89623716	10q23.31	0	normal	.	G	snv	A	GG.GG	het-ref	79	0.48	.	2	.	PASS	601728	C	153480(MK);155600(MK);158350(MK);176807(SK);188470(MK);275355(MK);276950(MK);601728(MK);605309(MK);607174(SK);608089(MK);613028(SK)	AD;AR	PTEN hamartoma tumor syndrome; Cowden syndrome; Bannayan-Riley-Ruvalcaba syndrome; Lhermitte-Duclos syndrome; Glioma susceptibility 2; Meningioma, familial; Endometrial cancer	AD	Allelic with Macrocephaly/autism syndrome (AD) (without reported associated malignancies); Reported as allelic with VACTERL association with hydrocephalus (AD)	Craniofacial; Dermatologic; Neurologic; Oncologic	Oncologic	23344409|23335809|22970944|22595938|21956414|21659347|21633361|20301661|18781191|17847000|17526801|17526800|17286265|16752378|16704655|15805158|14566704|14518069|12938083|12833416|12085208|11875759|11748304|11238682|10400993|10353779|10234502|9856571|9832032|9832031|9662392|9545417|9445133|9425889|9399897|9286463|9259288|9241266|9140396|8207516|7449178|7079022|6881215|6507473|5345120|5091590|3707175|3698331|3340479|1350505|1336932|957004	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HR14;MC58;MH43	5728	PTEN	5U1E	EX1	.	.	utr-5	NM_000314.4	NP_000305.3	+	Y	c.-510G>A	.	.	.	NM_000314.4(PTEN): c.-510G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.160343	U	0.3313	0.160343	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12573787	.	.	.	0.480	1.153	1.810	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	89623715	89623716	10q23.31	0	normal	.	G	ref	G	GG.GG	het-alt	87	0.52	.	1	.	PASS	601728	C	153480(MK);155600(MK);158350(MK);176807(SK);188470(MK);275355(MK);276950(MK);601728(MK);605309(MK);607174(SK);608089(MK);613028(SK)	AD;AR	PTEN hamartoma tumor syndrome; Cowden syndrome; Bannayan-Riley-Ruvalcaba syndrome; Lhermitte-Duclos syndrome; Glioma susceptibility 2; Meningioma, familial; Endometrial cancer	AD	Allelic with Macrocephaly/autism syndrome (AD) (without reported associated malignancies); Reported as allelic with VACTERL association with hydrocephalus (AD)	Craniofacial; Dermatologic; Neurologic; Oncologic	Oncologic	23344409|23335809|22970944|22595938|21956414|21659347|21633361|20301661|18781191|17847000|17526801|17526800|17286265|16752378|16704655|15805158|14566704|14518069|12938083|12833416|12085208|11875759|11748304|11238682|10400993|10353779|10234502|9856571|9832032|9832031|9662392|9545417|9445133|9425889|9399897|9286463|9259288|9241266|9140396|8207516|7449178|7079022|6881215|6507473|5345120|5091590|3707175|3698331|3340479|1350505|1336932|957004	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HR14;MC58;MH43	5728	PTEN	5U1E	EX1	.	.	no-change	NM_000314.4	NP_000305.3	+	Y	c.-510G=	.	.	.	NM_000314.4(PTEN): c.-510G=	;maf-5-some-pop,maf-5-all-pops	5008	0.839657	U	0.3313	0.160343	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12573787	.	.	.	0.480	1.153	1.810	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	89623860	89623861	10q23.31	0	nullSample	.	T	ref	T	GC.GG	homo-ref	.	.	.	0	.	.	601728	C	153480(MK);155600(MK);158350(MK);176807(SK);188470(MK);275355(MK);276950(MK);601728(MK);605309(MK);607174(SK);608089(MK);613028(SK)	AD;AR	PTEN hamartoma tumor syndrome; Cowden syndrome; Bannayan-Riley-Ruvalcaba syndrome; Lhermitte-Duclos syndrome; Glioma susceptibility 2; Meningioma, familial; Endometrial cancer	AD	Allelic with Macrocephaly/autism syndrome (AD) (without reported associated malignancies); Reported as allelic with VACTERL association with hydrocephalus (AD)	Craniofacial; Dermatologic; Neurologic; Oncologic	Oncologic	23344409|23335809|22970944|22595938|21956414|21659347|21633361|20301661|18781191|17847000|17526801|17526800|17286265|16752378|16704655|15805158|14566704|14518069|12938083|12833416|12085208|11875759|11748304|11238682|10400993|10353779|10234502|9856571|9832032|9832031|9662392|9545417|9445133|9425889|9399897|9286463|9259288|9241266|9140396|8207516|7449178|7079022|6881215|6507473|5345120|5091590|3707175|3698331|3340479|1350505|1336932|957004	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HR14;MC58;MH43	5728	PTEN	5U1E	EX1	.	.	utr-5	NM_000314.4	NP_000305.3	+	Y	c.-366_-365insT	.	.	.	NM_000314.4(PTEN): c.-366_-365insT	DuplicateObserved;	5008	0.000000	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs71022512	.	.	.	0.000	0.000	0.000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
10	89623860	89623861	10q23.31	0	normal	.	T	del	.	GC.GG	hom-alt	296	0.95	.	0	.	PASS	601728	C	153480(MK);155600(MK);158350(MK);176807(SK);188470(MK);275355(MK);276950(MK);601728(MK);605309(MK);607174(SK);608089(MK);613028(SK)	AD;AR	PTEN hamartoma tumor syndrome; Cowden syndrome; Bannayan-Riley-Ruvalcaba syndrome; Lhermitte-Duclos syndrome; Glioma susceptibility 2; Meningioma, familial; Endometrial cancer	AD	Allelic with Macrocephaly/autism syndrome (AD) (without reported associated malignancies); Reported as allelic with VACTERL association with hydrocephalus (AD)	Craniofacial; Dermatologic; Neurologic; Oncologic	Oncologic	23344409|23335809|22970944|22595938|21956414|21659347|21633361|20301661|18781191|17847000|17526801|17526800|17286265|16752378|16704655|15805158|14566704|14518069|12938083|12833416|12085208|11875759|11748304|11238682|10400993|10353779|10234502|9856571|9832032|9832031|9662392|9545417|9445133|9425889|9399897|9286463|9259288|9241266|9140396|8207516|7449178|7079022|6881215|6507473|5345120|5091590|3707175|3698331|3340479|1350505|1336932|957004	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HR14;MC58;MH43	5728	PTEN	5U1E	EX1	.	.	no-change	NM_000314.4	NP_000305.3	+	Y	c.=	.	.	.	NM_000314.4(PTEN): c.=	DuplicateObserved;	5008	1.000000	U	1	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs71022512	.	.	.	0.000	0.000	0.000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	440216	criteria_provided,_single_submitter	Benign	Benign
10	89623900	89623901	10q23.31	0	nullSample	.	G	ref	G	GT.cg	homo-ref	.	.	.	0	GC_rich|Low_complexity|Low_complexity|+|49	.	601728	C	153480(MK);155600(MK);158350(MK);176807(SK);188470(MK);275355(MK);276950(MK);601728(MK);605309(MK);607174(SK);608089(MK);613028(SK)	AD;AR	PTEN hamartoma tumor syndrome; Cowden syndrome; Bannayan-Riley-Ruvalcaba syndrome; Lhermitte-Duclos syndrome; Glioma susceptibility 2; Meningioma, familial; Endometrial cancer	AD	Allelic with Macrocephaly/autism syndrome (AD) (without reported associated malignancies); Reported as allelic with VACTERL association with hydrocephalus (AD)	Craniofacial; Dermatologic; Neurologic; Oncologic	Oncologic	23344409|23335809|22970944|22595938|21956414|21659347|21633361|20301661|18781191|17847000|17526801|17526800|17286265|16752378|16704655|15805158|14566704|14518069|12938083|12833416|12085208|11875759|11748304|11238682|10400993|10353779|10234502|9856571|9832032|9832031|9662392|9545417|9445133|9425889|9399897|9286463|9259288|9241266|9140396|8207516|7449178|7079022|6881215|6507473|5345120|5091590|3707175|3698331|3340479|1350505|1336932|957004	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HR14;MC58;MH43	5728	PTEN	5U1E	EX1	.	.	utr-5	NM_000314.4	NP_000305.3	+	Y	c.-326C>G	.	.	.	NM_000314.4(PTEN): c.-326C>G	;	5008	0.000000	U	1	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2943772	.	.	.	-0.334	0.988	0.683	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	89623900	89623901	10q23.31	0	normal	.	G	snv	C	GT.cg	hom-alt	381	0.99	.	0	GC_rich|Low_complexity|Low_complexity|+|49	PASS	601728	C	153480(MK);155600(MK);158350(MK);176807(SK);188470(MK);275355(MK);276950(MK);601728(MK);605309(MK);607174(SK);608089(MK);613028(SK)	AD;AR	PTEN hamartoma tumor syndrome; Cowden syndrome; Bannayan-Riley-Ruvalcaba syndrome; Lhermitte-Duclos syndrome; Glioma susceptibility 2; Meningioma, familial; Endometrial cancer	AD	Allelic with Macrocephaly/autism syndrome (AD) (without reported associated malignancies); Reported as allelic with VACTERL association with hydrocephalus (AD)	Craniofacial; Dermatologic; Neurologic; Oncologic	Oncologic	23344409|23335809|22970944|22595938|21956414|21659347|21633361|20301661|18781191|17847000|17526801|17526800|17286265|16752378|16704655|15805158|14566704|14518069|12938083|12833416|12085208|11875759|11748304|11238682|10400993|10353779|10234502|9856571|9832032|9832031|9662392|9545417|9445133|9425889|9399897|9286463|9259288|9241266|9140396|8207516|7449178|7079022|6881215|6507473|5345120|5091590|3707175|3698331|3340479|1350505|1336932|957004	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HR14;MC58;MH43	5728	PTEN	5U1E	EX1	.	.	no-change	NM_000314.4	NP_000305.3	+	Y	c.-326C=	.	.	.	NM_000314.4(PTEN): c.-326C=	;	5008	1.000000	U	1	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2943772	.	.	.	-0.334	0.988	0.683	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	440217	criteria_provided,_single_submitter	Benign	Benign
10	89720632	89720633	10q23.31	0	normal	.	C	ref	C	tt.tt	het-alt	138	0.62	.	1	(T)n|Simple_repeat|Simple_repeat|+|30	PASS	601728	C	153480(MK);155600(MK);158350(MK);176807(SK);188470(MK);275355(MK);276950(MK);601728(MK);605309(MK);607174(SK);608089(MK);613028(SK)	AD;AR	PTEN hamartoma tumor syndrome; Cowden syndrome; Bannayan-Riley-Ruvalcaba syndrome; Lhermitte-Duclos syndrome; Glioma susceptibility 2; Meningioma, familial; Endometrial cancer	AD	Allelic with Macrocephaly/autism syndrome (AD) (without reported associated malignancies); Reported as allelic with VACTERL association with hydrocephalus (AD)	Craniofacial; Dermatologic; Neurologic; Oncologic	Oncologic	23344409|23335809|22970944|22595938|21956414|21659347|21633361|20301661|18781191|17847000|17526801|17526800|17286265|16752378|16704655|15805158|14566704|14518069|12938083|12833416|12085208|11875759|11748304|11238682|10400993|10353779|10234502|9856571|9832032|9832031|9662392|9545417|9445133|9425889|9399897|9286463|9259288|9241266|9140396|8207516|7449178|7079022|6881215|6507473|5345120|5091590|3707175|3698331|3340479|1350505|1336932|957004	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HR14;MC58;MH43	5728	PTEN	IC7	IVS7	.	.	no-change	NM_000314.4	NP_000305.3	+	Y	c.802-18C=	.	.	.	NM_000314.4(PTEN): c.802-18C=	;clinically-assoc,submitted-by-lsdb	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs376702513	.	.	.	-1.215	0.395	0.010	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
10	89720633	89720633	10q23.31	1	normal	.	.	ins	T	tc.tt	het-ref	83	0.38	.	2	(T)n|Simple_repeat|Simple_repeat|+|30	PASS	601728	C	153480(MK);155600(MK);158350(MK);176807(SK);188470(MK);275355(MK);276950(MK);601728(MK);605309(MK);607174(SK);608089(MK);613028(SK)	AD;AR	PTEN hamartoma tumor syndrome; Cowden syndrome; Bannayan-Riley-Ruvalcaba syndrome; Lhermitte-Duclos syndrome; Glioma susceptibility 2; Meningioma, familial; Endometrial cancer	AD	Allelic with Macrocephaly/autism syndrome (AD) (without reported associated malignancies); Reported as allelic with VACTERL association with hydrocephalus (AD)	Craniofacial; Dermatologic; Neurologic; Oncologic	Oncologic	23344409|23335809|22970944|22595938|21956414|21659347|21633361|20301661|18781191|17847000|17526801|17526800|17286265|16752378|16704655|15805158|14566704|14518069|12938083|12833416|12085208|11875759|11748304|11238682|10400993|10353779|10234502|9856571|9832032|9832031|9662392|9545417|9445133|9425889|9399897|9286463|9259288|9241266|9140396|8207516|7449178|7079022|6881215|6507473|5345120|5091590|3707175|3698331|3340479|1350505|1336932|957004	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HR14;MC58;MH43	5728	PTEN	IC7	IVS7	.	.	intron	NM_000314.4	NP_000305.3	+	Y	c.802-18_802-17insT	.	.	.	NM_000314.4(PTEN): c.802-18_802-17insT	;rs-cluster-nonoverlapping-alleles	38480	0.010915	U	.	.	.	.	PASS	3	2764	0.307164	22	47182	0.176169	.	.	.	.	.	.	rs762344516	.	4024	0.299000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	92831	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
10	89720652	89720653	10q23.31	0	normal	.	C	ref	C	GA.AA	het-alt	224	0.74	.	1	.	DUBIOUS	601728	C	153480(MK);155600(MK);158350(MK);176807(SK);188470(MK);275355(MK);276950(MK);601728(MK);605309(MK);607174(SK);608089(MK);613028(SK)	AD;AR	PTEN hamartoma tumor syndrome; Cowden syndrome; Bannayan-Riley-Ruvalcaba syndrome; Lhermitte-Duclos syndrome; Glioma susceptibility 2; Meningioma, familial; Endometrial cancer	AD	Allelic with Macrocephaly/autism syndrome (AD) (without reported associated malignancies); Reported as allelic with VACTERL association with hydrocephalus (AD)	Craniofacial; Dermatologic; Neurologic; Oncologic	Oncologic	23344409|23335809|22970944|22595938|21956414|21659347|21633361|20301661|18781191|17847000|17526801|17526800|17286265|16752378|16704655|15805158|14566704|14518069|12938083|12833416|12085208|11875759|11748304|11238682|10400993|10353779|10234502|9856571|9832032|9832031|9662392|9545417|9445133|9425889|9399897|9286463|9259288|9241266|9140396|8207516|7449178|7079022|6881215|6507473|5345120|5091590|3707175|3698331|3340479|1350505|1336932|957004	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HR14;MC58;MH43	5728	PTEN	C8	EX8	.	.	no-change	NM_000314.4	NP_000305.3	+	Y	c.804C=	.	.	.	NM_000314.4(PTEN): c.804C=	;clinically-assoc,submitted-by-lsdb	85912	0.999069	U	.	.	.	.	PASS	.	5446	0.999449	42876	85912	0.999069	.	.	.	.	.	.	rs398123328	.	4024	0.927900	-0.469	0.015	0.202	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	89720652	89720653	10q23.31	1	normal	.	C	snv	A	GA.AA	het-ref	78	0.26	.	2	.	DUBIOUS	601728	C	153480(MK);155600(MK);158350(MK);176807(SK);188470(MK);275355(MK);276950(MK);601728(MK);605309(MK);607174(SK);608089(MK);613028(SK)	AD;AR	PTEN hamartoma tumor syndrome; Cowden syndrome; Bannayan-Riley-Ruvalcaba syndrome; Lhermitte-Duclos syndrome; Glioma susceptibility 2; Meningioma, familial; Endometrial cancer	AD	Allelic with Macrocephaly/autism syndrome (AD) (without reported associated malignancies); Reported as allelic with VACTERL association with hydrocephalus (AD)	Craniofacial; Dermatologic; Neurologic; Oncologic	Oncologic	23344409|23335809|22970944|22595938|21956414|21659347|21633361|20301661|18781191|17847000|17526801|17526800|17286265|16752378|16704655|15805158|14566704|14518069|12938083|12833416|12085208|11875759|11748304|11238682|10400993|10353779|10234502|9856571|9832032|9832031|9662392|9545417|9445133|9425889|9399897|9286463|9259288|9241266|9140396|8207516|7449178|7079022|6881215|6507473|5345120|5091590|3707175|3698331|3340479|1350505|1336932|957004	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HR14;MC58;MH43	5728	PTEN	C8	EX8	.	.	missense	NM_000314.4	NP_000305.3	+	Y	c.804C>A	p.D268E | p.Asp268Glu	GAC=>GAA	P-=>P-	NM_000314.4(PTEN): c.804C>A (p.D268E)	;clinically-assoc,submitted-by-lsdb	85912	0.000931	U	.	.	.	.	PASS	0	5446	0.000551	0	85912	0.000931	0	2	1.44279e-04	0	138	6.95558e-04	rs398123328	.	4024	2.000000	-0.469	0.015	0.202	1	0.012	0.001	0.001	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
10	89720906	89720907	10q23.31	0	normal	.	T	ref	T	TG.TG	het-alt	158	0.53	.	1	.	PASS	601728	C	153480(MK);155600(MK);158350(MK);176807(SK);188470(MK);275355(MK);276950(MK);601728(MK);605309(MK);607174(SK);608089(MK);613028(SK)	AD;AR	PTEN hamartoma tumor syndrome; Cowden syndrome; Bannayan-Riley-Ruvalcaba syndrome; Lhermitte-Duclos syndrome; Glioma susceptibility 2; Meningioma, familial; Endometrial cancer	AD	Allelic with Macrocephaly/autism syndrome (AD) (without reported associated malignancies); Reported as allelic with VACTERL association with hydrocephalus (AD)	Craniofacial; Dermatologic; Neurologic; Oncologic	Oncologic	23344409|23335809|22970944|22595938|21956414|21659347|21633361|20301661|18781191|17847000|17526801|17526800|17286265|16752378|16704655|15805158|14566704|14518069|12938083|12833416|12085208|11875759|11748304|11238682|10400993|10353779|10234502|9856571|9832032|9832031|9662392|9545417|9445133|9425889|9399897|9286463|9259288|9241266|9140396|8207516|7449178|7079022|6881215|6507473|5345120|5091590|3707175|3698331|3340479|1350505|1336932|957004	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HR14;MC58;MH43	5728	PTEN	IC8	IVS8	.	.	no-change	NM_000314.4	NP_000305.3	+	Y	c.1026+32T=	.	.	.	NM_000314.4(PTEN): c.1026+32T=	;maf-5-some-pop,maf-5-all-pops	123676	0.627551	U	0.504	0.432508	12970	0.621357	PASS	.	8534	0.517108	23818	118668	0.630086	.	.	.	.	.	.	rs555895	.	4024	0.490800	-1.869	-2.168	-1.840	.	.	.	.	.	ENST00000371953: c.1026+32G>T (p.?)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_I|pilocytic|NS]	CSV	5914	.	.	.	.	.	.	.	.	.	Benign
10	89720906	89720907	10q23.31	0	normal	.	T	snv	G	TG.TG	het-ref	141	0.47	.	2	.	PASS	601728	C	153480(MK);155600(MK);158350(MK);176807(SK);188470(MK);275355(MK);276950(MK);601728(MK);605309(MK);607174(SK);608089(MK);613028(SK)	AD;AR	PTEN hamartoma tumor syndrome; Cowden syndrome; Bannayan-Riley-Ruvalcaba syndrome; Lhermitte-Duclos syndrome; Glioma susceptibility 2; Meningioma, familial; Endometrial cancer	AD	Allelic with Macrocephaly/autism syndrome (AD) (without reported associated malignancies); Reported as allelic with VACTERL association with hydrocephalus (AD)	Craniofacial; Dermatologic; Neurologic; Oncologic	Oncologic	23344409|23335809|22970944|22595938|21956414|21659347|21633361|20301661|18781191|17847000|17526801|17526800|17286265|16752378|16704655|15805158|14566704|14518069|12938083|12833416|12085208|11875759|11748304|11238682|10400993|10353779|10234502|9856571|9832032|9832031|9662392|9545417|9445133|9425889|9399897|9286463|9259288|9241266|9140396|8207516|7449178|7079022|6881215|6507473|5345120|5091590|3707175|3698331|3340479|1350505|1336932|957004	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HR14;MC58;MH43	5728	PTEN	IC8	IVS8	.	.	intron	NM_000314.4	NP_000305.3	+	Y	c.1026+32T>G	.	.	.	NM_000314.4(PTEN): c.1026+32T>G	;maf-5-some-pop,maf-5-all-pops	123676	0.372449	U	0.504	0.432508	12970	0.378643	PASS	979	8534	0.482892	8381	118668	0.369914	2063	8393	4.88249e-01	17524	90864	3.72580e-01	rs555895	.	4024	0.509200	-1.869	-2.168	-1.840	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	92810	reviewed_by_expert_panel	Benign	Benign
10	89725293	89725294	10q23.31	0	normal	.	T	ref	T	CC.TT	het-alt	147	0.80	.	1	dup	PASS	601728	C	153480(MK);155600(MK);158350(MK);176807(SK);188470(MK);275355(MK);276950(MK);601728(MK);605309(MK);607174(SK);608089(MK);613028(SK)	AD;AR	PTEN hamartoma tumor syndrome; Cowden syndrome; Bannayan-Riley-Ruvalcaba syndrome; Lhermitte-Duclos syndrome; Glioma susceptibility 2; Meningioma, familial; Endometrial cancer	AD	Allelic with Macrocephaly/autism syndrome (AD) (without reported associated malignancies); Reported as allelic with VACTERL association with hydrocephalus (AD)	Craniofacial; Dermatologic; Neurologic; Oncologic	Oncologic	23344409|23335809|22970944|22595938|21956414|21659347|21633361|20301661|18781191|17847000|17526801|17526800|17286265|16752378|16704655|15805158|14566704|14518069|12938083|12833416|12085208|11875759|11748304|11238682|10400993|10353779|10234502|9856571|9832032|9832031|9662392|9545417|9445133|9425889|9399897|9286463|9259288|9241266|9140396|8207516|7449178|7079022|6881215|6507473|5345120|5091590|3707175|3698331|3340479|1350505|1336932|957004	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HR14;MC58;MH43	5728	PTEN	3U1E	EX9E	.	.	no-change	NM_000314.4	NP_000305.3	+	Y	c.*65T=	.	.	.	NM_000314.4(PTEN): c.*65T=	SingleAlleleFreq;	2	1.000000	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1044487	.	4024	0.691600	0.383	4.317	1.825	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	89725293	89725294	10q23.31	0	normal	.	T	del	.	CC.TT	het-ref	37	0.20	.	2	dup	PASS	601728	C	153480(MK);155600(MK);158350(MK);176807(SK);188470(MK);275355(MK);276950(MK);601728(MK);605309(MK);607174(SK);608089(MK);613028(SK)	AD;AR	PTEN hamartoma tumor syndrome; Cowden syndrome; Bannayan-Riley-Ruvalcaba syndrome; Lhermitte-Duclos syndrome; Glioma susceptibility 2; Meningioma, familial; Endometrial cancer	AD	Allelic with Macrocephaly/autism syndrome (AD) (without reported associated malignancies); Reported as allelic with VACTERL association with hydrocephalus (AD)	Craniofacial; Dermatologic; Neurologic; Oncologic	Oncologic	23344409|23335809|22970944|22595938|21956414|21659347|21633361|20301661|18781191|17847000|17526801|17526800|17286265|16752378|16704655|15805158|14566704|14518069|12938083|12833416|12085208|11875759|11748304|11238682|10400993|10353779|10234502|9856571|9832032|9832031|9662392|9545417|9445133|9425889|9399897|9286463|9259288|9241266|9140396|8207516|7449178|7079022|6881215|6507473|5345120|5091590|3707175|3698331|3340479|1350505|1336932|957004	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HR14;MC58;MH43	5728	PTEN	3U1E	EX9E	.	.	utr-3	NM_000314.4	NP_000305.3	+	Y	c.*65T[11>10] (std: c.*65T[10] alt: c.*75delT )	.	.	.	NM_000314.4(PTEN): c.*65T[10]	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.308400	0.383	4.317	1.825	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	237636	criteria_provided,_single_submitter	Benign	Benign
10	90767394	90767395	10q23.31	0	nullSample	.	G	ref	G	TA.TT	homo-ref	.	.	.	0	.	.	134637	C	134637(MK);601859(SK)	NN	Autoimmune lymphoproliferative syndrome, type IA	AD/AR	.	Allergy/Immunology/Infectious; Hematologic; Oncologic; Renal	Allergy/Immunology/Infectious; Oncologic	20301287|15459302|10709732|8929361|7540117|4165068|1386609	.	355	FAS	IC2	IVS2	.	.	no-change	NM_000043.4	NP_000034.1	+	Y	c.197-62G=	.	.	.	NM_000043.4(FAS): c.197-62G=	;maf-5-some-pop,genotype-conflict	5008	0.191294	U	0.9573	0.808706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2031611	.	4024	0.017400	-0.120	0.000	0.007	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	90767394	90767395	10q23.31	0	normal	.	G	snv	C	TA.TT	hom-alt	232	1.00	.	0	.	PASS	134637	C	134637(MK);601859(SK)	NN	Autoimmune lymphoproliferative syndrome, type IA	AD/AR	.	Allergy/Immunology/Infectious; Hematologic; Oncologic; Renal	Allergy/Immunology/Infectious; Oncologic	20301287|15459302|10709732|8929361|7540117|4165068|1386609	.	355	FAS	IC2	IVS2	.	.	intron	NM_000043.4	NP_000034.1	+	Y	c.197-62G>C	.	.	.	NM_000043.4(FAS): c.197-62G>C	;maf-5-some-pop,genotype-conflict	5008	0.808706	U	0.9573	0.808706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2031611	.	4024	0.982600	-0.120	0.000	0.007	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	90767639	90767640	10q23.31	0	normal	.	C	ref	C	TT.AT	het-alt	143	0.49	.	1	.	PASS	134637	C	134637(MK);601859(SK)	NN	Autoimmune lymphoproliferative syndrome, type IA	AD/AR	.	Allergy/Immunology/Infectious; Hematologic; Oncologic; Renal	Allergy/Immunology/Infectious; Oncologic	20301287|15459302|10709732|8929361|7540117|4165068|1386609	.	355	FAS	IC3	IVS3	.	.	no-change	NM_000043.4	NP_000034.1	+	Y	c.334+46C=	.	.	.	NM_000043.4(FAS): c.334+46C=	;maf-5-some-pop,maf-5-all-pops	125680	0.833211	U	0.4286	0.242013	13006	0.856374	PASS	-1061	8574	0.553767	42775	120672	0.836333	.	.	.	.	.	.	rs2296601	.	4024	0.595200	0.655	1.185	1.194	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	90767639	90767640	10q23.31	0	normal	.	C	snv	T	TT.AT	het-ref	148	0.51	.	2	.	PASS	134637	C	134637(MK);601859(SK)	NN	Autoimmune lymphoproliferative syndrome, type IA	AD/AR	.	Allergy/Immunology/Infectious; Hematologic; Oncologic; Renal	Allergy/Immunology/Infectious; Oncologic	20301287|15459302|10709732|8929361|7540117|4165068|1386609	.	355	FAS	IC3	IVS3	.	.	intron	NM_000043.4	NP_000034.1	+	Y	c.334+46C>T	.	.	.	NM_000043.4(FAS): c.334+46C>T	;maf-5-some-pop,maf-5-all-pops	125680	0.166789	U	0.4286	0.242013	13006	0.143626	PASS	852	8574	0.446233	2189	120672	0.163667	1715	7741	4.50163e-01	4310	40103	1.64304e-01	rs2296601	.	4024	0.404800	0.655	1.185	1.194	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	90770438	90770439	10q23.31	0	normal	.	C	ref	C	TA.TA	het-alt	224	0.47	.	1	.	PASS	134637	C	134637(MK);601859(SK)	NN	Autoimmune lymphoproliferative syndrome, type IA	AD/AR	.	Allergy/Immunology/Infectious; Hematologic; Oncologic; Renal	Allergy/Immunology/Infectious; Oncologic	20301287|15459302|10709732|8929361|7540117|4165068|1386609	.	355	FAS	IC5	IVS5	.	.	no-change	NM_000043.4	NP_000034.1	+	Y	c.506-71C=	.	.	.	NM_000043.4(FAS): c.506-71C=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.592652	U	0.501	0.407348	4566	0.629654	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2296600	.	4024	0.451000	-0.247	-0.891	-1.020	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	90770438	90770439	10q23.31	0	normal	.	C	snv	G	TA.TA	het-ref	257	0.53	.	2	.	PASS	134637	C	134637(MK);601859(SK)	NN	Autoimmune lymphoproliferative syndrome, type IA	AD/AR	.	Allergy/Immunology/Infectious; Hematologic; Oncologic; Renal	Allergy/Immunology/Infectious; Oncologic	20301287|15459302|10709732|8929361|7540117|4165068|1386609	.	355	FAS	IC5	IVS5	.	.	intron	NM_000043.4	NP_000034.1	+	Y	c.506-71C>G	.	.	.	NM_000043.4(FAS): c.506-71C>G	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.407348	U	0.501	0.407348	4566	0.370346	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2296600	.	4024	0.549000	-0.247	-0.891	-1.020	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	90771828	90771829	10q23.31	0	nullSample	.	T	ref	T	AC.TT	homo-ref	.	.	.	0	.	.	134637	C	134637(MK);601859(SK)	NN	Autoimmune lymphoproliferative syndrome, type IA	AD/AR	.	Allergy/Immunology/Infectious; Hematologic; Oncologic; Renal	Allergy/Immunology/Infectious; Oncologic	20301287|15459302|10709732|8929361|7540117|4165068|1386609	.	355	FAS	C7	EX7	.	.	no-change	NM_000043.4	NP_000034.1	+	Y	c.642T=	.	.	.	NM_000043.4(FAS): c.642T=	;maf-5-some-pop,microattr-tpa,genotype-conflict	126200	0.243106	U	0.9573	0.775359	13006	0.304782	PASS	-71	8654	0.016871	4092	121192	0.243869	.	.	.	.	.	.	rs2234978	.	4024	0.017400	-2.209	-0.410	-0.415	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	90771828	90771829	10q23.31	1	normal	.	T	snv	C	AC.TT	hom-alt	353	1.00	.	0	.	PASS	134637	C	134637(MK);601859(SK)	NN	Autoimmune lymphoproliferative syndrome, type IA	AD/AR	.	Allergy/Immunology/Infectious; Hematologic; Oncologic; Renal	Allergy/Immunology/Infectious; Oncologic	20301287|15459302|10709732|8929361|7540117|4165068|1386609	.	355	FAS	C7	EX7	.	.	coding-synon	NM_000043.4	NP_000034.1	+	Y	c.642T>C	p.(T214=) | p.(Thr214=)	ACT=>ACC	.	NM_000043.4(FAS): c.642T>C (p.(T214=))	;maf-5-some-pop,microattr-tpa,genotype-conflict	126200	0.756894	U	0.9573	0.775359	13006	0.695218	PASS	4183	8654	0.983129	35133	121192	0.756131	8354	16974	9.84114e-01	72996	188167	7.65137e-01	rs2234978	.	4024	0.982600	-2.209	-0.410	-0.415	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	254734	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
10	90771880	90771881	10q23.31	0	normal	.	T	ref	T	AA.AG	het-alt	137	0.50	.	1	.	PASS	134637	C	134637(MK);601859(SK)	NN	Autoimmune lymphoproliferative syndrome, type IA	AD/AR	.	Allergy/Immunology/Infectious; Hematologic; Oncologic; Renal	Allergy/Immunology/Infectious; Oncologic	20301287|15459302|10709732|8929361|7540117|4165068|1386609	.	355	FAS	IC7	IVS7	.	.	no-change	NM_000043.4	NP_000034.1	+	Y	c.651+43T=	.	.	.	NM_000043.4(FAS): c.651+43T=	;maf-5-some-pop	122234	0.993447	U	0.0526	0.0115815	13004	0.999462	PASS	.	8008	0.930445	57898	117226	0.993662	.	.	.	.	.	.	rs3740282	.	4024	0.920500	-0.410	-0.727	-0.810	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	90771880	90771881	10q23.31	0	normal	.	T	snv	G	AA.AG	het-ref	139	0.50	.	2	.	PASS	134637	C	134637(MK);601859(SK)	NN	Autoimmune lymphoproliferative syndrome, type IA	AD/AR	.	Allergy/Immunology/Infectious; Hematologic; Oncologic; Renal	Allergy/Immunology/Infectious; Oncologic	20301287|15459302|10709732|8929361|7540117|4165068|1386609	.	355	FAS	IC7	IVS7	.	.	intron	NM_000043.4	NP_000034.1	+	Y	c.651+43T>G	.	.	.	NM_000043.4(FAS): c.651+43T>G	;maf-5-some-pop	122234	0.006553	U	0.0526	0.0115815	13004	0.000538	PASS	27	8008	0.069555	28	117226	0.006338	47	1134	6.66823e-02	50	1507	6.19904e-03	rs3740282	.	4024	0.079500	-0.410	-0.727	-0.810	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	95279505	95279506	10q23.33	0	normal	.	A	snv	T	GC.TG	het-ref	243	0.52	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr10: g.95279505A>T (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126358	0.697629	U	0.5437	0.559704	13006	0.610257	PASS	1396	8636	0.567508	31183	121350	0.703321	2867	9875	5.72796e-01	64940	176125	7.15752e-01	rs2293277	.	.	.	0.459	4.417	2.208	.	.	.	.	.	ENST00000371485: c.1133A>T (p.H378L)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5008468	.	.	.	.	.	.	.	.	.	Benign
10	95279505	95279506	10q23.33	0	normal	.	A	ref	A	GC.TG	het-alt	224	0.48	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr10: g.95279505A= (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126358	0.302371	U	0.5437	0.559704	13006	0.389743	PASS	.	8636	0.432492	6510	121350	0.296679	.	.	.	.	.	.	rs2293277	.	.	.	0.459	4.417	2.208	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	104264106	104264107	10q24.32	0	normal	.	C	ref	C	CG.GG	het-alt	199	0.49	.	1	.	PASS	607035	C	109400(MK);155255(MK);607174(SK)	AD	Medulloblastoma; Basal cell nevus syndrome	AD	.	Dermatologic; Oncologic	Oncologic	22670904|22670903|21188540|19833601|19533801|12068298	GO2	51684	SUFU	IC1	IVS1	.	.	no-change	NM_016169.3	NP_057253.2	+	Y	c.182+16C=	.	.	.	NM_016169.3(SUFU): c.182+16C=	;maf-5-some-pop,maf-5-all-pops	122594	0.517986	U	0.3065	0.396166	13006	0.520452	PASS	-897	8380	0.681623	16123	117586	0.514330	.	.	.	.	.	.	rs2274351	.	4024	0.678200	0.455	-0.208	0.003	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	104264106	104264107	10q24.32	1	normal	.	C	snv	T	CG.GG	het-ref	210	0.51	.	2	.	PASS	607035	C	109400(MK);155255(MK);607174(SK)	AD	Medulloblastoma; Basal cell nevus syndrome	AD	.	Dermatologic; Oncologic	Oncologic	22670904|22670903|21188540|19833601|19533801|12068298	GO2	51684	SUFU	IC1	IVS1	.	.	intron	NM_016169.3	NP_057253.2	+	Y	c.182+16C>T	.	.	.	NM_016169.3(SUFU): c.182+16C>T	;maf-5-some-pop,maf-5-all-pops	122594	0.482014	U	0.3065	0.396166	13006	0.479548	PASS	437	8380	0.318377	14438	117586	0.485670	910	5501	3.20833e-01	29023	115015	4.76138e-01	rs2274351	.	4024	0.321800	0.455	-0.208	0.003	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	260689	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
10	104268858	104268859	10q24.32	0	normal	.	G	ref	G	GA.CG	het-alt	146	0.48	.	1	.	PASS	607035	C	109400(MK);155255(MK);607174(SK)	AD	Medulloblastoma; Basal cell nevus syndrome	AD	.	Dermatologic; Oncologic	Oncologic	22670904|22670903|21188540|19833601|19533801|12068298	GO2	51684	SUFU	IC1	IVS1	.	.	no-change	NM_016169.3	NP_057253.2	+	Y	c.183-67G=	.	.	.	NM_016169.3(SUFU): c.183-67G=	MixedObserved;maf-5-some-pop|MixedObserved;	5008|0	0.796126|0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs139516830|rs193185980	.	4024	0.585000	0.462	0.679	1.086	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	104268858	104268859	10q24.32	0	normal	.	G	del	.	GA.CG	het-ref	156	0.52	.	2	.	PASS	607035	C	109400(MK);155255(MK);607174(SK)	AD	Medulloblastoma; Basal cell nevus syndrome	AD	.	Dermatologic; Oncologic	Oncologic	22670904|22670903|21188540|19833601|19533801|12068298	GO2	51684	SUFU	IC1	IVS1	.	.	intron	NM_016169.3	NP_057253.2	+	Y	c.183-67delG	.	.	.	NM_016169.3(SUFU): c.183-67delG	MixedObserved;maf-5-some-pop|MixedObserved;	5008|0	0.203874|0	U	0.4335	0.203874	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs139516830|rs193185980	.	4024	0.415000	0.462	0.679	1.086	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	104268859	104268860	10q24.32	0	normal	.	C	ref	C	AG.GC	het-alt	146	0.48	.	1	.	PASS	607035	C	109400(MK);155255(MK);607174(SK)	AD	Medulloblastoma; Basal cell nevus syndrome	AD	.	Dermatologic; Oncologic	Oncologic	22670904|22670903|21188540|19833601|19533801|12068298	GO2	51684	SUFU	IC1	IVS1	.	.	no-change	NM_016169.3	NP_057253.2	+	Y	c.183-66C=	.	.	.	NM_016169.3(SUFU): c.183-66C=	MixedObserved;maf-5-some-pop|MixedObserved;	5008|0	0.796126|0	U	0.4335	0.203874	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs185072800|rs778985585	.	4024	0.588000	-1.020	-1.127	-1.153	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	104268859	104268860	10q24.32	0	normal	.	C	snv	A	AG.GC	het-ref	159	0.52	.	2	.	PASS	607035	C	109400(MK);155255(MK);607174(SK)	AD	Medulloblastoma; Basal cell nevus syndrome	AD	.	Dermatologic; Oncologic	Oncologic	22670904|22670903|21188540|19833601|19533801|12068298	GO2	51684	SUFU	IC1	IVS1	.	.	intron	NM_016169.3	NP_057253.2	+	Y	c.183-66C>A	.	.	.	NM_016169.3(SUFU): c.183-66C>A	MixedObserved;maf-5-some-pop|MixedObserved;	5008|0	0.203874|0	U	0.4335	0.203874	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs185072800|rs778985585	.	4024	0.412000	-1.020	-1.127	-1.153	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	104356821	104356822	10q24.32	0	nullSample	.	A	ref	A	GC.GT	homo-ref	.	.	.	0	.	.	607035	C	109400(MK);155255(MK);607174(SK)	AD	Medulloblastoma; Basal cell nevus syndrome	AD	.	Dermatologic; Oncologic	Oncologic	22670904|22670903|21188540|19833601|19533801|12068298	GO2	51684	SUFU	IC6	IVS6	.	.	no-change	NM_016169.3	NP_057253.2	+	Y	c.757-75A=	.	.	.	NM_016169.3(SUFU): c.757-75A=	;	5008	0.009784	U	0.999	0.990216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10786690	.	4024	0.001700	-0.119	0.105	-0.406	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	104356821	104356822	10q24.32	0	normal	.	A	snv	G	GC.GT	hom-alt	259	1.00	.	0	.	PASS	607035	C	109400(MK);155255(MK);607174(SK)	AD	Medulloblastoma; Basal cell nevus syndrome	AD	.	Dermatologic; Oncologic	Oncologic	22670904|22670903|21188540|19833601|19533801|12068298	GO2	51684	SUFU	IC6	IVS6	.	.	intron	NM_016169.3	NP_057253.2	+	Y	c.757-75A>G	.	.	.	NM_016169.3(SUFU): c.757-75A>G	;	5008	0.990216	U	0.999	0.990216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10786690	.	4024	0.998300	-0.119	0.105	-0.406	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	104359349	104359350	10q24.32	0	normal	.	T	ref	T	TC.GA	het-alt	137	0.55	.	1	.	PASS	607035	C	109400(MK);155255(MK);607174(SK)	AD	Medulloblastoma; Basal cell nevus syndrome	AD	.	Dermatologic; Oncologic	Oncologic	22670904|22670903|21188540|19833601|19533801|12068298	GO2	51684	SUFU	IC8	IVS8	.	.	no-change	NM_016169.3	NP_057253.2	+	Y	c.1022+49T=	.	.	.	NM_016169.3(SUFU): c.1022+49T=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118994	0.835698	U	0.4355	0.248003	13002	0.871327	PASS	.	7854	0.566208	40721	113986	0.839375	.	.	.	.	.	.	rs3824756	.	4024	0.588000	0.379	0.026	-0.268	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	104359349	104359350	10q24.32	0	normal	.	T	snv	C	TC.GA	het-ref	110	0.45	.	2	.	PASS	607035	C	109400(MK);155255(MK);607174(SK)	AD	Medulloblastoma; Basal cell nevus syndrome	AD	.	Dermatologic; Oncologic	Oncologic	22670904|22670903|21188540|19833601|19533801|12068298	GO2	51684	SUFU	IC8	IVS8	.	.	intron	NM_016169.3	NP_057253.2	+	Y	c.1022+49T>C	.	.	.	NM_016169.3(SUFU): c.1022+49T>C	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	118994	0.164286	U	0.4355	0.248003	13002	0.128673	PASS	709	7854	0.433792	2036	113986	0.160607	1449	7016	4.19417e-01	4399	38415	1.60981e-01	rs3824756	.	4024	0.412000	0.379	0.026	-0.268	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	104375257	104375258	10q24.32	0	normal	.	G	ref	G	GC.TC	het-alt	105	0.44	.	1	.	PASS	607035	C	109400(MK);155255(MK);607174(SK)	AD	Medulloblastoma; Basal cell nevus syndrome	AD	.	Dermatologic; Oncologic	Oncologic	22670904|22670903|21188540|19833601|19533801|12068298	GO2	51684	SUFU	IC9	IVS9	.	.	no-change	NM_016169.3	NP_057253.2	+	Y	c.1157+99G=	.	.	.	NM_016169.3(SUFU): c.1157+99G=	;maf-5-some-pop,maf-5-all-pops	5008	0.483826	U	0.6915	0.516174	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2001389	.	4020	0.324400	-0.459	-1.794	-1.843	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	104375257	104375258	10q24.32	0	normal	.	G	snv	A	GC.TC	het-ref	135	0.56	.	2	.	PASS	607035	C	109400(MK);155255(MK);607174(SK)	AD	Medulloblastoma; Basal cell nevus syndrome	AD	.	Dermatologic; Oncologic	Oncologic	22670904|22670903|21188540|19833601|19533801|12068298	GO2	51684	SUFU	IC9	IVS9	.	.	intron	NM_016169.3	NP_057253.2	+	Y	c.1157+99G>A	.	.	.	NM_016169.3(SUFU): c.1157+99G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.516174	U	0.6915	0.516174	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2001389	.	4020	0.675600	-0.459	-1.794	-1.843	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	104378749	104378750	10q24.32	0	normal	.	G	ref	G	AC.TT	het-alt	63	0.46	.	1	.	PASS	607035	C	109400(MK);155255(MK);607174(SK)	AD	Medulloblastoma; Basal cell nevus syndrome	AD	.	Dermatologic; Oncologic	Oncologic	22670904|22670903|21188540|19833601|19533801|12068298	GO2	51684	SUFU	IC10	IVS10	.	.	no-change	NM_016169.3	NP_057253.2	+	Y	c.1296+1565G=	.	.	.	NM_016169.3(SUFU): c.1296+1565G=	;maf-5-some-pop,maf-5-all-pops	5008	0.483826	U	0.6915	0.516174	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10786698	.	4012	0.335500	-0.672	-0.028	-0.196	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	104378749	104378750	10q24.32	0	normal	.	G	snv	A	AC.TT	het-ref	73	0.54	.	2	.	PASS	607035	C	109400(MK);155255(MK);607174(SK)	AD	Medulloblastoma; Basal cell nevus syndrome	AD	.	Dermatologic; Oncologic	Oncologic	22670904|22670903|21188540|19833601|19533801|12068298	GO2	51684	SUFU	IC10	IVS10	.	.	intron	NM_016169.3	NP_057253.2	+	Y	c.1296+1565G>A	.	.	.	NM_016169.3(SUFU): c.1296+1565G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.516174	U	0.6915	0.516174	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10786698	.	4012	0.664500	-0.672	-0.028	-0.196	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	104386933	104386934	10q24.32	0	normal	.	T	ref	T	AT.CT	het-alt	262	0.56	.	1	.	PASS	607035	C	109400(MK);155255(MK);607174(SK)	AD	Medulloblastoma; Basal cell nevus syndrome	AD	.	Dermatologic; Oncologic	Oncologic	22670904|22670903|21188540|19833601|19533801|12068298	GO2	51684	SUFU	C11	EX11	Suppressor of Fused Gli/Ci N terminal binding domain	PF12470.3	no-change	NM_016169.3	NP_057253.2	+	Y	c.1299T=	.	.	.	NM_016169.3(SUFU): c.1299T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126366	0.837860	U	0.4335	0.246006	13006	0.871521	PASS	-1047	8638	0.576059	43655	121358	0.841321	.	.	.	.	.	.	rs17114803	.	4024	0.588700	0.459	0.602	0.717	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	104386933	104386934	10q24.32	1	normal	.	T	snv	C	AT.CT	het-ref	207	0.44	.	2	.	PASS	607035	C	109400(MK);155255(MK);607174(SK)	AD	Medulloblastoma; Basal cell nevus syndrome	AD	.	Dermatologic; Oncologic	Oncologic	22670904|22670903|21188540|19833601|19533801|12068298	GO2	51684	SUFU	C11	EX11	Suppressor of Fused Gli/Ci N terminal binding domain	PF12470.3	coding-synon	NM_016169.3	NP_057253.2	+	Y	c.1299T>C	p.(I433=) | p.(Ile433=)	ATT=>ATC	.	NM_016169.3(SUFU): c.1299T>C (p.(I433=))	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126366	0.162140	U	0.4335	0.246006	13006	0.128479	PASS	784	8638	0.423941	2233	121358	0.158679	1486	7153	4.14763e-01	4546	39264	1.59441e-01	rs17114803	.	4024	0.411300	0.459	0.602	0.717	.	.	.	.	.	ENST00000369902: c.1299T>C (p.I433I)	biliary_tract [gallbladder|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4767793	.	.	.	.	.	no_record	260687	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
10	104387018	104387019	10q24.32	0	nullSample	.	T	ref	T	TT.CC	homo-ref	.	.	.	0	.	.	607035	C	109400(MK);155255(MK);607174(SK)	AD	Medulloblastoma; Basal cell nevus syndrome	AD	.	Dermatologic; Oncologic	Oncologic	22670904|22670903|21188540|19833601|19533801|12068298	GO2	51684	SUFU	IC11	IVS11	.	.	no-change	NM_016169.3	NP_057253.2	+	Y	c.1365+19T=	.	.	.	NM_016169.3(SUFU): c.1365+19T=	;maf-5-some-pop,maf-5-all-pops	126376	0.334992	U	0.75	0.719649	13006	0.318853	PASS	.	8640	0.253356	7139	121368	0.337247	.	.	.	.	.	.	rs12414407	.	4024	0.259200	-0.642	1.729	0.680	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	104387018	104387019	10q24.32	1	normal	.	T	snv	C	TT.CC	hom-alt	315	1.00	.	0	.	PASS	607035	C	109400(MK);155255(MK);607174(SK)	AD	Medulloblastoma; Basal cell nevus syndrome	AD	.	Dermatologic; Oncologic	Oncologic	22670904|22670903|21188540|19833601|19533801|12068298	GO2	51684	SUFU	IC11	IVS11	.	.	intron	NM_016169.3	NP_057253.2	+	Y	c.1365+19T>C	.	.	.	NM_016169.3(SUFU): c.1365+19T>C	;maf-5-some-pop,maf-5-all-pops	126376	0.665008	U	0.75	0.719649	13006	0.681147	PASS	2405	8640	0.746644	26892	121368	0.662753	4809	12853	7.45188e-01	53795	162021	6.58001e-01	rs12414407	.	4024	0.740800	-0.642	1.729	0.680	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	260688	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
10	104389931	104389932	10q24.32	0	nullSample	.	T	ref	T	AG.GG	homo-ref	.	.	.	0	.	.	607035	C	109400(MK);155255(MK);607174(SK)	AD	Medulloblastoma; Basal cell nevus syndrome	AD	.	Dermatologic; Oncologic	Oncologic	22670904|22670903|21188540|19833601|19533801|12068298	GO2	51684	SUFU	3U1E	EX12E	.	.	utr-3	NM_016169.3	NP_057253.2	+	Y	c.*20G>T	.	.	.	NM_016169.3(SUFU): c.*20G>T	;	126404	0.000680	U	1	0.997404	13006	0.002153	PASS	0	8654	0.000000	0	121396	0.000601	.	.	.	.	.	.	rs4917980	.	.	.	-0.217	0.497	1.301	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	104389931	104389932	10q24.32	0	normal	.	T	snv	G	AG.GG	hom-alt	251	1.00	.	0	.	PASS	607035	C	109400(MK);155255(MK);607174(SK)	AD	Medulloblastoma; Basal cell nevus syndrome	AD	.	Dermatologic; Oncologic	Oncologic	22670904|22670903|21188540|19833601|19533801|12068298	GO2	51684	SUFU	3U1E	EX12E	.	.	no-change	NM_016169.3	NP_057253.2	+	Y	c.*20G=	.	.	.	NM_016169.3(SUFU): c.*20G=	;	126404	0.999320	U	1	0.997404	13006	0.997847	PASS	4327	8654	1.000000	60625	121396	0.999399	8624	17248	1.00000e+00	122935	246002	9.99464e-01	rs4917980	.	.	.	-0.217	0.497	1.301	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	104389967	104389971	10q24.32	0	normal	.	CCAG	ref	CCAG	TT.TG	het-alt	160	0.88	.	1	.	PASS	607035	C	109400(MK);155255(MK);607174(SK)	AD	Medulloblastoma; Basal cell nevus syndrome	AD	.	Dermatologic; Oncologic	Oncologic	22670904|22670903|21188540|19833601|19533801|12068298	GO2	51684	SUFU	3U1E	EX12E	.	.	no-change	NM_016169.3	NP_057253.2	+	Y	c.*56_*59=	.	.	.	NM_016169.3(SUFU): c.*56_*59=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.934400	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	104389967	104389971	10q24.32	0	normal	.	CCAG	del	.	TT.TG	het-ref	21	0.12	.	2	.	PASS	607035	C	109400(MK);155255(MK);607174(SK)	AD	Medulloblastoma; Basal cell nevus syndrome	AD	.	Dermatologic; Oncologic	Oncologic	22670904|22670903|21188540|19833601|19533801|12068298	GO2	51684	SUFU	3U1E	EX12E	.	.	utr-3	NM_016169.3	NP_057253.2	+	Y	c.*56_*59delCCAG	.	.	.	NM_016169.3(SUFU): c.*56_*59delCCAG	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.065600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	114905718	114905719	10q25.3	0	normal	.	C	ref	C	TC.CC	het-alt	3	0.43	.	1	.	DUBIOUS	602228	C	125853(SK)	AD	.	.	.	.	.	.	.	6934	TCF7L2	IC6	IVS6	.	.	no-change	NM_030756.4	NP_110383.2	+	Y	c.720-51C=	.	.	.	NM_030756.4(TCF7L2): c.720-51C=	;	120840	0.999992	U	.	.	.	.	PASS	.	8654	0.999884	60419	120840	0.999992	.	.	.	.	.	.	rs749393352	.	.	.	0.555	1.817	2.868	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	114905718	114905719	10q25.3	0	normal	.	C	snv	G	TC.CC	het-ref	4	0.57	.	2	.	DUBIOUS	602228	C	125853(SK)	AD	.	.	.	.	.	.	.	6934	TCF7L2	IC6	IVS6	.	.	intron	NM_030756.4	NP_110383.2	+	Y	c.720-51C>G	.	.	.	NM_030756.4(TCF7L2): c.720-51C>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.555	1.817	2.868	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
10	114910666	114910667	10q25.3	0	normal	.	G	ref	G	CT.TT	het-alt	100	0.53	.	1	.	PASS	602228	C	125853(SK)	AD	.	.	.	.	.	.	.	6934	TCF7L2	IC7	IVS7	.	.	no-change	NM_030756.4	NP_110383.2	+	Y	c.807-90G=	.	.	.	NM_030756.4(TCF7L2): c.807-90G=	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs201543140	.	.	.	-0.181	-1.510	-1.212	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
10	114910667	114910667	10q25.3	0	normal	.	.	ins	T	TG.TT	het-ref	87	0.47	.	2	.	PASS	602228	C	125853(SK)	AD	.	.	.	.	.	.	.	6934	TCF7L2	IC7	IVS7	.	.	intron	NM_030756.4	NP_110383.2	+	Y	c.807-90_807-89insT	.	.	.	NM_030756.4(TCF7L2): c.807-90_807-89insT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.247300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	114925368	114925369	10q25.3	0	normal	.	C	ref	C	CA.CC	het-alt	255	0.47	.	1	.	PASS	602228	C	125853(SK)	AD	.	.	.	.	.	.	.	6934	TCF7L2	C14E	EX14E	.	.	no-change	NM_030756.4	NP_110383.2	+	Y	c.1429C=	.	.	.	NM_030756.4(TCF7L2): c.1429C=	;maf-5-some-pop	125804	0.948944	U	0.2411	0.0696885	13006	0.978010	PASS	-838	8618	0.741935	54696	120796	0.949717	.	.	.	.	.	.	rs77961654	.	4024	0.750700	0.655	1.655	1.227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	114925368	114925369	10q25.3	1	normal	.	C	snv	A	CA.CC	het-ref	282	0.53	.	2	.	PASS	602228	C	125853(SK)	AD	.	.	.	.	.	.	.	6934	TCF7L2	C14E	EX14E	.	.	missense	NM_030756.4	NP_110383.2	+	Y	c.1429C>A	p.P477T | p.Pro477Thr	CCC=>ACC	NP=>P0	NM_030756.4(TCF7L2): c.1429C>A (p.P477T)	;maf-5-some-pop	125804	0.051056	U	0.2411	0.0696885	13006	0.021990	PASS	274	8618	0.258065	372	120796	0.050283	546	4377	2.53945e-01	771	12787	5.20093e-02	rs77961654	.	4024	0.249300	0.655	1.655	1.227	0.3	0.991	0.998	0.473	deleterious	ENST00000543371: c.1447C>A (p.P483T)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5021036	.	.	.	.	.	.	.	.	.	Likely Benign
10	120917444	120917445	10q26.11	0	normal	.	G	ref	G	CC.AG	het-alt	265	0.51	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr10: g.120917444G= (intergenic)	;maf-5-some-pop,microattr-tpa	126368	0.503134	U	0.7123	0.509984	13006	0.517607	PASS	-865	8636	0.281380	15702	121360	0.503675	.	.	.	.	.	.	rs2275111	.	.	.	-0.133	-0.301	-0.209	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	120917444	120917445	10q26.11	0	normal	.	G	snv	A	CC.AG	het-ref	259	0.49	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr10: g.120917444G>A (intergenic)	;maf-5-some-pop,microattr-tpa	126368	0.496866	U	0.7123	0.509984	13006	0.482393	PASS	2238	8636	0.718620	15256	121360	0.496325	4600	12553	7.27879e-01	31267	122591	4.97969e-01	rs2275111	.	.	.	-0.133	-0.301	-0.209	.	.	.	.	.	ENST00000355697: c.415-6C>T (p.?)	oesophagus [NS|NS|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	CSV	5438328	.	.	.	.	.	no_record	380007	criteria_provided,_single_submitter	Benign	Benign
10	123240286	123240287	10q26.13	0	nullSample	.	T	ref	T	CT.TG	homo-ref	.	.	.	0	.	.	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	IC16	IVS17	.	.	no-change	NM_000141.4	NP_000132.3	-	Y	c.2302-752A=	.	.	.	NM_000141.4(FGFR2): c.2302-752A=	;maf-5-some-pop	5008	0.022364	U	1	0.977636	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1649163	.	4024	0.001500	-0.119	0.117	0.103	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123240286	123240287	10q26.13	0	normal	.	T	snv	C	CT.TG	hom-alt	513	1.00	.	0	.	PASS	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	IC16	IVS17	.	.	intron	NM_000141.4	NP_000132.3	-	Y	c.2302-752A>G	.	.	.	NM_000141.4(FGFR2): c.2302-752A>G	;maf-5-some-pop	5008	0.977636	U	1	0.977636	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1649163	.	4024	0.998500	-0.119	0.117	0.103	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123240624	123240625	10q26.13	0	nullSample	.	A	ref	A	gc.aa	homo-ref	.	.	.	0	MER58B|DNA|hAT-Charlie|+|300	.	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	IC16	IVS17	.	.	no-change	NM_000141.4	NP_000132.3	-	Y	c.2302-1090T=	.	.	.	NM_000141.4(FGFR2): c.2302-1090T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.447284	U	0.6558	0.552716	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1649202	.	4024	0.409000	-1.595	-3.156	-3.308	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123240624	123240625	10q26.13	0	normal	.	A	snv	G	gc.aa	hom-alt	216	1.00	.	0	MER58B|DNA|hAT-Charlie|+|300	PASS	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	IC16	IVS17	.	.	intron	NM_000141.4	NP_000132.3	-	Y	c.2302-1090T>C	.	.	.	NM_000141.4(FGFR2): c.2302-1090T>C	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.552716	U	0.6558	0.552716	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1649202	.	4024	0.591000	-1.595	-3.156	-3.308	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123240903	123240915	10q26.13	0	nullSample	.	ACACACACACAC	ref	ACACACACACAC	AG.ac	homo-ref	.	.	.	0	(CA)n|Simple_repeat|Simple_repeat|+|33;trf	.	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	IC16	IVS17	.	.	no-change	NM_000141.4	NP_000132.3	-	Y	c.2302-1380_2302-1369=	.	.	.	NM_000141.4(FGFR2): c.2302-1380_2302-1369=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.678900	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123240903	123240915	10q26.13	0	normal	.	ACACACACACAC	del	.	AG.ac	het-alt	52	0.14	.	1	(CA)n|Simple_repeat|Simple_repeat|+|33;trf	PASS	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	IC16	IVS17	.	.	intron	NM_000141.4	NP_000132.3	-	Y	c.2302-1380_2302-1369delGTGTGTGTGTGT	.	.	.	NM_000141.4(FGFR2): c.2302-1380_2302-1369delGTGTGTGTGTGT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.160500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123240903	123240915	10q26.13	0	normal	.	ACACACACACAC	rep	AC	AG.ac	het-alt	304	0.82	.	2	(CA)n|Simple_repeat|Simple_repeat|+|33;trf	PASS	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	IC16	IVS17	.	.	intron	NM_000141.4	NP_000132.3	-	Y	c.2302-1380GT[6>1] (std: c.2302-1380GT[1] alt: c.2302-1378_2302-1369delGTGTGTGTGT )	.	.	.	NM_000141.4(FGFR2): c.2302-1380GT[1]	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.160500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123241331	123241332	10q26.13	0	nullSample	.	G	ref	G	CC.GT	homo-ref	.	.	.	0	.	.	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	IC16	IVS17	.	.	no-change	NM_000141.4	NP_000132.3	-	Y	c.2302-1797C=	.	.	.	NM_000141.4(FGFR2): c.2302-1797C=	;maf-5-some-pop	5008	0.027556	U	1	0.972444	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1649164	.	4024	0.095400	-0.817	-0.894	-0.960	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123241331	123241332	10q26.13	0	normal	.	G	snv	A	CC.GT	hom-alt	161	1.00	.	0	.	PASS	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	IC16	IVS17	.	.	intron	NM_000141.4	NP_000132.3	-	Y	c.2302-1797C>T	.	.	.	NM_000141.4(FGFR2): c.2302-1797C>T	;maf-5-some-pop	5008	0.972444	U	1	0.972444	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1649164	.	4024	0.904600	-0.817	-0.894	-0.960	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123241347	123241348	10q26.13	0	nullSample	.	A	ref	A	tt.tt	homo-ref	.	.	.	0	AluSx3|SINE|Alu|-|312	.	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	IC16	IVS17	.	.	no-change	NM_000141.4	NP_000132.3	-	Y	c.2302-1813T=	.	.	.	NM_000141.4(FGFR2): c.2302-1813T=	;maf-5-some-pop,maf-5-all-pops	5008	0.567093	U	0.6419	0.432907	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1649165	.	3992	0.802000	-2.123	-1.887	-2.102	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123241347	123241348	10q26.13	0	normal	.	A	del	.	tt.tt	hom-alt	44	1.00	.	0	AluSx3|SINE|Alu|-|312	PASS	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	IC16	IVS17	.	.	intron	NM_000141.4	NP_000132.3	-	Y	c.2302-1813delT	.	.	.	NM_000141.4(FGFR2): c.2302-1813delT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3992	0.032800	-2.123	-1.887	-2.102	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
10	123241353	123241354	10q26.13	0	nullSample	.	A	ref	A	tt.tt	homo-ref	.	.	.	0	AluSx3|SINE|Alu|-|312	.	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	IC16	IVS17	.	.	no-change	NM_000141.4	NP_000132.3	-	Y	c.2302-1819T=	.	.	.	NM_000141.4(FGFR2): c.2302-1819T=	MixedObserved;	2|0	0.500000|0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1799603|rs199952842	.	3991	0.828500	-1.715	-2.055	-2.286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123241353	123241354	10q26.13	0	normal	.	A	snv	T	tt.tt	hom-alt	31	1.00	.	0	AluSx3|SINE|Alu|-|312	PASS	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	IC16	IVS17	.	.	intron	NM_000141.4	NP_000132.3	-	Y	c.2302-1819T>A	.	.	.	NM_000141.4(FGFR2): c.2302-1819T>A	MixedObserved;	2|0	0.500000|0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1799603|rs199952842	.	3991	0.129500	-1.715	-2.055	-2.286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123241382	123241383	10q26.13	0	nullSample	.	C	ref	C	cg.tc	homo-ref	.	.	.	0	AluSx3|SINE|Alu|-|312	.	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	IC16	IVS17	.	.	no-change	NM_000141.4	NP_000132.3	-	Y	c.2301+1829G=	.	.	.	NM_000141.4(FGFR2): c.2301+1829G=	;maf-5-some-pop,maf-5-all-pops	5008	0.563898	U	0.6389	0.436102	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1649166	.	3964	0.465400	0.313	0.317	0.308	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123241382	123241383	10q26.13	0	normal	.	C	snv	T	cg.tc	hom-alt	63	1.00	.	0	AluSx3|SINE|Alu|-|312	PASS	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	IC16	IVS17	.	.	intron	NM_000141.4	NP_000132.3	-	Y	c.2301+1829G>A	.	.	.	NM_000141.4(FGFR2): c.2301+1829G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.436102	U	0.6389	0.436102	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1649166	.	3964	0.534600	0.313	0.317	0.308	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123241793	123241794	10q26.13	0	normal	.	C	snv	T	TT.CC	hom-alt	625	1.00	.	0	.	PASS	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	IC16	IVS17	.	.	intron	NM_000141.4	NP_000132.3	-	Y	c.2301+1418G>A	.	.	.	NM_000141.4(FGFR2): c.2301+1418G>A	MixedObserved;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.442692	U	0.6468	0.442692	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2556537	.	4024	0.583300	-1.213	-0.290	-0.601	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123241793	123241794	10q26.13	0	nullSample	.	C	ref	C	TT.CC	homo-ref	.	.	.	0	.	.	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	IC16	IVS17	.	.	no-change	NM_000141.4	NP_000132.3	-	Y	c.2301+1418G=	.	.	.	NM_000141.4(FGFR2): c.2301+1418G=	MixedObserved;maf-5-some-pop,maf-5-all-pops,genotype-conflict|MixedObserved;	5008	0.557308|0.995407	U	0.6468	0.442692	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2556537|rs542104965	.	4024	0.416700	-1.213	-0.290	-0.601	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123242025	123242026	10q26.13	0	nullSample	.	T	ref	T	AC.TT	homo-ref	.	.	.	0	.	.	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	IC16	IVS17	.	.	no-change	NM_000141.4	NP_000132.3	-	Y	c.2301+1186A=	.	.	.	NM_000141.4(FGFR2): c.2301+1186A=	;maf-5-some-pop	5008	0.199081	U	0.994	0.800919	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3135814	.	4024	0.020900	-0.215	-0.926	-1.291	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123242025	123242026	10q26.13	0	normal	.	T	snv	C	AC.TT	hom-alt	453	1.00	.	0	.	PASS	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	IC16	IVS17	.	.	intron	NM_000141.4	NP_000132.3	-	Y	c.2301+1186A>G	.	.	.	NM_000141.4(FGFR2): c.2301+1186A>G	;maf-5-some-pop	5008	0.800919	U	0.994	0.800919	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3135814	.	4024	0.979100	-0.215	-0.926	-1.291	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123242723	123242724	10q26.13	0	nullSample	.	T	ref	T	TA.AG	homo-ref	.	.	.	0	.	.	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	IC16	IVS17	.	.	no-change	NM_000141.4	NP_000132.3	-	Y	c.2301+488A=	.	.	.	NM_000141.4(FGFR2): c.2301+488A=	;maf-5-some-pop,genotype-conflict	5008	0.200879	U	0.994	0.799121	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3135811	.	4024	0.020900	-1.281	-2.089	-2.164	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123242723	123242724	10q26.13	0	normal	.	T	snv	C	TA.AG	hom-alt	458	1.00	.	0	.	PASS	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	IC16	IVS17	.	.	intron	NM_000141.4	NP_000132.3	-	Y	c.2301+488A>G	.	.	.	NM_000141.4(FGFR2): c.2301+488A>G	;maf-5-some-pop,genotype-conflict	5008	0.799121	U	0.994	0.799121	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3135811	.	4024	0.979100	-1.281	-2.089	-2.164	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123242779	123242780	10q26.13	0	nullSample	.	G	ref	G	TA.AA	homo-ref	.	.	.	0	.	.	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	IC16	IVS17	.	.	no-change	NM_000141.4	NP_000132.3	-	Y	c.2301+432C=	.	.	.	NM_000141.4(FGFR2): c.2301+432C=	;maf-5-some-pop	5008	0.141374	U	0.998	0.858626	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3135810	.	4024	0.005200	-1.154	-1.579	-1.726	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123242779	123242780	10q26.13	0	normal	.	G	snv	C	TA.AA	hom-alt	531	1.00	.	0	.	PASS	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	IC16	IVS17	.	.	intron	NM_000141.4	NP_000132.3	-	Y	c.2301+432C>G	.	.	.	NM_000141.4(FGFR2): c.2301+432C>G	;maf-5-some-pop	5008	0.858626	U	0.998	0.858626	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3135810	.	4024	0.994800	-1.154	-1.579	-1.726	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123279744	123279745	10q26.13	0	nullSample	.	C	ref	C	AG.TG	homo-ref	.	.	.	0	.	.	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	IC5	IVS6	.	.	no-change	NM_000141.4	NP_000132.3	-	Y	c.749-62G=	.	.	.	NM_000141.4(FGFR2): c.749-62G=	;maf-5-some-pop	5008	0.113618	U	1	0.886382	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2981448	.	4024	0.001000	-2.697	-0.328	-0.827	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123279744	123279745	10q26.13	0	normal	.	C	snv	T	AG.TG	hom-alt	261	1.00	.	0	.	PASS	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	IC5	IVS6	.	.	intron	NM_000141.4	NP_000132.3	-	Y	c.749-62G>A	.	.	.	NM_000141.4(FGFR2): c.749-62G>A	;maf-5-some-pop	5008	0.886382	U	1	0.886382	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2981448	.	4024	0.999000	-2.697	-0.328	-0.827	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123298157	123298158	10q26.13	0	nullSample	.	T	ref	T	AC.AC	homo-ref	.	.	.	0	.	.	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	C5	EX6	Immunoglobulin domain;Immunoglobulin I-set domain;Immunoglobulin domain;Immunoglobulin domain	PF00047.20;PF07679.11;PF13895.1;PF13927.1	no-change	NM_000141.4	NP_000132.3	-	Y	c.696A=	.	.	.	NM_000141.4(FGFR2): c.696A=	SingleClassTriAllelic;maf-5-some-pop	126386	0.219692	U	0.9355	0.795327	13006	0.233277	PASS	-308	8644	0.076585	3224	121378	0.220312	.	.	.	.	.	.	rs1047100	.	4024	0.081800	-0.119	0.576	0.961	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123298157	123298158	10q26.13	1	normal	.	T	snv	C	AC.AC	hom-alt	637	1.00	.	0	.	PASS	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	C5	EX6	Immunoglobulin domain;Immunoglobulin I-set domain;Immunoglobulin domain;Immunoglobulin domain	PF00047.20;PF07679.11;PF13895.1;PF13927.1	coding-synon	NM_000141.4	NP_000132.3	-	Y	c.696A>G	p.(V232=) | p.(Val232=)	GTA=>GTG	.	NM_000141.4(FGFR2): c.696A>G (p.(V232=))	SingleClassTriAllelic;maf-5-some-pop	126386	0.780300	U	0.9355	0.795327	13006	0.766723	PASS	3683	8644	0.923415	37171	121378	0.779680	7352	15919	9.23590e-01	75579	192307	7.81323e-01	rs1047100	.	4024	0.918200	-0.119	0.576	0.961	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	255319	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
10	123353868	123353869	10q26.13	0	normal	.	C	ref	C	CT.GG	het-alt	330	0.51	.	1	.	PASS	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	I5U1	IVS1	.	.	no-change	NM_000141.4	NP_000132.3	-	Y	c.-150-388G=	.	.	.	NM_000141.4(FGFR2): c.-150-388G=	;maf-5-some-pop,maf-5-all-pops	5008	0.467452	U	0.6042	0.532548	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3135718	.	4024	0.393900	-0.182	0.170	-0.081	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123353868	123353869	10q26.13	0	normal	.	C	snv	T	CT.GG	het-ref	320	0.49	.	2	.	PASS	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	I5U1	IVS1	.	.	intron	NM_000141.4	NP_000132.3	-	Y	c.-150-388G>A	.	.	.	NM_000141.4(FGFR2): c.-150-388G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.532548	U	0.6042	0.532548	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3135718	.	4024	0.606100	-0.182	0.170	-0.081	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123354725	123354726	10q26.13	0	normal	.	T	ref	T	GA.GT	het-alt	254	0.48	.	1	.	PASS	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	I5U1	IVS1	.	.	no-change	NM_000141.4	NP_000132.3	-	Y	c.-150-1245A=	.	.	.	NM_000141.4(FGFR2): c.-150-1245A=	;maf-5-some-pop,maf-5-all-pops	5008	0.775958	U	0.2937	0.224042	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3135715	.	4024	0.700000	0.416	0.517	0.195	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123354725	123354726	10q26.13	0	normal	.	T	snv	G	GA.GT	het-ref	274	0.52	.	2	.	PASS	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	I5U1	IVS1	.	.	intron	NM_000141.4	NP_000132.3	-	Y	c.-150-1245A>C	.	.	.	NM_000141.4(FGFR2): c.-150-1245A>C	;maf-5-some-pop,maf-5-all-pops	5008	0.224042	U	0.2937	0.224042	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3135715	.	4024	0.300000	0.416	0.517	0.195	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123354944	123354945	10q26.13	0	normal	.	G	ref	G	gt.tg	het-alt	323	0.50	.	1	(TG)n|Simple_repeat|Simple_repeat|+|109;trf	PASS	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	I5U1	IVS1	.	.	no-change	NM_000141.4	NP_000132.3	-	Y	c.-150-1464C=	.	.	.	NM_000141.4(FGFR2): c.-150-1464C=	;maf-5-some-pop	5008	0.968650	U	0.0784	0.0313498	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1236090	.	4024	0.927700	0.134	-0.042	0.497	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123354944	123354945	10q26.13	0	normal	.	G	snv	A	gt.tg	het-ref	319	0.50	.	2	(TG)n|Simple_repeat|Simple_repeat|+|109;trf	PASS	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	I5U1	IVS1	.	.	intron	NM_000141.4	NP_000132.3	-	Y	c.-150-1464C>T	.	.	.	NM_000141.4(FGFR2): c.-150-1464C>T	;maf-5-some-pop	5008	0.031350	U	0.0784	0.0313498	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1236090	.	4024	0.072300	0.134	-0.042	0.497	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123354950	123354951	10q26.13	0	normal	.	G	ref	G	gt.tg	het-alt	337	0.52	.	1	(TG)n|Simple_repeat|Simple_repeat|+|109;trf	PASS	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	I5U1	IVS1	.	.	no-change	NM_000141.4	NP_000132.3	-	Y	c.-150-1470C=	.	.	.	NM_000141.4(FGFR2): c.-150-1470C=	;maf-5-some-pop,genotype-conflict	5008	0.968650	U	0.0784	0.0313498	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1219646	.	4024	0.927700	0.460	0.318	1.050	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123354950	123354951	10q26.13	0	normal	.	G	snv	C	gt.tg	het-ref	311	0.48	.	2	(TG)n|Simple_repeat|Simple_repeat|+|109;trf	PASS	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	I5U1	IVS1	.	.	intron	NM_000141.4	NP_000132.3	-	Y	c.-150-1470C>G	.	.	.	NM_000141.4(FGFR2): c.-150-1470C>G	;maf-5-some-pop,genotype-conflict	5008	0.031350	U	0.0784	0.0313498	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1219646	.	4024	0.072300	0.460	0.318	1.050	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123356174	123356175	10q26.13	0	normal	.	A	ref	A	AC.CA	het-alt	334	0.51	.	1	.	PASS	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	I5U1	IVS1	.	.	no-change	NM_000141.4	NP_000132.3	-	Y	c.-151+1301T=	.	.	.	NM_000141.4(FGFR2): c.-151+1301T=	;maf-5-some-pop,maf-5-all-pops	5008	0.329872	U	0.6448	0.670128	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2936871	.	4024	0.343400	-0.341	0.619	0.114	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123356174	123356175	10q26.13	0	normal	.	A	snv	T	AC.CA	het-ref	322	0.49	.	2	.	PASS	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	I5U1	IVS1	.	.	intron	NM_000141.4	NP_000132.3	-	Y	c.-151+1301T>A	.	.	.	NM_000141.4(FGFR2): c.-151+1301T>A	;maf-5-some-pop,maf-5-all-pops	5008	0.670128	U	0.6448	0.670128	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2936871	.	4024	0.656600	-0.341	0.619	0.114	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123356196	123356197	10q26.13	0	nullSample	.	A	ref	A	AA.GC	homo-ref	.	.	.	0	.	.	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	I5U1	IVS1	.	.	no-change	NM_000141.4	NP_000132.3	-	Y	c.-151+1279T=	.	.	.	NM_000141.4(FGFR2): c.-151+1279T=	;	5008	0.009984	U	1	0.990016	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1231198	.	4024	0.001500	-0.992	-0.854	-1.196	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123356196	123356197	10q26.13	0	normal	.	A	snv	T	AA.GC	hom-alt	616	1.00	.	0	.	PASS	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	I5U1	IVS1	.	.	intron	NM_000141.4	NP_000132.3	-	Y	c.-151+1279T>A	.	.	.	NM_000141.4(FGFR2): c.-151+1279T>A	;	5008	0.990016	U	1	0.990016	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1231198	.	4024	0.998500	-0.992	-0.854	-1.196	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123357560	123357561	10q26.13	0	nullSample	.	C	ref	C	TG.GG	homo-ref	.	.	.	0	.	.	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	5U2E	EX1	.	.	no-change	NM_000141.4	NP_000132.3	-	Y	c.-236G=	.	.	.	NM_000141.4(FGFR2): c.-236G=	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	5008	0.139177	U	0.2619	0.150559	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1047111	.	.	.	-2.135	-0.119	-0.573	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
10	123357560	123357561	10q26.13	0	normal	.	C	snv	T	TG.GG	hom-alt	195	1.00	.	0	.	PASS	176943	C	101200(MK);101400(MK);101600(MK);123150(MK);123500(MK);123790(MK);149730(MK);176943(MK);207410(MK);609579(MK);613659(MK);614592(MK)	AD;AR	Lacrimoauriculodentodigital syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Apert syndrome; Beare-Stevenson cutis gyrata syndrome	AD	Allelic with Bent bone dysplasia syndrome (AD); Scaphocephaly, maxillary retrusion, and mental retardation (AD)	Audiologic/Otolaryngologic; Craniofacial; Dental; Musculoskeletal; Neurologic	Audiologic/Otolaryngologic	22387015|19610084|18247426|17529973|16969861|16876521|16691624|16501574|16440883|16061565|15996217|15793702|13801313|12900791|12400058|11343323|10951518|10945669|10735635|10712195|10633130|10076887|10076886|10067911|9973282|9714439|9664610|9605588|9585583|9475591|9475590|9150725|9002682|8696350|8683284|8673103|8651276|8644708|8528214|7987400|7874170|7795583|7719345|7719344|7719333|7674004|5781468|1519658|1271196|660365	.	2263	FGFR2	5U2E	EX1	.	.	utr-5	NM_000141.4	NP_000132.3	-	Y	c.-236G>A	.	.	.	NM_000141.4(FGFR2): c.-236G>A	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	5008	0.710264	U	0.7361	0.710264	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1047111	.	.	.	-2.135	-0.119	-0.573	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	299019	criteria_provided,_single_submitter	Benign	Benign
11	320771	320772	11p15.5	0	normal	.	A	ref	A	CC.CT	het-alt	193	0.55	.	1	dup	PASS	605579	P	614680(SK)	NN	.	.	.	.	.	.	.	10410	IFITM3	C1	EX1	.	.	no-change	NM_021034.2	NP_066362.2	-	Y	c.42T=	.	.	.	NM_021034.2(IFITM3): c.42T=	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	125570	0.870885	U	0.5278	0.236422	12184	0.899540	PASS	.	8600	0.437791	47396	120562	0.875342	.	.	.	.	.	.	rs12252	.	4024	0.440100	-1.472	-3.123	-3.754	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	320771	320772	11p15.5	1	normal	.	A	snv	G	CC.CT	het-ref	158	0.45	.	2	dup	PASS	605579	P	614680(SK)	NN	.	.	.	.	.	.	.	10410	IFITM3	C1	EX1	.	.	coding-synon	NM_021034.2	NP_066362.2	-	Y	c.42T>C	p.(S14=) | p.(Ser14=)	AGT=>AGC	.	NM_021034.2(IFITM3): c.42T>C (p.(S14=))	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	125570	0.129115	U	0.5278	0.236422	12184	0.100460	PASS	1367	8600	0.562209	2144	120562	0.124658	2701	9684	5.61912e-01	4309	31127	1.26554e-01	rs12252	.	4024	0.559900	-1.472	-3.123	-3.754	.	.	.	.	.	ENST00000399808: c.42T>C (p.S14S)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3752325	.	.	.	.	.	no_record	31527	no_assertion_criteria_provided	risk_factor	Likely Benign
11	1651240	1651241	11p15.5	0	normal	.	A	ref	A	gg.tg	het-alt	50	0.69	.	1	(CTGGGG)n|Simple_repeat|Simple_repeat|+|178;trf	DUBIOUS	.	.	.	.	.	.	.	.	.	.	.	439915	KRTAP5-5	C1E	EX1E	.	.	no-change	NM_001001480.2	NP_001001480.2	+	Y	c.171A=	.	.	.	NM_001001480.2(KRTAP5-5): c.171A=	;	118094	0.997841	U	.	.	.	.	VQSRTrancheSNP99.60to99.80	.	8626	0.999652	58792	118094	0.997841	.	.	.	.	.	.	rs754353217	.	4024	0.945100	-4.915	0.126	-0.955	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	1651240	1651241	11p15.5	1	normal	.	A	snv	C	gg.tg	het-ref	22	0.31	.	2	(CTGGGG)n|Simple_repeat|Simple_repeat|+|178;trf	DUBIOUS	.	.	.	.	.	.	.	.	.	.	.	439915	KRTAP5-5	C1E	EX1E	.	.	coding-synon	NM_001001480.2	NP_001001480.2	+	Y	c.171A>C	p.(G57=) | p.(Gly57=)	GGA=>GGC	.	NM_001001480.2(KRTAP5-5): c.171A>C (p.(G57=))	;	118094	0.002159	U	.	.	.	.	VQSRTrancheSNP99.60to99.80	0	8626	0.000348	0	118094	0.002159	0	1	6.01106e-05	0	440	1.98881e-03	rs754353217	.	4024	0.054900	-4.915	0.126	-0.955	.	.	.	.	.	ENST00000399676: c.171A>C (p.G57G)	breast [NS|NS|NS]	carcinoma [NS|NS|NS]	CSV	3808861	.	.	.	.	.	.	.	.	.	Unknown
11	2940491	2940492	11p15.4	0	normal	.	T	snv	C	GG.CG	hom-alt	213	1.00	.	0	.	PASS	602631	P	114480(MK);211980(MK);268210(MK)	AD;AR	.	.	.	.	.	.	.	5002	SLC22A18	IC6	IVS7	.	.	intron	NM_183233.2	NP_899056.2	+	Y	c.764-45T>C	.	.	.	NM_183233.2(SLC22A18): c.764-45T>C	;maf-5-some-pop,maf-5-all-pops	124704	0.905841	U	0.8998	0.906749	13000	0.911769	PASS	3507	8620	0.902204	49140	119696	0.905803	6930	15296	9.05303e-01	97388	215605	9.02559e-01	rs450244	.	4024	0.879000	-1.026	-0.689	-1.035	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	2940491	2940492	11p15.4	0	nullSample	.	T	ref	T	GG.CG	homo-ref	.	.	.	0	.	.	602631	P	114480(MK);211980(MK);268210(MK)	AD;AR	.	.	.	.	.	.	.	5002	SLC22A18	IC6	IVS7	.	.	no-change	NM_183233.2	NP_899056.2	+	Y	c.764-45T=	.	.	.	NM_183233.2(SLC22A18): c.764-45T=	;maf-5-some-pop,maf-5-all-pops	124704	0.094159	U	0.8998	0.906749	13000	0.088231	PASS	.	8620	0.097796	567	119696	0.094197	.	.	.	.	.	.	rs450244	.	4024	0.121000	-1.026	-0.689	-1.035	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	4159456	4159457	11p15.4	0	normal	.	A	ref	A	AC.AG	het-alt	207	0.62	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.4159456A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	124706	0.543326	U	0.3819	0.344649	12998	0.588783	PASS	.	8636	0.618458	18053	119698	0.538639	.	.	.	.	.	.	rs9937	.	.	.	0.482	-0.001	0.913	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	4159456	4159457	11p15.4	0	normal	.	A	snv	G	AC.AG	het-ref	125	0.38	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.4159456A>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	124706	0.456674	U	0.3819	0.344649	12998	0.411217	PASS	651	8636	0.381542	13428	119698	0.461361	1203	6329	3.74187e-01	27115	111370	4.61255e-01	rs9937	.	.	.	0.482	-0.001	0.913	.	.	.	.	.	ENST00000300738: c.2223A>G (p.T741T)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3998402	.	.	.	.	.	.	.	.	.	Benign
11	4159465	4159466	11p15.4	0	normal	.	G	ref	G	GC.GC	het-alt	206	0.62	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.4159465G= (intergenic)	SingleClassTriAllelic;maf-5-some-pop	126214	0.109401	U	0.7619	0.845647	12998	0.106709	PASS	.	8644	0.258792	936	121206	0.107544	.	.	.	.	.	.	rs1042858	.	.	.	-0.290	-0.556	-0.878	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	4159465	4159466	11p15.4	0	normal	.	G	snv	A	GC.GC	het-ref	124	0.38	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.4159465G>A (intergenic)	SingleClassTriAllelic;maf-5-some-pop	126214	0.890591	U	0.7619	0.845647	12998	0.893291	PASS	2371	8644	0.741208	48503	121206	0.892448	4632	12574	7.37219e-01	96975	216760	8.89703e-01	rs1042858	.	.	.	-0.290	-0.556	-0.878	.	.	.	.	.	ENST00000300738: c.2232G>A (p.A744A)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3998403	.	.	.	.	.	.	.	.	.	Benign
11	9069045	9069046	11p15.4	1	normal	.	G	snv	A	GC.TG	het-ref	207	0.48	.	2	.	PASS	611747	P	.	NN	.	.	.	.	.	.	.	57758	SCUBE2	C16	EX16	.	.	missense	NM_020974.2	NP_066025.2	-	Y	c.1859C>T	p.T620M | p.Thr620Met	ACG=>ATG	P0=>NP	NM_020974.2(SCUBE2): c.1859C>T (p.T620M)	;maf-5-some-pop,genotype-conflict	126334	0.154543	U	0.256	0.154353	12994	0.115053	PASS	345	8642	0.279333	1725	121326	0.154551	664	4805	2.78680e-01	3328	36856	1.50003e-01	rs3751055	.	4024	0.276800	0.655	2.479	0.594	.	.	.	.	.	ENST00000309263: c.1772C>T (p.T591M)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	147143	.	.	.	.	.	.	.	.	.	Likely Benign
11	9069045	9069046	11p15.4	0	normal	.	G	ref	G	GC.TG	het-alt	223	0.52	.	1	.	PASS	611747	P	.	NN	.	.	.	.	.	.	.	57758	SCUBE2	C16	EX16	.	.	no-change	NM_020974.2	NP_066025.2	-	Y	c.1859C=	.	.	.	NM_020974.2(SCUBE2): c.1859C=	;maf-5-some-pop,genotype-conflict	126334	0.845457	U	0.256	0.154353	12994	0.884947	PASS	-862	8642	0.720667	43637	121326	0.845449	.	.	.	.	.	.	rs3751055	.	4024	0.722900	0.655	2.479	0.594	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	22647365	22647366	11p14.3	0	normal	.	G	ref	G	GC.AA	het-alt	231	0.47	.	1	.	PASS	613897	P	603467(MK)	NN	Fanconia anemia, complementation group F	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	20301575|10615118	.	2188	FANCF	5U1E	EX1E	.	.	no-change	NM_022725.3	NP_073562.1	-	Y	c.-10C=	.	.	.	NM_022725.3(FANCF): c.-10C=	SingleClassTriAllelic;maf-5-some-pop	124650	0.844990	U	0.1964	0.113818	13006	0.853375	PASS	.	8532	0.782583	42850	119642	0.843266	.	.	.	.	.	.	rs3740615	.	.	.	-1.885	-3.432	-3.747	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	22647365	22647366	11p14.3	0	normal	.	G	snv	A	GC.AA	het-ref	260	0.53	.	2	.	PASS	613897	P	603467(MK)	NN	Fanconia anemia, complementation group F	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	20301575|10615118	.	2188	FANCF	5U1E	EX1E	.	.	utr-5	NM_022725.3	NP_073562.1	-	Y	c.-10C>T	.	.	.	NM_022725.3(FANCF): c.-10C>T	SingleClassTriAllelic;maf-5-some-pop	124650	0.154962	U	0.1964	0.113818	13006	0.146625	PASS	207	8532	0.217417	1779	119642	0.156684	407	3733	2.17237e-01	3683	38520	1.58206e-01	rs3740615	.	.	.	-1.885	-3.432	-3.747	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	261630	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
11	32410773	32410774	11p13	0	normal	.	A	snv	G	GC.CA	het-ref	165	0.48	.	2	.	PASS	607102	C	136680(MK);156240(MK);194070(MK);194080(MK);256370(MK);608978(MK)	AD;AR	Denys-Drash syndrome; Wilms tumor, type 1; Frasier syndrome	AD	Allelic with Meacham syndrome, which involves multiple malformations, but typically does not involve findins such as Wilms tumor (AD); Allelic with Nephrotic syndrome, type 4 (AD), though it is unclear if this disorder typically occurs without oncologic manifestations	Cardiovascular; Endocrine; Genitourinary; Oncologic; Renal; Pulmonary	Oncologic; Renal	24161391|22876585|22585769|21614510|21559934|21434831|20301471|20150449|18688870|18203154|17853480|14149008|12050205|11241056|9607189|9529364|9398852|9108089|8386697|8071974|7645607|7607640|4316066|4292870|4153449|3130865|3026952|3000666|2172500|1655284|1338906|1338905|331956	H62;H68	7490	WT1	IC9	IVS9	.	.	intron	NM_001198551.1	NP_001185480.1	-	Y	c.788-49T>C	.	.	.	NM_001198551.1(WT1): c.788-49T>C	;maf-5-some-pop,maf-5-all-pops	126130	0.352985	U	0.7202	0.507987	13002	0.334026	PASS	2226	8632	0.718142	8869	121122	0.346576	4477	12412	7.20371e-01	17829	85185	3.47439e-01	rs1799937	.	4024	0.731900	-1.277	-1.726	-1.946	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	261709	criteria_provided,_single_submitter	Benign	Benign
11	32410773	32410774	11p13	0	normal	.	A	snv	G	GC.CA	het-ref	165	0.48	.	2	.	PASS	607102	C	136680(MK);156240(MK);194070(MK);194080(MK);256370(MK);608978(MK)	AD;AR	Denys-Drash syndrome; Wilms tumor, type 1; Frasier syndrome	AD	Allelic with Meacham syndrome, which involves multiple malformations, but typically does not involve findins such as Wilms tumor (AD); Allelic with Nephrotic syndrome, type 4 (AD), though it is unclear if this disorder typically occurs without oncologic manifestations	Cardiovascular; Endocrine; Genitourinary; Oncologic; Renal; Pulmonary	Oncologic; Renal	24161391|22876585|22585769|21614510|21559934|21434831|20301471|20150449|18688870|18203154|17853480|14149008|12050205|11241056|9607189|9529364|9398852|9108089|8386697|8071974|7645607|7607640|4316066|4292870|4153449|3130865|3026952|3000666|2172500|1655284|1338906|1338905|331956	H62;H68	7490	WT1	IC9	IVS9	.	.	intron	NM_024426.4	NP_077744.3	-	N	c.1433-49T>C	.	.	.	NM_024426.4(WT1): c.1433-49T>C	;maf-5-some-pop,maf-5-all-pops	126130	0.352985	U	0.7202	0.507987	13002	0.334026	PASS	2226	8632	0.718142	8869	121122	0.346576	4477	12412	7.20371e-01	17829	85185	3.47439e-01	rs1799937	.	4024	0.731900	-1.277	-1.726	-1.946	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	261709	criteria_provided,_single_submitter	Benign	Benign
11	32410773	32410774	11p13	0	normal	.	A	ref	A	GC.CA	het-alt	182	0.52	.	1	.	PASS	607102	C	136680(MK);156240(MK);194070(MK);194080(MK);256370(MK);608978(MK)	AD;AR	Denys-Drash syndrome; Wilms tumor, type 1; Frasier syndrome	AD	Allelic with Meacham syndrome, which involves multiple malformations, but typically does not involve findins such as Wilms tumor (AD); Allelic with Nephrotic syndrome, type 4 (AD), though it is unclear if this disorder typically occurs without oncologic manifestations	Cardiovascular; Endocrine; Genitourinary; Oncologic; Renal; Pulmonary	Oncologic; Renal	24161391|22876585|22585769|21614510|21559934|21434831|20301471|20150449|18688870|18203154|17853480|14149008|12050205|11241056|9607189|9529364|9398852|9108089|8386697|8071974|7645607|7607640|4316066|4292870|4153449|3130865|3026952|3000666|2172500|1655284|1338906|1338905|331956	H62;H68	7490	WT1	IC9	IVS9	.	.	no-change	NM_001198551.1	NP_001185480.1	-	Y	c.788-49T=	.	.	.	NM_001198551.1(WT1): c.788-49T=	;maf-5-some-pop,maf-5-all-pops	126130	0.647015	U	0.7202	0.507987	13002	0.665974	PASS	.	8632	0.281858	27452	121122	0.653424	.	.	.	.	.	.	rs1799937	.	4024	0.268100	-1.277	-1.726	-1.946	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	32410773	32410774	11p13	0	normal	.	A	ref	A	GC.CA	het-alt	182	0.52	.	1	.	PASS	607102	C	136680(MK);156240(MK);194070(MK);194080(MK);256370(MK);608978(MK)	AD;AR	Denys-Drash syndrome; Wilms tumor, type 1; Frasier syndrome	AD	Allelic with Meacham syndrome, which involves multiple malformations, but typically does not involve findins such as Wilms tumor (AD); Allelic with Nephrotic syndrome, type 4 (AD), though it is unclear if this disorder typically occurs without oncologic manifestations	Cardiovascular; Endocrine; Genitourinary; Oncologic; Renal; Pulmonary	Oncologic; Renal	24161391|22876585|22585769|21614510|21559934|21434831|20301471|20150449|18688870|18203154|17853480|14149008|12050205|11241056|9607189|9529364|9398852|9108089|8386697|8071974|7645607|7607640|4316066|4292870|4153449|3130865|3026952|3000666|2172500|1655284|1338906|1338905|331956	H62;H68	7490	WT1	IC9	IVS9	.	.	no-change	NM_024426.4	NP_077744.3	-	N	c.1433-49T=	.	.	.	NM_024426.4(WT1): c.1433-49T=	;maf-5-some-pop,maf-5-all-pops	126130	0.647015	U	0.7202	0.507987	13002	0.665974	PASS	.	8632	0.281858	27452	121122	0.653424	.	.	.	.	.	.	rs1799937	.	4024	0.268100	-1.277	-1.726	-1.946	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	32417944	32417945	11p13	0	normal	.	T	ref	T	CG.CG	het-alt	327	0.52	.	1	.	PASS	607102	C	136680(MK);156240(MK);194070(MK);194080(MK);256370(MK);608978(MK)	AD;AR	Denys-Drash syndrome; Wilms tumor, type 1; Frasier syndrome	AD	Allelic with Meacham syndrome, which involves multiple malformations, but typically does not involve findins such as Wilms tumor (AD); Allelic with Nephrotic syndrome, type 4 (AD), though it is unclear if this disorder typically occurs without oncologic manifestations	Cardiovascular; Endocrine; Genitourinary; Oncologic; Renal; Pulmonary	Oncologic; Renal	24161391|22876585|22585769|21614510|21559934|21434831|20301471|20150449|18688870|18203154|17853480|14149008|12050205|11241056|9607189|9529364|9398852|9108089|8386697|8071974|7645607|7607640|4316066|4292870|4153449|3130865|3026952|3000666|2172500|1655284|1338906|1338905|331956	H62;H68	7490	WT1	C7	EX7	Wilm's tumour protein	PF02165.10	no-change	NM_001198551.1	NP_001185480.1	-	Y	c.471A=	.	.	.	NM_001198551.1(WT1): c.471A=	;maf-5-some-pop	126080	0.762651	U	0.6984	0.33147	13002	0.869712	PASS	.	8620	0.306845	37230	121072	0.766544	.	.	.	.	.	.	rs16754	.	4024	0.290000	-0.119	-0.899	-0.854	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	32417944	32417945	11p13	0	normal	.	T	ref	T	CG.CG	het-alt	327	0.52	.	1	.	PASS	607102	C	136680(MK);156240(MK);194070(MK);194080(MK);256370(MK);608978(MK)	AD;AR	Denys-Drash syndrome; Wilms tumor, type 1; Frasier syndrome	AD	Allelic with Meacham syndrome, which involves multiple malformations, but typically does not involve findins such as Wilms tumor (AD); Allelic with Nephrotic syndrome, type 4 (AD), though it is unclear if this disorder typically occurs without oncologic manifestations	Cardiovascular; Endocrine; Genitourinary; Oncologic; Renal; Pulmonary	Oncologic; Renal	24161391|22876585|22585769|21614510|21559934|21434831|20301471|20150449|18688870|18203154|17853480|14149008|12050205|11241056|9607189|9529364|9398852|9108089|8386697|8071974|7645607|7607640|4316066|4292870|4153449|3130865|3026952|3000666|2172500|1655284|1338906|1338905|331956	H62;H68	7490	WT1	C7	EX7	Wilm's tumour protein	PF02165.10	no-change	NM_024426.4	NP_077744.3	-	N	c.1107A=	.	.	.	NM_024426.4(WT1): c.1107A=	;maf-5-some-pop	126080	0.762651	U	0.6984	0.33147	13002	0.869712	PASS	.	8620	0.306845	37230	121072	0.766544	.	.	.	.	.	.	rs16754	.	4024	0.290000	-0.119	-0.899	-0.854	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	32417944	32417945	11p13	1	normal	.	T	snv	C	CG.CG	het-ref	303	0.48	.	2	.	PASS	607102	C	136680(MK);156240(MK);194070(MK);194080(MK);256370(MK);608978(MK)	AD;AR	Denys-Drash syndrome; Wilms tumor, type 1; Frasier syndrome	AD	Allelic with Meacham syndrome, which involves multiple malformations, but typically does not involve findins such as Wilms tumor (AD); Allelic with Nephrotic syndrome, type 4 (AD), though it is unclear if this disorder typically occurs without oncologic manifestations	Cardiovascular; Endocrine; Genitourinary; Oncologic; Renal; Pulmonary	Oncologic; Renal	24161391|22876585|22585769|21614510|21559934|21434831|20301471|20150449|18688870|18203154|17853480|14149008|12050205|11241056|9607189|9529364|9398852|9108089|8386697|8071974|7645607|7607640|4316066|4292870|4153449|3130865|3026952|3000666|2172500|1655284|1338906|1338905|331956	H62;H68	7490	WT1	C7	EX7	Wilm's tumour protein	PF02165.10	coding-synon	NM_001198551.1	NP_001185480.1	-	Y	c.471A>G	p.(R157=) | p.(Arg157=)	CGA=>CGG	.	NM_001198551.1(WT1): c.471A>G (p.(R157=))	;maf-5-some-pop	126080	0.237349	U	0.6984	0.33147	13002	0.130288	PASS	2079	8620	0.693155	4959	121072	0.233456	4176	11960	6.94299e-01	10439	59678	2.42672e-01	rs16754	.	4024	0.710000	-0.119	-0.899	-0.854	.	.	.	.	.	ENST00000379079: c.471A>G (p.R157R)	bone [femur|NS|NS]	osteosarcoma [NS|NS|NS]	CSV	1353507	.	.	.	.	.	no_record	198591	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
11	32417944	32417945	11p13	1	normal	.	T	snv	C	CG.CG	het-ref	303	0.48	.	2	.	PASS	607102	C	136680(MK);156240(MK);194070(MK);194080(MK);256370(MK);608978(MK)	AD;AR	Denys-Drash syndrome; Wilms tumor, type 1; Frasier syndrome	AD	Allelic with Meacham syndrome, which involves multiple malformations, but typically does not involve findins such as Wilms tumor (AD); Allelic with Nephrotic syndrome, type 4 (AD), though it is unclear if this disorder typically occurs without oncologic manifestations	Cardiovascular; Endocrine; Genitourinary; Oncologic; Renal; Pulmonary	Oncologic; Renal	24161391|22876585|22585769|21614510|21559934|21434831|20301471|20150449|18688870|18203154|17853480|14149008|12050205|11241056|9607189|9529364|9398852|9108089|8386697|8071974|7645607|7607640|4316066|4292870|4153449|3130865|3026952|3000666|2172500|1655284|1338906|1338905|331956	H62;H68	7490	WT1	C7	EX7	Wilm's tumour protein	PF02165.10	coding-synon	NM_024426.4	NP_077744.3	-	N	c.1107A>G	p.(R369=) | p.(Arg369=)	CGA=>CGG	.	NM_024426.4(WT1): c.1107A>G (p.(R369=))	;maf-5-some-pop	126080	0.237349	U	0.6984	0.33147	13002	0.130288	PASS	2079	8620	0.693155	4959	121072	0.233456	4176	11960	6.94299e-01	10439	59678	2.42672e-01	rs16754	.	4024	0.710000	-0.119	-0.899	-0.854	.	.	.	.	.	ENST00000379079: c.471A>G (p.R157R)	bone [femur|NS|NS]	osteosarcoma [NS|NS|NS]	CSV	1353507	.	.	.	.	.	no_record	198591	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
11	32449660	32449661	11p13	0	normal	.	G	ref	G	GA.GC	het-alt	57	0.41	.	1	.	PASS	607102	C	136680(MK);156240(MK);194070(MK);194080(MK);256370(MK);608978(MK)	AD;AR	Denys-Drash syndrome; Wilms tumor, type 1; Frasier syndrome	AD	Allelic with Meacham syndrome, which involves multiple malformations, but typically does not involve findins such as Wilms tumor (AD); Allelic with Nephrotic syndrome, type 4 (AD), though it is unclear if this disorder typically occurs without oncologic manifestations	Cardiovascular; Endocrine; Genitourinary; Oncologic; Renal; Pulmonary	Oncologic; Renal	24161391|22876585|22585769|21614510|21559934|21434831|20301471|20150449|18688870|18203154|17853480|14149008|12050205|11241056|9607189|9529364|9398852|9108089|8386697|8071974|7645607|7607640|4316066|4292870|4153449|3130865|3026952|3000666|2172500|1655284|1338906|1338905|331956	H62;H68	7490	WT1	IC2	IVS2	.	.	no-change	NM_001198551.1	NP_001185480.1	-	Y	c.134-57C=	.	.	.	NM_001198551.1(WT1): c.134-57C=	;maf-5-some-pop,maf-5-all-pops	5008	0.628794	U	0.7202	0.371206	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2234585	.	4024	0.283300	-0.264	0.455	0.248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	32449660	32449661	11p13	0	normal	.	G	ref	G	GA.GC	het-alt	57	0.41	.	1	.	PASS	607102	C	136680(MK);156240(MK);194070(MK);194080(MK);256370(MK);608978(MK)	AD;AR	Denys-Drash syndrome; Wilms tumor, type 1; Frasier syndrome	AD	Allelic with Meacham syndrome, which involves multiple malformations, but typically does not involve findins such as Wilms tumor (AD); Allelic with Nephrotic syndrome, type 4 (AD), though it is unclear if this disorder typically occurs without oncologic manifestations	Cardiovascular; Endocrine; Genitourinary; Oncologic; Renal; Pulmonary	Oncologic; Renal	24161391|22876585|22585769|21614510|21559934|21434831|20301471|20150449|18688870|18203154|17853480|14149008|12050205|11241056|9607189|9529364|9398852|9108089|8386697|8071974|7645607|7607640|4316066|4292870|4153449|3130865|3026952|3000666|2172500|1655284|1338906|1338905|331956	H62;H68	7490	WT1	IC2	IVS2	.	.	no-change	NM_024426.4	NP_077744.3	-	N	c.770-57C=	.	.	.	NM_024426.4(WT1): c.770-57C=	;maf-5-some-pop,maf-5-all-pops	5008	0.628794	U	0.7202	0.371206	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2234585	.	4024	0.283300	-0.264	0.455	0.248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	32449660	32449661	11p13	0	normal	.	G	snv	A	GA.GC	het-ref	82	0.59	.	2	.	PASS	607102	C	136680(MK);156240(MK);194070(MK);194080(MK);256370(MK);608978(MK)	AD;AR	Denys-Drash syndrome; Wilms tumor, type 1; Frasier syndrome	AD	Allelic with Meacham syndrome, which involves multiple malformations, but typically does not involve findins such as Wilms tumor (AD); Allelic with Nephrotic syndrome, type 4 (AD), though it is unclear if this disorder typically occurs without oncologic manifestations	Cardiovascular; Endocrine; Genitourinary; Oncologic; Renal; Pulmonary	Oncologic; Renal	24161391|22876585|22585769|21614510|21559934|21434831|20301471|20150449|18688870|18203154|17853480|14149008|12050205|11241056|9607189|9529364|9398852|9108089|8386697|8071974|7645607|7607640|4316066|4292870|4153449|3130865|3026952|3000666|2172500|1655284|1338906|1338905|331956	H62;H68	7490	WT1	IC2	IVS2	.	.	intron	NM_001198551.1	NP_001185480.1	-	Y	c.134-57C>T	.	.	.	NM_001198551.1(WT1): c.134-57C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.371206	U	0.7202	0.371206	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2234585	.	4024	0.716700	-0.264	0.455	0.248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	32449660	32449661	11p13	0	normal	.	G	snv	A	GA.GC	het-ref	82	0.59	.	2	.	PASS	607102	C	136680(MK);156240(MK);194070(MK);194080(MK);256370(MK);608978(MK)	AD;AR	Denys-Drash syndrome; Wilms tumor, type 1; Frasier syndrome	AD	Allelic with Meacham syndrome, which involves multiple malformations, but typically does not involve findins such as Wilms tumor (AD); Allelic with Nephrotic syndrome, type 4 (AD), though it is unclear if this disorder typically occurs without oncologic manifestations	Cardiovascular; Endocrine; Genitourinary; Oncologic; Renal; Pulmonary	Oncologic; Renal	24161391|22876585|22585769|21614510|21559934|21434831|20301471|20150449|18688870|18203154|17853480|14149008|12050205|11241056|9607189|9529364|9398852|9108089|8386697|8071974|7645607|7607640|4316066|4292870|4153449|3130865|3026952|3000666|2172500|1655284|1338906|1338905|331956	H62;H68	7490	WT1	IC2	IVS2	.	.	intron	NM_024426.4	NP_077744.3	-	N	c.770-57C>T	.	.	.	NM_024426.4(WT1): c.770-57C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.371206	U	0.7202	0.371206	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2234585	.	4024	0.716700	-0.264	0.455	0.248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	32451978	32451980	11p13	0	normal	.	AG	ref	AG	ac.ag	het-alt	58	0.69	.	1	(GA)n|Simple_repeat|Simple_repeat|+|87;trf	PASS	607102	C	136680(MK);156240(MK);194070(MK);194080(MK);256370(MK);608978(MK)	AD;AR	Denys-Drash syndrome; Wilms tumor, type 1; Frasier syndrome	AD	Allelic with Meacham syndrome, which involves multiple malformations, but typically does not involve findins such as Wilms tumor (AD); Allelic with Nephrotic syndrome, type 4 (AD), though it is unclear if this disorder typically occurs without oncologic manifestations	Cardiovascular; Endocrine; Genitourinary; Oncologic; Renal; Pulmonary	Oncologic; Renal	24161391|22876585|22585769|21614510|21559934|21434831|20301471|20150449|18688870|18203154|17853480|14149008|12050205|11241056|9607189|9529364|9398852|9108089|8386697|8071974|7645607|7607640|4316066|4292870|4153449|3130865|3026952|3000666|2172500|1655284|1338906|1338905|331956	H62;H68	7490	WT1	IC1	IVS1	.	.	no-change	NM_001198551.1	NP_001185480.1	-	Y	c.10+96_10+97=	.	.	.	NM_001198551.1(WT1): c.10+96_10+97=	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs370524588	.	4028	0.876200	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	32451978	32451980	11p13	0	normal	.	AG	ref	AG	ac.ag	het-alt	58	0.69	.	1	(GA)n|Simple_repeat|Simple_repeat|+|87;trf	PASS	607102	C	136680(MK);156240(MK);194070(MK);194080(MK);256370(MK);608978(MK)	AD;AR	Denys-Drash syndrome; Wilms tumor, type 1; Frasier syndrome	AD	Allelic with Meacham syndrome, which involves multiple malformations, but typically does not involve findins such as Wilms tumor (AD); Allelic with Nephrotic syndrome, type 4 (AD), though it is unclear if this disorder typically occurs without oncologic manifestations	Cardiovascular; Endocrine; Genitourinary; Oncologic; Renal; Pulmonary	Oncologic; Renal	24161391|22876585|22585769|21614510|21559934|21434831|20301471|20150449|18688870|18203154|17853480|14149008|12050205|11241056|9607189|9529364|9398852|9108089|8386697|8071974|7645607|7607640|4316066|4292870|4153449|3130865|3026952|3000666|2172500|1655284|1338906|1338905|331956	H62;H68	7490	WT1	IC1	IVS1	.	.	no-change	NM_024426.4	NP_077744.3	-	N	c.647-1815_647-1814=	.	.	.	NM_024426.4(WT1): c.647-1815_647-1814=	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs370524588	.	4028	0.876200	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	32451978	32451980	11p13	0	normal	.	AG	del	.	ac.ag	het-ref	26	0.31	.	2	(GA)n|Simple_repeat|Simple_repeat|+|87;trf	PASS	607102	C	136680(MK);156240(MK);194070(MK);194080(MK);256370(MK);608978(MK)	AD;AR	Denys-Drash syndrome; Wilms tumor, type 1; Frasier syndrome	AD	Allelic with Meacham syndrome, which involves multiple malformations, but typically does not involve findins such as Wilms tumor (AD); Allelic with Nephrotic syndrome, type 4 (AD), though it is unclear if this disorder typically occurs without oncologic manifestations	Cardiovascular; Endocrine; Genitourinary; Oncologic; Renal; Pulmonary	Oncologic; Renal	24161391|22876585|22585769|21614510|21559934|21434831|20301471|20150449|18688870|18203154|17853480|14149008|12050205|11241056|9607189|9529364|9398852|9108089|8386697|8071974|7645607|7607640|4316066|4292870|4153449|3130865|3026952|3000666|2172500|1655284|1338906|1338905|331956	H62;H68	7490	WT1	IC1	IVS1	.	.	intron	NM_001198551.1	NP_001185480.1	-	Y	c.10+96_10+97delCT	.	.	.	NM_001198551.1(WT1): c.10+96_10+97delCT	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs370524588	.	4028	0.122800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	32451978	32451980	11p13	0	normal	.	AG	del	.	ac.ag	het-ref	26	0.31	.	2	(GA)n|Simple_repeat|Simple_repeat|+|87;trf	PASS	607102	C	136680(MK);156240(MK);194070(MK);194080(MK);256370(MK);608978(MK)	AD;AR	Denys-Drash syndrome; Wilms tumor, type 1; Frasier syndrome	AD	Allelic with Meacham syndrome, which involves multiple malformations, but typically does not involve findins such as Wilms tumor (AD); Allelic with Nephrotic syndrome, type 4 (AD), though it is unclear if this disorder typically occurs without oncologic manifestations	Cardiovascular; Endocrine; Genitourinary; Oncologic; Renal; Pulmonary	Oncologic; Renal	24161391|22876585|22585769|21614510|21559934|21434831|20301471|20150449|18688870|18203154|17853480|14149008|12050205|11241056|9607189|9529364|9398852|9108089|8386697|8071974|7645607|7607640|4316066|4292870|4153449|3130865|3026952|3000666|2172500|1655284|1338906|1338905|331956	H62;H68	7490	WT1	IC1	IVS1	.	.	intron	NM_024426.4	NP_077744.3	-	N	c.647-1815_647-1814delCT	.	.	.	NM_024426.4(WT1): c.647-1815_647-1814delCT	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs370524588	.	4028	0.122800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	32452001	32452005	11p13	0	normal	.	GAGA	ref	GAGA	gg.ga	het-alt	36	0.65	.	1	(GA)n|Simple_repeat|Simple_repeat|+|87;trf	PASS	607102	C	136680(MK);156240(MK);194070(MK);194080(MK);256370(MK);608978(MK)	AD;AR	Denys-Drash syndrome; Wilms tumor, type 1; Frasier syndrome	AD	Allelic with Meacham syndrome, which involves multiple malformations, but typically does not involve findins such as Wilms tumor (AD); Allelic with Nephrotic syndrome, type 4 (AD), though it is unclear if this disorder typically occurs without oncologic manifestations	Cardiovascular; Endocrine; Genitourinary; Oncologic; Renal; Pulmonary	Oncologic; Renal	24161391|22876585|22585769|21614510|21559934|21434831|20301471|20150449|18688870|18203154|17853480|14149008|12050205|11241056|9607189|9529364|9398852|9108089|8386697|8071974|7645607|7607640|4316066|4292870|4153449|3130865|3026952|3000666|2172500|1655284|1338906|1338905|331956	H62;H68	7490	WT1	IC1	IVS1	.	.	no-change	NM_001198551.1	NP_001185480.1	-	Y	c.10+71_10+74=	.	.	.	NM_001198551.1(WT1): c.10+71_10+74=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.882300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	32452001	32452005	11p13	0	normal	.	GAGA	ref	GAGA	gg.ga	het-alt	36	0.65	.	1	(GA)n|Simple_repeat|Simple_repeat|+|87;trf	PASS	607102	C	136680(MK);156240(MK);194070(MK);194080(MK);256370(MK);608978(MK)	AD;AR	Denys-Drash syndrome; Wilms tumor, type 1; Frasier syndrome	AD	Allelic with Meacham syndrome, which involves multiple malformations, but typically does not involve findins such as Wilms tumor (AD); Allelic with Nephrotic syndrome, type 4 (AD), though it is unclear if this disorder typically occurs without oncologic manifestations	Cardiovascular; Endocrine; Genitourinary; Oncologic; Renal; Pulmonary	Oncologic; Renal	24161391|22876585|22585769|21614510|21559934|21434831|20301471|20150449|18688870|18203154|17853480|14149008|12050205|11241056|9607189|9529364|9398852|9108089|8386697|8071974|7645607|7607640|4316066|4292870|4153449|3130865|3026952|3000666|2172500|1655284|1338906|1338905|331956	H62;H68	7490	WT1	IC1	IVS1	.	.	no-change	NM_024426.4	NP_077744.3	-	N	c.647-1840_647-1837=	.	.	.	NM_024426.4(WT1): c.647-1840_647-1837=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.882300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	32452001	32452005	11p13	0	normal	.	GAGA	del	.	gg.ga	het-ref	19	0.35	.	2	(GA)n|Simple_repeat|Simple_repeat|+|87;trf	PASS	607102	C	136680(MK);156240(MK);194070(MK);194080(MK);256370(MK);608978(MK)	AD;AR	Denys-Drash syndrome; Wilms tumor, type 1; Frasier syndrome	AD	Allelic with Meacham syndrome, which involves multiple malformations, but typically does not involve findins such as Wilms tumor (AD); Allelic with Nephrotic syndrome, type 4 (AD), though it is unclear if this disorder typically occurs without oncologic manifestations	Cardiovascular; Endocrine; Genitourinary; Oncologic; Renal; Pulmonary	Oncologic; Renal	24161391|22876585|22585769|21614510|21559934|21434831|20301471|20150449|18688870|18203154|17853480|14149008|12050205|11241056|9607189|9529364|9398852|9108089|8386697|8071974|7645607|7607640|4316066|4292870|4153449|3130865|3026952|3000666|2172500|1655284|1338906|1338905|331956	H62;H68	7490	WT1	IC1	IVS1	.	.	intron	NM_001198551.1	NP_001185480.1	-	Y	c.10+71_10+74delTCTC	.	.	.	NM_001198551.1(WT1): c.10+71_10+74delTCTC	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.113300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	32452001	32452005	11p13	0	normal	.	GAGA	del	.	gg.ga	het-ref	19	0.35	.	2	(GA)n|Simple_repeat|Simple_repeat|+|87;trf	PASS	607102	C	136680(MK);156240(MK);194070(MK);194080(MK);256370(MK);608978(MK)	AD;AR	Denys-Drash syndrome; Wilms tumor, type 1; Frasier syndrome	AD	Allelic with Meacham syndrome, which involves multiple malformations, but typically does not involve findins such as Wilms tumor (AD); Allelic with Nephrotic syndrome, type 4 (AD), though it is unclear if this disorder typically occurs without oncologic manifestations	Cardiovascular; Endocrine; Genitourinary; Oncologic; Renal; Pulmonary	Oncologic; Renal	24161391|22876585|22585769|21614510|21559934|21434831|20301471|20150449|18688870|18203154|17853480|14149008|12050205|11241056|9607189|9529364|9398852|9108089|8386697|8071974|7645607|7607640|4316066|4292870|4153449|3130865|3026952|3000666|2172500|1655284|1338906|1338905|331956	H62;H68	7490	WT1	IC1	IVS1	.	.	intron	NM_024426.4	NP_077744.3	-	N	c.647-1840_647-1837delTCTC	.	.	.	NM_024426.4(WT1): c.647-1840_647-1837delTCTC	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.113300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	32456561	32456562	11p13	0	normal	.	G	ref	G	GG.GG	het-alt	316	0.53	.	1	.	PASS	607102	C	136680(MK);156240(MK);194070(MK);194080(MK);256370(MK);608978(MK)	AD;AR	Denys-Drash syndrome; Wilms tumor, type 1; Frasier syndrome	AD	Allelic with Meacham syndrome, which involves multiple malformations, but typically does not involve findins such as Wilms tumor (AD); Allelic with Nephrotic syndrome, type 4 (AD), though it is unclear if this disorder typically occurs without oncologic manifestations	Cardiovascular; Endocrine; Genitourinary; Oncologic; Renal; Pulmonary	Oncologic; Renal	24161391|22876585|22585769|21614510|21559934|21434831|20301471|20150449|18688870|18203154|17853480|14149008|12050205|11241056|9607189|9529364|9398852|9108089|8386697|8071974|7645607|7607640|4316066|4292870|4153449|3130865|3026952|3000666|2172500|1655284|1338906|1338905|331956	H62;H68	7490	WT1	PROM	.	.	.	no-change	NM_001198551.1	NP_001185480.1	-	Y	c.-278-u4199C=	.	.	.	NM_001198551.1(WT1): c.-278-u4199C=	;maf-5-some-pop,maf-5-all-pops	10004	0.685926	U	0.6855	0.303914	.	.	PASS	.	70	0.357143	1163	4996	0.675741	.	.	.	.	.	.	rs1799925	.	4024	0.309900	0.306	2.024	0.012	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	32456561	32456562	11p13	0	normal	.	G	ref	G	GG.GG	het-alt	316	0.53	.	1	.	PASS	607102	C	136680(MK);156240(MK);194070(MK);194080(MK);256370(MK);608978(MK)	AD;AR	Denys-Drash syndrome; Wilms tumor, type 1; Frasier syndrome	AD	Allelic with Meacham syndrome, which involves multiple malformations, but typically does not involve findins such as Wilms tumor (AD); Allelic with Nephrotic syndrome, type 4 (AD), though it is unclear if this disorder typically occurs without oncologic manifestations	Cardiovascular; Endocrine; Genitourinary; Oncologic; Renal; Pulmonary	Oncologic; Renal	24161391|22876585|22585769|21614510|21559934|21434831|20301471|20150449|18688870|18203154|17853480|14149008|12050205|11241056|9607189|9529364|9398852|9108089|8386697|8071974|7645607|7607640|4316066|4292870|4153449|3130865|3026952|3000666|2172500|1655284|1338906|1338905|331956	H62;H68	7490	WT1	C1	EX1	Wilm's tumour protein	PF02165.10	no-change	NM_024426.4	NP_077744.3	-	N	c.330C=	.	.	.	NM_024426.4(WT1): c.330C=	;maf-5-some-pop,maf-5-all-pops	10004	0.685926	U	0.6855	0.303914	.	.	PASS	.	70	0.357143	1163	4996	0.675741	.	.	.	.	.	.	rs1799925	.	4024	0.309900	0.306	2.024	0.012	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	32456561	32456562	11p13	0	normal	.	G	snv	A	GG.GG	het-ref	281	0.47	.	2	.	PASS	607102	C	136680(MK);156240(MK);194070(MK);194080(MK);256370(MK);608978(MK)	AD;AR	Denys-Drash syndrome; Wilms tumor, type 1; Frasier syndrome	AD	Allelic with Meacham syndrome, which involves multiple malformations, but typically does not involve findins such as Wilms tumor (AD); Allelic with Nephrotic syndrome, type 4 (AD), though it is unclear if this disorder typically occurs without oncologic manifestations	Cardiovascular; Endocrine; Genitourinary; Oncologic; Renal; Pulmonary	Oncologic; Renal	24161391|22876585|22585769|21614510|21559934|21434831|20301471|20150449|18688870|18203154|17853480|14149008|12050205|11241056|9607189|9529364|9398852|9108089|8386697|8071974|7645607|7607640|4316066|4292870|4153449|3130865|3026952|3000666|2172500|1655284|1338906|1338905|331956	H62;H68	7490	WT1	PROM	.	.	.	promoter	NM_001198551.1	NP_001185480.1	-	Y	c.-278-u4199C>T	.	.	.	NM_001198551.1(WT1): c.-278-u4199C>T	;maf-5-some-pop,maf-5-all-pops	10004	0.314074	U	0.6855	0.303914	.	.	PASS	16	70	0.642857	285	4996	0.324259	1734	4984	6.91646e-01	4312	22175	2.74919e-01	rs1799925	.	4024	0.690100	0.306	2.024	0.012	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	193454	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
11	32456561	32456562	11p13	1	normal	.	G	snv	A	GG.GG	het-ref	281	0.47	.	2	.	PASS	607102	C	136680(MK);156240(MK);194070(MK);194080(MK);256370(MK);608978(MK)	AD;AR	Denys-Drash syndrome; Wilms tumor, type 1; Frasier syndrome	AD	Allelic with Meacham syndrome, which involves multiple malformations, but typically does not involve findins such as Wilms tumor (AD); Allelic with Nephrotic syndrome, type 4 (AD), though it is unclear if this disorder typically occurs without oncologic manifestations	Cardiovascular; Endocrine; Genitourinary; Oncologic; Renal; Pulmonary	Oncologic; Renal	24161391|22876585|22585769|21614510|21559934|21434831|20301471|20150449|18688870|18203154|17853480|14149008|12050205|11241056|9607189|9529364|9398852|9108089|8386697|8071974|7645607|7607640|4316066|4292870|4153449|3130865|3026952|3000666|2172500|1655284|1338906|1338905|331956	H62;H68	7490	WT1	C1	EX1	Wilm's tumour protein	PF02165.10	coding-synon	NM_024426.4	NP_077744.3	-	N	c.330C>T	p.(P110=) | p.(Pro110=)	CCC=>CCT	.	NM_024426.4(WT1): c.330C>T (p.(P110=))	;maf-5-some-pop,maf-5-all-pops	10004	0.314074	U	0.6855	0.303914	.	.	PASS	16	70	0.642857	285	4996	0.324259	1734	4984	6.91646e-01	4312	22175	2.74919e-01	rs1799925	.	4024	0.690100	0.306	2.024	0.012	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	193454	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
11	34460703	34460704	11p13	0	normal	.	C	ref	C	TC.CC	het-alt	244	0.52	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.34460703C= (intergenic)	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop	5008	0.874601	U	0.3036	0.125399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10836235	.	.	.	0.491	-0.376	-0.350	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	34460703	34460704	11p13	0	normal	.	C	snv	T	TC.CC	het-ref	226	0.48	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.34460703C>T (intergenic)	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop	5008	0.125399	U	0.3036	0.125399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10836235	.	.	.	0.491	-0.376	-0.350	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	35308368	35308369	11p13	1	normal	.	T	snv	C	GC.AC	hom-alt	353	1.00	.	0	.	PASS	600300	C	.	NN	.	.	.	.	.	.	.	6506	SLC1A2	C8	EX8	Sodium:dicarboxylate symporter family	PF00375.13	coding-synon	NM_004171.3	NP_004162.2	-	Y	c.1221A>G	p.(V407=) | p.(Val407=)	GTA=>GTG	.	NM_004171.3(SLC1A2): c.1221A>G (p.(V407=))	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126364	0.239665	U	0.1885	0.230431	13000	0.254769	PASS	185	8632	0.204703	3809	121356	0.240046	377	3529	2.04651e-01	7861	60156	2.44523e-01	rs1042113	.	4024	0.214700	-0.215	0.225	0.106	.	.	.	.	.	ENST00000278379: c.1221A>G (p.V407V)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	3752347	.	.	.	.	.	.	.	.	.	Likely Benign
11	35308368	35308369	11p13	0	nullSample	.	T	ref	T	GC.AC	homo-ref	.	.	.	0	.	.	600300	C	.	NN	.	.	.	.	.	.	.	6506	SLC1A2	C8	EX8	Sodium:dicarboxylate symporter family	PF00375.13	no-change	NM_004171.3	NP_004162.2	-	Y	c.1221A=	.	.	.	NM_004171.3(SLC1A2): c.1221A=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126364	0.760335	U	0.1885	0.230431	13000	0.745231	PASS	.	8632	0.795297	35356	121356	0.759954	.	.	.	.	.	.	rs1042113	.	4024	0.785300	-0.215	0.225	0.106	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	44117423	44117424	11p11.2	0	nullSample	.	G	ref	G	gc.gc	homo-ref	.	.	.	0	GC_rich|Low_complexity|Low_complexity|+|21	.	608210	C	133701(MK)	AD	Exostoses, multiple, type 2	AD	.	Musculoskeletal; Oncologic	Oncologic	23629877|22258776|20301413|19344451|16879194|11432960|10679937|9463333|9326317|8894688|8782816|7726168	H62;H68	2132	EXT2	PROM	.	.	.	no-change	NM_000401.3	NP_000392.3	+	N	c.-56-u323G=	.	.	.	NM_000401.3(EXT2): c.-56-u323G=	;maf-5-some-pop,maf-5-all-pops	5008	0.478035	U	0.745	0.521965	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12365753	.	4024	0.208000	0.313	-1.023	-0.902	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	44117423	44117424	11p11.2	0	nullSample	.	G	ref	G	gc.gc	homo-ref	.	.	.	0	GC_rich|Low_complexity|Low_complexity|+|21	.	608210	C	133701(MK)	AD	Exostoses, multiple, type 2	AD	.	Musculoskeletal; Oncologic	Oncologic	23629877|22258776|20301413|19344451|16879194|11432960|10679937|9463333|9326317|8894688|8782816|7726168	H62;H68	2132	EXT2	I5U1	IVS1	.	.	no-change	NM_207122.1	NP_997005.1	+	Y	c.-31+22G=	.	.	.	NM_207122.1(EXT2): c.-31+22G=	;maf-5-some-pop,maf-5-all-pops	5008	0.478035	U	0.745	0.521965	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12365753	.	4024	0.208000	0.313	-1.023	-0.902	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	44117423	44117424	11p11.2	0	normal	.	G	snv	A	gc.gc	hom-alt	463	1.00	.	0	GC_rich|Low_complexity|Low_complexity|+|21	PASS	608210	C	133701(MK)	AD	Exostoses, multiple, type 2	AD	.	Musculoskeletal; Oncologic	Oncologic	23629877|22258776|20301413|19344451|16879194|11432960|10679937|9463333|9326317|8894688|8782816|7726168	H62;H68	2132	EXT2	PROM	.	.	.	promoter	NM_000401.3	NP_000392.3	+	N	c.-56-u323G>A	.	.	.	NM_000401.3(EXT2): c.-56-u323G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.521965	U	0.745	0.521965	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12365753	.	4024	0.792000	0.313	-1.023	-0.902	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	44117423	44117424	11p11.2	0	normal	.	G	snv	A	gc.gc	hom-alt	463	1.00	.	0	GC_rich|Low_complexity|Low_complexity|+|21	PASS	608210	C	133701(MK)	AD	Exostoses, multiple, type 2	AD	.	Musculoskeletal; Oncologic	Oncologic	23629877|22258776|20301413|19344451|16879194|11432960|10679937|9463333|9326317|8894688|8782816|7726168	H62;H68	2132	EXT2	I5U1	IVS1	.	.	intron	NM_207122.1	NP_997005.1	+	Y	c.-31+22G>A	.	.	.	NM_207122.1(EXT2): c.-31+22G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.521965	U	0.745	0.521965	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12365753	.	4024	0.792000	0.313	-1.023	-0.902	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	44117443	44117444	11p11.2	0	nullSample	.	A	ref	A	GA.GC	homo-ref	.	.	.	0	.	.	608210	C	133701(MK)	AD	Exostoses, multiple, type 2	AD	.	Musculoskeletal; Oncologic	Oncologic	23629877|22258776|20301413|19344451|16879194|11432960|10679937|9463333|9326317|8894688|8782816|7726168	H62;H68	2132	EXT2	PROM	.	.	.	no-change	NM_000401.3	NP_000392.3	+	N	c.-56-u303A=	.	.	.	NM_000401.3(EXT2): c.-56-u303A=	;maf-5-some-pop,maf-5-all-pops	5008	0.239417	U	0.9107	0.760583	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12362775	.	4024	0.066400	-0.642	0.175	0.059	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	44117443	44117444	11p11.2	0	nullSample	.	A	ref	A	GA.GC	homo-ref	.	.	.	0	.	.	608210	C	133701(MK)	AD	Exostoses, multiple, type 2	AD	.	Musculoskeletal; Oncologic	Oncologic	23629877|22258776|20301413|19344451|16879194|11432960|10679937|9463333|9326317|8894688|8782816|7726168	H62;H68	2132	EXT2	I5U1	IVS1	.	.	no-change	NM_207122.1	NP_997005.1	+	Y	c.-31+42A=	.	.	.	NM_207122.1(EXT2): c.-31+42A=	;maf-5-some-pop,maf-5-all-pops	5008	0.239417	U	0.9107	0.760583	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12362775	.	4024	0.066400	-0.642	0.175	0.059	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	44117443	44117444	11p11.2	0	normal	.	A	snv	G	GA.GC	hom-alt	443	1.00	.	0	.	PASS	608210	C	133701(MK)	AD	Exostoses, multiple, type 2	AD	.	Musculoskeletal; Oncologic	Oncologic	23629877|22258776|20301413|19344451|16879194|11432960|10679937|9463333|9326317|8894688|8782816|7726168	H62;H68	2132	EXT2	PROM	.	.	.	promoter	NM_000401.3	NP_000392.3	+	N	c.-56-u303A>G	.	.	.	NM_000401.3(EXT2): c.-56-u303A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.760583	U	0.9107	0.760583	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12362775	.	4024	0.933600	-0.642	0.175	0.059	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	44117443	44117444	11p11.2	0	normal	.	A	snv	G	GA.GC	hom-alt	443	1.00	.	0	.	PASS	608210	C	133701(MK)	AD	Exostoses, multiple, type 2	AD	.	Musculoskeletal; Oncologic	Oncologic	23629877|22258776|20301413|19344451|16879194|11432960|10679937|9463333|9326317|8894688|8782816|7726168	H62;H68	2132	EXT2	I5U1	IVS1	.	.	intron	NM_207122.1	NP_997005.1	+	Y	c.-31+42A>G	.	.	.	NM_207122.1(EXT2): c.-31+42A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.760583	U	0.9107	0.760583	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12362775	.	4024	0.933600	-0.642	0.175	0.059	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	44117892	44117969	11p11.2	0	normal	.	TGTTATGCCGGGGACTGGGTGGTCGGGGGCGTGTTAGGCCGGGGACTGGGTGACCGGGAACTAGATGGCCGGGGGCG	ref	TGTTATGCCGGGGACTGGGTGGTCGGGGGCGTGTTAGGCCGGGGACTGGGTGACCGGGAACTAGATGGCCGGGGGCG	CA.TG	het-alt	219	0.54	.	1	trf	PASS	608210	C	133701(MK)	AD	Exostoses, multiple, type 2	AD	.	Musculoskeletal; Oncologic	Oncologic	23629877|22258776|20301413|19344451|16879194|11432960|10679937|9463333|9326317|8894688|8782816|7726168	H62;H68	2132	EXT2	IC1	IVS1	.	.	no-change	NM_000401.3	NP_000392.3	+	Y	c.69+22_69+98=	.	.	.	NM_000401.3(EXT2): c.69+22_69+98=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4665	0.551200	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	44117892	44117969	11p11.2	0	normal	.	TGTTATGCCGGGGACTGGGTGGTCGGGGGCGTGTTAGGCCGGGGACTGGGTGACCGGGAACTAGATGGCCGGGGGCG	ref	TGTTATGCCGGGGACTGGGTGGTCGGGGGCGTGTTAGGCCGGGGACTGGGTGACCGGGAACTAGATGGCCGGGGGCG	CA.TG	het-alt	219	0.54	.	1	trf	PASS	608210	C	133701(MK)	AD	Exostoses, multiple, type 2	AD	.	Musculoskeletal; Oncologic	Oncologic	23629877|22258776|20301413|19344451|16879194|11432960|10679937|9463333|9326317|8894688|8782816|7726168	H62;H68	2132	EXT2	I5U1	IVS1	.	.	no-change	NM_207122.1	NP_997005.1	+	N	c.-31+491_-31+567=	.	.	.	NM_207122.1(EXT2): c.-31+491_-31+567=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4665	0.551200	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	44117892	44117969	11p11.2	0	normal	.	TGTTATGCCGGGGACTGGGTGGTCGGGGGCGTGTTAGGCCGGGGACTGGGTGACCGGGAACTAGATGGCCGGGGGCG	del	.	CA.TG	het-ref	188	0.46	.	2	trf	PASS	608210	C	133701(MK)	AD	Exostoses, multiple, type 2	AD	.	Musculoskeletal; Oncologic	Oncologic	23629877|22258776|20301413|19344451|16879194|11432960|10679937|9463333|9326317|8894688|8782816|7726168	H62;H68	2132	EXT2	IC1	IVS1	.	.	intron	NM_000401.3	NP_000392.3	+	Y	c.69+22_69+98del	.	.	.	NM_000401.3(EXT2): c.69+22_69+98del	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4665	0.026100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
11	44117892	44117969	11p11.2	0	normal	.	TGTTATGCCGGGGACTGGGTGGTCGGGGGCGTGTTAGGCCGGGGACTGGGTGACCGGGAACTAGATGGCCGGGGGCG	del	.	CA.TG	het-ref	188	0.46	.	2	trf	PASS	608210	C	133701(MK)	AD	Exostoses, multiple, type 2	AD	.	Musculoskeletal; Oncologic	Oncologic	23629877|22258776|20301413|19344451|16879194|11432960|10679937|9463333|9326317|8894688|8782816|7726168	H62;H68	2132	EXT2	I5U1	IVS1	.	.	intron	NM_207122.1	NP_997005.1	+	N	c.-31+491_-31+567del	.	.	.	NM_207122.1(EXT2): c.-31+491_-31+567del	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4665	0.026100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
11	44117897	44117898	11p11.2	0	normal	.	T	ref	T	TA.GC	het-alt	185	0.51	.	1	.	DUBIOUS	608210	C	133701(MK)	AD	Exostoses, multiple, type 2	AD	.	Musculoskeletal; Oncologic	Oncologic	23629877|22258776|20301413|19344451|16879194|11432960|10679937|9463333|9326317|8894688|8782816|7726168	H62;H68	2132	EXT2	IC1	IVS1	.	.	no-change	NM_000401.3	NP_000392.3	+	Y	c.69+27T=	.	.	.	NM_000401.3(EXT2): c.69+27T=	;maf-5-some-pop,maf-5-all-pops	17370	0.275533	U	0.9107	0.741813	.	.	PASS	.	210	0.061905	530	12362	0.282559	.	.	.	.	.	.	rs11037860	.	4235	0.191200	-1.043	-1.089	-1.147	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	44117897	44117898	11p11.2	0	normal	.	T	ref	T	TA.GC	het-alt	185	0.51	.	1	.	DUBIOUS	608210	C	133701(MK)	AD	Exostoses, multiple, type 2	AD	.	Musculoskeletal; Oncologic	Oncologic	23629877|22258776|20301413|19344451|16879194|11432960|10679937|9463333|9326317|8894688|8782816|7726168	H62;H68	2132	EXT2	I5U1	IVS1	.	.	no-change	NM_207122.1	NP_997005.1	+	N	c.-31+496T=	.	.	.	NM_207122.1(EXT2): c.-31+496T=	;maf-5-some-pop,maf-5-all-pops	17370	0.275533	U	0.9107	0.741813	.	.	PASS	.	210	0.061905	530	12362	0.282559	.	.	.	.	.	.	rs11037860	.	4235	0.191200	-1.043	-1.089	-1.147	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	44117897	44117898	11p11.2	0	normal	.	T	snv	G	TA.GC	het-ref	181	0.49	.	2	.	DUBIOUS	608210	C	133701(MK)	AD	Exostoses, multiple, type 2	AD	.	Musculoskeletal; Oncologic	Oncologic	23629877|22258776|20301413|19344451|16879194|11432960|10679937|9463333|9326317|8894688|8782816|7726168	H62;H68	2132	EXT2	IC1	IVS1	.	.	intron	NM_000401.3	NP_000392.3	+	Y	c.69+27T>G	.	.	.	NM_000401.3(EXT2): c.69+27T>G	;maf-5-some-pop,maf-5-all-pops	17370	0.724467	U	0.9107	0.741813	.	.	PASS	92	210	0.938095	3218	12362	0.717441	4193	9083	9.21945e-01	37303	97826	7.51756e-01	rs11037860	.	4235	0.761400	-1.043	-1.089	-1.147	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	44117897	44117898	11p11.2	0	normal	.	T	snv	G	TA.GC	het-ref	181	0.49	.	2	.	DUBIOUS	608210	C	133701(MK)	AD	Exostoses, multiple, type 2	AD	.	Musculoskeletal; Oncologic	Oncologic	23629877|22258776|20301413|19344451|16879194|11432960|10679937|9463333|9326317|8894688|8782816|7726168	H62;H68	2132	EXT2	I5U1	IVS1	.	.	intron	NM_207122.1	NP_997005.1	+	N	c.-31+496T>G	.	.	.	NM_207122.1(EXT2): c.-31+496T>G	;maf-5-some-pop,maf-5-all-pops	17370	0.724467	U	0.9107	0.741813	.	.	PASS	92	210	0.938095	3218	12362	0.717441	4193	9083	9.21945e-01	37303	97826	7.51756e-01	rs11037860	.	4235	0.761400	-1.043	-1.089	-1.147	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	44129289	44129290	11p11.2	0	nullSample	.	C	ref	C	TC.GG	homo-ref	.	.	.	0	.	.	608210	C	133701(MK)	AD	Exostoses, multiple, type 2	AD	.	Musculoskeletal; Oncologic	Oncologic	23629877|22258776|20301413|19344451|16879194|11432960|10679937|9463333|9326317|8894688|8782816|7726168	H62;H68	2132	EXT2	C2	EX2	.	.	no-change	NM_000401.3	NP_000392.3	+	Y	c.127C=	.	.	.	NM_000401.3(EXT2): c.127C=	SingleClassTriAllelic;maf-5-some-pop	126366	0.964801	U	0.2788	0.0780751	13006	0.994157	PASS	.	8638	0.718569	56992	121358	0.966570	.	.	.	.	.	.	rs4755228	.	4024	0.686900	0.650	4.333	1.215	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	44129289	44129290	11p11.2	0	nullSample	.	C	ref	C	TC.GG	homo-ref	.	.	.	0	.	.	608210	C	133701(MK)	AD	Exostoses, multiple, type 2	AD	.	Musculoskeletal; Oncologic	Oncologic	23629877|22258776|20301413|19344451|16879194|11432960|10679937|9463333|9326317|8894688|8782816|7726168	H62;H68	2132	EXT2	C1	EX2	.	.	no-change	NM_207122.1	NP_997005.1	+	N	c.28C=	.	.	.	NM_207122.1(EXT2): c.28C=	SingleClassTriAllelic;maf-5-some-pop	126366	0.964801	U	0.2788	0.0780751	13006	0.994157	PASS	.	8638	0.718569	56992	121358	0.966570	.	.	.	.	.	.	rs4755228	.	4024	0.686900	0.650	4.333	1.215	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	44129289	44129290	11p11.2	1	normal	.	C	snv	A	TC.GG	hom-alt	669	1.00	.	0	.	PASS	608210	C	133701(MK)	AD	Exostoses, multiple, type 2	AD	.	Musculoskeletal; Oncologic	Oncologic	23629877|22258776|20301413|19344451|16879194|11432960|10679937|9463333|9326317|8894688|8782816|7726168	H62;H68	2132	EXT2	C2	EX2	.	.	coding-synon	NM_000401.3	NP_000392.3	+	Y	c.127C>A	p.(R43=) | p.(Arg43=)	CGG=>AGG	.	NM_000401.3(EXT2): c.127C>A (p.(R43=))	SingleClassTriAllelic;maf-5-some-pop	126366	0.035191	U	0.2788	0.0780751	13006	0.005843	PASS	342	8638	0.281431	370	121358	0.033422	680	4839	2.80587e-01	745	8511	3.45742e-02	rs4755228	.	4024	0.313100	0.650	4.333	1.215	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	195445	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
11	44129289	44129290	11p11.2	1	normal	.	C	snv	A	TC.GG	hom-alt	669	1.00	.	0	.	PASS	608210	C	133701(MK)	AD	Exostoses, multiple, type 2	AD	.	Musculoskeletal; Oncologic	Oncologic	23629877|22258776|20301413|19344451|16879194|11432960|10679937|9463333|9326317|8894688|8782816|7726168	H62;H68	2132	EXT2	C1	EX2	.	.	coding-synon	NM_207122.1	NP_997005.1	+	N	c.28C>A	p.(R10=) | p.(Arg10=)	CGG=>AGG	.	NM_207122.1(EXT2): c.28C>A (p.(R10=))	SingleClassTriAllelic;maf-5-some-pop	126366	0.035191	U	0.2788	0.0780751	13006	0.005843	PASS	342	8638	0.281431	370	121358	0.033422	680	4839	2.80587e-01	745	8511	3.45742e-02	rs4755228	.	4024	0.313100	0.650	4.333	1.215	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	195445	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
11	60231723	60231724	11q12.2	0	normal	.	A	snv	G	CC.CC	hom-alt	12	1.00	.	0	.	PASS	112210	C	613495(MK)	NN	Immunodeficiency, common variable, 5	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	20038800	.	931	MS4A1	IC2	IVS4	.	.	intron	NM_152866.2	NP_690605.1	+	Y	c.280-37A>G	.	.	.	NM_152866.2(MS4A1): c.280-37A>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.528	-0.738	-0.784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
11	60231723	60231724	11q12.2	0	nullSample	.	A	ref	A	CC.CC	homo-ref	.	.	.	0	.	.	112210	C	613495(MK)	NN	Immunodeficiency, common variable, 5	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	20038800	.	931	MS4A1	IC2	IVS4	.	.	no-change	NM_152866.2	NP_690605.1	+	Y	c.280-37A=	.	.	.	NM_152866.2(MS4A1): c.280-37A=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.528	-0.738	-0.784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
11	61205433	61205434	11q12.2	0	normal	.	G	snv	A	CA.CC	hom-alt	370	0.99	.	0	.	PASS	613019	P	601650(MK)	NN	Paragangliomas 2	AD	.	Oncologic	Oncologic	23078982|23061808|22584701|21348866|21224366|20301715|20071235|19628817|6286462	FC59;H54;H62;H68;HE15;MC58	54949	SDHAF2	IC2	IVS2	.	.	intron	NM_017841.2	NP_060311.1	+	Y	c.261-42G>A	.	.	.	NM_017841.2(SDHAF2): c.261-42G>A	;maf-5-some-pop,genotype-conflict	123686	0.815395	U	0.9712	0.718051	13002	0.686587	PASS	3821	8264	0.961641	41097	118678	0.819503	7910	16421	9.62996e-01	86155	202120	8.31763e-01	rs879647	.	4024	0.956500	0.655	0.149	0.374	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	260942	criteria_provided,_single_submitter	Benign	Benign
11	61205433	61205434	11q12.2	0	nullSample	.	G	ref	G	CA.CC	homo-ref	.	.	.	0	.	.	613019	P	601650(MK)	NN	Paragangliomas 2	AD	.	Oncologic	Oncologic	23078982|23061808|22584701|21348866|21224366|20301715|20071235|19628817|6286462	FC59;H54;H62;H68;HE15;MC58	54949	SDHAF2	IC2	IVS2	.	.	no-change	NM_017841.2	NP_060311.1	+	Y	c.261-42G=	.	.	.	NM_017841.2(SDHAF2): c.261-42G=	;maf-5-some-pop,genotype-conflict	123686	0.184605	U	0.9712	0.718051	13002	0.313413	PASS	.	8264	0.038359	3179	118678	0.180497	.	.	.	.	.	.	rs879647	.	4024	0.043500	0.655	0.149	0.374	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	62293821	62293822	11q12.3	0	normal	.	C	ref	C	AA.TT	het-alt	257	0.51	.	1	trf	PASS	103390	P	.	NN	.	.	.	.	.	.	.	79026	AHNAK	C3E	EX5E	.	.	no-change	NM_001620.1	NP_001611.1	-	Y	c.8067G=	.	.	.	NM_001620.1(AHNAK): c.8067G=	;maf-5-some-pop,genotype-conflict	126412	0.906346	U	0.2222	0.081869	13002	0.917013	PASS	.	8646	0.743812	50022	121404	0.905860	.	.	.	.	.	.	rs12366127	.	4024	0.765200	-1.676	-0.981	-2.529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	62293821	62293822	11q12.3	1	normal	.	C	snv	T	AA.TT	het-ref	248	0.49	.	2	trf	PASS	103390	P	.	NN	.	.	.	.	.	.	.	79026	AHNAK	C3E	EX5E	.	.	coding-synon	NM_001620.1	NP_001611.1	-	Y	c.8067G>A	p.(K2689=) | p.(Lys2689=)	AAG=>AAA	.	NM_001620.1(AHNAK): c.8067G>A (p.(K2689=))	;maf-5-some-pop,genotype-conflict	126412	0.093654	U	0.2222	0.081869	13002	0.082987	PASS	288	8646	0.256188	749	121404	0.094140	573	4396	2.55107e-01	1477	23122	9.39033e-02	rs12366127	.	4024	0.234800	-1.676	-0.981	-2.529	.	.	.	.	.	ENST00000378024: c.8067G>A (p.K2689K)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4415231	.	.	.	.	.	.	.	.	.	Likely Benign
11	64572017	64572018	11q13.1	0	normal	.	T	snv	C	TG.GG	hom-alt	628	1.00	.	0	.	PASS	613733	C	131100(MK);613733(MK)	AD	Multiple endocrine neoplasia type I; Hyperparathyroidism, familial primary	AD	.	Endocrine; Oncologic	Endocrine; Oncologic	24058102|24037737|24014011|23961499|23956349|23919339|23809488|23652667|23645327|23443490|23376981|23052745|22584706|22581216|22549346|22522645|20301710|17879353|15531478|15292304|15240620|14985373|14871962|12791038|12417605|12112656|12050235|11836268|11739416|11344233|11295574|10439966|10193936|9832038|9792884|9709923|9683585|9554741|9506756|9463336|9236523|9215690|9215689|9103196|6108714|2857681	FC59;H41;H54;H62;H68;HE15;MC58	4221	MEN1	C9E	EX10E	Menin	PF05053.8	no-change	NM_000244.3	NP_000235.2	-	Y	c.1636G=	.	.	.	NM_000244.3(MEN1): c.1636G=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126278	0.933678	U	0.6964	0.834465	12996	0.908433	PASS	2138	8632	0.700185	54048	121270	0.937775	4210	12031	6.98016e-01	109716	230904	9.39046e-01	rs2959656	.	.	.	-0.366	1.381	0.982	.	.	.	.	.	ENST00000312049: c.1621A>G (p.T541A)	lung [NS|NS|NS]	carcinoid-endocrine_tumour [typical|NS|NS]	CSV	255213	.	.	.	.	.	no_record	134640	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
11	64572017	64572018	11q13.1	0	normal	.	T	snv	C	TG.GG	hom-alt	628	1.00	.	0	.	PASS	613733	C	131100(MK);613733(MK)	AD	Multiple endocrine neoplasia type I; Hyperparathyroidism, familial primary	AD	.	Endocrine; Oncologic	Endocrine; Oncologic	24058102|24037737|24014011|23961499|23956349|23919339|23809488|23652667|23645327|23443490|23376981|23052745|22584706|22581216|22549346|22522645|20301710|17879353|15531478|15292304|15240620|14985373|14871962|12791038|12417605|12112656|12050235|11836268|11739416|11344233|11295574|10439966|10193936|9832038|9792884|9709923|9683585|9554741|9506756|9463336|9236523|9215690|9215689|9103196|6108714|2857681	FC59;H41;H54;H62;H68;HE15;MC58	4221	MEN1	C9E	EX10E	Menin	PF05053.8	no-change	NM_130799.2	NP_570711.1	-	N	c.1621G=	.	.	.	NM_130799.2(MEN1): c.1621G=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126278	0.933678	U	0.6964	0.834465	12996	0.908433	PASS	2138	8632	0.700185	54048	121270	0.937775	4210	12031	6.98016e-01	109716	230904	9.39046e-01	rs2959656	.	.	.	-0.366	1.381	0.982	.	.	.	.	.	ENST00000312049: c.1621A>G (p.T541A)	lung [NS|NS|NS]	carcinoid-endocrine_tumour [typical|NS|NS]	CSV	255213	.	.	.	.	.	no_record	134640	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
11	64572017	64572018	11q13.1	1	nullSample	.	T	ref	T	TG.GG	homo-ref	.	.	.	0	.	.	613733	C	131100(MK);613733(MK)	AD	Multiple endocrine neoplasia type I; Hyperparathyroidism, familial primary	AD	.	Endocrine; Oncologic	Endocrine; Oncologic	24058102|24037737|24014011|23961499|23956349|23919339|23809488|23652667|23645327|23443490|23376981|23052745|22584706|22581216|22549346|22522645|20301710|17879353|15531478|15292304|15240620|14985373|14871962|12791038|12417605|12112656|12050235|11836268|11739416|11344233|11295574|10439966|10193936|9832038|9792884|9709923|9683585|9554741|9506756|9463336|9236523|9215690|9215689|9103196|6108714|2857681	FC59;H41;H54;H62;H68;HE15;MC58	4221	MEN1	C9E	EX10E	Menin	PF05053.8	missense	NM_000244.3	NP_000235.2	-	Y	c.1636G>A	p.A546T | p.Ala546Thr	GCA=>ACA	NP=>P0	NM_000244.3(MEN1): c.1636G>A (p.A546T)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126278	0.066322	U	0.6964	0.834465	12996	0.091567	PASS	-884	8632	0.299815	959	121270	0.062225	.	.	.	.	.	.	rs2959656	.	.	.	-0.366	1.381	0.982	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
11	64572017	64572018	11q13.1	1	nullSample	.	T	ref	T	TG.GG	homo-ref	.	.	.	0	.	.	613733	C	131100(MK);613733(MK)	AD	Multiple endocrine neoplasia type I; Hyperparathyroidism, familial primary	AD	.	Endocrine; Oncologic	Endocrine; Oncologic	24058102|24037737|24014011|23961499|23956349|23919339|23809488|23652667|23645327|23443490|23376981|23052745|22584706|22581216|22549346|22522645|20301710|17879353|15531478|15292304|15240620|14985373|14871962|12791038|12417605|12112656|12050235|11836268|11739416|11344233|11295574|10439966|10193936|9832038|9792884|9709923|9683585|9554741|9506756|9463336|9236523|9215690|9215689|9103196|6108714|2857681	FC59;H41;H54;H62;H68;HE15;MC58	4221	MEN1	C9E	EX10E	Menin	PF05053.8	missense	NM_130799.2	NP_570711.1	-	N	c.1621G>A	p.A541T | p.Ala541Thr	GCA=>ACA	NP=>P0	NM_130799.2(MEN1): c.1621G>A (p.A541T)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126278	0.066322	U	0.6964	0.834465	12996	0.091567	PASS	-884	8632	0.299815	959	121270	0.062225	.	.	.	.	.	.	rs2959656	.	.	.	-0.366	1.381	0.982	.	.	.	.	.	.	.	.	.	.	CM085535	NM_130799.2(MEN1): c.1621G>A (p.A541T)	"Impaired sensitisation to apoptosis, association with"	18775714	FP	.	.	.	.	Likely Benign
11	64572556	64572557	11q13.1	0	normal	.	A	snv	G	AC.TG	hom-alt	570	1.00	.	0	.	PASS	613733	C	131100(MK);613733(MK)	AD	Multiple endocrine neoplasia type I; Hyperparathyroidism, familial primary	AD	.	Endocrine; Oncologic	Endocrine; Oncologic	24058102|24037737|24014011|23961499|23956349|23919339|23809488|23652667|23645327|23443490|23376981|23052745|22584706|22581216|22549346|22522645|20301710|17879353|15531478|15292304|15240620|14985373|14871962|12791038|12417605|12112656|12050235|11836268|11739416|11344233|11295574|10439966|10193936|9832038|9792884|9709923|9683585|9554741|9506756|9463336|9236523|9215690|9215689|9103196|6108714|2857681	FC59;H41;H54;H62;H68;HE15;MC58	4221	MEN1	C8	EX9	Menin	PF05053.8	no-change	NM_000244.3	NP_000235.2	-	Y	c.1314C=	.	.	.	NM_000244.3(MEN1): c.1314C=	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	126224	0.992086	U	1	0.976038	12996	0.976147	PASS	4324	8648	1.000000	59759	121216	0.992748	8622	17245	9.99942e-01	121701	244692	9.94351e-01	rs540012	.	.	.	-3.035	-0.438	-1.048	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	167288	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
11	64572556	64572557	11q13.1	0	normal	.	A	snv	G	AC.TG	hom-alt	570	1.00	.	0	.	PASS	613733	C	131100(MK);613733(MK)	AD	Multiple endocrine neoplasia type I; Hyperparathyroidism, familial primary	AD	.	Endocrine; Oncologic	Endocrine; Oncologic	24058102|24037737|24014011|23961499|23956349|23919339|23809488|23652667|23645327|23443490|23376981|23052745|22584706|22581216|22549346|22522645|20301710|17879353|15531478|15292304|15240620|14985373|14871962|12791038|12417605|12112656|12050235|11836268|11739416|11344233|11295574|10439966|10193936|9832038|9792884|9709923|9683585|9554741|9506756|9463336|9236523|9215690|9215689|9103196|6108714|2857681	FC59;H41;H54;H62;H68;HE15;MC58	4221	MEN1	C8	EX9	Menin	PF05053.8	no-change	NM_130799.2	NP_570711.1	-	N	c.1299C=	.	.	.	NM_130799.2(MEN1): c.1299C=	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	126224	0.992086	U	1	0.976038	12996	0.976147	PASS	4324	8648	1.000000	59759	121216	0.992748	8622	17245	9.99942e-01	121701	244692	9.94351e-01	rs540012	.	.	.	-3.035	-0.438	-1.048	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	167288	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
11	64572556	64572557	11q13.1	1	nullSample	.	A	ref	A	AC.TG	homo-ref	.	.	.	0	.	.	613733	C	131100(MK);613733(MK)	AD	Multiple endocrine neoplasia type I; Hyperparathyroidism, familial primary	AD	.	Endocrine; Oncologic	Endocrine; Oncologic	24058102|24037737|24014011|23961499|23956349|23919339|23809488|23652667|23645327|23443490|23376981|23052745|22584706|22581216|22549346|22522645|20301710|17879353|15531478|15292304|15240620|14985373|14871962|12791038|12417605|12112656|12050235|11836268|11739416|11344233|11295574|10439966|10193936|9832038|9792884|9709923|9683585|9554741|9506756|9463336|9236523|9215690|9215689|9103196|6108714|2857681	FC59;H41;H54;H62;H68;HE15;MC58	4221	MEN1	C8	EX9	Menin	PF05053.8	coding-synon	NM_000244.3	NP_000235.2	-	Y	c.1314C>T	p.(H438=) | p.(His438=)	CAC=>CAT	.	NM_000244.3(MEN1): c.1314C>T (p.(H438=))	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	126224	0.007915	U	1	0.976038	12996	0.023853	PASS	0	8648	0.000000	30	121216	0.007252	.	.	.	.	.	.	rs540012	.	.	.	-3.035	-0.438	-1.048	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
11	64572556	64572557	11q13.1	1	nullSample	.	A	ref	A	AC.TG	homo-ref	.	.	.	0	.	.	613733	C	131100(MK);613733(MK)	AD	Multiple endocrine neoplasia type I; Hyperparathyroidism, familial primary	AD	.	Endocrine; Oncologic	Endocrine; Oncologic	24058102|24037737|24014011|23961499|23956349|23919339|23809488|23652667|23645327|23443490|23376981|23052745|22584706|22581216|22549346|22522645|20301710|17879353|15531478|15292304|15240620|14985373|14871962|12791038|12417605|12112656|12050235|11836268|11739416|11344233|11295574|10439966|10193936|9832038|9792884|9709923|9683585|9554741|9506756|9463336|9236523|9215690|9215689|9103196|6108714|2857681	FC59;H41;H54;H62;H68;HE15;MC58	4221	MEN1	C8	EX9	Menin	PF05053.8	coding-synon	NM_130799.2	NP_570711.1	-	N	c.1299C>T	p.(H433=) | p.(His433=)	CAC=>CAT	.	NM_130799.2(MEN1): c.1299C>T (p.(H433=))	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	126224	0.007915	U	1	0.976038	12996	0.023853	PASS	0	8648	0.000000	30	121216	0.007252	.	.	.	.	.	.	rs540012	.	.	.	-3.035	-0.438	-1.048	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
11	64572601	64572602	11q13.1	0	normal	.	G	ref	G	CC.TC	het-alt	303	0.55	.	1	.	PASS	613733	C	131100(MK);613733(MK)	AD	Multiple endocrine neoplasia type I; Hyperparathyroidism, familial primary	AD	.	Endocrine; Oncologic	Endocrine; Oncologic	24058102|24037737|24014011|23961499|23956349|23919339|23809488|23652667|23645327|23443490|23376981|23052745|22584706|22581216|22549346|22522645|20301710|17879353|15531478|15292304|15240620|14985373|14871962|12791038|12417605|12112656|12050235|11836268|11739416|11344233|11295574|10439966|10193936|9832038|9792884|9709923|9683585|9554741|9506756|9463336|9236523|9215690|9215689|9103196|6108714|2857681	FC59;H41;H54;H62;H68;HE15;MC58	4221	MEN1	C8	EX9	Menin	PF05053.8	no-change	NM_000244.3	NP_000235.2	-	Y	c.1269C=	.	.	.	NM_000244.3(MEN1): c.1269C=	;maf-5-some-pop	125890	0.610048	U	0.372	0.307907	12996	0.695983	PASS	.	8614	0.617483	23017	120882	0.606649	.	.	.	.	.	.	rs2071313	.	4024	0.591200	-0.390	-0.047	-0.408	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	64572601	64572602	11q13.1	0	normal	.	G	ref	G	CC.TC	het-alt	303	0.55	.	1	.	PASS	613733	C	131100(MK);613733(MK)	AD	Multiple endocrine neoplasia type I; Hyperparathyroidism, familial primary	AD	.	Endocrine; Oncologic	Endocrine; Oncologic	24058102|24037737|24014011|23961499|23956349|23919339|23809488|23652667|23645327|23443490|23376981|23052745|22584706|22581216|22549346|22522645|20301710|17879353|15531478|15292304|15240620|14985373|14871962|12791038|12417605|12112656|12050235|11836268|11739416|11344233|11295574|10439966|10193936|9832038|9792884|9709923|9683585|9554741|9506756|9463336|9236523|9215690|9215689|9103196|6108714|2857681	FC59;H41;H54;H62;H68;HE15;MC58	4221	MEN1	C8	EX9	Menin	PF05053.8	no-change	NM_130799.2	NP_570711.1	-	N	c.1254C=	.	.	.	NM_130799.2(MEN1): c.1254C=	;maf-5-some-pop	125890	0.610048	U	0.372	0.307907	12996	0.695983	PASS	.	8614	0.617483	23017	120882	0.606649	.	.	.	.	.	.	rs2071313	.	4024	0.591200	-0.390	-0.047	-0.408	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	64572601	64572602	11q13.1	1	normal	.	G	snv	A	CC.TC	het-ref	251	0.45	.	2	.	PASS	613733	C	131100(MK);613733(MK)	AD	Multiple endocrine neoplasia type I; Hyperparathyroidism, familial primary	AD	.	Endocrine; Oncologic	Endocrine; Oncologic	24058102|24037737|24014011|23961499|23956349|23919339|23809488|23652667|23645327|23443490|23376981|23052745|22584706|22581216|22549346|22522645|20301710|17879353|15531478|15292304|15240620|14985373|14871962|12791038|12417605|12112656|12050235|11836268|11739416|11344233|11295574|10439966|10193936|9832038|9792884|9709923|9683585|9554741|9506756|9463336|9236523|9215690|9215689|9103196|6108714|2857681	FC59;H41;H54;H62;H68;HE15;MC58	4221	MEN1	C8	EX9	Menin	PF05053.8	coding-synon	NM_000244.3	NP_000235.2	-	Y	c.1269C>T	p.(D423=) | p.(Asp423=)	GAC=>GAT	.	NM_000244.3(MEN1): c.1269C>T (p.(D423=))	;maf-5-some-pop	125890	0.389952	U	0.372	0.307907	12996	0.304017	PASS	653	8614	0.382517	10125	120882	0.393351	1307	6631	3.84852e-01	20211	96630	3.92968e-01	rs2071313	.	4024	0.408800	-0.390	-0.047	-0.408	.	.	.	.	.	ENST00000312049: c.1254C>T (p.D418D)	large_intestine [colon|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3752612	.	.	.	.	.	no_record	96249	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
11	64572601	64572602	11q13.1	1	normal	.	G	snv	A	CC.TC	het-ref	251	0.45	.	2	.	PASS	613733	C	131100(MK);613733(MK)	AD	Multiple endocrine neoplasia type I; Hyperparathyroidism, familial primary	AD	.	Endocrine; Oncologic	Endocrine; Oncologic	24058102|24037737|24014011|23961499|23956349|23919339|23809488|23652667|23645327|23443490|23376981|23052745|22584706|22581216|22549346|22522645|20301710|17879353|15531478|15292304|15240620|14985373|14871962|12791038|12417605|12112656|12050235|11836268|11739416|11344233|11295574|10439966|10193936|9832038|9792884|9709923|9683585|9554741|9506756|9463336|9236523|9215690|9215689|9103196|6108714|2857681	FC59;H41;H54;H62;H68;HE15;MC58	4221	MEN1	C8	EX9	Menin	PF05053.8	coding-synon	NM_130799.2	NP_570711.1	-	N	c.1254C>T	p.(D418=) | p.(Asp418=)	GAC=>GAT	.	NM_130799.2(MEN1): c.1254C>T (p.(D418=))	;maf-5-some-pop	125890	0.389952	U	0.372	0.307907	12996	0.304017	PASS	653	8614	0.382517	10125	120882	0.393351	1307	6631	3.84852e-01	20211	96630	3.92968e-01	rs2071313	.	4024	0.408800	-0.390	-0.047	-0.408	.	.	.	.	.	ENST00000312049: c.1254C>T (p.D418D)	large_intestine [colon|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3752612	.	.	.	.	.	no_record	96249	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
11	64577619	64577620	11q13.1	0	normal	.	G	ref	G	CG.GG	het-alt	50	0.50	.	1	.	PASS	613733	C	131100(MK);613733(MK)	AD	Multiple endocrine neoplasia type I; Hyperparathyroidism, familial primary	AD	.	Endocrine; Oncologic	Endocrine; Oncologic	24058102|24037737|24014011|23961499|23956349|23919339|23809488|23652667|23645327|23443490|23376981|23052745|22584706|22581216|22549346|22522645|20301710|17879353|15531478|15292304|15240620|14985373|14871962|12791038|12417605|12112656|12050235|11836268|11739416|11344233|11295574|10439966|10193936|9832038|9792884|9709923|9683585|9554741|9506756|9463336|9236523|9215690|9215689|9103196|6108714|2857681	FC59;H41;H54;H62;H68;HE15;MC58	4221	MEN1	I5U1	IVS1	.	.	no-change	NM_000244.3	NP_000235.2	-	Y	c.-23-16C=	.	.	.	NM_000244.3(MEN1): c.-23-16C=	;maf-5-some-pop,maf-5-all-pops	12848	0.743618	U	0.2718	0.17492	.	.	PASS	.	568	0.501761	1835	7840	0.691582	.	.	.	.	.	.	rs509606	.	4020	0.711400	-1.972	-1.922	-2.035	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	64577619	64577620	11q13.1	0	normal	.	G	ref	G	CG.GG	het-alt	50	0.50	.	1	.	PASS	613733	C	131100(MK);613733(MK)	AD	Multiple endocrine neoplasia type I; Hyperparathyroidism, familial primary	AD	.	Endocrine; Oncologic	Endocrine; Oncologic	24058102|24037737|24014011|23961499|23956349|23919339|23809488|23652667|23645327|23443490|23376981|23052745|22584706|22581216|22549346|22522645|20301710|17879353|15531478|15292304|15240620|14985373|14871962|12791038|12417605|12112656|12050235|11836268|11739416|11344233|11295574|10439966|10193936|9832038|9792884|9709923|9683585|9554741|9506756|9463336|9236523|9215690|9215689|9103196|6108714|2857681	FC59;H41;H54;H62;H68;HE15;MC58	4221	MEN1	I5U1	IVS1	.	.	no-change	NM_130799.2	NP_570711.1	-	N	c.-23-16C=	.	.	.	NM_130799.2(MEN1): c.-23-16C=	;maf-5-some-pop,maf-5-all-pops	12848	0.743618	U	0.2718	0.17492	.	.	PASS	.	568	0.501761	1835	7840	0.691582	.	.	.	.	.	.	rs509606	.	4020	0.711400	-1.972	-1.922	-2.035	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	64577619	64577620	11q13.1	1	normal	.	G	snv	C	CG.GG	het-ref	50	0.50	.	2	.	PASS	613733	C	131100(MK);613733(MK)	AD	Multiple endocrine neoplasia type I; Hyperparathyroidism, familial primary	AD	.	Endocrine; Oncologic	Endocrine; Oncologic	24058102|24037737|24014011|23961499|23956349|23919339|23809488|23652667|23645327|23443490|23376981|23052745|22584706|22581216|22549346|22522645|20301710|17879353|15531478|15292304|15240620|14985373|14871962|12791038|12417605|12112656|12050235|11836268|11739416|11344233|11295574|10439966|10193936|9832038|9792884|9709923|9683585|9554741|9506756|9463336|9236523|9215690|9215689|9103196|6108714|2857681	FC59;H41;H54;H62;H68;HE15;MC58	4221	MEN1	I5U1	IVS1	.	.	intron	NM_000244.3	NP_000235.2	-	Y	c.-23-16C>G	.	.	.	NM_000244.3(MEN1): c.-23-16C>G	;maf-5-some-pop,maf-5-all-pops	12848	0.256382	U	0.2718	0.17492	.	.	PASS	60	568	0.498239	333	7840	0.308418	449	2844	2.90086e-01	2310	18976	1.81307e-01	rs509606	.	4020	0.288300	-1.972	-1.922	-2.035	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	439889	criteria_provided,_single_submitter	Benign	Benign
11	64577619	64577620	11q13.1	1	normal	.	G	snv	C	CG.GG	het-ref	50	0.50	.	2	.	PASS	613733	C	131100(MK);613733(MK)	AD	Multiple endocrine neoplasia type I; Hyperparathyroidism, familial primary	AD	.	Endocrine; Oncologic	Endocrine; Oncologic	24058102|24037737|24014011|23961499|23956349|23919339|23809488|23652667|23645327|23443490|23376981|23052745|22584706|22581216|22549346|22522645|20301710|17879353|15531478|15292304|15240620|14985373|14871962|12791038|12417605|12112656|12050235|11836268|11739416|11344233|11295574|10439966|10193936|9832038|9792884|9709923|9683585|9554741|9506756|9463336|9236523|9215690|9215689|9103196|6108714|2857681	FC59;H41;H54;H62;H68;HE15;MC58	4221	MEN1	I5U1	IVS1	.	.	intron	NM_130799.2	NP_570711.1	-	N	c.-23-16C>G	.	.	.	NM_130799.2(MEN1): c.-23-16C>G	;maf-5-some-pop,maf-5-all-pops	12848	0.256382	U	0.2718	0.17492	.	.	PASS	60	568	0.498239	333	7840	0.308418	449	2844	2.90086e-01	2310	18976	1.81307e-01	rs509606	.	4020	0.288300	-1.972	-1.922	-2.035	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	439889	criteria_provided,_single_submitter	Benign	Benign
11	67352688	67352689	11q13.2	0	normal	.	A	ref	A	AC.TC	het-alt	182	0.54	.	1	.	PASS	134660	C	.	NN	.	.	.	.	.	.	.	2950	GSTP1	C5	EX5	Glutathione S-transferase, C-terminal domain	PF00043.20	no-change	NM_000852.3	NP_000843.1	+	Y	c.313A=	.	.	.	NM_000852.3(GSTP1): c.313A=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	124826	0.665751	U	0.1786	0.352636	12568	0.639163	PASS	-627	8602	0.819344	27130	119818	0.666519	.	.	.	.	.	.	rs1695	.	4024	0.809900	-2.931	-0.428	-0.473	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	67352688	67352689	11q13.2	1	normal	.	A	snv	G	AC.TC	het-ref	156	0.46	.	2	.	PASS	134660	C	.	NN	.	.	.	.	.	.	.	2950	GSTP1	C5	EX5	Glutathione S-transferase, C-terminal domain	PF00043.20	missense	NM_000852.3	NP_000843.1	+	Y	c.313A>G	p.I105V | p.Ile105Val	ATC=>GTC	NP=>NP	NM_000852.3(GSTP1): c.313A>G (p.I105V)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	124826	0.334249	U	0.1786	0.352636	12568	0.360837	PASS	150	8602	0.180656	7178	119818	0.333481	311	3071	1.78236e-01	15398	83108	3.38796e-01	rs1695	.	4024	0.189400	-2.931	-0.428	-0.473	1	0	0	0.000	neutral	ENST00000398606: c.313A>G (p.I105V)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3752683	CM990713	NM_000852.3(GSTP1): c.313A>G (p.I105V)	"Oral cancer, association with"	10376763	DFP	no_record	37340	reviewed_by_expert_panel	drug_response	Likely Benign
11	69408468	69408469	11q13.3	0	nullSample	.	T	ref	T	CA.GG	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69408468T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.440296	U	0.5268	0.559704	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6606648	.	.	.	-0.415	-0.203	-0.212	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69408468	69408469	11q13.3	0	normal	.	T	snv	C	CA.GG	hom-alt	443	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69408468T>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.559704	U	0.5268	0.559704	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6606648	.	.	.	-0.415	-0.203	-0.212	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69411102	69411103	11q13.3	0	normal	.	T	snv	C	CT.CC	hom-alt	219	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69411102T>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.629792	U	0.5268	0.629792	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10908194	.	.	.	-0.473	-0.053	-0.067	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69411102	69411103	11q13.3	0	nullSample	.	T	ref	T	CT.CC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69411102T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.370208	U	0.5268	0.629792	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10908194	.	.	.	-0.473	-0.053	-0.067	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69411310	69411311	11q13.3	0	normal	.	G	ref	G	CC.TG	het-alt	110	0.53	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69411310G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.509385	U	0.2946	0.490615	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10796824	.	.	.	0.411	-0.261	-0.281	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69411310	69411311	11q13.3	0	normal	.	G	snv	A	CC.TG	het-ref	98	0.47	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69411310G>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.490615	U	0.2946	0.490615	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10796824	.	.	.	0.411	-0.261	-0.281	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69415366	69415367	11q13.3	0	normal	.	C	ref	C	GT.TC	het-alt	90	0.51	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69415366C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.578474	U	0.2976	0.421526	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7938336	.	.	.	0.561	0.552	0.550	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69415366	69415367	11q13.3	0	normal	.	C	snv	T	GT.TC	het-ref	86	0.49	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69415366C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.421526	U	0.2976	0.421526	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7938336	.	.	.	0.561	0.552	0.550	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69415559	69415560	11q13.3	0	normal	.	G	ref	G	CA.TG	het-alt	80	0.45	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69415559G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.576278	U	0.2976	0.423722	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7927491	.	.	.	0.561	-0.469	-0.492	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69415559	69415560	11q13.3	0	normal	.	G	snv	C	CA.TG	het-ref	98	0.55	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69415559G>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.423722	U	0.2976	0.423722	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7927491	.	.	.	0.561	-0.469	-0.492	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69426695	69426696	11q13.3	0	normal	.	G	ref	G	GC.CC	het-alt	121	0.49	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69426695G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.505791	U	0.2232	0.494209	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7950525	.	.	.	-1.855	-1.394	-1.471	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69426695	69426696	11q13.3	0	normal	.	G	snv	A	GC.CC	het-ref	125	0.51	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69426695G>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.494209	U	0.2232	0.494209	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7950525	.	.	.	-1.855	-1.394	-1.471	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69426821	69426822	11q13.3	0	normal	.	C	ref	C	CA.GA	het-alt	147	0.55	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69426821C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.505591	U	0.2232	0.494409	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7933440	.	.	.	0.491	0.092	0.072	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69426821	69426822	11q13.3	0	normal	.	C	snv	T	CA.GA	het-ref	119	0.45	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69426821C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.494409	U	0.2232	0.494409	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7933440	.	.	.	0.491	0.092	0.072	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69426848	69426849	11q13.3	0	normal	.	C	ref	C	AC.GT	het-alt	115	0.57	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69426848C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.505391	U	0.2242	0.494609	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7933453	.	.	.	0.491	-0.510	-0.512	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69426848	69426849	11q13.3	0	normal	.	C	snv	T	AC.GT	het-ref	88	0.43	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69426848C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.494609	U	0.2242	0.494609	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7933453	.	.	.	0.491	-0.510	-0.512	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69431415	69431416	11q13.3	0	normal	.	A	ref	A	GA.CC	het-alt	148	0.59	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69431415A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.610024	U	0.2292	0.389976	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10908195	.	.	.	-0.297	-0.015	-0.038	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69431415	69431416	11q13.3	0	normal	.	A	snv	G	GA.CC	het-ref	102	0.41	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69431415A>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.389976	U	0.2292	0.389976	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10908195	.	.	.	-0.297	-0.015	-0.038	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69442500	69442501	11q13.3	0	normal	.	C	ref	C	GG.GG	het-alt	209	0.53	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69442500C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.614617	U	0.2292	0.385383	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs618777	.	.	.	-1.401	-1.749	-1.750	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69442500	69442501	11q13.3	0	normal	.	C	snv	T	GG.GG	het-ref	188	0.47	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69442500C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.385383	U	0.2292	0.385383	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs618777	.	.	.	-1.401	-1.749	-1.750	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69462909	69462910	11q13.3	0	normal	.	G	ref	G	CC.GT	het-alt	263	0.53	.	1	.	PASS	168461	C	114500(SK);193300(SK);254500(SK)	AD	.	.	.	.	.	.	.	595	CCND1	C4	EX4	Cyclin, C-terminal domain	PF02984.14	no-change	NM_053056.2	NP_444284.1	+	Y	c.723G=	.	.	.	NM_053056.2(CCND1): c.723G=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	125954	0.546525	U	0.5714	0.413538	12988	0.613258	PASS	-1056	8622	0.430527	18443	120946	0.544871	.	.	.	.	.	.	rs9344	.	4024	0.443100	0.561	1.320	0.141	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69462909	69462910	11q13.3	1	normal	.	G	snv	A	CC.GT	het-ref	232	0.47	.	2	.	PASS	168461	C	114500(SK);193300(SK);254500(SK)	AD	.	.	.	.	.	.	.	595	CCND1	C4	EX4	Cyclin, C-terminal domain	PF02984.14	coding-synon	NM_053056.2	NP_444284.1	+	Y	c.723G>A	p.(P241=) | p.(Pro241=)	CCG=>CCA	.	NM_053056.2(CCND1): c.723G>A (p.(P241=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	125954	0.453475	U	0.5714	0.413538	12988	0.386742	PASS	1399	8622	0.569473	13016	120946	0.455129	2752	9765	5.66941e-01	26130	111484	4.53825e-01	rs9344	.	4024	0.556900	0.561	1.320	0.141	.	.	.	.	.	ENST00000227507: c.723G>A (p.P241P)	prostate [NS|NS|NS]	adenoma [NS|NS|NS]	CSV	1179751	.	.	.	.	.	no_record	13755	no_assertion_criteria_provided	risk_factor	Likely Benign
11	69466114	69466115	11q13.3	0	nullSample	.	C	ref	C	CC.CT	homo-ref	.	.	.	0	.	.	168461	C	114500(SK);193300(SK);254500(SK)	AD	.	.	.	.	.	.	.	595	CCND1	3U1E	EX5E	.	.	no-change	NM_053056.2	NP_444284.1	+	Y	c.*65C=	.	.	.	NM_053056.2(CCND1): c.*65C=	;maf-5-some-pop,maf-5-all-pops	5008	0.508986	U	0.8591	0.491014	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7177	.	.	.	0.655	0.957	0.634	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69466114	69466115	11q13.3	0	normal	.	C	snv	A	CC.CT	hom-alt	358	1.00	.	0	.	PASS	168461	C	114500(SK);193300(SK);254500(SK)	AD	.	.	.	.	.	.	.	595	CCND1	3U1E	EX5E	.	.	utr-3	NM_053056.2	NP_444284.1	+	Y	c.*65C>A	.	.	.	NM_053056.2(CCND1): c.*65C>A	;maf-5-some-pop,maf-5-all-pops	5008	0.491014	U	0.8591	0.491014	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7177	.	.	.	0.655	0.957	0.634	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69481968	69481969	11q13.3	0	nullSample	.	G	ref	G	CT.AC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69481968G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.462859	U	0.8651	0.537141	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1789165	.	.	.	0.549	-0.661	-0.770	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69481968	69481969	11q13.3	0	normal	.	G	snv	A	CT.AC	hom-alt	287	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69481968G>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.537141	U	0.8651	0.537141	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1789165	.	.	.	0.549	-0.661	-0.770	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69482090	69482091	11q13.3	0	nullSample	.	C	ref	C	GG.GA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69482090C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.250799	U	0.8948	0.749201	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1789166	.	.	.	-0.471	-2.501	-2.649	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69482090	69482091	11q13.3	0	normal	.	C	snv	A	GG.GA	hom-alt	228	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69482090C>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.749201	U	0.8948	0.749201	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1789166	.	.	.	-0.471	-2.501	-2.649	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69490345	69490346	11q13.3	0	nullSample	.	T	ref	T	AC.GC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69490345T= (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.458067	U	0.876	0.541933	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10796828	.	.	.	-0.381	-1.442	-1.562	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69490345	69490346	11q13.3	0	normal	.	T	snv	G	AC.GC	hom-alt	404	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69490345T>G (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.541933	U	0.876	0.541933	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10796828	.	.	.	-0.381	-1.442	-1.562	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69497243	69497244	11q13.3	0	normal	.	C	ref	C	tt.aa	het-alt	26	0.16	.	1	AluJb|SINE|Alu|+|300	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69497243C= (intergenic)	.	.	.	.	0.875	0.73123	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-1.953	-1.805	-1.895	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69497244	69497244	11q13.3	0	normal	.	.	ins	A	tc.aa	het-ref	135	0.84	.	2	AluJb|SINE|Alu|+|300	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69497244_69497245insA (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.731230	U	0.875	0.73123	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11386923	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69501870	69501871	11q13.3	0	nullSample	.	A	ref	A	CA.CC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69501870A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.425719	U	0.875	0.574281	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1201515	.	.	.	-2.578	-1.573	-1.579	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69501870	69501871	11q13.3	0	normal	.	A	snv	G	CA.CC	hom-alt	446	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr11: g.69501870A>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.574281	U	0.875	0.574281	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1201515	.	.	.	-2.578	-1.573	-1.579	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69588019	69588020	11q13.3	0	normal	.	C	ref	C	AC.CT	het-alt	196	0.49	.	1	.	PASS	164980	C	.	NN	.	.	.	.	.	.	.	2249	FGF4	3U1E	EX3E	.	.	no-change	NM_002007.2	NP_001998.1	-	Y	c.*57G=	.	.	.	NM_002007.2(FGF4): c.*57G=	;maf-5-some-pop	5008	0.823682	U	0.1627	0.176318	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3740639	.	.	.	-0.181	-0.118	-0.179	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69588019	69588020	11q13.3	0	normal	.	C	snv	T	AC.CT	het-ref	202	0.51	.	2	.	PASS	164980	C	.	NN	.	.	.	.	.	.	.	2249	FGF4	3U1E	EX3E	.	.	utr-3	NM_002007.2	NP_001998.1	-	Y	c.*57G>A	.	.	.	NM_002007.2(FGF4): c.*57G>A	;maf-5-some-pop	5008	0.176318	U	0.1627	0.176318	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3740639	.	.	.	-0.181	-0.118	-0.179	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69625510	69625511	11q13.3	0	normal	.	T	ref	T	TG.GG	het-alt	161	0.53	.	1	.	PASS	164950	C	610706(MK)	NN	Deafness, congenital with inner ear agenesis, microtia, and microdontia	AR	.	Audiologic/Otolaryngologic; Craniofacial; Dental	Audiologic/Otolaryngologic	21480479|18701883|18435799|17236138	.	2248	FGF3	IC2	IVS2	.	.	no-change	NM_005247.2	NP_005238.1	-	Y	c.325-43A=	.	.	.	NM_005247.2(FGF3): c.325-43A=	SingleClassTriAllelic;maf-5-some-pop	110070	0.516081	U	0.623	0.458267	12806	0.547243	PASS	.	8352	0.378233	14280	105062	0.514858	.	.	.	.	.	.	rs7932320	.	4024	0.400300	-0.479	-0.653	-0.247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	69625510	69625511	11q13.3	0	normal	.	T	snv	C	TG.GG	het-ref	140	0.47	.	2	.	PASS	164950	C	610706(MK)	NN	Deafness, congenital with inner ear agenesis, microtia, and microdontia	AR	.	Audiologic/Otolaryngologic; Craniofacial; Dental	Audiologic/Otolaryngologic	21480479|18701883|18435799|17236138	.	2248	FGF3	IC2	IVS2	.	.	intron	NM_005247.2	NP_005238.1	-	Y	c.325-43A>G	.	.	.	NM_005247.2(FGF3): c.325-43A>G	SingleClassTriAllelic;maf-5-some-pop	110070	0.483910	U	0.623	0.458267	12806	0.452757	PASS	1576	8352	0.621767	12719	105062	0.485133	2003	7062	5.82866e-01	18145	75100	4.61013e-01	rs7932320	.	4024	0.599700	-0.479	-0.653	-0.247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	76157922	76157923	11q13.5	0	normal	.	T	ref	T	AC.TT	het-alt	178	0.85	.	1	.	PASS	608574	P	.	NN	.	.	.	.	.	.	.	56946	C11orf30	I5U1	IVS1	.	.	no-change	NM_020193.3	NP_064578.2	+	Y	c.-39-21T=	.	.	.	NM_020193.3(C11orf30): c.-39-21T=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs367735381|rs774181297	.	4024	0.852100	-0.361	0.587	0.389	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	76157922	76157923	11q13.5	0	normal	.	T	del	.	AC.TT	het-ref	32	0.15	.	2	.	PASS	608574	P	.	NN	.	.	.	.	.	.	.	56946	C11orf30	I5U1	IVS1	.	.	intron	NM_020193.3	NP_064578.2	+	Y	c.-39-21delT	.	.	.	NM_020193.3(C11orf30): c.-39-21delT	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs367735381|rs774181297	.	4024	0.147900	-0.361	0.587	0.389	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	76183923	76183924	11q13.5	0	normal	.	A	snv	G	CT.TA	het-ref	182	0.48	.	2	.	PASS	608574	P	.	NN	.	.	.	.	.	.	.	56946	C11orf30	IC7	IVS8	.	.	intron	NM_020193.3	NP_064578.2	+	Y	c.1108+40A>G	.	.	.	NM_020193.3(C11orf30): c.1108+40A>G	;maf-5-some-pop,maf-5-all-pops	125310	0.612976	U	0.6944	0.583666	12984	0.521796	PASS	2214	8634	0.721334	23362	120302	0.614196	4445	12411	7.21906e-01	48107	149885	6.22756e-01	rs4245443	.	4024	0.726600	-0.290	-1.871	-2.252	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	76183923	76183924	11q13.5	0	normal	.	A	ref	A	CT.TA	het-alt	201	0.52	.	1	.	PASS	608574	P	.	NN	.	.	.	.	.	.	.	56946	C11orf30	IC7	IVS8	.	.	no-change	NM_020193.3	NP_064578.2	+	Y	c.1108+40A=	.	.	.	NM_020193.3(C11orf30): c.1108+40A=	;maf-5-some-pop,maf-5-all-pops	125310	0.387024	U	0.6944	0.583666	12984	0.478204	PASS	-900	8634	0.278666	9624	120302	0.385804	.	.	.	.	.	.	rs4245443	.	4024	0.273400	-0.290	-1.871	-2.252	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	76227181	76227182	11q13.5	0	normal	.	G	ref	G	CT.TA	het-alt	310	0.53	.	1	.	PASS	608574	P	.	NN	.	.	.	.	.	.	.	56946	C11orf30	IC9	IVS10	.	.	no-change	NM_020193.3	NP_064578.2	+	Y	c.1514-4G=	.	.	.	NM_020193.3(C11orf30): c.1514-4G=	;maf-5-some-pop,maf-5-all-pops	126198	0.356456	U	0.8006	0.636182	12984	0.450092	PASS	-644	8646	0.179042	8426	121190	0.356151	.	.	.	.	.	.	rs2508740	.	4024	0.190400	-0.381	-0.580	-1.250	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	76227181	76227182	11q13.5	1	normal	.	G	snv	A	CT.TA	het-ref	275	0.47	.	2	.	PASS	608574	P	.	NN	.	.	.	.	.	.	.	56946	C11orf30	IC9	IVS10	.	.	intron	NM_020193.3	NP_064578.2	+	Y	c.1514-4G>A	.	.	.	NM_020193.3(C11orf30): c.1514-4G>A	;maf-5-some-pop,maf-5-all-pops	126198	0.643544	U	0.8006	0.636182	12984	0.549908	PASS	2905	8646	0.820958	25859	121190	0.643849	5772	14056	8.24592e-01	52418	156435	6.50701e-01	rs2508740	.	4024	0.809600	-0.381	-0.580	-1.250	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	76237725	76237726	11q13.5	0	normal	.	A	ref	A	TC.AT	het-alt	153	0.48	.	1	.	PASS	608574	P	.	NN	.	.	.	.	.	.	.	56946	C11orf30	IC12	IVS13	.	.	no-change	NM_020193.3	NP_064578.2	+	Y	c.1995+47A=	.	.	.	NM_020193.3(C11orf30): c.1995+47A=	;maf-5-some-pop,maf-5-all-pops	120820	0.732321	U	.	.	12504	0.714091	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11363199	.	4024	0.867800	-0.414	-0.850	-0.589	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	76237725	76237726	11q13.5	0	normal	.	A	del	.	TC.AT	het-ref	167	0.52	.	2	.	PASS	608574	P	.	NN	.	.	.	.	.	.	.	56946	C11orf30	IC12	IVS13	.	.	intron	NM_020193.3	NP_064578.2	+	Y	c.1995+47delA	.	.	.	NM_020193.3(C11orf30): c.1995+47delA	;maf-5-some-pop,maf-5-all-pops	120820	0.267679	U	0.1379	0.20647	12504	0.285909	PASS	66	8470	0.123967	4540	115812	0.270326	95	1619	1.21748e-01	7632	51455	2.73525e-01	rs11363199	.	4024	0.132200	-0.414	-0.850	-0.589	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	76246874	76246875	11q13.5	0	normal	.	T	ref	T	TG.TT	het-alt	207	0.81	.	1	.	PASS	608574	P	.	NN	.	.	.	.	.	.	.	56946	C11orf30	IC13	IVS14	.	.	no-change	NM_020193.3	NP_064578.2	+	Y	c.2195-64T=	.	.	.	NM_020193.3(C11orf30): c.2195-64T=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.931900	-0.576	-0.573	-0.587	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	76246874	76246875	11q13.5	0	normal	.	T	del	.	TG.TT	het-ref	48	0.19	.	2	.	PASS	608574	P	.	NN	.	.	.	.	.	.	.	56946	C11orf30	IC13	IVS14	.	.	intron	NM_020193.3	NP_064578.2	+	Y	c.2195-64delT	.	.	.	NM_020193.3(C11orf30): c.2195-64delT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.068100	-0.576	-0.573	-0.587	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	76257214	76257215	11q13.5	0	normal	.	T	ref	T	AC.GT	het-alt	436	0.50	.	1	.	PASS	608574	P	.	NN	.	.	.	.	.	.	.	56946	C11orf30	C19	EX20	.	.	no-change	NM_020193.3	NP_064578.2	+	Y	c.3648T=	.	.	.	NM_020193.3(C11orf30): c.3648T=	SingleClassTriAllelic;maf-5-some-pop	126336	0.732958	U	0.1379	0.206869	12984	0.713725	PASS	-472	8644	0.875058	32743	121328	0.730474	.	.	.	.	.	.	rs3753051	.	4024	0.867500	0.528	1.761	2.322	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	76257214	76257215	11q13.5	1	normal	.	T	snv	C	AC.GT	het-ref	432	0.50	.	2	.	PASS	608574	P	.	NN	.	.	.	.	.	.	.	56946	C11orf30	C19	EX20	.	.	coding-synon	NM_020193.3	NP_064578.2	+	Y	c.3648T>C	p.(T1216=) | p.(Thr1216=)	ACT=>ACC	.	NM_020193.3(C11orf30): c.3648T>C (p.(T1216=))	SingleClassTriAllelic;maf-5-some-pop	126336	0.267034	U	0.1379	0.206869	12984	0.286275	PASS	68	8644	0.124942	4780	121328	0.269517	118	2088	1.21240e-01	9762	65966	2.68220e-01	rs3753051	.	4024	0.132500	0.528	1.761	2.322	.	.	.	.	.	ENST00000334736: c.3648T>C (p.T1216T)	stomach [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	VUO	147292	.	.	.	.	.	.	.	.	.	Likely Benign
11	85977116	85977117	11q14.2	1	normal	.	G	snv	A	TT.CA	het-ref	134	0.46	.	2	.	PASS	605984	P	.	NN	.	.	.	.	.	.	.	8726	EED	IC7	IVS7	.	.	intron	NM_003797.3	NP_003788.2	+	Y	c.727-8G>A	.	.	.	NM_003797.3(EED): c.727-8G>A	;maf-5-some-pop,maf-5-all-pops	126164	0.786286	U	0.7212	0.764976	12972	0.818378	PASS	2428	8652	0.744452	37842	121156	0.787167	4204	11309	7.36071e-01	67076	170740	7.80162e-01	rs10898460	.	.	.	-0.360	0.526	0.414	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	85977116	85977117	11q14.2	0	normal	.	G	ref	G	TT.CA	het-alt	160	0.54	.	1	.	PASS	605984	P	.	NN	.	.	.	.	.	.	.	8726	EED	IC7	IVS7	.	.	no-change	NM_003797.3	NP_003788.2	+	Y	c.727-8G=	.	.	.	NM_003797.3(EED): c.727-8G=	;maf-5-some-pop,maf-5-all-pops	126164	0.213714	U	0.7212	0.764976	12972	0.181622	PASS	.	8652	0.255548	3050	121156	0.212833	.	.	.	.	.	.	rs10898460	.	.	.	-0.360	0.526	0.414	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	94179124	94179125	11q21	0	normal	.	T	ref	T	AC.AA	het-alt	114	0.53	.	1	.	PASS	600814	P	604391(MK)	NN	Ataxia-telangiectasia-like disorder	AR	.	Dermatologic; Neurologic; Ophthalmologic	General	22863007|22006311|21227757|20087742|19732584|19584272|19383352|15574463|15269180|11371508|10612394|8684395|8445618	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	4361	MRE11A	IC14	IVS15	.	.	no-change	NM_005591.3	NP_005582.1	-	Y	c.1784-66A=	.	.	.	NM_005591.3(MRE11A): c.1784-66A=	;maf-5-some-pop,maf-5-all-pops	5008	0.482827	U	0.505	0.517173	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1014666	.	4024	0.508700	-0.128	-0.538	-0.530	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	94179124	94179125	11q21	0	normal	.	T	snv	C	AC.AA	het-ref	102	0.47	.	2	.	PASS	600814	P	604391(MK)	NN	Ataxia-telangiectasia-like disorder	AR	.	Dermatologic; Neurologic; Ophthalmologic	General	22863007|22006311|21227757|20087742|19732584|19584272|19383352|15574463|15269180|11371508|10612394|8684395|8445618	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	4361	MRE11A	IC14	IVS15	.	.	intron	NM_005591.3	NP_005582.1	-	Y	c.1784-66A>G	.	.	.	NM_005591.3(MRE11A): c.1784-66A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.517173	U	0.505	0.517173	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1014666	.	4024	0.491300	-0.128	-0.538	-0.530	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	94197259	94197260	11q21	0	normal	.	A	ref	A	TC.TA	het-alt	252	0.54	.	1	.	PASS	600814	P	604391(MK)	NN	Ataxia-telangiectasia-like disorder	AR	.	Dermatologic; Neurologic; Ophthalmologic	General	22863007|22006311|21227757|20087742|19732584|19584272|19383352|15574463|15269180|11371508|10612394|8684395|8445618	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	4361	MRE11A	IC10	IVS11	.	.	no-change	NM_005591.3	NP_005582.1	-	Y	c.1225+19T=	.	.	.	NM_005591.3(MRE11A): c.1225+19T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125016	0.621273	U	0.4028	0.388778	12998	0.647869	PASS	.	8538	0.584797	23321	120008	0.621692	.	.	.	.	.	.	rs641936	.	4024	0.582000	-0.766	-2.678	-2.962	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	94197259	94197260	11q21	1	normal	.	A	snv	G	TC.TA	het-ref	213	0.46	.	2	.	PASS	600814	P	604391(MK)	NN	Ataxia-telangiectasia-like disorder	AR	.	Dermatologic; Neurologic; Ophthalmologic	General	22863007|22006311|21227757|20087742|19732584|19584272|19383352|15574463|15269180|11371508|10612394|8684395|8445618	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	4361	MRE11A	IC10	IVS11	.	.	intron	NM_005591.3	NP_005582.1	-	Y	c.1225+19T>C	.	.	.	NM_005591.3(MRE11A): c.1225+19T>C	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125016	0.378728	U	0.4028	0.388778	12998	0.352131	PASS	764	8538	0.415203	8717	120008	0.378308	1468	6999	4.07392e-01	18125	93588	3.81553e-01	rs641936	.	4024	0.418000	-0.766	-2.678	-2.962	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	193884	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
11	94203867	94203868	11q21	0	nullSample	.	A	ref	A	CA.AC	homo-ref	.	.	.	0	.	.	600814	P	604391(MK)	NN	Ataxia-telangiectasia-like disorder	AR	.	Dermatologic; Neurologic; Ophthalmologic	General	22863007|22006311|21227757|20087742|19732584|19584272|19383352|15574463|15269180|11371508|10612394|8684395|8445618	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	4361	MRE11A	IC7	IVS8	.	.	no-change	NM_005591.3	NP_005582.1	-	Y	c.846-60T=	.	.	.	NM_005591.3(MRE11A): c.846-60T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.275559	U	0.7173	0.724441	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs610611	.	4024	0.252500	-2.285	-1.093	-1.039	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	94203867	94203868	11q21	0	normal	.	A	snv	T	CA.AC	hom-alt	356	1.00	.	0	.	PASS	600814	P	604391(MK)	NN	Ataxia-telangiectasia-like disorder	AR	.	Dermatologic; Neurologic; Ophthalmologic	General	22863007|22006311|21227757|20087742|19732584|19584272|19383352|15574463|15269180|11371508|10612394|8684395|8445618	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	4361	MRE11A	IC7	IVS8	.	.	intron	NM_005591.3	NP_005582.1	-	Y	c.846-60T>A	.	.	.	NM_005591.3(MRE11A): c.846-60T>A	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.724441	U	0.7173	0.724441	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs610611	.	4024	0.747500	-2.285	-1.093	-1.039	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	94212047	94212048	11q21	0	normal	.	C	ref	C	TG.AA	het-alt	280	0.52	.	1	.	PASS	600814	P	604391(MK)	NN	Ataxia-telangiectasia-like disorder	AR	.	Dermatologic; Neurologic; Ophthalmologic	General	22863007|22006311|21227757|20087742|19732584|19584272|19383352|15574463|15269180|11371508|10612394|8684395|8445618	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	4361	MRE11A	IC4	IVS5	.	.	no-change	NM_005591.3	NP_005582.1	-	Y	c.403-6G=	.	.	.	NM_005591.3(MRE11A): c.403-6G=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	125526	0.675255	U	0.3859	0.313099	12998	0.730420	PASS	.	8574	0.594238	27651	120518	0.674771	.	.	.	.	.	.	rs535801	.	4024	0.591000	-1.685	-1.531	-0.929	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	94212047	94212048	11q21	1	normal	.	C	snv	T	TG.AA	het-ref	256	0.48	.	2	.	PASS	600814	P	604391(MK)	NN	Ataxia-telangiectasia-like disorder	AR	.	Dermatologic; Neurologic; Ophthalmologic	General	22863007|22006311|21227757|20087742|19732584|19584272|19383352|15574463|15269180|11371508|10612394|8684395|8445618	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	4361	MRE11A	IC4	IVS5	.	.	intron	NM_005591.3	NP_005582.1	-	Y	c.403-6G>A	.	.	.	NM_005591.3(MRE11A): c.403-6G>A	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	125526	0.324745	U	0.3859	0.313099	12998	0.269580	PASS	735	8574	0.405762	6588	120518	0.325229	1406	6842	3.98300e-01	14112	81867	3.34525e-01	rs535801	.	4024	0.409000	-1.685	-1.531	-0.929	.	.	.	.	.	ENST00000323929: c.403-6G>A (p.?)	oesophagus [NS|NS|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	CSV	5430952	.	.	.	.	.	no_record	129623	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
11	94225919	94225920	11q21	0	normal	.	C	snv	T	AA.AA	het-ref	203	0.51	.	2	.	PASS	600814	P	604391(MK)	NN	Ataxia-telangiectasia-like disorder	AR	.	Dermatologic; Neurologic; Ophthalmologic	General	22863007|22006311|21227757|20087742|19732584|19584272|19383352|15574463|15269180|11371508|10612394|8684395|8445618	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	4361	MRE11A	IC1	IVS2	.	.	intron	NM_005591.3	NP_005582.1	-	Y	c.20+28G>A	.	.	.	NM_005591.3(MRE11A): c.20+28G>A	SingleClassTriAllelic;maf-5-some-pop	126250	0.461917	U	0.5	0.457268	12998	0.410140	PASS	1108	8636	0.498958	13291	121242	0.462109	2130	8493	4.92805e-01	27472	115336	4.68750e-01	rs497763	.	4024	0.492000	-0.268	0.519	0.679	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	259798	criteria_provided,_single_submitter	Benign	Benign
11	94225919	94225920	11q21	0	normal	.	C	ref	C	AA.AA	het-alt	196	0.49	.	1	.	PASS	600814	P	604391(MK)	NN	Ataxia-telangiectasia-like disorder	AR	.	Dermatologic; Neurologic; Ophthalmologic	General	22863007|22006311|21227757|20087742|19732584|19584272|19383352|15574463|15269180|11371508|10612394|8684395|8445618	FC59;FH44;H54;H62;H68;HB23;HBO28;MC58;MH43	4361	MRE11A	IC1	IVS2	.	.	no-change	NM_005591.3	NP_005582.1	-	Y	c.20+28G=	.	.	.	NM_005591.3(MRE11A): c.20+28G=	SingleClassTriAllelic;maf-5-some-pop	126250	0.538075	U	0.5	0.457268	12998	0.589860	PASS	.	8636	0.501042	17884	121242	0.537883	.	.	.	.	.	.	rs497763	.	4024	0.508000	-0.268	0.519	0.679	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	95725058	95725059	11q21	0	normal	.	A	ref	A	GC.TA	het-alt	339	0.49	.	1	.	PASS	607537	P	607537(MK)	NN	.	.	.	.	.	.	.	84441	MAML2	IC2	IVS2	.	.	no-change	NM_032427.1	NP_115803.1	-	Y	c.2140-172T=	.	.	.	NM_032427.1(MAML2): c.2140-172T=	;	5008	0.999800	U	0.001	0.000199681	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs545424174	.	4024	0.999800	-0.321	-0.876	-0.475	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	95725058	95725059	11q21	0	normal	.	A	snv	G	GC.TA	het-ref	351	0.51	.	2	.	PASS	607537	P	607537(MK)	NN	.	.	.	.	.	.	.	84441	MAML2	IC2	IVS2	.	.	intron	NM_032427.1	NP_115803.1	-	Y	c.2140-172T>C	.	.	.	NM_032427.1(MAML2): c.2140-172T>C	;	5008	0.000200	U	0.001	0.000199681	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs545424174	.	4024	0.000200	-0.321	-0.876	-0.475	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
11	95824592	95824593	11q21	0	normal	.	A	snv	G	TA.AT	het-ref	258	0.58	.	2	.	PASS	607537	P	607537(MK)	NN	.	.	.	.	.	.	.	84441	MAML2	IC2	IVS2	.	.	intron	NM_032427.1	NP_115803.1	-	Y	c.2139+463T>C	.	.	.	NM_032427.1(MAML2): c.2139+463T>C	;maf-5-some-pop,maf-5-all-pops	5008	0.498003	U	0.2004	0.498003	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7104859	.	4024	0.199800	-0.119	0.016	0.012	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	95824592	95824593	11q21	0	normal	.	A	ref	A	TA.AT	het-alt	184	0.42	.	1	.	PASS	607537	P	607537(MK)	NN	.	.	.	.	.	.	.	84441	MAML2	IC2	IVS2	.	.	no-change	NM_032427.1	NP_115803.1	-	Y	c.2139+463T=	.	.	.	NM_032427.1(MAML2): c.2139+463T=	;maf-5-some-pop,maf-5-all-pops	5008	0.501997	U	0.2004	0.498003	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7104859	.	4024	0.800200	-0.119	0.016	0.012	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	95824617	95824618	11q21	0	normal	.	G	ref	G	GT.TA	het-alt	180	0.42	.	1	.	PASS	607537	P	607537(MK)	NN	.	.	.	.	.	.	.	84441	MAML2	IC2	IVS2	.	.	no-change	NM_032427.1	NP_115803.1	-	Y	c.2139+438C=	.	.	.	NM_032427.1(MAML2): c.2139+438C=	;maf-5-some-pop,maf-5-all-pops	5008	0.548323	U	0.2004	0.451677	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7118784	.	4024	0.800900	-0.137	-1.990	-2.011	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	95824617	95824618	11q21	0	normal	.	G	snv	A	GT.TA	het-ref	248	0.58	.	2	.	PASS	607537	P	607537(MK)	NN	.	.	.	.	.	.	.	84441	MAML2	IC2	IVS2	.	.	intron	NM_032427.1	NP_115803.1	-	Y	c.2139+438C>T	.	.	.	NM_032427.1(MAML2): c.2139+438C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.451677	U	0.2004	0.451677	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7118784	.	4024	0.199100	-0.137	-1.990	-2.011	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	95824659	95824660	11q21	0	normal	.	T	ref	T	at.ca	het-alt	266	0.50	.	1	L2c|LINE|L2|+|76	PASS	607537	P	607537(MK)	NN	.	.	.	.	.	.	.	84441	MAML2	IC2	IVS2	.	.	no-change	NM_032427.1	NP_115803.1	-	Y	c.2139+396A=	.	.	.	NM_032427.1(MAML2): c.2139+396A=	;	0	0	U	0.2014	0.498203	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs200799597	.	.	.	0.533	0.045	0.008	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	95824660	95824660	11q21	0	normal	.	.	ins	C	tt.ca	het-ref	271	0.50	.	2	L2c|LINE|L2|+|76	PASS	607537	P	607537(MK)	NN	.	.	.	.	.	.	.	84441	MAML2	IC2	IVS2	.	.	intron	NM_032427.1	NP_115803.1	-	Y	c.2139+395_2139+396insG	.	.	.	NM_032427.1(MAML2): c.2139+395_2139+396insG	;maf-5-some-pop,maf-5-all-pops	5008	0.498203	U	0.2014	0.498203	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11395389	.	4024	0.199600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	95824760	95824761	11q21	0	normal	.	T	ref	T	GA.TG	het-alt	302	0.51	.	1	.	PASS	607537	P	607537(MK)	NN	.	.	.	.	.	.	.	84441	MAML2	IC2	IVS2	.	.	no-change	NM_032427.1	NP_115803.1	-	Y	c.2139+295A=	.	.	.	NM_032427.1(MAML2): c.2139+295A=	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	5008	0.508586	U	0.2014	0.491414	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7108260	.	4024	0.800400	-0.242	-1.711	-1.795	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	95824760	95824761	11q21	0	normal	.	T	snv	C	GA.TG	het-ref	288	0.49	.	2	.	PASS	607537	P	607537(MK)	NN	.	.	.	.	.	.	.	84441	MAML2	IC2	IVS2	.	.	intron	NM_032427.1	NP_115803.1	-	Y	c.2139+295A>G	.	.	.	NM_032427.1(MAML2): c.2139+295A>G	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	5008	0.491414	U	0.2014	0.491414	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7108260	.	4024	0.199600	-0.242	-1.711	-1.795	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	95824784	95824785	11q21	0	normal	.	A	ref	A	AC.GC	het-alt	297	0.48	.	1	.	PASS	607537	P	607537(MK)	NN	.	.	.	.	.	.	.	84441	MAML2	IC2	IVS2	.	.	no-change	NM_032427.1	NP_115803.1	-	Y	c.2139+271T=	.	.	.	NM_032427.1(MAML2): c.2139+271T=	;maf-5-some-pop,maf-5-all-pops	5008	0.501997	U	0.2014	0.498003	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7105034	.	4024	0.800400	-1.736	-2.521	-2.591	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	95824784	95824785	11q21	0	normal	.	A	snv	G	AC.GC	het-ref	317	0.52	.	2	.	PASS	607537	P	607537(MK)	NN	.	.	.	.	.	.	.	84441	MAML2	IC2	IVS2	.	.	intron	NM_032427.1	NP_115803.1	-	Y	c.2139+271T>C	.	.	.	NM_032427.1(MAML2): c.2139+271T>C	;maf-5-some-pop,maf-5-all-pops	5008	0.498003	U	0.2014	0.498003	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7105034	.	4024	0.199600	-1.736	-2.521	-2.591	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	99690285	99690286	11q22.1	0	normal	.	T	ref	T	AA.CT	het-alt	147	0.32	.	1	.	PASS	607219	P	.	NN	.	.	.	.	.	.	.	53942	CNTN5	C2	EX4	.	.	no-change	NM_014361.3	NP_055176.1	+	Y	c.67T=	.	.	.	NM_014361.3(CNTN5): c.67T=	SingleClassTriAllelic;maf-5-some-pop	119198	0.503456	U	.	.	.	.	InbreedingCoeff_Filter	.	8560	0.575350	2494	119198	0.503456	.	.	.	.	.	.	rs10790978	.	4024	0.588200	-0.127	1.786	0.875	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	99690285	99690286	11q22.1	1	normal	.	T	snv	G	AA.CT	het-ref	315	0.68	.	2	.	PASS	607219	P	.	NN	.	.	.	.	.	.	.	53942	CNTN5	C2	EX4	.	.	missense	NM_014361.3	NP_055176.1	+	Y	c.67T>G	p.S23A | p.Ser23Ala	TCT=>GCT	P0=>NP	NM_014361.3(CNTN5): c.67T>G (p.S23A)	SingleClassTriAllelic;maf-5-some-pop	119198	0.496527	U	.	.	.	.	InbreedingCoeff_Filter	174	8560	0.424416	2080	119198	0.496527	360	7129	4.24396e-01	4227	119331	4.94690e-01	rs10790978	.	4024	0.411800	-0.127	1.786	0.875	1	0	0	0.000	neutral	ENST00000524871: c.67T>G (p.S23A)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	RSS	1476010	.	.	.	.	.	.	.	.	.	Likely Benign
11	99690427	99690428	11q22.1	0	normal	.	T	ref	T	GC.AG	het-alt	417	0.74	.	1	.	PASS	607219	P	.	NN	.	.	.	.	.	.	.	53942	CNTN5	C2	EX4	.	.	no-change	NM_014361.3	NP_055176.1	+	Y	c.209T=	.	.	.	NM_014361.3(CNTN5): c.209T=	;maf-5-some-pop,maf-5-all-pops	117400	0.515094	U	.	.	.	.	InbreedingCoeff_Filter	.	8072	0.577676	1773	117400	0.515094	.	.	.	.	.	.	rs7125822	.	4024	0.612800	-0.127	1.034	0.778	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	99690427	99690428	11q22.1	1	normal	.	T	snv	G	GC.AG	het-ref	147	0.26	.	2	.	PASS	607219	P	.	NN	.	.	.	.	.	.	.	53942	CNTN5	C2	EX4	.	.	missense	NM_014361.3	NP_055176.1	+	Y	c.209T>G	p.L70R | p.Leu70Arg	CTA=>CGA	NP=>P+	NM_014361.3(CNTN5): c.209T>G (p.L70R)	;maf-5-some-pop,maf-5-all-pops	117400	0.484906	U	.	.	.	.	InbreedingCoeff_Filter	0	8072	0.422324	1	117400	0.484906	0	5864	3.92188e-01	2	110845	4.77702e-01	rs7125822	.	4024	0.387200	-0.127	1.034	0.778	0.86	0	0	0.001	neutral	ENST00000524871: c.209T>G (p.L70R)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3931469	.	.	.	.	.	.	.	.	.	Likely Benign
11	99690460	99690461	11q22.1	0	normal	.	A	ref	A	CA.TC	het-alt	314	0.87	.	1	.	DUBIOUS	607219	P	.	NN	.	.	.	.	.	.	.	53942	CNTN5	C2	EX4	.	.	no-change	NM_014361.3	NP_055176.1	+	Y	c.242A=	.	.	.	NM_014361.3(CNTN5): c.242A=	;maf-5-some-pop,maf-5-all-pops	101874	0.638269	U	.	.	.	.	InbreedingCoeff_Filter	-724	6140	0.764169	14086	101874	0.638269	.	.	.	.	.	.	rs10893933	.	4024	0.858600	0.528	0.692	0.128	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	99690460	99690461	11q22.1	1	normal	.	A	snv	G	CA.TC	het-ref	49	0.13	.	2	.	DUBIOUS	607219	P	.	NN	.	.	.	.	.	.	.	53942	CNTN5	C2	EX4	.	.	missense	NM_014361.3	NP_055176.1	+	Y	c.242A>G	p.N81S | p.Asn81Ser	AAT=>AGT	P0=>P0	NM_014361.3(CNTN5): c.242A>G (p.N81S)	;maf-5-some-pop,maf-5-all-pops	101874	0.361731	U	.	.	.	.	InbreedingCoeff_Filter	0	6140	0.235831	0	101874	0.361731	0	2171	1.60506e-01	0	58168	3.11866e-01	rs10893933	.	4024	0.141400	0.528	0.692	0.128	1	0.006	0.007	0.000	neutral	ENST00000524871: c.242A>G (p.N81S)	large_intestine [colon|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4592079	.	.	.	.	.	.	.	.	.	Unknown
11	102100428	102100429	11q22.2	0	normal	.	C	ref	C	CA.TA	het-alt	149	0.49	.	1	.	PASS	606608	P	120433(MK)	AD	.	.	.	.	.	.	.	10413	YAP1	IC8	IVS8	.	.	no-change	NM_001130145.2	NP_001123617.1	+	Y	c.1277-4C=	.	.	.	NM_001130145.2(YAP1): c.1277-4C=	;	125988	0.995508	U	0.0446	0.00898562	13004	0.999077	PASS	.	8650	0.946012	59978	120980	0.995694	.	.	.	.	.	.	rs116990751	.	.	.	-0.268	-0.106	-0.335	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	102100428	102100429	11q22.2	1	normal	.	C	snv	T	CA.TA	het-ref	156	0.51	.	2	.	PASS	606608	P	120433(MK)	AD	.	.	.	.	.	.	.	10413	YAP1	IC8	IVS8	.	.	intron	NM_001130145.2	NP_001123617.1	+	Y	c.1277-4C>T	.	.	.	NM_001130145.2(YAP1): c.1277-4C>T	;	125988	0.004492	U	0.0446	0.00898562	13004	0.000923	PASS	9	8650	0.053988	9	120980	0.004306	27	984	5.70501e-02	27	1089	4.43505e-03	rs116990751	.	.	.	-0.268	-0.106	-0.335	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
11	108098459	108098461	11q22.3	0	normal	.	AA	ref	AA	AT.GT	het-alt	335	0.49	.	1	.	PASS	607585	C	114480(SK);208900(MK);607585(MK)	AD;AR	Ataxia-Telangiectasia	AR	.	Allergy/Immunology/Infectious; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Oncologic	23900766|23612382|23264026|21429505|20301790|19535770|19440741|16864838|16832357|15942625|12552559|12226795|11826028|10980530|10677309|10571946|10425038|9887333|9463314|9259193|9054948|9054927|8976369|8365732|7836845|7792600|7124732|4515676|4132004|3788973|3785360|3574400|3496017|2916583|2253179|2136770|2005780|1961222|1377828|1304718|311128|310962	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HP16;MC58;MH43	472	ATM	IC1	IVS2	.	.	no-change	NM_000051.3	NP_000042.3	+	Y	c.72+37_72+38=	.	.	.	NM_000051.3(ATM): c.72+37_72+38=	DuplicateObserved;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126282	0.576408	U	.	.	12514	0.664216	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2066734	.	4024	0.597700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	108098459	108098461	11q22.3	0	normal	.	AA	del	.	AT.GT	het-ref	355	0.51	.	2	.	PASS	607585	C	114480(SK);208900(MK);607585(MK)	AD;AR	Ataxia-Telangiectasia	AR	.	Allergy/Immunology/Infectious; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Oncologic	23900766|23612382|23264026|21429505|20301790|19535770|19440741|16864838|16832357|15942625|12552559|12226795|11826028|10980530|10677309|10571946|10425038|9887333|9463314|9259193|9054948|9054927|8976369|8365732|7836845|7792600|7124732|4515676|4132004|3788973|3785360|3574400|3496017|2916583|2253179|2136770|2005780|1961222|1377828|1304718|311128|310962	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HP16;MC58;MH43	472	ATM	IC1	IVS2	.	.	intron	NM_000051.3	NP_000042.3	+	Y	c.72+37_72+38delAA	.	.	.	NM_000051.3(ATM): c.72+37_72+38delAA	DuplicateObserved;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126282	0.423592	U	0.3839	0.38119	12514	0.335784	PASS	654	8642	0.387642	11714	121274	0.425343	1312	6727	3.90107e-01	24815	107380	4.36281e-01	rs2066734	.	4024	0.402300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	108100104	108100105	11q22.3	0	normal	.	G	ref	G	GA.TT	het-alt	61	0.49	.	1	.	PASS	607585	C	114480(SK);208900(MK);607585(MK)	AD;AR	Ataxia-Telangiectasia	AR	.	Allergy/Immunology/Infectious; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Oncologic	23900766|23612382|23264026|21429505|20301790|19535770|19440741|16864838|16832357|15942625|12552559|12226795|11826028|10980530|10677309|10571946|10425038|9887333|9463314|9259193|9054948|9054927|8976369|8365732|7836845|7792600|7124732|4515676|4132004|3788973|3785360|3574400|3496017|2916583|2253179|2136770|2005780|1961222|1377828|1304718|311128|310962	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HP16;MC58;MH43	472	ATM	IC3	IVS4	.	.	no-change	NM_000051.3	NP_000042.3	+	Y	c.331+55G=	.	.	.	NM_000051.3(ATM): c.331+55G=	MixedObserved;	0|25008	0|0.999960	U	0.4335	0.484824	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs114106540|rs750761029	.	4025	0.998500	-0.350	-0.379	-0.406	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	108100105	108100105	11q22.3	0	normal	.	.	ins	T	AG.TT	het-ref	63	0.51	.	2	.	PASS	607585	C	114480(SK);208900(MK);607585(MK)	AD;AR	Ataxia-Telangiectasia	AR	.	Allergy/Immunology/Infectious; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Oncologic	23900766|23612382|23264026|21429505|20301790|19535770|19440741|16864838|16832357|15942625|12552559|12226795|11826028|10980530|10677309|10571946|10425038|9887333|9463314|9259193|9054948|9054927|8976369|8365732|7836845|7792600|7124732|4515676|4132004|3788973|3785360|3574400|3496017|2916583|2253179|2136770|2005780|1961222|1377828|1304718|311128|310962	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HP16;MC58;MH43	472	ATM	IC3	IVS4	.	.	intron	NM_000051.3	NP_000042.3	+	Y	c.331+55_331+56insT	.	.	.	NM_000051.3(ATM): c.331+55_331+56insT	.	.	.	.	0.4335	0.484824	.	.	PASS	10	808	0.394802	391	22634	0.439560	.	.	.	.	.	.	.	.	4024	0.475600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	108119615	108119616	11q22.3	0	normal	.	A	ref	A	tc.aa	het-alt	168	0.76	.	1	AluSp|SINE|Alu|+|303	PASS	607585	C	114480(SK);208900(MK);607585(MK)	AD;AR	Ataxia-Telangiectasia	AR	.	Allergy/Immunology/Infectious; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Oncologic	23900766|23612382|23264026|21429505|20301790|19535770|19440741|16864838|16832357|15942625|12552559|12226795|11826028|10980530|10677309|10571946|10425038|9887333|9463314|9259193|9054948|9054927|8976369|8365732|7836845|7792600|7124732|4515676|4132004|3788973|3785360|3574400|3496017|2916583|2253179|2136770|2005780|1961222|1377828|1304718|311128|310962	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HP16;MC58;MH43	472	ATM	IC7	IVS8	.	.	no-change	NM_000051.3	NP_000042.3	+	Y	c.1066-44A=	.	.	.	NM_000051.3(ATM): c.1066-44A=	MixedObserved;	850|2	0.892941|0.500000	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs35813860|rs79642100	.	4024	0.624500	0.378	0.407	0.383	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	108119615	108119616	11q22.3	0	normal	.	A	del	.	tc.aa	het-ref	53	0.24	.	2	AluSp|SINE|Alu|+|303	PASS	607585	C	114480(SK);208900(MK);607585(MK)	AD;AR	Ataxia-Telangiectasia	AR	.	Allergy/Immunology/Infectious; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Oncologic	23900766|23612382|23264026|21429505|20301790|19535770|19440741|16864838|16832357|15942625|12552559|12226795|11826028|10980530|10677309|10571946|10425038|9887333|9463314|9259193|9054948|9054927|8976369|8365732|7836845|7792600|7124732|4515676|4132004|3788973|3785360|3574400|3496017|2916583|2253179|2136770|2005780|1961222|1377828|1304718|311128|310962	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HP16;MC58;MH43	472	ATM	IC7	IVS8	.	.	intron	NM_000051.3	NP_000042.3	+	Y	c.1066-44delA	.	.	.	NM_000051.3(ATM): c.1066-44delA	MixedObserved;	850	0.107059	U	.	.	.	.	PASS	0	948	0.364979	0	23050	0.360824	.	.	.	.	.	.	rs35813860	.	4024	0.375500	0.378	0.407	0.383	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	108121409	108121410	11q22.3	0	normal	.	C	ref	C	TC.TT	het-alt	215	0.75	.	1	.	PASS	607585	C	114480(SK);208900(MK);607585(MK)	AD;AR	Ataxia-Telangiectasia	AR	.	Allergy/Immunology/Infectious; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Oncologic	23900766|23612382|23264026|21429505|20301790|19535770|19440741|16864838|16832357|15942625|12552559|12226795|11826028|10980530|10677309|10571946|10425038|9887333|9463314|9259193|9054948|9054927|8976369|8365732|7836845|7792600|7124732|4515676|4132004|3788973|3785360|3574400|3496017|2916583|2253179|2136770|2005780|1961222|1377828|1304718|311128|310962	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HP16;MC58;MH43	472	ATM	IC8	IVS9	.	.	no-change	NM_000051.3	NP_000042.3	+	Y	c.1236-18C=	.	.	.	NM_000051.3(ATM): c.1236-18C=	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs201767651	.	.	.	-0.229	-0.122	-0.385	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
11	108121410	108121410	11q22.3	1	normal	.	.	ins	T	CC.TT	het-ref	72	0.25	.	2	.	PASS	607585	C	114480(SK);208900(MK);607585(MK)	AD;AR	Ataxia-Telangiectasia	AR	.	Allergy/Immunology/Infectious; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Oncologic	23900766|23612382|23264026|21429505|20301790|19535770|19440741|16864838|16832357|15942625|12552559|12226795|11826028|10980530|10677309|10571946|10425038|9887333|9463314|9259193|9054948|9054927|8976369|8365732|7836845|7792600|7124732|4515676|4132004|3788973|3785360|3574400|3496017|2916583|2253179|2136770|2005780|1961222|1377828|1304718|311128|310962	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HP16;MC58;MH43	472	ATM	IC8	IVS9	.	.	intron	NM_000051.3	NP_000042.3	+	Y	c.1236-18_1236-17insT	.	.	.	NM_000051.3(ATM): c.1236-18_1236-17insT	MixedObserved;rs-cluster-nonoverlapping-alleles	57710	0.012493	U	0.3641	0.40595	.	.	InbreedingCoeff_Filter	17	6820	0.305718	241	94020	0.371719	.	.	.	.	.	.	rs34325032	.	4024	0.239600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	181847	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
11	108129656	108129657	11q22.3	0	normal	.	A	ref	A	CC.AG	het-alt	195	0.57	.	1	.	PASS	607585	C	114480(SK);208900(MK);607585(MK)	AD;AR	Ataxia-Telangiectasia	AR	.	Allergy/Immunology/Infectious; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Oncologic	23900766|23612382|23264026|21429505|20301790|19535770|19440741|16864838|16832357|15942625|12552559|12226795|11826028|10980530|10677309|10571946|10425038|9887333|9463314|9259193|9054948|9054927|8976369|8365732|7836845|7792600|7124732|4515676|4132004|3788973|3785360|3574400|3496017|2916583|2253179|2136770|2005780|1961222|1377828|1304718|311128|310962	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HP16;MC58;MH43	472	ATM	IC14	IVS15	.	.	no-change	NM_000051.3	NP_000042.3	+	Y	c.2377-56A=	.	.	.	NM_000051.3(ATM): c.2377-56A=	;maf-5-some-pop,genotype-conflict	5008	0.523562	U	0.4196	0.476438	4564	0.520815	.	.	.	.	.	.	.	.	.	.	.	.	.	rs672655	.	4024	0.579800	0.533	1.192	2.182	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	108129656	108129657	11q22.3	0	normal	.	A	snv	G	CC.AG	het-ref	150	0.43	.	2	.	PASS	607585	C	114480(SK);208900(MK);607585(MK)	AD;AR	Ataxia-Telangiectasia	AR	.	Allergy/Immunology/Infectious; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Oncologic	23900766|23612382|23264026|21429505|20301790|19535770|19440741|16864838|16832357|15942625|12552559|12226795|11826028|10980530|10677309|10571946|10425038|9887333|9463314|9259193|9054948|9054927|8976369|8365732|7836845|7792600|7124732|4515676|4132004|3788973|3785360|3574400|3496017|2916583|2253179|2136770|2005780|1961222|1377828|1304718|311128|310962	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HP16;MC58;MH43	472	ATM	IC14	IVS15	.	.	intron	NM_000051.3	NP_000042.3	+	Y	c.2377-56A>G	.	.	.	NM_000051.3(ATM): c.2377-56A>G	;maf-5-some-pop,genotype-conflict	5008	0.476438	U	0.4196	0.476438	4564	0.479185	.	.	.	.	.	.	.	.	.	.	.	.	.	rs672655	.	4024	0.420200	0.533	1.192	2.182	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	108141955	108141956	11q22.3	0	normal	.	T	ref	T	AC.TT	het-alt	243	0.65	.	1	.	PASS	607585	C	114480(SK);208900(MK);607585(MK)	AD;AR	Ataxia-Telangiectasia	AR	.	Allergy/Immunology/Infectious; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Oncologic	23900766|23612382|23264026|21429505|20301790|19535770|19440741|16864838|16832357|15942625|12552559|12226795|11826028|10980530|10677309|10571946|10425038|9887333|9463314|9259193|9054948|9054927|8976369|8365732|7836845|7792600|7124732|4515676|4132004|3788973|3785360|3574400|3496017|2916583|2253179|2136770|2005780|1961222|1377828|1304718|311128|310962	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HP16;MC58;MH43	472	ATM	IC18	IVS19	.	.	no-change	NM_000051.3	NP_000042.3	+	Y	c.2922-22T=	.	.	.	NM_000051.3(ATM): c.2922-22T=	MixedObserved;	0	0	U	.	.	.	.	InbreedingCoeff_Filter	0	26	1.000000	291	586	0.996587	.	.	.	.	.	.	rs373881770	.	4024	0.539300	0.318	0.345	0.324	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	108141955	108141956	11q22.3	0	normal	.	T	del	.	AC.TT	het-ref	129	0.35	.	2	.	PASS	607585	C	114480(SK);208900(MK);607585(MK)	AD;AR	Ataxia-Telangiectasia	AR	.	Allergy/Immunology/Infectious; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Oncologic	23900766|23612382|23264026|21429505|20301790|19535770|19440741|16864838|16832357|15942625|12552559|12226795|11826028|10980530|10677309|10571946|10425038|9887333|9463314|9259193|9054948|9054927|8976369|8365732|7836845|7792600|7124732|4515676|4132004|3788973|3785360|3574400|3496017|2916583|2253179|2136770|2005780|1961222|1377828|1304718|311128|310962	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HP16;MC58;MH43	472	ATM	IC18	IVS19	.	.	intron	NM_000051.3	NP_000042.3	+	Y	c.2922-22delT	.	.	.	NM_000051.3(ATM): c.2922-22delT	MixedObserved;	0	0	U	.	.	.	.	InbreedingCoeff_Filter	1	7004	0.445174	1	101178	0.436300	.	.	.	.	.	.	rs373881770	.	4024	0.460700	0.318	0.345	0.324	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	490504	criteria_provided,_single_submitter	Likely_benign	Benign
11	108151706	108151707	11q22.3	0	normal	.	T	ref	T	TT.AA	het-alt	181	0.50	.	1	.	PASS	607585	C	114480(SK);208900(MK);607585(MK)	AD;AR	Ataxia-Telangiectasia	AR	.	Allergy/Immunology/Infectious; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Oncologic	23900766|23612382|23264026|21429505|20301790|19535770|19440741|16864838|16832357|15942625|12552559|12226795|11826028|10980530|10677309|10571946|10425038|9887333|9463314|9259193|9054948|9054927|8976369|8365732|7836845|7792600|7124732|4515676|4132004|3788973|3785360|3574400|3496017|2916583|2253179|2136770|2005780|1961222|1377828|1304718|311128|310962	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HP16;MC58;MH43	472	ATM	IC22	IVS23	.	.	no-change	NM_000051.3	NP_000042.3	+	Y	c.3403-15T=	.	.	.	NM_000051.3(ATM): c.3403-15T=	MixedObserved;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	52895	0.969487	U	0.0109	0.0349441	.	.	PASS	.	8304	0.603926	10409	117198	0.419487	.	.	.	.	.	.	rs79701258	.	4024	0.997800	-2.436	-0.989	-1.661	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	108151707	108151707	11q22.3	1	normal	.	.	ins	A	TT.AA	het-ref	180	0.50	.	2	.	PASS	607585	C	114480(SK);208900(MK);607585(MK)	AD;AR	Ataxia-Telangiectasia	AR	.	Allergy/Immunology/Infectious; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Oncologic	23900766|23612382|23264026|21429505|20301790|19535770|19440741|16864838|16832357|15942625|12552559|12226795|11826028|10980530|10677309|10571946|10425038|9887333|9463314|9259193|9054948|9054927|8976369|8365732|7836845|7792600|7124732|4515676|4132004|3788973|3785360|3574400|3496017|2916583|2253179|2136770|2005780|1961222|1377828|1304718|311128|310962	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HP16;MC58;MH43	472	ATM	IC22	IVS23	.	.	intron	NM_000051.3	NP_000042.3	+	Y	c.3403-15_3403-14insA	.	.	.	NM_000051.3(ATM): c.3403-15_3403-14insA	InconsistentAlleles;maf-5-some-pop,maf-5-all-pops,genotype-conflict,rs-cluster-nonoverlapping-alleles	120592	0.574026	U	0.4058	0.542133	12460	0.556180	PASS	602	8304	0.384513	18905	117198	0.567484	.	.	.	.	.	.	rs3218681	.	4024	0.405600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	181858	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
11	108183166	108183167	11q22.3	0	normal	.	A	snv	G	GA.TA	hom-alt	556	1.00	.	0	.	PASS	607585	C	114480(SK);208900(MK);607585(MK)	AD;AR	Ataxia-Telangiectasia	AR	.	Allergy/Immunology/Infectious; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Oncologic	23900766|23612382|23264026|21429505|20301790|19535770|19440741|16864838|16832357|15942625|12552559|12226795|11826028|10980530|10677309|10571946|10425038|9887333|9463314|9259193|9054948|9054927|8976369|8365732|7836845|7792600|7124732|4515676|4132004|3788973|3785360|3574400|3496017|2916583|2253179|2136770|2005780|1961222|1377828|1304718|311128|310962	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HP16;MC58;MH43	472	ATM	C39	EX40	.	.	no-change	NM_000051.3	NP_000042.3	+	Y	c.5948G=	.	.	.	NM_000051.3(ATM): c.5948G=	;clinically-assoc,submitted-by-lsdb	126316	1.000000	U	1	1	.	.	PASS	4327	8654	1.000000	60654	121308	1.000000	8624	17248	1.00000e+00	123057	246114	1.00000e+00	rs659243	.	.	.	-0.119	-0.585	-0.191	.	.	.	.	.	ENST00000278616: c.5948A>G (p.N1983S)	upper_aerodigestive_tract [head_neck|NS|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	VUO	4590263	.	.	.	.	.	no_record	133627	criteria_provided,_single_submitter	Benign	Benign
11	108183166	108183167	11q22.3	1	nullSample	.	A	ref	A	GA.TA	homo-ref	.	.	.	0	.	.	607585	C	114480(SK);208900(MK);607585(MK)	AD;AR	Ataxia-Telangiectasia	AR	.	Allergy/Immunology/Infectious; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Oncologic	23900766|23612382|23264026|21429505|20301790|19535770|19440741|16864838|16832357|15942625|12552559|12226795|11826028|10980530|10677309|10571946|10425038|9887333|9463314|9259193|9054948|9054927|8976369|8365732|7836845|7792600|7124732|4515676|4132004|3788973|3785360|3574400|3496017|2916583|2253179|2136770|2005780|1961222|1377828|1304718|311128|310962	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HP16;MC58;MH43	472	ATM	C39	EX40	.	.	missense	NM_000051.3	NP_000042.3	+	Y	c.5948G>A	p.S1983N | p.Ser1983Asn	AGT=>AAT	P0=>P0	NM_000051.3(ATM): c.5948G>A (p.S1983N)	;clinically-assoc,submitted-by-lsdb	126316	0.000000	U	1	1	.	.	PASS	0	8654	0.000000	0	121308	0.000000	.	.	.	.	.	.	rs659243	.	.	.	-0.119	-0.585	-0.191	0.61	0.001	0	0.004	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
11	108188266	108188267	11q22.3	0	normal	.	T	ref	T	GA.TT	het-alt	285	0.78	.	1	.	PASS	607585	C	114480(SK);208900(MK);607585(MK)	AD;AR	Ataxia-Telangiectasia	AR	.	Allergy/Immunology/Infectious; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Oncologic	23900766|23612382|23264026|21429505|20301790|19535770|19440741|16864838|16832357|15942625|12552559|12226795|11826028|10980530|10677309|10571946|10425038|9887333|9463314|9259193|9054948|9054927|8976369|8365732|7836845|7792600|7124732|4515676|4132004|3788973|3785360|3574400|3496017|2916583|2253179|2136770|2005780|1961222|1377828|1304718|311128|310962	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HP16;MC58;MH43	472	ATM	IC42	IVS43	.	.	no-change	NM_000051.3	NP_000042.3	+	Y	c.6347+19T=	.	.	.	NM_000051.3(ATM): c.6347+19T=	MixedObserved;	29281	0.993204	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs766810400	.	4024	0.512400	0.164	-0.007	-0.020	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	108188266	108188267	11q22.3	1	normal	.	T	del	.	GA.TT	het-ref	82	0.22	.	2	.	PASS	607585	C	114480(SK);208900(MK);607585(MK)	AD;AR	Ataxia-Telangiectasia	AR	.	Allergy/Immunology/Infectious; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Oncologic	23900766|23612382|23264026|21429505|20301790|19535770|19440741|16864838|16832357|15942625|12552559|12226795|11826028|10980530|10677309|10571946|10425038|9887333|9463314|9259193|9054948|9054927|8976369|8365732|7836845|7792600|7124732|4515676|4132004|3788973|3785360|3574400|3496017|2916583|2253179|2136770|2005780|1961222|1377828|1304718|311128|310962	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HP16;MC58;MH43	472	ATM	IC42	IVS43	.	.	intron	NM_000051.3	NP_000042.3	+	Y	c.6347+19delT	.	.	.	NM_000051.3(ATM): c.6347+19delT	MixedObserved;	29281	0.006796	U	.	.	.	.	InbreedingCoeff_Filter	0	6358	0.280591	470	91512	0.317794	.	.	.	.	.	.	rs766810400	.	4024	0.487600	0.164	-0.007	-0.020	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	522241	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
11	108196712	108196715	11q22.3	0	normal	.	ATT	ref	ATT	TC.AT	het-alt	117	0.52	.	1	.	PASS	607585	C	114480(SK);208900(MK);607585(MK)	AD;AR	Ataxia-Telangiectasia	AR	.	Allergy/Immunology/Infectious; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Oncologic	23900766|23612382|23264026|21429505|20301790|19535770|19440741|16864838|16832357|15942625|12552559|12226795|11826028|10980530|10677309|10571946|10425038|9887333|9463314|9259193|9054948|9054927|8976369|8365732|7836845|7792600|7124732|4515676|4132004|3788973|3785360|3574400|3496017|2916583|2253179|2136770|2005780|1961222|1377828|1304718|311128|310962	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HP16;MC58;MH43	472	ATM	IC45	IVS46	.	.	no-change	NM_000051.3	NP_000042.3	+	Y	c.6808-72_6808-70=	.	.	.	NM_000051.3(ATM): c.6808-72_6808-70=	MixedObserved;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.515176	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3212322	.	4024	0.581500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	108196712	108196715	11q22.3	0	normal	.	ATT	del	.	TC.AT	het-ref	109	0.48	.	2	.	PASS	607585	C	114480(SK);208900(MK);607585(MK)	AD;AR	Ataxia-Telangiectasia	AR	.	Allergy/Immunology/Infectious; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Oncologic	23900766|23612382|23264026|21429505|20301790|19535770|19440741|16864838|16832357|15942625|12552559|12226795|11826028|10980530|10677309|10571946|10425038|9887333|9463314|9259193|9054948|9054927|8976369|8365732|7836845|7792600|7124732|4515676|4132004|3788973|3785360|3574400|3496017|2916583|2253179|2136770|2005780|1961222|1377828|1304718|311128|310962	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HP16;MC58;MH43	472	ATM	IC45	IVS46	.	.	intron	NM_000051.3	NP_000042.3	+	Y	c.6808-72_6808-70delATT	.	.	.	NM_000051.3(ATM): c.6808-72_6808-70delATT	MixedObserved;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.484824	U	0.4157	0.484824	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3212322	.	4024	0.418500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	108225482	108225483	11q22.3	0	normal	.	C	ref	C	TA.GT	het-alt	156	0.57	.	1	.	PASS	607585	C	114480(SK);208900(MK);607585(MK)	AD;AR	Ataxia-Telangiectasia	AR	.	Allergy/Immunology/Infectious; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Oncologic	23900766|23612382|23264026|21429505|20301790|19535770|19440741|16864838|16832357|15942625|12552559|12226795|11826028|10980530|10677309|10571946|10425038|9887333|9463314|9259193|9054948|9054927|8976369|8365732|7836845|7792600|7124732|4515676|4132004|3788973|3785360|3574400|3496017|2916583|2253179|2136770|2005780|1961222|1377828|1304718|311128|310962	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HP16;MC58;MH43	472	ATM	IC59	IVS60	.	.	no-change	NM_000051.3	NP_000042.3	+	Y	c.8787-55C=	.	.	.	NM_000051.3(ATM): c.8787-55C=	;maf-5-some-pop,maf-5-all-pops	5008	0.464856	U	0.4345	0.535144	4566	0.481822	.	.	.	.	.	.	.	.	.	.	.	.	.	rs664982	.	4024	0.562900	-1.376	-1.200	-1.292	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	108225482	108225483	11q22.3	0	normal	.	C	snv	T	TA.GT	het-ref	118	0.43	.	2	.	PASS	607585	C	114480(SK);208900(MK);607585(MK)	AD;AR	Ataxia-Telangiectasia	AR	.	Allergy/Immunology/Infectious; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Oncologic	23900766|23612382|23264026|21429505|20301790|19535770|19440741|16864838|16832357|15942625|12552559|12226795|11826028|10980530|10677309|10571946|10425038|9887333|9463314|9259193|9054948|9054927|8976369|8365732|7836845|7792600|7124732|4515676|4132004|3788973|3785360|3574400|3496017|2916583|2253179|2136770|2005780|1961222|1377828|1304718|311128|310962	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HP16;MC58;MH43	472	ATM	IC59	IVS60	.	.	intron	NM_000051.3	NP_000042.3	+	Y	c.8787-55C>T	.	.	.	NM_000051.3(ATM): c.8787-55C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.535144	U	0.4345	0.535144	4566	0.518178	.	.	.	.	.	.	.	.	.	.	.	.	.	rs664982	.	4024	0.437100	-1.376	-1.200	-1.292	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	108225660	108225661	11q22.3	0	normal	.	A	ref	A	TC.TC	het-alt	102	0.52	.	1	.	PASS	607585	C	114480(SK);208900(MK);607585(MK)	AD;AR	Ataxia-Telangiectasia	AR	.	Allergy/Immunology/Infectious; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Oncologic	23900766|23612382|23264026|21429505|20301790|19535770|19440741|16864838|16832357|15942625|12552559|12226795|11826028|10980530|10677309|10571946|10425038|9887333|9463314|9259193|9054948|9054927|8976369|8365732|7836845|7792600|7124732|4515676|4132004|3788973|3785360|3574400|3496017|2916583|2253179|2136770|2005780|1961222|1377828|1304718|311128|310962	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HP16;MC58;MH43	472	ATM	IC60	IVS61	.	.	no-change	NM_000051.3	NP_000042.3	+	Y	c.8850+60A=	.	.	.	NM_000051.3(ATM): c.8850+60A=	;maf-5-some-pop,maf-5-all-pops	5008	0.371805	U	0.4474	0.628195	4566	0.397722	.	.	.	.	.	.	.	.	.	.	.	.	.	rs664143	.	4024	0.553900	-4.376	-1.904	-2.063	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	108225660	108225661	11q22.3	0	normal	.	A	snv	G	TC.TC	het-ref	94	0.48	.	2	.	PASS	607585	C	114480(SK);208900(MK);607585(MK)	AD;AR	Ataxia-Telangiectasia	AR	.	Allergy/Immunology/Infectious; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Oncologic	23900766|23612382|23264026|21429505|20301790|19535770|19440741|16864838|16832357|15942625|12552559|12226795|11826028|10980530|10677309|10571946|10425038|9887333|9463314|9259193|9054948|9054927|8976369|8365732|7836845|7792600|7124732|4515676|4132004|3788973|3785360|3574400|3496017|2916583|2253179|2136770|2005780|1961222|1377828|1304718|311128|310962	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HP16;MC58;MH43	472	ATM	IC60	IVS61	.	.	intron	NM_000051.3	NP_000042.3	+	Y	c.8850+60A>G	.	.	.	NM_000051.3(ATM): c.8850+60A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.628195	U	0.4474	0.628195	4566	0.602278	.	.	.	.	.	.	.	.	.	.	.	.	.	rs664143	.	4024	0.446100	-4.376	-1.904	-2.063	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	117079625	117079626	11q23.3	0	normal	.	G	ref	G	GC.GG	het-alt	331	0.89	.	1	dup	DUBIOUS	604872	P	.	NN	.	.	.	.	.	.	.	9159	PCSK7	C11	EX13	Proprotein convertase P-domain	PF01483.15	no-change	NM_004716.2	NP_004707.2	-	Y	c.1678C=	.	.	.	NM_004716.2(PCSK7): c.1678C=	MixedObserved,SingleClassTriAllelic;	97528	0.989593	U	.	.	.	.	PASS	.	5800	0.976724	47749	97528	0.989593	.	.	.	.	.	.	rs202038275	.	4024	0.983600	-0.362	1.519	1.207	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	117079625	117079626	11q23.3	1	normal	.	G	snv	C	GC.GG	het-ref	39	0.11	.	2	dup	DUBIOUS	604872	P	.	NN	.	.	.	.	.	.	.	9159	PCSK7	C11	EX13	Proprotein convertase P-domain	PF01483.15	missense	NM_004716.2	NP_004707.2	-	Y	c.1678C>G	p.R560G | p.Arg560Gly	CGC=>GGC	P+=>P0	NM_004716.2(PCSK7): c.1678C>G (p.R560G)	MixedObserved,SingleClassTriAllelic;	97528	0.010397	U	.	.	.	.	PASS	0	5800	0.023276	0	97528	0.010397	0	45	2.81426e-03	0	356	1.52444e-03	rs202038275	.	4024	0.016400	-0.362	1.519	1.207	0	0.996	1	0.906	deleterious	ENST00000320934: c.1678C>G (p.R560G)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4597599	.	.	.	.	.	.	.	.	.	VUS
11	118369265	118369266	11q23.3	0	normal	.	A	ref	A	TT.AA	het-alt	108	0.66	.	1	.	PASS	159555	C	159555(ML);605130(MK)	AD	.	.	.	.	.	.	.	4297	MLL	IC22	IVS22	.	.	no-change	NM_001197104.1	NP_001184033.1	+	Y	c.5961+23A=	.	.	.	NM_001197104.1(MLL): c.5961+23A=	MixedObserved,SingleAlleleFreq;|MixedObserved;	414|0	1.000000|0	U	.	.	12508	0.573073	.	.	.	.	.	.	.	.	.	.	.	.	.	rs524616|rs782131394	.	4024	0.540800	-1.020	-1.626	-2.254	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	118369265	118369266	11q23.3	0	normal	.	A	ref	A	TT.AA	het-alt	108	0.66	.	1	.	PASS	159555	C	159555(ML);605130(MK)	AD	.	.	.	.	.	.	.	4297	MLL	IC22	IVS22	.	.	no-change	NM_005933.3	NP_005924.2	+	N	c.5952+23A=	.	.	.	NM_005933.3(MLL): c.5952+23A=	MixedObserved,SingleAlleleFreq;|MixedObserved;	414|0	1.000000|0	U	.	.	12508	0.573073	.	.	.	.	.	.	.	.	.	.	.	.	.	rs524616|rs782131394	.	4024	0.540800	-1.020	-1.626	-2.254	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	118369265	118369266	11q23.3	0	normal	.	A	del	.	TT.AA	het-ref	55	0.34	.	2	.	PASS	159555	C	159555(ML);605130(MK)	AD	.	.	.	.	.	.	.	4297	MLL	IC22	IVS22	.	.	intron	NM_001197104.1	NP_001184033.1	+	Y	c.5961+23delA	.	.	.	NM_001197104.1(MLL): c.5961+23delA	MixedObserved;	0	0	U	.	.	12508	0.254157	InbreedingCoeff_Filter	0	7798	0.476019	0	105868	0.399847	.	.	.	.	.	.	rs782131394	.	4024	0.458500	-1.020	-1.626	-2.254	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	118369265	118369266	11q23.3	0	normal	.	A	del	.	TT.AA	het-ref	55	0.34	.	2	.	PASS	159555	C	159555(ML);605130(MK)	AD	.	.	.	.	.	.	.	4297	MLL	IC22	IVS22	.	.	intron	NM_005933.3	NP_005924.2	+	N	c.5952+23delA	.	.	.	NM_005933.3(MLL): c.5952+23delA	MixedObserved;	0	0	U	.	.	12508	0.254157	InbreedingCoeff_Filter	0	7798	0.476019	0	105868	0.399847	.	.	.	.	.	.	rs782131394	.	4024	0.458500	-1.020	-1.626	-2.254	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	119144791	119144792	11q23.3	0	normal	.	T	ref	T	GC.tt	het-alt	52	0.54	.	1	AT_rich|Low_complexity|Low_complexity|+|23	PASS	165360	C	613563(MK)	NN	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Oncologic	20694012|20543203	.	867	CBL	IC4	IVS4	.	.	no-change	NM_005188.3	NP_005179.2	+	Y	c.747+58T=	.	.	.	NM_005188.3(CBL): c.747+58T=	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs373788107	.	4024	0.642100	0.335	1.894	0.733	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	119144791	119144792	11q23.3	0	normal	.	T	del	.	GC.tt	het-ref	45	0.46	.	2	AT_rich|Low_complexity|Low_complexity|+|23	PASS	165360	C	613563(MK)	NN	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Oncologic	20694012|20543203	.	867	CBL	IC4	IVS4	.	.	intron	NM_005188.3	NP_005179.2	+	Y	c.747+58delT	.	.	.	NM_005188.3(CBL): c.747+58delT	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs373788107	.	4024	0.357900	0.335	1.894	0.733	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	119145462	119145463	11q23.3	0	normal	.	G	ref	G	TT.TT	het-alt	105	0.82	.	1	.	PASS	165360	C	613563(MK)	NN	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Oncologic	20694012|20543203	.	867	CBL	IC4	IVS4	.	.	no-change	NM_005188.3	NP_005179.2	+	Y	c.748-79G=	.	.	.	NM_005188.3(CBL): c.748-79G=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.366	0.147	0.049	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
11	119145463	119145463	11q23.3	0	normal	.	.	ins	T	TG.TT	het-ref	23	0.18	.	2	.	PASS	165360	C	613563(MK)	NN	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Oncologic	20694012|20543203	.	867	CBL	IC4	IVS4	.	.	intron	NM_005188.3	NP_005179.2	+	Y	c.748-79_748-78insT	.	.	.	NM_005188.3(CBL): c.748-79_748-78insT	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs367590251	.	4024	0.256500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	119145704	119145705	11q23.3	0	nullSample	.	G	ref	G	TC.TT	homo-ref	.	.	.	0	.	.	165360	C	613563(MK)	NN	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Oncologic	20694012|20543203	.	867	CBL	IC5	IVS5	.	.	no-change	NM_005188.3	NP_005179.2	+	Y	c.869+42G=	.	.	.	NM_005188.3(CBL): c.869+42G=	SingleClassTriAllelic;	80918	0.999852	U	0.5139	0.383986	.	.	PASS	-1082	8596	0.511168	28013	121084	0.668181	.	.	.	.	.	.	rs756156834	.	.	.	-0.253	-1.512	-1.731	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	119145705	119145705	11q23.3	0	normal	.	.	ins	T	CG.TT	hom-alt	356	1.00	.	0	.	PASS	165360	C	613563(MK)	NN	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Oncologic	20694012|20543203	.	867	CBL	IC5	IVS5	.	.	intron	NM_005188.3	NP_005179.2	+	Y	c.869+42_869+43insT	.	.	.	NM_005188.3(CBL): c.869+42_869+43insT	;maf-5-some-pop,maf-5-all-pops	126080	0.333828	U	0.5139	0.383986	12518	0.268573	PASS	1019	8596	0.488832	7645	121084	0.331720	2083	8454	4.91283e-01	14781	79408	3.23204e-01	rs3842642	.	4024	0.499500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	119146658	119146659	11q23.3	0	nullSample	.	G	ref	G	CC.TA	homo-ref	.	.	.	0	.	.	165360	C	613563(MK)	NN	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Oncologic	20694012|20543203	.	867	CBL	IC5	IVS5	.	.	no-change	NM_005188.3	NP_005179.2	+	Y	c.870-48G=	.	.	.	NM_005188.3(CBL): c.870-48G=	SingleClassTriAllelic;maf-5-some-pop	126336	0.391599	U	0.8829	0.731829	12988	0.373576	PASS	-442	8644	0.113142	10922	121328	0.396693	.	.	.	.	.	.	rs2511854	.	4024	0.109800	-0.215	1.030	0.520	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	119146658	119146659	11q23.3	0	normal	.	G	snv	C	CC.TA	hom-alt	300	1.00	.	0	.	PASS	165360	C	613563(MK)	NN	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Oncologic	20694012|20543203	.	867	CBL	IC5	IVS5	.	.	intron	NM_005188.3	NP_005179.2	+	Y	c.870-48G>C	.	.	.	NM_005188.3(CBL): c.870-48G>C	SingleClassTriAllelic;maf-5-some-pop	126336	0.608393	U	0.8829	0.731829	12988	0.626424	PASS	3391	8644	0.886858	23456	121328	0.603298	6724	15228	8.83090e-01	45593	145153	5.89712e-01	rs2511854	.	4024	0.890200	-0.215	1.030	0.520	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	119148572	119148573	11q23.3	0	nullSample	.	G	ref	G	AT.AT	homo-ref	.	.	.	0	.	.	165360	C	613563(MK)	NN	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Oncologic	20694012|20543203	.	867	CBL	IC7	IVS7	.	.	no-change	NM_005188.3	NP_005179.2	+	Y	c.1095+19G=	.	.	.	NM_005188.3(CBL): c.1095+19G=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125958	0.393806	U	0.879	0.728634	12988	0.375423	PASS	.	8630	0.117381	10926	120950	0.398876	.	.	.	.	.	.	rs2510152	.	4024	0.114600	-0.256	0.027	-0.068	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	119148572	119148573	11q23.3	1	normal	.	G	snv	T	AT.AT	hom-alt	327	1.00	.	0	.	PASS	165360	C	613563(MK)	NN	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Oncologic	20694012|20543203	.	867	CBL	IC7	IVS7	.	.	intron	NM_005188.3	NP_005179.2	+	Y	c.1095+19G>T	.	.	.	NM_005188.3(CBL): c.1095+19G>T	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125958	0.606194	U	0.879	0.728634	12988	0.624577	PASS	3353	8630	0.882619	23157	120950	0.601124	6666	15154	8.79717e-01	45063	144256	5.86922e-01	rs2510152	.	4024	0.885400	-0.256	0.027	-0.068	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	55796	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
11	119155617	119155618	11q23.3	0	nullSample	.	G	ref	G	GA.AG	homo-ref	.	.	.	0	.	.	165360	C	613563(MK)	NN	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Oncologic	20694012|20543203	.	867	CBL	IC9	IVS9	.	.	no-change	NM_005188.3	NP_005179.2	+	Y	c.1432-61G=	.	.	.	NM_005188.3(CBL): c.1432-61G=	;maf-5-some-pop,maf-5-all-pops	5008	0.620407	U	0.5119	0.379593	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2298650	.	4024	0.502500	0.650	0.704	1.145	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	119155617	119155618	11q23.3	0	normal	.	G	snv	T	GA.AG	hom-alt	293	0.99	.	0	.	PASS	165360	C	613563(MK)	NN	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Oncologic	20694012|20543203	.	867	CBL	IC9	IVS9	.	.	intron	NM_005188.3	NP_005179.2	+	Y	c.1432-61G>T	.	.	.	NM_005188.3(CBL): c.1432-61G>T	;maf-5-some-pop,maf-5-all-pops	5008	0.379593	U	0.5119	0.379593	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2298650	.	4024	0.497500	0.650	0.704	1.145	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	124739986	124739987	11q24.2	0	normal	.	T	ref	T	CA.TA	het-alt	209	0.53	.	1	.	PASS	608630	C	607313(MK)	NN	Gaze palsy, horizontal, with progressive scoliosis	AR	.	Musculoskeletal; Neurologic	General	21850172|21592015|19633821|18829051|16525029|15105459	.	64221	ROBO3	IC4	IVS4	.	.	no-change	NM_022370.3	NP_071765.2	+	Y	c.766+23T=	.	.	.	NM_022370.3(ROBO3): c.766+23T=	;	120750	0.999967	U	.	.	12502	0.999920	PASS	0	8626	1.000000	60371	120750	0.999967	.	.	.	.	.	.	rs367768485	.	.	.	0.379	0.697	0.651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	124739986	124739987	11q24.2	0	normal	.	T	snv	C	CA.TA	het-ref	188	0.47	.	2	.	PASS	608630	C	607313(MK)	NN	Gaze palsy, horizontal, with progressive scoliosis	AR	.	Musculoskeletal; Neurologic	General	21850172|21592015|19633821|18829051|16525029|15105459	.	64221	ROBO3	IC4	IVS4	.	.	intron	NM_022370.3	NP_071765.2	+	Y	c.766+23T>C	.	.	.	NM_022370.3(ROBO3): c.766+23T>C	;	120750	0.000033	U	.	.	12502	0.000080	PASS	0	8626	0.000000	0	120750	0.000033	0	0	0.00000e+00	0	14	5.68828e-05	rs367768485	.	.	.	0.379	0.697	0.651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
11	124739987	124739988	11q24.2	0	normal	.	T	ref	T	AT.AT	het-alt	205	0.53	.	1	.	PASS	608630	C	607313(MK)	NN	Gaze palsy, horizontal, with progressive scoliosis	AR	.	Musculoskeletal; Neurologic	General	21850172|21592015|19633821|18829051|16525029|15105459	.	64221	ROBO3	IC4	IVS4	.	.	no-change	NM_022370.3	NP_071765.2	+	Y	c.766+24T=	.	.	.	NM_022370.3(ROBO3): c.766+24T=	SingleClassTriAllelic;maf-5-some-pop	125690	0.393977	U	0.3909	0.54353	12496	0.341389	PASS	-984	8592	0.609637	10158	120682	0.391384	.	.	.	.	.	.	rs4936957	.	4024	0.623300	0.379	-0.341	-0.395	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	124739987	124739988	11q24.2	0	normal	.	T	snv	C	AT.AT	het-ref	184	0.47	.	2	.	PASS	608630	C	607313(MK)	NN	Gaze palsy, horizontal, with progressive scoliosis	AR	.	Musculoskeletal; Neurologic	General	21850172|21592015|19633821|18829051|16525029|15105459	.	64221	ROBO3	IC4	IVS4	.	.	intron	NM_022370.3	NP_071765.2	+	Y	c.766+24T>C	.	.	.	NM_022370.3(ROBO3): c.766+24T>C	SingleClassTriAllelic;maf-5-some-pop	125690	0.606015	U	0.3909	0.54353	12496	0.658611	PASS	693	8592	0.390363	23265	120682	0.608608	1314	6570	3.81090e-01	46427	147550	5.99670e-01	rs4936957	.	4024	0.376700	0.379	-0.341	-0.395	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	124740409	124740410	11q24.2	0	normal	.	A	ref	A	TA.GT	het-alt	113	0.50	.	1	.	PASS	608630	C	607313(MK)	NN	Gaze palsy, horizontal, with progressive scoliosis	AR	.	Musculoskeletal; Neurologic	General	21850172|21592015|19633821|18829051|16525029|15105459	.	64221	ROBO3	IC5	IVS5	.	.	no-change	NM_022370.3	NP_071765.2	+	Y	c.906-87A=	.	.	.	NM_022370.3(ROBO3): c.906-87A=	;maf-5-some-pop	5008	0.366613	U	0.3958	0.633387	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3923890	.	4024	0.614800	-0.527	0.174	-0.052	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	124740409	124740410	11q24.2	0	normal	.	A	snv	T	TA.GT	het-ref	112	0.50	.	2	.	PASS	608630	C	607313(MK)	NN	Gaze palsy, horizontal, with progressive scoliosis	AR	.	Musculoskeletal; Neurologic	General	21850172|21592015|19633821|18829051|16525029|15105459	.	64221	ROBO3	IC5	IVS5	.	.	intron	NM_022370.3	NP_071765.2	+	Y	c.906-87A>T	.	.	.	NM_022370.3(ROBO3): c.906-87A>T	;maf-5-some-pop	5008	0.633387	U	0.3958	0.633387	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3923890	.	4024	0.385200	-0.527	0.174	-0.052	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	124742364	124742365	11q24.2	0	normal	.	G	ref	G	GC.TG	het-alt	319	0.51	.	1	.	PASS	608630	C	607313(MK)	NN	Gaze palsy, horizontal, with progressive scoliosis	AR	.	Musculoskeletal; Neurologic	General	21850172|21592015|19633821|18829051|16525029|15105459	.	64221	ROBO3	C8	EX8	Immunoglobulin domain;Immunoglobulin I-set domain;Immunoglobulin V-set domain;Immunoglobulin domain;Immunoglobulin domain	PF00047.20;PF07679.11;PF07686.12;PF13895.1;PF13927.1	no-change	NM_022370.3	NP_071765.2	+	Y	c.1247G=	.	.	.	NM_022370.3(ROBO3): c.1247G=	;maf-5-some-pop,genotype-conflict	125684	0.872991	U	0.2698	0.128794	12734	0.919507	PASS	-799	8590	0.742724	46252	120676	0.873065	.	.	.	.	.	.	rs3862618	.	4024	0.753200	-0.126	0.537	0.728	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	124742364	124742365	11q24.2	1	normal	.	G	snv	A	GC.TG	het-ref	302	0.49	.	2	.	PASS	608630	C	607313(MK)	NN	Gaze palsy, horizontal, with progressive scoliosis	AR	.	Musculoskeletal; Neurologic	General	21850172|21592015|19633821|18829051|16525029|15105459	.	64221	ROBO3	C8	EX8	Immunoglobulin domain;Immunoglobulin I-set domain;Immunoglobulin V-set domain;Immunoglobulin domain;Immunoglobulin domain	PF00047.20;PF07679.11;PF07686.12;PF13895.1;PF13927.1	missense	NM_022370.3	NP_071765.2	+	Y	c.1247G>A	p.R416H | p.Arg416His	CGT=>CAT	P+=>P+	NM_022370.3(ROBO3): c.1247G>A (p.R416H)	;maf-5-some-pop,genotype-conflict	125684	0.127009	U	0.2698	0.128794	12734	0.080493	PASS	306	8590	0.257276	1232	120676	0.126935	557	4361	2.52900e-01	2466	31599	1.28341e-01	rs3862618	.	4024	0.246800	-0.126	0.537	0.728	0.13	0.014	0.235	0.253	neutral	ENST00000397801: c.1247G>A (p.R416H)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3752201	.	.	.	.	.	no_record	303235	criteria_provided,_single_submitter	Benign	Likely Benign
11	124744694	124744695	11q24.2	0	normal	.	T	ref	T	CC.CT	het-alt	112	0.52	.	1	.	PASS	608630	C	607313(MK)	NN	Gaze palsy, horizontal, with progressive scoliosis	AR	.	Musculoskeletal; Neurologic	General	21850172|21592015|19633821|18829051|16525029|15105459	.	64221	ROBO3	C13	EX13	.	.	no-change	NM_022370.3	NP_071765.2	+	Y	c.1963T=	.	.	.	NM_022370.3(ROBO3): c.1963T=	;	74524	0.999973	U	.	.	12254	0.999918	PASS	0	5764	1.000000	37260	74524	0.999973	.	.	.	.	.	.	rs373747570	.	.	.	-0.256	0.996	0.210	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	124744694	124744695	11q24.2	1	normal	.	T	snv	C	CC.CT	het-ref	105	0.48	.	2	.	PASS	608630	C	607313(MK)	NN	Gaze palsy, horizontal, with progressive scoliosis	AR	.	Musculoskeletal; Neurologic	General	21850172|21592015|19633821|18829051|16525029|15105459	.	64221	ROBO3	C13	EX13	.	.	missense	NM_022370.3	NP_071765.2	+	Y	c.1963T>C	p.S655P | p.Ser655Pro	TCT=>CCT	P0=>NP	NM_022370.3(ROBO3): c.1963T>C (p.S655P)	;	74524	0.000027	U	.	.	12254	0.000082	PASS	0	5764	0.000000	0	74524	0.000027	0	0	0.00000e+00	0	11	4.78911e-05	rs373747570	.	.	.	-0.256	0.996	0.210	0.3	0.256	0.767	0.055	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
11	124747836	124747837	11q24.2	0	normal	.	G	ref	G	GC.GG	het-alt	221	0.52	.	1	.	PASS	608630	C	607313(MK)	NN	Gaze palsy, horizontal, with progressive scoliosis	AR	.	Musculoskeletal; Neurologic	General	21850172|21592015|19633821|18829051|16525029|15105459	.	64221	ROBO3	C21	EX21	.	.	no-change	NM_022370.3	NP_071765.2	+	Y	c.2991G=	.	.	.	NM_022370.3(ROBO3): c.2991G=	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	95094	0.323922	U	0.4276	0.631989	11888	0.271198	PASS	.	5800	0.495345	3806	90086	0.321471	.	.	.	.	.	.	rs7933204	.	4024	0.585500	-0.254	-0.930	-0.532	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	124747836	124747837	11q24.2	1	normal	.	G	snv	A	GC.GG	het-ref	207	0.48	.	2	.	PASS	608630	C	607313(MK)	NN	Gaze palsy, horizontal, with progressive scoliosis	AR	.	Musculoskeletal; Neurologic	General	21850172|21592015|19633821|18829051|16525029|15105459	.	64221	ROBO3	C21	EX21	.	.	coding-synon	NM_022370.3	NP_071765.2	+	Y	c.2991G>A	p.(A997=) | p.(Ala997=)	GCG=>GCA	.	NM_022370.3(ROBO3): c.2991G>A (p.(A997=))	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	95094	0.676078	U	0.4276	0.631989	11888	0.728802	PASS	621	5800	0.504655	19889	90086	0.678529	1422	6676	4.16158e-01	44329	137216	6.19788e-01	rs7933204	.	4024	0.414500	-0.254	-0.930	-0.532	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	303262	criteria_provided,_single_submitter	Benign	Likely Benign
11	124750231	124750232	11q24.2	0	nullSample	.	C	ref	C	GC.TG	homo-ref	.	.	.	0	.	.	608630	C	607313(MK)	NN	Gaze palsy, horizontal, with progressive scoliosis	AR	.	Musculoskeletal; Neurologic	General	21850172|21592015|19633821|18829051|16525029|15105459	.	64221	ROBO3	IC26	IVS26	.	.	no-change	NM_022370.3	NP_071765.2	+	Y	c.3959-82C=	.	.	.	NM_022370.3(ROBO3): c.3959-82C=	;maf-5-some-pop	5008	0.102436	U	0.996	0.897564	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4366494	.	4024	0.003000	-1.062	-1.974	-1.770	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	124750231	124750232	11q24.2	0	normal	.	C	snv	T	GC.TG	hom-alt	307	1.00	.	0	.	PASS	608630	C	607313(MK)	NN	Gaze palsy, horizontal, with progressive scoliosis	AR	.	Musculoskeletal; Neurologic	General	21850172|21592015|19633821|18829051|16525029|15105459	.	64221	ROBO3	IC26	IVS26	.	.	intron	NM_022370.3	NP_071765.2	+	Y	c.3959-82C>T	.	.	.	NM_022370.3(ROBO3): c.3959-82C>T	;maf-5-some-pop	5008	0.897564	U	0.996	0.897564	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4366494	.	4024	0.997000	-1.062	-1.974	-1.770	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	124750447	124750453	11q24.2	0	normal	.	CGGAGT	ref	CGGAGT	gc.cg	het-alt	274	0.53	.	1	trf	PASS	608630	C	607313(MK)	NN	Gaze palsy, horizontal, with progressive scoliosis	AR	.	Musculoskeletal; Neurologic	General	21850172|21592015|19633821|18829051|16525029|15105459	.	64221	ROBO3	C27	EX27	.	.	no-change	NM_022370.3	NP_071765.2	+	Y	c.4093_4098=	.	.	.	NM_022370.3(ROBO3): c.4093_4098=	MixedObserved;maf-5-some-pop,maf-5-all-pops	29508	0.629423	U	.	.	11436	0.658797	VQSRTrancheINDEL97.00to99.00	0	396	1.000000	5025	10078	0.998611	.	.	.	.	.	.	rs71859853	.	4024	0.655600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	124750447	124750453	11q24.2	1	normal	.	CGGAGT	del	.	gc.cg	het-ref	241	0.47	.	2	trf	PASS	608630	C	607313(MK)	NN	Gaze palsy, horizontal, with progressive scoliosis	AR	.	Musculoskeletal; Neurologic	General	21850172|21592015|19633821|18829051|16525029|15105459	.	64221	ROBO3	C27	EX27	.	.	cds-del	NM_022370.3	NP_071765.2	+	Y	c.4094GGAGTC[2>1] (std: c.4094GGAGTC[1] alt: c.4100_4105delGGAGTC )	p.R1363_S1364[3>2] (std: p.R1363_S1364[2] alt: p.R1367_S1368del ) | p.Arg1363_Ser1364[3>2] (std: p.Arg1363_Ser1364[2] alt: p.Arg1367_Ser1368del )	.	.	NM_022370.3(ROBO3): c.4094GGAGTC[1] (p.R1363_S1364[2])	MixedObserved;maf-5-some-pop,maf-5-all-pops	29508	0.370577	U	0.378	0.420727	11436	0.341203	PASS	58	1006	0.350895	1614	24500	0.360327	658	3684	3.41998e-01	7705	45882	3.03320e-01	rs71859853	.	4024	0.344400	.	.	.	.	.	.	.	.	ENST00000397801: c.4093_4098delCGGAGT (p.R1367_S1368delRS)	large_intestine [colon|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5825672	.	.	.	.	.	no_record	303279	criteria_provided,_single_submitter	Benign	Benign
11	125514572	125514573	11q24.2	0	normal	.	G	ref	G	CT.AA	het-alt	217	0.52	.	1	.	PASS	603078	P	.	NN	.	.	.	.	.	.	.	1111	CHEK1	IC10	IVS11	.	.	no-change	NM_001114121.2	NP_001107593.1	+	Y	c.1233+35G=	.	.	.	NM_001114121.2(CHEK1): c.1233+35G=	MixedObserved;maf-5-some-pop,maf-5-all-pops,genotype-conflict	124944	0.496927	U	0.4058	0.436102	13000	0.563538	PASS	-1032	8562	0.609671	15080	119936	0.494130	.	.	.	.	.	.	rs521102	.	4024	0.637200	-0.300	0.098	-0.097	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	125514572	125514573	11q24.2	0	normal	.	G	snv	A	CT.AA	het-ref	203	0.48	.	2	.	PASS	603078	P	.	NN	.	.	.	.	.	.	.	1111	CHEK1	IC10	IVS11	.	.	intron	NM_001114121.2	NP_001107593.1	+	Y	c.1233+35G>A	.	.	.	NM_001114121.2(CHEK1): c.1233+35G>A	MixedObserved;maf-5-some-pop,maf-5-all-pops,genotype-conflict	124944	0.503073	U	0.4058	0.436102	13000	0.436462	PASS	639	8562	0.390329	15784	119936	0.505870	1231	6363	3.86386e-01	31406	119119	5.12225e-01	rs521102	.	4024	0.362800	-0.300	0.098	-0.097	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	125525194	125525195	11q24.2	0	nullSample	.	A	ref	A	AG.TT	homo-ref	.	.	.	0	.	.	603078	P	.	NN	.	.	.	.	.	.	.	1111	CHEK1	C12E	EX13	.	.	no-change	NM_001114121.2	NP_001107593.1	+	Y	c.1411A=	.	.	.	NM_001114121.2(CHEK1): c.1411A=	SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	126192	0.026880	U	1	0.985823	13000	0.026154	PASS	.	8654	0.000347	92	121184	0.027405	.	.	.	.	.	.	rs506504	.	4024	0.002000	-0.227	0.026	0.448	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	125525194	125525195	11q24.2	1	normal	.	A	snv	G	AG.TT	hom-alt	390	1.00	.	0	.	PASS	603078	P	.	NN	.	.	.	.	.	.	.	1111	CHEK1	C12E	EX13	.	.	missense	NM_001114121.2	NP_001107593.1	+	Y	c.1411A>G	p.I471V | p.Ile471Val	ATT=>GTT	NP=>NP	NM_001114121.2(CHEK1): c.1411A>G (p.I471V)	SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	126192	0.973120	U	1	0.985823	13000	0.973846	PASS	4324	8654	0.999653	57363	121184	0.972595	8617	17241	9.99594e-01	116453	239299	9.72879e-01	rs506504	.	4024	0.998000	-0.227	0.026	0.448	1	0.001	0	0.000	neutral	.	.	.	.	.	.	.	.	.	.	no_record	496139	criteria_provided,_single_submitter	Benign	Likely Benign
11	134181100	134181101	11q25	0	normal	.	T	ref	T	CA.TG	het-alt	112	0.53	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	112937	GLB1L3	IC13	IVS13	.	.	no-change	NM_001080407.2	NP_001073876.2	+	Y	c.1287+37T=	.	.	.	NM_001080407.2(GLB1L3): c.1287+37T=	;maf-5-some-pop	125206	0.585627	U	0.376	0.304912	12164	0.641565	PASS	.	8586	0.579665	20956	120198	0.581066	.	.	.	.	.	.	rs1144218	.	4024	0.570800	-0.475	-2.026	-2.408	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
11	134181100	134181101	11q25	0	normal	.	T	snv	C	CA.TG	het-ref	99	0.47	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	112937	GLB1L3	IC13	IVS13	.	.	intron	NM_001080407.2	NP_001073876.2	+	Y	c.1287+37T>C	.	.	.	NM_001080407.2(GLB1L3): c.1287+37T>C	;maf-5-some-pop	125206	0.414373	U	0.376	0.304912	12164	0.358435	PASS	746	8586	0.420335	11212	120198	0.418934	1515	7225	4.20254e-01	23622	104297	4.28560e-01	rs1144218	.	4024	0.429200	-0.475	-2.026	-2.408	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	416046	416047	12p13.33	0	normal	.	T	ref	T	GC.TT	het-alt	165	0.76	.	1	.	PASS	180202	P	.	NN	.	.	.	.	.	.	.	5927	KDM5A	IC24	IVS24	.	.	no-change	NM_001042603.1	NP_001036068.1	-	Y	c.4074+65A=	.	.	.	NM_001042603.1(KDM5A): c.4074+65A=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.877500	0.172	0.621	0.606	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	416046	416047	12p13.33	0	normal	.	T	del	.	GC.TT	het-ref	53	0.24	.	2	.	PASS	180202	P	.	NN	.	.	.	.	.	.	.	5927	KDM5A	IC24	IVS24	.	.	intron	NM_001042603.1	NP_001036068.1	-	Y	c.4074+65delA	.	.	.	NM_001042603.1(KDM5A): c.4074+65delA	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.122500	0.172	0.621	0.606	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	418915	418916	12p13.33	0	normal	.	C	ref	C	CT.TA	het-alt	218	0.54	.	1	.	PASS	180202	P	.	NN	.	.	.	.	.	.	.	5927	KDM5A	IC22	IVS22	.	.	no-change	NM_001042603.1	NP_001036068.1	-	Y	c.3378+53G=	.	.	.	NM_001042603.1(KDM5A): c.3378+53G=	;maf-5-some-pop,maf-5-all-pops	5008	0.580671	U	0.5635	0.419329	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4980877	.	4024	0.424500	-0.254	0.733	0.792	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	418915	418916	12p13.33	0	normal	.	C	snv	T	CT.TA	het-ref	184	0.46	.	2	.	PASS	180202	P	.	NN	.	.	.	.	.	.	.	5927	KDM5A	IC22	IVS22	.	.	intron	NM_001042603.1	NP_001036068.1	-	Y	c.3378+53G>A	.	.	.	NM_001042603.1(KDM5A): c.3378+53G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.419329	U	0.5635	0.419329	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4980877	.	4024	0.575500	-0.254	0.733	0.792	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	461597	461598	12p13.33	0	nullSample	.	C	ref	C	TC.AG	homo-ref	.	.	.	0	.	.	180202	P	.	NN	.	.	.	.	.	.	.	5927	KDM5A	IC8	IVS8	.	.	no-change	NM_001042603.1	NP_001036068.1	-	Y	c.1030-108G=	.	.	.	NM_001042603.1(KDM5A): c.1030-108G=	;maf-5-some-pop,maf-5-all-pops	5008	0.353035	U	0.4931	0.646965	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs715230	.	4020	0.503700	0.561	-0.014	-0.215	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	461597	461598	12p13.33	0	normal	.	C	snv	A	TC.AG	hom-alt	262	1.00	.	0	.	PASS	180202	P	.	NN	.	.	.	.	.	.	.	5927	KDM5A	IC8	IVS8	.	.	intron	NM_001042603.1	NP_001036068.1	-	Y	c.1030-108G>T	.	.	.	NM_001042603.1(KDM5A): c.1030-108G>T	;maf-5-some-pop,maf-5-all-pops	5008	0.646965	U	0.4931	0.646965	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs715230	.	4020	0.496300	0.561	-0.014	-0.215	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	463247	463248	12p13.33	0	normal	.	G	ref	G	GC.AC	het-alt	310	0.49	.	1	.	PASS	180202	P	.	NN	.	.	.	.	.	.	.	5927	KDM5A	C8	EX8	PHD-finger	PF00628.24	no-change	NM_001042603.1	NP_001036068.1	-	Y	c.1023C=	.	.	.	NM_001042603.1(KDM5A): c.1023C=	SingleClassTriAllelic;maf-5-some-pop	125734	0.994353	U	0.0486	0.0109824	12072	0.999751	PASS	.	8620	0.934223	59729	120726	0.994574	.	.	.	.	.	.	rs2229352	.	4024	0.929400	-0.469	0.127	0.075	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	463247	463248	12p13.33	1	normal	.	G	snv	C	GC.AC	het-ref	318	0.51	.	2	.	PASS	180202	P	.	NN	.	.	.	.	.	.	.	5927	KDM5A	C8	EX8	PHD-finger	PF00628.24	coding-synon	NM_001042603.1	NP_001036068.1	-	Y	c.1023C>G	p.(V341=) | p.(Val341=)	GTC=>GTG	.	NM_001042603.1(KDM5A): c.1023C>G (p.(V341=))	SingleClassTriAllelic;maf-5-some-pop	125734	0.005631	U	0.0486	0.0109824	12072	0.000249	PASS	21	8620	0.065777	21	120726	0.005409	47	1210	7.01856e-02	49	1447	5.87667e-03	rs2229352	.	4024	0.070600	-0.469	0.127	0.075	.	.	.	.	.	ENST00000399788: c.1023C>G (p.V341V)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4418535	.	.	.	.	.	.	.	.	.	Likely Benign
12	463420	463421	12p13.33	0	normal	.	G	ref	G	at.aa	het-alt	224	0.51	.	1	AT_rich|Low_complexity|Low_complexity|+|53	PASS	180202	P	.	NN	.	.	.	.	.	.	.	5927	KDM5A	IC7	IVS7	.	.	no-change	NM_001042603.1	NP_001036068.1	-	Y	c.871-21C=	.	.	.	NM_001042603.1(KDM5A): c.871-21C=	SingleClassTriAllelic;maf-5-some-pop	102918	0.943178	U	0.0615	0.0571086	11680	0.983818	PASS	.	6200	0.858226	43795	97910	0.944071	.	.	.	.	.	.	rs35769302	.	4024	0.849900	-0.959	-2.001	-2.089	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	463420	463421	12p13.33	0	normal	.	G	snv	T	at.aa	het-ref	217	0.49	.	2	AT_rich|Low_complexity|Low_complexity|+|53	PASS	180202	P	.	NN	.	.	.	.	.	.	.	5927	KDM5A	IC7	IVS7	.	.	intron	NM_001042603.1	NP_001036068.1	-	Y	c.871-21C>A	.	.	.	NM_001042603.1(KDM5A): c.871-21C>A	SingleClassTriAllelic;maf-5-some-pop	102918	0.020628	U	0.0357	0.0171725	11680	0.016182	PASS	12	6200	0.069516	27	97910	0.020805	38	1061	6.99960e-02	77	4383	1.91674e-02	rs35769302	.	4024	0.070600	-0.959	-2.001	-2.089	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	493426	493427	12p13.33	0	normal	.	T	ref	T	cc.gt	het-alt	90	0.59	.	1	MER1B|DNA|hAT-Charlie|+|304	PASS	180202	P	.	NN	.	.	.	.	.	.	.	5927	KDM5A	IC2	IVS2	.	.	no-change	NM_001042603.1	NP_001036068.1	-	Y	c.244-108A=	.	.	.	NM_001042603.1(KDM5A): c.244-108A=	;	5008	0.989018	U	0.0486	0.0109824	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs117908763	.	4020	0.929600	0.248	0.840	0.250	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	493426	493427	12p13.33	0	normal	.	T	snv	C	cc.gt	het-ref	63	0.41	.	2	MER1B|DNA|hAT-Charlie|+|304	PASS	180202	P	.	NN	.	.	.	.	.	.	.	5927	KDM5A	IC2	IVS2	.	.	intron	NM_001042603.1	NP_001036068.1	-	Y	c.244-108A>G	.	.	.	NM_001042603.1(KDM5A): c.244-108A>G	;	5008	0.010982	U	0.0486	0.0109824	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs117908763	.	4020	0.070400	0.248	0.840	0.250	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	498267	498271	12p13.33	0	normal	.	GGGG	ref	GGGG	CC.GG	het-alt	85	0.76	.	1	.	PASS	180202	P	.	NN	.	.	.	.	.	.	.	5927	KDM5A	5U1E	EX1	.	.	no-change	NM_001042603.1	NP_001036068.1	-	Y	c.-14_-11=	.	.	.	NM_001042603.1(KDM5A): c.-14_-11=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs773599992	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
12	498267	498271	12p13.33	0	normal	.	GGGG	del	.	CC.GG	het-ref	27	0.24	.	2	.	PASS	180202	P	.	NN	.	.	.	.	.	.	.	5927	KDM5A	5U1E	EX1	.	.	utr-5	NM_001042603.1	NP_001036068.1	-	Y	c.-25C[15>11] (std: c.-25C[11] alt: c.-14_-11delCCCC )	.	.	.	NM_001042603.1(KDM5A): c.-25C[11]	MixedObserved;	0	0	U	.	.	.	.	VQSRTrancheINDEL99.00to99.50	0	1560	0.019231	1	13856	0.063438	.	.	.	.	.	.	rs773599992	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	939301	939302	12p13.33	0	nullSample	.	A	ref	A	GC.CA	homo-ref	.	.	.	0	.	.	605232	C	201300(MK);614492(MK)	AR	Pseudohypoaldosteronism, type IIC; Neuropathy, hereditary sensory and autonomic, type II	AD/AR	.	Neurologic; Renal	Neurologic; Renal	22934535|22910560|22266938|22080857|22073419|21768522|20323803|18521183|16946995|16636245|16534117|15911806|15060842|11498583|10869238|5455397	.	65125	WNK1	C4	EX4	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	no-change	NM_213655.4	NP_998820.3	+	Y	c.1287A=	.	.	.	NM_213655.4(WNK1): c.1287A=	;maf-5-some-pop,maf-5-all-pops	126368	0.256956	U	0.871	0.69349	13006	0.314470	PASS	.	8648	0.134713	4377	121360	0.254911	.	.	.	.	.	.	rs10774466	.	4024	0.132700	-1.400	-2.298	-3.155	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	939301	939302	12p13.33	1	normal	.	A	snv	G	GC.CA	hom-alt	338	1.00	.	0	.	PASS	605232	C	201300(MK);614492(MK)	AR	Pseudohypoaldosteronism, type IIC; Neuropathy, hereditary sensory and autonomic, type II	AD/AR	.	Neurologic; Renal	Neurologic; Renal	22934535|22910560|22266938|22080857|22073419|21768522|20323803|18521183|16946995|16636245|16534117|15911806|15060842|11498583|10869238|5455397	.	65125	WNK1	C4	EX4	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_213655.4	NP_998820.3	+	Y	c.1287A>G	p.(A429=) | p.(Ala429=)	GCA=>GCG	.	NM_213655.4(WNK1): c.1287A>G (p.(A429=))	;maf-5-some-pop,maf-5-all-pops	126368	0.743044	U	0.871	0.69349	13006	0.685530	PASS	3239	8648	0.865287	34121	121360	0.745089	6480	14954	8.66999e-01	69918	184549	7.49590e-01	rs10774466	.	4024	0.867300	-1.400	-2.298	-3.155	.	.	.	.	.	ENST00000537687: c.1287A>G (p.A429A)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3753538	.	.	.	.	.	no_record	261066	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
12	1022678	1022679	12p13.33	0	normal	.	A	ref	A	TA.TG	het-alt	163	0.52	.	1	.	PASS	600392	P	.	NN	.	.	.	.	.	.	.	5893	RAD52	IC10	IVS11	.	.	no-change	NM_134424.2	NP_602296.2	-	Y	c.1196-61T=	.	.	.	NM_134424.2(RAD52): c.1196-61T=	;maf-5-some-pop,maf-5-all-pops,microattr-tpa	5008	0.625599	U	0.5367	0.374401	4566	0.659658	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6413436	.	.	.	0.459	-1.780	-1.829	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	1022678	1022679	12p13.33	0	normal	.	A	snv	G	TA.TG	het-ref	148	0.48	.	2	.	PASS	600392	P	.	NN	.	.	.	.	.	.	.	5893	RAD52	IC10	IVS11	.	.	intron	NM_134424.2	NP_602296.2	-	Y	c.1196-61T>C	.	.	.	NM_134424.2(RAD52): c.1196-61T>C	;maf-5-some-pop,maf-5-all-pops,microattr-tpa	5008	0.374401	U	0.5367	0.374401	4566	0.340342	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6413436	.	.	.	0.459	-1.780	-1.829	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	1040372	1040373	12p13.33	0	normal	.	T	ref	T	CA.GA	het-alt	174	0.56	.	1	.	PASS	600392	P	.	NN	.	.	.	.	.	.	.	5893	RAD52	IC2	IVS3	.	.	no-change	NM_134424.2	NP_602296.2	-	Y	c.186+13A=	.	.	.	NM_134424.2(RAD52): c.186+13A=	SingleClassTriAllelic;maf-5-some-pop	125784	0.451154	U	0.4623	0.544928	13006	0.448793	PASS	.	8578	0.514222	12645	120776	0.450992	.	.	.	.	.	.	rs7303748	.	.	.	-2.497	-1.529	-1.206	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	1040372	1040373	12p13.33	1	normal	.	T	snv	C	CA.GA	het-ref	137	0.44	.	2	.	PASS	600392	P	.	NN	.	.	.	.	.	.	.	5893	RAD52	IC2	IVS3	.	.	intron	NM_134424.2	NP_602296.2	-	Y	c.186+13A>G	.	.	.	NM_134424.2(RAD52): c.186+13A>G	SingleClassTriAllelic;maf-5-some-pop	125784	0.548838	U	0.4623	0.544928	13006	0.551207	PASS	1006	8578	0.485778	18564	120776	0.549000	1885	8023	4.71886e-01	36537	131692	5.42420e-01	rs7303748	.	.	.	-2.497	-1.529	-1.206	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	1042261	1042262	12p13.33	0	normal	.	A	ref	A	GG.AA	het-alt	102	0.44	.	1	.	PASS	600392	P	.	NN	.	.	.	.	.	.	.	5893	RAD52	I5U1	IVS1	.	.	no-change	NM_134424.2	NP_602296.2	-	Y	c.-18-20T=	.	.	.	NM_134424.2(RAD52): c.-18-20T=	MixedObserved;|MixedObserved;maf-5-some-pop,maf-5-all-pops	48878|34742	0.999918|0.962610	U	0	0.000399361	12518	0.716408	PASS	0	2280	1.000000	21933	43870	0.999954	.	.	.	.	.	.	rs200469868|rs56170870	.	.	.	-1.232	-1.165	-1.221	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	1042261	1042262	12p13.33	0	normal	.	A	del	.	GG.AA	het-ref	130	0.56	.	2	.	PASS	600392	P	.	NN	.	.	.	.	.	.	.	5893	RAD52	I5U1	IVS1	.	.	intron	NM_134424.2	NP_602296.2	-	Y	c.-18-20delT	.	.	.	NM_134424.2(RAD52): c.-18-20delT	MixedObserved;maf-5-some-pop,maf-5-all-pops	34742	0.037390	U	0.3542	0.258986	12518	0.263860	PASS	552	7570	0.402774	3833	103008	0.289744	.	.	.	.	.	.	rs56170870	.	.	.	-1.232	-1.165	-1.221	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	4383157	4383158	12p13.32	0	nullSample	.	T	ref	T	CC.TT	homo-ref	.	.	.	0	.	.	123833	C	615938(MK)	NN	.	.	.	.	.	.	.	894	CCND2	5U1E	EX1	.	.	utr-5	NM_001759.3	NP_001750.1	+	Y	c.-49C>T	.	.	.	NM_001759.3(CCND2): c.-49C>T	;maf-5-some-pop	86272	0.008728	U	1	0.970647	12850	0.023891	PASS	0	5878	0.000000	19	81264	0.007457	.	.	.	.	.	.	rs3217786	.	.	.	-0.320	0.305	-0.014	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	4383157	4383158	12p13.32	0	normal	.	T	snv	C	CC.TT	hom-alt	399	1.00	.	0	.	PASS	123833	C	615938(MK)	NN	.	.	.	.	.	.	.	894	CCND2	5U1E	EX1	.	.	no-change	NM_001759.3	NP_001750.1	+	Y	c.-49C=	.	.	.	NM_001759.3(CCND2): c.-49C=	;maf-5-some-pop	86272	0.991272	U	1	0.970647	12850	0.976109	PASS	2939	5878	1.000000	40045	81264	0.992543	7136	14273	9.99930e-01	98026	197217	9.93767e-01	rs3217786	.	.	.	-0.320	0.305	-0.014	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	4554547	4554548	12p13.32	0	normal	.	G	snv	C	CC.GC	hom-alt	350	1.00	.	0	.	PASS	134921	C	.	NN	.	.	.	.	.	.	.	2251	FGF6	C1	EX1	.	.	no-change	NM_020996.1	NP_066276.2	-	Y	c.189G=	.	.	.	NM_020996.1(FGF6): c.189G=	SingleClassTriAllelic;maf-5-some-pop	126362	0.969413	U	1	0.903155	13006	0.905582	PASS	4322	8646	0.999884	57777	121354	0.972148	8620	17241	9.99942e-01	118280	240554	9.77894e-01	rs7358740	.	.	.	-1.240	-0.278	-1.894	.	.	.	.	.	ENST00000228837: c.189C>G (p.A63A)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4147046	.	.	.	.	.	.	.	.	.	Benign
12	4554547	4554548	12p13.32	1	nullSample	.	G	ref	G	CC.GC	homo-ref	.	.	.	0	.	.	134921	C	.	NN	.	.	.	.	.	.	.	2251	FGF6	C1	EX1	.	.	coding-synon	NM_020996.1	NP_066276.2	-	Y	c.189G>C	p.(A63=) | p.(Ala63=)	GCG=>GCC	.	NM_020996.1(FGF6): c.189G>C (p.(A63=))	SingleClassTriAllelic;maf-5-some-pop	126362	0.030547	U	1	0.903155	13006	0.094418	PASS	.	8646	0.000116	480	121354	0.027811	.	.	.	.	.	.	rs7358740	.	.	.	-1.240	-0.278	-1.894	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
12	12006543	12006544	12p13.2	0	normal	.	G	ref	G	CA.GA	het-alt	342	0.53	.	1	.	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC4	IVS4	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.463+49G=	.	.	.	NM_001987.4(ETV6): c.463+49G=	;maf-5-some-pop,genotype-conflict	125376	0.827375	U	0.3968	0.217252	13006	0.837152	PASS	-1042	8354	0.595882	41778	120368	0.829232	.	.	.	.	.	.	rs17210957	.	.	.	-2.092	-2.283	-2.504	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12006543	12006544	12p13.2	0	normal	.	G	snv	A	CA.GA	het-ref	306	0.47	.	2	.	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC4	IVS4	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.463+49G>A	.	.	.	NM_001987.4(ETV6): c.463+49G>A	;maf-5-some-pop,genotype-conflict	125376	0.172625	U	0.3968	0.217252	13006	0.162848	PASS	646	8354	0.404118	2149	120368	0.170768	1320	6653	3.97194e-01	4614	42416	1.78500e-01	rs17210957	.	.	.	-2.092	-2.283	-2.504	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12007892	12007893	12p13.2	0	normal	.	C	ref	C	AC.TA	het-alt	314	0.51	.	1	.	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC4	IVS4	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.463+1398C=	.	.	.	NM_001987.4(ETV6): c.463+1398C=	;maf-5-some-pop,maf-5-all-pops	5008	0.409145	U	0.8056	0.590855	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2238124	.	.	.	0.467	-0.795	-0.861	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12007892	12007893	12p13.2	0	normal	.	C	snv	G	AC.TA	het-ref	307	0.49	.	2	.	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC4	IVS4	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.463+1398C>G	.	.	.	NM_001987.4(ETV6): c.463+1398C>G	;maf-5-some-pop,maf-5-all-pops	5008	0.590855	U	0.8056	0.590855	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2238124	.	.	.	0.467	-0.795	-0.861	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12009740	12009741	12p13.2	0	nullSample	.	A	ref	A	AG.TC	homo-ref	.	.	.	0	.	.	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC4	IVS4	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.463+3246A=	.	.	.	NM_001987.4(ETV6): c.463+3246A=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.769968	U	0.4673	0.230032	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2238126	.	.	.	-1.783	-0.072	-0.109	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12009740	12009741	12p13.2	0	normal	.	A	snv	G	AG.TC	hom-alt	580	1.00	.	0	.	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC4	IVS4	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.463+3246A>G	.	.	.	NM_001987.4(ETV6): c.463+3246A>G	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.230032	U	0.4673	0.230032	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2238126	.	.	.	-1.783	-0.072	-0.109	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12012052	12012053	12p13.2	0	nullSample	.	G	ref	G	TG.tt	homo-ref	.	.	.	0	.	.	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC4	IVS4	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.463+5558G=	.	.	.	NM_001987.4(ETV6): c.463+5558G=	;maf-5-some-pop	5008	0.035743	U	1	0.964257	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4763729	.	.	.	-1.160	-1.215	-1.296	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12012052	12012053	12p13.2	0	normal	.	G	snv	C	TG.tt	hom-alt	87	1.00	.	0	.	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC4	IVS4	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.463+5558G>C	.	.	.	NM_001987.4(ETV6): c.463+5558G>C	;maf-5-some-pop	5008	0.964257	U	1	0.964257	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4763729	.	.	.	-1.160	-1.215	-1.296	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12012105	12012106	12p13.2	0	nullSample	.	T	ref	T	ct.gc	homo-ref	.	.	.	0	AluY|SINE|Alu|-|311	.	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC4	IVS4	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.463+5611T=	.	.	.	NM_001987.4(ETV6): c.463+5611T=	MixedObserved;maf-5-some-pop	5008	0.079273	U	0.999	0.920727	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10845413	.	.	.	-1.762	-1.084	-1.117	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12012105	12012106	12p13.2	0	normal	.	T	snv	C	ct.gc	hom-alt	74	1.00	.	0	AluY|SINE|Alu|-|311	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC4	IVS4	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.463+5611T>C	.	.	.	NM_001987.4(ETV6): c.463+5611T>C	MixedObserved;maf-5-some-pop	5008	0.920727	U	0.999	0.920727	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10845413	.	.	.	-1.762	-1.084	-1.117	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12012800	12012801	12p13.2	0	nullSample	.	A	ref	A	AC.TT	homo-ref	.	.	.	0	.	.	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC4	IVS4	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.463+6306A=	.	.	.	NM_001987.4(ETV6): c.463+6306A=	;maf-5-some-pop	5008	0.034145	U	1	0.965855	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2855706	.	.	.	-1.595	-0.626	-0.677	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12012800	12012801	12p13.2	0	normal	.	A	snv	G	AC.TT	hom-alt	664	1.00	.	0	.	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC4	IVS4	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.463+6306A>G	.	.	.	NM_001987.4(ETV6): c.463+6306A>G	;maf-5-some-pop	5008	0.965855	U	1	0.965855	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2855706	.	.	.	-1.595	-0.626	-0.677	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12013497	12013498	12p13.2	0	normal	.	C	ref	C	ct.aa	het-alt	275	0.83	.	1	AluSz6|SINE|Alu|+|64	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC4	IVS4	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.463+7003C=	.	.	.	NM_001987.4(ETV6): c.463+7003C=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.205	0.487	0.466	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
12	12013498	12013498	12p13.2	0	normal	.	.	ins	A	tc.aa	het-ref	56	0.17	.	2	AluSz6|SINE|Alu|+|64	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC4	IVS4	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.463+7003_463+7004insA	.	.	.	NM_001987.4(ETV6): c.463+7003_463+7004insA	;	2	0.500000	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11413276	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
12	12013611	12013612	12p13.2	0	nullSample	.	G	ref	G	CT.TT	homo-ref	.	.	.	0	.	.	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC4	IVS4	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.463+7117G=	.	.	.	NM_001987.4(ETV6): c.463+7117G=	;maf-5-some-pop	5008	0.372005	U	0.8016	0.627995	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6488463	.	.	.	-2.337	-2.180	-2.342	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12013611	12013612	12p13.2	0	normal	.	G	snv	A	CT.TT	hom-alt	549	1.00	.	0	.	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC4	IVS4	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.463+7117G>A	.	.	.	NM_001987.4(ETV6): c.463+7117G>A	;maf-5-some-pop	5008	0.627995	U	0.8016	0.627995	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6488463	.	.	.	-2.337	-2.180	-2.342	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12013625	12013626	12p13.2	0	nullSample	.	T	ref	T	TT.CC	homo-ref	.	.	.	0	.	.	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC4	IVS4	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.463+7131T=	.	.	.	NM_001987.4(ETV6): c.463+7131T=	;	5008	0.998602	U	0	0.00139776	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs188896307	.	.	.	0.533	0.448	0.419	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
12	12013626	12013626	12p13.2	0	normal	.	.	ins	C	TT.CC	hom-alt	502	0.99	.	0	.	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC4	IVS4	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.463+7131_463+7132insC	.	.	.	NM_001987.4(ETV6): c.463+7131_463+7132insC	;	4	0.750000	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs71057774	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
12	12016007	12016008	12p13.2	0	nullSample	.	G	ref	G	AC.GT	homo-ref	.	.	.	0	.	.	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC4	IVS4	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.464-6350G=	.	.	.	NM_001987.4(ETV6): c.464-6350G=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.156350	U	0.9048	0.84365	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2238130	.	.	.	-1.396	-1.141	-1.171	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12016007	12016008	12p13.2	0	normal	.	G	snv	A	AC.GT	hom-alt	619	1.00	.	0	.	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC4	IVS4	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.464-6350G>A	.	.	.	NM_001987.4(ETV6): c.464-6350G>A	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.843650	U	0.9048	0.84365	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2238130	.	.	.	-1.396	-1.141	-1.171	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12017284	12017285	12p13.2	0	nullSample	.	T	ref	T	GA.GG	homo-ref	.	.	.	0	.	.	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC4	IVS4	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.464-5073T=	.	.	.	NM_001987.4(ETV6): c.464-5073T=	;	5008	0.005391	U	1	0.994609	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2723843	.	.	.	-3.074	-0.857	-0.685	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12017284	12017285	12p13.2	0	normal	.	T	snv	C	GA.GG	hom-alt	744	1.00	.	0	.	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC4	IVS4	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.464-5073T>C	.	.	.	NM_001987.4(ETV6): c.464-5073T>C	;	5008	0.994609	U	1	0.994609	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2723843	.	.	.	-3.074	-0.857	-0.685	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12017687	12017688	12p13.2	0	normal	.	A	ref	A	TT.AA	het-alt	389	0.83	.	1	.	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC4	IVS4	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.464-4670A=	.	.	.	NM_001987.4(ETV6): c.464-4670A=	;maf-5-some-pop,maf-5-all-pops	5008	0.797324	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs112545930	.	.	.	0.000	0.691	0.633	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
12	12017687	12017688	12p13.2	0	normal	.	A	del	.	TT.AA	het-ref	78	0.17	.	2	.	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC4	IVS4	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.464-4670delA	.	.	.	NM_001987.4(ETV6): c.464-4670delA	;maf-5-some-pop,maf-5-all-pops	5008	0.202676	U	0.1319	0.202676	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs112545930	.	.	.	0.000	0.691	0.633	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12021372	12021373	12p13.2	0	normal	.	T	ref	T	tc.tt	het-alt	135	0.71	.	1	AluSz6|SINE|Alu|-|176	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC4	IVS4	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.464-985T=	.	.	.	NM_001987.4(ETV6): c.464-985T=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs201136765	.	.	.	0.374	0.543	0.526	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
12	12021372	12021373	12p13.2	0	normal	.	T	del	.	tc.tt	het-ref	54	0.29	.	2	AluSz6|SINE|Alu|-|176	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC4	IVS4	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.464-985delT	.	.	.	NM_001987.4(ETV6): c.464-985delT	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs201136765	.	.	.	0.374	0.543	0.526	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
12	12022175	12022176	12p13.2	0	normal	.	A	ref	A	ag.aa	het-alt	175	0.77	.	1	AluY|SINE|Alu|+|301	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC4	IVS4	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.464-182A=	.	.	.	NM_001987.4(ETV6): c.464-182A=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs767077796	.	.	.	0.000	0.000	0.000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
12	12022175	12022176	12p13.2	0	normal	.	A	del	.	ag.aa	het-ref	52	0.23	.	2	AluY|SINE|Alu|+|301	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC4	IVS4	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.464-182delA	.	.	.	NM_001987.4(ETV6): c.464-182delA	MixedObserved,SingleAlleleFreq;|MixedObserved;	2|0	1.000000|0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11302289|rs767077796	.	.	.	0.000	0.000	0.000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
12	12025362	12025363	12p13.2	0	nullSample	.	A	ref	A	GG.GT	homo-ref	.	.	.	0	.	.	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.1009+2460A=	.	.	.	NM_001987.4(ETV6): c.1009+2460A=	;maf-5-some-pop,maf-5-all-pops	5008	0.502995	U	0.6766	0.497005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2739091	.	4024	0.278800	-0.509	0.026	-0.008	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12025362	12025363	12p13.2	0	normal	.	A	snv	C	GG.GT	hom-alt	583	1.00	.	0	.	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.1009+2460A>C	.	.	.	NM_001987.4(ETV6): c.1009+2460A>C	;maf-5-some-pop,maf-5-all-pops	5008	0.497005	U	0.6766	0.497005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2739091	.	4024	0.721200	-0.509	0.026	-0.008	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12025428	12025439	12p13.2	0	nullSample	.	TTTTTTTTTTT	ref	TTTTTTTTTTT	AC.tt	homo-ref	.	.	.	0	AluSz|SINE|Alu|-|301	.	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.1009+2526_1009+2536=	.	.	.	NM_001987.4(ETV6): c.1009+2526_1009+2536=	MixedObserved;maf-5-some-pop	5008	0.155351	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs145195498	.	4024	0.183300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12025428	12025439	12p13.2	0	normal	.	TTTTTTTTTTT	del	.	AC.tt	hom-alt	218	0.99	.	0	AluSz|SINE|Alu|-|301	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.1009+2526_1009+2536delTTTTTTTTTTT	.	.	.	NM_001987.4(ETV6): c.1009+2526_1009+2536delTTTTTTTTTTT	MixedObserved;maf-5-some-pop	5008	0.844649	U	0.9563	0.844649	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs145195498	.	4024	0.815000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12027372	12027374	12p13.2	0	nullSample	.	TA	ref	TA	tg.ta	homo-ref	.	.	.	0	trf;(TA)n|Simple_repeat|Simple_repeat|+|343	.	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.1009+4470_1009+4471=	.	.	.	NM_001987.4(ETV6): c.1009+4470_1009+4471=	MixedObserved;maf-5-some-pop,maf-5-all-pops	5008	0.159145	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs71057776	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
12	12027372	12027374	12p13.2	0	normal	.	TA	del	.	tg.ta	hom-alt	9	1.00	.	0	trf;(TA)n|Simple_repeat|Simple_repeat|+|343	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.1009+4470_1009+4471delTA	.	.	.	NM_001987.4(ETV6): c.1009+4470_1009+4471delTA	MixedObserved;maf-5-some-pop,maf-5-all-pops	5008	0.840855	U	0.9167	0.840855	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs71057776	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12027744	12027745	12p13.2	0	nullSample	.	A	ref	A	GC.GA	homo-ref	.	.	.	0	.	.	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.1009+4842A=	.	.	.	NM_001987.4(ETV6): c.1009+4842A=	;maf-5-some-pop	5008	0.895966	U	0.2222	0.104034	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17818396	.	4024	0.762200	0.113	0.482	0.459	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12027744	12027745	12p13.2	0	normal	.	A	snv	C	GC.GA	hom-alt	85	1.00	.	0	.	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.1009+4842A>C	.	.	.	NM_001987.4(ETV6): c.1009+4842A>C	;maf-5-some-pop	5008	0.104034	U	0.2222	0.104034	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17818396	.	4024	0.237800	0.113	0.482	0.459	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12029747	12029748	12p13.2	0	nullSample	.	G	ref	G	CA.TT	homo-ref	.	.	.	0	.	.	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.1009+6845G=	.	.	.	NM_001987.4(ETV6): c.1009+6845G=	;maf-5-some-pop	5008	0.053315	U	1	0.946685	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2723838	.	4024	0.001500	-0.972	-0.791	-0.815	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12029747	12029748	12p13.2	0	normal	.	G	snv	A	CA.TT	hom-alt	719	1.00	.	0	.	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.1009+6845G>A	.	.	.	NM_001987.4(ETV6): c.1009+6845G>A	;maf-5-some-pop	5008	0.946685	U	1	0.946685	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2723838	.	4024	0.998500	-0.972	-0.791	-0.815	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12030051	12030052	12p13.2	0	nullSample	.	A	ref	A	TT.GG	homo-ref	.	.	.	0	.	.	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.1009+7149A=	.	.	.	NM_001987.4(ETV6): c.1009+7149A=	;maf-5-some-pop	5008	0.063099	U	1	0.936901	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2855710	.	4024	0.001500	-1.544	-0.802	-0.810	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12030051	12030052	12p13.2	0	normal	.	A	snv	C	TT.GG	hom-alt	638	1.00	.	0	.	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.1009+7149A>C	.	.	.	NM_001987.4(ETV6): c.1009+7149A>C	;maf-5-some-pop	5008	0.936901	U	1	0.936901	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2855710	.	4024	0.998500	-1.544	-0.802	-0.810	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12030116	12030117	12p13.2	0	nullSample	.	A	ref	A	TT.TC	homo-ref	.	.	.	0	.	.	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.1009+7214A=	.	.	.	NM_001987.4(ETV6): c.1009+7214A=	;maf-5-some-pop	5008	0.067891	U	1	0.932109	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2739101	.	4024	0.001500	-0.119	0.015	-0.002	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12030116	12030117	12p13.2	0	normal	.	A	snv	G	TT.TC	hom-alt	575	1.00	.	0	.	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.1009+7214A>G	.	.	.	NM_001987.4(ETV6): c.1009+7214A>G	;maf-5-some-pop	5008	0.932109	U	1	0.932109	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2739101	.	4024	0.998500	-0.119	0.015	-0.002	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12030236	12030237	12p13.2	0	normal	.	T	ref	T	AC.tt	het-alt	145	0.55	.	1	AT_rich|Low_complexity|Low_complexity|+|22	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.1010-7142T=	.	.	.	NM_001987.4(ETV6): c.1010-7142T=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.617300	0.491	-1.086	-1.243	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12030236	12030237	12p13.2	0	normal	.	T	del	.	AC.tt	het-ref	117	0.45	.	2	AT_rich|Low_complexity|Low_complexity|+|22	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.1010-7142delT	.	.	.	NM_001987.4(ETV6): c.1010-7142delT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.382700	0.491	-1.086	-1.243	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12030305	12030306	12p13.2	0	nullSample	.	A	ref	A	AA.GA	homo-ref	.	.	.	0	.	.	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.1010-7073A=	.	.	.	NM_001987.4(ETV6): c.1010-7073A=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.228834	U	0.8958	0.771166	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2855711	.	4024	0.141900	-1.334	-0.722	-0.823	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12030305	12030306	12p13.2	0	normal	.	A	snv	G	AA.GA	hom-alt	628	1.00	.	0	.	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.1010-7073A>G	.	.	.	NM_001987.4(ETV6): c.1010-7073A>G	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.771166	U	0.8958	0.771166	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2855711	.	4024	0.858100	-1.334	-0.722	-0.823	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12031464	12031465	12p13.2	0	nullSample	.	A	ref	A	CC.AG	homo-ref	.	.	.	0	.	.	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.1010-5914A=	.	.	.	NM_001987.4(ETV6): c.1010-5914A=	;maf-5-some-pop	5008	0.382588	U	0.6141	0.617412	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2238133	.	4024	0.411000	-2.898	-0.171	-0.190	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12031464	12031465	12p13.2	0	normal	.	A	snv	C	CC.AG	hom-alt	707	1.00	.	0	.	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.1010-5914A>C	.	.	.	NM_001987.4(ETV6): c.1010-5914A>C	;maf-5-some-pop	5008	0.617412	U	0.6141	0.617412	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2238133	.	4024	0.589000	-2.898	-0.171	-0.190	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12031758	12031759	12p13.2	0	normal	.	G	ref	G	GA.GG	het-alt	112	0.80	.	1	.	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.1010-5620G=	.	.	.	NM_001987.4(ETV6): c.1010-5620G=	MixedObserved;	2|0	0.500000|0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs61921363|rs761493935	.	4024	0.932200	-0.474	-1.557	-1.542	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12031758	12031759	12p13.2	0	normal	.	G	del	.	GA.GG	het-ref	28	0.20	.	2	.	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.1010-5620delG	.	.	.	NM_001987.4(ETV6): c.1010-5620delG	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs761493935	.	4024	0.067800	-0.474	-1.557	-1.542	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12031760	12031761	12p13.2	0	normal	.	G	ref	G	GG.GA	het-alt	117	0.81	.	1	.	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.1010-5618G=	.	.	.	NM_001987.4(ETV6): c.1010-5618G=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-1.368	-0.724	-0.744	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
12	12031761	12031761	12p13.2	0	normal	.	.	ins	A	GG.GA	het-ref	27	0.19	.	2	.	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.1010-5618_1010-5617insA	.	.	.	NM_001987.4(ETV6): c.1010-5618_1010-5617insA	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.141700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12031761	12031762	12p13.2	0	normal	.	G	ref	G	GG.AA	het-alt	44	0.29	.	1	.	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.1010-5617G=	.	.	.	NM_001987.4(ETV6): c.1010-5617G=	MixedObserved;maf-5-some-pop,maf-5-all-pops	5008	0.261781	U	0.7917	0.738219	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2723818	.	4024	0.342700	0.134	0.553	0.558	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12031761	12031762	12p13.2	0	normal	.	G	snv	A	GG.AA	het-ref	109	0.71	.	2	.	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.1010-5617G>A	.	.	.	NM_001987.4(ETV6): c.1010-5617G>A	MixedObserved;maf-5-some-pop,maf-5-all-pops	5008	0.738219	U	0.7917	0.738219	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2723818	.	4024	0.657300	0.134	0.553	0.558	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12032965	12032966	12p13.2	0	nullSample	.	T	ref	T	TT.aa	homo-ref	.	.	.	0	.	.	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.1010-4413T=	.	.	.	NM_001987.4(ETV6): c.1010-4413T=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.333	-0.719	-0.783	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
12	12032966	12032966	12p13.2	0	normal	.	.	ins	A	TT.aa	het-alt	36	0.27	.	1	(A)n|Simple_repeat|Simple_repeat|+|29	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.1010-4413_1010-4412insA	.	.	.	NM_001987.4(ETV6): c.1010-4413_1010-4412insA	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs369918913	.	4024	0.034300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
12	12032966	12032966	12p13.2	0	normal	.	.	ins	AA	TT.aa	het-alt	66	0.49	.	2	(A)n|Simple_repeat|Simple_repeat|+|29	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.1010-4413_1010-4412insAA	.	.	.	NM_001987.4(ETV6): c.1010-4413_1010-4412insAA	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs369918913	.	4024	0.202800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12035648	12035649	12p13.2	0	nullSample	.	C	ref	C	aa.ag	homo-ref	.	.	.	0	MIRb|SINE|MIR|-|110	.	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.1010-1730C=	.	.	.	NM_001987.4(ETV6): c.1010-1730C=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.797923	U	0.2708	0.202077	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2710310	.	4024	0.700300	0.650	-0.752	-0.864	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12035648	12035649	12p13.2	0	normal	.	C	snv	T	aa.ag	hom-alt	789	1.00	.	0	MIRb|SINE|MIR|-|110	PASS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.1010-1730C>T	.	.	.	NM_001987.4(ETV6): c.1010-1730C>T	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.202077	U	0.2708	0.202077	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2710310	.	4024	0.299700	0.650	-0.752	-0.864	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12036209	12036210	12p13.2	0	nullSample	.	C	ref	C	TT.tt	homo-ref	.	.	.	0	.	.	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	no-change	NM_001987.4	NP_001978.1	+	Y	c.1010-1169C=	.	.	.	NM_001987.4(ETV6): c.1010-1169C=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.999500	-1.629	-0.423	-0.473	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12036210	12036210	12p13.2	0	normal	.	.	ins	TTCTTCTTTTTTTTTT	TC.tt	hom-alt	3	1.00	.	0	trf	DUBIOUS	600618	C	601626(MK)	NN	.	.	.	.	.	.	.	2120	ETV6	IC5	IVS5	.	.	intron	NM_001987.4	NP_001978.1	+	Y	c.1010-1169_1010-1168insTTCTTCTTTTTTTTTT	.	.	.	NM_001987.4(ETV6): c.1010-1169_1010-1168insTTCTTCTTTTTTTTTT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.002000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
12	12870937	12870938	12p13.1	0	normal	.	G	ref	G	GC.AG	het-alt	352	0.49	.	1	.	PASS	600778	C	610755(MK)	NN	Multiple endocrine neoplasia, type IV	AD	.	Endocrine; Oncologic	Endocrine; Oncologic	22129891|21289244|20824794|20507346|17030811	FC59;H41;H54;H62;H68;HE15;MC58	1027	CDKN1B	C1	EX1	Cyclin-dependent kinase inhibitor	PF02234.14	no-change	NM_004064.3	NP_004055.1	+	Y	c.165G=	.	.	.	NM_004064.3(CDKN1B): c.165G=	;	126366	0.996732	U	0.0208	0.00658946	.	.	PASS	.	8654	0.971920	60303	121358	0.996869	.	.	.	.	.	.	rs16908375	.	4024	0.961700	-0.367	-2.884	-4.041	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	12870937	12870938	12p13.1	1	normal	.	G	snv	A	GC.AG	het-ref	365	0.51	.	2	.	PASS	600778	C	610755(MK)	NN	Multiple endocrine neoplasia, type IV	AD	.	Endocrine; Oncologic	Endocrine; Oncologic	22129891|21289244|20824794|20507346|17030811	FC59;H41;H54;H62;H68;HE15;MC58	1027	CDKN1B	C1	EX1	Cyclin-dependent kinase inhibitor	PF02234.14	coding-synon	NM_004064.3	NP_004055.1	+	Y	c.165G>A	p.(A55=) | p.(Ala55=)	GCG=>GCA	.	NM_004064.3(CDKN1B): c.165G>A (p.(A55=))	;	126366	0.003268	U	0.0208	0.00658946	.	.	PASS	3	8654	0.028080	4	121358	0.003131	4	500	2.89889e-02	7	750	3.04541e-03	rs16908375	.	4024	0.038300	-0.367	-2.884	-4.041	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	239617	criteria_provided,_multiple_submitters,_no_conflicts	Benign	VUS
12	21623121	21623122	12p12.1	0	nullSample	.	T	ref	T	CA.TC	homo-ref	.	.	.	0	dup	.	600537	P	.	NN	.	.	.	.	.	.	.	5965	RECQL	3U1E	EX15E	.	.	no-change	NM_002907.3	NP_002898.2	-	Y	c.*6A=	.	.	.	NM_002907.3(RECQL): c.*6A=	;maf-5-some-pop,maf-5-all-pops	125788	0.574300	U	0.4534	0.369409	12998	0.660409	PASS	.	8628	0.571743	20251	120780	0.571966	.	.	.	.	.	.	rs13035	.	.	.	-0.417	-0.537	-0.597	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	21623121	21623122	12p12.1	0	normal	.	T	snv	G	CA.TC	hom-alt	364	1.00	.	0	dup	DUBIOUS	600537	P	.	NN	.	.	.	.	.	.	.	5965	RECQL	3U1E	EX15E	.	.	utr-3	NM_002907.3	NP_002898.2	-	Y	c.*6A>C	.	.	.	NM_002907.3(RECQL): c.*6A>C	;maf-5-some-pop,maf-5-all-pops	125788	0.425700	U	0.4534	0.369409	12998	0.339591	PASS	755	8628	0.428257	11559	120780	0.428034	1476	7245	4.24180e-01	23635	105382	4.32930e-01	rs13035	.	.	.	-0.417	-0.537	-0.597	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	21624308	21624309	12p12.1	0	nullSample	.	A	ref	A	TT.AA	homo-ref	.	.	.	0	.	.	600537	P	.	NN	.	.	.	.	.	.	.	5965	RECQL	IC12	IVS13	.	.	no-change	NM_002907.3	NP_002898.2	-	Y	c.1667+53T=	.	.	.	NM_002907.3(RECQL): c.1667+53T=	MixedObserved;maf-5-some-pop,maf-5-all-pops	5008|5006	0.597045|0.693568	U	0.4702	0.402955	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11046076|rs56736899	.	.	.	-0.417	-1.017	-0.819	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	21624308	21624309	12p12.1	0	normal	.	A	snv	T	TT.AA	hom-alt	199	0.97	.	0	.	PASS	600537	P	.	NN	.	.	.	.	.	.	.	5965	RECQL	IC12	IVS13	.	.	intron	NM_002907.3	NP_002898.2	-	Y	c.1667+53T>A	.	.	.	NM_002907.3(RECQL): c.1667+53T>A	MixedObserved;maf-5-some-pop,maf-5-all-pops	5008	0.402955	U	0.4702	0.402955	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11046076	.	.	.	-0.417	-1.017	-0.819	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	21627744	21627745	12p12.1	0	nullSample	.	A	ref	A	TG.TA	homo-ref	.	.	.	0	.	.	600537	P	.	NN	.	.	.	.	.	.	.	5965	RECQL	IC10	IVS11	.	.	no-change	NM_002907.3	NP_002898.2	-	Y	c.1355+30T=	.	.	.	NM_002907.3(RECQL): c.1355+30T=	;maf-5-some-pop	125484	0.574671	U	0.4544	0.363219	13002	0.662206	PASS	.	8598	0.570947	20250	120476	0.572089	.	.	.	.	.	.	rs2159943	.	.	.	0.260	0.609	0.474	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	21627744	21627745	12p12.1	0	normal	.	A	snv	G	TG.TA	hom-alt	409	1.00	.	0	.	PASS	600537	P	.	NN	.	.	.	.	.	.	.	5965	RECQL	IC10	IVS11	.	.	intron	NM_002907.3	NP_002898.2	-	Y	c.1355+30T>C	.	.	.	NM_002907.3(RECQL): c.1355+30T>C	;maf-5-some-pop	125484	0.425329	U	0.4544	0.363219	13002	0.337794	PASS	763	8598	0.429053	11565	120476	0.427911	1561	7398	4.32227e-01	24156	105746	4.36253e-01	rs2159943	.	.	.	0.260	0.609	0.474	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	21628811	21628812	12p12.1	0	nullSample	.	G	ref	G	AT.GT	homo-ref	.	.	.	0	.	.	600537	P	.	NN	.	.	.	.	.	.	.	5965	RECQL	IC7	IVS8	.	.	no-change	NM_002907.3	NP_002898.2	-	Y	c.950-54C=	.	.	.	NM_002907.3(RECQL): c.950-54C=	;	5008	0.013778	U	1	0.986222	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10160843	.	.	.	-1.527	-1.435	-2.116	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	21628811	21628812	12p12.1	0	normal	.	G	snv	A	AT.GT	hom-alt	341	1.00	.	0	.	PASS	600537	P	.	NN	.	.	.	.	.	.	.	5965	RECQL	IC7	IVS8	.	.	intron	NM_002907.3	NP_002898.2	-	Y	c.950-54C>T	.	.	.	NM_002907.3(RECQL): c.950-54C>T	;	5008	0.986222	U	1	0.986222	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10160843	.	.	.	-1.527	-1.435	-2.116	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	21629986	21629987	12p12.1	0	nullSample	.	T	ref	T	TA.GT	homo-ref	.	.	.	0	.	.	600537	P	.	NN	.	.	.	.	.	.	.	5965	RECQL	IC6	IVS7	.	.	no-change	NM_002907.3	NP_002898.2	-	Y	c.868-61A=	.	.	.	NM_002907.3(RECQL): c.868-61A=	;maf-5-some-pop	5008	0.023762	U	1	0.976238	4562	0.026085	.	.	.	.	.	.	.	.	.	.	.	.	.	rs917854	.	.	.	-0.226	0.208	0.106	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	21629986	21629987	12p12.1	0	normal	.	T	snv	C	TA.GT	hom-alt	241	1.00	.	0	.	PASS	600537	P	.	NN	.	.	.	.	.	.	.	5965	RECQL	IC6	IVS7	.	.	intron	NM_002907.3	NP_002898.2	-	Y	c.868-61A>G	.	.	.	NM_002907.3(RECQL): c.868-61A>G	;maf-5-some-pop	5008	0.976238	U	1	0.976238	4562	0.973915	.	.	.	.	.	.	.	.	.	.	.	.	.	rs917854	.	.	.	-0.226	0.208	0.106	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	21639385	21639386	12p12.1	0	normal	.	A	ref	A	TT.AA	het-alt	88	0.81	.	1	.	PASS	600537	P	.	NN	.	.	.	.	.	.	.	5965	RECQL	IC4	IVS5	.	.	no-change	NM_002907.3	NP_002898.2	-	Y	c.501+27T=	.	.	.	NM_002907.3(RECQL): c.501+27T=	MixedObserved;	740|2	0.991892|0.500000	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs369525826|rs78838077	.	.	.	-1.145	-3.569	-3.737	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
12	21639385	21639386	12p12.1	0	normal	.	A	del	.	TT.AA	het-ref	21	0.19	.	2	.	PASS	600537	P	.	NN	.	.	.	.	.	.	.	5965	RECQL	IC4	IVS5	.	.	intron	NM_002907.3	NP_002898.2	-	Y	c.501+27delT	.	.	.	NM_002907.3(RECQL): c.501+27delT	MixedObserved;	740	0.008108	U	.	.	.	.	InbreedingCoeff_Filter	0	4726	0.423614	371	72952	0.446348	.	.	.	.	.	.	rs369525826	.	.	.	-1.145	-3.569	-3.737	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	21644428	21644429	12p12.1	0	normal	.	A	ref	A	GC.AA	het-alt	98	0.61	.	1	.	PASS	600537	P	.	NN	.	.	.	.	.	.	.	5965	RECQL	IC2	IVS3	.	.	no-change	NM_002907.3	NP_002898.2	-	Y	c.214+24T=	.	.	.	NM_002907.3(RECQL): c.214+24T=	;maf-5-some-pop,maf-5-all-pops	5008	0.565495	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs140439673	.	.	.	0.533	2.662	1.596	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
12	21644428	21644429	12p12.1	0	normal	.	A	del	.	GC.AA	het-ref	62	0.39	.	2	.	PASS	600537	P	.	NN	.	.	.	.	.	.	.	5965	RECQL	IC2	IVS3	.	.	intron	NM_002907.3	NP_002898.2	-	Y	c.214+24delT	.	.	.	NM_002907.3(RECQL): c.214+24delT	;maf-5-some-pop,maf-5-all-pops	5008	0.434505	U	0.4385	0.434505	.	.	PASS	0	2752	0.346294	0	41718	0.350137	.	.	.	.	.	.	rs140439673	.	.	.	0.533	2.662	1.596	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	21644666	21644667	12p12.1	0	nullSample	.	G	ref	G	GC.GA	homo-ref	.	.	.	0	.	.	600537	P	.	NN	.	.	.	.	.	.	.	5965	RECQL	IC1	IVS2	.	.	no-change	NM_002907.3	NP_002898.2	-	Y	c.17-17C=	.	.	.	NM_002907.3(RECQL): c.17-17C=	;maf-5-some-pop,maf-5-all-pops	107156	0.535285	U	0.4623	0.373203	13004	0.633344	PASS	-1024	7510	0.530226	13779	102148	0.530798	.	.	.	.	.	.	rs10841834	.	.	.	-0.302	0.830	0.740	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	21644666	21644667	12p12.1	1	normal	.	G	snv	A	GC.GA	hom-alt	379	1.00	.	0	.	PASS	600537	P	.	NN	.	.	.	.	.	.	.	5965	RECQL	IC1	IVS2	.	.	intron	NM_002907.3	NP_002898.2	-	Y	c.17-17C>T	.	.	.	NM_002907.3(RECQL): c.17-17C>T	;maf-5-some-pop,maf-5-all-pops	107156	0.464715	U	0.4623	0.373203	13004	0.366656	PASS	740	7510	0.469774	10633	102148	0.469202	1558	7113	4.49507e-01	22805	99359	4.49661e-01	rs10841834	.	.	.	-0.302	0.830	0.740	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	25348671	25348672	12p12.1	0	nullSample	.	A	ref	A	CT.AA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr12: g.25348671A= (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.514377	U	0.8135	0.485623	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11047887	.	.	.	0.528	-0.612	-0.706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	25348671	25348672	12p12.1	0	normal	.	A	snv	C	CT.AA	hom-alt	198	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr12: g.25348671A>C (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.485623	U	0.8135	0.485623	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11047887	.	.	.	0.528	-0.612	-0.706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	25348775	25348776	12p12.1	0	nullSample	.	T	ref	T	TT.TA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr12: g.25348775T= (intergenic)	;	5008	0.002796	U	1	0.997204	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7979670	.	.	.	-0.752	0.385	0.374	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	25348775	25348776	12p12.1	0	normal	.	T	snv	G	TT.TA	hom-alt	259	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr12: g.25348775T>G (intergenic)	;	5008	0.997204	U	1	0.997204	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7979670	.	.	.	-0.752	0.385	0.374	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	25348815	25348816	12p12.1	0	nullSample	.	C	ref	C	CA.AT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr12: g.25348815C= (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.452276	U	0.8135	0.547724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11047888	.	.	.	0.650	0.355	0.326	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	25348815	25348816	12p12.1	0	normal	.	C	snv	T	CA.AT	hom-alt	184	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr12: g.25348815C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.547724	U	0.8135	0.547724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11047888	.	.	.	0.650	0.355	0.326	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	25358649	25358650	12p12.1	0	nullSample	.	A	ref	A	AT.TC	homo-ref	.	.	.	0	dup	.	190070	C	109800(MK);114480(MK);137215(MK);163200(MK);190070(MK);211980(MK);260350(MK);609942(MK);615278(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Hematologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Hematologic; Oncologic	23885229|22777296|22510777|22211815|21797849|20876176|20602484|20358587|20301365|20301303|19396835|18456719|18042262|17468812|17056636|16474405|16474404	.	3845	KRAS	3U2E	EX6E	.	.	no-change	NM_033360.2	NP_203524.1	-	Y	c.*4200T=	.	.	.	NM_033360.2(KRAS): c.*4200T=	;maf-5-some-pop,maf-5-all-pops	5008	0.451677	U	0.8175	0.548323	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12245	.	.	.	-1.211	0.578	0.460	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	25358649	25358650	12p12.1	0	normal	.	A	snv	T	AT.TC	hom-alt	132	0.99	.	0	dup	PASS	190070	C	109800(MK);114480(MK);137215(MK);163200(MK);190070(MK);211980(MK);260350(MK);609942(MK);615278(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Hematologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Hematologic; Oncologic	23885229|22777296|22510777|22211815|21797849|20876176|20602484|20358587|20301365|20301303|19396835|18456719|18042262|17468812|17056636|16474405|16474404	.	3845	KRAS	3U2E	EX6E	.	.	utr-3	NM_033360.2	NP_203524.1	-	Y	c.*4200T>A	.	.	.	NM_033360.2(KRAS): c.*4200T>A	;maf-5-some-pop,maf-5-all-pops	5008	0.548323	U	0.8175	0.548323	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12245	.	.	.	-1.211	0.578	0.460	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	308059	criteria_provided,_single_submitter	Likely_benign	Benign
12	25358662	25358664	12p12.1	0	nullSample	.	TT	ref	TT	AC.TT	homo-ref	.	.	.	0	dup	.	190070	C	109800(MK);114480(MK);137215(MK);163200(MK);190070(MK);211980(MK);260350(MK);609942(MK);615278(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Hematologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Hematologic; Oncologic	23885229|22777296|22510777|22211815|21797849|20876176|20602484|20358587|20301365|20301303|19396835|18456719|18042262|17468812|17056636|16474405|16474404	.	3845	KRAS	3U2E	EX6E	.	.	no-change	NM_033360.2	NP_203524.1	-	Y	c.*4186_*4187=	.	.	.	NM_033360.2(KRAS): c.*4186_*4187=	;maf-5-some-pop,maf-5-all-pops	4982	0.453633	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs57698689	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
12	25358662	25358664	12p12.1	0	normal	.	TT	del	.	AC.TT	hom-alt	143	1.00	.	0	dup	PASS	190070	C	109800(MK);114480(MK);137215(MK);163200(MK);190070(MK);211980(MK);260350(MK);609942(MK);615278(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Hematologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Hematologic; Oncologic	23885229|22777296|22510777|22211815|21797849|20876176|20602484|20358587|20301365|20301303|19396835|18456719|18042262|17468812|17056636|16474405|16474404	.	3845	KRAS	3U2E	EX6E	.	.	utr-3	NM_033360.2	NP_203524.1	-	Y	c.*4180A[8>6] (std: c.*4180A[6] alt: c.*4186_*4187delAA )	.	.	.	NM_033360.2(KRAS): c.*4180A[6]	;maf-5-some-pop,maf-5-all-pops	4982	0.546367	U	0.8175	0.54353	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs57698689	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	308062	criteria_provided,_single_submitter	Likely_benign	Benign
12	25358827	25358828	12p12.1	0	nullSample	.	T	ref	T	AG.TT	homo-ref	.	.	.	0	dup	.	190070	C	109800(MK);114480(MK);137215(MK);163200(MK);190070(MK);211980(MK);260350(MK);609942(MK);615278(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Hematologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Hematologic; Oncologic	23885229|22777296|22510777|22211815|21797849|20876176|20602484|20358587|20301365|20301303|19396835|18456719|18042262|17468812|17056636|16474405|16474404	.	3845	KRAS	3U2E	EX6E	.	.	no-change	NM_033360.2	NP_203524.1	-	Y	c.*4022A=	.	.	.	NM_033360.2(KRAS): c.*4022A=	;maf-5-some-pop,maf-5-all-pops	5008	0.451677	U	0.8175	0.548323	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12587	.	.	.	0.482	1.588	2.200	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	25358827	25358828	12p12.1	0	normal	.	T	snv	G	AG.TT	hom-alt	150	1.00	.	0	dup	PASS	190070	C	109800(MK);114480(MK);137215(MK);163200(MK);190070(MK);211980(MK);260350(MK);609942(MK);615278(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Hematologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Hematologic; Oncologic	23885229|22777296|22510777|22211815|21797849|20876176|20602484|20358587|20301365|20301303|19396835|18456719|18042262|17468812|17056636|16474405|16474404	.	3845	KRAS	3U2E	EX6E	.	.	utr-3	NM_033360.2	NP_203524.1	-	Y	c.*4022A>C	.	.	.	NM_033360.2(KRAS): c.*4022A>C	;maf-5-some-pop,maf-5-all-pops	5008	0.548323	U	0.8175	0.548323	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12587	.	.	.	0.482	1.588	2.200	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	308064	criteria_provided,_single_submitter	Likely_benign	Benign
12	25368461	25368462	12p12.1	0	nullSample	.	C	ref	C	TC.CT	homo-ref	.	.	.	0	.	.	190070	C	109800(MK);114480(MK);137215(MK);163200(MK);190070(MK);211980(MK);260350(MK);609942(MK);615278(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Hematologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Hematologic; Oncologic	23885229|22777296|22510777|22211815|21797849|20876176|20602484|20358587|20301365|20301303|19396835|18456719|18042262|17468812|17056636|16474405|16474404	.	3845	KRAS	C4E	EX5	Elongation factor Tu GTP binding domain;Ras family	PF00009.22;PF00071.17	no-change	NM_033360.2	NP_203524.1	-	Y	c.483G=	.	.	.	NM_033360.2(KRAS): c.483G=	;	126384	0.000538	U	1	0.997604	13006	0.001461	PASS	0	8654	0.000000	0	121376	0.000461	.	.	.	.	.	.	rs4362222	.	4024	0.001000	-0.332	2.341	1.061	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	25368461	25368462	12p12.1	1	normal	.	C	snv	T	TC.CT	hom-alt	542	1.00	.	0	.	PASS	190070	C	109800(MK);114480(MK);137215(MK);163200(MK);190070(MK);211980(MK);260350(MK);609942(MK);615278(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Hematologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Hematologic; Oncologic	23885229|22777296|22510777|22211815|21797849|20876176|20602484|20358587|20301365|20301303|19396835|18456719|18042262|17468812|17056636|16474405|16474404	.	3845	KRAS	C4E	EX5	Elongation factor Tu GTP binding domain;Ras family	PF00009.22;PF00071.17	coding-synon	NM_033360.2	NP_203524.1	-	Y	c.483G>A	p.(R161=) | p.(Arg161=)	AGG=>AGA	.	NM_033360.2(KRAS): c.483G>A (p.(R161=))	;	126384	0.999462	U	1	0.997604	13006	0.998539	PASS	4327	8654	1.000000	60632	121376	0.999539	8624	17248	1.00000e+00	122932	245955	9.99630e-01	rs4362222	.	4024	0.999000	-0.332	2.341	1.061	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	46538	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
12	25368593	25368594	12p12.1	0	normal	.	T	ref	T	GA.TT	het-alt	96	0.77	.	1	.	PASS	190070	C	109800(MK);114480(MK);137215(MK);163200(MK);190070(MK);211980(MK);260350(MK);609942(MK);615278(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Hematologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Hematologic; Oncologic	23885229|22777296|22510777|22211815|21797849|20876176|20602484|20358587|20301365|20301303|19396835|18456719|18042262|17468812|17056636|16474405|16474404	.	3845	KRAS	IC3	IVS4	.	.	no-change	NM_033360.2	NP_203524.1	-	Y	c.451-100A=	.	.	.	NM_033360.2(KRAS): c.451-100A=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs376992543	.	4024	0.605900	-0.649	-0.548	-0.808	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	25368593	25368594	12p12.1	0	normal	.	T	del	.	GA.TT	het-ref	28	0.23	.	2	.	PASS	190070	C	109800(MK);114480(MK);137215(MK);163200(MK);190070(MK);211980(MK);260350(MK);609942(MK);615278(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Hematologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Hematologic; Oncologic	23885229|22777296|22510777|22211815|21797849|20876176|20602484|20358587|20301365|20301303|19396835|18456719|18042262|17468812|17056636|16474405|16474404	.	3845	KRAS	IC3	IVS4	.	.	intron	NM_033360.2	NP_203524.1	-	Y	c.451-100delA	.	.	.	NM_033360.2(KRAS): c.451-100delA	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs376992543	.	4024	0.394100	-0.649	-0.548	-0.808	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	25408086	25408087	12p12.1	0	nullSample	.	T	ref	T	CA.GG	homo-ref	.	.	.	0	.	.	190070	C	109800(MK);114480(MK);137215(MK);163200(MK);190070(MK);211980(MK);260350(MK);609942(MK);615278(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Hematologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Hematologic; Oncologic	23885229|22777296|22510777|22211815|21797849|20876176|20602484|20358587|20301365|20301303|19396835|18456719|18042262|17468812|17056636|16474405|16474404	.	3845	KRAS	PROM	.	.	.	no-change	NM_033360.2	NP_203524.1	-	Y	c.-181-u4233A=	.	.	.	NM_033360.2(KRAS): c.-181-u4233A=	;maf-5-some-pop,maf-5-all-pops	5008	0.674521	U	0.3919	0.325479	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2955407	.	.	.	-1.382	-0.368	-0.448	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	25408086	25408087	12p12.1	0	normal	.	T	snv	C	CA.GG	hom-alt	368	1.00	.	0	.	PASS	190070	C	109800(MK);114480(MK);137215(MK);163200(MK);190070(MK);211980(MK);260350(MK);609942(MK);615278(MK)	AD;AR	Noonan syndrome; Cardiofaciocutaneous syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Hematologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Hematologic; Oncologic	23885229|22777296|22510777|22211815|21797849|20876176|20602484|20358587|20301365|20301303|19396835|18456719|18042262|17468812|17056636|16474405|16474404	.	3845	KRAS	PROM	.	.	.	promoter	NM_033360.2	NP_203524.1	-	Y	c.-181-u4233A>G	.	.	.	NM_033360.2(KRAS): c.-181-u4233A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.325479	U	0.3919	0.325479	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2955407	.	.	.	-1.382	-0.368	-0.448	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	25421727	25421728	12p12.1	0	nullSample	.	T	ref	T	GG.CT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr12: g.25421727T= (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.252396	U	0.8085	0.747604	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7295034	.	.	.	-0.412	0.058	0.025	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	25421727	25421728	12p12.1	0	normal	.	T	snv	A	GG.CT	hom-alt	221	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr12: g.25421727T>A (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.747604	U	0.8085	0.747604	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7295034	.	.	.	-0.412	0.058	0.025	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	25429739	25429740	12p12.1	0	nullSample	.	G	ref	G	CT.TA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr12: g.25429739G= (intergenic)	;maf-5-some-pop	5008	0.152157	U	0.9276	0.847843	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10743554	.	.	.	-0.187	0.080	0.089	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	25429739	25429740	12p12.1	0	normal	.	G	snv	C	CT.TA	hom-alt	248	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr12: g.25429739G>C (intergenic)	;maf-5-some-pop	5008	0.847843	U	0.9276	0.847843	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10743554	.	.	.	-0.187	0.080	0.089	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	25429767	25429768	12p12.1	0	nullSample	.	A	ref	A	AC.GC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr12: g.25429767A= (intergenic)	;maf-5-some-pop	5008	0.152356	U	0.9276	0.847644	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10743555	.	.	.	-0.478	0.042	0.048	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	25429767	25429768	12p12.1	0	normal	.	A	snv	C	AC.GC	hom-alt	275	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr12: g.25429767A>C (intergenic)	;maf-5-some-pop	5008	0.847644	U	0.9276	0.847644	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10743555	.	.	.	-0.478	0.042	0.048	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	25435214	25435215	12p12.1	0	nullSample	.	T	ref	T	TA.GA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr12: g.25435214T= (intergenic)	SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	5008	0.387780	U	0.6458	0.61222	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4129617	.	.	.	-0.128	-1.370	-1.406	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	25435214	25435215	12p12.1	0	normal	.	T	snv	C	TA.GA	hom-alt	314	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr12: g.25435214T>C (intergenic)	SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	5008	0.612220	U	0.6458	0.61222	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4129617	.	.	.	-0.128	-1.370	-1.406	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	25446672	25446673	12p12.1	0	nullSample	.	T	ref	T	AA.CA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr12: g.25446672T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.437899	U	0.87	0.562101	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7305334	.	.	.	-0.257	0.656	0.418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	25446672	25446673	12p12.1	0	normal	.	T	snv	A	AA.CA	hom-alt	262	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr12: g.25446672T>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.562101	U	0.87	0.562101	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7305334	.	.	.	-0.257	0.656	0.418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	46243405	46243406	12q12	0	normal	.	A	ref	A	CC.GT	het-alt	300	0.51	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	196528	ARID2	C14	EX14	RFX DNA-binding domain	PF02257.10	no-change	NM_152641.2	NP_689854.2	+	Y	c.1759A=	.	.	.	NM_152641.2(ARID2): c.1759A=	;clinically-assoc,submitted-by-lsdb	126304	0.997332	U	0.0238	0.00519169	13006	0.999616	PASS	-124	8640	0.969907	60343	121296	0.997436	.	.	.	.	.	.	rs78128744	.	4024	0.966000	0.533	1.996	1.011	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	46243405	46243406	12q12	1	normal	.	A	snv	G	CC.GT	het-ref	288	0.49	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	196528	ARID2	C14	EX14	RFX DNA-binding domain	PF02257.10	missense	NM_152641.2	NP_689854.2	+	Y	c.1759A>G	p.S587G | p.Ser587Gly	AGT=>GGT	P0=>P0	NM_152641.2(ARID2): c.1759A>G (p.S587G)	;clinically-assoc,submitted-by-lsdb	126304	0.002668	U	0.0238	0.00519169	13006	0.000384	PASS	6	8640	0.030093	6	121296	0.002564	8	500	2.90192e-02	10	632	2.56961e-03	rs78128744	.	4024	0.034000	0.533	1.996	1.011	0.24	0.003	0.002	0.037	neutral	.	.	.	.	.	.	.	.	.	.	no_record	133559	no_assertion_provided	not_provided	VUS
12	46287170	46287172	12q12	0	normal	.	TC	del	.	AT.tc	het-ref	58	0.16	.	2	(TC)n|Simple_repeat|Simple_repeat|+|21	PASS	.	.	.	.	.	.	.	.	.	.	.	196528	ARID2	IC18	IVS18	.	.	intron	NM_152641.2	NP_689854.2	+	Y	c.5148-32_5148-31delTC	.	.	.	NM_152641.2(ARID2): c.5148-32_5148-31delTC	MixedObserved;	10	0.400000	U	.	.	.	.	PASS	0	1572	0.292621	0	34888	0.297380	.	.	.	.	.	.	rs138252675	.	4024	0.491600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	46287170	46287172	12q12	0	normal	.	TC	ref	TC	AT.tc	het-alt	316	0.84	.	1	(TC)n|Simple_repeat|Simple_repeat|+|21	PASS	.	.	.	.	.	.	.	.	.	.	.	196528	ARID2	IC18	IVS18	.	.	no-change	NM_152641.2	NP_689854.2	+	Y	c.5148-32_5148-31=	.	.	.	NM_152641.2(ARID2): c.5148-32_5148-31=	MixedObserved;	10	0.600000	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs138252675	.	4024	0.508400	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	49421178	49421179	12q13.12	0	nullSample	.	G	ref	G	AT.CC	homo-ref	.	.	.	0	.	.	602113	P	147920(MK)	AD	Kabuki syndrome 	AD	.	Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dental; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Renal	23535010|22126750|21882399|21671394|21607748|20711175|15887282|15108197|12002156|11665999|11343317|10190924|8048822|3067577	.	8085	MLL2	IC47	IVS47	.	.	no-change	NM_003482.3	NP_003473.3	-	Y	c.14644-74C=	.	.	.	NM_003482.3(MLL2): c.14644-74C=	;maf-5-some-pop	5008	0.023562	U	1	0.976438	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs833817	.	4020	0.000500	-1.077	-0.311	-0.369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	49421178	49421179	12q13.12	0	normal	.	G	snv	C	AT.CC	hom-alt	270	1.00	.	0	.	PASS	602113	P	147920(MK)	AD	Kabuki syndrome 	AD	.	Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dental; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Renal	23535010|22126750|21882399|21671394|21607748|20711175|15887282|15108197|12002156|11665999|11343317|10190924|8048822|3067577	.	8085	MLL2	IC47	IVS47	.	.	intron	NM_003482.3	NP_003473.3	-	Y	c.14644-74C>G	.	.	.	NM_003482.3(MLL2): c.14644-74C>G	;maf-5-some-pop	5008	0.976438	U	1	0.976438	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs833817	.	4020	0.999500	-1.077	-0.311	-0.369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	49424533	49424534	12q13.12	0	normal	.	G	ref	G	AG.GG	het-alt	302	0.47	.	1	.	PASS	602113	P	147920(MK)	AD	Kabuki syndrome 	AD	.	Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dental; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Renal	23535010|22126750|21882399|21671394|21607748|20711175|15887282|15108197|12002156|11665999|11343317|10190924|8048822|3067577	.	8085	MLL2	C41	EX41	.	.	no-change	NM_003482.3	NP_003473.3	-	Y	c.13689C=	.	.	.	NM_003482.3(MLL2): c.13689C=	;maf-5-some-pop	123838	0.904294	U	0.256	0.122804	12102	0.961907	PASS	.	8572	0.736468	49421	118830	0.905436	.	.	.	.	.	.	rs11168830	.	4024	0.712000	-1.134	-0.428	0.030	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	49424533	49424534	12q13.12	1	normal	.	G	snv	A	AG.GG	het-ref	337	0.53	.	2	.	PASS	602113	P	147920(MK)	AD	Kabuki syndrome 	AD	.	Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dental; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Renal	23535010|22126750|21882399|21671394|21607748|20711175|15887282|15108197|12002156|11665999|11343317|10190924|8048822|3067577	.	8085	MLL2	C41	EX41	.	.	coding-synon	NM_003482.3	NP_003473.3	-	Y	c.13689C>T	p.(P4563=) | p.(Pro4563=)	CCC=>CCT	.	NM_003482.3(MLL2): c.13689C>T (p.(P4563=))	;maf-5-some-pop	123838	0.095706	U	0.256	0.122804	12102	0.038093	PASS	297	8572	0.263532	1243	118830	0.094564	570	4428	2.57083e-01	2873	25091	1.02170e-01	rs11168830	.	4024	0.288000	-1.134	-0.428	0.030	.	.	.	.	.	ENST00000301067: c.13689C>T (p.P4563P)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3753292	.	.	.	.	.	no_record	94169	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
12	49436723	49436724	12q13.12	0	normal	.	A	snv	G	CT.CA	het-ref	144	0.47	.	2	.	PASS	602113	P	147920(MK)	AD	Kabuki syndrome 	AD	.	Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dental; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Renal	23535010|22126750|21882399|21671394|21607748|20711175|15887282|15108197|12002156|11665999|11343317|10190924|8048822|3067577	.	8085	MLL2	IC25	IVS25	.	.	intron	NM_003482.3	NP_003473.3	-	Y	c.5645-63T>C	.	.	.	NM_003482.3(MLL2): c.5645-63T>C	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.302716	U	0.4315	0.302716	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12580349	.	4024	0.412000	0.533	1.131	1.856	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	49436723	49436724	12q13.12	0	normal	.	A	ref	A	CT.CA	het-alt	161	0.53	.	1	.	PASS	602113	P	147920(MK)	AD	Kabuki syndrome 	AD	.	Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dental; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Renal	23535010|22126750|21882399|21671394|21607748|20711175|15887282|15108197|12002156|11665999|11343317|10190924|8048822|3067577	.	8085	MLL2	IC25	IVS25	.	.	no-change	NM_003482.3	NP_003473.3	-	Y	c.5645-63T=	.	.	.	NM_003482.3(MLL2): c.5645-63T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.697284	U	0.4315	0.302716	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12580349	.	4024	0.588000	0.533	1.131	1.856	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	49439658	49439659	12q13.12	0	nullSample	.	C	ref	C	tc.ga	homo-ref	.	.	.	0	MIR3|SINE|MIR|+|217	.	602113	P	147920(MK)	AD	Kabuki syndrome 	AD	.	Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dental; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Renal	23535010|22126750|21882399|21671394|21607748|20711175|15887282|15108197|12002156|11665999|11343317|10190924|8048822|3067577	.	8085	MLL2	IC18	IVS18	.	.	no-change	NM_003482.3	NP_003473.3	-	Y	c.4741+44G=	.	.	.	NM_003482.3(MLL2): c.4741+44G=	;maf-5-some-pop	122908	0.007477	U	1	0.975439	12204	0.021468	PASS	0	8388	0.000000	31	117900	0.006751	.	.	.	.	.	.	rs833818	.	4024	0.001500	-1.062	-1.369	-1.286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	49439658	49439659	12q13.12	0	normal	.	C	snv	T	tc.ga	hom-alt	247	1.00	.	0	MIR3|SINE|MIR|+|217	PASS	602113	P	147920(MK)	AD	Kabuki syndrome 	AD	.	Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dental; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Renal	23535010|22126750|21882399|21671394|21607748|20711175|15887282|15108197|12002156|11665999|11343317|10190924|8048822|3067577	.	8085	MLL2	IC18	IVS18	.	.	intron	NM_003482.3	NP_003473.3	-	Y	c.4741+44G>A	.	.	.	NM_003482.3(MLL2): c.4741+44G>A	;maf-5-some-pop	122908	0.992523	U	1	0.975439	12204	0.978532	PASS	4194	8388	1.000000	58185	117900	0.993249	8538	17076	1.00000e+00	120464	242192	9.94391e-01	rs833818	.	4024	0.998500	-1.062	-1.369	-1.286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	49444544	49444545	12q13.12	0	normal	.	G	ref	G	AT.AT	het-alt	353	0.47	.	1	.	PASS	602113	P	147920(MK)	AD	Kabuki syndrome 	AD	.	Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dental; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Renal	23535010|22126750|21882399|21671394|21607748|20711175|15887282|15108197|12002156|11665999|11343317|10190924|8048822|3067577	.	8085	MLL2	C11	EX11	.	.	no-change	NM_003482.3	NP_003473.3	-	Y	c.2826C=	.	.	.	NM_003482.3(MLL2): c.2826C=	;maf-5-some-pop,maf-5-all-pops	124236	0.619466	U	0.4306	0.403554	12104	0.614590	PASS	-1051	8514	0.583979	23180	119228	0.620433	.	.	.	.	.	.	rs2241726	.	4024	0.591500	-0.360	0.077	-0.059	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	49444544	49444545	12q13.12	1	normal	.	G	snv	A	AT.AT	het-ref	394	0.53	.	2	.	PASS	602113	P	147920(MK)	AD	Kabuki syndrome 	AD	.	Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dental; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Renal	23535010|22126750|21882399|21671394|21607748|20711175|15887282|15108197|12002156|11665999|11343317|10190924|8048822|3067577	.	8085	MLL2	C11	EX11	.	.	coding-synon	NM_003482.3	NP_003473.3	-	Y	c.2826C>T	p.(I942=) | p.(Ile942=)	ATC=>ATT	.	NM_003482.3(MLL2): c.2826C>T (p.(I942=))	;maf-5-some-pop,maf-5-all-pops	124236	0.380534	U	0.4306	0.403554	12104	0.385410	PASS	720	8514	0.416021	8821	119228	0.379567	1515	7227	4.21252e-01	17605	91101	3.74775e-01	rs2241726	.	4024	0.408500	-0.360	0.077	-0.059	.	.	.	.	.	ENST00000301067: c.2015-8C>T (p.?)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	147497	.	.	.	.	.	no_record	94206	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
12	49445308	49445309	12q13.12	0	normal	.	C	ref	C	AG.GG	het-alt	296	0.48	.	1	.	PASS	602113	P	147920(MK)	AD	Kabuki syndrome 	AD	.	Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dental; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Renal	23535010|22126750|21882399|21671394|21607748|20711175|15887282|15108197|12002156|11665999|11343317|10190924|8048822|3067577	.	8085	MLL2	C10	EX10	.	.	no-change	NM_003482.3	NP_003473.3	-	Y	c.2157G=	.	.	.	NM_003482.3(MLL2): c.2157G=	SingleClassTriAllelic,InconsistentAlleles;	117232	0.999991	U	.	.	.	.	PASS	0	8574	1.000000	58615	117232	0.999991	.	.	.	.	.	.	rs568204324	.	.	.	-1.214	-1.781	-1.994	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	49445308	49445309	12q13.12	1	normal	.	C	snv	T	AG.GG	het-ref	316	0.52	.	2	.	PASS	602113	P	147920(MK)	AD	Kabuki syndrome 	AD	.	Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dental; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic; Renal	Cardiovascular; Renal	23535010|22126750|21882399|21671394|21607748|20711175|15887282|15108197|12002156|11665999|11343317|10190924|8048822|3067577	.	8085	MLL2	C10	EX10	.	.	coding-synon	NM_003482.3	NP_003473.3	-	Y	c.2157G>A	p.(P719=) | p.(Pro719=)	CCG=>CCA	.	NM_003482.3(MLL2): c.2157G>A (p.(P719=))	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0.00000e+00	0	3	1.23037e-05	.	.	.	.	-1.214	-1.781	-1.994	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
12	52345497	52345500	12q13.13	0	nullSample	.	GCG	ref	GCG	ct.gc	homo-ref	.	.	.	0	(CGG)n|Simple_repeat|Simple_repeat|+|29	.	601300	C	601300(MK)	NN	.	.	.	.	.	.	.	91	ACVR1B	5U1E	EX1	.	.	no-change	NM_020328.3	NP_064733.3	+	Y	c.-30_-28=	.	.	.	NM_020328.3(ACVR1B): c.-30_-28=	MixedObserved;maf-5-some-pop	5005	0.147453	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10540557	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
12	52345497	52345500	12q13.13	0	normal	.	GCG	del	.	ct.gc	hom-alt	99	1.00	.	0	(CGG)n|Simple_repeat|Simple_repeat|+|29	PASS	601300	C	601300(MK)	NN	.	.	.	.	.	.	.	91	ACVR1B	5U1E	EX1	.	.	utr-5	NM_020328.3	NP_064733.3	+	Y	c.-29CGG[7>6] (std: c.-29CGG[6] alt: c.-11_-9delCGG )	.	.	.	NM_020328.3(ACVR1B): c.-29CGG[6]	MixedObserved;maf-5-some-pop	5005	0.852547	U	0.9742	0.852037	.	.	PASS	237	514	0.957198	2101	5620	0.842705	.	.	.	.	.	.	rs10540557	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	52369299	52369300	12q13.13	0	normal	.	C	ref	C	TG.CC	het-alt	335	0.55	.	1	.	PASS	601300	C	601300(MK)	NN	.	.	.	.	.	.	.	91	ACVR1B	IC2	IVS2	.	.	no-change	NM_020328.3	NP_064733.3	+	Y	c.331+12C=	.	.	.	NM_020328.3(ACVR1B): c.331+12C=	;maf-5-some-pop,maf-5-all-pops	125028	0.711097	U	0.3056	0.29353	13006	0.768645	PASS	-945	8546	0.683361	31356	120020	0.711290	.	.	.	.	.	.	rs2242106	.	4024	0.668500	0.650	0.899	0.633	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	52369299	52369300	12q13.13	1	normal	.	C	snv	T	TG.CC	het-ref	274	0.45	.	2	.	PASS	601300	C	601300(MK)	NN	.	.	.	.	.	.	.	91	ACVR1B	IC2	IVS2	.	.	intron	NM_020328.3	NP_064733.3	+	Y	c.331+12C>T	.	.	.	NM_020328.3(ACVR1B): c.331+12C>T	;maf-5-some-pop,maf-5-all-pops	125028	0.288903	U	0.3056	0.29353	13006	0.231355	PASS	408	8546	0.316639	5997	120020	0.288710	840	5434	3.16335e-01	13701	73239	3.00727e-01	rs2242106	.	4024	0.331500	0.650	0.899	0.633	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	52375021	52375022	12q13.13	0	normal	.	G	ref	G	AG.AT	het-alt	118	0.55	.	1	.	PASS	601300	C	601300(MK)	NN	.	.	.	.	.	.	.	91	ACVR1B	IC4	IVS4	.	.	no-change	NM_020328.3	NP_064733.3	+	Y	c.811+39G=	.	.	.	NM_020328.3(ACVR1B): c.811+39G=	;	123608	0.999919	U	0.001	0.000199681	13006	0.999846	PASS	-3	8608	0.999071	59292	118600	0.999924	.	.	.	.	.	.	rs185863515	.	4024	0.999800	0.655	1.110	0.483	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	52375021	52375022	12q13.13	0	normal	.	G	snv	A	AG.AT	het-ref	96	0.45	.	2	.	PASS	601300	C	601300(MK)	NN	.	.	.	.	.	.	.	91	ACVR1B	IC4	IVS4	.	.	intron	NM_020328.3	NP_064733.3	+	Y	c.811+39G>A	.	.	.	NM_020328.3(ACVR1B): c.811+39G>A	;	123608	0.000081	U	0.001	0.000199681	13006	0.000154	PASS	1	8608	0.000929	1	118600	0.000076	1	17	9.88832e-04	1	20	8.42843e-05	rs185863515	.	4024	0.000200	0.655	1.110	0.483	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
12	52376666	52376667	12q13.13	0	normal	.	T	ref	T	CA.GT	het-alt	130	0.49	.	1	.	PASS	601300	C	601300(MK)	NN	.	.	.	.	.	.	.	91	ACVR1B	IC5	IVS5	.	.	no-change	NM_020328.3	NP_064733.3	+	Y	c.934+75T=	.	.	.	NM_020328.3(ACVR1B): c.934+75T=	;maf-5-some-pop	5008	0.997204	U	0.0139	0.00279553	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs117766220	.	4024	0.980100	0.533	-0.967	-1.045	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	52376666	52376667	12q13.13	0	normal	.	T	snv	C	CA.GT	het-ref	137	0.51	.	2	.	PASS	601300	C	601300(MK)	NN	.	.	.	.	.	.	.	91	ACVR1B	IC5	IVS5	.	.	intron	NM_020328.3	NP_064733.3	+	Y	c.934+75T>C	.	.	.	NM_020328.3(ACVR1B): c.934+75T>C	;maf-5-some-pop	5008	0.002796	U	0.0139	0.00279553	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs117766220	.	4024	0.019900	0.533	-0.967	-1.045	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
12	56477693	56477694	12q13.2	1	normal	.	A	snv	T	TG.GC	het-ref	256	0.46	.	2	.	PASS	190151	C	607598(MK)	NN	Lethal congenital contractural syndrome 2	AR	.	Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Renal	General	17701904|12548738	.	2065	ERBB3	IC2	IVS2	.	.	intron	NM_001982.3	NP_001973.2	+	Y	c.234+8A>T	.	.	.	NM_001982.3(ERBB3): c.234+8A>T	;maf-5-some-pop,maf-5-all-pops	126392	0.616273	U	0.7808	0.592252	13006	0.495541	PASS	2664	8642	0.785929	24096	121384	0.617264	5288	13527	7.84265e-01	50149	154441	6.27172e-01	rs2271194	.	4024	0.759400	-1.147	-1.917	-1.723	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	56477693	56477694	12q13.2	0	normal	.	A	ref	A	TG.GC	het-alt	303	0.54	.	1	.	PASS	190151	C	607598(MK)	NN	Lethal congenital contractural syndrome 2	AR	.	Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Renal	General	17701904|12548738	.	2065	ERBB3	IC2	IVS2	.	.	no-change	NM_001982.3	NP_001973.2	+	Y	c.234+8A=	.	.	.	NM_001982.3(ERBB3): c.234+8A=	;maf-5-some-pop,maf-5-all-pops	126392	0.383727	U	0.7808	0.592252	13006	0.504459	PASS	-732	8642	0.214071	9862	121384	0.382736	.	.	.	.	.	.	rs2271194	.	4024	0.240600	-1.147	-1.917	-1.723	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	56481333	56481334	12q13.2	0	normal	.	C	ref	C	CC.CT	het-alt	193	0.53	.	1	.	PASS	190151	C	607598(MK)	NN	Lethal congenital contractural syndrome 2	AR	.	Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Renal	General	17701904|12548738	.	2065	ERBB3	IC4	IVS4	.	.	no-change	NM_001982.3	NP_001973.2	+	Y	c.548-27C=	.	.	.	NM_001982.3(ERBB3): c.548-27C=	;maf-5-some-pop	126414	0.993822	U	0.0665	0.0141773	.	.	PASS	-254	8652	0.936200	60017	121406	0.994152	.	.	.	.	.	.	rs116960611	.	4024	0.934100	0.655	-0.648	-0.876	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	56481333	56481334	12q13.2	0	normal	.	C	snv	G	CC.CT	het-ref	174	0.47	.	2	.	PASS	190151	C	607598(MK)	NN	Lethal congenital contractural syndrome 2	AR	.	Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Renal	General	17701904|12548738	.	2065	ERBB3	IC4	IVS4	.	.	intron	NM_001982.3	NP_001973.2	+	Y	c.548-27C>G	.	.	.	NM_001982.3(ERBB3): c.548-27C>G	;maf-5-some-pop	126414	0.006178	U	0.0665	0.0141773	.	.	PASS	22	8652	0.063800	24	121406	0.005848	34	1072	6.21521e-02	37	1422	5.77490e-03	rs116960611	.	4024	0.065900	0.655	-0.648	-0.876	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	56487716	56487717	12q13.2	0	normal	.	T	ref	T	GG.GG	het-alt	128	0.72	.	1	.	DUBIOUS	190151	C	607598(MK)	NN	Lethal congenital contractural syndrome 2	AR	.	Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Renal	General	17701904|12548738	.	2065	ERBB3	IC13	IVS13	.	.	no-change	NM_001982.3	NP_001973.2	+	Y	c.1613+37T=	.	.	.	NM_001982.3(ERBB3): c.1613+37T=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.973700	0.402	-0.284	0.069	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	56487716	56487717	12q13.2	0	normal	.	T	snv	G	GG.GG	het-ref	51	0.28	.	2	.	DUBIOUS	190151	C	607598(MK)	NN	Lethal congenital contractural syndrome 2	AR	.	Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Renal	General	17701904|12548738	.	2065	ERBB3	IC13	IVS13	.	.	intron	NM_001982.3	NP_001973.2	+	Y	c.1613+37T>G	.	.	.	NM_001982.3(ERBB3): c.1613+37T>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.026300	0.402	-0.284	0.069	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
12	56492739	56492740	12q13.2	0	normal	.	T	ref	T	tc.tt	het-alt	107	0.77	.	1	trf;AluSq2|SINE|Alu|-|313	PASS	190151	C	607598(MK)	NN	Lethal congenital contractural syndrome 2	AR	.	Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Renal	General	17701904|12548738	.	2065	ERBB3	IC23	IVS23	.	.	no-change	NM_001982.3	NP_001973.2	+	Y	c.2839+51T=	.	.	.	NM_001982.3(ERBB3): c.2839+51T=	MixedObserved;	879	0.852105	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs372817506	.	4025	0.816900	-1.492	-2.256	-2.109	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	56492739	56492740	12q13.2	0	normal	.	T	del	.	tc.tt	het-ref	32	0.23	.	2	trf;AluSq2|SINE|Alu|-|313	PASS	190151	C	607598(MK)	NN	Lethal congenital contractural syndrome 2	AR	.	Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Renal	General	17701904|12548738	.	2065	ERBB3	IC23	IVS23	.	.	intron	NM_001982.3	NP_001973.2	+	Y	c.2839+51delT	.	.	.	NM_001982.3(ERBB3): c.2839+51delT	MixedObserved;	879	0.147895	U	.	.	.	.	PASS	0	1092	0.333333	1	24716	0.329341	.	.	.	.	.	.	rs372817506	.	4025	0.182600	-1.492	-2.256	-2.109	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	58144664	58144665	12q14.1	0	normal	.	C	ref	C	TA.TC	het-alt	242	0.53	.	1	.	PASS	123829	C	609048(SK)	NN	Melanoma, cutaneous malignant, susceptibility to, 3	AD	.	Dermatologic; Oncologic	Dermatologic; Oncologic	23546221|23384855|21801156|15880589|9425228|8528263|7652577	FC59;FH44;H41;H54;H62;H68;HD31;HD32;HP16;MC58;MH43	1019	CDK4	IC3	IVS4	.	.	no-change	NM_000075.3	NP_000066.1	-	Y	c.522+41G=	.	.	.	NM_000075.3(CDK4): c.522+41G=	;maf-5-some-pop	126354	0.646636	U	0.6409	0.336661	13006	0.760418	PASS	.	8636	0.359310	26485	121346	0.645946	.	.	.	.	.	.	rs2069502	.	4024	0.384200	0.655	0.743	0.809	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	58144664	58144665	12q14.1	0	normal	.	C	snv	T	TA.TC	het-ref	215	0.47	.	2	.	PASS	123829	C	609048(SK)	NN	Melanoma, cutaneous malignant, susceptibility to, 3	AD	.	Dermatologic; Oncologic	Dermatologic; Oncologic	23546221|23384855|21801156|15880589|9425228|8528263|7652577	FC59;FH44;H41;H54;H62;H68;HD31;HD32;HP16;MC58;MH43	1019	CDK4	IC3	IVS4	.	.	intron	NM_000075.3	NP_000066.1	-	Y	c.522+41G>A	.	.	.	NM_000075.3(CDK4): c.522+41G>A	;maf-5-some-pop	126354	0.353364	U	0.6409	0.336661	13006	0.239582	PASS	1778	8636	0.640690	8775	121346	0.354054	3508	10974	6.36248e-01	17527	87436	3.55211e-01	rs2069502	.	4024	0.615800	0.655	0.743	0.809	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	64491001	64491002	12q14.2	0	normal	.	G	ref	G	GA.TT	het-alt	105	0.80	.	1	.	PASS	606523	P	.	NN	.	.	.	.	.	.	.	57522	SRGAP1	IC14	IVS14	.	.	no-change	NM_020762.2	NP_065813.1	+	Y	c.1679-19G=	.	.	.	NM_020762.2(SRGAP1): c.1679-19G=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-1.144	-0.946	-1.321	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
12	64491002	64491002	12q14.2	1	normal	.	.	ins	T	AG.TT	het-ref	27	0.20	.	2	.	PASS	606523	P	.	NN	.	.	.	.	.	.	.	57522	SRGAP1	IC14	IVS14	.	.	intron	NM_020762.2	NP_065813.1	+	Y	c.1679-19_1679-18insT	.	.	.	NM_020762.2(SRGAP1): c.1679-19_1679-18insT	MixedObserved;rs-cluster-nonoverlapping-alleles	71558	0.008245	U	.	.	.	.	PASS	0	5714	0.110431	0	82780	0.124656	.	.	.	.	.	.	rs765660234	.	4024	0.108800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	68552041	68552042	12q15	0	normal	.	A	ref	A	CT.AA	het-alt	114	0.47	.	1	.	PASS	147570	C	607948(SK);609135(SK);609423(SK);609532(SK);613254(SK)	NN	.	.	.	.	.	.	.	3458	IFNG	IC1	IVS1	.	.	no-change	NM_000619.2	NP_000610.2	-	Y	c.115-3T=	.	.	.	NM_000619.2(IFNG): c.115-3T=	MixedObserved;	14156	0.989404	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2234686	.	4024	0.708700	-0.146	0.101	0.195	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	68552041	68552042	12q15	1	normal	.	A	del	.	CT.AA	het-ref	129	0.53	.	2	.	PASS	147570	C	607948(SK);609135(SK);609423(SK);609532(SK);613254(SK)	NN	.	.	.	.	.	.	.	3458	IFNG	IC1	IVS1	.	.	intron	NM_000619.2	NP_000610.2	-	Y	c.115-3delT	.	.	.	NM_000619.2(IFNG): c.115-3delT	MixedObserved;	14156	0.010596	U	0.5863	0.625799	.	.	PASS	586	6482	0.583308	9527	91328	0.597309	.	.	.	.	.	.	rs2234686	.	4024	0.291000	-0.146	0.101	0.195	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	402962	criteria_provided,_single_submitter	Benign	Benign
12	69214081	69214082	12q15	0	normal	.	T	ref	T	TA.TT	het-alt	120	0.83	.	1	.	PASS	164785	C	614401(SK)	NN	.	.	.	.	.	.	.	4193	MDM2	IC4	IVS4	.	.	no-change	NM_002392.4	NP_002383.2	+	Y	c.309-23T=	.	.	.	NM_002392.4(MDM2): c.309-23T=	MixedObserved;	6195|2	0.996933|0.500000	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs765244028|rs78856502	.	4024	0.924500	0.300	0.325	0.306	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	69214081	69214082	12q15	0	normal	.	T	del	.	TA.TT	het-ref	24	0.17	.	2	.	PASS	164785	C	614401(SK)	NN	.	.	.	.	.	.	.	4193	MDM2	IC4	IVS4	.	.	intron	NM_002392.4	NP_002383.2	+	Y	c.309-23delT	.	.	.	NM_002392.4(MDM2): c.309-23delT	MixedObserved;	6195	0.003067	U	.	.	.	.	PASS	0	5136	0.069315	0	69880	0.088380	.	.	.	.	.	.	rs765244028	.	4024	0.075500	0.300	0.325	0.306	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	71029732	71029733	12q15	0	normal	.	C	ref	C	AT.CT	het-alt	163	0.58	.	1	.	PASS	176882	P	.	NN	.	.	.	.	.	.	.	5787	PTPRB	C2	EX2	Ricin-type beta-trefoil lectin domain	PF00652.17	no-change	NM_001109754.2	NP_001103224.1	-	Y	c.169G=	.	.	.	NM_001109754.2(PTPRB): c.169G=	;maf-5-some-pop	122294	0.843075	U	0.4028	0.253794	12436	0.891685	PASS	.	8390	0.641836	42949	117286	0.847211	.	.	.	.	.	.	rs2584021	.	4024	0.640700	0.563	1.957	0.714	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	71029732	71029733	12q15	1	normal	.	C	snv	T	AT.CT	het-ref	118	0.42	.	2	.	PASS	176882	P	.	NN	.	.	.	.	.	.	.	5787	PTPRB	C2	EX2	Ricin-type beta-trefoil lectin domain	PF00652.17	missense	NM_001109754.2	NP_001103224.1	-	Y	c.169G>A	p.D57N | p.Asp57Asn	GAT=>AAT	P-=>P0	NM_001109754.2(PTPRB): c.169G>A (p.D57N)	;maf-5-some-pop	122294	0.156925	U	0.4028	0.253794	12436	0.108315	PASS	541	8390	0.358164	2226	117286	0.152789	1052	6054	3.53456e-01	4721	37828	1.54512e-01	rs2584021	.	4024	0.359300	0.563	1.957	0.714	0.36	0.005	0.002	0.020	neutral	ENST00000334414: c.169G>A (p.D57N)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3753481	.	.	.	.	.	.	.	.	.	Likely Benign
12	76449899	76449900	12q21.2	0	nullSample	.	T	ref	T	TC.TT	homo-ref	.	.	.	0	.	.	164060	P	.	NN	.	.	.	.	.	.	.	4673	NAP1L1	C6	EX7	Nucleosome assembly protein (NAP)	PF00956.13	no-change	NM_004537.4	NP_004528.1	-	Y	c.471A=	.	.	.	NM_004537.4(NAP1L1): c.471A=	SingleClassTriAllelic;maf-5-some-pop	125784	0.132751	U	0.999	0.920128	13002	0.142901	PASS	-2	8596	0.000465	1412	120776	0.134944	.	.	.	.	.	.	rs1059143	.	4024	0.002500	-0.748	-0.576	-0.696	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	76449899	76449900	12q21.2	1	normal	.	T	snv	C	TC.TT	hom-alt	408	1.00	.	0	.	PASS	164060	P	.	NN	.	.	.	.	.	.	.	4673	NAP1L1	C6	EX7	Nucleosome assembly protein (NAP)	PF00956.13	coding-synon	NM_004537.4	NP_004528.1	-	Y	c.471A>G	p.(K157=) | p.(Lys157=)	AAA=>AAG	.	NM_004537.4(NAP1L1): c.471A>G (p.(K157=))	SingleClassTriAllelic;maf-5-some-pop	125784	0.867241	U	0.999	0.920128	13002	0.857099	PASS	4294	8596	0.999535	45501	120776	0.865048	8578	17166	9.99418e-01	92049	211707	8.63976e-01	rs1059143	.	4024	0.997500	-0.748	-0.576	-0.696	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
12	115114035	115114036	12q24.21	0	nullSample	.	C	ref	C	CC.TG	homo-ref	.	.	.	0	.	.	601621	C	181450(MK)	AD	Ulnar-Mammary syndrome	AD	.	Cardiovascular; Dental; Endocrine; Genitourinary; Musculoskeletal; Renal	Cardiovascular	21199695|19938096|12668170|12116211|9207801	.	6926	TBX3	IC6	IVS6	.	.	no-change	NM_016569.3	NP_057653.3	-	Y	c.1099+82G=	.	.	.	NM_016569.3(TBX3): c.1099+82G=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.541334	U	0.3661	0.458666	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs551510	.	4024	0.621800	0.563	-0.039	0.006	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	115114035	115114036	12q24.21	0	normal	.	C	snv	T	CC.TG	hom-alt	256	1.00	.	0	.	PASS	601621	C	181450(MK)	AD	Ulnar-Mammary syndrome	AD	.	Cardiovascular; Dental; Endocrine; Genitourinary; Musculoskeletal; Renal	Cardiovascular	21199695|19938096|12668170|12116211|9207801	.	6926	TBX3	IC6	IVS6	.	.	intron	NM_016569.3	NP_057653.3	-	Y	c.1099+82G>A	.	.	.	NM_016569.3(TBX3): c.1099+82G>A	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.458666	U	0.3661	0.458666	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs551510	.	4024	0.378200	0.563	-0.039	0.006	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	115118996	115118997	12q24.21	0	nullSample	.	G	ref	G	CC.TA	homo-ref	.	.	.	0	.	.	601621	C	181450(MK)	AD	Ulnar-Mammary syndrome	AD	.	Cardiovascular; Dental; Endocrine; Genitourinary; Musculoskeletal; Renal	Cardiovascular	21199695|19938096|12668170|12116211|9207801	.	6926	TBX3	IC1	IVS1	.	.	no-change	NM_016569.3	NP_057653.3	-	Y	c.390-46C=	.	.	.	NM_016569.3(TBX3): c.390-46C=	;maf-5-some-pop,maf-5-all-pops	124132	0.511061	U	0.371	0.444888	12974	0.511947	PASS	-990	8546	0.644980	15617	119124	0.509209	.	.	.	.	.	.	rs515746	.	4024	0.621500	-0.254	-0.199	-0.112	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	115118996	115118997	12q24.21	0	normal	.	G	snv	A	CC.TA	hom-alt	376	1.00	.	0	.	PASS	601621	C	181450(MK)	AD	Ulnar-Mammary syndrome	AD	.	Cardiovascular; Dental; Endocrine; Genitourinary; Musculoskeletal; Renal	Cardiovascular	21199695|19938096|12668170|12116211|9207801	.	6926	TBX3	IC1	IVS1	.	.	intron	NM_016569.3	NP_057653.3	-	Y	c.390-46C>T	.	.	.	NM_016569.3(TBX3): c.390-46C>T	;maf-5-some-pop,maf-5-all-pops	124132	0.488939	U	0.371	0.444888	12974	0.488053	PASS	527	8546	0.355020	14520	119124	0.490791	1002	5933	3.48590e-01	29022	117193	4.87971e-01	rs515746	.	4024	0.378500	-0.254	-0.199	-0.112	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	120536798	120536799	12q24.23	0	normal	.	A	ref	A	CC.CC	het-alt	305	0.75	.	1	.	DUBIOUS	.	.	.	.	.	.	.	.	.	.	.	11021	RAB35	IC4	IVS4	.	.	no-change	NM_006861.6	NP_006852.1	-	Y	c.352+35T=	.	.	.	NM_006861.6(RAB35): c.352+35T=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.963500	0.454	-1.515	-1.765	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	120536798	120536799	12q24.23	0	normal	.	A	snv	C	CC.CC	het-ref	100	0.25	.	2	.	DUBIOUS	.	.	.	.	.	.	.	.	.	.	.	11021	RAB35	IC4	IVS4	.	.	intron	NM_006861.6	NP_006852.1	-	Y	c.352+35T>G	.	.	.	NM_006861.6(RAB35): c.352+35T>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.036500	0.454	-1.515	-1.765	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
12	120995331	120995332	12q24.31	0	nullSample	.	G	ref	G	AT.AG	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr12: g.120995331G= (intergenic)	MixedObserved;maf-5-some-pop,maf-5-all-pops	126376	0.385461	U	0.749	0.523363	13006	0.495541	PASS	.	8636	0.228231	10110	121368	0.381699	.	.	.	.	.	.	rs2292681	.	.	.	-0.360	-0.392	-0.317	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	120995331	120995332	12q24.31	0	normal	.	G	snv	A	AT.AG	hom-alt	413	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr12: g.120995331G>A (intergenic)	MixedObserved;maf-5-some-pop,maf-5-all-pops	126376	0.614539	U	0.749	0.523363	13006	0.504459	PASS	2580	8636	0.771769	24468	121368	0.618301	5115	13271	7.69423e-01	50970	155127	6.30341e-01	rs2292681	.	.	.	-0.360	-0.392	-0.317	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	121416621	121416622	12q24.31	0	normal	.	C	ref	C	CT.GA	het-alt	273	0.51	.	1	.	PASS	142410	C	125853(SK);142330(MK);144700(MK);222100(SK);600496(MK);612520(MK)	AD;AR	Renal cell carcinoma, nonpapillary clear cell; Liver adenomatosis; Maturity onset diabetes of the young, type III	AD	Mutations may also cause or be associated with Diabetes mellitus, as in Diabetes mellitus, insulin-dependent, 20 (AD)	Endocrine; Oncologic	Endocrine; Oncologic	22802087|22517943|21683639|21120312|15649945|15001650|14598263|12355088|12050210|11904371|11668618|11575290|11058894|10649494|10482964|9313763|8945470	.	6927	HNF1A	C1	EX1	Hepatocyte nuclear factor 1 (HNF-1), N terminus	PF04814.8	no-change	NM_000545.5	NP_000536.5	+	Y	c.51C=	.	.	.	NM_000545.5(HNF1A): c.51C=	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	122414	0.529613	U	0.3819	0.428514	12990	0.582525	PASS	-1028	8496	0.603107	16592	117406	0.527827	.	.	.	.	.	.	rs1169289	.	4024	0.616100	-2.001	0.039	-1.025	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	121416621	121416622	12q24.31	1	normal	.	C	snv	G	CT.GA	het-ref	265	0.49	.	2	.	PASS	142410	C	125853(SK);142330(MK);144700(MK);222100(SK);600496(MK);612520(MK)	AD;AR	Renal cell carcinoma, nonpapillary clear cell; Liver adenomatosis; Maturity onset diabetes of the young, type III	AD	Mutations may also cause or be associated with Diabetes mellitus, as in Diabetes mellitus, insulin-dependent, 20 (AD)	Endocrine; Oncologic	Endocrine; Oncologic	22802087|22517943|21683639|21120312|15649945|15001650|14598263|12355088|12050210|11904371|11668618|11575290|11058894|10649494|10482964|9313763|8945470	.	6927	HNF1A	C1	EX1	Hepatocyte nuclear factor 1 (HNF-1), N terminus	PF04814.8	coding-synon	NM_000545.5	NP_000536.5	+	Y	c.51C>G	p.(L17=) | p.(Leu17=)	CTC=>CTG	.	NM_000545.5(HNF1A): c.51C>G (p.(L17=))	SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	122414	0.470387	U	0.3819	0.428514	12990	0.417475	PASS	658	8496	0.396893	13325	117406	0.472173	1328	6743	3.92674e-01	27609	114359	4.70215e-01	rs1169289	.	4024	0.383900	-2.001	0.039	-1.025	.	.	.	.	.	ENST00000257555: c.51C>G (p.L17L)	large_intestine [colon|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	430521	.	.	.	.	.	no_record	129234	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
12	121426900	121426901	12q24.31	0	normal	.	G	ref	G	GT.GG	het-alt	110	0.47	.	1	.	PASS	142410	C	125853(SK);142330(MK);144700(MK);222100(SK);600496(MK);612520(MK)	AD;AR	Renal cell carcinoma, nonpapillary clear cell; Liver adenomatosis; Maturity onset diabetes of the young, type III	AD	Mutations may also cause or be associated with Diabetes mellitus, as in Diabetes mellitus, insulin-dependent, 20 (AD)	Endocrine; Oncologic	Endocrine; Oncologic	22802087|22517943|21683639|21120312|15649945|15001650|14598263|12355088|12050210|11904371|11668618|11575290|11058894|10649494|10482964|9313763|8945470	.	6927	HNF1A	IC2	IVS2	.	.	no-change	NM_000545.5	NP_000536.5	+	Y	c.526+66G=	.	.	.	NM_000545.5(HNF1A): c.526+66G=	;maf-5-some-pop	5008	0.937500	U	0.001	0.0625	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12427353	.	4024	0.998300	0.530	1.404	1.396	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	121426900	121426901	12q24.31	0	normal	.	G	snv	C	GT.GG	het-ref	126	0.53	.	2	.	PASS	142410	C	125853(SK);142330(MK);144700(MK);222100(SK);600496(MK);612520(MK)	AD;AR	Renal cell carcinoma, nonpapillary clear cell; Liver adenomatosis; Maturity onset diabetes of the young, type III	AD	Mutations may also cause or be associated with Diabetes mellitus, as in Diabetes mellitus, insulin-dependent, 20 (AD)	Endocrine; Oncologic	Endocrine; Oncologic	22802087|22517943|21683639|21120312|15649945|15001650|14598263|12355088|12050210|11904371|11668618|11575290|11058894|10649494|10482964|9313763|8945470	.	6927	HNF1A	IC2	IVS2	.	.	intron	NM_000545.5	NP_000536.5	+	Y	c.526+66G>C	.	.	.	NM_000545.5(HNF1A): c.526+66G>C	;maf-5-some-pop	5008	0.062500	U	0.001	0.0625	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12427353	.	4024	0.001700	0.530	1.404	1.396	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	121432116	121432117	12q24.31	0	normal	.	G	ref	G	GG.CC	het-alt	320	0.59	.	1	.	PASS	142410	C	125853(SK);142330(MK);144700(MK);222100(SK);600496(MK);612520(MK)	AD;AR	Renal cell carcinoma, nonpapillary clear cell; Liver adenomatosis; Maturity onset diabetes of the young, type III	AD	Mutations may also cause or be associated with Diabetes mellitus, as in Diabetes mellitus, insulin-dependent, 20 (AD)	Endocrine; Oncologic	Endocrine; Oncologic	22802087|22517943|21683639|21120312|15649945|15001650|14598263|12355088|12050210|11904371|11668618|11575290|11058894|10649494|10482964|9313763|8945470	.	6927	HNF1A	C4	EX4	Hepatocyte nuclear factor 1 (HNF-1), beta isoform C terminus	PF04812.8	no-change	NM_000545.5	NP_000536.5	+	Y	c.864G=	.	.	.	NM_000545.5(HNF1A): c.864G=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	5008	0.818890	U	0.005	0.18111	13004	0.764226	.	.	.	.	.	.	.	.	.	.	.	.	.	rs56348580	.	4024	0.997500	0.163	0.596	0.390	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	121432116	121432117	12q24.31	1	normal	.	G	snv	C	GG.CC	het-ref	226	0.41	.	2	.	PASS	142410	C	125853(SK);142330(MK);144700(MK);222100(SK);600496(MK);612520(MK)	AD;AR	Renal cell carcinoma, nonpapillary clear cell; Liver adenomatosis; Maturity onset diabetes of the young, type III	AD	Mutations may also cause or be associated with Diabetes mellitus, as in Diabetes mellitus, insulin-dependent, 20 (AD)	Endocrine; Oncologic	Endocrine; Oncologic	22802087|22517943|21683639|21120312|15649945|15001650|14598263|12355088|12050210|11904371|11668618|11575290|11058894|10649494|10482964|9313763|8945470	.	6927	HNF1A	C4	EX4	Hepatocyte nuclear factor 1 (HNF-1), beta isoform C terminus	PF04812.8	coding-synon	NM_000545.5	NP_000536.5	+	Y	c.864G>C	p.(G288=) | p.(Gly288=)	GGG=>GGC	.	NM_000545.5(HNF1A): c.864G>C (p.(G288=))	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	5008	0.181110	U	0.005	0.18111	13004	0.235774	PASS	0	5984	0.001003	3183	88434	0.278784	0	24	1.50075e-03	8875	59263	2.65499e-01	rs56348580	.	4024	0.002500	0.163	0.596	0.390	.	.	.	.	.	ENST00000257555: c.864G>C (p.G288G)	liver [NS|NS|NS]	other [adenoma|NS|NS]	CSV	5019699	CM067044	NM_000545.5(HNF1A): c.864G>C (p.G288G)	"Diabetes, MODY3"	16834925	DM	no_record	129236	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
12	121437113	121437114	12q24.31	1	normal	.	G	snv	A	AC.GG	het-ref	326	0.49	.	2	.	PASS	142410	C	125853(SK);142330(MK);144700(MK);222100(SK);600496(MK);612520(MK)	AD;AR	Renal cell carcinoma, nonpapillary clear cell; Liver adenomatosis; Maturity onset diabetes of the young, type III	AD	Mutations may also cause or be associated with Diabetes mellitus, as in Diabetes mellitus, insulin-dependent, 20 (AD)	Endocrine; Oncologic	Endocrine; Oncologic	22802087|22517943|21683639|21120312|15649945|15001650|14598263|12355088|12050210|11904371|11668618|11575290|11058894|10649494|10482964|9313763|8945470	.	6927	HNF1A	C8	EX8	Hepatocyte nuclear factor 1 (HNF-1), beta isoform C terminus	PF04812.8	coding-synon	NM_000545.5	NP_000536.5	+	Y	c.1545G>A	p.(T515=) | p.(Thr515=)	ACG=>ACA	.	NM_000545.5(HNF1A): c.1545G>A (p.(T515=))	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	125696	0.137268	U	0.001	0.0628994	13004	0.140649	PASS	0	8618	0.000232	1602	120688	0.140354	0	5	2.90091e-04	3188	34503	1.40254e-01	rs55834942	.	4024	0.001700	-0.157	-1.625	-0.997	.	.	.	.	.	ENST00000257555: c.1545G>A (p.T515T)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	RSS	1559373	.	.	.	.	.	no_record	129232	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
12	121437113	121437114	12q24.31	0	normal	.	G	ref	G	AC.GG	het-alt	337	0.51	.	1	.	PASS	142410	C	125853(SK);142330(MK);144700(MK);222100(SK);600496(MK);612520(MK)	AD;AR	Renal cell carcinoma, nonpapillary clear cell; Liver adenomatosis; Maturity onset diabetes of the young, type III	AD	Mutations may also cause or be associated with Diabetes mellitus, as in Diabetes mellitus, insulin-dependent, 20 (AD)	Endocrine; Oncologic	Endocrine; Oncologic	22802087|22517943|21683639|21120312|15649945|15001650|14598263|12355088|12050210|11904371|11668618|11575290|11058894|10649494|10482964|9313763|8945470	.	6927	HNF1A	C8	EX8	Hepatocyte nuclear factor 1 (HNF-1), beta isoform C terminus	PF04812.8	no-change	NM_000545.5	NP_000536.5	+	Y	c.1545G=	.	.	.	NM_000545.5(HNF1A): c.1545G=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	125696	0.862708	U	0.001	0.0628994	13004	0.859351	PASS	-1	8618	0.999768	45004	120688	0.859622	.	.	.	.	.	.	rs55834942	.	4024	0.998300	-0.157	-1.625	-0.997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	121437220	121437221	12q24.31	0	normal	.	T	ref	T	CT.GG	het-alt	276	0.49	.	1	.	PASS	142410	C	125853(SK);142330(MK);144700(MK);222100(SK);600496(MK);612520(MK)	AD;AR	Renal cell carcinoma, nonpapillary clear cell; Liver adenomatosis; Maturity onset diabetes of the young, type III	AD	Mutations may also cause or be associated with Diabetes mellitus, as in Diabetes mellitus, insulin-dependent, 20 (AD)	Endocrine; Oncologic	Endocrine; Oncologic	22802087|22517943|21683639|21120312|15649945|15001650|14598263|12355088|12050210|11904371|11668618|11575290|11058894|10649494|10482964|9313763|8945470	.	6927	HNF1A	IC8	IVS8	.	.	no-change	NM_000545.5	NP_000536.5	+	Y	c.1623+29T=	.	.	.	NM_000545.5(HNF1A): c.1623+29T=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126020	0.186954	U	0.8542	0.776957	13006	0.256113	PASS	.	8630	0.124565	2505	121012	0.185461	.	.	.	.	.	.	rs1169304	.	4024	0.133700	-3.835	-2.952	-2.680	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	121437220	121437221	12q24.31	0	normal	.	T	snv	C	CT.GG	het-ref	284	0.51	.	2	.	PASS	142410	C	125853(SK);142330(MK);144700(MK);222100(SK);600496(MK);612520(MK)	AD;AR	Renal cell carcinoma, nonpapillary clear cell; Liver adenomatosis; Maturity onset diabetes of the young, type III	AD	Mutations may also cause or be associated with Diabetes mellitus, as in Diabetes mellitus, insulin-dependent, 20 (AD)	Endocrine; Oncologic	Endocrine; Oncologic	22802087|22517943|21683639|21120312|15649945|15001650|14598263|12355088|12050210|11904371|11668618|11575290|11058894|10649494|10482964|9313763|8945470	.	6927	HNF1A	IC8	IVS8	.	.	intron	NM_000545.5	NP_000536.5	+	Y	c.1623+29T>C	.	.	.	NM_000545.5(HNF1A): c.1623+29T>C	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126020	0.813046	U	0.8542	0.776957	13006	0.743887	PASS	3304	8630	0.875435	40568	121012	0.814539	6595	15081	8.75479e-01	84036	202304	8.23030e-01	rs1169304	.	4024	0.866300	-3.835	-2.952	-2.680	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	135505	no_assertion_provided	not_provided	Benign
12	121437381	121437382	12q24.31	1	nullSample	.	A	ref	A	CC.GC	homo-ref	.	.	.	0	.	.	142410	C	125853(SK);142330(MK);144700(MK);222100(SK);600496(MK);612520(MK)	AD;AR	Renal cell carcinoma, nonpapillary clear cell; Liver adenomatosis; Maturity onset diabetes of the young, type III	AD	Mutations may also cause or be associated with Diabetes mellitus, as in Diabetes mellitus, insulin-dependent, 20 (AD)	Endocrine; Oncologic	Endocrine; Oncologic	22802087|22517943|21683639|21120312|15649945|15001650|14598263|12355088|12050210|11904371|11668618|11575290|11058894|10649494|10482964|9313763|8945470	.	6927	HNF1A	C9	EX9	Hepatocyte nuclear factor 1 (HNF-1), alpha isoform C terminus	PF04813.7	missense	NM_000545.5	NP_000536.5	+	Y	c.1720G>A	p.G574S | p.Gly574Ser	GGC=>AGC	P0=>P0	NM_000545.5(HNF1A): c.1720G>A (p.G574S)	MixedObserved;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict	121592	0.004589	U	1	0.985224	12964	0.013113	PASS	-1	8542	0.000234	12	116584	0.004152	.	.	.	.	.	.	rs1169305	.	.	.	-0.128	0.076	-0.004	0.69	0.04	0.061	0.005	neutral	.	.	.	.	.	CM020516	NM_000545.5(HNF1A): c.1720G>A (p.G574S)	"Diabetes, type 2, association with"	10096793	DFP	.	.	.	.	Likely Benign
12	121437381	121437382	12q24.31	0	normal	.	A	snv	G	CC.GC	hom-alt	489	1.00	.	0	.	PASS	142410	C	125853(SK);142330(MK);144700(MK);222100(SK);600496(MK);612520(MK)	AD;AR	Renal cell carcinoma, nonpapillary clear cell; Liver adenomatosis; Maturity onset diabetes of the young, type III	AD	Mutations may also cause or be associated with Diabetes mellitus, as in Diabetes mellitus, insulin-dependent, 20 (AD)	Endocrine; Oncologic	Endocrine; Oncologic	22802087|22517943|21683639|21120312|15649945|15001650|14598263|12355088|12050210|11904371|11668618|11575290|11058894|10649494|10482964|9313763|8945470	.	6927	HNF1A	C9	EX9	Hepatocyte nuclear factor 1 (HNF-1), alpha isoform C terminus	PF04813.7	no-change	NM_000545.5	NP_000536.5	+	Y	c.1720G=	.	.	.	NM_000545.5(HNF1A): c.1720G=	MixedObserved;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict	121592	0.995411	U	1	0.985224	12964	0.986887	PASS	4269	8542	0.999766	57820	116584	0.995848	8573	17149	9.99825e-01	118646	238065	9.96597e-01	rs1169305	.	.	.	-0.128	0.076	-0.004	.	.	.	.	.	ENST00000257555: c.1720A>G (p.S574G)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4445211	.	.	.	.	.	no_record	36810	criteria_provided,_single_submitter	Benign	Benign
12	124862696	124862697	12q24.31	0	normal	.	G	snv	A	GA.GC	het-ref	194	0.48	.	2	.	PASS	600848	P	.	NN	.	.	.	.	.	.	.	9612	NCOR2	IC18	IVS20	.	.	intron	NM_006312.5	NP_006303.4	-	Y	c.2167+86C>T	.	.	.	NM_006312.5(NCOR2): c.2167+86C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.124201	U	0.3482	0.124201	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1244050	.	4024	0.398100	-1.268	-1.298	-1.347	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	124862696	124862697	12q24.31	0	normal	.	G	ref	G	GA.GC	het-alt	212	0.52	.	1	.	PASS	600848	P	.	NN	.	.	.	.	.	.	.	9612	NCOR2	IC18	IVS20	.	.	no-change	NM_006312.5	NP_006303.4	-	Y	c.2167+86C=	.	.	.	NM_006312.5(NCOR2): c.2167+86C=	;maf-5-some-pop,maf-5-all-pops	5008	0.875799	U	0.3482	0.124201	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1244050	.	4024	0.601900	-1.268	-1.298	-1.347	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133202214	133202215	12q24.33	0	nullSample	.	G	ref	G	GC.GC	homo-ref	.	.	.	0	.	.	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC47	IVS47	.	.	no-change	NM_006231.2	NP_006222.2	-	Y	c.6657+16C=	.	.	.	NM_006231.2(POLE): c.6657+16C=	;maf-5-some-pop,maf-5-all-pops	125778	0.627574	U	0.6657	0.423323	13006	0.679686	PASS	-901	8630	0.299421	24760	120770	0.629685	.	.	.	.	.	.	rs5745075	.	4024	0.318800	-1.434	-0.654	-0.920	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133202214	133202215	12q24.33	1	normal	.	G	snv	A	GC.GC	hom-alt	429	1.00	.	0	.	PASS	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC47	IVS47	.	.	intron	NM_006231.2	NP_006222.2	-	Y	c.6657+16C>T	.	.	.	NM_006231.2(POLE): c.6657+16C>T	;maf-5-some-pop,maf-5-all-pops	125778	0.372426	U	0.6657	0.423323	13006	0.320314	PASS	2122	8630	0.700579	9098	120770	0.370315	4196	12006	6.96404e-01	18946	91845	3.75380e-01	rs5745075	.	4024	0.681200	-1.434	-0.654	-0.920	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	371835	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
12	133202427	133202428	12q24.33	0	nullSample	.	G	ref	G	AG.AG	homo-ref	.	.	.	0	.	.	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC46	IVS46	.	.	no-change	NM_006231.2	NP_006222.2	-	Y	c.6532-72C=	.	.	.	NM_006231.2(POLE): c.6532-72C=	;maf-5-some-pop,maf-5-all-pops	5008	0.581869	U	0.6647	0.418131	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs5745073	.	4024	0.318800	0.491	-0.579	-0.716	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133202427	133202428	12q24.33	0	normal	.	G	snv	A	AG.AG	hom-alt	345	1.00	.	0	.	PASS	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC46	IVS46	.	.	intron	NM_006231.2	NP_006222.2	-	Y	c.6532-72C>T	.	.	.	NM_006231.2(POLE): c.6532-72C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.418131	U	0.6647	0.418131	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs5745073	.	4024	0.681200	0.491	-0.579	-0.716	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133208885	133208886	12q24.33	0	nullSample	.	C	ref	C	CA.GC	homo-ref	.	.	.	0	.	.	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC45	IVS45	.	.	no-change	NM_006231.2	NP_006222.2	-	Y	c.6330+15G=	.	.	.	NM_006231.2(POLE): c.6330+15G=	;maf-5-some-pop,maf-5-all-pops	124040	0.503080	U	0.6736	0.565096	13006	0.519683	PASS	.	8558	0.291073	15589	119032	0.505948	.	.	.	.	.	.	rs5745023	.	4024	0.313400	0.305	-0.628	-1.067	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133208885	133208886	12q24.33	1	normal	.	C	snv	T	CA.GC	hom-alt	359	1.00	.	0	.	PASS	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC45	IVS45	.	.	intron	NM_006231.2	NP_006222.2	-	Y	c.6330+15G>A	.	.	.	NM_006231.2(POLE): c.6330+15G>A	;maf-5-some-pop,maf-5-all-pops	124040	0.496920	U	0.6736	0.565096	13006	0.480317	PASS	2137	8558	0.708927	14881	119032	0.494052	4272	12111	7.04128e-01	30611	120109	4.92331e-01	rs5745023	.	4024	0.686600	0.305	-0.628	-1.067	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	380218	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
12	133208978	133208979	12q24.33	0	nullSample	.	T	ref	T	TC.GA	homo-ref	.	.	.	0	.	.	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	C45	EX45	.	.	no-change	NM_006231.2	NP_006222.2	-	Y	c.6252A=	.	.	.	NM_006231.2(POLE): c.6252A=	;maf-5-some-pop,maf-5-all-pops	126346	0.359442	U	0.7788	0.699081	13006	0.357297	PASS	-643	8644	0.186719	8497	121338	0.361857	.	.	.	.	.	.	rs5745022	.	4024	0.205300	-3.008	-3.713	-2.142	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133208978	133208979	12q24.33	1	normal	.	T	snv	C	TC.GA	hom-alt	544	1.00	.	0	.	PASS	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	C45	EX45	.	.	coding-synon	NM_006231.2	NP_006222.2	-	Y	c.6252A>G	p.(S2084=) | p.(Ser2084=)	TCA=>TCG	.	NM_006231.2(POLE): c.6252A>G (p.(S2084=))	;maf-5-some-pop,maf-5-all-pops	126346	0.640558	U	0.7788	0.699081	13006	0.642703	PASS	2872	8644	0.813281	25259	121338	0.638143	5728	14015	8.12746e-01	51967	158088	6.42175e-01	rs5745022	.	4024	0.794700	-3.008	-3.713	-2.142	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	380217	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
12	133210984	133210985	12q24.33	0	nullSample	.	C	ref	C	CG.GG	homo-ref	.	.	.	0	.	.	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC42	IVS42	.	.	no-change	NM_006231.2	NP_006222.2	-	Y	c.5812-21G=	.	.	.	NM_006231.2(POLE): c.5812-21G=	;maf-5-some-pop,maf-5-all-pops	124920	0.352458	U	0.7788	0.713458	13006	0.343457	PASS	.	8644	0.187066	8113	119912	0.355210	.	.	.	.	.	.	rs5745005	.	4024	0.205000	-0.657	0.112	0.116	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133210984	133210985	12q24.33	0	normal	.	C	snv	T	CG.GG	hom-alt	337	1.00	.	0	.	PASS	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC42	IVS42	.	.	intron	NM_006231.2	NP_006222.2	-	Y	c.5812-21G>A	.	.	.	NM_006231.2(POLE): c.5812-21G>A	;maf-5-some-pop,maf-5-all-pops	124920	0.647542	U	0.7788	0.713458	13006	0.656543	PASS	2869	8644	0.812934	25475	119912	0.644790	5725	14002	8.12935e-01	51557	155455	6.47163e-01	rs5745005	.	4024	0.795000	-0.657	0.112	0.116	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133212691	133212692	12q24.33	0	nullSample	.	T	ref	T	TC.GT	homo-ref	.	.	.	0	.	.	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC41	IVS41	.	.	no-change	NM_006231.2	NP_006222.2	-	Y	c.5679-82A=	.	.	.	NM_006231.2(POLE): c.5679-82A=	;maf-5-some-pop,maf-5-all-pops	5008	0.272364	U	0.7798	0.727636	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4883625	.	4024	0.205000	-1.771	-0.765	-0.849	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133212691	133212692	12q24.33	0	normal	.	T	snv	C	TC.GT	hom-alt	316	1.00	.	0	.	PASS	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC41	IVS41	.	.	intron	NM_006231.2	NP_006222.2	-	Y	c.5679-82A>G	.	.	.	NM_006231.2(POLE): c.5679-82A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.727636	U	0.7798	0.727636	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4883625	.	4024	0.795000	-1.771	-0.765	-0.849	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133214516	133214517	12q24.33	0	nullSample	.	G	ref	G	AG.AG	homo-ref	.	.	.	0	.	.	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC41	IVS41	.	.	no-change	NM_006231.2	NP_006222.2	-	Y	c.5678+83C=	.	.	.	NM_006231.2(POLE): c.5678+83C=	;maf-5-some-pop,maf-5-all-pops	5008	0.414736	U	0.6696	0.585264	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs5744975	.	4024	0.314600	-0.345	-0.048	0.094	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133214516	133214517	12q24.33	0	normal	.	G	snv	A	AG.AG	hom-alt	262	1.00	.	0	.	PASS	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC41	IVS41	.	.	intron	NM_006231.2	NP_006222.2	-	Y	c.5678+83C>T	.	.	.	NM_006231.2(POLE): c.5678+83C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.585264	U	0.6696	0.585264	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs5744975	.	4024	0.685400	-0.345	-0.048	0.094	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133214521	133214522	12q24.33	0	nullSample	.	G	ref	G	GA.AG	homo-ref	.	.	.	0	.	.	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC41	IVS41	.	.	no-change	NM_006231.2	NP_006222.2	-	Y	c.5678+78C=	.	.	.	NM_006231.2(POLE): c.5678+78C=	;maf-5-some-pop,maf-5-all-pops	5008	0.283946	U	0.7768	0.716054	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs5744974	.	4024	0.206000	-0.120	-0.740	-0.514	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133214521	133214522	12q24.33	0	normal	.	G	snv	C	GA.AG	hom-alt	262	1.00	.	0	.	PASS	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC41	IVS41	.	.	intron	NM_006231.2	NP_006222.2	-	Y	c.5678+78C>G	.	.	.	NM_006231.2(POLE): c.5678+78C>G	;maf-5-some-pop,maf-5-all-pops	5008	0.716054	U	0.7768	0.716054	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs5744974	.	4024	0.794000	-0.120	-0.740	-0.514	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133214767	133214768	12q24.33	0	nullSample	.	A	ref	A	TC.TG	homo-ref	.	.	.	0	.	.	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC40	IVS40	.	.	no-change	NM_006231.2	NP_006222.2	-	Y	c.5553-43T=	.	.	.	NM_006231.2(POLE): c.5553-43T=	SingleClassTriAllelic;maf-5-some-pop	124764	0.348939	U	0.7788	0.729034	13006	0.325235	PASS	.	8468	0.186939	8037	119756	0.352199	.	.	.	.	.	.	rs5744970	.	4024	0.204800	-2.865	-3.483	-3.363	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133214767	133214768	12q24.33	0	normal	.	A	snv	G	TC.TG	hom-alt	390	1.00	.	0	.	PASS	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC40	IVS40	.	.	intron	NM_006231.2	NP_006222.2	-	Y	c.5553-43T>C	.	.	.	NM_006231.2(POLE): c.5553-43T>C	SingleClassTriAllelic;maf-5-some-pop	124764	0.651053	U	0.7788	0.729034	13006	0.674765	PASS	2806	8468	0.813061	25736	119756	0.647792	5640	13781	8.14287e-01	52161	156405	6.50425e-01	rs5744970	.	4024	0.795200	-2.865	-3.483	-3.363	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133218723	133218724	12q24.33	0	nullSample	.	C	ref	C	AC.AG	homo-ref	.	.	.	0	.	.	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC38	IVS38	.	.	no-change	NM_006231.2	NP_006222.2	-	Y	c.5173+39G=	.	.	.	NM_006231.2(POLE): c.5173+39G=	;maf-5-some-pop,maf-5-all-pops	115806	0.499750	U	0.6736	0.588658	13006	0.497078	PASS	-887	8528	0.291745	14642	110798	0.503746	.	.	.	.	.	.	rs5744951	.	4024	0.312900	0.655	0.472	2.506	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133218723	133218724	12q24.33	0	normal	.	C	snv	T	AC.AG	hom-alt	312	1.00	.	0	.	PASS	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC38	IVS38	.	.	intron	NM_006231.2	NP_006222.2	-	Y	c.5173+39G>A	.	.	.	NM_006231.2(POLE): c.5173+39G>A	;maf-5-some-pop,maf-5-all-pops	115806	0.500250	U	0.6736	0.588658	13006	0.502922	PASS	2133	8528	0.708255	14227	110798	0.496254	3787	10744	7.03141e-01	23443	89910	4.99295e-01	rs5744951	.	4024	0.687100	0.655	0.472	2.506	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133219830	133219831	12q24.33	0	nullSample	.	T	ref	T	GA.GC	homo-ref	.	.	.	0	.	.	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	C35	EX35	.	.	no-change	NM_006231.2	NP_006222.2	-	Y	c.4530A=	.	.	.	NM_006231.2(POLE): c.4530A=	;maf-5-some-pop,maf-5-all-pops	124888	0.492705	U	0.6736	0.605232	13006	0.477626	PASS	.	8566	0.291968	15455	119880	0.496797	.	.	.	.	.	.	rs5744944	.	4024	0.312600	-1.752	-0.821	-2.108	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133219830	133219831	12q24.33	1	normal	.	T	snv	C	GA.GC	hom-alt	424	1.00	.	0	.	PASS	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	C35	EX35	.	.	coding-synon	NM_006231.2	NP_006222.2	-	Y	c.4530A>G	p.(A1510=) | p.(Ala1510=)	GCA=>GCG	.	NM_006231.2(POLE): c.4530A>G (p.(A1510=))	;maf-5-some-pop,maf-5-all-pops	124888	0.507295	U	0.6736	0.605232	13006	0.522374	PASS	2140	8566	0.708032	15839	119880	0.503203	4270	12095	7.04180e-01	31845	121301	5.02723e-01	rs5744944	.	4024	0.687400	-1.752	-0.821	-2.108	.	.	.	.	.	ENST00000320574: c.4530A>G (p.A1510A)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4146901	.	.	.	.	.	no_record	380214	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
12	133220651	133220652	12q24.33	0	nullSample	.	A	ref	A	CT.ga	homo-ref	.	.	.	0	L1MEf|LINE|L1|+|88	.	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC32	IVS32	.	.	no-change	NM_006231.2	NP_006222.2	-	Y	c.4150-89T=	.	.	.	NM_006231.2(POLE): c.4150-89T=	;	0	0	U	0.7798	0.728834	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs76893760	.	.	.	0.456	-0.254	-0.287	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133220652	133220652	12q24.33	0	normal	.	.	ins	G	Ta.ga	hom-alt	239	1.00	.	0	L1MEf|LINE|L1|+|88	PASS	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC32	IVS32	.	.	intron	NM_006231.2	NP_006222.2	-	Y	c.4150-90_4150-89insC	.	.	.	NM_006231.2(POLE): c.4150-90_4150-89insC	;maf-5-some-pop,maf-5-all-pops	5008	0.728834	U	0.7798	0.728834	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs5744932	.	4024	0.796000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133225445	133225446	12q24.33	0	nullSample	.	G	ref	G	CA.GC	homo-ref	.	.	.	0	.	.	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC32	IVS32	.	.	no-change	NM_006231.2	NP_006222.2	-	Y	c.4149+69C=	.	.	.	NM_006231.2(POLE): c.4149+69C=	;maf-5-some-pop,maf-5-all-pops	5008	0.411142	U	0.6736	0.588858	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4883538	.	4024	0.313100	-3.583	-3.344	-3.492	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133225445	133225446	12q24.33	0	normal	.	G	snv	T	CA.GC	hom-alt	336	1.00	.	0	.	PASS	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC32	IVS32	.	.	intron	NM_006231.2	NP_006222.2	-	Y	c.4149+69C>A	.	.	.	NM_006231.2(POLE): c.4149+69C>A	;maf-5-some-pop,maf-5-all-pops	5008	0.588858	U	0.6736	0.588858	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4883538	.	4024	0.686900	-3.583	-3.344	-3.492	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133226158	133226159	12q24.33	0	nullSample	.	T	ref	T	CA.GA	homo-ref	.	.	.	0	.	.	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC30	IVS30	.	.	no-change	NM_006231.2	NP_006222.2	-	Y	c.3796-58A=	.	.	.	NM_006231.2(POLE): c.3796-58A=	;maf-5-some-pop,maf-5-all-pops	5008	0.271166	U	0.7798	0.728834	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4883613	.	4024	0.204000	-0.924	-1.000	-0.831	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133226158	133226159	12q24.33	0	normal	.	T	snv	C	CA.GA	hom-alt	421	1.00	.	0	.	PASS	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC30	IVS30	.	.	intron	NM_006231.2	NP_006222.2	-	Y	c.3796-58A>G	.	.	.	NM_006231.2(POLE): c.3796-58A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.728834	U	0.7798	0.728834	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4883613	.	4024	0.796000	-0.924	-1.000	-0.831	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133233704	133233705	12q24.33	0	nullSample	.	T	ref	T	CT.GG	homo-ref	.	.	.	0	.	.	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC29	IVS29	.	.	no-change	NM_006231.2	NP_006222.2	-	Y	c.3582+17A=	.	.	.	NM_006231.2(POLE): c.3582+17A=	;	126350	0.028326	U	1	0.983826	13006	0.027064	PASS	-1	8654	0.000231	66	121342	0.028828	.	.	.	.	.	.	rs5744889	.	4024	0.002000	-0.124	-0.023	-0.027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133233704	133233705	12q24.33	1	normal	.	T	snv	C	CT.GG	hom-alt	494	1.00	.	0	.	PASS	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC29	IVS29	.	.	intron	NM_006231.2	NP_006222.2	-	Y	c.3582+17A>G	.	.	.	NM_006231.2(POLE): c.3582+17A>G	;	126350	0.971674	U	1	0.983826	13006	0.972936	PASS	4325	8654	0.999769	57239	121342	0.971172	8621	17244	9.99884e-01	115966	238802	9.70992e-01	rs5744889	.	4024	0.998000	-0.124	-0.023	-0.027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	380211	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
12	133235999	133236000	12q24.33	0	nullSample	.	C	ref	C	GA.GT	homo-ref	.	.	.	0	.	.	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	C26	EX26	DNA polymerase family B	PF00136.16	no-change	NM_006231.2	NP_006222.2	-	Y	c.3156G=	.	.	.	NM_006231.2(POLE): c.3156G=	;maf-5-some-pop,maf-5-all-pops	126340	0.493082	U	0.6736	0.605431	13006	0.477549	PASS	-896	8646	0.292158	15720	121332	0.497148	.	.	.	.	.	.	rs5744857	.	4024	0.312900	-2.000	-1.976	-3.001	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133235999	133236000	12q24.33	1	normal	.	C	snv	T	GA.GT	hom-alt	546	1.00	.	0	.	PASS	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	C26	EX26	DNA polymerase family B	PF00136.16	coding-synon	NM_006231.2	NP_006222.2	-	Y	c.3156G>A	p.(T1052=) | p.(Thr1052=)	ACG=>ACA	.	NM_006231.2(POLE): c.3156G>A (p.(T1052=))	;maf-5-some-pop,maf-5-all-pops	126340	0.506918	U	0.6736	0.605431	13006	0.522451	PASS	2164	8646	0.707842	16066	121332	0.502852	4292	12150	7.04593e-01	32434	123567	5.01925e-01	rs5744857	.	4024	0.687100	-2.000	-1.976	-3.001	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	380212	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
12	133237753	133237754	12q24.33	0	normal	.	A	ref	A	TG.AA	het-alt	90	0.71	.	1	.	PASS	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC24	IVS24	.	.	no-change	NM_006231.2	NP_006222.2	-	Y	c.2865-4T=	.	.	.	NM_006231.2(POLE): c.2865-4T=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs369732588	.	4024	0.757200	0.235	-0.336	0.115	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133237753	133237754	12q24.33	1	normal	.	A	del	.	TG.AA	het-ref	36	0.29	.	2	.	PASS	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC24	IVS24	.	.	intron	NM_006231.2	NP_006222.2	-	Y	c.2865-4delT	.	.	.	NM_006231.2(POLE): c.2865-4delT	MixedObserved;	0	0	U	.	.	.	.	InbreedingCoeff_Filter	0	7622	0.446471	12	103024	0.453069	.	.	.	.	.	.	rs369732588	.	4024	0.242800	0.235	-0.336	0.115	.	.	.	.	.	ENST00000320574: c.2865-4delT (p.?)	skin [NS|NS|NS]	carcinoma [basal_cell_carcinoma|NS|NS]	CSV	5895362	.	.	.	.	.	.	.	.	.	Benign
12	133238075	133238076	12q24.33	0	nullSample	.	T	ref	T	CA.GT	homo-ref	.	.	.	0	.	.	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC24	IVS24	.	.	no-change	NM_006231.2	NP_006222.2	-	Y	c.2864+37A=	.	.	.	NM_006231.2(POLE): c.2864+37A=	;maf-5-some-pop,maf-5-all-pops	125632	0.501194	U	0.6736	0.577276	13006	0.507304	PASS	-894	8644	0.291763	15891	120624	0.504452	.	.	.	.	.	.	rs5744844	.	4024	0.312900	0.436	-0.176	0.023	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133238075	133238076	12q24.33	0	normal	.	T	snv	C	CA.GT	hom-alt	355	1.00	.	0	.	PASS	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC24	IVS24	.	.	intron	NM_006231.2	NP_006222.2	-	Y	c.2864+37A>G	.	.	.	NM_006231.2(POLE): c.2864+37A>G	;maf-5-some-pop,maf-5-all-pops	125632	0.498806	U	0.6736	0.577276	13006	0.492696	PASS	2167	8644	0.708237	15354	120624	0.495548	4270	12092	7.04088e-01	31082	120614	4.95677e-01	rs5744844	.	4024	0.687100	0.436	-0.176	0.023	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133245148	133245149	12q24.33	0	nullSample	.	A	ref	A	CC.AG	homo-ref	.	.	.	0	.	.	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC18	IVS18	.	.	no-change	NM_006231.2	NP_006222.2	-	Y	c.2027-61T=	.	.	.	NM_006231.2(POLE): c.2027-61T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.397564	U	0.6736	0.602436	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs5744798	.	4024	0.312900	-0.505	-0.474	-0.504	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133245148	133245149	12q24.33	0	normal	.	A	snv	G	CC.AG	hom-alt	462	1.00	.	0	.	PASS	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC18	IVS18	.	.	intron	NM_006231.2	NP_006222.2	-	Y	c.2027-61T>C	.	.	.	NM_006231.2(POLE): c.2027-61T>C	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.602436	U	0.6736	0.602436	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs5744798	.	4024	0.687100	-0.505	-0.474	-0.504	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133250117	133250118	12q24.33	0	nullSample	.	C	ref	C	TG.GT	homo-ref	.	.	.	0	trf	.	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC13	IVS13	.	.	no-change	NM_006231.2	NP_006222.2	-	Y	c.1359+43G=	.	.	.	NM_006231.2(POLE): c.1359+43G=	;maf-5-some-pop,maf-5-all-pops	124728	0.501090	U	0.6736	0.576478	13002	0.507383	PASS	-885	8516	0.290042	15760	119720	0.504335	.	.	.	.	.	.	rs4883555	.	4024	0.312400	0.121	0.056	-0.715	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
12	133250117	133250118	12q24.33	0	normal	.	C	snv	T	TG.GT	hom-alt	409	1.00	.	0	trf	PASS	174762	P	615083(SK);615139(MK)	NN	Colorectal cancer, susceptibility to, 12; Facial dysmorphism, immunodeficiency, livedo, and short stature syndrome (FILS syndrome)	AD/AR	.	Oncologic	Oncologic	23263490|23230001	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	5426	POLE	IC13	IVS13	.	.	intron	NM_006231.2	NP_006222.2	-	Y	c.1359+43G>A	.	.	.	NM_006231.2(POLE): c.1359+43G>A	;maf-5-some-pop,maf-5-all-pops	124728	0.498910	U	0.6736	0.576478	13002	0.492617	PASS	2138	8516	0.709958	15241	119720	0.495665	4275	12090	7.05450e-01	30502	117910	4.98364e-01	rs4883555	.	4024	0.687600	0.121	0.056	-0.715	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	19751656	19751657	13q12.11	0	normal	.	G	ref	G	CC.CT	het-alt	155	0.56	.	1	.	PASS	602528	P	.	NN	.	.	.	.	.	.	.	7278	TUBA3C	C4	EX4	.	.	no-change	NM_006001.2	NP_005992.1	-	Y	c.466C=	.	.	.	NM_006001.2(TUBA3C): c.466C=	;maf-5-some-pop	126106	0.956782	U	0.0129	0.0305511	13006	0.955482	PASS	.	8652	0.986246	55418	121098	0.956259	.	.	.	.	.	.	rs9507566	.	4024	0.988800	0.162	3.661	0.966	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	19751656	19751657	13q12.11	1	normal	.	G	snv	T	CC.CT	het-ref	123	0.44	.	2	.	PASS	602528	P	.	NN	.	.	.	.	.	.	.	7278	TUBA3C	C4	EX4	.	.	coding-synon	NM_006001.2	NP_005992.1	-	Y	c.466C>A	p.(R156=) | p.(Arg156=)	CGG=>AGG	.	NM_006001.2(TUBA3C): c.466C>A (p.(R156=))	;maf-5-some-pop	126106	0.043218	U	0.0129	0.0305511	13006	0.044518	PASS	1	8652	0.013754	166	121098	0.043741	3	192	1.11317e-02	296	10431	4.23714e-02	rs9507566	.	4024	0.011200	0.162	3.661	0.966	.	.	.	.	.	ENST00000400113: c.466C>A (p.R156R)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3753608	.	.	.	.	.	.	.	.	.	VUS
13	19751693	19751694	13q12.11	0	normal	.	A	ref	A	CC.CC	het-alt	128	0.67	.	1	.	PASS	602528	P	.	NN	.	.	.	.	.	.	.	7278	TUBA3C	C4	EX4	.	.	no-change	NM_006001.2	NP_005992.1	-	Y	c.429T=	.	.	.	NM_006001.2(TUBA3C): c.429T=	;maf-5-some-pop	123078	0.956523	U	0.0129	0.0305511	13006	0.956097	PASS	.	8646	0.986236	53993	118070	0.955975	.	.	.	.	.	.	rs9507567	.	4024	0.988800	-1.680	-1.690	-1.014	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	19751693	19751694	13q12.11	1	normal	.	A	snv	G	CC.CC	het-ref	64	0.33	.	2	.	PASS	602528	P	.	NN	.	.	.	.	.	.	.	7278	TUBA3C	C4	EX4	.	.	coding-synon	NM_006001.2	NP_005992.1	-	Y	c.429T>C	p.(G143=) | p.(Gly143=)	GGT=>GGC	.	NM_006001.2(TUBA3C): c.429T>C (p.(G143=))	;maf-5-some-pop	123078	0.043476	U	0.0129	0.0305511	13006	0.043903	PASS	1	8646	0.013764	156	118070	0.044025	3	192	1.11485e-02	278	10086	4.14080e-02	rs9507567	.	4024	0.011200	-1.680	-1.690	-1.014	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
13	26828725	26828726	13q12.13	0	normal	.	A	snv	C	CC.CC	het-ref	16	0.84	.	2	.	DUBIOUS	603184	P	.	NN	.	.	.	.	.	.	.	1024	CDK8	PROM	.	.	.	promoter	NM_001260.1	NP_001251.1	+	Y	c.-26-u30A>C	.	.	.	NM_001260.1(CDK8): c.-26-u30A>C	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.459	0.080	-0.154	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
13	26828725	26828726	13q12.13	0	normal	.	A	ref	A	CC.CC	het-alt	3	0.16	.	1	.	DUBIOUS	603184	P	.	NN	.	.	.	.	.	.	.	1024	CDK8	PROM	.	.	.	no-change	NM_001260.1	NP_001251.1	+	Y	c.-26-u30A=	.	.	.	NM_001260.1(CDK8): c.-26-u30A=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.459	0.080	-0.154	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
13	26974561	26974562	13q12.13	0	normal	.	G	snv	A	CC.TC	hom-alt	290	1.00	.	0	.	PASS	603184	P	.	NN	.	.	.	.	.	.	.	1024	CDK8	IC9	IVS9	.	.	intron	NM_001260.1	NP_001251.1	+	Y	c.934-28G>A	.	.	.	NM_001260.1(CDK8): c.934-28G>A	;maf-5-some-pop,genotype-conflict	126384	0.848770	U	0.9296	0.746006	13006	0.757804	PASS	3739	8648	0.929232	45141	121376	0.853010	7440	16006	9.28853e-01	92264	211082	8.59720e-01	rs998692	.	4024	0.932400	0.650	-0.392	-0.061	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	26974561	26974562	13q12.13	0	nullSample	.	G	ref	G	CC.TC	homo-ref	.	.	.	0	.	.	603184	P	.	NN	.	.	.	.	.	.	.	1024	CDK8	IC9	IVS9	.	.	no-change	NM_001260.1	NP_001251.1	+	Y	c.934-28G=	.	.	.	NM_001260.1(CDK8): c.934-28G=	;maf-5-some-pop,genotype-conflict	126384	0.151230	U	0.9296	0.746006	13006	0.242196	PASS	-279	8648	0.070768	2294	121376	0.146990	.	.	.	.	.	.	rs998692	.	4024	0.067600	0.650	-0.392	-0.061	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	28589266	28589267	13q12.2	0	normal	.	C	ref	C	AA.CA	het-alt	146	0.51	.	1	.	PASS	136351	C	601626(MK);613065(MK)	NN	.	.	.	.	.	.	.	2322	FLT3	IC22	IVS22	.	.	no-change	NM_004119.2	NP_004110.2	-	Y	c.2753+27G=	.	.	.	NM_004119.2(FLT3): c.2753+27G=	;maf-5-some-pop,maf-5-all-pops	96134	0.504275	U	0.4107	0.392173	13004	0.559674	PASS	-859	6350	0.561890	10737	91126	0.498584	.	.	.	.	.	.	rs4073630	.	4024	0.562400	0.655	1.174	0.951	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	28589266	28589267	13q12.2	0	normal	.	C	snv	T	AA.CA	het-ref	141	0.49	.	2	.	PASS	136351	C	601626(MK);613065(MK)	NN	.	.	.	.	.	.	.	2322	FLT3	IC22	IVS22	.	.	intron	NM_004119.2	NP_004110.2	-	Y	c.2753+27G>A	.	.	.	NM_004119.2(FLT3): c.2753+27G>A	;maf-5-some-pop,maf-5-all-pops	96134	0.495725	U	0.4107	0.392173	13004	0.440326	PASS	532	6350	0.438110	10866	91126	0.501416	1265	6424	4.04585e-01	26207	106588	4.76938e-01	rs4073630	.	4024	0.437600	0.655	1.174	0.951	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	28607988	28607989	13q12.2	0	normal	.	T	snv	G	TG.GC	hom-alt	337	1.00	.	0	.	PASS	136351	C	601626(MK);613065(MK)	NN	.	.	.	.	.	.	.	2322	FLT3	IC15	IVS15	.	.	intron	NM_004119.2	NP_004110.2	-	Y	c.1942+35A>C	.	.	.	NM_004119.2(FLT3): c.1942+35A>C	SingleClassTriAllelic;maf-5-some-pop	126318	0.698689	U	0.7302	0.578674	13006	0.635783	PASS	2369	8642	0.742074	31108	121310	0.703644	4765	12799	7.43868e-01	64159	174393	7.14456e-01	rs2491223	.	4024	0.720200	0.533	-1.061	-1.530	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	28607988	28607989	13q12.2	0	nullSample	.	T	ref	T	TG.GC	homo-ref	.	.	.	0	.	.	136351	C	601626(MK);613065(MK)	NN	.	.	.	.	.	.	.	2322	FLT3	IC15	IVS15	.	.	no-change	NM_004119.2	NP_004110.2	-	Y	c.1942+35A=	.	.	.	NM_004119.2(FLT3): c.1942+35A=	SingleClassTriAllelic;maf-5-some-pop	126318	0.301295	U	0.7302	0.578674	13006	0.364217	PASS	.	8642	0.257926	6404	121310	0.296340	.	.	.	.	.	.	rs2491223	.	4024	0.279800	0.533	-1.061	-1.530	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	28609824	28609825	13q12.2	0	nullSample	.	A	ref	A	AT.GC	homo-ref	.	.	.	0	.	.	136351	C	601626(MK);613065(MK)	NN	.	.	.	.	.	.	.	2322	FLT3	IC11	IVS11	.	.	no-change	NM_004119.2	NP_004110.2	-	Y	c.1419-15T=	.	.	.	NM_004119.2(FLT3): c.1419-15T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125460	0.304081	U	0.7351	0.563099	13006	0.383592	PASS	-835	8638	0.257004	6575	120452	0.298559	.	.	.	.	.	.	rs2491227	.	4024	0.278600	-0.119	0.083	0.485	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	28609824	28609825	13q12.2	1	normal	.	A	snv	G	AT.GC	hom-alt	365	1.00	.	0	.	PASS	136351	C	601626(MK);613065(MK)	NN	.	.	.	.	.	.	.	2322	FLT3	IC11	IVS11	.	.	intron	NM_004119.2	NP_004110.2	-	Y	c.1419-15T>C	.	.	.	NM_004119.2(FLT3): c.1419-15T>C	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125460	0.695919	U	0.7351	0.563099	13006	0.616408	PASS	2374	8638	0.742996	30839	120452	0.701441	4473	11966	7.47595e-01	59595	161221	7.13790e-01	rs2491227	.	4024	0.721400	-0.119	0.083	0.485	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	28609845	28609846	13q12.2	0	nullSample	.	A	ref	A	TG.GC	homo-ref	.	.	.	0	.	.	136351	C	601626(MK);613065(MK)	NN	.	.	.	.	.	.	.	2322	FLT3	IC11	IVS11	.	.	no-change	NM_004119.2	NP_004110.2	-	Y	c.1419-36T=	.	.	.	NM_004119.2(FLT3): c.1419-36T=	;maf-5-some-pop,maf-5-all-pops	123284	0.302756	U	0.7351	0.563099	13006	0.383438	PASS	.	8606	0.256449	6400	118276	0.297076	.	.	.	.	.	.	rs2491228	.	4024	0.278600	-0.242	-0.508	-0.296	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	28609845	28609846	13q12.2	0	normal	.	A	snv	T	TG.GC	hom-alt	346	1.00	.	0	.	PASS	136351	C	601626(MK);613065(MK)	NN	.	.	.	.	.	.	.	2322	FLT3	IC11	IVS11	.	.	intron	NM_004119.2	NP_004110.2	-	Y	c.1419-36T>A	.	.	.	NM_004119.2(FLT3): c.1419-36T>A	;maf-5-some-pop,maf-5-all-pops	123284	0.697244	U	0.7351	0.563099	13006	0.616562	PASS	2365	8606	0.743551	30401	118276	0.702924	4539	12148	7.48952e-01	59187	160032	7.16290e-01	rs2491228	.	4024	0.721400	-0.242	-0.508	-0.296	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	28610182	28610183	13q12.2	0	nullSample	.	A	ref	A	CT.TA	homo-ref	.	.	.	0	.	.	136351	C	601626(MK);613065(MK)	NN	.	.	.	.	.	.	.	2322	FLT3	IC10	IVS10	.	.	no-change	NM_004119.2	NP_004110.2	-	Y	c.1310-3T=	.	.	.	NM_004119.2(FLT3): c.1310-3T=	;maf-5-some-pop,maf-5-all-pops	126242	0.306079	U	0.7351	0.563299	13006	0.383592	PASS	-835	8638	0.256541	6772	121234	0.300683	.	.	.	.	.	.	rs2491231	.	4024	0.278600	-0.468	0.844	0.617	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	28610182	28610183	13q12.2	1	normal	.	A	snv	G	CT.TA	hom-alt	325	1.00	.	0	.	PASS	136351	C	601626(MK);613065(MK)	NN	.	.	.	.	.	.	.	2322	FLT3	IC10	IVS10	.	.	intron	NM_004119.2	NP_004110.2	-	Y	c.1310-3T>C	.	.	.	NM_004119.2(FLT3): c.1310-3T>C	;maf-5-some-pop,maf-5-all-pops	126242	0.693921	U	0.7351	0.563299	13006	0.616408	PASS	2376	8638	0.743459	30936	121234	0.699317	4802	12863	7.46114e-01	64072	174196	7.10621e-01	rs2491231	.	4024	0.721400	-0.468	0.844	0.617	.	.	.	.	.	ENST00000241453: c.1310-3T>C (p.?)	bone [femur|NS|NS]	osteosarcoma [NS|NS|NS]	CSV	3999060	.	.	.	.	.	.	.	.	.	Benign
13	28622355	28622356	13q12.2	0	nullSample	.	G	ref	G	GC.AC	homo-ref	.	.	.	0	.	.	136351	C	601626(MK);613065(MK)	NN	.	.	.	.	.	.	.	2322	FLT3	IC9	IVS9	.	.	no-change	NM_004119.2	NP_004110.2	-	Y	c.1205+56C=	.	.	.	NM_004119.2(FLT3): c.1205+56C=	;maf-5-some-pop,genotype-conflict	5008	0.162939	U	0.9712	0.837061	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2153000	.	4024	0.032100	-0.521	-0.069	-0.058	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	28622355	28622356	13q12.2	0	normal	.	G	snv	A	GC.AC	hom-alt	389	1.00	.	0	.	PASS	136351	C	601626(MK);613065(MK)	NN	.	.	.	.	.	.	.	2322	FLT3	IC9	IVS9	.	.	intron	NM_004119.2	NP_004110.2	-	Y	c.1205+56C>T	.	.	.	NM_004119.2(FLT3): c.1205+56C>T	;maf-5-some-pop,genotype-conflict	5008	0.837061	U	0.9712	0.837061	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2153000	.	4024	0.967900	-0.521	-0.069	-0.058	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	28624293	28624294	13q12.2	0	nullSample	.	G	ref	G	CC.TC	homo-ref	.	.	.	0	.	.	136351	C	601626(MK);613065(MK)	NN	.	.	.	.	.	.	.	2322	FLT3	C6	EX6	.	.	no-change	NM_004119.2	NP_004110.2	-	Y	c.680C=	.	.	.	NM_004119.2(FLT3): c.680C=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126374	0.402812	U	0.7688	0.558706	13006	0.477087	PASS	.	8644	0.233110	10390	121366	0.401224	.	.	.	.	.	.	rs1933437	.	4024	0.269100	-0.311	1.607	0.687	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	28624293	28624294	13q12.2	1	normal	.	G	snv	A	CC.TC	hom-alt	594	1.00	.	0	.	PASS	136351	C	601626(MK);613065(MK)	NN	.	.	.	.	.	.	.	2322	FLT3	C6	EX6	.	.	missense	NM_004119.2	NP_004110.2	-	Y	c.680C>T	p.T227M | p.Thr227Met	ACG=>ATG	P0=>NP	NM_004119.2(FLT3): c.680C>T (p.T227M)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126374	0.597188	U	0.7688	0.558706	13006	0.522913	PASS	2539	8644	0.766890	22378	121366	0.598776	5046	13199	7.65337e-01	46008	148966	6.05189e-01	rs1933437	.	4024	0.730900	-0.311	1.607	0.687	0.03	0.803	0.999	0.667	deleterious	ENST00000241453: c.680C>T (p.T227M)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5019176	.	.	.	.	.	no_record	134447	no_assertion_provided	not_provided	Likely Benign
13	28636083	28636084	13q12.2	0	nullSample	.	G	ref	G	GC.TC	homo-ref	.	.	.	0	.	.	136351	C	601626(MK);613065(MK)	NN	.	.	.	.	.	.	.	2322	FLT3	C3	EX3	.	.	no-change	NM_004119.2	NP_004110.2	-	Y	c.288C=	.	.	.	NM_004119.2(FLT3): c.288C=	;maf-5-some-pop	126416	0.018233	U	0.996	0.958067	13006	0.040058	PASS	-6	8654	0.001387	57	121408	0.017256	.	.	.	.	.	.	rs7338903	.	4024	0.002500	0.508	0.158	0.035	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	28636083	28636084	13q12.2	1	normal	.	G	snv	A	GC.TC	hom-alt	510	1.00	.	0	.	PASS	136351	C	601626(MK);613065(MK)	NN	.	.	.	.	.	.	.	2322	FLT3	C3	EX3	.	.	coding-synon	NM_004119.2	NP_004110.2	-	Y	c.288C>T	p.(D96=) | p.(Asp96=)	GAC=>GAT	.	NM_004119.2(FLT3): c.288C>T (p.(D96=))	;maf-5-some-pop	126416	0.981767	U	0.996	0.958067	13006	0.959942	PASS	4315	8654	0.998613	58666	121408	0.982744	8602	17224	9.98840e-01	119469	242440	9.85064e-01	rs7338903	.	4024	0.997500	0.508	0.158	0.035	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
13	28882947	28882948	13q12.2	0	nullSample	.	G	ref	G	GG.GT	homo-ref	.	.	.	0	.	.	165070	C	.	NN	.	.	.	.	.	.	.	2321	FLT1	IC28	IVS28	.	.	no-change	NM_002019.4	NP_002010.2	-	Y	c.3720+32C=	.	.	.	NM_002019.4(FLT1): c.3720+32C=	;maf-5-some-pop	126236	0.210289	U	1	0.73103	13006	0.352760	PASS	.	8648	0.001503	4002	121228	0.207865	.	.	.	.	.	.	rs9579177	.	4024	0.003000	-1.268	-0.629	-0.623	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	28882947	28882948	13q12.2	0	normal	.	G	snv	A	GG.GT	hom-alt	272	1.00	.	0	.	PASS	165070	C	.	NN	.	.	.	.	.	.	.	2321	FLT1	IC28	IVS28	.	.	intron	NM_002019.4	NP_002010.2	-	Y	c.3720+32C>T	.	.	.	NM_002019.4(FLT1): c.3720+32C>T	;maf-5-some-pop	126236	0.789711	U	1	0.73103	13006	0.647240	PASS	4311	8648	0.998497	39417	121228	0.792135	8597	17217	9.98666e-01	81920	197967	8.04593e-01	rs9579177	.	4024	0.997000	-1.268	-0.629	-0.623	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	28883060	28883061	13q12.2	0	nullSample	.	G	ref	G	AC.TA	homo-ref	.	.	.	0	.	.	165070	C	.	NN	.	.	.	.	.	.	.	2321	FLT1	C28	EX28	.	.	no-change	NM_002019.4	NP_002010.2	-	Y	c.3639C=	.	.	.	NM_002019.4(FLT1): c.3639C=	;maf-5-some-pop	126322	0.210320	U	1	0.730831	13006	0.353452	PASS	.	8654	0.001502	4005	121314	0.207890	.	.	.	.	.	.	rs7993418	.	4024	0.003000	-1.322	-1.579	-1.877	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	28883060	28883061	13q12.2	1	normal	.	G	snv	A	AC.TA	hom-alt	371	1.00	.	0	.	PASS	165070	C	.	NN	.	.	.	.	.	.	.	2321	FLT1	C28	EX28	.	.	coding-synon	NM_002019.4	NP_002010.2	-	Y	c.3639C>T	p.(Y1213=) | p.(Tyr1213=)	TAC=>TAT	.	NM_002019.4(FLT1): c.3639C>T (p.(Y1213=))	;maf-5-some-pop	126322	0.789680	U	1	0.730831	13006	0.646548	PASS	4314	8654	0.998498	39442	121314	0.792110	8601	17225	9.98667e-01	81945	198012	8.04534e-01	rs7993418	.	4024	0.997000	-1.322	-1.579	-1.877	.	.	.	.	.	ENST00000282397: c.3639C>T (p.Y1213Y)	bone [femur|NS|NS]	osteosarcoma [NS|NS|NS]	CSV	5021791	.	.	.	.	.	.	.	.	.	Likely Benign
13	28885671	28885672	13q12.2	0	nullSample	.	C	ref	C	tc.tt	homo-ref	.	.	.	0	trf;(TTTC)n|Simple_repeat|Simple_repeat|+|93	.	165070	C	.	NN	.	.	.	.	.	.	.	2321	FLT1	IC27	IVS27	.	.	no-change	NM_002019.4	NP_002010.2	-	Y	c.3635+55G=	.	.	.	NM_002019.4(FLT1): c.3635+55G=	;maf-5-some-pop	5008	0.018970	U	1	0.98103	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4771238	.	4024	0.001500	-1.464	-1.911	-1.950	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	28885671	28885672	13q12.2	0	normal	.	C	snv	T	tc.tt	hom-alt	409	1.00	.	0	trf;(TTTC)n|Simple_repeat|Simple_repeat|+|93	PASS	165070	C	.	NN	.	.	.	.	.	.	.	2321	FLT1	IC27	IVS27	.	.	intron	NM_002019.4	NP_002010.2	-	Y	c.3635+55G>A	.	.	.	NM_002019.4(FLT1): c.3635+55G>A	;maf-5-some-pop	5008	0.981030	U	1	0.98103	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4771238	.	4024	0.998500	-1.464	-1.911	-1.950	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	28886092	28886093	13q12.2	0	normal	.	T	snv	C	CA.TC	hom-alt	353	1.00	.	0	.	PASS	165070	C	.	NN	.	.	.	.	.	.	.	2321	FLT1	IC26	IVS26	.	.	intron	NM_002019.4	NP_002010.2	-	Y	c.3492+37A>G	.	.	.	NM_002019.4(FLT1): c.3492+37A>G	;maf-5-some-pop	123974	0.018859	U	0.1538	0.0375399	13006	0.003229	PASS	99	8284	0.169845	108	118966	0.018072	239	2968	1.72900e-01	257	4483	1.84423e-02	rs2296186	.	4024	0.184100	-2.424	-0.841	-0.990	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	28886092	28886093	13q12.2	0	nullSample	.	T	ref	T	CA.TC	homo-ref	.	.	.	0	.	.	165070	C	.	NN	.	.	.	.	.	.	.	2321	FLT1	IC26	IVS26	.	.	no-change	NM_002019.4	NP_002010.2	-	Y	c.3492+37A=	.	.	.	NM_002019.4(FLT1): c.3492+37A=	;maf-5-some-pop	123974	0.981141	U	0.1538	0.0375399	13006	0.996771	PASS	.	8284	0.830155	57441	118966	0.981928	.	.	.	.	.	.	rs2296186	.	4024	0.815900	-2.424	-0.841	-0.990	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	28886112	28886113	13q12.2	0	nullSample	.	A	ref	A	TA.AT	homo-ref	.	.	.	0	.	.	165070	C	.	NN	.	.	.	.	.	.	.	2321	FLT1	IC26	IVS26	.	.	no-change	NM_002019.4	NP_002010.2	-	Y	c.3492+17T=	.	.	.	NM_002019.4(FLT1): c.3492+17T=	SingleClassTriAllelic;maf-5-some-pop	126348	0.007408	U	0	0.00239617	13006	0.024912	PASS	0	8646	0.000000	20	121340	0.006741	.	.	.	.	.	.	rs7328692	.	4024	0.001500	-0.119	-0.523	-0.236	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
13	28886112	28886113	13q12.2	1	normal	.	A	snv	G	TA.AT	hom-alt	342	1.00	.	0	.	PASS	165070	C	.	NN	.	.	.	.	.	.	.	2321	FLT1	IC26	IVS26	.	.	intron	NM_002019.4	NP_002010.2	-	Y	c.3492+17T>C	.	.	.	NM_002019.4(FLT1): c.3492+17T>C	SingleClassTriAllelic;maf-5-some-pop	126348	0.992141	U	1	0.974042	13006	0.975088	PASS	4323	8646	1.000000	59834	121340	0.992888	8620	17241	9.99942e-01	120922	243208	9.94057e-01	rs7328692	.	4024	0.998500	-0.119	-0.523	-0.236	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	28958954	28958955	13q12.3	0	normal	.	C	ref	C	GA.TG	het-alt	150	0.49	.	1	.	PASS	165070	C	.	NN	.	.	.	.	.	.	.	2321	FLT1	IC14	IVS14	.	.	no-change	NM_002019.4	NP_002010.2	-	Y	c.2116+67G=	.	.	.	NM_002019.4(FLT1): c.2116+67G=	;maf-5-some-pop,maf-5-all-pops	5008	0.402356	U	0.6081	0.597644	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3751395	.	4024	0.345400	-0.256	-0.007	0.098	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	28958954	28958955	13q12.3	0	normal	.	C	snv	A	GA.TG	het-ref	158	0.51	.	2	.	PASS	165070	C	.	NN	.	.	.	.	.	.	.	2321	FLT1	IC14	IVS14	.	.	intron	NM_002019.4	NP_002010.2	-	Y	c.2116+67G>T	.	.	.	NM_002019.4(FLT1): c.2116+67G>T	;maf-5-some-pop,maf-5-all-pops	5008	0.597644	U	0.6081	0.597644	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3751395	.	4024	0.654600	-0.256	-0.007	0.098	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	28964324	28964325	13q12.3	0	normal	.	G	ref	G	TC.TG	het-alt	133	0.46	.	1	.	PASS	165070	C	.	NN	.	.	.	.	.	.	.	2321	FLT1	IC12	IVS12	.	.	no-change	NM_001159920.1	NP_001153392.1	-	Y	c.1661-84C=	.	.	.	NM_001159920.1(FLT1): c.1661-84C=	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	5008	0.720847	U	0.4464	0.279153	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7983774	.	4020	0.591300	-0.153	0.179	0.350	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	28964324	28964325	13q12.3	0	normal	.	G	ref	G	TC.TG	het-alt	133	0.46	.	1	.	PASS	165070	C	.	NN	.	.	.	.	.	.	.	2321	FLT1	IC12	IVS12	.	.	no-change	NM_002019.4	NP_002010.2	-	N	c.1661-84C=	.	.	.	NM_002019.4(FLT1): c.1661-84C=	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	5008	0.720847	U	0.4464	0.279153	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7983774	.	4020	0.591300	-0.153	0.179	0.350	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	28964324	28964325	13q12.3	0	normal	.	G	snv	A	TC.TG	het-ref	156	0.54	.	2	.	PASS	165070	C	.	NN	.	.	.	.	.	.	.	2321	FLT1	IC12	IVS12	.	.	intron	NM_001159920.1	NP_001153392.1	-	Y	c.1661-84C>T	.	.	.	NM_001159920.1(FLT1): c.1661-84C>T	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	5008	0.279153	U	0.4464	0.279153	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7983774	.	4020	0.408700	-0.153	0.179	0.350	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	28964324	28964325	13q12.3	0	normal	.	G	snv	A	TC.TG	het-ref	156	0.54	.	2	.	PASS	165070	C	.	NN	.	.	.	.	.	.	.	2321	FLT1	IC12	IVS12	.	.	intron	NM_002019.4	NP_002010.2	-	N	c.1661-84C>T	.	.	.	NM_002019.4(FLT1): c.1661-84C>T	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	5008	0.279153	U	0.4464	0.279153	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7983774	.	4020	0.408700	-0.153	0.179	0.350	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	32841618	32841619	13q13.1	0	nullSample	.	C	ref	C	CA.CC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr13: g.32841618C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.540935	U	0.4673	0.459065	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1380945	.	.	.	0.484	-0.260	-0.582	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	32841618	32841619	13q13.1	0	normal	.	C	snv	T	CA.CC	hom-alt	310	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr13: g.32841618C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.459065	U	0.4673	0.459065	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1380945	.	.	.	0.484	-0.260	-0.582	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	32847832	32847833	13q13.1	0	normal	.	T	ref	T	AG.TT	het-alt	246	0.51	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr13: g.32847832T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.680511	U	0.4177	0.319489	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12877839	.	.	.	0.397	1.125	1.080	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	32847832	32847833	13q13.1	0	normal	.	T	snv	A	AG.TT	het-ref	233	0.49	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr13: g.32847832T>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.319489	U	0.4177	0.319489	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12877839	.	.	.	0.397	1.125	1.080	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	32859153	32859154	13q13.1	0	normal	.	C	ref	C	AT.TT	het-alt	140	0.56	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr13: g.32859153C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.699880	U	0.5308	0.30012	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1460818	.	.	.	0.561	-1.913	-1.975	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	32859153	32859154	13q13.1	0	normal	.	C	snv	A	AT.TT	het-ref	109	0.44	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr13: g.32859153C>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.300120	U	0.5308	0.30012	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1460818	.	.	.	0.561	-1.913	-1.975	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	32859158	32859159	13q13.1	0	normal	.	G	ref	G	TT.TT	het-alt	110	0.44	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr13: g.32859158G= (intergenic)	;maf-5-some-pop	5008	0.770966	U	0.0437	0.229034	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs206092	.	.	.	-0.372	0.156	0.103	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	32859158	32859159	13q13.1	0	normal	.	G	snv	T	TT.TT	het-ref	140	0.56	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr13: g.32859158G>T (intergenic)	;maf-5-some-pop	5008	0.229034	U	0.0437	0.229034	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs206092	.	.	.	-0.372	0.156	0.103	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	32906728	32906729	13q13.1	0	nullSample	.	A	ref	A	CA.AT	homo-ref	.	.	.	0	.	.	600185	C	114480(SK);155255(SK);176807(MK);194070(MK);600185(SK);605724(MK);612555(SK);613029(SK);613347(MK)	AD	Breast-ovarian cancer, familial, susceptibility to; Pancreatic cancer, susceptibility to, 2; Glioma susceptibility 3; Fanconi anemia, complementation group D1; Wilms tumor; Medulloblastoma	AD/AR	.	Allergy/Immunology/Infectious; Dermatologic; Hematologic; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Oncologic	23285130|22614657|21593217|21531449|21118973|20216074|19190154|18413374|18355772|18349832|18264087|16825431|15948173|15912495|15689453|14670928|14569130|12556369|12161607|12097290|12065746|12036267|12023993|12023992|11133358|10807385|10441598|9140390|8524414|8091231|7597059	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	675	BRCA2	C9	EX10	.	.	no-change	NM_000059.3	NP_000050.2	+	Y	c.1114A=	.	.	.	NM_000059.3(BRCA2): c.1114A=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125776	0.723206	U	0.2847	0.249401	12894	0.766791	PASS	.	8646	0.727157	31758	120768	0.722070	.	.	.	.	.	.	rs144848	.	4024	0.734300	-0.250	0.020	-0.147	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	32906728	32906729	13q13.1	1	normal	.	A	snv	C	CA.AT	hom-alt	715	1.00	.	0	.	PASS	600185	C	114480(SK);155255(SK);176807(MK);194070(MK);600185(SK);605724(MK);612555(SK);613029(SK);613347(MK)	AD	Breast-ovarian cancer, familial, susceptibility to; Pancreatic cancer, susceptibility to, 2; Glioma susceptibility 3; Fanconi anemia, complementation group D1; Wilms tumor; Medulloblastoma	AD/AR	.	Allergy/Immunology/Infectious; Dermatologic; Hematologic; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Oncologic	23285130|22614657|21593217|21531449|21118973|20216074|19190154|18413374|18355772|18349832|18264087|16825431|15948173|15912495|15689453|14670928|14569130|12556369|12161607|12097290|12065746|12036267|12023993|12023992|11133358|10807385|10441598|9140390|8524414|8091231|7597059	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	675	BRCA2	C9	EX10	.	.	missense	NM_000059.3	NP_000050.2	+	Y	c.1114A>C	p.N372H | p.Asn372His	AAT=>CAT	P0=>P+	NM_000059.3(BRCA2): c.1114A>C (p.N372H)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125776	0.276794	U	0.2847	0.249401	12894	0.233209	PASS	347	8646	0.272843	4939	120768	0.277930	654	4624	2.68307e-01	10055	68695	2.79496e-01	rs144848	.	4024	0.265700	-0.250	0.020	-0.147	0.14	0.116	0.739	0.259	neutral	ENST00000544455: c.1114A>C (p.N372H)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	147663	CM002750	NM_000059.3(BRCA2): c.1114A>C (p.N372H)	"Breast cancer, association with"	11062481	DFP	no_record	9329	reviewed_by_expert_panel	Benign	Likely Benign
13	32907534	32907535	13q13.1	0	normal	.	C	ref	C	GT.TT	het-alt	310	0.86	.	1	.	PASS	600185	C	114480(SK);155255(SK);176807(MK);194070(MK);600185(SK);605724(MK);612555(SK);613029(SK);613347(MK)	AD	Breast-ovarian cancer, familial, susceptibility to; Pancreatic cancer, susceptibility to, 2; Glioma susceptibility 3; Fanconi anemia, complementation group D1; Wilms tumor; Medulloblastoma	AD/AR	.	Allergy/Immunology/Infectious; Dermatologic; Hematologic; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Oncologic	23285130|22614657|21593217|21531449|21118973|20216074|19190154|18413374|18355772|18349832|18264087|16825431|15948173|15912495|15689453|14670928|14569130|12556369|12161607|12097290|12065746|12036267|12023993|12023992|11133358|10807385|10441598|9140390|8524414|8091231|7597059	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	675	BRCA2	IC9	IVS10	.	.	no-change	NM_000059.3	NP_000050.2	+	Y	c.1909+11C=	.	.	.	NM_000059.3(BRCA2): c.1909+11C=	;clinically-assoc,submitted-by-lsdb	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs794726968	.	.	.	-0.378	-2.467	-2.697	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
13	32907535	32907535	13q13.1	1	normal	.	.	ins	T	TC.TT	het-ref	50	0.14	.	2	.	PASS	600185	C	114480(SK);155255(SK);176807(MK);194070(MK);600185(SK);605724(MK);612555(SK);613029(SK);613347(MK)	AD	Breast-ovarian cancer, familial, susceptibility to; Pancreatic cancer, susceptibility to, 2; Glioma susceptibility 3; Fanconi anemia, complementation group D1; Wilms tumor; Medulloblastoma	AD/AR	.	Allergy/Immunology/Infectious; Dermatologic; Hematologic; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Oncologic	23285130|22614657|21593217|21531449|21118973|20216074|19190154|18413374|18355772|18349832|18264087|16825431|15948173|15912495|15689453|14670928|14569130|12556369|12161607|12097290|12065746|12036267|12023993|12023992|11133358|10807385|10441598|9140390|8524414|8091231|7597059	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	675	BRCA2	IC9	IVS10	.	.	intron	NM_000059.3	NP_000050.2	+	Y	c.1909+11_1909+12insT	.	.	.	NM_000059.3(BRCA2): c.1909+11_1909+12insT	MixedObserved;clinically-assoc,submitted-by-lsdb	64378	0.187968	U	.	.	.	.	VQSRTrancheINDEL96.00to97.00	0	4866	0.062269	0	68792	0.063888	.	.	.	.	.	.	rs587780560	.	4024	0.041500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	220876	criteria_provided,_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	Likely Benign
13	32913054	32913055	13q13.1	0	nullSample	.	A	ref	A	CT.TT	homo-ref	.	.	.	0	.	.	600185	C	114480(SK);155255(SK);176807(MK);194070(MK);600185(SK);605724(MK);612555(SK);613029(SK);613347(MK)	AD	Breast-ovarian cancer, familial, susceptibility to; Pancreatic cancer, susceptibility to, 2; Glioma susceptibility 3; Fanconi anemia, complementation group D1; Wilms tumor; Medulloblastoma	AD/AR	.	Allergy/Immunology/Infectious; Dermatologic; Hematologic; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Oncologic	23285130|22614657|21593217|21531449|21118973|20216074|19190154|18413374|18355772|18349832|18264087|16825431|15948173|15912495|15689453|14670928|14569130|12556369|12161607|12097290|12065746|12036267|12023993|12023992|11133358|10807385|10441598|9140390|8524414|8091231|7597059	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	675	BRCA2	C10	EX11	BRCA2 repeat	PF00634.13	no-change	NM_000059.3	NP_000050.2	+	Y	c.4563A=	.	.	.	NM_000059.3(BRCA2): c.4563A=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict	125962	0.007613	U	1	0.974042	13002	0.024227	PASS	.	8652	0.000116	25	120954	0.006854	.	.	.	.	.	.	rs206075	.	4024	0.001000	-0.213	0.602	0.599	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	32913054	32913055	13q13.1	1	normal	.	A	snv	G	CT.TT	hom-alt	732	1.00	.	0	.	PASS	600185	C	114480(SK);155255(SK);176807(MK);194070(MK);600185(SK);605724(MK);612555(SK);613029(SK);613347(MK)	AD	Breast-ovarian cancer, familial, susceptibility to; Pancreatic cancer, susceptibility to, 2; Glioma susceptibility 3; Fanconi anemia, complementation group D1; Wilms tumor; Medulloblastoma	AD/AR	.	Allergy/Immunology/Infectious; Dermatologic; Hematologic; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Oncologic	23285130|22614657|21593217|21531449|21118973|20216074|19190154|18413374|18355772|18349832|18264087|16825431|15948173|15912495|15689453|14670928|14569130|12556369|12161607|12097290|12065746|12036267|12023993|12023992|11133358|10807385|10441598|9140390|8524414|8091231|7597059	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	675	BRCA2	C10	EX11	BRCA2 repeat	PF00634.13	coding-synon	NM_000059.3	NP_000050.2	+	Y	c.4563A>G	p.(L1521=) | p.(Leu1521=)	CTA=>CTG	.	NM_000059.3(BRCA2): c.4563A>G (p.(L1521=))	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict	125962	0.992379	U	1	0.974042	13002	0.975773	PASS	4325	8652	0.999884	59672	120954	0.993138	8621	17243	9.99942e-01	121497	244277	9.94476e-01	rs206075	.	4024	0.999000	-0.213	0.602	0.599	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	132779	reviewed_by_expert_panel	Benign	Likely Benign
13	32915004	32915005	13q13.1	0	nullSample	.	G	ref	G	GT.TC	homo-ref	.	.	.	0	.	.	600185	C	114480(SK);155255(SK);176807(MK);194070(MK);600185(SK);605724(MK);612555(SK);613029(SK);613347(MK)	AD	Breast-ovarian cancer, familial, susceptibility to; Pancreatic cancer, susceptibility to, 2; Glioma susceptibility 3; Fanconi anemia, complementation group D1; Wilms tumor; Medulloblastoma	AD/AR	.	Allergy/Immunology/Infectious; Dermatologic; Hematologic; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Oncologic	23285130|22614657|21593217|21531449|21118973|20216074|19190154|18413374|18355772|18349832|18264087|16825431|15948173|15912495|15689453|14670928|14569130|12556369|12161607|12097290|12065746|12036267|12023993|12023992|11133358|10807385|10441598|9140390|8524414|8091231|7597059	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	675	BRCA2	C10	EX11	.	.	no-change	NM_000059.3	NP_000050.2	+	Y	c.6513G=	.	.	.	NM_000059.3(BRCA2): c.6513G=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	125994	0.007667	U	1	0.973642	13006	0.024527	PASS	.	8642	0.000116	26	120986	0.006910	.	.	.	.	.	.	rs206076	.	4024	0.001000	-1.471	-1.732	-1.095	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	32915004	32915005	13q13.1	1	normal	.	G	snv	C	GT.TC	hom-alt	707	1.00	.	0	.	PASS	600185	C	114480(SK);155255(SK);176807(MK);194070(MK);600185(SK);605724(MK);612555(SK);613029(SK);613347(MK)	AD	Breast-ovarian cancer, familial, susceptibility to; Pancreatic cancer, susceptibility to, 2; Glioma susceptibility 3; Fanconi anemia, complementation group D1; Wilms tumor; Medulloblastoma	AD/AR	.	Allergy/Immunology/Infectious; Dermatologic; Hematologic; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Oncologic	23285130|22614657|21593217|21531449|21118973|20216074|19190154|18413374|18355772|18349832|18264087|16825431|15948173|15912495|15689453|14670928|14569130|12556369|12161607|12097290|12065746|12036267|12023993|12023992|11133358|10807385|10441598|9140390|8524414|8091231|7597059	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	675	BRCA2	C10	EX11	.	.	coding-synon	NM_000059.3	NP_000050.2	+	Y	c.6513G>C	p.(V2171=) | p.(Val2171=)	GTG=>GTC	.	NM_000059.3(BRCA2): c.6513G>C (p.(V2171=))	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	125994	0.992262	U	1	0.973642	13006	0.975473	PASS	4320	8642	0.999884	59677	120986	0.993032	8269	16539	9.99940e-01	116135	233536	9.94303e-01	rs206076	.	4024	0.999000	-1.471	-1.732	-1.095	.	.	.	.	.	ENST00000544455: c.6513G>C (p.V2171V)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4147689	.	.	.	.	.	no_record	132780	reviewed_by_expert_panel	Benign	Likely Benign
13	32929386	32929387	13q13.1	0	normal	.	T	snv	C	AG.AG	hom-alt	595	1.00	.	0	.	PASS	600185	C	114480(SK);155255(SK);176807(MK);194070(MK);600185(SK);605724(MK);612555(SK);613029(SK);613347(MK)	AD	Breast-ovarian cancer, familial, susceptibility to; Pancreatic cancer, susceptibility to, 2; Glioma susceptibility 3; Fanconi anemia, complementation group D1; Wilms tumor; Medulloblastoma	AD/AR	.	Allergy/Immunology/Infectious; Dermatologic; Hematologic; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Oncologic	23285130|22614657|21593217|21531449|21118973|20216074|19190154|18413374|18355772|18349832|18264087|16825431|15948173|15912495|15689453|14670928|14569130|12556369|12161607|12097290|12065746|12036267|12023993|12023992|11133358|10807385|10441598|9140390|8524414|8091231|7597059	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	675	BRCA2	C13	EX14	.	.	no-change	NM_000059.3	NP_000050.2	+	Y	c.7397C=	.	.	.	NM_000059.3(BRCA2): c.7397C=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	126312	0.993009	U	1	0.975839	13002	0.977696	PASS	4324	8650	0.999884	59912	121304	0.993718	8618	17237	9.99942e-01	121794	244758	9.94984e-01	rs169547	.	.	.	-0.226	2.216	1.274	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	133738	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
13	32929386	32929387	13q13.1	1	nullSample	.	T	ref	T	AG.AG	homo-ref	.	.	.	0	.	.	600185	C	114480(SK);155255(SK);176807(MK);194070(MK);600185(SK);605724(MK);612555(SK);613029(SK);613347(MK)	AD	Breast-ovarian cancer, familial, susceptibility to; Pancreatic cancer, susceptibility to, 2; Glioma susceptibility 3; Fanconi anemia, complementation group D1; Wilms tumor; Medulloblastoma	AD/AR	.	Allergy/Immunology/Infectious; Dermatologic; Hematologic; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Oncologic	23285130|22614657|21593217|21531449|21118973|20216074|19190154|18413374|18355772|18349832|18264087|16825431|15948173|15912495|15689453|14670928|14569130|12556369|12161607|12097290|12065746|12036267|12023993|12023992|11133358|10807385|10441598|9140390|8524414|8091231|7597059	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	675	BRCA2	C13	EX14	.	.	missense	NM_000059.3	NP_000050.2	+	Y	c.7397C>T	p.A2466V | p.Ala2466Val	GCA=>GTA	NP=>NP	NM_000059.3(BRCA2): c.7397C>T (p.A2466V)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	126312	0.006991	U	1	0.975839	13002	0.022304	PASS	.	8650	0.000116	22	121304	0.006282	.	.	.	.	.	.	rs169547	.	.	.	-0.226	2.216	1.274	0.02	0.074	0.572	0.388	neutral	.	.	.	.	.	CM960194	NM_000059.3(BRCA2): c.7397C>T (p.A2466V)	Breast cancer	8665505	DM	.	.	.	.	Likely Benign
13	32930632	32930633	13q13.1	0	normal	.	C	ref	C	AA.GC	het-alt	301	0.52	.	1	.	PASS	600185	C	114480(SK);155255(SK);176807(MK);194070(MK);600185(SK);605724(MK);612555(SK);613029(SK);613347(MK)	AD	Breast-ovarian cancer, familial, susceptibility to; Pancreatic cancer, susceptibility to, 2; Glioma susceptibility 3; Fanconi anemia, complementation group D1; Wilms tumor; Medulloblastoma	AD/AR	.	Allergy/Immunology/Infectious; Dermatologic; Hematologic; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Oncologic	23285130|22614657|21593217|21531449|21118973|20216074|19190154|18413374|18355772|18349832|18264087|16825431|15948173|15912495|15689453|14670928|14569130|12556369|12161607|12097290|12065746|12036267|12023993|12023992|11133358|10807385|10441598|9140390|8524414|8091231|7597059	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	675	BRCA2	C14	EX15	BRCA2, helical	PF09169.5	no-change	NM_000059.3	NP_000050.2	+	Y	c.7504C=	.	.	.	NM_000059.3(BRCA2): c.7504C=	;clinically-assoc,submitted-by-lsdb	126032	0.999698	U	0	0.000399361	13006	0.998847	PASS	0	8642	1.000000	60476	121024	0.999703	.	.	.	.	.	.	rs55716624	.	.	.	-0.143	0.173	0.107	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	32930632	32930633	13q13.1	1	normal	.	C	snv	T	AA.GC	het-ref	279	0.48	.	2	.	PASS	600185	C	114480(SK);155255(SK);176807(MK);194070(MK);600185(SK);605724(MK);612555(SK);613029(SK);613347(MK)	AD	Breast-ovarian cancer, familial, susceptibility to; Pancreatic cancer, susceptibility to, 2; Glioma susceptibility 3; Fanconi anemia, complementation group D1; Wilms tumor; Medulloblastoma	AD/AR	.	Allergy/Immunology/Infectious; Dermatologic; Hematologic; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Oncologic	23285130|22614657|21593217|21531449|21118973|20216074|19190154|18413374|18355772|18349832|18264087|16825431|15948173|15912495|15689453|14670928|14569130|12556369|12161607|12097290|12065746|12036267|12023993|12023992|11133358|10807385|10441598|9140390|8524414|8091231|7597059	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	675	BRCA2	C14	EX15	BRCA2, helical	PF09169.5	missense	NM_000059.3	NP_000050.2	+	Y	c.7504C>T	p.R2502C | p.Arg2502Cys	CGC=>TGC	P+=>P0	NM_000059.3(BRCA2): c.7504C>T (p.R2502C)	;clinically-assoc,submitted-by-lsdb	126032	0.000302	U	0	0.000399361	13006	0.001153	PASS	0	8642	0.000000	0	121024	0.000297	0	0	0.00000e+00	0	65	2.64026e-04	rs55716624	.	.	.	-0.143	0.173	0.107	0.14	0	0.001	0.249	neutral	.	.	.	.	.	CM012590	NM_000059.3(BRCA2): c.7504C>T (p.R2502C)	Breast and/or ovarian cancer	.	DM	no_record	41563	criteria_provided,_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	Certain
13	32989793	32989794	13q13.1	0	normal	.	T	ref	T	TT.AG	het-alt	74	0.52	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr13: g.32989793T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.573882	U	0.2996	0.426118	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs472873	.	.	.	-0.355	-0.113	-0.111	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	32989793	32989794	13q13.1	0	normal	.	T	snv	C	TT.AG	het-ref	67	0.48	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr13: g.32989793T>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.426118	U	0.2996	0.426118	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs472873	.	.	.	-0.355	-0.113	-0.111	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	32998361	32998362	13q13.1	0	nullSample	.	A	ref	A	CA.TC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr13: g.32998361A= (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.619010	U	0.6548	0.38099	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs169562	.	.	.	-1.272	-0.058	-0.069	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	32998361	32998362	13q13.1	0	normal	.	A	snv	G	CA.TC	hom-alt	348	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr13: g.32998361A>G (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.380990	U	0.6548	0.38099	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs169562	.	.	.	-1.272	-0.058	-0.069	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	33000580	33000581	13q13.1	0	nullSample	.	G	ref	G	AG.GT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr13: g.33000580G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.537340	U	0.6548	0.46266	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs206336	.	.	.	0.514	-0.174	-0.179	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	33000580	33000581	13q13.1	0	normal	.	G	snv	C	AG.GT	hom-alt	418	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr13: g.33000580G>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.462660	U	0.6548	0.46266	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs206336	.	.	.	0.514	-0.174	-0.179	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	33011823	33011824	13q13.1	0	nullSample	.	C	ref	C	CA.AT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr13: g.33011823C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.183107	U	0.8839	0.816893	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2761365	.	.	.	-0.256	-0.200	-0.250	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	33011823	33011824	13q13.1	0	normal	.	C	snv	A	CA.AT	hom-alt	298	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr13: g.33011823C>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.816893	U	0.8839	0.816893	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2761365	.	.	.	-0.256	-0.200	-0.250	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	33011871	33011872	13q13.1	0	nullSample	.	C	ref	C	GC.GG	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr13: g.33011871C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.183307	U	0.8839	0.816693	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2761366	.	.	.	-0.254	-0.459	-0.545	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	33011871	33011872	13q13.1	0	normal	.	C	snv	T	GC.GG	hom-alt	265	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr13: g.33011871C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.816693	U	0.8839	0.816693	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2761366	.	.	.	-0.254	-0.459	-0.545	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	41515370	41515371	13q14.11	0	normal	.	C	ref	C	AG.GA	het-alt	245	0.54	.	1	.	PASS	189973	P	.	NN	.	.	.	.	.	.	.	1997	ELF1	C7	EX8	.	.	no-change	NM_172373.3	NP_758961.1	-	Y	c.942G=	.	.	.	NM_172373.3(ELF1): c.942G=	;maf-5-some-pop	126400	0.858204	U	0.0843	0.132388	13006	0.810933	PASS	-322	8652	0.915626	44850	121392	0.857816	.	.	.	.	.	.	rs7987185	.	4024	0.899400	-0.294	-0.272	-0.119	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	41515370	41515371	13q14.11	1	normal	.	C	snv	T	AG.GA	het-ref	209	0.46	.	2	.	PASS	189973	P	.	NN	.	.	.	.	.	.	.	1997	ELF1	C7	EX8	.	.	coding-synon	NM_172373.3	NP_758961.1	-	Y	c.942G>A	p.(S314=) | p.(Ser314=)	TCG=>TCA	.	NM_172373.3(ELF1): c.942G>A (p.(S314=))	;maf-5-some-pop	126400	0.141796	U	0.0843	0.132388	13006	0.189067	PASS	43	8652	0.084374	1414	121392	0.142184	72	1466	8.49954e-02	2685	34571	1.40405e-01	rs7987185	.	4024	0.100600	-0.294	-0.272	-0.119	.	.	.	.	.	ENST00000239882: c.942G>A (p.S314S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3999084	.	.	.	.	.	.	.	.	.	Likely Benign
13	48869012	48869013	13q14.2	0	nullSample	.	A	ref	A	CT.TG	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr13: g.48869012A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.426518	U	0.6875	0.573482	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10219833	.	.	.	-0.624	-0.470	-0.526	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	48869012	48869013	13q14.2	0	normal	.	A	snv	G	CT.TG	hom-alt	458	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr13: g.48869012A>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.573482	U	0.6875	0.573482	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10219833	.	.	.	-0.624	-0.470	-0.526	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	48878270	48878271	13q14.2	0	nullSample	.	T	ref	T	GA.CC	homo-ref	.	.	.	0	.	.	614041	C	109800(MK);180200(MK);182280(MK);259500(MK)	AD;AR	Retinoblastoma	AD	.	Oncologic	Oncologic	22355046|22293180|22237022|22103627|22084214|21150892|20301625|19280657|17613328|17096365|16936756|16631255|16606893|14996857|12598449|12541220|12523888|12488270|12096963|11709011|11449317|11382640|11382638|11097606|10561222|10502774|9311732|8651278|7795591|6930517|6696673|6654325|3175621|2895471|2885916|2876425|1066869|268552	H62;H68	5925	RB1	IC1	IVS1	.	.	no-change	NM_000321.2	NP_000312.2	+	Y	c.137+86T=	.	.	.	NM_000321.2(RB1): c.137+86T=	;	5008	0.008986	U	0.999	0.991014	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2854351	.	4024	0.001000	-0.368	0.097	0.275	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	48878270	48878271	13q14.2	0	normal	.	T	snv	C	GA.CC	hom-alt	220	1.00	.	0	.	PASS	614041	C	109800(MK);180200(MK);182280(MK);259500(MK)	AD;AR	Retinoblastoma	AD	.	Oncologic	Oncologic	22355046|22293180|22237022|22103627|22084214|21150892|20301625|19280657|17613328|17096365|16936756|16631255|16606893|14996857|12598449|12541220|12523888|12488270|12096963|11709011|11449317|11382640|11382638|11097606|10561222|10502774|9311732|8651278|7795591|6930517|6696673|6654325|3175621|2895471|2885916|2876425|1066869|268552	H62;H68	5925	RB1	IC1	IVS1	.	.	intron	NM_000321.2	NP_000312.2	+	Y	c.137+86T>C	.	.	.	NM_000321.2(RB1): c.137+86T>C	;	5008	0.991014	U	0.999	0.991014	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2854351	.	4024	0.999000	-0.368	0.097	0.275	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	48919357	48919358	13q14.2	0	nullSample	.	T	ref	T	GG.TT	homo-ref	.	.	.	0	.	.	614041	C	109800(MK);180200(MK);182280(MK);259500(MK)	AD;AR	Retinoblastoma	AD	.	Oncologic	Oncologic	22355046|22293180|22237022|22103627|22084214|21150892|20301625|19280657|17613328|17096365|16936756|16631255|16606893|14996857|12598449|12541220|12523888|12488270|12096963|11709011|11449317|11382640|11382638|11097606|10561222|10502774|9311732|8651278|7795591|6930517|6696673|6654325|3175621|2895471|2885916|2876425|1066869|268552	H62;H68	5925	RB1	IC4	IVS4	.	.	no-change	NM_000321.2	NP_000312.2	+	Y	c.500+23T=	.	.	.	NM_000321.2(RB1): c.500+23T=	;maf-5-some-pop,genotype-conflict	126194	0.041119	U	0.998	0.913738	12988	0.071682	PASS	.	8652	0.002658	256	121186	0.039254	.	.	.	.	.	.	rs198617	.	4024	0.004200	-0.335	-2.501	-2.345	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	48919357	48919358	13q14.2	0	normal	.	T	snv	G	GG.TT	hom-alt	544	1.00	.	0	.	PASS	614041	C	109800(MK);180200(MK);182280(MK);259500(MK)	AD;AR	Retinoblastoma	AD	.	Oncologic	Oncologic	22355046|22293180|22237022|22103627|22084214|21150892|20301625|19280657|17613328|17096365|16936756|16631255|16606893|14996857|12598449|12541220|12523888|12488270|12096963|11709011|11449317|11382640|11382638|11097606|10561222|10502774|9311732|8651278|7795591|6930517|6696673|6654325|3175621|2895471|2885916|2876425|1066869|268552	H62;H68	5925	RB1	IC4	IVS4	.	.	intron	NM_000321.2	NP_000312.2	+	Y	c.500+23T>G	.	.	.	NM_000321.2(RB1): c.500+23T>G	;maf-5-some-pop,genotype-conflict	126194	0.958881	U	0.998	0.913738	12988	0.928318	PASS	4304	8652	0.997342	56092	121186	0.960746	8568	17190	9.96753e-01	113188	234508	9.62977e-01	rs198617	.	4024	0.995800	-0.335	-2.501	-2.345	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	255825	criteria_provided,_single_submitter	Benign	Benign
13	48921883	48921884	13q14.2	0	nullSample	.	A	ref	A	AT.AA	homo-ref	.	.	.	0	.	.	614041	C	109800(MK);180200(MK);182280(MK);259500(MK)	AD;AR	Retinoblastoma	AD	.	Oncologic	Oncologic	22355046|22293180|22237022|22103627|22084214|21150892|20301625|19280657|17613328|17096365|16936756|16631255|16606893|14996857|12598449|12541220|12523888|12488270|12096963|11709011|11449317|11382640|11382638|11097606|10561222|10502774|9311732|8651278|7795591|6930517|6696673|6654325|3175621|2895471|2885916|2876425|1066869|268552	H62;H68	5925	RB1	IC4	IVS4	.	.	no-change	NM_000321.2	NP_000312.2	+	Y	c.501-77A=	.	.	.	NM_000321.2(RB1): c.501-77A=	;maf-5-some-pop,genotype-conflict	5008	0.096645	U	0.998	0.903355	4522	0.077621	.	.	.	.	.	.	.	.	.	.	.	.	.	rs198616	.	4024	0.004200	-0.119	-1.404	-0.972	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	48921883	48921884	13q14.2	0	normal	.	A	snv	G	AT.AA	hom-alt	346	1.00	.	0	.	PASS	614041	C	109800(MK);180200(MK);182280(MK);259500(MK)	AD;AR	Retinoblastoma	AD	.	Oncologic	Oncologic	22355046|22293180|22237022|22103627|22084214|21150892|20301625|19280657|17613328|17096365|16936756|16631255|16606893|14996857|12598449|12541220|12523888|12488270|12096963|11709011|11449317|11382640|11382638|11097606|10561222|10502774|9311732|8651278|7795591|6930517|6696673|6654325|3175621|2895471|2885916|2876425|1066869|268552	H62;H68	5925	RB1	IC4	IVS4	.	.	intron	NM_000321.2	NP_000312.2	+	Y	c.501-77A>G	.	.	.	NM_000321.2(RB1): c.501-77A>G	;maf-5-some-pop,genotype-conflict	5008	0.903355	U	0.998	0.903355	4522	0.922379	.	.	.	.	.	.	.	.	.	.	.	.	.	rs198616	.	4024	0.995800	-0.119	-1.404	-0.972	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	48953654	48953655	13q14.2	0	normal	.	C	ref	C	ct.aa	het-alt	26	0.26	.	1	FLAM_C|SINE|Alu|+|130	PASS	614041	C	109800(MK);180200(MK);182280(MK);259500(MK)	AD;AR	Retinoblastoma	AD	.	Oncologic	Oncologic	22355046|22293180|22237022|22103627|22084214|21150892|20301625|19280657|17613328|17096365|16936756|16631255|16606893|14996857|12598449|12541220|12523888|12488270|12096963|11709011|11449317|11382640|11382638|11097606|10561222|10502774|9311732|8651278|7795591|6930517|6696673|6654325|3175621|2895471|2885916|2876425|1066869|268552	H62;H68	5925	RB1	IC13	IVS13	.	.	no-change	NM_000321.2	NP_000312.2	+	Y	c.1333-75C=	.	.	.	NM_000321.2(RB1): c.1333-75C=	;	0	0	U	0.752	0.72524	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs202022369	.	.	.	-0.444	-0.038	-0.182	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	48953655	48953655	13q14.2	0	normal	.	.	ins	A	tc.aa	het-ref	74	0.74	.	2	FLAM_C|SINE|Alu|+|130	PASS	614041	C	109800(MK);180200(MK);182280(MK);259500(MK)	AD;AR	Retinoblastoma	AD	.	Oncologic	Oncologic	22355046|22293180|22237022|22103627|22084214|21150892|20301625|19280657|17613328|17096365|16936756|16631255|16606893|14996857|12598449|12541220|12523888|12488270|12096963|11709011|11449317|11382640|11382638|11097606|10561222|10502774|9311732|8651278|7795591|6930517|6696673|6654325|3175621|2895471|2885916|2876425|1066869|268552	H62;H68	5925	RB1	IC13	IVS13	.	.	intron	NM_000321.2	NP_000312.2	+	Y	c.1333-75_1333-74insA	.	.	.	NM_000321.2(RB1): c.1333-75_1333-74insA	;maf-5-some-pop,maf-5-all-pops	5008	0.725240	U	0.752	0.72524	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11449461	.	4024	0.502700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	48954093	48954095	13q14.2	0	normal	.	AA	ref	AA	ct.aa	het-alt	4	0.36	.	1	AluSc|SINE|Alu|+|303;trf	DUBIOUS	614041	C	109800(MK);180200(MK);182280(MK);259500(MK)	AD;AR	Retinoblastoma	AD	.	Oncologic	Oncologic	22355046|22293180|22237022|22103627|22084214|21150892|20301625|19280657|17613328|17096365|16936756|16631255|16606893|14996857|12598449|12541220|12523888|12488270|12096963|11709011|11449317|11382640|11382638|11097606|10561222|10502774|9311732|8651278|7795591|6930517|6696673|6654325|3175621|2895471|2885916|2876425|1066869|268552	H62;H68	5925	RB1	IC14	IVS14	.	.	no-change	NM_000321.2	NP_000312.2	+	Y	c.1390-95_1390-94=	.	.	.	NM_000321.2(RB1): c.1390-95_1390-94=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
13	48954093	48954095	13q14.2	0	normal	.	AA	del	.	ct.aa	het-ref	7	0.64	.	2	AluSc|SINE|Alu|+|303;trf	DUBIOUS	614041	C	109800(MK);180200(MK);182280(MK);259500(MK)	AD;AR	Retinoblastoma	AD	.	Oncologic	Oncologic	22355046|22293180|22237022|22103627|22084214|21150892|20301625|19280657|17613328|17096365|16936756|16631255|16606893|14996857|12598449|12541220|12523888|12488270|12096963|11709011|11449317|11382640|11382638|11097606|10561222|10502774|9311732|8651278|7795591|6930517|6696673|6654325|3175621|2895471|2885916|2876425|1066869|268552	H62;H68	5925	RB1	IC14	IVS14	.	.	intron	NM_000321.2	NP_000312.2	+	Y	c.1390-95_1390-94delAA	.	.	.	NM_000321.2(RB1): c.1390-95_1390-94delAA	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
13	48954159	48954160	13q14.2	0	normal	.	T	ref	T	TC.TT	het-alt	145	0.78	.	1	.	PASS	614041	C	109800(MK);180200(MK);182280(MK);259500(MK)	AD;AR	Retinoblastoma	AD	.	Oncologic	Oncologic	22355046|22293180|22237022|22103627|22084214|21150892|20301625|19280657|17613328|17096365|16936756|16631255|16606893|14996857|12598449|12541220|12523888|12488270|12096963|11709011|11449317|11382640|11382638|11097606|10561222|10502774|9311732|8651278|7795591|6930517|6696673|6654325|3175621|2895471|2885916|2876425|1066869|268552	H62;H68	5925	RB1	IC14	IVS14	.	.	no-change	NM_000321.2	NP_000312.2	+	Y	c.1390-29T=	.	.	.	NM_000321.2(RB1): c.1390-29T=	MixedObserved;	5495	0.993813	U	.	.	8674	0.870302	.	.	.	.	.	.	.	.	.	.	.	.	.	rs755845243	.	4020	0.566900	0.260	-0.095	0.585	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	48954159	48954160	13q14.2	0	normal	.	T	del	.	TC.TT	het-ref	40	0.22	.	2	.	PASS	614041	C	109800(MK);180200(MK);182280(MK);259500(MK)	AD;AR	Retinoblastoma	AD	.	Oncologic	Oncologic	22355046|22293180|22237022|22103627|22084214|21150892|20301625|19280657|17613328|17096365|16936756|16631255|16606893|14996857|12598449|12541220|12523888|12488270|12096963|11709011|11449317|11382640|11382638|11097606|10561222|10502774|9311732|8651278|7795591|6930517|6696673|6654325|3175621|2895471|2885916|2876425|1066869|268552	H62;H68	5925	RB1	IC14	IVS14	.	.	intron	NM_000321.2	NP_000312.2	+	Y	c.1390-29delT	.	.	.	NM_000321.2(RB1): c.1390-29delT	MixedObserved;	5495	0.006187	U	.	.	8674	0.061333	PASS	0	334	0.365269	0	13546	0.403145	.	.	.	.	.	.	rs755845243	.	4020	0.433100	0.260	-0.095	0.585	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	495815	criteria_provided,_single_submitter	Benign	Benign
13	49033746	49033747	13q14.2	0	nullSample	.	G	ref	G	GC.AT	homo-ref	.	.	.	0	.	.	614041	C	109800(MK);180200(MK);182280(MK);259500(MK)	AD;AR	Retinoblastoma	AD	.	Oncologic	Oncologic	22355046|22293180|22237022|22103627|22084214|21150892|20301625|19280657|17613328|17096365|16936756|16631255|16606893|14996857|12598449|12541220|12523888|12488270|12096963|11709011|11449317|11382640|11382638|11097606|10561222|10502774|9311732|8651278|7795591|6930517|6696673|6654325|3175621|2895471|2885916|2876425|1066869|268552	H62;H68	5925	RB1	IC19	IVS19	.	.	no-change	NM_000321.2	NP_000312.2	+	Y	c.1961-77G=	.	.	.	NM_000321.2(RB1): c.1961-77G=	;maf-5-some-pop,genotype-conflict	5008	0.132788	U	0.998	0.867212	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs198580	.	4024	0.004200	-0.269	0.239	0.078	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	49033746	49033747	13q14.2	0	normal	.	G	snv	A	GC.AT	hom-alt	347	1.00	.	0	.	PASS	614041	C	109800(MK);180200(MK);182280(MK);259500(MK)	AD;AR	Retinoblastoma	AD	.	Oncologic	Oncologic	22355046|22293180|22237022|22103627|22084214|21150892|20301625|19280657|17613328|17096365|16936756|16631255|16606893|14996857|12598449|12541220|12523888|12488270|12096963|11709011|11449317|11382640|11382638|11097606|10561222|10502774|9311732|8651278|7795591|6930517|6696673|6654325|3175621|2895471|2885916|2876425|1066869|268552	H62;H68	5925	RB1	IC19	IVS19	.	.	intron	NM_000321.2	NP_000312.2	+	Y	c.1961-77G>A	.	.	.	NM_000321.2(RB1): c.1961-77G>A	;maf-5-some-pop,genotype-conflict	5008	0.867212	U	0.998	0.867212	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs198580	.	4024	0.995800	-0.269	0.239	0.078	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	49051011	49051012	13q14.2	0	nullSample	.	C	ref	C	GC.GA	homo-ref	.	.	.	0	.	.	614041	C	109800(MK);180200(MK);182280(MK);259500(MK)	AD;AR	Retinoblastoma	AD	.	Oncologic	Oncologic	22355046|22293180|22237022|22103627|22084214|21150892|20301625|19280657|17613328|17096365|16936756|16631255|16606893|14996857|12598449|12541220|12523888|12488270|12096963|11709011|11449317|11382640|11382638|11097606|10561222|10502774|9311732|8651278|7795591|6930517|6696673|6654325|3175621|2895471|2885916|2876425|1066869|268552	H62;H68	5925	RB1	IC25	IVS25	.	.	no-change	NM_000321.2	NP_000312.2	+	Y	c.2663+33C=	.	.	.	NM_000321.2(RB1): c.2663+33C=	;maf-5-some-pop	126278	0.047578	U	0.998	0.884984	13006	0.104183	PASS	-10	8652	0.002543	476	121270	0.044793	.	.	.	.	.	.	rs3020646	.	4024	0.004200	-0.332	-0.171	-0.319	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	49051011	49051012	13q14.2	0	normal	.	C	snv	T	GC.GA	hom-alt	411	1.00	.	0	.	PASS	614041	C	109800(MK);180200(MK);182280(MK);259500(MK)	AD;AR	Retinoblastoma	AD	.	Oncologic	Oncologic	22355046|22293180|22237022|22103627|22084214|21150892|20301625|19280657|17613328|17096365|16936756|16631255|16606893|14996857|12598449|12541220|12523888|12488270|12096963|11709011|11449317|11382640|11382638|11097606|10561222|10502774|9311732|8651278|7795591|6930517|6696673|6654325|3175621|2895471|2885916|2876425|1066869|268552	H62;H68	5925	RB1	IC25	IVS25	.	.	intron	NM_000321.2	NP_000312.2	+	Y	c.2663+33C>T	.	.	.	NM_000321.2(RB1): c.2663+33C>T	;maf-5-some-pop	126278	0.952422	U	0.998	0.884984	13006	0.895817	PASS	4305	8652	0.997457	55679	121270	0.955207	8573	17195	9.97043e-01	113585	235649	9.59061e-01	rs3020646	.	4024	0.995800	-0.332	-0.171	-0.319	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	255823	criteria_provided,_single_submitter	Benign	Benign
13	95713714	95713715	13q32.1	0	normal	.	G	snv	T	CC.GT	het-ref	167	0.51	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr13: g.95713714G>T (intergenic)	SingleClassTriAllelic;maf-5-some-pop,maf-5-all-pops	5008	0.163339	U	0.2688	0.163339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9561778	.	.	.	-0.868	-0.489	-0.502	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	95713714	95713715	13q32.1	0	normal	.	G	ref	G	CC.GT	het-alt	160	0.49	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr13: g.95713714G= (intergenic)	SingleClassTriAllelic;maf-5-some-pop,maf-5-all-pops	5008	0.835264	U	0	0.00139776	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9561778	.	.	.	-0.868	-0.489	-0.502	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
13	95713722	95713723	13q32.1	0	normal	.	G	ref	G	AC.TT	het-alt	165	0.50	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr13: g.95713722G= (intergenic)	;	5008	0.999601	U	0	0.000399361	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs147250554	.	.	.	0.460	0.846	0.856	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
13	95713722	95713723	13q32.1	0	normal	.	G	snv	A	AC.TT	het-ref	166	0.50	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr13: g.95713722G>A (intergenic)	;	5008	0.000399	U	0	0.000399361	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs147250554	.	.	.	0.460	0.846	0.856	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
13	103385298	103385299	13q33.1	0	nullSample	.	A	ref	A	AG.AA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	643677	CCDC168	C4E	EX4E	.	.	no-change	NM_001146197.1	NP_001139669.1	-	Y	c.17748T=	.	.	.	NM_001146197.1(CCDC168): c.17748T=	;maf-5-some-pop	24842	0.013163	U	1	0.972843	4566	0.025843	PASS	0	622	0.000000	11	19834	0.009630	.	.	.	.	.	.	rs7335290	.	4024	0.001500	-0.366	-2.356	-2.514	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	103385298	103385299	13q33.1	1	normal	.	A	snv	C	AG.AA	hom-alt	182	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	643677	CCDC168	C4E	EX4E	.	.	missense	NM_001146197.1	NP_001139669.1	-	Y	c.17748T>G	p.F5916L | p.Phe5916Leu	TTT=>TTG	NP=>NP	NM_001146197.1(CCDC168): c.17748T>G (p.F5916L)	;maf-5-some-pop	24842	0.986837	U	1	0.972843	4566	0.974157	PASS	311	622	1.000000	9737	19834	0.990370	5120	10240	1.00000e+00	73459	147656	9.94571e-01	rs7335290	.	4024	0.998500	-0.366	-2.356	-2.514	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
13	103504516	103504517	13q33.1	0	normal	.	T	ref	T	CA.GG	het-alt	290	0.49	.	1	.	PASS	133530	C	278780(MK)	AR	Xeroderma pigmentosum, group G; Xeroderma pigmentosum, group G/Cockayne syndrome	AR	Allelic with Cerebrooculofacioskeletal syndrome 3 (AR)	Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Dermatologic; Oncologic	20301571|11841555|11228268|11219864|9096355|8818951|8317483|3620347|492197	.	2073	ERCC5	C2	EX2	XPG N-terminal domain	PF00752.12	no-change	NM_000123.3	NP_000114.2	+	Y	c.138T=	.	.	.	NM_000123.3(ERCC5): c.138T=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126394	0.472333	U	0.25	0.493011	13006	0.388205	PASS	-833	8646	0.733981	14543	121386	0.470903	.	.	.	.	.	.	rs1047768	.	.	.	-1.444	-0.189	-0.522	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	103504516	103504517	13q33.1	1	normal	.	T	snv	C	CA.GG	het-ref	299	0.51	.	2	.	PASS	133530	C	278780(MK)	AR	Xeroderma pigmentosum, group G; Xeroderma pigmentosum, group G/Cockayne syndrome	AR	Allelic with Cerebrooculofacioskeletal syndrome 3 (AR)	Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Dermatologic; Oncologic	20301571|11841555|11228268|11219864|9096355|8818951|8317483|3620347|492197	.	2073	ERCC5	C2	EX2	XPG N-terminal domain	PF00752.12	coding-synon	NM_000123.3	NP_000114.2	+	Y	c.138T>C	p.(H46=) | p.(His46=)	CAT=>CAC	.	NM_000123.3(ERCC5): c.138T>C (p.(H46=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126394	0.527667	U	0.25	0.493011	13006	0.611795	PASS	317	8646	0.266019	18075	121386	0.529097	633	4569	2.64992e-01	35633	128018	5.20009e-01	rs1047768	.	.	.	-1.444	-0.189	-0.522	.	.	.	.	.	ENST00000355739: c.138T>C (p.H46H)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3753565	.	.	.	.	.	no_record	129009	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
13	103506685	103506686	13q33.1	0	normal	.	C	ref	C	CT.TA	het-alt	268	0.54	.	1	.	PASS	133530	C	278780(MK)	AR	Xeroderma pigmentosum, group G; Xeroderma pigmentosum, group G/Cockayne syndrome	AR	Allelic with Cerebrooculofacioskeletal syndrome 3 (AR)	Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Dermatologic; Oncologic	20301571|11841555|11228268|11219864|9096355|8818951|8317483|3620347|492197	.	2073	ERCC5	C4	EX4	.	.	no-change	NM_000123.3	NP_000114.2	+	Y	c.429C=	.	.	.	NM_000123.3(ERCC5): c.429C=	;maf-5-some-pop	126370	0.988613	U	0.0149	0.0371406	13006	0.974704	PASS	.	8650	0.983237	59475	121362	0.989676	.	.	.	.	.	.	rs4140390	.	.	.	-0.795	0.447	0.888	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	103506685	103506686	13q33.1	1	normal	.	C	snv	G	CT.TA	het-ref	225	0.46	.	2	.	PASS	133530	C	278780(MK)	AR	Xeroderma pigmentosum, group G; Xeroderma pigmentosum, group G/Cockayne syndrome	AR	Allelic with Cerebrooculofacioskeletal syndrome 3 (AR)	Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Dermatologic; Oncologic	20301571|11841555|11228268|11219864|9096355|8818951|8317483|3620347|492197	.	2073	ERCC5	C4	EX4	.	.	coding-synon	NM_000123.3	NP_000114.2	+	Y	c.429C>G	p.(L143=) | p.(Leu143=)	CTC=>CTG	.	NM_000123.3(ERCC5): c.429C>G (p.(L143=))	;maf-5-some-pop	126370	0.011387	U	0.0149	0.0371406	13006	0.025296	PASS	1	8650	0.016763	47	121362	0.010324	4	323	1.87290e-02	65	2133	8.66193e-03	rs4140390	.	.	.	-0.795	0.447	0.888	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	310912	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	VUS
13	103510735	103510736	13q33.1	0	normal	.	C	ref	C	AG.GC	het-alt	357	0.55	.	1	.	PASS	133530	C	278780(MK)	AR	Xeroderma pigmentosum, group G; Xeroderma pigmentosum, group G/Cockayne syndrome	AR	Allelic with Cerebrooculofacioskeletal syndrome 3 (AR)	Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Dermatologic; Oncologic	20301571|11841555|11228268|11219864|9096355|8818951|8317483|3620347|492197	.	2073	ERCC5	C6	EX6	.	.	no-change	NM_000123.3	NP_000114.2	+	Y	c.640C=	.	.	.	NM_000123.3(ERCC5): c.640C=	;clinically-assoc,submitted-by-lsdb	126352	0.997135	U	0.0149	0.00519169	13006	0.999692	PASS	.	8654	0.983245	60338	121344	0.997231	.	.	.	.	.	.	rs56255799	.	.	.	-0.182	1.100	0.585	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	103510735	103510736	13q33.1	1	normal	.	C	snv	T	AG.GC	het-ref	295	0.45	.	2	.	PASS	133530	C	278780(MK)	AR	Xeroderma pigmentosum, group G; Xeroderma pigmentosum, group G/Cockayne syndrome	AR	Allelic with Cerebrooculofacioskeletal syndrome 3 (AR)	Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Dermatologic; Oncologic	20301571|11841555|11228268|11219864|9096355|8818951|8317483|3620347|492197	.	2073	ERCC5	C6	EX6	.	.	missense	NM_000123.3	NP_000114.2	+	Y	c.640C>T	p.R214C | p.Arg214Cys	CGC=>TGC	P+=>P0	NM_000123.3(ERCC5): c.640C>T (p.R214C)	;clinically-assoc,submitted-by-lsdb	126352	0.002865	U	0.0149	0.00519169	13006	0.000308	PASS	1	8654	0.016755	2	121344	0.002769	4	323	1.87268e-02	8	692	2.81244e-03	rs56255799	.	.	.	-0.182	1.100	0.585	0	1	1	0.945	deleterious	.	.	.	.	.	.	.	.	.	.	no_record	134180	criteria_provided,_single_submitter	Likely_benign	VUS
13	103513950	103513951	13q33.1	0	normal	.	A	ref	A	TC.GC	het-alt	305	0.47	.	1	.	PASS	133530	C	278780(MK)	AR	Xeroderma pigmentosum, group G; Xeroderma pigmentosum, group G/Cockayne syndrome	AR	Allelic with Cerebrooculofacioskeletal syndrome 3 (AR)	Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Dermatologic; Oncologic	20301571|11841555|11228268|11219864|9096355|8818951|8317483|3620347|492197	.	2073	ERCC5	C7	EX7	.	.	no-change	NM_000123.3	NP_000114.2	+	Y	c.767A=	.	.	.	NM_000123.3(ERCC5): c.767A=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	126366	0.987204	U	0.0149	0.0373403	13006	0.974012	PASS	.	8650	0.983237	59301	121358	0.988217	.	.	.	.	.	.	rs4150313	.	.	.	0.455	4.597	2.121	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	103513950	103513951	13q33.1	1	normal	.	A	snv	G	TC.GC	het-ref	348	0.53	.	2	.	PASS	133530	C	278780(MK)	AR	Xeroderma pigmentosum, group G; Xeroderma pigmentosum, group G/Cockayne syndrome	AR	Allelic with Cerebrooculofacioskeletal syndrome 3 (AR)	Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Dermatologic; Oncologic	20301571|11841555|11228268|11219864|9096355|8818951|8317483|3620347|492197	.	2073	ERCC5	C7	EX7	.	.	missense	NM_000123.3	NP_000114.2	+	Y	c.767A>G	p.Q256R | p.Gln256Arg	CAG=>CGG	P0=>P+	NM_000123.3(ERCC5): c.767A>G (p.Q256R)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	126366	0.012796	U	0.0149	0.0373403	13006	0.025988	PASS	1	8650	0.016763	52	121358	0.011783	4	323	1.87268e-02	72	2438	9.90461e-03	rs4150313	.	.	.	0.455	4.597	2.121	0	0.996	1	0.906	deleterious	.	.	.	.	.	.	.	.	.	.	no_record	134182	criteria_provided,_multiple_submitters,_no_conflicts	Likely_benign	VUS
13	103514090	103514091	13q33.1	0	nullSample	.	T	ref	T	TT.AC	homo-ref	.	.	.	0	.	.	133530	C	278780(MK)	AR	Xeroderma pigmentosum, group G; Xeroderma pigmentosum, group G/Cockayne syndrome	AR	Allelic with Cerebrooculofacioskeletal syndrome 3 (AR)	Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Dermatologic; Oncologic	20301571|11841555|11228268|11219864|9096355|8818951|8317483|3620347|492197	.	2073	ERCC5	IC7	IVS7	.	.	no-change	NM_000123.3	NP_000114.2	+	Y	c.880+27T=	.	.	.	NM_000123.3(ERCC5): c.880+27T=	;	125868	0.000588	U	1	0.998203	13002	0.002307	PASS	0	8626	0.000000	0	120860	0.000538	.	.	.	.	.	.	rs7982448	.	.	.	-0.460	-0.391	-0.053	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	103514090	103514091	13q33.1	0	normal	.	T	snv	C	TT.AC	hom-alt	417	1.00	.	0	.	PASS	133530	C	278780(MK)	AR	Xeroderma pigmentosum, group G; Xeroderma pigmentosum, group G/Cockayne syndrome	AR	Allelic with Cerebrooculofacioskeletal syndrome 3 (AR)	Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Dermatologic; Oncologic	20301571|11841555|11228268|11219864|9096355|8818951|8317483|3620347|492197	.	2073	ERCC5	IC7	IVS7	.	.	intron	NM_000123.3	NP_000114.2	+	Y	c.880+27T>C	.	.	.	NM_000123.3(ERCC5): c.880+27T>C	;	125868	0.999412	U	1	0.998203	13002	0.997693	PASS	4313	8626	1.000000	60365	120860	0.999462	8618	17236	1.00000e+00	122521	245156	9.99535e-01	rs7982448	.	.	.	-0.460	-0.391	-0.053	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	103518768	103518769	13q33.1	0	nullSample	.	T	ref	T	TC.TC	homo-ref	.	.	.	0	.	.	133530	C	278780(MK)	AR	Xeroderma pigmentosum, group G; Xeroderma pigmentosum, group G/Cockayne syndrome	AR	Allelic with Cerebrooculofacioskeletal syndrome 3 (AR)	Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Dermatologic; Oncologic	20301571|11841555|11228268|11219864|9096355|8818951|8317483|3620347|492197	.	2073	ERCC5	IC10	IVS10	.	.	no-change	NM_000123.3	NP_000114.2	+	Y	c.2319+38T=	.	.	.	NM_000123.3(ERCC5): c.2319+38T=	;	126386	0.000601	U	1	0.998203	13006	0.002537	PASS	0	8652	0.000000	0	121378	0.000552	.	.	.	.	.	.	rs6491716	.	.	.	-0.215	0.611	-0.250	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	103518768	103518769	13q33.1	0	normal	.	T	snv	C	TC.TC	hom-alt	455	1.00	.	0	.	PASS	133530	C	278780(MK)	AR	Xeroderma pigmentosum, group G; Xeroderma pigmentosum, group G/Cockayne syndrome	AR	Allelic with Cerebrooculofacioskeletal syndrome 3 (AR)	Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Dermatologic; Oncologic	20301571|11841555|11228268|11219864|9096355|8818951|8317483|3620347|492197	.	2073	ERCC5	IC10	IVS10	.	.	intron	NM_000123.3	NP_000114.2	+	Y	c.2319+38T>C	.	.	.	NM_000123.3(ERCC5): c.2319+38T>C	;	126386	0.999399	U	1	0.998203	13006	0.997463	PASS	4326	8652	1.000000	60622	121378	0.999448	8622	17244	1.00000e+00	122751	245616	9.99536e-01	rs6491716	.	.	.	-0.215	0.611	-0.250	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	103527848	103527849	13q33.1	0	normal	.	G	snv	C	AA.GA	hom-alt	846	1.00	.	0	.	PASS	133530	C	278780(MK)	AR	Xeroderma pigmentosum, group G; Xeroderma pigmentosum, group G/Cockayne syndrome	AR	Allelic with Cerebrooculofacioskeletal syndrome 3 (AR)	Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Dermatologic; Oncologic	20301571|11841555|11228268|11219864|9096355|8818951|8317483|3620347|492197	.	2073	ERCC5	C15E	EX15E	.	.	no-change	NM_000123.3	NP_000114.2	+	Y	c.3157C=	.	.	.	NM_000123.3(ERCC5): c.3157C=	SingleClassTriAllelic;	126354	0.999375	U	1	0.998203	13006	0.997463	PASS	4326	8652	1.000000	60603	121346	0.999423	8622	17245	9.99942e-01	122917	245954	9.99512e-01	rs9514066	.	.	.	0.650	0.695	1.267	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	134172	no_assertion_provided	not_provided	Benign
13	103527848	103527849	13q33.1	1	nullSample	.	G	ref	G	AA.GA	homo-ref	.	.	.	0	.	.	133530	C	278780(MK)	AR	Xeroderma pigmentosum, group G; Xeroderma pigmentosum, group G/Cockayne syndrome	AR	Allelic with Cerebrooculofacioskeletal syndrome 3 (AR)	Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Dermatologic; Oncologic	20301571|11841555|11228268|11219864|9096355|8818951|8317483|3620347|492197	.	2073	ERCC5	C15E	EX15E	.	.	missense	NM_000123.3	NP_000114.2	+	Y	c.3157C>G	p.R1053G | p.Arg1053Gly	CGA=>GGA	P+=>P0	NM_000123.3(ERCC5): c.3157C>G (p.R1053G)	SingleClassTriAllelic;	126354	0.000601	U	1	0.998203	13006	0.002537	PASS	0	8652	0.000000	0	121346	0.000552	.	.	.	.	.	.	rs9514066	.	.	.	0.650	0.695	1.267	0.6	0	0	0.004	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
13	103527929	103527930	13q33.1	1	nullSample	.	G	ref	G	AA.GA	homo-ref	.	.	.	0	.	.	133530	C	278780(MK)	AR	Xeroderma pigmentosum, group G; Xeroderma pigmentosum, group G/Cockayne syndrome	AR	Allelic with Cerebrooculofacioskeletal syndrome 3 (AR)	Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Dermatologic; Oncologic	20301571|11841555|11228268|11219864|9096355|8818951|8317483|3620347|492197	.	2073	ERCC5	C15E	EX15E	.	.	missense	NM_000123.3	NP_000114.2	+	Y	c.3238C>G	p.R1080G | p.Arg1080Gly	CGA=>GGA	P+=>P0	NM_000123.3(ERCC5): c.3238C>G (p.R1080G)	MixedObserved,SingleClassTriAllelic;maf-5-some-pop	126324	0.000602	U	1	0.997204	13006	0.002537	PASS	0	8646	0.000000	0	121316	0.000552	.	.	.	.	.	.	rs9514067	.	.	.	-0.219	-0.053	0.061	0.42	0	0	0.014	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
13	103527929	103527930	13q33.1	0	normal	.	G	snv	C	AA.GA	hom-alt	801	1.00	.	0	.	PASS	133530	C	278780(MK)	AR	Xeroderma pigmentosum, group G; Xeroderma pigmentosum, group G/Cockayne syndrome	AR	Allelic with Cerebrooculofacioskeletal syndrome 3 (AR)	Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Dermatologic; Oncologic	20301571|11841555|11228268|11219864|9096355|8818951|8317483|3620347|492197	.	2073	ERCC5	C15E	EX15E	.	.	no-change	NM_000123.3	NP_000114.2	+	Y	c.3238C=	.	.	.	NM_000123.3(ERCC5): c.3238C=	MixedObserved,SingleClassTriAllelic;maf-5-some-pop	126324	0.999224	U	1	0.997204	13006	0.997463	PASS	4323	8646	1.000000	60574	121316	0.999308	8607	17215	9.99942e-01	122506	245159	9.99401e-01	rs9514067	.	.	.	-0.219	-0.053	0.061	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	134173	no_assertion_provided	not_provided	Benign
13	103528001	103528002	13q33.1	0	normal	.	G	ref	G	AA.AT	het-alt	370	0.52	.	1	.	PASS	133530	C	278780(MK)	AR	Xeroderma pigmentosum, group G; Xeroderma pigmentosum, group G/Cockayne syndrome	AR	Allelic with Cerebrooculofacioskeletal syndrome 3 (AR)	Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Dermatologic; Oncologic	20301571|11841555|11228268|11219864|9096355|8818951|8317483|3620347|492197	.	2073	ERCC5	C15E	EX15E	.	.	no-change	NM_000123.3	NP_000114.2	+	Y	c.3310G=	.	.	.	NM_000123.3(ERCC5): c.3310G=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126190	0.718995	U	0.4623	0.361422	13006	0.694218	PASS	.	8630	0.493743	32319	121182	0.722318	.	.	.	.	.	.	rs17655	.	.	.	0.650	3.426	1.221	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	103528001	103528002	13q33.1	1	normal	.	G	snv	C	AA.AT	het-ref	336	0.48	.	2	.	PASS	133530	C	278780(MK)	AR	Xeroderma pigmentosum, group G; Xeroderma pigmentosum, group G/Cockayne syndrome	AR	Allelic with Cerebrooculofacioskeletal syndrome 3 (AR)	Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Dermatologic; Oncologic	20301571|11841555|11228268|11219864|9096355|8818951|8317483|3620347|492197	.	2073	ERCC5	C15E	EX15E	.	.	missense	NM_000123.3	NP_000114.2	+	Y	c.3310G>C	p.D1104H | p.Asp1104His	GAT=>CAT	P-=>P+	NM_000123.3(ERCC5): c.3310G>C (p.D1104H)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126190	0.281005	U	0.4623	0.361422	13006	0.305782	PASS	1106	8630	0.506257	5378	121182	0.277682	2126	8536	4.95415e-01	10617	68103	2.76959e-01	rs17655	.	.	.	0.650	3.426	1.221	0.06	0.986	1	0.757	deleterious	ENST00000355739: c.3310G>C (p.D1104H)	biliary_tract [gallbladder|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3753566	.	.	.	.	.	no_record	129011	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
13	110408607	110408608	13q34	0	nullSample	.	C	ref	C	TA.TC	homo-ref	.	.	.	0	.	.	600797	P	125853(SK)	AD	.	.	.	.	.	.	.	8660	IRS2	3U1E	EX2E	.	.	no-change	NM_003749.2	NP_003740.2	-	Y	c.*43G=	.	.	.	NM_003749.2(IRS2): c.*43G=	;maf-5-some-pop,maf-5-all-pops	126200	0.150388	U	0.7788	0.822484	13006	0.158081	PASS	.	8628	0.219866	1485	121192	0.149267	.	.	.	.	.	.	rs1865434	.	.	.	-0.360	0.245	0.030	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	110408607	110408608	13q34	0	normal	.	C	snv	T	TA.TC	hom-alt	304	1.00	.	0	.	PASS	600797	P	125853(SK)	AD	.	.	.	.	.	.	.	8660	IRS2	3U1E	EX2E	.	.	utr-3	NM_003749.2	NP_003740.2	-	Y	c.*43G>A	.	.	.	NM_003749.2(IRS2): c.*43G>A	;maf-5-some-pop,maf-5-all-pops	126200	0.849612	U	0.7788	0.822484	13006	0.841919	PASS	2620	8628	0.780134	43991	121192	0.850733	5289	13503	7.83873e-01	90224	210330	8.55529e-01	rs1865434	.	.	.	-0.360	0.245	0.030	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	110435230	110435231	13q34	0	normal	.	C	ref	C	CG.CC	het-alt	288	0.47	.	1	.	PASS	600797	P	125853(SK)	AD	.	.	.	.	.	.	.	8660	IRS2	C1	EX1	.	.	no-change	NM_003749.2	NP_003740.2	-	Y	c.3170G=	.	.	.	NM_003749.2(IRS2): c.3170G=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	31554	0.633612	U	0.3929	0.283347	11934	0.767387	PASS	.	1896	0.533228	4854	26546	0.617946	.	.	.	.	.	.	rs1805097	.	4024	0.650300	0.644	0.768	0.922	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	110435230	110435231	13q34	1	normal	.	C	snv	T	CG.CC	het-ref	320	0.53	.	2	.	PASS	600797	P	125853(SK)	AD	.	.	.	.	.	.	.	8660	IRS2	C1	EX1	.	.	missense	NM_003749.2	NP_003740.2	-	Y	c.3170G>A	p.G1057D | p.Gly1057Asp	GGC=>GAC	P0=>P-	NM_003749.2(IRS2): c.3170G>A (p.G1057D)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	31554	0.366388	U	0.3929	0.283347	11934	0.232613	PASS	170	1896	0.466772	1723	26546	0.382054	900	4696	4.01848e-01	9751	53126	3.50454e-01	rs1805097	.	4024	0.349700	0.644	0.768	0.922	0.53	0.029	0.205	0.009	neutral	ENST00000375856: c.3170G>A (p.G1057D)	large_intestine [caecum|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3753571	CM003938	NM_003749.2(IRS2): c.3170G>A (p.G1057D)	"Diabetes in overweight people, association with"	11030756	DP	no_record	8820	no_assertion_criteria_provided	risk_factor	Likely Benign
13	110435301	110435302	13q34	0	normal	.	T	ref	T	gg.gg	het-alt	388	0.60	.	1	(CGG)n|Simple_repeat|Simple_repeat|+|117	PASS	600797	P	125853(SK)	AD	.	.	.	.	.	.	.	8660	IRS2	C1	EX1	.	.	no-change	NM_003749.2	NP_003740.2	-	Y	c.3099A=	.	.	.	NM_003749.2(IRS2): c.3099A=	;maf-5-some-pop,maf-5-all-pops	5008	0.724641	U	0.0595	0.275359	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9583424	.	4024	0.927900	-1.876	-3.826	-3.715	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	110435301	110435302	13q34	1	normal	.	T	snv	C	gg.gg	het-ref	259	0.40	.	2	(CGG)n|Simple_repeat|Simple_repeat|+|117	PASS	600797	P	125853(SK)	AD	.	.	.	.	.	.	.	8660	IRS2	C1	EX1	.	.	coding-synon	NM_003749.2	NP_003740.2	-	Y	c.3099A>G	p.(P1033=) | p.(Pro1033=)	CCA=>CCG	.	NM_003749.2(IRS2): c.3099A>G (p.(P1033=))	;maf-5-some-pop,maf-5-all-pops	5008	0.275359	U	0.0595	0.275359	.	.	VQSRTrancheINDEL97.00to99.00	0	52	0.038462	108	5118	0.214732	0	72	2.07493e-02	799	8560	1.73525e-01	rs9583424	.	4024	0.072100	-1.876	-3.826	-3.715	.	.	.	.	.	ENST00000375856: c.3099A>G (p.P1033P)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3753572	.	.	.	.	.	.	.	.	.	Likely Benign
13	110435727	110435728	13q34	0	normal	.	C	ref	C	CG.GT	het-alt	287	0.49	.	1	.	PASS	600797	P	125853(SK)	AD	.	.	.	.	.	.	.	8660	IRS2	C1	EX1	.	.	no-change	NM_003749.2	NP_003740.2	-	Y	c.2673G=	.	.	.	NM_003749.2(IRS2): c.2673G=	;maf-5-some-pop	28440	0.941174	U	0.0367	0.0269569	12142	0.981881	PASS	.	1218	0.908867	10222	23432	0.934363	.	.	.	.	.	.	rs75172981	.	4024	0.952000	-0.254	0.022	-0.452	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	110435727	110435728	13q34	1	normal	.	C	snv	G	CG.GT	het-ref	304	0.51	.	2	.	PASS	600797	P	125853(SK)	AD	.	.	.	.	.	.	.	8660	IRS2	C1	EX1	.	.	coding-synon	NM_003749.2	NP_003740.2	-	Y	c.2673G>C	p.(T891=) | p.(Thr891=)	ACG=>ACC	.	NM_003749.2(IRS2): c.2673G>C (p.(T891=))	;maf-5-some-pop	28440	0.058826	U	0.0367	0.0269569	12142	0.018119	PASS	5	1218	0.091133	44	23432	0.065637	10	387	5.42169e-02	144	4962	4.42199e-02	rs75172981	.	4024	0.048000	-0.254	0.022	-0.452	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
13	110435952	110435953	13q34	0	nullSample	.	A	ref	A	CC.CA	homo-ref	.	.	.	0	.	.	600797	P	125853(SK)	AD	.	.	.	.	.	.	.	8660	IRS2	C1	EX1	.	.	no-change	NM_003749.2	NP_003740.2	-	Y	c.2448T=	.	.	.	NM_003749.2(IRS2): c.2448T=	;maf-5-some-pop,maf-5-all-pops	24596	0.417629	U	0.4514	0.563898	12390	0.398224	PASS	-122	812	0.460591	1549	19588	0.412906	.	.	.	.	.	.	rs4773092	.	4024	0.578000	-0.945	-0.272	-0.221	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	110435952	110435953	13q34	1	normal	.	A	snv	G	CC.CA	hom-alt	592	1.00	.	0	.	PASS	600797	P	125853(SK)	AD	.	.	.	.	.	.	.	8660	IRS2	C1	EX1	.	.	coding-synon	NM_003749.2	NP_003740.2	-	Y	c.2448T>C	p.(C816=) | p.(Cys816=)	TGT=>TGC	.	NM_003749.2(IRS2): c.2448T>C (p.(C816=))	;maf-5-some-pop,maf-5-all-pops	24596	0.582371	U	0.4514	0.563898	12390	0.601776	PASS	97	812	0.539409	3255	19588	0.587094	1123	4925	4.67445e-01	24998	83847	5.87271e-01	rs4773092	.	4024	0.422000	-0.945	-0.272	-0.221	.	.	.	.	.	ENST00000375856: c.2448T>C (p.C816C)	large_intestine [caecum|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	432101	.	.	.	.	.	.	.	.	.	Likely Benign
13	110436231	110436232	13q34	0	nullSample	.	G	ref	G	CC.CT	homo-ref	.	.	.	0	.	.	600797	P	125853(SK)	AD	.	.	.	.	.	.	.	8660	IRS2	C1	EX1	.	.	no-change	NM_003749.2	NP_003740.2	-	Y	c.2169C=	.	.	.	NM_003749.2(IRS2): c.2169C=	;maf-5-some-pop,maf-5-all-pops	19372	0.444766	U	0.4514	0.559505	10348	0.360456	PASS	-48	352	0.477273	1430	14364	0.446255	.	.	.	.	.	.	rs3742210	.	4024	0.578800	-2.019	-0.710	-1.113	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
13	110436231	110436232	13q34	1	normal	.	G	snv	A	CC.CT	hom-alt	614	1.00	.	0	.	PASS	600797	P	125853(SK)	AD	.	.	.	.	.	.	.	8660	IRS2	C1	EX1	.	.	coding-synon	NM_003749.2	NP_003740.2	-	Y	c.2169C>T	p.(S723=) | p.(Ser723=)	AGC=>AGT	.	NM_003749.2(IRS2): c.2169C>T (p.(S723=))	;maf-5-some-pop,maf-5-all-pops	19372	0.555234	U	0.4514	0.559505	10348	0.639544	PASS	44	352	0.522727	2202	14364	0.553745	1071	4679	4.67433e-01	23301	78496	5.84648e-01	rs3742210	.	4024	0.421200	-2.019	-0.710	-1.113	.	.	.	.	.	ENST00000375856: c.2169C>T (p.S723S)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3749236	.	.	.	.	.	.	.	.	.	Likely Benign
14	20665789	20665790	14q11.2	0	nullSample	.	T	ref	T	CA.CC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	390439	OR11G2	C1E	EX1E	7 transmembrane receptor (rhodopsin family)	PF00001.16	no-change	NM_001005503.1	NP_001005503.1	+	Y	c.296T=	.	.	.	NM_001005503.1(OR11G2): c.296T=	SingleClassQuadAllelic;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	126386	0.507699	U	0.5109	0.442692	13006	0.546056	PASS	.	8640	0.507292	15707	121378	0.505652	.	.	.	.	.	.	rs4981822	.	4024	0.531100	0.528	4.498	1.955	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	20665789	20665790	14q11.2	1	normal	.	T	snv	A	CA.CC	hom-alt	297	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	390439	OR11G2	C1E	EX1E	7 transmembrane receptor (rhodopsin family)	PF00001.16	missense	NM_001005503.1	NP_001005503.1	+	Y	c.296T>A	p.I99N | p.Ile99Asn	ATC=>AAC	NP=>P0	NM_001005503.1(OR11G2): c.296T>A (p.I99N)	SingleClassQuadAllelic;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	126386	0.492270	U	0.5109	0.442692	13006	0.453944	PASS	1052	8640	0.492361	15019	121378	0.494315	2054	8452	4.90028e-01	31089	122796	4.98765e-01	rs4981822	.	4024	0.468900	0.528	4.498	1.955	0.02	0.533	0.851	0.563	deleterious	ENST00000357366: c.296T>A (p.I99N)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3999203	.	.	.	.	.	.	.	.	.	Likely Benign
14	20665839	20665840	14q11.2	0	nullSample	.	G	ref	G	CA.TC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	390439	OR11G2	C1E	EX1E	7 transmembrane receptor (rhodopsin family)	PF00001.16	no-change	NM_001005503.1	NP_001005503.1	+	Y	c.346G=	.	.	.	NM_001005503.1(OR11G2): c.346G=	;maf-5-some-pop,maf-5-all-pops	126268	0.505092	U	0.5437	0.44988	13006	0.546440	PASS	.	8632	0.478568	15514	121260	0.503233	.	.	.	.	.	.	rs4981088	.	4024	0.504700	0.650	1.513	2.414	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	20665839	20665840	14q11.2	1	normal	.	G	snv	A	CA.TC	hom-alt	396	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	390439	OR11G2	C1E	EX1E	7 transmembrane receptor (rhodopsin family)	PF00001.16	missense	NM_001005503.1	NP_001005503.1	+	Y	c.346G>A	p.V116I | p.Val116Ile	GTC=>ATC	NP=>NP	NM_001005503.1(OR11G2): c.346G>A (p.V116I)	;maf-5-some-pop,maf-5-all-pops	126268	0.494908	U	0.5437	0.44988	13006	0.453560	PASS	1160	8632	0.521432	15122	121260	0.496767	2302	8937	5.18207e-01	31258	123119	5.00406e-01	rs4981088	.	4024	0.495300	0.650	1.513	2.414	0.14	0.052	0.007	0.253	neutral	ENST00000357366: c.346G>A (p.V116I)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3999204	.	.	.	.	.	.	.	.	.	Likely Benign
14	20665886	20665887	14q11.2	0	nullSample	.	G	ref	G	TC.TT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	390439	OR11G2	C1E	EX1E	7 transmembrane receptor (rhodopsin family)	PF00001.16	no-change	NM_001005503.1	NP_001005503.1	+	Y	c.393G=	.	.	.	NM_001005503.1(OR11G2): c.393G=	;maf-5-some-pop	126324	0.063187	U	0.7192	0.905751	13006	0.015685	PASS	.	8618	0.296705	636	121316	0.061904	.	.	.	.	.	.	rs4981823	.	4024	0.324100	-0.744	0.133	0.026	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	20665886	20665887	14q11.2	1	normal	.	G	snv	C	TC.TT	hom-alt	314	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	390439	OR11G2	C1E	EX1E	7 transmembrane receptor (rhodopsin family)	PF00001.16	coding-synon	NM_001005503.1	NP_001005503.1	+	Y	c.393G>C	p.(S131=) | p.(Ser131=)	TCG=>TCC	.	NM_001005503.1(OR11G2): c.393G>C (p.(S131=))	;maf-5-some-pop	126324	0.936813	U	0.7192	0.905751	13006	0.984315	PASS	2109	8618	0.703295	53784	121316	0.938096	4232	12126	7.03446e-01	108025	229677	9.33009e-01	rs4981823	.	4024	0.675900	-0.744	0.133	0.026	.	.	.	.	.	ENST00000357366: c.393G>C (p.S131S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3999205	.	.	.	.	.	.	.	.	.	Likely Benign
14	23495610	23495611	14q11.2	0	normal	.	A	ref	A	GG.AA	het-alt	211	0.85	.	1	.	PASS	600306	P	.	NN	.	.	.	.	.	.	.	5693	PSMB5	IC2	IVS2	.	.	no-change	NM_002797.3	NP_002788.1	-	Y	c.506-27T=	.	.	.	NM_002797.3(PSMB5): c.506-27T=	MixedObserved;	0|10851	0|0.993272	U	.	.	12518	0.857246	.	.	.	.	.	.	.	.	.	.	.	.	.	rs552742758|rs750434117	.	4024	0.871300	0.235	0.938	0.238	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	23495610	23495611	14q11.2	0	normal	.	A	del	.	GG.AA	het-ref	38	0.15	.	2	.	PASS	600306	P	.	NN	.	.	.	.	.	.	.	5693	PSMB5	IC2	IVS2	.	.	intron	NM_002797.3	NP_002788.1	-	Y	c.506-27delT	.	.	.	NM_002797.3(PSMB5): c.506-27delT	MixedObserved;	0|10851	0|0.006727	U	.	.	12518	0.116153	PASS	0	5236	0.156035	0	74820	0.144052	.	.	.	.	.	.	rs552742758|rs750434117	.	4024	0.128700	0.235	0.938	0.238	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	23532864	23532865	14q11.2	0	normal	.	A	ref	A	GT.AG	het-alt	124	0.50	.	1	.	PASS	604562	P	.	NN	.	.	.	.	.	.	.	22985	ACIN1	IC12	IVS12	.	.	no-change	NM_014977.3	NP_055792.1	-	Y	c.2770-79T=	.	.	.	NM_014977.3(ACIN1): c.2770-79T=	;maf-5-some-pop,maf-5-all-pops	5008	0.564297	U	0.2927	0.435703	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs57315948	.	4024	0.726100	-2.258	-1.357	-1.878	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	23532864	23532865	14q11.2	0	normal	.	A	snv	G	GT.AG	het-ref	126	0.50	.	2	.	PASS	604562	P	.	NN	.	.	.	.	.	.	.	22985	ACIN1	IC12	IVS12	.	.	intron	NM_014977.3	NP_055792.1	-	Y	c.2770-79T>C	.	.	.	NM_014977.3(ACIN1): c.2770-79T>C	;maf-5-some-pop,maf-5-all-pops	5008	0.435703	U	0.2927	0.435703	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs57315948	.	4024	0.273600	-2.258	-1.357	-1.878	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	23548782	23548783	14q11.2	0	normal	.	A	ref	A	CG.GA	het-alt	231	0.50	.	1	.	PASS	604562	P	.	NN	.	.	.	.	.	.	.	22985	ACIN1	C6	EX6	.	.	no-change	NM_014977.3	NP_055792.1	-	Y	c.1935T=	.	.	.	NM_014977.3(ACIN1): c.1935T=	;maf-5-some-pop,maf-5-all-pops	83654	0.999821	U	0.4226	0.38778	.	.	VQSRTrancheINDEL99.00to99.50	-1077	8648	0.574006	29647	120400	0.694676	.	.	.	.	.	.	rs78164858	.	.	.	0.533	-0.685	-1.386	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	23548783	23548783	14q11.2	1	normal	.	.	ins	GAACGT	GA.GA	het-ref	235	0.50	.	2	.	PASS	604562	P	.	NN	.	.	.	.	.	.	.	22985	ACIN1	C6	EX6	.	.	cds-ins	NM_014977.3	NP_055792.1	-	Y	c.1923ACGTTC[2>3] (std: c.1929_1934dupACGTTC alt: c.1934_1935insACGTTC )	p.R638_S639[5>6] (std: p.R646_S647dup alt: p.S647_A648insRS ) | p.Arg638_Ser639[5>6] (std: p.Arg646_Ser647dup alt: p.Ser647_Ala648insArgSer )	.	.	NM_014977.3(ACIN1): c.1929_1934dupACGTTC (p.R646_S647dup)	ObservedTooLong;maf-5-some-pop,maf-5-all-pops,rs-cluster-nonoverlapping-alleles	125393	0.289554	U	0.4226	0.38778	12518	0.455983	VQSRTrancheINDEL99.00to99.50	764	8648	0.425532	5945	120400	0.301561	.	.	.	.	.	.	rs148403158	.	4024	0.420500	.	.	.	.	.	.	.	.	ENST00000262710: c.1934_1935insACGTTC (p.S647_A648insRS)	pancreas [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	1162679	.	.	.	.	.	.	.	.	.	Benign
14	23549284	23549285	14q11.2	0	normal	.	G	ref	G	GA.AC	het-alt	310	0.53	.	1	.	PASS	604562	P	.	NN	.	.	.	.	.	.	.	22985	ACIN1	C6	EX6	.	.	no-change	NM_014977.3	NP_055792.1	-	Y	c.1433C=	.	.	.	NM_014977.3(ACIN1): c.1433C=	;maf-5-some-pop,genotype-conflict	126282	0.946524	U	0.1389	0.0517173	13006	0.955943	PASS	-465	8640	0.879630	54350	121274	0.946452	.	.	.	.	.	.	rs3751501	.	4024	0.888700	0.650	3.140	2.821	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	23549284	23549285	14q11.2	1	normal	.	G	snv	A	GA.AC	het-ref	275	0.47	.	2	.	PASS	604562	P	.	NN	.	.	.	.	.	.	.	22985	ACIN1	C6	EX6	.	.	missense	NM_014977.3	NP_055792.1	-	Y	c.1433C>T	p.S478F | p.Ser478Phe	TCT=>TTT	P0=>NP	NM_014977.3(ACIN1): c.1433C>T (p.S478F)	;maf-5-some-pop,genotype-conflict	126282	0.053476	U	0.1389	0.0517173	13006	0.044057	PASS	55	8640	0.120370	207	121274	0.053548	122	2148	1.24565e-01	413	12878	5.23330e-02	rs3751501	.	4024	0.111300	0.650	3.140	2.821	.	.	.	.	.	ENST00000262710: c.1433C>T (p.S478F)	soft_tissue [striated_muscle|NS|NS]	rhabdomyosarcoma [alveolar|NS|NS]	VUO	4986737	.	.	.	.	.	.	.	.	.	Likely Benign
14	23549318	23549319	14q11.2	0	normal	.	A	ref	A	AG.TA	het-alt	338	0.53	.	1	.	PASS	604562	P	.	NN	.	.	.	.	.	.	.	22985	ACIN1	C6	EX6	.	.	no-change	NM_014977.3	NP_055792.1	-	Y	c.1399T=	.	.	.	NM_014977.3(ACIN1): c.1399T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126320	0.577185	U	0.3948	0.428315	13006	0.554744	PASS	-998	8632	0.646200	20449	121312	0.577412	.	.	.	.	.	.	rs1885097	.	4024	0.641200	0.528	-0.027	-0.196	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	23549318	23549319	14q11.2	1	normal	.	A	snv	G	AG.TA	het-ref	302	0.47	.	2	.	PASS	604562	P	.	NN	.	.	.	.	.	.	.	22985	ACIN1	C6	EX6	.	.	missense	NM_014977.3	NP_055792.1	-	Y	c.1399T>C	p.S467P | p.Ser467Pro	TCT=>CCT	P0=>NP	NM_014977.3(ACIN1): c.1399T>C (p.S467P)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126320	0.422815	U	0.3948	0.428315	13006	0.445256	PASS	529	8632	0.353800	11058	121312	0.422588	1056	6035	3.49977e-01	21554	102009	4.14519e-01	rs1885097	.	4024	0.358800	0.528	-0.027	-0.196	.	.	.	.	.	ENST00000262710: c.1399T>C (p.S467P)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3753892	.	.	.	.	.	.	.	.	.	Likely Benign
14	23549378	23549379	14q11.2	0	normal	.	C	snv	G	AG.GG	hom-alt	603	1.00	.	0	.	PASS	604562	P	.	NN	.	.	.	.	.	.	.	22985	ACIN1	C6	EX6	.	.	no-change	NM_014977.3	NP_055792.1	-	Y	c.1339C=	.	.	.	NM_014977.3(ACIN1): c.1339C=	MixedObserved,SingleClassQuadAllelic;rs-cluster-nonoverlapping-alleles	126372	0.997317	U	1	0.999601	13006	0.996617	PASS	4326	8654	0.999884	60346	121364	0.997223	8621	17245	9.99826e-01	122467	245554	9.97473e-01	rs941719	.	4024	0.998000	-0.127	1.814	1.539	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	23549378	23549379	14q11.2	1	nullSample	.	C	ref	C	AG.GG	homo-ref	.	.	.	0	.	.	604562	P	.	NN	.	.	.	.	.	.	.	22985	ACIN1	C6	EX6	.	.	missense	NM_014977.3	NP_055792.1	-	Y	c.1339C>G	p.P447A | p.Pro447Ala	CCT=>GCT	NP=>NP	NM_014977.3(ACIN1): c.1339C>G (p.P447A)	MixedObserved,SingleClassQuadAllelic;rs-cluster-nonoverlapping-alleles	126372	0.002643	U	1	0.999601	13006	0.003383	PASS	0	8654	0.000000	1	121364	0.002736	.	.	.	.	.	.	rs941719	.	4024	0.001500	-0.127	1.814	1.539	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
14	23549382	23549383	14q11.2	1	normal	.	G	snv	T	GG.GC	het-ref	303	0.53	.	2	.	PASS	604562	P	.	NN	.	.	.	.	.	.	.	22985	ACIN1	C6	EX6	.	.	coding-synon	NM_014977.3	NP_055792.1	-	Y	c.1335C>A	p.(A445=) | p.(Ala445=)	GCC=>GCA	.	NM_014977.3(ACIN1): c.1335C>A (p.(A445=))	SingleClassQuadAllelic;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	126274	0.053519	U	0.1389	0.0517173	13006	0.000231	PASS	55	8648	0.120259	209	121266	0.053593	122	2149	1.24594e-01	416	12897	5.24055e-02	rs45510791	.	4024	0.111300	0.650	-0.615	-0.531	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
14	23549382	23549383	14q11.2	0	normal	.	G	ref	G	GG.GC	het-alt	274	0.47	.	1	.	PASS	604562	P	.	NN	.	.	.	.	.	.	.	22985	ACIN1	C6	EX6	.	.	no-change	NM_014977.3	NP_055792.1	-	Y	c.1335C=	.	.	.	NM_014977.3(ACIN1): c.1335C=	SingleClassQuadAllelic;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	126274	0.946331	U	0.1389	0.0517173	13006	0.999769	PASS	-465	8648	0.879741	54326	121266	0.946250	.	.	.	.	.	.	rs45510791	.	4024	0.888400	0.650	-0.615	-0.531	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	23549784	23549785	14q11.2	0	normal	.	T	ref	T	GG.AT	het-alt	372	0.52	.	1	.	PASS	604562	P	.	NN	.	.	.	.	.	.	.	22985	ACIN1	C6	EX6	.	.	no-change	NM_014977.3	NP_055792.1	-	Y	c.933A=	.	.	.	NM_014977.3(ACIN1): c.933A=	;maf-5-some-pop,maf-5-all-pops	126388	0.554333	U	0.4554	0.500799	13006	0.506997	PASS	.	8644	0.569759	19235	121380	0.556607	.	.	.	.	.	.	rs3811182	.	4024	0.576000	-2.211	-0.283	-0.194	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	23549784	23549785	14q11.2	1	normal	.	T	snv	C	GG.AT	het-ref	341	0.48	.	2	.	PASS	604562	P	.	NN	.	.	.	.	.	.	.	22985	ACIN1	C6	EX6	.	.	missense	NM_014977.3	NP_055792.1	-	Y	c.933A>G	p.I311M | p.Ile311Met	ATA=>ATG	NP=>NP	NM_014977.3(ACIN1): c.933A>G (p.I311M)	;maf-5-some-pop,maf-5-all-pops	126388	0.445667	U	0.4554	0.500799	13006	0.493003	PASS	794	8644	0.430241	12364	121380	0.443393	1585	7366	4.27064e-01	23756	106428	4.32262e-01	rs3811182	.	4024	0.424000	-2.211	-0.283	-0.194	.	.	.	.	.	ENST00000262710: c.933A>G (p.I311M)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3753894	.	.	.	.	.	.	.	.	.	Likely Benign
14	23549878	23549881	14q11.2	0	normal	.	TCC	ref	TCC	ct.tc	het-alt	235	0.57	.	1	CT-rich|Low_complexity|Low_complexity|+|53;trf	PASS	604562	P	.	NN	.	.	.	.	.	.	.	22985	ACIN1	C6	EX6	.	.	no-change	NM_014977.3	NP_055792.1	-	Y	c.837_839=	.	.	.	NM_014977.3(ACIN1): c.837_839=	MixedObserved;maf-5-some-pop	13895	0.960202	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3841035	.	4024	0.819800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	23549878	23549881	14q11.2	1	normal	.	TCC	del	.	ct.tc	het-ref	180	0.43	.	2	CT-rich|Low_complexity|Low_complexity|+|53;trf	PASS	604562	P	.	NN	.	.	.	.	.	.	.	22985	ACIN1	C6	EX6	.	.	cds-del	NM_014977.3	NP_055792.1	-	Y	c.822GGA[6>5] (std: c.822GGA[5] alt: c.837_839delGGA )	p.E270[12>11] (std: p.E270[11] alt: p.E281del ) | p.Glu270[12>11] (std: p.Glu270[11] alt: p.Glu281del )	.	.	NM_014977.3(ACIN1): c.822GGA[5] (p.E270[11])	MixedObserved;maf-5-some-pop	13895	0.039798	U	0.2073	0.107228	.	.	VQSRTrancheINDEL97.00to99.00	189	8640	0.204398	458	121296	0.073135	.	.	.	.	.	.	rs3841035	.	4024	0.180200	.	.	.	.	.	.	.	.	ENST00000262710: c.837_839delGGA (p.E281delE)	upper_aerodigestive_tract [head_neck|NS|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	VUO	4592001	.	.	.	.	.	.	.	.	.	Benign
14	23550125	23550126	14q11.2	0	normal	.	T	ref	T	TA.AC	het-alt	148	0.47	.	1	.	PASS	604562	P	.	NN	.	.	.	.	.	.	.	22985	ACIN1	IC5	IVS5	.	.	no-change	NM_014977.3	NP_055792.1	-	Y	c.700-108A=	.	.	.	NM_014977.3(ACIN1): c.700-108A=	;maf-5-some-pop	5008	0.607029	U	0.3948	0.392971	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4982727	.	4024	0.640900	-0.472	-2.425	-2.148	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	23550125	23550126	14q11.2	0	normal	.	T	snv	C	TA.AC	het-ref	165	0.53	.	2	.	PASS	604562	P	.	NN	.	.	.	.	.	.	.	22985	ACIN1	IC5	IVS5	.	.	intron	NM_014977.3	NP_055792.1	-	Y	c.700-108A>G	.	.	.	NM_014977.3(ACIN1): c.700-108A>G	;maf-5-some-pop	5008	0.392971	U	0.3948	0.392971	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4982727	.	4024	0.359100	-0.472	-2.425	-2.148	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	23652345	23652346	14q11.2	0	normal	.	T	ref	T	GC.aa	het-alt	12	0.28	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr14: g.23652345T= (intergenic)	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.459	-0.364	-0.420	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
14	23652346	23652346	14q11.2	0	normal	.	.	ins	AA	CT.aa	het-ref	31	0.72	.	2	(A)n|Simple_repeat|Simple_repeat|+|21	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr14: g.23652346_23652347insAA (intergenic)	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs369029261	.	4024	0.126000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	35871216	35871217	14q13.2	0	normal	.	G	snv	A	GC.CT	hom-alt	372	1.00	.	0	.	PASS	164008	C	612132(MK)	NN	Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency	AD	.	Allergy/Immunology/Infectious; Dental; Dermatologic; Gastrointestinal	Allergy/Immunology/Infectious	18412279|17931563|16769798|15337789|14523047	.	4792	NFKBIA	3U1E	EX6E	.	.	utr-3	NM_020529.2	NP_065390.1	-	Y	c.*2C>T	.	.	.	NM_020529.2(NFKBIA): c.*2C>T	;maf-5-some-pop,maf-5-all-pops	126360	0.402952	U	0.3948	0.447883	13006	0.444872	PASS	781	8646	0.422161	10068	121352	0.401098	1519	7248	4.20271e-01	19458	96412	3.92059e-01	rs8904	.	.	.	-0.140	-0.593	-1.115	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	313108	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
14	35871216	35871217	14q13.2	0	nullSample	.	G	ref	G	GC.CT	homo-ref	.	.	.	0	.	.	164008	C	612132(MK)	NN	Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency	AD	.	Allergy/Immunology/Infectious; Dental; Dermatologic; Gastrointestinal	Allergy/Immunology/Infectious	18412279|17931563|16769798|15337789|14523047	.	4792	NFKBIA	3U1E	EX6E	.	.	no-change	NM_020529.2	NP_065390.1	-	Y	c.*2C=	.	.	.	NM_020529.2(NFKBIA): c.*2C=	;maf-5-some-pop,maf-5-all-pops	126360	0.597048	U	0.3948	0.447883	13006	0.555128	PASS	-1044	8646	0.577839	22070	121352	0.598902	.	.	.	.	.	.	rs8904	.	.	.	-0.140	-0.593	-1.115	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	35873769	35873770	14q13.2	0	normal	.	G	ref	G	TC.TC	het-alt	210	0.53	.	1	.	PASS	164008	C	612132(MK)	NN	Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency	AD	.	Allergy/Immunology/Infectious; Dental; Dermatologic; Gastrointestinal	Allergy/Immunology/Infectious	18412279|17931563|16769798|15337789|14523047	.	4792	NFKBIA	C1	EX1	.	.	no-change	NM_020529.2	NP_065390.1	-	Y	c.81C=	.	.	.	NM_020529.2(NFKBIA): c.81C=	;maf-5-some-pop,maf-5-all-pops	87316	0.662570	U	0.2649	0.244409	12672	0.771307	PASS	-741	6142	0.673396	17044	82308	0.656911	.	.	.	.	.	.	rs1957106	.	.	.	0.313	0.869	0.672	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	35873769	35873770	14q13.2	1	normal	.	G	snv	A	TC.TC	het-ref	186	0.47	.	2	.	PASS	164008	C	612132(MK)	NN	Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency	AD	.	Allergy/Immunology/Infectious; Dental; Dermatologic; Gastrointestinal	Allergy/Immunology/Infectious	18412279|17931563|16769798|15337789|14523047	.	4792	NFKBIA	C1	EX1	.	.	coding-synon	NM_020529.2	NP_065390.1	-	Y	c.81C>T	p.(D27=) | p.(Asp27=)	GAC=>GAT	.	NM_020529.2(NFKBIA): c.81C>T (p.(D27=))	;maf-5-some-pop,maf-5-all-pops	87316	0.337430	U	0.2649	0.244409	12672	0.228693	PASS	262	6142	0.326604	4129	82308	0.343089	510	3853	2.62145e-01	8933	60008	2.84414e-01	rs1957106	.	.	.	0.313	0.869	0.672	.	.	.	.	.	NM_020529.1: c.81C>T (p.D27D)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3753951	.	.	.	.	.	no_record	313117	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
14	38061741	38061742	14q21.1	0	normal	.	C	ref	C	GG.TA	het-alt	262	0.51	.	1	.	PASS	602294	C	.	NN	.	.	.	.	.	.	.	3169	FOXA1	C2E	EX2E	Forkhead N-terminal region	PF08430.7	no-change	NM_004496.3	NP_004487.2	-	Y	c.247G=	.	.	.	NM_004496.3(FOXA1): c.247G=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	124080	0.392610	U	0.8442	0.583067	12562	0.461312	PASS	.	8598	0.136194	9602	119072	0.391587	.	.	.	.	.	.	rs7144658	.	4024	0.129200	0.511	1.200	0.784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	38061741	38061742	14q21.1	1	normal	.	C	snv	T	GG.TA	het-ref	249	0.49	.	2	.	PASS	602294	C	.	NN	.	.	.	.	.	.	.	3169	FOXA1	C2E	EX2E	Forkhead N-terminal region	PF08430.7	missense	NM_004496.3	NP_004487.2	-	Y	c.247G>A	p.A83T | p.Ala83Thr	GCC=>ACC	NP=>P0	NM_004496.3(FOXA1): c.247G>A (p.A83T)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	124080	0.607390	U	0.8442	0.583067	12562	0.538688	PASS	3194	8598	0.863806	22511	119072	0.608413	6418	14875	8.64625e-01	47141	149313	6.16090e-01	rs7144658	.	4024	0.870800	0.511	1.200	0.784	0.07	0.139	0.783	0.331	neutral	ENST00000250448: c.247G>A (p.A83T)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3753953	.	.	.	.	.	.	.	.	.	Likely Benign
14	38064214	38064215	14q21.1	0	normal	.	G	ref	G	CT.TG	het-alt	39	0.47	.	1	.	PASS	602294	C	.	NN	.	.	.	.	.	.	.	3169	FOXA1	5U1E	EX1	.	.	no-change	NM_004496.3	NP_004487.2	-	Y	c.-38C=	.	.	.	NM_004496.3(FOXA1): c.-38C=	;maf-5-some-pop,maf-5-all-pops	119738	0.557300	U	0.506	0.384585	13006	0.597493	PASS	-1054	8212	0.432538	17665	114730	0.554763	.	.	.	.	.	.	rs79519281	.	.	.	0.281	-0.057	1.444	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	38064214	38064215	14q21.1	0	normal	.	G	snv	C	CT.TG	het-ref	44	0.53	.	2	.	PASS	602294	C	.	NN	.	.	.	.	.	.	.	3169	FOXA1	5U1E	EX1	.	.	utr-5	NM_004496.3	NP_004487.2	-	Y	c.-38C>G	.	.	.	NM_004496.3(FOXA1): c.-38C>G	;maf-5-some-pop,maf-5-all-pops	119738	0.442700	U	0.506	0.384585	13006	0.402507	PASS	1276	8212	0.567462	11382	114730	0.445237	2292	8238	5.63090e-01	22789	99579	4.49831e-01	rs79519281	.	.	.	0.281	-0.057	1.444	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	65472873	65472874	14q23.3	0	normal	.	C	ref	C	GT.TT	het-alt	40	0.53	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr14: g.65472873C= (intergenic)	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.456	0.836	0.863	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
14	65472874	65472874	14q23.3	0	normal	.	.	ins	T	TC.TT	het-ref	36	0.47	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr14: g.65472874_65472875insT (intergenic)	MixedObserved;rs-cluster-nonoverlapping-alleles	72912	0.088655	U	.	.	.	.	PASS	3	6144	0.187500	75	88106	0.140694	.	.	.	.	.	.	rs367570902	.	4024	0.190100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	65568214	65568215	14q23.3	0	nullSample	.	G	ref	G	AG.AA	homo-ref	.	.	.	0	.	.	154950	P	171300(SK)	AD	Pheochromocytoma	AD	.	Oncologic	Oncologic	21685915	FC59;H54;H62;H68;HE15;MC58	4149	MAX	IC2	IVS2	.	.	no-change	NM_002382.4	NP_002373.3	-	Y	c.63+49C=	.	.	.	NM_002382.4(MAX): c.63+49C=	;maf-5-some-pop,maf-5-all-pops	115820	0.586401	U	0.4097	0.512181	13004	0.492848	PASS	.	8048	0.586357	20186	110812	0.590857	.	.	.	.	.	.	rs2781373	.	4024	0.602900	-0.306	0.325	0.064	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	65568214	65568215	14q23.3	0	normal	.	G	snv	A	AG.AA	hom-alt	318	1.00	.	0	.	PASS	154950	P	171300(SK)	AD	Pheochromocytoma	AD	.	Oncologic	Oncologic	21685915	FC59;H54;H62;H68;HE15;MC58	4149	MAX	IC2	IVS2	.	.	intron	NM_002382.4	NP_002373.3	-	Y	c.63+49C>T	.	.	.	NM_002382.4(MAX): c.63+49C>T	;maf-5-some-pop,maf-5-all-pops	115820	0.413599	U	0.4097	0.512181	13004	0.507152	PASS	655	8048	0.413643	10118	110812	0.409143	1317	6569	4.07759e-01	19615	90531	3.91753e-01	rs2781373	.	4024	0.397100	-0.306	0.325	0.064	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	75483811	75483812	14q24.3	0	nullSample	.	T	ref	T	GA.TG	homo-ref	.	.	.	0	.	.	604395	C	114500(MK);608089(SK);614385(MK)	AD	Colorectal cancer, hereditary nonpolyposis type 7; Endometrial carcinoma	AD	.	Oncologic	Oncologic	16885347|12702580	C1021;H54;H62;H68;HC22;HD31;HD32	27030	MLH3	C12E	EX13E	.	.	no-change	NM_001040108.1	NP_001035197.1	-	Y	c.4335A=	.	.	.	NM_001040108.1(MLH3): c.4335A=	;maf-5-some-pop,genotype-conflict	126392	0.435906	U	0.8393	0.580072	13006	0.498078	PASS	-615	8646	0.170946	12473	121384	0.436565	.	.	.	.	.	.	rs13712	.	4024	0.172000	-0.938	-0.109	-0.539	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	75483811	75483812	14q24.3	1	normal	.	T	snv	C	GA.TG	hom-alt	480	1.00	.	0	.	PASS	604395	C	114500(MK);608089(SK);614385(MK)	AD	Colorectal cancer, hereditary nonpolyposis type 7; Endometrial carcinoma	AD	.	Oncologic	Oncologic	16885347|12702580	C1021;H54;H62;H68;HC22;HD31;HD32	27030	MLH3	C12E	EX13E	.	.	coding-synon	NM_001040108.1	NP_001035197.1	-	Y	c.4335A>G	p.(Q1445=) | p.(Gln1445=)	CAA=>CAG	.	NM_001040108.1(MLH3): c.4335A>G (p.(Q1445=))	;maf-5-some-pop,genotype-conflict	126392	0.564094	U	0.8393	0.580072	13006	0.501922	PASS	2969	8646	0.829054	20173	121384	0.563435	6020	14381	8.33778e-01	42434	141462	5.74456e-01	rs13712	.	4024	0.828000	-0.938	-0.109	-0.539	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	257253	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
14	75485488	75485489	14q24.3	0	nullSample	.	A	ref	A	AA.AT	homo-ref	.	.	.	0	.	.	604395	C	114500(MK);608089(SK);614385(MK)	AD	Colorectal cancer, hereditary nonpolyposis type 7; Endometrial carcinoma	AD	.	Oncologic	Oncologic	16885347|12702580	C1021;H54;H62;H68;HC22;HD31;HD32	27030	MLH3	IC11	IVS12	.	.	no-change	NM_001040108.1	NP_001035197.1	-	Y	c.4242+43T=	.	.	.	NM_001040108.1(MLH3): c.4242+43T=	;	126364	0.003403	U	1	0.990615	13006	0.011149	PASS	0	8652	0.000000	7	121356	0.003156	.	.	.	.	.	.	rs175053	.	4024	0.001500	-0.119	0.421	0.566	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	75485488	75485489	14q24.3	0	normal	.	A	snv	G	AA.AT	hom-alt	412	1.00	.	0	.	PASS	604395	C	114500(MK);608089(SK);614385(MK)	AD	Colorectal cancer, hereditary nonpolyposis type 7; Endometrial carcinoma	AD	.	Oncologic	Oncologic	16885347|12702580	C1021;H54;H62;H68;HC22;HD31;HD32	27030	MLH3	IC11	IVS12	.	.	intron	NM_001040108.1	NP_001035197.1	-	Y	c.4242+43T>C	.	.	.	NM_001040108.1(MLH3): c.4242+43T>C	;	126364	0.996597	U	1	0.990615	13006	0.988851	PASS	4326	8652	1.000000	60302	121356	0.996844	8623	17246	1.00000e+00	122264	245134	9.97445e-01	rs175053	.	4024	0.998500	-0.119	0.421	0.566	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	75497428	75497429	14q24.3	0	normal	.	A	del	.	TT.AA	het-ref	39	0.14	.	2	.	PASS	604395	C	114500(MK);608089(SK);614385(MK)	AD	Colorectal cancer, hereditary nonpolyposis type 7; Endometrial carcinoma	AD	.	Oncologic	Oncologic	16885347|12702580	C1021;H54;H62;H68;HC22;HD31;HD32	27030	MLH3	IC7	IVS8	.	.	intron	NM_001040108.1	NP_001035197.1	-	Y	c.3828-24delT	.	.	.	NM_001040108.1(MLH3): c.3828-24delT	MixedObserved;	10040	0.003088	U	.	.	12518	0.041700	PASS	0	5168	0.085333	0	76862	0.130220	.	.	.	.	.	.	rs767006941	.	4024	0.300000	0.379	0.904	0.512	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	492691	no_assertion_criteria_provided	Likely_benign	Benign
14	75497428	75497429	14q24.3	0	normal	.	A	ref	A	TT.AA	het-alt	240	0.86	.	1	.	PASS	604395	C	114500(MK);608089(SK);614385(MK)	AD	Colorectal cancer, hereditary nonpolyposis type 7; Endometrial carcinoma	AD	.	Oncologic	Oncologic	16885347|12702580	C1021;H54;H62;H68;HC22;HD31;HD32	27030	MLH3	IC7	IVS8	.	.	no-change	NM_001040108.1	NP_001035197.1	-	Y	c.3828-24T=	.	.	.	NM_001040108.1(MLH3): c.3828-24T=	MixedObserved;	10040	0.996912	U	.	.	12518	0.943362	.	.	.	.	.	.	.	.	.	.	.	.	.	rs767006941	.	4024	0.700000	0.379	0.904	0.512	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	75505007	75505008	14q24.3	0	nullSample	.	G	ref	G	CA.CT	homo-ref	.	.	.	0	.	.	604395	C	114500(MK);608089(SK);614385(MK)	AD	Colorectal cancer, hereditary nonpolyposis type 7; Endometrial carcinoma	AD	.	Oncologic	Oncologic	16885347|12702580	C1021;H54;H62;H68;HC22;HD31;HD32	27030	MLH3	IC5	IVS6	.	.	no-change	NM_001040108.1	NP_001035197.1	-	Y	c.3643+35C=	.	.	.	NM_001040108.1(MLH3): c.3643+35C=	;maf-5-some-pop,maf-5-all-pops	126316	0.496358	U	0.8373	0.496605	13006	0.599108	PASS	-615	8650	0.172023	16277	121308	0.496068	.	.	.	.	.	.	rs3742780	.	4024	0.172200	0.561	0.134	0.662	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	75505007	75505008	14q24.3	0	normal	.	G	snv	C	CA.CT	hom-alt	395	1.00	.	0	.	PASS	604395	C	114500(MK);608089(SK);614385(MK)	AD	Colorectal cancer, hereditary nonpolyposis type 7; Endometrial carcinoma	AD	.	Oncologic	Oncologic	16885347|12702580	C1021;H54;H62;H68;HC22;HD31;HD32	27030	MLH3	IC5	IVS6	.	.	intron	NM_001040108.1	NP_001035197.1	-	Y	c.3643+35C>G	.	.	.	NM_001040108.1(MLH3): c.3643+35C>G	;maf-5-some-pop,maf-5-all-pops	126316	0.503642	U	0.8373	0.496605	13006	0.400892	PASS	2966	8650	0.827977	16754	121308	0.503932	6003	14361	8.32715e-01	35915	127821	5.19775e-01	rs3742780	.	4024	0.827800	0.561	0.134	0.662	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	75505015	75505016	14q24.3	0	nullSample	.	A	ref	A	TA.TC	homo-ref	.	.	.	0	.	.	604395	C	114500(MK);608089(SK);614385(MK)	AD	Colorectal cancer, hereditary nonpolyposis type 7; Endometrial carcinoma	AD	.	Oncologic	Oncologic	16885347|12702580	C1021;H54;H62;H68;HC22;HD31;HD32	27030	MLH3	IC5	IVS6	.	.	no-change	NM_001040108.1	NP_001035197.1	-	Y	c.3643+27T=	.	.	.	NM_001040108.1(MLH3): c.3643+27T=	;maf-5-some-pop	126400	0.004747	U	1	0.986222	13006	0.015531	PASS	0	8654	0.000000	14	121392	0.004374	.	.	.	.	.	.	rs175075	.	4024	0.001500	-0.215	-0.492	-1.032	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	75505015	75505016	14q24.3	0	normal	.	A	snv	G	TA.TC	hom-alt	420	1.00	.	0	.	PASS	604395	C	114500(MK);608089(SK);614385(MK)	AD	Colorectal cancer, hereditary nonpolyposis type 7; Endometrial carcinoma	AD	.	Oncologic	Oncologic	16885347|12702580	C1021;H54;H62;H68;HC22;HD31;HD32	27030	MLH3	IC5	IVS6	.	.	intron	NM_001040108.1	NP_001035197.1	-	Y	c.3643+27T>C	.	.	.	NM_001040108.1(MLH3): c.3643+27T>C	;maf-5-some-pop	126400	0.995253	U	1	0.986222	13006	0.984469	PASS	4327	8654	1.000000	60179	121392	0.995626	8623	17247	9.99942e-01	122232	245300	9.96425e-01	rs175075	.	4024	0.998500	-0.215	-0.492	-1.032	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	75513539	75513540	14q24.3	0	normal	.	G	ref	G	CA.AA	het-alt	411	0.55	.	1	.	PASS	604395	C	114500(MK);608089(SK);614385(MK)	AD	Colorectal cancer, hereditary nonpolyposis type 7; Endometrial carcinoma	AD	.	Oncologic	Oncologic	16885347|12702580	C1021;H54;H62;H68;HC22;HD31;HD32	27030	MLH3	C1	EX2	.	.	no-change	NM_001040108.1	NP_001035197.1	-	Y	c.2819C=	.	.	.	NM_001040108.1(MLH3): c.2819C=	;	121366	0.999959	U	.	.	.	.	PASS	.	8652	0.999422	60678	121366	0.999959	.	.	.	.	.	.	rs746725349	.	.	.	0.650	0.927	0.857	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	75513539	75513540	14q24.3	1	normal	.	G	snv	A	CA.AA	het-ref	337	0.45	.	2	.	PASS	604395	C	114500(MK);608089(SK);614385(MK)	AD	Colorectal cancer, hereditary nonpolyposis type 7; Endometrial carcinoma	AD	.	Oncologic	Oncologic	16885347|12702580	C1021;H54;H62;H68;HC22;HD31;HD32	27030	MLH3	C1	EX2	.	.	missense	NM_001040108.1	NP_001035197.1	-	Y	c.2819C>T	p.S940F | p.Ser940Phe	TCT=>TTT	P0=>NP	NM_001040108.1(MLH3): c.2819C>T (p.S940F)	;	121366	0.000041	U	.	.	.	.	PASS	0	8652	0.000578	0	121366	0.000041	0	7	4.05844e-04	0	7	2.84393e-05	rs746725349	.	.	.	0.650	0.927	0.857	0.01	0.707	0.983	0.661	deleterious	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
14	75513882	75513883	14q24.3	0	nullSample	.	T	ref	T	GT.AA	homo-ref	.	.	.	0	.	.	604395	C	114500(MK);608089(SK);614385(MK)	AD	Colorectal cancer, hereditary nonpolyposis type 7; Endometrial carcinoma	AD	.	Oncologic	Oncologic	16885347|12702580	C1021;H54;H62;H68;HC22;HD31;HD32	27030	MLH3	C1	EX2	.	.	no-change	NM_001040108.1	NP_001035197.1	-	Y	c.2476A=	.	.	.	NM_001040108.1(MLH3): c.2476A=	;maf-5-some-pop,genotype-conflict	126408	0.003457	U	1	0.990415	13006	0.011226	PASS	0	8654	0.000000	7	121400	0.003204	.	.	.	.	.	.	rs175081	.	4024	0.001500	-1.059	0.274	-0.121	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	75513882	75513883	14q24.3	1	normal	.	T	snv	C	GT.AA	hom-alt	698	1.00	.	0	.	PASS	604395	C	114500(MK);608089(SK);614385(MK)	AD	Colorectal cancer, hereditary nonpolyposis type 7; Endometrial carcinoma	AD	.	Oncologic	Oncologic	16885347|12702580	C1021;H54;H62;H68;HC22;HD31;HD32	27030	MLH3	C1	EX2	.	.	missense	NM_001040108.1	NP_001035197.1	-	Y	c.2476A>G	p.N826D | p.Asn826Asp	AAC=>GAC	P0=>P-	NM_001040108.1(MLH3): c.2476A>G (p.N826D)	;maf-5-some-pop,genotype-conflict	126408	0.996543	U	1	0.990415	13006	0.988774	PASS	4327	8654	1.000000	60318	121400	0.996796	8624	17248	1.00000e+00	122457	245532	9.97392e-01	rs175081	.	4024	0.998500	-1.059	0.274	-0.121	0.23	0	0	0.042	neutral	.	.	.	.	.	.	.	.	.	.	no_record	257251	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
14	81574838	81574839	14q31.1	0	normal	.	T	ref	T	tc.tt	het-alt	267	0.74	.	1	(T)n|Simple_repeat|Simple_repeat|+|23	PASS	603372	C	275200(MK);603372(MK);603373(MK);609152(MK)	AR	Hyperthyroidism, familial, gestational; Hyperthyroidism, nonautoimmune; Hypothyroidism, congenital, nongoitrous, 1	AD/AR	.	Endocrine	Endocrine	23698639|23563316|23412867|23329763|23154162|22876533|22763653|22405933|21714469|21677043|21283701|21186955|20718767|20146656|12050212|10487707|9854118|9385128|9329388|9185526|9100579|8954020|7920658|7800007|7528344	.	7253	TSHR	IC8	IVS8	.	.	no-change	NM_000369.2	NP_000360.2	+	Y	c.692+43T=	.	.	.	NM_000369.2(TSHR): c.692+43T=	MixedObserved;	0	0	U	.	.	.	.	VQSRTrancheINDEL99.50to99.90	0	708	1.000000	7584	15170	0.999934	.	.	.	.	.	.	rs375160114	.	.	.	0.392	-0.139	-0.199	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	81574838	81574839	14q31.1	0	normal	.	T	del	.	tc.tt	het-ref	93	0.26	.	2	(T)n|Simple_repeat|Simple_repeat|+|23	PASS	603372	C	275200(MK);603372(MK);603373(MK);609152(MK)	AR	Hyperthyroidism, familial, gestational; Hyperthyroidism, nonautoimmune; Hypothyroidism, congenital, nongoitrous, 1	AD/AR	.	Endocrine	Endocrine	23698639|23563316|23412867|23329763|23154162|22876533|22763653|22405933|21714469|21677043|21283701|21186955|20718767|20146656|12050212|10487707|9854118|9385128|9329388|9185526|9100579|8954020|7920658|7800007|7528344	.	7253	TSHR	IC8	IVS8	.	.	intron	NM_000369.2	NP_000360.2	+	Y	c.692+43delT	.	.	.	NM_000369.2(TSHR): c.692+43delT	MixedObserved;	0	0	U	.	.	.	.	VQSRTrancheINDEL97.00to99.00	0	4582	0.376691	0	50436	0.230014	.	.	.	.	.	.	rs375160114	.	.	.	0.392	-0.139	-0.199	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	81610582	81610583	14q31.1	0	nullSample	.	G	ref	G	GA.AT	homo-ref	.	.	.	0	.	.	603372	C	275200(MK);603372(MK);603373(MK);609152(MK)	AR	Hyperthyroidism, familial, gestational; Hyperthyroidism, nonautoimmune; Hypothyroidism, congenital, nongoitrous, 1	AD/AR	.	Endocrine	Endocrine	23698639|23563316|23412867|23329763|23154162|22876533|22763653|22405933|21714469|21677043|21283701|21186955|20718767|20146656|12050212|10487707|9854118|9385128|9329388|9185526|9100579|8954020|7920658|7800007|7528344	.	7253	TSHR	C10E	EX10E	.	.	no-change	NM_000369.2	NP_000360.2	+	Y	c.2181G=	.	.	.	NM_000369.2(TSHR): c.2181G=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126336	0.099766	U	0.8472	0.896765	13006	0.076657	PASS	.	8642	0.174844	656	121328	0.099623	.	.	.	.	.	.	rs1991517	.	.	.	-0.232	0.216	0.675	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	81610582	81610583	14q31.1	1	normal	.	G	snv	C	GA.AT	hom-alt	568	1.00	.	0	.	PASS	603372	C	275200(MK);603372(MK);603373(MK);609152(MK)	AR	Hyperthyroidism, familial, gestational; Hyperthyroidism, nonautoimmune; Hypothyroidism, congenital, nongoitrous, 1	AD/AR	.	Endocrine	Endocrine	23698639|23563316|23412867|23329763|23154162|22876533|22763653|22405933|21714469|21677043|21283701|21186955|20718767|20146656|12050212|10487707|9854118|9385128|9329388|9185526|9100579|8954020|7920658|7800007|7528344	.	7253	TSHR	C10E	EX10E	.	.	missense	NM_000369.2	NP_000360.2	+	Y	c.2181G>C	p.E727D | p.Glu727Asp	GAG=>GAC	P-=>P-	NM_000369.2(TSHR): c.2181G>C (p.E727D)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126336	0.900234	U	0.8472	0.896765	13006	0.923343	PASS	2937	8642	0.825156	49233	121328	0.900377	5817	14142	8.20016e-01	98812	220175	8.95792e-01	rs1991517	.	.	.	-0.232	0.216	0.675	0.7	0.001	0	0.002	neutral	.	.	.	.	.	.	.	.	.	.	no_record	135400	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
14	95566093	95566094	14q32.13	0	normal	.	C	ref	C	ca.ac	het-alt	161	0.84	.	1	(CA)n|Simple_repeat|Simple_repeat|+|41;trf	PASS	606241	P	138800(MK);180295(MK);601200(MK)	AD	DICER1 syndrome	AD	.	Oncologic	Oncologic	21882293|21266384|21036787|19556464|18570301|9345104|9295070|6261577|799599	.	23405	DICER1	IC21	IVS22	.	.	no-change	NM_177438.2	NP_803187.1	-	Y	c.4206+23G=	.	.	.	NM_177438.2(DICER1): c.4206+23G=	MixedObserved;	103102|0	0.999728|0	U	0.002	0.00199681	.	.	VQSRTrancheINDEL97.00to99.00	-7	5138	0.997275	49028	98096	0.999796	.	.	.	.	.	.	rs542935652|rs762786263	.	4024	0.794500	0.205	0.155	0.202	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	95566093	95566094	14q32.13	0	normal	.	C	del	.	ca.ac	het-ref	30	0.16	.	2	(CA)n|Simple_repeat|Simple_repeat|+|41;trf	PASS	606241	P	138800(MK);180295(MK);601200(MK)	AD	DICER1 syndrome	AD	.	Oncologic	Oncologic	21882293|21266384|21036787|19556464|18570301|9345104|9295070|6261577|799599	.	23405	DICER1	IC21	IVS22	.	.	intron	NM_177438.2	NP_803187.1	-	Y	c.4206+23delG	.	.	.	NM_177438.2(DICER1): c.4206+23delG	MixedObserved;	0	0	U	.	.	.	.	PASS	0	6930	0.095238	0	107082	0.022403	.	.	.	.	.	.	rs762786263	.	4024	0.205000	0.205	0.155	0.202	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	95566095	95566096	14q32.13	0	normal	.	C	ref	C	ca.ac	het-alt	77	0.49	.	1	(CA)n|Simple_repeat|Simple_repeat|+|41;trf	PASS	606241	P	138800(MK);180295(MK);601200(MK)	AD	DICER1 syndrome	AD	.	Oncologic	Oncologic	21882293|21266384|21036787|19556464|18570301|9345104|9295070|6261577|799599	.	23405	DICER1	IC21	IVS22	.	.	no-change	NM_177438.2	NP_803187.1	-	Y	c.4206+21G=	.	.	.	NM_177438.2(DICER1): c.4206+21G=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs200057362|rs781195791	.	4029	0.781600	0.561	1.535	0.352	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	95566095	95566096	14q32.13	0	normal	.	C	del	.	ca.ac	het-ref	81	0.51	.	2	(CA)n|Simple_repeat|Simple_repeat|+|41;trf	PASS	606241	P	138800(MK);180295(MK);601200(MK)	AD	DICER1 syndrome	AD	.	Oncologic	Oncologic	21882293|21266384|21036787|19556464|18570301|9345104|9295070|6261577|799599	.	23405	DICER1	IC21	IVS22	.	.	intron	NM_177438.2	NP_803187.1	-	Y	c.4206+21delG	.	.	.	NM_177438.2(DICER1): c.4206+21delG	MixedObserved;	0	0	U	.	.	.	.	PASS	92	7284	0.282949	186	111004	0.096357	.	.	.	.	.	.	rs200057362|rs781195791	.	4029	0.217200	0.561	1.535	0.352	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	95566097	95566108	14q32.13	0	normal	.	CACACACACAC	ref	CACACACACAC	ca.aA	het-alt	96	0.55	.	1	(CA)n|Simple_repeat|Simple_repeat|+|41;trf	PASS	606241	P	138800(MK);180295(MK);601200(MK)	AD	DICER1 syndrome	AD	.	Oncologic	Oncologic	21882293|21266384|21036787|19556464|18570301|9345104|9295070|6261577|799599	.	23405	DICER1	IC21	IVS22	.	.	no-change	NM_177438.2	NP_803187.1	-	Y	c.4206+9_4206+19=	.	.	.	NM_177438.2(DICER1): c.4206+9_4206+19=	MixedObserved;	110836	0.902487	U	.	.	.	.	PASS	.	584	0.816781	8459	21790	0.887793	.	.	.	.	.	.	rs748368348	.	7464	0.525800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	95566097	95566108	14q32.13	1	normal	.	CACACACACAC	del	.	ca.aA	het-ref	79	0.45	.	2	(CA)n|Simple_repeat|Simple_repeat|+|41;trf	PASS	606241	P	138800(MK);180295(MK);601200(MK)	AD	DICER1 syndrome	AD	.	Oncologic	Oncologic	21882293|21266384|21036787|19556464|18570301|9345104|9295070|6261577|799599	.	23405	DICER1	IC21	IVS22	.	.	intron	NM_177438.2	NP_803187.1	-	Y	c.4206+9_4206+19delGTGTGTGTGTG	.	.	.	NM_177438.2(DICER1): c.4206+9_4206+19delGTGTGTGTGTG	MixedObserved;	110836	0.097513	U	.	.	.	.	VQSRTrancheINDEL99.00to99.50	89	7372	0.286761	178	111472	0.096957	690	2927	1.76581e-01	1701	13789	6.03315e-02	rs748368348	.	7464	0.094700	.	.	.	.	.	.	.	.	ENST00000343455: c.4206+9_4206+19delGTGTGTGTGTG (p.?)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	4603892	.	.	.	.	.	no_record	477187	criteria_provided,_single_submitter	Benign	Benign
14	95566103	95566104	14q32.13	1	normal	.	C	del	.	ca.ac	het-ref	24	0.17	.	2	(CA)n|Simple_repeat|Simple_repeat|+|41;trf	PASS	606241	P	138800(MK);180295(MK);601200(MK)	AD	DICER1 syndrome	AD	.	Oncologic	Oncologic	21882293|21266384|21036787|19556464|18570301|9345104|9295070|6261577|799599	.	23405	DICER1	IC21	IVS22	.	.	intron	NM_177438.2	NP_803187.1	-	Y	c.4206+13delG	.	.	.	NM_177438.2(DICER1): c.4206+13delG	MixedObserved;	0	0	U	.	.	.	.	VQSRTrancheINDEL97.00to99.00	15	2492	0.350321	462	58084	0.297070	.	.	.	.	.	.	rs35300142	.	5202	0.139300	-0.823	-0.779	-0.818	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	95566103	95566104	14q32.13	0	normal	.	C	ref	C	ca.ac	het-alt	118	0.83	.	1	(CA)n|Simple_repeat|Simple_repeat|+|41;trf	PASS	606241	P	138800(MK);180295(MK);601200(MK)	AD	DICER1 syndrome	AD	.	Oncologic	Oncologic	21882293|21266384|21036787|19556464|18570301|9345104|9295070|6261577|799599	.	23405	DICER1	IC21	IVS22	.	.	no-change	NM_177438.2	NP_803187.1	-	Y	c.4206+13G=	.	.	.	NM_177438.2(DICER1): c.4206+13G=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs35300142	.	5202	0.612300	-0.823	-0.779	-0.818	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	95574593	95574594	14q32.13	0	normal	.	G	ref	G	TA.TT	het-alt	186	0.78	.	1	.	PASS	606241	P	138800(MK);180295(MK);601200(MK)	AD	DICER1 syndrome	AD	.	Oncologic	Oncologic	21882293|21266384|21036787|19556464|18570301|9345104|9295070|6261577|799599	.	23405	DICER1	IC14	IVS15	.	.	no-change	NM_177438.2	NP_803187.1	-	Y	c.2436+67C=	.	.	.	NM_177438.2(DICER1): c.2436+67C=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.302	-1.199	-1.203	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
14	95574594	95574594	14q32.13	0	normal	.	.	ins	T	AG.TT	het-ref	54	0.23	.	2	.	PASS	606241	P	138800(MK);180295(MK);601200(MK)	AD	DICER1 syndrome	AD	.	Oncologic	Oncologic	21882293|21266384|21036787|19556464|18570301|9345104|9295070|6261577|799599	.	23405	DICER1	IC14	IVS15	.	.	intron	NM_177438.2	NP_803187.1	-	Y	c.2436+66_2436+67insA	.	.	.	NM_177438.2(DICER1): c.2436+66_2436+67insA	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs34975585	.	4024	0.399400	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	95581960	95581961	14q32.13	0	normal	.	G	ref	G	GT.CA	het-alt	120	0.50	.	1	.	PASS	606241	P	138800(MK);180295(MK);601200(MK)	AD	DICER1 syndrome	AD	.	Oncologic	Oncologic	21882293|21266384|21036787|19556464|18570301|9345104|9295070|6261577|799599	.	23405	DICER1	IC10	IVS11	.	.	no-change	NM_177438.2	NP_803187.1	-	Y	c.1907+43C=	.	.	.	NM_177438.2(DICER1): c.1907+43C=	;maf-5-some-pop	126416	0.932145	U	0	0.028754	13006	0.922651	PASS	0	8654	1.000000	52702	121408	0.930532	.	.	.	.	.	.	rs11624081	.	4024	0.999800	0.655	0.485	-0.043	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	95581960	95581961	14q32.13	0	normal	.	G	snv	A	GT.CA	het-ref	122	0.50	.	2	.	PASS	606241	P	138800(MK);180295(MK);601200(MK)	AD	DICER1 syndrome	AD	.	Oncologic	Oncologic	21882293|21266384|21036787|19556464|18570301|9345104|9295070|6261577|799599	.	23405	DICER1	IC10	IVS11	.	.	intron	NM_177438.2	NP_803187.1	-	Y	c.1907+43C>T	.	.	.	NM_177438.2(DICER1): c.1907+43C>T	;maf-5-some-pop	126416	0.067855	U	0	0.028754	13006	0.077349	PASS	0	8654	0.000000	432	121408	0.069468	0	1	5.79777e-05	915	16983	6.91079e-02	rs11624081	.	4024	0.000200	0.655	0.485	-0.043	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	95593159	95593161	14q32.13	0	normal	.	AA	ref	AA	gc.aa	het-alt	32	0.73	.	1	A-rich|Low_complexity|Low_complexity|+|49	PASS	606241	P	138800(MK);180295(MK);601200(MK)	AD	DICER1 syndrome	AD	.	Oncologic	Oncologic	21882293|21266384|21036787|19556464|18570301|9345104|9295070|6261577|799599	.	23405	DICER1	IC5	IVS6	.	.	no-change	NM_177438.2	NP_803187.1	-	Y	c.735-76_735-75=	.	.	.	NM_177438.2(DICER1): c.735-76_735-75=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4025	0.923000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	95593159	95593161	14q32.13	0	normal	.	AA	del	.	gc.aa	het-ref	12	0.27	.	2	A-rich|Low_complexity|Low_complexity|+|49	PASS	606241	P	138800(MK);180295(MK);601200(MK)	AD	DICER1 syndrome	AD	.	Oncologic	Oncologic	21882293|21266384|21036787|19556464|18570301|9345104|9295070|6261577|799599	.	23405	DICER1	IC5	IVS6	.	.	intron	NM_177438.2	NP_803187.1	-	Y	c.735-76_735-75delTT	.	.	.	NM_177438.2(DICER1): c.735-76_735-75delTT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4025	0.076800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	102550087	102550088	14q32.31	0	normal	.	C	ref	C	aa.TA	het-alt	74	0.66	.	1	.	PASS	140571	C	.	NN	.	.	.	.	.	.	.	3320	HSP90AA1	IC8	IVS8	.	.	no-change	NM_001017963.2	NP_001017963.2	-	Y	c.1704+42G=	.	.	.	NM_001017963.2(HSP90AA1): c.1704+42G=	MixedObserved;	99506|117850	0.999960|0.999975	U	.	.	.	.	VQSRTrancheSNP99.90to99.95	0	6894	1.000000	49749	99506	0.999960	.	.	.	.	.	.	rs753232453|rs779760515	.	4024	0.983800	0.420	1.124	0.578	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	102550087	102550088	14q32.31	0	normal	.	C	snv	A	aa.TA	het-ref	38	0.34	.	2	.	PASS	140571	C	.	NN	.	.	.	.	.	.	.	3320	HSP90AA1	IC8	IVS8	.	.	intron	NM_001017963.2	NP_001017963.2	-	Y	c.1704+42G>T	.	.	.	NM_001017963.2(HSP90AA1): c.1704+42G>T	MixedObserved;	99506	0.000040	U	.	.	.	.	VQSRTrancheSNP99.90to99.95	0	6894	0.000000	0	99506	0.000040	0	0	0.00000e+00	0	10	5.46430e-05	rs753232453	.	4024	0.016200	0.420	1.124	0.578	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
14	102568295	102568296	14q32.31	0	normal	.	G	ref	G	GC.GT	het-alt	164	0.52	.	1	.	PASS	140571	C	.	NN	.	.	.	.	.	.	.	3320	HSP90AA1	C2	EX2	.	.	no-change	NM_001017963.2	NP_001017963.2	-	Y	c.282C=	.	.	.	NM_001017963.2(HSP90AA1): c.282C=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126390	0.209091	U	0.7708	0.664537	13006	0.302322	PASS	-828	8640	0.245602	3889	121382	0.203877	.	.	.	.	.	.	rs10873531	.	4024	0.248500	-0.602	-0.312	-0.372	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	102568295	102568296	14q32.31	1	normal	.	G	snv	A	GC.GT	het-ref	149	0.48	.	2	.	PASS	140571	C	.	NN	.	.	.	.	.	.	.	3320	HSP90AA1	C2	EX2	.	.	coding-synon	NM_001017963.2	NP_001017963.2	-	Y	c.282C>T	p.(T94=) | p.(Thr94=)	ACC=>ACT	.	NM_001017963.2(HSP90AA1): c.282C>T (p.(T94=))	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126390	0.790909	U	0.7708	0.664537	13006	0.697678	PASS	2431	8640	0.754398	39833	121382	0.796123	4870	12994	7.53363e-01	82332	198588	8.06481e-01	rs10873531	.	4024	0.751500	-0.602	-0.312	-0.372	.	.	.	.	.	ENST00000334701: c.282C>T (p.T94T)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3753784	.	.	.	.	.	.	.	.	.	Likely Benign
14	102568366	102568367	14q32.31	0	normal	.	T	ref	T	CA.CA	het-alt	113	0.50	.	1	.	PASS	140571	C	.	NN	.	.	.	.	.	.	.	3320	HSP90AA1	C2	EX2	.	.	no-change	NM_001017963.2	NP_001017963.2	-	Y	c.211A=	.	.	.	NM_001017963.2(HSP90AA1): c.211A=	;maf-5-some-pop	126404	0.137353	U	0.8194	0.801118	13006	0.181839	PASS	-695	8644	0.194123	1467	121396	0.134815	.	.	.	.	.	.	rs8005905	.	4024	0.195300	-3.168	-3.174	-3.338	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	102568366	102568367	14q32.31	1	normal	.	T	snv	A	CA.CA	het-ref	111	0.50	.	2	.	PASS	140571	C	.	NN	.	.	.	.	.	.	.	3320	HSP90AA1	C2	EX2	.	.	missense	NM_001017963.2	NP_001017963.2	-	Y	c.211A>T	p.M71L | p.Met71Leu	ATG=>TTG	NP=>NP	NM_001017963.2(HSP90AA1): c.211A>T (p.M71L)	;maf-5-some-pop	126404	0.862647	U	0.8194	0.801118	13006	0.818161	PASS	2788	8644	0.805877	45799	121396	0.865185	5529	13832	8.01948e-01	93795	214186	8.69869e-01	rs8005905	.	4024	0.804700	-3.168	-3.174	-3.338	.	.	.	.	.	ENST00000334701: c.211A>T (p.M71L)	oesophagus [NS|NS|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	CSV	5438547	.	.	.	.	.	.	.	.	.	Likely Benign
14	104165863	104165864	14q32.33	0	normal	.	C	ref	C	CC.GA	het-alt	187	0.48	.	1	.	PASS	600675	P	114480(SK);613972(SK)	AD	.	.	.	.	.	.	.	7517	XRCC3	C5	EX8	.	.	no-change	NM_001100119.1	NP_001093589.1	-	Y	c.611G=	.	.	.	NM_001100119.1(XRCC3): c.611G=	;	120550	0.999967	U	.	.	.	.	PASS	-2	8610	0.999535	60271	120550	0.999967	.	.	.	.	.	.	rs756095186	.	.	.	0.462	2.956	0.994	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	104165863	104165864	14q32.33	1	normal	.	C	snv	T	CC.GA	het-ref	203	0.52	.	2	.	PASS	600675	P	114480(SK);613972(SK)	AD	.	.	.	.	.	.	.	7517	XRCC3	C5	EX8	.	.	missense	NM_001100119.1	NP_001093589.1	-	Y	c.611G>A	p.R204Q | p.Arg204Gln	CGG=>CAG	P+=>P0	NM_001100119.1(XRCC3): c.611G>A (p.R204Q)	;	120550	0.000033	U	.	.	.	.	PASS	0	8610	0.000465	0	120550	0.000033	0	4	2.31965e-04	0	5	2.03290e-05	rs756095186	.	.	.	0.462	2.956	0.994	0.03	0.962	0.999	0.770	deleterious	ENST00000554913: c.611G>A (p.R204Q)	ovary [NS|NS|NS]	carcinoma [mixed_adenosquamous_carcinoma|NS|NS]	CSV	3983115	.	.	.	.	.	.	.	.	.	VUS
14	104165926	104165927	14q32.33	0	normal	.	T	ref	T	GC.GT	het-alt	114	0.52	.	1	.	PASS	600675	P	114480(SK);613972(SK)	AD	.	.	.	.	.	.	.	7517	XRCC3	IC4	IVS7	.	.	no-change	NM_001100119.1	NP_001093589.1	-	Y	c.562-14A=	.	.	.	NM_001100119.1(XRCC3): c.562-14A=	;maf-5-some-pop,maf-5-all-pops	124898	0.697569	U	0.3641	0.246805	13006	0.735660	PASS	.	8554	0.639818	29310	119890	0.695246	.	.	.	.	.	.	rs1799796	.	4024	0.648400	-2.905	-2.618	-2.452	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	104165926	104165927	14q32.33	1	normal	.	T	snv	C	GC.GT	het-ref	104	0.48	.	2	.	PASS	600675	P	114480(SK);613972(SK)	AD	.	.	.	.	.	.	.	7517	XRCC3	IC4	IVS7	.	.	intron	NM_001100119.1	NP_001093589.1	-	Y	c.562-14A>G	.	.	.	NM_001100119.1(XRCC3): c.562-14A>G	;maf-5-some-pop,maf-5-all-pops	124898	0.302431	U	0.3641	0.246805	13006	0.264340	PASS	538	8554	0.360182	5902	119890	0.304754	1123	6241	3.62764e-01	12306	75075	3.07937e-01	rs1799796	.	4024	0.351600	-2.905	-2.618	-2.452	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105238635	105238636	14q32.33	0	normal	.	G	ref	G	AC.TG	het-alt	78	0.53	.	1	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC11	IVS12	.	.	no-change	NM_001014431.1	NP_001014431.1	-	Y	c.1260+66C=	.	.	.	NM_001014431.1(AKT1): c.1260+66C=	SingleClassTriAllelic;maf-5-some-pop	5008	0.936502	U	0.0149	0.00938498	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17846832	.	4024	0.951000	-1.042	-0.240	-0.257	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105238635	105238636	14q32.33	0	normal	.	G	ref	G	AC.TG	het-alt	78	0.53	.	1	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC11	IVS13	.	.	no-change	NM_001014432.1	NP_001014432.1	-	N	c.1260+66C=	.	.	.	NM_001014432.1(AKT1): c.1260+66C=	SingleClassTriAllelic;maf-5-some-pop	5008	0.936502	U	0.0149	0.00938498	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17846832	.	4024	0.951000	-1.042	-0.240	-0.257	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105238635	105238636	14q32.33	0	normal	.	G	ref	G	AC.TG	het-alt	78	0.53	.	1	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC11	IVS12	.	.	no-change	NM_005163.2	NP_005154.2	-	N	c.1260+66C=	.	.	.	NM_005163.2(AKT1): c.1260+66C=	SingleClassTriAllelic;maf-5-some-pop	5008	0.936502	U	0.0149	0.00938498	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17846832	.	4024	0.951000	-1.042	-0.240	-0.257	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105238635	105238636	14q32.33	0	normal	.	G	snv	A	AC.TG	het-ref	68	0.47	.	2	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC11	IVS12	.	.	intron	NM_001014431.1	NP_001014431.1	-	Y	c.1260+66C>T	.	.	.	NM_001014431.1(AKT1): c.1260+66C>T	SingleClassTriAllelic;maf-5-some-pop	5008	0.009385	U	0.0149	0.00938498	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17846832	.	4024	0.021900	-1.042	-0.240	-0.257	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
14	105238635	105238636	14q32.33	0	normal	.	G	snv	A	AC.TG	het-ref	68	0.47	.	2	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC11	IVS13	.	.	intron	NM_001014432.1	NP_001014432.1	-	N	c.1260+66C>T	.	.	.	NM_001014432.1(AKT1): c.1260+66C>T	SingleClassTriAllelic;maf-5-some-pop	5008	0.009385	U	0.0149	0.00938498	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17846832	.	4024	0.021900	-1.042	-0.240	-0.257	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
14	105238635	105238636	14q32.33	0	normal	.	G	snv	A	AC.TG	het-ref	68	0.47	.	2	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC11	IVS12	.	.	intron	NM_005163.2	NP_005154.2	-	N	c.1260+66C>T	.	.	.	NM_005163.2(AKT1): c.1260+66C>T	SingleClassTriAllelic;maf-5-some-pop	5008	0.009385	U	0.0149	0.00938498	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17846832	.	4024	0.021900	-1.042	-0.240	-0.257	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
14	105239191	105239192	14q32.33	0	nullSample	.	T	ref	T	TG.AG	homo-ref	.	.	.	0	.	.	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC10	IVS11	.	.	no-change	NM_001014431.1	NP_001014431.1	-	Y	c.1172+23A=	.	.	.	NM_001014431.1(AKT1): c.1172+23A=	;maf-5-some-pop,maf-5-all-pops	104316	0.475047	U	0.7341	0.574081	13004	0.546986	PASS	.	7248	0.257036	10872	99308	0.477524	.	.	.	.	.	.	rs2494732	.	4024	0.265400	-1.042	-2.265	-2.340	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105239191	105239192	14q32.33	0	nullSample	.	T	ref	T	TG.AG	homo-ref	.	.	.	0	.	.	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC10	IVS12	.	.	no-change	NM_001014432.1	NP_001014432.1	-	N	c.1172+23A=	.	.	.	NM_001014432.1(AKT1): c.1172+23A=	;maf-5-some-pop,maf-5-all-pops	104316	0.475047	U	0.7341	0.574081	13004	0.546986	PASS	.	7248	0.257036	10872	99308	0.477524	.	.	.	.	.	.	rs2494732	.	4024	0.265400	-1.042	-2.265	-2.340	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105239191	105239192	14q32.33	0	nullSample	.	T	ref	T	TG.AG	homo-ref	.	.	.	0	.	.	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC10	IVS11	.	.	no-change	NM_005163.2	NP_005154.2	-	N	c.1172+23A=	.	.	.	NM_005163.2(AKT1): c.1172+23A=	;maf-5-some-pop,maf-5-all-pops	104316	0.475047	U	0.7341	0.574081	13004	0.546986	PASS	.	7248	0.257036	10872	99308	0.477524	.	.	.	.	.	.	rs2494732	.	4024	0.265400	-1.042	-2.265	-2.340	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105239191	105239192	14q32.33	0	normal	.	T	snv	C	TG.AG	hom-alt	278	1.00	.	0	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC10	IVS11	.	.	intron	NM_001014431.1	NP_001014431.1	-	Y	c.1172+23A>G	.	.	.	NM_001014431.1(AKT1): c.1172+23A>G	;maf-5-some-pop,maf-5-all-pops	104316	0.524953	U	0.7341	0.574081	13004	0.453014	PASS	1959	7248	0.742964	13104	99308	0.522476	4346	11900	7.30779e-01	28938	111724	4.98034e-01	rs2494732	.	4024	0.734600	-1.042	-2.265	-2.340	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105239191	105239192	14q32.33	0	normal	.	T	snv	C	TG.AG	hom-alt	278	1.00	.	0	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC10	IVS12	.	.	intron	NM_001014432.1	NP_001014432.1	-	N	c.1172+23A>G	.	.	.	NM_001014432.1(AKT1): c.1172+23A>G	;maf-5-some-pop,maf-5-all-pops	104316	0.524953	U	0.7341	0.574081	13004	0.453014	PASS	1959	7248	0.742964	13104	99308	0.522476	4346	11900	7.30779e-01	28938	111724	4.98034e-01	rs2494732	.	4024	0.734600	-1.042	-2.265	-2.340	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105239191	105239192	14q32.33	0	normal	.	T	snv	C	TG.AG	hom-alt	278	1.00	.	0	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC10	IVS11	.	.	intron	NM_005163.2	NP_005154.2	-	N	c.1172+23A>G	.	.	.	NM_005163.2(AKT1): c.1172+23A>G	;maf-5-some-pop,maf-5-all-pops	104316	0.524953	U	0.7341	0.574081	13004	0.453014	PASS	1959	7248	0.742964	13104	99308	0.522476	4346	11900	7.30779e-01	28938	111724	4.98034e-01	rs2494732	.	4024	0.734600	-1.042	-2.265	-2.340	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105239893	105239894	14q32.33	0	normal	.	C	ref	C	CG.TC	het-alt	222	0.50	.	1	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	C8	EX9	.	.	no-change	NM_001014431.1	NP_001014431.1	-	Y	c.726G=	.	.	.	NM_001014431.1(AKT1): c.726G=	;maf-5-some-pop	102212	0.685458	U	0.6002	0.322484	13004	0.798370	PASS	-920	7370	0.412754	23027	97204	0.685867	.	.	.	.	.	.	rs1130233	.	4024	0.415000	0.561	0.705	2.198	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105239893	105239894	14q32.33	0	normal	.	C	ref	C	CG.TC	het-alt	222	0.50	.	1	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	C8	EX10	.	.	no-change	NM_001014432.1	NP_001014432.1	-	N	c.726G=	.	.	.	NM_001014432.1(AKT1): c.726G=	;maf-5-some-pop	102212	0.685458	U	0.6002	0.322484	13004	0.798370	PASS	-920	7370	0.412754	23027	97204	0.685867	.	.	.	.	.	.	rs1130233	.	4024	0.415000	0.561	0.705	2.198	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105239893	105239894	14q32.33	0	normal	.	C	ref	C	CG.TC	het-alt	222	0.50	.	1	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	C8	EX9	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	no-change	NM_005163.2	NP_005154.2	-	N	c.726G=	.	.	.	NM_005163.2(AKT1): c.726G=	;maf-5-some-pop	102212	0.685458	U	0.6002	0.322484	13004	0.798370	PASS	-920	7370	0.412754	23027	97204	0.685867	.	.	.	.	.	.	rs1130233	.	4024	0.415000	0.561	0.705	2.198	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105239893	105239894	14q32.33	1	normal	.	C	snv	T	CG.TC	het-ref	224	0.50	.	2	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	C8	EX9	.	.	coding-synon	NM_001014431.1	NP_001014431.1	-	Y	c.726G>A	p.(E242=) | p.(Glu242=)	GAG=>GAA	.	NM_001014431.1(AKT1): c.726G>A (p.(E242=))	;maf-5-some-pop	102212	0.314542	U	0.6002	0.322484	13004	0.201630	PASS	1244	7370	0.587246	4960	97204	0.314133	2739	9429	5.80389e-01	12028	69118	2.97121e-01	rs1130233	.	4024	0.585000	0.561	0.705	2.198	.	.	.	.	.	ENST00000349310: c.726G>A (p.E242E)	biliary_tract [bile_duct|NS|NS]	carcinoma [NS|NS|NS]	CSV	3765730	CM081515	NM_005163.2(AKT1): c.726G>A (p.E242E)	"Schizophrenia, familial, association with"	18497887	DFP	no_record	498670	criteria_provided,_single_submitter	Benign	Likely Benign
14	105239893	105239894	14q32.33	1	normal	.	C	snv	T	CG.TC	het-ref	224	0.50	.	2	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	C8	EX10	.	.	coding-synon	NM_001014432.1	NP_001014432.1	-	N	c.726G>A	p.(E242=) | p.(Glu242=)	GAG=>GAA	.	NM_001014432.1(AKT1): c.726G>A (p.(E242=))	;maf-5-some-pop	102212	0.314542	U	0.6002	0.322484	13004	0.201630	PASS	1244	7370	0.587246	4960	97204	0.314133	2739	9429	5.80389e-01	12028	69118	2.97121e-01	rs1130233	.	4024	0.585000	0.561	0.705	2.198	.	.	.	.	.	ENST00000349310: c.726G>A (p.E242E)	biliary_tract [bile_duct|NS|NS]	carcinoma [NS|NS|NS]	CSV	3765730	CM081515	NM_005163.2(AKT1): c.726G>A (p.E242E)	"Schizophrenia, familial, association with"	18497887	DFP	no_record	498670	criteria_provided,_single_submitter	Benign	Likely Benign
14	105239893	105239894	14q32.33	1	normal	.	C	snv	T	CG.TC	het-ref	224	0.50	.	2	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	C8	EX9	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_005163.2	NP_005154.2	-	N	c.726G>A	p.(E242=) | p.(Glu242=)	GAG=>GAA	.	NM_005163.2(AKT1): c.726G>A (p.(E242=))	;maf-5-some-pop	102212	0.314542	U	0.6002	0.322484	13004	0.201630	PASS	1244	7370	0.587246	4960	97204	0.314133	2739	9429	5.80389e-01	12028	69118	2.97121e-01	rs1130233	.	4024	0.585000	0.561	0.705	2.198	.	.	.	.	.	ENST00000349310: c.726G>A (p.E242E)	biliary_tract [bile_duct|NS|NS]	carcinoma [NS|NS|NS]	CSV	3765730	CM081515	NM_005163.2(AKT1): c.726G>A (p.E242E)	"Schizophrenia, familial, association with"	18497887	DFP	no_record	498670	criteria_provided,_single_submitter	Benign	Likely Benign
14	105242227	105242228	14q32.33	0	nullSample	.	T	ref	T	GT.CC	homo-ref	.	.	.	0	.	.	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC3	IVS4	.	.	no-change	NM_001014431.1	NP_001014431.1	-	Y	c.288-92A=	.	.	.	NM_001014431.1(AKT1): c.288-92A=	;maf-5-some-pop,maf-5-all-pops	5008	0.475240	U	0.6409	0.52476	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2498797	.	4024	0.361100	-0.414	-0.251	-0.413	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105242227	105242228	14q32.33	0	nullSample	.	T	ref	T	GT.CC	homo-ref	.	.	.	0	.	.	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC3	IVS5	.	.	no-change	NM_001014432.1	NP_001014432.1	-	N	c.288-92A=	.	.	.	NM_001014432.1(AKT1): c.288-92A=	;maf-5-some-pop,maf-5-all-pops	5008	0.475240	U	0.6409	0.52476	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2498797	.	4024	0.361100	-0.414	-0.251	-0.413	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105242227	105242228	14q32.33	0	nullSample	.	T	ref	T	GT.CC	homo-ref	.	.	.	0	.	.	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC3	IVS4	.	.	no-change	NM_005163.2	NP_005154.2	-	N	c.288-92A=	.	.	.	NM_005163.2(AKT1): c.288-92A=	;maf-5-some-pop,maf-5-all-pops	5008	0.475240	U	0.6409	0.52476	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2498797	.	4024	0.361100	-0.414	-0.251	-0.413	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105242227	105242228	14q32.33	0	normal	.	T	snv	C	GT.CC	hom-alt	253	1.00	.	0	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC3	IVS4	.	.	intron	NM_001014431.1	NP_001014431.1	-	Y	c.288-92A>G	.	.	.	NM_001014431.1(AKT1): c.288-92A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.524760	U	0.6409	0.52476	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2498797	.	4024	0.638900	-0.414	-0.251	-0.413	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105242227	105242228	14q32.33	0	normal	.	T	snv	C	GT.CC	hom-alt	253	1.00	.	0	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC3	IVS5	.	.	intron	NM_001014432.1	NP_001014432.1	-	N	c.288-92A>G	.	.	.	NM_001014432.1(AKT1): c.288-92A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.524760	U	0.6409	0.52476	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2498797	.	4024	0.638900	-0.414	-0.251	-0.413	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105242227	105242228	14q32.33	0	normal	.	T	snv	C	GT.CC	hom-alt	253	1.00	.	0	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC3	IVS4	.	.	intron	NM_005163.2	NP_005154.2	-	N	c.288-92A>G	.	.	.	NM_005163.2(AKT1): c.288-92A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.524760	U	0.6409	0.52476	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2498797	.	4024	0.638900	-0.414	-0.251	-0.413	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105242965	105242966	14q32.33	0	nullSample	.	T	ref	T	AG.GC	homo-ref	.	.	.	0	.	.	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC3	IVS4	.	.	no-change	NM_001014431.1	NP_001014431.1	-	Y	c.287+30A=	.	.	.	NM_001014431.1(AKT1): c.287+30A=	;maf-5-some-pop,maf-5-all-pops	121326	0.529722	U	0.6548	0.596446	13004	0.528222	PASS	-965	8416	0.350998	17574	116318	0.535154	.	.	.	.	.	.	rs2494735	.	4024	0.344400	-2.894	-3.985	-4.098	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105242965	105242966	14q32.33	0	nullSample	.	T	ref	T	AG.GC	homo-ref	.	.	.	0	.	.	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC3	IVS5	.	.	no-change	NM_001014432.1	NP_001014432.1	-	N	c.287+30A=	.	.	.	NM_001014432.1(AKT1): c.287+30A=	;maf-5-some-pop,maf-5-all-pops	121326	0.529722	U	0.6548	0.596446	13004	0.528222	PASS	-965	8416	0.350998	17574	116318	0.535154	.	.	.	.	.	.	rs2494735	.	4024	0.344400	-2.894	-3.985	-4.098	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105242965	105242966	14q32.33	0	nullSample	.	T	ref	T	AG.GC	homo-ref	.	.	.	0	.	.	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC3	IVS4	.	.	no-change	NM_005163.2	NP_005154.2	-	N	c.287+30A=	.	.	.	NM_005163.2(AKT1): c.287+30A=	;maf-5-some-pop,maf-5-all-pops	121326	0.529722	U	0.6548	0.596446	13004	0.528222	PASS	-965	8416	0.350998	17574	116318	0.535154	.	.	.	.	.	.	rs2494735	.	4024	0.344400	-2.894	-3.985	-4.098	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105242965	105242966	14q32.33	0	normal	.	T	snv	C	AG.GC	hom-alt	191	1.00	.	0	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC3	IVS4	.	.	intron	NM_001014431.1	NP_001014431.1	-	Y	c.287+30A>G	.	.	.	NM_001014431.1(AKT1): c.287+30A>G	;maf-5-some-pop,maf-5-all-pops	121326	0.470278	U	0.6548	0.596446	13004	0.471778	PASS	1766	8416	0.649002	13485	116318	0.464846	3542	10992	6.47502e-01	27155	109415	4.58763e-01	rs2494735	.	4024	0.655600	-2.894	-3.985	-4.098	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105242965	105242966	14q32.33	0	normal	.	T	snv	C	AG.GC	hom-alt	191	1.00	.	0	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC3	IVS5	.	.	intron	NM_001014432.1	NP_001014432.1	-	N	c.287+30A>G	.	.	.	NM_001014432.1(AKT1): c.287+30A>G	;maf-5-some-pop,maf-5-all-pops	121326	0.470278	U	0.6548	0.596446	13004	0.471778	PASS	1766	8416	0.649002	13485	116318	0.464846	3542	10992	6.47502e-01	27155	109415	4.58763e-01	rs2494735	.	4024	0.655600	-2.894	-3.985	-4.098	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105242965	105242966	14q32.33	0	normal	.	T	snv	C	AG.GC	hom-alt	191	1.00	.	0	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC3	IVS4	.	.	intron	NM_005163.2	NP_005154.2	-	N	c.287+30A>G	.	.	.	NM_005163.2(AKT1): c.287+30A>G	;maf-5-some-pop,maf-5-all-pops	121326	0.470278	U	0.6548	0.596446	13004	0.471778	PASS	1766	8416	0.649002	13485	116318	0.464846	3542	10992	6.47502e-01	27155	109415	4.58763e-01	rs2494735	.	4024	0.655600	-2.894	-3.985	-4.098	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105246324	105246325	14q32.33	0	nullSample	.	T	ref	T	AC.TG	homo-ref	.	.	.	0	.	.	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC2	IVS3	.	.	no-change	NM_001014431.1	NP_001014431.1	-	Y	c.175+100A=	.	.	.	NM_001014431.1(AKT1): c.175+100A=	;maf-5-some-pop,maf-5-all-pops	5008	0.486222	U	0.6478	0.513778	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2494737	.	4024	0.353900	-0.827	-2.024	-2.318	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105246324	105246325	14q32.33	0	nullSample	.	T	ref	T	AC.TG	homo-ref	.	.	.	0	.	.	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC2	IVS4	.	.	no-change	NM_001014432.1	NP_001014432.1	-	N	c.175+100A=	.	.	.	NM_001014432.1(AKT1): c.175+100A=	;maf-5-some-pop,maf-5-all-pops	5008	0.486222	U	0.6478	0.513778	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2494737	.	4024	0.353900	-0.827	-2.024	-2.318	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105246324	105246325	14q32.33	0	nullSample	.	T	ref	T	AC.TG	homo-ref	.	.	.	0	.	.	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC2	IVS3	.	.	no-change	NM_005163.2	NP_005154.2	-	N	c.175+100A=	.	.	.	NM_005163.2(AKT1): c.175+100A=	;maf-5-some-pop,maf-5-all-pops	5008	0.486222	U	0.6478	0.513778	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2494737	.	4024	0.353900	-0.827	-2.024	-2.318	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105246324	105246325	14q32.33	0	normal	.	T	snv	A	AC.TG	hom-alt	199	1.00	.	0	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC2	IVS3	.	.	intron	NM_001014431.1	NP_001014431.1	-	Y	c.175+100A>T	.	.	.	NM_001014431.1(AKT1): c.175+100A>T	;maf-5-some-pop,maf-5-all-pops	5008	0.513778	U	0.6478	0.513778	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2494737	.	4024	0.646100	-0.827	-2.024	-2.318	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105246324	105246325	14q32.33	0	normal	.	T	snv	A	AC.TG	hom-alt	199	1.00	.	0	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC2	IVS4	.	.	intron	NM_001014432.1	NP_001014432.1	-	N	c.175+100A>T	.	.	.	NM_001014432.1(AKT1): c.175+100A>T	;maf-5-some-pop,maf-5-all-pops	5008	0.513778	U	0.6478	0.513778	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2494737	.	4024	0.646100	-0.827	-2.024	-2.318	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105246324	105246325	14q32.33	0	normal	.	T	snv	A	AC.TG	hom-alt	199	1.00	.	0	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC2	IVS3	.	.	intron	NM_005163.2	NP_005154.2	-	N	c.175+100A>T	.	.	.	NM_005163.2(AKT1): c.175+100A>T	;maf-5-some-pop,maf-5-all-pops	5008	0.513778	U	0.6478	0.513778	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2494737	.	4024	0.646100	-0.827	-2.024	-2.318	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105258891	105258892	14q32.33	0	normal	.	C	ref	C	CC.AT	het-alt	120	0.50	.	1	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC1	IVS2	.	.	no-change	NM_001014431.1	NP_001014431.1	-	Y	c.46+43G=	.	.	.	NM_001014431.1(AKT1): c.46+43G=	MixedObserved;maf-5-some-pop,maf-5-all-pops	124614	0.495474	U	0.2083	0.35623	13002	0.570605	PASS	.	8536	0.804007	15656	119606	0.489265	.	.	.	.	.	.	rs2494748	.	4024	0.801700	-0.350	0.390	-0.364	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105258891	105258892	14q32.33	0	normal	.	C	ref	C	CC.AT	het-alt	120	0.50	.	1	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC1	IVS3	.	.	no-change	NM_001014432.1	NP_001014432.1	-	N	c.46+43G=	.	.	.	NM_001014432.1(AKT1): c.46+43G=	MixedObserved;maf-5-some-pop,maf-5-all-pops	124614	0.495474	U	0.2083	0.35623	13002	0.570605	PASS	.	8536	0.804007	15656	119606	0.489265	.	.	.	.	.	.	rs2494748	.	4024	0.801700	-0.350	0.390	-0.364	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105258891	105258892	14q32.33	0	normal	.	C	ref	C	CC.AT	het-alt	120	0.50	.	1	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC1	IVS2	.	.	no-change	NM_005163.2	NP_005154.2	-	N	c.46+43G=	.	.	.	NM_005163.2(AKT1): c.46+43G=	MixedObserved;maf-5-some-pop,maf-5-all-pops	124614	0.495474	U	0.2083	0.35623	13002	0.570605	PASS	.	8536	0.804007	15656	119606	0.489265	.	.	.	.	.	.	rs2494748	.	4024	0.801700	-0.350	0.390	-0.364	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105258891	105258892	14q32.33	0	normal	.	C	snv	T	CC.AT	het-ref	119	0.50	.	2	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC1	IVS2	.	.	intron	NM_001014431.1	NP_001014431.1	-	Y	c.46+43G>A	.	.	.	NM_001014431.1(AKT1): c.46+43G>A	MixedObserved;maf-5-some-pop,maf-5-all-pops	124614	0.504526	U	0.2083	0.35623	13002	0.429395	PASS	155	8536	0.195993	16940	119606	0.510735	322	3373	1.96082e-01	34758	125482	5.14760e-01	rs2494748	.	4024	0.198300	-0.350	0.390	-0.364	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105258891	105258892	14q32.33	0	normal	.	C	snv	T	CC.AT	het-ref	119	0.50	.	2	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC1	IVS3	.	.	intron	NM_001014432.1	NP_001014432.1	-	N	c.46+43G>A	.	.	.	NM_001014432.1(AKT1): c.46+43G>A	MixedObserved;maf-5-some-pop,maf-5-all-pops	124614	0.504526	U	0.2083	0.35623	13002	0.429395	PASS	155	8536	0.195993	16940	119606	0.510735	322	3373	1.96082e-01	34758	125482	5.14760e-01	rs2494748	.	4024	0.198300	-0.350	0.390	-0.364	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105258891	105258892	14q32.33	0	normal	.	C	snv	T	CC.AT	het-ref	119	0.50	.	2	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC1	IVS2	.	.	intron	NM_005163.2	NP_005154.2	-	N	c.46+43G>A	.	.	.	NM_005163.2(AKT1): c.46+43G>A	MixedObserved;maf-5-some-pop,maf-5-all-pops	124614	0.504526	U	0.2083	0.35623	13002	0.429395	PASS	155	8536	0.195993	16940	119606	0.510735	322	3373	1.96082e-01	34758	125482	5.14760e-01	rs2494748	.	4024	0.198300	-0.350	0.390	-0.364	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105258892	105258893	14q32.33	0	normal	.	A	ref	A	CC.TC	het-alt	122	0.50	.	1	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC1	IVS2	.	.	no-change	NM_001014431.1	NP_001014431.1	-	Y	c.46+42T=	.	.	.	NM_001014431.1(AKT1): c.46+42T=	;maf-5-some-pop,maf-5-all-pops	124731	0.180845	U	0.3304	0.709265	13002	0.090909	PASS	.	8510	0.657932	3550	119724	0.176247	.	.	.	.	.	.	rs2494749	.	4024	0.669200	-3.925	-4.632	-4.703	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105258892	105258893	14q32.33	0	normal	.	A	ref	A	CC.TC	het-alt	122	0.50	.	1	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC1	IVS3	.	.	no-change	NM_001014432.1	NP_001014432.1	-	N	c.46+42T=	.	.	.	NM_001014432.1(AKT1): c.46+42T=	;maf-5-some-pop,maf-5-all-pops	124731	0.180845	U	0.3304	0.709265	13002	0.090909	PASS	.	8510	0.657932	3550	119724	0.176247	.	.	.	.	.	.	rs2494749	.	4024	0.669200	-3.925	-4.632	-4.703	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105258892	105258893	14q32.33	0	normal	.	A	ref	A	CC.TC	het-alt	122	0.50	.	1	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC1	IVS2	.	.	no-change	NM_005163.2	NP_005154.2	-	N	c.46+42T=	.	.	.	NM_005163.2(AKT1): c.46+42T=	;maf-5-some-pop,maf-5-all-pops	124731	0.180845	U	0.3304	0.709265	13002	0.090909	PASS	.	8510	0.657932	3550	119724	0.176247	.	.	.	.	.	.	rs2494749	.	4024	0.669200	-3.925	-4.632	-4.703	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105258892	105258893	14q32.33	0	normal	.	A	snv	G	CC.TC	het-ref	124	0.50	.	2	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC1	IVS2	.	.	intron	NM_001014431.1	NP_001014431.1	-	Y	c.46+42T>C	.	.	.	NM_001014431.1(AKT1): c.46+42T>C	;maf-5-some-pop,maf-5-all-pops	124731	0.819155	U	0.3304	0.709265	13002	0.909091	PASS	489	8510	0.342068	42310	119724	0.823745	957	5744	3.34303e-01	85132	199572	8.18012e-01	rs2494749	.	4024	0.330800	-3.925	-4.632	-4.703	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105258892	105258893	14q32.33	0	normal	.	A	snv	G	CC.TC	het-ref	124	0.50	.	2	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC1	IVS3	.	.	intron	NM_001014432.1	NP_001014432.1	-	N	c.46+42T>C	.	.	.	NM_001014432.1(AKT1): c.46+42T>C	;maf-5-some-pop,maf-5-all-pops	124731	0.819155	U	0.3304	0.709265	13002	0.909091	PASS	489	8510	0.342068	42310	119724	0.823745	957	5744	3.34303e-01	85132	199572	8.18012e-01	rs2494749	.	4024	0.330800	-3.925	-4.632	-4.703	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
14	105258892	105258893	14q32.33	0	normal	.	A	snv	G	CC.TC	het-ref	124	0.50	.	2	.	PASS	164730	C	114480(MK);114500(MK);167000(MK);176920(MK);181500(SL);615109(MK)	AD	Cowden syndrome 6; Proteus syndrome 	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Cardiovascular; Hematologic; Oncologic; Pulmonary	23246288|22876373|21793738	.	207	AKT1	IC1	IVS2	.	.	intron	NM_005163.2	NP_005154.2	-	N	c.46+42T>C	.	.	.	NM_005163.2(AKT1): c.46+42T>C	;maf-5-some-pop,maf-5-all-pops	124731	0.819155	U	0.3304	0.709265	13002	0.909091	PASS	489	8510	0.342068	42310	119724	0.823745	957	5744	3.34303e-01	85132	199572	8.18012e-01	rs2494749	.	4024	0.330800	-3.925	-4.632	-4.703	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	40998341	40998342	15q15.1	0	nullSample	.	T	ref	T	TA.TT	homo-ref	.	.	.	0	.	.	179617	C	114480(SK);614508(MK)	AD	Mirror movements 2	AD	.	Neurologic	General	22305526|21242494	.	5888	RAD51	IC2	IVS3	.	.	no-change	NM_002875.4	NP_002866.2	+	Y	c.226-33T=	.	.	.	NM_002875.4(RAD51): c.226-33T=	;maf-5-some-pop,maf-5-all-pops	124900	0.731209	U	0.6438	0.354233	13004	0.811212	PASS	.	8608	0.323304	34154	119892	0.734778	.	.	.	.	.	.	rs45457497	.	4024	0.302200	0.332	1.900	0.549	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	40998341	40998342	15q15.1	0	normal	.	T	snv	G	TA.TT	hom-alt	277	1.00	.	0	.	PASS	179617	C	114480(SK);614508(MK)	AD	Mirror movements 2	AD	.	Neurologic	General	22305526|21242494	.	5888	RAD51	IC2	IVS3	.	.	intron	NM_002875.4	NP_002866.2	+	Y	c.226-33T>G	.	.	.	NM_002875.4(RAD51): c.226-33T>G	;maf-5-some-pop,maf-5-all-pops	124900	0.268791	U	0.6438	0.354233	13004	0.188788	PASS	1968	8608	0.676696	6006	119892	0.265222	3915	11623	6.75677e-01	12779	66482	2.70791e-01	rs45457497	.	4024	0.697800	0.332	1.900	0.549	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	50781962	50781963	15q21.2	0	normal	.	T	ref	T	Aa.tt	het-alt	80	0.51	.	1	(TTTTA)n|Simple_repeat|Simple_repeat|+|31	PASS	603158	P	.	NN	.	.	.	.	.	.	.	9101	USP8	IC11	IVS13	.	.	no-change	NM_001128611.1	NP_001122083.1	+	Y	c.1891-35T=	.	.	.	NM_001128611.1(USP8): c.1891-35T=	MixedObserved;maf-5-some-pop,maf-5-all-pops|MixedObserved;	21928|0	0.508300|0	U	0.623	0.536741	6694	0.582163	PASS	-44	350	0.405714	2150	16920	0.521631	.	.	.	.	.	.	rs3098176|rs750549784	.	4024	0.411500	-4.084	-0.508	-0.543	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	50781962	50781963	15q21.2	0	normal	.	T	snv	A	Aa.tt	het-ref	78	0.49	.	2	(TTTTA)n|Simple_repeat|Simple_repeat|+|31	PASS	603158	P	.	NN	.	.	.	.	.	.	.	9101	USP8	IC11	IVS13	.	.	intron	NM_001128611.1	NP_001122083.1	+	Y	c.1891-35T>A	.	.	.	NM_001128611.1(USP8): c.1891-35T>A	MixedObserved;maf-5-some-pop,maf-5-all-pops|MixedObserved;	21928|0	0.491700|0	U	0.623	0.536741	6694	0	PASS	60	350	0.594286	1784	16920	0.478369	438	1616	5.39746e-01	8150	36414	4.35033e-01	rs3098176|rs750549784	.	4024	0.588500	-4.084	-0.508	-0.543	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	51502843	51502844	15q21.2	0	nullSample	.	A	ref	A	AC.AA	homo-ref	.	.	.	0	.	.	107910	C	139300(MK);613546(MK)	AD;AR;XL	Aromatase deficiency	AR	Allelic with Aromatase excess syndrome (AD), in which medical treatment (eg, with aromatase inhibitors) can be beneficial, but it is unclear if early (genetic) diagnosis would be advantageous	Endocrine	Endocrine	21521281|21470988|17452968|15811932|12736278|9543166|8265607|1825497	.	1588	CYP19A1	3U1E	EX11E	.	.	no-change	NM_031226.2	NP_112503.1	-	Y	c.*161T=	.	.	.	NM_031226.2(CYP19A1): c.*161T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	99676	0.290250	U	0.7034	0.664337	.	.	PASS	.	5894	0.293010	2926	94668	0.287848	.	.	.	.	.	.	rs4646	.	.	.	-1.110	-2.523	-2.358	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	51502843	51502844	15q21.2	0	normal	.	A	snv	C	AC.AA	hom-alt	320	1.00	.	0	.	PASS	107910	C	139300(MK);613546(MK)	AD;AR;XL	Aromatase deficiency	AR	Allelic with Aromatase excess syndrome (AD), in which medical treatment (eg, with aromatase inhibitors) can be beneficial, but it is unclear if early (genetic) diagnosis would be advantageous	Endocrine	Endocrine	21521281|21470988|17452968|15811932|12736278|9543166|8265607|1825497	.	1588	CYP19A1	3U1E	EX11E	.	.	utr-3	NM_031226.2	NP_112503.1	-	Y	c.*161T>G	.	.	.	NM_031226.2(CYP19A1): c.*161T>G	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	99676	0.709750	U	0.7034	0.664337	.	.	PASS	1369	5894	0.706990	23010	94668	0.712152	3496	10401	6.75302e-01	49566	145044	6.71836e-01	rs4646	.	.	.	-1.110	-2.523	-2.358	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	316467	reviewed_by_expert_panel	drug_response	Benign
15	66679648	66679649	15q22.31	0	normal	.	T	ref	T	CC.CC	het-alt	84	0.56	.	1	.	PASS	176872	C	615279(MK)	NN	Cardiofaciocutaneous syndrome	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Oncologic	21495173|20301365|20301303|18456719|18042262|17567882|17551924|16439621	.	5604	MAP2K1	5U1E	EX1	.	.	no-change	NM_002755.3	NP_002746.1	+	Y	c.-37T=	.	.	.	NM_002755.3(MAP2K1): c.-37T=	.	.	.	.	0.3214	0.147165	.	.	PASS	-69	662	0.685801	8098	20290	0.891917	.	.	.	.	.	.	.	.	.	.	-0.475	-0.284	-0.334	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	66679649	66679649	15q22.31	0	normal	.	.	ins	C	CT.CC	het-ref	66	0.44	.	2	.	PASS	176872	C	615279(MK)	NN	Cardiofaciocutaneous syndrome	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Oncologic	21495173|20301365|20301303|18456719|18042262|17567882|17551924|16439621	.	5604	MAP2K1	5U1E	EX1	.	.	utr-5	NM_002755.3	NP_002746.1	+	Y	c.-36C[6>7] (std: c.-31dupC alt: c.-31_-30insC )	.	.	.	NM_002755.3(MAP2K1): c.-31dupC	;maf-5-some-pop,maf-5-all-pops	25298	0.115819	U	0.3214	0.147165	.	.	PASS	35	662	0.314199	146	20290	0.108083	574	3426	3.33268e-01	1409	17428	1.18513e-01	rs142027715	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	40710	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
15	66727596	66727597	15q22.31	0	normal	.	G	ref	G	CA.GT	het-alt	114	0.47	.	1	.	PASS	176872	C	615279(MK)	NN	Cardiofaciocutaneous syndrome	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Oncologic	21495173|20301365|20301303|18456719|18042262|17567882|17551924|16439621	.	5604	MAP2K1	IC2	IVS2	.	.	no-change	NM_002755.3	NP_002746.1	+	Y	c.291+22G=	.	.	.	NM_002755.3(MAP2K1): c.291+22G=	SingleClassTriAllelic;maf-5-some-pop	126086	0.686468	U	0.3155	0.270767	13000	0.726846	PASS	-943	8610	0.680836	28533	121078	0.684699	.	.	.	.	.	.	rs16949924	.	4024	0.683600	0.591	0.239	0.215	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	66727596	66727597	15q22.31	0	normal	.	G	snv	C	CA.GT	het-ref	131	0.53	.	2	.	PASS	176872	C	615279(MK)	NN	Cardiofaciocutaneous syndrome	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Oncologic	21495173|20301365|20301303|18456719|18042262|17567882|17551924|16439621	.	5604	MAP2K1	IC2	IVS2	.	.	intron	NM_002755.3	NP_002746.1	+	Y	c.291+22G>C	.	.	.	NM_002755.3(MAP2K1): c.291+22G>C	SingleClassTriAllelic;maf-5-some-pop	126086	0.313524	U	0.3155	0.270767	13000	0.273154	PASS	431	8610	0.319048	6170	121078	0.315293	847	5454	3.16357e-01	12983	78465	3.19584e-01	rs16949924	.	4024	0.316400	0.591	0.239	0.215	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	40784	criteria_provided,_single_submitter	Benign	Benign
15	66735550	66735551	15q22.31	0	normal	.	C	snv	T	GC.GA	hom-alt	153	1.00	.	0	.	PASS	176872	C	615279(MK)	NN	Cardiofaciocutaneous syndrome	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Oncologic	21495173|20301365|20301303|18456719|18042262|17567882|17551924|16439621	.	5604	MAP2K1	IC3	IVS3	.	.	intron	NM_002755.3	NP_002746.1	+	Y	c.439-67C>T	.	.	.	NM_002755.3(MAP2K1): c.439-67C>T	;maf-5-some-pop	5008	0.855232	U	0.999	0.855232	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6494573	.	4024	0.998500	-0.424	-0.360	-0.081	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	66735550	66735551	15q22.31	0	nullSample	.	C	ref	C	GC.GA	homo-ref	.	.	.	0	.	.	176872	C	615279(MK)	NN	Cardiofaciocutaneous syndrome	AD	.	Cardiovascular; Craniofacial; Hematologic; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Oncologic	21495173|20301365|20301303|18456719|18042262|17567882|17551924|16439621	.	5604	MAP2K1	IC3	IVS3	.	.	no-change	NM_002755.3	NP_002746.1	+	Y	c.439-67C=	.	.	.	NM_002755.3(MAP2K1): c.439-67C=	;maf-5-some-pop	5008	0.144768	U	0.999	0.855232	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6494573	.	4024	0.001500	-0.424	-0.360	-0.081	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	67457334	67457335	15q22.33	0	normal	.	A	ref	A	CT.CG	het-alt	307	0.52	.	1	.	PASS	603109	P	613795(MK)	NN	Aneurysms-osteoarthritis syndrome; Loeys-Dietz syndrome, type 1C	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal	Cardiovascular	22167769|21778426|21217753	.	4088	SMAD3	C2	EX2	MH1 domain	PF03165.11	no-change	NM_005902.3	NP_005893.1	+	Y	c.309A=	.	.	.	NM_005902.3(SMAD3): c.309A=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126384	0.137644	U	0.7619	0.834065	13000	0.120000	PASS	.	8630	0.241367	1309	121376	0.136477	.	.	.	.	.	.	rs1065080	.	.	.	-0.215	0.513	0.478	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	67457334	67457335	15q22.33	1	normal	.	A	snv	G	CT.CG	het-ref	285	0.48	.	2	.	PASS	603109	P	613795(MK)	NN	Aneurysms-osteoarthritis syndrome; Loeys-Dietz syndrome, type 1C	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal	Cardiovascular	22167769|21778426|21217753	.	4088	SMAD3	C2	EX2	MH1 domain	PF03165.11	coding-synon	NM_005902.3	NP_005893.1	+	Y	c.309A>G	p.(L103=) | p.(Leu103=)	CTA=>CTG	.	NM_005902.3(SMAD3): c.309A>G (p.(L103=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126384	0.862356	U	0.7619	0.834065	13000	0.880000	PASS	2497	8630	0.758633	45432	121376	0.863523	4935	13032	7.55653e-01	92899	213492	8.67099e-01	rs1065080	.	.	.	-0.215	0.513	0.478	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	139217	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
15	67476969	67476970	15q22.33	0	nullSample	.	T	ref	T	GC.CT	homo-ref	.	.	.	0	.	.	603109	P	613795(MK)	NN	Aneurysms-osteoarthritis syndrome; Loeys-Dietz syndrome, type 1C	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal	Cardiovascular	22167769|21778426|21217753	.	4088	SMAD3	IC6	IVS6	.	.	no-change	NM_005902.3	NP_005893.1	+	Y	c.872-95T=	.	.	.	NM_005902.3(SMAD3): c.872-95T=	;maf-5-some-pop,maf-5-all-pops	5008	0.728235	U	0.4464	0.271765	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2289790	.	.	.	-0.227	-0.499	-0.544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	67476969	67476970	15q22.33	0	normal	.	T	snv	C	GC.CT	hom-alt	204	1.00	.	0	.	PASS	603109	P	613795(MK)	NN	Aneurysms-osteoarthritis syndrome; Loeys-Dietz syndrome, type 1C	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal	Cardiovascular	22167769|21778426|21217753	.	4088	SMAD3	IC6	IVS6	.	.	intron	NM_005902.3	NP_005893.1	+	Y	c.872-95T>C	.	.	.	NM_005902.3(SMAD3): c.872-95T>C	;maf-5-some-pop,maf-5-all-pops	5008	0.271765	U	0.4464	0.271765	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2289790	.	.	.	-0.227	-0.499	-0.544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	75012984	75012985	15q24.1	0	nullSample	.	T	ref	T	AA.GG	homo-ref	.	.	.	0	.	.	108330	C	.	NN	.	.	.	.	.	.	.	1543	CYP1A1	C6E	EX7E	Cytochrome P450	PF00067.17	no-change	NM_000499.3	NP_000490.1	-	Y	c.1384A=	.	.	.	NM_000499.3(CYP1A1): c.1384A=	SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop,genotype-conflict,rs-cluster-nonoverlapping-alleles	126362	0.904417	U	0.252	0.133387	12986	0.972817	PASS	-807	8644	0.756363	50684	121354	0.905978	.	.	.	.	.	.	rs1048943	.	4024	0.751700	0.529	2.595	0.935	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	75012984	75012985	15q24.1	1	normal	.	T	snv	C	AA.GG	hom-alt	355	1.00	.	0	.	PASS	108330	C	.	NN	.	.	.	.	.	.	.	1543	CYP1A1	C6E	EX7E	Cytochrome P450	PF00067.17	missense	NM_000499.3	NP_000490.1	-	Y	c.1384A>G	p.I462V | p.Ile462Val	ATT=>GTT	NP=>NP	NM_000499.3(CYP1A1): c.1384A>G (p.I462V)	SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop,genotype-conflict,rs-cluster-nonoverlapping-alleles	126362	0.095583	U	0.252	0.133387	12986	0.027183	PASS	246	8644	0.243637	1417	121354	0.094022	508	4231	2.45475e-01	3519	26534	1.07790e-01	rs1048943	.	4024	0.248300	0.529	2.595	0.935	0.37	0.35	0.053	0.130	neutral	ENST00000395048: c.1384A>G (p.I462V)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3999600	CM940327	NM_000499.3(CYP1A1): c.1384A>G (p.I462V)	"Lung cancer, smoking induced, association with"	1722803	DFP	.	.	.	.	Likely Benign
15	77344792	77344793	15q24.3	0	nullSample	.	T	ref	T	AC.AC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr15: g.77344792T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	126362	0.404386	U	0.4028	0.491214	12980	0.394145	PASS	-1031	8640	0.584028	10320	121354	0.400077	.	.	.	.	.	.	rs11737	.	.	.	-0.265	0.974	0.434	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	77344792	77344793	15q24.3	0	normal	.	T	snv	A	AC.AC	hom-alt	396	0.99	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr15: g.77344792T>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	126362	0.595614	U	0.4028	0.491214	12980	0.605855	PASS	766	8640	0.415972	22446	121354	0.599923	1426	6926	4.01554e-01	45556	147517	5.99210e-01	rs11737	.	.	.	-0.265	0.974	0.434	.	.	.	.	.	ENST00000267970: c.603A>T (p.V201V)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3754479	.	.	.	.	.	.	.	.	.	Benign
15	80263216	80263217	15q25.1	0	normal	.	C	ref	C	TG.CG	het-alt	186	0.55	.	1	.	PASS	601056	P	.	NN	.	.	.	.	.	.	.	597	BCL2A1	C1	EX1	Apoptosis regulator proteins, Bcl-2 family	PF00452.14	no-change	NM_001114735.1	NP_001108207.1	-	Y	c.245G=	.	.	.	NM_001114735.1(BCL2A1): c.245G=	;maf-5-some-pop	126410	0.766838	U	0.2063	0.203474	13006	0.800707	PASS	.	8654	0.759764	35894	121402	0.765613	.	.	.	.	.	.	rs3826007	.	4024	0.769900	0.655	3.904	2.652	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	80263216	80263217	15q25.1	1	normal	.	C	snv	T	TG.CG	het-ref	153	0.45	.	2	.	PASS	601056	P	.	NN	.	.	.	.	.	.	.	597	BCL2A1	C1	EX1	Apoptosis regulator proteins, Bcl-2 family	PF00452.14	missense	NM_001114735.1	NP_001108207.1	-	Y	c.245G>A	p.G82D | p.Gly82Asp	GGC=>GAC	P0=>P-	NM_001114735.1(BCL2A1): c.245G>A (p.G82D)	;maf-5-some-pop	126410	0.233162	U	0.2063	0.203474	13006	0.199293	PASS	257	8654	0.240236	3648	121402	0.234387	506	4118	2.38752e-01	7231	56932	2.31331e-01	rs3826007	.	4024	0.230100	0.655	3.904	2.652	0	0.999	1	0.935	deleterious	ENST00000267953: c.245G>A (p.G82D)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3999615	CM064994	NM_004049.3(BCL2A1): c.245G>A (p.G82D)	"Colorectal cancer, increased risk, assoc. with"	17000706	DP	.	.	.	.	Likely Benign
15	88670336	88670337	15q25.3	0	normal	.	A	snv	T	GA.GT	het-ref	141	0.53	.	2	.	PASS	191316	C	.	NN	.	.	.	.	.	.	.	4916	NTRK3	IC10	IVS12	.	.	intron	NM_001012338.2	NP_001012338.1	-	Y	c.1293+56T>A	.	.	.	NM_001012338.2(NTRK3): c.1293+56T>A	;	5008	0.000399	U	0.002	0.000399361	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs189282727	.	4024	0.000200	-1.874	-0.236	-0.464	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
15	88670336	88670337	15q25.3	0	normal	.	A	ref	A	GA.GT	het-alt	125	0.47	.	1	.	PASS	191316	C	.	NN	.	.	.	.	.	.	.	4916	NTRK3	IC10	IVS12	.	.	no-change	NM_001012338.2	NP_001012338.1	-	Y	c.1293+56T=	.	.	.	NM_001012338.2(NTRK3): c.1293+56T=	;	5008	0.999601	U	0.002	0.000399361	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs189282727	.	4024	0.999800	-1.874	-0.236	-0.464	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	88678679	88678680	15q25.3	0	nullSample	.	T	ref	T	CC.GC	homo-ref	.	.	.	0	.	.	191316	C	.	NN	.	.	.	.	.	.	.	4916	NTRK3	IC7	IVS9	.	.	no-change	NM_001012338.2	NP_001012338.1	-	Y	c.908-52A=	.	.	.	NM_001012338.2(NTRK3): c.908-52A=	;maf-5-some-pop,maf-5-all-pops	93728	0.469049	U	0.5625	0.588059	7244	0.419934	PASS	-776	6046	0.453192	9950	88720	0.472272	.	.	.	.	.	.	rs2059588	.	4024	0.450300	-1.309	-1.018	-1.350	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	88678679	88678680	15q25.3	0	normal	.	T	snv	C	CC.GC	hom-alt	289	1.00	.	0	.	PASS	191316	C	.	NN	.	.	.	.	.	.	.	4916	NTRK3	IC7	IVS9	.	.	intron	NM_001012338.2	NP_001012338.1	-	Y	c.908-52A>G	.	.	.	NM_001012338.2(NTRK3): c.908-52A>G	;maf-5-some-pop,maf-5-all-pops	93728	0.530951	U	0.5625	0.588059	7244	0.580066	PASS	877	6046	0.546808	12410	88720	0.527728	2271	8357	5.47282e-01	27829	106934	5.08972e-01	rs2059588	.	4024	0.549700	-1.309	-1.018	-1.350	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	88679784	88679785	15q25.3	1	nullSample	.	G	ref	G	GC.TT	homo-ref	.	.	.	0	.	.	191316	C	.	NN	.	.	.	.	.	.	.	4916	NTRK3	C6	EX8	Immunoglobulin domain;Immunoglobulin I-set domain;Immunoglobulin domain	PF00047.20;PF07679.11;PF13895.1	coding-synon	NM_001012338.2	NP_001012338.1	-	Y	c.678T>C	p.(N226=) | p.(Asn226=)	AAT=>AAC	.	NM_001012338.2(NTRK3): c.678T>C (p.(N226=))	;	126286	0.003199	U	1	0.998203	13000	0.004154	PASS	0	8648	0.000000	0	121278	0.003257	.	.	.	.	.	.	rs1863480	.	.	.	-0.254	-1.347	-1.397	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
15	88679784	88679785	15q25.3	0	normal	.	G	snv	A	GC.TT	hom-alt	484	1.00	.	0	.	PASS	191316	C	.	NN	.	.	.	.	.	.	.	4916	NTRK3	C6	EX8	Immunoglobulin domain;Immunoglobulin I-set domain;Immunoglobulin domain	PF00047.20;PF07679.11;PF13895.1	no-change	NM_001012338.2	NP_001012338.1	-	Y	c.678T=	.	.	.	NM_001012338.2(NTRK3): c.678T=	;	126286	0.996801	U	1	0.998203	13000	0.995846	PASS	4324	8648	1.000000	60244	121278	0.996743	8619	17239	9.99942e-01	122243	245289	9.96696e-01	rs1863480	.	.	.	-0.254	-1.347	-1.397	.	.	.	.	.	ENST00000360948: c.678C>T (p.N226N)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4128521	.	.	.	.	.	.	.	.	.	Benign
15	88726585	88726586	15q25.3	0	normal	.	G	ref	G	cc.gt	het-alt	118	0.54	.	1	MIR3|SINE|MIR|-|145	PASS	191316	C	.	NN	.	.	.	.	.	.	.	4916	NTRK3	IC3	IVS5	.	.	no-change	NM_001012338.2	NP_001012338.1	-	Y	c.395+63C=	.	.	.	NM_001012338.2(NTRK3): c.395+63C=	;maf-5-some-pop,maf-5-all-pops	5008	0.782348	U	0.1498	0.217652	4560	0.809211	.	.	.	.	.	.	.	.	.	.	.	.	.	rs55725904	.	4024	0.845400	-2.010	-1.705	-2.070	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	88726585	88726586	15q25.3	0	normal	.	G	snv	A	cc.gt	het-ref	101	0.46	.	2	MIR3|SINE|MIR|-|145	PASS	191316	C	.	NN	.	.	.	.	.	.	.	4916	NTRK3	IC3	IVS5	.	.	intron	NM_001012338.2	NP_001012338.1	-	Y	c.395+63C>T	.	.	.	NM_001012338.2(NTRK3): c.395+63C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.217652	U	0.1498	0.217652	4560	0.190789	.	.	.	.	.	.	.	.	.	.	.	.	.	rs55725904	.	4024	0.154600	-2.010	-1.705	-2.070	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	90630629	90630630	15q26.1	0	normal	.	G	ref	G	GG.AA	het-alt	256	0.54	.	1	.	PASS	147650	C	613657(MK)	NN	D-2-hydroxyglutaric aciduria 2	AD	.	Biochemical; Cardiovascular; Craniofacial; Neurologic	General	20847235	.	3418	IDH2	IC6	IVS6	.	.	no-change	NM_002168.2	NP_002159.2	-	Y	c.815+41C=	.	.	.	NM_002168.2(IDH2): c.815+41C=	;maf-5-some-pop	126418	0.989922	U	0.0556	0.0159744	12996	0.999692	PASS	-185	8654	0.953779	59557	121410	0.990166	.	.	.	.	.	.	rs77211768	.	4024	0.954000	0.313	-0.571	-0.258	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	90630629	90630630	15q26.1	0	normal	.	G	snv	A	GG.AA	het-ref	222	0.46	.	2	.	PASS	147650	C	613657(MK)	NN	D-2-hydroxyglutaric aciduria 2	AD	.	Biochemical; Cardiovascular; Craniofacial; Neurologic	General	20847235	.	3418	IDH2	IC6	IVS6	.	.	intron	NM_002168.2	NP_002159.2	-	Y	c.815+41C>T	.	.	.	NM_002168.2(IDH2): c.815+41C>T	;maf-5-some-pop	126418	0.010078	U	0.0556	0.0159744	12996	0.000308	PASS	15	8654	0.046221	46	121410	0.009834	23	776	4.49907e-02	107	2855	1.15933e-02	rs77211768	.	4024	0.046000	0.313	-0.571	-0.258	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
15	91295109	91295110	15q26.1	0	normal	.	C	ref	C	TA.GG	het-alt	300	0.54	.	1	.	PASS	604610	C	210900(MK)	AR	Bloom syndrome	AR	.	Allergy/Immunology/Infectious; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Oncologic	24118499|23443610|23028338|22514588|21815139|20301572|18974064|18471088|17407155|15137905|12242432|11477604|10464606|9285778|9062585|8875252|7585968|7386453|7273457|6705251|5923432|3808032|3808031|3040954|2721026|1809225	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	641	BLM	C3	EX4	.	.	no-change	NM_000057.2	NP_000048.1	+	Y	c.893C=	.	.	.	NM_000057.2(BLM): c.893C=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126328	0.990841	U	0.0923	0.0229633	12990	0.999384	PASS	-348	8654	0.909868	59661	121320	0.991411	.	.	.	.	.	.	rs28384991	.	4024	0.909000	-0.946	0.118	-0.107	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	91295109	91295110	15q26.1	1	normal	.	C	snv	T	TA.GG	het-ref	251	0.46	.	2	.	PASS	604610	C	210900(MK)	AR	Bloom syndrome	AR	.	Allergy/Immunology/Infectious; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Oncologic	24118499|23443610|23028338|22514588|21815139|20301572|18974064|18471088|17407155|15137905|12242432|11477604|10464606|9285778|9062585|8875252|7585968|7386453|7273457|6705251|5923432|3808032|3808031|3040954|2721026|1809225	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	641	BLM	C3	EX4	.	.	missense	NM_000057.2	NP_000048.1	+	Y	c.893C>T	p.T298M | p.Thr298Met	ACG=>ATG	P0=>NP	NM_000057.2(BLM): c.893C>T (p.T298M)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126328	0.009159	U	0.0923	0.0229633	12990	0.000616	PASS	42	8654	0.090132	43	121320	0.008589	96	1666	9.66357e-02	102	2330	9.46977e-03	rs28384991	.	4024	0.091000	-0.946	0.118	-0.107	0.23	0.001	0	0.042	neutral	ENST00000355112: c.893C>T (p.T298M)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	VUO	147984	.	.	.	.	.	no_record	92397	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
15	91312312	91312313	15q26.1	0	normal	.	G	ref	G	AT.AG	het-alt	94	0.49	.	1	.	PASS	604610	C	210900(MK)	AR	Bloom syndrome	AR	.	Allergy/Immunology/Infectious; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Oncologic	24118499|23443610|23028338|22514588|21815139|20301572|18974064|18471088|17407155|15137905|12242432|11477604|10464606|9285778|9062585|8875252|7585968|7386453|7273457|6705251|5923432|3808032|3808031|3040954|2721026|1809225	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	641	BLM	IC9	IVS10	.	.	no-change	NM_000057.2	NP_000048.1	+	Y	c.2308-50G=	.	.	.	NM_000057.2(BLM): c.2308-50G=	;maf-5-some-pop,maf-5-all-pops	126282	0.844475	U	0.244	0.160942	12992	0.830049	PASS	-766	8614	0.764569	43359	121274	0.844699	.	.	.	.	.	.	rs17273206	.	4024	0.739100	-0.332	0.002	-0.590	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	91312312	91312313	15q26.1	0	normal	.	G	snv	A	AT.AG	het-ref	98	0.51	.	2	.	PASS	604610	C	210900(MK)	AR	Bloom syndrome	AR	.	Allergy/Immunology/Infectious; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Oncologic	24118499|23443610|23028338|22514588|21815139|20301572|18974064|18471088|17407155|15137905|12242432|11477604|10464606|9285778|9062585|8875252|7585968|7386453|7273457|6705251|5923432|3808032|3808031|3040954|2721026|1809225	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	641	BLM	IC9	IVS10	.	.	intron	NM_000057.2	NP_000048.1	+	Y	c.2308-50G>A	.	.	.	NM_000057.2(BLM): c.2308-50G>A	;maf-5-some-pop,maf-5-all-pops	126282	0.155525	U	0.244	0.160942	12992	0.169951	PASS	248	8614	0.235431	1556	121274	0.155301	544	4247	2.46517e-01	3093	37439	1.52247e-01	rs17273206	.	4024	0.260900	-0.332	0.002	-0.590	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	254778	criteria_provided,_single_submitter	Benign	Benign
15	91312822	91312823	15q26.1	0	normal	.	T	ref	T	GT.GT	het-alt	222	0.51	.	1	.	PASS	604610	C	210900(MK)	AR	Bloom syndrome	AR	.	Allergy/Immunology/Infectious; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Oncologic	24118499|23443610|23028338|22514588|21815139|20301572|18974064|18471088|17407155|15137905|12242432|11477604|10464606|9285778|9062585|8875252|7585968|7386453|7273457|6705251|5923432|3808032|3808031|3040954|2721026|1809225	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	641	BLM	IC11	IVS12	.	.	no-change	NM_000057.2	NP_000048.1	+	Y	c.2555+7T=	.	.	.	NM_000057.2(BLM): c.2555+7T=	;maf-5-some-pop,maf-5-all-pops	121548	0.701484	U	0.3185	0.366613	12992	0.618073	PASS	.	8198	0.683215	29376	116540	0.704411	.	.	.	.	.	.	rs3815003	.	4024	0.678900	0.482	1.388	0.826	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	91312822	91312823	15q26.1	1	normal	.	T	snv	C	GT.GT	het-ref	215	0.49	.	2	.	PASS	604610	C	210900(MK)	AR	Bloom syndrome	AR	.	Allergy/Immunology/Infectious; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Oncologic	24118499|23443610|23028338|22514588|21815139|20301572|18974064|18471088|17407155|15137905|12242432|11477604|10464606|9285778|9062585|8875252|7585968|7386453|7273457|6705251|5923432|3808032|3808031|3040954|2721026|1809225	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	641	BLM	IC11	IVS12	.	.	intron	NM_000057.2	NP_000048.1	+	Y	c.2555+7T>C	.	.	.	NM_000057.2(BLM): c.2555+7T>C	;maf-5-some-pop,maf-5-all-pops	121548	0.298516	U	0.3185	0.366613	12992	0.381927	PASS	399	8198	0.316785	5554	116540	0.295589	833	5382	3.13783e-01	10529	68191	2.78424e-01	rs3815003	.	4024	0.321100	0.482	1.388	0.826	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	92392	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
15	91358270	91358271	15q26.1	0	nullSample	.	G	ref	G	GA.GA	homo-ref	.	.	.	0	.	.	604610	C	210900(MK)	AR	Bloom syndrome	AR	.	Allergy/Immunology/Infectious; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Oncologic	24118499|23443610|23028338|22514588|21815139|20301572|18974064|18471088|17407155|15137905|12242432|11477604|10464606|9285778|9062585|8875252|7585968|7386453|7273457|6705251|5923432|3808032|3808031|3040954|2721026|1809225	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	641	BLM	IC20	IVS21	.	.	no-change	NM_000057.2	NP_000048.1	+	Y	c.4077-61G=	.	.	.	NM_000057.2(BLM): c.4077-61G=	;	0	0	U	0.8115	0.66853	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs202095393	.	.	.	0.603	-0.158	-0.162	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	91358271	91358271	15q26.1	0	normal	.	.	ins	GAA	AG.GA	hom-alt	200	1.00	.	0	.	PASS	604610	C	210900(MK)	AR	Bloom syndrome	AR	.	Allergy/Immunology/Infectious; Dermatologic; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Oncologic; Pulmonary	Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Oncologic	24118499|23443610|23028338|22514588|21815139|20301572|18974064|18471088|17407155|15137905|12242432|11477604|10464606|9285778|9062585|8875252|7585968|7386453|7273457|6705251|5923432|3808032|3808031|3040954|2721026|1809225	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	641	BLM	IC20	IVS21	.	.	intron	NM_000057.2	NP_000048.1	+	Y	c.4077-61_4077-60insGAA	.	.	.	NM_000057.2(BLM): c.4077-61_4077-60insGAA	;maf-5-some-pop,maf-5-all-pops	5008	0.668530	U	0.8115	0.66853	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10685387	.	4024	0.840700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	210530	criteria_provided,_single_submitter	Likely_benign	Benign
15	99456552	99456553	15q26.3	0	normal	.	G	snv	A	TC.CA	hom-alt	197	1.00	.	0	.	PASS	147370	C	270450(MK)	AD;AR	Insulin-like growth factor I, resistance to	AD/AR	.	Endocrine	Endocrine	23045302|22998174|22130793|14657428	.	3480	IGF1R	IC8	IVS8	.	.	intron	NM_000875.3	NP_000866.1	+	Y	c.1828+42G>A	.	.	.	NM_000875.3(IGF1R): c.1828+42G>A	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126232	0.639315	U	0.5159	0.631589	12988	0.649061	PASS	1076	8620	0.499768	25067	121224	0.639634	2111	8496	4.93036e-01	50243	156354	6.36258e-01	rs951715	.	4024	0.490300	-2.094	-2.509	-2.485	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	99456552	99456553	15q26.3	0	nullSample	.	G	ref	G	TC.CA	homo-ref	.	.	.	0	.	.	147370	C	270450(MK)	AD;AR	Insulin-like growth factor I, resistance to	AD/AR	.	Endocrine	Endocrine	23045302|22998174|22130793|14657428	.	3480	IGF1R	IC8	IVS8	.	.	no-change	NM_000875.3	NP_000866.1	+	Y	c.1828+42G=	.	.	.	NM_000875.3(IGF1R): c.1828+42G=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126232	0.360685	U	0.5159	0.631589	12988	0.350939	PASS	-1078	8620	0.500232	8140	121224	0.360366	.	.	.	.	.	.	rs951715	.	4024	0.509700	-2.094	-2.509	-2.485	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	99473605	99473606	15q26.3	0	normal	.	A	ref	A	TA.TT	het-alt	144	0.48	.	1	.	PASS	147370	C	270450(MK)	AD;AR	Insulin-like growth factor I, resistance to	AD/AR	.	Endocrine	Endocrine	23045302|22998174|22130793|14657428	.	3480	IGF1R	IC15	IVS15	.	.	no-change	NM_000875.3	NP_000866.1	+	Y	c.2956+72A=	.	.	.	NM_000875.3(IGF1R): c.2956+72A=	;maf-5-some-pop,maf-5-all-pops	5008	0.769569	U	0.3909	0.230431	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs33982004	.	4024	0.647900	0.533	0.016	-0.031	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	99473605	99473606	15q26.3	0	normal	.	A	snv	G	TA.TT	het-ref	154	0.52	.	2	.	PASS	147370	C	270450(MK)	AD;AR	Insulin-like growth factor I, resistance to	AD/AR	.	Endocrine	Endocrine	23045302|22998174|22130793|14657428	.	3480	IGF1R	IC15	IVS15	.	.	intron	NM_000875.3	NP_000866.1	+	Y	c.2956+72A>G	.	.	.	NM_000875.3(IGF1R): c.2956+72A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.230431	U	0.3909	0.230431	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs33982004	.	4024	0.352100	0.533	0.016	-0.031	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	99478492	99478493	15q26.3	0	nullSample	.	T	ref	T	CA.CA	homo-ref	.	.	.	0	.	.	147370	C	270450(MK)	AD;AR	Insulin-like growth factor I, resistance to	AD/AR	.	Endocrine	Endocrine	23045302|22998174|22130793|14657428	.	3480	IGF1R	IC16	IVS16	.	.	no-change	NM_000875.3	NP_000866.1	+	Y	c.3187-52T=	.	.	.	NM_000875.3(IGF1R): c.3187-52T=	;	5008	0.011981	U	1	0.988019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10400894	.	4024	0.001500	-0.821	0.021	-0.328	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	99478492	99478493	15q26.3	0	normal	.	T	snv	C	CA.CA	hom-alt	261	1.00	.	0	.	PASS	147370	C	270450(MK)	AD;AR	Insulin-like growth factor I, resistance to	AD/AR	.	Endocrine	Endocrine	23045302|22998174|22130793|14657428	.	3480	IGF1R	IC16	IVS16	.	.	intron	NM_000875.3	NP_000866.1	+	Y	c.3187-52T>C	.	.	.	NM_000875.3(IGF1R): c.3187-52T>C	;	5008	0.988019	U	1	0.988019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10400894	.	4024	0.998500	-0.821	0.021	-0.328	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	99478504	99478505	15q26.3	0	nullSample	.	A	ref	A	CC.CC	homo-ref	.	.	.	0	.	.	147370	C	270450(MK)	AD;AR	Insulin-like growth factor I, resistance to	AD/AR	.	Endocrine	Endocrine	23045302|22998174|22130793|14657428	.	3480	IGF1R	IC16	IVS16	.	.	no-change	NM_000875.3	NP_000866.1	+	Y	c.3187-40A=	.	.	.	NM_000875.3(IGF1R): c.3187-40A=	.	.	.	.	1	0.988019	.	.	PASS	0	678	0.000000	4	21556	0.005381	.	.	.	.	.	.	.	.	.	.	-0.256	-1.172	-1.403	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	99478505	99478505	15q26.3	0	normal	.	.	ins	C	CA.CC	hom-alt	298	1.00	.	0	.	PASS	147370	C	270450(MK)	AD;AR	Insulin-like growth factor I, resistance to	AD/AR	.	Endocrine	Endocrine	23045302|22998174|22130793|14657428	.	3480	IGF1R	IC16	IVS16	.	.	intron	NM_000875.3	NP_000866.1	+	Y	c.3187-40_3187-39insC	.	.	.	NM_000875.3(IGF1R): c.3187-40_3187-39insC	InconsistentAlleles;	26564	0.993374	U	1	0.988019	.	.	PASS	339	678	1.000000	10666	21556	0.994619	5134	10268	1.00000e+00	73849	148057	9.97474e-01	rs34389972	.	4024	0.998500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	99500255	99500256	15q26.3	0	normal	.	G	ref	G	CC.GT	het-alt	214	0.50	.	1	.	PASS	147370	C	270450(MK)	AD;AR	Insulin-like growth factor I, resistance to	AD/AR	.	Endocrine	Endocrine	23045302|22998174|22130793|14657428	.	3480	IGF1R	IC20	IVS20	.	.	no-change	NM_000875.3	NP_000866.1	+	Y	c.3723-34G=	.	.	.	NM_000875.3(IGF1R): c.3723-34G=	;maf-5-some-pop,maf-5-all-pops	126290	0.647423	U	0.2609	0.287939	12988	0.674931	PASS	.	8624	0.726925	25730	121282	0.644754	.	.	.	.	.	.	rs2593053	.	4024	0.763900	-1.266	-0.683	-1.155	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
15	99500255	99500256	15q26.3	0	normal	.	G	snv	A	CC.GT	het-ref	214	0.50	.	2	.	PASS	147370	C	270450(MK)	AD;AR	Insulin-like growth factor I, resistance to	AD/AR	.	Endocrine	Endocrine	23045302|22998174|22130793|14657428	.	3480	IGF1R	IC20	IVS20	.	.	intron	NM_000875.3	NP_000866.1	+	Y	c.3723-34G>A	.	.	.	NM_000875.3(IGF1R): c.3723-34G>A	;maf-5-some-pop,maf-5-all-pops	126290	0.352577	U	0.2609	0.287939	12988	0.325069	PASS	342	8624	0.273075	8174	121282	0.355246	639	4688	2.71926e-01	16231	86806	3.53681e-01	rs2593053	.	4024	0.236100	-1.266	-0.683	-1.155	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	1823739	1823740	16p13.3	0	normal	.	G	ref	G	AT.GA	het-alt	110	0.48	.	1	.	PASS	610886	P	.	NN	.	.	.	.	.	.	.	197342	EME2	C2	EX2	ERCC4 domain	PF02732.10	no-change	NM_001257370.1	NP_001244299.1	+	Y	c.282G=	.	.	.	NM_001257370.1(EME2): c.282G=	;	17674	0.999264	U	0.0079	0.00159744	.	.	PASS	.	342	0.985380	6328	12666	0.999605	.	.	.	.	.	.	rs201737681	.	4024	0.991600	0.306	1.533	1.707	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	1823739	1823740	16p13.3	1	normal	.	G	snv	T	AT.GA	het-ref	118	0.52	.	2	.	PASS	610886	P	.	NN	.	.	.	.	.	.	.	197342	EME2	C2	EX2	ERCC4 domain	PF02732.10	missense	NM_001257370.1	NP_001244299.1	+	Y	c.282G>T	p.M94I | p.Met94Ile	ATG=>ATT	NP=>NP	NM_001257370.1(EME2): c.282G>T (p.M94I)	;	17674	0.000736	U	0.0079	0.00159744	.	.	PASS	0	342	0.014620	0	12666	0.000395	0	72	7.14286e-03	0	74	5.36566e-04	rs201737681	.	4024	0.008400	0.306	1.533	1.707	0.37	0.01	0.008	0.019	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
16	1825773	1825774	16p13.3	0	normal	.	T	ref	T	TC.AA	het-alt	200	0.54	.	1	.	PASS	610886	P	.	NN	.	.	.	.	.	.	.	197342	EME2	IC6	IVS6	.	.	no-change	NM_001257370.1	NP_001244299.1	+	Y	c.780-24T=	.	.	.	NM_001257370.1(EME2): c.780-24T=	;maf-5-some-pop,maf-5-all-pops	124824	0.858240	U	0.252	0.155751	12998	0.904908	PASS	-795	8604	0.752673	44383	119816	0.858825	.	.	.	.	.	.	rs13339350	.	4024	0.758400	0.459	-0.319	-0.113	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	1825773	1825774	16p13.3	0	normal	.	T	snv	C	TC.AA	het-ref	169	0.46	.	2	.	PASS	610886	P	.	NN	.	.	.	.	.	.	.	197342	EME2	IC6	IVS6	.	.	intron	NM_001257370.1	NP_001244299.1	+	Y	c.780-24T>C	.	.	.	NM_001257370.1(EME2): c.780-24T>C	;maf-5-some-pop,maf-5-all-pops	124824	0.141760	U	0.252	0.155751	12998	0.095092	PASS	269	8604	0.247327	1390	119816	0.141175	508	4158	2.41239e-01	2755	33948	1.38410e-01	rs13339350	.	4024	0.241600	0.459	-0.319	-0.113	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	1826022	1826023	16p13.3	0	normal	.	G	ref	G	CA.AA	het-alt	322	0.51	.	1	.	PASS	610886	P	.	NN	.	.	.	.	.	.	.	197342	EME2	IC7	IVS7	.	.	no-change	NM_001257370.1	NP_001244299.1	+	Y	c.969+36G=	.	.	.	NM_001257370.1(EME2): c.969+36G=	;maf-5-some-pop,maf-5-all-pops	116616	0.854428	U	0.247	0.154153	12922	0.908373	PASS	-776	8306	0.751505	40916	111608	0.854813	.	.	.	.	.	.	rs9929680	.	4024	0.759900	-0.258	0.024	0.244	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	1826022	1826023	16p13.3	0	normal	.	G	snv	A	CA.AA	het-ref	309	0.49	.	2	.	PASS	610886	P	.	NN	.	.	.	.	.	.	.	197342	EME2	IC7	IVS7	.	.	intron	NM_001257370.1	NP_001244299.1	+	Y	c.969+36G>A	.	.	.	NM_001257370.1(EME2): c.969+36G>A	;maf-5-some-pop,maf-5-all-pops	116616	0.145572	U	0.247	0.154153	12922	0.091627	PASS	256	8306	0.248495	1316	111608	0.145187	498	4095	2.40430e-01	2622	32313	1.38422e-01	rs9929680	.	4024	0.240100	-0.258	0.024	0.244	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	2111778	2111779	16p13.3	0	nullSample	.	T	ref	T	GG.GT	homo-ref	.	.	.	0	trf	.	191092	C	606690(MK);613254(MK)	NN	Tuberous sclerosis 2; Lymphangioleiomyomatosis 	AD	.	Cardiovascular; Dental; Dermatologic; Neurologic; Oncologic; Ophthalmologic; Pulmonary; Renal	Cardiovascular; Neurologic; Oncologic; Pulmonary; Renal	23852707|23845174|23796861|23757617|23743818|23733802|23158522|22490766|22189265|21813552|21266383|20301399|19419980|19332694|19258298|18722871|18032745|17304050|17120248|17005952|17003820|15955990|14985384|14421523|11829138|9579160|9463313|9302281|9132502|8824721|8782048|8534286|8162074|3210031|2823681|2706800|1303246	H62;H68;HT2	7249	TSC2	IC10	IVS11	.	.	no-change	NM_000548.3	NP_000539.2	+	Y	c.1120-93T=	.	.	.	NM_000548.3(TSC2): c.1120-93T=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5008	0.389377	U	0.8155	0.610623	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17135764	.	4024	0.187900	-1.741	-0.545	-0.853	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	2111778	2111779	16p13.3	0	normal	.	T	snv	C	GG.GT	hom-alt	224	1.00	.	0	trf	PASS	191092	C	606690(MK);613254(MK)	NN	Tuberous sclerosis 2; Lymphangioleiomyomatosis 	AD	.	Cardiovascular; Dental; Dermatologic; Neurologic; Oncologic; Ophthalmologic; Pulmonary; Renal	Cardiovascular; Neurologic; Oncologic; Pulmonary; Renal	23852707|23845174|23796861|23757617|23743818|23733802|23158522|22490766|22189265|21813552|21266383|20301399|19419980|19332694|19258298|18722871|18032745|17304050|17120248|17005952|17003820|15955990|14985384|14421523|11829138|9579160|9463313|9302281|9132502|8824721|8782048|8534286|8162074|3210031|2823681|2706800|1303246	H62;H68;HT2	7249	TSC2	IC10	IVS11	.	.	intron	NM_000548.3	NP_000539.2	+	Y	c.1120-93T>C	.	.	.	NM_000548.3(TSC2): c.1120-93T>C	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5008	0.610623	U	0.8155	0.610623	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17135764	.	4024	0.812100	-1.741	-0.545	-0.853	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	49143	no_assertion_provided	not_provided	Benign
16	2120401	2120402	16p13.3	0	normal	.	T	ref	T	TC.TA	het-alt	150	0.50	.	1	.	PASS	191092	C	606690(MK);613254(MK)	NN	Tuberous sclerosis 2; Lymphangioleiomyomatosis 	AD	.	Cardiovascular; Dental; Dermatologic; Neurologic; Oncologic; Ophthalmologic; Pulmonary; Renal	Cardiovascular; Neurologic; Oncologic; Pulmonary; Renal	23852707|23845174|23796861|23757617|23743818|23733802|23158522|22490766|22189265|21813552|21266383|20301399|19419980|19332694|19258298|18722871|18032745|17304050|17120248|17005952|17003820|15955990|14985384|14421523|11829138|9579160|9463313|9302281|9132502|8824721|8782048|8534286|8162074|3210031|2823681|2706800|1303246	H62;H68;HT2	7249	TSC2	IC15	IVS16	.	.	no-change	NM_000548.3	NP_000539.2	+	Y	c.1717-55T=	.	.	.	NM_000548.3(TSC2): c.1717-55T=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5008	0.606629	U	0.2212	0.393371	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7187438	.	4024	0.785800	0.402	-0.886	-1.156	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	2120401	2120402	16p13.3	0	normal	.	T	snv	C	TC.TA	het-ref	151	0.50	.	2	.	PASS	191092	C	606690(MK);613254(MK)	NN	Tuberous sclerosis 2; Lymphangioleiomyomatosis 	AD	.	Cardiovascular; Dental; Dermatologic; Neurologic; Oncologic; Ophthalmologic; Pulmonary; Renal	Cardiovascular; Neurologic; Oncologic; Pulmonary; Renal	23852707|23845174|23796861|23757617|23743818|23733802|23158522|22490766|22189265|21813552|21266383|20301399|19419980|19332694|19258298|18722871|18032745|17304050|17120248|17005952|17003820|15955990|14985384|14421523|11829138|9579160|9463313|9302281|9132502|8824721|8782048|8534286|8162074|3210031|2823681|2706800|1303246	H62;H68;HT2	7249	TSC2	IC15	IVS16	.	.	intron	NM_000548.3	NP_000539.2	+	Y	c.1717-55T>C	.	.	.	NM_000548.3(TSC2): c.1717-55T>C	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5008	0.393371	U	0.2212	0.393371	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7187438	.	4024	0.214200	0.402	-0.886	-1.156	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	65157	no_assertion_provided	not_provided	Benign
16	3639138	3639139	16p13.3	0	normal	.	A	ref	A	CT.TT	het-alt	352	0.54	.	1	.	PASS	613278	P	613951(MK)	NN	Fanconi anemia type P	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	21240277|21240275|20301575	FC59;FH44;H68;HBO28;MC58;MH43	84464	SLX4	C11	EX12	.	.	no-change	NM_032444.2	NP_115820.2	-	Y	c.4500T=	.	.	.	NM_032444.2(SLX4): c.4500T=	;maf-5-some-pop	126018	0.383326	U	0.7103	0.739617	12994	0.373403	PASS	-844	8636	0.276748	10188	121010	0.388414	.	.	.	.	.	.	rs3810812	.	4024	0.288000	-0.119	1.203	0.827	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	3639138	3639139	16p13.3	1	normal	.	A	snv	G	CT.TT	het-ref	302	0.46	.	2	.	PASS	613278	P	613951(MK)	NN	Fanconi anemia type P	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	21240277|21240275|20301575	FC59;FH44;H68;HBO28;MC58;MH43	84464	SLX4	C11	EX12	.	.	coding-synon	NM_032444.2	NP_115820.2	-	Y	c.4500T>C	p.(N1500=) | p.(Asn1500=)	AAT=>AAC	.	NM_032444.2(SLX4): c.4500T>C (p.(N1500=))	;maf-5-some-pop	126018	0.616674	U	0.7103	0.739617	12994	0.626597	PASS	2279	8636	0.723252	23691	121010	0.611586	4527	12439	7.21520e-01	46760	148380	6.03102e-01	rs3810812	.	4024	0.712000	-0.119	1.203	0.827	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	262053	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
16	3639826	3639827	16p13.3	1	normal	.	G	snv	A	GG.AA	het-ref	295	0.49	.	2	.	PASS	613278	P	613951(MK)	NN	Fanconi anemia type P	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	21240277|21240275|20301575	FC59;FH44;H68;HBO28;MC58;MH43	84464	SLX4	C11	EX12	.	.	missense	NM_032444.2	NP_115820.2	-	Y	c.3812C>T	p.S1271F | p.Ser1271Phe	TCC=>TTC	P0=>NP	NM_032444.2(SLX4): c.3812C>T (p.S1271F)	;maf-5-some-pop,genotype-conflict	125964	0.064114	U	0.1429	0.0628994	12994	0.040557	PASS	141	8582	0.186320	333	120956	0.064164	300	3175	1.84464e-01	738	16208	6.60150e-02	rs3810813	.	4024	0.171000	0.655	2.019	2.884	0	0.996	0.999	0.906	deleterious	ENST00000294008: c.3812C>T (p.S1271F)	skin [NS|NS|NS]	carcinoma [basal_cell_carcinoma|NS|NS]	CSV	1377772	.	.	.	.	.	no_record	262050	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
16	3639826	3639827	16p13.3	0	normal	.	G	ref	G	GG.AA	het-alt	302	0.51	.	1	.	PASS	613278	P	613951(MK)	NN	Fanconi anemia type P	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	21240277|21240275|20301575	FC59;FH44;H68;HBO28;MC58;MH43	84464	SLX4	C11	EX12	.	.	no-change	NM_032444.2	NP_115820.2	-	Y	c.3812C=	.	.	.	NM_032444.2(SLX4): c.3812C=	;maf-5-some-pop,genotype-conflict	125964	0.935886	U	0.1429	0.0628994	12994	0.959443	PASS	.	8582	0.813680	53050	120956	0.935836	.	.	.	.	.	.	rs3810813	.	4024	0.829000	0.655	2.019	2.884	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	3656481	3656482	16p13.3	0	normal	.	C	ref	C	CC.GC	het-alt	241	0.58	.	1	.	PASS	613278	P	613951(MK)	NN	Fanconi anemia type P	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	21240277|21240275|20301575	FC59;FH44;H68;HBO28;MC58;MH43	84464	SLX4	C2	EX3	.	.	no-change	NM_032444.2	NP_115820.2	-	Y	c.753G=	.	.	.	NM_032444.2(SLX4): c.753G=	SingleClassTriAllelic;maf-5-some-pop	126406	0.785517	U	0.2808	0.230831	12994	0.781053	PASS	.	8650	0.692139	37668	121398	0.786191	.	.	.	.	.	.	rs8061528	.	4024	0.701500	-1.623	-3.059	-3.472	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	3656481	3656482	16p13.3	1	normal	.	C	snv	T	CC.GC	het-ref	177	0.42	.	2	.	PASS	613278	P	613951(MK)	NN	Fanconi anemia type P	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	21240277|21240275|20301575	FC59;FH44;H68;HBO28;MC58;MH43	84464	SLX4	C2	EX3	.	.	coding-synon	NM_032444.2	NP_115820.2	-	Y	c.753G>A	p.(A251=) | p.(Ala251=)	GCG=>GCA	.	NM_032444.2(SLX4): c.753G>A (p.(A251=))	SingleClassTriAllelic;maf-5-some-pop	126406	0.214476	U	0.2808	0.230831	12994	0.218947	PASS	437	8650	0.307861	2924	121398	0.213801	838	5206	3.01832e-01	5865	51965	2.12329e-01	rs8061528	.	4024	0.298500	-1.623	-3.059	-3.472	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	262058	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
16	3781312	3781313	16p13.3	0	normal	.	G	ref	G	TT.GA	het-alt	305	0.52	.	1	.	PASS	600140	C	180849(MK)	AD	Rubinstein-Taybi syndrome	AD	.	Allergy/Immunology/Infectious; Cardiovascular; Craniofacial; Musculoskeletal; Neurologic ; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Hematologic; Cardiovascular; Oncologic; Ophthalmologic	23432975|22426292|21189944|21085895|20949605|20717166|20301699|19852432|18792986|16913274|15706485|13983033|10573006|7747773|7630403|7137629	.	1387	CREBBP	C30	EX30	.	.	no-change	NM_004380.2	NP_004371.2	-	Y	c.5052C=	.	.	.	NM_004380.2(CREBBP): c.5052C=	;maf-5-some-pop	122420	0.990925	U	0.1062	0.0217652	.	.	PASS	-414	8468	0.891356	57750	117412	0.991466	.	.	.	.	.	.	rs2072381	.	4024	0.877500	0.655	4.574	1.445	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	3781312	3781313	16p13.3	1	normal	.	G	snv	A	TT.GA	het-ref	283	0.48	.	2	.	PASS	600140	C	180849(MK)	AD	Rubinstein-Taybi syndrome	AD	.	Allergy/Immunology/Infectious; Cardiovascular; Craniofacial; Musculoskeletal; Neurologic ; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Hematologic; Cardiovascular; Oncologic; Ophthalmologic	23432975|22426292|21189944|21085895|20949605|20717166|20301699|19852432|18792986|16913274|15706485|13983033|10573006|7747773|7630403|7137629	.	1387	CREBBP	C30	EX30	.	.	coding-synon	NM_004380.2	NP_004371.2	-	Y	c.5052C>T	p.(S1684=) | p.(Ser1684=)	TCC=>TCT	.	NM_004380.2(CREBBP): c.5052C>T (p.(S1684=))	;maf-5-some-pop	122420	0.009075	U	0.1062	0.0217652	.	.	PASS	46	8468	0.108644	46	117412	0.008534	103	1877	1.09014e-01	104	2035	8.28340e-03	rs2072381	.	4024	0.122500	0.655	4.574	1.445	.	.	.	.	.	ENST00000262367: c.5052C>T (p.S1684S)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5021088	.	.	.	.	.	no_record	95052	criteria_provided,_single_submitter	Benign	Likely Benign
16	3808051	3808052	16p13.3	0	normal	.	T	ref	T	CT.AA	het-alt	315	0.81	.	1	.	PASS	600140	C	180849(MK)	AD	Rubinstein-Taybi syndrome	AD	.	Allergy/Immunology/Infectious; Cardiovascular; Craniofacial; Musculoskeletal; Neurologic ; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Hematologic; Cardiovascular; Oncologic; Ophthalmologic	23432975|22426292|21189944|21085895|20949605|20717166|20301699|19852432|18792986|16913274|15706485|13983033|10573006|7747773|7630403|7137629	.	1387	CREBBP	IC17	IVS17	.	.	no-change	NM_004380.2	NP_004371.2	-	Y	c.3370-3A=	.	.	.	NM_004380.2(CREBBP): c.3370-3A=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.438	0.340	0.067	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
16	3808052	3808052	16p13.3	1	normal	.	.	ins	A	TT.AA	het-ref	75	0.19	.	2	.	PASS	600140	C	180849(MK)	AD	Rubinstein-Taybi syndrome	AD	.	Allergy/Immunology/Infectious; Cardiovascular; Craniofacial; Musculoskeletal; Neurologic ; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Hematologic; Cardiovascular; Oncologic; Ophthalmologic	23432975|22426292|21189944|21085895|20949605|20717166|20301699|19852432|18792986|16913274|15706485|13983033|10573006|7747773|7630403|7137629	.	1387	CREBBP	IC17	IVS17	.	.	intron	NM_004380.2	NP_004371.2	-	Y	c.3370-4_3370-3insT	.	.	.	NM_004380.2(CREBBP): c.3370-4_3370-3insT	MixedObserved;	25394	0.019178	U	.	.	.	.	PASS	0	6056	0.045079	0	79498	0.086858	.	.	.	.	.	.	rs777371170	.	4024	0.152100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	9892344	9892345	16p13.2	0	normal	.	G	ref	G	GG.TC	het-alt	162	0.53	.	1	.	PASS	138253	P	245570(MK)	AD	Epilepsy with neurodevelopmental defects	AD	.	Neurologic	General	20890276	.	2903	GRIN2A	IC9	IVS11	.	.	no-change	NM_000833.3	NP_000824.1	-	Y	c.2169-24C=	.	.	.	NM_000833.3(GRIN2A): c.2169-24C=	SingleClassTriAllelic;	124396	0.999887	U	0.001	0.000399361	.	.	PASS	-1	8434	0.999763	59682	119388	0.999899	.	.	.	.	.	.	rs529918738	.	4024	0.999800	-0.312	0.661	0.569	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	9892344	9892345	16p13.2	0	normal	.	G	snv	T	GG.TC	het-ref	143	0.47	.	2	.	PASS	138253	P	245570(MK)	AD	Epilepsy with neurodevelopmental defects	AD	.	Neurologic	General	20890276	.	2903	GRIN2A	IC9	IVS11	.	.	intron	NM_000833.3	NP_000824.1	-	Y	c.2169-24C>A	.	.	.	NM_000833.3(GRIN2A): c.2169-24C>A	SingleClassTriAllelic;	124396	0.000096	U	0.001	0.000399361	.	.	PASS	0	8434	0.000237	0	119388	0.000084	0	3	1.74723e-04	0	17	6.94620e-05	rs529918738	.	4024	0.000200	-0.312	0.661	0.569	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
16	11349402	11349403	16p13.13	0	nullSample	.	A	ref	A	AG.GG	homo-ref	.	.	.	0	.	.	603597	P	.	NN	.	.	.	.	.	.	.	8651	SOCS1	I5U1	IVS1	.	.	no-change	NM_003745.1	NP_003736.1	-	Y	c.-50-18T=	.	.	.	NM_003745.1(SOCS1): c.-50-18T=	SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	5008	0.021366	U	1	0.978634	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs27829	.	.	.	-0.323	0.198	0.546	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	11349402	11349403	16p13.13	1	normal	.	A	snv	C	AG.GG	hom-alt	160	1.00	.	0	.	PASS	603597	P	.	NN	.	.	.	.	.	.	.	8651	SOCS1	I5U1	IVS1	.	.	intron	NM_003745.1	NP_003736.1	-	Y	c.-50-18T>G	.	.	.	NM_003745.1(SOCS1): c.-50-18T>G	SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	5008	0.978634	U	1	0.978634	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs27829	.	.	.	-0.323	0.198	0.546	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	14014277	14014278	16p13.12	0	normal	.	G	ref	G	GG.CC	het-alt	123	0.47	.	1	.	PASS	133520	C	278760(MK);610965(MK);615272(MK)	AR	Fanconi anemia, complementation group Q; Xeroderma pigmentosum, group F	AR	Allelic with XFE progeroid syndrome (AR)	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Dermatologic; Hematologic; Oncologic	23623386|20301571|17183314|10447254|8427828|3834095|3372781|2696553	.	2072	ERCC4	IC1	IVS1	.	.	no-change	NM_005236.2	NP_005227.1	+	Y	c.207+49G=	.	.	.	NM_005236.2(ERCC4): c.207+49G=	;maf-5-some-pop	20288	0.858981	U	0.123	0.112021	12024	0.944112	PASS	.	384	0.846354	5599	15280	0.849476	.	.	.	.	.	.	rs1799798	.	.	.	0.655	0.281	0.104	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	14014277	14014278	16p13.12	0	normal	.	G	snv	A	GG.CC	het-ref	137	0.53	.	2	.	PASS	133520	C	278760(MK);610965(MK);615272(MK)	AR	Fanconi anemia, complementation group Q; Xeroderma pigmentosum, group F	AR	Allelic with XFE progeroid syndrome (AR)	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Dermatologic; Hematologic; Oncologic	23623386|20301571|17183314|10447254|8427828|3834095|3372781|2696553	.	2072	ERCC4	IC1	IVS1	.	.	intron	NM_005236.2	NP_005227.1	+	Y	c.207+49G>A	.	.	.	NM_005236.2(ERCC4): c.207+49G>A	;maf-5-some-pop	20288	0.141019	U	0.123	0.112021	12024	0.055888	PASS	6	384	0.153646	259	15280	0.150524	75	1195	1.18764e-01	1408	16621	1.25779e-01	rs1799798	.	.	.	0.655	0.281	0.104	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	14016109	14016110	16p13.12	0	normal	.	T	ref	T	AC.TT	het-alt	213	0.82	.	1	.	PASS	133520	C	278760(MK);610965(MK);615272(MK)	AR	Fanconi anemia, complementation group Q; Xeroderma pigmentosum, group F	AR	Allelic with XFE progeroid syndrome (AR)	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Dermatologic; Hematologic; Oncologic	23623386|20301571|17183314|10447254|8427828|3834095|3372781|2696553	.	2072	ERCC4	IC2	IVS2	.	.	no-change	NM_005236.2	NP_005227.1	+	Y	c.388+42T=	.	.	.	NM_005236.2(ERCC4): c.388+42T=	MixedObserved;	20	0.950000	U	.	.	12112	0.901915	.	.	.	.	.	.	.	.	.	.	.	.	.	rs113434368	.	.	.	0.260	0.446	0.082	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	14016109	14016110	16p13.12	0	normal	.	T	del	.	AC.TT	het-ref	46	0.18	.	2	.	PASS	133520	C	278760(MK);610965(MK);615272(MK)	AR	Fanconi anemia, complementation group Q; Xeroderma pigmentosum, group F	AR	Allelic with XFE progeroid syndrome (AR)	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Dermatologic; Hematologic; Oncologic	23623386|20301571|17183314|10447254|8427828|3834095|3372781|2696553	.	2072	ERCC4	IC2	IVS2	.	.	intron	NM_005236.2	NP_005227.1	+	Y	c.388+42delT	.	.	.	NM_005236.2(ERCC4): c.388+42delT	MixedObserved;	20	0.050000	U	.	.	12112	0.073398	PASS	0	1272	0.077044	0	27562	0.124048	.	.	.	.	.	.	rs113434368	.	.	.	0.260	0.446	0.082	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	14026006	14026007	16p13.12	0	nullSample	.	G	ref	G	TC.TA	homo-ref	.	.	.	0	.	.	133520	C	278760(MK);610965(MK);615272(MK)	AR	Fanconi anemia, complementation group Q; Xeroderma pigmentosum, group F	AR	Allelic with XFE progeroid syndrome (AR)	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Dermatologic; Hematologic; Oncologic	23623386|20301571|17183314|10447254|8427828|3834095|3372781|2696553	.	2072	ERCC4	IC5	IVS5	.	.	no-change	NM_005236.2	NP_005227.1	+	Y	c.974-7G=	.	.	.	NM_005236.2(ERCC4): c.974-7G=	SingleClassTriAllelic;maf-5-some-pop	126372	0.034628	U	0.7847	0.946486	12994	0.015392	PASS	.	8648	0.212188	229	121364	0.033849	.	.	.	.	.	.	rs254942	.	.	.	-0.254	-1.591	-1.804	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	14026006	14026007	16p13.12	1	normal	.	G	snv	A	TC.TA	hom-alt	558	1.00	.	0	.	PASS	133520	C	278760(MK);610965(MK);615272(MK)	AR	Fanconi anemia, complementation group Q; Xeroderma pigmentosum, group F	AR	Allelic with XFE progeroid syndrome (AR)	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Dermatologic; Endocrine; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Dermatologic; Hematologic; Oncologic	23623386|20301571|17183314|10447254|8427828|3834095|3372781|2696553	.	2072	ERCC4	IC5	IVS5	.	.	intron	NM_005236.2	NP_005227.1	+	Y	c.974-7G>A	.	.	.	NM_005236.2(ERCC4): c.974-7G>A	SingleClassTriAllelic;maf-5-some-pop	126372	0.965364	U	0.7847	0.946486	12994	0.984608	PASS	2692	8648	0.787812	56802	121364	0.966143	5382	13591	7.88250e-01	115232	237821	9.66296e-01	rs254942	.	.	.	-0.254	-1.591	-1.804	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	259686	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
16	20986505	20986506	16p12.3	0	nullSample	.	C	ref	C	ca.gc	homo-ref	.	.	.	0	MIRc|SINE|MIR|+|67	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr16: g.20986505C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	124288	0.507748	U	0.4821	0.519968	13002	0.518074	PASS	-1077	8640	0.482176	15643	119280	0.508912	.	.	.	.	.	.	rs3115438	.	.	.	-1.878	-0.695	-1.104	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	20986505	20986506	16p12.3	0	normal	.	C	snv	T	ca.gc	hom-alt	341	1.00	.	0	MIRc|SINE|MIR|+|67	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr16: g.20986505C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	124288	0.492252	U	0.4821	0.519968	13002	0.481926	PASS	1160	8640	0.517824	14580	119280	0.491088	2317	8887	5.20377e-01	28707	116090	4.88381e-01	rs3115438	.	.	.	-1.878	-0.695	-1.104	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	23615042	23615043	16p12.2	0	normal	.	A	del	.	TT.AA	het-ref	51	0.33	.	2	.	PASS	610355	P	114480(SK);610832(MK);613348(SK)	AD	Breast cancer, Pancreatic cancer, susceptibility to 3, Fanconi anemia, complementation group N	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22241545|20858716|20301575|19264984|17287723|17200672|17200671|17200668	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HD31;HD32;HP16;MC58;MH43	79728	PALB2	IC12	IVS12	.	.	intron	NM_024675.3	NP_078951.2	-	Y	c.3351-53delT	.	.	.	NM_024675.3(PALB2): c.3351-53delT	MixedObserved;	12502	0.022396	U	.	.	.	.	PASS	11	1544	0.424223	43	30008	0.407291	.	.	.	.	.	.	rs35294437	.	4024	0.438400	0.063	0.067	0.064	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	23615042	23615043	16p12.2	0	normal	.	A	ref	A	TT.AA	het-alt	103	0.67	.	1	.	PASS	610355	P	114480(SK);610832(MK);613348(SK)	AD	Breast cancer, Pancreatic cancer, susceptibility to 3, Fanconi anemia, complementation group N	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22241545|20858716|20301575|19264984|17287723|17200672|17200671|17200668	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HD31;HD32;HP16;MC58;MH43	79728	PALB2	IC12	IVS12	.	.	no-change	NM_024675.3	NP_078951.2	-	Y	c.3351-53T=	.	.	.	NM_024675.3(PALB2): c.3351-53T=	MixedObserved;	12502	0.977604	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs35294437	.	4024	0.561600	0.063	0.067	0.064	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	23625462	23625463	16p12.2	0	nullSample	.	A	ref	A	GT.TT	homo-ref	.	.	.	0	.	.	610355	P	114480(SK);610832(MK);613348(SK)	AD	Breast cancer, Pancreatic cancer, susceptibility to 3, Fanconi anemia, complementation group N	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22241545|20858716|20301575|19264984|17287723|17200672|17200671|17200668	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HD31;HD32;HP16;MC58;MH43	79728	PALB2	IC10	IVS10	.	.	no-change	NM_024675.3	NP_078951.2	-	Y	c.3114-51T=	.	.	.	NM_024675.3(PALB2): c.3114-51T=	;clinically-assoc,has-omim-omia,submitted-by-lsdb	80362	0.002576	U	1	0.996805	.	.	PASS	0	5046	0.000000	2	75354	0.002535	.	.	.	.	.	.	rs249936	.	4024	0.001500	-0.265	0.719	1.076	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	23625462	23625463	16p12.2	0	normal	.	A	snv	T	GT.TT	hom-alt	231	1.00	.	0	.	PASS	610355	P	114480(SK);610832(MK);613348(SK)	AD	Breast cancer, Pancreatic cancer, susceptibility to 3, Fanconi anemia, complementation group N	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22241545|20858716|20301575|19264984|17287723|17200672|17200671|17200668	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HD31;HD32;HP16;MC58;MH43	79728	PALB2	IC10	IVS10	.	.	intron	NM_024675.3	NP_078951.2	-	Y	c.3114-51T>A	.	.	.	NM_024675.3(PALB2): c.3114-51T>A	;clinically-assoc,has-omim-omia,submitted-by-lsdb	80362	0.997424	U	1	0.996805	.	.	PASS	2523	5046	1.000000	37488	75354	0.997465	7128	14258	9.99860e-01	100528	201436	9.98087e-01	rs249936	.	4024	0.998500	-0.265	0.719	1.076	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	126714	no_assertion_criteria_provided	Likely_benign	Benign
16	23634521	23634523	16p12.2	0	nullSample	.	TT	ref	TT	AC.tt	homo-ref	.	.	.	0	AluSx3|SINE|Alu|-|301	.	610355	P	114480(SK);610832(MK);613348(SK)	AD	Breast cancer, Pancreatic cancer, susceptibility to 3, Fanconi anemia, complementation group N	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22241545|20858716|20301575|19264984|17287723|17200672|17200671|17200668	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HD31;HD32;HP16;MC58;MH43	79728	PALB2	IC8	IVS8	.	.	no-change	NM_024675.3	NP_078951.2	-	Y	c.2835-72_2835-71=	.	.	.	NM_024675.3(PALB2): c.2835-72_2835-71=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.949100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	23634521	23634523	16p12.2	0	normal	.	TT	del	.	AC.tt	hom-alt	20	0.87	.	0	AluSx3|SINE|Alu|-|301	PASS	610355	P	114480(SK);610832(MK);613348(SK)	AD	Breast cancer, Pancreatic cancer, susceptibility to 3, Fanconi anemia, complementation group N	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22241545|20858716|20301575|19264984|17287723|17200672|17200671|17200668	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HD31;HD32;HP16;MC58;MH43	79728	PALB2	IC8	IVS8	.	.	intron	NM_024675.3	NP_078951.2	-	Y	c.2835-72_2835-71delAA	.	.	.	NM_024675.3(PALB2): c.2835-72_2835-71delAA	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.049700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
16	23640466	23640467	16p12.2	0	normal	.	G	ref	G	CA.TT	het-alt	134	0.47	.	1	.	PASS	610355	P	114480(SK);610832(MK);613348(SK)	AD	Breast cancer, Pancreatic cancer, susceptibility to 3, Fanconi anemia, complementation group N	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22241545|20858716|20301575|19264984|17287723|17200672|17200671|17200668	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HD31;HD32;HP16;MC58;MH43	79728	PALB2	IC6	IVS6	.	.	no-change	NM_024675.3	NP_078951.2	-	Y	c.2586+58C=	.	.	.	NM_024675.3(PALB2): c.2586+58C=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	5008	0.649960	U	0.3512	0.35004	4566	0.698861	.	.	.	.	.	.	.	.	.	.	.	.	.	rs249954	.	4024	0.627000	-0.254	0.353	0.493	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	23640466	23640467	16p12.2	0	normal	.	G	snv	A	CA.TT	het-ref	149	0.53	.	2	.	PASS	610355	P	114480(SK);610832(MK);613348(SK)	AD	Breast cancer, Pancreatic cancer, susceptibility to 3, Fanconi anemia, complementation group N	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	22241545|20858716|20301575|19264984|17287723|17200672|17200671|17200668	C1021;FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HD31;HD32;HP16;MC58;MH43	79728	PALB2	IC6	IVS6	.	.	intron	NM_024675.3	NP_078951.2	-	Y	c.2586+58C>T	.	.	.	NM_024675.3(PALB2): c.2586+58C>T	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	5008	0.350040	U	0.3512	0.35004	4566	0.301139	.	.	.	.	.	.	.	.	.	.	.	.	.	rs249954	.	4024	0.373000	-0.254	0.353	0.493	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	126663	no_assertion_criteria_provided	Benign	Benign
16	28617484	28617485	16p11.2	0	nullSample	.	C	ref	C	CA.GA	homo-ref	.	.	.	0	dup	.	171150	P	.	NN	.	.	.	.	.	.	.	6817	SULT1A1	C6	EX7	.	.	no-change	NM_177530.2	NP_803566.1	-	Y	c.667G=	.	.	.	NM_177530.2(SULT1A1): c.667G=	;maf-5-some-pop	117542	0.028577	U	.	.	12986	0.127137	PASS	0	8602	0.000000	532	117542	0.028577	.	.	.	.	.	.	rs1801030	.	4022	0.001500	-0.848	0.654	0.299	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	28617484	28617485	16p11.2	1	normal	.	C	snv	T	CA.GA	hom-alt	176	1.00	.	0	dup	DUBIOUS	171150	P	.	NN	.	.	.	.	.	.	.	6817	SULT1A1	C6	EX7	.	.	missense	NM_177530.2	NP_803566.1	-	Y	c.667G>A	p.V223M | p.Val223Met	GTG=>ATG	NP=>NP	NM_177530.2(SULT1A1): c.667G>A (p.V223M)	;maf-5-some-pop	117542	0.971423	U	.	.	12986	0.872863	PASS	4301	8602	1.000000	55944	117542	0.971423	8604	17209	9.99942e-01	116403	236182	9.80847e-01	rs1801030	.	4022	0.998500	-0.848	0.654	0.299	0.04	0.004	0.001	0.349	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
16	30134321	30134322	16p11.2	0	normal	.	T	ref	T	CC.CC	het-alt	17	0.38	.	1	.	PASS	601795	P	.	NN	.	.	.	.	.	.	.	5595	MAPK3	IC1	IVS1	.	.	no-change	NM_002746.2	NP_002737.2	-	Y	c.170+39A=	.	.	.	NM_002746.2(MAPK3): c.170+39A=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2988	0.996300	0.369	0.301	0.063	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	30134321	30134322	16p11.2	0	normal	.	T	snv	G	CC.CC	het-ref	28	0.62	.	2	.	PASS	601795	P	.	NN	.	.	.	.	.	.	.	5595	MAPK3	IC1	IVS1	.	.	intron	NM_002746.2	NP_002737.2	-	Y	c.170+39A>C	.	.	.	NM_002746.2(MAPK3): c.170+39A>C	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2988	0.003000	0.369	0.301	0.063	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
16	30134655	30134656	16p11.2	0	normal	.	T	ref	T	CG.GG	het-alt	59	0.53	.	1	.	PASS	601795	P	.	NN	.	.	.	.	.	.	.	5595	MAPK3	PROM	.	.	.	no-change	NM_002746.2	NP_002737.2	-	Y	c.-100-u26A=	.	.	.	NM_002746.2(MAPK3): c.-100-u26A=	;maf-5-some-pop,maf-5-all-pops	5008	0.466853	U	0.5823	0.533147	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs28529403	.	.	.	-0.355	0.404	0.319	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	30134655	30134656	16p11.2	0	normal	.	T	snv	C	CG.GG	het-ref	52	0.47	.	2	.	PASS	601795	P	.	NN	.	.	.	.	.	.	.	5595	MAPK3	PROM	.	.	.	promoter	NM_002746.2	NP_002737.2	-	Y	c.-100-u26A>G	.	.	.	NM_002746.2(MAPK3): c.-100-u26A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.533147	U	0.5823	0.533147	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs28529403	.	.	.	-0.355	0.404	0.319	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	48234326	48234327	16q12.1	0	normal	.	C	ref	C	GA.GG	het-alt	248	0.52	.	1	.	PASS	607040	C	117800(NK)	AD	Apocrine gland secretion, variation in	AR	.	Dermatologic	General	19710689|16444273	.	85320	ABCC11	C14	EX15	.	.	no-change	NM_032583.3	NP_115972.2	-	Y	c.1942G=	.	.	.	NM_032583.3(ABCC11): c.1942G=	;maf-5-some-pop,genotype-conflict	126110	0.955111	U	0.2996	0.0716853	13002	0.986771	PASS	.	8604	0.665388	55755	121102	0.956219	.	.	.	.	.	.	rs16945930	.	4024	0.621500	0.655	1.093	0.356	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	48234326	48234327	16q12.1	1	normal	.	C	snv	T	GA.GG	het-ref	231	0.48	.	2	.	PASS	607040	C	117800(NK)	AD	Apocrine gland secretion, variation in	AR	.	Dermatologic	General	19710689|16444273	.	85320	ABCC11	C14	EX15	.	.	missense	NM_032583.3	NP_115972.2	-	Y	c.1942G>A	p.V648I | p.Val648Ile	GTC=>ATC	NP=>NP	NM_032583.3(ABCC11): c.1942G>A (p.V648I)	;maf-5-some-pop,genotype-conflict	126110	0.044889	U	0.2996	0.0716853	13002	0.013229	PASS	471	8604	0.334612	506	121102	0.043781	963	5761	3.34631e-01	1061	10990	4.46559e-02	rs16945930	.	4024	0.378500	0.655	1.093	0.356	0.11	0.036	0.132	0.274	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
16	48258197	48258198	16q12.1	0	nullSample	.	C	ref	C	CC.GA	homo-ref	.	.	.	0	.	.	607040	C	117800(NK)	AD	Apocrine gland secretion, variation in	AR	.	Dermatologic	General	19710689|16444273	.	85320	ABCC11	C4	EX5	.	.	no-change	NM_032583.3	NP_115972.2	-	Y	c.538G=	.	.	.	NM_032583.3(ABCC11): c.538G=	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	126146	0.771883	U	0.7798	0.300919	13000	0.902000	PASS	.	8650	0.118035	39134	121138	0.774893	.	.	.	.	.	.	rs17822931	.	4024	0.078000	0.460	2.744	2.161	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	48258197	48258198	16q12.1	1	normal	.	C	snv	T	CC.GA	hom-alt	586	1.00	.	0	.	PASS	607040	C	117800(NK)	AD	Apocrine gland secretion, variation in	AR	.	Dermatologic	General	19710689|16444273	.	85320	ABCC11	C4	EX5	.	.	missense	NM_032583.3	NP_115972.2	-	Y	c.538G>A	p.G180R | p.Gly180Arg	GGG=>AGG	P0=>P+	NM_032583.3(ABCC11): c.538G>A (p.G180R)	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	126146	0.228117	U	0.7798	0.300919	13000	0.098000	PASS	3405	8650	0.881965	5834	121138	0.225107	6646	15062	8.73666e-01	11509	54943	2.23433e-01	rs17822931	.	4024	0.922000	0.460	2.744	2.161	0	0.986	0.999	0.879	deleterious	ENST00000356608: c.538G>A (p.G180R)	soft_tissue [striated_muscle|NS|NS]	rhabdomyosarcoma [alveolar|NS|NS]	VUO	4987072	CM062373	NM_032583.3(ABCC11): c.538G>A (p.G180R)	"Earwax type, assoc. with"	16444273	DFP	no_record	3558	no_assertion_criteria_provided	Benign	Likely Benign
16	50827600	50827601	16q12.1	0	normal	.	A	snv	G	AT.AA	het-ref	145	0.49	.	2	.	PASS	605018	P	132700(MK);601606(MK);605041(MK)	AD	Spiegler-Brooke syndrome; Trichoepithelioma, multiple familial, 1; Cylindromatosis, familial	AD	.	Dermatologic; Oncologic	Dermatologic; Oncologic	23694822|23567228|23260808|23249834|22882113|22689134|22588548|22296260|22049921|21712687|20972631|20151946|19917957|19807742|19076795|18234730|16922728|16307661|15854031|14632188|12950348|12190880|11703297|10835629|8436650|7684205	.	1540	CYLD	IC15	IVS18	.	.	intron	NM_015247.2	NP_056062.1	+	Y	c.2469+26A>G	.	.	.	NM_015247.2(CYLD): c.2469+26A>G	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	125732	0.786793	U	0.7034	0.798323	11852	0.862808	PASS	2107	8616	0.701370	37673	120724	0.786314	4330	12236	7.09580e-01	77153	193883	7.88187e-01	rs2302759	.	4024	0.697600	-2.405	-2.335	-1.915	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	50827600	50827601	16q12.1	0	normal	.	A	ref	A	AT.AA	het-alt	148	0.51	.	1	.	PASS	605018	P	132700(MK);601606(MK);605041(MK)	AD	Spiegler-Brooke syndrome; Trichoepithelioma, multiple familial, 1; Cylindromatosis, familial	AD	.	Dermatologic; Oncologic	Dermatologic; Oncologic	23694822|23567228|23260808|23249834|22882113|22689134|22588548|22296260|22049921|21712687|20972631|20151946|19917957|19807742|19076795|18234730|16922728|16307661|15854031|14632188|12950348|12190880|11703297|10835629|8436650|7684205	.	1540	CYLD	IC15	IVS18	.	.	no-change	NM_015247.2	NP_056062.1	+	Y	c.2469+26A=	.	.	.	NM_015247.2(CYLD): c.2469+26A=	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	125732	0.213199	U	0.7034	0.798323	11852	0.137192	PASS	.	8616	0.298630	3108	120724	0.213677	.	.	.	.	.	.	rs2302759	.	4024	0.302400	-2.405	-2.335	-1.915	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	65016086	65016087	16q21	0	nullSample	.	A	ref	A	TG.GA	homo-ref	.	.	.	0	.	.	600023	P	.	NN	.	.	.	.	.	.	.	1009	CDH11	C6	EX8	Cadherin domain	PF00028.12	no-change	NM_001797.2	NP_001788.2	-	Y	c.1117T=	.	.	.	NM_001797.2(CDH11): c.1117T=	SingleClassTriAllelic;maf-5-some-pop,microattr-tpa	126400	0.197571	U	0.995	0.745407	13006	0.307243	PASS	.	8652	0.001271	3246	121392	0.195252	.	.	.	.	.	.	rs35213	.	4024	0.003000	-0.121	0.068	0.151	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	65016086	65016087	16q21	1	normal	.	A	snv	C	TG.GA	hom-alt	484	1.00	.	0	.	PASS	600023	P	.	NN	.	.	.	.	.	.	.	1009	CDH11	C6	EX8	Cadherin domain	PF00028.12	missense	NM_001797.2	NP_001788.2	-	Y	c.1117T>G	p.S373A | p.Ser373Ala	TCA=>GCA	P0=>NP	NM_001797.2(CDH11): c.1117T>G (p.S373A)	SingleClassTriAllelic;maf-5-some-pop,microattr-tpa	126400	0.801922	U	0.995	0.745407	13006	0.692757	PASS	4315	8652	0.998729	40192	121392	0.804254	8596	17219	9.98434e-01	82773	199962	8.12523e-01	rs35213	.	4024	0.997000	-0.121	0.068	0.151	0.58	0.003	0	0.005	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
16	68770846	68770847	16q22.1	0	nullSample	.	A	ref	A	ag.cc	homo-ref	.	.	.	0	AluJo|SINE|Alu|+|345	.	192090	C	114480(SK);137215(MK);167000(MK);176807(SK);608089(MK)	AD	CDH1-related cancer	AD	.	Craniofacial; Oncologic	Oncologic	24037103|23197654|23124477|22020549|20301318|19168852|17660459|16189707|15235021|14961571|12588804|11968084|11968083|11443625|10477433|10319582|10072428|9751616|9537325	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HD31;HD32;HG15;MC58;MH43	999	CDH1	PROM	.	.	.	no-change	NM_004360.3	NP_004351.1	+	Y	c.-124-u348A=	.	.	.	NM_004360.3(CDH1): c.-124-u348A=	MixedObserved;maf-5-some-pop|MixedObserved;	5008|0	0.237420|0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs5030625|rs869120289	.	.	.	0.482	0.679	0.641	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
16	68770846	68770847	16q22.1	0	normal	.	A	del	.	ag.cc	hom-alt	279	1.00	.	0	AluJo|SINE|Alu|+|345	PASS	192090	C	114480(SK);137215(MK);167000(MK);176807(SK);608089(MK)	AD	CDH1-related cancer	AD	.	Craniofacial; Oncologic	Oncologic	24037103|23197654|23124477|22020549|20301318|19168852|17660459|16189707|15235021|14961571|12588804|11968084|11968083|11443625|10477433|10319582|10072428|9751616|9537325	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HD31;HD32;HG15;MC58;MH43	999	CDH1	PROM	.	.	.	promoter	NM_004360.3	NP_004351.1	+	Y	c.-124-u348delA	.	.	.	NM_004360.3(CDH1): c.-124-u348delA	MixedObserved;maf-5-some-pop|MixedObserved;	5008|0	0.762580|0	U	0.7698	0.76258	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs5030625|rs869120289	.	.	.	0.482	0.679	0.641	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	68771033	68771034	16q22.1	0	normal	.	C	ref	C	CA.CG	het-alt	286	0.45	.	1	.	PASS	192090	C	114480(SK);137215(MK);167000(MK);176807(SK);608089(MK)	AD	CDH1-related cancer	AD	.	Craniofacial; Oncologic	Oncologic	24037103|23197654|23124477|22020549|20301318|19168852|17660459|16189707|15235021|14961571|12588804|11968084|11968083|11443625|10477433|10319582|10072428|9751616|9537325	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HD31;HD32;HG15;MC58;MH43	999	CDH1	PROM	.	.	.	no-change	NM_004360.3	NP_004351.1	+	Y	c.-124-u161C=	.	.	.	NM_004360.3(CDH1): c.-124-u161C=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	5008	0.764377	U	0.3075	0.235623	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs16260	.	.	.	-0.182	0.469	0.301	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	68771033	68771034	16q22.1	0	normal	.	C	snv	A	CA.CG	het-ref	343	0.55	.	2	.	PASS	192090	C	114480(SK);137215(MK);167000(MK);176807(SK);608089(MK)	AD	CDH1-related cancer	AD	.	Craniofacial; Oncologic	Oncologic	24037103|23197654|23124477|22020549|20301318|19168852|17660459|16189707|15235021|14961571|12588804|11968084|11968083|11443625|10477433|10319582|10072428|9751616|9537325	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HD31;HD32;HG15;MC58;MH43	999	CDH1	PROM	.	.	.	promoter	NM_004360.3	NP_004351.1	+	Y	c.-124-u161C>A	.	.	.	NM_004360.3(CDH1): c.-124-u161C>A	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	5008	0.235623	U	0.3075	0.235623	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs16260	.	.	.	-0.182	0.469	0.301	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	12247	no_assertion_criteria_provided	risk_factor	Benign
16	68771371	68771372	16q22.1	0	nullSample	.	C	ref	C	CC.CG	homo-ref	.	.	.	0	.	.	192090	C	114480(SK);137215(MK);167000(MK);176807(SK);608089(MK)	AD	CDH1-related cancer	AD	.	Craniofacial; Oncologic	Oncologic	24037103|23197654|23124477|22020549|20301318|19168852|17660459|16189707|15235021|14961571|12588804|11968084|11968083|11443625|10477433|10319582|10072428|9751616|9537325	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HD31;HD32;HG15;MC58;MH43	999	CDH1	IC1	IVS1	.	.	no-change	NM_004360.3	NP_004351.1	+	Y	c.48+6C=	.	.	.	NM_004360.3(CDH1): c.48+6C=	MixedObserved;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	21322	0.200075	U	0.7688	0.763379	9830	0.139674	PASS	.	620	0.272581	228	16314	0.188856	.	.	.	.	.	.	rs3743674	.	4024	0.231100	-1.988	-0.529	-0.174	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	68771371	68771372	16q22.1	1	normal	.	C	snv	T	CC.CG	hom-alt	379	1.00	.	0	.	PASS	192090	C	114480(SK);137215(MK);167000(MK);176807(SK);608089(MK)	AD	CDH1-related cancer	AD	.	Craniofacial; Oncologic	Oncologic	24037103|23197654|23124477|22020549|20301318|19168852|17660459|16189707|15235021|14961571|12588804|11968084|11968083|11443625|10477433|10319582|10072428|9751616|9537325	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HD31;HD32;HG15;MC58;MH43	999	CDH1	IC1	IVS1	.	.	intron	NM_004360.3	NP_004351.1	+	Y	c.48+6C>T	.	.	.	NM_004360.3(CDH1): c.48+6C>T	MixedObserved;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	21322	0.799925	U	0.7688	0.763379	9830	0.860326	PASS	148	620	0.727419	5304	16314	0.811144	2978	7765	7.64422e-01	43188	104774	8.14956e-01	rs3743674	.	4024	0.768900	-1.988	-0.529	-0.174	.	.	.	.	.	ENST00000261769: c.48+6C>T (p.?)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5461723	.	.	.	.	.	no_record	136692	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
16	68771417	68771418	16q22.1	0	nullSample	.	C	ref	C	CG.GC	homo-ref	.	.	.	0	.	.	192090	C	114480(SK);137215(MK);167000(MK);176807(SK);608089(MK)	AD	CDH1-related cancer	AD	.	Craniofacial; Oncologic	Oncologic	24037103|23197654|23124477|22020549|20301318|19168852|17660459|16189707|15235021|14961571|12588804|11968084|11968083|11443625|10477433|10319582|10072428|9751616|9537325	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HD31;HD32;HG15;MC58;MH43	999	CDH1	IC1	IVS1	.	.	no-change	NM_004360.3	NP_004351.1	+	Y	c.48+52C=	.	.	.	NM_004360.3(CDH1): c.48+52C=	;	0	0	U	0.745	0.688698	.	.	PASS	.	178	0.264045	255	10834	0.189865	.	.	.	.	.	.	rs112070254	.	.	.	-0.339	-0.048	-0.156	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	68771418	68771418	16q22.1	0	normal	.	.	ins	GCCCCAGCCCCGT	GC.GC	hom-alt	223	1.00	.	0	.	PASS	192090	C	114480(SK);137215(MK);167000(MK);176807(SK);608089(MK)	AD	CDH1-related cancer	AD	.	Craniofacial; Oncologic	Oncologic	24037103|23197654|23124477|22020549|20301318|19168852|17660459|16189707|15235021|14961571|12588804|11968084|11968083|11443625|10477433|10319582|10072428|9751616|9537325	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HD31;HD32;HG15;MC58;MH43	999	CDH1	IC1	IVS1	.	.	intron	NM_004360.3	NP_004351.1	+	Y	c.48+52_48+53insGCCCCAGCCCCGT	.	.	.	NM_004360.3(CDH1): c.48+52_48+53insGCCCCAGCCCCGT	;maf-5-some-pop,maf-5-all-pops	15842	0.771683	U	0.745	0.688698	7010	0.803281	PASS	51	178	0.735955	3615	10834	0.810042	2628	6750	7.59964e-01	38268	92209	8.09945e-01	rs147838237	.	4024	0.767900	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	68857440	68857441	16q22.1	0	nullSample	.	T	ref	T	GC.GG	homo-ref	.	.	.	0	.	.	192090	C	114480(SK);137215(MK);167000(MK);176807(SK);608089(MK)	AD	CDH1-related cancer	AD	.	Craniofacial; Oncologic	Oncologic	24037103|23197654|23124477|22020549|20301318|19168852|17660459|16189707|15235021|14961571|12588804|11968084|11968083|11443625|10477433|10319582|10072428|9751616|9537325	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HD31;HD32;HG15;MC58;MH43	999	CDH1	C13	EX13	.	.	no-change	NM_004360.3	NP_004351.1	+	Y	c.2076T=	.	.	.	NM_004360.3(CDH1): c.2076T=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	126378	0.342662	U	0.6448	0.71865	12996	0.283857	PASS	-1001	8632	0.360056	7615	121370	0.345192	.	.	.	.	.	.	rs1801552	.	4024	0.357100	-0.213	0.311	0.396	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	68857440	68857441	16q22.1	1	normal	.	T	snv	C	GC.GG	hom-alt	562	1.00	.	0	.	PASS	192090	C	114480(SK);137215(MK);167000(MK);176807(SK);608089(MK)	AD	CDH1-related cancer	AD	.	Craniofacial; Oncologic	Oncologic	24037103|23197654|23124477|22020549|20301318|19168852|17660459|16189707|15235021|14961571|12588804|11968084|11968083|11443625|10477433|10319582|10072428|9751616|9537325	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HD31;HD32;HG15;MC58;MH43	999	CDH1	C13	EX13	.	.	coding-synon	NM_004360.3	NP_004351.1	+	Y	c.2076T>C	p.(A692=) | p.(Ala692=)	GCT=>GCC	.	NM_004360.3(CDH1): c.2076T>C (p.(A692=))	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	126378	0.657337	U	0.6448	0.71865	12996	0.716143	PASS	1761	8632	0.639944	26404	121370	0.654808	3636	11177	6.48619e-01	52683	159955	6.49996e-01	rs1801552	.	4024	0.642900	-0.213	0.311	0.396	.	.	.	.	.	ENST00000261769: c.2076T>C (p.A692A)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3755010	.	.	.	.	.	no_record	142770	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
16	69745144	69745145	16q22.1	0	normal	.	G	ref	G	AG.TT	het-alt	256	0.56	.	1	.	PASS	125860	C	125860(SK)	NN	.	.	.	.	.	.	.	1728	NQO1	C6E	EX6E	Flavodoxin-like fold	PF02525.12	no-change	NM_000903.2	NP_000894.1	-	Y	c.559C=	.	.	.	NM_000903.2(NQO1): c.559C=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	126140	0.753100	U	0.4187	0.288938	12996	0.802632	PASS	-1072	8646	0.549850	35133	121132	0.754838	.	.	.	.	.	.	rs1800566	.	4024	0.541700	0.655	5.855	2.696	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	69745144	69745145	16q22.1	1	normal	.	G	snv	A	AG.TT	het-ref	203	0.44	.	2	.	PASS	125860	C	125860(SK)	NN	.	.	.	.	.	.	.	1728	NQO1	C6E	EX6E	Flavodoxin-like fold	PF02525.12	missense	NM_000903.2	NP_000894.1	-	Y	c.559C>T	p.P187S | p.Pro187Ser	CCT=>TCT	NP=>P0	NM_000903.2(NQO1): c.559C>T (p.P187S)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	126140	0.246900	U	0.4187	0.288938	12996	0.197368	PASS	874	8646	0.450150	4264	121132	0.245162	1773	7875	4.56734e-01	8997	61327	2.52065e-01	rs1800566	.	4024	0.458300	0.655	5.855	2.696	0.04	0.787	0.961	0.643	deleterious	ENST00000320623: c.559C>T (p.P187S)	biliary_tract [bile_duct|NS|NS]	carcinoma [NS|NS|NS]	CSV	148097	CM950861	NM_000903.2(NQO1): c.559C>T (p.P187S)	"Lung cancer, smoking induced, association with"	8528266	DFP	no_record	16809	reviewed_by_expert_panel	drug_response	Likely Benign
16	72821176	72821177	16q22.2	0	normal	.	C	ref	C	TC.GT	het-alt	216	0.51	.	1	.	PASS	104155	C	176807(SK)	AD	.	.	.	.	.	.	.	463	ZFHX3	C9E	EX10E	.	.	no-change	NM_006885.3	NP_008816.3	-	Y	c.10998G=	.	.	.	NM_006885.3(ZFHX3): c.10998G=	;	121340	0.999983	U	.	.	.	.	PASS	.	8654	0.999884	60668	121340	0.999984	.	.	.	.	.	.	rs759515178	.	.	.	0.557	1.465	1.029	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	72821176	72821177	16q22.2	1	normal	.	C	snv	G	TC.GT	het-ref	209	0.49	.	2	.	PASS	104155	C	176807(SK)	AD	.	.	.	.	.	.	.	463	ZFHX3	C9E	EX10E	.	.	coding-synon	NM_006885.3	NP_008816.3	-	Y	c.10998G>C	p.(T3666=) | p.(Thr3666=)	ACG=>ACC	.	NM_006885.3(ZFHX3): c.10998G>C (p.(T3666=))	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.557	1.465	1.029	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
16	72821959	72821960	16q22.2	0	normal	.	G	ref	G	CC.GG	het-alt	89	0.51	.	1	.	PASS	104155	C	176807(SK)	AD	.	.	.	.	.	.	.	463	ZFHX3	C9E	EX10E	.	.	no-change	NM_006885.3	NP_008816.3	-	Y	c.10215C=	.	.	.	NM_006885.3(ZFHX3): c.10215C=	SingleClassTriAllelic;	121264	0.997287	U	0.0337	0.00678914	.	.	PASS	-130	8440	0.968957	57834	116256	0.997462	.	.	.	.	.	.	rs190630380	.	4024	0.967400	-0.224	0.623	0.066	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	72821959	72821960	16q22.2	1	normal	.	G	snv	C	CC.GG	het-ref	86	0.49	.	2	.	PASS	104155	C	176807(SK)	AD	.	.	.	.	.	.	.	463	ZFHX3	C9E	EX10E	.	.	coding-synon	NM_006885.3	NP_008816.3	-	Y	c.10215C>G	p.(P3405=) | p.(Pro3405=)	CCC=>CCG	.	NM_006885.3(ZFHX3): c.10215C>G (p.(P3405=))	SingleClassTriAllelic;	121264	0.002705	U	0.0337	0.00678914	.	.	PASS	1	8440	0.031043	1	116256	0.002529	7	521	3.04216e-02	7	606	2.53939e-03	rs190630380	.	4024	0.032600	-0.224	0.623	0.066	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
16	72827757	72827758	16q22.2	0	nullSample	.	T	ref	T	TC.CC	homo-ref	.	.	.	0	.	.	104155	C	176807(SK)	AD	.	.	.	.	.	.	.	463	ZFHX3	C8	EX9	.	.	no-change	NM_006885.3	NP_008816.3	-	Y	c.8823A=	.	.	.	NM_006885.3(ZFHX3): c.8823A=	MixedObserved;maf-5-some-pop,genotype-conflict	126412	0.121151	U	0.998	0.920727	12996	0.118421	PASS	-5	8654	0.001156	1132	121404	0.122879	.	.	.	.	.	.	rs699444	.	4024	0.003700	-0.119	1.700	1.644	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	72827757	72827758	16q22.2	1	normal	.	T	snv	C	TC.CC	hom-alt	661	1.00	.	0	.	PASS	104155	C	176807(SK)	AD	.	.	.	.	.	.	.	463	ZFHX3	C8	EX9	.	.	coding-synon	NM_006885.3	NP_008816.3	-	Y	c.8823A>G	p.(G2941=) | p.(Gly2941=)	GGA=>GGG	.	NM_006885.3(ZFHX3): c.8823A>G (p.(G2941=))	MixedObserved;maf-5-some-pop,genotype-conflict	126412	0.878849	U	0.998	0.920727	12996	0.881579	PASS	4317	8654	0.998844	46916	121404	0.877121	8602	17226	9.98724e-01	94776	215585	8.75437e-01	rs699444	.	4024	0.996300	-0.119	1.700	1.644	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
16	72829425	72829426	16q22.2	0	normal	.	C	ref	C	AT.GG	het-alt	221	0.47	.	1	.	PASS	104155	C	176807(SK)	AD	.	.	.	.	.	.	.	463	ZFHX3	C8	EX9	.	.	no-change	NM_006885.3	NP_008816.3	-	Y	c.7155G=	.	.	.	NM_006885.3(ZFHX3): c.7155G=	;maf-5-some-pop	126398	0.973370	U	0.1032	0.0419329	12996	0.990074	PASS	-360	8648	0.907493	57651	121390	0.974001	.	.	.	.	.	.	rs62639997	.	4024	0.893400	0.561	-1.661	-2.109	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	72829425	72829426	16q22.2	1	normal	.	C	snv	T	AT.GG	het-ref	246	0.53	.	2	.	PASS	104155	C	176807(SK)	AD	.	.	.	.	.	.	.	463	ZFHX3	C8	EX9	.	.	coding-synon	NM_006885.3	NP_008816.3	-	Y	c.7155G>A	p.(P2385=) | p.(Pro2385=)	CCG=>CCA	.	NM_006885.3(ZFHX3): c.7155G>A (p.(P2385=))	;maf-5-some-pop	126398	0.026630	U	0.1032	0.0419329	12996	0.009926	PASS	40	8648	0.092507	112	121390	0.025999	85	1602	9.28803e-02	223	6136	2.49194e-02	rs62639997	.	4024	0.106600	0.561	-1.661	-2.109	.	.	.	.	.	ENST00000268489: c.7155G>A (p.P2385P)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4417318	.	.	.	.	.	.	.	.	.	Likely Benign
16	72832134	72832135	16q22.2	0	nullSample	.	T	ref	T	TC.GC	homo-ref	.	.	.	0	.	.	104155	C	176807(SK)	AD	.	.	.	.	.	.	.	463	ZFHX3	C8	EX9	.	.	no-change	NM_006885.3	NP_008816.3	-	Y	c.4446A=	.	.	.	NM_006885.3(ZFHX3): c.4446A=	;maf-5-some-pop,genotype-conflict	126386	0.161853	U	0.9603	0.886182	12996	0.145199	PASS	.	8654	0.031084	1909	121378	0.163835	.	.	.	.	.	.	rs740178	.	4024	0.044000	-1.220	-3.042	-2.790	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	72832134	72832135	16q22.2	1	normal	.	T	snv	A	TC.GC	hom-alt	362	1.00	.	0	.	PASS	104155	C	176807(SK)	AD	.	.	.	.	.	.	.	463	ZFHX3	C8	EX9	.	.	coding-synon	NM_006885.3	NP_008816.3	-	Y	c.4446A>T	p.(A1482=) | p.(Ala1482=)	GCA=>GCT	.	NM_006885.3(ZFHX3): c.4446A>T (p.(A1482=))	;maf-5-some-pop,genotype-conflict	126386	0.838147	U	0.9603	0.886182	12996	0.854801	PASS	4063	8654	0.968916	42712	121378	0.836165	8100	16716	9.69156e-01	86144	205261	8.33818e-01	rs740178	.	4024	0.956000	-1.220	-3.042	-2.790	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
16	72832618	72832619	16q22.2	0	normal	.	A	ref	A	TT.AA	het-alt	57	0.55	.	1	.	PASS	104155	C	176807(SK)	AD	.	.	.	.	.	.	.	463	ZFHX3	IC7	IVS8	.	.	no-change	NM_006885.3	NP_008816.3	-	Y	c.3968-6T=	.	.	.	NM_006885.3(ZFHX3): c.3968-6T=	MixedObserved;	35043	0.982136	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs748528556	.	4024	0.745000	-0.368	2.063	1.111	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	72832618	72832619	16q22.2	1	normal	.	A	del	.	TT.AA	het-ref	46	0.45	.	2	.	PASS	104155	C	176807(SK)	AD	.	.	.	.	.	.	.	463	ZFHX3	IC7	IVS8	.	.	intron	NM_006885.3	NP_008816.3	-	Y	c.3968-6delT	.	.	.	NM_006885.3(ZFHX3): c.3968-6delT	MixedObserved;	35043	0.017864	U	.	.	.	.	InbreedingCoeff_Filter	0	6006	0.272561	2	84684	0.406417	.	.	.	.	.	.	rs748528556	.	4024	0.247500	-0.368	2.063	1.111	.	.	.	.	.	ENST00000268489: c.3968-6delT (p.?)	skin [NS|NS|NS]	carcinoma [basal_cell_carcinoma|NS|NS]	CSV	5943577	.	.	.	.	.	.	.	.	.	Benign
16	72993489	72993490	16q22.3	0	normal	.	C	ref	C	CA.GA	het-alt	290	0.46	.	1	.	PASS	104155	C	176807(SK)	AD	.	.	.	.	.	.	.	463	ZFHX3	C1	EX2	.	.	no-change	NM_006885.3	NP_008816.3	-	Y	c.555G=	.	.	.	NM_006885.3(ZFHX3): c.555G=	;	120741	0.999992	U	.	.	.	.	VQSRTrancheINDEL99.50to99.90	0	8624	1.000000	60369	120742	0.999983	.	.	.	.	.	.	rs747235758	.	.	.	-1.086	-1.301	-0.909	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	72993489	72993490	16q22.3	1	normal	.	C	snv	T	CA.GA	het-ref	344	0.54	.	2	.	PASS	104155	C	176807(SK)	AD	.	.	.	.	.	.	.	463	ZFHX3	C1	EX2	.	.	coding-synon	NM_006885.3	NP_008816.3	-	Y	c.555G>A	p.(S185=) | p.(Ser185=)	TCG=>TCA	.	NM_006885.3(ZFHX3): c.555G>A (p.(S185=))	;	120741	0.000008	U	.	.	.	.	VQSRTrancheINDEL99.50to99.90	0	8624	0.000000	0	120742	0.000008	0	0	0.00000e+00	0	3	1.21952e-05	rs747235758	.	.	.	-1.086	-1.301	-0.909	.	.	.	.	.	ENST00000268489: c.555G>A (p.S185S)	large_intestine [colon|ascending|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1379734	.	.	.	.	.	.	.	.	.	VUS
16	72993830	72993831	16q22.3	0	normal	.	A	ref	A	GG.GG	het-alt	337	0.52	.	1	.	PASS	104155	C	176807(SK)	AD	.	.	.	.	.	.	.	463	ZFHX3	C1	EX2	.	.	no-change	NM_006885.3	NP_008816.3	-	Y	c.214T=	.	.	.	NM_006885.3(ZFHX3): c.214T=	SingleClassTriAllelic;maf-5-some-pop	101354	0.595152	U	0.2599	0.470447	12952	0.526096	PASS	-657	7008	0.750000	18255	96346	0.598561	.	.	.	.	.	.	rs7193297	.	4024	0.719900	-0.358	1.246	1.168	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	72993830	72993831	16q22.3	1	normal	.	A	snv	C	GG.GG	het-ref	313	0.48	.	2	.	PASS	104155	C	176807(SK)	AD	.	.	.	.	.	.	.	463	ZFHX3	C1	EX2	.	.	missense	NM_006885.3	NP_008816.3	-	Y	c.214T>G	p.S72A | p.Ser72Ala	TCC=>GCC	P0=>NP	NM_006885.3(ZFHX3): c.214T>G (p.S72A)	SingleClassTriAllelic;maf-5-some-pop	101354	0.404829	U	0.2599	0.470447	12952	0.473904	PASS	219	7008	0.250000	8758	96346	0.401418	566	4328	2.64969e-01	18119	85853	3.86844e-01	rs7193297	.	4024	0.280100	-0.358	1.246	1.168	.	.	.	.	.	ENST00000268489: c.214T>G (p.S72A)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1563502	.	.	.	.	.	.	.	.	.	Likely Benign
16	79633805	79633808	16q23.2	0	nullSample	.	GCC	ref	GCC	CT.gc	homo-ref	.	.	.	0	(CCG)n|Simple_repeat|Simple_repeat|+|26;trf	.	177075	P	610202(MK)	NN	Cataract 21, multiple types	AD	.	Ophthalmologic	General	16470690|11772997	.	4094	MAF	5U1E	EX1	.	.	no-change	NM_005360.4	NP_005351.2	-	Y	c.-9_-7=	.	.	.	NM_005360.4(MAF): c.-9_-7=	MixedObserved;maf-5-some-pop	5561	0.224420	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs5818251	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
16	79633805	79633808	16q23.2	0	normal	.	GCC	del	.	CT.gc	hom-alt	186	0.98	.	0	(CCG)n|Simple_repeat|Simple_repeat|+|26;trf	PASS	177075	P	610202(MK)	NN	Cataract 21, multiple types	AD	.	Ophthalmologic	General	16470690|11772997	.	4094	MAF	5U1E	EX1	.	.	utr-5	NM_005360.4	NP_005351.2	-	Y	c.-30GGC[8>7] (std: c.-30GGC[7] alt: c.-9_-7delGGC )	.	.	.	NM_005360.4(MAF): c.-30GGC[7]	MixedObserved;maf-5-some-pop	5561	0.775580	U	0.9534	0.808706	.	.	PASS	3026	7488	0.891159	26115	100218	0.710711	.	.	.	.	.	.	rs5818251	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	259752	criteria_provided,_single_submitter	Benign	Benign
16	81181782	81181783	16q23.2	0	normal	.	T	ref	T	CA.GG	het-alt	185	0.49	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	114780	PKD1L2	C29	EX29	.	.	no-change	NM_052892.3	NP_443124.3	-	Y	c.4933A=	.	.	.	NM_052892.3(PKD1L2): c.4933A=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	110480	0.852037	U	0.3125	0.178315	12066	0.891762	PASS	.	7796	0.713828	38531	105472	0.853478	.	.	.	.	.	.	rs9921748	.	4024	0.735600	-2.955	-1.781	-3.778	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	81181782	81181783	16q23.2	1	normal	.	T	snv	C	CA.GG	het-ref	192	0.51	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	114780	PKD1L2	C29	EX29	.	.	missense	NM_052892.3	NP_443124.3	-	Y	c.4933A>G	p.M1645V | p.Met1645Val	ATG=>GTG	NP=>NP	NM_052892.3(PKD1L2): c.4933A>G (p.M1645V)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	110480	0.147963	U	0.3125	0.178315	12066	0.108238	PASS	261	7796	0.286172	1249	105472	0.146522	550	4428	2.59160e-01	3014	33475	1.37365e-01	rs9921748	.	4024	0.264400	-2.955	-1.781	-3.778	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
16	81181868	81181869	16q23.2	0	normal	.	T	ref	T	TC.GA	het-alt	138	0.55	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	114780	PKD1L2	C29	EX29	.	.	no-change	NM_052892.3	NP_443124.3	-	Y	c.4847A=	.	.	.	NM_052892.3(PKD1L2): c.4847A=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125388	0.864963	U	0.3125	0.178315	11996	0.890297	PASS	.	8598	0.732147	45576	120380	0.866764	.	.	.	.	.	.	rs9921827	.	4024	0.735800	-0.757	3.041	0.420	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	81181868	81181869	16q23.2	1	normal	.	T	snv	C	TC.GA	het-ref	112	0.45	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	114780	PKD1L2	C29	EX29	.	.	missense	NM_052892.3	NP_443124.3	-	Y	c.4847A>G	p.Q1616R | p.Gln1616Arg	CAG=>CGG	P0=>P+	NM_052892.3(PKD1L2): c.4847A>G (p.Q1616R)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125388	0.135037	U	0.3125	0.178315	11996	0.109703	PASS	289	8598	0.267853	1425	120380	0.133236	574	4499	2.60933e-01	3190	34124	1.38680e-01	rs9921827	.	4024	0.264200	-0.757	3.041	0.420	.	.	.	.	.	ENST00000525539: c.4847A>G (p.Q1616R)	bone [femur|NS|NS]	osteosarcoma [NS|NS|NS]	CSV	4419109	.	.	.	.	.	.	.	.	.	Likely Benign
16	88713235	88713236	16q24.3	0	nullSample	.	A	ref	A	GT.CT	homo-ref	.	.	.	0	.	.	608508	C	233690(MK)	AR	Chronic granulomatous disease, autosomal, due to deficiency of CYBA	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	23910690|22924696|22876374|22562447|22336310|20407811|18422995|12073015|11060536|10759707|4384563|3368442|2770793|2713485|2243141|1415254	.	1535	CYBA	C4	EX4	Cytochrome Cytochrome b558 alpha-subunit	PF05038.8	no-change	NM_000101.3	NP_000092.2	-	Y	c.214T=	.	.	.	NM_000101.3(CYBA): c.214T=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125796	0.310225	U	0.9157	0.664337	12996	0.378424	PASS	.	8634	0.087677	6402	120788	0.309170	.	.	.	.	.	.	rs4673	.	4024	0.081000	0.448	2.070	0.616	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	88713235	88713236	16q24.3	1	normal	.	A	snv	G	GT.CT	hom-alt	380	1.00	.	0	.	PASS	608508	C	233690(MK)	AR	Chronic granulomatous disease, autosomal, due to deficiency of CYBA	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	23910690|22924696|22876374|22562447|22336310|20407811|18422995|12073015|11060536|10759707|4384563|3368442|2770793|2713485|2243141|1415254	.	1535	CYBA	C4	EX4	Cytochrome Cytochrome b558 alpha-subunit	PF05038.8	missense	NM_000101.3	NP_000092.2	-	Y	c.214T>C	p.Y72H | p.Tyr72His	TAC=>CAC	P0=>P+	NM_000101.3(CYBA): c.214T>C (p.Y72H)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125796	0.689776	U	0.9157	0.664337	12996	0.621576	PASS	3586	8634	0.912323	29452	120788	0.690830	7196	15750	9.13891e-01	61167	171415	6.97501e-01	rs4673	.	4024	0.919000	0.448	2.070	0.616	0.4	0.999	1	0.506	deleterious	ENST00000261623: c.214T>C (p.Y72H)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3755197	.	.	.	.	.	no_record	2263	criteria_provided,_single_submitter	Benign	Likely Benign
16	89805260	89805261	16q24.3	0	nullSample	.	A	ref	A	AC.TG	homo-ref	.	.	.	0	.	.	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC42	IVS42	.	.	no-change	NM_000135.2	NP_000126.2	-	Y	c.4260+29T=	.	.	.	NM_000135.2(FANCA): c.4260+29T=	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	126104	0.289729	U	0.9901	0.850839	12996	0.300939	PASS	.	8648	0.012835	6562	121096	0.295542	.	.	.	.	.	.	rs1800359	.	4024	0.014200	-1.427	-1.424	-1.452	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	89805260	89805261	16q24.3	0	normal	.	A	snv	G	AC.TG	hom-alt	361	1.00	.	0	.	PASS	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC42	IVS42	.	.	intron	NM_000135.2	NP_000126.2	-	Y	c.4260+29T>C	.	.	.	NM_000135.2(FANCA): c.4260+29T>C	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	126104	0.710255	U	0.9901	0.850839	12996	0.699061	PASS	4213	8648	0.987165	31320	121096	0.704441	8386	17005	9.86483e-01	62969	172433	7.01449e-01	rs1800359	.	4024	0.985800	-1.427	-1.424	-1.452	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	255266	criteria_provided,_single_submitter	Benign	Benign
16	89805976	89805977	16q24.3	1	normal	.	G	snv	A	AA.TG	hom-alt	346	1.00	.	0	.	PASS	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC39	IVS39	.	.	intron	NM_000135.2	NP_000126.2	-	Y	c.3935-16C>T	.	.	.	NM_000135.2(FANCA): c.3935-16C>T	;maf-5-some-pop,maf-5-all-pops	24726	0.435776	U	0.7073	0.538139	11744	0.347497	PASS	163	642	0.700935	1784	19718	0.409778	2723	7436	7.26598e-01	15261	62824	4.24825e-01	rs1061646	.	4024	0.749000	0.561	0.450	0.505	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	255264	criteria_provided,_single_submitter	Benign	Benign
16	89805976	89805977	16q24.3	0	nullSample	.	G	ref	G	AA.TG	homo-ref	.	.	.	0	.	.	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC39	IVS39	.	.	no-change	NM_000135.2	NP_000126.2	-	Y	c.3935-16C=	.	.	.	NM_000135.2(FANCA): c.3935-16C=	;maf-5-some-pop,maf-5-all-pops	24726	0.564224	U	0.7073	0.538139	11744	0.652503	PASS	-62	642	0.299065	3563	19718	0.590222	.	.	.	.	.	.	rs1061646	.	4024	0.251000	0.561	0.450	0.505	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	89806346	89806347	16q24.3	0	nullSample	.	A	ref	A	AG.TG	homo-ref	.	.	.	0	.	.	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC39	IVS39	.	.	no-change	NM_000135.2	NP_000126.2	-	Y	c.3934+55T=	.	.	.	NM_000135.2(FANCA): c.3934+55T=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	125160	0.469934	U	0.9871	0.70647	.	.	PASS	.	8650	0.016763	15950	120152	0.477287	.	.	.	.	.	.	rs7195906	.	4024	0.017100	-0.376	-1.103	-1.192	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	89806346	89806347	16q24.3	0	normal	.	A	snv	T	AG.TG	hom-alt	193	1.00	.	0	.	PASS	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC39	IVS39	.	.	intron	NM_000135.2	NP_000126.2	-	Y	c.3934+55T>A	.	.	.	NM_000135.2(FANCA): c.3934+55T>A	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	125160	0.530066	U	0.9871	0.70647	.	.	PASS	4180	8650	0.983237	18679	120152	0.522713	8317	16932	9.82705e-01	37663	127243	5.21103e-01	rs7195906	.	4024	0.982900	-0.376	-1.103	-1.192	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	135541	no_assertion_provided	not_provided	Benign
16	89815216	89815217	16q24.3	0	nullSample	.	C	ref	C	TA.AC	homo-ref	.	.	.	0	.	.	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC32	IVS32	.	.	no-change	NM_000135.2	NP_000126.2	-	Y	c.3240-42G=	.	.	.	NM_000135.2(FANCA): c.3240-42G=	;maf-5-some-pop,maf-5-all-pops	92924	0.562804	U	0.7252	0.544928	12990	0.619630	PASS	-578	6310	0.228526	14906	87916	0.568941	.	.	.	.	.	.	rs1800345	.	4024	0.236100	-0.672	-0.274	-0.291	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	89815216	89815217	16q24.3	0	normal	.	C	snv	T	TA.AC	hom-alt	206	1.00	.	0	.	PASS	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC32	IVS32	.	.	intron	NM_000135.2	NP_000126.2	-	Y	c.3240-42G>A	.	.	.	NM_000135.2(FANCA): c.3240-42G>A	;maf-5-some-pop,maf-5-all-pops	92924	0.437196	U	0.7252	0.544928	12990	0.380370	PASS	1856	6310	0.771474	8845	87916	0.431059	4405	11679	7.56020e-01	22106	91441	4.27187e-01	rs1800345	.	4024	0.763900	-0.672	-0.274	-0.291	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	255254	criteria_provided,_single_submitter	Benign	Benign
16	89818490	89818491	16q24.3	0	nullSample	.	T	ref	T	AA.AG	homo-ref	.	.	.	0	.	.	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC31	IVS31	.	.	no-change	NM_000135.2	NP_000126.2	-	Y	c.3066+55A=	.	.	.	NM_000135.2(FANCA): c.3066+55A=	;maf-5-some-pop,maf-5-all-pops	5008	0.413538	U	0.7312	0.586462	4566	0.566141	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3743860	.	4024	0.231600	-0.372	0.041	-0.082	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	89818490	89818491	16q24.3	0	normal	.	T	snv	C	AA.AG	hom-alt	255	1.00	.	0	.	PASS	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC31	IVS31	.	.	intron	NM_000135.2	NP_000126.2	-	Y	c.3066+55A>G	.	.	.	NM_000135.2(FANCA): c.3066+55A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.586462	U	0.7312	0.586462	4566	0.433859	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3743860	.	4024	0.768400	-0.372	0.041	-0.082	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	89836322	89836323	16q24.3	0	nullSample	.	C	ref	C	CA.CA	homo-ref	.	.	.	0	.	.	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	C26	EX26	.	.	no-change	NM_000135.2	NP_000126.2	-	Y	c.2426G=	.	.	.	NM_000135.2(FANCA): c.2426G=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	125746	0.523134	U	0.9881	0.666733	12996	0.569329	PASS	-63	8646	0.014573	19814	120738	0.531009	.	.	.	.	.	.	rs7195066	.	4024	0.017100	-1.562	-0.205	-0.200	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	89836322	89836323	16q24.3	1	normal	.	C	snv	T	CA.CA	hom-alt	580	1.00	.	0	.	PASS	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	C26	EX26	.	.	missense	NM_000135.2	NP_000126.2	-	Y	c.2426G>A	p.G809D | p.Gly809Asp	GGT=>GAT	P0=>P-	NM_000135.2(FANCA): c.2426G>A (p.G809D)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	125746	0.476866	U	0.9881	0.666733	12996	0.430671	PASS	4197	8646	0.985427	16070	120738	0.468991	8363	16983	9.85093e-01	32766	115831	4.71042e-01	rs7195066	.	4024	0.982900	-1.562	-0.205	-0.200	0.3	0	0	0.029	neutral	ENST00000389301: c.2426G>A (p.G809D)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	435949	.	.	.	.	.	no_record	134254	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
16	89836506	89836507	16q24.3	0	nullSample	.	T	ref	T	AA.TG	homo-ref	.	.	.	0	.	.	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC25	IVS25	.	.	no-change	NM_000135.2	NP_000126.2	-	Y	c.2316+67A=	.	.	.	NM_000135.2(FANCA): c.2316+67A=	MixedObserved;maf-5-some-pop	66358	0.028120	U	1	0.988219	.	.	PASS	.	3858	0.000259	34	61350	0.029454	.	.	.	.	.	.	rs7200990	.	4024	0.001500	-0.746	-0.306	-0.130	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	89836506	89836507	16q24.3	0	normal	.	T	snv	C	AA.TG	hom-alt	467	1.00	.	0	.	PASS	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC25	IVS25	.	.	intron	NM_000135.2	NP_000126.2	-	Y	c.2316+67A>G	.	.	.	NM_000135.2(FANCA): c.2316+67A>G	MixedObserved;maf-5-some-pop	66358	0.971880	U	1	0.988219	.	.	PASS	1928	3858	0.999741	28902	61350	0.970546	6601	13203	9.99924e-01	88172	181657	9.70400e-01	rs7200990	.	4024	0.998500	-0.746	-0.306	-0.130	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	89838077	89838078	16q24.3	0	nullSample	.	A	ref	A	CT.CA	homo-ref	.	.	.	0	.	.	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC23	IVS23	.	.	no-change	NM_000135.2	NP_000126.2	-	Y	c.2151+8T=	.	.	.	NM_000135.2(FANCA): c.2151+8T=	;maf-5-some-pop,maf-5-all-pops	126382	0.563427	U	0.7242	0.559904	12996	0.625731	PASS	.	8634	0.248436	21293	121374	0.568515	.	.	.	.	.	.	rs1800340	.	4024	0.239300	-0.483	-0.898	-1.473	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	89838077	89838078	16q24.3	1	normal	.	A	snv	G	CT.CA	hom-alt	486	1.00	.	0	.	PASS	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC23	IVS23	.	.	intron	NM_000135.2	NP_000126.2	-	Y	c.2151+8T>C	.	.	.	NM_000135.2(FANCA): c.2151+8T>C	;maf-5-some-pop,maf-5-all-pops	126382	0.436573	U	0.7242	0.559904	12996	0.374269	PASS	2437	8634	0.751564	12977	121374	0.431485	4805	12860	7.45594e-01	26883	107622	4.37111e-01	rs1800340	.	4024	0.760700	-0.483	-0.898	-1.473	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	255245	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
16	89838135	89838136	16q24.3	0	normal	.	T	ref	T	CT.TG	het-alt	263	0.52	.	1	.	PASS	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	C23	EX23	.	.	no-change	NM_000135.2	NP_000126.2	-	Y	c.2101A=	.	.	.	NM_000135.2(FANCA): c.2101A=	;clinically-assoc,submitted-by-lsdb	126420	0.999525	U	0.006	0.00119808	12996	0.999923	PASS	.	8654	0.994800	60653	121412	0.999555	.	.	.	.	.	.	rs56369086	.	4024	0.991800	-0.388	-0.381	-0.757	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	89838135	89838136	16q24.3	1	normal	.	T	snv	C	CT.TG	het-ref	243	0.48	.	2	.	PASS	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	C23	EX23	.	.	missense	NM_000135.2	NP_000126.2	-	Y	c.2101A>G	p.K701E | p.Lys701Glu	AAG=>GAG	P+=>P-	NM_000135.2(FANCA): c.2101A>G (p.K701E)	;clinically-assoc,submitted-by-lsdb	126420	0.000475	U	0.006	0.00119808	12996	0.000077	PASS	1	8654	0.005200	1	121412	0.000445	3	120	6.95733e-03	3	139	5.64421e-04	rs56369086	.	4024	0.008200	-0.388	-0.381	-0.757	0.65	0.012	0.009	0.004	neutral	.	.	.	.	.	.	.	.	.	.	no_record	134251	criteria_provided,_single_submitter	Likely_benign	VUS
16	89845193	89845194	16q24.3	0	nullSample	.	A	ref	A	TA.CC	homo-ref	.	.	.	0	.	.	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC20	IVS20	.	.	no-change	NM_000135.2	NP_000126.2	-	Y	c.1826+15T=	.	.	.	NM_000135.2(FANCA): c.1826+15T=	;maf-5-some-pop	126364	0.481743	U	0.9871	0.682508	12996	0.511850	PASS	-67	8652	0.015488	16664	121356	0.488521	.	.	.	.	.	.	rs1800337	.	4024	0.018400	-1.159	-0.850	-1.125	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	89845193	89845194	16q24.3	1	normal	.	A	snv	G	TA.CC	hom-alt	349	1.00	.	0	.	PASS	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC20	IVS20	.	.	intron	NM_000135.2	NP_000126.2	-	Y	c.1826+15T>C	.	.	.	NM_000135.2(FANCA): c.1826+15T>C	;maf-5-some-pop	126364	0.518257	U	0.9871	0.682508	12996	0.488150	PASS	4192	8652	0.984512	18057	121356	0.511479	8347	16970	9.83996e-01	36874	126799	5.15054e-01	rs1800337	.	4024	0.981600	-1.159	-0.850	-1.125	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	255241	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
16	89849479	89849480	16q24.3	0	nullSample	.	C	ref	C	GC.GG	homo-ref	.	.	.	0	.	.	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	C16	EX16	.	.	no-change	NM_000135.2	NP_000126.2	-	Y	c.1501G=	.	.	.	NM_000135.2(FANCA): c.1501G=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126136	0.495576	U	0.8671	0.624002	12996	0.517698	PASS	-518	8640	0.144907	16510	121128	0.500520	.	.	.	.	.	.	rs2239359	.	4024	0.165000	-1.234	-0.896	-1.689	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	89849479	89849480	16q24.3	1	normal	.	C	snv	T	GC.GG	hom-alt	475	1.00	.	0	.	PASS	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	C16	EX16	.	.	missense	NM_000135.2	NP_000126.2	-	Y	c.1501G>A	p.G501S | p.Gly501Ser	GGC=>AGC	P0=>P0	NM_000135.2(FANCA): c.1501G>A (p.G501S)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	126136	0.504424	U	0.8671	0.624002	12996	0.482302	PASS	3176	8640	0.855093	16447	121128	0.499480	6297	14733	8.54682e-01	33734	123344	5.01468e-01	rs2239359	.	4024	0.835000	-1.234	-0.896	-1.689	0.91	0	0	0.000	neutral	ENST00000389301: c.1501G>A (p.G501S)	kidney [NS|NS|NS]	carcinoma [papillary_renal_cell_carcinoma|NS|NS]	VUO	4984954	.	.	.	.	.	no_record	134244	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
16	89857963	89857964	16q24.3	0	normal	.	T	snv	C	CA.AG	hom-alt	499	1.00	.	0	.	PASS	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC13	IVS13	.	.	intron	NM_000135.2	NP_000126.2	-	Y	c.1226-20A>G	.	.	.	NM_000135.2(FANCA): c.1226-20A>G	;maf-5-some-pop,maf-5-all-pops	124994	0.442381	U	0.7341	0.571885	12996	0.390659	PASS	2484	8594	0.761112	13077	119986	0.436976	4926	13002	7.56106e-01	27102	107566	4.40180e-01	rs1800330	.	4024	0.770600	-1.408	-2.105	-2.278	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	255232	criteria_provided,_single_submitter	Benign	Benign
16	89857963	89857964	16q24.3	0	nullSample	.	T	ref	T	CA.AG	homo-ref	.	.	.	0	.	.	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC13	IVS13	.	.	no-change	NM_000135.2	NP_000126.2	-	Y	c.1226-20A=	.	.	.	NM_000135.2(FANCA): c.1226-20A=	;maf-5-some-pop,maf-5-all-pops	124994	0.557619	U	0.7341	0.571885	12996	0.609341	PASS	.	8594	0.238888	20639	119986	0.563024	.	.	.	.	.	.	rs1800330	.	4024	0.229400	-1.408	-2.105	-2.278	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	89858023	89858024	16q24.3	0	normal	.	A	snv	G	CA.GT	hom-alt	351	1.00	.	0	.	PASS	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC13	IVS13	.	.	intron	NM_000135.2	NP_000126.2	-	Y	c.1226-80T>C	.	.	.	NM_000135.2(FANCA): c.1226-80T>C	;maf-5-some-pop,genotype-conflict	5008	0.703075	U	0.9881	0.703075	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6500450	.	4024	0.982100	-1.574	-2.508	-2.704	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	89858023	89858024	16q24.3	0	nullSample	.	A	ref	A	CA.GT	homo-ref	.	.	.	0	.	.	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC13	IVS13	.	.	no-change	NM_000135.2	NP_000126.2	-	Y	c.1226-80T=	.	.	.	NM_000135.2(FANCA): c.1226-80T=	;maf-5-some-pop,genotype-conflict	5008	0.296925	U	0.9881	0.703075	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6500450	.	4024	0.017900	-1.574	-2.508	-2.704	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	89858504	89858505	16q24.3	0	nullSample	.	T	ref	T	AA.AT	homo-ref	.	.	.	0	.	.	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC12	IVS12	.	.	no-change	NM_000135.2	NP_000126.2	-	Y	c.1084-29A=	.	.	.	NM_000135.2(FANCA): c.1084-29A=	;maf-5-some-pop,maf-5-all-pops	126324	0.583492	U	0.7292	0.531749	12996	0.630040	PASS	.	8644	0.242365	22572	121316	0.588249	.	.	.	.	.	.	rs6500452	.	4024	0.233100	-0.304	-1.633	-1.447	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	89858504	89858505	16q24.3	0	normal	.	T	snv	C	AA.AT	hom-alt	476	1.00	.	0	.	PASS	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC12	IVS12	.	.	intron	NM_000135.2	NP_000126.2	-	Y	c.1084-29A>G	.	.	.	NM_000135.2(FANCA): c.1084-29A>G	;maf-5-some-pop,maf-5-all-pops	126324	0.416508	U	0.7292	0.531749	12996	0.369960	PASS	2477	8644	0.757635	11866	121316	0.411751	4895	12973	7.52232e-01	24760	102816	4.17771e-01	rs6500452	.	4024	0.766900	-0.304	-1.633	-1.447	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	255229	criteria_provided,_single_submitter	Benign	Benign
16	89858524	89858525	16q24.3	0	nullSample	.	C	ref	C	TG.GA	homo-ref	.	.	.	0	.	.	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC12	IVS12	.	.	no-change	NM_000135.2	NP_000126.2	-	Y	c.1084-49G=	.	.	.	NM_000135.2(FANCA): c.1084-49G=	SingleClassTriAllelic;maf-5-some-pop	126122	0.475135	U	0.9871	0.702676	12996	0.488150	PASS	-67	8650	0.015491	16384	121114	0.482488	.	.	.	.	.	.	rs1800287	.	4024	0.018600	-1.099	-0.223	-0.252	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	89858524	89858525	16q24.3	0	normal	.	C	snv	G	TG.GA	hom-alt	384	1.00	.	0	.	PASS	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC12	IVS12	.	.	intron	NM_000135.2	NP_000126.2	-	Y	c.1084-49G>C	.	.	.	NM_000135.2(FANCA): c.1084-49G>C	SingleClassTriAllelic;maf-5-some-pop	126122	0.524841	U	0.9871	0.702676	12996	0.511850	PASS	4191	8650	0.984509	18504	121114	0.517488	8343	16965	9.83820e-01	37551	127599	5.19350e-01	rs1800287	.	4024	0.981400	-1.099	-0.223	-0.252	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	255230	criteria_provided,_single_submitter	Benign	Benign
16	89859007	89859008	16q24.3	0	nullSample	.	G	ref	G	TG.GT	homo-ref	.	.	.	0	.	.	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC11	IVS11	.	.	no-change	NM_000135.2	NP_000126.2	-	Y	c.1007-53C=	.	.	.	NM_000135.2(FANCA): c.1007-53C=	MixedObserved;maf-5-some-pop,maf-5-all-pops	5008	0.469848	U	0.7282	0.530152	4566	0.644328	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3856	.	4024	0.234300	0.306	0.548	0.559	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	89859007	89859008	16q24.3	0	normal	.	G	snv	A	TG.GT	hom-alt	240	1.00	.	0	.	PASS	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC11	IVS11	.	.	intron	NM_000135.2	NP_000126.2	-	Y	c.1007-53C>T	.	.	.	NM_000135.2(FANCA): c.1007-53C>T	MixedObserved;maf-5-some-pop,maf-5-all-pops	5008	0.530152	U	0.7282	0.530152	4566	0.355672	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3856	.	4024	0.765700	0.306	0.548	0.559	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	89859015	89859016	16q24.3	0	normal	.	T	del	.	TG.ta	hom-alt	223	1.00	.	0	.	PASS	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC11	IVS11	.	.	intron	NM_000135.2	NP_000126.2	-	Y	c.1007-61delA	.	.	.	NM_000135.2(FANCA): c.1007-61delA	MixedObserved;|MixedObserved;maf-5-some-pop|MixedObserved;	0|5008|0	0|0.642971|0	U	0.9871	0.642971	12506	0.452263	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17232539|rs35617323|rs869107558	.	4024	0.981400	0.000	0.000	0.000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	89859015	89859016	16q24.3	0	nullSample	.	T	ref	T	TG.ta	homo-ref	.	.	.	0	.	.	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC11	IVS11	.	.	no-change	NM_000135.2	NP_000126.2	-	Y	c.1007-61A=	.	.	.	NM_000135.2(FANCA): c.1007-61A=	MixedObserved;|MixedObserved;maf-5-some-pop|MixedObserved;	0|5008|0	0|0.357029|0	U	.	.	12506	0.547737	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17232539|rs35617323|rs869107558	.	4024	0.018600	0.000	0.000	0.000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	89866042	89866043	16q24.3	1	normal	.	T	snv	C	CG.GA	hom-alt	360	1.00	.	0	.	PASS	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	C9	EX9	.	.	missense	NM_000135.2	NP_000126.2	-	Y	c.796A>G	p.T266A | p.Thr266Ala	ACG=>GCG	P0=>NP	NM_000135.2(FANCA): c.796A>G (p.T266A)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	126340	0.523492	U	0.9871	0.690495	12996	0.506002	PASS	4194	8652	0.984743	18422	121332	0.516599	8349	16972	9.84112e-01	37457	127801	5.19242e-01	rs7190823	.	4024	0.981600	-0.222	0.329	0.381	1	0	0	0.000	neutral	.	.	.	.	.	.	.	.	.	.	no_record	134294	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
16	89866042	89866043	16q24.3	0	nullSample	.	T	ref	T	CG.GA	homo-ref	.	.	.	0	.	.	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	C9	EX9	.	.	no-change	NM_000135.2	NP_000126.2	-	Y	c.796A=	.	.	.	NM_000135.2(FANCA): c.796A=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	126340	0.476508	U	0.9871	0.690495	12996	0.493998	PASS	-66	8652	0.015257	16408	121332	0.483401	.	.	.	.	.	.	rs7190823	.	4024	0.018400	-0.222	0.329	0.381	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	89869760	89869761	16q24.3	0	nullSample	.	T	ref	T	CA.AA	homo-ref	.	.	.	0	.	.	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC7	IVS7	.	.	no-change	NM_000135.2	NP_000126.2	-	Y	c.710-12A=	.	.	.	NM_000135.2(FANCA): c.710-12A=	SingleClassTriAllelic;maf-5-some-pop	126318	0.293102	U	0.9911	0.842851	12996	0.304247	PASS	-45	8654	0.010400	6672	121310	0.298714	.	.	.	.	.	.	rs1800286	.	4024	0.013400	-0.235	-1.416	-1.083	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
16	89869760	89869761	16q24.3	1	normal	.	T	snv	C	CA.AA	hom-alt	343	1.00	.	0	.	PASS	607139	C	227650(MK)	AR	Fanconi anemia, complementation group A	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23973728|23898106|23067021|22950077|22480464|21273304|20507306|20301575|17105750|14605744|14504102|13826667|11389461|10094191|9371798|8781414|8502512|8081006|6338978|2571931|1536187|1521091	.	2175	FANCA	IC7	IVS7	.	.	intron	NM_000135.2	NP_000126.2	-	Y	c.710-12A>G	.	.	.	NM_000135.2(FANCA): c.710-12A>G	SingleClassTriAllelic;maf-5-some-pop	126318	0.706891	U	0.9911	0.842851	12996	0.695753	PASS	4237	8654	0.989600	31090	121310	0.701278	8425	17048	9.88519e-01	62427	171768	6.98051e-01	rs1800286	.	4024	0.986600	-0.235	-1.416	-1.083	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	255269	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	5991343	5991344	17p13.2	0	nullSample	.	C	ref	C	CA.GA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.5991343C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	126394	0.446540	U	0.8204	0.526757	13006	0.572121	PASS	-636	8652	0.179149	13155	121386	0.445439	.	.	.	.	.	.	rs2302836	.	.	.	-0.211	1.225	0.841	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	5991343	5991344	17p13.2	0	normal	.	C	snv	T	CA.GA	hom-alt	446	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.5991343C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	126394	0.553460	U	0.8204	0.526757	13006	0.427879	PASS	2915	8652	0.820851	19778	121386	0.554561	5766	14085	8.16806e-01	40904	138579	5.62876e-01	rs2302836	.	.	.	-0.211	1.225	0.841	.	.	.	.	.	ENST00000317744: c.462C>T (p.H154H)	bone [femur|NS|NS]	osteosarcoma [NS|NS|NS]	CSV	5021915	.	.	.	.	.	.	.	.	.	Benign
17	7569697	7569698	17p13.1	0	normal	.	A	ref	A	ga.ca	het-alt	63	0.45	.	1	L2a|LINE|L2|+|93	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.7569697A= (intergenic)	;maf-5-some-pop	5008	0.720248	U	0.0645	0.279752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs8073498	.	.	.	-0.224	-0.053	-0.070	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7569697	7569698	17p13.1	0	normal	.	A	snv	C	ga.ca	het-ref	78	0.55	.	2	L2a|LINE|L2|+|93	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.7569697A>C (intergenic)	;maf-5-some-pop	5008	0.279752	U	0.0645	0.279752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs8073498	.	.	.	-0.224	-0.053	-0.070	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579471	7579472	17p13.1	0	normal	.	G	ref	G	CG.GG	het-alt	224	0.43	.	1	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	C3	EX4	.	.	no-change	NM_000546.5	NP_000537.3	-	Y	c.215C=	.	.	.	NM_000546.5(TP53): c.215C=	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125932	0.344694	U	0.5863	0.542931	13004	0.369963	PASS	.	8620	0.410789	7963	120924	0.340040	.	.	.	.	.	.	rs1042522	.	4024	0.442100	0.561	3.310	1.355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579471	7579472	17p13.1	0	normal	.	G	ref	G	CG.GG	het-alt	224	0.43	.	1	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	C3	EX4	.	.	no-change	NM_001126112.2	NP_001119584.1	-	N	c.215C=	.	.	.	NM_001126112.2(TP53): c.215C=	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125932	0.344694	U	0.5863	0.542931	13004	0.369963	PASS	.	8620	0.410789	7963	120924	0.340040	.	.	.	.	.	.	rs1042522	.	4024	0.442100	0.561	3.310	1.355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579471	7579472	17p13.1	0	normal	.	G	ref	G	CG.GG	het-alt	224	0.43	.	1	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	C3	EX4	.	.	no-change	NM_001126113.2	NP_001119585.1	-	N	c.215C=	.	.	.	NM_001126113.2(TP53): c.215C=	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125932	0.344694	U	0.5863	0.542931	13004	0.369963	PASS	.	8620	0.410789	7963	120924	0.340040	.	.	.	.	.	.	rs1042522	.	4024	0.442100	0.561	3.310	1.355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579471	7579472	17p13.1	0	normal	.	G	ref	G	CG.GG	het-alt	224	0.43	.	1	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	C3	EX4	.	.	no-change	NM_001126114.2	NP_001119586.1	-	N	c.215C=	.	.	.	NM_001126114.2(TP53): c.215C=	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125932	0.344694	U	0.5863	0.542931	13004	0.369963	PASS	.	8620	0.410789	7963	120924	0.340040	.	.	.	.	.	.	rs1042522	.	4024	0.442100	0.561	3.310	1.355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579471	7579472	17p13.1	0	normal	.	G	ref	G	CG.GG	het-alt	224	0.43	.	1	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	PROM	.	.	.	no-change	NM_001126115.1	NP_001119587.1	-	N	c.-278-u661C=	.	.	.	NM_001126115.1(TP53): c.-278-u661C=	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125932	0.344694	U	0.5863	0.542931	13004	0.369963	PASS	.	8620	0.410789	7963	120924	0.340040	.	.	.	.	.	.	rs1042522	.	4024	0.442100	0.561	3.310	1.355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579471	7579472	17p13.1	0	normal	.	G	ref	G	CG.GG	het-alt	224	0.43	.	1	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	PROM	.	.	.	no-change	NM_001126116.1	NP_001119588.1	-	N	c.-278-u661C=	.	.	.	NM_001126116.1(TP53): c.-278-u661C=	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125932	0.344694	U	0.5863	0.542931	13004	0.369963	PASS	.	8620	0.410789	7963	120924	0.340040	.	.	.	.	.	.	rs1042522	.	4024	0.442100	0.561	3.310	1.355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579471	7579472	17p13.1	0	normal	.	G	ref	G	CG.GG	het-alt	224	0.43	.	1	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	PROM	.	.	.	no-change	NM_001126117.1	NP_001119589.1	-	N	c.-278-u661C=	.	.	.	NM_001126117.1(TP53): c.-278-u661C=	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125932	0.344694	U	0.5863	0.542931	13004	0.369963	PASS	.	8620	0.410789	7963	120924	0.340040	.	.	.	.	.	.	rs1042522	.	4024	0.442100	0.561	3.310	1.355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579471	7579472	17p13.1	0	normal	.	G	ref	G	CG.GG	het-alt	224	0.43	.	1	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	C1	EX3	.	.	no-change	NM_001126118.1	NP_001119590.1	-	N	c.98C=	.	.	.	NM_001126118.1(TP53): c.98C=	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125932	0.344694	U	0.5863	0.542931	13004	0.369963	PASS	.	8620	0.410789	7963	120924	0.340040	.	.	.	.	.	.	rs1042522	.	4024	0.442100	0.561	3.310	1.355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579471	7579472	17p13.1	1	normal	.	G	snv	C	CG.GG	het-ref	291	0.57	.	2	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	C3	EX4	.	.	missense	NM_000546.5	NP_000537.3	-	Y	c.215C>G	p.P72R | p.Pro72Arg	CCC=>CGC	NP=>P+	NM_000546.5(TP53): c.215C>G (p.P72R)	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125932	0.655306	U	0.5863	0.542931	13004	0.630037	PASS	1510	8620	0.589211	27306	120924	0.659960	2833	9842	5.70882e-01	56629	164592	6.68584e-01	rs1042522	.	4024	0.557900	0.561	3.310	1.355	0.56	0.033	0.059	0.008	neutral	ENST00000269305: c.215C>G (p.P72R)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	CSV	250061	.	.	.	.	.	no_record	12351	reviewed_by_expert_panel	drug_response	Likely Benign
17	7579471	7579472	17p13.1	1	normal	.	G	snv	C	CG.GG	het-ref	291	0.57	.	2	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	C3	EX4	.	.	missense	NM_001126112.2	NP_001119584.1	-	N	c.215C>G	p.P72R | p.Pro72Arg	CCC=>CGC	NP=>P+	NM_001126112.2(TP53): c.215C>G (p.P72R)	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125932	0.655306	U	0.5863	0.542931	13004	0.630037	PASS	1510	8620	0.589211	27306	120924	0.659960	2833	9842	5.70882e-01	56629	164592	6.68584e-01	rs1042522	.	4024	0.557900	0.561	3.310	1.355	0.56	0.033	0.059	0.008	neutral	ENST00000269305: c.215C>G (p.P72R)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	CSV	250061	.	.	.	.	.	no_record	12351	reviewed_by_expert_panel	drug_response	Likely Benign
17	7579471	7579472	17p13.1	1	normal	.	G	snv	C	CG.GG	het-ref	291	0.57	.	2	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	C3	EX4	.	.	missense	NM_001126113.2	NP_001119585.1	-	N	c.215C>G	p.P72R | p.Pro72Arg	CCC=>CGC	NP=>P+	NM_001126113.2(TP53): c.215C>G (p.P72R)	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125932	0.655306	U	0.5863	0.542931	13004	0.630037	PASS	1510	8620	0.589211	27306	120924	0.659960	2833	9842	5.70882e-01	56629	164592	6.68584e-01	rs1042522	.	4024	0.557900	0.561	3.310	1.355	0.55	0.002	0	0.007	neutral	ENST00000269305: c.215C>G (p.P72R)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	CSV	250061	.	.	.	.	.	no_record	12351	reviewed_by_expert_panel	drug_response	Likely Benign
17	7579471	7579472	17p13.1	1	normal	.	G	snv	C	CG.GG	het-ref	291	0.57	.	2	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	C3	EX4	.	.	missense	NM_001126114.2	NP_001119586.1	-	N	c.215C>G	p.P72R | p.Pro72Arg	CCC=>CGC	NP=>P+	NM_001126114.2(TP53): c.215C>G (p.P72R)	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125932	0.655306	U	0.5863	0.542931	13004	0.630037	PASS	1510	8620	0.589211	27306	120924	0.659960	2833	9842	5.70882e-01	56629	164592	6.68584e-01	rs1042522	.	4024	0.557900	0.561	3.310	1.355	0.55	0.145	0.232	0.019	neutral	ENST00000269305: c.215C>G (p.P72R)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	CSV	250061	.	.	.	.	.	no_record	12351	reviewed_by_expert_panel	drug_response	Likely Benign
17	7579471	7579472	17p13.1	0	normal	.	G	snv	C	CG.GG	het-ref	291	0.57	.	2	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	PROM	.	.	.	promoter	NM_001126115.1	NP_001119587.1	-	N	c.-278-u661C>G	.	.	.	NM_001126115.1(TP53): c.-278-u661C>G	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125932	0.655306	U	0.5863	0.542931	13004	0.630037	PASS	1510	8620	0.589211	27306	120924	0.659960	2833	9842	5.70882e-01	56629	164592	6.68584e-01	rs1042522	.	4024	0.557900	0.561	3.310	1.355	.	.	.	.	.	ENST00000269305: c.215C>G (p.P72R)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	CSV	250061	.	.	.	.	.	no_record	12351	reviewed_by_expert_panel	drug_response	Benign
17	7579471	7579472	17p13.1	0	normal	.	G	snv	C	CG.GG	het-ref	291	0.57	.	2	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	PROM	.	.	.	promoter	NM_001126116.1	NP_001119588.1	-	N	c.-278-u661C>G	.	.	.	NM_001126116.1(TP53): c.-278-u661C>G	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125932	0.655306	U	0.5863	0.542931	13004	0.630037	PASS	1510	8620	0.589211	27306	120924	0.659960	2833	9842	5.70882e-01	56629	164592	6.68584e-01	rs1042522	.	4024	0.557900	0.561	3.310	1.355	.	.	.	.	.	ENST00000269305: c.215C>G (p.P72R)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	CSV	250061	.	.	.	.	.	no_record	12351	reviewed_by_expert_panel	drug_response	Benign
17	7579471	7579472	17p13.1	0	normal	.	G	snv	C	CG.GG	het-ref	291	0.57	.	2	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	PROM	.	.	.	promoter	NM_001126117.1	NP_001119589.1	-	N	c.-278-u661C>G	.	.	.	NM_001126117.1(TP53): c.-278-u661C>G	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125932	0.655306	U	0.5863	0.542931	13004	0.630037	PASS	1510	8620	0.589211	27306	120924	0.659960	2833	9842	5.70882e-01	56629	164592	6.68584e-01	rs1042522	.	4024	0.557900	0.561	3.310	1.355	.	.	.	.	.	ENST00000269305: c.215C>G (p.P72R)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	CSV	250061	.	.	.	.	.	no_record	12351	reviewed_by_expert_panel	drug_response	Benign
17	7579471	7579472	17p13.1	1	normal	.	G	snv	C	CG.GG	het-ref	291	0.57	.	2	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	C1	EX3	.	.	missense	NM_001126118.1	NP_001119590.1	-	N	c.98C>G	p.P33R | p.Pro33Arg	CCC=>CGC	NP=>P+	NM_001126118.1(TP53): c.98C>G (p.P33R)	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	125932	0.655306	U	0.5863	0.542931	13004	0.630037	PASS	1510	8620	0.589211	27306	120924	0.659960	2833	9842	5.70882e-01	56629	164592	6.68584e-01	rs1042522	.	4024	0.557900	0.561	3.310	1.355	0.39	0.033	0.059	0.018	neutral	ENST00000269305: c.215C>G (p.P72R)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	CSV	250061	.	.	.	.	.	no_record	12351	reviewed_by_expert_panel	drug_response	Likely Benign
17	7579618	7579619	17p13.1	0	normal	.	G	ref	G	GA.GA	het-alt	213	0.57	.	1	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	IC2	IVS3	.	.	no-change	NM_000546.5	NP_000537.3	-	Y	c.97-29C=	.	.	.	NM_000546.5(TP53): c.97-29C=	;maf-5-some-pop	125762	0.933660	U	0.0734	0.0776757	13006	0.929187	PASS	.	8580	0.931818	52745	120754	0.934131	.	.	.	.	.	.	rs17883323	.	4024	0.928200	0.561	-0.663	-0.699	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579618	7579619	17p13.1	0	normal	.	G	ref	G	GA.GA	het-alt	213	0.57	.	1	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	IC2	IVS3	.	.	no-change	NM_001126112.2	NP_001119584.1	-	N	c.97-29C=	.	.	.	NM_001126112.2(TP53): c.97-29C=	;maf-5-some-pop	125762	0.933660	U	0.0734	0.0776757	13006	0.929187	PASS	.	8580	0.931818	52745	120754	0.934131	.	.	.	.	.	.	rs17883323	.	4024	0.928200	0.561	-0.663	-0.699	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579618	7579619	17p13.1	0	normal	.	G	ref	G	GA.GA	het-alt	213	0.57	.	1	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	IC2	IVS3	.	.	no-change	NM_001126113.2	NP_001119585.1	-	N	c.97-29C=	.	.	.	NM_001126113.2(TP53): c.97-29C=	;maf-5-some-pop	125762	0.933660	U	0.0734	0.0776757	13006	0.929187	PASS	.	8580	0.931818	52745	120754	0.934131	.	.	.	.	.	.	rs17883323	.	4024	0.928200	0.561	-0.663	-0.699	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579618	7579619	17p13.1	0	normal	.	G	ref	G	GA.GA	het-alt	213	0.57	.	1	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	IC2	IVS3	.	.	no-change	NM_001126114.2	NP_001119586.1	-	N	c.97-29C=	.	.	.	NM_001126114.2(TP53): c.97-29C=	;maf-5-some-pop	125762	0.933660	U	0.0734	0.0776757	13006	0.929187	PASS	.	8580	0.931818	52745	120754	0.934131	.	.	.	.	.	.	rs17883323	.	4024	0.928200	0.561	-0.663	-0.699	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579618	7579619	17p13.1	0	normal	.	G	ref	G	GA.GA	het-alt	213	0.57	.	1	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	PROM	.	.	.	no-change	NM_001126115.1	NP_001119587.1	-	N	c.-278-u808C=	.	.	.	NM_001126115.1(TP53): c.-278-u808C=	;maf-5-some-pop	125762	0.933660	U	0.0734	0.0776757	13006	0.929187	PASS	.	8580	0.931818	52745	120754	0.934131	.	.	.	.	.	.	rs17883323	.	4024	0.928200	0.561	-0.663	-0.699	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579618	7579619	17p13.1	0	normal	.	G	ref	G	GA.GA	het-alt	213	0.57	.	1	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	PROM	.	.	.	no-change	NM_001126116.1	NP_001119588.1	-	N	c.-278-u808C=	.	.	.	NM_001126116.1(TP53): c.-278-u808C=	;maf-5-some-pop	125762	0.933660	U	0.0734	0.0776757	13006	0.929187	PASS	.	8580	0.931818	52745	120754	0.934131	.	.	.	.	.	.	rs17883323	.	4024	0.928200	0.561	-0.663	-0.699	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579618	7579619	17p13.1	0	normal	.	G	ref	G	GA.GA	het-alt	213	0.57	.	1	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	PROM	.	.	.	no-change	NM_001126117.1	NP_001119589.1	-	N	c.-278-u808C=	.	.	.	NM_001126117.1(TP53): c.-278-u808C=	;maf-5-some-pop	125762	0.933660	U	0.0734	0.0776757	13006	0.929187	PASS	.	8580	0.931818	52745	120754	0.934131	.	.	.	.	.	.	rs17883323	.	4024	0.928200	0.561	-0.663	-0.699	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579618	7579619	17p13.1	0	normal	.	G	ref	G	GA.GA	het-alt	213	0.57	.	1	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	I5U1	IVS2	.	.	no-change	NM_001126118.1	NP_001119590.1	-	N	c.-21-29C=	.	.	.	NM_001126118.1(TP53): c.-21-29C=	;maf-5-some-pop	125762	0.933660	U	0.0734	0.0776757	13006	0.929187	PASS	.	8580	0.931818	52745	120754	0.934131	.	.	.	.	.	.	rs17883323	.	4024	0.928200	0.561	-0.663	-0.699	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579618	7579619	17p13.1	0	normal	.	G	snv	T	GA.GA	het-ref	161	0.43	.	2	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	IC2	IVS3	.	.	intron	NM_000546.5	NP_000537.3	-	Y	c.97-29C>A	.	.	.	NM_000546.5(TP53): c.97-29C>A	;maf-5-some-pop	125762	0.066340	U	0.0734	0.0776757	13006	0.070813	PASS	17	8580	0.068182	322	120754	0.065869	30	1158	6.72865e-02	628	15979	6.49701e-02	rs17883323	.	4024	0.071800	0.561	-0.663	-0.699	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	256604	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	7579618	7579619	17p13.1	0	normal	.	G	snv	T	GA.GA	het-ref	161	0.43	.	2	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	IC2	IVS3	.	.	intron	NM_001126112.2	NP_001119584.1	-	N	c.97-29C>A	.	.	.	NM_001126112.2(TP53): c.97-29C>A	;maf-5-some-pop	125762	0.066340	U	0.0734	0.0776757	13006	0.070813	PASS	17	8580	0.068182	322	120754	0.065869	30	1158	6.72865e-02	628	15979	6.49701e-02	rs17883323	.	4024	0.071800	0.561	-0.663	-0.699	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	256604	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	7579618	7579619	17p13.1	0	normal	.	G	snv	T	GA.GA	het-ref	161	0.43	.	2	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	IC2	IVS3	.	.	intron	NM_001126113.2	NP_001119585.1	-	N	c.97-29C>A	.	.	.	NM_001126113.2(TP53): c.97-29C>A	;maf-5-some-pop	125762	0.066340	U	0.0734	0.0776757	13006	0.070813	PASS	17	8580	0.068182	322	120754	0.065869	30	1158	6.72865e-02	628	15979	6.49701e-02	rs17883323	.	4024	0.071800	0.561	-0.663	-0.699	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	256604	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	7579618	7579619	17p13.1	0	normal	.	G	snv	T	GA.GA	het-ref	161	0.43	.	2	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	IC2	IVS3	.	.	intron	NM_001126114.2	NP_001119586.1	-	N	c.97-29C>A	.	.	.	NM_001126114.2(TP53): c.97-29C>A	;maf-5-some-pop	125762	0.066340	U	0.0734	0.0776757	13006	0.070813	PASS	17	8580	0.068182	322	120754	0.065869	30	1158	6.72865e-02	628	15979	6.49701e-02	rs17883323	.	4024	0.071800	0.561	-0.663	-0.699	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	256604	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	7579618	7579619	17p13.1	0	normal	.	G	snv	T	GA.GA	het-ref	161	0.43	.	2	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	PROM	.	.	.	promoter	NM_001126115.1	NP_001119587.1	-	N	c.-278-u808C>A	.	.	.	NM_001126115.1(TP53): c.-278-u808C>A	;maf-5-some-pop	125762	0.066340	U	0.0734	0.0776757	13006	0.070813	PASS	17	8580	0.068182	322	120754	0.065869	30	1158	6.72865e-02	628	15979	6.49701e-02	rs17883323	.	4024	0.071800	0.561	-0.663	-0.699	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	256604	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	7579618	7579619	17p13.1	0	normal	.	G	snv	T	GA.GA	het-ref	161	0.43	.	2	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	PROM	.	.	.	promoter	NM_001126116.1	NP_001119588.1	-	N	c.-278-u808C>A	.	.	.	NM_001126116.1(TP53): c.-278-u808C>A	;maf-5-some-pop	125762	0.066340	U	0.0734	0.0776757	13006	0.070813	PASS	17	8580	0.068182	322	120754	0.065869	30	1158	6.72865e-02	628	15979	6.49701e-02	rs17883323	.	4024	0.071800	0.561	-0.663	-0.699	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	256604	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	7579618	7579619	17p13.1	0	normal	.	G	snv	T	GA.GA	het-ref	161	0.43	.	2	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	PROM	.	.	.	promoter	NM_001126117.1	NP_001119589.1	-	N	c.-278-u808C>A	.	.	.	NM_001126117.1(TP53): c.-278-u808C>A	;maf-5-some-pop	125762	0.066340	U	0.0734	0.0776757	13006	0.070813	PASS	17	8580	0.068182	322	120754	0.065869	30	1158	6.72865e-02	628	15979	6.49701e-02	rs17883323	.	4024	0.071800	0.561	-0.663	-0.699	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	256604	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	7579618	7579619	17p13.1	0	normal	.	G	snv	T	GA.GA	het-ref	161	0.43	.	2	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	I5U1	IVS2	.	.	intron	NM_001126118.1	NP_001119590.1	-	N	c.-21-29C>A	.	.	.	NM_001126118.1(TP53): c.-21-29C>A	;maf-5-some-pop	125762	0.066340	U	0.0734	0.0776757	13006	0.070813	PASS	17	8580	0.068182	322	120754	0.065869	30	1158	6.72865e-02	628	15979	6.49701e-02	rs17883323	.	4024	0.071800	0.561	-0.663	-0.699	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	256604	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	7579643	7579659	17p13.1	0	nullSample	.	CCCCAGCCCTCCAGGT	ref	CCCCAGCCCTCCAGGT	cc.cc	homo-ref	.	.	.	0	trf	.	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	IC2	IVS3	.	.	no-change	NM_000546.5	NP_000537.3	-	Y	c.96+41_97-54=	.	.	.	NM_000546.5(TP53): c.96+41_97-54=	;maf-5-some-pop,maf-5-all-pops	5008	0.413538	U	.	.	10964	0.251094	.	.	.	.	.	.	.	.	.	.	.	.	.	rs146534833	.	4024	0.079300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579643	7579659	17p13.1	0	nullSample	.	CCCCAGCCCTCCAGGT	ref	CCCCAGCCCTCCAGGT	cc.cc	homo-ref	.	.	.	0	trf	.	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	IC2	IVS3	.	.	no-change	NM_001126112.2	NP_001119584.1	-	N	c.96+41_97-54=	.	.	.	NM_001126112.2(TP53): c.96+41_97-54=	;maf-5-some-pop,maf-5-all-pops	5008	0.413538	U	.	.	10964	0.251094	.	.	.	.	.	.	.	.	.	.	.	.	.	rs146534833	.	4024	0.079300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579643	7579659	17p13.1	0	nullSample	.	CCCCAGCCCTCCAGGT	ref	CCCCAGCCCTCCAGGT	cc.cc	homo-ref	.	.	.	0	trf	.	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	IC2	IVS3	.	.	no-change	NM_001126113.2	NP_001119585.1	-	N	c.96+41_97-54=	.	.	.	NM_001126113.2(TP53): c.96+41_97-54=	;maf-5-some-pop,maf-5-all-pops	5008	0.413538	U	.	.	10964	0.251094	.	.	.	.	.	.	.	.	.	.	.	.	.	rs146534833	.	4024	0.079300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579643	7579659	17p13.1	0	nullSample	.	CCCCAGCCCTCCAGGT	ref	CCCCAGCCCTCCAGGT	cc.cc	homo-ref	.	.	.	0	trf	.	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	IC2	IVS3	.	.	no-change	NM_001126114.2	NP_001119586.1	-	N	c.96+41_97-54=	.	.	.	NM_001126114.2(TP53): c.96+41_97-54=	;maf-5-some-pop,maf-5-all-pops	5008	0.413538	U	.	.	10964	0.251094	.	.	.	.	.	.	.	.	.	.	.	.	.	rs146534833	.	4024	0.079300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579643	7579659	17p13.1	0	nullSample	.	CCCCAGCCCTCCAGGT	ref	CCCCAGCCCTCCAGGT	cc.cc	homo-ref	.	.	.	0	trf	.	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	PROM	.	.	.	no-change	NM_001126115.1	NP_001119587.1	-	N	c.-278-u848_-278-u833=	.	.	.	NM_001126115.1(TP53): c.-278-u848_-278-u833=	;maf-5-some-pop,maf-5-all-pops	5008	0.413538	U	.	.	10964	0.251094	.	.	.	.	.	.	.	.	.	.	.	.	.	rs146534833	.	4024	0.079300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579643	7579659	17p13.1	0	nullSample	.	CCCCAGCCCTCCAGGT	ref	CCCCAGCCCTCCAGGT	cc.cc	homo-ref	.	.	.	0	trf	.	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	PROM	.	.	.	no-change	NM_001126116.1	NP_001119588.1	-	N	c.-278-u848_-278-u833=	.	.	.	NM_001126116.1(TP53): c.-278-u848_-278-u833=	;maf-5-some-pop,maf-5-all-pops	5008	0.413538	U	.	.	10964	0.251094	.	.	.	.	.	.	.	.	.	.	.	.	.	rs146534833	.	4024	0.079300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579643	7579659	17p13.1	0	nullSample	.	CCCCAGCCCTCCAGGT	ref	CCCCAGCCCTCCAGGT	cc.cc	homo-ref	.	.	.	0	trf	.	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	PROM	.	.	.	no-change	NM_001126117.1	NP_001119589.1	-	N	c.-278-u848_-278-u833=	.	.	.	NM_001126117.1(TP53): c.-278-u848_-278-u833=	;maf-5-some-pop,maf-5-all-pops	5008	0.413538	U	.	.	10964	0.251094	.	.	.	.	.	.	.	.	.	.	.	.	.	rs146534833	.	4024	0.079300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579643	7579659	17p13.1	0	nullSample	.	CCCCAGCCCTCCAGGT	ref	CCCCAGCCCTCCAGGT	cc.cc	homo-ref	.	.	.	0	trf	.	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	I5U1	IVS2	.	.	no-change	NM_001126118.1	NP_001119590.1	-	N	c.-22+41_-21-54=	.	.	.	NM_001126118.1(TP53): c.-22+41_-21-54=	;maf-5-some-pop,maf-5-all-pops	5008	0.413538	U	.	.	10964	0.251094	.	.	.	.	.	.	.	.	.	.	.	.	.	rs146534833	.	4024	0.079300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579643	7579659	17p13.1	0	normal	.	CCCCAGCCCTCCAGGT	del	.	cc.cc	hom-alt	161	0.89	.	0	trf	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	IC2	IVS3	.	.	intron	NM_000546.5	NP_000537.3	-	Y	c.96+41_97-54delACCTGGAGGGCTGGGG	.	.	.	NM_000546.5(TP53): c.96+41_97-54delACCTGGAGGGCTGGGG	;maf-5-some-pop,maf-5-all-pops	5008	0.586462	U	0.6815	0.586462	10964	0.748906	.	.	.	.	.	.	.	.	.	.	.	.	.	rs146534833	.	4024	0.920700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	440349	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	7579643	7579659	17p13.1	0	normal	.	CCCCAGCCCTCCAGGT	del	.	cc.cc	hom-alt	161	0.89	.	0	trf	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	IC2	IVS3	.	.	intron	NM_001126112.2	NP_001119584.1	-	N	c.96+41_97-54delACCTGGAGGGCTGGGG	.	.	.	NM_001126112.2(TP53): c.96+41_97-54delACCTGGAGGGCTGGGG	;maf-5-some-pop,maf-5-all-pops	5008	0.586462	U	0.6815	0.586462	10964	0.748906	.	.	.	.	.	.	.	.	.	.	.	.	.	rs146534833	.	4024	0.920700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	440349	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	7579643	7579659	17p13.1	0	normal	.	CCCCAGCCCTCCAGGT	del	.	cc.cc	hom-alt	161	0.89	.	0	trf	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	IC2	IVS3	.	.	intron	NM_001126113.2	NP_001119585.1	-	N	c.96+41_97-54delACCTGGAGGGCTGGGG	.	.	.	NM_001126113.2(TP53): c.96+41_97-54delACCTGGAGGGCTGGGG	;maf-5-some-pop,maf-5-all-pops	5008	0.586462	U	0.6815	0.586462	10964	0.748906	.	.	.	.	.	.	.	.	.	.	.	.	.	rs146534833	.	4024	0.920700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	440349	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	7579643	7579659	17p13.1	0	normal	.	CCCCAGCCCTCCAGGT	del	.	cc.cc	hom-alt	161	0.89	.	0	trf	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	IC2	IVS3	.	.	intron	NM_001126114.2	NP_001119586.1	-	N	c.96+41_97-54delACCTGGAGGGCTGGGG	.	.	.	NM_001126114.2(TP53): c.96+41_97-54delACCTGGAGGGCTGGGG	;maf-5-some-pop,maf-5-all-pops	5008	0.586462	U	0.6815	0.586462	10964	0.748906	.	.	.	.	.	.	.	.	.	.	.	.	.	rs146534833	.	4024	0.920700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	440349	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	7579643	7579659	17p13.1	0	normal	.	CCCCAGCCCTCCAGGT	del	.	cc.cc	hom-alt	161	0.89	.	0	trf	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	PROM	.	.	.	promoter	NM_001126115.1	NP_001119587.1	-	N	c.-278-u848_-278-u833delACCTGGAGGGCTGGGG	.	.	.	NM_001126115.1(TP53): c.-278-u848_-278-u833delACCTGGAGGGCTGGGG	;maf-5-some-pop,maf-5-all-pops	5008	0.586462	U	0.6815	0.586462	10964	0.748906	.	.	.	.	.	.	.	.	.	.	.	.	.	rs146534833	.	4024	0.920700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	440349	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	7579643	7579659	17p13.1	0	normal	.	CCCCAGCCCTCCAGGT	del	.	cc.cc	hom-alt	161	0.89	.	0	trf	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	PROM	.	.	.	promoter	NM_001126116.1	NP_001119588.1	-	N	c.-278-u848_-278-u833delACCTGGAGGGCTGGGG	.	.	.	NM_001126116.1(TP53): c.-278-u848_-278-u833delACCTGGAGGGCTGGGG	;maf-5-some-pop,maf-5-all-pops	5008	0.586462	U	0.6815	0.586462	10964	0.748906	.	.	.	.	.	.	.	.	.	.	.	.	.	rs146534833	.	4024	0.920700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	440349	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	7579643	7579659	17p13.1	0	normal	.	CCCCAGCCCTCCAGGT	del	.	cc.cc	hom-alt	161	0.89	.	0	trf	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	PROM	.	.	.	promoter	NM_001126117.1	NP_001119589.1	-	N	c.-278-u848_-278-u833delACCTGGAGGGCTGGGG	.	.	.	NM_001126117.1(TP53): c.-278-u848_-278-u833delACCTGGAGGGCTGGGG	;maf-5-some-pop,maf-5-all-pops	5008	0.586462	U	0.6815	0.586462	10964	0.748906	.	.	.	.	.	.	.	.	.	.	.	.	.	rs146534833	.	4024	0.920700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	440349	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	7579643	7579659	17p13.1	0	normal	.	CCCCAGCCCTCCAGGT	del	.	cc.cc	hom-alt	161	0.89	.	0	trf	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	I5U1	IVS2	.	.	intron	NM_001126118.1	NP_001119590.1	-	N	c.-22+41_-21-54delACCTGGAGGGCTGGGG	.	.	.	NM_001126118.1(TP53): c.-22+41_-21-54delACCTGGAGGGCTGGGG	;maf-5-some-pop,maf-5-all-pops	5008	0.586462	U	0.6815	0.586462	10964	0.748906	.	.	.	.	.	.	.	.	.	.	.	.	.	rs146534833	.	4024	0.920700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	440349	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	7579800	7579801	17p13.1	0	normal	.	G	ref	G	GT.GG	het-alt	133	0.53	.	1	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	IC1	IVS2	.	.	no-change	NM_000546.5	NP_000537.3	-	N	c.74+38C=	.	.	.	NM_000546.5(TP53): c.74+38C=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	122764	0.334512	U	0.5823	0.584864	13004	0.333051	PASS	-1009	8390	0.407390	6999	117756	0.331083	.	.	.	.	.	.	rs1642785	.	4024	0.450800	0.561	0.620	0.369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579800	7579801	17p13.1	0	normal	.	G	ref	G	GT.GG	het-alt	133	0.53	.	1	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	IC1	IVS2	.	.	no-change	NM_001126112.2	NP_001119584.1	-	N	c.74+38C=	.	.	.	NM_001126112.2(TP53): c.74+38C=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	122764	0.334512	U	0.5823	0.584864	13004	0.333051	PASS	-1009	8390	0.407390	6999	117756	0.331083	.	.	.	.	.	.	rs1642785	.	4024	0.450800	0.561	0.620	0.369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579800	7579801	17p13.1	0	normal	.	G	ref	G	GT.GG	het-alt	133	0.53	.	1	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	IC1	IVS2	.	.	no-change	NM_001126113.2	NP_001119585.1	-	N	c.74+38C=	.	.	.	NM_001126113.2(TP53): c.74+38C=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	122764	0.334512	U	0.5823	0.584864	13004	0.333051	PASS	-1009	8390	0.407390	6999	117756	0.331083	.	.	.	.	.	.	rs1642785	.	4024	0.450800	0.561	0.620	0.369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579800	7579801	17p13.1	0	normal	.	G	ref	G	GT.GG	het-alt	133	0.53	.	1	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	IC1	IVS2	.	.	no-change	NM_001126114.2	NP_001119586.1	-	N	c.74+38C=	.	.	.	NM_001126114.2(TP53): c.74+38C=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	122764	0.334512	U	0.5823	0.584864	13004	0.333051	PASS	-1009	8390	0.407390	6999	117756	0.331083	.	.	.	.	.	.	rs1642785	.	4024	0.450800	0.561	0.620	0.369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579800	7579801	17p13.1	0	normal	.	G	ref	G	GT.GG	het-alt	133	0.53	.	1	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	PROM	.	.	.	no-change	NM_001126115.1	NP_001119587.1	-	N	c.-278-u990C=	.	.	.	NM_001126115.1(TP53): c.-278-u990C=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	122764	0.334512	U	0.5823	0.584864	13004	0.333051	PASS	-1009	8390	0.407390	6999	117756	0.331083	.	.	.	.	.	.	rs1642785	.	4024	0.450800	0.561	0.620	0.369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579800	7579801	17p13.1	0	normal	.	G	ref	G	GT.GG	het-alt	133	0.53	.	1	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	PROM	.	.	.	no-change	NM_001126116.1	NP_001119588.1	-	N	c.-278-u990C=	.	.	.	NM_001126116.1(TP53): c.-278-u990C=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	122764	0.334512	U	0.5823	0.584864	13004	0.333051	PASS	-1009	8390	0.407390	6999	117756	0.331083	.	.	.	.	.	.	rs1642785	.	4024	0.450800	0.561	0.620	0.369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579800	7579801	17p13.1	0	normal	.	G	ref	G	GT.GG	het-alt	133	0.53	.	1	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	PROM	.	.	.	no-change	NM_001126117.1	NP_001119589.1	-	N	c.-278-u990C=	.	.	.	NM_001126117.1(TP53): c.-278-u990C=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	122764	0.334512	U	0.5823	0.584864	13004	0.333051	PASS	-1009	8390	0.407390	6999	117756	0.331083	.	.	.	.	.	.	rs1642785	.	4024	0.450800	0.561	0.620	0.369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579800	7579801	17p13.1	0	normal	.	G	ref	G	GT.GG	het-alt	133	0.53	.	1	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	5U2	EX2	.	.	no-change	NM_001126118.1	NP_001119590.1	-	Y	c.-123C=	.	.	.	NM_001126118.1(TP53): c.-123C=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	122764	0.334512	U	0.5823	0.584864	13004	0.333051	PASS	-1009	8390	0.407390	6999	117756	0.331083	.	.	.	.	.	.	rs1642785	.	4024	0.450800	0.561	0.620	0.369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	7579800	7579801	17p13.1	0	normal	.	G	snv	C	GT.GG	het-ref	120	0.47	.	2	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	IC1	IVS2	.	.	intron	NM_000546.5	NP_000537.3	-	N	c.74+38C>G	.	.	.	NM_000546.5(TP53): c.74+38C>G	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	122764	0.665472	U	0.5823	0.584864	13004	0.666949	PASS	1477	8390	0.592610	26890	117756	0.668900	2804	9754	5.72216e-01	56219	163840	6.73823e-01	rs1642785	.	4024	0.549200	0.561	0.620	0.369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	137691	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	7579800	7579801	17p13.1	0	normal	.	G	snv	C	GT.GG	het-ref	120	0.47	.	2	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	IC1	IVS2	.	.	intron	NM_001126112.2	NP_001119584.1	-	N	c.74+38C>G	.	.	.	NM_001126112.2(TP53): c.74+38C>G	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	122764	0.665472	U	0.5823	0.584864	13004	0.666949	PASS	1477	8390	0.592610	26890	117756	0.668900	2804	9754	5.72216e-01	56219	163840	6.73823e-01	rs1642785	.	4024	0.549200	0.561	0.620	0.369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	137691	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	7579800	7579801	17p13.1	0	normal	.	G	snv	C	GT.GG	het-ref	120	0.47	.	2	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	IC1	IVS2	.	.	intron	NM_001126113.2	NP_001119585.1	-	N	c.74+38C>G	.	.	.	NM_001126113.2(TP53): c.74+38C>G	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	122764	0.665472	U	0.5823	0.584864	13004	0.666949	PASS	1477	8390	0.592610	26890	117756	0.668900	2804	9754	5.72216e-01	56219	163840	6.73823e-01	rs1642785	.	4024	0.549200	0.561	0.620	0.369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	137691	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	7579800	7579801	17p13.1	0	normal	.	G	snv	C	GT.GG	het-ref	120	0.47	.	2	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	IC1	IVS2	.	.	intron	NM_001126114.2	NP_001119586.1	-	N	c.74+38C>G	.	.	.	NM_001126114.2(TP53): c.74+38C>G	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	122764	0.665472	U	0.5823	0.584864	13004	0.666949	PASS	1477	8390	0.592610	26890	117756	0.668900	2804	9754	5.72216e-01	56219	163840	6.73823e-01	rs1642785	.	4024	0.549200	0.561	0.620	0.369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	137691	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	7579800	7579801	17p13.1	0	normal	.	G	snv	C	GT.GG	het-ref	120	0.47	.	2	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	PROM	.	.	.	promoter	NM_001126115.1	NP_001119587.1	-	N	c.-278-u990C>G	.	.	.	NM_001126115.1(TP53): c.-278-u990C>G	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	122764	0.665472	U	0.5823	0.584864	13004	0.666949	PASS	1477	8390	0.592610	26890	117756	0.668900	2804	9754	5.72216e-01	56219	163840	6.73823e-01	rs1642785	.	4024	0.549200	0.561	0.620	0.369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	137691	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	7579800	7579801	17p13.1	0	normal	.	G	snv	C	GT.GG	het-ref	120	0.47	.	2	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	PROM	.	.	.	promoter	NM_001126116.1	NP_001119588.1	-	N	c.-278-u990C>G	.	.	.	NM_001126116.1(TP53): c.-278-u990C>G	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	122764	0.665472	U	0.5823	0.584864	13004	0.666949	PASS	1477	8390	0.592610	26890	117756	0.668900	2804	9754	5.72216e-01	56219	163840	6.73823e-01	rs1642785	.	4024	0.549200	0.561	0.620	0.369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	137691	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	7579800	7579801	17p13.1	0	normal	.	G	snv	C	GT.GG	het-ref	120	0.47	.	2	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	PROM	.	.	.	promoter	NM_001126117.1	NP_001119589.1	-	N	c.-278-u990C>G	.	.	.	NM_001126117.1(TP53): c.-278-u990C>G	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	122764	0.665472	U	0.5823	0.584864	13004	0.666949	PASS	1477	8390	0.592610	26890	117756	0.668900	2804	9754	5.72216e-01	56219	163840	6.73823e-01	rs1642785	.	4024	0.549200	0.561	0.620	0.369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	137691	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	7579800	7579801	17p13.1	0	normal	.	G	snv	C	GT.GG	het-ref	120	0.47	.	2	.	PASS	191170	C	114480(MK);114500(MK);114550(MK);137800(SK);151623(MK);202300(MK);259500(MK);260350(MK);260500(MK);607107(MK);614740(SK)	AD;AR	Li-Fraumeni syndrome; Choroid plexus papilloma; Ependymoma, intracranial; Osteogenic sarcoma; Breast cancer, familial; Hepatoblastoma; Non-Hodgkin lymphoma; Adrenocortical carcinoma; Colorectal cancer	AD	.	Oncologic	Oncologic	23894400|23667851|23409989|23355100|23175693|23015295|22939227|22878818|22672556|22551548|22170717|21990040|21946351|21837677|21601526|21056402|20301488|19652052|19556618|19171829|18762572|15977174|15741269|15695383|15381368|14583457|12619118|12610779|12524418|12085209|11600572|11498785|11481490|11332399|11219776|10612830|9242456|8718514|8118819|7887414|6016796|3409256|1978757|1679237|1591732|1565144|1565143|1349175	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;HPro6;HR14;MC58;MH43	7157	TP53	5U2	EX2	.	.	utr-5	NM_001126118.1	NP_001119590.1	-	Y	c.-123C>G	.	.	.	NM_001126118.1(TP53): c.-123C>G	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	122764	0.665472	U	0.5823	0.584864	13004	0.666949	PASS	1477	8390	0.592610	26890	117756	0.668900	2804	9754	5.72216e-01	56219	163840	6.73823e-01	rs1642785	.	4024	0.549200	0.561	0.620	0.369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	137691	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	8108330	8108331	17p13.1	0	normal	.	A	ref	A	CC.TG	het-alt	333	0.48	.	1	.	PASS	604970	P	.	NN	.	.	.	.	.	.	.	9212	AURKB	C8E	EX9E	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	no-change	NM_004217.3	NP_004208.2	-	Y	c.893T=	.	.	.	NM_004217.3(AURKB): c.893T=	;maf-5-some-pop,maf-5-all-pops	125942	0.173207	U	0.5516	0.736022	13006	0.178149	PASS	-1077	8598	0.451500	2328	120934	0.169448	.	.	.	.	.	.	rs1059476	.	4024	0.424200	-1.234	-0.114	-0.814	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	8108330	8108331	17p13.1	1	normal	.	A	snv	G	CC.TG	het-ref	359	0.52	.	2	.	PASS	604970	P	.	NN	.	.	.	.	.	.	.	9212	AURKB	C8E	EX9E	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	missense	NM_004217.3	NP_004208.2	-	Y	c.893T>C	p.M298T | p.Met298Thr	ATG=>ACG	NP=>P0	NM_004217.3(AURKB): c.893T>C (p.M298T)	;maf-5-some-pop,maf-5-all-pops	125942	0.826793	U	0.5516	0.736022	13006	0.821851	PASS	1281	8598	0.548500	42303	120934	0.830552	2399	8726	5.50606e-01	80602	191311	8.32170e-01	rs1059476	.	4024	0.575800	-1.234	-0.114	-0.814	0.45	0	0	0.012	neutral	ENST00000585124: c.893T>C (p.M298T)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4130880	.	.	.	.	.	.	.	.	.	Likely Benign
17	8108338	8108339	17p13.1	0	normal	.	G	ref	G	AC.GA	het-alt	327	0.48	.	1	.	PASS	604970	P	.	NN	.	.	.	.	.	.	.	9212	AURKB	C8E	EX9E	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	no-change	NM_004217.3	NP_004208.2	-	Y	c.885C=	.	.	.	NM_004217.3(AURKB): c.885C=	;maf-5-some-pop,maf-5-all-pops	125492	0.346660	U	0.5179	0.620807	13006	0.381670	PASS	.	8610	0.496051	7373	120484	0.345307	.	.	.	.	.	.	rs2241909	.	4024	0.463000	-1.815	-1.228	-2.150	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	8108338	8108339	17p13.1	1	normal	.	G	snv	A	AC.GA	het-ref	358	0.52	.	2	.	PASS	604970	P	.	NN	.	.	.	.	.	.	.	9212	AURKB	C8E	EX9E	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_004217.3	NP_004208.2	-	Y	c.885C>T	p.(S295=) | p.(Ser295=)	TCC=>TCT	.	NM_004217.3(AURKB): c.885C>T (p.(S295=))	;maf-5-some-pop,maf-5-all-pops	125492	0.653340	U	0.5179	0.620807	13006	0.618330	PASS	1082	8610	0.503949	26011	120484	0.654693	2004	7922	5.06587e-01	49153	148353	6.57955e-01	rs2241909	.	4024	0.537000	-1.815	-1.228	-2.150	.	.	.	.	.	ENST00000585124: c.885C>T (p.S295S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3766233	.	.	.	.	.	.	.	.	.	Likely Benign
17	12921090	12921091	17p12	1	normal	.	C	snv	T	TA.AC	het-ref	131	0.46	.	2	.	PASS	605367	C	614731(SK);615440(MK)	NN	Combined oxidative phosphorylation deficiency 17	AR	.	Biochemical; Cardiovascular; Neurologic	Biochemical; Cardiovascular	23849775	.	60528	ELAC2	C1	EX1	.	.	coding-synon	NM_018127.6	NP_060597.4	-	Y	c.174G>A	p.(V58=) | p.(Val58=)	GTG=>GTA	.	NM_018127.6(ELAC2): c.174G>A (p.(V58=))	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop	95000	0.007147	U	0.0506	0.0101837	.	.	PASS	14	6876	0.076353	14	89992	0.006978	38	1039	6.18379e-02	38	1224	5.34727e-03	rs2286334	.	4024	0.059100	0.655	0.876	1.406	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	382955	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
17	12921090	12921091	17p12	0	normal	.	C	ref	C	TA.AC	het-alt	155	0.54	.	1	.	PASS	605367	C	614731(SK);615440(MK)	NN	Combined oxidative phosphorylation deficiency 17	AR	.	Biochemical; Cardiovascular; Neurologic	Biochemical; Cardiovascular	23849775	.	60528	ELAC2	C1	EX1	.	.	no-change	NM_018127.6	NP_060597.4	-	Y	c.174G=	.	.	.	NM_018127.6(ELAC2): c.174G=	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop	95000	0.992853	U	0.0506	0.0101837	.	.	PASS	.	6876	0.923647	44382	89992	0.993022	.	.	.	.	.	.	rs2286334	.	4024	0.940900	0.655	0.876	1.406	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	15961365	15961366	17p12	0	normal	.	C	ref	C	GT.TG	het-alt	309	0.52	.	1	.	PASS	600849	P	.	NN	.	.	.	.	.	.	.	9611	NCOR1	C38	EX39	.	.	no-change	NM_006311.3	NP_006302.2	-	Y	c.6023G=	.	.	.	NM_006311.3(NCOR1): c.6023G=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.655	3.576	1.363	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
17	15961365	15961366	17p12	1	normal	.	C	snv	G	GT.TG	het-ref	285	0.48	.	2	.	PASS	600849	P	.	NN	.	.	.	.	.	.	.	9611	NCOR1	C38	EX39	.	.	missense	NM_006311.3	NP_006302.2	-	Y	c.6023G>C	p.R2008T | p.Arg2008Thr	AGA=>ACA	P+=>P0	NM_006311.3(NCOR1): c.6023G>C (p.R2008T)	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.655	3.576	1.363	0.26	0.004	0.012	0.034	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
17	15973417	15973418	17p12	0	normal	.	T	ref	T	GG.tt	het-alt	123	0.71	.	1	AT_rich|Low_complexity|Low_complexity|+|21	PASS	600849	P	.	NN	.	.	.	.	.	.	.	9611	NCOR1	IC30	IVS31	.	.	no-change	NM_006311.3	NP_006302.2	-	Y	c.4513+61A=	.	.	.	NM_006311.3(NCOR1): c.4513+61A=	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs368198526	.	4024	0.626200	0.460	2.403	1.972	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	15973417	15973418	17p12	0	normal	.	T	del	.	GG.tt	het-ref	51	0.29	.	2	AT_rich|Low_complexity|Low_complexity|+|21	PASS	600849	P	.	NN	.	.	.	.	.	.	.	9611	NCOR1	IC30	IVS31	.	.	intron	NM_006311.3	NP_006302.2	-	Y	c.4513+61delA	.	.	.	NM_006311.3(NCOR1): c.4513+61delA	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs368198526	.	4024	0.373800	0.460	2.403	1.972	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	15984134	15984135	17p12	0	normal	.	A	ref	A	tt.aa	het-alt	90	0.81	.	1	AT_rich|Low_complexity|Low_complexity|+|22	PASS	600849	P	.	NN	.	.	.	.	.	.	.	9611	NCOR1	IC22	IVS23	.	.	no-change	NM_006311.3	NP_006302.2	-	Y	c.3178-94T=	.	.	.	NM_006311.3(NCOR1): c.3178-94T=	;	5008	0.998602	U	0	0.00139776	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs572976554	.	4024	0.715500	0.225	0.242	0.228	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	15984134	15984135	17p12	0	normal	.	A	del	.	tt.aa	het-ref	21	0.19	.	2	AT_rich|Low_complexity|Low_complexity|+|22	PASS	600849	P	.	NN	.	.	.	.	.	.	.	9611	NCOR1	IC22	IVS23	.	.	intron	NM_006311.3	NP_006302.2	-	Y	c.3178-94delT	.	.	.	NM_006311.3(NCOR1): c.3178-94delT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.284500	0.225	0.242	0.228	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	16041577	16041578	17p11.2	0	normal	.	T	ref	T	AC.AA	het-alt	136	0.78	.	1	.	PASS	600849	P	.	NN	.	.	.	.	.	.	.	9611	NCOR1	IC11	IVS12	.	.	no-change	NM_006311.3	NP_006302.2	-	Y	c.1353-52A=	.	.	.	NM_006311.3(NCOR1): c.1353-52A=	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs745720309	.	4025	0.998300	-0.264	-0.076	-0.453	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	16041578	16041578	17p11.2	0	normal	.	.	ins	A	CT.AA	het-ref	39	0.22	.	2	.	PASS	600849	P	.	NN	.	.	.	.	.	.	.	9611	NCOR1	IC11	IVS12	.	.	intron	NM_006311.3	NP_006302.2	-	Y	c.1353-53_1353-52insT	.	.	.	NM_006311.3(NCOR1): c.1353-53_1353-52insT	;rs-cluster-nonoverlapping-alleles	39353	0.120347	U	.	.	.	.	PASS	0	2136	0.102060	0	39464	0.129612	.	.	.	.	.	.	rs758255363	.	4024	0.345400	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	17122285	17122286	17p11.2	0	normal	.	C	snv	T	GA.TG	hom-alt	342	1.00	.	0	.	PASS	607273	C	114500(MK);135150(MK);144700(MK);173600(MK)	AD	Birt-Hogg-Dube syndrome; Pneumothorax, primary spontaneous 	AD	.	Dermatologic; Oncologic; Pulmonary	Oncologic; Pulmonary	23995526|23846428|23715758|23542717|23414156|23264078|22146830|20618353|20413710|19320655|18505456|18234728|17496196|15852235|15657874|12471204|12204536|11533913|10522666|596896	FC59;H41;H54;H62;H68;HR14;MC58	201163	FLCN	IC6	IVS9	.	.	intron	NM_144997.5	NP_659434.2	-	Y	c.1062+47G>A	.	.	.	NM_144997.5(FLCN): c.1062+47G>A	SingleClassTriAllelic;	119686	0.993825	U	1	0.995807	13004	0.998308	PASS	4017	8036	0.999876	56634	114678	0.993739	8485	16971	9.99941e-01	116848	235627	9.91471e-01	rs8065572	.	4024	0.998500	-0.269	-0.979	-1.093	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	17122285	17122286	17p11.2	0	nullSample	.	C	ref	C	GA.TG	homo-ref	.	.	.	0	.	.	607273	C	114500(MK);135150(MK);144700(MK);173600(MK)	AD	Birt-Hogg-Dube syndrome; Pneumothorax, primary spontaneous 	AD	.	Dermatologic; Oncologic; Pulmonary	Oncologic; Pulmonary	23995526|23846428|23715758|23542717|23414156|23264078|22146830|20618353|20413710|19320655|18505456|18234728|17496196|15852235|15657874|12471204|12204536|11533913|10522666|596896	FC59;H41;H54;H62;H68;HR14;MC58	201163	FLCN	IC6	IVS9	.	.	no-change	NM_144997.5	NP_659434.2	-	Y	c.1062+47G=	.	.	.	NM_144997.5(FLCN): c.1062+47G=	SingleClassTriAllelic;	119686	0.006166	U	1	0.995807	13004	0.001692	PASS	.	8036	0.000124	13	114678	0.006252	.	.	.	.	.	.	rs8065572	.	4024	0.001500	-0.269	-0.979	-1.093	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	17124814	17124815	17p11.2	0	normal	.	C	ref	C	TC.GG	het-alt	356	0.51	.	1	.	PASS	607273	C	114500(MK);135150(MK);144700(MK);173600(MK)	AD	Birt-Hogg-Dube syndrome; Pneumothorax, primary spontaneous 	AD	.	Dermatologic; Oncologic; Pulmonary	Oncologic; Pulmonary	23995526|23846428|23715758|23542717|23414156|23264078|22146830|20618353|20413710|19320655|18505456|18234728|17496196|15852235|15657874|12471204|12204536|11533913|10522666|596896	FC59;H41;H54;H62;H68;HR14;MC58	201163	FLCN	IC5	IVS8	.	.	no-change	NM_144997.5	NP_659434.2	-	Y	c.871+36G=	.	.	.	NM_144997.5(FLCN): c.871+36G=	;maf-5-some-pop	125714	0.926412	U	0.1488	0.0996406	13006	0.922497	PASS	.	8624	0.802296	52101	120706	0.927493	.	.	.	.	.	.	rs3744124	.	4024	0.817600	-2.200	-1.637	-1.647	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	17124814	17124815	17p11.2	0	normal	.	C	snv	T	TC.GG	het-ref	343	0.49	.	2	.	PASS	607273	C	114500(MK);135150(MK);144700(MK);173600(MK)	AD	Birt-Hogg-Dube syndrome; Pneumothorax, primary spontaneous 	AD	.	Dermatologic; Oncologic; Pulmonary	Oncologic; Pulmonary	23995526|23846428|23715758|23542717|23414156|23264078|22146830|20618353|20413710|19320655|18505456|18234728|17496196|15852235|15657874|12471204|12204536|11533913|10522666|596896	FC59;H41;H54;H62;H68;HR14;MC58	201163	FLCN	IC5	IVS8	.	.	intron	NM_144997.5	NP_659434.2	-	Y	c.871+36G>A	.	.	.	NM_144997.5(FLCN): c.871+36G>A	;maf-5-some-pop	125714	0.073588	U	0.1488	0.0996406	13006	0.077503	PASS	159	8624	0.197704	500	120706	0.072507	335	3376	1.95756e-01	952	16861	6.85585e-02	rs3744124	.	4024	0.182400	-2.200	-1.637	-1.647	.	.	.	.	.	ENST00000389169: c.907G>A (p.G303R)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	4129627	.	.	.	.	.	no_record	41861	criteria_provided,_single_submitter	Benign	Benign
17	17126040	17126041	17p11.2	0	normal	.	G	ref	G	TC.TT	het-alt	184	0.53	.	1	.	PASS	607273	C	114500(MK);135150(MK);144700(MK);173600(MK)	AD	Birt-Hogg-Dube syndrome; Pneumothorax, primary spontaneous 	AD	.	Dermatologic; Oncologic; Pulmonary	Oncologic; Pulmonary	23995526|23846428|23715758|23542717|23414156|23264078|22146830|20618353|20413710|19320655|18505456|18234728|17496196|15852235|15657874|12471204|12204536|11533913|10522666|596896	FC59;H41;H54;H62;H68;HR14;MC58	201163	FLCN	IC3	IVS6	.	.	no-change	NM_144997.5	NP_659434.2	-	Y	c.619-66C=	.	.	.	NM_144997.5(FLCN): c.619-66C=	;maf-5-some-pop,genotype-conflict	5008	0.924920	U	0.1438	0.0750799	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2292527	.	4024	0.865100	-1.598	-2.212	-2.369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	17126040	17126041	17p11.2	0	normal	.	G	snv	A	TC.TT	het-ref	165	0.47	.	2	.	PASS	607273	C	114500(MK);135150(MK);144700(MK);173600(MK)	AD	Birt-Hogg-Dube syndrome; Pneumothorax, primary spontaneous 	AD	.	Dermatologic; Oncologic; Pulmonary	Oncologic; Pulmonary	23995526|23846428|23715758|23542717|23414156|23264078|22146830|20618353|20413710|19320655|18505456|18234728|17496196|15852235|15657874|12471204|12204536|11533913|10522666|596896	FC59;H41;H54;H62;H68;HR14;MC58	201163	FLCN	IC3	IVS6	.	.	intron	NM_144997.5	NP_659434.2	-	Y	c.619-66C>T	.	.	.	NM_144997.5(FLCN): c.619-66C>T	;maf-5-some-pop,genotype-conflict	5008	0.075080	U	0.1438	0.0750799	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2292527	.	4024	0.134900	-1.598	-2.212	-2.369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29486151	29486152	17q11.2	0	normal	.	G	ref	G	TT.AT	het-alt	136	0.56	.	1	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC3	IVS3	.	.	no-change	NM_000267.3	NP_000258.1	+	Y	c.288+41G=	.	.	.	NM_000267.3(NF1): c.288+41G=	;maf-5-some-pop,maf-5-all-pops	123864	0.381580	U	0.5486	0.509784	13002	0.425858	PASS	.	8448	0.441170	9362	118856	0.377002	.	.	.	.	.	.	rs2952976	.	4024	0.437400	-0.254	-0.002	0.205	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29486151	29486152	17q11.2	0	normal	.	G	ref	G	TT.AT	het-alt	136	0.56	.	1	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC3	IVS3	.	.	no-change	NM_001042492.2	NP_001035957.1	+	N	c.288+41G=	.	.	.	NM_001042492.2(NF1): c.288+41G=	;maf-5-some-pop,maf-5-all-pops	123864	0.381580	U	0.5486	0.509784	13002	0.425858	PASS	.	8448	0.441170	9362	118856	0.377002	.	.	.	.	.	.	rs2952976	.	4024	0.437400	-0.254	-0.002	0.205	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29486151	29486152	17q11.2	0	normal	.	G	snv	A	TT.AT	het-ref	109	0.44	.	2	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC3	IVS3	.	.	intron	NM_000267.3	NP_000258.1	+	Y	c.288+41G>A	.	.	.	NM_000267.3(NF1): c.288+41G>A	;maf-5-some-pop,maf-5-all-pops	123864	0.618420	U	0.5486	0.509784	13002	0.574142	PASS	1322	8448	0.558830	23981	118856	0.622998	2672	9571	5.60560e-01	49431	152336	6.26768e-01	rs2952976	.	4024	0.562600	-0.254	-0.002	0.205	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	257283	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	29486151	29486152	17q11.2	0	normal	.	G	snv	A	TT.AT	het-ref	109	0.44	.	2	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC3	IVS3	.	.	intron	NM_001042492.2	NP_001035957.1	+	N	c.288+41G>A	.	.	.	NM_001042492.2(NF1): c.288+41G>A	;maf-5-some-pop,maf-5-all-pops	123864	0.618420	U	0.5486	0.509784	13002	0.574142	PASS	1322	8448	0.558830	23981	118856	0.622998	2672	9571	5.60560e-01	49431	152336	6.26768e-01	rs2952976	.	4024	0.562600	-0.254	-0.002	0.205	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	257283	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	29508774	29508775	17q11.2	0	normal	.	G	ref	G	CT.TA	het-alt	265	0.55	.	1	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	C7	EX7	.	.	no-change	NM_000267.3	NP_000258.1	+	Y	c.702G=	.	.	.	NM_000267.3(NF1): c.702G=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126260	0.381601	U	0.5506	0.511781	12998	0.425604	PASS	.	8650	0.443353	9723	121252	0.377198	.	.	.	.	.	.	rs1801052	.	4024	0.436400	-2.242	-2.259	-3.805	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29508774	29508775	17q11.2	0	normal	.	G	ref	G	CT.TA	het-alt	265	0.55	.	1	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	C7	EX7	.	.	no-change	NM_001042492.2	NP_001035957.1	+	N	c.702G=	.	.	.	NM_001042492.2(NF1): c.702G=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126260	0.381601	U	0.5506	0.511781	12998	0.425604	PASS	.	8650	0.443353	9723	121252	0.377198	.	.	.	.	.	.	rs1801052	.	4024	0.436400	-2.242	-2.259	-3.805	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29508774	29508775	17q11.2	1	normal	.	G	snv	A	CT.TA	het-ref	213	0.45	.	2	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	C7	EX7	.	.	coding-synon	NM_000267.3	NP_000258.1	+	Y	c.702G>A	p.(L234=) | p.(Leu234=)	CTG=>CTA	.	NM_000267.3(NF1): c.702G>A (p.(L234=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126260	0.618399	U	0.5506	0.511781	12998	0.574396	PASS	1363	8650	0.556647	24613	121252	0.622802	2707	9659	5.60202e-01	50357	154487	6.27950e-01	rs1801052	.	4024	0.563600	-2.242	-2.259	-3.805	.	.	.	.	.	ENST00000358273: c.702G>A (p.L234L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [diffuse_large_B_cell_lymphoma|NS|NS]	CSV	3755377	.	.	.	.	.	no_record	183825	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
17	29508774	29508775	17q11.2	1	normal	.	G	snv	A	CT.TA	het-ref	213	0.45	.	2	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	C7	EX7	.	.	coding-synon	NM_001042492.2	NP_001035957.1	+	N	c.702G>A	p.(L234=) | p.(Leu234=)	CTG=>CTA	.	NM_001042492.2(NF1): c.702G>A (p.(L234=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126260	0.618399	U	0.5506	0.511781	12998	0.574396	PASS	1363	8650	0.556647	24613	121252	0.622802	2707	9659	5.60202e-01	50357	154487	6.27950e-01	rs1801052	.	4024	0.563600	-2.242	-2.259	-3.805	.	.	.	.	.	ENST00000358273: c.702G>A (p.L234L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [diffuse_large_B_cell_lymphoma|NS|NS]	CSV	3755377	.	.	.	.	.	no_record	183825	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
17	29541436	29541437	17q11.2	0	normal	.	T	ref	T	TA.GT	het-alt	238	0.55	.	1	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC12	IVS12	.	.	no-change	NM_000267.3	NP_000258.1	+	Y	c.1393-32T=	.	.	.	NM_000267.3(NF1): c.1393-32T=	SingleClassTriAllelic;maf-5-some-pop	120572	0.390804	U	0.5516	0.474042	12232	0.436151	PASS	.	8298	0.443119	9856	115564	0.384947	.	.	.	.	.	.	rs2905876	.	4024	0.435400	-0.353	0.768	0.019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29541436	29541437	17q11.2	0	normal	.	T	ref	T	TA.GT	het-alt	238	0.55	.	1	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC12	IVS12	.	.	no-change	NM_001042492.2	NP_001035957.1	+	N	c.1393-32T=	.	.	.	NM_001042492.2(NF1): c.1393-32T=	SingleClassTriAllelic;maf-5-some-pop	120572	0.390804	U	0.5516	0.474042	12232	0.436151	PASS	.	8298	0.443119	9856	115564	0.384947	.	.	.	.	.	.	rs2905876	.	4024	0.435400	-0.353	0.768	0.019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29541436	29541437	17q11.2	0	normal	.	T	snv	C	TA.GT	het-ref	195	0.45	.	2	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC12	IVS12	.	.	intron	NM_000267.3	NP_000258.1	+	Y	c.1393-32T>C	.	.	.	NM_000267.3(NF1): c.1393-32T>C	SingleClassTriAllelic;maf-5-some-pop	120572	0.609163	U	0.5516	0.474042	12232	0.563849	PASS	1292	8298	0.556881	23148	115564	0.615019	2607	9355	5.58441e-01	47898	146967	6.19215e-01	rs2905876	.	4024	0.564600	-0.353	0.768	0.019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	257276	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	29541436	29541437	17q11.2	0	normal	.	T	snv	C	TA.GT	het-ref	195	0.45	.	2	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC12	IVS12	.	.	intron	NM_001042492.2	NP_001035957.1	+	N	c.1393-32T>C	.	.	.	NM_001042492.2(NF1): c.1393-32T>C	SingleClassTriAllelic;maf-5-some-pop	120572	0.609163	U	0.5516	0.474042	12232	0.563849	PASS	1292	8298	0.556881	23148	115564	0.615019	2607	9355	5.58441e-01	47898	146967	6.19215e-01	rs2905876	.	4024	0.564600	-0.353	0.768	0.019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	257276	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	29545986	29545987	17q11.2	0	normal	.	A	ref	A	TT.TT	het-alt	121	0.49	.	1	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC13	IVS13	.	.	no-change	NM_000267.3	NP_000258.1	+	Y	c.1528-36A=	.	.	.	NM_000267.3(NF1): c.1528-36A=	.	.	.	.	0.5516	0.51877	.	.	PASS	-513	3678	0.386079	2803	55780	0.341484	.	.	.	.	.	.	.	.	.	.	-2.032	-2.260	-2.567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29545986	29545987	17q11.2	0	normal	.	A	ref	A	TT.TT	het-alt	121	0.49	.	1	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC13	IVS13	.	.	no-change	NM_001042492.2	NP_001035957.1	+	N	c.1528-36A=	.	.	.	NM_001042492.2(NF1): c.1528-36A=	.	.	.	.	0.5516	0.51877	.	.	PASS	-513	3678	0.386079	2803	55780	0.341484	.	.	.	.	.	.	.	.	.	.	-2.032	-2.260	-2.567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29545987	29545987	17q11.2	0	normal	.	.	ins	T	TA.TT	het-ref	128	0.51	.	2	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC13	IVS13	.	.	intron	NM_000267.3	NP_000258.1	+	Y	c.1528-36_1528-35insT	.	.	.	NM_000267.3(NF1): c.1528-36_1528-35insT	;maf-5-some-pop,maf-5-all-pops	60788	0.647003	U	0.5516	0.51877	.	.	PASS	616	3678	0.613921	11645	55780	0.658516	2099	7544	5.59561e-01	37990	117821	6.25410e-01	rs67472948	.	4024	0.564600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	257277	criteria_provided,_single_submitter	Benign	Benign
17	29545987	29545987	17q11.2	0	normal	.	.	ins	T	TA.TT	het-ref	128	0.51	.	2	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC13	IVS13	.	.	intron	NM_001042492.2	NP_001035957.1	+	N	c.1528-36_1528-35insT	.	.	.	NM_001042492.2(NF1): c.1528-36_1528-35insT	;maf-5-some-pop,maf-5-all-pops	60788	0.647003	U	0.5516	0.51877	.	.	PASS	616	3678	0.613921	11645	55780	0.658516	2099	7544	5.59561e-01	37990	117821	6.25410e-01	rs67472948	.	4024	0.564600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	257277	criteria_provided,_single_submitter	Benign	Benign
17	29546174	29546175	17q11.2	0	normal	.	T	ref	T	GA.TG	het-alt	123	0.51	.	1	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC14	IVS14	.	.	no-change	NM_000267.3	NP_000258.1	+	Y	c.1641+39T=	.	.	.	NM_000267.3(NF1): c.1641+39T=	;maf-5-some-pop,maf-5-all-pops	94554	0.374537	U	0.5516	0.473442	13006	0.464017	PASS	.	6678	0.416742	6311	89546	0.366035	.	.	.	.	.	.	rs2905880	.	4024	0.435400	0.397	-0.765	-0.514	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29546174	29546175	17q11.2	0	normal	.	T	ref	T	GA.TG	het-alt	123	0.51	.	1	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC14	IVS14	.	.	no-change	NM_001042492.2	NP_001035957.1	+	N	c.1641+39T=	.	.	.	NM_001042492.2(NF1): c.1641+39T=	;maf-5-some-pop,maf-5-all-pops	94554	0.374537	U	0.5516	0.473442	13006	0.464017	PASS	.	6678	0.416742	6311	89546	0.366035	.	.	.	.	.	.	rs2905880	.	4024	0.435400	0.397	-0.765	-0.514	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29546174	29546175	17q11.2	0	normal	.	T	snv	C	GA.TG	het-ref	117	0.49	.	2	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC14	IVS14	.	.	intron	NM_000267.3	NP_000258.1	+	Y	c.1641+39T>C	.	.	.	NM_000267.3(NF1): c.1641+39T>C	;maf-5-some-pop,maf-5-all-pops	94554	0.625463	U	0.5516	0.473442	13006	0.535983	PASS	1079	6678	0.583258	18307	89546	0.633965	2519	9044	5.63279e-01	44018	135778	6.21461e-01	rs2905880	.	4024	0.564600	0.397	-0.765	-0.514	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	257278	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	29546174	29546175	17q11.2	0	normal	.	T	snv	C	GA.TG	het-ref	117	0.49	.	2	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC14	IVS14	.	.	intron	NM_001042492.2	NP_001035957.1	+	N	c.1641+39T>C	.	.	.	NM_001042492.2(NF1): c.1641+39T>C	;maf-5-some-pop,maf-5-all-pops	94554	0.625463	U	0.5516	0.473442	13006	0.535983	PASS	1079	6678	0.583258	18307	89546	0.633965	2519	9044	5.63279e-01	44018	135778	6.21461e-01	rs2905880	.	4024	0.564600	0.397	-0.765	-0.514	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	257278	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	29553484	29553485	17q11.2	0	normal	.	G	ref	G	CC.AT	het-alt	224	0.52	.	1	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	C18	EX18	.	.	no-change	NM_000267.3	NP_000258.1	+	Y	c.2034G=	.	.	.	NM_000267.3(NF1): c.2034G=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125942	0.612734	U	0.5258	0.496805	13006	0.583654	PASS	.	8594	0.466721	24107	120934	0.617271	.	.	.	.	.	.	rs2285892	.	4024	0.469700	-0.300	-1.454	-2.418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29553484	29553485	17q11.2	0	normal	.	G	ref	G	CC.AT	het-alt	224	0.52	.	1	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	C18	EX18	.	.	no-change	NM_001042492.2	NP_001035957.1	+	N	c.2034G=	.	.	.	NM_001042492.2(NF1): c.2034G=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125942	0.612734	U	0.5258	0.496805	13006	0.583654	PASS	.	8594	0.466721	24107	120934	0.617271	.	.	.	.	.	.	rs2285892	.	4024	0.469700	-0.300	-1.454	-2.418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29553484	29553485	17q11.2	1	normal	.	G	snv	A	CC.AT	het-ref	206	0.48	.	2	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	C18	EX18	.	.	coding-synon	NM_000267.3	NP_000258.1	+	Y	c.2034G>A	p.(P678=) | p.(Pro678=)	CCG=>CCA	.	NM_000267.3(NF1): c.2034G>A (p.(P678=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125942	0.387266	U	0.5258	0.496805	13006	0.416346	PASS	1231	8594	0.533279	9925	120934	0.382729	2333	8947	5.19812e-01	19270	92408	3.76862e-01	rs2285892	.	4024	0.530300	-0.300	-1.454	-2.418	.	.	.	.	.	ENST00000358273: c.2034G>A (p.P678P)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5009864	.	.	.	.	.	no_record	183826	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
17	29553484	29553485	17q11.2	1	normal	.	G	snv	A	CC.AT	het-ref	206	0.48	.	2	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	C18	EX18	.	.	coding-synon	NM_001042492.2	NP_001035957.1	+	N	c.2034G>A	p.(P678=) | p.(Pro678=)	CCG=>CCA	.	NM_001042492.2(NF1): c.2034G>A (p.(P678=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125942	0.387266	U	0.5258	0.496805	13006	0.416346	PASS	1231	8594	0.533279	9925	120934	0.382729	2333	8947	5.19812e-01	19270	92408	3.76862e-01	rs2285892	.	4024	0.530300	-0.300	-1.454	-2.418	.	.	.	.	.	ENST00000358273: c.2034G>A (p.P678P)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5009864	.	.	.	.	.	no_record	183826	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
17	29559931	29559932	17q11.2	0	normal	.	C	ref	C	TA.AA	het-alt	327	0.55	.	1	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC26	IVS26	.	.	no-change	NM_000267.3	NP_000258.1	+	Y	c.3496+33C=	.	.	.	NM_000267.3(NF1): c.3496+33C=	MixedObserved;|MixedObserved;maf-5-some-pop,maf-5-all-pops,genotype-conflict	0|124798	0|0.628744	U	0.4474	0.458067	13006	0.609642	PASS	.	8246	0.558453	24637	119790	0.632373	.	.	.	.	.	.	rs150049290|rs2066736	.	4024	0.566100	-0.378	-0.389	-0.185	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29559931	29559932	17q11.2	0	normal	.	C	ref	C	TA.AA	het-alt	327	0.55	.	1	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC26	IVS26	.	.	no-change	NM_001042492.2	NP_001035957.1	+	N	c.3496+33C=	.	.	.	NM_001042492.2(NF1): c.3496+33C=	MixedObserved;|MixedObserved;maf-5-some-pop,maf-5-all-pops,genotype-conflict	0|124798	0|0.628744	U	0.4474	0.458067	13006	0.609642	PASS	.	8246	0.558453	24637	119790	0.632373	.	.	.	.	.	.	rs150049290|rs2066736	.	4024	0.566100	-0.378	-0.389	-0.185	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29559931	29559932	17q11.2	0	normal	.	C	snv	A	TA.AA	het-ref	268	0.45	.	2	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC26	IVS26	.	.	intron	NM_000267.3	NP_000258.1	+	Y	c.3496+33C>A	.	.	.	NM_000267.3(NF1): c.3496+33C>A	MixedObserved;|MixedObserved;maf-5-some-pop,maf-5-all-pops,genotype-conflict	0|124798	0|0.371256	U	0.4474	0.458067	13006	0.390358	PASS	805	8246	0.441547	8780	119790	0.367627	1625	7463	4.38175e-01	17542	89090	3.64370e-01	rs150049290|rs2066736	.	4024	0.433900	-0.378	-0.389	-0.185	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	257285	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	29559931	29559932	17q11.2	0	normal	.	C	snv	A	TA.AA	het-ref	268	0.45	.	2	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC26	IVS26	.	.	intron	NM_001042492.2	NP_001035957.1	+	N	c.3496+33C>A	.	.	.	NM_001042492.2(NF1): c.3496+33C>A	MixedObserved;|MixedObserved;maf-5-some-pop,maf-5-all-pops,genotype-conflict	0|124798	0|0.371256	U	0.4474	0.458067	13006	0.390358	PASS	805	8246	0.441547	8780	119790	0.367627	1625	7463	4.38175e-01	17542	89090	3.64370e-01	rs150049290|rs2066736	.	4024	0.433900	-0.378	-0.389	-0.185	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	257285	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	29563075	29563076	17q11.2	0	normal	.	T	ref	T	TG.TT	het-alt	142	0.63	.	1	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC29	IVS29	.	.	no-change	NM_000267.3	NP_000258.1	+	Y	c.3974+37T=	.	.	.	NM_000267.3(NF1): c.3974+37T=	MixedObserved;	16464	0.796708	U	0.4067	0.402756	.	.	VQSRTrancheINDEL97.00to99.00	-487	3222	0.618870	6775	42452	0.624070	.	.	.	.	.	.	rs538807032	.	4024	0.986600	0.164	-0.597	-0.743	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29563075	29563076	17q11.2	0	normal	.	T	ref	T	TG.TT	het-alt	142	0.63	.	1	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC29	IVS29	.	.	no-change	NM_001042492.2	NP_001035957.1	+	N	c.3974+37T=	.	.	.	NM_001042492.2(NF1): c.3974+37T=	MixedObserved;	16464	0.796708	U	0.4067	0.402756	.	.	VQSRTrancheINDEL97.00to99.00	-487	3222	0.618870	6775	42452	0.624070	.	.	.	.	.	.	rs538807032	.	4024	0.986600	0.164	-0.597	-0.743	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29563076	29563076	17q11.2	0	normal	.	.	ins	G	GT.TT	het-ref	83	0.37	.	2	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC29	IVS29	.	.	intron	NM_000267.3	NP_000258.1	+	Y	c.3974+37_3974+38insG	.	.	.	NM_000267.3(NF1): c.3974+37_3974+38insG	InconsistentAlleles;rs-cluster-nonoverlapping-alleles	47460	0.378382	U	0.4067	0.402756	.	.	VQSRTrancheINDEL97.00to99.00	127	3222	0.381130	1505	42452	0.375506	917	3604	3.99026e-01	11882	52570	3.97920e-01	rs59745739	.	4024	0.439600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29563076	29563076	17q11.2	0	normal	.	.	ins	G	GT.TT	het-ref	83	0.37	.	2	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC29	IVS29	.	.	intron	NM_001042492.2	NP_001035957.1	+	N	c.3974+37_3974+38insG	.	.	.	NM_001042492.2(NF1): c.3974+37_3974+38insG	InconsistentAlleles;rs-cluster-nonoverlapping-alleles	47460	0.378382	U	0.4067	0.402756	.	.	VQSRTrancheINDEL97.00to99.00	127	3222	0.381130	1505	42452	0.375506	917	3604	3.99026e-01	11882	52570	3.97920e-01	rs59745739	.	4024	0.439600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29563084	29563085	17q11.2	0	normal	.	T	ref	T	TT.TT	het-alt	149	0.63	.	1	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC29	IVS29	.	.	no-change	NM_000267.3	NP_000258.1	+	Y	c.3974+46T=	.	.	.	NM_000267.3(NF1): c.3974+46T=	;maf-5-some-pop	2847	0.826133	U	0.0536	0.0988419	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs72813695	.	4024	0.997800	-1.234	-0.023	-0.518	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29563084	29563085	17q11.2	0	normal	.	T	ref	T	TT.TT	het-alt	149	0.63	.	1	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC29	IVS29	.	.	no-change	NM_001042492.2	NP_001035957.1	+	N	c.3974+46T=	.	.	.	NM_001042492.2(NF1): c.3974+46T=	;maf-5-some-pop	2847	0.826133	U	0.0536	0.0988419	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs72813695	.	4024	0.997800	-1.234	-0.023	-0.518	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29563085	29563085	17q11.2	0	normal	.	.	ins	G	TT.TT	het-ref	89	0.37	.	2	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC29	IVS29	.	.	intron	NM_000267.3	NP_000258.1	+	Y	c.3974+46_3974+47insG	.	.	.	NM_000267.3(NF1): c.3974+46_3974+47insG	MixedObserved,InconsistentAlleles;rs-cluster-nonoverlapping-alleles	71616	0.030133	U	0.4067	0.430911	.	.	PASS	131	5704	0.272966	2051	88476	0.235081	.	.	.	.	.	.	rs56874702	.	4024	0.437900	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29563085	29563085	17q11.2	0	normal	.	.	ins	G	TT.TT	het-ref	89	0.37	.	2	dup	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC29	IVS29	.	.	intron	NM_001042492.2	NP_001035957.1	+	N	c.3974+46_3974+47insG	.	.	.	NM_001042492.2(NF1): c.3974+46_3974+47insG	MixedObserved,InconsistentAlleles;rs-cluster-nonoverlapping-alleles	71616	0.030133	U	0.4067	0.430911	.	.	PASS	131	5704	0.272966	2051	88476	0.235081	.	.	.	.	.	.	rs56874702	.	4024	0.437900	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29653292	29653293	17q11.2	0	normal	.	T	ref	T	TG.AA	het-alt	251	0.55	.	1	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC36	IVS36	.	.	no-change	NM_000267.3	NP_000258.1	+	Y	c.5205+23T=	.	.	.	NM_000267.3(NF1): c.5205+23T=	;maf-5-some-pop,maf-5-all-pops	122928	0.399714	U	0.4494	0.605831	13006	0.323312	PASS	.	8342	0.555622	9991	117920	0.399949	.	.	.	.	.	.	rs9894648	.	4024	0.555900	-1.213	-0.287	-0.167	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29653292	29653293	17q11.2	0	normal	.	T	ref	T	TG.AA	het-alt	251	0.55	.	1	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC37	IVS37	.	.	no-change	NM_001042492.2	NP_001035957.1	+	N	c.5268+23T=	.	.	.	NM_001042492.2(NF1): c.5268+23T=	;maf-5-some-pop,maf-5-all-pops	122928	0.399714	U	0.4494	0.605831	13006	0.323312	PASS	.	8342	0.555622	9991	117920	0.399949	.	.	.	.	.	.	rs9894648	.	4024	0.555900	-1.213	-0.287	-0.167	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29653292	29653293	17q11.2	0	normal	.	T	snv	C	TG.AA	het-ref	205	0.45	.	2	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC36	IVS36	.	.	intron	NM_000267.3	NP_000258.1	+	Y	c.5205+23T>C	.	.	.	NM_000267.3(NF1): c.5205+23T>C	;maf-5-some-pop,maf-5-all-pops	122928	0.600286	U	0.4494	0.605831	13006	0.676688	PASS	833	8342	0.444378	21789	117920	0.600051	1637	7479	4.39373e-01	41983	137578	5.91454e-01	rs9894648	.	4024	0.444100	-1.213	-0.287	-0.167	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	257293	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	29653292	29653293	17q11.2	0	normal	.	T	snv	C	TG.AA	het-ref	205	0.45	.	2	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC37	IVS37	.	.	intron	NM_001042492.2	NP_001035957.1	+	N	c.5268+23T>C	.	.	.	NM_001042492.2(NF1): c.5268+23T>C	;maf-5-some-pop,maf-5-all-pops	122928	0.600286	U	0.4494	0.605831	13006	0.676688	PASS	833	8342	0.444378	21789	117920	0.600051	1637	7479	4.39373e-01	41983	137578	5.91454e-01	rs9894648	.	4024	0.444100	-1.213	-0.287	-0.167	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	257293	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	29654875	29654876	17q11.2	0	normal	.	T	ref	T	TC.CT	het-alt	201	0.52	.	1	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC37	IVS37	.	.	no-change	NM_000267.3	NP_000258.1	+	Y	c.5546+19T=	.	.	.	NM_000267.3(NF1): c.5546+19T=	;maf-5-some-pop,maf-5-all-pops	125188	0.467800	U	0.371	0.431909	13006	0.483777	PASS	-967	8480	0.646698	13824	120180	0.463621	.	.	.	.	.	.	rs2285894	.	4024	0.656600	-0.265	-1.310	-1.591	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29654875	29654876	17q11.2	0	normal	.	T	ref	T	TC.CT	het-alt	201	0.52	.	1	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC38	IVS38	.	.	no-change	NM_001042492.2	NP_001035957.1	+	N	c.5609+19T=	.	.	.	NM_001042492.2(NF1): c.5609+19T=	;maf-5-some-pop,maf-5-all-pops	125188	0.467800	U	0.371	0.431909	13006	0.483777	PASS	-967	8480	0.646698	13824	120180	0.463621	.	.	.	.	.	.	rs2285894	.	4024	0.656600	-0.265	-1.310	-1.591	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29654875	29654876	17q11.2	1	normal	.	T	snv	A	TC.CT	het-ref	189	0.48	.	2	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC37	IVS37	.	.	intron	NM_000267.3	NP_000258.1	+	Y	c.5546+19T>A	.	.	.	NM_000267.3(NF1): c.5546+19T>A	;maf-5-some-pop,maf-5-all-pops	125188	0.532200	U	0.371	0.431909	13006	0.516223	PASS	531	8480	0.353302	18196	120180	0.536379	1085	6101	3.54627e-01	37119	131238	5.36291e-01	rs2285894	.	4024	0.343400	-0.265	-1.310	-1.591	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	257294	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	29654875	29654876	17q11.2	1	normal	.	T	snv	A	TC.CT	het-ref	189	0.48	.	2	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC38	IVS38	.	.	intron	NM_001042492.2	NP_001035957.1	+	N	c.5609+19T>A	.	.	.	NM_001042492.2(NF1): c.5609+19T>A	;maf-5-some-pop,maf-5-all-pops	125188	0.532200	U	0.371	0.431909	13006	0.516223	PASS	531	8480	0.353302	18196	120180	0.536379	1085	6101	3.54627e-01	37119	131238	5.36291e-01	rs2285894	.	4024	0.343400	-0.265	-1.310	-1.591	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	257294	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	29663623	29663624	17q11.2	0	normal	.	T	ref	T	tt.ta	het-alt	245	0.70	.	1	AT_rich|Low_complexity|Low_complexity|+|23	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC40	IVS40	.	.	no-change	NM_000267.3	NP_000258.1	+	Y	c.6085-29T=	.	.	.	NM_000267.3(NF1): c.6085-29T=	;maf-5-some-pop,maf-5-all-pops	42769	0.561318	U	0.3095	0.315096	.	.	PASS	-352	2070	0.591304	2774	39458	0.521491	.	.	.	.	.	.	rs7406038	.	4024	0.727900	-1.668	-1.576	-1.625	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29663623	29663624	17q11.2	0	normal	.	T	ref	T	tt.ta	het-alt	245	0.70	.	1	AT_rich|Low_complexity|Low_complexity|+|23	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC41	IVS41	.	.	no-change	NM_001042492.2	NP_001035957.1	+	N	c.6148-29T=	.	.	.	NM_001042492.2(NF1): c.6148-29T=	;maf-5-some-pop,maf-5-all-pops	42769	0.561318	U	0.3095	0.315096	.	.	PASS	-352	2070	0.591304	2774	39458	0.521491	.	.	.	.	.	.	rs7406038	.	4024	0.727900	-1.668	-1.576	-1.625	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29663623	29663624	17q11.2	0	normal	.	T	snv	A	tt.ta	het-ref	105	0.30	.	2	AT_rich|Low_complexity|Low_complexity|+|23	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC40	IVS40	.	.	intron	NM_000267.3	NP_000258.1	+	Y	c.6085-29T>A	.	.	.	NM_000267.3(NF1): c.6085-29T>A	;maf-5-some-pop,maf-5-all-pops	42769	0.438682	U	0.3095	0.315096	.	.	PASS	41	2070	0.340580	1534	39458	0.435501	131	3198	3.15945e-01	5269	62838	4.30734e-01	rs7406038	.	4024	0.272100	-1.668	-1.576	-1.625	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29663623	29663624	17q11.2	0	normal	.	T	snv	A	tt.ta	het-ref	105	0.30	.	2	AT_rich|Low_complexity|Low_complexity|+|23	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC41	IVS41	.	.	intron	NM_001042492.2	NP_001035957.1	+	N	c.6148-29T>A	.	.	.	NM_001042492.2(NF1): c.6148-29T>A	;maf-5-some-pop,maf-5-all-pops	42769	0.438682	U	0.3095	0.315096	.	.	PASS	41	2070	0.340580	1534	39458	0.435501	131	3198	3.15945e-01	5269	62838	4.30734e-01	rs7406038	.	4024	0.272100	-1.668	-1.576	-1.625	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29665862	29665863	17q11.2	0	normal	.	A	ref	A	GT.TC	het-alt	144	0.56	.	1	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC45	IVS45	.	.	no-change	NM_000267.3	NP_000258.1	+	Y	c.6858+40A=	.	.	.	NM_000267.3(NF1): c.6858+40A=	;	125434	0.998023	U	0.0159	0.00359425	12996	0.999769	PASS	-92	8618	0.978185	59985	120426	0.998090	.	.	.	.	.	.	rs188244160	.	4024	0.971700	-0.344	0.060	-0.542	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29665862	29665863	17q11.2	0	normal	.	A	ref	A	GT.TC	het-alt	144	0.56	.	1	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC46	IVS46	.	.	no-change	NM_001042492.2	NP_001035957.1	+	N	c.6921+40A=	.	.	.	NM_001042492.2(NF1): c.6921+40A=	;	125434	0.998023	U	0.0159	0.00359425	12996	0.999769	PASS	-92	8618	0.978185	59985	120426	0.998090	.	.	.	.	.	.	rs188244160	.	4024	0.971700	-0.344	0.060	-0.542	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29665862	29665863	17q11.2	0	normal	.	A	snv	G	GT.TC	het-ref	112	0.44	.	2	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC45	IVS45	.	.	intron	NM_000267.3	NP_000258.1	+	Y	c.6858+40A>G	.	.	.	NM_000267.3(NF1): c.6858+40A>G	;	125434	0.001977	U	0.0159	0.00359425	12996	0.000231	PASS	2	8618	0.021815	2	120426	0.001910	2	371	2.15222e-02	2	470	1.91981e-03	rs188244160	.	4024	0.028300	-0.344	0.060	-0.542	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	257298	criteria_provided,_single_submitter	Likely_benign	Likely Benign
17	29665862	29665863	17q11.2	0	normal	.	A	snv	G	GT.TC	het-ref	112	0.44	.	2	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC46	IVS46	.	.	intron	NM_001042492.2	NP_001035957.1	+	N	c.6921+40A>G	.	.	.	NM_001042492.2(NF1): c.6921+40A>G	;	125434	0.001977	U	0.0159	0.00359425	12996	0.000231	PASS	2	8618	0.021815	2	120426	0.001910	2	371	2.15222e-02	2	470	1.91981e-03	rs188244160	.	4024	0.028300	-0.344	0.060	-0.542	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	257298	criteria_provided,_single_submitter	Likely_benign	Likely Benign
17	29670189	29670190	17q11.2	0	normal	.	C	snv	G	TA.TA	hom-alt	392	1.00	.	0	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC47	IVS47	.	.	intron	NM_000267.3	NP_000258.1	+	Y	c.7126+37C>G	.	.	.	NM_000267.3(NF1): c.7126+37C>G	;maf-5-some-pop,genotype-conflict	120234	0.905476	U	0.9028	0.873802	12996	0.883118	PASS	3181	8044	0.888115	47463	115226	0.906853	6528	14783	8.80150e-01	98897	217339	9.08175e-01	rs7405740	.	4024	0.880500	-0.215	-1.433	-1.167	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	257300	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	29670189	29670190	17q11.2	0	normal	.	C	snv	G	TA.TA	hom-alt	392	1.00	.	0	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC48	IVS48	.	.	intron	NM_001042492.2	NP_001035957.1	+	N	c.7189+37C>G	.	.	.	NM_001042492.2(NF1): c.7189+37C>G	;maf-5-some-pop,genotype-conflict	120234	0.905476	U	0.9028	0.873802	12996	0.883118	PASS	3181	8044	0.888115	47463	115226	0.906853	6528	14783	8.80150e-01	98897	217339	9.08175e-01	rs7405740	.	4024	0.880500	-0.215	-1.433	-1.167	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	257300	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	29670189	29670190	17q11.2	0	nullSample	.	C	ref	C	TA.TA	homo-ref	.	.	.	0	.	.	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC47	IVS47	.	.	no-change	NM_000267.3	NP_000258.1	+	Y	c.7126+37C=	.	.	.	NM_000267.3(NF1): c.7126+37C=	;maf-5-some-pop,genotype-conflict	120234	0.094524	U	0.9028	0.873802	12996	0.116882	PASS	-391	8044	0.111885	583	115226	0.093147	.	.	.	.	.	.	rs7405740	.	4024	0.119500	-0.215	-1.433	-1.167	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29670189	29670190	17q11.2	0	nullSample	.	C	ref	C	TA.TA	homo-ref	.	.	.	0	.	.	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC48	IVS48	.	.	no-change	NM_001042492.2	NP_001035957.1	+	N	c.7189+37C=	.	.	.	NM_001042492.2(NF1): c.7189+37C=	;maf-5-some-pop,genotype-conflict	120234	0.094524	U	0.9028	0.873802	12996	0.116882	PASS	-391	8044	0.111885	583	115226	0.093147	.	.	.	.	.	.	rs7405740	.	4024	0.119500	-0.215	-1.433	-1.167	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29679245	29679246	17q11.2	0	normal	.	G	ref	G	TT.AT	het-alt	208	0.51	.	1	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC49	IVS49	.	.	no-change	NM_000267.3	NP_000258.1	+	Y	c.7395-29G=	.	.	.	NM_000267.3(NF1): c.7395-29G=	SingleClassTriAllelic;maf-5-some-pop	125272	0.470712	U	0.369	0.430911	13006	0.486622	PASS	.	8544	0.652271	14051	120264	0.466615	.	.	.	.	.	.	rs964288	.	4024	0.658100	-0.254	0.126	0.443	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29679245	29679246	17q11.2	0	normal	.	G	ref	G	TT.AT	het-alt	208	0.51	.	1	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC50	IVS50	.	.	no-change	NM_001042492.2	NP_001035957.1	+	N	c.7458-29G=	.	.	.	NM_001042492.2(NF1): c.7458-29G=	SingleClassTriAllelic;maf-5-some-pop	125272	0.470712	U	0.369	0.430911	13006	0.486622	PASS	.	8544	0.652271	14051	120264	0.466615	.	.	.	.	.	.	rs964288	.	4024	0.658100	-0.254	0.126	0.443	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	29679245	29679246	17q11.2	0	normal	.	G	snv	A	TT.AT	het-ref	198	0.49	.	2	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC49	IVS49	.	.	intron	NM_000267.3	NP_000258.1	+	Y	c.7395-29G>A	.	.	.	NM_000267.3(NF1): c.7395-29G>A	SingleClassTriAllelic;maf-5-some-pop	125272	0.529272	U	0.369	0.430911	13006	0.513378	PASS	518	8544	0.347729	18065	120264	0.533368	1072	6064	3.52886e-01	37163	131395	5.36197e-01	rs964288	.	4024	0.341900	-0.254	0.126	0.443	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	257303	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	29679245	29679246	17q11.2	0	normal	.	G	snv	A	TT.AT	het-ref	198	0.49	.	2	.	PASS	613113	C	162200(MK);162210(MK);193520(MK);601321(MK);607785(MK)	AD	Neurofibromatosis type 1, Neurofibromatosis-Noonan syndrome; Watson syndrome	AD	.	Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Cardiovascular; Oncologic; Ophthalmologic	23696535|23099008|23071069|23060584|23047742|23047517|22965773|22965642|22961690|22943186|22934576|20301288|19845691|19449407|19117870|17932395|17362838|17327286|17105749|16787982|16380919|15690406|15019338|14050005|12707950|12588224|12566521|12180143|12089128|12011145|11704931|11453810|11298367|11296017|11292406|11283797|11176707|11078559|11041400|10951462|10699117|10480204|10204844|9529361|9128932|9126041|8644707|8317503|7931405|7874161|7502979|7477989|6814376|6798841|6786260|6777096|6422759|6417335|6025371|4965691|4633999|3083645|3083258|2897130|2510517|2134734|1909491|1770531|1719426|1302608|1131001	FC59;FH44;H41;H62;H68;HB23;HBO28;HE15;MC58;MH43	4763	NF1	IC50	IVS50	.	.	intron	NM_001042492.2	NP_001035957.1	+	N	c.7458-29G>A	.	.	.	NM_001042492.2(NF1): c.7458-29G>A	SingleClassTriAllelic;maf-5-some-pop	125272	0.529272	U	0.369	0.430911	13006	0.513378	PASS	518	8544	0.347729	18065	120264	0.533368	1072	6064	3.52886e-01	37163	131395	5.36197e-01	rs964288	.	4024	0.341900	-0.254	0.126	0.443	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	257303	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	37651001	37651002	17q12	0	normal	.	C	ref	C	tt.tt	het-alt	189	0.86	.	1	trf	PASS	615514	C	.	NN	.	.	.	.	.	.	.	51755	CDK12	IC5	IVS5	.	.	no-change	NM_016507.2	NP_057591.2	+	Y	c.2419+55C=	.	.	.	NM_016507.2(CDK12): c.2419+55C=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.693	-1.544	-1.662	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
17	37651002	37651002	17q12	0	normal	.	.	ins	T	tc.tt	het-ref	31	0.14	.	2	trf	PASS	615514	C	.	NN	.	.	.	.	.	.	.	51755	CDK12	IC5	IVS5	.	.	intron	NM_016507.2	NP_057591.2	+	Y	c.2419+55_2419+56insT	.	.	.	NM_016507.2(CDK12): c.2419+55_2419+56insT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.080000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37651026	37651027	17q12	0	normal	.	T	ref	T	tc.tt	het-alt	69	0.70	.	1	trf;AluY|SINE|Alu|-|313	PASS	615514	C	.	NN	.	.	.	.	.	.	.	51755	CDK12	IC5	IVS5	.	.	no-change	NM_016507.2	NP_057591.2	+	Y	c.2419+80T=	.	.	.	NM_016507.2(CDK12): c.2419+80T=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.816400	0.486	0.641	0.608	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37651026	37651027	17q12	0	normal	.	T	del	.	tc.tt	het-ref	30	0.30	.	2	trf;AluY|SINE|Alu|-|313	PASS	615514	C	.	NN	.	.	.	.	.	.	.	51755	CDK12	IC5	IVS5	.	.	intron	NM_016507.2	NP_057591.2	+	Y	c.2419+80delT	.	.	.	NM_016507.2(CDK12): c.2419+80delT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.183600	0.486	0.641	0.608	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37815898	37815899	17q12	0	normal	.	G	snv	A	AT.GG	het-ref	159	0.48	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.37815898G>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.474241	U	0.4117	0.474241	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11658786	.	.	.	0.655	-0.017	-0.021	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37815898	37815899	17q12	0	normal	.	G	ref	G	AT.GG	het-alt	172	0.52	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.37815898G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.525759	U	0.4117	0.474241	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11658786	.	.	.	0.655	-0.017	-0.021	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37822310	37822311	17q12	0	normal	.	A	ref	A	GC.CT	het-alt	226	0.48	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.37822310A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	125160	0.334236	U	0.4167	0.54972	12988	0.381660	PASS	-1024	8546	0.601685	7332	120152	0.329399	.	.	.	.	.	.	rs1053651	.	.	.	-0.323	1.145	0.312	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37822310	37822311	17q12	0	normal	.	A	snv	C	GC.CT	het-ref	249	0.52	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.37822310A>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	125160	0.665764	U	0.4167	0.54972	12988	0.618340	PASS	678	8546	0.398315	27830	120152	0.670601	1300	6671	3.87669e-01	55387	160516	6.69810e-01	rs1053651	.	.	.	-0.323	1.145	0.312	.	.	.	.	.	ENST00000309889: c.453A>C (p.A151A)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [diffuse_large_B_cell_lymphoma|NS|NS]	CSV	436493	.	.	.	.	.	no_record	44709	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
17	37828744	37828745	17q12	0	normal	.	A	ref	A	TG.TG	het-alt	231	0.51	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.37828744A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.429113	U	0.4058	0.570887	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2941503	.	.	.	-2.640	-1.974	-1.128	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37828744	37828745	17q12	0	normal	.	A	snv	G	TG.TG	het-ref	220	0.49	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.37828744A>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.570887	U	0.4058	0.570887	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2941503	.	.	.	-2.640	-1.974	-1.128	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37828786	37828787	17q12	0	normal	.	G	ref	G	GA.CA	het-alt	235	0.57	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.37828786G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.395367	U	0.4058	0.604633	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs907087	.	.	.	-0.521	-0.675	-0.386	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37828786	37828787	17q12	0	normal	.	G	snv	A	GA.CA	het-ref	176	0.43	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.37828786G>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.604633	U	0.4058	0.604633	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs907087	.	.	.	-0.521	-0.675	-0.386	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37832102	37832103	17q12	0	normal	.	C	ref	C	GC.CC	het-alt	84	0.48	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.37832102C= (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.438898	U	0.4067	0.561102	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1495101	.	.	.	-1.366	0.116	0.270	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37832102	37832103	17q12	0	normal	.	C	snv	A	GC.CC	het-ref	90	0.52	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.37832102C>A (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.561102	U	0.4067	0.561102	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1495101	.	.	.	-1.366	0.116	0.270	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37832278	37832279	17q12	0	normal	.	C	ref	C	CT.CT	het-alt	115	0.49	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.37832278C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.537340	U	0.4018	0.46266	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1495100	.	.	.	-0.253	0.275	0.277	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37832278	37832279	17q12	0	normal	.	C	snv	T	CT.CT	het-ref	119	0.51	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.37832278C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.462660	U	0.4018	0.46266	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1495100	.	.	.	-0.253	0.275	0.277	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37832314	37832315	17q12	0	normal	.	T	ref	T	AC.CA	het-alt	89	0.51	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.37832314T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.439896	U	0.4058	0.560104	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2934953	.	.	.	0.460	-0.154	-0.354	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37832314	37832315	17q12	0	normal	.	T	snv	A	AC.CA	het-ref	87	0.49	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.37832314T>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.560104	U	0.4058	0.560104	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2934953	.	.	.	0.460	-0.154	-0.354	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37836242	37836243	17q12	0	normal	.	C	ref	C	CA.GA	het-alt	128	0.52	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.37836242C= (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.519569	U	0.4038	0.480431	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1476278	.	.	.	-0.339	-0.032	-0.038	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37836242	37836243	17q12	0	normal	.	C	snv	T	CA.GA	het-ref	119	0.48	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.37836242C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.480431	U	0.4038	0.480431	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1476278	.	.	.	-0.339	-0.032	-0.038	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37836352	37836353	17q12	0	normal	.	T	ref	T	AT.CA	het-alt	144	0.53	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.37836352T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.519569	U	0.4038	0.480431	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9303274	.	.	.	0.402	0.414	0.369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37836352	37836353	17q12	0	normal	.	T	snv	C	AT.CA	het-ref	126	0.47	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.37836352T>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.480431	U	0.4038	0.480431	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9303274	.	.	.	0.402	0.414	0.369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37843680	37843681	17q12	0	normal	.	C	ref	C	CC.AC	het-alt	115	0.49	.	1	.	PASS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	PROM	.	.	.	no-change	NM_001005862.1	NP_001005862.1	+	Y	c.-520-u712C=	.	.	.	NM_001005862.1(ERBB2): c.-520-u712C=	;maf-5-some-pop,maf-5-all-pops	5008	0.543730	U	0.3978	0.45627	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2517955	.	.	.	-0.233	-0.207	-0.202	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37843680	37843681	17q12	0	normal	.	C	snv	T	CC.AC	het-ref	119	0.51	.	2	.	PASS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	PROM	.	.	.	promoter	NM_001005862.1	NP_001005862.1	+	Y	c.-520-u712C>T	.	.	.	NM_001005862.1(ERBB2): c.-520-u712C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.456270	U	0.3978	0.45627	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2517955	.	.	.	-0.233	-0.207	-0.202	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37843858	37843859	17q12	0	normal	.	G	ref	G	GT.GC	het-alt	143	0.49	.	1	.	PASS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	PROM	.	.	.	no-change	NM_001005862.1	NP_001005862.1	+	Y	c.-520-u534G=	.	.	.	NM_001005862.1(ERBB2): c.-520-u534G=	;maf-5-some-pop,maf-5-all-pops	5008	0.427915	U	0.4018	0.572085	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2517956	.	.	.	-0.361	0.393	0.348	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37843858	37843859	17q12	0	normal	.	G	snv	A	GT.GC	het-ref	151	0.51	.	2	.	PASS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	PROM	.	.	.	promoter	NM_001005862.1	NP_001005862.1	+	Y	c.-520-u534G>A	.	.	.	NM_001005862.1(ERBB2): c.-520-u534G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.572085	U	0.4018	0.572085	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2517956	.	.	.	-0.361	0.393	0.348	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37866004	37866005	17q12	0	normal	.	C	ref	C	TA.TA	het-alt	121	0.49	.	1	.	PASS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC3	IVS7	.	.	no-change	NM_001005862.1	NP_001005862.1	+	Y	c.485-61C=	.	.	.	NM_001005862.1(ERBB2): c.485-61C=	;maf-5-some-pop,maf-5-all-pops	5008	0.416334	U	0.4048	0.583666	4566	0.364433	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1810132	.	4024	0.606900	-0.521	-0.058	-0.000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37866004	37866005	17q12	0	normal	.	C	ref	C	TA.TA	het-alt	121	0.49	.	1	.	PASS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC4	IVS4	.	.	no-change	NM_004448.2	NP_004439.2	+	N	c.575-61C=	.	.	.	NM_004448.2(ERBB2): c.575-61C=	;maf-5-some-pop,maf-5-all-pops	5008	0.416334	U	0.4048	0.583666	4566	0.364433	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1810132	.	4024	0.606900	-0.521	-0.058	-0.000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37866004	37866005	17q12	0	normal	.	C	snv	T	TA.TA	het-ref	125	0.51	.	2	.	PASS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC3	IVS7	.	.	intron	NM_001005862.1	NP_001005862.1	+	Y	c.485-61C>T	.	.	.	NM_001005862.1(ERBB2): c.485-61C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.583666	U	0.4048	0.583666	4566	0.635567	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1810132	.	4024	0.393100	-0.521	-0.058	-0.000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37866004	37866005	17q12	0	normal	.	C	snv	T	TA.TA	het-ref	125	0.51	.	2	.	PASS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC4	IVS4	.	.	intron	NM_004448.2	NP_004439.2	+	N	c.575-61C>T	.	.	.	NM_004448.2(ERBB2): c.575-61C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.583666	U	0.4048	0.583666	4566	0.635567	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1810132	.	4024	0.393100	-0.521	-0.058	-0.000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37868550	37868551	17q12	0	normal	.	C	ref	C	TT.CC	het-alt	201	0.83	.	1	.	DUBIOUS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC7	IVS11	.	.	no-change	NM_001005862.1	NP_001005862.1	+	Y	c.932-24C=	.	.	.	NM_001005862.1(ERBB2): c.932-24C=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.935400	0.591	-0.315	-0.202	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37868550	37868551	17q12	0	normal	.	C	ref	C	TT.CC	het-alt	201	0.83	.	1	.	DUBIOUS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC8	IVS8	.	.	no-change	NM_004448.2	NP_004439.2	+	N	c.1022-24C=	.	.	.	NM_004448.2(ERBB2): c.1022-24C=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.935400	0.591	-0.315	-0.202	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37868550	37868551	17q12	0	normal	.	C	snv	G	TT.CC	het-ref	40	0.17	.	2	.	DUBIOUS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC7	IVS11	.	.	intron	NM_001005862.1	NP_001005862.1	+	Y	c.932-24C>G	.	.	.	NM_001005862.1(ERBB2): c.932-24C>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.058900	0.591	-0.315	-0.202	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37868550	37868551	17q12	0	normal	.	C	snv	G	TT.CC	het-ref	40	0.17	.	2	.	DUBIOUS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC8	IVS8	.	.	intron	NM_004448.2	NP_004439.2	+	N	c.1022-24C>G	.	.	.	NM_004448.2(ERBB2): c.1022-24C>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.058900	0.591	-0.315	-0.202	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37868554	37868555	17q12	0	normal	.	A	ref	A	CC.CC	het-alt	196	0.77	.	1	.	DUBIOUS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC7	IVS11	.	.	no-change	NM_001005862.1	NP_001005862.1	+	Y	c.932-20A=	.	.	.	NM_001005862.1(ERBB2): c.932-20A=	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs57390350	.	4024	0.865600	-0.353	-1.766	-1.098	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37868554	37868555	17q12	0	normal	.	A	ref	A	CC.CC	het-alt	196	0.77	.	1	.	DUBIOUS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC8	IVS8	.	.	no-change	NM_004448.2	NP_004439.2	+	N	c.1022-20A=	.	.	.	NM_004448.2(ERBB2): c.1022-20A=	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs57390350	.	4024	0.865600	-0.353	-1.766	-1.098	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37868554	37868555	17q12	0	normal	.	A	snv	C	CC.CC	het-ref	59	0.23	.	2	.	DUBIOUS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC7	IVS11	.	.	intron	NM_001005862.1	NP_001005862.1	+	Y	c.932-20A>C	.	.	.	NM_001005862.1(ERBB2): c.932-20A>C	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	0	0	0.00000e+00	0	9	3.72356e-05	rs57390350	.	4024	0.134400	-0.353	-1.766	-1.098	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37868554	37868555	17q12	0	normal	.	A	snv	C	CC.CC	het-ref	59	0.23	.	2	.	DUBIOUS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC8	IVS8	.	.	intron	NM_004448.2	NP_004439.2	+	N	c.1022-20A>C	.	.	.	NM_004448.2(ERBB2): c.1022-20A>C	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	0	0	0.00000e+00	0	9	3.72356e-05	rs57390350	.	4024	0.134400	-0.353	-1.766	-1.098	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37868714	37868715	17q12	0	normal	.	C	ref	C	CA.GA	het-alt	246	0.53	.	1	.	PASS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC8	IVS12	.	.	no-change	NM_001005862.1	NP_001005862.1	+	Y	c.1058+14C=	.	.	.	NM_001005862.1(ERBB2): c.1058+14C=	;maf-5-some-pop,maf-5-all-pops	121264	0.400844	U	0.3988	0.444489	13006	0.487698	PASS	.	8290	0.618938	10007	116256	0.394182	.	.	.	.	.	.	rs4252627	.	4024	0.608600	-0.216	-0.189	-0.258	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37868714	37868715	17q12	0	normal	.	C	ref	C	CA.GA	het-alt	246	0.53	.	1	.	PASS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC9	IVS9	.	.	no-change	NM_004448.2	NP_004439.2	+	N	c.1148+14C=	.	.	.	NM_004448.2(ERBB2): c.1148+14C=	;maf-5-some-pop,maf-5-all-pops	121264	0.400844	U	0.3988	0.444489	13006	0.487698	PASS	.	8290	0.618938	10007	116256	0.394182	.	.	.	.	.	.	rs4252627	.	4024	0.608600	-0.216	-0.189	-0.258	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37868714	37868715	17q12	1	normal	.	C	snv	T	CA.GA	het-ref	217	0.47	.	2	.	PASS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC8	IVS12	.	.	intron	NM_001005862.1	NP_001005862.1	+	Y	c.1058+14C>T	.	.	.	NM_001005862.1(ERBB2): c.1058+14C>T	;maf-5-some-pop,maf-5-all-pops	121264	0.599156	U	0.3988	0.444489	13006	0.512302	PASS	577	8290	0.381062	22309	116256	0.605818	1140	6214	3.64629e-01	46936	147218	6.07852e-01	rs4252627	.	4024	0.391400	-0.216	-0.189	-0.258	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37868714	37868715	17q12	1	normal	.	C	snv	T	CA.GA	het-ref	217	0.47	.	2	.	PASS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC9	IVS9	.	.	intron	NM_004448.2	NP_004439.2	+	N	c.1148+14C>T	.	.	.	NM_004448.2(ERBB2): c.1148+14C>T	;maf-5-some-pop,maf-5-all-pops	121264	0.599156	U	0.3988	0.444489	13006	0.512302	PASS	577	8290	0.381062	22309	116256	0.605818	1140	6214	3.64629e-01	46936	147218	6.07852e-01	rs4252627	.	4024	0.391400	-0.216	-0.189	-0.258	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37879526	37879527	17q12	0	normal	.	A	ref	A	CC.CC	het-alt	143	0.79	.	1	.	DUBIOUS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC15	IVS19	.	.	no-change	NM_001005862.1	NP_001005862.1	+	Y	c.1857-45A=	.	.	.	NM_001005862.1(ERBB2): c.1857-45A=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.867500	0.459	-1.085	-1.073	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37879526	37879527	17q12	0	normal	.	A	ref	A	CC.CC	het-alt	143	0.79	.	1	.	DUBIOUS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC16	IVS16	.	.	no-change	NM_004448.2	NP_004439.2	+	N	c.1947-45A=	.	.	.	NM_004448.2(ERBB2): c.1947-45A=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.867500	0.459	-1.085	-1.073	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37879526	37879527	17q12	0	normal	.	A	snv	C	CC.CC	het-ref	37	0.21	.	2	.	DUBIOUS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC15	IVS19	.	.	intron	NM_001005862.1	NP_001005862.1	+	Y	c.1857-45A>C	.	.	.	NM_001005862.1(ERBB2): c.1857-45A>C	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.132500	0.459	-1.085	-1.073	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37879526	37879527	17q12	0	normal	.	A	snv	C	CC.CC	het-ref	37	0.21	.	2	.	DUBIOUS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC16	IVS16	.	.	intron	NM_004448.2	NP_004439.2	+	N	c.1947-45A>C	.	.	.	NM_004448.2(ERBB2): c.1947-45A>C	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.132500	0.459	-1.085	-1.073	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37879761	37879762	17q12	0	normal	.	G	ref	G	CC.GC	het-alt	252	0.48	.	1	.	PASS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC16	IVS20	.	.	no-change	NM_001005862.1	NP_001005862.1	+	Y	c.1996-29G=	.	.	.	NM_001005862.1(ERBB2): c.1996-29G=	;maf-5-some-pop,maf-5-all-pops	120562	0.391359	U	0.4018	0.451278	13002	0.486387	PASS	.	8128	0.610359	9327	115554	0.384539	.	.	.	.	.	.	rs903506	.	4024	0.605600	-0.367	-1.347	-0.888	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37879761	37879762	17q12	0	normal	.	G	ref	G	CC.GC	het-alt	252	0.48	.	1	.	PASS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC17	IVS17	.	.	no-change	NM_004448.2	NP_004439.2	+	N	c.2086-29G=	.	.	.	NM_004448.2(ERBB2): c.2086-29G=	;maf-5-some-pop,maf-5-all-pops	120562	0.391359	U	0.4018	0.451278	13002	0.486387	PASS	.	8128	0.610359	9327	115554	0.384539	.	.	.	.	.	.	rs903506	.	4024	0.605600	-0.367	-1.347	-0.888	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37879761	37879762	17q12	0	normal	.	G	snv	A	CC.GC	het-ref	272	0.52	.	2	.	PASS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC16	IVS20	.	.	intron	NM_001005862.1	NP_001005862.1	+	Y	c.1996-29G>A	.	.	.	NM_001005862.1(ERBB2): c.1996-29G>A	;maf-5-some-pop,maf-5-all-pops	120562	0.608641	U	0.4018	0.451278	13002	0.513613	PASS	588	8128	0.389641	22669	115554	0.615461	1133	6209	3.64678e-01	47445	148141	6.12021e-01	rs903506	.	4024	0.394400	-0.367	-1.347	-0.888	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37879761	37879762	17q12	0	normal	.	G	snv	A	CC.GC	het-ref	272	0.52	.	2	.	PASS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC17	IVS17	.	.	intron	NM_004448.2	NP_004439.2	+	N	c.2086-29G>A	.	.	.	NM_004448.2(ERBB2): c.2086-29G>A	;maf-5-some-pop,maf-5-all-pops	120562	0.608641	U	0.4018	0.451278	13002	0.513613	PASS	588	8128	0.389641	22669	115554	0.615461	1133	6209	3.64678e-01	47445	148141	6.12021e-01	rs903506	.	4024	0.394400	-0.367	-1.347	-0.888	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37881682	37881683	17q12	0	normal	.	T	snv	G	GG.GG	het-ref	46	0.38	.	2	.	DUBIOUS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC21	IVS25	.	.	intron	NM_001005862.1	NP_001005862.1	+	Y	c.2635+28T>G	.	.	.	NM_001005862.1(ERBB2): c.2635+28T>G	;	120658	0.000008	U	.	.	.	.	VQSRTrancheSNP99.60to99.80	0	8636	0.000000	0	120658	0.000008	0	0	0.00000e+00	0	2	8.21632e-06	rs762150448	.	4024	0.061600	0.460	1.053	0.310	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37881682	37881683	17q12	0	normal	.	T	snv	G	GG.GG	het-ref	46	0.38	.	2	.	DUBIOUS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC22	IVS22	.	.	intron	NM_004448.2	NP_004439.2	+	N	c.2725+28T>G	.	.	.	NM_004448.2(ERBB2): c.2725+28T>G	;	120658	0.000008	U	.	.	.	.	VQSRTrancheSNP99.60to99.80	0	8636	0.000000	0	120658	0.000008	0	0	0.00000e+00	0	2	8.21632e-06	rs762150448	.	4024	0.061600	0.460	1.053	0.310	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37881682	37881683	17q12	0	normal	.	T	ref	T	GG.GG	het-alt	76	0.62	.	1	.	DUBIOUS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC21	IVS25	.	.	no-change	NM_001005862.1	NP_001005862.1	+	Y	c.2635+28T=	.	.	.	NM_001005862.1(ERBB2): c.2635+28T=	;	120658	0.999992	U	.	.	.	.	VQSRTrancheSNP99.60to99.80	0	8636	1.000000	60328	120658	0.999992	.	.	.	.	.	.	rs762150448	.	4024	0.938400	0.460	1.053	0.310	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37881682	37881683	17q12	0	normal	.	T	ref	T	GG.GG	het-alt	76	0.62	.	1	.	DUBIOUS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	IC22	IVS22	.	.	no-change	NM_004448.2	NP_004439.2	+	N	c.2725+28T=	.	.	.	NM_004448.2(ERBB2): c.2725+28T=	;	120658	0.999992	U	.	.	.	.	VQSRTrancheSNP99.60to99.80	0	8636	1.000000	60328	120658	0.999992	.	.	.	.	.	.	rs762150448	.	4024	0.938400	0.460	1.053	0.310	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37884036	37884037	17q12	0	normal	.	C	ref	C	GG.CC	het-alt	289	0.48	.	1	.	PASS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	C26E	EX30E	.	.	no-change	NM_001005862.1	NP_001005862.1	+	Y	c.3418C=	.	.	.	NM_001005862.1(ERBB2): c.3418C=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	125262	0.399211	U	0.4018	0.452077	13006	0.486468	PASS	.	8588	0.624243	10550	120254	0.393018	.	.	.	.	.	.	rs1058808	.	4024	0.602400	0.450	4.777	2.326	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37884036	37884037	17q12	0	normal	.	C	ref	C	GG.CC	het-alt	289	0.48	.	1	.	PASS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	C27E	EX27E	.	.	no-change	NM_004448.2	NP_004439.2	+	N	c.3508C=	.	.	.	NM_004448.2(ERBB2): c.3508C=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	125262	0.399211	U	0.4018	0.452077	13006	0.486468	PASS	.	8588	0.624243	10550	120254	0.393018	.	.	.	.	.	.	rs1058808	.	4024	0.602400	0.450	4.777	2.326	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37884036	37884037	17q12	1	normal	.	C	snv	G	GG.CC	het-ref	316	0.52	.	2	.	PASS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	C26E	EX30E	.	.	missense	NM_001005862.1	NP_001005862.1	+	Y	c.3418C>G	p.P1140A | p.Pro1140Ala	CCC=>GCC	NP=>NP	NM_001005862.1(ERBB2): c.3418C>G (p.P1140A)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	125262	0.600789	U	0.4018	0.452077	13006	0.513532	PASS	611	8588	0.375757	23415	120254	0.606982	1167	6298	3.65993e-01	48130	149768	6.11757e-01	rs1058808	.	4024	0.397600	0.450	4.777	2.326	0.19	0.324	0.921	0.151	neutral	ENST00000269571: c.3508C>G (p.P1170A)	biliary_tract [bile_duct|NS|NS]	carcinoma [NS|NS|NS]	CSV	5436892	.	.	.	.	.	no_record	134082	no_assertion_provided	not_provided	Likely Benign
17	37884036	37884037	17q12	1	normal	.	C	snv	G	GG.CC	het-ref	316	0.52	.	2	.	PASS	164870	C	137800(MK);164870(MK);211980(MK);613659(MK)	AD;AR	.	.	.	.	.	.	.	2064	ERBB2	C27E	EX27E	.	.	missense	NM_004448.2	NP_004439.2	+	N	c.3508C>G	p.P1170A | p.Pro1170Ala	CCC=>GCC	NP=>NP	NM_004448.2(ERBB2): c.3508C>G (p.P1170A)	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	125262	0.600789	U	0.4018	0.452077	13006	0.513532	PASS	611	8588	0.375757	23415	120254	0.606982	1167	6298	3.65993e-01	48130	149768	6.11757e-01	rs1058808	.	4024	0.397600	0.450	4.777	2.326	0.2	0.324	0.921	0.151	neutral	ENST00000269571: c.3508C>G (p.P1170A)	biliary_tract [bile_duct|NS|NS]	carcinoma [NS|NS|NS]	CSV	5436892	CM087578	NM_004448.2(ERBB2): c.3508C>G (p.P1170A)	"Lung cancer, incr. risk in females, non-smokers and non-drinkers"	19055823	DP	no_record	134082	no_assertion_provided	not_provided	Likely Benign
17	37910367	37910368	17q12	0	nullSample	.	C	ref	C	GC.GG	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.37910367C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.443091	U	0.7004	0.556909	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2941522	.	.	.	0.462	0.572	0.704	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37910367	37910368	17q12	0	normal	.	C	snv	T	GC.GG	hom-alt	336	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.37910367C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.556909	U	0.7004	0.556909	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2941522	.	.	.	0.462	0.572	0.704	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37921741	37921742	17q12	0	nullSample	.	C	ref	C	TC.GG	homo-ref	.	.	.	0	.	.	606221	P	.	NN	.	.	.	.	.	.	.	22806	IKZF3	3U1E	EX8E	.	.	no-change	NM_012481.4	NP_036613.2	-	Y	c.*301G=	.	.	.	NM_012481.4(IKZF3): c.*301G=	;maf-5-some-pop,maf-5-all-pops	5008	0.470048	U	0.6994	0.529952	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs907091	.	.	.	-1.982	-1.123	-0.839	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37921741	37921742	17q12	0	normal	.	C	snv	T	TC.GG	hom-alt	432	1.00	.	0	.	PASS	606221	P	.	NN	.	.	.	.	.	.	.	22806	IKZF3	3U1E	EX8E	.	.	utr-3	NM_012481.4	NP_036613.2	-	Y	c.*301G>A	.	.	.	NM_012481.4(IKZF3): c.*301G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.529952	U	0.6994	0.529952	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs907091	.	.	.	-1.982	-1.123	-0.839	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37929815	37929816	17q12	0	nullSample	.	T	ref	T	TT.TT	homo-ref	.	.	.	0	.	.	606221	P	.	NN	.	.	.	.	.	.	.	22806	IKZF3	IC7	IVS7	.	.	no-change	NM_012481.4	NP_036613.2	-	Y	c.826+4088A=	.	.	.	NM_012481.4(IKZF3): c.826+4088A=	;maf-5-some-pop,maf-5-all-pops	5008	0.456470	U	0.6984	0.54353	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2313430	.	.	.	0.454	0.118	0.135	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	37929815	37929816	17q12	0	normal	.	T	snv	C	TT.TT	hom-alt	326	1.00	.	0	.	PASS	606221	P	.	NN	.	.	.	.	.	.	.	22806	IKZF3	IC7	IVS7	.	.	intron	NM_012481.4	NP_036613.2	-	Y	c.826+4088A>G	.	.	.	NM_012481.4(IKZF3): c.826+4088A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.543530	U	0.6984	0.54353	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2313430	.	.	.	0.454	0.118	0.135	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	38556769	38556770	17q21.2	0	normal	.	T	ref	T	CA.AA	het-alt	337	0.51	.	1	.	PASS	126430	C	126430(MK)	NN	.	.	.	.	.	.	.	7153	TOP2A	IC22	IVS22	.	.	no-change	NM_001067.3	NP_001058.2	-	Y	c.2799+11A=	.	.	.	NM_001067.3(TOP2A): c.2799+11A=	;maf-5-some-pop	120380	0.203522	U	0.7867	0.812899	11780	0.138455	PASS	-822	8156	0.268514	2636	115372	0.204235	.	.	.	.	.	.	rs471692	.	4024	0.276100	-0.821	-1.117	-1.531	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	38556769	38556770	17q21.2	1	normal	.	T	snv	C	CA.AA	het-ref	323	0.49	.	2	.	PASS	126430	C	126430(MK)	NN	.	.	.	.	.	.	.	7153	TOP2A	IC22	IVS22	.	.	intron	NM_001067.3	NP_001058.2	-	Y	c.2799+11A>G	.	.	.	NM_001067.3(TOP2A): c.2799+11A>G	;maf-5-some-pop	120380	0.796478	U	0.7867	0.812899	11780	0.861545	PASS	2161	8156	0.731486	36759	115372	0.795765	4456	12186	7.36581e-01	73620	184534	7.88445e-01	rs471692	.	4024	0.723900	-0.821	-1.117	-1.531	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	38563709	38563710	17q21.2	0	normal	.	C	ref	C	AA.TA	het-alt	112	0.46	.	1	.	PASS	126430	C	126430(MK)	NN	.	.	.	.	.	.	.	7153	TOP2A	IC13	IVS13	.	.	no-change	NM_001067.3	NP_001058.2	-	Y	c.1626+91G=	.	.	.	NM_001067.3(TOP2A): c.1626+91G=	;maf-5-some-pop,genotype-conflict	5008	0.189896	U	0.7778	0.810104	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs558068	.	4038	0.281800	-2.315	-2.513	-2.385	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	38563709	38563710	17q21.2	0	normal	.	C	snv	G	AA.TA	het-ref	132	0.54	.	2	.	PASS	126430	C	126430(MK)	NN	.	.	.	.	.	.	.	7153	TOP2A	IC13	IVS13	.	.	intron	NM_001067.3	NP_001058.2	-	Y	c.1626+91G>C	.	.	.	NM_001067.3(TOP2A): c.1626+91G>C	;maf-5-some-pop,genotype-conflict	5008	0.810104	U	0.7778	0.810104	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs558068	.	4038	0.714700	-2.315	-2.513	-2.385	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	38569920	38569921	17q21.2	0	normal	.	C	ref	C	AA.GA	het-alt	188	0.53	.	1	.	PASS	126430	C	126430(MK)	NN	.	.	.	.	.	.	.	7153	TOP2A	IC4	IVS4	.	.	no-change	NM_001067.3	NP_001058.2	-	Y	c.333-44G=	.	.	.	NM_001067.3(TOP2A): c.333-44G=	;	20570	0.999562	U	0.001	0.000199681	.	.	PASS	0	544	1.000000	7773	15562	0.999486	.	.	.	.	.	.	rs182023725	.	4024	0.995300	-0.252	-1.175	-1.669	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	38569920	38569921	17q21.2	0	normal	.	C	snv	T	AA.GA	het-ref	166	0.47	.	2	.	PASS	126430	C	126430(MK)	NN	.	.	.	.	.	.	.	7153	TOP2A	IC4	IVS4	.	.	intron	NM_001067.3	NP_001058.2	-	Y	c.333-44G>A	.	.	.	NM_001067.3(TOP2A): c.333-44G>A	;	20570	0.000438	U	0.001	0.000199681	.	.	PASS	0	544	0.000000	0	15562	0.000514	0	15	3.08769e-03	0	41	5.38595e-04	rs182023725	.	4024	0.004700	-0.252	-1.175	-1.669	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
17	38572365	38572366	17q21.2	0	normal	.	G	ref	G	AA.AA	het-alt	142	0.53	.	1	.	PASS	126430	C	126430(MK)	NN	.	.	.	.	.	.	.	7153	TOP2A	IC3	IVS3	.	.	no-change	NM_001067.3	NP_001058.2	-	Y	c.269-46C=	.	.	.	NM_001067.3(TOP2A): c.269-46C=	;maf-5-some-pop	29444	0.201535	U	0.7857	0.813299	11436	0.132739	PASS	-78	786	0.274809	577	24436	0.204575	.	.	.	.	.	.	rs2586112	.	4024	0.276300	-0.340	0.156	0.283	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	38572365	38572366	17q21.2	0	normal	.	G	snv	A	AA.AA	het-ref	128	0.47	.	2	.	PASS	126430	C	126430(MK)	NN	.	.	.	.	.	.	.	7153	TOP2A	IC3	IVS3	.	.	intron	NM_001067.3	NP_001058.2	-	Y	c.269-46C>T	.	.	.	NM_001067.3(TOP2A): c.269-46C>T	;maf-5-some-pop	29444	0.798465	U	0.7857	0.813299	11436	0.867261	PASS	207	786	0.725191	7796	24436	0.795425	2789	7613	7.37980e-01	46990	118846	7.80044e-01	rs2586112	.	4024	0.723700	-0.340	0.156	0.283	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	40475055	40475056	17q21.2	0	normal	.	G	ref	G	AC.CC	het-alt	354	0.52	.	1	.	PASS	102582	P	147060(MK);615952(MK)	AD	Hyper-IgE recurrent infection syndrome	AD	.	Allergy/Immunology/Infectious; Cardiovascular; Dermatologic; Musculoskeletal; Oncologic	Allergy/Immunology/Infectious; Cardiovascular; Oncologic	22751495|22084479|21703716|17942886|17881745|17676033|10053178|6806658|5059313|4161105	.	6774	STAT3	C19	EX20	SH2 domain	PF00017.19	no-change	NM_139276.2	NP_644805.1	-	Y	c.1854C=	.	.	.	NM_139276.2(STAT3): c.1854C=	;	126408	0.996116	U	0.0337	0.00758786	.	.	PASS	.	8650	0.955723	60258	121400	0.996269	.	.	.	.	.	.	rs117691970	.	4024	0.957800	-0.274	-1.100	-2.970	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	40475055	40475056	17q21.2	1	normal	.	G	snv	A	AC.CC	het-ref	333	0.48	.	2	.	PASS	102582	P	147060(MK);615952(MK)	AD	Hyper-IgE recurrent infection syndrome	AD	.	Allergy/Immunology/Infectious; Cardiovascular; Dermatologic; Musculoskeletal; Oncologic	Allergy/Immunology/Infectious; Cardiovascular; Oncologic	22751495|22084479|21703716|17942886|17881745|17676033|10053178|6806658|5059313|4161105	.	6774	STAT3	C19	EX20	SH2 domain	PF00017.19	coding-synon	NM_139276.2	NP_644805.1	-	Y	c.1854C>T	p.(G618=) | p.(Gly618=)	GGC=>GGT	.	NM_139276.2(STAT3): c.1854C>T (p.(G618=))	;	126408	0.003884	U	0.0337	0.00758786	.	.	PASS	11	8650	0.044277	11	121400	0.003731	8	665	3.85552e-02	9	843	3.42413e-03	rs117691970	.	4024	0.042200	-0.274	-1.100	-2.970	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	323243	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	VUS
17	40481528	40481529	17q21.2	0	normal	.	G	snv	C	CC.GC	het-ref	295	0.51	.	2	.	PASS	102582	P	147060(MK);615952(MK)	AD	Hyper-IgE recurrent infection syndrome	AD	.	Allergy/Immunology/Infectious; Cardiovascular; Dermatologic; Musculoskeletal; Oncologic	Allergy/Immunology/Infectious; Cardiovascular; Oncologic	22751495|22084479|21703716|17942886|17881745|17676033|10053178|6806658|5059313|4161105	.	6774	STAT3	IC12	IVS13	.	.	intron	NM_139276.2	NP_644805.1	-	Y	c.1233+43C>G	.	.	.	NM_139276.2(STAT3): c.1233+43C>G	MixedObserved,SingleClassQuadAllelic;maf-5-some-pop,microattr-tpa,genotype-conflict,rs-cluster-nonoverlapping-alleles	126388	0.604535	U	0.5198	0.653754	13006	0.687913	PASS	1121	8646	0.518968	22585	121380	0.602505	2348	9027	5.23729e-01	43672	144650	5.87545e-01	rs2293152	.	4024	0.531300	-0.120	0.616	1.355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	40481528	40481529	17q21.2	0	normal	.	G	ref	G	CC.GC	het-alt	285	0.49	.	1	.	PASS	102582	P	147060(MK);615952(MK)	AD	Hyper-IgE recurrent infection syndrome	AD	.	Allergy/Immunology/Infectious; Cardiovascular; Dermatologic; Musculoskeletal; Oncologic	Allergy/Immunology/Infectious; Cardiovascular; Oncologic	22751495|22084479|21703716|17942886|17881745|17676033|10053178|6806658|5059313|4161105	.	6774	STAT3	IC12	IVS13	.	.	no-change	NM_139276.2	NP_644805.1	-	Y	c.1233+43C=	.	.	.	NM_139276.2(STAT3): c.1233+43C=	MixedObserved,SingleClassQuadAllelic;maf-5-some-pop,microattr-tpa,genotype-conflict,rs-cluster-nonoverlapping-alleles|MixedObserved;	126388|121330	0.395409|0.999992	U	0.5198	0.653754	13006	0.312087	PASS	.	8646	0.480569	10140	121380	0.397438	.	.	.	.	.	.	rs2293152|rs751750536	.	4024	0.467700	-0.120	0.616	1.355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	40491273	40491274	17q21.2	0	normal	.	A	ref	A	tc.aa	het-alt	61	0.58	.	1	AluJb|SINE|Alu|+|303	PASS	102582	P	147060(MK);615952(MK)	AD	Hyper-IgE recurrent infection syndrome	AD	.	Allergy/Immunology/Infectious; Cardiovascular; Dermatologic; Musculoskeletal; Oncologic	Allergy/Immunology/Infectious; Cardiovascular; Oncologic	22751495|22084479|21703716|17942886|17881745|17676033|10053178|6806658|5059313|4161105	.	6774	STAT3	IC4	IVS5	.	.	no-change	NM_139276.2	NP_644805.1	-	Y	c.468+58T=	.	.	.	NM_139276.2(STAT3): c.468+58T=	;maf-5-some-pop,maf-5-all-pops	5008	0.595048	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs558351915	.	4024	0.835000	0.338	0.064	-0.178	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	40491273	40491274	17q21.2	0	normal	.	A	del	.	tc.aa	het-ref	44	0.42	.	2	AluJb|SINE|Alu|+|303	PASS	102582	P	147060(MK);615952(MK)	AD	Hyper-IgE recurrent infection syndrome	AD	.	Allergy/Immunology/Infectious; Cardiovascular; Dermatologic; Musculoskeletal; Oncologic	Allergy/Immunology/Infectious; Cardiovascular; Oncologic	22751495|22084479|21703716|17942886|17881745|17676033|10053178|6806658|5059313|4161105	.	6774	STAT3	IC4	IVS5	.	.	intron	NM_139276.2	NP_644805.1	-	Y	c.468+58delT	.	.	.	NM_139276.2(STAT3): c.468+58delT	;maf-5-some-pop,maf-5-all-pops	5008	0.404952	U	0.4038	0.404952	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs558351915	.	4024	0.164500	0.338	0.064	-0.178	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41150948	41150949	17q21.31	0	normal	.	G	ref	G	TA.CC	het-alt	210	0.54	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41150948G= (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	99424	0.365968	U	0.5754	0.480232	.	.	PASS	.	6730	0.425111	6179	94416	0.357810	.	.	.	.	.	.	rs2271539	.	.	.	0.467	-0.896	-0.890	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41150948	41150949	17q21.31	0	normal	.	G	snv	A	TA.CC	het-ref	176	0.46	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41150948G>A (intergenic)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	99424	0.634032	U	0.5754	0.480232	.	.	PASS	1040	6730	0.574889	19604	94416	0.642190	2340	8520	5.53606e-01	41109	125666	6.31063e-01	rs2271539	.	.	.	0.467	-0.896	-0.890	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41150982	41150983	17q21.31	0	normal	.	T	snv	C	AG.TT	hom-alt	261	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41150982T>C (intergenic)	;maf-5-some-pop,genotype-conflict	5008	0.977037	U	1	0.977037	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs691954	.	.	.	-0.913	-0.095	-0.091	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41150982	41150983	17q21.31	0	nullSample	.	T	ref	T	AG.TT	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41150982T= (intergenic)	;maf-5-some-pop,genotype-conflict	5008	0.022963	U	1	0.977037	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs691954	.	.	.	-0.913	-0.095	-0.091	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41154523	41154524	17q21.31	0	normal	.	A	ref	A	tc.aa	het-alt	162	0.81	.	1	AluY|SINE|Alu|+|295	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41154523A= (intergenic)	MixedObserved;	2	0.500000	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs76067241	.	.	.	0.102	-0.627	-0.766	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
17	41154523	41154524	17q21.31	0	normal	.	A	del	.	tc.aa	het-ref	37	0.19	.	2	AluY|SINE|Alu|+|295	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41154524delA (intergenic)	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.102	-0.627	-0.766	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
17	41154599	41154600	17q21.31	0	normal	.	C	ref	C	AC.CT	het-alt	243	0.54	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41154599C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.251198	U	0.8472	0.748802	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs8076790	.	.	.	0.650	-0.415	-0.282	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41154599	41154600	17q21.31	0	normal	.	C	snv	T	AC.CT	het-ref	211	0.46	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41154599C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.748802	U	0.8472	0.748802	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs8076790	.	.	.	0.650	-0.415	-0.282	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41172480	41172481	17q21.31	0	normal	.	G	ref	G	AA.CC	het-alt	207	0.54	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41172480G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.605032	U	0.2421	0.394968	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs28678167	.	.	.	0.462	0.342	0.341	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41172480	41172481	17q21.31	0	normal	.	G	snv	T	AA.CC	het-ref	174	0.46	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41172480G>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.394968	U	0.2421	0.394968	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs28678167	.	.	.	0.462	0.342	0.341	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41176687	41176688	17q21.31	0	normal	.	T	ref	T	TG.AA	het-alt	116	0.46	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41176687T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.657149	U	0.373	0.342851	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2298862	.	.	.	-0.344	1.481	1.216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41176687	41176688	17q21.31	0	normal	.	T	snv	C	TG.AA	het-ref	137	0.54	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41176687T>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.342851	U	0.373	0.342851	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2298862	.	.	.	-0.344	1.481	1.216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41176830	41176831	17q21.31	0	normal	.	G	ref	G	AA.AG	het-alt	118	0.48	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41176830G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.657149	U	0.374	0.342851	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2298861	.	.	.	-0.556	-0.679	-0.262	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41176830	41176831	17q21.31	0	normal	.	G	snv	A	AA.AG	het-ref	130	0.52	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41176830G>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.342851	U	0.374	0.342851	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2298861	.	.	.	-0.556	-0.679	-0.262	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41181296	41181297	17q21.31	0	normal	.	T	ref	T	CT.TA	het-alt	220	0.57	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41181296T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.657748	U	0.371	0.342252	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs36036395	.	.	.	-0.213	-0.625	-0.187	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41181296	41181297	17q21.31	0	normal	.	T	snv	C	CT.TA	het-ref	166	0.43	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41181296T>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.342252	U	0.371	0.342252	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs36036395	.	.	.	-0.213	-0.625	-0.187	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41191128	41191129	17q21.31	0	normal	.	G	ref	G	GG.AA	het-alt	226	0.56	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41191128G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.657947	U	0.37	0.342053	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11657053	.	.	.	-2.048	-0.217	-0.207	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41191128	41191129	17q21.31	0	normal	.	G	snv	T	GG.AA	het-ref	177	0.44	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41191128G>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.342053	U	0.37	0.342053	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11657053	.	.	.	-2.048	-0.217	-0.207	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41196407	41196408	17q21.31	0	normal	.	G	ref	G	CT.GG	het-alt	414	0.52	.	1	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	3U1E	EX23E	.	.	no-change	NM_007294.3	NP_009225.1	-	Y	c.*1287C=	.	.	.	NM_007294.3(BRCA1): c.*1287C=	MixedObserved;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	16940	0.585478	U	0.373	0.342252	.	.	PASS	-28	182	0.571429	1865	11932	0.555146	.	.	.	.	.	.	rs12516	.	.	.	0.561	0.359	0.184	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41196407	41196408	17q21.31	0	normal	.	G	snv	A	CT.GG	het-ref	378	0.48	.	2	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	3U1E	EX23E	.	.	utr-3	NM_007294.3	NP_009225.1	-	Y	c.*1287C>T	.	.	.	NM_007294.3(BRCA1): c.*1287C>T	MixedObserved;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	16940	0.414522	U	0.373	0.342252	.	.	PASS	11	182	0.428571	1207	11932	0.444854	747	3787	3.82371e-01	8475	45170	3.43331e-01	rs12516	.	.	.	0.561	0.359	0.184	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	132777	reviewed_by_expert_panel	Benign	Benign
17	41196821	41196824	17q21.31	0	normal	.	TTT	del	.	cc.tt	het-alt	35	0.56	.	1	AluSx1|SINE|Alu|-|308	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	3U1E	EX23E	.	.	utr-3	NM_007294.3	NP_009225.1	-	Y	c.*855A[19>16] (std: c.*855A[16] alt: c.*871_*873delAAA )	.	.	.	NM_007294.3(BRCA1): c.*855A[16]	MixedObserved;	0	0	U	.	.	.	.	PASS	0	80	0.150000	0	4698	0.128778	.	.	.	.	.	.	rs767388616	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41196821	41196824	17q21.31	0	nullSample	.	TTT	ref	TTT	cc.tt	homo-ref	.	.	.	0	AluSx1|SINE|Alu|-|308	.	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	3U1E	EX23E	.	.	no-change	NM_007294.3	NP_009225.1	-	Y	c.*871_*873=	.	.	.	NM_007294.3(BRCA1): c.*871_*873=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs767388616	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
17	41196821	41196824	17q21.31	0	normal	.	TTT	rep	T	cc.tt	het-alt	23	0.37	.	2	AluSx1|SINE|Alu|-|308	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	3U1E	EX23E	.	.	utr-3	NM_007294.3	NP_009225.1	-	Y	c.*855A[19>17] (std: c.*855A[17] alt: c.*872_*873delAA )	.	.	.	NM_007294.3(BRCA1): c.*855A[17]	MixedObserved;	0	0	U	.	.	.	.	PASS	1	80	0.325000	40	4698	0.320988	.	.	.	.	.	.	rs767388616	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41197273	41197274	17q21.31	0	normal	.	C	ref	C	GC.TT	het-alt	345	0.49	.	1	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	3U1E	EX23E	.	.	no-change	NM_007294.3	NP_009225.1	-	Y	c.*421G=	.	.	.	NM_007294.3(BRCA1): c.*421G=	;maf-5-some-pop,maf-5-all-pops	15768	0.592276	U	0.372	0.324481	.	.	PASS	-19	134	0.552239	1686	10760	0.553532	.	.	.	.	.	.	rs8176318	.	.	.	-0.373	0.354	0.610	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41197273	41197274	17q21.31	0	normal	.	C	snv	A	GC.TT	het-ref	356	0.51	.	2	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	3U1E	EX23E	.	.	utr-3	NM_007294.3	NP_009225.1	-	Y	c.*421G>T	.	.	.	NM_007294.3(BRCA1): c.*421G>T	;maf-5-some-pop,maf-5-all-pops	15768	0.407724	U	0.372	0.324481	.	.	PASS	11	134	0.447761	1110	10760	0.446468	730	3713	3.77337e-01	7975	42588	3.39444e-01	rs8176318	.	.	.	-0.373	0.354	0.610	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	209234	reviewed_by_expert_panel	Benign	Benign
17	41197939	41197940	17q21.31	0	normal	.	T	ref	T	AA.tt	het-alt	46	0.69	.	1	AluSx|SINE|Alu|-|300	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC21	IVS22	.	.	no-change	NM_007294.3	NP_009225.1	-	Y	c.5468-121A=	.	.	.	NM_007294.3(BRCA1): c.5468-121A=	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs375078966	.	4024	0.784500	-0.464	-0.493	-0.571	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41197939	41197940	17q21.31	0	normal	.	T	del	.	AA.tt	het-ref	21	0.31	.	2	AluSx|SINE|Alu|-|300	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC21	IVS22	.	.	intron	NM_007294.3	NP_009225.1	-	Y	c.5468-121delA	.	.	.	NM_007294.3(BRCA1): c.5468-121delA	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs375078966	.	4024	0.215500	-0.464	-0.493	-0.571	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41215824	41215825	17q21.31	0	normal	.	C	ref	C	AA.GT	het-alt	135	0.52	.	1	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC16	IVS17	.	.	no-change	NM_007294.3	NP_009225.1	-	Y	c.5152+66G=	.	.	.	NM_007294.3(BRCA1): c.5152+66G=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	5008	0.657548	U	0.371	0.342452	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3092994	.	4024	0.630200	-1.214	-0.751	-0.688	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41215824	41215825	17q21.31	0	normal	.	C	snv	T	AA.GT	het-ref	125	0.48	.	2	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC16	IVS17	.	.	intron	NM_007294.3	NP_009225.1	-	Y	c.5152+66G>A	.	.	.	NM_007294.3(BRCA1): c.5152+66G>A	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	5008	0.342452	U	0.371	0.342452	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3092994	.	4024	0.369800	-1.214	-0.751	-0.688	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	55428	reviewed_by_expert_panel	Benign	Benign
17	41219559	41219560	17q21.31	0	normal	.	C	ref	C	ac.gt	het-alt	99	0.49	.	1	AluSc|SINE|Alu|-|314	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC15	IVS16	.	.	no-change	NM_007294.3	NP_009225.1	-	Y	c.5074+65G=	.	.	.	NM_007294.3(BRCA1): c.5074+65G=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	5008	0.693091	U	0.372	0.306909	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs8176235	.	4024	0.630200	0.195	0.497	0.507	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41219559	41219560	17q21.31	0	normal	.	C	snv	T	ac.gt	het-ref	101	0.51	.	2	AluSc|SINE|Alu|-|314	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC15	IVS16	.	.	intron	NM_007294.3	NP_009225.1	-	Y	c.5074+65G>A	.	.	.	NM_007294.3(BRCA1): c.5074+65G>A	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	5008	0.306909	U	0.372	0.306909	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs8176235	.	4024	0.369800	0.195	0.497	0.507	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	127126	reviewed_by_expert_panel	Benign	Benign
17	41223093	41223094	17q21.31	0	normal	.	T	ref	T	AC.CT	het-alt	355	0.48	.	1	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	C14	EX15	.	.	no-change	NM_007294.3	NP_009225.1	-	Y	c.4837A=	.	.	.	NM_007294.3(BRCA1): c.4837A=	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict|;clinically-assoc,has-omim-omia,submitted-by-lsdb	126368|0	0.650117|0	U	0.372	0.355831	13006	0.701830	PASS	.	8612	0.619484	26103	121360	0.650363	.	.	.	.	.	.	rs1799966|rs397509199	.	4024	0.629500	0.533	0.264	0.128	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41223093	41223094	17q21.31	1	normal	.	T	snv	C	AC.CT	het-ref	385	0.52	.	2	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	C14	EX15	.	.	missense	NM_007294.3	NP_009225.1	-	Y	c.4837A>G	p.S1613G | p.Ser1613Gly	AGT=>GGT	P0=>P0	NM_007294.3(BRCA1): c.4837A>G (p.S1613G)	SingleClassTriAllelic;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict|;clinically-assoc,has-omim-omia,submitted-by-lsdb	126368|0	0.349820|0	U	0.372	0.355831	13006	0.298170	PASS	642	8612	0.380516	7852	121360	0.349572	1285	6528	3.78523e-01	16323	87283	3.54601e-01	rs1799966|rs397509199	.	4024	0.370500	0.533	0.264	0.128	0.24	0.006	0.012	0.037	neutral	ENST00000471181: c.4900A>G (p.S1634G)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3755559	.	.	.	.	.	no_record	41827	reviewed_by_expert_panel	Benign	Likely Benign
17	41226600	41226601	17q21.31	0	normal	.	G	ref	G	TT.CT	het-alt	117	0.50	.	1	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC12	IVS13	.	.	no-change	NM_007294.3	NP_009225.1	-	Y	c.4485-63C=	.	.	.	NM_007294.3(BRCA1): c.4485-63C=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5008	0.646565	U	0.371	0.353435	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs273900734	.	4024	0.631500	-0.719	0.112	-0.003	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41226600	41226601	17q21.31	0	normal	.	G	snv	C	TT.CT	het-ref	116	0.50	.	2	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC12	IVS13	.	.	intron	NM_007294.3	NP_009225.1	-	Y	c.4485-63C>G	.	.	.	NM_007294.3(BRCA1): c.4485-63C>G	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	5008	0.353435	U	0.371	0.353435	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs273900734	.	4024	0.368500	-0.719	0.112	-0.003	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	209374	reviewed_by_expert_panel	Benign	Benign
17	41230523	41230524	17q21.31	0	normal	.	T	ref	T	GT.AA	het-alt	272	0.56	.	1	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC11	IVS12	.	.	no-change	NM_007294.3	NP_009225.1	-	Y	c.4358-1893A=	.	.	.	NM_007294.3(BRCA1): c.4358-1893A=	;maf-5-some-pop,maf-5-all-pops	5008	0.747005	U	0.1786	0.252995	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs8176199	.	4024	0.814900	0.374	0.589	0.216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41230523	41230524	17q21.31	0	normal	.	T	snv	G	GT.AA	het-ref	216	0.44	.	2	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC11	IVS12	.	.	intron	NM_007294.3	NP_009225.1	-	Y	c.4358-1893A>C	.	.	.	NM_007294.3(BRCA1): c.4358-1893A>C	;maf-5-some-pop,maf-5-all-pops	5008	0.252995	U	0.1786	0.252995	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs8176199	.	4024	0.185100	0.374	0.589	0.216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	209392	reviewed_by_expert_panel	Benign	Benign
17	41230536	41230537	17q21.31	0	normal	.	A	ref	A	AA.GT	het-alt	285	0.54	.	1	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC11	IVS12	.	.	no-change	NM_007294.3	NP_009225.1	-	Y	c.4358-1906T=	.	.	.	NM_007294.3(BRCA1): c.4358-1906T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.497604	U	0.371	0.502396	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs8176198	.	4024	0.631700	-0.545	-1.473	-1.311	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41230536	41230537	17q21.31	0	normal	.	A	snv	T	AA.GT	het-ref	240	0.46	.	2	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC11	IVS12	.	.	intron	NM_007294.3	NP_009225.1	-	Y	c.4358-1906T>A	.	.	.	NM_007294.3(BRCA1): c.4358-1906T>A	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.502396	U	0.371	0.502396	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs8176198	.	4024	0.368300	-0.545	-1.473	-1.311	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	209393	reviewed_by_expert_panel	Benign	Benign
17	41230989	41230990	17q21.31	0	normal	.	A	ref	A	gg.ca	het-alt	120	0.49	.	1	AluSq2|SINE|Alu|+|290	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC11	IVS12	.	.	no-change	NM_007294.3	NP_009225.1	-	Y	c.4358-2359T=	.	.	.	NM_007294.3(BRCA1): c.4358-2359T=	;maf-5-some-pop,maf-5-all-pops	5008	0.497005	U	0.371	0.502995	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs8176196	.	4024	0.631700	-1.428	-1.346	-1.416	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41230989	41230990	17q21.31	0	normal	.	A	snv	G	gg.ca	het-ref	126	0.51	.	2	AluSq2|SINE|Alu|+|290	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC11	IVS12	.	.	intron	NM_007294.3	NP_009225.1	-	Y	c.4358-2359T>C	.	.	.	NM_007294.3(BRCA1): c.4358-2359T>C	;maf-5-some-pop,maf-5-all-pops	5008	0.502995	U	0.371	0.502995	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs8176196	.	4024	0.368300	-1.428	-1.346	-1.416	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	209396	reviewed_by_expert_panel	Benign	Benign
17	41231220	41231221	17q21.31	0	normal	.	A	ref	A	aa.aa	het-alt	260	0.62	.	1	AluSq2|SINE|Alu|+|290;trf	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC11	IVS12	.	.	no-change	NM_007294.3	NP_009225.1	-	Y	c.4358-2590T=	.	.	.	NM_007294.3(BRCA1): c.4358-2590T=	;maf-5-some-pop,maf-5-all-pops	5008	0.664537	U	0.371	0.335463	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs8176194	.	4024	0.632000	0.260	0.892	0.838	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41231220	41231221	17q21.31	0	normal	.	A	snv	C	aa.aa	het-ref	158	0.38	.	2	AluSq2|SINE|Alu|+|290;trf	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC11	IVS12	.	.	intron	NM_007294.3	NP_009225.1	-	Y	c.4358-2590T>G	.	.	.	NM_007294.3(BRCA1): c.4358-2590T>G	;maf-5-some-pop,maf-5-all-pops	5008	0.335463	U	0.371	0.335463	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs8176194	.	4024	0.368000	0.260	0.892	0.838	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	209398	reviewed_by_expert_panel	Benign	Benign
17	41231515	41231516	17q21.31	0	normal	.	C	ref	C	AA.GT	het-alt	345	0.54	.	1	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC11	IVS12	.	.	no-change	NM_007294.3	NP_009225.1	-	Y	c.4358-2885G=	.	.	.	NM_007294.3(BRCA1): c.4358-2885G=	;maf-5-some-pop,maf-5-all-pops	5008	0.646565	U	0.371	0.353435	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs8176193	.	4024	0.632000	-1.539	-0.481	-1.537	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41231515	41231516	17q21.31	0	normal	.	C	snv	T	AA.GT	het-ref	289	0.46	.	2	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC11	IVS12	.	.	intron	NM_007294.3	NP_009225.1	-	Y	c.4358-2885G>A	.	.	.	NM_007294.3(BRCA1): c.4358-2885G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.353435	U	0.371	0.353435	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs8176193	.	4024	0.368000	-1.539	-0.481	-1.537	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	209399	reviewed_by_expert_panel	Benign	Benign
17	41231805	41231806	17q21.31	0	normal	.	A	ref	A	TT.AA	het-alt	204	0.59	.	1	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC11	IVS12	.	.	no-change	NM_007294.3	NP_009225.1	-	Y	c.4357+2615T=	.	.	.	NM_007294.3(BRCA1): c.4357+2615T=	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs201508566	.	4024	0.587000	0.076	-0.052	-0.156	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41231805	41231806	17q21.31	0	normal	.	A	del	.	TT.AA	het-ref	139	0.41	.	2	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC11	IVS12	.	.	intron	NM_007294.3	NP_009225.1	-	Y	c.4357+2615delT	.	.	.	NM_007294.3(BRCA1): c.4357+2615delT	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs201508566	.	4024	0.412500	0.076	-0.052	-0.156	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41231901	41231902	17q21.31	0	normal	.	G	ref	G	AT.GG	het-alt	362	0.50	.	1	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC11	IVS12	.	.	no-change	NM_007294.3	NP_009225.1	-	Y	c.4357+2519C=	.	.	.	NM_007294.3(BRCA1): c.4357+2519C=	;maf-5-some-pop,maf-5-all-pops	5008	0.665136	U	0.371	0.334864	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4793197	.	4024	0.631500	0.596	0.071	-0.027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41231901	41231902	17q21.31	0	normal	.	G	snv	A	AT.GG	het-ref	364	0.50	.	2	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC11	IVS12	.	.	intron	NM_007294.3	NP_009225.1	-	Y	c.4357+2519C>T	.	.	.	NM_007294.3(BRCA1): c.4357+2519C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.334864	U	0.371	0.334864	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4793197	.	4024	0.368500	0.596	0.071	-0.027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	209401	reviewed_by_expert_panel	Benign	Benign
17	41234303	41234304	17q21.31	0	normal	.	C	ref	C	AC.CA	het-alt	391	0.55	.	1	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC11	IVS12	.	.	no-change	NM_007294.3	NP_009225.1	-	Y	c.4357+117G=	.	.	.	NM_007294.3(BRCA1): c.4357+117G=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	5008	0.935703	U	0.0913	0.0642971	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3737559	.	4024	0.900600	-0.244	-0.318	-0.325	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41234303	41234304	17q21.31	0	normal	.	C	snv	T	AC.CA	het-ref	318	0.45	.	2	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC11	IVS12	.	.	intron	NM_007294.3	NP_009225.1	-	Y	c.4357+117G>A	.	.	.	NM_007294.3(BRCA1): c.4357+117G>A	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb,genotype-conflict	5008	0.064297	U	0.0913	0.0642971	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3737559	.	4024	0.099400	-0.244	-0.318	-0.325	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	125708	reviewed_by_expert_panel	Benign	Benign
17	41234469	41234470	17q21.31	0	normal	.	A	ref	A	GA.GA	het-alt	440	0.53	.	1	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	C11	EX12	.	.	no-change	NM_007294.3	NP_009225.1	-	Y	c.4308T=	.	.	.	NM_007294.3(BRCA1): c.4308T=	MixedObserved;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	126386	0.657169	U	0.371	0.336262	13006	0.720437	PASS	.	8638	0.622251	26697	121378	0.656898	.	.	.	.	.	.	rs1060915	.	4024	0.631700	0.533	-0.053	0.129	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41234469	41234470	17q21.31	1	normal	.	A	snv	G	GA.GA	het-ref	390	0.47	.	2	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	C11	EX12	.	.	coding-synon	NM_007294.3	NP_009225.1	-	Y	c.4308T>C	p.(S1436=) | p.(Ser1436=)	TCT=>TCC	.	NM_007294.3(BRCA1): c.4308T>C (p.(S1436=))	MixedObserved;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	126386	0.342831	U	0.371	0.336262	13006	0.279563	PASS	637	8638	0.377749	7653	121378	0.343102	1276	6504	3.77087e-01	15965	85980	3.49274e-01	rs1060915	.	4024	0.368300	0.533	-0.053	0.129	.	.	.	.	.	ENST00000471181: c.4308T>C (p.S1436S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4416374	.	.	.	.	.	no_record	125703	reviewed_by_expert_panel	Benign	Likely Benign
17	41235798	41235799	17q21.31	0	nullSample	.	G	ref	G	GA.TG	homo-ref	.	.	.	0	.	.	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC10	IVS11	.	.	no-change	NM_007294.3	NP_009225.1	-	Y	c.4186-1207C=	.	.	.	NM_007294.3(BRCA1): c.4186-1207C=	;maf-5-some-pop	5008	0.414537	U	0.4435	0.585463	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs8067269	.	4024	0.581000	-0.891	-0.213	-0.246	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41235798	41235799	17q21.31	0	normal	.	G	snv	A	GA.TG	hom-alt	388	1.00	.	0	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC10	IVS11	.	.	intron	NM_007294.3	NP_009225.1	-	Y	c.4186-1207C>T	.	.	.	NM_007294.3(BRCA1): c.4186-1207C>T	;maf-5-some-pop	5008	0.585463	U	0.4435	0.585463	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs8067269	.	4024	0.419000	-0.891	-0.213	-0.246	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	209413	reviewed_by_expert_panel	Benign	Benign
17	41243999	41244000	17q21.31	0	normal	.	T	ref	T	CT.TC	het-alt	382	0.49	.	1	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	C9	EX10	.	.	no-change	NM_007294.3	NP_009225.1	-	Y	c.3548A=	.	.	.	NM_007294.3(BRCA1): c.3548A=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125780	0.650851	U	0.371	0.352636	13006	0.704752	PASS	-996	8508	0.617301	26004	120772	0.650995	.	.	.	.	.	.	rs16942	.	4024	0.631500	-0.726	-0.684	-0.437	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41243999	41244000	17q21.31	1	normal	.	T	snv	C	CT.TC	het-ref	405	0.51	.	2	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	C9	EX10	.	.	missense	NM_007294.3	NP_009225.1	-	Y	c.3548A>G	p.K1183R | p.Lys1183Arg	AAA=>AGA	P+=>P+	NM_007294.3(BRCA1): c.3548A>G (p.K1183R)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125780	0.349149	U	0.371	0.352636	13006	0.295248	PASS	632	8508	0.382699	7768	120772	0.349005	1272	6502	3.77848e-01	16165	86829	3.53368e-01	rs16942	.	4024	0.368500	-0.726	-0.684	-0.437	1	0.001	0	0.000	neutral	ENST00000357654: c.3548A>G (p.K1183R)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	148277	.	.	.	.	.	no_record	41818	reviewed_by_expert_panel	Benign	Likely Benign
17	41244434	41244435	17q21.31	0	normal	.	T	ref	T	CT.CT	het-alt	434	0.51	.	1	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	C9	EX10	.	.	no-change	NM_007294.3	NP_009225.1	-	Y	c.3113A=	.	.	.	NM_007294.3(BRCA1): c.3113A=	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict	126350	0.657420	U	0.371	0.335663	13006	0.720975	PASS	-995	8648	0.622340	26708	121342	0.657134	.	.	.	.	.	.	rs16941	.	4024	0.631700	0.455	-0.304	0.112	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41244434	41244435	17q21.31	1	normal	.	T	snv	C	CT.CT	het-ref	417	0.49	.	2	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	C9	EX10	.	.	missense	NM_007294.3	NP_009225.1	-	Y	c.3113A>G	p.E1038G | p.Glu1038Gly	GAA=>GGA	P-=>P0	NM_007294.3(BRCA1): c.3113A>G (p.E1038G)	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict	126350	0.342580	U	0.371	0.335663	13006	0.279025	PASS	638	8648	0.377660	7641	121342	0.342866	1276	6507	3.77261e-01	15910	85785	3.49026e-01	rs16941	.	4024	0.368300	0.455	-0.304	0.112	0.06	0.033	0.022	0.324	neutral	ENST00000471181: c.3113A>G (p.E1038G)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3755562	CM032861	NM_007294.3(BRCA1): c.3113A>G (p.E1038G)	"Endometriosis, association with ?"	12568865	DP	no_record	41815	reviewed_by_expert_panel	Benign	Likely Benign
17	41244935	41244936	17q21.31	0	normal	.	G	ref	G	AC.GA	het-alt	421	0.50	.	1	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	C9	EX10	Ethylene insensitive 3	PF04873.8	no-change	NM_007294.3	NP_009225.1	-	Y	c.2612C=	.	.	.	NM_007294.3(BRCA1): c.2612C=	MixedObserved,FlankMismatchGenomeLonger;clinically-assoc,has-omim-omia,submitted-by-lsdb|MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict,rs-cluster-nonoverlapping-alleles	0|126364	0|0.584644	U	0.371	0.54393	13006	0.506843	PASS	.	8642	0.621963	22502	121356	0.589950	.	.	.	.	.	.	rs397508986|rs799917	.	4024	0.629500	-0.524	1.726	0.938	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41244935	41244936	17q21.31	1	normal	.	G	snv	A	AC.GA	het-ref	413	0.50	.	2	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	C9	EX10	Ethylene insensitive 3	PF04873.8	missense	NM_007294.3	NP_009225.1	-	Y	c.2612C>T	p.P871L | p.Pro871Leu	CCG=>CTG	NP=>NP	NM_007294.3(BRCA1): c.2612C>T (p.P871L)	MixedObserved,FlankMismatchGenomeLonger;clinically-assoc,has-omim-omia,submitted-by-lsdb|MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb,genotype-conflict,rs-cluster-nonoverlapping-alleles	0|126364	0|0.415356	U	0.371	0.54393	13006	0.493157	PASS	637	8642	0.378037	11586	121356	0.410050	1274	6507	3.77349e-01	22183	99097	4.03158e-01	rs397508986|rs799917	.	4024	0.370500	-0.524	1.726	0.938	1	0	0	0.000	neutral	ENST00000357654: c.2612C>T (p.P871L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	148278	CM096315	NM_007294.3(BRCA1): c.2612C>T (p.P871L)	"Cervical cancer, decreased risk, association with"	19482343	DFP	no_record	41812	reviewed_by_expert_panel	Benign	Likely Benign
17	41245236	41245237	17q21.31	0	normal	.	A	ref	A	CA.TG	het-alt	444	0.54	.	1	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	C9	EX10	Ethylene insensitive 3	PF04873.8	no-change	NM_007294.3	NP_009225.1	-	Y	c.2311T=	.	.	.	NM_007294.3(BRCA1): c.2311T=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	126328	0.658302	U	0.371	0.335264	13006	0.722359	PASS	.	8632	0.621525	26776	121320	0.658037	.	.	.	.	.	.	rs16940	.	4024	0.631700	-0.441	-0.467	-0.828	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41245236	41245237	17q21.31	1	normal	.	A	snv	G	CA.TG	het-ref	382	0.46	.	2	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	C9	EX10	Ethylene insensitive 3	PF04873.8	coding-synon	NM_007294.3	NP_009225.1	-	Y	c.2311T>C	p.(L771=) | p.(Leu771=)	TTG=>CTG	.	NM_007294.3(BRCA1): c.2311T>C (p.(L771=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	126328	0.341698	U	0.371	0.335264	13006	0.277641	PASS	638	8632	0.378475	7603	121320	0.341963	1277	6508	3.77407e-01	15828	85559	3.48191e-01	rs16940	.	4024	0.368300	-0.441	-0.467	-0.828	.	.	.	.	.	ENST00000471181: c.2311T>C (p.L771L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3755565	.	.	.	.	.	no_record	125554	reviewed_by_expert_panel	Benign	Likely Benign
17	41245465	41245466	17q21.31	0	normal	.	G	ref	G	TC.CT	het-alt	394	0.49	.	1	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	C9	EX10	Ethylene insensitive 3	PF04873.8	no-change	NM_007294.3	NP_009225.1	-	Y	c.2082C=	.	.	.	NM_007294.3(BRCA1): c.2082C=	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	126272	0.652203	U	0.371	0.336462	13004	0.704322	PASS	.	8630	0.621669	26196	121264	0.651735	.	.	.	.	.	.	rs1799949	.	4024	0.631500	-0.340	-0.216	-0.084	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41245465	41245466	17q21.31	1	normal	.	G	snv	A	TC.CT	het-ref	410	0.51	.	2	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	C9	EX10	Ethylene insensitive 3	PF04873.8	coding-synon	NM_007294.3	NP_009225.1	-	Y	c.2082C>T	p.(S694=) | p.(Ser694=)	AGC=>AGT	.	NM_007294.3(BRCA1): c.2082C>T (p.(S694=))	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	126272	0.347797	U	0.371	0.336462	13004	0.295678	PASS	638	8630	0.378331	7796	121264	0.348265	1275	6504	3.77218e-01	16184	86878	3.53326e-01	rs1799949	.	4024	0.368500	-0.340	-0.216	-0.084	.	.	.	.	.	ENST00000357654: c.2082C>T (p.S694S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	148280	.	.	.	.	.	no_record	125536	reviewed_by_expert_panel	Benign	Likely Benign
17	41249363	41249364	17q21.31	0	normal	.	A	ref	A	TT.AA	het-alt	135	0.55	.	1	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC6	IVS7	.	.	no-change	NM_007294.3	NP_009225.1	-	Y	c.548-58T=	.	.	.	NM_007294.3(BRCA1): c.548-58T=	MixedObserved;|MixedObserved;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb|MixedObserved;	0|5008|0	0|0.665136|0	U	.	.	12282	0.721625	.	.	.	.	.	.	.	.	.	.	.	.	.	rs201664159|rs8176144|rs869086558	.	4024	0.631700	0.459	2.725	2.128	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41249363	41249364	17q21.31	0	normal	.	A	del	.	TT.AA	het-ref	111	0.45	.	2	.	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC6	IVS7	.	.	intron	NM_007294.3	NP_009225.1	-	Y	c.548-58delT	.	.	.	NM_007294.3(BRCA1): c.548-58delT	MixedObserved;|MixedObserved;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb|MixedObserved;	0|5008|0	0|0.334864|0	U	0.371	0.334864	12282	0.278375	.	.	.	.	.	.	.	.	.	.	.	.	.	rs201664159|rs8176144|rs869086558	.	4024	0.368300	0.459	2.725	2.128	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	125889	reviewed_by_expert_panel	Benign	Benign
17	41256074	41256075	17q21.31	0	normal	.	A	ref	A	tc.aa	het-alt	47	0.24	.	1	AluSx|SINE|Alu|+|52;trf	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC5	IVS6	.	.	no-change	NM_007294.3	NP_009225.1	-	Y	c.441+64T=	.	.	.	NM_007294.3(BRCA1): c.441+64T=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs368252296	.	4024	0.607900	0.172	0.410	0.394	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41256074	41256075	17q21.31	0	normal	.	A	del	.	tc.aa	het-ref	146	0.76	.	2	AluSx|SINE|Alu|+|52;trf	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC5	IVS6	.	.	intron	NM_007294.3	NP_009225.1	-	Y	c.441+64delT	.	.	.	NM_007294.3(BRCA1): c.441+64delT	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs368252296	.	4024	0.391900	0.172	0.410	0.394	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41256089	41256103	17q21.31	0	normal	.	AAAAAAAAGAAAAG	ref	AAAAAAAAGAAAAG	aa.aa	het-alt	244	0.76	.	1	AluSx|SINE|Alu|+|52;trf;(GAA)n|Simple_repeat|Simple_repeat|+|28	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC5	IVS6	.	.	no-change	NM_007294.3	NP_009225.1	-	Y	c.441+36_441+49=	.	.	.	NM_007294.3(BRCA1): c.441+36_441+49=	MixedObserved;	0	0	U	.	.	.	.	PASS	0	4336	1.000000	32538	65098	0.999723	.	.	.	.	.	.	rs373413425	.	4027	0.650900	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41256089	41256103	17q21.31	0	normal	.	AAAAAAAAGAAAAG	del	.	aa.aa	het-ref	78	0.24	.	2	AluSx|SINE|Alu|+|52;trf;(GAA)n|Simple_repeat|Simple_repeat|+|28	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	IC5	IVS6	.	.	intron	NM_007294.3	NP_009225.1	-	Y	c.441+36_441+49delCTTTTCTTTTTTTT	.	.	.	NM_007294.3(BRCA1): c.441+36_441+49delCTTTTCTTTTTTTT	MixedObserved;	0	0	U	.	.	.	.	VQSRTrancheINDEL99.00to99.50	437	8238	0.348992	5802	117684	0.327623	.	.	.	.	.	.	rs373413425	.	4027	0.348400	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	225705	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
17	41277186	41277187	17q21.31	0	normal	.	G	ref	G	CC.TC	het-alt	145	0.65	.	1	dup	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	I5U1	IVS1	.	.	no-change	NM_007294.3	NP_009225.1	-	Y	c.-20+101C=	.	.	.	NM_007294.3(BRCA1): c.-20+101C=	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	15792	0.498987	U	0.371	0.545128	.	.	PASS	.	134	0.559701	1495	10784	0.519473	.	.	.	.	.	.	rs799905	.	4024	0.632500	-1.042	-0.542	-0.680	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41277186	41277187	17q21.31	0	normal	.	G	snv	C	CC.TC	het-ref	77	0.35	.	2	dup	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	I5U1	IVS1	.	.	intron	NM_007294.3	NP_009225.1	-	Y	c.-20+101C>G	.	.	.	NM_007294.3(BRCA1): c.-20+101C>G	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	15792	0.501013	U	0.371	0.545128	.	.	PASS	10	134	0.440299	1285	10784	0.480527	734	3723	3.80286e-01	11368	50777	4.11403e-01	rs799905	.	4024	0.367500	-1.042	-0.542	-0.680	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	189123	reviewed_by_expert_panel	Benign	Benign
17	41283376	41283377	17q21.31	0	normal	.	C	ref	C	CG.TT	het-alt	228	0.61	.	1	dup	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	PROM	.	.	.	no-change	NM_007294.3	NP_009225.1	-	Y	c.-232-u5877G=	.	.	.	NM_007294.3(BRCA1): c.-232-u5877G=	;maf-5-some-pop,maf-5-all-pops	5008	0.646366	U	0.371	0.353634	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11653069	.	.	.	-1.461	-0.756	-0.843	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41283376	41283377	17q21.31	0	normal	.	C	snv	T	CG.TT	het-ref	145	0.39	.	2	dup	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	PROM	.	.	.	promoter	NM_007294.3	NP_009225.1	-	Y	c.-232-u5877G>A	.	.	.	NM_007294.3(BRCA1): c.-232-u5877G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.353634	U	0.371	0.353634	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11653069	.	.	.	-1.461	-0.756	-0.843	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41283397	41283400	17q21.31	0	normal	.	AAT	ref	AAT	AA.aa	het-alt	126	0.58	.	1	(TAA)n|Simple_repeat|Simple_repeat|+|27	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	PROM	.	.	.	no-change	NM_007294.3	NP_009225.1	-	Y	c.-232-u5900_-232-u5898=	.	.	.	NM_007294.3(BRCA1): c.-232-u5900_-232-u5898=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs141325957	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
17	41283397	41283400	17q21.31	0	normal	.	AAT	del	.	AA.aa	het-ref	93	0.42	.	2	(TAA)n|Simple_repeat|Simple_repeat|+|27	PASS	113705	C	604370(SK);614320(SK)	NN	Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to	AD	.	Oncologic	Oncologic	22614657|22317870|21531449|20495085|20216074|19656774|19190154|18762988|18413374|18349832|17307836|17233897|14569130|12677558|12161607|12036267|12023993|12023992|11463017|11463009|11133358|10885351|10441598|9450858|9012404|7894493|7894491|7545954	C1021;FC59;FH44;H41;H54;H62;H68;HB2;HB23;HBO28;HD31;HD32;HP16;HPro6;MC58;MH43	672	BRCA1	PROM	.	.	.	promoter	NM_007294.3	NP_009225.1	-	Y	c.-232-u5900_-232-u5898delATT	.	.	.	NM_007294.3(BRCA1): c.-232-u5900_-232-u5898delATT	MixedObserved;	0	0	U	0.372	0.355431	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs141325957	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41287879	41287880	17q21.31	0	normal	.	A	ref	A	AG.TG	het-alt	238	0.57	.	1	dup	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41287879A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.646166	U	0.372	0.353834	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs33988650	.	.	.	-1.873	-1.450	-1.373	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41287879	41287880	17q21.31	0	normal	.	A	snv	G	AG.TG	het-ref	177	0.43	.	2	dup	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41287879A>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.353834	U	0.372	0.353834	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs33988650	.	.	.	-1.873	-1.450	-1.373	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41287923	41287924	17q21.31	0	normal	.	C	ref	C	CC.TC	het-alt	216	0.52	.	1	dup	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41287923C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.663738	U	0.372	0.336262	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs33961729	.	.	.	0.442	0.594	0.591	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41287923	41287924	17q21.31	0	normal	.	C	snv	A	CC.TC	het-ref	198	0.48	.	2	dup	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41287923C>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.336262	U	0.372	0.336262	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs33961729	.	.	.	0.442	0.594	0.591	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41295488	41295489	17q21.31	0	normal	.	G	ref	G	GG.AT	het-alt	250	0.54	.	1	dup	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41295488G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.662540	U	0.372	0.33746	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11652332	.	.	.	0.437	1.124	1.116	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41295488	41295489	17q21.31	0	normal	.	G	snv	A	GG.AT	het-ref	217	0.46	.	2	dup	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41295488G>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.337460	U	0.372	0.33746	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11652332	.	.	.	0.437	1.124	1.116	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41299830	41299831	17q21.31	0	nullSample	.	C	ref	C	GC.CT	homo-ref	.	.	.	0	dup	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41299830C= (intergenic)	.	.	.	.	0.4435	0.580072	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.545	0.193	0.180	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41299831	41299831	17q21.31	0	normal	.	.	ins	CT	CC.CT	hom-alt	213	1.00	.	0	dup	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41299831_41299832insCT (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.580072	U	0.4435	0.580072	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs35678438	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41299927	41299928	17q21.31	0	normal	.	G	ref	G	AC.AC	het-alt	220	0.49	.	1	dup	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41299927G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.646965	U	0.372	0.353035	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12950607	.	.	.	-1.737	-1.102	-1.161	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41299927	41299928	17q21.31	0	normal	.	G	snv	C	AC.AC	het-ref	226	0.51	.	2	dup	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41299927G>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.353035	U	0.372	0.353035	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12950607	.	.	.	-1.737	-1.102	-1.161	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41310494	41310495	17q21.31	0	normal	.	T	ref	T	GA.TG	het-alt	206	0.58	.	1	dup	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41310494T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.664537	U	0.372	0.335463	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1973646	.	.	.	0.260	0.458	1.118	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41310494	41310495	17q21.31	0	normal	.	T	snv	C	GA.TG	het-ref	150	0.42	.	2	dup	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41310494T>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.335463	U	0.372	0.335463	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1973646	.	.	.	0.260	0.458	1.118	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41321845	41321846	17q21.31	0	normal	.	C	ref	C	GT.CC	het-alt	188	0.54	.	1	dup	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41321845C= (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.647165	U	0.37	0.352835	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs33946455	.	.	.	0.591	-0.686	-0.712	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41321845	41321846	17q21.31	0	normal	.	C	snv	T	GT.CC	het-ref	161	0.46	.	2	dup	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41321845C>T (intergenic)	;maf-5-some-pop,maf-5-all-pops	5008	0.352835	U	0.37	0.352835	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs33946455	.	.	.	0.591	-0.686	-0.712	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41321909	41321910	17q21.31	0	nullSample	.	C	ref	C	CA.TG	homo-ref	.	.	.	0	dup	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41321909C= (intergenic)	;maf-5-some-pop	5008	0.117013	U	1	0.882987	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9908805	.	.	.	-1.140	-1.133	-1.223	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	41321909	41321910	17q21.31	0	normal	.	C	snv	T	CA.TG	hom-alt	190	1.00	.	0	dup	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr17: g.41321909C>T (intergenic)	;maf-5-some-pop	5008	0.882987	U	1	0.882987	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs9908805	.	.	.	-1.140	-1.133	-1.223	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	45369776	45369777	17q21.32	0	normal	.	A	ref	A	GA.TG	het-alt	226	0.58	.	1	.	PASS	173470	C	173470(MK);187800(MK);273800(MK);608446(SK)	AD;AR	Glanzmann thrombasthenia	AD/AR	.	Hematologic	Hematologic	23929305|23253071|23146053|22890234|22250950|22102273|21917754|20345392|20081061|20020534|19408193|19336737|18065693|16721604|16463284|11723016|11425767|10583927|10559451|9845537|9700201|9351872|9160670|8878424|8471765|8093349|7694683|7193688|2565345|2428841|2392682|2257303|2014236|1967954|1602006|1438206|1430225|1371279	.	3690	ITGB3	C10	EX10	.	.	no-change	NM_000212.2	NP_000203.2	+	Y	c.1533A=	.	.	.	NM_000212.2(ITGB3): c.1533A=	;maf-5-some-pop,maf-5-all-pops	126022	0.712852	U	0.3313	0.28734	13006	0.716054	PASS	.	8614	0.652775	30765	121014	0.712860	.	.	.	.	.	.	rs4642	.	4024	0.684100	-0.355	2.116	1.283	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	45369776	45369777	17q21.32	1	normal	.	A	snv	G	GA.TG	het-ref	162	0.42	.	2	.	PASS	173470	C	173470(MK);187800(MK);273800(MK);608446(SK)	AD;AR	Glanzmann thrombasthenia	AD/AR	.	Hematologic	Hematologic	23929305|23253071|23146053|22890234|22250950|22102273|21917754|20345392|20081061|20020534|19408193|19336737|18065693|16721604|16463284|11723016|11425767|10583927|10559451|9845537|9700201|9351872|9160670|8878424|8471765|8093349|7694683|7193688|2565345|2428841|2392682|2257303|2014236|1967954|1602006|1438206|1430225|1371279	.	3690	ITGB3	C10	EX10	.	.	coding-synon	NM_000212.2	NP_000203.2	+	Y	c.1533A>G	p.(E511=) | p.(Glu511=)	GAA=>GAG	.	NM_000212.2(ITGB3): c.1533A>G (p.(E511=))	;maf-5-some-pop,maf-5-all-pops	126022	0.287148	U	0.3313	0.28734	13006	0.283946	PASS	499	8614	0.347225	5006	121014	0.287140	997	5948	3.44932e-01	10071	70036	2.85563e-01	rs4642	.	4024	0.315900	-0.355	2.116	1.283	.	.	.	.	.	ENST00000262017: c.1533A>G (p.E511E)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	1383908	.	.	.	.	.	no_record	255536	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
17	45369788	45369789	17q21.32	0	normal	.	G	ref	G	CG.GA	het-alt	205	0.58	.	1	.	PASS	173470	C	173470(MK);187800(MK);273800(MK);608446(SK)	AD;AR	Glanzmann thrombasthenia	AD/AR	.	Hematologic	Hematologic	23929305|23253071|23146053|22890234|22250950|22102273|21917754|20345392|20081061|20020534|19408193|19336737|18065693|16721604|16463284|11723016|11425767|10583927|10559451|9845537|9700201|9351872|9160670|8878424|8471765|8093349|7694683|7193688|2565345|2428841|2392682|2257303|2014236|1967954|1602006|1438206|1430225|1371279	.	3690	ITGB3	C10	EX10	.	.	no-change	NM_000212.2	NP_000203.2	+	Y	c.1545G=	.	.	.	NM_000212.2(ITGB3): c.1545G=	;maf-5-some-pop,maf-5-all-pops	125902	0.712697	U	0.3313	0.28734	13006	0.716131	PASS	.	8606	0.652452	30720	120894	0.712699	.	.	.	.	.	.	rs4634	.	4024	0.684100	0.462	0.837	0.591	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	45369788	45369789	17q21.32	1	normal	.	G	snv	A	CG.GA	het-ref	147	0.42	.	2	.	PASS	173470	C	173470(MK);187800(MK);273800(MK);608446(SK)	AD;AR	Glanzmann thrombasthenia	AD/AR	.	Hematologic	Hematologic	23929305|23253071|23146053|22890234|22250950|22102273|21917754|20345392|20081061|20020534|19408193|19336737|18065693|16721604|16463284|11723016|11425767|10583927|10559451|9845537|9700201|9351872|9160670|8878424|8471765|8093349|7694683|7193688|2565345|2428841|2392682|2257303|2014236|1967954|1602006|1438206|1430225|1371279	.	3690	ITGB3	C10	EX10	.	.	coding-synon	NM_000212.2	NP_000203.2	+	Y	c.1545G>A	p.(R515=) | p.(Arg515=)	CGG=>CGA	.	NM_000212.2(ITGB3): c.1545G>A (p.(R515=))	;maf-5-some-pop,maf-5-all-pops	125902	0.287303	U	0.3313	0.28734	13006	0.283869	PASS	500	8606	0.347548	5006	120894	0.287301	997	5947	3.44874e-01	10066	69968	2.85570e-01	rs4634	.	4024	0.315900	0.462	0.837	0.591	.	.	.	.	.	ENST00000262017: c.1545G>A (p.R515R)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	1383912	.	.	.	.	.	no_record	255537	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
17	46805294	46805295	17q21.32	0	normal	.	T	snv	C	AA.GC	het-ref	154	0.48	.	2	.	PASS	604607	P	.	NN	.	.	.	.	.	.	H41;H54;H62;H68;HPro6;MC58;MH43	10481	HOXB13	IC1	IVS1	.	.	intron	NM_006361.5	NP_006352.2	-	Y	c.601+60A>G	.	.	.	NM_006361.5(HOXB13): c.601+60A>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.005000	0.459	-0.754	-0.981	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
17	46805294	46805295	17q21.32	0	normal	.	T	ref	T	AA.GC	het-alt	168	0.52	.	1	.	PASS	604607	P	.	NN	.	.	.	.	.	.	H41;H54;H62;H68;HPro6;MC58;MH43	10481	HOXB13	IC1	IVS1	.	.	no-change	NM_006361.5	NP_006352.2	-	Y	c.601+60A=	.	.	.	NM_006361.5(HOXB13): c.601+60A=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.995000	0.459	-0.754	-0.981	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	47688880	47688881	17q21.33	0	normal	.	T	ref	T	GA.AG	het-alt	193	0.52	.	1	.	PASS	602650	P	.	NN	.	.	.	.	.	.	.	8405	SPOP	IC4	IVS7	.	.	no-change	NM_001007226.1	NP_001007227.1	-	Y	c.481-62A=	.	.	.	NM_001007226.1(SPOP): c.481-62A=	.	.	.	.	0.7917	0.734425	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.353	-0.697	-0.343	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	47688881	47688881	17q21.33	0	normal	.	.	ins	AGAG	AT.AG	het-ref	180	0.48	.	2	.	PASS	602650	P	.	NN	.	.	.	.	.	.	.	8405	SPOP	IC4	IVS7	.	.	intron	NM_001007226.1	NP_001007227.1	-	Y	c.481-63_481-62insCTCT	.	.	.	NM_001007226.1(SPOP): c.481-63_481-62insCTCT	;maf-5-some-pop,maf-5-all-pops	5008	0.734425	U	0.7917	0.734425	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs140209761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	47696819	47696820	17q21.33	0	normal	.	G	ref	G	GA.AG	het-alt	173	0.50	.	1	.	PASS	602650	P	.	NN	.	.	.	.	.	.	.	8405	SPOP	IC2	IVS5	.	.	no-change	NM_001007226.1	NP_001007227.1	-	Y	c.201-73C=	.	.	.	NM_001007226.1(SPOP): c.201-73C=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.784545	U	0.3433	0.215455	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7219984	.	.	.	0.557	0.169	0.187	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	47696819	47696820	17q21.33	0	normal	.	G	snv	A	GA.AG	het-ref	171	0.50	.	2	.	PASS	602650	P	.	NN	.	.	.	.	.	.	.	8405	SPOP	IC2	IVS5	.	.	intron	NM_001007226.1	NP_001007227.1	-	Y	c.201-73C>T	.	.	.	NM_001007226.1(SPOP): c.201-73C>T	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.215455	U	0.3433	0.215455	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7219984	.	.	.	0.557	0.169	0.187	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	56435884	56435885	17q22	0	normal	.	G	ref	G	CA.TC	het-alt	341	0.49	.	1	.	PASS	612482	P	.	NN	.	.	.	.	.	.	.	54894	RNF43	C8	EX9	.	.	no-change	NM_017763.4	NP_060233.3	-	Y	c.1252C=	.	.	.	NM_017763.4(RNF43): c.1252C=	;maf-5-some-pop,maf-5-all-pops	122970	0.602708	U	0.4494	0.399561	13006	0.626249	PASS	-1064	8460	0.533570	21570	117962	0.602804	.	.	.	.	.	.	rs2526374	.	4024	0.537300	0.195	2.132	2.179	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	56435884	56435885	17q22	1	normal	.	G	snv	T	CA.TC	het-ref	349	0.51	.	2	.	PASS	612482	P	.	NN	.	.	.	.	.	.	.	54894	RNF43	C8	EX9	.	.	missense	NM_017763.4	NP_060233.3	-	Y	c.1252C>A	p.L418M | p.Leu418Met	CTG=>ATG	NP=>NP	NM_017763.4(RNF43): c.1252C>A (p.L418M)	;maf-5-some-pop,maf-5-all-pops	122970	0.397292	U	0.4494	0.399561	13006	0.373751	PASS	909	8460	0.466430	9443	117962	0.397196	1828	7907	4.60459e-01	19799	96295	3.94435e-01	rs2526374	.	4024	0.462700	0.195	2.132	2.179	0	0.674	0.978	0.684	deleterious	ENST00000407977: c.1252C>A (p.L418M)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4130449	.	.	.	.	.	no_record	403384	criteria_provided,_single_submitter	Benign	Likely Benign
17	56438079	56438080	17q22	0	normal	.	A	snv	C	CC.CC	het-ref	58	0.44	.	2	.	PASS	612482	P	.	NN	.	.	.	.	.	.	.	54894	RNF43	IC6	IVS7	.	.	intron	NM_017763.4	NP_060233.3	-	Y	c.849+64T>G	.	.	.	NM_017763.4(RNF43): c.849+64T>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.113800	-0.425	-0.180	0.018	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	56438079	56438080	17q22	0	normal	.	A	ref	A	CC.CC	het-alt	75	0.56	.	1	.	PASS	612482	P	.	NN	.	.	.	.	.	.	.	54894	RNF43	IC6	IVS7	.	.	no-change	NM_017763.4	NP_060233.3	-	Y	c.849+64T=	.	.	.	NM_017763.4(RNF43): c.849+64T=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.886200	-0.425	-0.180	0.018	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	56439994	56439995	17q22	0	normal	.	C	ref	C	CA.AC	het-alt	158	0.48	.	1	.	PASS	612482	P	.	NN	.	.	.	.	.	.	.	54894	RNF43	C5	EX6	.	.	no-change	NM_017763.4	NP_060233.3	-	Y	c.597G=	.	.	.	NM_017763.4(RNF43): c.597G=	;	125700	0.997605	U	0.0159	0.00359425	13006	0.999769	PASS	.	8650	0.983468	60068	120692	0.997655	.	.	.	.	.	.	rs77499318	.	4024	0.992000	-0.320	0.697	0.305	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	56439994	56439995	17q22	1	normal	.	C	snv	T	CA.AC	het-ref	173	0.52	.	2	.	PASS	612482	P	.	NN	.	.	.	.	.	.	.	54894	RNF43	C5	EX6	.	.	coding-synon	NM_017763.4	NP_060233.3	-	Y	c.597G>A	p.(V199=) | p.(Val199=)	GTG=>GTA	.	NM_017763.4(RNF43): c.597G>A (p.(V199=))	;	125700	0.002395	U	0.0159	0.00359425	13006	0.000231	PASS	5	8650	0.016532	5	120692	0.002345	6	242	1.43331e-02	8	467	1.91840e-03	rs77499318	.	4024	0.008000	-0.320	0.697	0.305	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
17	56448296	56448297	17q22	0	normal	.	C	ref	C	GG.GG	het-alt	338	0.56	.	1	.	PASS	612482	P	.	NN	.	.	.	.	.	.	.	54894	RNF43	C2	EX3	.	.	no-change	NM_017763.4	NP_060233.3	-	Y	c.350G=	.	.	.	NM_017763.4(RNF43): c.350G=	SingleClassTriAllelic;maf-5-some-pop,microattr-tpa	121350	0.833350	U	0.373	0.226238	13006	0.865293	PASS	-1009	8606	0.615152	41088	116342	0.835915	.	.	.	.	.	.	rs2257205	.	4024	0.622300	0.655	1.772	2.555	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	56448296	56448297	17q22	1	normal	.	C	snv	T	GG.GG	het-ref	265	0.44	.	2	.	PASS	612482	P	.	NN	.	.	.	.	.	.	.	54894	RNF43	C2	EX3	.	.	missense	NM_017763.4	NP_060233.3	-	Y	c.350G>A	p.R117H | p.Arg117His	CGC=>CAC	P+=>P+	NM_017763.4(RNF43): c.350G>A (p.R117H)	SingleClassTriAllelic;maf-5-some-pop,microattr-tpa	121350	0.166642	U	0.373	0.226238	13006	0.134707	PASS	647	8606	0.384848	2007	116342	0.164077	1301	6583	3.86508e-01	4012	37598	1.57424e-01	rs2257205	.	4024	0.377700	0.655	1.772	2.555	0.02	0.362	0.968	0.498	deleterious	ENST00000407977: c.350G>A (p.R117H)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3755721	.	.	.	.	.	.	.	.	.	Likely Benign
17	56492799	56492800	17q22	0	normal	.	T	ref	T	AA.AG	het-alt	425	0.58	.	1	.	PASS	612482	P	.	NN	.	.	.	.	.	.	.	54894	RNF43	C1	EX2	.	.	no-change	NM_017763.4	NP_060233.3	-	Y	c.139A=	.	.	.	NM_017763.4(RNF43): c.139A=	;maf-5-some-pop,maf-5-all-pops	126364	0.596428	U	0.5258	0.373802	13006	0.671690	PASS	.	8620	0.475058	22043	121356	0.595199	.	.	.	.	.	.	rs3744093	.	4024	0.503700	0.533	0.617	0.973	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	56492799	56492800	17q22	1	normal	.	T	snv	C	AA.AG	het-ref	308	0.42	.	2	.	PASS	612482	P	.	NN	.	.	.	.	.	.	.	54894	RNF43	C1	EX2	.	.	missense	NM_017763.4	NP_060233.3	-	Y	c.139A>G	p.I47V | p.Ile47Val	ATT=>GTT	NP=>NP	NM_017763.4(RNF43): c.139A>G (p.I47V)	;maf-5-some-pop,maf-5-all-pops	126364	0.403572	U	0.5258	0.373802	13006	0.328310	PASS	1201	8620	0.524942	10490	121356	0.404801	2312	8921	5.17279e-01	22003	101383	4.11815e-01	rs3744093	.	4024	0.496300	0.533	0.617	0.973	0.38	0.001	0.001	0.018	neutral	ENST00000407977: c.139A>G (p.I47V)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	5618411	.	.	.	.	.	no_record	403385	criteria_provided,_single_submitter	Benign	Likely Benign
17	56780458	56780459	17q22	0	normal	.	C	ref	C	AT.CA	het-alt	153	0.54	.	1	.	PASS	602774	P	613390(MK);613399(SK)	NN	Fanconi anemia goup O; Breast-ovarian cancer, familial, susceptibility to	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular; Gastrointestinal; Musculoskeletal; Neurologic; Oncologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	21568838|20400964|20400963|20301575	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;MC58;MH43	5889	RAD51C	IC3	IVS3	.	.	no-change	NM_058216.1	NP_478123.1	+	Y	c.572-98C=	.	.	.	NM_058216.1(RAD51C): c.572-98C=	;maf-5-some-pop,maf-5-all-pops	5008	0.766573	U	0.3016	0.233427	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6503874	.	4024	0.670700	-4.860	-2.246	-1.966	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	56780458	56780459	17q22	0	normal	.	C	snv	G	AT.CA	het-ref	130	0.46	.	2	.	PASS	602774	P	613390(MK);613399(SK)	NN	Fanconi anemia goup O; Breast-ovarian cancer, familial, susceptibility to	AD/AR	.	Allergy/Immunology/Infectious; Cardiovascular; Gastrointestinal; Musculoskeletal; Neurologic; Oncologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	21568838|20400964|20400963|20301575	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;MC58;MH43	5889	RAD51C	IC3	IVS3	.	.	intron	NM_058216.1	NP_478123.1	+	Y	c.572-98C>G	.	.	.	NM_058216.1(RAD51C): c.572-98C>G	;maf-5-some-pop,maf-5-all-pops	5008	0.233427	U	0.3016	0.233427	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6503874	.	4024	0.329300	-4.860	-2.246	-1.966	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	59760995	59760996	17q23.2	0	normal	.	A	ref	A	TC.TA	het-alt	370	0.54	.	1	.	PASS	605882	C	114480(MK);609054(MK)	AD	Fanconi anemia, complementation group J	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22441895|22006311|21964575|21568838|17033622|16116424|16116423|14630800	FC59;FH44;H41;H54;H62;H68;HB23;HBO28	83990	BRIP1	C19E	EX20E	.	.	no-change	NM_032043.2	NP_114432.2	-	Y	c.3411T=	.	.	.	NM_032043.2(BRIP1): c.3411T=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	125994	0.404821	U	0.754	0.620807	13004	0.393956	PASS	.	8638	0.277032	10656	120986	0.405882	.	.	.	.	.	.	rs4986763	.	4024	0.301400	0.460	1.710	1.050	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	59760995	59760996	17q23.2	1	normal	.	A	snv	G	TC.TA	het-ref	311	0.46	.	2	.	PASS	605882	C	114480(MK);609054(MK)	AD	Fanconi anemia, complementation group J	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22441895|22006311|21964575|21568838|17033622|16116424|16116423|14630800	FC59;FH44;H41;H54;H62;H68;HB23;HBO28	83990	BRIP1	C19E	EX20E	.	.	coding-synon	NM_032043.2	NP_114432.2	-	Y	c.3411T>C	p.(Y1137=) | p.(Tyr1137=)	TAT=>TAC	.	NM_032043.2(BRIP1): c.3411T>C (p.(Y1137=))	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	125994	0.595179	U	0.754	0.620807	13004	0.606044	PASS	2283	8638	0.722968	22043	120986	0.594118	4451	12327	7.15272e-01	45314	146251	5.97294e-01	rs4986763	.	4024	0.698600	0.460	1.710	1.050	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	183702	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
17	59763346	59763347	17q23.2	0	normal	.	A	ref	A	TG.GG	het-alt	362	0.52	.	1	.	PASS	605882	C	114480(MK);609054(MK)	AD	Fanconi anemia, complementation group J	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22441895|22006311|21964575|21568838|17033622|16116424|16116423|14630800	FC59;FH44;H41;H54;H62;H68;HB23;HBO28	83990	BRIP1	C18	EX19	.	.	no-change	NM_032043.2	NP_114432.2	-	Y	c.2755T=	.	.	.	NM_032043.2(BRIP1): c.2755T=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126398	0.401565	U	0.755	0.627796	13006	0.386591	PASS	.	8648	0.276480	10563	121390	0.402776	.	.	.	.	.	.	rs4986764	.	4024	0.301700	-0.802	-0.085	0.011	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	59763346	59763347	17q23.2	1	normal	.	A	snv	G	TG.GG	het-ref	329	0.48	.	2	.	PASS	605882	C	114480(MK);609054(MK)	AD	Fanconi anemia, complementation group J	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22441895|22006311|21964575|21568838|17033622|16116424|16116423|14630800	FC59;FH44;H41;H54;H62;H68;HB23;HBO28	83990	BRIP1	C18	EX19	.	.	missense	NM_032043.2	NP_114432.2	-	Y	c.2755T>C	p.S919P | p.Ser919Pro	TCA=>CCA	P0=>NP	NM_032043.2(BRIP1): c.2755T>C (p.S919P)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	126398	0.598435	U	0.755	0.627796	13006	0.613409	PASS	2290	8648	0.723520	22365	121390	0.597224	4456	12337	7.15271e-01	46002	147651	5.99822e-01	rs4986764	.	4024	0.698300	-0.802	-0.085	0.011	0.51	0	0	0.009	neutral	.	.	.	.	.	.	.	.	.	.	no_record	133756	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
17	59763464	59763465	17q23.2	0	nullSample	.	T	ref	T	GA.TC	homo-ref	.	.	.	0	.	.	605882	C	114480(MK);609054(MK)	AD	Fanconi anemia, complementation group J	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22441895|22006311|21964575|21568838|17033622|16116424|16116423|14630800	FC59;FH44;H41;H54;H62;H68;HB23;HBO28	83990	BRIP1	C18	EX19	.	.	no-change	NM_032043.2	NP_114432.2	-	Y	c.2637A=	.	.	.	NM_032043.2(BRIP1): c.2637A=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126316	0.277392	U	0.9127	0.815096	13006	0.265724	PASS	.	8654	0.106656	5547	121308	0.281210	.	.	.	.	.	.	rs4986765	.	4024	0.132200	-0.733	0.234	0.116	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	59763464	59763465	17q23.2	1	normal	.	T	snv	C	GA.TC	hom-alt	615	1.00	.	0	.	PASS	605882	C	114480(MK);609054(MK)	AD	Fanconi anemia, complementation group J	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22441895|22006311|21964575|21568838|17033622|16116424|16116423|14630800	FC59;FH44;H41;H54;H62;H68;HB23;HBO28	83990	BRIP1	C18	EX19	.	.	coding-synon	NM_032043.2	NP_114432.2	-	Y	c.2637A>G	p.(E879=) | p.(Glu879=)	GAA=>GAG	.	NM_032043.2(BRIP1): c.2637A>G (p.(E879=))	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126316	0.722608	U	0.9127	0.815096	13006	0.734276	PASS	3465	8654	0.893344	32088	121308	0.718790	6863	15374	8.91350e-01	64801	176173	7.15877e-01	rs4986765	.	4024	0.867800	-0.733	0.234	0.116	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	183703	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
17	59820337	59820338	17q23.2	0	normal	.	C	ref	C	CT.CT	het-alt	256	0.55	.	1	.	PASS	605882	C	114480(MK);609054(MK)	AD	Fanconi anemia, complementation group J	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22441895|22006311|21964575|21568838|17033622|16116424|16116423|14630800	FC59;FH44;H41;H54;H62;H68;HB23;HBO28	83990	BRIP1	IC15	IVS16	.	.	no-change	NM_032043.2	NP_114432.2	-	Y	c.2379+36G=	.	.	.	NM_032043.2(BRIP1): c.2379+36G=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.270	0.034	0.025	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
17	59820337	59820338	17q23.2	0	normal	.	C	snv	A	CT.CT	het-ref	211	0.45	.	2	.	PASS	605882	C	114480(MK);609054(MK)	AD	Fanconi anemia, complementation group J	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22441895|22006311|21964575|21568838|17033622|16116424|16116423|14630800	FC59;FH44;H41;H54;H62;H68;HB23;HBO28	83990	BRIP1	IC15	IVS16	.	.	intron	NM_032043.2	NP_114432.2	-	Y	c.2379+36G>T	.	.	.	NM_032043.2(BRIP1): c.2379+36G>T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.270	0.034	0.025	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
17	59857598	59857599	17q23.2	0	normal	.	C	ref	C	TC.AA	het-alt	317	0.83	.	1	.	PASS	605882	C	114480(MK);609054(MK)	AD	Fanconi anemia, complementation group J	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22441895|22006311|21964575|21568838|17033622|16116424|16116423|14630800	FC59;FH44;H41;H54;H62;H68;HB23;HBO28	83990	BRIP1	IC12	IVS13	.	.	no-change	NM_032043.2	NP_114432.2	-	Y	c.1935+23G=	.	.	.	NM_032043.2(BRIP1): c.1935+23G=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.516	0.667	0.135	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
17	59857599	59857599	17q23.2	0	normal	.	.	ins	A	CC.AA	het-ref	67	0.17	.	2	.	PASS	605882	C	114480(MK);609054(MK)	AD	Fanconi anemia, complementation group J	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22441895|22006311|21964575|21568838|17033622|16116424|16116423|14630800	FC59;FH44;H41;H54;H62;H68;HB23;HBO28	83990	BRIP1	IC12	IVS13	.	.	intron	NM_032043.2	NP_114432.2	-	Y	c.1935+22_1935+23insT	.	.	.	NM_032043.2(BRIP1): c.1935+22_1935+23insT	MixedObserved;	1362	0.000734	U	.	.	.	.	PASS	0	6072	0.120224	0	84832	0.160847	.	.	.	.	.	.	rs776579803	.	4024	0.423700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	59857808	59857809	17q23.2	0	nullSample	.	C	ref	C	gg.tg	homo-ref	.	.	.	0	AluJb|SINE|Alu|+|283	.	605882	C	114480(MK);609054(MK)	AD	Fanconi anemia, complementation group J	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22441895|22006311|21964575|21568838|17033622|16116424|16116423|14630800	FC59;FH44;H41;H54;H62;H68;HB23;HBO28	83990	BRIP1	IC11	IVS12	.	.	no-change	NM_032043.2	NP_114432.2	-	Y	c.1795-47G=	.	.	.	NM_032043.2(BRIP1): c.1795-47G=	SingleClassTriAllelic;maf-5-some-pop	123258	0.250726	U	0.8026	0.789736	13002	0.214121	PASS	.	8440	0.173341	4365	118250	0.252440	.	.	.	.	.	.	rs4988351	.	4024	0.195600	0.313	1.358	0.308	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	59857808	59857809	17q23.2	0	normal	.	C	snv	G	gg.tg	hom-alt	244	1.00	.	0	AluJb|SINE|Alu|+|283	PASS	605882	C	114480(MK);609054(MK)	AD	Fanconi anemia, complementation group J	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22441895|22006311|21964575|21568838|17033622|16116424|16116423|14630800	FC59;FH44;H41;H54;H62;H68;HB23;HBO28	83990	BRIP1	IC11	IVS12	.	.	intron	NM_032043.2	NP_114432.2	-	Y	c.1795-47G>C	.	.	.	NM_032043.2(BRIP1): c.1795-47G>C	SingleClassTriAllelic;maf-5-some-pop	123258	0.749266	U	0.8026	0.789736	13002	0.785879	PASS	2892	8440	0.826659	33638	118250	0.747552	5920	14211	8.31442e-01	67544	179367	7.37262e-01	rs4988351	.	4024	0.804400	0.313	1.358	0.308	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	262005	criteria_provided,_single_submitter	Benign	Benign
17	59885812	59885813	17q23.2	0	normal	.	A	ref	A	AA.AT	het-alt	256	0.53	.	1	.	PASS	605882	C	114480(MK);609054(MK)	AD	Fanconi anemia, complementation group J	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22441895|22006311|21964575|21568838|17033622|16116424|16116423|14630800	FC59;FH44;H41;H54;H62;H68;HB23;HBO28	83990	BRIP1	IC6	IVS7	.	.	no-change	NM_032043.2	NP_114432.2	-	Y	c.918+15T=	.	.	.	NM_032043.2(BRIP1): c.918+15T=	;clinically-assoc,submitted-by-lsdb	125866	0.996870	U	0.0427	0.00858626	.	.	PASS	.	8630	0.960487	60085	120858	0.997096	.	.	.	.	.	.	rs117820198	.	4024	0.964200	0.472	0.656	0.075	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	59885812	59885813	17q23.2	1	normal	.	A	snv	T	AA.AT	het-ref	226	0.47	.	2	.	PASS	605882	C	114480(MK);609054(MK)	AD	Fanconi anemia, complementation group J	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22441895|22006311|21964575|21568838|17033622|16116424|16116423|14630800	FC59;FH44;H41;H54;H62;H68;HB23;HBO28	83990	BRIP1	IC6	IVS7	.	.	intron	NM_032043.2	NP_114432.2	-	Y	c.918+15T>A	.	.	.	NM_032043.2(BRIP1): c.918+15T>A	;clinically-assoc,submitted-by-lsdb	125866	0.003130	U	0.0427	0.00858626	.	.	PASS	7	8630	0.039513	7	120858	0.002904	10	700	4.06080e-02	10	725	2.95764e-03	rs117820198	.	4024	0.035800	0.472	0.656	0.075	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	136583	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
17	59924611	59924612	17q23.2	0	normal	.	G	ref	G	AA.GT	het-alt	251	0.53	.	1	.	PASS	605882	C	114480(MK);609054(MK)	AD	Fanconi anemia, complementation group J	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22441895|22006311|21964575|21568838|17033622|16116424|16116423|14630800	FC59;FH44;H41;H54;H62;H68;HB23;HBO28	83990	BRIP1	IC4	IVS5	.	.	no-change	NM_032043.2	NP_114432.2	-	Y	c.508-31C=	.	.	.	NM_032043.2(BRIP1): c.508-31C=	;maf-5-some-pop,maf-5-all-pops	126234	0.809037	U	0.5625	0.215655	13006	0.870752	PASS	-1080	8636	0.445345	40494	121226	0.810057	.	.	.	.	.	.	rs4988344	.	4024	0.449100	-0.457	-0.689	-0.651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	59924611	59924612	17q23.2	0	normal	.	G	snv	C	AA.GT	het-ref	223	0.47	.	2	.	PASS	605882	C	114480(MK);609054(MK)	AD	Fanconi anemia, complementation group J	AR	.	Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal	Allergy/Immunology/Infectious; Hematologic; Oncologic	23285130|22441895|22006311|21964575|21568838|17033622|16116424|16116423|14630800	FC59;FH44;H41;H54;H62;H68;HB23;HBO28	83990	BRIP1	IC4	IVS5	.	.	intron	NM_032043.2	NP_114432.2	-	Y	c.508-31C>G	.	.	.	NM_032043.2(BRIP1): c.508-31C>G	;maf-5-some-pop,maf-5-all-pops	126234	0.190963	U	0.5625	0.215655	13006	0.129248	PASS	1315	8636	0.554655	2907	121226	0.189943	2655	9610	5.57619e-01	6231	48326	1.96565e-01	rs4988344	.	4024	0.550900	-0.457	-0.689	-0.651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	262007	criteria_provided,_single_submitter	Benign	Benign
17	63533767	63533768	17q24.1	0	normal	.	G	ref	G	CG.GG	het-alt	350	0.53	.	1	.	PASS	604025	C	114500(MK);608615(MK)	AD	Oligodontia-colorectal cancer syndrome	AD	Allelic with Oligondontia, isolated (AD)	Dental; Oncologic	Oncologic	21626677|21416598|15042511	FC59;FH44;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	8313	AXIN2	C5	EX6	Axin beta-catenin binding domain	PF08833.5	no-change	NM_004655.3	NP_004646.3	-	Y	c.1386C=	.	.	.	NM_004655.3(AXIN2): c.1386C=	;maf-5-some-pop,maf-5-all-pops	62022	0.390700	U	0.3472	0.446086	12804	0.459934	PASS	-414	3290	0.603040	4099	57014	0.376364	.	.	.	.	.	.	rs1133683	.	4024	0.687100	0.650	-0.080	0.088	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	63533767	63533768	17q24.1	1	normal	.	G	snv	A	CG.GG	het-ref	310	0.47	.	2	.	PASS	604025	C	114500(MK);608615(MK)	AD	Oligodontia-colorectal cancer syndrome	AD	Allelic with Oligondontia, isolated (AD)	Dental; Oncologic	Oncologic	21626677|21416598|15042511	FC59;FH44;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	8313	AXIN2	C5	EX6	Axin beta-catenin binding domain	PF08833.5	coding-synon	NM_004655.3	NP_004646.3	-	Y	c.1386C>T	p.(P462=) | p.(Pro462=)	CCC=>CCT	.	NM_004655.3(AXIN2): c.1386C>T (p.(P462=))	;maf-5-some-pop,maf-5-all-pops	62022	0.609300	U	0.3472	0.446086	12804	0.540066	PASS	239	3290	0.396960	11148	57014	0.623636	811	4533	3.50689e-01	34060	108815	6.02139e-01	rs1133683	.	4024	0.312900	0.650	-0.080	0.088	.	.	.	.	.	ENST00000307078: c.1386C>T (p.P462P)	large_intestine [caecum|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3749411	.	.	.	.	.	no_record	259510	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
17	63533788	63533789	17q24.1	0	normal	.	T	ref	T	CC.GG	het-alt	377	0.53	.	1	.	PASS	604025	C	114500(MK);608615(MK)	AD	Oligodontia-colorectal cancer syndrome	AD	Allelic with Oligondontia, isolated (AD)	Dental; Oncologic	Oncologic	21626677|21416598|15042511	FC59;FH44;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	8313	AXIN2	C5	EX6	Axin beta-catenin binding domain	PF08833.5	no-change	NM_004655.3	NP_004646.3	-	Y	c.1365A=	.	.	.	NM_004655.3(AXIN2): c.1365A=	;maf-5-some-pop	47776	0.086089	U	0.8264	0.909744	12702	0.089120	PASS	.	2448	0.151552	116	42768	0.085601	.	.	.	.	.	.	rs9915936	.	4024	0.192800	-0.124	-1.318	-0.818	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	63533788	63533789	17q24.1	1	normal	.	T	snv	C	CC.GG	het-ref	332	0.47	.	2	.	PASS	604025	C	114500(MK);608615(MK)	AD	Oligodontia-colorectal cancer syndrome	AD	Allelic with Oligondontia, isolated (AD)	Dental; Oncologic	Oncologic	21626677|21416598|15042511	FC59;FH44;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	8313	AXIN2	C5	EX6	Axin beta-catenin binding domain	PF08833.5	coding-synon	NM_004655.3	NP_004646.3	-	Y	c.1365A>G	p.(P455=) | p.(Pro455=)	CCA=>CCG	.	NM_004655.3(AXIN2): c.1365A>G (p.(P455=))	;maf-5-some-pop	47776	0.913911	U	0.8264	0.909744	12702	0.910880	PASS	871	2448	0.848448	17839	42768	0.914399	4064	9859	8.24745e-01	67530	149405	9.02444e-01	rs9915936	.	4024	0.807200	-0.124	-1.318	-0.818	.	.	.	.	.	ENST00000307078: c.1365A>G (p.P455P)	large_intestine [colon|transverse|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3755754	.	.	.	.	.	no_record	259509	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
17	63534249	63534250	17q24.1	0	normal	.	T	ref	T	CA.GC	het-alt	157	0.52	.	1	trf	PASS	604025	C	114500(MK);608615(MK)	AD	Oligodontia-colorectal cancer syndrome	AD	Allelic with Oligondontia, isolated (AD)	Dental; Oncologic	Oncologic	21626677|21416598|15042511	FC59;FH44;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	8313	AXIN2	IC4	IVS5	.	.	no-change	NM_004655.3	NP_004646.3	-	Y	c.1200+71A=	.	.	.	NM_004655.3(AXIN2): c.1200+71A=	MixedObserved,SingleClassQuadAllelic;maf-5-some-pop,maf-5-all-pops,rs-cluster-nonoverlapping-alleles	122295	0.099023	U	0	0.000998403	.	.	PASS	.	8348	0.169741	500	117288	0.099192	.	.	.	.	.	.	rs8078753	.	4024	0.194100	-2.108	-3.103	-2.968	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	63534249	63534250	17q24.1	0	normal	.	T	snv	C	CA.GC	het-ref	146	0.48	.	2	trf	PASS	604025	C	114500(MK);608615(MK)	AD	Oligodontia-colorectal cancer syndrome	AD	Allelic with Oligondontia, isolated (AD)	Dental; Oncologic	Oncologic	21626677|21416598|15042511	FC59;FH44;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	8313	AXIN2	IC4	IVS5	.	.	intron	NM_004655.3	NP_004646.3	-	Y	c.1200+71A>G	.	.	.	NM_004655.3(AXIN2): c.1200+71A>G	MixedObserved,SingleClassQuadAllelic;maf-5-some-pop,maf-5-all-pops,rs-cluster-nonoverlapping-alleles	122295	0.900740	U	0.8264	0.903954	.	.	PASS	2850	8348	0.830139	47490	117288	0.900595	5774	14043	8.23250e-01	96575	214821	8.98156e-01	rs8078753	.	4024	0.805700	-2.108	-3.103	-2.968	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	63534301	63534302	17q24.1	0	normal	.	A	ref	A	AG.AG	het-alt	293	0.59	.	1	.	PASS	604025	C	114500(MK);608615(MK)	AD	Oligodontia-colorectal cancer syndrome	AD	Allelic with Oligondontia, isolated (AD)	Dental; Oncologic	Oncologic	21626677|21416598|15042511	FC59;FH44;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	8313	AXIN2	IC4	IVS5	.	.	no-change	NM_004655.3	NP_004646.3	-	Y	c.1200+19T=	.	.	.	NM_004655.3(AXIN2): c.1200+19T=	MixedObserved;	125334	0.996457	U	0.0427	0.0103834	13006	0.999769	PASS	-164	8636	0.959935	59780	120326	0.996742	.	.	.	.	.	.	rs116931989	.	4024	0.955500	-0.466	-1.139	-0.772	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	63534301	63534302	17q24.1	1	normal	.	A	snv	G	AG.AG	het-ref	205	0.41	.	2	.	PASS	604025	C	114500(MK);608615(MK)	AD	Oligodontia-colorectal cancer syndrome	AD	Allelic with Oligondontia, isolated (AD)	Dental; Oncologic	Oncologic	21626677|21416598|15042511	FC59;FH44;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	8313	AXIN2	IC4	IVS5	.	.	intron	NM_004655.3	NP_004646.3	-	Y	c.1200+19T>C	.	.	.	NM_004655.3(AXIN2): c.1200+19T>C	MixedObserved;	125334	0.003543	U	0.0427	0.0103834	13006	0.000231	PASS	9	8636	0.040065	9	120326	0.003258	20	727	4.21743e-02	20	821	3.35310e-03	rs116931989	.	4024	0.044500	-0.466	-1.139	-0.772	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	516712	criteria_provided,_single_submitter	Likely_benign	Likely Benign
17	63534302	63534303	17q24.1	0	normal	.	A	ref	A	GA.GG	het-alt	293	0.58	.	1	.	PASS	604025	C	114500(MK);608615(MK)	AD	Oligodontia-colorectal cancer syndrome	AD	Allelic with Oligondontia, isolated (AD)	Dental; Oncologic	Oncologic	21626677|21416598|15042511	FC59;FH44;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	8313	AXIN2	IC4	IVS5	.	.	no-change	NM_004655.3	NP_004646.3	-	Y	c.1200+18T=	.	.	.	NM_004655.3(AXIN2): c.1200+18T=	;	125350	0.996466	U	0.0427	0.0103834	13006	0.999769	PASS	-164	8636	0.959935	59789	120342	0.996751	.	.	.	.	.	.	rs117258157	.	4024	0.955500	-0.994	-0.449	-0.204	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	63534302	63534303	17q24.1	1	normal	.	A	snv	C	GA.GG	het-ref	208	0.42	.	2	.	PASS	604025	C	114500(MK);608615(MK)	AD	Oligodontia-colorectal cancer syndrome	AD	Allelic with Oligondontia, isolated (AD)	Dental; Oncologic	Oncologic	21626677|21416598|15042511	FC59;FH44;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	8313	AXIN2	IC4	IVS5	.	.	intron	NM_004655.3	NP_004646.3	-	Y	c.1200+18T>G	.	.	.	NM_004655.3(AXIN2): c.1200+18T>G	;	125350	0.003534	U	0.0427	0.0103834	13006	0.000231	PASS	9	8636	0.040065	9	120342	0.003249	20	727	4.21743e-02	20	820	3.34888e-03	rs117258157	.	4024	0.044500	-0.994	-0.449	-0.204	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
17	63534537	63534538	17q24.1	0	normal	.	C	ref	C	CG.AC	het-alt	132	0.50	.	1	.	PASS	604025	C	114500(MK);608615(MK)	AD	Oligodontia-colorectal cancer syndrome	AD	Allelic with Oligondontia, isolated (AD)	Dental; Oncologic	Oncologic	21626677|21416598|15042511	FC59;FH44;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	8313	AXIN2	IC3	IVS4	.	.	no-change	NM_004655.3	NP_004646.3	-	Y	c.1060-77G=	.	.	.	NM_004655.3(AXIN2): c.1060-77G=	;maf-5-some-pop,maf-5-all-pops	5008	0.661142	U	0.3056	0.338858	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4541111	.	4024	0.724200	-0.321	0.555	0.607	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	63534537	63534538	17q24.1	0	normal	.	C	snv	A	CG.AC	het-ref	131	0.50	.	2	.	PASS	604025	C	114500(MK);608615(MK)	AD	Oligodontia-colorectal cancer syndrome	AD	Allelic with Oligondontia, isolated (AD)	Dental; Oncologic	Oncologic	21626677|21416598|15042511	FC59;FH44;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	8313	AXIN2	IC3	IVS4	.	.	intron	NM_004655.3	NP_004646.3	-	Y	c.1060-77G>T	.	.	.	NM_004655.3(AXIN2): c.1060-77G>T	;maf-5-some-pop,maf-5-all-pops	5008	0.338858	U	0.3056	0.338858	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4541111	.	4024	0.275800	-0.321	0.555	0.607	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	63554590	63554591	17q24.1	0	normal	.	G	ref	G	AG.CA	het-alt	349	0.48	.	1	.	PASS	604025	C	114500(MK);608615(MK)	AD	Oligodontia-colorectal cancer syndrome	AD	Allelic with Oligondontia, isolated (AD)	Dental; Oncologic	Oncologic	21626677|21416598|15042511	FC59;FH44;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	8313	AXIN2	C1	EX2	.	.	no-change	NM_004655.3	NP_004646.3	-	Y	c.148C=	.	.	.	NM_004655.3(AXIN2): c.148C=	;maf-5-some-pop	124164	0.531756	U	0.3234	0.33766	13006	0.605182	PASS	-921	8620	0.677958	17524	119156	0.526268	.	.	.	.	.	.	rs2240308	.	4024	0.706300	0.561	0.711	0.980	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	63554590	63554591	17q24.1	1	normal	.	G	snv	A	AG.CA	het-ref	380	0.52	.	2	.	PASS	604025	C	114500(MK);608615(MK)	AD	Oligodontia-colorectal cancer syndrome	AD	Allelic with Oligondontia, isolated (AD)	Dental; Oncologic	Oncologic	21626677|21416598|15042511	FC59;FH44;H54;H62;H68;HC22;HD31;HD32;MC58;MH43	8313	AXIN2	C1	EX2	.	.	missense	NM_004655.3	NP_004646.3	-	Y	c.148C>T	p.P50S | p.Pro50Ser	CCT=>TCT	NP=>P0	NM_004655.3(AXIN2): c.148C>T (p.P50S)	;maf-5-some-pop	124164	0.468244	U	0.3234	0.33766	13006	0.394818	PASS	467	8620	0.322042	14394	119156	0.473732	950	5573	3.23673e-01	29214	114976	4.75693e-01	rs2240308	.	4024	0.293700	0.561	0.711	0.980	0.53	0.007	0.013	0.007	neutral	ENST00000307078: c.148C>T (p.P50S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4000258	.	.	.	.	.	no_record	259511	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
17	66519856	66519857	17q24.2	0	normal	.	C	ref	C	TT.TT	het-alt	188	0.53	.	1	.	PASS	188830	C	101800(MK);160980(MK);188550(MK);188830(MK);255960(MK);610489(MK)	AD;AR	Pigmented nodular adrenocortical disease, primary, 1; Carney complex; Myxoma, intracardiac; Acrodysostosis 1, with/without hormone resistance 	AD	.	Cardiovascular; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Endocrine; Oncologic	22464252|22464250|21651393|20507346|20301463|12213893|11549623|10974026|10973256|10523219|9805140|9415461|9215269|6329005|4010501|3465316|3365080|2605794|2586567|1571257|1263542|579530	.	5573	PRKAR1A	IC2	IVS3	.	.	no-change	NM_212472.1	NP_997637.1	+	Y	c.349-9C=	.	.	.	NM_212472.1(PRKAR1A): c.349-9C=	.	.	.	.	0.1845	0.22524	.	.	PASS	-532	8620	0.848028	36769	121134	0.777610	.	.	.	.	.	.	.	.	.	.	0.655	0.007	0.117	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	66519857	66519857	17q24.2	1	normal	.	.	ins	T	TC.TT	het-ref	169	0.47	.	2	.	PASS	188830	C	101800(MK);160980(MK);188550(MK);188830(MK);255960(MK);610489(MK)	AD;AR	Pigmented nodular adrenocortical disease, primary, 1; Carney complex; Myxoma, intracardiac; Acrodysostosis 1, with/without hormone resistance 	AD	.	Cardiovascular; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Endocrine; Oncologic	22464252|22464250|21651393|20507346|20301463|12213893|11549623|10974026|10973256|10523219|9805140|9415461|9215269|6329005|4010501|3465316|3365080|2605794|2586567|1571257|1263542|579530	.	5573	PRKAR1A	IC2	IVS3	.	.	intron	NM_212472.1	NP_997637.1	+	Y	c.349-9_349-8insT	.	.	.	NM_212472.1(PRKAR1A): c.349-9_349-8insT	;maf-5-some-pop,maf-5-all-pops	126142	0.222503	U	0.1845	0.22524	12518	0.226793	PASS	123	8620	0.151972	3141	121134	0.222390	211	2574	1.49287e-01	6289	54326	2.21017e-01	rs35723852	.	4024	0.157300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	41046	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Benign
17	66524986	66524987	17q24.2	0	nullSample	.	G	ref	G	CA.TT	homo-ref	.	.	.	0	.	.	188830	C	101800(MK);160980(MK);188550(MK);188830(MK);255960(MK);610489(MK)	AD;AR	Pigmented nodular adrenocortical disease, primary, 1; Carney complex; Myxoma, intracardiac; Acrodysostosis 1, with/without hormone resistance 	AD	.	Cardiovascular; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Endocrine; Oncologic	22464252|22464250|21651393|20507346|20301463|12213893|11549623|10974026|10973256|10523219|9805140|9415461|9215269|6329005|4010501|3465316|3365080|2605794|2586567|1571257|1263542|579530	.	5573	PRKAR1A	IC7	IVS8	.	.	no-change	NM_212472.1	NP_997637.1	+	Y	c.770-24G=	.	.	.	NM_212472.1(PRKAR1A): c.770-24G=	SingleClassTriAllelic;maf-5-some-pop	126360	0.281940	U	0.8909	0.804113	13006	0.270029	PASS	.	8654	0.096949	5503	121352	0.285492	.	.	.	.	.	.	rs2302230	.	4024	0.096400	-2.360	-0.175	-0.366	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	66524986	66524987	17q24.2	0	normal	.	G	snv	A	CA.TT	hom-alt	483	1.00	.	0	.	PASS	188830	C	101800(MK);160980(MK);188550(MK);188830(MK);255960(MK);610489(MK)	AD;AR	Pigmented nodular adrenocortical disease, primary, 1; Carney complex; Myxoma, intracardiac; Acrodysostosis 1, with/without hormone resistance 	AD	.	Cardiovascular; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Endocrine; Oncologic	22464252|22464250|21651393|20507346|20301463|12213893|11549623|10974026|10973256|10523219|9805140|9415461|9215269|6329005|4010501|3465316|3365080|2605794|2586567|1571257|1263542|579530	.	5573	PRKAR1A	IC7	IVS8	.	.	intron	NM_212472.1	NP_997637.1	+	Y	c.770-24G>A	.	.	.	NM_212472.1(PRKAR1A): c.770-24G>A	SingleClassTriAllelic;maf-5-some-pop	126360	0.718052	U	0.8909	0.804113	13006	0.729971	PASS	3532	8654	0.903051	31533	121352	0.714500	7008	15555	9.01844e-01	63993	175996	7.15408e-01	rs2302230	.	4024	0.903300	-2.360	-0.175	-0.366	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	66526026	66526027	17q24.2	0	nullSample	.	G	ref	G	GT.TG	homo-ref	.	.	.	0	.	.	188830	C	101800(MK);160980(MK);188550(MK);188830(MK);255960(MK);610489(MK)	AD;AR	Pigmented nodular adrenocortical disease, primary, 1; Carney complex; Myxoma, intracardiac; Acrodysostosis 1, with/without hormone resistance 	AD	.	Cardiovascular; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Endocrine; Oncologic	22464252|22464250|21651393|20507346|20301463|12213893|11549623|10974026|10973256|10523219|9805140|9415461|9215269|6329005|4010501|3465316|3365080|2605794|2586567|1571257|1263542|579530	.	5573	PRKAR1A	IC8	IVS9	.	.	no-change	NM_212472.1	NP_997637.1	+	Y	c.892-34G=	.	.	.	NM_212472.1(PRKAR1A): c.892-34G=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126347	0.290177	U	0.8909	0.780551	13006	0.295018	PASS	.	8650	0.096994	5673	121340	0.293094	.	.	.	.	.	.	rs2302231	.	4024	0.096700	-2.178	-1.717	-1.852	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	66526026	66526027	17q24.2	0	normal	.	G	snv	T	GT.TG	hom-alt	332	1.00	.	0	.	PASS	188830	C	101800(MK);160980(MK);188550(MK);188830(MK);255960(MK);610489(MK)	AD;AR	Pigmented nodular adrenocortical disease, primary, 1; Carney complex; Myxoma, intracardiac; Acrodysostosis 1, with/without hormone resistance 	AD	.	Cardiovascular; Dermatologic; Endocrine; Musculoskeletal; Neurologic; Oncologic	Endocrine; Oncologic	22464252|22464250|21651393|20507346|20301463|12213893|11549623|10974026|10973256|10523219|9805140|9415461|9215269|6329005|4010501|3465316|3365080|2605794|2586567|1571257|1263542|579530	.	5573	PRKAR1A	IC8	IVS9	.	.	intron	NM_212472.1	NP_997637.1	+	Y	c.892-34G>T	.	.	.	NM_212472.1(PRKAR1A): c.892-34G>T	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	126347	0.709823	U	0.8909	0.780551	13006	0.704982	PASS	3530	8650	0.903006	30779	121340	0.706898	7002	15548	9.01542e-01	62808	174594	7.09322e-01	rs2302231	.	4024	0.903300	-2.178	-1.717	-1.852	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	70120550	70120551	17q24.3	0	nullSample	.	A	ref	A	GA.GA	homo-ref	.	.	.	0	.	.	608160	C	114290(MK)	AD	Campomelic dysplasia	XL	Allelic with 46,XX sex reversal 2 (AD), which has been reported as resulting from SOX9 promoter anomalies or cytogenetic aberrations	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Oncologic; Renal; Genitourinary	Oncologic; Genitourinary	21208124|20301724|10588843	.	6662	SOX9	3U1E	EX3E	.	.	no-change	NM_000346.3	NP_000337.1	+	Y	c.*23A=	.	.	.	NM_000346.3(SOX9): c.*23A=	;maf-5-some-pop,maf-5-all-pops	122300	0.600777	U	0.5298	0.354433	12998	0.635482	PASS	.	8376	0.465735	21679	117292	0.598864	.	.	.	.	.	.	rs1042667	.	.	.	0.379	-1.487	-1.358	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	70120550	70120551	17q24.3	0	normal	.	A	snv	C	GA.GA	hom-alt	531	1.00	.	0	.	PASS	608160	C	114290(MK)	AD	Campomelic dysplasia	XL	Allelic with 46,XX sex reversal 2 (AD), which has been reported as resulting from SOX9 promoter anomalies or cytogenetic aberrations	Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Oncologic; Renal; Genitourinary	Oncologic; Genitourinary	21208124|20301724|10588843	.	6662	SOX9	3U1E	EX3E	.	.	utr-3	NM_000346.3	NP_000337.1	+	Y	c.*23A>C	.	.	.	NM_000346.3(SOX9): c.*23A>C	;maf-5-some-pop,maf-5-all-pops	122300	0.399223	U	0.5298	0.354433	12998	0.364518	PASS	1210	8376	0.534265	10083	117292	0.401136	2522	9270	5.44397e-01	20702	94861	4.07437e-01	rs1042667	.	.	.	0.379	-1.487	-1.358	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	324922	criteria_provided,_single_submitter	Benign	Benign
17	78681589	78681590	17q25.3	0	normal	.	A	ref	A	CA.GC	het-alt	161	0.48	.	1	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	IC3	IVS3	.	.	no-change	NM_020761.2	NP_065812.1	+	Y	c.349-51A=	.	.	.	NM_020761.2(RPTOR): c.349-51A=	SingleClassTriAllelic;maf-5-some-pop	112014	0.373900	U	0.63	0.673123	13006	0.280640	PASS	.	7880	0.372970	8187	107006	0.376100	.	.	.	.	.	.	rs2306690	.	.	.	-0.119	0.003	0.008	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	78681589	78681590	17q25.3	0	normal	.	A	snv	G	CA.GC	het-ref	176	0.52	.	2	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	IC3	IVS3	.	.	intron	NM_020761.2	NP_065812.1	+	Y	c.349-51A>G	.	.	.	NM_020761.2(RPTOR): c.349-51A>G	SingleClassTriAllelic;maf-5-some-pop	112014	0.626091	U	0.63	0.673123	13006	0.719360	PASS	1516	7880	0.627030	21444	107006	0.623890	3286	10448	6.27658e-01	42739	135125	6.06769e-01	rs2306690	.	.	.	-0.119	0.003	0.008	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	78704574	78704575	17q25.3	0	normal	.	T	ref	T	GG.GG	het-alt	10	0.50	.	1	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	IC5	IVS5	.	.	no-change	NM_020761.2	NP_065812.1	+	Y	c.654+69T=	.	.	.	NM_020761.2(RPTOR): c.654+69T=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.533	-1.463	-1.600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
17	78704574	78704575	17q25.3	0	normal	.	T	snv	G	GG.GG	het-ref	10	0.50	.	2	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	IC5	IVS5	.	.	intron	NM_020761.2	NP_065812.1	+	Y	c.654+69T>G	.	.	.	NM_020761.2(RPTOR): c.654+69T>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.533	-1.463	-1.600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
17	78727733	78727734	17q25.3	0	normal	.	T	ref	T	GT.AC	het-alt	126	0.52	.	1	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	IC5	IVS5	.	.	no-change	NM_020761.2	NP_065812.1	+	Y	c.655-76T=	.	.	.	NM_020761.2(RPTOR): c.655-76T=	;maf-5-some-pop	5008	0.831270	U	0.2341	0.16873	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12944923	.	.	.	-0.408	-0.756	-1.219	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	78727733	78727734	17q25.3	0	normal	.	T	snv	C	GT.AC	het-ref	115	0.48	.	2	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	IC5	IVS5	.	.	intron	NM_020761.2	NP_065812.1	+	Y	c.655-76T>C	.	.	.	NM_020761.2(RPTOR): c.655-76T>C	;maf-5-some-pop	5008	0.168730	U	0.2341	0.16873	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12944923	.	.	.	-0.408	-0.756	-1.219	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	78765218	78765219	17q25.3	0	nullSample	.	A	ref	A	TC.TG	homo-ref	.	.	.	0	.	.	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	IC6	IVS6	.	.	no-change	NM_020761.2	NP_065812.1	+	Y	c.831-31A=	.	.	.	NM_020761.2(RPTOR): c.831-31A=	;maf-5-some-pop,maf-5-all-pops	125620	0.275975	U	0.75	0.73762	13006	0.250654	PASS	.	8602	0.262381	4629	120612	0.276540	.	.	.	.	.	.	rs4969429	.	.	.	-0.213	-2.253	-2.011	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	78765218	78765219	17q25.3	0	normal	.	A	snv	G	TC.TG	hom-alt	363	1.00	.	0	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	IC6	IVS6	.	.	intron	NM_020761.2	NP_065812.1	+	Y	c.831-31A>G	.	.	.	NM_020761.2(RPTOR): c.831-31A>G	;maf-5-some-pop,maf-5-all-pops	125620	0.724025	U	0.75	0.73762	13006	0.749346	PASS	2316	8602	0.737619	31581	120612	0.723460	4502	12303	7.29629e-01	63273	174610	7.21851e-01	rs4969429	.	.	.	-0.213	-2.253	-2.011	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	78797065	78797066	17q25.3	0	normal	.	T	ref	T	CC.CC	het-alt	173	0.46	.	1	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	IC9	IVS9	.	.	no-change	NM_020761.2	NP_065812.1	+	Y	c.1136+43T=	.	.	.	NM_020761.2(RPTOR): c.1136+43T=	;maf-5-some-pop	124816	0.867853	U	0.2302	0.112819	13006	0.889897	PASS	.	8618	0.774078	45247	119808	0.867046	.	.	.	.	.	.	rs2019040	.	.	.	0.528	-0.225	-0.271	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	78797065	78797066	17q25.3	0	normal	.	T	snv	A	CC.CC	het-ref	200	0.54	.	2	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	IC9	IVS9	.	.	intron	NM_020761.2	NP_065812.1	+	Y	c.1136+43T>A	.	.	.	NM_020761.2(RPTOR): c.1136+43T>A	;maf-5-some-pop	124816	0.132147	U	0.2302	0.112819	13006	0.110103	PASS	223	8618	0.225922	1272	119808	0.132954	448	3834	2.23244e-01	2369	30884	1.28261e-01	rs2019040	.	.	.	0.528	-0.225	-0.271	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	78820328	78820329	17q25.3	0	normal	.	C	ref	C	GG.GT	het-alt	218	0.50	.	1	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	C11	EX11	.	.	no-change	NM_020761.2	NP_065812.1	+	Y	c.1269C=	.	.	.	NM_020761.2(RPTOR): c.1269C=	;maf-5-some-pop,maf-5-all-pops	126352	0.427884	U	0.4345	0.436701	13006	0.503844	PASS	-1063	8634	0.555247	11745	121344	0.422295	.	.	.	.	.	.	rs3751945	.	.	.	0.467	-1.023	-0.386	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	78820328	78820329	17q25.3	1	normal	.	C	snv	T	GG.GT	het-ref	222	0.50	.	2	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	C11	EX11	.	.	coding-synon	NM_020761.2	NP_065812.1	+	Y	c.1269C>T	p.(G423=) | p.(Gly423=)	GGC=>GGT	.	NM_020761.2(RPTOR): c.1269C>T (p.(G423=))	;maf-5-some-pop,maf-5-all-pops	126352	0.572116	U	0.4345	0.436701	13006	0.496156	PASS	857	8634	0.444753	21174	121344	0.577705	1751	7715	4.47558e-01	43800	144161	5.85992e-01	rs3751945	.	.	.	0.467	-1.023	-0.386	.	.	.	.	.	ENST00000306801: c.1269C>T (p.G423G)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3755999	.	.	.	.	.	.	.	.	.	Likely Benign
17	78854222	78854223	17q25.3	0	normal	.	A	ref	A	CA.GC	het-alt	173	0.59	.	1	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	C14	EX14	.	.	no-change	NM_020761.2	NP_065812.1	+	Y	c.1518A=	.	.	.	NM_020761.2(RPTOR): c.1518A=	;maf-5-some-pop,maf-5-all-pops	126028	0.746215	U	0.3879	0.248003	13006	0.776949	PASS	.	8616	0.615251	33905	121020	0.745976	.	.	.	.	.	.	rs2289759	.	.	.	-0.964	-0.329	-0.561	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	78854222	78854223	17q25.3	1	normal	.	A	snv	G	CA.GC	het-ref	119	0.41	.	2	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	C14	EX14	.	.	coding-synon	NM_020761.2	NP_065812.1	+	Y	c.1518A>G	p.(Q506=) | p.(Gln506=)	CAA=>CAG	.	NM_020761.2(RPTOR): c.1518A>G (p.(Q506=))	;maf-5-some-pop,maf-5-all-pops	126028	0.253785	U	0.3879	0.248003	13006	0.223051	PASS	672	8616	0.384749	4137	121020	0.254024	1316	6607	3.83326e-01	8576	63417	2.57669e-01	rs2289759	.	.	.	-0.964	-0.329	-0.561	.	.	.	.	.	ENST00000306801: c.1518A>G (p.Q506Q)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	3756001	CM092499	NM_020761.2(RPTOR): c.1518A>G (p.Q506Q)	"Altered splicing, association with ?"	19388141	FP	.	.	.	.	Likely Benign
17	78854315	78854316	17q25.3	0	normal	.	C	ref	C	CA.GG	het-alt	129	0.54	.	1	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	IC14	IVS14	.	.	no-change	NM_020761.2	NP_065812.1	+	Y	c.1584+27C=	.	.	.	NM_020761.2(RPTOR): c.1584+27C=	;maf-5-some-pop	123722	0.740192	U	0.377	0.25	13004	0.779452	PASS	.	8448	0.620384	32599	118714	0.739778	.	.	.	.	.	.	rs2289760	.	.	.	-0.219	-0.080	-0.205	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	78854315	78854316	17q25.3	0	normal	.	C	snv	T	CA.GG	het-ref	109	0.46	.	2	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	IC14	IVS14	.	.	intron	NM_020761.2	NP_065812.1	+	Y	c.1584+27C>T	.	.	.	NM_020761.2(RPTOR): c.1584+27C>T	;maf-5-some-pop	123722	0.259808	U	0.377	0.25	13004	0.220548	PASS	632	8448	0.379616	4134	118714	0.260222	1273	6498	3.79290e-01	8904	64638	2.64604e-01	rs2289760	.	.	.	-0.219	-0.080	-0.205	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	78857711	78857712	17q25.3	1	normal	.	C	snv	T	TG.GG	het-ref	259	0.53	.	2	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	C16	EX16	.	.	coding-synon	NM_020761.2	NP_065812.1	+	Y	c.1782C>T	p.(C594=) | p.(Cys594=)	TGC=>TGT	.	NM_020761.2(RPTOR): c.1782C>T (p.(C594=))	;	120438	0.000017	U	.	.	.	.	PASS	0	8600	0.000233	0	120438	0.000017	0	2	1.16023e-04	0	2	8.13650e-06	rs767341540	.	.	.	-0.259	-0.449	-1.281	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
17	78857711	78857712	17q25.3	0	normal	.	C	ref	C	TG.GG	het-alt	229	0.47	.	1	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	C16	EX16	.	.	no-change	NM_020761.2	NP_065812.1	+	Y	c.1782C=	.	.	.	NM_020761.2(RPTOR): c.1782C=	;	120438	0.999983	U	.	.	.	.	PASS	-1	8600	0.999767	60217	120438	0.999983	.	.	.	.	.	.	rs767341540	.	.	.	-0.259	-0.449	-1.281	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	78859003	78859004	17q25.3	0	normal	.	C	ref	C	CA.CT	het-alt	173	0.50	.	1	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	IC17	IVS17	.	.	no-change	NM_020761.2	NP_065812.1	+	Y	c.1983+56C=	.	.	.	NM_020761.2(RPTOR): c.1983+56C=	;maf-5-some-pop,maf-5-all-pops	5008	0.750000	U	0.4048	0.25	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2016817	.	.	.	0.313	-0.067	-0.000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	78859003	78859004	17q25.3	0	normal	.	C	snv	T	CA.CT	het-ref	175	0.50	.	2	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	IC17	IVS17	.	.	intron	NM_020761.2	NP_065812.1	+	Y	c.1983+56C>T	.	.	.	NM_020761.2(RPTOR): c.1983+56C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.250000	U	0.4048	0.25	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2016817	.	.	.	0.313	-0.067	-0.000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	78896487	78896488	17q25.3	0	normal	.	C	ref	C	CC.GT	het-alt	93	0.44	.	1	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	IC21	IVS21	.	.	no-change	NM_020761.2	NP_065812.1	+	Y	c.2521-36C=	.	.	.	NM_020761.2(RPTOR): c.2521-36C=	;maf-5-some-pop,maf-5-all-pops	35398	0.597209	U	0.4633	0.355431	12726	0.682068	PASS	.	1438	0.426287	4982	30390	0.589404	.	.	.	.	.	.	rs2271602	.	.	.	-0.225	-1.446	-1.456	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	78896487	78896488	17q25.3	0	normal	.	C	snv	T	CC.GT	het-ref	120	0.56	.	2	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	IC21	IVS21	.	.	intron	NM_020761.2	NP_065812.1	+	Y	c.2521-36C>T	.	.	.	NM_020761.2(RPTOR): c.2521-36C>T	;maf-5-some-pop,maf-5-all-pops	35398	0.402791	U	0.4633	0.355431	12726	0.317932	PASS	198	1438	0.573713	2265	30390	0.410596	1295	5354	4.88504e-01	9662	54675	3.48577e-01	rs2271602	.	.	.	-0.225	-1.446	-1.456	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	78896528	78896529	17q25.3	0	normal	.	C	ref	C	AC.GT	het-alt	171	0.59	.	1	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	C22	EX22	.	.	no-change	NM_020761.2	NP_065812.1	+	Y	c.2526C=	.	.	.	NM_020761.2(RPTOR): c.2526C=	;maf-5-some-pop,maf-5-all-pops	61108	0.642976	U	0.1964	0.245407	12938	0.727392	PASS	-379	3194	0.725736	10286	56100	0.633012	.	.	.	.	.	.	rs2271603	.	.	.	-1.080	-3.030	-1.570	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	78896528	78896529	17q25.3	1	normal	.	C	snv	T	AC.GT	het-ref	118	0.41	.	2	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	C22	EX22	.	.	coding-synon	NM_020761.2	NP_065812.1	+	Y	c.2526C>T	p.(T842=) | p.(Thr842=)	ACC=>ACT	.	NM_020761.2(RPTOR): c.2526C>T (p.(T842=))	;maf-5-some-pop,maf-5-all-pops	61108	0.357024	U	0.1964	0.245407	12938	0.272608	PASS	59	3194	0.274264	2824	56100	0.366988	294	2759	1.92077e-01	8555	57282	2.87872e-01	rs2271603	.	.	.	-1.080	-3.030	-1.570	.	.	.	.	.	ENST00000306801: c.2526C>T (p.T842T)	large_intestine [colon|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	437758	.	.	.	.	.	.	.	.	.	Likely Benign
17	78897546	78897547	17q25.3	0	normal	.	C	ref	C	AG.CT	het-alt	130	0.52	.	1	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	IC23	IVS23	.	.	no-change	NM_020761.2	NP_065812.1	+	Y	c.2808+74C=	.	.	.	NM_020761.2(RPTOR): c.2808+74C=	;maf-5-some-pop,maf-5-all-pops	16148	0.692655	U	0.1994	0.249201	.	.	PASS	-59	618	0.783172	2435	11140	0.666517	.	.	.	.	.	.	rs7217786	.	.	.	-0.262	-1.507	-1.838	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	78897546	78897547	17q25.3	0	normal	.	C	snv	T	AG.CT	het-ref	119	0.48	.	2	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	IC23	IVS23	.	.	intron	NM_020761.2	NP_065812.1	+	Y	c.2808+74C>T	.	.	.	NM_020761.2(RPTOR): c.2808+74C>T	;maf-5-some-pop,maf-5-all-pops	16148	0.307345	U	0.1994	0.249201	.	.	PASS	8	618	0.216828	580	11140	0.333483	228	1923	2.13762e-01	4398	28169	3.02100e-01	rs7217786	.	.	.	-0.262	-1.507	-1.838	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	78914244	78914245	17q25.3	0	normal	.	G	ref	G	ga.ac	het-alt	81	0.50	.	1	MER2|DNA|TcMar-Tigger|+|327	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	IC24	IVS24	.	.	no-change	NM_020761.2	NP_065812.1	+	Y	c.2920-51G=	.	.	.	NM_020761.2(RPTOR): c.2920-51G=	;maf-5-some-pop,maf-5-all-pops	77010	0.652279	U	0.4633	0.348442	12996	0.673669	PASS	-608	4566	0.519930	15156	72002	0.652329	.	.	.	.	.	.	rs17848659	.	.	.	-0.192	0.068	0.048	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	78914244	78914245	17q25.3	0	normal	.	G	snv	T	ga.ac	het-ref	82	0.50	.	2	MER2|DNA|TcMar-Tigger|+|327	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	IC24	IVS24	.	.	intron	NM_020761.2	NP_065812.1	+	Y	c.2920-51G>T	.	.	.	NM_020761.2(RPTOR): c.2920-51G>T	;maf-5-some-pop,maf-5-all-pops	77010	0.347721	U	0.4633	0.348442	12996	0.326331	PASS	488	4566	0.480070	4188	72002	0.347671	1562	6620	4.79780e-01	11622	67292	3.43200e-01	rs17848659	.	.	.	-0.192	0.068	0.048	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	78919557	78919558	17q25.3	0	normal	.	C	ref	C	GC.GT	het-alt	186	0.52	.	1	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	C26	EX26	.	.	no-change	NM_020761.2	NP_065812.1	+	Y	c.3117C=	.	.	.	NM_020761.2(RPTOR): c.3117C=	;maf-5-some-pop,maf-5-all-pops	126134	0.639867	U	0.4544	0.374601	13006	0.637783	PASS	-1103	8634	0.534862	24946	121126	0.640465	.	.	.	.	.	.	rs1567962	.	.	.	0.655	-0.537	-0.037	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	78919557	78919558	17q25.3	1	normal	.	C	snv	T	GC.GT	het-ref	170	0.48	.	2	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	C26	EX26	.	.	coding-synon	NM_020761.2	NP_065812.1	+	Y	c.3117C>T	p.(A1039=) | p.(Ala1039=)	GCC=>GCT	.	NM_020761.2(RPTOR): c.3117C>T (p.(A1039=))	;maf-5-some-pop,maf-5-all-pops	126134	0.360133	U	0.4544	0.374601	13006	0.362217	PASS	905	8634	0.465138	7932	121126	0.359535	1638	7333	4.50651e-01	15112	84645	3.51478e-01	rs1567962	.	.	.	0.655	-0.537	-0.037	.	.	.	.	.	ENST00000306801: c.3117C>T (p.A1039A)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4000341	.	.	.	.	.	.	.	.	.	Likely Benign
17	78921116	78921117	17q25.3	0	normal	.	C	ref	C	AA.GG	het-alt	235	0.48	.	1	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	C27	EX27	.	.	no-change	NM_020761.2	NP_065812.1	+	Y	c.3231C=	.	.	.	NM_020761.2(RPTOR): c.3231C=	;maf-5-some-pop	124612	0.728188	U	0.2044	0.197684	13006	0.763263	PASS	.	8612	0.804343	31764	119604	0.725084	.	.	.	.	.	.	rs4969231	.	.	.	-1.492	-1.052	-2.134	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	78921116	78921117	17q25.3	1	normal	.	C	snv	T	AA.GG	het-ref	250	0.52	.	2	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	C27	EX27	.	.	coding-synon	NM_020761.2	NP_065812.1	+	Y	c.3231C>T	p.(N1077=) | p.(Asn1077=)	AAC=>AAT	.	NM_020761.2(RPTOR): c.3231C>T (p.(N1077=))	;maf-5-some-pop	124612	0.271812	U	0.2044	0.197684	13006	0.236737	PASS	165	8612	0.195657	4843	119604	0.274916	313	2994	1.94390e-01	8858	61559	2.69910e-01	rs4969231	.	.	.	-1.492	-1.052	-2.134	.	.	.	.	.	ENST00000306801: c.3231C>T (p.N1077N)	large_intestine [colon|ascending|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1387173	.	.	.	.	.	.	.	.	.	Likely Benign
17	78923402	78923403	17q25.3	0	normal	.	A	ref	A	GC.CT	het-alt	83	0.46	.	1	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	IC28	IVS28	.	.	no-change	NM_020761.2	NP_065812.1	+	Y	c.3370+56A=	.	.	.	NM_020761.2(RPTOR): c.3370+56A=	;	5008	0.998802	U	0.006	0.00119808	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs149622069	.	.	.	-0.736	-0.935	-0.738	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
17	78923402	78923403	17q25.3	0	normal	.	A	snv	G	GC.CT	het-ref	96	0.54	.	2	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	IC28	IVS28	.	.	intron	NM_020761.2	NP_065812.1	+	Y	c.3370+56A>G	.	.	.	NM_020761.2(RPTOR): c.3370+56A>G	;	5008	0.001198	U	0.006	0.00119808	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs149622069	.	.	.	-0.736	-0.935	-0.738	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
17	78935196	78935197	17q25.3	0	normal	.	C	ref	C	CG.GT	het-alt	162	0.56	.	1	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	C31	EX31	.	.	no-change	NM_020761.2	NP_065812.1	+	Y	c.3609C=	.	.	.	NM_020761.2(RPTOR): c.3609C=	;maf-5-some-pop	25968	0.674137	U	0.5546	0.309505	12674	0.749803	PASS	-88	656	0.426829	4758	20960	0.670229	.	.	.	.	.	.	rs9899178	.	.	.	-0.186	-1.020	-0.395	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	78935196	78935197	17q25.3	1	normal	.	C	snv	T	CG.GT	het-ref	126	0.44	.	2	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	C31	EX31	.	.	coding-synon	NM_020761.2	NP_065812.1	+	Y	c.3609C>T	p.(R1203=) | p.(Arg1203=)	CGC=>CGT	.	NM_020761.2(RPTOR): c.3609C>T (p.(R1203=))	;maf-5-some-pop	25968	0.325863	U	0.5546	0.309505	12674	0.250197	PASS	100	656	0.573171	1190	20960	0.329771	1593	5674	5.52698e-01	10019	52960	3.56619e-01	rs9899178	.	.	.	-0.186	-1.020	-0.395	.	.	.	.	.	ENST00000306801: c.3609C>T (p.R1203R)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4130785	.	.	.	.	.	.	.	.	.	Likely Benign
17	78938002	78938003	17q25.3	0	normal	.	G	ref	G	CC.CC	het-alt	12	0.50	.	1	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	IC33	IVS33	.	.	no-change	NM_020761.2	NP_065812.1	+	Y	c.3940-59G=	.	.	.	NM_020761.2(RPTOR): c.3940-59G=	SingleClassTriAllelic;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs113454622	.	.	.	-2.819	-1.692	-1.668	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
17	78938002	78938003	17q25.3	0	normal	.	G	snv	C	CC.CC	het-ref	12	0.50	.	2	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	IC33	IVS33	.	.	intron	NM_020761.2	NP_065812.1	+	Y	c.3940-59G>C	.	.	.	NM_020761.2(RPTOR): c.3940-59G>C	SingleClassTriAllelic;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs113454622	.	.	.	-2.819	-1.692	-1.668	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
17	78938203	78938204	17q25.3	0	normal	.	G	ref	G	GG.CG	het-alt	72	0.46	.	1	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	3U1E	EX34E	.	.	no-change	NM_020761.2	NP_065812.1	+	Y	c.*74G=	.	.	.	NM_020761.2(RPTOR): c.*74G=	;maf-5-some-pop	5008	0.791334	U	0.2688	0.208666	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3751936	.	.	.	0.591	0.315	-0.096	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
17	78938203	78938204	17q25.3	0	normal	.	G	snv	C	GG.CG	het-ref	85	0.54	.	2	.	PASS	607130	P	.	NN	.	.	.	.	.	.	.	57521	RPTOR	3U1E	EX34E	.	.	utr-3	NM_020761.2	NP_065812.1	+	Y	c.*74G>C	.	.	.	NM_020761.2(RPTOR): c.*74G>C	;maf-5-some-pop	5008	0.208666	U	0.2688	0.208666	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3751936	.	.	.	0.591	0.315	-0.096	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
18	657684	657685	18p11.32	0	normal	.	G	ref	G	TT.GC	het-alt	231	0.60	.	1	trf	PASS	188350	C	.	NN	.	.	.	.	.	.	.	7298	TYMS	5U1E	EX1	.	.	no-change	NM_001071.2	NP_001062.1	+	Y	c.-58G=	.	.	.	NM_001071.2(TYMS): c.-58G=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-1.528	-2.092	-1.298	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
18	657684	657685	18p11.32	0	normal	.	G	snv	C	TT.GC	het-ref	156	0.40	.	2	trf	PASS	188350	C	.	NN	.	.	.	.	.	.	.	7298	TYMS	5U1E	EX1	.	.	utr-5	NM_001071.2	NP_001062.1	+	Y	c.-58G>C	.	.	.	NM_001071.2(TYMS): c.-58G>C	SingleAlleleFreq;	2	1.000000	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2853542	.	.	.	-1.528	-2.092	-1.298	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
18	670887	670888	18p11.32	0	normal	.	T	ref	T	GG.GA	het-alt	94	0.45	.	1	.	PASS	188350	C	.	NN	.	.	.	.	.	.	.	7298	TYMS	IC5	IVS5	.	.	no-change	NM_001071.2	NP_001062.1	+	Y	c.732+21T=	.	.	.	NM_001071.2(TYMS): c.732+21T=	;maf-5-some-pop	125184	0.951839	U	0.2232	0.114417	13006	0.936875	PASS	.	8612	0.759522	55101	120176	0.954600	.	.	.	.	.	.	rs3826626	.	4024	0.779800	-0.468	-2.964	-3.059	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
18	670887	670888	18p11.32	0	normal	.	T	snv	C	GG.GA	het-ref	114	0.55	.	2	.	PASS	188350	C	.	NN	.	.	.	.	.	.	.	7298	TYMS	IC5	IVS5	.	.	intron	NM_001071.2	NP_001062.1	+	Y	c.732+21T>C	.	.	.	NM_001071.2(TYMS): c.732+21T>C	;maf-5-some-pop	125184	0.048161	U	0.2232	0.114417	13006	0.063125	PASS	247	8612	0.240478	469	120176	0.045400	501	4167	2.42127e-01	875	10730	4.39365e-02	rs3826626	.	4024	0.220200	-0.468	-2.964	-3.059	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
18	673443	673449	18p11.32	0	normal	.	TTAAAG	ref	TTAAAG	CT.TT	het-alt	219	0.62	.	1	.	PASS	188350	C	.	NN	.	.	.	.	.	.	.	7298	TYMS	3U1E	EX7E	.	.	no-change	NM_001071.2	NP_001062.1	+	Y	c.*447_*452=	.	.	.	NM_001071.2(TYMS): c.*447_*452=	;maf-5-some-pop,maf-5-all-pops	5008	0.507987	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs151264360	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
18	673443	673449	18p11.32	0	normal	.	TTAAAG	del	.	CT.TT	het-ref	134	0.38	.	2	.	PASS	188350	C	.	NN	.	.	.	.	.	.	.	7298	TYMS	3U1E	EX7E	.	.	utr-3	NM_001071.2	NP_001062.1	+	Y	c.*450_*455delAAGTTA	.	.	.	NM_001071.2(TYMS): c.*450_*455delAAGTTA	;maf-5-some-pop,maf-5-all-pops	5008	0.492013	U	0.6944	0.492013	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs151264360	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	375663	reviewed_by_expert_panel	drug_response	Benign
18	14851755	14851756	18p11.21	0	normal	.	G	ref	G	AC.GC	het-alt	128	0.82	.	1	dup	PASS	.	.	.	.	.	.	.	.	.	.	.	374860	ANKRD30B	C36E	EX36E	CCDC144C protein coiled-coil region	PF14915.1	no-change	NM_001145029.1	NP_001138501.1	+	Y	c.3456G=	.	.	.	NM_001145029.1(ANKRD30B): c.3456G=	SingleClassTriAllelic;maf-5-some-pop	74312	0.752395	U	0.4157	0.528554	.	.	PASS	-324	5304	0.829186	22088	69304	0.772697	.	.	.	.	.	.	rs9676225	.	4024	0.597900	-2.900	-0.553	-0.696	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
18	14851755	14851756	18p11.21	1	normal	.	G	snv	A	AC.GC	het-ref	29	0.18	.	2	dup	PASS	.	.	.	.	.	.	.	.	.	.	.	374860	ANKRD30B	C36E	EX36E	CCDC144C protein coiled-coil region	PF14915.1	coding-synon	NM_001145029.1	NP_001138501.1	+	Y	c.3456G>A	p.(T1152=) | p.(Thr1152=)	ACG=>ACA	.	NM_001145029.1(ANKRD30B): c.3456G>A (p.(T1152=))	SingleClassTriAllelic;maf-5-some-pop	74312	0.247591	U	0.4157	0.528554	.	.	PASS	129	5304	0.170814	3188	69304	0.227288	734	3122	2.55650e-01	11942	37070	2.46748e-01	rs9676225	.	4024	0.402100	-2.900	-0.553	-0.696	.	.	.	.	.	ENST00000358984: c.3456G>A (p.T1152T)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4130926	.	.	.	.	.	.	.	.	.	Likely Benign
18	18619415	18619416	18q11.1	0	normal	.	G	ref	G	AA.AA	het-alt	213	0.83	.	1	.	PASS	601702	P	.	NN	.	.	.	.	.	.	.	6093	ROCK1	IC9	IVS9	.	.	no-change	NM_005406.2	NP_005397.1	-	Y	c.1051+17C=	.	.	.	NM_005406.2(ROCK1): c.1051+17C=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.650	0.715	1.383	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
18	18619416	18619416	18q11.1	1	normal	.	.	ins	A	AG.AA	het-ref	45	0.17	.	2	.	PASS	601702	P	.	NN	.	.	.	.	.	.	.	6093	ROCK1	IC9	IVS9	.	.	intron	NM_005406.2	NP_005397.1	-	Y	c.1051+16_1051+17insT	.	.	.	NM_005406.2(ROCK1): c.1051+16_1051+17insT	MixedObserved;	48017	0.023471	U	.	.	.	.	PASS	0	3548	0.134442	0	57392	0.162131	.	.	.	.	.	.	rs773222097	.	4024	0.400100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
18	45395845	45395846	18q21.1	0	normal	.	A	ref	A	tt.aa	het-alt	37	0.48	.	1	AT_rich|Low_complexity|Low_complexity|+|21	PASS	601366	P	.	NN	.	.	.	.	.	.	.	4087	SMAD2	IC1	IVS2	.	.	no-change	NM_001135937.2	NP_001129409.1	-	Y	c.237-39T=	.	.	.	NM_001135937.2(SMAD2): c.237-39T=	MixedObserved;maf-5-some-pop,maf-5-all-pops	7297	0.635741	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs34501809	.	4024	0.638200	0.397	0.009	-0.659	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
18	45395845	45395846	18q21.1	0	normal	.	A	del	.	tt.aa	het-ref	40	0.52	.	2	AT_rich|Low_complexity|Low_complexity|+|21	PASS	601366	P	.	NN	.	.	.	.	.	.	.	4087	SMAD2	IC1	IVS2	.	.	intron	NM_001135937.2	NP_001129409.1	-	Y	c.237-39delT	.	.	.	NM_001135937.2(SMAD2): c.237-39delT	MixedObserved;maf-5-some-pop,maf-5-all-pops	7297	0.364259	U	0.5526	0.520168	.	.	PASS	13	932	0.493562	170	22976	0.448947	.	.	.	.	.	.	rs34501809	.	4024	0.360800	0.397	0.009	-0.659	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
18	48573688	48573689	18q21.2	0	normal	.	A	snv	G	CT.TA	het-ref	198	0.51	.	2	.	PASS	600993	C	139210(MK);174900(MK);175050(MK);260350(MK)	AD	Hereditary hemorrhagic telangiectasia, type 1; Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome; Polyposis, juvenile intestinal; Myhre syndrome	AD	.	Audiologic/Otolaryngologic; Cardiovascular; Gastrointestinal; Hematologic; Oncologic	Audiologic/Otolaryngologic; Cardiovascular; Gastrointestinal; Hematologic; Oncologic	22810475|22243968|22158539|21835029|21490502|21465659|20301525|20101697|18824676|17873119|16690726|16613914|16152648|15754356|15723310|15235019|15031030|12136244|11568925|9582123|7372073|7296942	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	4089	SMAD4	IC1	IVS2	.	.	intron	NM_005359.5	NP_005350.1	+	Y	c.249+24A>G	.	.	.	NM_005359.5(SMAD4): c.249+24A>G	;	124392	0.006697	U	0.0417	0.0119808	12998	0.000231	PASS	8	8600	0.039767	15	119384	0.006475	14	711	4.13228e-02	35	1850	7.60316e-03	rs77389132	.	4024	0.039000	-0.899	-2.899	-2.739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	492736	no_assertion_criteria_provided	Benign	Likely Benign
18	48573688	48573689	18q21.2	0	normal	.	A	ref	A	CT.TA	het-alt	194	0.49	.	1	.	PASS	600993	C	139210(MK);174900(MK);175050(MK);260350(MK)	AD	Hereditary hemorrhagic telangiectasia, type 1; Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome; Polyposis, juvenile intestinal; Myhre syndrome	AD	.	Audiologic/Otolaryngologic; Cardiovascular; Gastrointestinal; Hematologic; Oncologic	Audiologic/Otolaryngologic; Cardiovascular; Gastrointestinal; Hematologic; Oncologic	22810475|22243968|22158539|21835029|21490502|21465659|20301525|20101697|18824676|17873119|16690726|16613914|16152648|15754356|15723310|15235019|15031030|12136244|11568925|9582123|7372073|7296942	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	4089	SMAD4	IC1	IVS2	.	.	no-change	NM_005359.5	NP_005350.1	+	Y	c.249+24A=	.	.	.	NM_005359.5(SMAD4): c.249+24A=	;	124392	0.993303	U	0.0417	0.0119808	12998	0.999769	PASS	-163	8600	0.960233	58934	119384	0.993525	.	.	.	.	.	.	rs77389132	.	4024	0.961000	-0.899	-2.899	-2.739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
18	48584855	48584856	18q21.2	0	normal	.	T	ref	T	TA.TT	het-alt	93	0.65	.	1	.	PASS	600993	C	139210(MK);174900(MK);175050(MK);260350(MK)	AD	Hereditary hemorrhagic telangiectasia, type 1; Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome; Polyposis, juvenile intestinal; Myhre syndrome	AD	.	Audiologic/Otolaryngologic; Cardiovascular; Gastrointestinal; Hematologic; Oncologic	Audiologic/Otolaryngologic; Cardiovascular; Gastrointestinal; Hematologic; Oncologic	22810475|22243968|22158539|21835029|21490502|21465659|20301525|20101697|18824676|17873119|16690726|16613914|16152648|15754356|15723310|15235019|15031030|12136244|11568925|9582123|7372073|7296942	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	4089	SMAD4	IC6	IVS7	.	.	no-change	NM_005359.5	NP_005350.1	+	Y	c.904+30T=	.	.	.	NM_005359.5(SMAD4): c.904+30T=	;maf-5-some-pop	49367	0.755464	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs540116851	.	4024	0.897600	-0.264	2.633	1.153	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
18	48584855	48584856	18q21.2	0	normal	.	T	del	.	TA.TT	het-ref	50	0.35	.	2	.	PASS	600993	C	139210(MK);174900(MK);175050(MK);260350(MK)	AD	Hereditary hemorrhagic telangiectasia, type 1; Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome; Polyposis, juvenile intestinal; Myhre syndrome	AD	.	Audiologic/Otolaryngologic; Cardiovascular; Gastrointestinal; Hematologic; Oncologic	Audiologic/Otolaryngologic; Cardiovascular; Gastrointestinal; Hematologic; Oncologic	22810475|22243968|22158539|21835029|21490502|21465659|20301525|20101697|18824676|17873119|16690726|16613914|16152648|15754356|15723310|15235019|15031030|12136244|11568925|9582123|7372073|7296942	FC59;FH44;H41;H54;H62;H68;HC22;HD31;HD32;HG15;HP16;MC58;MH43	4089	SMAD4	IC6	IVS7	.	.	intron	NM_005359.5	NP_005350.1	+	Y	c.904+30delT	.	.	.	NM_005359.5(SMAD4): c.904+30delT	;maf-5-some-pop	49367	0.244536	U	0.0149	0.038738	.	.	PASS	0	5342	0.095283	1	78164	0.151963	.	.	.	.	.	.	rs540116851	.	4024	0.100600	-0.264	2.633	1.153	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	492738	no_assertion_criteria_provided	Benign	Benign
18	61170720	61170721	18q21.33	0	nullSample	.	T	ref	T	AG.GA	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr18: g.61170720T= (intergenic)	;maf-5-some-pop,maf-5-all-pops	126392	0.387279	U	0.5972	0.525759	13006	0.413117	PASS	.	8644	0.442272	9729	121384	0.383691	.	.	.	.	.	.	rs1455556	.	.	.	-0.899	-0.259	-0.903	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
18	61170720	61170721	18q21.33	0	normal	.	T	snv	C	AG.GA	hom-alt	399	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr18: g.61170720T>C (intergenic)	;maf-5-some-pop,maf-5-all-pops	126392	0.612721	U	0.5972	0.525759	13006	0.586883	PASS	1341	8644	0.557728	23847	121384	0.616309	2725	9671	5.60703e-01	48918	152942	6.21463e-01	rs1455556	.	.	.	-0.899	-0.259	-0.903	.	.	.	.	.	ENST00000382771: c.894T>C (p.S298S)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	5009616	.	.	.	.	.	.	.	.	.	Benign
18	61170781	61170782	18q21.33	0	nullSample	.	A	ref	A	TT.TC	homo-ref	.	.	.	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr18: g.61170781A= (intergenic)	;maf-5-some-pop,maf-5-all-pops	126324	0.572884	U	0.4871	0.364816	13006	0.595033	PASS	-1097	8636	0.541686	20300	121316	0.570312	.	.	.	.	.	.	rs1455555	.	.	.	-0.290	0.447	0.088	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
18	61170781	61170782	18q21.33	0	normal	.	A	snv	G	TT.TC	hom-alt	255	1.00	.	0	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr18: g.61170781A>G (intergenic)	;maf-5-some-pop,maf-5-all-pops	126324	0.427116	U	0.4871	0.364816	13006	0.404967	PASS	882	8636	0.458314	11770	121316	0.429688	1815	7934	4.60155e-01	23778	105889	4.30524e-01	rs1455555	.	.	.	-0.290	0.447	0.088	.	.	.	.	.	ENST00000382771: c.955A>G (p.I319V)	large_intestine [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3756195	.	.	.	.	.	.	.	.	.	Benign
18	61308894	61308895	18q21.33	0	nullSample	.	A	ref	A	TG.GT	homo-ref	.	.	.	0	dup	.	600518	P	.	NN	.	.	.	.	.	.	.	6318	SERPINB4	IC3	IVS4	.	.	no-change	NM_002974.2	NP_002965.1	-	Y	c.351+99T=	.	.	.	NM_002974.2(SERPINB4): c.351+99T=	;maf-5-some-pop	5008	0.004792	U	1	0.995208	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2518061	.	4020	0.000500	-1.157	-0.496	-0.581	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
18	61308894	61308895	18q21.33	0	normal	.	A	snv	G	TG.GT	hom-alt	328	1.00	.	0	dup	PASS	600518	P	.	NN	.	.	.	.	.	.	.	6318	SERPINB4	IC3	IVS4	.	.	intron	NM_002974.2	NP_002965.1	-	Y	c.351+99T>C	.	.	.	NM_002974.2(SERPINB4): c.351+99T>C	;maf-5-some-pop	5008	0.995208	U	1	0.995208	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2518061	.	4020	0.999500	-1.157	-0.496	-0.581	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
18	61322994	61322995	18q21.33	0	normal	.	T	ref	T	AG.AG	het-alt	458	0.54	.	1	dup	PASS	600517	C	.	NN	.	.	.	.	.	.	.	6317	SERPINB3	C7E	EX8E	Serpin (serine protease inhibitor)	PF00079.15	no-change	NM_006919.2	NP_008850.1	-	Y	c.1069A=	.	.	.	NM_006919.2(SERPINB3): c.1069A=	;maf-5-some-pop	126262	0.854168	U	0.4405	0.192492	13006	0.914962	PASS	.	8604	0.564040	45095	121254	0.856095	.	.	.	.	.	.	rs1065205	.	4024	0.553200	-1.855	-0.962	-1.670	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
18	61322994	61322995	18q21.33	1	normal	.	T	snv	C	AG.AG	het-ref	383	0.46	.	2	dup	PASS	600517	C	.	NN	.	.	.	.	.	.	.	6317	SERPINB3	C7E	EX8E	Serpin (serine protease inhibitor)	PF00079.15	missense	NM_006919.2	NP_008850.1	-	Y	c.1069A>G	p.T357A | p.Thr357Ala	ACT=>GCT	P0=>NP	NM_006919.2(SERPINB3): c.1069A>G (p.T357A)	;maf-5-some-pop	126262	0.145832	U	0.4405	0.192492	13006	0.085038	PASS	807	8604	0.435960	1917	121254	0.143905	1688	7597	4.40917e-01	4183	36619	1.49042e-01	rs1065205	.	4024	0.446800	-1.855	-0.962	-1.670	0.8	0	0	0.001	neutral	ENST00000283752: c.1069A>G (p.T357A)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4000445	.	.	.	.	.	.	.	.	.	Likely Benign
18	61324032	61324033	18q21.33	0	normal	.	T	ref	T	AG.AG	het-alt	279	0.56	.	1	dup	PASS	600517	C	.	NN	.	.	.	.	.	.	.	6317	SERPINB3	IC6	IVS7	.	.	no-change	NM_006919.2	NP_008850.1	-	Y	c.768+32A=	.	.	.	NM_006919.2(SERPINB3): c.768+32A=	;maf-5-some-pop,maf-5-all-pops	125862	0.677115	U	0.6171	0.399161	13006	0.707750	PASS	.	8608	0.393936	28523	120854	0.680275	.	.	.	.	.	.	rs3786333	.	4024	0.375000	0.374	-1.282	-1.350	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
18	61324032	61324033	18q21.33	0	normal	.	T	snv	C	AG.AG	het-ref	217	0.44	.	2	dup	PASS	600517	C	.	NN	.	.	.	.	.	.	.	6317	SERPINB3	IC6	IVS7	.	.	intron	NM_006919.2	NP_008850.1	-	Y	c.768+32A>G	.	.	.	NM_006919.2(SERPINB3): c.768+32A>G	;maf-5-some-pop,maf-5-all-pops	125862	0.322885	U	0.6171	0.399161	13006	0.292250	PASS	1567	8608	0.606064	6736	120854	0.319725	3127	10222	6.10342e-01	13332	76291	3.19578e-01	rs3786333	.	4024	0.625000	0.374	-1.282	-1.350	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
18	61325904	61325905	18q21.33	0	normal	.	T	ref	T	AT.TA	het-alt	165	0.47	.	1	dup	PASS	600517	C	.	NN	.	.	.	.	.	.	.	6317	SERPINB3	IC3	IVS4	.	.	no-change	NM_006919.2	NP_008850.1	-	Y	c.352-41A=	.	.	.	NM_006919.2(SERPINB3): c.352-41A=	;maf-5-some-pop,maf-5-all-pops	123196	0.561958	U	0.255	0.317093	12996	0.599646	PASS	.	8356	0.721757	19270	118188	0.556833	.	.	.	.	.	.	rs7228687	.	4024	0.739800	-0.714	0.202	-0.201	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
18	61325904	61325905	18q21.33	0	normal	.	T	snv	G	AT.TA	het-ref	183	0.53	.	2	dup	PASS	600517	C	.	NN	.	.	.	.	.	.	.	6317	SERPINB3	IC3	IVS4	.	.	intron	NM_006919.2	NP_008850.1	-	Y	c.352-41A>C	.	.	.	NM_006919.2(SERPINB3): c.352-41A>C	;maf-5-some-pop,maf-5-all-pops	123196	0.438042	U	0.255	0.317093	12996	0.400354	PASS	330	8356	0.278243	12553	118188	0.443167	643	4616	2.75122e-01	25243	105932	4.42945e-01	rs7228687	.	4024	0.260200	-0.714	0.202	-0.201	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
18	61326596	61326597	18q21.33	0	nullSample	.	A	ref	A	GG.TG	homo-ref	.	.	.	0	dup	.	600517	C	.	NN	.	.	.	.	.	.	.	6317	SERPINB3	IC3	IVS4	.	.	no-change	NM_006919.2	NP_008850.1	-	Y	c.351+36T=	.	.	.	NM_006919.2(SERPINB3): c.351+36T=	;maf-5-some-pop	124448	0.014392	U	1	0.993011	.	.	PASS	.	8492	0.004122	0	119440	0.014702	.	.	.	.	.	.	rs8085479	.	4024	0.081800	-1.568	-0.616	-0.585	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
18	61326596	61326597	18q21.33	0	normal	.	A	snv	C	GG.TG	hom-alt	254	1.00	.	0	dup	PASS	600517	C	.	NN	.	.	.	.	.	.	.	6317	SERPINB3	IC3	IVS4	.	.	intron	NM_006919.2	NP_008850.1	-	Y	c.351+36T>G	.	.	.	NM_006919.2(SERPINB3): c.351+36T>G	;maf-5-some-pop	124448	0.985608	U	1	0.993011	.	.	PASS	4211	8492	0.995878	57964	119440	0.985298	8431	16937	9.95591e-01	115921	235725	9.83762e-01	rs8085479	.	4024	0.918200	-1.568	-0.616	-0.585	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
18	61326601	61326602	18q21.33	0	nullSample	.	A	ref	A	CA.AT	homo-ref	.	.	.	0	dup	.	600517	C	.	NN	.	.	.	.	.	.	.	6317	SERPINB3	IC3	IVS4	.	.	no-change	NM_006919.2	NP_008850.1	-	Y	c.351+31T=	.	.	.	NM_006919.2(SERPINB3): c.351+31T=	;	124504	0.013847	U	1	0.994409	.	.	PASS	-16	8496	0.003766	0	119496	0.014193	.	.	.	.	.	.	rs8085482	.	4024	0.075300	-0.374	1.269	0.842	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
18	61326601	61326602	18q21.33	0	normal	.	A	snv	G	CA.AT	hom-alt	266	1.00	.	0	dup	PASS	600517	C	.	NN	.	.	.	.	.	.	.	6317	SERPINB3	IC3	IVS4	.	.	intron	NM_006919.2	NP_008850.1	-	Y	c.351+31T>C	.	.	.	NM_006919.2(SERPINB3): c.351+31T>C	;	124504	0.986153	U	1	0.994409	.	.	PASS	4216	8496	0.996234	58052	119496	0.985807	8436	16945	9.95710e-01	116319	236273	9.84824e-01	rs8085482	.	4024	0.924700	-0.374	1.269	0.842	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
18	61326608	61326609	18q21.33	0	nullSample	.	T	ref	T	AA.GT	homo-ref	.	.	.	0	dup	.	600517	C	.	NN	.	.	.	.	.	.	.	6317	SERPINB3	IC3	IVS4	.	.	no-change	NM_006919.2	NP_008850.1	-	Y	c.351+24A=	.	.	.	NM_006919.2(SERPINB3): c.351+24A=	SingleClassTriAllelic;	124594	0.013917	U	0.004	0.000798722	.	.	PASS	-16	8512	0.003759	0	119586	0.014258	.	.	.	.	.	.	rs8089201	.	4024	0.072800	-0.392	0.133	0.287	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
18	61326608	61326609	18q21.33	0	normal	.	T	snv	G	AA.GT	hom-alt	293	1.00	.	0	dup	PASS	600517	C	.	NN	.	.	.	.	.	.	.	6317	SERPINB3	IC3	IVS4	.	.	intron	NM_006919.2	NP_008850.1	-	Y	c.351+24A>C	.	.	.	NM_006919.2(SERPINB3): c.351+24A>C	SingleClassTriAllelic;	124594	0.985858	U	0.996	0.993411	.	.	PASS	4200	8512	0.993421	58064	119586	0.985542	8400	16921	9.92900e-01	116653	236882	9.85104e-01	rs8089201	.	4024	0.921700	-0.392	0.133	0.287	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
18	61326627	61326628	18q21.33	0	nullSample	.	A	ref	A	AA.TT	homo-ref	.	.	.	0	dup	.	600517	C	.	NN	.	.	.	.	.	.	.	6317	SERPINB3	IC3	IVS4	.	.	no-change	NM_006919.2	NP_008850.1	-	Y	c.351+5T=	.	.	.	NM_006919.2(SERPINB3): c.351+5T=	.	.	.	.	1	0.994808	.	.	PASS	.	8602	0.000581	0	121150	0.002344	.	.	.	.	.	.	.	.	.	.	0.374	2.501	1.678	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
18	61326628	61326628	18q21.33	1	normal	.	.	ins	T	AA.TT	hom-alt	396	1.00	.	0	dup	PASS	600517	C	.	NN	.	.	.	.	.	.	.	6317	SERPINB3	IC3	IVS4	.	.	intron	NM_006919.2	NP_008850.1	-	Y	c.351+4_351+5insA	.	.	.	NM_006919.2(SERPINB3): c.351+4_351+5insA	;	126158	0.997543	U	1	0.994808	12518	0.993370	PASS	4296	8602	0.999419	60291	121150	0.997656	8586	17181	9.99476e-01	122153	244815	9.97901e-01	rs11370831	.	4024	0.990300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	1207237	1207238	19p13.3	0	nullSample	.	G	ref	G	GG.CC	homo-ref	.	.	.	0	.	.	602216	C	175200(MK);260350(MK);273300(MK);602216(MK)	AD	Peutz-Jeghers syndrome	AD	.	Dermatologic; Gastrointestinal; Oncologic	Gastrointestinal; Oncologic	20581245|20301443|15863673|15617552|15399020|15200509|15121768|14279723|14214503|12044140|11389158|10874301|10689645|10408777|9850045|9428765|9425897|7802138|7776109|7436458|5466889|3943856|3697923|3587280|3181678|2599445|1986290|990720	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;MC58;MH43	6794	STK11	IC1	IVS1	.	.	no-change	NM_000455.4	NP_000446.1	+	Y	c.290+36G=	.	.	.	NM_000455.4(STK11): c.290+36G=	;maf-5-some-pop,maf-5-all-pops,microattr-tpa,genotype-conflict	43882	0.671984	U	0.7004	0.353435	12252	0.770486	PASS	.	2696	0.323813	8811	38874	0.675259	.	.	.	.	.	.	rs3764640	.	4024	0.341500	0.462	1.140	0.539	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	1207237	1207238	19p13.3	0	normal	.	G	snv	T	GG.CC	hom-alt	310	0.97	.	0	.	PASS	602216	C	175200(MK);260350(MK);273300(MK);602216(MK)	AD	Peutz-Jeghers syndrome	AD	.	Dermatologic; Gastrointestinal; Oncologic	Gastrointestinal; Oncologic	20581245|20301443|15863673|15617552|15399020|15200509|15121768|14279723|14214503|12044140|11389158|10874301|10689645|10408777|9850045|9428765|9425897|7802138|7776109|7436458|5466889|3943856|3697923|3587280|3181678|2599445|1986290|990720	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;MC58;MH43	6794	STK11	IC1	IVS1	.	.	intron	NM_000455.4	NP_000446.1	+	Y	c.290+36G>T	.	.	.	NM_000455.4(STK11): c.290+36G>T	;maf-5-some-pop,maf-5-all-pops,microattr-tpa,genotype-conflict	43882	0.328016	U	0.7004	0.353435	12252	0.229514	PASS	597	2696	0.676187	1998	38874	0.324741	2879	8346	6.88273e-01	8330	48878	2.92004e-01	rs3764640	.	4024	0.658500	0.462	1.140	0.539	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	256203	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
19	1207279	1207280	19p13.3	0	normal	.	C	ref	C	tc.tc	het-alt	122	0.56	.	1	CT-rich|Low_complexity|Low_complexity|+|38	PASS	602216	C	175200(MK);260350(MK);273300(MK);602216(MK)	AD	Peutz-Jeghers syndrome	AD	.	Dermatologic; Gastrointestinal; Oncologic	Gastrointestinal; Oncologic	20581245|20301443|15863673|15617552|15399020|15200509|15121768|14279723|14214503|12044140|11389158|10874301|10689645|10408777|9850045|9428765|9425897|7802138|7776109|7436458|5466889|3943856|3697923|3587280|3181678|2599445|1986290|990720	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;MC58;MH43	6794	STK11	IC1	IVS1	.	.	no-change	NM_000455.4	NP_000446.1	+	Y	c.290+78C=	.	.	.	NM_000455.4(STK11): c.290+78C=	;maf-5-some-pop	5008	0.836661	U	0.4028	0.163339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3764641	.	4024	0.653100	0.448	1.223	0.431	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	1207279	1207280	19p13.3	0	normal	.	C	snv	T	tc.tc	het-ref	95	0.44	.	2	CT-rich|Low_complexity|Low_complexity|+|38	PASS	602216	C	175200(MK);260350(MK);273300(MK);602216(MK)	AD	Peutz-Jeghers syndrome	AD	.	Dermatologic; Gastrointestinal; Oncologic	Gastrointestinal; Oncologic	20581245|20301443|15863673|15617552|15399020|15200509|15121768|14279723|14214503|12044140|11389158|10874301|10689645|10408777|9850045|9428765|9425897|7802138|7776109|7436458|5466889|3943856|3697923|3587280|3181678|2599445|1986290|990720	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;MC58;MH43	6794	STK11	IC1	IVS1	.	.	intron	NM_000455.4	NP_000446.1	+	Y	c.290+78C>T	.	.	.	NM_000455.4(STK11): c.290+78C>T	;maf-5-some-pop	5008	0.163339	U	0.4028	0.163339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3764641	.	4024	0.346900	0.448	1.223	0.431	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	1218522	1218523	19p13.3	0	nullSample	.	G	ref	G	CC.CG	homo-ref	.	.	.	0	.	.	602216	C	175200(MK);260350(MK);273300(MK);602216(MK)	AD	Peutz-Jeghers syndrome	AD	.	Dermatologic; Gastrointestinal; Oncologic	Gastrointestinal; Oncologic	20581245|20301443|15863673|15617552|15399020|15200509|15121768|14279723|14214503|12044140|11389158|10874301|10689645|10408777|9850045|9428765|9425897|7802138|7776109|7436458|5466889|3943856|3697923|3587280|3181678|2599445|1986290|990720	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;MC58;MH43	6794	STK11	IC2	IVS2	.	.	no-change	NM_000455.4	NP_000446.1	+	Y	c.374+24G=	.	.	.	NM_000455.4(STK11): c.374+24G=	SingleClassTriAllelic;maf-5-some-pop	124578	0.833799	U	0.4355	0.269569	12016	0.821155	PASS	.	8568	0.579015	42629	119570	0.838128	.	.	.	.	.	.	rs2075604	.	4024	0.604400	-0.694	-0.869	-0.775	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	1218522	1218523	19p13.3	0	normal	.	G	snv	T	CC.CG	hom-alt	243	1.00	.	0	.	PASS	602216	C	175200(MK);260350(MK);273300(MK);602216(MK)	AD	Peutz-Jeghers syndrome	AD	.	Dermatologic; Gastrointestinal; Oncologic	Gastrointestinal; Oncologic	20581245|20301443|15863673|15617552|15399020|15200509|15121768|14279723|14214503|12044140|11389158|10874301|10689645|10408777|9850045|9428765|9425897|7802138|7776109|7436458|5466889|3943856|3697923|3587280|3181678|2599445|1986290|990720	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;MC58;MH43	6794	STK11	IC2	IVS2	.	.	intron	NM_000455.4	NP_000446.1	+	Y	c.374+24G>T	.	.	.	NM_000455.4(STK11): c.374+24G>T	SingleClassTriAllelic;maf-5-some-pop	124578	0.166177	U	0.4355	0.269569	12016	0.178845	PASS	739	8568	0.420985	2199	119570	0.161847	1490	7229	4.19754e-01	4528	39479	1.60922e-01	rs2075604	.	4024	0.395600	-0.694	-0.869	-0.775	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	256204	criteria_provided,_single_submitter	Benign	Benign
19	1219273	1219274	19p13.3	0	nullSample	.	G	ref	G	TG.GC	homo-ref	.	.	.	0	.	.	602216	C	175200(MK);260350(MK);273300(MK);602216(MK)	AD	Peutz-Jeghers syndrome	AD	.	Dermatologic; Gastrointestinal; Oncologic	Gastrointestinal; Oncologic	20581245|20301443|15863673|15617552|15399020|15200509|15121768|14279723|14214503|12044140|11389158|10874301|10689645|10408777|9850045|9428765|9425897|7802138|7776109|7436458|5466889|3943856|3697923|3587280|3181678|2599445|1986290|990720	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;MC58;MH43	6794	STK11	IC2	IVS2	.	.	no-change	NM_000455.4	NP_000446.1	+	Y	c.375-49G=	.	.	.	NM_000455.4(STK11): c.375-49G=	;maf-5-some-pop,maf-5-all-pops	28602	0.522726	U	0.8522	0.530152	12612	0.576356	PASS	-75	906	0.185430	3411	23594	0.533949	.	.	.	.	.	.	rs34928889	.	4024	0.157600	0.205	0.451	0.575	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	1219273	1219274	19p13.3	0	normal	.	G	snv	A	TG.GC	hom-alt	218	1.00	.	0	.	PASS	602216	C	175200(MK);260350(MK);273300(MK);602216(MK)	AD	Peutz-Jeghers syndrome	AD	.	Dermatologic; Gastrointestinal; Oncologic	Gastrointestinal; Oncologic	20581245|20301443|15863673|15617552|15399020|15200509|15121768|14279723|14214503|12044140|11389158|10874301|10689645|10408777|9850045|9428765|9425897|7802138|7776109|7436458|5466889|3943856|3697923|3587280|3181678|2599445|1986290|990720	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;MC58;MH43	6794	STK11	IC2	IVS2	.	.	intron	NM_000455.4	NP_000446.1	+	Y	c.375-49G>A	.	.	.	NM_000455.4(STK11): c.375-49G>A	;maf-5-some-pop,maf-5-all-pops	28602	0.477274	U	0.8522	0.530152	12612	0.423644	PASS	294	906	0.814570	2610	23594	0.466051	3833	8965	8.55276e-01	17704	71064	4.67896e-01	rs34928889	.	4024	0.842400	0.205	0.451	0.575	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	256205	criteria_provided,_single_submitter	Benign	Benign
19	1220320	1220321	19p13.3	0	nullSample	.	T	ref	T	CC.GT	homo-ref	.	.	.	0	.	.	602216	C	175200(MK);260350(MK);273300(MK);602216(MK)	AD	Peutz-Jeghers syndrome	AD	.	Dermatologic; Gastrointestinal; Oncologic	Gastrointestinal; Oncologic	20581245|20301443|15863673|15617552|15399020|15200509|15121768|14279723|14214503|12044140|11389158|10874301|10689645|10408777|9850045|9428765|9425897|7802138|7776109|7436458|5466889|3943856|3697923|3587280|3181678|2599445|1986290|990720	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;MC58;MH43	6794	STK11	IC3	IVS3	.	.	no-change	NM_000455.4	NP_000446.1	+	Y	c.465-51T=	.	.	.	NM_000455.4(STK11): c.465-51T=	;maf-5-some-pop,maf-5-all-pops	5008	0.640375	U	0.5417	0.359625	6654	0.731590	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2075606	.	4024	0.514700	0.358	-0.157	-0.558	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	1220320	1220321	19p13.3	0	normal	.	T	snv	C	CC.GT	hom-alt	291	1.00	.	0	.	PASS	602216	C	175200(MK);260350(MK);273300(MK);602216(MK)	AD	Peutz-Jeghers syndrome	AD	.	Dermatologic; Gastrointestinal; Oncologic	Gastrointestinal; Oncologic	20581245|20301443|15863673|15617552|15399020|15200509|15121768|14279723|14214503|12044140|11389158|10874301|10689645|10408777|9850045|9428765|9425897|7802138|7776109|7436458|5466889|3943856|3697923|3587280|3181678|2599445|1986290|990720	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HG15;HP16;MC58;MH43	6794	STK11	IC3	IVS3	.	.	intron	NM_000455.4	NP_000446.1	+	Y	c.465-51T>C	.	.	.	NM_000455.4(STK11): c.465-51T>C	;maf-5-some-pop,maf-5-all-pops	5008	0.359625	U	0.5417	0.359625	6654	0.268410	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2075606	.	4024	0.485300	0.358	-0.157	-0.558	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	2208858	2208859	19p13.3	0	normal	.	T	ref	T	TG.TA	het-alt	85	0.53	.	1	.	PASS	607375	C	.	NN	.	.	.	.	.	.	.	84444	DOT1L	IC11	IVS11	.	.	no-change	NM_032482.2	NP_115871.1	+	Y	c.964-75T=	.	.	.	NM_032482.2(DOT1L): c.964-75T=	;maf-5-some-pop,maf-5-all-pops	5008	0.588658	U	0.4454	0.411342	4566	0.546211	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2301799	.	.	.	0.397	0.040	-0.098	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	2208858	2208859	19p13.3	0	normal	.	T	snv	C	TG.TA	het-ref	75	0.47	.	2	.	PASS	607375	C	.	NN	.	.	.	.	.	.	.	84444	DOT1L	IC11	IVS11	.	.	intron	NM_032482.2	NP_115871.1	+	Y	c.964-75T>C	.	.	.	NM_032482.2(DOT1L): c.964-75T>C	;maf-5-some-pop,maf-5-all-pops	5008	0.411342	U	0.4454	0.411342	4566	0.453789	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2301799	.	.	.	0.397	0.040	-0.098	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	2214056	2214057	19p13.3	0	normal	.	C	ref	C	TG.GG	het-alt	137	0.49	.	1	.	PASS	607375	C	.	NN	.	.	.	.	.	.	.	84444	DOT1L	IC18	IVS18	.	.	no-change	NM_032482.2	NP_115871.1	+	Y	c.1797+72C=	.	.	.	NM_032482.2(DOT1L): c.1797+72C=	;maf-5-some-pop,maf-5-all-pops	5008	0.538339	U	0.4752	0.461661	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2074552	.	.	.	-0.448	-1.813	-2.736	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	2214056	2214057	19p13.3	0	normal	.	C	snv	T	TG.GG	het-ref	140	0.51	.	2	.	PASS	607375	C	.	NN	.	.	.	.	.	.	.	84444	DOT1L	IC18	IVS18	.	.	intron	NM_032482.2	NP_115871.1	+	Y	c.1797+72C>T	.	.	.	NM_032482.2(DOT1L): c.1797+72C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.461661	U	0.4752	0.461661	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2074552	.	.	.	-0.448	-1.813	-2.736	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	2223326	2223327	19p13.3	0	normal	.	G	ref	G	CC.GA	het-alt	221	0.52	.	1	.	PASS	607375	C	.	NN	.	.	.	.	.	.	.	84444	DOT1L	C25	EX25	.	.	no-change	NM_032482.2	NP_115871.1	+	Y	c.3438G=	.	.	.	NM_032482.2(DOT1L): c.3438G=	;maf-5-some-pop	125204	0.937350	U	0.122	0.124002	12324	0.922996	PASS	.	8600	0.853372	53321	120196	0.939906	.	.	.	.	.	.	rs2286329	.	.	.	-2.105	-3.592	-4.716	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	2223326	2223327	19p13.3	1	normal	.	G	snv	A	CC.GA	het-ref	204	0.48	.	2	.	PASS	607375	C	.	NN	.	.	.	.	.	.	.	84444	DOT1L	C25	EX25	.	.	coding-synon	NM_032482.2	NP_115871.1	+	Y	c.3438G>A	p.(P1146=) | p.(Pro1146=)	CCG=>CCA	.	NM_032482.2(DOT1L): c.3438G>A (p.(P1146=))	;maf-5-some-pop	125204	0.062650	U	0.122	0.124002	12324	0.077004	PASS	95	8600	0.146628	446	120196	0.060094	194	2568	1.48921e-01	874	14208	5.82706e-02	rs2286329	.	.	.	-2.105	-3.592	-4.716	.	.	.	.	.	ENST00000398665: c.3438G>A (p.P1146P)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5021077	.	.	.	.	.	.	.	.	.	Likely Benign
19	2223547	2223548	19p13.3	0	normal	.	T	ref	T	AC.GT	het-alt	39	0.57	.	1	.	PASS	607375	C	.	NN	.	.	.	.	.	.	.	84444	DOT1L	IC25	IVS25	.	.	no-change	NM_032482.2	NP_115871.1	+	Y	c.3596+63T=	.	.	.	NM_032482.2(DOT1L): c.3596+63T=	;maf-5-some-pop	5008	0.846046	U	0.123	0.153954	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2286330	.	.	.	-0.642	-0.456	-0.552	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	2223547	2223548	19p13.3	0	normal	.	T	snv	C	AC.GT	het-ref	30	0.43	.	2	.	PASS	607375	C	.	NN	.	.	.	.	.	.	.	84444	DOT1L	IC25	IVS25	.	.	intron	NM_032482.2	NP_115871.1	+	Y	c.3596+63T>C	.	.	.	NM_032482.2(DOT1L): c.3596+63T>C	;maf-5-some-pop	5008	0.153954	U	0.123	0.153954	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2286330	.	.	.	-0.642	-0.456	-0.552	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	2226771	2226772	19p13.3	0	normal	.	G	ref	G	AG.TC	het-alt	346	0.50	.	1	.	PASS	607375	C	.	NN	.	.	.	.	.	.	.	84444	DOT1L	C27	EX27	.	.	no-change	NM_032482.2	NP_115871.1	+	Y	c.4252G=	.	.	.	NM_032482.2(DOT1L): c.4252G=	;maf-5-some-pop,maf-5-all-pops	103578	0.808289	U	0.25	0.255791	12200	0.810574	PASS	.	7680	0.716797	32621	98570	0.811545	.	.	.	.	.	.	rs2302061	.	.	.	-0.216	-0.206	-0.033	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	2226771	2226772	19p13.3	1	normal	.	G	snv	C	AG.TC	het-ref	345	0.50	.	2	.	PASS	607375	C	.	NN	.	.	.	.	.	.	.	84444	DOT1L	C27	EX27	.	.	missense	NM_032482.2	NP_115871.1	+	Y	c.4252G>C	p.V1418L | p.Val1418Leu	GTC=>CTC	NP=>NP	NM_032482.2(DOT1L): c.4252G>C (p.V1418L)	;maf-5-some-pop,maf-5-all-pops	103578	0.191711	U	0.25	0.255791	12200	0.189426	PASS	279	7680	0.283203	1912	98570	0.188455	589	4219	2.78005e-01	3540	34211	1.69432e-01	rs2302061	.	.	.	-0.216	-0.206	-0.033	1	0	0	0.000	neutral	ENST00000398665: c.4252G>C (p.V1418L)	large_intestine [caecum|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3756557	.	.	.	.	.	.	.	.	.	Likely Benign
19	2229692	2229693	19p13.3	0	normal	.	G	ref	G	TG.GA	het-alt	101	0.44	.	1	.	PASS	607375	C	.	NN	.	.	.	.	.	.	.	84444	DOT1L	IC27	IVS27	.	.	no-change	NM_032482.2	NP_115871.1	+	Y	c.4607-91G=	.	.	.	NM_032482.2(DOT1L): c.4607-91G=	;maf-5-some-pop	5008	0.994409	U	0.0278	0.00559105	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs79111351	.	.	.	0.561	2.089	1.621	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
19	2229692	2229693	19p13.3	0	normal	.	G	snv	A	TG.GA	het-ref	131	0.56	.	2	.	PASS	607375	C	.	NN	.	.	.	.	.	.	.	84444	DOT1L	IC27	IVS27	.	.	intron	NM_032482.2	NP_115871.1	+	Y	c.4607-91G>A	.	.	.	NM_032482.2(DOT1L): c.4607-91G>A	;maf-5-some-pop	5008	0.005591	U	0.0278	0.00559105	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs79111351	.	.	.	0.561	2.089	1.621	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
19	3110348	3110349	19p13.3	0	normal	.	T	ref	T	CC.GG	het-alt	167	0.57	.	1	.	PASS	139313	C	145981(MK);615361(MK)	AD	Hypocalcemia 2, autosomal dominant; Hypocalciuric hypercalcemia, autosomal dominant	AD	.	Endocrine	Endocrine	23802516|23782177	.	2767	GNA11	IC2	IVS2	.	.	no-change	NM_002067.2	NP_002058.2	+	Y	c.321+18T=	.	.	.	NM_002067.2(GNA11): c.321+18T=	;maf-5-some-pop,maf-5-all-pops	121338	0.583362	U	0.4048	0.344249	13000	0.633923	PASS	-1024	8458	0.585481	19768	116330	0.580246	.	.	.	.	.	.	rs11085000	.	4024	0.606600	0.166	-0.469	-0.627	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	3110348	3110349	19p13.3	1	normal	.	T	snv	G	CC.GG	het-ref	125	0.43	.	2	.	PASS	139313	C	145981(MK);615361(MK)	AD	Hypocalcemia 2, autosomal dominant; Hypocalciuric hypercalcemia, autosomal dominant	AD	.	Endocrine	Endocrine	23802516|23782177	.	2767	GNA11	IC2	IVS2	.	.	intron	NM_002067.2	NP_002058.2	+	Y	c.321+18T>G	.	.	.	NM_002067.2(GNA11): c.321+18T>G	;maf-5-some-pop,maf-5-all-pops	121338	0.416638	U	0.4048	0.344249	13000	0.366077	PASS	729	8458	0.414519	10433	116330	0.419754	1410	6939	4.06693e-01	21486	100321	4.17041e-01	rs11085000	.	4024	0.393400	0.166	-0.469	-0.627	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	258546	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
19	3110360	3110361	19p13.3	0	normal	.	C	ref	C	AG.GC	het-alt	137	0.53	.	1	.	PASS	139313	C	145981(MK);615361(MK)	AD	Hypocalcemia 2, autosomal dominant; Hypocalciuric hypercalcemia, autosomal dominant	AD	.	Endocrine	Endocrine	23802516|23782177	.	2767	GNA11	IC2	IVS2	.	.	no-change	NM_002067.2	NP_002058.2	+	Y	c.321+30C=	.	.	.	NM_002067.2(GNA11): c.321+30C=	;maf-5-some-pop	119062	0.874956	U	0.1925	0.111621	13002	0.909245	PASS	.	8392	0.804457	43738	114054	0.874367	.	.	.	.	.	.	rs41276846	.	4024	0.818800	0.306	1.442	0.200	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	3110360	3110361	19p13.3	0	normal	.	C	snv	T	AG.GC	het-ref	123	0.47	.	2	.	PASS	139313	C	145981(MK);615361(MK)	AD	Hypocalcemia 2, autosomal dominant; Hypocalciuric hypercalcemia, autosomal dominant	AD	.	Endocrine	Endocrine	23802516|23782177	.	2767	GNA11	IC2	IVS2	.	.	intron	NM_002067.2	NP_002058.2	+	Y	c.321+30C>T	.	.	.	NM_002067.2(GNA11): c.321+30C>T	;maf-5-some-pop	119062	0.125044	U	0.1925	0.111621	13002	0.090755	PASS	167	8392	0.195543	1040	114054	0.125633	317	3196	1.87845e-01	2074	28810	1.21062e-01	rs41276846	.	4024	0.181200	0.306	1.442	0.200	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	3113304	3113305	19p13.3	0	normal	.	G	ref	G	AC.TC	het-alt	215	0.52	.	1	.	PASS	139313	C	145981(MK);615361(MK)	AD	Hypocalcemia 2, autosomal dominant; Hypocalciuric hypercalcemia, autosomal dominant	AD	.	Endocrine	Endocrine	23802516|23782177	.	2767	GNA11	IC2	IVS2	.	.	no-change	NM_002067.2	NP_002058.2	+	Y	c.322-23G=	.	.	.	NM_002067.2(GNA11): c.322-23G=	SingleClassTriAllelic;maf-5-some-pop,maf-5-all-pops	125398	0.150537	U	0.7659	0.835663	13004	0.125115	PASS	.	8604	0.233728	1559	120392	0.149960	.	.	.	.	.	.	rs1682811	.	4024	0.245000	-1.145	-0.914	-0.723	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	3113304	3113305	19p13.3	0	normal	.	G	snv	C	AC.TC	het-ref	199	0.48	.	2	.	PASS	139313	C	145981(MK);615361(MK)	AD	Hypocalcemia 2, autosomal dominant; Hypocalciuric hypercalcemia, autosomal dominant	AD	.	Endocrine	Endocrine	23802516|23782177	.	2767	GNA11	IC2	IVS2	.	.	intron	NM_002067.2	NP_002058.2	+	Y	c.322-23G>C	.	.	.	NM_002067.2(GNA11): c.322-23G>C	SingleClassTriAllelic;maf-5-some-pop,maf-5-all-pops	125398	0.849439	U	0.7659	0.835663	13004	0.874885	PASS	2524	8604	0.766039	43698	120392	0.849998	4989	13086	7.60814e-01	89273	208608	8.51503e-01	rs1682811	.	4024	0.755000	-1.145	-0.914	-0.723	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	3114863	3114864	19p13.3	0	normal	.	C	ref	C	CC.GC	het-alt	115	0.53	.	1	.	PASS	139313	C	145981(MK);615361(MK)	AD	Hypocalcemia 2, autosomal dominant; Hypocalciuric hypercalcemia, autosomal dominant	AD	.	Endocrine	Endocrine	23802516|23782177	.	2767	GNA11	IC3	IVS3	.	.	no-change	NM_002067.2	NP_002058.2	+	Y	c.477-78C=	.	.	.	NM_002067.2(GNA11): c.477-78C=	;maf-5-some-pop	5008	0.830072	U	0.252	0.169928	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3746069	.	4024	0.741800	-0.318	-1.043	-0.992	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	3114863	3114864	19p13.3	0	normal	.	C	snv	T	CC.GC	het-ref	102	0.47	.	2	.	PASS	139313	C	145981(MK);615361(MK)	AD	Hypocalcemia 2, autosomal dominant; Hypocalciuric hypercalcemia, autosomal dominant	AD	.	Endocrine	Endocrine	23802516|23782177	.	2767	GNA11	IC3	IVS3	.	.	intron	NM_002067.2	NP_002058.2	+	Y	c.477-78C>T	.	.	.	NM_002067.2(GNA11): c.477-78C>T	;maf-5-some-pop	5008	0.169928	U	0.252	0.169928	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3746069	.	4024	0.258200	-0.318	-1.043	-0.992	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	3119183	3119184	19p13.3	0	normal	.	T	ref	T	CC.CT	het-alt	275	0.47	.	1	.	PASS	139313	C	145981(MK);615361(MK)	AD	Hypocalcemia 2, autosomal dominant; Hypocalciuric hypercalcemia, autosomal dominant	AD	.	Endocrine	Endocrine	23802516|23782177	.	2767	GNA11	IC5	IVS5	.	.	no-change	NM_002067.2	NP_002058.2	+	Y	c.736-20T=	.	.	.	NM_002067.2(GNA11): c.736-20T=	;maf-5-some-pop,maf-5-all-pops	126114	0.168364	U	0.7659	0.773562	13006	0.184069	PASS	-775	8650	0.234913	1931	121106	0.165962	.	.	.	.	.	.	rs308046	.	4024	0.245000	-1.481	-1.359	-2.056	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	3119183	3119184	19p13.3	0	normal	.	T	snv	G	CC.CT	het-ref	308	0.53	.	2	.	PASS	139313	C	145981(MK);615361(MK)	AD	Hypocalcemia 2, autosomal dominant; Hypocalciuric hypercalcemia, autosomal dominant	AD	.	Endocrine	Endocrine	23802516|23782177	.	2767	GNA11	IC5	IVS5	.	.	intron	NM_002067.2	NP_002058.2	+	Y	c.736-20T>G	.	.	.	NM_002067.2(GNA11): c.736-20T>G	;maf-5-some-pop,maf-5-all-pops	126114	0.831636	U	0.7659	0.773562	13006	0.815931	PASS	2534	8650	0.765087	42385	121106	0.834038	5010	13127	7.61515e-01	86750	205472	8.39298e-01	rs308046	.	4024	0.755000	-1.481	-1.359	-2.056	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	258547	criteria_provided,_single_submitter	Benign	Benign
19	3119238	3119239	19p13.3	0	normal	.	C	ref	C	AC.AT	het-alt	300	0.47	.	1	.	PASS	139313	C	145981(MK);615361(MK)	AD	Hypocalcemia 2, autosomal dominant; Hypocalciuric hypercalcemia, autosomal dominant	AD	.	Endocrine	Endocrine	23802516|23782177	.	2767	GNA11	C6	EX6	ADP-ribosylation factor family;G-protein alpha subunit	PF00025.16;PF00503.15	no-change	NM_002067.2	NP_002058.2	+	Y	c.771C=	.	.	.	NM_002067.2(GNA11): c.771C=	;maf-5-some-pop,maf-5-all-pops	126324	0.576795	U	0.4058	0.348842	13006	0.617792	PASS	.	8626	0.583469	20300	121316	0.573725	.	.	.	.	.	.	rs4900	.	4024	0.603100	0.491	0.720	0.075	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	3119238	3119239	19p13.3	1	normal	.	C	snv	T	AC.AT	het-ref	332	0.53	.	2	.	PASS	139313	C	145981(MK);615361(MK)	AD	Hypocalcemia 2, autosomal dominant; Hypocalciuric hypercalcemia, autosomal dominant	AD	.	Endocrine	Endocrine	23802516|23782177	.	2767	GNA11	C6	EX6	ADP-ribosylation factor family;G-protein alpha subunit	PF00025.16;PF00503.15	coding-synon	NM_002067.2	NP_002058.2	+	Y	c.771C>T	p.(T257=) | p.(Thr257=)	ACC=>ACT	.	NM_002067.2(GNA11): c.771C>T (p.(T257=))	;maf-5-some-pop,maf-5-all-pops	126324	0.423205	U	0.4058	0.348842	13006	0.382208	PASS	761	8626	0.416531	11356	121316	0.426275	1441	7025	4.07388e-01	23046	105006	4.26881e-01	rs4900	.	4024	0.396900	0.491	0.720	0.075	.	.	.	.	.	ENST00000078429: c.771C>T (p.T257T)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	3756588	.	.	.	.	.	no_record	258548	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
19	3119404	3119405	19p13.3	0	normal	.	T	ref	T	AC.GG	het-alt	103	0.47	.	1	.	PASS	139313	C	145981(MK);615361(MK)	AD	Hypocalcemia 2, autosomal dominant; Hypocalciuric hypercalcemia, autosomal dominant	AD	.	Endocrine	Endocrine	23802516|23782177	.	2767	GNA11	IC6	IVS6	.	.	no-change	NM_002067.2	NP_002058.2	+	Y	c.889+48T=	.	.	.	NM_002067.2(GNA11): c.889+48T=	MixedObserved,SingleClassQuadAllelic;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	118142	0.143725	U	0.7669	0.856829	12916	0.141375	PASS	-769	8430	0.235587	1333	113134	0.143750	.	.	.	.	.	.	rs370286	.	4018	0.267000	-2.768	-4.558	-4.739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	3119404	3119405	19p13.3	0	normal	.	T	snv	G	AC.GG	het-ref	115	0.53	.	2	.	PASS	139313	C	145981(MK);615361(MK)	AD	Hypocalcemia 2, autosomal dominant; Hypocalciuric hypercalcemia, autosomal dominant	AD	.	Endocrine	Endocrine	23802516|23782177	.	2767	GNA11	IC6	IVS6	.	.	intron	NM_002067.2	NP_002058.2	+	Y	c.889+48T>G	.	.	.	NM_002067.2(GNA11): c.889+48T>G	MixedObserved,SingleClassQuadAllelic;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	118142	0.856182	U	0.7669	0.856829	12916	0.858625	PASS	2453	8430	0.764413	41628	113134	0.856153	4922	12940	7.60550e-01	84641	196669	8.56431e-01	rs370286	.	4018	0.733000	-2.768	-4.558	-4.739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	3119405	3119406	19p13.3	0	normal	.	G	snv	T	CT.GG	het-ref	110	0.53	.	2	.	PASS	139313	C	145981(MK);615361(MK)	AD	Hypocalcemia 2, autosomal dominant; Hypocalciuric hypercalcemia, autosomal dominant	AD	.	Endocrine	Endocrine	23802516|23782177	.	2767	GNA11	IC6	IVS6	.	.	intron	NM_002067.2	NP_002058.2	+	Y	c.889+49G>T	.	.	.	NM_002067.2(GNA11): c.889+49G>T	SingleClassTriAllelic;maf-5-some-pop,maf-5-all-pops	115919	0.433234	U	0.4048	0.349042	.	.	PASS	720	8348	0.416866	10681	110944	0.436905	1370	6835	4.02722e-01	21318	97513	4.31882e-01	rs451778	.	4020	0.385100	-0.549	-0.018	-0.190	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	3119405	3119406	19p13.3	0	normal	.	G	ref	G	CT.GG	het-alt	98	0.47	.	1	.	PASS	139313	C	145981(MK);615361(MK)	AD	Hypocalcemia 2, autosomal dominant; Hypocalciuric hypercalcemia, autosomal dominant	AD	.	Endocrine	Endocrine	23802516|23782177	.	2767	GNA11	IC6	IVS6	.	.	no-change	NM_002067.2	NP_002058.2	+	Y	c.889+49G=	.	.	.	NM_002067.2(GNA11): c.889+49G=	SingleClassTriAllelic;maf-5-some-pop,maf-5-all-pops	115919	0.566758	U	0.4048	0.349042	.	.	PASS	-1020	8348	0.583134	17665	110944	0.562788	.	.	.	.	.	.	rs451778	.	4020	0.614900	-0.549	-0.018	-0.190	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	4099186	4099187	19p13.3	0	nullSample	.	T	ref	T	GA.TC	homo-ref	.	.	.	0	.	.	601263	P	615280(MK)	NN	Cardiofaciocutaneous syndrome	AD	.	Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Oncologic	21495173|21178588|20358587|20301365|18042262|16439621|8456719	.	5605	MAP2K2	IC7	IVS7	.	.	no-change	NM_030662.3	NP_109587.1	-	Y	c.919+12A=	.	.	.	NM_030662.3(MAP2K2): c.919+12A=	;maf-5-some-pop	82212	0.228130	U	0.9216	0.773562	12690	0.255871	PASS	.	6164	0.069598	1428	77204	0.228239	.	.	.	.	.	.	rs350911	.	4024	0.061600	-0.349	-0.288	-0.657	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	4099186	4099187	19p13.3	1	normal	.	T	snv	C	GA.TC	hom-alt	357	1.00	.	0	.	PASS	601263	P	615280(MK)	NN	Cardiofaciocutaneous syndrome	AD	.	Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Oncologic	21495173|21178588|20358587|20301365|18042262|16439621|8456719	.	5605	MAP2K2	IC7	IVS7	.	.	intron	NM_030662.3	NP_109587.1	-	Y	c.919+12A>G	.	.	.	NM_030662.3(MAP2K2): c.919+12A>G	;maf-5-some-pop	82212	0.771870	U	0.9216	0.773562	12690	0.744129	PASS	2659	6164	0.930402	22409	77204	0.771761	6446	14002	9.21669e-01	58750	154567	7.53023e-01	rs350911	.	4024	0.938400	-0.349	-0.288	-0.657	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	40835	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
19	4101061	4101062	19p13.3	0	normal	.	G	ref	G	TC.AT	het-alt	251	0.52	.	1	.	PASS	601263	P	615280(MK)	NN	Cardiofaciocutaneous syndrome	AD	.	Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Oncologic	21495173|21178588|20358587|20301365|18042262|16439621|8456719	.	5605	MAP2K2	C6	EX6	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	no-change	NM_030662.3	NP_109587.1	-	Y	c.660C=	.	.	.	NM_030662.3(MAP2K2): c.660C=	;maf-5-some-pop,maf-5-all-pops	67842	0.461233	U	0.625	0.433307	12990	0.582063	PASS	-592	4350	0.338391	5133	62834	0.452828	.	.	.	.	.	.	rs10250	.	4024	0.389700	0.561	0.062	-0.031	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	4101061	4101062	19p13.3	1	normal	.	G	snv	T	TC.AT	het-ref	231	0.48	.	2	.	PASS	601263	P	615280(MK)	NN	Cardiofaciocutaneous syndrome	AD	.	Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Oncologic	21495173|21178588|20358587|20301365|18042262|16439621|8456719	.	5605	MAP2K2	C6	EX6	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_030662.3	NP_109587.1	-	Y	c.660C>A	p.(I220=) | p.(Ile220=)	ATC=>ATA	.	NM_030662.3(MAP2K2): c.660C>A (p.(I220=))	;maf-5-some-pop,maf-5-all-pops	67842	0.538767	U	0.625	0.433307	12990	0.417937	PASS	847	4350	0.661609	8097	62834	0.547172	2440	8330	5.92377e-01	23429	96372	4.78282e-01	rs10250	.	4024	0.610300	0.561	0.062	-0.031	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	40816	reviewed_by_expert_panel	Benign	Likely Benign
19	4117380	4117381	19p13.3	0	normal	.	A	ref	A	CC.CC	het-alt	84	0.72	.	1	.	DUBIOUS	601263	P	615280(MK)	NN	Cardiofaciocutaneous syndrome	AD	.	Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Oncologic	21495173|21178588|20358587|20301365|18042262|16439621|8456719	.	5605	MAP2K2	IC2	IVS2	.	.	no-change	NM_030662.3	NP_109587.1	-	Y	c.303+36T=	.	.	.	NM_030662.3(MAP2K2): c.303+36T=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.947800	-0.558	-0.755	-0.691	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	4117380	4117381	19p13.3	0	normal	.	A	snv	C	CC.CC	het-ref	33	0.28	.	2	.	DUBIOUS	601263	P	615280(MK)	NN	Cardiofaciocutaneous syndrome	AD	.	Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Oncologic	Cardiovascular; Oncologic	21495173|21178588|20358587|20301365|18042262|16439621|8456719	.	5605	MAP2K2	IC2	IVS2	.	.	intron	NM_030662.3	NP_109587.1	-	Y	c.303+36T>G	.	.	.	NM_030662.3(MAP2K2): c.303+36T>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.052200	-0.558	-0.755	-0.691	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	10602425	10602426	19p13.2	0	normal	.	G	ref	G	TC.GG	het-alt	361	0.50	.	1	.	PASS	606016	P	.	NN	.	.	.	.	.	.	.	9817	KEAP1	C2	EX3	.	.	no-change	NM_203500.1	NP_987096.1	-	Y	c.1152C=	.	.	.	NM_203500.1(KEAP1): c.1152C=	;	41476	0.999687	U	0.003	0.000599042	12882	0.999767	PASS	-4	1952	0.995902	18224	36468	0.999726	.	.	.	.	.	.	rs201119783	.	4024	0.997300	-1.740	-0.943	-2.178	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	10602425	10602426	19p13.2	1	normal	.	G	snv	A	TC.GG	het-ref	365	0.50	.	2	.	PASS	606016	P	.	NN	.	.	.	.	.	.	.	9817	KEAP1	C2	EX3	.	.	coding-synon	NM_203500.1	NP_987096.1	-	Y	c.1152C>T	p.(P384=) | p.(Pro384=)	CCC=>CCT	.	NM_203500.1(KEAP1): c.1152C>T (p.(P384=))	;	41476	0.000313	U	0.003	0.000599042	12882	0.000233	PASS	0	1952	0.004098	0	36468	0.000274	0	48	3.91773e-03	0	52	2.96357e-04	rs201119783	.	4024	0.002700	-1.740	-0.943	-2.178	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
19	11105607	11105608	19p13.2	0	normal	.	T	ref	T	CA.GC	het-alt	267	0.48	.	1	.	PASS	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	C8	EX10	.	.	no-change	NM_001128844.1	NP_001122316.1	+	Y	c.1524T=	.	.	.	NM_001128844.1(SMARCA4): c.1524T=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	124940	0.665608	U	0.2639	0.311502	13006	0.671690	PASS	-795	8536	0.761715	26677	119932	0.664652	.	.	.	.	.	.	rs7935	.	4024	0.760900	-2.223	-0.319	-1.566	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	11105607	11105608	19p13.2	0	normal	.	T	ref	T	CA.GC	het-alt	267	0.48	.	1	.	PASS	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	C8	EX9	HSA	PF07529.8	no-change	NM_001128849.1	NP_001122321.1	+	N	c.1524T=	.	.	.	NM_001128849.1(SMARCA4): c.1524T=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	124940	0.665608	U	0.2639	0.311502	13006	0.671690	PASS	-795	8536	0.761715	26677	119932	0.664652	.	.	.	.	.	.	rs7935	.	4024	0.760900	-2.223	-0.319	-1.566	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	11105607	11105608	19p13.2	1	normal	.	T	snv	C	CA.GC	het-ref	286	0.52	.	2	.	PASS	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	C8	EX10	.	.	coding-synon	NM_001128844.1	NP_001122316.1	+	Y	c.1524T>C	p.(H508=) | p.(His508=)	CAT=>CAC	.	NM_001128844.1(SMARCA4): c.1524T>C (p.(H508=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	124940	0.334393	U	0.2639	0.311502	13006	0.328310	PASS	222	8536	0.238285	6930	119932	0.335348	449	4030	2.34112e-01	13798	80555	3.27963e-01	rs7935	.	4024	0.239100	-2.223	-0.319	-1.566	.	.	.	.	.	ENST00000358026: c.1524T>C (p.H508H)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	4131184	.	.	.	.	.	no_record	126359	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
19	11105607	11105608	19p13.2	1	normal	.	T	snv	C	CA.GC	het-ref	286	0.52	.	2	.	PASS	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	C8	EX9	HSA	PF07529.8	coding-synon	NM_001128849.1	NP_001122321.1	+	N	c.1524T>C	p.(H508=) | p.(His508=)	CAT=>CAC	.	NM_001128849.1(SMARCA4): c.1524T>C (p.(H508=))	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb,genotype-conflict	124940	0.334393	U	0.2639	0.311502	13006	0.328310	PASS	222	8536	0.238285	6930	119932	0.335348	449	4030	2.34112e-01	13798	80555	3.27963e-01	rs7935	.	4024	0.239100	-2.223	-0.319	-1.566	.	.	.	.	.	ENST00000358026: c.1524T>C (p.H508H)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	4131184	.	.	.	.	.	no_record	126359	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
19	11107132	11107133	19p13.2	0	normal	.	T	ref	T	TG.GG	het-alt	300	0.55	.	1	.	PASS	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	IC9	IVS11	.	.	no-change	NM_001128844.1	NP_001122316.1	+	Y	c.1762-37T=	.	.	.	NM_001128844.1(SMARCA4): c.1762-37T=	MixedObserved;maf-5-some-pop,maf-5-all-pops	126384	0.654102	U	0.2659	0.332268	13006	0.663079	PASS	-793	8640	0.761806	26380	121376	0.653539	.	.	.	.	.	.	rs2304087	.	4024	0.759700	-0.733	-1.126	-1.025	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	11107132	11107133	19p13.2	0	normal	.	T	ref	T	TG.GG	het-alt	300	0.55	.	1	.	PASS	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	IC9	IVS10	.	.	no-change	NM_001128849.1	NP_001122321.1	+	N	c.1762-37T=	.	.	.	NM_001128849.1(SMARCA4): c.1762-37T=	MixedObserved;maf-5-some-pop,maf-5-all-pops	126384	0.654102	U	0.2659	0.332268	13006	0.663079	PASS	-793	8640	0.761806	26380	121376	0.653539	.	.	.	.	.	.	rs2304087	.	4024	0.759700	-0.733	-1.126	-1.025	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	11107132	11107133	19p13.2	0	normal	.	T	snv	C	TG.GG	het-ref	249	0.45	.	2	.	PASS	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	IC9	IVS11	.	.	intron	NM_001128844.1	NP_001122316.1	+	Y	c.1762-37T>C	.	.	.	NM_001128844.1(SMARCA4): c.1762-37T>C	MixedObserved;maf-5-some-pop,maf-5-all-pops	126384	0.345898	U	0.2659	0.332268	13006	0.336921	PASS	236	8640	0.238194	7744	121376	0.346461	464	4057	2.35216e-01	15152	83763	3.40171e-01	rs2304087	.	4024	0.240300	-0.733	-1.126	-1.025	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	11107132	11107133	19p13.2	0	normal	.	T	snv	C	TG.GG	het-ref	249	0.45	.	2	.	PASS	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	IC9	IVS10	.	.	intron	NM_001128849.1	NP_001122321.1	+	N	c.1762-37T>C	.	.	.	NM_001128849.1(SMARCA4): c.1762-37T>C	MixedObserved;maf-5-some-pop,maf-5-all-pops	126384	0.345898	U	0.2659	0.332268	13006	0.336921	PASS	236	8640	0.238194	7744	121376	0.346461	464	4057	2.35216e-01	15152	83763	3.40171e-01	rs2304087	.	4024	0.240300	-0.733	-1.126	-1.025	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	11113901	11113902	19p13.2	0	normal	.	G	snv	A	GA.GT	het-ref	214	0.52	.	2	.	PASS	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	IC11	IVS13	.	.	intron	NM_001128844.1	NP_001122316.1	+	Y	c.1943+67G>A	.	.	.	NM_001128844.1(SMARCA4): c.1943+67G>A	;maf-5-some-pop	5008	0.193291	U	0.2183	0.193291	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2288844	.	4024	0.211000	-0.253	-0.990	-1.078	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	11113901	11113902	19p13.2	0	normal	.	G	snv	A	GA.GT	het-ref	214	0.52	.	2	.	PASS	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	IC11	IVS12	.	.	intron	NM_001128849.1	NP_001122321.1	+	N	c.1943+67G>A	.	.	.	NM_001128849.1(SMARCA4): c.1943+67G>A	;maf-5-some-pop	5008	0.193291	U	0.2183	0.193291	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2288844	.	4024	0.211000	-0.253	-0.990	-1.078	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	11113901	11113902	19p13.2	0	normal	.	G	ref	G	GA.GT	het-alt	201	0.48	.	1	.	PASS	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	IC11	IVS13	.	.	no-change	NM_001128844.1	NP_001122316.1	+	Y	c.1943+67G=	.	.	.	NM_001128844.1(SMARCA4): c.1943+67G=	;maf-5-some-pop	5008	0.806709	U	0.2183	0.193291	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2288844	.	4024	0.789000	-0.253	-0.990	-1.078	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	11113901	11113902	19p13.2	0	normal	.	G	ref	G	GA.GT	het-alt	201	0.48	.	1	.	PASS	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	IC11	IVS12	.	.	no-change	NM_001128849.1	NP_001122321.1	+	N	c.1943+67G=	.	.	.	NM_001128849.1(SMARCA4): c.1943+67G=	;maf-5-some-pop	5008	0.806709	U	0.2183	0.193291	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2288844	.	4024	0.789000	-0.253	-0.990	-1.078	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	11132314	11132315	19p13.2	0	normal	.	G	ref	G	TG.CT	het-alt	116	0.49	.	1	.	PASS	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	IC17	IVS19	.	.	no-change	NM_001128844.1	NP_001122316.1	+	Y	c.2617-86G=	.	.	.	NM_001128844.1(SMARCA4): c.2617-86G=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	20714	0.920971	U	0.0298	0.0860623	.	.	PASS	-8	448	0.959821	6728	15706	0.923214	.	.	.	.	.	.	rs75904516	.	4024	0.973400	0.561	0.040	-0.045	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	11132314	11132315	19p13.2	0	normal	.	G	ref	G	TG.CT	het-alt	116	0.49	.	1	.	PASS	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	IC17	IVS18	.	.	no-change	NM_001128849.1	NP_001122321.1	+	N	c.2617-86G=	.	.	.	NM_001128849.1(SMARCA4): c.2617-86G=	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	20714	0.920971	U	0.0298	0.0860623	.	.	PASS	-8	448	0.959821	6728	15706	0.923214	.	.	.	.	.	.	rs75904516	.	4024	0.973400	0.561	0.040	-0.045	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	11132314	11132315	19p13.2	0	normal	.	G	snv	A	TG.CT	het-ref	120	0.51	.	2	.	PASS	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	IC17	IVS19	.	.	intron	NM_001128844.1	NP_001122316.1	+	Y	c.2617-86G>A	.	.	.	NM_001128844.1(SMARCA4): c.2617-86G>A	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	20714	0.079029	U	0.0298	0.0860623	.	.	PASS	1	448	0.040179	81	15706	0.076786	4	222	2.16332e-02	248	4149	2.92121e-02	rs75904516	.	4024	0.026600	0.561	0.040	-0.045	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	133384	no_assertion_provided	not_provided	Benign
19	11132314	11132315	19p13.2	0	normal	.	G	snv	A	TG.CT	het-ref	120	0.51	.	2	.	PASS	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	IC17	IVS18	.	.	intron	NM_001128849.1	NP_001122321.1	+	N	c.2617-86G>A	.	.	.	NM_001128849.1(SMARCA4): c.2617-86G>A	;clinically-assoc,maf-5-some-pop,submitted-by-lsdb	20714	0.079029	U	0.0298	0.0860623	.	.	PASS	1	448	0.040179	81	15706	0.076786	4	222	2.16332e-02	248	4149	2.92121e-02	rs75904516	.	4024	0.026600	0.561	0.040	-0.045	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	133384	no_assertion_provided	not_provided	Benign
19	11136043	11136044	19p13.2	0	normal	.	A	ref	A	CC.CC	het-alt	88	0.81	.	1	.	DUBIOUS	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	IC20	IVS22	.	.	no-change	NM_001128844.1	NP_001122316.1	+	Y	c.3082-54A=	.	.	.	NM_001128844.1(SMARCA4): c.3082-54A=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.993300	0.533	0.183	0.150	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	11136043	11136044	19p13.2	0	normal	.	A	ref	A	CC.CC	het-alt	88	0.81	.	1	.	DUBIOUS	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	IC20	IVS21	.	.	no-change	NM_001128849.1	NP_001122321.1	+	N	c.3082-54A=	.	.	.	NM_001128849.1(SMARCA4): c.3082-54A=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.993300	0.533	0.183	0.150	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	11136043	11136044	19p13.2	0	normal	.	A	snv	C	CC.CC	het-ref	20	0.19	.	2	.	DUBIOUS	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	IC20	IVS22	.	.	intron	NM_001128844.1	NP_001122316.1	+	Y	c.3082-54A>C	.	.	.	NM_001128844.1(SMARCA4): c.3082-54A>C	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.006700	0.533	0.183	0.150	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
19	11136043	11136044	19p13.2	0	normal	.	A	snv	C	CC.CC	het-ref	20	0.19	.	2	.	DUBIOUS	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	IC20	IVS21	.	.	intron	NM_001128849.1	NP_001122321.1	+	N	c.3082-54A>C	.	.	.	NM_001128849.1(SMARCA4): c.3082-54A>C	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.006700	0.533	0.183	0.150	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
19	11136214	11136215	19p13.2	0	nullSample	.	C	ref	C	GG.CC	homo-ref	.	.	.	0	.	.	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	IC21	IVS23	.	.	no-change	NM_001128844.1	NP_001122316.1	+	Y	c.3168+31C=	.	.	.	NM_001128844.1(SMARCA4): c.3168+31C=	MixedObserved;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb|MixedObserved;	125220|120476	0.579780|0.999959	U	0.5585	0.450879	13006	0.609180	PASS	.	8588	0.440498	20592	120212	0.581057	.	.	.	.	.	.	rs2075021|rs770888164	.	4024	0.434600	-0.812	-0.845	-0.769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	11136214	11136215	19p13.2	0	nullSample	.	C	ref	C	GG.CC	homo-ref	.	.	.	0	.	.	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	IC21	IVS22	.	.	no-change	NM_001128849.1	NP_001122321.1	+	N	c.3168+31C=	.	.	.	NM_001128849.1(SMARCA4): c.3168+31C=	MixedObserved;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb|MixedObserved;	125220|120476	0.579780|0.999959	U	0.5585	0.450879	13006	0.609180	PASS	.	8588	0.440498	20592	120212	0.581057	.	.	.	.	.	.	rs2075021|rs770888164	.	4024	0.434600	-0.812	-0.845	-0.769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	11136214	11136215	19p13.2	0	normal	.	C	snv	G	GG.CC	hom-alt	236	1.00	.	0	.	PASS	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	IC21	IVS23	.	.	intron	NM_001128844.1	NP_001122316.1	+	Y	c.3168+31C>G	.	.	.	NM_001128844.1(SMARCA4): c.3168+31C>G	MixedObserved;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125220	0.420220	U	0.5585	0.450879	13006	0.390820	PASS	1306	8588	0.559502	10848	120212	0.418943	2575	9440	5.48901e-01	21320	100245	4.12419e-01	rs2075021	.	4024	0.565400	-0.812	-0.845	-0.769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	126360	no_assertion_criteria_provided	Likely_benign	Benign
19	11136214	11136215	19p13.2	0	normal	.	C	snv	G	GG.CC	hom-alt	236	1.00	.	0	.	PASS	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	IC21	IVS22	.	.	intron	NM_001128849.1	NP_001122321.1	+	N	c.3168+31C>G	.	.	.	NM_001128849.1(SMARCA4): c.3168+31C>G	MixedObserved;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	125220	0.420220	U	0.5585	0.450879	13006	0.390820	PASS	1306	8588	0.559502	10848	120212	0.418943	2575	9440	5.48901e-01	21320	100245	4.12419e-01	rs2075021	.	4024	0.565400	-0.812	-0.845	-0.769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	126360	no_assertion_criteria_provided	Likely_benign	Benign
19	11144753	11144754	19p13.2	0	normal	.	A	ref	A	CC.CC	het-alt	93	0.66	.	1	.	DUBIOUS	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	IC26	IVS28	.	.	no-change	NM_001128844.1	NP_001122316.1	+	Y	c.3874-45A=	.	.	.	NM_001128844.1(SMARCA4): c.3874-45A=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.866100	0.379	0.740	0.209	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	11144753	11144754	19p13.2	0	normal	.	A	ref	A	CC.CC	het-alt	93	0.66	.	1	.	DUBIOUS	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	IC26	IVS27	.	.	no-change	NM_001128849.1	NP_001122321.1	+	N	c.3874-45A=	.	.	.	NM_001128849.1(SMARCA4): c.3874-45A=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.866100	0.379	0.740	0.209	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	11144753	11144754	19p13.2	0	normal	.	A	snv	C	CC.CC	het-ref	47	0.34	.	2	.	DUBIOUS	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	IC26	IVS28	.	.	intron	NM_001128844.1	NP_001122316.1	+	Y	c.3874-45A>C	.	.	.	NM_001128844.1(SMARCA4): c.3874-45A>C	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.133900	0.379	0.740	0.209	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	11144753	11144754	19p13.2	0	normal	.	A	snv	C	CC.CC	het-ref	47	0.34	.	2	.	DUBIOUS	603254	P	613325(SK);614609(MK)	NN	Rhabdoid tumor predisposition syndrome 2	AD	Allelic with Mental retardation, autosomal dominant 16 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	23775540|22426308|20137775	FC59;FH44;H68;HBO28;MC58;MH43	6597	SMARCA4	IC26	IVS27	.	.	intron	NM_001128849.1	NP_001122321.1	+	N	c.3874-45A>C	.	.	.	NM_001128849.1(SMARCA4): c.3874-45A>C	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.133900	0.379	0.740	0.209	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15273220	15273221	19p13.12	0	normal	.	T	ref	T	ga.tg	het-alt	109	0.51	.	1	AluYc|SINE|Alu|-|63	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC32	IVS32	.	.	no-change	NM_000435.2	NP_000426.2	-	Y	c.5913+55A=	.	.	.	NM_000435.2(NOTCH3): c.5913+55A=	;maf-5-some-pop,maf-5-all-pops	122226	0.141247	U	0.8016	0.83147	.	.	PASS	.	8230	0.199149	1171	117218	0.140081	.	.	.	.	.	.	rs757472	.	4024	0.203000	-3.642	-1.026	-1.039	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15273220	15273221	19p13.12	0	normal	.	T	snv	C	ga.tg	het-ref	104	0.49	.	2	AluYc|SINE|Alu|-|63	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC32	IVS32	.	.	intron	NM_000435.2	NP_000426.2	-	Y	c.5913+55A>G	.	.	.	NM_000435.2(NOTCH3): c.5913+55A>G	;maf-5-some-pop,maf-5-all-pops	122226	0.858753	U	0.8016	0.83147	.	.	PASS	2603	8230	0.800851	43360	117218	0.859919	5388	13568	7.97648e-01	87749	205005	8.51611e-01	rs757472	.	4024	0.797000	-3.642	-1.026	-1.039	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15273230	15273231	19p13.12	0	normal	.	A	ref	A	gc.cT	het-alt	109	0.51	.	1	AluYc|SINE|Alu|-|63	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC32	IVS32	.	.	no-change	NM_000435.2	NP_000426.2	-	Y	c.5913+45T=	.	.	.	NM_000435.2(NOTCH3): c.5913+45T=	SingleClassTriAllelic;maf-5-some-pop	123558	0.129623	U	0.8016	0.86861	13006	0.077887	PASS	-703	8384	0.201336	1159	118550	0.129549	.	.	.	.	.	.	rs4809028	.	4024	0.203000	-0.176	0.453	0.436	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15273230	15273231	19p13.12	0	normal	.	A	snv	G	gc.cT	het-ref	104	0.49	.	2	AluYc|SINE|Alu|-|63	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC32	IVS32	.	.	intron	NM_000435.2	NP_000426.2	-	Y	c.5913+45T>C	.	.	.	NM_000435.2(NOTCH3): c.5913+45T>C	SingleClassTriAllelic;maf-5-some-pop	123558	0.870369	U	0.8016	0.86861	13006	0.922113	PASS	2645	8384	0.798664	45075	118550	0.870443	5407	13604	7.98076e-01	90484	208755	8.61435e-01	rs4809028	.	4024	0.797000	-0.176	0.453	0.436	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15273247	15273248	19p13.12	0	normal	.	A	ref	A	AC.CC	het-alt	105	0.53	.	1	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC32	IVS32	.	.	no-change	NM_000435.2	NP_000426.2	-	Y	c.5913+28T=	.	.	.	NM_000435.2(NOTCH3): c.5913+28T=	;maf-5-some-pop	125396	0.126527	U	0.8016	0.870407	13006	0.076196	PASS	.	8570	0.196149	1229	120388	0.126400	.	.	.	.	.	.	rs4809029	.	4024	0.202800	-2.304	-1.124	-1.312	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15273247	15273248	19p13.12	0	normal	.	A	snv	C	AC.CC	het-ref	94	0.47	.	2	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC32	IVS32	.	.	intron	NM_000435.2	NP_000426.2	-	Y	c.5913+28T>G	.	.	.	NM_000435.2(NOTCH3): c.5913+28T>G	;maf-5-some-pop	125396	0.873473	U	0.8016	0.870407	13006	0.923804	PASS	2758	8570	0.803851	46206	120388	0.873600	5499	13767	8.00873e-01	91845	211233	8.63727e-01	rs4809029	.	4024	0.797200	-2.304	-1.124	-1.312	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15273380	15273381	19p13.12	0	normal	.	A	ref	A	GG.TG	het-alt	138	0.55	.	1	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC31	IVS31	.	.	no-change	NM_000435.2	NP_000426.2	-	Y	c.5816-8T=	.	.	.	NM_000435.2(NOTCH3): c.5816-8T=	SingleClassTriAllelic;maf-5-some-pop	125458	0.125699	U	0.8016	0.86901	13006	0.076734	PASS	-684	8558	0.193503	1176	120450	0.125479	.	.	.	.	.	.	rs4809030	.	4024	0.202800	-2.438	-0.298	-0.955	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15273380	15273381	19p13.12	1	normal	.	A	snv	G	GG.TG	het-ref	113	0.45	.	2	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC31	IVS31	.	.	intron	NM_000435.2	NP_000426.2	-	Y	c.5816-8T>C	.	.	.	NM_000435.2(NOTCH3): c.5816-8T>C	SingleClassTriAllelic;maf-5-some-pop	125458	0.874293	U	0.8016	0.86901	13006	0.923266	PASS	2767	8558	0.806497	46287	120450	0.874512	5503	13775	8.01058e-01	92095	211805	8.63904e-01	rs4809030	.	4024	0.797200	-2.438	-0.298	-0.955	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	256145	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
19	15276142	15276143	19p13.12	0	normal	.	C	ref	C	AC.AA	het-alt	186	0.51	.	1	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC31	IVS31	.	.	no-change	NM_000435.2	NP_000426.2	-	Y	c.5815+36G=	.	.	.	NM_000435.2(NOTCH3): c.5815+36G=	;maf-5-some-pop	125774	0.127347	U	0.8006	0.866613	13006	0.077810	PASS	.	8568	0.195261	1262	120766	0.127097	.	.	.	.	.	.	rs2074618	.	4024	0.202800	-1.785	-1.182	-1.215	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15276142	15276143	19p13.12	0	normal	.	C	snv	T	AC.AA	het-ref	176	0.49	.	2	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC31	IVS31	.	.	intron	NM_000435.2	NP_000426.2	-	Y	c.5815+36G>A	.	.	.	NM_000435.2(NOTCH3): c.5815+36G>A	;maf-5-some-pop	125774	0.872653	U	0.8006	0.866613	13006	0.922190	PASS	2760	8568	0.804739	46296	120766	0.872903	5489	13761	8.00058e-01	88602	204089	8.62161e-01	rs2074618	.	4024	0.797200	-1.785	-1.182	-1.215	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15276918	15276919	19p13.12	0	normal	.	G	ref	G	GT.TG	het-alt	195	0.54	.	1	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC29	IVS29	.	.	no-change	NM_000435.2	NP_000426.2	-	Y	c.5363-17C=	.	.	.	NM_000435.2(NOTCH3): c.5363-17C=	;maf-5-some-pop	125630	0.128480	U	0.8006	0.866613	13006	0.077810	PASS	.	8592	0.197975	1242	120622	0.128277	.	.	.	.	.	.	rs2074619	.	4024	0.203000	-0.165	-1.185	-1.859	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15276918	15276919	19p13.12	1	normal	.	G	snv	A	GT.TG	het-ref	163	0.46	.	2	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC29	IVS29	.	.	intron	NM_000435.2	NP_000426.2	-	Y	c.5363-17C>T	.	.	.	NM_000435.2(NOTCH3): c.5363-17C>T	;maf-5-some-pop	125630	0.871520	U	0.8006	0.866613	13006	0.922190	PASS	2743	8592	0.802025	46080	120622	0.871723	5457	13726	7.98580e-01	91270	210453	8.61813e-01	rs2074619	.	4024	0.797000	-0.165	-1.185	-1.859	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	256141	criteria_provided,_single_submitter	Benign	Benign
19	15276922	15276923	19p13.12	0	normal	.	C	ref	C	GT.AG	het-alt	198	0.56	.	1	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC29	IVS29	.	.	no-change	NM_000435.2	NP_000426.2	-	Y	c.5363-21G=	.	.	.	NM_000435.2(NOTCH3): c.5363-21G=	;maf-5-some-pop	125484	0.128431	U	0.8006	0.866613	13006	0.077656	PASS	-702	8584	0.197810	1233	120476	0.128225	.	.	.	.	.	.	rs10416777	.	4024	0.203000	0.655	0.489	0.631	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15276922	15276923	19p13.12	0	normal	.	C	snv	T	GT.AG	het-ref	154	0.44	.	2	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC29	IVS29	.	.	intron	NM_000435.2	NP_000426.2	-	Y	c.5363-21G>A	.	.	.	NM_000435.2(NOTCH3): c.5363-21G>A	;maf-5-some-pop	125484	0.871569	U	0.8006	0.866613	13006	0.922344	PASS	2741	8584	0.802190	46023	120476	0.871775	5450	13712	7.98509e-01	91135	210172	8.61792e-01	rs10416777	.	4024	0.797000	0.655	0.489	0.631	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15278056	15278057	19p13.12	0	normal	.	A	ref	A	CT.AC	het-alt	303	0.56	.	1	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC29	IVS29	.	.	no-change	NM_000435.2	NP_000426.2	-	Y	c.5362+3T=	.	.	.	NM_000435.2(NOTCH3): c.5362+3T=	;maf-5-some-pop,genotype-conflict	126336	0.126092	U	0.8016	0.870008	13006	0.076349	PASS	.	8626	0.192557	1262	121328	0.125931	.	.	.	.	.	.	rs1548555	.	4024	0.202800	-0.186	0.487	0.618	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15278056	15278057	19p13.12	1	normal	.	A	snv	G	CT.AC	het-ref	239	0.44	.	2	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC29	IVS29	.	.	intron	NM_000435.2	NP_000426.2	-	Y	c.5362+3T>C	.	.	.	NM_000435.2(NOTCH3): c.5362+3T>C	;maf-5-some-pop,genotype-conflict	126336	0.873908	U	0.8016	0.870008	13006	0.923651	PASS	2800	8626	0.807443	46647	121328	0.874069	5523	13817	8.01078e-01	92365	212328	8.63958e-01	rs1548555	.	4024	0.797200	-0.186	0.487	0.618	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	256140	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
19	15285051	15285052	19p13.12	0	normal	.	T	ref	T	TC.GG	het-alt	280	0.49	.	1	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	C25	EX25	NOTCH protein	PF06816.8	no-change	NM_000435.2	NP_000426.2	-	Y	c.4563A=	.	.	.	NM_000435.2(NOTCH3): c.4563A=	;maf-5-some-pop	93348	0.119263	U	0.8006	0.871805	12862	0.073861	PASS	-486	5818	0.181162	473	88340	0.118757	.	.	.	.	.	.	rs1044006	.	4024	0.203000	-0.320	-1.685	-1.429	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15285051	15285052	19p13.12	1	normal	.	T	snv	C	TC.GG	het-ref	296	0.51	.	2	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	C25	EX25	NOTCH protein	PF06816.8	coding-synon	NM_000435.2	NP_000426.2	-	Y	c.4563A>G	p.(P1521=) | p.(Pro1521=)	CCA=>CCG	.	NM_000435.2(NOTCH3): c.4563A>G (p.(P1521=))	;maf-5-some-pop	93348	0.880737	U	0.8006	0.871805	12862	0.926139	PASS	1896	5818	0.818838	34152	88340	0.881243	4817	12115	8.01363e-01	79323	182960	8.62645e-01	rs1044006	.	4024	0.797000	-0.320	-1.685	-1.429	.	.	.	.	.	ENST00000263388: c.4563A>G (p.P1521P)	large_intestine [caecum|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1480700	.	.	.	.	.	no_record	256138	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
19	15285271	15285272	19p13.12	0	normal	.	T	ref	T	CT.CC	het-alt	86	0.52	.	1	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC24	IVS24	.	.	no-change	NM_000435.2	NP_000426.2	-	Y	c.4404-61A=	.	.	.	NM_000435.2(NOTCH3): c.4404-61A=	;maf-5-some-pop,maf-5-all-pops	5008	0.149561	U	0.7996	0.850439	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10422818	.	4020	0.203200	-0.589	-0.035	-0.459	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15285271	15285272	19p13.12	0	normal	.	T	snv	C	CT.CC	het-ref	78	0.48	.	2	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC24	IVS24	.	.	intron	NM_000435.2	NP_000426.2	-	Y	c.4404-61A>G	.	.	.	NM_000435.2(NOTCH3): c.4404-61A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.850439	U	0.7996	0.850439	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10422818	.	4020	0.796800	-0.589	-0.035	-0.459	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15291095	15291096	19p13.12	0	normal	.	G	ref	G	CA.AG	het-alt	208	0.56	.	1	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC19	IVS19	.	.	no-change	NM_000435.2	NP_000426.2	-	Y	c.3143-29C=	.	.	.	NM_000435.2(NOTCH3): c.3143-29C=	SingleClassTriAllelic;maf-5-some-pop	121898	0.986070	U	0.0694	0.0201677	13004	0.992310	PASS	-295	8466	0.925821	56879	116890	0.986338	.	.	.	.	.	.	rs137943075	.	4024	0.933200	-0.165	0.404	0.060	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15291095	15291096	19p13.12	0	normal	.	G	snv	A	CA.AG	het-ref	164	0.44	.	2	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC19	IVS19	.	.	intron	NM_000435.2	NP_000426.2	-	Y	c.3143-29C>T	.	.	.	NM_000435.2(NOTCH3): c.3143-29C>T	SingleClassTriAllelic;maf-5-some-pop	121898	0.013921	U	0.0694	0.0201677	13004	0.007690	PASS	19	8466	0.074179	31	116890	0.013654	34	1206	7.01571e-02	53	3273	1.34479e-02	rs137943075	.	4024	0.066800	-0.165	0.404	0.060	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15292365	15292366	19p13.12	0	nullSample	.	C	ref	C	CT.CA	homo-ref	.	.	.	0	.	.	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC17	IVS17	.	.	no-change	NM_000435.2	NP_000426.2	-	Y	c.2792+21G=	.	.	.	NM_000435.2(NOTCH3): c.2792+21G=	;maf-5-some-pop,maf-5-all-pops	21816	0.212780	U	0.8294	0.739217	11040	0.197283	PASS	.	578	0.205882	365	16808	0.198477	.	.	.	.	.	.	rs11669982	.	4024	0.178700	-0.500	0.466	-0.188	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15292365	15292366	19p13.12	0	normal	.	C	snv	T	CT.CA	hom-alt	267	1.00	.	0	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC17	IVS17	.	.	intron	NM_000435.2	NP_000426.2	-	Y	c.2792+21G>A	.	.	.	NM_000435.2(NOTCH3): c.2792+21G>A	;maf-5-some-pop,maf-5-all-pops	21816	0.787220	U	0.8294	0.739217	11040	0.802717	PASS	177	578	0.794118	5433	16808	0.801523	3330	8243	8.09725e-01	46522	114813	8.02888e-01	rs11669982	.	4024	0.821300	-0.500	0.466	-0.188	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15292436	15292437	19p13.12	0	nullSample	.	T	ref	T	CC.GG	homo-ref	.	.	.	0	.	.	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	C17	EX17	.	.	no-change	NM_000435.2	NP_000426.2	-	Y	c.2742A=	.	.	.	NM_000435.2(NOTCH3): c.2742A=	;maf-5-some-pop,maf-5-all-pops	24410	0.210979	U	0.8284	0.739018	12276	0.209514	PASS	.	658	0.196049	422	19402	0.198072	.	.	.	.	.	.	rs1043997	.	4024	0.177900	-2.251	-4.386	-4.375	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15292436	15292437	19p13.12	1	normal	.	T	snv	C	CC.GG	hom-alt	460	1.00	.	0	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	C17	EX17	.	.	coding-synon	NM_000435.2	NP_000426.2	-	Y	c.2742A>G	p.(P914=) | p.(Pro914=)	CCA=>CCG	.	NM_000435.2(NOTCH3): c.2742A>G (p.(P914=))	;maf-5-some-pop,maf-5-all-pops	24410	0.789021	U	0.8284	0.739018	12276	0.790486	PASS	206	658	0.803951	6280	19402	0.801928	3360	8310	8.10415e-01	48026	118414	8.03657e-01	rs1043997	.	4024	0.822100	-2.251	-4.386	-4.375	.	.	.	.	.	ENST00000263388: c.2742A>G (p.P914P)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4131309	.	.	.	.	.	no_record	256130	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
19	15300068	15300069	19p13.12	0	nullSample	.	T	ref	T	GA.GG	homo-ref	.	.	.	0	.	.	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC7	IVS7	.	.	no-change	NM_000435.2	NP_000426.2	-	Y	c.1192+15A=	.	.	.	NM_000435.2(NOTCH3): c.1192+15A=	;maf-5-some-pop,maf-5-all-pops	126250	0.142891	U	0.869	0.854233	13006	0.110949	PASS	-502	8634	0.132268	1471	121242	0.142772	.	.	.	.	.	.	rs10423702	.	4024	0.136900	0.260	-0.794	-0.790	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15300068	15300069	19p13.12	1	normal	.	T	snv	C	GA.GG	hom-alt	617	1.00	.	0	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC7	IVS7	.	.	intron	NM_000435.2	NP_000426.2	-	Y	c.1192+15A>G	.	.	.	NM_000435.2(NOTCH3): c.1192+15A>G	;maf-5-some-pop,maf-5-all-pops	126250	0.857109	U	0.869	0.854233	13006	0.889051	PASS	3244	8634	0.867732	44782	121242	0.857228	6421	14885	8.63299e-01	88901	208528	8.47716e-01	rs10423702	.	4024	0.863100	0.260	-0.794	-0.790	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	256118	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
19	15302843	15302844	19p13.12	0	nullSample	.	T	ref	T	GG.GC	homo-ref	.	.	.	0	.	.	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	C4	EX4	.	.	no-change	NM_000435.2	NP_000426.2	-	Y	c.606A=	.	.	.	NM_000435.2(NOTCH3): c.606A=	;maf-5-some-pop	125330	0.141969	U	0.871	0.855831	13006	0.110718	PASS	-502	8624	0.132653	1442	120322	0.141878	.	.	.	.	.	.	rs1043994	.	4024	0.137200	-4.680	-1.208	-2.590	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15302843	15302844	19p13.12	1	normal	.	T	snv	C	GG.GC	hom-alt	602	1.00	.	0	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	C4	EX4	.	.	coding-synon	NM_000435.2	NP_000426.2	-	Y	c.606A>G	p.(A202=) | p.(Ala202=)	GCA=>GCG	.	NM_000435.2(NOTCH3): c.606A>G (p.(A202=))	;maf-5-some-pop	125330	0.858031	U	0.871	0.855831	13006	0.889282	PASS	3238	8624	0.867347	44532	120322	0.858122	6419	14878	8.63694e-01	88822	208202	8.48391e-01	rs1043994	.	4024	0.862800	-4.680	-1.208	-2.590	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	256148	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
19	15303224	15303225	19p13.12	0	nullSample	.	G	ref	G	GC.GT	homo-ref	.	.	.	0	.	.	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	C3	EX3	.	.	no-change	NM_000435.2	NP_000426.2	-	Y	c.303C=	.	.	.	NM_000435.2(NOTCH3): c.303C=	;maf-5-some-pop,maf-5-all-pops	116356	0.816004	U	0.3899	0.224042	12982	0.816592	PASS	-989	8402	0.640562	37408	111348	0.817805	.	.	.	.	.	.	rs3815188	.	4024	0.650600	-1.047	-0.018	-0.552	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15303224	15303225	19p13.12	1	normal	.	G	snv	A	GC.GT	hom-alt	626	1.00	.	0	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	C3	EX3	.	.	coding-synon	NM_000435.2	NP_000426.2	-	Y	c.303C>T	p.(T101=) | p.(Thr101=)	ACC=>ACT	.	NM_000435.2(NOTCH3): c.303C>T (p.(T101=))	;maf-5-some-pop,maf-5-all-pops	116356	0.183996	U	0.3899	0.224042	12982	0.183408	PASS	521	8402	0.359438	2021	111348	0.182195	985	5916	3.45480e-01	4011	41665	1.73714e-01	rs3815188	.	4024	0.349400	-1.047	-0.018	-0.552	.	.	.	.	.	ENST00000263388: c.303C>T (p.T101T)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019657	.	.	.	.	.	no_record	256131	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
19	15308264	15308265	19p13.12	0	normal	.	G	ref	G	CC.CC	het-alt	24	0.53	.	1	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC2	IVS2	.	.	no-change	NM_000435.2	NP_000426.2	-	Y	c.197+46C=	.	.	.	NM_000435.2(NOTCH3): c.197+46C=	SingleClassQuadAllelic;rs-cluster-nonoverlapping-alleles	53136	0.995766	U	0.001	0.000599042	.	.	VQSRTrancheSNP99.80to99.90	-6	4596	0.997389	23842	48128	0.995387	.	.	.	.	.	.	rs542120843	.	4016	0.813000	0.297	-0.374	-0.413	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15308264	15308265	19p13.12	0	normal	.	G	snv	C	CC.CC	het-ref	21	0.47	.	2	.	PASS	600276	C	125310(MK);615293(UK)	AD	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	AD	.	Cardiovascular; Neurologic	General; Pharmacogenomic	23025651|22996955|22218279|20301673|20038773|19174371|18765654|17135568|16864835|16717210|16263847|16009764|15851739|15378071|15313839|15210914|15096408|12136071|10371078|9818928|8878478|7654071|7564728|7500094|7486874	.	4854	NOTCH3	IC2	IVS2	.	.	intron	NM_000435.2	NP_000426.2	-	Y	c.197+46C>G	.	.	.	NM_000435.2(NOTCH3): c.197+46C>G	SingleClassQuadAllelic;rs-cluster-nonoverlapping-alleles	53136	0.004009	U	.	.	.	.	VQSRTrancheSNP99.80to99.90	0	4596	0.002176	0	48128	0.004426	0	1440	1.48945e-01	0	19541	1.30937e-01	rs542120843	.	4016	0.186800	0.297	-0.374	-0.413	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15357988	15357989	19p13.12	0	normal	.	A	ref	A	CC.CC	het-alt	199	0.81	.	1	.	PASS	608749	P	.	NN	.	.	.	.	.	.	.	23476	BRD4	IC10	IVS11	.	.	no-change	NM_058243.2	NP_490597.1	-	Y	c.2159-2416T=	.	.	.	NM_058243.2(BRD4): c.2159-2416T=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.986600	-1.136	-0.025	-0.048	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15357989	15357989	19p13.12	0	normal	.	.	ins	GC	CA.CC	het-ref	47	0.19	.	2	.	PASS	608749	P	.	NN	.	.	.	.	.	.	.	23476	BRD4	IC10	IVS11	.	.	intron	NM_058243.2	NP_490597.1	-	Y	c.2159-2417_2159-2416insGC	.	.	.	NM_058243.2(BRD4): c.2159-2417_2159-2416insGC	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.018600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
19	15357992	15357993	19p13.12	0	normal	.	A	ref	A	CC.CC	het-alt	207	0.83	.	1	.	DUBIOUS	608749	P	.	NN	.	.	.	.	.	.	.	23476	BRD4	IC10	IVS11	.	.	no-change	NM_058243.2	NP_490597.1	-	Y	c.2159-2420T=	.	.	.	NM_058243.2(BRD4): c.2159-2420T=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.960500	-0.327	-0.183	-0.238	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15357992	15357993	19p13.12	0	normal	.	A	snv	C	CC.CC	het-ref	42	0.17	.	2	.	DUBIOUS	608749	P	.	NN	.	.	.	.	.	.	.	23476	BRD4	IC10	IVS11	.	.	intron	NM_058243.2	NP_490597.1	-	Y	c.2159-2420T>G	.	.	.	NM_058243.2(BRD4): c.2159-2420T>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.039500	-0.327	-0.183	-0.238	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
19	15357999	15358001	19p13.12	0	normal	.	AG	ref	AG	CC.CC	het-alt	223	0.88	.	1	.	PASS	608749	P	.	NN	.	.	.	.	.	.	.	23476	BRD4	IC10	IVS11	.	.	no-change	NM_058243.2	NP_490597.1	-	Y	c.2159-2428_2159-2427=	.	.	.	NM_058243.2(BRD4): c.2159-2428_2159-2427=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4203	0.923800	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15357999	15358001	19p13.12	0	normal	.	AG	del	.	CC.CC	het-ref	29	0.12	.	2	.	PASS	608749	P	.	NN	.	.	.	.	.	.	.	23476	BRD4	IC10	IVS11	.	.	intron	NM_058243.2	NP_490597.1	-	Y	c.2159-2428_2159-2427delCT	.	.	.	NM_058243.2(BRD4): c.2159-2428_2159-2427delCT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4203	0.035400	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
19	15359258	15359259	19p13.12	0	normal	.	G	ref	G	TG.GG	het-alt	314	0.50	.	1	.	PASS	608749	P	.	NN	.	.	.	.	.	.	.	23476	BRD4	IC10	IVS11	.	.	no-change	NM_058243.2	NP_490597.1	-	Y	c.2159-3686C=	.	.	.	NM_058243.2(BRD4): c.2159-3686C=	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	5008	0.424521	U	0.625	0.575479	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3787030	.	4024	0.391700	0.313	0.546	0.524	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15359258	15359259	19p13.12	0	normal	.	G	snv	A	TG.GG	het-ref	308	0.50	.	2	.	PASS	608749	P	.	NN	.	.	.	.	.	.	.	23476	BRD4	IC10	IVS11	.	.	intron	NM_058243.2	NP_490597.1	-	Y	c.2159-3686C>T	.	.	.	NM_058243.2(BRD4): c.2159-3686C>T	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	5008	0.575479	U	0.625	0.575479	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3787030	.	4024	0.608300	0.313	0.546	0.524	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15362607	15362608	19p13.12	0	normal	.	A	ref	A	TC.GT	het-alt	292	0.51	.	1	.	PASS	608749	P	.	NN	.	.	.	.	.	.	.	23476	BRD4	IC10	IVS11	.	.	no-change	NM_058243.2	NP_490597.1	-	Y	c.2158+2355T=	.	.	.	NM_058243.2(BRD4): c.2158+2355T=	;	5008	0.998602	U	0.0069	0.00139776	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs536183353	.	4024	0.988800	0.529	0.098	-0.171	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	15362607	15362608	19p13.12	0	normal	.	A	snv	G	TC.GT	het-ref	281	0.49	.	2	.	PASS	608749	P	.	NN	.	.	.	.	.	.	.	23476	BRD4	IC10	IVS11	.	.	intron	NM_058243.2	NP_490597.1	-	Y	c.2158+2355T>C	.	.	.	NM_058243.2(BRD4): c.2158+2355T>C	;	5008	0.001398	U	0.0069	0.00139776	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs536183353	.	4024	0.011200	0.529	0.098	-0.171	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
19	17941293	17941294	19p13.11	0	normal	.	T	ref	T	GC.CT	het-alt	131	0.49	.	1	.	PASS	600173	P	600802(MK)	NN	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, natural killer cell-negative 	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	23001410|21732012|21184155|14615376|7659163|7481768	.	3718	JAK3	IC21	IVS22	.	.	no-change	NM_000215.3	NP_000206.2	-	Y	c.3096+18A=	.	.	.	NM_000215.3(JAK3): c.3096+18A=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	105636	0.589184	U	0.4702	0.434305	13000	0.652077	PASS	-962	6866	0.508884	16965	100628	0.590353	.	.	.	.	.	.	rs2302603	.	4024	0.543200	-0.642	-0.460	-0.484	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	17941293	17941294	19p13.11	1	normal	.	T	snv	C	GC.CT	het-ref	134	0.51	.	2	.	PASS	600173	P	600802(MK)	NN	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, natural killer cell-negative 	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	23001410|21732012|21184155|14615376|7659163|7481768	.	3718	JAK3	IC21	IVS22	.	.	intron	NM_000215.3	NP_000206.2	-	Y	c.3096+18A>G	.	.	.	NM_000215.3(JAK3): c.3096+18A>G	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,submitted-by-lsdb	105636	0.410816	U	0.4702	0.434305	13000	0.347923	PASS	724	6866	0.491116	7873	100628	0.409647	1699	7570	4.60126e-01	17241	88712	3.76629e-01	rs2302603	.	4024	0.456800	-0.642	-0.460	-0.484	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	36421	criteria_provided,_single_submitter	Benign	Benign
19	17942004	17942005	19p13.11	0	normal	.	A	ref	A	ga.ta	het-alt	188	0.57	.	1	G-rich|Low_complexity|Low_complexity|+|139	PASS	600173	P	600802(MK)	NN	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, natural killer cell-negative 	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	23001410|21732012|21184155|14615376|7659163|7481768	.	3718	JAK3	IC20	IVS21	.	.	no-change	NM_000215.3	NP_000206.2	-	Y	c.2978+32T=	.	.	.	NM_000215.3(JAK3): c.2978+32T=	;maf-5-some-pop,maf-5-all-pops	124040	0.619687	U	0.4722	0.433706	13004	0.649877	PASS	-1065	8458	0.545519	23375	119032	0.621934	.	.	.	.	.	.	rs3212774	.	4024	0.541700	-0.479	-1.145	-0.955	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	17942004	17942005	19p13.11	0	normal	.	A	snv	G	ga.ta	het-ref	143	0.43	.	2	G-rich|Low_complexity|Low_complexity|+|139	PASS	600173	P	600802(MK)	NN	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, natural killer cell-negative 	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	23001410|21732012|21184155|14615376|7659163|7481768	.	3718	JAK3	IC20	IVS21	.	.	intron	NM_000215.3	NP_000206.2	-	Y	c.2978+32T>C	.	.	.	NM_000215.3(JAK3): c.2978+32T>C	;maf-5-some-pop,maf-5-all-pops	124040	0.380313	U	0.4722	0.433706	13004	0.350123	PASS	857	8458	0.454481	8861	119032	0.378066	1798	7887	4.60044e-01	17732	89732	3.76851e-01	rs3212774	.	4024	0.458300	-0.479	-1.145	-0.955	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	17945356	17945357	19p13.11	0	normal	.	A	ref	A	CC.CC	het-alt	185	0.75	.	1	.	DUBIOUS	600173	P	600802(MK)	NN	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, natural killer cell-negative 	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	23001410|21732012|21184155|14615376|7659163|7481768	.	3718	JAK3	IC16	IVS17	.	.	no-change	NM_000215.3	NP_000206.2	-	Y	c.2350+23T=	.	.	.	NM_000215.3(JAK3): c.2350+23T=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.938600	0.397	-0.813	-0.913	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	17945356	17945357	19p13.11	0	normal	.	A	snv	C	CC.CC	het-ref	61	0.25	.	2	.	DUBIOUS	600173	P	600802(MK)	NN	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, natural killer cell-negative 	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	23001410|21732012|21184155|14615376|7659163|7481768	.	3718	JAK3	IC16	IVS17	.	.	intron	NM_000215.3	NP_000206.2	-	Y	c.2350+23T>G	.	.	.	NM_000215.3(JAK3): c.2350+23T>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.061400	0.397	-0.813	-0.913	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	17946053	17946054	19p13.11	0	normal	.	G	ref	G	CC.GG	het-alt	227	0.54	.	1	.	PASS	600173	P	600802(MK)	NN	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, natural killer cell-negative 	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	23001410|21732012|21184155|14615376|7659163|7481768	.	3718	JAK3	IC13	IVS14	.	.	no-change	NM_000215.3	NP_000206.2	-	Y	c.1915-30C=	.	.	.	NM_000215.3(JAK3): c.1915-30C=	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops,genotype-conflict	117598	0.881937	U	0.2847	0.137181	12996	0.902047	PASS	.	8198	0.720786	43977	112590	0.882787	.	.	.	.	.	.	rs2072496	.	4024	0.717400	-1.105	-2.696	-2.644	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	17946053	17946054	19p13.11	0	normal	.	G	snv	A	CC.GG	het-ref	196	0.46	.	2	.	PASS	600173	P	600802(MK)	NN	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, natural killer cell-negative 	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	23001410|21732012|21184155|14615376|7659163|7481768	.	3718	JAK3	IC13	IVS14	.	.	intron	NM_000215.3	NP_000206.2	-	Y	c.1915-30C>T	.	.	.	NM_000215.3(JAK3): c.1915-30C>T	MixedObserved,SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops,genotype-conflict	117598	0.118063	U	0.2847	0.137181	12996	0.097953	PASS	286	8198	0.279214	879	112590	0.117213	611	4652	2.73615e-01	1751	26519	1.11364e-01	rs2072496	.	4024	0.282600	-1.105	-2.696	-2.644	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	18271302	18271303	19p13.11	0	normal	.	C	ref	C	CC.GA	het-alt	131	0.51	.	1	.	PASS	603157	P	603387(MK)	NN	.	.	.	.	.	.	.	5296	PIK3R2	C2	EX3	.	.	no-change	NM_005027.2	NP_005018.1	+	Y	c.345C=	.	.	.	NM_005027.2(PIK3R2): c.345C=	SingleClassTriAllelic;	120082	0.999983	U	.	.	.	.	PASS	0	8620	1.000000	60039	120082	0.999983	.	.	.	.	.	.	rs755095052	.	.	.	-1.610	-3.114	-3.525	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	18271302	18271303	19p13.11	1	normal	.	C	snv	T	CC.GA	het-ref	124	0.49	.	2	.	PASS	603157	P	603387(MK)	NN	.	.	.	.	.	.	.	5296	PIK3R2	C2	EX3	.	.	coding-synon	NM_005027.2	NP_005018.1	+	Y	c.345C>T	p.(P115=) | p.(Pro115=)	CCC=>CCT	.	NM_005027.2(PIK3R2): c.345C>T (p.(P115=))	SingleClassTriAllelic;	120082	0.000008	U	.	.	.	.	PASS	0	8620	0.000000	0	120082	0.000008	0	0	0.00000e+00	0	1	4.06577e-06	rs755095052	.	.	.	-1.610	-3.114	-3.525	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
19	18272189	18272190	19p13.11	0	normal	.	A	snv	C	CC.GC	hom-alt	452	1.00	.	0	.	PASS	603157	P	603387(MK)	NN	.	.	.	.	.	.	.	5296	PIK3R2	C5	EX6	RhoGAP domain	PF00620.22	no-change	NM_005027.2	NP_005018.1	+	Y	c.700C=	.	.	.	NM_005027.2(PIK3R2): c.700C=	;maf-5-some-pop	6682	0.916941	U	0.9117	0.923922	.	.	PASS	12	28	0.928571	665	1674	0.896057	8	19	7.91667e-01	3786	8466	8.84085e-01	rs2241088	.	.	.	-0.368	1.035	0.149	.	.	.	.	.	ENST00000222254: c.700A>C (p.S234R)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4131465	.	.	.	.	.	no_record	497079	criteria_provided,_single_submitter	Benign	Benign
19	18272189	18272190	19p13.11	1	nullSample	.	A	ref	A	CC.GC	homo-ref	.	.	.	0	.	.	603157	P	603387(MK)	NN	.	.	.	.	.	.	.	5296	PIK3R2	C5	EX6	RhoGAP domain	PF00620.22	missense	NM_005027.2	NP_005018.1	+	Y	c.700C>A	p.R234S | p.Arg234Ser	CGC=>AGC	P+=>P0	NM_005027.2(PIK3R2): c.700C>A (p.R234S)	;maf-5-some-pop	6682	0.083059	U	0.9117	0.923922	.	.	PASS	-1	28	0.071429	2	1674	0.103943	.	.	.	.	.	.	rs2241088	.	.	.	-0.368	1.035	0.149	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
19	18273046	18273047	19p13.11	1	nullSample	.	T	ref	T	CC.CC	homo-ref	.	.	.	0	.	.	603157	P	603387(MK)	NN	.	.	.	.	.	.	.	5296	PIK3R2	C7	EX8	.	.	missense	NM_005027.2	NP_005018.1	+	Y	c.937C>T	p.P313S | p.Pro313Ser	CCC=>TCC	NP=>P0	NM_005027.2(PIK3R2): c.937C>T (p.P313S)	;maf-5-some-pop,genotype-conflict	123912	0.049801	U	0.9633	0.953474	13000	0.044846	PASS	-142	8602	0.033248	173	118904	0.049939	.	.	.	.	.	.	rs1011320	.	.	.	-0.320	-0.081	-0.251	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
19	18273046	18273047	19p13.11	0	normal	.	T	snv	C	CC.CC	hom-alt	369	1.00	.	0	.	PASS	603157	P	603387(MK)	NN	.	.	.	.	.	.	.	5296	PIK3R2	C7	EX8	.	.	no-change	NM_005027.2	NP_005018.1	+	Y	c.937C=	.	.	.	NM_005027.2(PIK3R2): c.937C=	;maf-5-some-pop,genotype-conflict	123912	0.950199	U	0.9633	0.953474	13000	0.955154	PASS	4016	8602	0.966752	53687	118904	0.950061	8052	16648	9.67682e-01	109653	230241	9.52007e-01	rs1011320	.	.	.	-0.320	-0.081	-0.251	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	18279510	18279511	19p13.11	0	normal	.	T	ref	T	CC.CC	het-alt	96	0.67	.	1	.	PASS	603157	P	603387(MK)	NN	.	.	.	.	.	.	.	5296	PIK3R2	IC13	IVS14	.	.	no-change	NM_005027.2	NP_005018.1	+	Y	c.1809-25T=	.	.	.	NM_005027.2(PIK3R2): c.1809-25T=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.983800	-0.736	0.630	0.030	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	18279511	18279511	19p13.11	0	normal	.	.	ins	CCCCCC	CT.CC	het-ref	47	0.33	.	2	.	PASS	603157	P	603387(MK)	NN	.	.	.	.	.	.	.	5296	PIK3R2	IC13	IVS14	.	.	intron	NM_005027.2	NP_005018.1	+	Y	c.1809-25_1809-24insCCCCCC	.	.	.	NM_005027.2(PIK3R2): c.1809-25_1809-24insCCCCCC	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.068100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	18279515	18279516	19p13.11	0	normal	.	G	ref	G	CC.CC	het-alt	123	0.78	.	1	.	DUBIOUS	603157	P	603387(MK)	NN	.	.	.	.	.	.	.	5296	PIK3R2	IC13	IVS14	.	.	no-change	NM_005027.2	NP_005018.1	+	Y	c.1809-20G=	.	.	.	NM_005027.2(PIK3R2): c.1809-20G=	;	103408	0.999990	U	.	.	.	.	PASS	0	7976	1.000000	51703	103408	0.999990	.	.	.	.	.	.	rs763301728	.	4032	0.792800	-1.786	-0.895	-1.100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	18279515	18279516	19p13.11	0	normal	.	G	snv	C	CC.CC	het-ref	35	0.22	.	2	.	DUBIOUS	603157	P	603387(MK)	NN	.	.	.	.	.	.	.	5296	PIK3R2	IC13	IVS14	.	.	intron	NM_005027.2	NP_005018.1	+	Y	c.1809-20G>C	.	.	.	NM_005027.2(PIK3R2): c.1809-20G>C	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4032	0.205200	-1.786	-0.895	-1.100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	18279518	18279519	19p13.11	0	normal	.	A	ref	A	CC.CC	het-alt	123	0.77	.	1	.	DUBIOUS	603157	P	603387(MK)	NN	.	.	.	.	.	.	.	5296	PIK3R2	IC13	IVS14	.	.	no-change	NM_005027.2	NP_005018.1	+	Y	c.1809-17A=	.	.	.	NM_005027.2(PIK3R2): c.1809-17A=	SingleClassTriAllelic;	104416	0.999828	U	.	.	12990	0.999153	PASS	0	8010	1.000000	52190	104416	0.999828	.	.	.	.	.	.	rs199501065	.	4060	0.774200	-0.753	-0.719	-0.755	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	18279518	18279519	19p13.11	1	normal	.	A	snv	C	CC.CC	het-ref	36	0.23	.	2	.	DUBIOUS	603157	P	603387(MK)	NN	.	.	.	.	.	.	.	5296	PIK3R2	IC13	IVS14	.	.	intron	NM_005027.2	NP_005018.1	+	Y	c.1809-17A>C	.	.	.	NM_005027.2(PIK3R2): c.1809-17A>C	SingleClassTriAllelic;	104416	0.000010	U	.	.	12990	0	PASS	0	8010	0.000000	0	104416	0.000010	0	0	0.00000e+00	0	1	4.31507e-06	rs199501065	.	4060	0.217000	-0.753	-0.719	-0.755	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	18279521	18279522	19p13.11	1	normal	.	G	snv	C	CC.CC	het-ref	25	0.14	.	2	.	DUBIOUS	603157	P	603387(MK)	NN	.	.	.	.	.	.	.	5296	PIK3R2	IC13	IVS14	.	.	intron	NM_005027.2	NP_005018.1	+	Y	c.1809-14G>C	.	.	.	NM_005027.2(PIK3R2): c.1809-14G>C	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4044	0.208400	-1.973	-1.984	-2.005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	18279521	18279522	19p13.11	0	normal	.	G	ref	G	CC.CC	het-alt	156	0.86	.	1	.	DUBIOUS	603157	P	603387(MK)	NN	.	.	.	.	.	.	.	5296	PIK3R2	IC13	IVS14	.	.	no-change	NM_005027.2	NP_005018.1	+	Y	c.1809-14G=	.	.	.	NM_005027.2(PIK3R2): c.1809-14G=	.	.	.	.	.	.	.	.	PASS	-1	8054	0.999752	52361	104846	0.999390	.	.	.	.	.	.	.	.	4044	0.786700	-1.973	-1.984	-2.005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	18279637	18279638	19p13.11	0	nullSample	.	T	ref	T	AG.GG	homo-ref	.	.	.	0	.	.	603157	P	603387(MK)	NN	.	.	.	.	.	.	.	5296	PIK3R2	C14	EX15	SH2 domain	PF00017.19	no-change	NM_005027.2	NP_005018.1	+	Y	c.1911T=	.	.	.	NM_005027.2(PIK3R2): c.1911T=	;maf-5-some-pop	124354	0.120704	U	0.9365	0.86242	13006	0.148931	PASS	-270	8566	0.069110	917	119346	0.119996	.	.	.	.	.	.	rs273269	.	4024	0.063900	-2.028	-2.347	-1.891	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	18279637	18279638	19p13.11	1	normal	.	T	snv	C	AG.GG	hom-alt	514	1.00	.	0	.	PASS	603157	P	603387(MK)	NN	.	.	.	.	.	.	.	5296	PIK3R2	C14	EX15	SH2 domain	PF00017.19	coding-synon	NM_005027.2	NP_005018.1	+	Y	c.1911T>C	p.(S637=) | p.(Ser637=)	AGT=>AGC	.	NM_005027.2(PIK3R2): c.1911T>C (p.(S637=))	;maf-5-some-pop	124354	0.879296	U	0.9365	0.86242	13006	0.851069	PASS	3717	8566	0.930890	46269	119346	0.880004	7431	15973	9.30177e-01	93730	212341	8.81456e-01	rs273269	.	4024	0.936100	-2.028	-2.347	-1.891	.	.	.	.	.	ENST00000222254: c.1911T>C (p.S637S)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4131467	.	.	.	.	.	no_record	518294	criteria_provided,_single_submitter	Benign	Likely Benign
19	30303713	30303714	19q12	0	normal	.	T	ref	T	CA.CC	het-alt	147	0.58	.	1	.	PASS	123837	C	.	NN	.	.	.	.	.	.	.	898	CCNE1	IC2	IVS3	.	.	no-change	NM_001238.2	NP_001229.1	+	Y	c.111+31T=	.	.	.	NM_001238.2(CCNE1): c.111+31T=	;	24182	0.999173	U	0	0.00379393	.	.	PASS	-587	4472	0.468247	3494	63006	0.353395	.	.	.	.	.	.	rs543759658	.	.	.	0.344	-0.169	-0.130	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	30303714	30303714	19q12	0	normal	.	.	ins	C	AT.CC	het-ref	108	0.42	.	2	.	PASS	123837	C	.	NN	.	.	.	.	.	.	.	898	CCNE1	IC2	IVS3	.	.	intron	NM_001238.2	NP_001229.1	+	Y	c.111+31_111+32insC	.	.	.	NM_001238.2(CCNE1): c.111+31_111+32insC	;maf-5-some-pop,maf-5-all-pops	67994	0.644439	U	0.5238	0.617612	.	.	PASS	602	4472	0.531753	12719	63006	0.646367	1835	7156	5.15042e-01	37822	120121	6.26374e-01	rs554624274	.	4024	0.476100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	30311541	30311542	19q12	0	normal	.	G	ref	G	AA.TT	het-alt	103	0.64	.	1	.	PASS	123837	C	.	NN	.	.	.	.	.	.	.	898	CCNE1	IC5	IVS6	.	.	no-change	NM_001238.2	NP_001229.1	+	Y	c.463-67G=	.	.	.	NM_001238.2(CCNE1): c.463-67G=	.	.	.	.	0.4554	0.392971	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-1.146	-0.227	-0.299	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	30311542	30311542	19q12	0	normal	.	.	ins	T	AG.TT	het-ref	57	0.36	.	2	.	PASS	123837	C	.	NN	.	.	.	.	.	.	.	898	CCNE1	IC5	IVS6	.	.	intron	NM_001238.2	NP_001229.1	+	Y	c.463-67_463-66insT	.	.	.	NM_001238.2(CCNE1): c.463-67_463-66insT	;maf-5-some-pop,maf-5-all-pops	5008	0.392971	U	0.4554	0.392971	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs549086621	.	4024	0.295000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	30314458	30314459	19q12	0	normal	.	A	ref	A	ag.aa	het-alt	121	0.58	.	1	AluSx1|SINE|Alu|+|321	PASS	123837	C	.	NN	.	.	.	.	.	.	.	898	CCNE1	IC10	IVS11	.	.	no-change	NM_001238.2	NP_001229.1	+	Y	c.1111-103A=	.	.	.	NM_001238.2(CCNE1): c.1111-103A=	;maf-5-some-pop,maf-5-all-pops	5008	0.815296	U	0.2609	0.184704	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4805483	.	4022	0.770300	0.296	0.326	0.306	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	30314458	30314459	19q12	0	normal	.	A	snv	G	ag.aa	het-ref	89	0.42	.	2	AluSx1|SINE|Alu|+|321	PASS	123837	C	.	NN	.	.	.	.	.	.	.	898	CCNE1	IC10	IVS11	.	.	intron	NM_001238.2	NP_001229.1	+	Y	c.1111-103A>G	.	.	.	NM_001238.2(CCNE1): c.1111-103A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.184704	U	0.2609	0.184704	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4805483	.	4022	0.224000	0.296	0.326	0.306	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	40742319	40742320	19q13.2	0	normal	.	T	ref	T	GG.GC	het-alt	242	0.51	.	1	.	PASS	164731	P	125853(MK);240900(MK)	AD	Hypoinsulinemic hypoglycemia with hemihypertrophy	AD	.	Endocrine; Musculoskeletal	Endocrine	21979934|19164855|15166380|14764948	.	208	AKT2	IC8	IVS9	.	.	no-change	NM_001626.4	NP_001617.1	-	Y	c.832-28A=	.	.	.	NM_001626.4(AKT2): c.832-28A=	;maf-5-some-pop,maf-5-all-pops	125844	0.282429	U	0.6776	0.74381	13006	0.265493	PASS	-933	8610	0.319628	4870	120836	0.283517	.	.	.	.	.	.	rs2304189	.	4024	0.348400	-0.215	-0.314	-0.113	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	40742319	40742320	19q13.2	0	normal	.	T	snv	C	GG.GC	het-ref	233	0.49	.	2	.	PASS	164731	P	125853(MK);240900(MK)	AD	Hypoinsulinemic hypoglycemia with hemihypertrophy	AD	.	Endocrine; Musculoskeletal	Endocrine	21979934|19164855|15166380|14764948	.	208	AKT2	IC8	IVS9	.	.	intron	NM_001626.4	NP_001617.1	-	Y	c.832-28A>G	.	.	.	NM_001626.4(AKT2): c.832-28A>G	;maf-5-some-pop,maf-5-all-pops	125844	0.717571	U	0.6776	0.74381	13006	0.734507	PASS	1996	8610	0.680372	31029	120836	0.716483	4050	11763	6.83180e-01	63043	175753	7.15787e-01	rs2304189	.	4024	0.651600	-0.215	-0.314	-0.113	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	40744902	40744903	19q13.2	0	normal	.	T	ref	T	GG.GG	het-alt	138	0.81	.	1	.	DUBIOUS	164731	P	125853(MK);240900(MK)	AD	Hypoinsulinemic hypoglycemia with hemihypertrophy	AD	.	Endocrine; Musculoskeletal	Endocrine	21979934|19164855|15166380|14764948	.	208	AKT2	IC6	IVS7	.	.	no-change	NM_001626.4	NP_001617.1	-	Y	c.640-23A=	.	.	.	NM_001626.4(AKT2): c.640-23A=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.992000	0.533	-0.020	-0.170	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	40744902	40744903	19q13.2	0	normal	.	T	snv	G	GG.GG	het-ref	33	0.19	.	2	.	DUBIOUS	164731	P	125853(MK);240900(MK)	AD	Hypoinsulinemic hypoglycemia with hemihypertrophy	AD	.	Endocrine; Musculoskeletal	Endocrine	21979934|19164855|15166380|14764948	.	208	AKT2	IC6	IVS7	.	.	intron	NM_001626.4	NP_001617.1	-	Y	c.640-23A>C	.	.	.	NM_001626.4(AKT2): c.640-23A>C	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.008000	0.533	-0.020	-0.170	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
19	40747819	40747820	19q13.2	0	normal	.	C	ref	C	CG.GA	het-alt	253	0.53	.	1	.	PASS	164731	P	125853(MK);240900(MK)	AD	Hypoinsulinemic hypoglycemia with hemihypertrophy	AD	.	Endocrine; Musculoskeletal	Endocrine	21979934|19164855|15166380|14764948	.	208	AKT2	IC5	IVS6	.	.	no-change	NM_001626.4	NP_001617.1	-	Y	c.573+25G=	.	.	.	NM_001626.4(AKT2): c.573+25G=	SingleClassTriAllelic;maf-5-some-pop	122434	0.985331	U	0.0308	0.0345447	13004	0.970009	PASS	-122	8562	0.970100	57133	117426	0.986179	.	.	.	.	.	.	rs3730259	.	4024	0.959700	0.462	0.494	0.053	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	40747819	40747820	19q13.2	0	normal	.	C	snv	G	CG.GA	het-ref	226	0.47	.	2	.	PASS	164731	P	125853(MK);240900(MK)	AD	Hypoinsulinemic hypoglycemia with hemihypertrophy	AD	.	Endocrine; Musculoskeletal	Endocrine	21979934|19164855|15166380|14764948	.	208	AKT2	IC5	IVS6	.	.	intron	NM_001626.4	NP_001617.1	-	Y	c.573+25G>C	.	.	.	NM_001626.4(AKT2): c.573+25G>C	SingleClassTriAllelic;maf-5-some-pop	122434	0.014661	U	0.0308	0.0345447	13004	0.029991	PASS	6	8562	0.029900	43	117426	0.013813	7	487	2.83008e-02	71	3083	1.26533e-02	rs3730259	.	4024	0.040300	0.462	0.494	0.053	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
19	41743860	41743861	19q13.2	1	nullSample	.	A	ref	A	CA.AC	homo-ref	.	.	.	0	.	.	109135	C	.	NN	.	.	.	.	.	.	.	558	AXL	C7	EX7	Fibronectin type III domain	PF00041.16	missense	NM_021913.3	NP_068713.2	+	Y	c.796G>A	p.D266N | p.Asp266Asn	GAC=>AAC	P-=>P0	NM_021913.3(AXL): c.796G>A (p.D266N)	;	126400	0.000000	U	1	1	.	.	PASS	0	8654	0.000000	0	121392	0.000000	.	.	.	.	.	.	rs7249222	.	.	.	-0.380	1.166	1.068	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
19	41743860	41743861	19q13.2	0	normal	.	A	snv	G	CA.AC	hom-alt	244	1.00	.	0	.	PASS	109135	C	.	NN	.	.	.	.	.	.	.	558	AXL	C7	EX7	Fibronectin type III domain	PF00041.16	no-change	NM_021913.3	NP_068713.2	+	Y	c.796G=	.	.	.	NM_021913.3(AXL): c.796G=	;	126400	1.000000	U	1	1	.	.	PASS	4327	8654	1.000000	60696	121392	1.000000	8622	17244	1.00000e+00	122038	244076	1.00000e+00	rs7249222	.	.	.	-0.380	1.166	1.068	.	.	.	.	.	ENST00000301178: c.796A>G (p.N266D)	upper_aerodigestive_tract [head_neck|NS|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	VUO	4590532	.	.	.	.	.	.	.	.	.	Benign
19	41748752	41748753	19q13.2	0	normal	.	T	ref	T	GC.TC	het-alt	201	0.59	.	1	.	PASS	109135	C	.	NN	.	.	.	.	.	.	.	558	AXL	IC10	IVS10	.	.	no-change	NM_021913.3	NP_068713.2	+	Y	c.1313-35T=	.	.	.	NM_021913.3(AXL): c.1313-35T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126210	0.587053	U	0.3591	0.463259	13006	0.524912	PASS	-960	8632	0.638323	21487	121202	0.589132	.	.	.	.	.	.	rs2304234	.	4024	0.664000	-0.253	0.077	-0.175	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	41748752	41748753	19q13.2	0	normal	.	T	snv	C	GC.TC	het-ref	140	0.41	.	2	.	PASS	109135	C	.	NN	.	.	.	.	.	.	.	558	AXL	IC10	IVS10	.	.	intron	NM_021913.3	NP_068713.2	+	Y	c.1313-35T>C	.	.	.	NM_021913.3(AXL): c.1313-35T>C	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	126210	0.412947	U	0.3591	0.463259	13006	0.475088	PASS	601	8632	0.361677	10684	121202	0.410868	1154	6192	3.59206e-01	20578	98264	4.01491e-01	rs2304234	.	4024	0.336000	-0.253	0.077	-0.175	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	41759631	41759634	19q13.2	0	nullSample	.	CCC	ref	CCC	GA.CC	homo-ref	.	.	.	0	.	.	109135	C	.	NN	.	.	.	.	.	.	.	558	AXL	IC17	IVS17	.	.	no-change	NM_021913.3	NP_068713.2	+	Y	c.2036+19_2036+21=	.	.	.	NM_021913.3(AXL): c.2036+19_2036+21=	MixedObserved;maf-5-some-pop,maf-5-all-pops	51335	0.466095	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs68001077	.	4027	0.652600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	41759631	41759634	19q13.2	1	normal	.	CCC	del	.	GA.CC	het-alt	89	0.78	.	1	.	PASS	109135	C	.	NN	.	.	.	.	.	.	.	558	AXL	IC17	IVS17	.	.	intron	NM_021913.3	NP_068713.2	+	Y	c.2036+19_2036+21delCCC	.	.	.	NM_021913.3(AXL): c.2036+19_2036+21delCCC	MixedObserved;maf-5-some-pop,maf-5-all-pops	51335	0.533905	U	0.5109	0.403754	.	.	VQSRTrancheINDEL97.00to99.00	399	4330	0.542725	3654	52242	0.485931	793	4651	3.69420e-01	7395	50889	3.22961e-01	rs68001077	.	4027	0.294500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	41759631	41759634	19q13.2	1	normal	.	CCC	rep	CC	GA.CC	het-alt	14	0.12	.	2	.	PASS	109135	C	.	NN	.	.	.	.	.	.	.	558	AXL	IC17	IVS17	.	.	intron	NM_021913.3	NP_068713.2	+	Y	c.2036+19C[3>2] (std: c.2036+19C[2] alt: c.2036+21delC )	.	.	.	NM_021913.3(AXL): c.2036+19C[2]	.	.	.	.	.	.	.	.	VQSRTrancheINDEL97.00to99.00	10	4330	0.052656	112	52242	0.082367	6	2792	2.21763e-01	131	36291	2.30317e-01	.	.	4027	0.049600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	41759636	41759637	19q13.2	0	normal	.	C	ref	C	CC.CC	het-alt	42	0.32	.	1	.	PASS	109135	C	.	NN	.	.	.	.	.	.	.	558	AXL	IC17	IVS17	.	.	no-change	NM_021913.3	NP_068713.2	+	Y	c.2036+24C=	.	.	.	NM_021913.3(AXL): c.2036+24C=	SingleClassQuadAllelic;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	80222	0.662524	U	0.5109	0.403754	13006	0.999923	PASS	-771	5654	0.587549	16166	75214	0.666937	.	.	.	.	.	.	rs116056574	.	4024	0.708300	0.491	0.700	0.302	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	41759636	41759637	19q13.2	0	normal	.	C	snv	T	CC.CC	het-ref	91	0.68	.	2	.	PASS	109135	C	.	NN	.	.	.	.	.	.	.	558	AXL	IC17	IVS17	.	.	intron	NM_021913.3	NP_068713.2	+	Y	c.2036+24C>T	.	.	.	NM_021913.3(AXL): c.2036+24C>T	SingleClassQuadAllelic;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	80222	0.337376	U	0.5109	0.403754	13006	0	PASS	395	5654	0.412451	3609	75214	0.332957	790	4996	3.35167e-01	7384	55113	2.70390e-01	rs116056574	.	4024	0.291700	0.491	0.700	0.302	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	41762524	41762525	19q13.2	0	normal	.	A	ref	A	GC.CT	het-alt	212	0.53	.	1	.	PASS	109135	C	.	NN	.	.	.	.	.	.	.	558	AXL	IC18	IVS18	.	.	no-change	NM_021913.3	NP_068713.2	+	Y	c.2196+9A=	.	.	.	NM_021913.3(AXL): c.2196+9A=	;maf-5-some-pop,maf-5-all-pops	126102	0.857814	U	0.2778	0.150958	13006	0.859988	PASS	.	8604	0.708624	44754	121094	0.858176	.	.	.	.	.	.	rs2304232	.	4024	0.722200	-0.353	-1.268	-1.195	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	41762524	41762525	19q13.2	1	normal	.	A	snv	G	GC.CT	het-ref	188	0.47	.	2	.	PASS	109135	C	.	NN	.	.	.	.	.	.	.	558	AXL	IC18	IVS18	.	.	intron	NM_021913.3	NP_068713.2	+	Y	c.2196+9A>G	.	.	.	NM_021913.3(AXL): c.2196+9A>G	;maf-5-some-pop,maf-5-all-pops	126102	0.142186	U	0.2778	0.150958	13006	0.140012	PASS	370	8604	0.291376	1381	121094	0.141824	736	4969	2.88392e-01	2847	34774	1.41439e-01	rs2304232	.	4024	0.277800	-0.353	-1.268	-1.195	.	.	.	.	.	ENST00000301178: c.2196+9A>G (p.?)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019815	.	.	.	.	.	.	.	.	.	Benign
19	41765406	41765407	19q13.2	0	normal	.	A	ref	A	GC.CC	het-alt	85	0.47	.	1	.	PASS	109135	C	.	NN	.	.	.	.	.	.	.	558	AXL	IC19	IVS19	.	.	no-change	NM_021913.3	NP_068713.2	+	Y	c.2334-51A=	.	.	.	NM_021913.3(AXL): c.2334-51A=	;maf-5-some-pop,maf-5-all-pops	109124	0.856649	U	0.2778	0.152157	13000	0.865692	PASS	.	7990	0.711765	38316	104116	0.857073	.	.	.	.	.	.	rs4591267	.	4020	0.721400	-1.372	-0.928	-1.310	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	41765406	41765407	19q13.2	0	normal	.	A	snv	C	GC.CC	het-ref	95	0.53	.	2	.	PASS	109135	C	.	NN	.	.	.	.	.	.	.	558	AXL	IC19	IVS19	.	.	intron	NM_021913.3	NP_068713.2	+	Y	c.2334-51A>C	.	.	.	NM_021913.3(AXL): c.2334-51A>C	;maf-5-some-pop,maf-5-all-pops	109124	0.143351	U	0.2778	0.152157	13000	0.134308	PASS	320	7990	0.288235	1139	104116	0.142927	646	4518	2.86712e-01	2151	26543	1.42686e-01	rs4591267	.	4020	0.278600	-1.372	-0.928	-1.310	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	42793589	42793590	19q13.2	0	nullSample	.	G	ref	G	CA.GA	homo-ref	.	.	.	0	.	.	612082	P	.	NN	.	.	.	.	.	.	.	23152	CIC	IC8	IVS8	.	.	no-change	NM_015125.3	NP_055940.3	+	Y	c.1360+32G=	.	.	.	NM_015125.3(CIC): c.1360+32G=	;maf-5-some-pop	30226	0.565738	U	0.6022	0.376198	12592	0.601414	PASS	.	848	0.392689	4098	25218	0.554207	.	.	.	.	.	.	rs3826706	.	4024	0.365300	0.491	3.645	2.391	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	42793589	42793590	19q13.2	0	normal	.	G	snv	A	CA.GA	hom-alt	210	1.00	.	0	.	PASS	612082	P	.	NN	.	.	.	.	.	.	.	23152	CIC	IC8	IVS8	.	.	intron	NM_015125.3	NP_055940.3	+	Y	c.1360+32G>A	.	.	.	NM_015125.3(CIC): c.1360+32G>A	;maf-5-some-pop	30226	0.434262	U	0.6022	0.376198	12592	0.398586	PASS	152	848	0.607311	2731	25218	0.445793	1983	6415	6.16946e-01	19406	73943	4.93249e-01	rs3826706	.	4024	0.634700	0.491	3.645	2.391	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	44055725	44055726	19q13.31	0	nullSample	.	T	ref	T	TC.GG	homo-ref	.	.	.	0	.	.	194360	C	.	NN	.	.	.	.	.	.	.	7515	XRCC1	C10	EX10	.	.	no-change	NM_006297.2	NP_006288.2	-	Y	c.1196A=	.	.	.	NM_006297.2(XRCC1): c.1196A=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125894	0.314360	U	0.7649	0.739617	13006	0.290789	PASS	.	8628	0.257881	6350	120886	0.316596	.	.	.	.	.	.	rs25487	.	4024	0.262400	-0.119	1.657	0.842	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	44055725	44055726	19q13.31	1	normal	.	T	snv	C	TC.GG	hom-alt	299	1.00	.	0	.	PASS	194360	C	.	NN	.	.	.	.	.	.	.	7515	XRCC1	C10	EX10	.	.	missense	NM_006297.2	NP_006288.2	-	Y	c.1196A>G	p.Q399R | p.Gln399Arg	CAG=>CGG	P0=>P+	NM_006297.2(XRCC1): c.1196A>G (p.Q399R)	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	125894	0.685640	U	0.7649	0.739617	13006	0.709211	PASS	2358	8628	0.742119	28521	120886	0.683404	4741	12795	7.42342e-01	57451	167030	6.80999e-01	rs25487	.	4024	0.737600	-0.119	1.657	0.842	.	.	.	.	.	ENST00000262887: c.1196A>G (p.Q399R)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3756906	.	.	.	.	.	no_record	225976	reviewed_by_expert_panel	drug_response	Likely Benign
19	45867215	45867216	19q13.32	0	normal	.	T	ref	T	AC.GG	het-alt	117	0.46	.	1	.	PASS	126340	C	278730(MK);601675(MK);610756(MK)	AR	Trichothiodystrophy; Xeroderma pigmentosum, group D	AR	Allelic with Cerebrooculofacioskeletal syndrome  (AR)	Allergy/Immunology/Infectious; Craniofacial; Dermatologic; Endocrine; Genitourinary; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Dermatologic; Oncologic	21959366|20301571|11709541|11443545|8783572|7802014|2189905|1372108	.	2068	ERCC2	IC10	IVS10	.	.	no-change	NM_000400.3	NP_000391.1	-	Y	c.949+28A=	.	.	.	NM_000400.3(ERCC2): c.949+28A=	.	.	.	.	0.4405	0.438099	.	.	PASS	.	314	0.461783	3580	13372	0.718741	.	.	.	.	.	.	.	.	.	.	-1.275	-2.708	-2.196	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	45867216	45867216	19q13.32	0	normal	.	.	ins	G	CT.GG	het-ref	138	0.54	.	2	.	PASS	126340	C	278730(MK);601675(MK);610756(MK)	AR	Trichothiodystrophy; Xeroderma pigmentosum, group D	AR	Allelic with Cerebrooculofacioskeletal syndrome  (AR)	Allergy/Immunology/Infectious; Craniofacial; Dermatologic; Endocrine; Genitourinary; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic	Allergy/Immunology/Infectious; Dermatologic; Oncologic	21959366|20301571|11709541|11443545|8783572|7802014|2189905|1372108	.	2068	ERCC2	IC10	IVS10	.	.	intron	NM_000400.3	NP_000391.1	-	Y	c.949+27_949+28insC	.	.	.	NM_000400.3(ERCC2): c.949+27_949+28insC	;maf-5-some-pop,maf-5-all-pops	18380	0.323776	U	0.4405	0.438099	10694	0.347765	PASS	39	314	0.538217	655	13372	0.280960	1065	4622	4.60909e-01	6285	35837	2.75567e-01	rs3916815	.	4024	0.471400	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	256023	criteria_provided,_single_submitter	Benign	Benign
19	45922322	45922323	19q13.32	0	nullSample	.	G	ref	G	CC.GT	homo-ref	.	.	.	0	.	.	126380	C	610758(MK)	NN	Cerebrooculofacioskeletal syndrome 4	AR	.	Craniofacial; Musculoskeletal; Neurologic; Renal	General	23623389|17273966	.	2067	ERCC1	IC4	IVS5	.	.	no-change	NM_001983.3	NP_001974.1	-	Y	c.525+33C=	.	.	.	NM_001983.3(ERCC1): c.525+33C=	SingleClassTriAllelic;maf-5-some-pop	22902	0.780500	U	.	.	12902	0.845140	PASS	-117	924	0.487013	7028	22902	0.780500	.	.	.	.	.	.	rs3212961	.	4024	0.548700	-1.677	-1.608	-1.827	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	45922322	45922323	19q13.32	0	normal	.	G	snv	T	CC.GT	hom-alt	213	1.00	.	0	.	PASS	126380	C	610758(MK)	NN	Cerebrooculofacioskeletal syndrome 4	AR	.	Craniofacial; Musculoskeletal; Neurologic; Renal	General	23623389|17273966	.	2067	ERCC1	IC4	IVS5	.	.	intron	NM_001983.3	NP_001974.1	-	Y	c.525+33C>A	.	.	.	NM_001983.3(ERCC1): c.525+33C>A	SingleClassTriAllelic;maf-5-some-pop	22902	0.219020	U	.	.	12902	0.154860	PASS	120	924	0.512987	601	22902	0.219020	1021	4690	4.45056e-01	3633	30287	2.00176e-01	rs3212961	.	4024	0.450800	-1.677	-1.608	-1.827	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	45923652	45923653	19q13.32	0	nullSample	.	A	ref	A	AC.TT	homo-ref	.	.	.	0	.	.	126380	C	610758(MK)	NN	Cerebrooculofacioskeletal syndrome 4	AR	.	Craniofacial; Musculoskeletal; Neurologic; Renal	General	23623389|17273966	.	2067	ERCC1	C3	EX4	Binding domain of DNA repair protein Ercc1 (rad10/Swi10)	PF03834.9	no-change	NM_001983.3	NP_001974.1	-	Y	c.354T=	.	.	.	NM_001983.3(ERCC1): c.354T=	;maf-5-some-pop,genotype-conflict	123014	0.485002	U	0.7381	0.66893	13006	0.459942	PASS	-854	8578	0.263465	15940	118006	0.491534	.	.	.	.	.	.	rs11615	.	4024	0.250500	-1.608	-1.441	-1.965	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	45923652	45923653	19q13.32	1	normal	.	A	snv	G	AC.TT	hom-alt	374	1.00	.	0	.	PASS	126380	C	610758(MK)	NN	Cerebrooculofacioskeletal syndrome 4	AR	.	Craniofacial; Musculoskeletal; Neurologic; Renal	General	23623389|17273966	.	2067	ERCC1	C3	EX4	Binding domain of DNA repair protein Ercc1 (rad10/Swi10)	PF03834.9	coding-synon	NM_001983.3	NP_001974.1	-	Y	c.354T>C	p.(N118=) | p.(Asn118=)	AAT=>AAC	.	NM_001983.3(ERCC1): c.354T>C (p.(N118=))	;maf-5-some-pop,genotype-conflict	123014	0.514998	U	0.7381	0.66893	13006	0.540058	PASS	2305	8578	0.736535	16939	118006	0.508466	4612	12624	7.34210e-01	34298	122024	4.99047e-01	rs11615	.	4024	0.749500	-1.608	-1.441	-1.965	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	225945	reviewed_by_expert_panel	drug_response	Likely Benign
19	50804976	50804977	19q13.33	0	normal	.	C	ref	C	AG.GG	het-alt	244	0.55	.	1	.	PASS	608568	C	600652(MK);614369(UK)	NN	Deafness, autosomal dominant 4; Deafness, autosomal dominant 4B; Peripheral neuropathy, myopathy, hoarseness, and hearing loss	AD	.	Audiologic/Otolaryngologic; Musculoskeletal; Neurologic	General	21480433|21368133|16222661|15015131|11938438|7655461	.	79784	MYH14	C39	EX40	Myosin tail	PF01576.14	no-change	NM_001145809.1	NP_001139281.1	+	Y	c.5529C=	.	.	.	NM_001145809.1(MYH14): c.5529C=	;maf-5-some-pop	125322	0.993186	U	0.0903	0.01877	12564	0.999761	PASS	.	8616	0.919104	59423	120314	0.993683	.	.	.	.	.	.	rs12610591	.	4024	0.910000	-0.218	-0.202	-0.206	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	50804976	50804977	19q13.33	1	normal	.	C	snv	T	AG.GG	het-ref	203	0.45	.	2	.	PASS	608568	C	600652(MK);614369(UK)	NN	Deafness, autosomal dominant 4; Deafness, autosomal dominant 4B; Peripheral neuropathy, myopathy, hoarseness, and hearing loss	AD	.	Audiologic/Otolaryngologic; Musculoskeletal; Neurologic	General	21480433|21368133|16222661|15015131|11938438|7655461	.	79784	MYH14	C39	EX40	Myosin tail	PF01576.14	coding-synon	NM_001145809.1	NP_001139281.1	+	Y	c.5529C>T	p.(S1843=) | p.(Ser1843=)	AGC=>AGT	.	NM_001145809.1(MYH14): c.5529C>T (p.(S1843=))	;maf-5-some-pop	125322	0.006814	U	0.0903	0.01877	12564	0.000239	PASS	26	8616	0.080896	26	120314	0.006317	61	1386	8.03758e-02	62	1524	6.19794e-03	rs12610591	.	4024	0.090000	-0.218	-0.202	-0.206	.	.	.	.	.	ENST00000262269: c.5529C>T (p.S1843S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3681008	.	.	.	.	.	no_record	226746	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	Likely Benign
19	52693288	52693289	19q13.41	0	normal	.	G	ref	G	TT.CC	het-alt	58	0.54	.	1	.	PASS	605983	P	.	NN	.	.	.	.	.	.	.	5518	PPP2R1A	5U1E	EX1	.	.	no-change	NM_014225.5	NP_055040.2	+	Y	c.-61G=	.	.	.	NM_014225.5(PPP2R1A): c.-61G=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.217	0.107	0.188	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
19	52693289	52693289	19q13.41	0	normal	.	.	ins	C	TG.CC	het-ref	49	0.46	.	2	.	PASS	605983	P	.	NN	.	.	.	.	.	.	.	5518	PPP2R1A	5U1E	EX1	.	.	utr-5	NM_014225.5	NP_055040.2	+	Y	c.-60C[8>9] (std: c.-53dupC alt: c.-53_-52insC )	.	.	.	NM_014225.5(PPP2R1A): c.-53dupC	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs761513244	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
19	52693297	52693298	19q13.41	0	normal	.	A	ref	A	CC.CG	het-alt	70	0.55	.	1	.	PASS	605983	P	.	NN	.	.	.	.	.	.	.	5518	PPP2R1A	5U1E	EX1	.	.	no-change	NM_014225.5	NP_055040.2	+	Y	c.-52A=	.	.	.	NM_014225.5(PPP2R1A): c.-52A=	MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops|MixedObserved,FlankMismatchGenomeLonger;	5008|0	0.864018|0	U	0.0992	0.135982	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17554825|rs3833207	.	.	.	-1.488	0.172	0.188	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	52693297	52693298	19q13.41	0	normal	.	A	snv	G	CC.CG	het-ref	57	0.45	.	2	.	PASS	605983	P	.	NN	.	.	.	.	.	.	.	5518	PPP2R1A	5U1E	EX1	.	.	utr-5	NM_014225.5	NP_055040.2	+	Y	c.-52A>G	.	.	.	NM_014225.5(PPP2R1A): c.-52A>G	MixedObserved,SingleClassQuadAllelic,InconsistentAlleles;maf-5-some-pop,maf-5-all-pops|MixedObserved,FlankMismatchGenomeLonger;	5008|0	0.135982|0	U	0.0992	0.135982	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs17554825|rs3833207	.	.	.	-1.488	0.172	0.188	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	52719189	52719190	19q13.41	0	normal	.	A	ref	A	CC.AG	het-alt	148	0.47	.	1	.	PASS	605983	P	.	NN	.	.	.	.	.	.	.	5518	PPP2R1A	IC7	IVS7	.	.	no-change	NM_014225.5	NP_055040.2	+	Y	c.922+44A=	.	.	.	NM_014225.5(PPP2R1A): c.922+44A=	;maf-5-some-pop	126238	0.881874	U	0.131	0.158946	13006	0.820314	PASS	.	8628	0.886532	47556	121230	0.883560	.	.	.	.	.	.	rs755531	.	.	.	-2.031	-1.866	-1.628	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
19	52719189	52719190	19q13.41	0	normal	.	A	snv	G	CC.AG	het-ref	167	0.53	.	2	.	PASS	605983	P	.	NN	.	.	.	.	.	.	.	5518	PPP2R1A	IC7	IVS7	.	.	intron	NM_014225.5	NP_055040.2	+	Y	c.922+44A>G	.	.	.	NM_014225.5(PPP2R1A): c.922+44A>G	;maf-5-some-pop	126238	0.118126	U	0.131	0.158946	13006	0.179686	PASS	66	8628	0.113468	1057	121230	0.116440	139	2050	1.18868e-01	1955	27625	1.12416e-01	rs755531	.	.	.	-2.031	-1.866	-1.628	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	20032997	20032998	20p11.23	0	normal	.	T	ref	T	AG.CG	het-alt	122	0.53	.	1	.	PASS	610952	C	.	NN	.	.	.	.	.	.	.	51340	CRNKL1	C2	EX2	.	.	no-change	NM_016652.4	NP_057736.4	-	Y	c.472A=	.	.	.	NM_016652.4(CRNKL1): c.472A=	;maf-5-some-pop,microattr-tpa,genotype-conflict	126016	0.489739	U	0.7024	0.51897	13006	0.536291	PASS	-855	8622	0.269543	14821	121008	0.490100	.	.	.	.	.	.	rs2255255	.	.	.	-0.119	-0.069	-0.461	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	20032997	20032998	20p11.23	1	normal	.	T	snv	C	AG.CG	het-ref	109	0.47	.	2	.	PASS	610952	C	.	NN	.	.	.	.	.	.	.	51340	CRNKL1	C2	EX2	.	.	missense	NM_016652.4	NP_057736.4	-	Y	c.472A>G	p.T158A | p.Thr158Ala	ACT=>GCT	P0=>NP	NM_016652.4(CRNKL1): c.472A>G (p.T158A)	;maf-5-some-pop,microattr-tpa,genotype-conflict	126016	0.510261	U	0.7024	0.51897	13006	0.463709	PASS	2294	8622	0.730457	16019	121008	0.509900	4611	12579	7.29979e-01	33128	126152	5.13280e-01	rs2255255	.	.	.	-0.119	-0.069	-0.461	0.21	0	0	0.044	neutral	ENST00000377340: c.472A>G (p.T158A)	pancreas [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	1565881	.	.	.	.	.	.	.	.	.	Likely Benign
20	20033136	20033137	20p11.23	0	nullSample	.	T	ref	T	GC.TG	homo-ref	.	.	.	0	.	.	610952	C	.	NN	.	.	.	.	.	.	.	51340	CRNKL1	C2	EX2	.	.	no-change	NM_016652.4	NP_057736.4	-	Y	c.333A=	.	.	.	NM_016652.4(CRNKL1): c.333A=	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	126324	0.345334	U	0.9375	0.700879	13006	0.409042	PASS	-239	8650	0.059653	7951	121316	0.347242	.	.	.	.	.	.	rs2255258	.	4024	0.061100	-0.257	-0.750	-0.422	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	20033136	20033137	20p11.23	1	normal	.	T	snv	A	GC.TG	hom-alt	493	0.99	.	0	.	PASS	610952	C	.	NN	.	.	.	.	.	.	.	51340	CRNKL1	C2	EX2	.	.	missense	NM_016652.4	NP_057736.4	-	Y	c.333A>T	p.Q111H | p.Gln111His	CAA=>CAT	P0=>P+	NM_016652.4(CRNKL1): c.333A>T (p.Q111H)	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	126324	0.654658	U	0.9375	0.700879	13006	0.590958	PASS	3828	8650	0.940347	26482	121316	0.652750	7662	16255	9.42537e-01	54685	161903	6.57554e-01	rs2255258	.	4024	0.938900	-0.257	-0.750	-0.422	0.77	0	0	0.001	neutral	ENST00000377340: c.333A>T (p.Q111H)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4134300	.	.	.	.	.	.	.	.	.	Likely Benign
20	20033241	20033242	20p11.23	0	normal	.	A	ref	A	GT.AC	het-alt	193	0.52	.	1	.	PASS	610952	C	.	NN	.	.	.	.	.	.	.	51340	CRNKL1	C2	EX2	.	.	no-change	NM_016652.4	NP_057736.4	-	Y	c.228T=	.	.	.	NM_016652.4(CRNKL1): c.228T=	;maf-5-some-pop,maf-5-all-pops	124692	0.488275	U	0.7024	0.51897	13004	0.536220	PASS	.	8532	0.267815	14475	119684	0.488578	.	.	.	.	.	.	rs2273057	.	4024	0.266400	-0.313	-0.261	-0.404	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	20033241	20033242	20p11.23	1	normal	.	A	snv	T	GT.AC	het-ref	176	0.48	.	2	.	PASS	610952	C	.	NN	.	.	.	.	.	.	.	51340	CRNKL1	C2	EX2	.	.	coding-synon	NM_016652.4	NP_057736.4	-	Y	c.228T>A	p.(V76=) | p.(Val76=)	GTT=>GTA	.	NM_016652.4(CRNKL1): c.228T>A (p.(V76=))	;maf-5-some-pop,maf-5-all-pops	124692	0.511725	U	0.7024	0.51897	13004	0.463780	PASS	2275	8532	0.732185	15842	119684	0.511422	4593	12530	7.30527e-01	32961	125725	5.13373e-01	rs2273057	.	4024	0.733600	-0.313	-0.261	-0.404	.	.	.	.	.	ENST00000377340: c.228T>A (p.V76V)	large_intestine [caecum|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	3758475	.	.	.	.	.	.	.	.	.	Likely Benign
20	30954294	30954295	20q11.21	0	nullSample	.	A	ref	A	AC.TG	homo-ref	.	.	.	0	.	.	612990	P	605039(MK);614286(MK)	NN	Bohring-Opitz syndrome	AD	.	Craniofacial; Dermatologic; Musculoskeletal; Neurologic	General	22419483|21706002	.	171023	ASXL1	IC2	IVS2	.	.	no-change	NM_015338.5	NP_056153.2	+	Y	c.140+26A=	.	.	.	NM_015338.5(ASXL1): c.140+26A=	;maf-5-some-pop,maf-5-all-pops	126236	0.581435	U	0.744	0.408746	13006	0.679302	PASS	.	8642	0.225989	21454	121228	0.581029	.	.	.	.	.	.	rs2295454	.	4024	0.225100	-0.781	-0.673	-1.238	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	30954294	30954295	20q11.21	0	normal	.	A	snv	G	AC.TG	hom-alt	283	1.00	.	0	.	PASS	612990	P	605039(MK);614286(MK)	NN	Bohring-Opitz syndrome	AD	.	Craniofacial; Dermatologic; Musculoskeletal; Neurologic	General	22419483|21706002	.	171023	ASXL1	IC2	IVS2	.	.	intron	NM_015338.5	NP_056153.2	+	Y	c.140+26A>G	.	.	.	NM_015338.5(ASXL1): c.140+26A>G	;maf-5-some-pop,maf-5-all-pops	126236	0.418565	U	0.744	0.408746	13006	0.320698	PASS	2613	8642	0.774011	11631	121228	0.418971	5263	13425	7.78622e-01	23945	104453	4.24437e-01	rs2295454	.	4024	0.774900	-0.781	-0.673	-1.238	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	31022958	31022959	20q11.21	0	normal	.	T	snv	C	TC.GT	hom-alt	720	1.00	.	0	.	PASS	612990	P	605039(MK);614286(MK)	NN	Bohring-Opitz syndrome	AD	.	Craniofacial; Dermatologic; Musculoskeletal; Neurologic	General	22419483|21706002	.	171023	ASXL1	C13E	EX13E	.	.	no-change	NM_015338.5	NP_056153.2	+	Y	c.2444C=	.	.	.	NM_015338.5(ASXL1): c.2444C=	;	125942	0.999976	U	1	1	13006	0.999923	PASS	4316	8632	1.000000	60464	120934	0.999975	8611	17222	1.00000e+00	122093	244188	9.99992e-01	rs6058694	.	.	.	-1.590	-0.995	-1.372	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	133599	no_assertion_provided	not_provided	Benign
20	31022958	31022959	20q11.21	1	nullSample	.	T	ref	T	TC.GT	homo-ref	.	.	.	0	.	.	612990	P	605039(MK);614286(MK)	NN	Bohring-Opitz syndrome	AD	.	Craniofacial; Dermatologic; Musculoskeletal; Neurologic	General	22419483|21706002	.	171023	ASXL1	C13E	EX13E	.	.	missense	NM_015338.5	NP_056153.2	+	Y	c.2444C>T	p.P815L | p.Pro815Leu	CCG=>CTG	NP=>NP	NM_015338.5(ASXL1): c.2444C>T (p.P815L)	;	125942	0.000024	U	1	1	13006	0.000077	PASS	0	8632	0.000000	0	120934	0.000025	.	.	.	.	.	.	rs6058694	.	.	.	-1.590	-0.995	-1.372	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
20	31024273	31024274	20q11.21	0	nullSample	.	T	ref	T	AG.AA	homo-ref	.	.	.	0	.	.	612990	P	605039(MK);614286(MK)	NN	Bohring-Opitz syndrome	AD	.	Craniofacial; Dermatologic; Musculoskeletal; Neurologic	General	22419483|21706002	.	171023	ASXL1	C13E	EX13E	.	.	no-change	NM_015338.5	NP_056153.2	+	Y	c.3759T=	.	.	.	NM_015338.5(ASXL1): c.3759T=	MixedObserved;maf-5-some-pop,maf-5-all-pops	126262	0.582170	U	0.7411	0.405751	13006	0.679917	PASS	-739	8640	0.230093	21493	121254	0.581672	.	.	.	.	.	.	rs4911231	.	4024	0.229900	0.459	0.273	0.081	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	31024273	31024274	20q11.21	1	normal	.	T	snv	C	AG.AA	hom-alt	690	1.00	.	0	.	PASS	612990	P	605039(MK);614286(MK)	NN	Bohring-Opitz syndrome	AD	.	Craniofacial; Dermatologic; Musculoskeletal; Neurologic	General	22419483|21706002	.	171023	ASXL1	C13E	EX13E	.	.	coding-synon	NM_015338.5	NP_056153.2	+	Y	c.3759T>C	p.(S1253=) | p.(Ser1253=)	AGT=>AGC	.	NM_015338.5(ASXL1): c.3759T>C (p.(S1253=))	MixedObserved;maf-5-some-pop,maf-5-all-pops	126262	0.417830	U	0.7411	0.405751	13006	0.320083	PASS	2587	8640	0.769907	11590	121254	0.418328	5218	13368	7.75406e-01	23890	104345	4.24287e-01	rs4911231	.	4024	0.770100	0.459	0.273	0.081	.	.	.	.	.	ENST00000375687: c.3759T>C (p.S1253S)	biliary_tract [gallbladder|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4134435	.	.	.	.	.	no_record	338113	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
20	31025162	31025163	20q11.21	0	nullSample	.	A	ref	A	AC.TT	homo-ref	.	.	.	0	.	.	612990	P	605039(MK);614286(MK)	NN	Bohring-Opitz syndrome	AD	.	Craniofacial; Dermatologic; Musculoskeletal; Neurologic	General	22419483|21706002	.	171023	ASXL1	3U1E	EX13E	.	.	no-change	NM_015338.5	NP_056153.2	+	Y	c.*22A=	.	.	.	NM_015338.5(ASXL1): c.*22A=	;maf-5-some-pop,maf-5-all-pops	126234	0.593754	U	0.7431	0.39996	13006	0.694833	PASS	-738	8646	0.228776	22403	121226	0.593495	.	.	.	.	.	.	rs2295764	.	.	.	-1.447	-0.021	-0.175	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	31025162	31025163	20q11.21	0	normal	.	A	snv	G	AC.TT	hom-alt	484	1.00	.	0	.	PASS	612990	P	605039(MK);614286(MK)	NN	Bohring-Opitz syndrome	AD	.	Craniofacial; Dermatologic; Musculoskeletal; Neurologic	General	22419483|21706002	.	171023	ASXL1	3U1E	EX13E	.	.	utr-3	NM_015338.5	NP_056153.2	+	Y	c.*22A>G	.	.	.	NM_015338.5(ASXL1): c.*22A>G	;maf-5-some-pop,maf-5-all-pops	126234	0.406246	U	0.7431	0.39996	13006	0.305167	PASS	2596	8646	0.771224	11069	121226	0.406505	5231	13387	7.76238e-01	22760	101305	4.12077e-01	rs2295764	.	.	.	-1.447	-0.021	-0.175	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	338120	criteria_provided,_single_submitter	Benign	Benign
20	31025230	31025231	20q11.21	0	nullSample	.	T	ref	T	TA.AA	homo-ref	.	.	.	0	.	.	612990	P	605039(MK);614286(MK)	NN	Bohring-Opitz syndrome	AD	.	Craniofacial; Dermatologic; Musculoskeletal; Neurologic	General	22419483|21706002	.	171023	ASXL1	3U1E	EX13E	.	.	no-change	NM_015338.5	NP_056153.2	+	Y	c.*90T=	.	.	.	NM_015338.5(ASXL1): c.*90T=	;maf-5-some-pop,maf-5-all-pops	5008	0.600240	U	0.7421	0.39976	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2295763	.	.	.	-1.163	-0.270	-1.047	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	31025230	31025231	20q11.21	0	normal	.	T	snv	C	TA.AA	hom-alt	246	1.00	.	0	.	PASS	612990	P	605039(MK);614286(MK)	NN	Bohring-Opitz syndrome	AD	.	Craniofacial; Dermatologic; Musculoskeletal; Neurologic	General	22419483|21706002	.	171023	ASXL1	3U1E	EX13E	.	.	utr-3	NM_015338.5	NP_056153.2	+	Y	c.*90T>C	.	.	.	NM_015338.5(ASXL1): c.*90T>C	;maf-5-some-pop,maf-5-all-pops	5008	0.399760	U	0.7421	0.39976	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2295763	.	.	.	-1.163	-0.270	-1.047	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	338123	criteria_provided,_single_submitter	Benign	Benign
20	36030938	36030939	20q11.23	0	normal	.	G	snv	C	GC.GA	hom-alt	458	1.00	.	0	.	PASS	190090	C	190090(MK)	NN	.	.	.	.	.	.	.	6714	SRC	C9	EX12	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	no-change	NM_005417.3	NP_005408.1	+	Y	c.1218C=	.	.	.	NM_005417.3(SRC): c.1218C=	;	126290	1.000000	U	1	1	.	.	PASS	4326	8652	1.000000	60641	121282	1.000000	8615	17230	1.00000e+00	122907	245818	9.99984e-01	rs1885257	.	.	.	-2.258	-2.991	-2.018	.	.	.	.	.	ENST00000445403: c.1218G>C (p.A406A)	upper_aerodigestive_tract [head_neck|NS|NS]	carcinoma [squamous_cell_carcinoma|NS|NS]	VUO	4594952	.	.	.	.	.	.	.	.	.	Benign
20	36030938	36030939	20q11.23	1	nullSample	.	G	ref	G	GC.GA	homo-ref	.	.	.	0	.	.	190090	C	190090(MK)	NN	.	.	.	.	.	.	.	6714	SRC	C9	EX12	Protein kinase domain;Protein tyrosine kinase	PF00069.20;PF07714.12	coding-synon	NM_005417.3	NP_005408.1	+	Y	c.1218C>G	p.(A406=) | p.(Ala406=)	GCC=>GCG	.	NM_005417.3(SRC): c.1218C>G (p.(A406=))	;	126290	0.000000	U	1	1	.	.	PASS	0	8652	0.000000	0	121282	0.000000	.	.	.	.	.	.	rs1885257	.	.	.	-2.258	-2.991	-2.018	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
20	36031096	36031097	20q11.23	0	nullSample	.	A	ref	A	ta.ca	homo-ref	.	.	.	0	MIRb|SINE|MIR|+|90	.	190090	C	190090(MK)	NN	.	.	.	.	.	.	.	6714	SRC	IC9	IVS12	.	.	no-change	NM_005417.3	NP_005408.1	+	Y	c.1271-55A=	.	.	.	NM_005417.3(SRC): c.1271-55A=	;	5008	0.000000	U	1	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2145792	.	4024	0.001500	-2.900	0.076	-0.271	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	36031096	36031097	20q11.23	0	normal	.	A	snv	G	ta.ca	hom-alt	486	1.00	.	0	MIRb|SINE|MIR|+|90	PASS	190090	C	190090(MK)	NN	.	.	.	.	.	.	.	6714	SRC	IC9	IVS12	.	.	intron	NM_005417.3	NP_005408.1	+	Y	c.1271-55A>G	.	.	.	NM_005417.3(SRC): c.1271-55A>G	;	5008	1.000000	U	1	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2145792	.	4024	0.998500	-2.900	0.076	-0.271	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	39794488	39794489	20q12	0	normal	.	G	snv	A	GC.TA	hom-alt	247	1.00	.	0	.	PASS	172420	C	.	NN	.	.	.	.	.	.	.	5335	PLCG1	IC16	IVS16	.	.	intron	NM_002660.2	NP_002651.2	+	Y	c.1799+23G>A	.	.	.	NM_002660.2(PLCG1): c.1799+23G>A	;maf-5-some-pop,maf-5-all-pops	115070	0.549639	U	0.8056	0.634784	13006	0.568353	PASS	2768	8488	0.809142	17026	110062	0.545765	5363	13224	8.11986e-01	31116	109569	5.45722e-01	rs6124323	.	4024	0.824600	-2.663	-3.900	-3.648	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	39794488	39794489	20q12	0	nullSample	.	G	ref	G	GC.TA	homo-ref	.	.	.	0	.	.	172420	C	.	NN	.	.	.	.	.	.	.	5335	PLCG1	IC16	IVS16	.	.	no-change	NM_002660.2	NP_002651.2	+	Y	c.1799+23G=	.	.	.	NM_002660.2(PLCG1): c.1799+23G=	;maf-5-some-pop,maf-5-all-pops	115070	0.450361	U	0.8056	0.634784	13006	0.431647	PASS	-666	8488	0.190858	11989	110062	0.454235	.	.	.	.	.	.	rs6124323	.	4024	0.175400	-2.663	-3.900	-3.648	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	40743828	40743829	20q12	1	normal	.	A	snv	G	CA.GA	het-ref	180	0.45	.	2	.	PASS	608712	P	.	NN	.	.	.	.	.	.	.	11122	PTPRT	IC23	IVS23	.	.	intron	NM_133170.3	NP_573400.3	-	Y	c.3156+10T>C	.	.	.	NM_133170.3(PTPRT): c.3156+10T>C	;maf-5-some-pop,maf-5-all-pops	125568	0.531863	U	0.5258	0.55651	12332	0.564953	PASS	1245	8580	0.547319	17023	120560	0.530839	2500	9345	5.42494e-01	34646	130184	5.30160e-01	rs2076248	.	.	.	-0.215	-0.252	-0.193	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	40743828	40743829	20q12	0	normal	.	A	ref	A	CA.GA	het-alt	222	0.55	.	1	.	PASS	608712	P	.	NN	.	.	.	.	.	.	.	11122	PTPRT	IC23	IVS23	.	.	no-change	NM_133170.3	NP_573400.3	-	Y	c.3156+10T=	.	.	.	NM_133170.3(PTPRT): c.3156+10T=	;maf-5-some-pop,maf-5-all-pops	125568	0.468137	U	0.5258	0.55651	12332	0.435047	PASS	-1103	8580	0.452681	13305	120560	0.469161	.	.	.	.	.	.	rs2076248	.	.	.	-0.215	-0.252	-0.193	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	41306487	41306488	20q12	0	nullSample	.	G	ref	G	GG.AA	homo-ref	.	.	.	0	.	.	608712	P	.	NN	.	.	.	.	.	.	.	11122	PTPRT	IC7	IVS7	.	.	no-change	NM_133170.3	NP_573400.3	-	Y	c.1153+18C=	.	.	.	NM_133170.3(PTPRT): c.1153+18C=	.	.	.	.	0.377	0.419728	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.238	0.038	0.359	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	41306488	41306488	20q12	1	normal	.	.	ins	A	GG.AA	het-alt	79	0.41	.	1	.	PASS	608712	P	.	NN	.	.	.	.	.	.	.	11122	PTPRT	IC7	IVS7	.	.	intron	NM_133170.3	NP_573400.3	-	Y	c.1153+17_1153+18insT	.	.	.	NM_133170.3(PTPRT): c.1153+17_1153+18insT	MixedObserved,InconsistentAlleles;rs-cluster-nonoverlapping-alleles	111210	0.130060	U	0.377	0.419728	.	.	PASS	196	7812	0.439196	2918	107324	0.446042	.	.	.	.	.	.	rs111229158	.	4024	0.389400	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	41306488	41306488	20q12	1	normal	.	.	ins	AA	GG.AA	het-alt	95	0.49	.	2	.	PASS	608712	P	.	NN	.	.	.	.	.	.	.	11122	PTPRT	IC7	IVS7	.	.	intron	NM_133170.3	NP_573400.3	-	Y	c.1153+17_1153+18insTT	.	.	.	NM_133170.3(PTPRT): c.1153+17_1153+18insTT	MixedObserved,InconsistentAlleles;rs-cluster-nonoverlapping-alleles	111210	0.451947	U	0.5069	0.477236	.	.	PASS	153	7812	0.416667	2623	107324	0.427733	.	.	.	.	.	.	rs111229158	.	4024	0.419700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	41306599	41306600	20q12	0	normal	.	A	ref	A	AC.TC	het-alt	314	0.53	.	1	.	PASS	608712	P	.	NN	.	.	.	.	.	.	.	11122	PTPRT	C7	EX7	Fibronectin type III domain	PF00041.16	no-change	NM_133170.3	NP_573400.3	-	Y	c.1059T=	.	.	.	NM_133170.3(PTPRT): c.1059T=	;maf-5-some-pop,maf-5-all-pops	125732	0.621274	U	0.3462	0.384784	12316	0.618789	PASS	.	8588	0.643805	23514	120724	0.621525	.	.	.	.	.	.	rs2425516	.	4024	0.613100	-3.342	-0.030	-1.131	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	41306599	41306600	20q12	1	normal	.	A	snv	G	AC.TC	het-ref	284	0.47	.	2	.	PASS	608712	P	.	NN	.	.	.	.	.	.	.	11122	PTPRT	C7	EX7	Fibronectin type III domain	PF00041.16	coding-synon	NM_133170.3	NP_573400.3	-	Y	c.1059T>C	p.(D353=) | p.(Asp353=)	GAT=>GAC	.	NM_133170.3(PTPRT): c.1059T>C (p.(D353=))	;maf-5-some-pop,maf-5-all-pops	125732	0.378726	U	0.3462	0.384784	12316	0.381211	PASS	552	8588	0.356195	8843	120724	0.378475	1142	6248	3.62329e-01	18299	93711	3.80927e-01	rs2425516	.	4024	0.386900	-3.342	-0.030	-1.131	.	.	.	.	.	NM_133170.2: c.1059T>C (p.D353D)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3758576	.	.	.	.	.	.	.	.	.	Likely Benign
20	43962593	43962596	20q13.12	0	normal	.	AAG	ref	AAG	AA.AA	het-alt	11	0.14	.	1	.	PASS	600017	P	.	NN	.	.	.	.	.	.	.	6385	SDC4	IC2	IVS2	.	.	no-change	NM_002999.3	NP_002990.2	-	Y	c.200-887_200-885=	.	.	.	NM_002999.3(SDC4): c.200-887_200-885=	;maf-5-some-pop,maf-5-all-pops	5008	0.505591	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs147893643	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
20	43962593	43962596	20q13.12	0	normal	.	AAG	del	.	AA.AA	het-ref	67	0.86	.	2	.	PASS	600017	P	.	NN	.	.	.	.	.	.	.	6385	SDC4	IC2	IVS2	.	.	intron	NM_002999.3	NP_002990.2	-	Y	c.200-887_200-885delCTT	.	.	.	NM_002999.3(SDC4): c.200-887_200-885delCTT	;maf-5-some-pop,maf-5-all-pops	5008	0.494409	U	0.5139	0.494409	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs147893643	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	43962640	43962641	20q13.12	0	normal	.	T	ref	T	ac.tt	het-alt	7	0.22	.	1	AluSc|SINE|Alu|-|296	DUBIOUS	600017	P	.	NN	.	.	.	.	.	.	.	6385	SDC4	IC2	IVS2	.	.	no-change	NM_002999.3	NP_002990.2	-	Y	c.200-932A=	.	.	.	NM_002999.3(SDC4): c.200-932A=	;maf-5-some-pop	5008	0.149161	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs35204147	.	.	.	0.148	0.162	0.150	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Unknown
20	43962640	43962641	20q13.12	0	normal	.	T	del	.	ac.tt	het-ref	25	0.78	.	2	AluSc|SINE|Alu|-|296	PASS	600017	P	.	NN	.	.	.	.	.	.	.	6385	SDC4	IC2	IVS2	.	.	intron	NM_002999.3	NP_002990.2	-	Y	c.200-932delA	.	.	.	NM_002999.3(SDC4): c.200-932delA	;maf-5-some-pop	5008	0.850839	U	0.9534	0.850839	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs35204147	.	.	.	0.148	0.162	0.150	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	43963046	43963047	20q13.12	0	nullSample	.	C	ref	C	ta.tt	homo-ref	.	.	.	0	L1MA9|LINE|L1|+|89	.	600017	P	.	NN	.	.	.	.	.	.	.	6385	SDC4	IC2	IVS2	.	.	no-change	NM_002999.3	NP_002990.2	-	Y	c.200-1338G=	.	.	.	NM_002999.3(SDC4): c.200-1338G=	;maf-5-some-pop,genotype-conflict	5008	0.149561	U	0.9554	0.850439	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4812891	.	.	.	-0.525	-0.446	-0.499	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	43963046	43963047	20q13.12	0	normal	.	C	snv	A	ta.tt	hom-alt	178	1.00	.	0	L1MA9|LINE|L1|+|89	PASS	600017	P	.	NN	.	.	.	.	.	.	.	6385	SDC4	IC2	IVS2	.	.	intron	NM_002999.3	NP_002990.2	-	Y	c.200-1338G>T	.	.	.	NM_002999.3(SDC4): c.200-1338G>T	;maf-5-some-pop,genotype-conflict	5008	0.850439	U	0.9554	0.850439	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs4812891	.	.	.	-0.525	-0.446	-0.499	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	43963734	43963735	20q13.12	0	nullSample	.	A	ref	A	GA.GC	homo-ref	.	.	.	0	.	.	600017	P	.	NN	.	.	.	.	.	.	.	6385	SDC4	IC2	IVS2	.	.	no-change	NM_002999.3	NP_002990.2	-	Y	c.199+687T=	.	.	.	NM_002999.3(SDC4): c.199+687T=	;maf-5-some-pop	5008	0.209065	U	0.9554	0.790935	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6104122	.	.	.	0.374	1.546	1.491	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	43963734	43963735	20q13.12	0	normal	.	A	snv	C	GA.GC	hom-alt	202	1.00	.	0	.	PASS	600017	P	.	NN	.	.	.	.	.	.	.	6385	SDC4	IC2	IVS2	.	.	intron	NM_002999.3	NP_002990.2	-	Y	c.199+687T>G	.	.	.	NM_002999.3(SDC4): c.199+687T>G	;maf-5-some-pop	5008	0.790935	U	0.9554	0.790935	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6104122	.	.	.	0.374	1.546	1.491	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	43964287	43964288	20q13.12	0	nullSample	.	T	ref	T	TT.TG	homo-ref	.	.	.	0	.	.	600017	P	.	NN	.	.	.	.	.	.	.	6385	SDC4	IC2	IVS2	.	.	no-change	NM_002999.3	NP_002990.2	-	Y	c.199+134A=	.	.	.	NM_002999.3(SDC4): c.199+134A=	;maf-5-some-pop,maf-5-all-pops	5008	0.504992	U	0.5149	0.495008	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2072792	.	.	.	-0.396	-0.196	-0.349	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	43964287	43964288	20q13.12	0	normal	.	T	snv	C	TT.TG	hom-alt	413	1.00	.	0	.	PASS	600017	P	.	NN	.	.	.	.	.	.	.	6385	SDC4	IC2	IVS2	.	.	intron	NM_002999.3	NP_002990.2	-	Y	c.199+134A>G	.	.	.	NM_002999.3(SDC4): c.199+134A>G	;maf-5-some-pop,maf-5-all-pops	5008	0.495008	U	0.5149	0.495008	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2072792	.	.	.	-0.396	-0.196	-0.349	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	444113	no_assertion_criteria_provided	Benign	Benign
20	43964406	43964407	20q13.12	0	nullSample	.	G	ref	G	CA.CA	homo-ref	.	.	.	0	.	.	600017	P	.	NN	.	.	.	.	.	.	.	6385	SDC4	IC2	IVS2	.	.	no-change	NM_002999.3	NP_002990.2	-	Y	c.199+15C=	.	.	.	NM_002999.3(SDC4): c.199+15C=	;maf-5-some-pop	126166	0.229103	U	0.9554	0.769369	13006	0.271951	PASS	.	8632	0.036029	3418	121158	0.229040	.	.	.	.	.	.	rs2072791	.	.	.	-0.216	-0.566	-0.363	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	43964406	43964407	20q13.12	1	normal	.	G	snv	C	CA.CA	hom-alt	361	1.00	.	0	.	PASS	600017	P	.	NN	.	.	.	.	.	.	.	6385	SDC4	IC2	IVS2	.	.	intron	NM_002999.3	NP_002990.2	-	Y	c.199+15C>G	.	.	.	NM_002999.3(SDC4): c.199+15C>G	;maf-5-some-pop	126166	0.770897	U	0.9554	0.769369	13006	0.728049	PASS	4013	8632	0.963971	36247	121158	0.770960	8047	16653	9.66063e-01	74070	190017	7.73880e-01	rs2072791	.	.	.	-0.216	-0.566	-0.363	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	46279836	46279839	20q13.12	0	normal	.	CAG	ref	CAG	aa.ca	het-alt	37	0.19	.	1	(CAG)n|Simple_repeat|Simple_repeat|+|87;trf	PASS	601937	P	.	NN	.	.	.	.	.	.	.	8202	NCOA3	C18	EX20	.	.	no-change	NM_181659.2	NP_858045.1	+	Y	c.3763_3765=	.	.	.	NM_181659.2(NCOA3): c.3763_3765=	MixedObserved;	30731	0.968631	U	.	.	12096	0.579034	.	.	.	.	.	.	.	.	.	.	.	.	.	rs147879509	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	46279836	46279839	20q13.12	1	normal	.	CAG	del	.	aa.ca	het-ref	160	0.81	.	2	(CAG)n|Simple_repeat|Simple_repeat|+|87;trf	PASS	601937	P	.	NN	.	.	.	.	.	.	.	8202	NCOA3	C18	EX20	.	.	cds-del	NM_181659.2	NP_858045.1	+	Y	c.3765GCA[9>8] (std: c.3765GCA[8] alt: c.3789_3791delGCA )	p.Q1248[29>28] (std: p.Q1248[28] alt: p.Q1276del ) | p.Gln1248[29>28] (std: p.Gln1248[28] alt: p.Gln1276del )	.	.	NM_181659.2(NCOA3): c.3765GCA[8] (p.Q1248[28])	MixedObserved;	30731	0.031369	U	.	.	12096	0.355324	PASS	121	7764	0.223854	2836	106396	0.279776	.	.	.	.	.	.	rs147879509	.	.	.	.	.	.	.	.	.	.	.	ENST00000371998: c.3763_3765delCAG (p.Q1255delQ)	liver [NS|NS|NS]	carcinoma [NS|NS|NS]	VUO	128730	.	.	.	.	.	.	.	.	.	Benign
20	52786218	52786219	20q13.2	0	normal	.	G	ref	G	TC.GC	het-alt	293	0.55	.	1	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr20: g.52786218G= (intergenic)	;maf-5-some-pop,maf-5-all-pops	126260	0.509005	U	0.4058	0.458067	13006	0.475704	PASS	.	8626	0.578831	15933	121252	0.507645	.	.	.	.	.	.	rs2296241	.	.	.	-0.360	-1.104	-0.530	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	52786218	52786219	20q13.2	0	normal	.	G	snv	A	TC.GC	het-ref	240	0.45	.	2	.	PASS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	chr20: g.52786218G>A (intergenic)	;maf-5-some-pop,maf-5-all-pops	126260	0.490995	U	0.4058	0.458067	13006	0.524296	PASS	770	8626	0.421169	15006	121252	0.492355	1499	7205	4.17972e-01	30308	120652	4.90304e-01	rs2296241	.	.	.	-0.360	-1.104	-0.530	.	.	.	.	.	ENST00000216862: c.552C>T (p.A184A)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4001955	.	.	.	.	.	no_record	338831	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
20	54945782	54945783	20q13.2	0	nullSample	.	A	ref	A	TC.TT	homo-ref	.	.	.	0	.	.	603072	C	114500(SK)	AD	.	.	.	.	.	.	.	6790	AURKA	IC6	IVS9	.	.	no-change	NM_198433.1	NP_940835.1	-	Y	c.855-68T=	.	.	.	NM_198433.1(AURKA): c.855-68T=	;maf-5-some-pop,maf-5-all-pops	5008	0.652556	U	0.7391	0.347444	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10485805	.	4024	0.245800	-0.256	0.625	0.364	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	54945782	54945783	20q13.2	0	normal	.	A	snv	G	TC.TT	hom-alt	265	1.00	.	0	.	PASS	603072	C	114500(SK)	AD	.	.	.	.	.	.	.	6790	AURKA	IC6	IVS9	.	.	intron	NM_198433.1	NP_940835.1	-	Y	c.855-68T>C	.	.	.	NM_198433.1(AURKA): c.855-68T>C	;maf-5-some-pop,maf-5-all-pops	5008	0.347444	U	0.7391	0.347444	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10485805	.	4024	0.754200	-0.256	0.625	0.364	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	54956706	54956707	20q13.2	0	nullSample	.	A	ref	A	TC.TG	homo-ref	.	.	.	0	.	.	603072	C	114500(SK)	AD	.	.	.	.	.	.	.	6790	AURKA	IC4	IVS7	.	.	no-change	NM_198433.1	NP_940835.1	-	Y	c.567-80T=	.	.	.	NM_198433.1(AURKA): c.567-80T=	;maf-5-some-pop,maf-5-all-pops	5008	0.553914	U	0.6865	0.446086	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6024840	.	4024	0.294700	0.533	-0.195	-1.024	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	54956706	54956707	20q13.2	0	normal	.	A	snv	G	TC.TG	hom-alt	258	1.00	.	0	.	PASS	603072	C	114500(SK)	AD	.	.	.	.	.	.	.	6790	AURKA	IC4	IVS7	.	.	intron	NM_198433.1	NP_940835.1	-	Y	c.567-80T>C	.	.	.	NM_198433.1(AURKA): c.567-80T>C	;maf-5-some-pop,maf-5-all-pops	5008	0.446086	U	0.6865	0.446086	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6024840	.	4024	0.705300	0.533	-0.195	-1.024	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	54959295	54959296	20q13.2	0	nullSample	.	G	ref	G	CA.TA	homo-ref	.	.	.	0	.	.	603072	C	114500(SK)	AD	.	.	.	.	.	.	.	6790	AURKA	IC3	IVS6	.	.	no-change	NM_198433.1	NP_940835.1	-	Y	c.374+30C=	.	.	.	NM_198433.1(AURKA): c.374+30C=	SingleClassTriAllelic;maf-5-some-pop	122796	0.704860	U	0.6508	0.334265	12948	0.780661	PASS	.	8438	0.322944	30136	117788	0.706524	.	.	.	.	.	.	rs2298016	.	.	.	0.655	-0.953	-0.868	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	54959295	54959296	20q13.2	0	normal	.	G	snv	C	CA.TA	hom-alt	524	1.00	.	0	.	PASS	603072	C	114500(SK)	AD	.	.	.	.	.	.	.	6790	AURKA	IC3	IVS6	.	.	intron	NM_198433.1	NP_940835.1	-	Y	c.374+30C>G	.	.	.	NM_198433.1(AURKA): c.374+30C>G	SingleClassTriAllelic;maf-5-some-pop	122796	0.295132	U	0.6508	0.334265	12948	0.219339	PASS	1905	8438	0.677056	5810	117788	0.293468	3860	11508	6.73140e-01	12013	70768	2.91796e-01	rs2298016	.	.	.	0.655	-0.953	-0.868	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	54959504	54959505	20q13.2	0	normal	.	G	ref	G	CT.TT	het-alt	152	0.84	.	1	.	PASS	603072	C	114500(SK)	AD	.	.	.	.	.	.	.	6790	AURKA	IC2	IVS5	.	.	no-change	NM_198433.1	NP_940835.1	-	Y	c.320-125C=	.	.	.	NM_198433.1(AURKA): c.320-125C=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.655	0.905	0.907	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
20	54959505	54959505	20q13.2	0	normal	.	.	ins	T	TG.TT	het-ref	29	0.16	.	2	.	PASS	603072	C	114500(SK)	AD	.	.	.	.	.	.	.	6790	AURKA	IC2	IVS5	.	.	intron	NM_198433.1	NP_940835.1	-	Y	c.320-126_320-125insA	.	.	.	NM_198433.1(AURKA): c.320-126_320-125insA	DuplicateObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs566227970	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
20	54961462	54961463	20q13.2	0	nullSample	.	T	ref	T	AA.GC	homo-ref	.	.	.	0	.	.	603072	C	114500(SK)	AD	.	.	.	.	.	.	.	6790	AURKA	C2	EX5	.	.	no-change	NM_198433.1	NP_940835.1	-	Y	c.169A=	.	.	.	NM_198433.1(AURKA): c.169A=	;maf-5-some-pop,genotype-conflict	126414	0.151747	U	0.877	0.84984	13006	0.162233	PASS	.	8654	0.122371	1462	121406	0.151813	.	.	.	.	.	.	rs1047972	.	4024	0.116300	-1.117	0.735	-0.000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	54961462	54961463	20q13.2	1	normal	.	T	snv	C	AA.GC	hom-alt	699	1.00	.	0	.	PASS	603072	C	114500(SK)	AD	.	.	.	.	.	.	.	6790	AURKA	C2	EX5	.	.	missense	NM_198433.1	NP_940835.1	-	Y	c.169A>G	p.I57V | p.Ile57Val	ATT=>GTT	NP=>NP	NM_198433.1(AURKA): c.169A>G (p.I57V)	;maf-5-some-pop,genotype-conflict	126414	0.848253	U	0.877	0.84984	13006	0.837767	PASS	3337	8654	0.877629	43734	121406	0.848187	6666	15159	8.78885e-01	89212	209460	8.50551e-01	rs1047972	.	4024	0.883700	-1.117	0.735	-0.000	1	0.001	0	0.000	neutral	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
20	54961540	54961541	20q13.2	1	normal	.	A	snv	T	AA.TT	hom-alt	599	1.00	.	0	.	PASS	603072	C	114500(SK)	AD	.	.	.	.	.	.	.	6790	AURKA	C2	EX5	.	.	missense	NM_198433.1	NP_940835.1	-	Y	c.91T>A	p.F31I | p.Phe31Ile	TTT=>ATT	NP=>NP	NM_198433.1(AURKA): c.91T>A (p.F31I)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	126348	0.274892	U	0.6587	0.309704	13006	0.188221	PASS	1974	8648	0.678423	5537	121340	0.273455	3947	11682	6.77296e-01	11395	68179	2.76894e-01	rs2273535	.	4024	0.683600	-0.371	-1.449	-1.226	0.47	0.001	0	0.011	neutral	ENST00000395909: c.91T>A (p.F31I)	skin [NS|NS|NS]	malignant_melanoma [NS|NS|NS]	CSV	3736282	CM042940	NM_198433.1(AURKA): c.91T>A (p.F31I)	"Oesophageal cancer, association with"	15087379	DFP	no_record	6642	no_assertion_criteria_provided	risk_factor	Likely Benign
20	54961540	54961541	20q13.2	0	nullSample	.	A	ref	A	AA.TT	homo-ref	.	.	.	0	.	.	603072	C	114500(SK)	AD	.	.	.	.	.	.	.	6790	AURKA	C2	EX5	.	.	no-change	NM_198433.1	NP_940835.1	-	Y	c.91T=	.	.	.	NM_198433.1(AURKA): c.91T=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb,genotype-conflict	126348	0.725108	U	0.6587	0.309704	13006	0.811779	PASS	.	8648	0.321577	33026	121340	0.726545	.	.	.	.	.	.	rs2273535	.	4024	0.316400	-0.371	-1.449	-1.226	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	54963148	54963149	20q13.2	0	nullSample	.	C	ref	C	CC.GA	homo-ref	.	.	.	0	.	.	603072	C	114500(SK)	AD	.	.	.	.	.	.	.	6790	AURKA	IC1	IVS4	.	.	no-change	NM_198433.1	NP_940835.1	-	Y	c.42+63G=	.	.	.	NM_198433.1(AURKA): c.42+63G=	;	0	0	U	0.8681	0.804313	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs201926111	.	.	.	-0.740	0.495	0.441	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	54963149	54963149	20q13.2	0	normal	.	.	ins	GACAAGACCAACCTCCATGTGGGTTTATAAATGTGAATGAGATTACAGATTATTCAATTTA	CC.GA	hom-alt	14	0.93	.	0	.	PASS	603072	C	114500(SK)	AD	.	.	.	.	.	.	.	6790	AURKA	IC1	IVS4	.	.	intron	NM_198433.1	NP_940835.1	-	Y	c.42+62_42+63insTAAATTGAATAATCTGTAATCTCATTCACATTTATAAACCCACATGGAGGTTGGTCTTGTC	.	.	.	NM_198433.1(AURKA): c.42+62_42+63insTAAATTGAATAATCTGTAATCTCATTCACATTTATAAACCCACATGGAGGTTGGTCTTGTC	MixedObserved;	0	0	U	0.8681	0.804313	12338	0.854109	.	.	.	.	.	.	.	.	.	.	.	.	.	rs141876643	.	4024	0.020100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	56136535	56136536	20q13.31	0	nullSample	.	A	ref	A	CT.CC	homo-ref	.	.	.	0	.	.	614168	C	261680(UA)	AR	.	.	.	.	.	.	.	5105	PCK1	C1	EX2	.	.	no-change	NM_002591.3	NP_002582.3	+	Y	c.69A=	.	.	.	NM_002591.3(PCK1): c.69A=	SingleClassTriAllelic;maf-5-some-pop	126140	0.548311	U	0.377	0.396965	13006	0.552053	PASS	-1003	8618	0.618473	18400	121132	0.546049	.	.	.	.	.	.	rs1042521	.	4024	0.604900	-0.215	1.426	1.312	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	56136535	56136536	20q13.31	1	normal	.	A	snv	G	CT.CC	hom-alt	494	1.00	.	0	.	PASS	614168	C	261680(UA)	AR	.	.	.	.	.	.	.	5105	PCK1	C1	EX2	.	.	coding-synon	NM_002591.3	NP_002582.3	+	Y	c.69A>G	p.(L23=) | p.(Leu23=)	CTA=>CTG	.	NM_002591.3(PCK1): c.69A>G (p.(L23=))	SingleClassTriAllelic;maf-5-some-pop	126140	0.451681	U	0.377	0.396965	13006	0.447947	PASS	641	8618	0.381527	12821	121132	0.453943	1257	6592	3.82367e-01	25624	110785	4.50653e-01	rs1042521	.	4024	0.395100	-0.215	1.426	1.312	.	.	.	.	.	ENST00000319441: c.69A>G (p.L23L)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4134687	.	.	.	.	.	no_record	338868	criteria_provided,_single_submitter	Benign	Likely Benign
20	56137797	56137798	20q13.31	0	normal	.	G	ref	G	TC.CC	het-alt	263	0.53	.	1	.	PASS	614168	C	261680(UA)	AR	.	.	.	.	.	.	.	5105	PCK1	C3	EX4	Phosphoenolpyruvate carboxykinase	PF00821.13	no-change	NM_002591.3	NP_002582.3	+	Y	c.453G=	.	.	.	NM_002591.3(PCK1): c.453G=	;maf-5-some-pop	125676	0.624511	U	0.0308	0.295128	13006	0.587267	PASS	-147	8638	0.963881	23977	120668	0.621175	.	.	.	.	.	.	rs1062600	.	4024	0.969700	-0.182	-1.716	-2.116	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	56137797	56137798	20q13.31	1	normal	.	G	snv	A	TC.CC	het-ref	230	0.47	.	2	.	PASS	614168	C	261680(UA)	AR	.	.	.	.	.	.	.	5105	PCK1	C3	EX4	Phosphoenolpyruvate carboxykinase	PF00821.13	coding-synon	NM_002591.3	NP_002582.3	+	Y	c.453G>A	p.(S151=) | p.(Ser151=)	TCG=>TCA	.	NM_002591.3(PCK1): c.453G>A (p.(S151=))	;maf-5-some-pop	125676	0.375489	U	0.0308	0.295128	13006	0.412733	PASS	9	8638	0.036119	9355	120668	0.378825	15	604	3.50307e-02	19366	92512	3.77887e-01	rs1062600	.	4024	0.030300	-0.182	-1.716	-2.116	.	.	.	.	.	ENST00000319441: c.453G>A (p.S151S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [diffuse_large_B_cell_lymphoma|NS|NS]	CSV	4134688	.	.	.	.	.	no_record	338875	criteria_provided,_single_submitter	Benign	Likely Benign
20	56137806	56137807	20q13.31	0	normal	.	A	ref	A	TC.AA	het-alt	269	0.55	.	1	.	PASS	614168	C	261680(UA)	AR	.	.	.	.	.	.	.	5105	PCK1	C3	EX4	Phosphoenolpyruvate carboxykinase	PF00821.13	no-change	NM_002591.3	NP_002582.3	+	Y	c.462A=	.	.	.	NM_002591.3(PCK1): c.462A=	;maf-5-some-pop	125772	0.592795	U	0.0308	0.313299	13006	0.550361	PASS	-147	8638	0.963881	21846	120764	0.588901	.	.	.	.	.	.	rs1042523	.	4024	0.969400	-3.430	-0.577	-1.018	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	56137806	56137807	20q13.31	1	normal	.	A	snv	G	TC.AA	het-ref	224	0.45	.	2	.	PASS	614168	C	261680(UA)	AR	.	.	.	.	.	.	.	5105	PCK1	C3	EX4	Phosphoenolpyruvate carboxykinase	PF00821.13	coding-synon	NM_002591.3	NP_002582.3	+	Y	c.462A>G	p.(S154=) | p.(Ser154=)	TCA=>TCG	.	NM_002591.3(PCK1): c.462A>G (p.(S154=))	;maf-5-some-pop	125772	0.407205	U	0.0308	0.313299	13006	0.449639	PASS	9	8638	0.036119	11110	120764	0.411099	16	607	3.52088e-02	22787	100286	4.09321e-01	rs1042523	.	4024	0.030600	-3.430	-0.577	-1.018	.	.	.	.	.	ENST00000319441: c.462A>G (p.S154S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [diffuse_large_B_cell_lymphoma|NS|NS]	CSV	4134690	.	.	.	.	.	no_record	338876	criteria_provided,_single_submitter	Benign	Likely Benign
20	56137833	56137834	20q13.31	0	normal	.	A	ref	A	TC.CC	het-alt	266	0.52	.	1	.	PASS	614168	C	261680(UA)	AR	.	.	.	.	.	.	.	5105	PCK1	C3	EX4	Phosphoenolpyruvate carboxykinase	PF00821.13	no-change	NM_002591.3	NP_002582.3	+	Y	c.489A=	.	.	.	NM_002591.3(PCK1): c.489A=	;maf-5-some-pop	126088	0.589517	U	0.0308	0.314097	13006	0.550438	PASS	-147	8634	0.963864	21848	121080	0.585530	.	.	.	.	.	.	rs1062601	.	4024	0.969700	-1.785	-2.004	-1.316	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	56137833	56137834	20q13.31	1	normal	.	A	snv	G	TC.CC	het-ref	243	0.48	.	2	.	PASS	614168	C	261680(UA)	AR	.	.	.	.	.	.	.	5105	PCK1	C3	EX4	Phosphoenolpyruvate carboxykinase	PF00821.13	coding-synon	NM_002591.3	NP_002582.3	+	Y	c.489A>G	p.(S163=) | p.(Ser163=)	TCA=>TCG	.	NM_002591.3(PCK1): c.489A>G (p.(S163=))	;maf-5-some-pop	126088	0.410483	U	0.0308	0.314097	13006	0.449562	PASS	9	8634	0.036136	11492	121080	0.414470	16	608	3.52586e-02	23011	100811	4.10535e-01	rs1062601	.	4024	0.030300	-1.785	-2.004	-1.316	.	.	.	.	.	ENST00000319441: c.489A>G (p.S163S)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	lymphoid_neoplasm [diffuse_large_B_cell_lymphoma|NS|NS]	CSV	3722977	.	.	.	.	.	no_record	338877	criteria_provided,_single_submitter	Benign	Likely Benign
20	56137894	56137895	20q13.31	0	nullSample	.	G	ref	G	CA.TG	homo-ref	.	.	.	0	.	.	614168	C	261680(UA)	AR	.	.	.	.	.	.	.	5105	PCK1	C3	EX4	Phosphoenolpyruvate carboxykinase	PF00821.13	no-change	NM_002591.3	NP_002582.3	+	Y	c.550G=	.	.	.	NM_002591.3(PCK1): c.550G=	;maf-5-some-pop,genotype-conflict	126314	0.153752	U	0.7798	0.846046	13006	0.098801	PASS	.	8644	0.216451	1690	121306	0.153743	.	.	.	.	.	.	rs707555	.	4024	0.213200	-0.120	3.984	1.304	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	56137894	56137895	20q13.31	1	normal	.	G	snv	C	CA.TG	hom-alt	570	1.00	.	0	.	PASS	614168	C	261680(UA)	AR	.	.	.	.	.	.	.	5105	PCK1	C3	EX4	Phosphoenolpyruvate carboxykinase	PF00821.13	missense	NM_002591.3	NP_002582.3	+	Y	c.550G>C	p.V184L | p.Val184Leu	GTG=>CTG	NP=>NP	NM_002591.3(PCK1): c.550G>C (p.V184L)	;maf-5-some-pop,genotype-conflict	126314	0.846248	U	0.7798	0.846046	13006	0.901199	PASS	2642	8644	0.783549	43693	121306	0.846257	5296	13509	7.83767e-01	87445	206921	8.40978e-01	rs707555	.	4024	0.786800	-0.120	3.984	1.304	1	0	0	0.000	neutral	ENST00000319441: c.550G>C (p.V184L)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3736801	.	.	.	.	.	no_record	338879	criteria_provided,_single_submitter	Benign	Likely Benign
20	56138039	56138040	20q13.31	0	normal	.	G	ref	G	AA.CA	het-alt	275	0.53	.	1	.	PASS	614168	C	261680(UA)	AR	.	.	.	.	.	.	.	5105	PCK1	IC3	IVS4	.	.	no-change	NM_002591.3	NP_002582.3	+	Y	c.611-44G=	.	.	.	NM_002591.3(PCK1): c.611-44G=	;maf-5-some-pop,maf-5-all-pops	123480	0.536961	U	0.3115	0.418331	13004	0.533528	PASS	-928	8570	0.688915	17111	118472	0.535072	.	.	.	.	.	.	rs2070755	.	4024	0.711500	-0.742	-1.675	-1.393	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	56138039	56138040	20q13.31	0	normal	.	G	snv	C	AA.CA	het-ref	243	0.47	.	2	.	PASS	614168	C	261680(UA)	AR	.	.	.	.	.	.	.	5105	PCK1	IC3	IVS4	.	.	intron	NM_002591.3	NP_002582.3	+	Y	c.611-44G>C	.	.	.	NM_002591.3(PCK1): c.611-44G>C	;maf-5-some-pop,maf-5-all-pops	123480	0.463039	U	0.3115	0.418331	13004	0.466472	PASS	405	8570	0.311085	12956	118472	0.464928	782	5236	3.05128e-01	26706	112069	4.69198e-01	rs2070755	.	4024	0.288500	-0.742	-1.675	-1.393	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	56139402	56139403	20q13.31	0	nullSample	.	T	ref	T	GG.GT	homo-ref	.	.	.	0	.	.	614168	C	261680(UA)	AR	.	.	.	.	.	.	.	5105	PCK1	C6	EX7	Phosphoenolpyruvate carboxykinase	PF00821.13	no-change	NM_002591.3	NP_002582.3	+	Y	c.1140T=	.	.	.	NM_002591.3(PCK1): c.1140T=	;maf-5-some-pop	126360	0.243985	U	0.7728	0.786941	13006	0.197755	PASS	.	8644	0.222929	3972	121352	0.245262	.	.	.	.	.	.	rs2070756	.	4024	0.222400	-1.653	-0.985	-1.206	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	56139402	56139403	20q13.31	1	normal	.	T	snv	C	GG.GT	hom-alt	629	1.00	.	0	.	PASS	614168	C	261680(UA)	AR	.	.	.	.	.	.	.	5105	PCK1	C6	EX7	Phosphoenolpyruvate carboxykinase	PF00821.13	coding-synon	NM_002591.3	NP_002582.3	+	Y	c.1140T>C	p.(G380=) | p.(Gly380=)	GGT=>GGC	.	NM_002591.3(PCK1): c.1140T>C (p.(G380=))	;maf-5-some-pop	126360	0.756015	U	0.7728	0.786941	13006	0.802245	PASS	2599	8644	0.777071	34885	121352	0.754738	5222	13414	7.77984e-01	69226	183954	7.47252e-01	rs2070756	.	4024	0.777600	-1.653	-0.985	-1.206	.	.	.	.	.	ENST00000319441: c.1140T>C (p.G380G)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4419746	.	.	.	.	.	no_record	338889	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
20	57478806	57478807	20q13.32	0	normal	.	C	ref	C	AT.CT	het-alt	321	0.53	.	1	.	PASS	139320	C	102200(MK);103580(MK);166350(MK);174800(MK);219080(MK);603233(MK);612462(MK);612463(MK)	AD	Pseudohypoparathyroidism, type IA; Pseudohypoparathyroidism, type IB; Pseudohypoparathyroidism, type IC; Progressive osseous heteroplasia; McCune-Albright syndrome	AD	.	Dermatologic; Endocrine; Musculoskeletal; Oncologic; Renal	Endocrine; Oncologic; Renal	22640971|21816789|21488135|21357941|20480732|19858129|18553568|18416659|18397987|17651445|17405850|16984995|16060910|15711092|15537666|15126527|15001590|14561710|14557424|13005676|12858292|12727968|12624854|12605446|12414879|12407707|12024004|11788646|11784876|11600516|11583302|11406605|11397863|11297617|11095461|11073544|11067869|11029463|10998448|10646121|10356155|10190480|9506752|9226216|8421479|8126161|8126048|7980957|7739708|7671486|6265935|5906056|3126297|3093862|2829196|2273209|2122458|2109828|1955519|1944469|1621772|1594625|1424186|1400888|1346061|1083395|0614538|431133|219790|198661	.	2778	GNAS	C5	EX5	G-protein alpha subunit	PF00503.15	no-change	NM_001077488.2	NP_001070956.1	+	Y	c.396C=	.	.	.	NM_001077488.2(GNAS): c.396C=	;maf-5-some-pop,maf-5-all-pops	126388	0.448824	U	0.6716	0.644369	13006	0.420575	PASS	.	8628	0.369842	13130	121380	0.452669	.	.	.	.	.	.	rs7121	.	4024	0.336000	-1.760	-1.518	-2.651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	57478806	57478807	20q13.32	1	normal	.	C	snv	T	AT.CT	het-ref	290	0.47	.	2	.	PASS	139320	C	102200(MK);103580(MK);166350(MK);174800(MK);219080(MK);603233(MK);612462(MK);612463(MK)	AD	Pseudohypoparathyroidism, type IA; Pseudohypoparathyroidism, type IB; Pseudohypoparathyroidism, type IC; Progressive osseous heteroplasia; McCune-Albright syndrome	AD	.	Dermatologic; Endocrine; Musculoskeletal; Oncologic; Renal	Endocrine; Oncologic; Renal	22640971|21816789|21488135|21357941|20480732|19858129|18553568|18416659|18397987|17651445|17405850|16984995|16060910|15711092|15537666|15126527|15001590|14561710|14557424|13005676|12858292|12727968|12624854|12605446|12414879|12407707|12024004|11788646|11784876|11600516|11583302|11406605|11397863|11297617|11095461|11073544|11067869|11029463|10998448|10646121|10356155|10190480|9506752|9226216|8421479|8126161|8126048|7980957|7739708|7671486|6265935|5906056|3126297|3093862|2829196|2273209|2122458|2109828|1955519|1944469|1621772|1594625|1424186|1400888|1346061|1083395|0614538|431133|219790|198661	.	2778	GNAS	C5	EX5	G-protein alpha subunit	PF00503.15	coding-synon	NM_001077488.2	NP_001070956.1	+	Y	c.396C>T	p.(I132=) | p.(Ile132=)	ATC=>ATT	.	NM_001077488.2(GNAS): c.396C>T (p.(I132=))	;maf-5-some-pop,maf-5-all-pops	126388	0.551176	U	0.6716	0.644369	13006	0.579425	PASS	1705	8628	0.630158	18875	121380	0.547331	3636	11149	6.46469e-01	37660	133380	5.41623e-01	rs7121	.	4024	0.664000	-1.760	-1.518	-2.651	.	.	.	.	.	ENST00000371100: c.2322C>T (p.I774I)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3758661	.	.	.	.	.	no_record	197681	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
20	57478938	57478939	20q13.32	0	normal	.	G	ref	G	CA.GA	het-alt	166	0.48	.	1	.	PASS	139320	C	102200(MK);103580(MK);166350(MK);174800(MK);219080(MK);603233(MK);612462(MK);612463(MK)	AD	Pseudohypoparathyroidism, type IA; Pseudohypoparathyroidism, type IB; Pseudohypoparathyroidism, type IC; Progressive osseous heteroplasia; McCune-Albright syndrome	AD	.	Dermatologic; Endocrine; Musculoskeletal; Oncologic; Renal	Endocrine; Oncologic; Renal	22640971|21816789|21488135|21357941|20480732|19858129|18553568|18416659|18397987|17651445|17405850|16984995|16060910|15711092|15537666|15126527|15001590|14561710|14557424|13005676|12858292|12727968|12624854|12605446|12414879|12407707|12024004|11788646|11784876|11600516|11583302|11406605|11397863|11297617|11095461|11073544|11067869|11029463|10998448|10646121|10356155|10190480|9506752|9226216|8421479|8126161|8126048|7980957|7739708|7671486|6265935|5906056|3126297|3093862|2829196|2273209|2122458|2109828|1955519|1944469|1621772|1594625|1424186|1400888|1346061|1083395|0614538|431133|219790|198661	.	2778	GNAS	IC5	IVS5	.	.	no-change	NM_001077488.2	NP_001070956.1	+	Y	c.435+93G=	.	.	.	NM_001077488.2(GNAS): c.435+93G=	;maf-5-some-pop,maf-5-all-pops	5008	0.647364	U	0.247	0.352636	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3730168	.	4024	0.747000	-1.501	-0.702	-0.667	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	57478938	57478939	20q13.32	0	normal	.	G	snv	A	CA.GA	het-ref	178	0.52	.	2	.	PASS	139320	C	102200(MK);103580(MK);166350(MK);174800(MK);219080(MK);603233(MK);612462(MK);612463(MK)	AD	Pseudohypoparathyroidism, type IA; Pseudohypoparathyroidism, type IB; Pseudohypoparathyroidism, type IC; Progressive osseous heteroplasia; McCune-Albright syndrome	AD	.	Dermatologic; Endocrine; Musculoskeletal; Oncologic; Renal	Endocrine; Oncologic; Renal	22640971|21816789|21488135|21357941|20480732|19858129|18553568|18416659|18397987|17651445|17405850|16984995|16060910|15711092|15537666|15126527|15001590|14561710|14557424|13005676|12858292|12727968|12624854|12605446|12414879|12407707|12024004|11788646|11784876|11600516|11583302|11406605|11397863|11297617|11095461|11073544|11067869|11029463|10998448|10646121|10356155|10190480|9506752|9226216|8421479|8126161|8126048|7980957|7739708|7671486|6265935|5906056|3126297|3093862|2829196|2273209|2122458|2109828|1955519|1944469|1621772|1594625|1424186|1400888|1346061|1083395|0614538|431133|219790|198661	.	2778	GNAS	IC5	IVS5	.	.	intron	NM_001077488.2	NP_001070956.1	+	Y	c.435+93G>A	.	.	.	NM_001077488.2(GNAS): c.435+93G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.352636	U	0.247	0.352636	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs3730168	.	4024	0.253000	-1.501	-0.702	-0.667	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	57484876	57484877	20q13.32	0	normal	.	C	ref	C	GC.CA	het-alt	313	0.53	.	1	.	PASS	139320	C	102200(MK);103580(MK);166350(MK);174800(MK);219080(MK);603233(MK);612462(MK);612463(MK)	AD	Pseudohypoparathyroidism, type IA; Pseudohypoparathyroidism, type IB; Pseudohypoparathyroidism, type IC; Progressive osseous heteroplasia; McCune-Albright syndrome	AD	.	Dermatologic; Endocrine; Musculoskeletal; Oncologic; Renal	Endocrine; Oncologic; Renal	22640971|21816789|21488135|21357941|20480732|19858129|18553568|18416659|18397987|17651445|17405850|16984995|16060910|15711092|15537666|15126527|15001590|14561710|14557424|13005676|12858292|12727968|12624854|12605446|12414879|12407707|12024004|11788646|11784876|11600516|11583302|11406605|11397863|11297617|11095461|11073544|11067869|11029463|10998448|10646121|10356155|10190480|9506752|9226216|8421479|8126161|8126048|7980957|7739708|7671486|6265935|5906056|3126297|3093862|2829196|2273209|2122458|2109828|1955519|1944469|1621772|1594625|1424186|1400888|1346061|1083395|0614538|431133|219790|198661	.	2778	GNAS	IC10	IVS10	.	.	no-change	NM_001077488.2	NP_001070956.1	+	Y	c.842+18C=	.	.	.	NM_001077488.2(GNAS): c.842+18C=	;	125952	0.999746	U	0.002	0.000399361	.	.	PASS	-12	8624	0.997217	60442	120944	0.999752	.	.	.	.	.	.	rs182674093	.	4024	0.997500	0.460	-1.818	-1.790	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
20	57484876	57484877	20q13.32	1	normal	.	C	snv	T	GC.CA	het-ref	282	0.47	.	2	.	PASS	139320	C	102200(MK);103580(MK);166350(MK);174800(MK);219080(MK);603233(MK);612462(MK);612463(MK)	AD	Pseudohypoparathyroidism, type IA; Pseudohypoparathyroidism, type IB; Pseudohypoparathyroidism, type IC; Progressive osseous heteroplasia; McCune-Albright syndrome	AD	.	Dermatologic; Endocrine; Musculoskeletal; Oncologic; Renal	Endocrine; Oncologic; Renal	22640971|21816789|21488135|21357941|20480732|19858129|18553568|18416659|18397987|17651445|17405850|16984995|16060910|15711092|15537666|15126527|15001590|14561710|14557424|13005676|12858292|12727968|12624854|12605446|12414879|12407707|12024004|11788646|11784876|11600516|11583302|11406605|11397863|11297617|11095461|11073544|11067869|11029463|10998448|10646121|10356155|10190480|9506752|9226216|8421479|8126161|8126048|7980957|7739708|7671486|6265935|5906056|3126297|3093862|2829196|2273209|2122458|2109828|1955519|1944469|1621772|1594625|1424186|1400888|1346061|1083395|0614538|431133|219790|198661	.	2778	GNAS	IC10	IVS10	.	.	intron	NM_001077488.2	NP_001070956.1	+	Y	c.842+18C>T	.	.	.	NM_001077488.2(GNAS): c.842+18C>T	;	125952	0.000254	U	0.002	0.000399361	.	.	PASS	0	8624	0.002783	0	120944	0.000248	0	58	3.36427e-03	0	77	3.13983e-04	rs182674093	.	4024	0.002500	0.460	-1.818	-1.790	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
21	36206931	36206932	21q22.12	0	normal	.	G	snv	A	gg.gg	hom-alt	40	0.95	.	0	G-rich|Low_complexity|Low_complexity|+|39	PASS	151385	C	601399(MK);601626(MK)	NN	Platelet disorder, familial, with associated myeloid malignancy	AD	.	Hematologic; Oncologic	Hematologic; Oncologic	22571758|20846103|19387465|19357396|18478040|11830488|10508512	.	861	RUNX1	IC5	IVS6	.	.	intron	NM_001754.4	NP_001745.2	-	Y	c.614-34C>T	.	.	.	NM_001754.4(RUNX1): c.614-34C>T	MixedObserved;	124924	1.000000	U	1	1	.	.	PASS	4279	8558	1.000000	59958	119916	1.000000	8587	17174	1.00000e+00	120447	240894	1.00000e+00	rs11702841	.	3908	0.624900	-0.688	-0.908	-1.387	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	258186	criteria_provided,_single_submitter	Benign	Benign
21	36206931	36206932	21q22.12	0	nullSample	.	G	ref	G	gg.gg	homo-ref	.	.	.	0	G-rich|Low_complexity|Low_complexity|+|39	.	151385	C	601399(MK);601626(MK)	NN	Platelet disorder, familial, with associated myeloid malignancy	AD	.	Hematologic; Oncologic	Hematologic; Oncologic	22571758|20846103|19387465|19357396|18478040|11830488|10508512	.	861	RUNX1	IC5	IVS6	.	.	no-change	NM_001754.4	NP_001745.2	-	Y	c.614-34C=	.	.	.	NM_001754.4(RUNX1): c.614-34C=	MixedObserved;	124924	0.000000	U	1	1	.	.	PASS	0	8558	0.000000	0	119916	0.000000	.	.	.	.	.	.	rs11702841	.	3908	0.375100	-0.688	-0.908	-1.387	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	36265322	36265323	21q22.12	0	normal	.	C	ref	C	GA.TT	het-alt	121	0.86	.	1	.	PASS	151385	C	601399(MK);601626(MK)	NN	Platelet disorder, familial, with associated myeloid malignancy	AD	.	Hematologic; Oncologic	Hematologic; Oncologic	22571758|20846103|19387465|19357396|18478040|11830488|10508512	.	861	RUNX1	IC1	IVS2	.	.	no-change	NM_001754.4	NP_001745.2	-	Y	c.59-63G=	.	.	.	NM_001754.4(RUNX1): c.59-63G=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-1.047	-0.371	-0.233	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
21	36265323	36265323	21q22.12	0	normal	.	.	ins	T	AC.TT	het-ref	20	0.14	.	2	.	PASS	151385	C	601399(MK);601626(MK)	NN	Platelet disorder, familial, with associated myeloid malignancy	AD	.	Hematologic; Oncologic	Hematologic; Oncologic	22571758|20846103|19387465|19357396|18478040|11830488|10508512	.	861	RUNX1	IC1	IVS2	.	.	intron	NM_001754.4	NP_001745.2	-	Y	c.59-64_59-63insA	.	.	.	NM_001754.4(RUNX1): c.59-64_59-63insA	DuplicateObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs575175678	.	4024	0.036300	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
21	37507500	37507501	21q22.12	0	normal	.	G	ref	G	CT.CA	het-alt	217	0.52	.	1	.	PASS	603608	P	.	NN	.	.	.	.	.	.	.	874	CBR3	C1	EX1	.	.	no-change	NM_001236.3	NP_001227.1	+	Y	c.11G=	.	.	.	NM_001236.3(CBR3): c.11G=	;maf-5-some-pop,maf-5-all-pops	22718	0.481997	U	0.4335	0.366813	12112	0.627725	PASS	-239	1512	0.428571	979	17710	0.439243	.	.	.	.	.	.	rs8133052	.	4024	0.589700	0.655	0.732	0.375	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	37507500	37507501	21q22.12	1	normal	.	G	snv	A	CT.CA	het-ref	204	0.48	.	2	.	PASS	603608	P	.	NN	.	.	.	.	.	.	.	874	CBR3	C1	EX1	.	.	missense	NM_001236.3	NP_001227.1	+	Y	c.11G>A	p.C4Y | p.Cys4Tyr	TGC=>TAC	P0=>P0	NM_001236.3(CBR3): c.11G>A (p.C4Y)	;maf-5-some-pop,maf-5-all-pops	22718	0.518003	U	0.4335	0.366813	12112	0.372275	PASS	193	1512	0.571429	2055	17710	0.560757	989	4336	4.53177e-01	10473	47302	4.38209e-01	rs8133052	.	4024	0.410300	0.655	0.732	0.375	0.18	0.001	0	0.056	neutral	ENST00000290354: c.11G>A (p.C4Y)	breast [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	444425	CM102483	NM_001236.3(CBR3): c.11G>A (p.C4Y)	"Reduced catalytic efficiency, association with"	20007405	FP	.	.	.	.	Likely Benign
21	37518705	37518706	21q22.12	0	normal	.	G	ref	G	CT.TG	het-alt	236	0.52	.	1	.	PASS	603608	P	.	NN	.	.	.	.	.	.	.	874	CBR3	C3E	EX3E	.	.	no-change	NM_001236.3	NP_001227.1	+	Y	c.730G=	.	.	.	NM_001236.3(CBR3): c.730G=	;maf-5-some-pop,maf-5-all-pops	126324	0.623745	U	0.4048	0.427117	13006	0.601261	PASS	.	8632	0.581905	24091	121316	0.625845	.	.	.	.	.	.	rs1056892	.	4024	0.552200	0.655	1.339	0.567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	37518705	37518706	21q22.12	1	normal	.	G	snv	A	CT.TG	het-ref	219	0.48	.	2	.	PASS	603608	P	.	NN	.	.	.	.	.	.	.	874	CBR3	C3E	EX3E	.	.	missense	NM_001236.3	NP_001227.1	+	Y	c.730G>A	p.V244M | p.Val244Met	GTG=>ATG	NP=>NP	NM_001236.3(CBR3): c.730G>A (p.V244M)	;maf-5-some-pop,maf-5-all-pops	126324	0.376255	U	0.4048	0.427117	13006	0.398739	PASS	766	8632	0.418095	8824	121316	0.374155	1549	7212	4.18135e-01	17426	90325	3.66936e-01	rs1056892	.	4024	0.447800	0.655	1.339	0.567	0.09	0.239	0.62	0.321	neutral	ENST00000290354: c.730G>A (p.V244M)	bone [femur|NS|NS]	osteosarcoma [NS|NS|NS]	CSV	3758864	CM057648	NM_001236.3(CBR3): c.730G>A (p.V244M)	"Increased catalytic efficiency, association with"	15537833	FP	no_record	225941	reviewed_by_expert_panel	drug_response	Likely Benign
21	39755975	39755976	21q22.2	0	normal	.	T	snv	A	ca.cc	het-ref	110	0.50	.	2	LTR16A1|LTR|ERVL|+|434	PASS	165080	C	.	NN	.	.	.	.	.	.	.	2078	ERG	IC9	IVS11	.	.	intron	NM_001136154.1	NP_001129626.1	-	Y	c.941-131A>T	.	.	.	NM_001136154.1(ERG): c.941-131A>T	;maf-5-some-pop	5008	0.172724	U	0.1925	0.172724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12233325	.	4020	0.236800	0.482	-0.493	-0.470	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	39755975	39755976	21q22.2	0	normal	.	T	ref	T	ca.cc	het-alt	110	0.50	.	1	LTR16A1|LTR|ERVL|+|434	PASS	165080	C	.	NN	.	.	.	.	.	.	.	2078	ERG	IC9	IVS11	.	.	no-change	NM_001136154.1	NP_001129626.1	-	Y	c.941-131A=	.	.	.	NM_001136154.1(ERG): c.941-131A=	;maf-5-some-pop	5008	0.827276	U	0.1925	0.172724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs12233325	.	4020	0.763200	0.482	-0.493	-0.470	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	39764436	39764437	21q22.2	0	normal	.	T	ref	T	AT.TG	het-alt	104	0.49	.	1	.	PASS	165080	C	.	NN	.	.	.	.	.	.	.	2078	ERG	IC6	IVS8	.	.	no-change	NM_001136154.1	NP_001129626.1	-	Y	c.767-71A=	.	.	.	NM_001136154.1(ERG): c.767-71A=	;maf-5-some-pop	5008	0.750399	U	0.2629	0.249601	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2836360	.	4024	0.714500	-0.313	-0.805	-0.418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	39764436	39764437	21q22.2	0	normal	.	T	snv	C	AT.TG	het-ref	109	0.51	.	2	.	PASS	165080	C	.	NN	.	.	.	.	.	.	.	2078	ERG	IC6	IVS8	.	.	intron	NM_001136154.1	NP_001129626.1	-	Y	c.767-71A>G	.	.	.	NM_001136154.1(ERG): c.767-71A>G	;maf-5-some-pop	5008	0.249601	U	0.2629	0.249601	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2836360	.	4024	0.285500	-0.313	-0.805	-0.418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	39775372	39775373	21q22.2	0	normal	.	A	ref	A	TC.GG	het-alt	125	0.52	.	1	.	PASS	165080	C	.	NN	.	.	.	.	.	.	.	2078	ERG	IC4	IVS6	.	.	no-change	NM_001136154.1	NP_001129626.1	-	Y	c.613+55T=	.	.	.	NM_001136154.1(ERG): c.613+55T=	;maf-5-some-pop	5008	0.196885	U	0.8423	0.803115	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2836373	.	4024	0.169200	0.533	-0.714	-1.015	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	39775372	39775373	21q22.2	0	normal	.	A	snv	G	TC.GG	het-ref	114	0.48	.	2	.	PASS	165080	C	.	NN	.	.	.	.	.	.	.	2078	ERG	IC4	IVS6	.	.	intron	NM_001136154.1	NP_001129626.1	-	Y	c.613+55T>C	.	.	.	NM_001136154.1(ERG): c.613+55T>C	;maf-5-some-pop	5008	0.803115	U	0.8423	0.803115	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2836373	.	4024	0.830800	0.533	-0.714	-1.015	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	39870309	39870310	21q22.2	0	nullSample	.	G	ref	G	GC.AT	homo-ref	.	.	.	0	.	.	165080	C	.	NN	.	.	.	.	.	.	.	2078	ERG	IC1	IVS3	.	.	no-change	NM_001136154.1	NP_001129626.1	-	Y	c.40-52766C=	.	.	.	NM_001136154.1(ERG): c.40-52766C=	;maf-5-some-pop	126338	0.128457	U	0.8442	0.890775	13006	0.112487	PASS	-630	8652	0.181692	1184	121330	0.129251	.	.	.	.	.	.	rs2836441	.	.	.	-0.269	0.675	0.444	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	39870309	39870310	21q22.2	0	normal	.	G	snv	A	GC.AT	hom-alt	530	1.00	.	0	.	PASS	165080	C	.	NN	.	.	.	.	.	.	.	2078	ERG	IC1	IVS3	.	.	intron	NM_001136154.1	NP_001129626.1	-	Y	c.40-52766C>T	.	.	.	NM_001136154.1(ERG): c.40-52766C>T	;maf-5-some-pop	126338	0.871543	U	0.8442	0.890775	13006	0.887513	PASS	2910	8652	0.818308	46167	121330	0.870749	5677	13789	8.19506e-01	90513	208176	8.66310e-01	rs2836441	.	.	.	-0.269	0.675	0.444	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42838103	42838104	21q22.3	0	normal	.	G	ref	G	AA.TG	het-alt	203	0.52	.	1	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC13	IVS13	.	.	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.1579-24C=	.	.	.	NM_001135099.1(TMPRSS2): c.1579-24C=	MixedObserved;maf-5-some-pop|MixedObserved;	124000|0	0.992806|0	U	0.0903	0.01877	13006	0.999846	PASS	.	8480	0.910259	58744	118992	0.993294	.	.	.	.	.	.	rs118028230|rs780026542	.	4024	0.911300	-0.331	-1.310	-1.442	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42838103	42838104	21q22.3	0	normal	.	G	snv	C	AA.TG	het-ref	186	0.48	.	2	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC13	IVS13	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.1579-24C>G	.	.	.	NM_001135099.1(TMPRSS2): c.1579-24C>G	MixedObserved;maf-5-some-pop|MixedObserved;	124000|0	0.007194|0	U	0.0903	0.01877	13006	0.000154	PASS	45	8480	0.089741	46	118992	0.006706	80	1548	9.04206e-02	81	1628	6.70533e-03	rs118028230|rs780026542	.	4024	0.088700	-0.331	-1.310	-1.442	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42842712	42842713	21q22.3	0	nullSample	.	C	ref	C	CA.CT	homo-ref	.	.	.	0	.	.	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC10	IVS10	.	.	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.1187-43G=	.	.	.	NM_001135099.1(TMPRSS2): c.1187-43G=	.	.	.	.	0.6508	0.829872	.	.	PASS	.	7794	0.345009	1230	111426	0.088767	.	.	.	.	.	.	.	.	.	.	-0.373	-0.260	-0.562	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42842713	42842713	21q22.3	0	normal	.	.	ins	CTAAGGCCTCGGG	AC.CT	hom-alt	182	1.00	.	0	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC10	IVS10	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.1187-44_1187-43insCCCGAGGCCTTAG	.	.	.	NM_001135099.1(TMPRSS2): c.1187-44_1187-43insCCCGAGGCCTTAG	MixedObserved,ObservedTooLong;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	116434	0.872005	U	0.6508	0.829872	12438	0.927963	PASS	1625	7794	0.654991	47049	111426	0.911197	.	.	.	.	.	.	rs112132031	.	4024	0.675700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42843959	42843960	21q22.3	0	nullSample	.	A	ref	A	TC.GT	homo-ref	.	.	.	0	.	.	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC9	IVS9	.	.	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.1011-52T=	.	.	.	NM_001135099.1(TMPRSS2): c.1011-52T=	MixedObserved;maf-5-some-pop	117086	0.076311	U	0.6508	0.873802	7272	0.013201	PASS	.	8496	0.337453	1182	112078	0.074082	.	.	.	.	.	.	rs464431	.	4024	0.324100	-1.773	-3.142	-3.611	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42843959	42843960	21q22.3	0	normal	.	A	snv	G	TC.GT	hom-alt	292	1.00	.	0	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC9	IVS9	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.1011-52T>C	.	.	.	NM_001135099.1(TMPRSS2): c.1011-52T>C	MixedObserved;maf-5-some-pop	117086	0.923689	U	0.6508	0.873802	7272	0.986799	PASS	1849	8496	0.662547	48918	112078	0.925918	3120	9557	6.53962e-01	81182	172989	9.20115e-01	rs464431	.	4024	0.675900	-1.773	-3.142	-3.611	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42845373	42845374	21q22.3	0	nullSample	.	G	ref	G	TC.CC	homo-ref	.	.	.	0	.	.	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	C9	EX9	Trypsin	PF00089.21	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.888C=	.	.	.	NM_001135099.1(TMPRSS2): c.888C=	;maf-5-some-pop,maf-5-all-pops	108898	0.746726	U	0.249	0.209465	12920	0.793266	PASS	.	7476	0.711744	28747	103890	0.744614	.	.	.	.	.	.	rs2298659	.	4024	0.718400	-0.143	-3.999	-3.916	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42845373	42845374	21q22.3	1	normal	.	G	snv	A	TC.CC	hom-alt	492	1.00	.	0	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	C9	EX9	Trypsin	PF00089.21	coding-synon	NM_001135099.1	NP_001128571.1	-	Y	c.888C>T	p.(G296=) | p.(Gly296=)	GGC=>GGT	.	NM_001135099.1(TMPRSS2): c.888C>T (p.(G296=))	;maf-5-some-pop,maf-5-all-pops	108898	0.253274	U	0.249	0.209465	12920	0.206734	PASS	275	7476	0.288256	3334	103890	0.255386	580	4451	2.64060e-01	7106	56371	2.38727e-01	rs2298659	.	4024	0.281600	-0.143	-3.999	-3.916	.	.	.	.	.	ENST00000398585: c.888C>T (p.G296G)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1483963	.	.	.	.	.	.	.	.	.	Likely Benign
21	42845382	42845383	21q22.3	0	normal	.	A	ref	A	AC.AT	het-alt	236	0.50	.	1	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	C9	EX9	Trypsin	PF00089.21	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.879T=	.	.	.	NM_001135099.1(TMPRSS2): c.879T=	;maf-5-some-pop,maf-5-all-pops	112170	0.509156	U	0.121	0.366214	12924	0.506809	PASS	-486	7354	0.848790	13662	107162	0.503331	.	.	.	.	.	.	rs17854725	.	4024	0.846700	-0.755	-1.885	-1.236	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42845382	42845383	21q22.3	1	normal	.	A	snv	G	AC.AT	het-ref	239	0.50	.	2	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	C9	EX9	Trypsin	PF00089.21	coding-synon	NM_001135099.1	NP_001128571.1	-	Y	c.879T>C	p.(I293=) | p.(Ile293=)	ATT=>ATC	.	NM_001135099.1(TMPRSS2): c.879T>C (p.(I293=))	;maf-5-some-pop,maf-5-all-pops	112170	0.490844	U	0.121	0.366214	12924	0.493191	PASS	70	7354	0.151210	13305	107162	0.496669	141	2218	1.30871e-01	28152	112106	4.74230e-01	rs17854725	.	4024	0.153300	-0.755	-1.885	-1.236	.	.	.	.	.	ENST00000398585: c.879T>C (p.I293I)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1483964	.	.	.	.	.	.	.	.	.	Likely Benign
21	42848560	42848562	21q22.3	0	nullSample	.	AG	ref	AG	AC.GG	homo-ref	.	.	.	0	.	.	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC7	IVS7	.	.	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.795-15_795-14=	.	.	.	NM_001135099.1(TMPRSS2): c.795-15_795-14=	MixedObserved;maf-5-some-pop	125674	0.097793	U	.	.	12512	0.085438	.	.	.	.	.	.	.	.	.	.	.	.	.	rs140530035	.	4024	0.321600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42848560	42848562	21q22.3	1	normal	.	AG	del	.	AC.GG	hom-alt	344	1.00	.	0	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC7	IVS7	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.795-15_795-14delCT	.	.	.	NM_001135099.1(TMPRSS2): c.795-15_795-14delCT	MixedObserved;maf-5-some-pop	125674	0.902207	U	0.6548	0.813299	12512	0.914562	PASS	1897	8630	0.664542	50542	120666	0.905897	3851	11514	6.68253e-01	101843	221313	9.00290e-01	rs140530035	.	4024	0.678400	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42852496	42852497	21q22.3	0	nullSample	.	C	ref	C	CA.CT	homo-ref	.	.	.	0	.	.	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	C6	EX6	Scavenger receptor cysteine-rich domain;Scavenger receptor cysteine-rich domain	PF00530.13;PF15494.1	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.589G=	.	.	.	NM_001135099.1(TMPRSS2): c.589G=	;maf-5-some-pop,maf-5-all-pops	125450	0.749398	U	0.3621	0.261382	13006	0.758650	PASS	.	8620	0.617981	34231	120442	0.749846	.	.	.	.	.	.	rs12329760	.	4024	0.592900	0.561	2.119	2.392	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42852496	42852497	21q22.3	1	normal	.	C	snv	T	CA.CT	hom-alt	671	1.00	.	0	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	C6	EX6	Scavenger receptor cysteine-rich domain;Scavenger receptor cysteine-rich domain	PF00530.13;PF15494.1	missense	NM_001135099.1	NP_001128571.1	-	Y	c.589G>A	p.V197M | p.Val197Met	GTG=>ATG	NP=>NP	NM_001135099.1(TMPRSS2): c.589G>A (p.V197M)	;maf-5-some-pop,maf-5-all-pops	125450	0.250602	U	0.3621	0.261382	13006	0.241350	PASS	628	8620	0.382019	4139	120442	0.250154	1270	6580	3.81892e-01	8117	60284	2.45182e-01	rs12329760	.	4024	0.407100	0.561	2.119	2.392	0.01	0.96	0.997	0.808	deleterious	ENST00000332149: c.478G>A (p.V160M)	stomach [NS|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	VUO	149228	.	.	.	.	.	.	.	.	.	Likely Benign
21	42862072	42862073	21q22.3	0	normal	.	C	ref	C	gt.aa	het-alt	46	0.68	.	1	AluSx1|SINE|Alu|+|297	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC3	IVS3	.	.	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.350-553G=	.	.	.	NM_001135099.1(TMPRSS2): c.350-553G=	.	.	.	.	0.1528	0.203275	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.313	0.317	0.308	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42862073	42862073	21q22.3	0	normal	.	.	ins	AA	tc.aa	het-ref	22	0.32	.	2	AluSx1|SINE|Alu|+|297	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC3	IVS3	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.350-554_350-553insTT	.	.	.	NM_001135099.1(TMPRSS2): c.350-554_350-553insTT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.081000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42862134	42862135	21q22.3	0	normal	.	A	ref	A	GT.AA	het-alt	201	0.63	.	1	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC3	IVS3	.	.	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.350-615T=	.	.	.	NM_001135099.1(TMPRSS2): c.350-615T=	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs760337568	.	4024	0.506000	-2.409	-1.722	-1.832	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42862134	42862135	21q22.3	0	normal	.	A	del	.	GT.AA	het-ref	117	0.37	.	2	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC3	IVS3	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.350-615delT	.	.	.	NM_001135099.1(TMPRSS2): c.350-615delT	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs760337568	.	4024	0.494000	-2.409	-1.722	-1.832	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42862274	42862275	21q22.3	0	normal	.	T	ref	T	AA.GG	het-alt	328	0.52	.	1	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC3	IVS3	.	.	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.350-755A=	.	.	.	NM_001135099.1(TMPRSS2): c.350-755A=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.631390	U	0.2917	0.36861	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11911394	.	4024	0.677200	-0.462	-0.777	-0.864	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42862274	42862275	21q22.3	0	normal	.	T	snv	C	AA.GG	het-ref	300	0.48	.	2	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC3	IVS3	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.350-755A>G	.	.	.	NM_001135099.1(TMPRSS2): c.350-755A>G	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.368610	U	0.2917	0.36861	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11911394	.	4024	0.322800	-0.462	-0.777	-0.864	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42862530	42862531	21q22.3	0	normal	.	C	ref	C	AA.GA	het-alt	377	0.53	.	1	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC3	IVS3	.	.	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.350-1011G=	.	.	.	NM_001135099.1(TMPRSS2): c.350-1011G=	;maf-5-some-pop,maf-5-all-pops	5008	0.628395	U	0.2917	0.371605	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs928871	.	4024	0.677400	-1.726	-1.869	-1.864	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42862530	42862531	21q22.3	0	normal	.	C	snv	T	AA.GA	het-ref	338	0.47	.	2	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC3	IVS3	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.350-1011G>A	.	.	.	NM_001135099.1(TMPRSS2): c.350-1011G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.371605	U	0.2917	0.371605	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs928871	.	4024	0.322600	-1.726	-1.869	-1.864	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42862935	42862936	21q22.3	0	normal	.	A	ref	A	AT.CC	het-alt	308	0.50	.	1	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC3	IVS3	.	.	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.350-1416T=	.	.	.	NM_001135099.1(TMPRSS2): c.350-1416T=	;maf-5-some-pop,maf-5-all-pops	5008	0.630791	U	0.2917	0.369209	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6517669	.	4024	0.676400	-1.653	-1.545	-1.524	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42862935	42862936	21q22.3	0	normal	.	A	snv	G	AT.CC	het-ref	314	0.50	.	2	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC3	IVS3	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.350-1416T>C	.	.	.	NM_001135099.1(TMPRSS2): c.350-1416T>C	;maf-5-some-pop,maf-5-all-pops	5008	0.369209	U	0.2917	0.369209	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6517669	.	4024	0.323600	-1.653	-1.545	-1.524	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42863077	42863078	21q22.3	0	normal	.	A	ref	A	gc.tt	het-alt	16	0.52	.	1	MER5A|DNA|hAT-Charlie|-|101	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC3	IVS3	.	.	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.350-1558T=	.	.	.	NM_001135099.1(TMPRSS2): c.350-1558T=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.907	-0.786	-0.863	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
21	42863078	42863078	21q22.3	0	normal	.	.	ins	TTTTTTTTTTT	ca.tt	het-ref	15	0.48	.	2	MER5A|DNA|hAT-Charlie|-|101;AluJb|SINE|Alu|-|295	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC3	IVS3	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.350-1559_350-1558insAAAAAAAAAAA	.	.	.	NM_001135099.1(TMPRSS2): c.350-1559_350-1558insAAAAAAAAAAA	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.003000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
21	42863325	42863326	21q22.3	0	normal	.	A	ref	A	tc.gc	het-alt	160	0.50	.	1	AluJb|SINE|Alu|-|295	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC3	IVS3	.	.	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.350-1806T=	.	.	.	NM_001135099.1(TMPRSS2): c.350-1806T=	;maf-5-some-pop,maf-5-all-pops	5008	0.375399	U	0.5863	0.624601	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs417888	.	4024	0.404100	-0.818	-0.396	-0.448	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42863325	42863326	21q22.3	0	normal	.	A	snv	G	tc.gc	het-ref	163	0.50	.	2	AluJb|SINE|Alu|-|295	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC3	IVS3	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.350-1806T>C	.	.	.	NM_001135099.1(TMPRSS2): c.350-1806T>C	;maf-5-some-pop,maf-5-all-pops	5008	0.624601	U	0.5863	0.624601	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs417888	.	4024	0.595900	-0.818	-0.396	-0.448	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42863722	42863723	21q22.3	0	normal	.	T	ref	T	AC.TT	het-alt	323	0.53	.	1	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC3	IVS3	.	.	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.350-2203A=	.	.	.	NM_001135099.1(TMPRSS2): c.350-2203A=	;maf-5-some-pop,maf-5-all-pops	5008	0.701877	U	0.2778	0.298123	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10154090	.	4024	0.691800	-0.256	-1.163	-1.219	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42863722	42863723	21q22.3	0	normal	.	T	snv	A	AC.TT	het-ref	289	0.47	.	2	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC3	IVS3	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.350-2203A>T	.	.	.	NM_001135099.1(TMPRSS2): c.350-2203A>T	;maf-5-some-pop,maf-5-all-pops	5008	0.298123	U	0.2778	0.298123	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs10154090	.	4024	0.308200	-0.256	-1.163	-1.219	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42864691	42864692	21q22.3	0	normal	.	A	ref	A	GA.AT	het-alt	313	0.53	.	1	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC3	IVS3	.	.	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.349+1591T=	.	.	.	NM_001135099.1(TMPRSS2): c.349+1591T=	;maf-5-some-pop	5008	0.669129	U	0.2748	0.330871	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2838040	.	4024	0.689400	-0.415	-0.181	-0.200	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42864691	42864692	21q22.3	0	normal	.	A	snv	G	GA.AT	het-ref	273	0.47	.	2	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC3	IVS3	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.349+1591T>C	.	.	.	NM_001135099.1(TMPRSS2): c.349+1591T>C	;maf-5-some-pop	5008	0.330871	U	0.2748	0.330871	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2838040	.	4024	0.310600	-0.415	-0.181	-0.200	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42864742	42864743	21q22.3	0	normal	.	A	ref	A	CC.TC	het-alt	325	0.53	.	1	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC3	IVS3	.	.	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.349+1540T=	.	.	.	NM_001135099.1(TMPRSS2): c.349+1540T=	;maf-5-some-pop,maf-5-all-pops	5008	0.376597	U	0.5774	0.623403	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs430915	.	4024	0.407600	-0.642	-1.320	-1.318	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42864742	42864743	21q22.3	0	normal	.	A	snv	G	CC.TC	het-ref	288	0.47	.	2	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC3	IVS3	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.349+1540T>C	.	.	.	NM_001135099.1(TMPRSS2): c.349+1540T>C	;maf-5-some-pop,maf-5-all-pops	5008	0.623403	U	0.5774	0.623403	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs430915	.	4024	0.592400	-0.642	-1.320	-1.318	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42865046	42865047	21q22.3	0	normal	.	C	ref	C	ac.gc	het-alt	241	0.48	.	1	MER20|DNA|hAT-Charlie|-|209	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC3	IVS3	.	.	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.349+1236G=	.	.	.	NM_001135099.1(TMPRSS2): c.349+1236G=	;maf-5-some-pop	5008	0.155950	U	0.505	0.84405	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs386638	.	4024	0.511400	-0.817	-0.455	-0.519	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42865046	42865047	21q22.3	0	normal	.	C	snv	T	ac.gc	het-ref	260	0.52	.	2	MER20|DNA|hAT-Charlie|-|209	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC3	IVS3	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.349+1236G>A	.	.	.	NM_001135099.1(TMPRSS2): c.349+1236G>A	;maf-5-some-pop	5008	0.844050	U	0.505	0.84405	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs386638	.	4024	0.488600	-0.817	-0.455	-0.519	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42865323	42865324	21q22.3	0	normal	.	G	ref	G	CG.CA	het-alt	231	0.50	.	1	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC3	IVS3	.	.	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.349+959C=	.	.	.	NM_001135099.1(TMPRSS2): c.349+959C=	;maf-5-some-pop,maf-5-all-pops	5008	0.470847	U	0.25	0.529153	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7275220	.	4024	0.724400	-0.524	-0.105	-0.139	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42865323	42865324	21q22.3	0	normal	.	G	snv	A	CG.CA	het-ref	233	0.50	.	2	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC3	IVS3	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.349+959C>T	.	.	.	NM_001135099.1(TMPRSS2): c.349+959C>T	;maf-5-some-pop,maf-5-all-pops	5008	0.529153	U	0.25	0.529153	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs7275220	.	4024	0.275600	-0.524	-0.105	-0.139	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42866994	42866997	21q22.3	0	nullSample	.	AAA	ref	AAA	tc.aa	homo-ref	.	.	.	0	AluSc|SINE|Alu|+|309	.	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC2	IVS2	.	.	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.127-492_127-490=	.	.	.	NM_001135099.1(TMPRSS2): c.127-492_127-490=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.946100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42866994	42866997	21q22.3	0	normal	.	AAA	del	.	tc.aa	het-alt	39	0.30	.	1	AluSc|SINE|Alu|+|309	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC2	IVS2	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.127-492_127-490delTTT	.	.	.	NM_001135099.1(TMPRSS2): c.127-492_127-490delTTT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.027100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
21	42866994	42866997	21q22.3	0	normal	.	AAA	rep	A	tc.aa	het-alt	85	0.66	.	2	AluSc|SINE|Alu|+|309	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC2	IVS2	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.127-492T[3>1] (std: c.127-492T[1] alt: c.127-491_127-490delTT )	.	.	.	NM_001135099.1(TMPRSS2): c.127-492T[1]	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4024	0.026100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
21	42867553	42867554	21q22.3	0	normal	.	A	ref	A	tc.aa	het-alt	29	0.25	.	1	AluSq2|SINE|Alu|+|301	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC2	IVS2	.	.	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.127-1049T=	.	.	.	NM_001135099.1(TMPRSS2): c.127-1049T=	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11336247	.	4024	0.550000	0.260	0.281	0.263	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42867553	42867554	21q22.3	0	normal	.	A	del	.	tc.aa	het-ref	86	0.75	.	2	AluSq2|SINE|Alu|+|301	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC2	IVS2	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.127-1049delT	.	.	.	NM_001135099.1(TMPRSS2): c.127-1049delT	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11336247	.	4024	0.424500	0.260	0.281	0.263	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42867666	42867667	21q22.3	0	normal	.	T	ref	T	TG.TG	het-alt	246	0.52	.	1	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC2	IVS2	.	.	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.127-1162A=	.	.	.	NM_001135099.1(TMPRSS2): c.127-1162A=	;maf-5-some-pop	5008	0.906949	U	0.0595	0.0930511	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs58146697	.	4024	0.948100	0.334	-0.031	-0.076	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42867666	42867667	21q22.3	0	normal	.	T	snv	C	TG.TG	het-ref	227	0.48	.	2	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC2	IVS2	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.127-1162A>G	.	.	.	NM_001135099.1(TMPRSS2): c.127-1162A>G	;maf-5-some-pop	5008	0.093051	U	0.0595	0.0930511	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs58146697	.	4024	0.051900	0.334	-0.031	-0.076	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42867842	42867843	21q22.3	0	normal	.	A	ref	A	tt.aa	het-alt	72	0.18	.	1	AT_rich|Low_complexity|Low_complexity|+|23	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC2	IVS2	.	.	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.127-1338T=	.	.	.	NM_001135099.1(TMPRSS2): c.127-1338T=	MixedObserved;|MixedObserved;maf-5-some-pop,maf-5-all-pops	0|5008	0|0.725639	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs199934444|rs57901138	.	4024	0.586500	-1.984	-0.781	-0.896	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42867842	42867843	21q22.3	0	normal	.	A	del	.	tt.aa	het-ref	320	0.82	.	2	AT_rich|Low_complexity|Low_complexity|+|23	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC2	IVS2	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.127-1338delT	.	.	.	NM_001135099.1(TMPRSS2): c.127-1338delT	MixedObserved;|MixedObserved;maf-5-some-pop,maf-5-all-pops	0|5008	0|0.274361	U	0.3115	0.274361	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs199934444|rs57901138	.	4024	0.412800	-1.984	-0.781	-0.896	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42869062	42869063	21q22.3	0	nullSample	.	A	ref	A	cc.gc	homo-ref	.	.	.	0	AluSp|SINE|Alu|-|310	.	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC2	IVS2	.	.	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.126+983T=	.	.	.	NM_001135099.1(TMPRSS2): c.126+983T=	;maf-5-some-pop,maf-5-all-pops	5008	0.286142	U	0.7073	0.713858	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs415731	.	4024	0.312900	-2.335	-1.758	-1.835	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42869062	42869063	21q22.3	0	normal	.	A	snv	G	cc.gc	hom-alt	289	1.00	.	0	AluSp|SINE|Alu|-|310	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC2	IVS2	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.126+983T>C	.	.	.	NM_001135099.1(TMPRSS2): c.126+983T>C	;maf-5-some-pop,maf-5-all-pops	5008	0.713858	U	0.7073	0.713858	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs415731	.	4024	0.687100	-2.335	-1.758	-1.835	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42870992	42870993	21q22.3	0	nullSample	.	G	ref	G	AG.CC	homo-ref	.	.	.	0	.	.	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC1	IVS1	.	.	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.56-877C=	.	.	.	NM_001135099.1(TMPRSS2): c.56-877C=	;maf-5-some-pop,genotype-conflict	5008	0.775160	U	0.3175	0.22484	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs422761	.	4024	0.687600	0.563	0.043	0.050	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42870992	42870993	21q22.3	0	normal	.	G	snv	A	AG.CC	hom-alt	597	1.00	.	0	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC1	IVS1	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.56-877C>T	.	.	.	NM_001135099.1(TMPRSS2): c.56-877C>T	;maf-5-some-pop,genotype-conflict	5008	0.224840	U	0.3175	0.22484	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs422761	.	4024	0.312400	0.563	0.043	0.050	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42871130	42871131	21q22.3	0	nullSample	.	A	ref	A	AG.TT	homo-ref	.	.	.	0	.	.	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC1	IVS1	.	.	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.56-1015T=	.	.	.	NM_001135099.1(TMPRSS2): c.56-1015T=	;maf-5-some-pop	5008	0.774960	U	0.3175	0.22504	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs389001	.	4024	0.686100	0.533	-0.042	-0.062	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42871130	42871131	21q22.3	0	normal	.	A	snv	G	AG.TT	hom-alt	646	1.00	.	0	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC1	IVS1	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.56-1015T>C	.	.	.	NM_001135099.1(TMPRSS2): c.56-1015T>C	;maf-5-some-pop	5008	0.225040	U	0.3175	0.22504	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs389001	.	4024	0.313900	0.533	-0.042	-0.062	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42871940	42871941	21q22.3	0	nullSample	.	G	ref	G	TG.CC	homo-ref	.	.	.	0	.	.	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC1	IVS1	.	.	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.56-1825C=	.	.	.	NM_001135099.1(TMPRSS2): c.56-1825C=	;maf-5-some-pop,genotype-conflict	5008	0.140375	U	0.7401	0.859625	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs429524	.	4024	0.279300	-0.187	-0.383	-0.389	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42871940	42871941	21q22.3	0	normal	.	G	snv	C	TG.CC	hom-alt	541	1.00	.	0	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC1	IVS1	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.56-1825C>G	.	.	.	NM_001135099.1(TMPRSS2): c.56-1825C>G	;maf-5-some-pop,genotype-conflict	5008	0.859625	U	0.7401	0.859625	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs429524	.	4024	0.720700	-0.187	-0.383	-0.389	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42872896	42872897	21q22.3	0	nullSample	.	G	ref	G	CT.TC	homo-ref	.	.	.	0	.	.	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC1	IVS1	.	.	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.56-2781C=	.	.	.	NM_001135099.1(TMPRSS2): c.56-2781C=	;maf-5-some-pop	5008	0.188299	U	0.7401	0.811701	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs435877	.	4024	0.279300	-0.120	0.535	0.270	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42872896	42872897	21q22.3	0	normal	.	G	snv	C	CT.TC	hom-alt	507	1.00	.	0	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC1	IVS1	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.56-2781C>G	.	.	.	NM_001135099.1(TMPRSS2): c.56-2781C>G	;maf-5-some-pop	5008	0.811701	U	0.7401	0.811701	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs435877	.	4024	0.720700	-0.120	0.535	0.270	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42875403	42875404	21q22.3	0	nullSample	.	A	ref	A	ca.ta	homo-ref	.	.	.	0	MIR|SINE|MIR|+|101	.	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC1	IVS1	.	.	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.55+4473T=	.	.	.	NM_001135099.1(TMPRSS2): c.55+4473T=	;maf-5-some-pop	5008	0.775359	U	0.3313	0.224641	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs420737	.	4024	0.675400	-1.266	-2.249	-2.260	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42875403	42875404	21q22.3	0	normal	.	A	snv	G	ca.ta	hom-alt	669	1.00	.	0	MIR|SINE|MIR|+|101	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC1	IVS1	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.55+4473T>C	.	.	.	NM_001135099.1(TMPRSS2): c.55+4473T>C	;maf-5-some-pop	5008	0.224641	U	0.3313	0.224641	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs420737	.	4024	0.324600	-1.266	-2.249	-2.260	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42876446	42876447	21q22.3	0	nullSample	.	T	ref	T	CA.TG	homo-ref	.	.	.	0	.	.	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC1	IVS1	.	.	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.55+3430A=	.	.	.	NM_001135099.1(TMPRSS2): c.55+3430A=	;maf-5-some-pop	5008	0.775759	U	0.3313	0.224241	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs395584	.	4024	0.675700	-1.145	-0.350	-0.354	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42876446	42876447	21q22.3	0	normal	.	T	snv	C	CA.TG	hom-alt	657	1.00	.	0	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC1	IVS1	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.55+3430A>G	.	.	.	NM_001135099.1(TMPRSS2): c.55+3430A>G	;maf-5-some-pop	5008	0.224241	U	0.3313	0.224241	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs395584	.	4024	0.324300	-1.145	-0.350	-0.354	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42877541	42877542	21q22.3	0	nullSample	.	C	ref	C	CA.GG	homo-ref	.	.	.	0	.	.	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC1	IVS1	.	.	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.55+2335G=	.	.	.	NM_001135099.1(TMPRSS2): c.55+2335G=	;maf-5-some-pop,maf-5-all-pops	5008	0.285543	U	0.6528	0.714457	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs378616	.	4024	0.343200	0.511	-0.198	-0.197	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42877541	42877542	21q22.3	0	normal	.	C	snv	A	CA.GG	hom-alt	598	1.00	.	0	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC1	IVS1	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.55+2335G>T	.	.	.	NM_001135099.1(TMPRSS2): c.55+2335G>T	;maf-5-some-pop,maf-5-all-pops	5008	0.714457	U	0.6528	0.714457	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs378616	.	4024	0.656800	0.511	-0.198	-0.197	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42878611	42878612	21q22.3	0	normal	.	T	ref	T	CC.TC	het-alt	370	0.55	.	1	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC1	IVS1	.	.	no-change	NM_001135099.1	NP_001128571.1	-	Y	c.55+1265A=	.	.	.	NM_001135099.1(TMPRSS2): c.55+1265A=	;maf-5-some-pop	5008	0.944089	U	0.0675	0.0559105	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs75200570	.	4024	0.941400	-0.256	0.172	0.137	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
21	42878611	42878612	21q22.3	0	normal	.	T	snv	C	CC.TC	het-ref	301	0.45	.	2	.	PASS	602060	P	.	NN	.	.	.	.	.	.	.	7113	TMPRSS2	IC1	IVS1	.	.	intron	NM_001135099.1	NP_001128571.1	-	Y	c.55+1265A>G	.	.	.	NM_001135099.1(TMPRSS2): c.55+1265A>G	;maf-5-some-pop	5008	0.055911	U	0.0675	0.0559105	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs75200570	.	4024	0.058600	-0.256	0.172	0.137	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	22127164	22127165	22q11.21	0	normal	.	G	ref	G	TC.TC	het-alt	179	0.56	.	1	.	PASS	176948	C	.	NN	.	.	.	.	.	.	.	5594	MAPK1	C7	EX7	.	.	no-change	NM_002745.4	NP_002736.3	-	Y	c.963C=	.	.	.	NM_002745.4(MAPK1): c.963C=	;maf-5-some-pop	126380	0.998568	U	0.0159	0.00379393	13006	0.999923	PASS	.	8652	0.985321	60525	121372	0.998665	.	.	.	.	.	.	rs1803545	.	4024	0.991600	-0.982	0.137	-0.747	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	22127164	22127165	22q11.21	1	normal	.	G	snv	A	TC.TC	het-ref	140	0.44	.	2	.	PASS	176948	C	.	NN	.	.	.	.	.	.	.	5594	MAPK1	C7	EX7	.	.	coding-synon	NM_002745.4	NP_002736.3	-	Y	c.963C>T	p.(D321=) | p.(Asp321=)	GAC=>GAT	.	NM_002745.4(MAPK1): c.963C>T (p.(D321=))	;maf-5-some-pop	126380	0.001432	U	0.0159	0.00379393	13006	0.000077	PASS	1	8652	0.014679	1	121372	0.001335	1	262	1.51919e-02	1	330	1.34114e-03	rs1803545	.	4024	0.008400	-0.982	0.137	-0.747	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
22	23653879	23653880	22q11.23	0	nullSample	.	G	ref	G	CC.CA	homo-ref	.	.	.	0	dup	.	151410	C	608232(MK);613065(MK)	NN	CML treatment, response to	AD	.	General	Pharmacogenomic	17684099|14534339|12654249|11423618	.	613	BCR	IC18	IVS18	.	.	no-change	NM_004327.3	NP_004318.3	+	Y	c.3183-4G=	.	.	.	NM_004327.3(BCR): c.3183-4G=	;maf-5-some-pop,maf-5-all-pops	90034	0.578282	U	0.6339	0.459465	.	.	VQSRTrancheSNP99.60to99.80	-841	6074	0.403359	12866	85026	0.580505	.	.	.	.	.	.	rs180801	.	4024	0.575800	-1.515	-1.000	-0.835	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	23653879	23653880	22q11.23	1	normal	.	G	snv	A	CC.CA	hom-alt	232	0.90	.	0	dup	DUBIOUS	151410	C	608232(MK);613065(MK)	NN	CML treatment, response to	AD	.	General	Pharmacogenomic	17684099|14534339|12654249|11423618	.	613	BCR	IC18	IVS18	.	.	intron	NM_004327.3	NP_004318.3	+	Y	c.3183-4G>A	.	.	.	NM_004327.3(BCR): c.3183-4G>A	;maf-5-some-pop,maf-5-all-pops	90034	0.421718	U	0.6339	0.459465	.	.	VQSRTrancheSNP99.60to99.80	971	6074	0.596641	6021	85026	0.419495	2188	8401	5.62693e-01	14346	82994	3.81620e-01	rs180801	.	4024	0.424200	-1.515	-1.000	-0.835	.	.	.	.	.	ENST00000305877: c.3183-4G>A (p.?)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	4002111	.	.	.	.	.	.	.	.	.	Benign
22	24135967	24135968	22q11.23	0	normal	.	C	ref	C	CA.tt	het-alt	25	0.38	.	1	.	PASS	601607	C	162091(SK);609322(SK);614608(MK)	AD	Schwannomatosis; Rhabdoid tumor predisposition syndrome	AD	Allelic with Mental retardation, autosomal dominant 15 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	22426308|22038540|20930055|19582488|18285426|18072270|17357086|10521299|9737241|6091860|2543225	.	6598	SMARCB1	IC3	IVS3	.	.	no-change	NM_003073.3	NP_003064.2	+	Y	c.362+93C=	.	.	.	NM_003073.3(SMARCB1): c.362+93C=	.	.	.	.	0.4613	0.458666	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.449	-0.384	-0.384	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	24135968	24135968	22q11.23	0	normal	.	.	ins	T	AC.tt	het-ref	40	0.62	.	2	AluSx|SINE|Alu|-|167	PASS	601607	C	162091(SK);609322(SK);614608(MK)	AD	Schwannomatosis; Rhabdoid tumor predisposition syndrome	AD	Allelic with Mental retardation, autosomal dominant 15 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	22426308|22038540|20930055|19582488|18285426|18072270|17357086|10521299|9737241|6091860|2543225	.	6598	SMARCB1	IC3	IVS3	.	.	intron	NM_003073.3	NP_003064.2	+	Y	c.362+93_362+94insT	.	.	.	NM_003073.3(SMARCB1): c.362+93_362+94insT	InconsistentAlleles;maf-5-some-pop,maf-5-all-pops	5008	0.458666	U	0.4613	0.458666	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs11413092	.	4024	0.247500	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	24145394	24145395	22q11.23	0	nullSample	.	A	ref	A	GA.GC	homo-ref	.	.	.	0	.	.	601607	C	162091(SK);609322(SK);614608(MK)	AD	Schwannomatosis; Rhabdoid tumor predisposition syndrome	AD	Allelic with Mental retardation, autosomal dominant 15 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	22426308|22038540|20930055|19582488|18285426|18072270|17357086|10521299|9737241|6091860|2543225	.	6598	SMARCB1	IC4	IVS4	.	.	no-change	NM_003073.3	NP_003064.2	+	Y	c.501-87A=	.	.	.	NM_003073.3(SMARCB1): c.501-87A=	;maf-5-some-pop	5008	0.133187	U	0.7351	0.866813	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs5760030	.	4024	0.280100	-0.134	0.199	0.051	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	24145394	24145395	22q11.23	0	normal	.	A	snv	G	GA.GC	hom-alt	239	1.00	.	0	.	PASS	601607	C	162091(SK);609322(SK);614608(MK)	AD	Schwannomatosis; Rhabdoid tumor predisposition syndrome	AD	Allelic with Mental retardation, autosomal dominant 15 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	22426308|22038540|20930055|19582488|18285426|18072270|17357086|10521299|9737241|6091860|2543225	.	6598	SMARCB1	IC4	IVS4	.	.	intron	NM_003073.3	NP_003064.2	+	Y	c.501-87A>G	.	.	.	NM_003073.3(SMARCB1): c.501-87A>G	;maf-5-some-pop	5008	0.866813	U	0.7351	0.866813	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs5760030	.	4024	0.719900	-0.134	0.199	0.051	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	24145674	24145675	22q11.23	0	nullSample	.	G	ref	G	CC.TT	homo-ref	.	.	.	0	.	.	601607	C	162091(SK);609322(SK);614608(MK)	AD	Schwannomatosis; Rhabdoid tumor predisposition syndrome	AD	Allelic with Mental retardation, autosomal dominant 15 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	22426308|22038540|20930055|19582488|18285426|18072270|17357086|10521299|9737241|6091860|2543225	.	6598	SMARCB1	IC5	IVS5	.	.	no-change	NM_003073.3	NP_003064.2	+	Y	c.628+66G=	.	.	.	NM_003073.3(SMARCB1): c.628+66G=	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop	5008	0.133187	U	0.7351	0.866813	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs5751738	.	4024	0.280100	-0.132	-1.060	-0.906	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	24145674	24145675	22q11.23	0	normal	.	G	snv	C	CC.TT	hom-alt	357	1.00	.	0	.	PASS	601607	C	162091(SK);609322(SK);614608(MK)	AD	Schwannomatosis; Rhabdoid tumor predisposition syndrome	AD	Allelic with Mental retardation, autosomal dominant 15 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	22426308|22038540|20930055|19582488|18285426|18072270|17357086|10521299|9737241|6091860|2543225	.	6598	SMARCB1	IC5	IVS5	.	.	intron	NM_003073.3	NP_003064.2	+	Y	c.628+66G>C	.	.	.	NM_003073.3(SMARCB1): c.628+66G>C	SingleClassTriAllelic,InconsistentAlleles;maf-5-some-pop	5008	0.866813	U	0.7351	0.866813	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs5751738	.	4024	0.719900	-0.132	-1.060	-0.906	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	24158898	24158899	22q11.23	0	normal	.	C	ref	C	GC.GG	het-alt	148	0.52	.	1	.	PASS	601607	C	162091(SK);609322(SK);614608(MK)	AD	Schwannomatosis; Rhabdoid tumor predisposition syndrome	AD	Allelic with Mental retardation, autosomal dominant 15 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	22426308|22038540|20930055|19582488|18285426|18072270|17357086|10521299|9737241|6091860|2543225	.	6598	SMARCB1	IC5	IVS5	.	.	no-change	NM_003073.3	NP_003064.2	+	Y	c.629-58C=	.	.	.	NM_003073.3(SMARCB1): c.629-58C=	;maf-5-some-pop,maf-5-all-pops	5008	0.728634	U	0.3185	0.271366	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2070457	.	4024	0.706300	-1.521	-0.237	-0.222	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	24158898	24158899	22q11.23	0	normal	.	C	snv	A	GC.GG	het-ref	136	0.48	.	2	.	PASS	601607	C	162091(SK);609322(SK);614608(MK)	AD	Schwannomatosis; Rhabdoid tumor predisposition syndrome	AD	Allelic with Mental retardation, autosomal dominant 15 (AD); Coffin-Siris syndrome (AD)	Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Genitourinary	Oncologic	22426308|22038540|20930055|19582488|18285426|18072270|17357086|10521299|9737241|6091860|2543225	.	6598	SMARCB1	IC5	IVS5	.	.	intron	NM_003073.3	NP_003064.2	+	Y	c.629-58C>A	.	.	.	NM_003073.3(SMARCB1): c.629-58C>A	;maf-5-some-pop,maf-5-all-pops	5008	0.271366	U	0.3185	0.271366	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2070457	.	4024	0.293500	-1.521	-0.237	-0.222	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	29085059	29085060	22q12.1	0	normal	.	C	snv	T	AT.AT	het-ref	44	0.19	.	2	dup	DUBIOUS	604373	P	114480(SK);176807(SK);259500(MK);604373(SK);609265(MK)	AD;AR	Li-Fraumeni syndrome 2	AD/AR	.	Oncologic	Oncologic	22201027|22114986|22072393|22058428|22006311|21956126|21807500|21787115|18178638|17085682|16835864|16551709|16257342|15492928|15466005|15239132|15122511|15087378|12690581|12533788|12094328|11967536|11719428|11479205|10617473	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HPro6;MC58;MH43	11200	CHEK2	IC13	IVS14	.	.	intron	NM_007194.3	NP_009125.1	-	Y	c.1542+63G>A	.	.	.	NM_007194.3(CHEK2): c.1542+63G>A	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs78525381	.	4024	0.408300	0.508	-0.287	-0.349	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	29085059	29085060	22q12.1	0	normal	.	C	ref	C	AT.AT	het-alt	190	0.81	.	1	dup	DUBIOUS	604373	P	114480(SK);176807(SK);259500(MK);604373(SK);609265(MK)	AD;AR	Li-Fraumeni syndrome 2	AD/AR	.	Oncologic	Oncologic	22201027|22114986|22072393|22058428|22006311|21956126|21807500|21787115|18178638|17085682|16835864|16551709|16257342|15492928|15466005|15239132|15122511|15087378|12690581|12533788|12094328|11967536|11719428|11479205|10617473	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HPro6;MC58;MH43	11200	CHEK2	IC13	IVS14	.	.	no-change	NM_007194.3	NP_009125.1	-	Y	c.1542+63G=	.	.	.	NM_007194.3(CHEK2): c.1542+63G=	;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs78525381	.	4024	0.591700	0.508	-0.287	-0.349	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	29085256	29085257	22q12.1	0	normal	.	A	ref	A	CT.GA	het-alt	196	0.86	.	1	dup	DUBIOUS	604373	P	114480(SK);176807(SK);259500(MK);604373(SK);609265(MK)	AD;AR	Li-Fraumeni syndrome 2	AD/AR	.	Oncologic	Oncologic	22201027|22114986|22072393|22058428|22006311|21956126|21807500|21787115|18178638|17085682|16835864|16551709|16257342|15492928|15466005|15239132|15122511|15087378|12690581|12533788|12094328|11967536|11719428|11479205|10617473	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HPro6;MC58;MH43	11200	CHEK2	IC12	IVS13	.	.	no-change	NM_007194.3	NP_009125.1	-	Y	c.1462-54T=	.	.	.	NM_007194.3(CHEK2): c.1462-54T=	;	112786	0.999991	U	.	.	.	.	PASS	0	8228	1.000000	56392	112786	0.999991	.	.	.	.	.	.	rs375281470	.	4024	0.771900	0.477	0.538	0.368	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	29085256	29085257	22q12.1	0	normal	.	A	snv	G	CT.GA	het-ref	32	0.14	.	2	dup	DUBIOUS	604373	P	114480(SK);176807(SK);259500(MK);604373(SK);609265(MK)	AD;AR	Li-Fraumeni syndrome 2	AD/AR	.	Oncologic	Oncologic	22201027|22114986|22072393|22058428|22006311|21956126|21807500|21787115|18178638|17085682|16835864|16551709|16257342|15492928|15466005|15239132|15122511|15087378|12690581|12533788|12094328|11967536|11719428|11479205|10617473	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HPro6;MC58;MH43	11200	CHEK2	IC12	IVS13	.	.	intron	NM_007194.3	NP_009125.1	-	Y	c.1462-54T>C	.	.	.	NM_007194.3(CHEK2): c.1462-54T>C	;	112786	0.000009	U	.	.	.	.	PASS	0	8228	0.000000	0	112786	0.000009	0	0	0.00000e+00	0	1	4.36643e-06	rs375281470	.	4024	0.228100	0.477	0.538	0.368	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	29130346	29130347	22q12.1	0	nullSample	.	G	ref	G	GT.TT	homo-ref	.	.	.	0	.	.	604373	P	114480(SK);176807(SK);259500(MK);604373(SK);609265(MK)	AD;AR	Li-Fraumeni syndrome 2	AD/AR	.	Oncologic	Oncologic	22201027|22114986|22072393|22058428|22006311|21956126|21807500|21787115|18178638|17085682|16835864|16551709|16257342|15492928|15466005|15239132|15122511|15087378|12690581|12533788|12094328|11967536|11719428|11479205|10617473	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HPro6;MC58;MH43	11200	CHEK2	IC1	IVS2	.	.	no-change	NM_007194.3	NP_009125.1	-	Y	c.319+44C=	.	.	.	NM_007194.3(CHEK2): c.319+44C=	.	.	.	.	0.4067	0.230431	.	.	PASS	.	8040	0.594154	35872	114684	0.786047	.	.	.	.	.	.	.	.	.	.	0.655	-0.092	0.073	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	29130347	29130347	22q12.1	0	normal	.	.	ins	T	TG.TT	hom-alt	304	1.00	.	0	.	PASS	604373	P	114480(SK);176807(SK);259500(MK);604373(SK);609265(MK)	AD;AR	Li-Fraumeni syndrome 2	AD/AR	.	Oncologic	Oncologic	22201027|22114986|22072393|22058428|22006311|21956126|21807500|21787115|18178638|17085682|16835864|16551709|16257342|15492928|15466005|15239132|15122511|15087378|12690581|12533788|12094328|11967536|11719428|11479205|10617473	FC59;FH44;H41;H54;H62;H68;HB23;HBO28;HC22;HD31;HD32;HPro6;MC58;MH43	11200	CHEK2	IC1	IVS2	.	.	intron	NM_007194.3	NP_009125.1	-	Y	c.319+43_319+44insA	.	.	.	NM_007194.3(CHEK2): c.319+43_319+44insA	;maf-5-some-pop,maf-5-all-pops	119692	0.214643	U	0.4067	0.230431	12510	0.142366	PASS	647	8040	0.405846	3067	114684	0.213953	1365	6812	4.04081e-01	7050	53469	2.23184e-01	rs3841692	.	4024	0.412000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	30034993	30034994	22q12.2	0	normal	.	G	ref	G	AT.CA	het-alt	161	0.49	.	1	.	PASS	607379	C	101000(MK);162091(MK);607174(MK)	AD	Neurofibromatosis type II	AD	.	Oncologic	Oncologic	23939548|23931824|23921933|23682341|22989157|22931905|22929112|22098617|21451418|21358190|20301380|19880713|19476995|16983642|16534111|16521120|16341811|15994874|15831594|15235024|15190457|12566519|12473765|12235555|12136076|12011146|11425952|11342693|11159946|10771486|10569966|10220142|9874852|9863591|9817927|9811917|9643284|9399891|8755919|8751853|8379998|8188242|7913580|7747758|5304294|4990044|1479599|1479598	H62;H68	4771	NF2	IC2	IVS2	.	.	no-change	NM_000268.3	NP_000259.1	+	Y	c.241-85G=	.	.	.	NM_000268.3(NF2): c.241-85G=	;maf-5-some-pop,maf-5-all-pops	5008	0.665935	U	0.2123	0.334065	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs5763378	.	4024	0.806200	-0.150	-0.762	-0.849	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	30034993	30034994	22q12.2	0	normal	.	G	ref	G	AT.CA	het-alt	161	0.49	.	1	.	PASS	607379	C	101000(MK);162091(MK);607174(MK)	AD	Neurofibromatosis type II	AD	.	Oncologic	Oncologic	23939548|23931824|23921933|23682341|22989157|22931905|22929112|22098617|21451418|21358190|20301380|19880713|19476995|16983642|16534111|16521120|16341811|15994874|15831594|15235024|15190457|12566519|12473765|12235555|12136076|12011146|11425952|11342693|11159946|10771486|10569966|10220142|9874852|9863591|9817927|9811917|9643284|9399891|8755919|8751853|8379998|8188242|7913580|7747758|5304294|4990044|1479599|1479598	H62;H68	4771	NF2	IC2	IVS2	.	.	no-change	NM_016418.5	NP_057502.2	+	N	c.241-85G=	.	.	.	NM_016418.5(NF2): c.241-85G=	;maf-5-some-pop,maf-5-all-pops	5008	0.665935	U	0.2123	0.334065	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs5763378	.	4024	0.806200	-0.150	-0.762	-0.849	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	30034993	30034994	22q12.2	0	normal	.	G	snv	T	AT.CA	het-ref	168	0.51	.	2	.	PASS	607379	C	101000(MK);162091(MK);607174(MK)	AD	Neurofibromatosis type II	AD	.	Oncologic	Oncologic	23939548|23931824|23921933|23682341|22989157|22931905|22929112|22098617|21451418|21358190|20301380|19880713|19476995|16983642|16534111|16521120|16341811|15994874|15831594|15235024|15190457|12566519|12473765|12235555|12136076|12011146|11425952|11342693|11159946|10771486|10569966|10220142|9874852|9863591|9817927|9811917|9643284|9399891|8755919|8751853|8379998|8188242|7913580|7747758|5304294|4990044|1479599|1479598	H62;H68	4771	NF2	IC2	IVS2	.	.	intron	NM_000268.3	NP_000259.1	+	Y	c.241-85G>T	.	.	.	NM_000268.3(NF2): c.241-85G>T	;maf-5-some-pop,maf-5-all-pops	5008	0.334065	U	0.2123	0.334065	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs5763378	.	4024	0.193800	-0.150	-0.762	-0.849	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	30034993	30034994	22q12.2	0	normal	.	G	snv	T	AT.CA	het-ref	168	0.51	.	2	.	PASS	607379	C	101000(MK);162091(MK);607174(MK)	AD	Neurofibromatosis type II	AD	.	Oncologic	Oncologic	23939548|23931824|23921933|23682341|22989157|22931905|22929112|22098617|21451418|21358190|20301380|19880713|19476995|16983642|16534111|16521120|16341811|15994874|15831594|15235024|15190457|12566519|12473765|12235555|12136076|12011146|11425952|11342693|11159946|10771486|10569966|10220142|9874852|9863591|9817927|9811917|9643284|9399891|8755919|8751853|8379998|8188242|7913580|7747758|5304294|4990044|1479599|1479598	H62;H68	4771	NF2	IC2	IVS2	.	.	intron	NM_016418.5	NP_057502.2	+	N	c.241-85G>T	.	.	.	NM_016418.5(NF2): c.241-85G>T	;maf-5-some-pop,maf-5-all-pops	5008	0.334065	U	0.2123	0.334065	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs5763378	.	4024	0.193800	-0.150	-0.762	-0.849	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	30051705	30051708	22q12.2	0	normal	.	TTT	ref	TTT	GC.TT	het-alt	117	0.81	.	1	.	PASS	607379	C	101000(MK);162091(MK);607174(MK)	AD	Neurofibromatosis type II	AD	.	Oncologic	Oncologic	23939548|23931824|23921933|23682341|22989157|22931905|22929112|22098617|21451418|21358190|20301380|19880713|19476995|16983642|16534111|16521120|16341811|15994874|15831594|15235024|15190457|12566519|12473765|12235555|12136076|12011146|11425952|11342693|11159946|10771486|10569966|10220142|9874852|9863591|9817927|9811917|9643284|9399891|8755919|8751853|8379998|8188242|7913580|7747758|5304294|4990044|1479599|1479598	H62;H68	4771	NF2	IC6	IVS6	.	.	no-change	NM_000268.3	NP_000259.1	+	Y	c.599+41_599+43=	.	.	.	NM_000268.3(NF2): c.599+41_599+43=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs771697548	.	4024	0.987100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	30051705	30051708	22q12.2	0	normal	.	TTT	ref	TTT	GC.TT	het-alt	117	0.81	.	1	.	PASS	607379	C	101000(MK);162091(MK);607174(MK)	AD	Neurofibromatosis type II	AD	.	Oncologic	Oncologic	23939548|23931824|23921933|23682341|22989157|22931905|22929112|22098617|21451418|21358190|20301380|19880713|19476995|16983642|16534111|16521120|16341811|15994874|15831594|15235024|15190457|12566519|12473765|12235555|12136076|12011146|11425952|11342693|11159946|10771486|10569966|10220142|9874852|9863591|9817927|9811917|9643284|9399891|8755919|8751853|8379998|8188242|7913580|7747758|5304294|4990044|1479599|1479598	H62;H68	4771	NF2	IC6	IVS6	.	.	no-change	NM_016418.5	NP_057502.2	+	N	c.599+41_599+43=	.	.	.	NM_016418.5(NF2): c.599+41_599+43=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs771697548	.	4024	0.987100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	30051705	30051708	22q12.2	0	normal	.	TTT	del	.	GC.TT	het-ref	27	0.19	.	2	.	PASS	607379	C	101000(MK);162091(MK);607174(MK)	AD	Neurofibromatosis type II	AD	.	Oncologic	Oncologic	23939548|23931824|23921933|23682341|22989157|22931905|22929112|22098617|21451418|21358190|20301380|19880713|19476995|16983642|16534111|16521120|16341811|15994874|15831594|15235024|15190457|12566519|12473765|12235555|12136076|12011146|11425952|11342693|11159946|10771486|10569966|10220142|9874852|9863591|9817927|9811917|9643284|9399891|8755919|8751853|8379998|8188242|7913580|7747758|5304294|4990044|1479599|1479598	H62;H68	4771	NF2	IC6	IVS6	.	.	intron	NM_000268.3	NP_000259.1	+	Y	c.599+41_599+43delTTT	.	.	.	NM_000268.3(NF2): c.599+41_599+43delTTT	MixedObserved;	0	0	U	.	.	.	.	PASS	0	5470	0.032907	0	79146	0.033950	.	.	.	.	.	.	rs771697548	.	4024	0.012700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
22	30051705	30051708	22q12.2	0	normal	.	TTT	del	.	GC.TT	het-ref	27	0.19	.	2	.	PASS	607379	C	101000(MK);162091(MK);607174(MK)	AD	Neurofibromatosis type II	AD	.	Oncologic	Oncologic	23939548|23931824|23921933|23682341|22989157|22931905|22929112|22098617|21451418|21358190|20301380|19880713|19476995|16983642|16534111|16521120|16341811|15994874|15831594|15235024|15190457|12566519|12473765|12235555|12136076|12011146|11425952|11342693|11159946|10771486|10569966|10220142|9874852|9863591|9817927|9811917|9643284|9399891|8755919|8751853|8379998|8188242|7913580|7747758|5304294|4990044|1479599|1479598	H62;H68	4771	NF2	IC6	IVS6	.	.	intron	NM_016418.5	NP_057502.2	+	N	c.599+41_599+43delTTT	.	.	.	NM_016418.5(NF2): c.599+41_599+43delTTT	MixedObserved;	0	0	U	.	.	.	.	PASS	0	5470	0.032907	0	79146	0.033950	.	.	.	.	.	.	rs771697548	.	4024	0.012700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
22	30077360	30077361	22q12.2	0	normal	.	G	snv	A	CC.CA	hom-alt	232	1.00	.	0	.	PASS	607379	C	101000(MK);162091(MK);607174(MK)	AD	Neurofibromatosis type II	AD	.	Oncologic	Oncologic	23939548|23931824|23921933|23682341|22989157|22931905|22929112|22098617|21451418|21358190|20301380|19880713|19476995|16983642|16534111|16521120|16341811|15994874|15831594|15235024|15190457|12566519|12473765|12235555|12136076|12011146|11425952|11342693|11159946|10771486|10569966|10220142|9874852|9863591|9817927|9811917|9643284|9399891|8755919|8751853|8379998|8188242|7913580|7747758|5304294|4990044|1479599|1479598	H62;H68	4771	NF2	IC14	IVS14	.	.	intron	NM_000268.3	NP_000259.1	+	Y	c.1575-67G>A	.	.	.	NM_000268.3(NF2): c.1575-67G>A	;	5008	1.000000	U	1	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs140086	.	4024	0.998500	-0.254	0.001	-0.013	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	30077360	30077361	22q12.2	0	normal	.	G	snv	A	CC.CA	hom-alt	232	1.00	.	0	.	PASS	607379	C	101000(MK);162091(MK);607174(MK)	AD	Neurofibromatosis type II	AD	.	Oncologic	Oncologic	23939548|23931824|23921933|23682341|22989157|22931905|22929112|22098617|21451418|21358190|20301380|19880713|19476995|16983642|16534111|16521120|16341811|15994874|15831594|15235024|15190457|12566519|12473765|12235555|12136076|12011146|11425952|11342693|11159946|10771486|10569966|10220142|9874852|9863591|9817927|9811917|9643284|9399891|8755919|8751853|8379998|8188242|7913580|7747758|5304294|4990044|1479599|1479598	H62;H68	4771	NF2	IC14	IVS14	.	.	intron	NM_016418.5	NP_057502.2	+	N	c.1575-67G>A	.	.	.	NM_016418.5(NF2): c.1575-67G>A	;	5008	1.000000	U	1	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs140086	.	4024	0.998500	-0.254	0.001	-0.013	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	30077360	30077361	22q12.2	0	nullSample	.	G	ref	G	CC.CA	homo-ref	.	.	.	0	.	.	607379	C	101000(MK);162091(MK);607174(MK)	AD	Neurofibromatosis type II	AD	.	Oncologic	Oncologic	23939548|23931824|23921933|23682341|22989157|22931905|22929112|22098617|21451418|21358190|20301380|19880713|19476995|16983642|16534111|16521120|16341811|15994874|15831594|15235024|15190457|12566519|12473765|12235555|12136076|12011146|11425952|11342693|11159946|10771486|10569966|10220142|9874852|9863591|9817927|9811917|9643284|9399891|8755919|8751853|8379998|8188242|7913580|7747758|5304294|4990044|1479599|1479598	H62;H68	4771	NF2	IC14	IVS14	.	.	no-change	NM_000268.3	NP_000259.1	+	Y	c.1575-67G=	.	.	.	NM_000268.3(NF2): c.1575-67G=	;	5008	0.000000	U	1	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs140086	.	4024	0.001500	-0.254	0.001	-0.013	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	30077360	30077361	22q12.2	0	nullSample	.	G	ref	G	CC.CA	homo-ref	.	.	.	0	.	.	607379	C	101000(MK);162091(MK);607174(MK)	AD	Neurofibromatosis type II	AD	.	Oncologic	Oncologic	23939548|23931824|23921933|23682341|22989157|22931905|22929112|22098617|21451418|21358190|20301380|19880713|19476995|16983642|16534111|16521120|16341811|15994874|15831594|15235024|15190457|12566519|12473765|12235555|12136076|12011146|11425952|11342693|11159946|10771486|10569966|10220142|9874852|9863591|9817927|9811917|9643284|9399891|8755919|8751853|8379998|8188242|7913580|7747758|5304294|4990044|1479599|1479598	H62;H68	4771	NF2	IC14	IVS14	.	.	no-change	NM_016418.5	NP_057502.2	+	N	c.1575-67G=	.	.	.	NM_016418.5(NF2): c.1575-67G=	;	5008	0.000000	U	1	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs140086	.	4024	0.001500	-0.254	0.001	-0.013	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	37256845	37256846	22q12.3	0	normal	.	G	ref	G	TG.CT	het-alt	241	0.53	.	1	.	PASS	601488	P	613960(MK)	NN	Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	22876374|22157170|19692703	.	4689	NCF4	PROM	.	.	.	no-change	NM_013416.3	NP_038202.2	+	Y	c.-184-u184G=	.	.	.	NM_013416.3(NCF4): c.-184-u184G=	;maf-5-some-pop,maf-5-all-pops	5008	0.586062	U	0.6657	0.413938	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1883112	.	.	.	0.563	0.536	0.519	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	37256845	37256846	22q12.3	0	normal	.	G	snv	A	TG.CT	het-ref	212	0.47	.	2	.	PASS	601488	P	613960(MK)	NN	Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III	AR	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	22876374|22157170|19692703	.	4689	NCF4	PROM	.	.	.	promoter	NM_013416.3	NP_038202.2	+	Y	c.-184-u184G>A	.	.	.	NM_013416.3(NCF4): c.-184-u184G>A	;maf-5-some-pop,maf-5-all-pops	5008	0.413938	U	0.6657	0.413938	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1883112	.	.	.	0.563	0.536	0.519	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	39387557	39387558	22q13.1	0	normal	.	C	ref	C	TA.GA	het-alt	465	0.70	.	1	dup	PASS	607110	P	.	NN	.	.	.	.	.	.	.	9582	APOBEC3B	C6	EX6	.	.	no-change	NM_004900.4	NP_004891.4	+	Y	c.945C=	.	.	.	NM_004900.4(APOBEC3B): c.945C=	SingleClassQuadAllelic;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	117514	0.527112	U	.	.	12964	0.516353	InbreedingCoeff_Filter	.	7552	0.495101	12823	117514	0.527112	.	.	.	.	.	.	rs1065184	.	3554	0.529000	0.407	-0.761	-1.013	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	39387557	39387558	22q13.1	1	normal	.	C	snv	T	TA.GA	het-ref	197	0.30	.	2	dup	PASS	607110	P	.	NN	.	.	.	.	.	.	.	9582	APOBEC3B	C6	EX6	.	.	coding-synon	NM_004900.4	NP_004891.4	+	Y	c.945C>T	p.(Y315=) | p.(Tyr315=)	TAC=>TAT	.	NM_004900.4(APOBEC3B): c.945C>T (p.(Y315=))	SingleClassQuadAllelic;maf-5-some-pop,rs-cluster-nonoverlapping-alleles	117514	0.472871	U	.	.	12964	0.483647	InbreedingCoeff_Filter	643	7552	0.504899	9636	117514	0.472871	1635	7866	5.24470e-01	20885	112260	4.72193e-01	rs1065184	.	3554	0.471000	0.407	-0.761	-1.013	.	.	.	.	.	ENST00000333467: c.945C>T (p.Y315Y)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3759194	.	.	.	.	.	.	.	.	.	Likely Benign
22	40816748	40816749	22q13.1	0	normal	.	G	ref	G	CG.GT	het-alt	129	0.51	.	1	.	PASS	606078	P	606078(MK)	NN	.	.	.	.	.	.	.	57591	MKL1	IC7	IVS10	.	.	no-change	NM_020831.3	NP_065882.1	-	Y	c.881+102C=	.	.	.	NM_020831.3(MKL1): c.881+102C=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.592652	U	0.1022	0.407348	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2072856	.	4024	0.880200	-0.500	-0.099	-0.705	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	40816748	40816749	22q13.1	0	normal	.	G	snv	A	CG.GT	het-ref	126	0.49	.	2	.	PASS	606078	P	606078(MK)	NN	.	.	.	.	.	.	.	57591	MKL1	IC7	IVS10	.	.	intron	NM_020831.3	NP_065882.1	-	Y	c.881+102C>T	.	.	.	NM_020831.3(MKL1): c.881+102C>T	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	5008	0.407348	U	0.1022	0.407348	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2072856	.	4024	0.119800	-0.500	-0.099	-0.705	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	41523771	41523772	22q13.2	0	normal	.	T	ref	T	GT.AC	het-alt	247	0.48	.	1	.	PASS	602700	P	114500(MK);613684(MK)	AD	Rubinstein-Taybi syndrome 2	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	21376300|20717166|20301699|20014264|19353645|17299436|17220215|15706485	.	2033	EP300	IC4	IVS4	.	.	no-change	NM_001429.3	NP_001420.2	+	Y	c.1168+20T=	.	.	.	NM_001429.3(EP300): c.1168+20T=	;	125604	0.997906	U	0.0169	0.00379393	13006	0.999769	PASS	-98	8614	0.976085	60059	120596	0.997977	.	.	.	.	.	.	rs3818121	.	4024	0.971400	0.455	-0.222	-0.084	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	41523771	41523772	22q13.2	0	normal	.	T	snv	C	GT.AC	het-ref	270	0.52	.	2	.	PASS	602700	P	114500(MK);613684(MK)	AD	Rubinstein-Taybi syndrome 2	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	21376300|20717166|20301699|20014264|19353645|17299436|17220215|15706485	.	2033	EP300	IC4	IVS4	.	.	intron	NM_001429.3	NP_001420.2	+	Y	c.1168+20T>C	.	.	.	NM_001429.3(EP300): c.1168+20T>C	;	125604	0.002094	U	0.0169	0.00379393	13006	0.000231	PASS	5	8614	0.023915	5	120596	0.002023	6	367	2.12926e-02	6	432	1.76806e-03	rs3818121	.	4024	0.028600	0.455	-0.222	-0.084	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
22	41537233	41537234	22q13.2	0	nullSample	.	G	ref	G	TG.TT	homo-ref	.	.	.	0	.	.	602700	P	114500(MK);613684(MK)	AD	Rubinstein-Taybi syndrome 2	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	21376300|20717166|20301699|20014264|19353645|17299436|17220215|15706485	.	2033	EP300	IC10	IVS10	.	.	no-change	NM_001429.3	NP_001420.2	+	Y	c.2053+8G=	.	.	.	NM_001429.3(EP300): c.2053+8G=	MixedObserved;maf-5-some-pop	126402	0.011914	U	1	0.961661	.	.	PASS	.	8654	0.000116	81	121394	0.010824	.	.	.	.	.	.	rs6002267	.	4024	0.002200	-1.382	-0.271	-0.259	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	41537233	41537234	22q13.2	1	normal	.	G	snv	T	TG.TT	hom-alt	503	1.00	.	0	.	PASS	602700	P	114500(MK);613684(MK)	AD	Rubinstein-Taybi syndrome 2	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	21376300|20717166|20301699|20014264|19353645|17299436|17220215|15706485	.	2033	EP300	IC10	IVS10	.	.	intron	NM_001429.3	NP_001420.2	+	Y	c.2053+8G>T	.	.	.	NM_001429.3(EP300): c.2053+8G>T	MixedObserved;maf-5-some-pop	126402	0.988086	U	1	0.961661	.	.	PASS	4326	8654	0.999884	59464	121394	0.989176	8622	17246	9.99884e-01	121094	244017	9.91641e-01	rs6002267	.	4024	0.997800	-1.382	-0.271	-0.259	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	93732	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
22	41545023	41545024	22q13.2	0	normal	.	G	ref	G	GT.TT	het-alt	126	0.78	.	1	.	PASS	602700	P	114500(MK);613684(MK)	AD	Rubinstein-Taybi syndrome 2	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	21376300|20717166|20301699|20014264|19353645|17299436|17220215|15706485	.	2033	EP300	IC12	IVS12	.	.	no-change	NM_001429.3	NP_001420.2	+	Y	c.2242-18G=	.	.	.	NM_001429.3(EP300): c.2242-18G=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.655	0.057	0.157	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
22	41545024	41545024	22q13.2	1	normal	.	.	ins	T	TG.TT	het-ref	35	0.22	.	2	.	PASS	602700	P	114500(MK);613684(MK)	AD	Rubinstein-Taybi syndrome 2	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	21376300|20717166|20301699|20014264|19353645|17299436|17220215|15706485	.	2033	EP300	IC12	IVS12	.	.	intron	NM_001429.3	NP_001420.2	+	Y	c.2242-18_2242-17insT	.	.	.	NM_001429.3(EP300): c.2242-18_2242-17insT	.	.	.	.	.	.	.	.	PASS	0	6344	0.270334	1	94006	0.251058	.	.	.	.	.	.	.	.	4024	0.398100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	41550953	41550954	22q13.2	0	nullSample	.	C	ref	C	TT.TG	homo-ref	.	.	.	0	.	.	602700	P	114500(MK);613684(MK)	AD	Rubinstein-Taybi syndrome 2	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	21376300|20717166|20301699|20014264|19353645|17299436|17220215|15706485	.	2033	EP300	IC16	IVS16	.	.	no-change	NM_001429.3	NP_001420.2	+	Y	c.3143-45C=	.	.	.	NM_001429.3(EP300): c.3143-45C=	;maf-5-some-pop,maf-5-all-pops	124180	0.340957	U	0.8175	0.673123	13004	0.417179	PASS	.	8246	0.191729	7515	119172	0.341548	.	.	.	.	.	.	rs4822011	.	4024	0.189100	-1.322	-0.168	-0.396	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	41550953	41550954	22q13.2	0	normal	.	C	snv	T	TT.TG	hom-alt	215	1.00	.	0	.	PASS	602700	P	114500(MK);613684(MK)	AD	Rubinstein-Taybi syndrome 2	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	21376300|20717166|20301699|20014264|19353645|17299436|17220215|15706485	.	2033	EP300	IC16	IVS16	.	.	intron	NM_001429.3	NP_001420.2	+	Y	c.3143-45C>T	.	.	.	NM_001429.3(EP300): c.3143-45C>T	;maf-5-some-pop,maf-5-all-pops	124180	0.659043	U	0.8175	0.673123	13004	0.582821	PASS	2708	8246	0.808271	26398	119172	0.658452	5621	13788	8.12301e-01	54974	161508	6.65069e-01	rs4822011	.	4024	0.810900	-1.322	-0.168	-0.396	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	41550983	41550984	22q13.2	0	normal	.	C	ref	C	CA.TT	het-alt	215	0.86	.	1	.	PASS	602700	P	114500(MK);613684(MK)	AD	Rubinstein-Taybi syndrome 2	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	21376300|20717166|20301699|20014264|19353645|17299436|17220215|15706485	.	2033	EP300	IC16	IVS16	.	.	no-change	NM_001429.3	NP_001420.2	+	Y	c.3143-15C=	.	.	.	NM_001429.3(EP300): c.3143-15C=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.561	0.385	0.117	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
22	41550984	41550984	22q13.2	1	normal	.	.	ins	T	AC.TT	het-ref	35	0.14	.	2	.	PASS	602700	P	114500(MK);613684(MK)	AD	Rubinstein-Taybi syndrome 2	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	21376300|20717166|20301699|20014264|19353645|17299436|17220215|15706485	.	2033	EP300	IC16	IVS16	.	.	intron	NM_001429.3	NP_001420.2	+	Y	c.3143-15_3143-14insT	.	.	.	NM_001429.3(EP300): c.3143-15_3143-14insT	MixedObserved;	91742	0.020307	U	.	.	.	.	PASS	0	6640	0.013404	0	94518	0.028566	.	.	.	.	.	.	rs778546367	.	4024	0.170000	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	194724	criteria_provided,_single_submitter	Benign	Benign
22	41551038	41551039	22q13.2	0	nullSample	.	T	ref	T	AC.TT	homo-ref	.	.	.	0	.	.	602700	P	114500(MK);613684(MK)	AD	Rubinstein-Taybi syndrome 2	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	21376300|20717166|20301699|20014264|19353645|17299436|17220215|15706485	.	2033	EP300	C17	EX17	.	.	no-change	NM_001429.3	NP_001420.2	+	Y	c.3183T=	.	.	.	NM_001429.3(EP300): c.3183T=	;maf-5-some-pop,maf-5-all-pops	126402	0.342091	U	0.8175	0.673922	13006	0.416885	PASS	.	8650	0.193179	7779	121394	0.342752	.	.	.	.	.	.	rs20552	.	4024	0.189100	-1.337	-0.929	-0.839	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	41551038	41551039	22q13.2	1	normal	.	T	snv	A	AC.TT	hom-alt	464	1.00	.	0	.	PASS	602700	P	114500(MK);613684(MK)	AD	Rubinstein-Taybi syndrome 2	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	21376300|20717166|20301699|20014264|19353645|17299436|17220215|15706485	.	2033	EP300	C17	EX17	.	.	coding-synon	NM_001429.3	NP_001420.2	+	Y	c.3183T>A	p.(T1061=) | p.(Thr1061=)	ACT=>ACA	.	NM_001429.3(EP300): c.3183T>A (p.(T1061=))	;maf-5-some-pop,maf-5-all-pops	126402	0.657909	U	0.8175	0.673922	13006	0.583115	PASS	2834	8650	0.806821	26868	121394	0.657248	5704	13999	8.11724e-01	55720	163639	6.64567e-01	rs20552	.	4024	0.810900	-1.337	-0.929	-0.839	.	.	.	.	.	ENST00000263253: c.3183T>A (p.T1061T)	biliary_tract [gallbladder|NS|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	4767796	.	.	.	.	.	no_record	93738	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
22	41568479	41568480	22q13.2	0	nullSample	.	T	ref	T	TA.AT	homo-ref	.	.	.	0	.	.	602700	P	114500(MK);613684(MK)	AD	Rubinstein-Taybi syndrome 2	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	21376300|20717166|20301699|20014264|19353645|17299436|17220215|15706485	.	2033	EP300	IC27	IVS27	.	.	no-change	NM_001429.3	NP_001420.2	+	Y	c.4453-23T=	.	.	.	NM_001429.3(EP300): c.4453-23T=	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	122914	0.380681	U	0.5913	0.534145	13006	0.505613	PASS	-1015	8508	0.401034	9246	117906	0.377063	.	.	.	.	.	.	rs2076577	.	4024	0.376500	-0.264	0.199	0.154	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	41568479	41568480	22q13.2	0	normal	.	T	snv	C	TA.AT	hom-alt	407	1.00	.	0	.	PASS	602700	P	114500(MK);613684(MK)	AD	Rubinstein-Taybi syndrome 2	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	21376300|20717166|20301699|20014264|19353645|17299436|17220215|15706485	.	2033	EP300	IC27	IVS27	.	.	intron	NM_001429.3	NP_001420.2	+	Y	c.4453-23T>C	.	.	.	NM_001429.3(EP300): c.4453-23T>C	;maf-5-some-pop,maf-5-all-pops,genotype-conflict	122914	0.619319	U	0.5913	0.534145	13006	0.494387	PASS	1533	8508	0.598966	23741	117906	0.622937	3032	10193	5.93790e-01	50322	153295	6.28748e-01	rs2076577	.	4024	0.623500	-0.264	0.199	0.154	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	41569608	41569609	22q13.2	0	nullSample	.	C	ref	C	TC.TT	homo-ref	.	.	.	0	.	.	602700	P	114500(MK);613684(MK)	AD	Rubinstein-Taybi syndrome 2	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	21376300|20717166|20301699|20014264|19353645|17299436|17220215|15706485	.	2033	EP300	IC28	IVS28	.	.	no-change	NM_001429.3	NP_001420.2	+	Y	c.4618-18C=	.	.	.	NM_001429.3(EP300): c.4618-18C=	;maf-5-some-pop,genotype-conflict	124172	0.693321	U	0.4712	0.264177	13004	0.741849	PASS	.	8368	0.520674	28979	119164	0.691534	.	.	.	.	.	.	rs2076578	.	4024	0.508900	0.655	1.126	1.373	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	41569608	41569609	22q13.2	1	normal	.	C	snv	T	TC.TT	hom-alt	395	1.00	.	0	.	PASS	602700	P	114500(MK);613684(MK)	AD	Rubinstein-Taybi syndrome 2	AD	.	Craniofacial; Musculoskeletal; Neurologic	General	21376300|20717166|20301699|20014264|19353645|17299436|17220215|15706485	.	2033	EP300	IC28	IVS28	.	.	intron	NM_001429.3	NP_001420.2	+	Y	c.4618-18C>T	.	.	.	NM_001429.3(EP300): c.4618-18C>T	;maf-5-some-pop,genotype-conflict	124172	0.306679	U	0.4712	0.264177	13004	0.258151	PASS	960	8368	0.479326	6155	119164	0.308466	1891	8035	4.68568e-01	12314	74282	3.03029e-01	rs2076578	.	4024	0.491100	0.655	1.126	1.373	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	93742	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Benign
22	42522612	42522613	22q13.2	1	normal	.	G	ref	G	GG.TC	het-alt	251	0.56	.	1	dup	PASS	124030	C	608902(SK)	NN	Drug metabolism, CYP2CD6-related	AD	.	General	Pharmacogenomic	22775532|22733239|22406651|19809024|15625333|11940091|9012401|8093319|7903454|4082245|1978251|1673290	.	1565	CYP2D6	C9E	EX9E	.	.	missense	NM_000106.5	NP_000097.3	-	Y	c.1457G>C	p.S486T | p.Ser486Thr	AGC=>ACC	P0=>P0	NM_000106.5(CYP2D6): c.1457G>C (p.S486T)	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	121276	0.546687	U	0.2956	0.401158	12980	0.591680	PASS	.	8314	0.701347	18154	116268	0.544440	.	.	.	.	.	.	rs1135840	.	.	.	-0.315	-0.224	-0.465	.	.	.	.	.	.	.	.	.	.	CM931123	NM_000106.4(CYP2D6): c.1457G>C (p.S486T)	Poor metaboliser, association with	8287064	FP	.	.	.	.	Likely Benign
22	42522612	42522613	22q13.2	0	normal	.	G	snv	C	GG.TC	het-ref	201	0.44	.	2	dup	PASS	124030	C	608902(SK)	NN	Drug metabolism, CYP2CD6-related	AD	.	General	Pharmacogenomic	22775532|22733239|22406651|19809024|15625333|11940091|9012401|8093319|7903454|4082245|1978251|1673290	.	1565	CYP2D6	C9E	EX9E	.	.	no-change	NM_000106.5	NP_000097.3	-	Y	c.1457G=	.	.	.	NM_000106.5(CYP2D6): c.1457G=	;clinically-assoc,maf-5-some-pop,has-omim-omia,submitted-by-lsdb	121276	0.453313	U	0.2956	0.401158	12980	0.408320	PASS	445	8314	0.298653	12987	116268	0.455560	852	4776	2.84150e-01	26996	108595	4.52389e-01	rs1135840	.	.	.	-0.315	-0.224	-0.465	.	.	.	.	.	ENST00000360608: c.1457C>G (p.T486S)	central_nervous_system [brain|NS|NS]	glioma [astrocytoma_Grade_IV|glioblastoma_multiforme|NS]	CSV	1599976	.	.	.	.	.	Paralog	516889	criteria_provided,_single_submitter	Likely_benign	Benign
22	42523002	42523003	22q13.2	0	nullSample	.	A	ref	A	AG.AG	homo-ref	.	.	.	0	dup	.	124030	C	608902(SK)	NN	Drug metabolism, CYP2CD6-related	AD	.	General	Pharmacogenomic	22775532|22733239|22406651|19809024|15625333|11940091|9012401|8093319|7903454|4082245|1978251|1673290	.	1565	CYP2D6	IC7	IVS7	.	.	no-change	NM_000106.5	NP_000097.3	-	Y	c.1174-9T=	.	.	.	NM_000106.5(CYP2D6): c.1174-9T=	;maf-5-some-pop,maf-5-all-pops	48756	0.940233	U	.	.	.	.	PASS	-27	1880	0.790426	22561	48756	0.940233	.	.	.	.	.	.	rs4987144	.	3920	0.771200	-1.172	-0.563	-0.768	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	42523002	42523003	22q13.2	1	normal	.	A	snv	G	AG.AG	hom-alt	25	1.00	.	0	dup	DUBIOUS	124030	C	608902(SK)	NN	Drug metabolism, CYP2CD6-related	AD	.	General	Pharmacogenomic	22775532|22733239|22406651|19809024|15625333|11940091|9012401|8093319|7903454|4082245|1978251|1673290	.	1565	CYP2D6	IC7	IVS7	.	.	intron	NM_000106.5	NP_000097.3	-	Y	c.1174-9T>C	.	.	.	NM_000106.5(CYP2D6): c.1174-9T>C	;maf-5-some-pop,maf-5-all-pops	48756	0.059767	U	.	.	.	.	PASS	170	1880	0.209574	1097	48756	0.059767	3359	7563	7.13221e-01	19706	49426	3.20428e-01	rs4987144	.	3920	0.228800	-1.172	-0.563	-0.768	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	42523942	42523943	22q13.2	1	nullSample	.	A	ref	A	GC.CA	homo-ref	.	.	.	0	dup	.	124030	C	608902(SK)	NN	Drug metabolism, CYP2CD6-related	AD	.	General	Pharmacogenomic	22775532|22733239|22406651|19809024|15625333|11940091|9012401|8093319|7903454|4082245|1978251|1673290	.	1565	CYP2D6	C6	EX6	.	.	missense	NM_000106.5	NP_000097.3	-	Y	c.886C>T	p.R296C | p.Arg296Cys	CGC=>TGC	P+=>P0	NM_000106.5(CYP2D6): c.886C>T (p.R296C)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	126050	0.343975	U	0.8601	0.640775	12988	0.400447	PASS	-512	8606	0.148501	8503	121042	0.343344	.	.	.	.	.	.	rs16947	.	.	.	-0.227	-0.197	-0.119	.	.	.	.	.	.	.	.	.	.	CM930187	NM_000106.4(CYP2D6): c.886C>T (p.R296C)	Parkinson disease, association with	7903297	DP	.	.	.	.	Likely Benign
22	42523942	42523943	22q13.2	0	normal	.	A	snv	G	GC.CA	hom-alt	779	1.00	.	0	dup	PASS	124030	C	608902(SK)	NN	Drug metabolism, CYP2CD6-related	AD	.	General	Pharmacogenomic	22775532|22733239|22406651|19809024|15625333|11940091|9012401|8093319|7903454|4082245|1978251|1673290	.	1565	CYP2D6	C6	EX6	.	.	no-change	NM_000106.5	NP_000097.3	-	Y	c.886C=	.	.	.	NM_000106.5(CYP2D6): c.886C=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	126050	0.656025	U	0.8601	0.640775	12988	0.599553	PASS	3152	8606	0.851499	27465	121042	0.656656	6355	14651	8.53191e-01	56070	162080	6.60155e-01	rs16947	.	.	.	-0.227	-0.197	-0.119	.	.	.	.	.	ENST00000360608: c.886T>C (p.C296R)	large_intestine [colon|sigmoid|NS]	carcinoma [adenocarcinoma|NS|NS]	CSV	1130422	.	.	.	.	.	Paralog	516890	criteria_provided,_single_submitter	Likely_benign	Benign
22	42525131	42525132	22q13.2	1	normal	.	G	ref	G	GA.AC	het-alt	360	0.75	.	1	dup	PASS	124030	C	608902(SK)	NN	Drug metabolism, CYP2CD6-related	AD	.	General	Pharmacogenomic	22775532|22733239|22406651|19809024|15625333|11940091|9012401|8093319|7903454|4082245|1978251|1673290	.	1565	CYP2D6	C3	EX3	.	.	coding-synon	NM_000106.5	NP_000097.3	-	Y	c.408G>C	p.(V136=) | p.(Val136=)	GTG=>GTC	.	NM_000106.5(CYP2D6): c.408G>C (p.(V136=))	;maf-5-some-pop,maf-5-all-pops	120514	0.550625	U	0.2907	0.400958	12388	0.607120	PASS	.	8336	0.712932	18312	115506	0.548526	.	.	.	.	.	.	rs1058164	.	.	.	-2.920	-0.545	-0.116	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
22	42525131	42525132	22q13.2	0	normal	.	G	snv	C	GA.AC	het-ref	117	0.25	.	2	dup	PASS	124030	C	608902(SK)	NN	Drug metabolism, CYP2CD6-related	AD	.	General	Pharmacogenomic	22775532|22733239|22406651|19809024|15625333|11940091|9012401|8093319|7903454|4082245|1978251|1673290	.	1565	CYP2D6	C3	EX3	.	.	no-change	NM_000106.5	NP_000097.3	-	Y	c.408G=	.	.	.	NM_000106.5(CYP2D6): c.408G=	;maf-5-some-pop,maf-5-all-pops	120514	0.449375	U	0.2907	0.400958	12388	0.392880	PASS	408	8336	0.287068	12707	115506	0.451474	823	4638	2.76730e-01	27221	108932	4.52484e-01	rs1058164	.	.	.	-2.920	-0.545	-0.116	.	.	.	.	.	ENST00000360608: c.408C>G (p.V136V)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3759229	.	.	.	.	.	.	.	.	.	Benign
22	42525755	42525756	22q13.2	0	normal	.	G	ref	G	CC.AA	het-alt	243	0.35	.	1	dup	PASS	124030	C	608902(SK)	NN	Drug metabolism, CYP2CD6-related	AD	.	General	Pharmacogenomic	22775532|22733239|22406651|19809024|15625333|11940091|9012401|8093319|7903454|4082245|1978251|1673290	.	1565	CYP2D6	C2	EX2	.	.	no-change	NM_000106.5	NP_000097.3	-	Y	c.336C=	.	.	.	NM_000106.5(CYP2D6): c.336C=	;maf-5-some-pop	120348	0.918628	U	0.5704	0.166933	12934	0.957167	PASS	-953	8432	0.443786	50352	115340	0.922343	.	.	.	.	.	.	rs1081003	.	4020	0.503700	-1.610	-0.200	-0.441	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	42525755	42525756	22q13.2	1	normal	.	G	snv	A	CC.AA	het-ref	445	0.65	.	2	dup	PASS	124030	C	608902(SK)	NN	Drug metabolism, CYP2CD6-related	AD	.	General	Pharmacogenomic	22775532|22733239|22406651|19809024|15625333|11940091|9012401|8093319|7903454|4082245|1978251|1673290	.	1565	CYP2D6	C2	EX2	.	.	coding-synon	NM_000106.5	NP_000097.3	-	Y	c.336C>T	p.(F112=) | p.(Phe112=)	TTC=>TTT	.	NM_000106.5(CYP2D6): c.336C>T (p.(F112=))	;maf-5-some-pop	120348	0.081372	U	0.5704	0.166933	12934	0.042833	PASS	1392	8432	0.556214	1639	115340	0.077657	2928	9675	5.67382e-01	3445	18563	7.69451e-02	rs1081003	.	4020	0.496300	-1.610	-0.200	-0.441	.	.	.	.	.	ENST00000360608: c.336C>T (p.F112F)	pancreas [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	3785566	.	.	.	.	.	.	.	.	.	Likely Benign
22	42525951	42525952	22q13.2	0	normal	.	C	ref	C	TC.CC	het-alt	229	0.64	.	1	dup	DUBIOUS	124030	C	608902(SK)	NN	Drug metabolism, CYP2CD6-related	AD	.	General	Pharmacogenomic	22775532|22733239|22406651|19809024|15625333|11940091|9012401|8093319|7903454|4082245|1978251|1673290	.	1565	CYP2D6	IC1	IVS1	.	.	no-change	NM_000106.5	NP_000097.3	-	Y	c.181-41G=	.	.	.	NM_000106.5(CYP2D6): c.181-41G=	;maf-5-some-pop,maf-5-all-pops	22338	0.549333	U	0.2748	0.370008	.	.	PASS	-121	1134	0.731922	2421	17330	0.526024	.	.	.	.	.	.	rs28371702	.	4024	0.700300	-1.212	0.111	-0.276	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	42525951	42525952	22q13.2	0	normal	.	C	snv	A	TC.CC	het-ref	128	0.36	.	2	dup	DUBIOUS	124030	C	608902(SK)	NN	Drug metabolism, CYP2CD6-related	AD	.	General	Pharmacogenomic	22775532|22733239|22406651|19809024|15625333|11940091|9012401|8093319|7903454|4082245|1978251|1673290	.	1565	CYP2D6	IC1	IVS1	.	.	intron	NM_000106.5	NP_000097.3	-	Y	c.181-41G>T	.	.	.	NM_000106.5(CYP2D6): c.181-41G>T	;maf-5-some-pop,maf-5-all-pops	22338	0.450667	U	0.2748	0.370008	.	.	PASS	31	1134	0.268078	1970	17330	0.473976	472	2890	2.62441e-01	15128	60341	4.51208e-01	rs28371702	.	4024	0.299700	-1.212	0.111	-0.276	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	42526693	42526694	22q13.2	0	normal	.	G	ref	G	TG.GT	het-alt	253	0.35	.	1	dup	PASS	124030	C	608902(SK)	NN	Drug metabolism, CYP2CD6-related	AD	.	General	Pharmacogenomic	22775532|22733239|22406651|19809024|15625333|11940091|9012401|8093319|7903454|4082245|1978251|1673290	.	1565	CYP2D6	C1	EX1	.	.	no-change	NM_000106.5	NP_000097.3	-	Y	c.100C=	.	.	.	NM_000106.5(CYP2D6): c.100C=	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	100846	0.753743	U	0.5714	0.238019	12990	0.811470	PASS	.	7870	0.409022	27847	95838	0.753313	.	.	.	.	.	.	rs1065852	.	4014	0.496000	0.484	4.426	2.218	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
22	42526693	42526694	22q13.2	1	normal	.	G	snv	A	TG.GT	het-ref	475	0.65	.	2	dup	PASS	124030	C	608902(SK)	NN	Drug metabolism, CYP2CD6-related	AD	.	General	Pharmacogenomic	22775532|22733239|22406651|19809024|15625333|11940091|9012401|8093319|7903454|4082245|1978251|1673290	.	1565	CYP2D6	C1	EX1	.	.	missense	NM_000106.5	NP_000097.3	-	Y	c.100C>T	p.P34S | p.Pro34Ser	CCA=>TCA	NP=>P0	NM_000106.5(CYP2D6): c.100C>T (p.P34S)	;clinically-assoc,maf-5-some-pop,maf-5-all-pops,has-omim-omia,submitted-by-lsdb	100846	0.246257	U	0.5714	0.238019	12990	0.188530	PASS	1376	7870	0.590978	3570	95838	0.246687	2921	9645	5.73084e-01	7559	48922	2.06804e-01	rs1065852	.	4014	0.504000	0.484	4.426	2.218	.	.	.	.	.	ENST00000360608: c.100C>T (p.P34S)	pancreas [NS|NS|NS]	carcinoma [ductal_carcinoma|NS|NS]	CSV	4999521	CM900081	NM_000106.5(CYP2D6): c.100C>T (p.P34S)	"Poor metaboliser, association with"	2211621	FP	Paralog	16893	criteria_provided,_single_submitter	Likely_benign	Likely Benign
X	1317403	1317404	Xp22.33	1	normal	.	T	snv	C	CG.GT	het-ref	190	0.64	.	2	.	PASS	300357|400023	P	.	NN	.	.	.	.	.	.	.	64109	CRLF2	IC5	IVS5	.	.	intron	NM_022148.2	NP_071431.2	-	Y	c.646+15A>G	.	.	.	NM_022148.2(CRLF2): c.646+15A>G	SingleClassTriAllelic;maf-5-some-pop	125690	0.478996	U	0.3462	0.507788	12668	0.551547	PASS	613	8580	0.368648	14106	120682	0.477801	1163	6296	3.65155e-01	27620	115182	4.69433e-01	rs9778721	.	4024	0.358800	-1.436	0.614	-0.346	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
X	1317403	1317404	Xp22.33	0	normal	.	T	ref	T	CG.GT	het-alt	108	0.36	.	1	.	PASS	300357|400023	P	.	NN	.	.	.	.	.	.	.	64109	CRLF2	IC5	IVS5	.	.	no-change	NM_022148.2	NP_071431.2	-	Y	c.646+15A=	.	.	.	NM_022148.2(CRLF2): c.646+15A=	SingleClassTriAllelic;maf-5-some-pop	125690	0.520996	U	0.3462	0.507788	12668	0.448453	PASS	-1937	8580	0.631352	33570	120682	0.522191	.	.	.	.	.	.	rs9778721	.	4024	0.641200	-1.436	0.614	-0.346	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
X	39913654	39913655	Xp11.4	0	nullSample	.	C	ref	C	CA.GT	homo-ref	.	.	.	0	.	.	300485	C	300166(MK)	XD	Microphthalmia, syndromic 2; Oculofaciocardiodental syndrome	XL	.	Cardiovascular; Craniofacial; Dental; Gastrointestinal; Genitourinary; Ophthalmologic; Musculoskeletal; Renal	General	22301464|21740180|20301694|15957158|15770227|15004558|13963827|10069716|1225823	.	54880	BCOR	IC11	IVS12	.	.	no-change	NM_001123385.1	NP_001116857.1	-	Y	c.4742-69G=	.	.	.	NM_001123385.1(BCOR): c.4742-69G=	;maf-5-some-pop	3775	0.927417	U	0.1348	0.0725828	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs112054628	.	4014	0.868200	-0.918	-0.190	-0.771	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
X	39913654	39913655	Xp11.4	0	normal	.	C	snv	T	CA.GT	hom-alt	121	1.00	.	0	.	PASS	300485	C	300166(MK)	XD	Microphthalmia, syndromic 2; Oculofaciocardiodental syndrome	XL	.	Cardiovascular; Craniofacial; Dental; Gastrointestinal; Genitourinary; Ophthalmologic; Musculoskeletal; Renal	General	22301464|21740180|20301694|15957158|15770227|15004558|13963827|10069716|1225823	.	54880	BCOR	IC11	IVS12	.	.	intron	NM_001123385.1	NP_001116857.1	-	Y	c.4742-69G>A	.	.	.	NM_001123385.1(BCOR): c.4742-69G>A	;maf-5-some-pop	3775	0.072583	U	0.1348	0.0725828	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs112054628	.	4014	0.131800	-0.918	-0.190	-0.771	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
X	39922906	39922907	Xp11.4	0	nullSample	.	G	ref	G	CT.TT	homo-ref	.	.	.	0	.	.	300485	C	300166(MK)	XD	Microphthalmia, syndromic 2; Oculofaciocardiodental syndrome	XL	.	Cardiovascular; Craniofacial; Dental; Gastrointestinal; Genitourinary; Ophthalmologic; Musculoskeletal; Renal	General	22301464|21740180|20301694|15957158|15770227|15004558|13963827|10069716|1225823	.	54880	BCOR	C7	EX8	.	.	no-change	NM_001123385.1	NP_001116857.1	-	Y	c.3801C=	.	.	.	NM_001123385.1(BCOR): c.3801C=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.529	1.219	1.097	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
X	39922906	39922907	Xp11.4	1	normal	.	G	snv	A	CT.TT	hom-alt	265	1.00	.	0	.	PASS	300485	C	300166(MK)	XD	Microphthalmia, syndromic 2; Oculofaciocardiodental syndrome	XL	.	Cardiovascular; Craniofacial; Dental; Gastrointestinal; Genitourinary; Ophthalmologic; Musculoskeletal; Renal	General	22301464|21740180|20301694|15957158|15770227|15004558|13963827|10069716|1225823	.	54880	BCOR	C7	EX8	.	.	coding-synon	NM_001123385.1	NP_001116857.1	-	Y	c.3801C>T	p.(N1267=) | p.(Asn1267=)	AAC=>AAT	.	NM_001123385.1(BCOR): c.3801C>T (p.(N1267=))	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.529	1.219	1.097	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	VUS
X	39930433	39930434	Xp11.4	0	normal	.	A	ref	A	GG.AA	het-alt	59	0.80	.	1	.	PASS	300485	C	300166(MK)	XD	Microphthalmia, syndromic 2; Oculofaciocardiodental syndrome	XL	.	Cardiovascular; Craniofacial; Dental; Gastrointestinal; Genitourinary; Ophthalmologic; Musculoskeletal; Renal	General	22301464|21740180|20301694|15957158|15770227|15004558|13963827|10069716|1225823	.	54880	BCOR	IC4	IVS5	.	.	no-change	NM_001123385.1	NP_001116857.1	-	Y	c.3052-22T=	.	.	.	NM_001123385.1(BCOR): c.3052-22T=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs768186186	.	4024	0.960700	0.158	0.460	-0.039	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
X	39930433	39930434	Xp11.4	0	normal	.	A	del	.	GG.AA	het-ref	15	0.20	.	2	.	PASS	300485	C	300166(MK)	XD	Microphthalmia, syndromic 2; Oculofaciocardiodental syndrome	XL	.	Cardiovascular; Craniofacial; Dental; Gastrointestinal; Genitourinary; Ophthalmologic; Musculoskeletal; Renal	General	22301464|21740180|20301694|15957158|15770227|15004558|13963827|10069716|1225823	.	54880	BCOR	IC4	IVS5	.	.	intron	NM_001123385.1	NP_001116857.1	-	Y	c.3052-22delT	.	.	.	NM_001123385.1(BCOR): c.3052-22delT	MixedObserved;	0	0	U	.	.	.	.	PASS	0	1028	0.190661	0	17555	0.153631	.	.	.	.	.	.	rs768186186	.	4024	0.039300	0.158	0.460	-0.039	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
X	39932906	39932907	Xp11.4	0	nullSample	.	T	ref	T	CC.GC	homo-ref	.	.	.	0	.	.	300485	C	300166(MK)	XD	Microphthalmia, syndromic 2; Oculofaciocardiodental syndrome	XL	.	Cardiovascular; Craniofacial; Dental; Gastrointestinal; Genitourinary; Ophthalmologic; Musculoskeletal; Renal	General	22301464|21740180|20301694|15957158|15770227|15004558|13963827|10069716|1225823	.	54880	BCOR	C3	EX4	.	.	no-change	NM_001123385.1	NP_001116857.1	-	Y	c.1692A=	.	.	.	NM_001123385.1(BCOR): c.1692A=	;maf-5-some-pop,genotype-conflict	91316	0.722283	U	0.6937	0.523974	10561	0.638481	PASS	-952	6601	0.288896	56973	87541	0.732902	.	.	.	.	.	.	rs6520618	.	4024	0.308600	-1.163	-3.590	-3.727	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
X	39932906	39932907	Xp11.4	1	normal	.	T	snv	C	CC.GC	hom-alt	316	1.00	.	0	.	PASS	300485	C	300166(MK)	XD	Microphthalmia, syndromic 2; Oculofaciocardiodental syndrome	XL	.	Cardiovascular; Craniofacial; Dental; Gastrointestinal; Genitourinary; Ophthalmologic; Musculoskeletal; Renal	General	22301464|21740180|20301694|15957158|15770227|15004558|13963827|10069716|1225823	.	54880	BCOR	C3	EX4	.	.	coding-synon	NM_001123385.1	NP_001116857.1	-	Y	c.1692A>G	p.(A564=) | p.(Ala564=)	GCA=>GCG	.	NM_001123385.1(BCOR): c.1692A>G (p.(A564=))	;maf-5-some-pop,genotype-conflict	91316	0.277717	U	0.6937	0.523974	10561	0.361519	PASS	1168	6601	0.711104	4014	87541	0.267098	2115	9041	7.03963e-01	6699	44406	2.49371e-01	rs6520618	.	4024	0.691400	-1.163	-3.590	-3.727	.	.	.	.	.	ENST00000378444: c.1692A>G (p.A564A)	soft_tissue [blood_vessel|central_nervous_system|NS]	haemangioblastoma [NS|NS|NS]	CSV	5019635	.	.	.	.	.	no_record	95766	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
X	39933338	39933339	Xp11.4	0	nullSample	.	A	ref	A	CC.TC	homo-ref	.	.	.	0	.	.	300485	C	300166(MK)	XD	Microphthalmia, syndromic 2; Oculofaciocardiodental syndrome	XL	.	Cardiovascular; Craniofacial; Dental; Gastrointestinal; Genitourinary; Ophthalmologic; Musculoskeletal; Renal	General	22301464|21740180|20301694|15957158|15770227|15004558|13963827|10069716|1225823	.	54880	BCOR	C3	EX4	.	.	no-change	NM_001123385.1	NP_001116857.1	-	Y	c.1260T=	.	.	.	NM_001123385.1(BCOR): c.1260T=	;maf-5-some-pop,genotype-conflict	90884	0.104430	U	0.9594	0.903046	10561	0.104251	PASS	-121	6596	0.025622	4505	87109	0.104754	.	.	.	.	.	.	rs5917933	.	4024	0.033800	-1.146	-0.575	-1.121	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
X	39933338	39933339	Xp11.4	1	normal	.	A	snv	G	CC.TC	hom-alt	389	0.99	.	0	.	PASS	300485	C	300166(MK)	XD	Microphthalmia, syndromic 2; Oculofaciocardiodental syndrome	XL	.	Cardiovascular; Craniofacial; Dental; Gastrointestinal; Genitourinary; Ophthalmologic; Musculoskeletal; Renal	General	22301464|21740180|20301694|15957158|15770227|15004558|13963827|10069716|1225823	.	54880	BCOR	C3	EX4	.	.	coding-synon	NM_001123385.1	NP_001116857.1	-	Y	c.1260T>C	p.(D420=) | p.(Asp420=)	GAT=>GAC	.	NM_001123385.1(BCOR): c.1260T>C (p.(D420=))	;maf-5-some-pop,genotype-conflict	90884	0.895570	U	0.9594	0.903046	10561	0.895749	PASS	2187	6596	0.974378	22091	87109	0.895246	4009	12492	9.72897e-01	45661	159614	8.97030e-01	rs5917933	.	4024	0.966200	-1.146	-0.575	-1.121	.	.	.	.	.	ENST00000378444: c.1260T>C (p.D420D)	thyroid [NS|NS|NS]	other [neoplasm|NS|NS]	CSV	4156839	.	.	.	.	.	no_record	95764	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
X	39934487	39934488	Xp11.4	0	nullSample	.	C	ref	C	CA.CC	homo-ref	.	.	.	0	.	.	300485	C	300166(MK)	XD	Microphthalmia, syndromic 2; Oculofaciocardiodental syndrome	XL	.	Cardiovascular; Craniofacial; Dental; Gastrointestinal; Genitourinary; Ophthalmologic; Musculoskeletal; Renal	General	22301464|21740180|20301694|15957158|15770227|15004558|13963827|10069716|1225823	.	54880	BCOR	IC2	IVS3	.	.	no-change	NM_001123385.1	NP_001116857.1	-	Y	c.166-55G=	.	.	.	NM_001123385.1(BCOR): c.166-55G=	;maf-5-some-pop	3775	0.615364	U	0.6819	0.384636	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6610384	.	4024	0.312600	0.525	-0.594	-0.527	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
X	39934487	39934488	Xp11.4	0	normal	.	C	snv	T	CA.CC	hom-alt	159	1.00	.	0	.	PASS	300485	C	300166(MK)	XD	Microphthalmia, syndromic 2; Oculofaciocardiodental syndrome	XL	.	Cardiovascular; Craniofacial; Dental; Gastrointestinal; Genitourinary; Ophthalmologic; Musculoskeletal; Renal	General	22301464|21740180|20301694|15957158|15770227|15004558|13963827|10069716|1225823	.	54880	BCOR	IC2	IVS3	.	.	intron	NM_001123385.1	NP_001116857.1	-	Y	c.166-55G>A	.	.	.	NM_001123385.1(BCOR): c.166-55G>A	;maf-5-some-pop	3775	0.384636	U	0.6819	0.384636	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs6610384	.	4024	0.687400	0.525	-0.594	-0.527	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
X	44918221	44918222	Xp11.3	0	normal	.	T	ref	T	GA.TT	het-alt	33	0.67	.	1	.	PASS	300128	P	300867(MK)	XD	Kabuki syndrome 2	XL	.	Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic	General	23076834|22197486	.	7403	KDM6A	IC10	IVS10	.	.	no-change	NM_021140.2	NP_066963.2	+	Y	c.876-29T=	.	.	.	NM_021140.2(KDM6A): c.876-29T=	MixedObserved;	0	0	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs757065586	.	4024	0.669200	0.339	0.206	-0.031	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
X	44918221	44918222	Xp11.3	0	normal	.	T	del	.	GA.TT	het-ref	16	0.33	.	2	.	PASS	300128	P	300867(MK)	XD	Kabuki syndrome 2	XL	.	Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic	General	23076834|22197486	.	7403	KDM6A	IC10	IVS10	.	.	intron	NM_021140.2	NP_066963.2	+	Y	c.876-29delT	.	.	.	NM_021140.2(KDM6A): c.876-29delT	MixedObserved;	0	0	U	.	.	.	.	InbreedingCoeff_Filter	0	4403	0.344538	0	59520	0.288659	.	.	.	.	.	.	rs757065586	.	4024	0.330800	0.339	0.206	-0.031	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
X	44935924	44935926	Xp11.3	0	nullSample	.	TT	ref	TT	CC.TT	homo-ref	.	.	.	0	.	.	300128	P	300867(MK)	XD	Kabuki syndrome 2	XL	.	Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic	General	23076834|22197486	.	7403	KDM6A	IC17	IVS17	.	.	no-change	NM_021140.2	NP_066963.2	+	Y	c.2703-17_2703-16=	.	.	.	NM_021140.2(KDM6A): c.2703-17_2703-16=	MixedObserved;maf-5-some-pop,maf-5-all-pops	1427	0.268395	U	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs200364326	.	4204	0.403700	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
X	44935924	44935926	Xp11.3	1	normal	.	TT	del	.	CC.TT	het-alt	25	0.22	.	1	.	PASS	300128	P	300867(MK)	XD	Kabuki syndrome 2	XL	.	Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic	General	23076834|22197486	.	7403	KDM6A	IC17	IVS17	.	.	intron	NM_021140.2	NP_066963.2	+	Y	c.2703-17_2703-16delTT	.	.	.	NM_021140.2(KDM6A): c.2703-17_2703-16delTT	MixedObserved;maf-5-some-pop,maf-5-all-pops	1427	0.731605	U	0.4424	0.276556	.	.	PASS	91	5722	0.465571	212	71820	0.334127	.	.	.	.	.	.	rs200364326	.	4204	0.363100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	167213	criteria_provided,_single_submitter	Likely_benign	Benign
X	44935924	44935926	Xp11.3	1	normal	.	TT	rep	T	CC.TT	het-alt	75	0.67	.	2	.	PASS	300128	P	300867(MK)	XD	Kabuki syndrome 2	XL	.	Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic	General	23076834|22197486	.	7403	KDM6A	IC17	IVS17	.	.	intron	NM_021140.2	NP_066963.2	+	Y	c.2703-17T[2>1] (std: c.2703-17T[1] alt: c.2703-16delT )	.	.	.	NM_021140.2(KDM6A): c.2703-17T[1]	.	.	.	.	0.0039	0.00874172	.	.	PASS	-18	253	0.731225	710	1362	0.649780	.	.	.	.	.	.	.	.	4204	0.192100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
X	48894468	48894469	Xp11.23	0	normal	.	T	snv	C	CT.GG	hom-alt	240	1.00	.	0	.	PASS	314310	P	300854(MK)	NN	.	.	.	.	.	.	.	7030	TFE3	IC5	IVS5	.	.	intron	NM_006521.4	NP_006512.2	-	Y	c.885+1066A>G	.	.	.	NM_006521.4(TFE3): c.885+1066A>G	;	3775	0.002649	U	0.0131	0.00264901	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs191541206	.	4024	0.018400	0.328	0.395	0.374	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
X	48894468	48894469	Xp11.23	0	nullSample	.	T	ref	T	CT.GG	homo-ref	.	.	.	0	.	.	314310	P	300854(MK)	NN	.	.	.	.	.	.	.	7030	TFE3	IC5	IVS5	.	.	no-change	NM_006521.4	NP_006512.2	-	Y	c.885+1066A=	.	.	.	NM_006521.4(TFE3): c.885+1066A=	;	3775	0.997351	U	0.0131	0.00264901	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs191541206	.	4024	0.981600	0.328	0.395	0.374	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
X	48895224	48895226	Xp11.23	0	normal	.	AA	ref	AA	cg.aa	het-alt	46	0.75	.	1	AluSg|SINE|Alu|+|301	PASS	314310	P	300854(MK)	NN	.	.	.	.	.	.	.	7030	TFE3	IC5	IVS5	.	.	no-change	NM_006521.4	NP_006512.2	-	Y	c.885+309_885+310=	.	.	.	NM_006521.4(TFE3): c.885+309_885+310=	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4025	0.990600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
X	48895224	48895226	Xp11.23	0	normal	.	AA	del	.	cg.aa	het-ref	15	0.25	.	2	AluSg|SINE|Alu|+|301	PASS	314310	P	300854(MK)	NN	.	.	.	.	.	.	.	7030	TFE3	IC5	IVS5	.	.	intron	NM_006521.4	NP_006512.2	-	Y	c.885+309_885+310delTT	.	.	.	NM_006521.4(TFE3): c.885+309_885+310delTT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4025	0.009200	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely Benign
X	53228147	53228148	Xp11.22	0	nullSample	.	C	ref	C	GG.CC	homo-ref	.	.	.	0	.	.	314690	C	300534(MK)	XL;XR	Mental retardation, X-linked, syndromic, Claes-Jensen type	XL	.	Craniofacial; Genitourinary; Musculoskeletal; Neurologic	General	22611640|22326837|21575681|19826449|18697827|18203167|16538222|15586325|10982473	.	8242	KDM5C	IC15	IVS15	.	.	no-change	NM_004187.3	NP_004178.2	-	Y	c.2243+11G=	.	.	.	NM_004187.3(KDM5C): c.2243+11G=	;maf-5-some-pop	91104	0.114715	U	0.7029	0.730331	10563	0.217078	PASS	-877	6557	0.264145	5291	87329	0.108017	.	.	.	.	.	.	rs1977364	.	4024	0.274600	0.425	-0.612	-0.653	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
X	53228147	53228148	Xp11.22	1	normal	.	C	snv	A	GG.CC	hom-alt	315	0.99	.	0	.	PASS	314690	C	300534(MK)	XL;XR	Mental retardation, X-linked, syndromic, Claes-Jensen type	XL	.	Craniofacial; Genitourinary; Musculoskeletal; Neurologic	General	22611640|22326837|21575681|19826449|18697827|18203167|16538222|15586325|10982473	.	8242	KDM5C	IC15	IVS15	.	.	intron	NM_004187.3	NP_004178.2	-	Y	c.2243+11G>T	.	.	.	NM_004187.3(KDM5C): c.2243+11G>T	;maf-5-some-pop	91104	0.885285	U	0.7029	0.730331	10563	0.782922	PASS	1266	6557	0.735855	21579	87329	0.891983	2334	9490	7.41638e-01	45551	160718	9.01861e-01	rs1977364	.	4024	0.725400	0.425	-0.612	-0.653	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	no_record	94872	criteria_provided,_single_submitter	Benign	Benign
X	66941596	66941597	Xq12	0	normal	.	T	snv	G	GA.GG	hom-alt	158	1.00	.	0	.	PASS	313700	C	176807(SK);300068(MK);300633(MK);312300(MK);313200(MK)	AD;XL;XR	Androgen insensitivity; Androgen insensitivity, partial	XL	Allelic with Spinal and bulbar muscular atrophy, X-linked 1 (XL) (a trinucleotide repeat disorder); Hypospadias 1, X-linked (XL)	Endocrine; Genitourinary; Neurologic; Oncologic	Endocrine; Oncologic; Genitourinary	22334387|15472213|15242343|12221177|12161529|11788616|11788615|11549642|11238515|10999816|8683794|8469342|8092978|7937057|7702080|7673412|6801070|4821173|4233749|2062380|1598912|1449253|1303283|1303262|876326|759869|176660	.	367	AR	IC5	IVS5	.	.	intron	NM_000044.3	NP_000035.2	+	Y	c.2319-78T>G	.	.	.	NM_000044.3(AR): c.2319-78T>G	;maf-5-some-pop,genotype-conflict	3775	0.904901	U	1	0.904901	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1337076	.	4024	0.999000	-0.178	-0.326	-0.161	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
X	66941596	66941597	Xq12	0	nullSample	.	T	ref	T	GA.GG	homo-ref	.	.	.	0	.	.	313700	C	176807(SK);300068(MK);300633(MK);312300(MK);313200(MK)	AD;XL;XR	Androgen insensitivity; Androgen insensitivity, partial	XL	Allelic with Spinal and bulbar muscular atrophy, X-linked 1 (XL) (a trinucleotide repeat disorder); Hypospadias 1, X-linked (XL)	Endocrine; Genitourinary; Neurologic; Oncologic	Endocrine; Oncologic; Genitourinary	22334387|15472213|15242343|12221177|12161529|11788616|11788615|11549642|11238515|10999816|8683794|8469342|8092978|7937057|7702080|7673412|6801070|4821173|4233749|2062380|1598912|1449253|1303283|1303262|876326|759869|176660	.	367	AR	IC5	IVS5	.	.	no-change	NM_000044.3	NP_000035.2	+	Y	c.2319-78T=	.	.	.	NM_000044.3(AR): c.2319-78T=	;maf-5-some-pop,genotype-conflict	3775	0.095099	U	1	0.904901	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs1337076	.	4024	0.001000	-0.178	-0.326	-0.161	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
X	76937962	76937963	Xq21.1	0	nullSample	.	G	ref	G	CT.CT	homo-ref	.	.	.	0	.	.	300032	C	300448(MK);301040(MK);309580(MK)	XD;XL	Mental retardation-hypotonic facies syndrome, X-linked; Juberg-Marsidi syndrome; Carpenter-Waziri syndrome; Holmes-Gang syndrome; Smith-Fineman-Myers syndrome; Alpha-thalassemia/mental retardation syndrome 	XL	.	Craniofacial; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Renal	General	22089611|20301622|19764021|17579672|16955409|16813605|16688741|16222662|16100724|15508018|11449489|11050622|10751095|10398237|10398234|8644709|7726225|6711605|6682021|6267462|3239563|1684092	.	546	ATRX	C9	EX9	.	.	no-change	NM_000489.3	NP_000480.2	-	Y	c.2785C=	.	.	.	NM_000489.3(ATRX): c.2785C=	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	91434	0.601024	U	0.4725	0.552318	10558	0.491665	PASS	-1145	6627	0.550777	42450	87659	0.607627	.	.	.	.	.	.	rs3088074	.	4024	0.552900	-0.273	0.582	0.607	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
X	76937962	76937963	Xq21.1	1	normal	.	G	snv	C	CT.CT	hom-alt	389	1.00	.	0	.	PASS	300032	C	300448(MK);301040(MK);309580(MK)	XD;XL	Mental retardation-hypotonic facies syndrome, X-linked; Juberg-Marsidi syndrome; Carpenter-Waziri syndrome; Holmes-Gang syndrome; Smith-Fineman-Myers syndrome; Alpha-thalassemia/mental retardation syndrome 	XL	.	Craniofacial; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Renal	General	22089611|20301622|19764021|17579672|16955409|16813605|16688741|16222662|16100724|15508018|11449489|11050622|10751095|10398237|10398234|8644709|7726225|6711605|6682021|6267462|3239563|1684092	.	546	ATRX	C9	EX9	.	.	missense	NM_000489.3	NP_000480.2	-	Y	c.2785C>G	p.Q929E | p.Gln929Glu	CAG=>GAG	P0=>P-	NM_000489.3(ATRX): c.2785C>G (p.Q929E)	SingleClassTriAllelic;maf-5-some-pop,genotype-conflict	91434	0.398965	U	0.4725	0.552318	10558	0.508335	PASS	454	6627	0.449223	5293	87659	0.392361	839	5788	4.50113e-01	9326	66364	3.73274e-01	rs3088074	.	4024	0.447100	-0.273	0.582	0.607	1	0	0	0.000	neutral	ENST00000373344: c.2785C>G (p.Q929E)	haematopoietic_and_lymphoid_tissue [NS|NS|NS]	haematopoietic_neoplasm [acute_myeloid_leukaemia|NS|NS]	CSV	3759543	.	.	.	.	.	no_record	93135	criteria_provided,_multiple_submitters,_no_conflicts	Benign	Likely Benign
X	76940533	76940534	Xq21.1	0	nullSample	.	A	ref	A	tc.aa	homo-ref	.	.	.	0	L1MA1|LINE|L1|+|1319	.	300032	C	300448(MK);301040(MK);309580(MK)	XD;XL	Mental retardation-hypotonic facies syndrome, X-linked; Juberg-Marsidi syndrome; Carpenter-Waziri syndrome; Holmes-Gang syndrome; Smith-Fineman-Myers syndrome; Alpha-thalassemia/mental retardation syndrome 	XL	.	Craniofacial; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Renal	General	22089611|20301622|19764021|17579672|16955409|16813605|16688741|16222662|16100724|15508018|11449489|11050622|10751095|10398237|10398234|8644709|7726225|6711605|6682021|6267462|3239563|1684092	.	546	ATRX	IC7	IVS7	.	.	no-change	NM_000489.3	NP_000480.2	-	Y	c.595-36T=	.	.	.	NM_000489.3(ATRX): c.595-36T=	;maf-5-some-pop,maf-5-all-pops	89890	0.600056	U	0.4817	0.550993	10548	0.492700	PASS	-1150	6529	0.543575	41451	86115	0.606677	.	.	.	.	.	.	rs35268552	.	4024	0.544700	-0.588	0.125	0.476	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
X	76940533	76940534	Xq21.1	0	normal	.	A	snv	G	tc.aa	hom-alt	161	1.00	.	0	L1MA1|LINE|L1|+|1319	PASS	300032	C	300448(MK);301040(MK);309580(MK)	XD;XL	Mental retardation-hypotonic facies syndrome, X-linked; Juberg-Marsidi syndrome; Carpenter-Waziri syndrome; Holmes-Gang syndrome; Smith-Fineman-Myers syndrome; Alpha-thalassemia/mental retardation syndrome 	XL	.	Craniofacial; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Renal	General	22089611|20301622|19764021|17579672|16955409|16813605|16688741|16222662|16100724|15508018|11449489|11050622|10751095|10398237|10398234|8644709|7726225|6711605|6682021|6267462|3239563|1684092	.	546	ATRX	IC7	IVS7	.	.	intron	NM_000489.3	NP_000480.2	-	Y	c.595-36T>C	.	.	.	NM_000489.3(ATRX): c.595-36T>C	;maf-5-some-pop,maf-5-all-pops	89890	0.399944	U	0.4817	0.550993	10548	0.507300	PASS	463	6529	0.456425	5229	86115	0.393323	861	5739	4.55332e-01	9268	64408	3.71712e-01	rs35268552	.	4024	0.455300	-0.588	0.125	0.476	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
X	100615022	100615023	Xq22.1	0	nullSample	.	T	ref	T	ta.aG	homo-ref	.	.	.	0	(TA)n|Simple_repeat|Simple_repeat|+|157;trf	.	300300	C	300755(MK);307200(MK)	XL;XR	Agammaglobulinemia, X-linked; Agammaglobulinemia and isolated hormone deficiency; Hypogammaglobulinemia, X-linked	XL	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	20301626|19651503|19302039|18241230|16377251|16297664|16159644|13380950|12958074|12378199|12217331|11445810|9545398|8982147|8380905|8013627|7722175|6783908|4578158|3488506	.	695	BTK	IC8	IVS9	.	.	no-change	NM_000061.2	NP_000052.1	-	Y	c.839+53A=	.	.	.	NM_000061.2(BTK): c.839+53A=	;maf-5-some-pop,maf-5-all-pops	3375	0.670519	U	0.3181	0.29457	3600	0.848333	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2746110	.	3984	0.690000	-2.931	-2.809	-2.479	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
X	100615022	100615023	Xq22.1	0	normal	.	T	snv	G	ta.aG	hom-alt	100	0.98	.	0	(TA)n|Simple_repeat|Simple_repeat|+|157;trf	PASS	300300	C	300755(MK);307200(MK)	XL;XR	Agammaglobulinemia, X-linked; Agammaglobulinemia and isolated hormone deficiency; Hypogammaglobulinemia, X-linked	XL	.	Allergy/Immunology/Infectious	Allergy/Immunology/Infectious	20301626|19651503|19302039|18241230|16377251|16297664|16159644|13380950|12958074|12378199|12217331|11445810|9545398|8982147|8380905|8013627|7722175|6783908|4578158|3488506	.	695	BTK	IC8	IVS9	.	.	intron	NM_000061.2	NP_000052.1	-	Y	c.839+53A>C	.	.	.	NM_000061.2(BTK): c.839+53A>C	;maf-5-some-pop,maf-5-all-pops	3375	0.329481	U	0.3181	0.29457	3600	0.151667	.	.	.	.	.	.	.	.	.	.	.	.	.	rs2746110	.	3984	0.310000	-2.931	-2.809	-2.479	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
X	123204978	123204979	Xq25	0	normal	.	T	ref	T	TC.TT	het-alt	93	0.78	.	1	.	PASS	300826	P	.	NN	.	.	.	.	.	.	.	10735	STAG2	IC22	IVS24	.	.	no-change	NM_001042749.1	NP_001036214.1	+	Y	c.2359-20T=	.	.	.	NM_001042749.1(STAG2): c.2359-20T=	MixedObserved;	15844	0.994256	U	.	.	10200	0.699020	.	.	.	.	.	.	.	.	.	.	.	.	.	rs759815507	.	4024	0.674000	0.225	-0.406	-0.223	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
X	123204978	123204979	Xq25	0	normal	.	T	del	.	TC.TT	het-ref	27	0.23	.	2	.	PASS	300826	P	.	NN	.	.	.	.	.	.	.	10735	STAG2	IC22	IVS24	.	.	intron	NM_001042749.1	NP_001036214.1	+	Y	c.2359-20delT	.	.	.	NM_001042749.1(STAG2): c.2359-20delT	MixedObserved;	15844	0.005743	U	.	.	10200	0.194314	InbreedingCoeff_Filter	0	5045	0.295144	0	61067	0.257963	.	.	.	.	.	.	rs759815507	.	4024	0.326000	0.225	-0.406	-0.223	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
X	133511987	133511988	Xq26.2	0	nullSample	.	G	ref	G	GT.AT	homo-ref	.	.	.	0	.	.	300414	C	301900(MK)	XL;XR	Borjeson-Forssman-Lehmann syndrome	XL	.	Craniofacial; Endocrine; Neurologic	General	22190899|19264739|16912705|15994862|15241480|14756673|13871358|12415272|4465467	.	84295	PHF6	IC1	IVS2	.	.	no-change	NM_001015877.1	NP_001015877.1	+	Y	c.139-47G=	.	.	.	NM_001015877.1(PHF6): c.139-47G=	;maf-5-some-pop	73066	0.219952	U	0.9594	0.811921	10040	0.254681	PASS	-171	4615	0.049621	7727	69291	0.221688	.	.	.	.	.	.	rs5978001	.	4024	0.042200	-0.400	1.445	0.321	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
X	133511987	133511988	Xq26.2	0	normal	.	G	snv	A	GT.AT	hom-alt	89	1.00	.	0	.	PASS	300414	C	301900(MK)	XL;XR	Borjeson-Forssman-Lehmann syndrome	XL	.	Craniofacial; Endocrine; Neurologic	General	22190899|19264739|16912705|15994862|15241480|14756673|13871358|12415272|4465467	.	84295	PHF6	IC1	IVS2	.	.	intron	NM_001015877.1	NP_001015877.1	+	Y	c.139-47G>A	.	.	.	NM_001015877.1(PHF6): c.139-47G>A	;maf-5-some-pop	73066	0.780048	U	0.9594	0.811921	10040	0.745319	PASS	1657	4615	0.950379	14106	69291	0.778312	3158	9303	9.49770e-01	29311	110745	7.76085e-01	rs5978001	.	4024	0.957800	-0.400	1.445	0.321	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
X	133548995	133548999	Xq26.2	0	nullSample	.	TCTC	ref	TCTC	TT.TC	homo-ref	.	.	.	0	.	.	300414	C	301900(MK)	XL;XR	Borjeson-Forssman-Lehmann syndrome	XL	.	Craniofacial; Endocrine; Neurologic	General	22190899|19264739|16912705|15994862|15241480|14756673|13871358|12415272|4465467	.	84295	PHF6	IC6	IVS7	.	.	no-change	NM_001015877.1	NP_001015877.1	+	Y	c.730-50_730-47=	.	.	.	NM_001015877.1(PHF6): c.730-50_730-47=	;maf-5-some-pop	64702	0.974251	U	.	.	10140	0.999211	.	.	.	.	.	.	.	.	.	.	.	.	.	rs201922281	.	4024	0.806400	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
X	133548995	133548999	Xq26.2	0	normal	.	TCTC	del	.	TT.TC	hom-alt	141	1.00	.	0	.	PASS	300414	C	301900(MK)	XL;XR	Borjeson-Forssman-Lehmann syndrome	XL	.	Craniofacial; Endocrine; Neurologic	General	22190899|19264739|16912705|15994862|15241480|14756673|13871358|12415272|4465467	.	84295	PHF6	IC6	IVS7	.	.	intron	NM_001015877.1	NP_001015877.1	+	Y	c.730-50_730-47delTCTC	.	.	.	NM_001015877.1(PHF6): c.730-50_730-47delTCTC	;maf-5-some-pop	64702	0.025749	U	0.1911	0.0445033	10140	0.000789	PASS	82	4996	0.205364	91	60927	0.024587	168	2367	2.11132e-01	191	3759	2.62463e-02	rs201922281	.	4024	0.193600	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign
